PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Garreta, A; Val-Moraes, SP; Garcia-Fernandez, Q; Busquets, M; Juan, C; Oliver, A; Ortiz, A; Gaffney, BJ; Fita, I; Manresa, A; Carpena, X				Garreta, Albert; Val-Moraes, Silvana P.; Garcia-Fernandez, Queralt; Busquets, Montserrat; Juan, Carlos; Oliver, Antonio; Ortiz, Antonio; Gaffney, Betty J.; Fita, Ignacio; Manresa, Angels; Carpena, Xavi			Structure and interaction with phospholipids of a prokaryotic lipoxygenase from Pseudomonas aeruginosa	FASEB JOURNAL			English	Article						lipid peroxidation; protein-phospholipid complexes; enzyme mechanisms; membrane interaction; host-pathogen interactions	CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MEMBRANES; FLUORESCENCE; OXYGENATION; TRYPTOPHAN; MECHANISM; SUGGESTS; BINDING; DOMAIN	Lipoxygenases (LOXs), which are essential in eukaryotes, have no confirmed function in prokaryotes that are devoid of polyunsaturated fatty acids. The structure of a secretable LOX from Pseudomonas aeruginosa (Pa_LOX), the first available from a prokaryote, presents significant differences with respect to eukaryotic LOXs, including a cluster of helices acting as a lid to the active center. The mobility of the lid and the structural variability of the N-terminal region of Pa_LOX was confirmed by comparing 2 crystal forms. The binding pocket contains a phosphatidylethanolamine phospholipid with branches of 18 (sn-1) and 14/16 (sn-2) carbon atoms in length. Carbon atoms from the sn-1 chain approach the catalytic iron in a manner that sheds light on how the enzymatic reaction might proceed. The findings in these studies suggest that Pa_LOX has the capacity to extract and modify unsaturated phospholipids from eukaryotic membranes, allowing this LOX to play a role in the interaction of P. aeruginosa with host cells.	[Garreta, Albert; Val-Moraes, Silvana P.; Manresa, Angels] Univ Barcelona, Fac Farm, Microbiol Lab, E-08028 Barcelona, Spain; [Busquets, Montserrat] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Garreta, Albert; Garcia-Fernandez, Queralt; Fita, Ignacio; Carpena, Xavi] CSIC, Inst Biol Mol IBMB, Barcelona, Spain; [Juan, Carlos; Oliver, Antonio] Hosp Univ Son Espases, Microbiol Serv, Palma De Mallorca, Spain; [Ortiz, Antonio] Univ Murcia, Fac Vet, Dept Biochem & Mol Biol A, Murcia, Spain; [Gaffney, Betty J.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	University of Barcelona; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Hospital Universitari Son Espases; University of Murcia; State University System of Florida; Florida State University	Carpena, X (corresponding author), Inst Mol Biol, Parc Cient Barcelona,Baldiri Reixac 10, Barcelona 08028, Spain.	xcvcri@ibmb.csic.es	Oliver, Antonio/E-4048-2012; Juan, Carlos/AAB-2183-2020; Fita, Ignasi/R-4515-2019; Gaffney, Betty J/C-9666-2015; Carpena, Xavi/J-5877-2017; Oliver, Antonio/V-5541-2019; Ortiz, Antonio/K-5592-2017	Oliver, Antonio/0000-0001-9327-1894; Juan, Carlos/0000-0002-1402-3516; Fita, Ignasi/0000-0002-7521-2679; Carpena, Xavi/0000-0002-8646-0440; Oliver, Antonio/0000-0001-9327-1894; Manresa, Angeles/0000-0003-2337-9060	Ministerio de Ciencia e Innovacion (MICINN) [CTQ2010-21283-C02/01/PPQ, HBP2006-0027]; Generilitat de Catalunya [2009SGR819]; MICINN [BFU2012-36827]; Generalitat de Catalunya [SGR2009-00327]; U.S. National Institutes of Health [R01GM065268]; Ministerio de Economia y Competitividad-Instituto de Salud Carlos III of Spain [SAF2012-38539, CP12/03324, RD12/0015]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065268] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generilitat de Catalunya; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Economia y Competitividad-Instituto de Salud Carlos III of Spain(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Special thanks go to S. Rodriguez-Puente, J. Linacero, J. Pous, and A. Guasch [Plataforma Automatitzada de Cristal.lografia (PAC), Parc Cientific de Barcelona, Barcelona, Spain] for valuable help with crystal preparation. The authors thank T. Bates for carefully revising the manuscript. This work was supported by grants CTQ2010-21283-C02/01/PPQ, HBP2006-0027 from the Ministerio de Ciencia e Innovacion (MICINN) and 2009SGR819 from the Generilitat de Catalunya to A. M.; grants BFU2012-36827 from MICINN and SGR2009-00327 from the Generalitat de Catalunya to I. F.; grant R01GM065268 from the U.S. National Institutes of Health to B. J. G.; and grants SAF2012-38539, CP12/03324, and RD12/0015 from the Ministerio de Economia y Competitividad-Instituto de Salud Carlos III of Spain to C. J. and A.Ol.	Bateman A, 1999, CURR BIOL, V9, pR588, DOI 10.1016/S0960-9822(99)80380-7; Bianconi ML, 2007, BIOPHYS CHEM, V126, P59, DOI 10.1016/j.bpc.2006.05.017; BOETTCHER C, 1961, ANAL CHIM ACTA, V24, P203, DOI 10.1016/0003-2670(61)80041-X; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Bricogne G, 2011, BUSTER 2 10 0; Bushnell EAC, 2013, J BIOL INORG CHEM, V18, P343, DOI 10.1007/s00775-013-0978-4; Callis PR, 2004, J PHYS CHEM B, V108, P4248, DOI 10.1021/jp0310551; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feussner I, 1997, FEBS LETT, V406, P1, DOI 10.1016/S0014-5793(97)00218-4; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gaffney BJ, 1996, ANNU REV BIOPH BIOM, V25, P431, DOI 10.1146/annurev.bb.25.060196.002243; GAFFNEY BJ, 1993, BIOPHYS J, V64, P773, DOI 10.1016/S0006-3495(93)81438-3; Gilbert NC, 2012, FASEB J, V26, P3222, DOI 10.1096/fj.12-205286; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Harrison EM, 2010, INFECT IMMUN, V78, P1437, DOI 10.1128/IAI.00621-09; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Kulkarni AP, 2001, CELL MOL LIFE SCI, V58, P1805, DOI 10.1007/PL00000820; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Montes LR, 2007, BBA-BIOMEMBRANES, V1768, P2365, DOI 10.1016/j.bbamem.2007.04.024; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oursel D, 2007, RAPID COMMUN MASS SP, V21, P3229, DOI 10.1002/rcm.3177; Oursel D, 2007, RAPID COMMUN MASS SP, V21, P1721, DOI 10.1002/rcm.3013; Pande AH, 2005, BIOPHYS J, V88, P4084, DOI 10.1529/biophysj.104.056788; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; RAPOPORT SM, 1986, BIOCHIM BIOPHYS ACTA, V864, P471, DOI 10.1016/0304-4157(86)90006-7; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Shaver CM, 2006, MICROBIOL-SGM, V152, P143, DOI 10.1099/mic.0.28368-0; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Su C, 1998, J BIOL CHEM, V273, P13072, DOI 10.1074/jbc.273.21.13072; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vance RE, 2004, P NATL ACAD SCI USA, V101, P2135, DOI 10.1073/pnas.0307308101; Vidal-Mas J, 2005, ANTON LEEUW INT J G, V87, P245, DOI 10.1007/s10482-004-4021-1; Xu S, 2012, STRUCTURE, V20, P1490, DOI 10.1016/j.str.2012.06.003; Youn B, 2006, PROTEINS, V65, P1008, DOI 10.1002/prot.21182	45	56	58	0	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4811	4821		10.1096/fj.13-235952	http://dx.doi.org/10.1096/fj.13-235952			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23985801	Green Published			2022-12-25	WOS:000329999000016
J	Matsumura, Y; Sakai, J; Skach, WR				Matsumura, Yoshihiro; Sakai, Juro; Skach, William R.			Endoplasmic Reticulum Protein Quality Control Is Determined by Cooperative Interactions between Hsp/c70 Protein and the CHIP E3 Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; HEAT-SHOCK PROTEINS; ER-ASSOCIATED DEGRADATION; UBIQUITIN-LIGASE; CYSTIC-FIBROSIS; MOLECULAR CHAPERONES; SODIUM 4-PHENYLBUTYRATE; PROTEASOMAL DEGRADATION; PARTIAL RESTORATION; TRIAGE DECISIONS	The C terminus of Hsp70 interacting protein (CHIP) E3 ligase functions as a key regulator of protein quality control by binding the C-terminal (M/I)EEVD peptide motif of Hsp/c70(90) with its N-terminal tetratricopeptide repeat (TPR) domain and facilitating polyubiquitination of misfolded client proteins via its C-terminal catalytic U-box. Using CFTR as a model client, we recently showed that the duration of the Hsc70-client binding cycle is a primary determinant of stability. However, molecular features that control CHIP recruitment to Hsp/c70, and hence the fate of the Hsp/c70 client, remain unknown. To understand how CHIP recognizes Hsp/c70, we utilized a dominant negative mutant in which loss of a conserved proline in the U-box domain (P269A) eliminates E3 ligaseactivity. In a cell-free reconstituted ER- associated degradation system, P269A CHIP inhibited Hsc70-dependent CFTR ubiquitination and degradation in a dose-dependent manner. Optimal inhibition required both the TPR and the U-box, indicating cooperativity between the two domains. Neither the wild type nor the P269A mutant changed the extent of Hsc70 association with CFTR nor the dissociation rate of the Hsc70-CFTR complex. However, the U-box mutation stimulated CHIP binding to Hsc70 while promoting CHIP oligomerization. CHIP binding to Hsc70 binding was also stimulated by the presence of an Hsc70 client with a preference for the ADP-bound state. Thus, the Hsp/c70 (M/I) EEVD motif is not a simple anchor for the TPR domain. Rather CHIP recruitment involves reciprocal allosteric interactions between its TPR and U-box domains and the substrate-binding and C-terminal domains of Hsp/c70.	[Matsumura, Yoshihiro; Skach, William R.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97231 USA; [Matsumura, Yoshihiro; Sakai, Juro] Univ Tokyo, Div Metab Med, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	Oregon Health & Science University; University of Tokyo	Skach, WR (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, MC L-224,3181 SW Sam Jackson Pk Rd, Portland, OR 97231 USA.	skachw@ohsu.edu		Sakai, Juro/0000-0003-4043-1035; Matsumura, Yoshihiro/0000-0002-3108-0440	National Institutes of Health [DK51818, GM53457]; American Cystic Fibrosis Foundation; Manpei Suzuki Diabetes Foundation; Translational Systems Biology and Medicine Initiative (TSBMI),Ministry of Education, Science, Sports and Culture (MEXT), Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053457] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24116507, 24650442] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cystic Fibrosis Foundation; Manpei Suzuki Diabetes Foundation; Translational Systems Biology and Medicine Initiative (TSBMI),Ministry of Education, Science, Sports and Culture (MEXT), Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants DK51818 and GM53457 (to W. R. S.). This work was also supported by grants from the American Cystic Fibrosis Foundation (to W. R. S.), the Manpei Suzuki Diabetes Foundation (to Y. M.), grants-in-aid for young scientists (to Y.M.), for scientific research (to J. S.), and for scientific research on innovative areas (to J.S.), and a grant from the Translational Systems Biology and Medicine Initiative (TSBMI) from the Ministry of Education, Science, Sports and Culture (MEXT), Japan.	Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Borges JC, 2005, J BIOL CHEM, V280, P13671, DOI 10.1074/jbc.M408349200; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; BROWN CR, 1993, J CELL BIOL, V120, P1101, DOI 10.1083/jcb.120.5.1101; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; Carlson Eric, 2005, V301, P185; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Carraway KL, 2010, SEMIN CELL DEV BIOL, V21, P936, DOI 10.1016/j.semcdb.2010.09.006; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Frydman J, 1997, TRENDS BIOCHEM SCI, V22, P87, DOI 10.1016/S0968-0004(97)01005-0; Graf C, 2010, BIOCHEMISTRY-US, V49, P2121, DOI 10.1021/bi901829f; Hatakeyama S, 2004, GENES CELLS, V9, P533, DOI 10.1111/j.1356-9597.2004.00742.x; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Jiang CW, 1998, AM J PHYSIOL-CELL PH, V275, pC171, DOI 10.1152/ajpcell.1998.275.1.C171; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kampinga HH, 2003, MOL CELL BIOL, V23, P4948, DOI 10.1128/MCB.23.14.4948-4958.2003; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Matsumura Y., 2009, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0003430.pub2, DOI 10.1002/9780470015902.A0003430.PUB2]; Matsumura Y, 2006, J BIOL CHEM, V281, P34503, DOI 10.1074/jbc.M600071200; Matsumura Y, 2011, MOL BIOL CELL, V22, P2797, DOI 10.1091/mbc.E11-02-0137; Matsumura Y, 2011, METHODS MOL BIOL, V741, P233, DOI 10.1007/978-1-61779-117-8_16; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Muller P, 2013, ONCOGENE, V32, P3101, DOI 10.1038/onc.2012.314; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Oberdorf J, 2006, J CELL SCI, V119, P303, DOI 10.1242/jcs.02732; Oberdorf Jon, 2002, Methods Mol Med, V70, P295; Park HJ, 2009, CHEM BIOL, V16, P461, DOI 10.1016/j.chembiol.2009.02.014; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Ramsey AJ, 2009, BIOCHEM J, V423, P411, DOI 10.1042/BJ20090543; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shibatani T, 2006, MOL BIOL CELL, V17, P4962, DOI 10.1091/mbc.E06-04-0311; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Stankiewicz M, 2010, FEBS J, V277, P3353, DOI 10.1111/j.1742-4658.2010.07737.x; Strickland E, 1997, J BIOL CHEM, V272, P25421, DOI 10.1074/jbc.272.41.25421; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Xiong XM, 1999, J BIOL CHEM, V274, P2616, DOI 10.1074/jbc.274.5.2616; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	66	43	45	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31069	31079		10.1074/jbc.M113.479345	http://dx.doi.org/10.1074/jbc.M113.479345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	23990462	Green Published, hybrid			2022-12-25	WOS:000330778900026
J	Kodama, T; Hikita, H; Kawaguchi, T; Saito, Y; Tanaka, S; Shigekawa, M; Shimizu, S; Li, W; Miyagi, T; Kanto, T; Hiramatsu, N; Tatsumi, T; Takehara, T				Kodama, Takahiro; Hikita, Hayato; Kawaguchi, Tsukasa; Saito, Yoshinobu; Tanaka, Satoshi; Shigekawa, Minoru; Shimizu, Satoshi; Li, Wei; Miyagi, Takuya; Kanto, Tatsuya; Hiramatsu, Naoki; Tatsumi, Tomohide; Takehara, Tetsuo			The Bcl-2 Homology Domain 3 (BH3)-only Proteins Bim and Bid Are Functionally Active and Restrained by Anti-apoptotic Bcl-2 Family Proteins in Healthy Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bcl-2 Family Proteins; Cell Biology; Hepatocyte; Liver Injury; Mitochondrial Apoptosis; Bcl-xl; Mcl-1	HEPATOCYTE APOPTOSIS; BH3-ONLY PROTEINS; CELL-DEATH; EXPRESSION; MICE; LIPOAPOPTOSIS; DISRUPTION; INCREASES; RESPONSES; INJURY	Background: A fine balance between the anti- and pro-apoptotic multidomain Bcl-2 family proteins controls hepatocyte apoptosis in the healthy liver. Results: Disruption of the BH3-only proteins Bim and Bid prevents spontaneous hepatocyte apoptosis in the absence of anti-apoptotic Bcl-2 family proteins. Conclusion: Hepatocyte integrity is maintained by the well orchestrated Bcl-2 network. Significance: We demonstrated the novel involvement of BH3-only proteins in the healthy Bcl-2 network of the liver. An intrinsic pathway of apoptosis is regulated by the B-cell lymphoma-2 (Bcl-2) family proteins. We previously reported that a fine rheostatic balance between the anti- and pro-apoptotic multidomain Bcl-2 family proteins controls hepatocyte apoptosis in the healthy liver. The Bcl-2 homology domain 3 (BH3)-only proteins set this rheostatic balance toward apoptosis upon activation in the diseased liver. However, their involvement in healthy Bcl-2 rheostasis remains unknown. In the present study, we focused on two BH3-only proteins, Bim and Bid, and we clarified the Bcl-2 network that governs hepatocyte life and death in the healthy liver. We generated hepatocyte-specific Bcl-xL- or Mcl-1-knock-out mice, with or without disrupting Bim and/or Bid, and we examined hepatocyte apoptosis under physiological conditions. We also examined the effect of both Bid and Bim disruption on the hepatocyte apoptosis caused by the inhibition of Bcl-xL and Mcl-1. Spontaneous hepatocyte apoptosis in Bcl-xL- or Mcl-1-knock-out mice was significantly ameliorated by Bim deletion. The disruption of both Bim and Bid completely prevented hepatocyte apoptosis in Bcl-xL-knock-out mice and weakened massive hepatocyte apoptosis via the additional in vivo knockdown of mcl-1 in these mice. Finally, the hepatocyte apoptosis caused by ABT-737, which is a Bcl-xL/Bcl-2/Bcl-w inhibitor, was completely prevented in Bim/Bid double knock-out mice. The BH3-only proteins Bim and Bid are functionally active but are restrained by the anti-apoptotic Bcl-2 family proteins under physiological conditions. Hepatocyte integrity is maintained by the dynamic and well orchestrated Bcl-2 network in the healthy liver.	[Kodama, Takahiro; Hikita, Hayato; Kawaguchi, Tsukasa; Saito, Yoshinobu; Tanaka, Satoshi; Shigekawa, Minoru; Shimizu, Satoshi; Li, Wei; Miyagi, Takuya; Kanto, Tatsuya; Hiramatsu, Naoki; Tatsumi, Tomohide; Takehara, Tetsuo] Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Suita, Osaka 5650871, Japan	Osaka University	Takehara, T (corresponding author), Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	takehara@gh.med.osaka-u.ac.jp	Kodama, Takahiro/AAW-9605-2021	Kodama, Takahiro/0000-0002-6250-1324; Saito, Yoshinobu/0000-0002-0624-0449; Tanaka, Satoshi/0000-0003-3950-783X	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. Takehara).	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Baskin-Bey ES, 2005, AM J PHYSIOL-GASTR L, V289, pG987, DOI 10.1152/ajpgi.00371.2005; Blom KG, 2009, CLIN EXP IMMUNOL, V155, P320, DOI 10.1111/j.1365-2249.2008.03815.x; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Garcia-Monzon C, 2011, J HEPATOL, V54, P142, DOI 10.1016/j.jhep.2010.06.021; Giam M, 2008, ONCOGENE, V27, pS128, DOI 10.1038/onc.2009.50; Higuchi H, 2001, J PHARMACOL EXP THER, V299, P866; Hikita H, 2009, HEPATOLOGY, V50, P1972, DOI 10.1002/hep.23207; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; Ibrahim SH, 2011, J PEDIATR GASTR NUTR, V53, P131, DOI 10.1097/MPG.0b013e31822578db; Ishihara Y, 2011, FEBS J, V278, P1873, DOI 10.1111/j.1742-4658.2011.08105.x; Ishihara Y, 2011, J CELL PHYSIOL, V226, P1007, DOI 10.1002/jcp.22414; Iwata M, 2000, HUM PATHOL, V31, P179, DOI 10.1016/S0046-8177(00)80217-8; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Kodama T, 2011, J CLIN INVEST, V121, P3343, DOI 10.1172/JCI44957; Kodama T, 2010, GASTROENTEROLOGY, V138, P2487, DOI 10.1053/j.gastro.2010.02.054; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Maruyama C, 2002, EXP ANIM TOKYO, V51, P391, DOI 10.1538/expanim.51.391; Masuoka HC, 2009, J BIOL CHEM, V284, P30039, DOI 10.1074/jbc.M109.039545; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Wagner KU, 2000, DEVELOPMENT, V127, P4949; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	33	11	11	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30009	30018		10.1074/jbc.M112.443093	http://dx.doi.org/10.1074/jbc.M112.443093			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986435	Green Published, hybrid			2022-12-25	WOS:000329868100002
J	Hueter, RE; Tyminski, JP; de la Parra, R				Hueter, Robert E.; Tyminski, John P.; de la Parra, Rafael			Horizontal Movements, Migration Patterns, and Population Structure of Whale Sharks in the Gulf of Mexico and Northwestern Caribbean Sea	PLOS ONE			English	Article							RHINCODON-TYPUS SMITH; SEXUAL SEGREGATION; SATELLITE TRACKING; NINGALOO REEF; ENVIRONMENTAL VARIABLES; DIVING BEHAVIOR; INDIAN-OCEAN; WESTERN; SIZE; CONSERVATION	Whale sharks, Rhincodon typus, aggregate by the hundreds in a summer feeding area off the northeastern Yucatan Peninsula, Mexico, where the Gulf of Mexico meets the Caribbean Sea. The aggregation remains in the nutrient-rich waters off Isla Holbox, Isla Contoy and Isla Mujeres, Quintana Roo for several months in the summer and then dissipates between August and October. Little has been known about where these sharks come from or migrate to after they disperse. From 2003-2012, we used conventional visual tags, photo-identification, and satellite tags to characterize the basic population structure and large-scale horizontal movements of whale sharks that come to this feeding area off Mexico. The aggregation comprised sharks ranging 2.5-10.0 m in total length and included juveniles, subadults, and adults of both sexes, with a male-biased sex ratio (72%). Individual sharks remained in the area for an estimated mean duration of 24-33 days with maximum residency up to about 6 months as determined by photo-identification. After leaving the feeding area the sharks showed horizontal movements in multiple directions throughout the Gulf of Mexico basin, the northwestern Caribbean Sea, and the Straits of Florida. Returns of individual sharks to the Quintana Roo feeding area in subsequent years were common, with some animals returning for six consecutive years. One female shark with an estimated total length of 7.5 m moved at least 7,213 km in 150 days, traveling through the northern Caribbean Sea and across the equator to the South Atlantic Ocean where her satellite tag popped up near the Mid-Atlantic Ridge. We hypothesize this journey to the open waters of the Mid-Atlantic was for reproductive purposes but alternative explanations are considered. The broad movements of whale sharks across multiple political boundaries corroborates genetics data supporting gene flow between geographically distinct areas and underscores the need for management and conservation strategies for this species on a global scale.	[Hueter, Robert E.; Tyminski, John P.] Mote Marine Lab, Ctr Shark Res, Sarasota, FL 34236 USA; [de la Parra, Rafael] Proyecto Domino Chooj Ajauil Asociac Civil, Cancun, Mexico	Mote Marine Laboratory & Aquarium	Hueter, RE (corresponding author), Mote Marine Lab, Ctr Shark Res, Sarasota, FL 34236 USA.	rhueter@mote.org			Georgia Aquarium; Christopher Reynolds Foundation; National Geographic Society; Mote Marine Laboratory	Georgia Aquarium; Christopher Reynolds Foundation; National Geographic Society(National Geographic Society); Mote Marine Laboratory	This research was supported by funding from Georgia Aquarium (www.georgiaaquarium.org), Christopher Reynolds Foundation (www.creynolds.org), National Geographic Society (www.ngs.org), Mote Marine Laboratory (www.mote.org) and an anonymous private foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aca EQ, 2011, ASIA LIFE SCI, V20, P361; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; BAUGHMAN J.L, 1950, TEXAS JOUR SCI, V2-2, P117; BAUGHMAN JL, 1950, AM MIDL NAT, V44, P96, DOI 10.2307/2421758; Beckley LE, 1997, ENVIRON BIOL FISH, V50, P343, DOI 10.1023/A:1007355709632; Biggs Douglas C., 2001, Gulf of Mexico Science, V19, P7; Borrell A, 2011, ENVIRON BIOL FISH, V92, P559, DOI 10.1007/s10641-011-9879-y; Brunnschweiler JM, 2009, J FISH BIOL, V74, P706, DOI 10.1111/j.1095-8649.2008.02155.x; Burks CM, 2006, FISH B-NOAA, V104, P579; Campagna C, 2011, BIOSCIENCE, V61, P393, DOI 10.1525/bio.2011.61.5.8; Cardenas-Palomo N, 2007, THESIS UNIDAD MERIDA, P1; Castro ALF, 2007, MOL ECOL, V16, P5183, DOI 10.1111/j.1365-294X.2007.03597.x; Chiang WC, 2011, J EXP MAR BIOL ECOL, V397, P129, DOI 10.1016/j.jembe.2010.11.018; Cochrane J.D., 1966, 6623T TAMU, P14; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; Compagno L. J. V., 2001, FAO SPECIES CATALOGU, V2; Dagg MJ, 2003, J MARINE SYST, V43, P133, DOI 10.1016/j.jmarsys.2003.09.002; Venegas RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018994; Eckert SA, 2002, J ZOOL, V257, P111, DOI 10.1017/S0952836902000705; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; EDWARDS AJ, 1982, COPEIA, P223; Gadig O.B.F., 1994, THESIS U FEDERAL PAR; Galuardi B, 2010, ANALYZEPSAT; Galuardi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037829; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Gifford A, 2007, FISH RES, V84, P17, DOI 10.1016/j.fishres.2006.11.011; Gonzalez-Quiros R, 2003, ICES J MAR SCI, V60, P198, DOI 10.1016/S1054-3139(03)00009-2; Graham RT, 2007, FISH RES, V84, P71, DOI 10.1016/j.fishres.2006.11.026; Graham RT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036834; Graham Rachel T., 2007, Gulf and Caribbean Research, V19, P149; Graham RT, 2006, J ROY SOC INTERFACE, V3, P109, DOI 10.1098/rsif.2005.0082; Gudger EW, 1939, SCI MON, V48, P261; Gudger E. W., 1936, Science New York, V84, P227, DOI 10.1126/science.84.2175.227; GUDGER E. W., 1931, BUTT AMER MUS NAT HIST, V61, P613; Gudger EW, 1936, SCI MON, V42, P84; Gudger EW, 1931, SCI MON, V32, P33; Gudger EW, 1939, NATURE, V143, P79, DOI 10.1038/143079b0; Gudger EW, 1941, J E MITCHELL SCI SOC, V57, P57; Gunter F, 1951, TEX J SCI, V1, P134; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hazin FHV, 2008, BRAZ J BIOL, V68, P385, DOI 10.1590/S1519-69842008000200021; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; HOFFMAN W, 1981, Northeast Gulf Science, V5, P55; Hoffmayer Eric R., 2005, Gulf and Caribbean Research, V17, P117; Hoffmayer Eric R., 2007, Gulf and Caribbean Research, V19, P69; Holdsworth JC, 2009, MAR BIOL, V156, P505, DOI 10.1007/s00227-008-1104-y; Holmberg J, 2008, ECOL APPL, V18, P222, DOI 10.1890/07-0315.1; Holmberg Jason, 2009, Endangered Species Research, V7, P39, DOI 10.3354/esr00186; Hsu HH, 2007, FISH RES, V84, P25, DOI 10.1016/j.fishres.2006.11.030; Hueter R. E., 2005, Journal of Northwest Atlantic Fishery Science, V35, P239; Hunter E, 2003, MAR BIOL, V142, P601, DOI 10.1007/s00227-002-0984-5; Huthnance J. M., 1981, Progress in Oceanography, V10, P193, DOI 10.1016/0079-6611(81)90004-5; Joung SJ, 1996, ENVIRON BIOL FISH, V46, P219, DOI 10.1007/BF00004997; Ketchum JT, 2013, ENVIRON BIOL FISH, V96, P779, DOI 10.1007/s10641-012-0071-9; KLIMLEY AP, 1987, ENVIRON BIOL FISH, V18, P27, DOI 10.1007/BF00002325; Kukuyev EI, 1996, J ICHTHYOLOGY, V36, P203; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; LEFEVRE J, 1986, ADV MAR BIOL, V23, P163; Lessa R. P., 1999, ARCH FISH RES, V47, P133; Martin RA, 2007, FISH RES, V84, P10, DOI 10.1016/j.fishres.2006.11.010; McKinney JA, 2012, MAR ECOL PROG SER, V458, P199, DOI 10.3354/meps09777; Meekan MG, 2006, MAR ECOL PROG SER, V319, P275, DOI 10.3354/meps319275; Merino M, 1997, J MARINE SYST, V13, P101, DOI 10.1016/S0924-7963(96)00123-6; MOROSHKIN KV, 1970, OCEANOLOGY-USSR, V10, P27; Motta PJ, 2010, ZOOLOGY, V113, P199, DOI 10.1016/j.zool.2009.12.001; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; Norman B, 2005, IUCN 2010 IUCN RED L; Norman BM, 2007, FISH RES, V84, P81, DOI 10.1016/j.fishres.2006.11.015; PEREZ R, 1999, EOS AGU T, V80, P153, DOI DOI 10.1029/99EO00104; PRATT HL, 1979, FISH B-NOAA, V77, P445; Pravin P, 2000, CURR SCI INDIA, V79, P310; R Core Team, 2022, R LANG ENV STAT COMP; Ramirez-Macias D, 2012, J FISH BIOL, V80, P1401, DOI 10.1111/j.1095-8649.2012.03258.x; Ramirez-Macias D, 2007, FISH RES, V84, P87, DOI 10.1016/j.fishres.2006.11.038; Rangel CE, 1998, B SBEEL, P3; Ressler PH, 2003, CONT SHELF RES, V23, P41, DOI 10.1016/S0278-4343(02)00149-8; Robbins RL, 2007, J FISH BIOL, V70, P1350, DOI 10.1111/j.1095-8649.2007.01414.x; Romero A., 2000, Biodiversity, V1, P11; Rowat D, 2008, ENVIRON BIOL FISH, V82, P215, DOI 10.1007/s10641-007-9280-z; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2007, ENVIRON BIOL FISH, V80, P465, DOI 10.1007/s10641-006-9148-7; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; Rowat D, 2011, MAR FRESHWATER RES, V62, P621, DOI 10.1071/MF10135; Rowat D, 2009, ORYX, V43, P591, DOI 10.1017/S0030605309990408; Ryan JP, 1999, LIMNOL OCEANOGR, V44, P1, DOI 10.4319/lo.1999.44.1.0001; Schmidt JV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004988; Sequeira AMM, 2013, J FISH BIOL, V82, P367, DOI 10.1111/jfb.12017; Sequeira A, 2012, DIVERS DISTRIB, V18, P504, DOI 10.1111/j.1472-4642.2011.00853.x; Service Argos, 2013, ARG US MAN; Sims DW, 2008, ADV MAR BIOL, V54, P171, DOI 10.1016/S0065-2881(08)00003-5; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187; Skomal GB, 2009, CURR BIOL, V19, P1019, DOI 10.1016/j.cub.2009.04.019; Sleeman JC, 2010, J EXP MAR BIOL ECOL, V382, P77, DOI 10.1016/j.jembe.2009.10.015; Sleeman JC, 2010, J EXP MAR BIOL ECOL, V390, P84, DOI 10.1016/j.jembe.2010.05.009; Speed CW, 2008, J FISH BIOL, V72, P1488, DOI 10.1111/j.1095-8649.2008.01810.x; SPRINGER S, 1957, ECOLOGY, V38, P166, DOI 10.2307/1932154; Stevens JD, 2007, FISH RES, V84, P4, DOI 10.1016/j.fishres.2006.11.008; Stewart BS, 2005, ENVIRON BIOL FISH, V74, P184, DOI 10.1007/s10641-005-2229-1; Taylor JG, 1994, WHALE SHARKS; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Travassos P, 1999, ARCH FISH MAR RES, V47, P211; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; VANBENNEKOM AJ, 1984, NETH J SEA RES, V17, P149, DOI 10.1016/0077-7579(84)90047-4; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Weir Caroline R., 2010, Marine Biodiversity Records, V3, pe50; Wilson SG, 2007, FISH OCEANOGR, V16, P547, DOI 10.1111/j.1365-2419.2007.00450.x; Wilson SG, 2006, MAR BIOL, V148, P1157, DOI 10.1007/s00227-005-0153-8; Wilson SG, 2001, ENVIRON BIOL FISH, V61, P1, DOI 10.1023/A:1011069914753; Wintner SP, 2000, ENVIRON BIOL FISH, V59, P441, DOI 10.1023/A:1026564707027; WOLFSON FH, 1983, J FISH BIOL, V22, P647, DOI 10.1111/j.1095-8649.1983.tb04224.x; Zavala-Hidalgo J, 2006, OCEAN DYNAM, V56, P333, DOI 10.1007/s10236-006-0072-3	112	63	65	3	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71883	10.1371/journal.pone.0071883	http://dx.doi.org/10.1371/journal.pone.0071883			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991000	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100060
J	Toullec, JY; Corre, E; Bernay, B; Thorne, MAS; Cascella, K; Ollivaux, C; Henry, J; Clark, MS				Toullec, Jean-Yves; Corre, Erwan; Bernay, Benoit; Thorne, Michael A. S.; Cascella, Kevin; Ollivaux, Celine; Henry, Joel; Clark, Melody S.			Transcriptome and Peptidome Characterisation of the Main Neuropeptides and Peptidic Hormones of a Euphausiid: The Ice Krill, Euphausia crystallorophias	PLOS ONE			English	Article							PIGMENT-DISPERSING HORMONE; CRUSTACEAN HYPERGLYCEMIC HORMONE; TACHYKININ-RELATED PEPTIDES; CENTRAL-NERVOUS-SYSTEM; CUTICLE-HARDENING HORMONE; ALLATOSTATIN-LIKE PEPTIDE; IN-SILICO ANALYSES; RED FLOUR BEETLE; AMERICAN LOBSTER; SHORE CRAB	Background: The Ice krill, Euphausia crystallorophias is one of the species at the base of the Southern Ocean food chain. Given their significant contribution to the biomass of the Southern Ocean, it is vitally important to gain a better understanding of their physiology and, in particular, anticipate their responses to climate change effects in the warming seas around Antarctica. Methodology/Principal Findings: Illumina sequencing was used to produce a transcriptome of the ice krill. Analysis of the assembled contigs via two different methods, produced 36 new pre-pro-peptides, coding for 61 neuropeptides or peptide hormones belonging to the following families: Allatostatins (A, B et C), Bursicon (alpha and beta), Crustacean Hyperglycemic Hormones (CHH and MIH/VIHs), Crustacean Cardioactive Peptide (CCAP), Corazonin, Diuretic Hormones (DH), the Eclosion Hormone (EH), Neuroparsin, Neuropeptide F (NPF), small Neuropeptide F (sNPF), Pigment Dispersing Hormone (PDH), Red Pigment Concentrating Hormone (RPCH) and finally Tachykinin. LC/MS/MS proteomics was also carried out on eyestalk extracts, which are the major site of neuropeptide synthesis in decapod crustaceans. Results confirmed the presence of six neuropeptides and six precursor-related peptides previously identified in the transcriptome analyses. Conclusions: This study represents the first comprehensive analysis of neuropeptide hormones in a Eucarida non-decapod Malacostraca, several of which are described for the first time in a non-decapod crustacean. Additionally, there is a potential expansion of PDH and Neuropeptide F family members, which may reflect certain life history traits such as circadian rhythms associated with diurnal migrations and also the confirmation via mass spectrometry of several novel pre-propeptides, of unknown function. Knowledge of these essential hormones provides a vital framework for understanding the physiological response of this key Southern Ocean species to climate change and provides a valuable resource for studies into the molecular phylogeny of these organisms and the evolution of neuropeptide hormones.	[Toullec, Jean-Yves; Cascella, Kevin] Univ Paris 06, UMR CNRS 7144, Stn Biol Roscoff, Roscoff, France; [Corre, Erwan] Univ Paris 06, FR CNRS 2424, ABiMS, Stn Biol Roscoff, Roscoff, France; [Ollivaux, Celine] Univ Paris 06, UMR CNRS 7150, Stn Biol Roscoff, Roscoff, France; [Toullec, Jean-Yves; Cascella, Kevin] CNRS, UMR 7144, Stn Biol Roscoff, Roscoff, France; [Ollivaux, Celine] CNRS, UMR 7150, Stn Biol Roscoff, Roscoff, France; [Bernay, Benoit; Henry, Joel] Univ Caen Basse Normandie, FRE CNRS 3484, Caen, France; [Bernay, Benoit; Henry, Joel] Univ Caen Basse Normandie, Plateforme PROTEOGEN, Caen, France; [Clark, Melody S.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite de Caen Normandie; Universite de Caen Normandie; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Toullec, JY (corresponding author), Univ Paris 06, UMR CNRS 7144, Stn Biol Roscoff, Roscoff, France.	jean-yves.toullec@sb-roscoff.fr	Clark, Melody S/D-7371-2014; corre, erwan/O-4669-2019	Clark, Melody S/0000-0002-3442-3824; corre, erwan/0000-0001-6354-2278; Thorne, Michael/0000-0001-7759-612X	Emergence-UPMC research program; Region Bretagne; Institut Paul Emile Victor (KREVET program); la Region Bretagne (SAD-1 - DRAKAR program); Natural Environment Research Council; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Emergence-UPMC research program; Region Bretagne(Region Bretagne); Institut Paul Emile Victor (KREVET program); la Region Bretagne (SAD-1 - DRAKAR program)(Region Bretagne); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	KC received a PhD grant by the Emergence-UPMC 2011 research program and the "Region Bretagne". JYT benefits from funding provided by Institut Paul Emile Victor (KREVET program) and also by la Region Bretagne (SAD-1 - DRAKAR program). MSC and MAST were funded by Natural Environment Research Council core funding to the British Antarctic Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane Y, 2008, MECH DEVELOP, V125, P984, DOI 10.1016/j.mod.2008.09.002; Audsley N, 2006, PEPTIDES, V27, P512, DOI 10.1016/j.peptides.2005.08.022; Badisco L, 2011, PLOS ONE, V6, pe17274; Belles X, 1999, PEPTIDES, V20, P11, DOI 10.1016/S0196-9781(98)00155-7; Bissinger BW, 2011, INSECT MOL BIOL, V20, P465, DOI 10.1111/j.1365-2583.2011.01086.x; Boerjan B, 2010, GEN COMP ENDOCR, V166, P222, DOI 10.1016/j.ygcen.2009.09.004; BOGERD J, 1995, J BIOL CHEM, V270, P23038, DOI 10.1074/jbc.270.39.23038; Buchholz F, 1996, MAR BIOL, V127, P201, DOI 10.1007/BF00942104; Chen HY, 2007, GEN COMP ENDOCR, V151, P72, DOI 10.1016/j.ygcen.2006.11.016; Christie AE, 2010, J EXP BIOL, V213, P118, DOI 10.1242/jeb.037077; Christie AE, 1997, J EXP BIOL, V200, P2279; Christie AE, 2008, PEPTIDES, V29, P1909, DOI 10.1016/j.peptides.2008.07.010; Christie AE, 2008, GEN COMP ENDOCR, V159, P67, DOI 10.1016/j.ygcen.2008.07.022; Christie AE, 2008, GEN COMP ENDOCR, V157, P174, DOI 10.1016/j.ygcen.2008.03.027; Christie AE, 2008, GEN COMP ENDOCR, V156, P246, DOI 10.1016/j.ygcen.2008.01.018; Christie AE, 2008, GEN COMP ENDOCR, V155, P526, DOI 10.1016/j.ygcen.2007.09.002; Christie AE, 2007, J EXP BIOL, V210, P699, DOI 10.1242/jeb.02696; Christie AE, 2011, J EXP BIOL, V214, P1386, DOI 10.1242/jeb.053173; Christie AE, 2011, GEN COMP ENDOCR, V171, P131, DOI 10.1016/j.ygcen.2011.01.002; Christie AE, 2011, GEN COMP ENDOCR, V170, P144, DOI 10.1016/j.ygcen.2010.09.018; Christie AE, 2010, GEN COMP ENDOCR, V167, P164, DOI 10.1016/j.ygcen.2010.01.005; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; Coast GM, 2010, PEPTIDES, V31, P468, DOI 10.1016/j.peptides.2009.09.017; Coast GM, 1996, PEPTIDES, V17, P327, DOI 10.1016/0196-9781(95)02096-9; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuzin-Roudy J, 2000, CAN J FISH AQUAT SCI, V57, P6, DOI 10.1139/cjfas-57-S3-6; Davis MM, 2007, DEVELOPMENT, V134, P4395, DOI 10.1242/dev.009902; Dickinson PS, 2008, GEN COMP ENDOCR, V156, P347, DOI 10.1016/j.ygcen.2008.01.011; Dickinson PS, 2009, J EXP BIOL, V212, P1140, DOI 10.1242/jeb.028621; Dircksen H, 2001, BIOCHEM J, V356, P159, DOI 10.1042/0264-6021:3560159; Dircksen H, 2011, J PROTEOME RES, V10, P4478, DOI 10.1021/pr200284e; FRAENKEL G, 1966, SCIENCE, V151, P91, DOI 10.1126/science.151.3706.91; Furuya K, 2000, P NATL ACAD SCI USA, V97, P6469, DOI 10.1073/pnas.97.12.6469; Gade G, 2009, ANN NY ACAD SCI, V1163, P125, DOI 10.1111/j.1749-6632.2008.03625.x; Gammie SC, 1999, J EXP BIOL, V202, P343; Gard AL, 2009, GEN COMP ENDOCR, V160, P271, DOI 10.1016/j.ygcen.2008.12.014; Glowik RM, 1997, J EXP BIOL, V200, P1421; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu PL, 2002, PEPTIDES, V23, P1875, DOI 10.1016/S0196-9781(02)00178-X; Harzsch S, 2009, CELL TISSUE RES, V335, P417, DOI 10.1007/s00441-008-0728-z; Helfrich-Forster C, 2009, SLEEP BIOL RHYTHMS, V7, P130, DOI 10.1111/j.1479-8425.2009.00408.x; HELFRICHFORSTER C, 1993, J COMP NEUROL, V337, P177, DOI 10.1002/cne.903370202; Honegger HW, 2008, J COMP PHYSIOL A, V194, P989, DOI 10.1007/s00359-008-0386-3; Hoste B, 2002, J INSECT PHYSIOL, V48, P981, DOI 10.1016/S0022-1910(02)00177-4; Hoste B, 2002, J INSECT PHYSIOL, V48, P791, DOI 10.1016/S0022-1910(02)00106-3; Hsu YWA, 2008, J COMP NEUROL, V508, P197, DOI 10.1002/cne.21659; Hsu YWA, 2010, J COMP NEUROL, V518, P4674, DOI 10.1002/cne.22474; Huybrechts J, 2010, INSECT MOL BIOL, V19, P87, DOI 10.1111/j.1365-2583.2009.00951.x; Janssen I, 1996, MOL CELL ENDOCRINOL, V117, P157, DOI 10.1016/0303-7207(95)03746-2; Jarman SN, 2000, CAN J FISH AQUAT SCI, V57, P51, DOI 10.1139/cjfas-57-S3-51; Jeffery NW, 2011, POLAR BIOL; Johansson ML, 2012, MOL BIOL REP, V39, P9009, DOI 10.1007/s11033-012-1772-z; KAY I, 1992, REGUL PEPTIDES, V42, P111, DOI 10.1016/0167-0115(92)90091-8; KEGEL G, 1989, FEBS LETT, V255, P10, DOI 10.1016/0014-5793(89)81051-8; Kirkwood, 1982, ANARE RES NOTES, V1; KRAMER SJ, 1991, P NATL ACAD SCI USA, V88, P9458, DOI 10.1073/pnas.88.21.9458; Krungkasem C, 2002, MAR BIOTECHNOL, V4, P132, DOI 10.1007/s10126-001-0079-1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LORENZ MW, 1995, REGUL PEPTIDES, V57, P227, DOI 10.1016/0167-0115(95)00036-B; Lorenz MW, 1999, EUR J ENTOMOL, V96, P267; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Ma MM, 2008, GEN COMP ENDOCR, V156, P395, DOI 10.1016/j.ygcen.2008.01.009; Ma MM, 2010, PEPTIDES, V31, P27, DOI 10.1016/j.peptides.2009.10.007; Ma MM, 2009, PEPTIDES, V30, P1660, DOI 10.1016/j.peptides.2009.05.023; Ma MM, 2009, GEN COMP ENDOCR, V161, P320, DOI 10.1016/j.ygcen.2009.01.015; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mendive FM, 2005, FEBS LETT, V579, P2171, DOI 10.1016/j.febslet.2005.03.006; MILLS RR, 1967, J INSECT PHYSIOL, V13, P815, DOI 10.1016/0022-1910(67)90129-1; Montagne N, 2008, FEBS J, V275, P1039, DOI 10.1111/j.1742-4658.2007.06245.x; Montagne N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-62; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; NASSEL DR, 1993, J COMP NEUROL, V331, P183, DOI 10.1002/cne.903310204; Ohira T, 2005, PEPTIDES, V26, P259, DOI 10.1016/j.peptides.2004.09.003; Paluzzi JPV, 2012, J INSECT PHYSIOL, V58, P534, DOI 10.1016/j.jinsphys.2011.11.020; Predel R, 2007, PEPTIDES, V28, P3, DOI 10.1016/j.peptides.2006.10.011; Rao KR, 2001, AM ZOOL, V41, P364, DOI 10.1668/0003-1569(2001)041[0364:CPEHCA]2.0.CO;2; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Schmieder R, 2012, BIOINFORMATICS, V28, P433, DOI 10.1093/bioinformatics/btr669; Sefiani M, 1996, GEN COMP ENDOCR, V103, P41, DOI 10.1006/gcen.1996.0092; Sharp J, 2008, COMP BIOCHEM PHYS A, V150, pS101, DOI 10.1016/j.cbpa.2008.04.207; Sharp JH, 2010, GEN COMP ENDOCR, V169, P65, DOI 10.1016/j.ygcen.2010.07.006; SHIGA S, 1993, ACTA BIOL HUNG, V44, P55; Sithigorngul P, 2002, PEPTIDES, V23, P1895, DOI 10.1016/S0196-9781(02)00176-6; Sithigorngul P, 2002, COMP BIOCHEM PHYS B, V131, P325, DOI 10.1016/S1096-4959(01)00499-7; Sousa GL, 2008, GEN COMP ENDOCR, V156, P454, DOI 10.1016/j.ygcen.2008.03.008; Stay B, 2007, ANNU REV ENTOMOL, V52, P277, DOI 10.1146/annurev.ento.51.110104.151050; Stemmler EA, 2007, PEPTIDES, V28, P2104, DOI 10.1016/j.peptides.2007.08.019; Stemmler EA, 2007, J NEUROCHEM, V101, P1351, DOI 10.1111/j.1471-4159.2007.04520.x; Stemmler EA, 2007, GEN COMP ENDOCR, V152, P1, DOI 10.1016/j.ygcen.2007.02.025; Stemmler EA, 2010, GEN COMP ENDOCR, V165, P1, DOI 10.1016/j.ygcen.2009.05.010; Strauss J, 2010, FRONTIERS BIOSCIENCE, V15, P1040; Strauss J, 2011, CELL MOL LIFE SCI, V68, P3403, DOI 10.1007/s00018-011-0636-3; Sullivan JM, 2009, CHRONOBIOL INT, V26, P1136, DOI 10.1080/07420520903217960; Szabo TM, 2011, J COMP NEUROL, V519, P2658, DOI 10.1002/cne.22654; Tawfik AI, 1999, P NATL ACAD SCI USA, V96, P7083, DOI 10.1073/pnas.96.12.7083; Te Brugge V, 2011, J EXP BIOL, V214, P371, DOI 10.1242/jeb.046292; Teschke M, 2007, LIMNOL OCEANOGR, V52, P1046, DOI 10.4319/lo.2007.52.3.1046; Teschke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026090; Veenstra JA, 2000, ARCH INSECT BIOCHEM, V43, P49, DOI 10.1002/(SICI)1520-6327(200002)43:2&lt;49::AID-ARCH1&gt;3.0.CO;2-M; VEENSTRA JA, 1989, FEBS LETT, V250, P231, DOI 10.1016/0014-5793(89)80727-6; Verde MA, 2007, COMP BIOCHEM PHYS A, V147, P983, DOI 10.1016/j.cbpa.2007.03.004; Verleyen P, 2004, BIOCHEM BIOPH RES CO, V320, P334, DOI 10.1016/j.bbrc.2004.05.173; Verleyen P, 2009, GEN COMP ENDOCR, V162, P27, DOI 10.1016/j.ygcen.2008.10.020; VINCENT JF, 1969, GEN COMP ENDOCR, V13, P538; Wang Zai-zhao, 2003, Acta Genetica Sinica, V30, P961; Weaver RJ, 2008, PEPTIDES, V29, P168, DOI 10.1016/j.peptides.2007.09.020; Webster SG, 2013, GEN COMP ENDOCR, V182, P54, DOI 10.1016/j.ygcen.2012.11.018; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Wilcockson DC, 2008, GEN COMP ENDOCR, V156, P113, DOI 10.1016/j.ygcen.2007.12.003; Wilcockson DC, 2011, J COMP NEUROL, V519, P562, DOI 10.1002/cne.22533; Yang WJ, 2001, BIOCHEM BIOPH RES CO, V289, P407, DOI 10.1006/bbrc.2001.6019; Yasuda A, 2004, GEN COMP ENDOCR, V135, P391, DOI 10.1016/j.ygcen.2003.10.001; Yasuda-Kamatani Y, 2006, J COMP NEUROL, V496, P135, DOI 10.1002/cne.20903; Yin GL, 2006, PEPTIDES, V27, P1241, DOI 10.1016/j.peptides.2005.11.015	118	52	53	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71609	10.1371/journal.pone.0071609	http://dx.doi.org/10.1371/journal.pone.0071609			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990964	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000324470100050
J	Zhang, RH; Li, X; Liang, ZJ; Zhu, KK; Lu, JY; Kong, XQ; Ouyang, SS; Li, L; Zheng, YG; Luo, C				Zhang, Ruihan; Li, Xin; Liang, Zhongjie; Zhu, Kongkai; Lu, Junyan; Kong, Xiangqian; Ouyang, Sisheng; Li, Lin; Zheng, Yujun George; Luo, Cheng			Theoretical Insights into Catalytic Mechanism of Protein Arginine Methyltransferase 1	PLOS ONE			English	Article							PRODUCT SPECIFICITY; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; METHYLATION; PRMT1; QM/MM; INHIBITORS; BINDING; ENZYME; SET7/9	Protein arginine methyltransferase 1 (PRMT1), the major arginine asymmetric dimethylation enzyme in mammals, is emerging as a potential drug target for cancer and cardiovascular disease. Understanding the catalytic mechanism of PRMT1 will facilitate inhibitor design. However, detailed mechanisms of the methyl transfer process and substrate deprotonation of PRMT1 remain unclear. In this study, we present a theoretical study on PRMT1 catalyzed arginine dimethylation by employing molecular dynamics (MD) simulation and quantum mechanics/molecular mechanics (QM/MM) calculation. Ternary complex models, composed of PRMT1, peptide substrate, and S-adenosyl-methionine (AdoMet) as cofactor, were constructed and verified by 30-ns MD simulation. The snapshots selected from the MD trajectory were applied for the QM/MM calculation. The typical S(N)2-favored transition states of the first and second methyl transfers were identified from the potential energy profile. Deprotonation of substrate arginine occurs immediately after methyl transfer, and the carboxylate group of E144 acts as proton acceptor. Furthermore, natural bond orbital analysis and electrostatic potential calculation showed that E144 facilitates the charge redistribution during the reaction and reduces the energy barrier. In this study, we propose the detailed mechanism of PRMT1-catalyzed asymmetric dimethylation, which increases insight on the small-molecule effectors design, and enables further investigations into the physiological function of this family.	[Zhang, Ruihan; Zhu, Kongkai; Lu, Junyan; Kong, Xiangqian; Ouyang, Sisheng; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Li, Xin; Li, Lin] Shanghai Changzheng Hosp, Div Nephrol, Shanghai, Peoples R China; [Liang, Zhongjie; Luo, Cheng] Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China; [Zheng, Yujun George] Georgia State Univ, Dept Chem, Program Mol Basis Dis, Atlanta, GA 30303 USA	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Naval Medical University; Soochow University - China; University System of Georgia; Georgia State University	Li, L (corresponding author), Shanghai Changzheng Hosp, Div Nephrol, Shanghai, Peoples R China.	lilin_616@163.com; cluo@mail.shcnc.ac.cn	Zheng, Yujun/P-8975-2014; zhang, ruihan/GZA-3812-2022; Kong, Xiangqian/J-4500-2017	Zheng, Yujun/0000-0001-7116-3067; Kong, Xiangqian/0000-0002-9596-7825; Lu, Junyan/0000-0002-9211-0746; Zhang, Ruihan/0000-0002-7350-1370	National High Technology Research and Development Program of China [2012AA020302]; State Key Program of Basic Research of China [2009CB918502]; National Natural Science Foundation of China [21021063, 91029704, 81230076, 21210003]; Chinese Academy of Sciences [XDA01040305]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" [2013ZX09507-004]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086717] Funding Source: NIH RePORTER	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge financial support from the National High Technology Research and Development Program of China (2012AA020302), State Key Program of Basic Research of China grant (2009CB918502), the National Natural Science Foundation of China grants (21021063, 91029704, 81230076 and 21210003), and the Chinese Academy of Sciences (XDA01040305), the National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" (2013ZX09507-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019856; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Butler JS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202416; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cha B, 2012, EXPERT OPIN THER TAR, V16, P651, DOI 10.1517/14728222.2012.688030; Cheng Y, 2011, J MOL BIOL, V414, P106, DOI 10.1016/j.jmb.2011.09.040; Chu Y, 2013, CAN J CHEM; Cornell WD, 1996, J AM CHEM SOC, V118, P2309, DOI 10.1021/ja955032e; DENG LQ, 1994, J AM CHEM SOC, V116, P10645, DOI 10.1021/ja00102a034; Feng Y, 2011, BIOCHEMISTRY-US, V50, P7033, DOI 10.1021/bi200456u; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Gui SY, 2013, BIOCHEMISTRY-US, V52, P199, DOI 10.1021/bi301283t; Gui SY, 2011, J BIOL CHEM, V286, P29118, DOI 10.1074/jbc.M111.224097; Guo H, 2012, J CHEM INF MODEL; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036660; Jobert L, 2009, EXP CELL RES, V315, P1273, DOI 10.1016/j.yexcr.2008.12.008; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kong XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025444; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Liang ZJ, 2010, J PHYS CHEM B, V114, P11927, DOI 10.1021/jp1054183; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Pople J.A, GAUSSIAN 03; Richon VM, 2011, CHEM BIOL DRUG DES, V78, P199, DOI 10.1111/j.1747-0285.2011.01135.x; Rust HL, 2011, BIOCHEMISTRY-US, V50, P3332, DOI 10.1021/bi102022e; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Spannhoff A, 2007, J MED CHEM, V50, P2319, DOI 10.1021/jm061250e; Sun LT, 2011, P NATL ACAD SCI USA, V108, P20538, DOI 10.1073/pnas.1106946108; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; Vreven T, 2003, J COMPUT CHEM, V24, P760, DOI 10.1002/jcc.10156; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JX, 2012, J MED CHEM, V55, P7978, DOI 10.1021/jm300521m; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; WIBERG KB, 1968, TETRAHEDRON, V24, P1083, DOI 10.1016/0040-4020(68)88057-3; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zhang X, 2008, P NATL ACAD SCI USA, V105, P5728, DOI 10.1073/pnas.0801788105; Zhang X, 2007, BIOCHEMISTRY-US, V46, P14838, DOI 10.1021/bi7014579; Zhang XD, 2007, BIOCHEMISTRY-US, V46, P9743, DOI 10.1021/bi700515q	50	19	19	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72424	10.1371/journal.pone.0072424	http://dx.doi.org/10.1371/journal.pone.0072424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977297	gold, Green Published, Green Submitted			2022-12-25	WOS:000324527300085
J	Choi, KH; Park, JK; Kim, HS; Uh, KJ; Son, DC; Lee, CK				Choi, Kwang-Hwan; Park, Jin-Kyu; Kim, Hye-Sun; Uh, Kyung-Jun; Son, Dong-Chan; Lee, Chang-Kyu			Epigenetic Changes of Lentiviral Transgenes in Porcine Stem Cells Derived from Embryonic Origin	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; GENE-EXPRESSION; PLURIPOTENT STATES; NONDIVIDING CELLS; MOUSE EMBRYOS; IN-VITRO; VECTOR; LINES; DIFFERENTIATION; ESTABLISHMENT	Because of the physiological and immunological similarities that exist between pigs and humans, porcine pluripotent cell lines have been identified as important candidates for preliminary studies on human disease as well as a source for generating transgenic animals. Therefore, the establishment and characterization of porcine embryonic stem cells (pESCs), along with the generation of stable transgenic cell lines, is essential. In this study, we attempted to efficiently introduce transgenes into Epiblast stem cell (EpiSC)-like pESCs. Consequently, a pluripotent cell line could be derived from a porcine-hatched blastocyst. Enhanced green fluorescent protein (EGFP) was successfully introduced into the cells via lentiviral vectors under various multiplicities of infection, with pluripotency and differentiation potential unaffected after transfection. However, EGFP expression gradually declined during extended culture. This silencing effect was recovered by in vitro differentiation and treatment with 5-azadeoxycytidine. This phenomenon was related to DNA methylation as determined by bisulfite sequencing. In conclusion, we were able to successfully derive EpiSC-like pESCs and introduce transgenes into these cells using lentiviral vectors. This cell line could potentially be used as a donor cell source for transgenic pigs and may be a useful tool for studies involving EpiSC-like pESCs as well as aid in the understanding of the epigenetic regulation of transgenes.	[Lee, Chang-Kyu] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, CK (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	leeck@snu.ac.kr		Choi, Kwang-Hwan/0000-0003-3919-7413	Next-generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ0094932013]	Next-generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by the Next-generation BioGreen 21 Program (PJ0094932013), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740; Bagchi B, 2006, CELL BIOL INT, V30, P505, DOI 10.1016/j.cellbi.2006.01.008; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; Brevini TAL, 2007, THERIOGENOLOGY, V68, pS206, DOI 10.1016/j.theriogenology.2007.05.043; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Golding MC, 2011, GENE THER, V18, P817, DOI 10.1038/gt.2011.26; Hall V, 2008, STEM CELL REV, V4, P275, DOI 10.1007/s12015-008-9040-2; Hamaguchi I, 2000, J VIROL, V74, P10778, DOI 10.1128/JVI.74.22.10778-10784.2000; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; HOEBEN RC, 1991, J VIROL, V65, P904, DOI 10.1128/JVI.65.2.904-912.1991; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Hohenstein KA, 2008, STEM CELLS, V26, P1436, DOI 10.1634/stemcells.2007-0857; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Houdebine LM, 2009, COMP IMMUNOL MICROB, V32, P107, DOI 10.1016/j.cimid.2007.11.005; Huang LZ, 2011, CELL REPROGRAM, V13, P93, DOI 10.1089/cell.2010.0069; Keefer CL, 2007, ANIM REPROD SCI, V98, P147, DOI 10.1016/j.anireprosci.2006.10.009; Ko BS, 2009, GENE THER, V16, P154, DOI 10.1038/gt.2008.125; Kong QR, 2011, MOL CELL BIOCHEM, V355, P157, DOI 10.1007/s11010-011-0849-7; Kosaka Y, 2004, ARTIF ORGANS, V28, P271, DOI 10.1111/j.1525-1594.2004.47297.x; Kues WA, 2013, STEM CELLS DEV, V22, P124, DOI 10.1089/scd.2012.0382; Laker C, 1998, J VIROL, V72, P339, DOI 10.1128/JVI.72.1.339-348.1998; Lee SG, 2007, MOL REPROD DEV, V74, P1436, DOI 10.1002/mrd.20728; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; Liu J, 2009, MOL REPROD DEV, V76, P580, DOI 10.1002/mrd.20983; LOH TP, 1990, MOL CELL BIOL, V10, P4045, DOI 10.1128/MCB.10.8.4045; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MARTIN GR, 1974, CELL, V2, P163, DOI 10.1016/0092-8674(74)90090-7; Meier JL, 1996, INTERVIROLOGY, V39, P331, DOI 10.1159/000150504; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nagano M, 2002, FEBS LETT, V524, P111, DOI 10.1016/S0014-5793(02)03010-7; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Norrman K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012413; Park JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052481; Park SH, 2010, THERIOGENOLOGY, V74, P805, DOI 10.1016/j.theriogenology.2010.04.005; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; PIEDRAHITA JA, 1990, THERIOGENOLOGY, V34, P879, DOI 10.1016/0093-691X(90)90559-C; Pierson RN, 2009, XENOTRANSPLANTATION, V16, P263, DOI 10.1111/j.1399-3089.2009.00534.x; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Rui R, 2006, THERIOGENOLOGY, V65, P713, DOI 10.1016/j.theriogenology.2005.04.033; Son HY, 2009, ASIAN AUSTRAL J ANIM, V22, P26, DOI 10.5713/ajas.2009.80343; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan G, 2011, ZYGOTE, P1; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang R, 2008, STEM CELLS DEV, V17, P279, DOI 10.1089/scd.2007.0084; Ward CM, 2002, STEM CELLS, V20, P472, DOI 10.1634/stemcells.20-5-472; Whitelaw CBA, 2008, REPROD DOMEST ANIM, V43, P355, DOI 10.1111/j.1439-0531.2008.01184.x; Yang JR, 2009, CLONING STEM CELLS, V11, P235, DOI 10.1089/clo.2008.0050; Zeng XM, 2003, STEM CELLS, V21, P647, DOI 10.1634/stemcells.21-6-647; Zhang XJ, 2006, ADV DRUG DELIVER REV, V58, P515, DOI 10.1016/j.addr.2006.03.006; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	60	8	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72184	10.1371/journal.pone.0072184	http://dx.doi.org/10.1371/journal.pone.0072184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977247	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700147
J	Kim, WK; Choi, EK; Sul, OJ; Park, YK; Kim, ES; Yu, R; Suh, JH; Choi, HS				Kim, Woon-Ki; Choi, Eun-Kyung; Sul, Ok-Joo; Park, Yeon-Kyung; Kim, Eun-Sook; Yu, Rina; Suh, Jae-Hee; Choi, Hye-Seon			Monocyte Chemoattractant Protein-1 Deficiency Attenuates Oxidative Stress and Protects against Ovariectomy-Induced Chronic Inflammation in Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; DENDRITIC CELLS; MCP-1; OBESITY; FAT; MENOPAUSE; ESTROGEN; DELETION; BLOOD	Background: Loss of ovarian function is highly associated with an elevated risk of metabolic disease. Monocyte chemoattractant protein-1 (MCP-1, C-C chemokine ligand 2) plays critical roles in the development of inflammation, but its role in ovariectomy (OVX)-induced metabolic disturbance has not been known. Methodology and Principal Findings: We investigated the role of MCP-1 in OVX-induced metabolic perturbation using MCP-1-knockout mice. OVX increased fat mass, serum levels of MCP-1, macrophage-colony stimulating factor (M-CSF), and reactive oxygen species (ROS), whereas MCP-1 deficiency attenuated these. OVX-induced increases of visceral fat resulted in elevated levels of highly inflammatory CD11c-expressing cells as well as other immune cells in adipose tissue, whereas a lack of MCP-1 significantly reduced all of these levels. MCP-1 deficiency attenuated activation of phospholipase C gamma 2, transforming oncogene from Ak strain, and extracellular signal-regulated kinase as well as generation of ROS, which is required for up-regulating CD11c expression upon M-CSF stimulation in bone marrow-derived macrophages. Conclusions/Significance: Our data suggested that MCP-1 plays a key role in developing metabolic perturbation caused by a loss of ovarian functions through elevating CD11c expression via ROS generation.	[Kim, Woon-Ki; Choi, Eun-Kyung; Sul, Ok-Joo; Park, Yeon-Kyung; Choi, Hye-Seon] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Kim, Eun-Sook] Ulsan Univ Hosp, Dept Endocrinol, Ulsan, South Korea; [Yu, Rina] Univ Ulsan, Dept Food Sci & Nutr, Ulsan 680749, South Korea; [Suh, Jae-Hee] Ulsan Univ Hosp, Dept Pathol, Ulsan, South Korea	University of Ulsan; University of Ulsan; Ulsan University Hospital; University of Ulsan; University of Ulsan; Ulsan University Hospital	Choi, HS (corresponding author), Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea.	hschoi@mail.ulsan.ac.kr		Yu, Rina/0000-0002-1965-3891; Choi, Hye-Seon/0000-0003-2992-2677; Ok Joo, Sul/0000-0002-8517-0898	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare Family Affairs [A111295]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare Family Affairs	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs (A111295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AM, 2011, CAN J PHYSIOL PHARM, V89, P497, DOI 10.1139/Y11-053; Abu-Taha M, 2009, J IMMUNOL, V183, P1393, DOI 10.4049/jimmunol.0803157; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Choi JS, 2012, NUTR RES, V32, P844, DOI 10.1016/j.nutres.2012.10.002; Fancke B, 2008, BLOOD, V111, P150, DOI 10.1182/blood-2007-05-089292; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hayasaki T, 2006, CIRC J, V70, P342, DOI 10.1253/circj.70.342; Jain SK, 2009, ANTIOXID REDOX SIGN, V11, P241, DOI 10.1089/ars.2008.2140; Kanaya N, 2010, NUTR RES, V30, P714, DOI 10.1016/j.nutres.2010.09.001; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim YY, 2010, MOL CELLS, V29, P277, DOI 10.1007/s10059-010-0027-x; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Li J, 2012, ANTIOXID REDOX SIGN, V17, P1083, DOI 10.1089/ars.2011.4417; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MacDonald KPA, 2005, J IMMUNOL, V175, P1399, DOI 10.4049/jimmunol.175.3.1399; Misawa E, 2004, INT IMMUNOPHARMACOL, V4, P791, DOI 10.1016/j.intimp.2004.03.004; Mohanty P, 2004, J CLIN ENDOCR METAB, V89, P2728, DOI 10.1210/jc.2003-032103; Moon EY, 2006, IMMUNOL LETT, V102, P184, DOI 10.1016/j.imlet.2005.09.003; Park KS, 2009, CLIN CHIM ACTA, V403, P92, DOI 10.1016/j.cca.2009.01.025; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955; Ponugoti B, 2012, EXP DIABETES RES, DOI 10.1155/2012/939751; Potter VJV, 2012, ENDOCRINOLOGY, V153, P4266, DOI 10.1210/en.2011-2006; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405; Sanchez-Rodriguez MA, 2012, MENOPAUSE, V19, P361, DOI 10.1097/gme.0b013e318229977d; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Simeoni E, 2004, DIABETOLOGIA, V47, P1574, DOI 10.1007/s00125-004-1494-4; Stubbins RE, 2012, DIABETES OBES METAB, V14, P58, DOI 10.1111/j.1463-1326.2011.01488.x; Sul OJ, 2012, J CELL PHYSIOL, V227, P1619, DOI 10.1002/jcp.22879; Takahashi K, 2003, J BIOL CHEM, V278, P46654, DOI 10.1074/jbc.M309895200; Tani A, 2013, CYTOKINE, V62, P86, DOI 10.1016/j.cyto.2013.02.011; Wu HZ, 2010, ARTERIOSCL THROM VAS, V30, P186, DOI 10.1161/ATVBAHA.109.198044; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Younce CW, 2010, CARDIOVASC RES, V87, P665, DOI 10.1093/cvr/cvq102; Younce CW, 2009, J BIOL CHEM, V284, P27620, DOI 10.1074/jbc.M109.025320	39	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72108	10.1371/journal.pone.0072108	http://dx.doi.org/10.1371/journal.pone.0072108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977220	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700133
J	Gervasi, MG; Marczylo, TH; Lam, PM; Rana, S; Franchi, AM; Konje, JC; Perez-Martinez, S				Gracia Gervasi, Maria; Marczylo, Timothy H.; Lam, Patricia M.; Rana, Shashi; Franchi, Ana M.; Konje, Justin C.; Perez-Martinez, Silvina			Anandamide Levels Fluctuate in the Bovine Oviduct during the Oestrous Cycle	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; EPITHELIUM IN-VITRO; ENDOCANNABINOID SYSTEM; ACROSOME REACTION; HUMAN-LYMPHOCYTES; EMBRYO-TRANSFER; SPERM; PALMITOYLETHANOLAMIDE; RELEASE; FERTILIZATION	Mammalian oviduct acts as a reservoir for spermatozoa and provides an environment in which they may compete for the opportunity to fertilize the oocyte. Whilst in the oviduct spermatozoa undergo capacitation essential for fertilization. Sperm-oviduct interaction is essential for sperm capacitation and is a tightly regulated process influenced by the local microenvironment. Previously we reported that the endocannabinoid anandamide ( AEA) regulates sperm release from epithelial oviductal cells by promoting sperm capacitation. The aims of this work were to measure the AEA content and to characterize the main AEA metabolic pathway in the bovine oviduct and determine how these change through the oestrous cycle. In this study, the levels of AEA and two other N-acylethanolamines, N-oleoylethanolamine and N-palmitoylethanolamine, were measured in bovine oviduct collected during different stages of oestrous cycle by ultra high performance liquid chromatography tandem mass spectrometry. Results indicated that intracellular oviductal epithelial levels of all three N-acylethanolamines fluctuate during oestrous cycle. Anandamide from oviductal fluid also varied during oestrous cycle, with the highest values detected during the periovulatory period. Endocannabinoid levels from ipsilateral oviduct to ovulation were higher than those detected in the contralateral one, suggesting that levels of oviductal AEA may be regulated by ovarian hormones. The expression and localization of N-acylethanolamines metabolizing enzymes in bovine oviduct were also determined by RT-PCR, Western blot, and immunohistochemistry but no change was found during the oestrous cycle. Furthermore, nanomolar levels of AEA were detected in follicular fluids, suggesting that during ovulation the mature follicle may contribute to oviductal AEA levels to create an endocannabinoid gradient conducive to the regulation of sperm function for successful fertilization.	[Gracia Gervasi, Maria; Perez-Martinez, Silvina] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Ctr Estudios Farmacol & Bot, Lab Biol Reprod Mamiferos, Buenos Aires, DF, Argentina; [Marczylo, Timothy H.; Lam, Patricia M.; Rana, Shashi; Konje, Justin C.] Univ Leicester, Endocannabinoid Res Grp, Reprod Sci Sect, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Franchi, Ana M.] Univ Buenos Aires, Ctr Estudios Farmacol & Bot, Consejo Nacl Invest Cient & Tecn, Lab Fisiopatol Prenez & Parto, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Leicester; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Konje, JC (corresponding author), Univ Leicester, Endocannabinoid Res Grp, Reprod Sci Sect, Dept Canc Studies & Mol Med, Leicester, Leics, England.	jck4@le.ac.uk; perezms@fmed.uba.ar	Marczylo, Tim/I-2470-2019	Marczylo, Tim/0000-0001-9744-473X; Gervasi, Maria Gracia/0000-0002-5468-2700	Agencia Nacional de Promocion Cientifica y Tecnologica (PICT) [2010-0813]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas [PIP 2008 2204]; Boehringer Ingelheim Fonds travel grant programme	Agencia Nacional de Promocion Cientifica y Tecnologica (PICT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas; Boehringer Ingelheim Fonds travel grant programme	This study was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (PICT No 2010-0813), Consejo Nacional de Investigaciones Cientificas y Tecnologicas (PIP 2008 2204), and Boehringer Ingelheim Fonds travel grant programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acone G, 2009, PLACENTA, V30, P203, DOI 10.1016/j.placenta.2008.11.018; Aquila S, 2009, J CELL PHYSIOL, V221, P147, DOI 10.1002/jcp.21837; Battista N, 2008, J NEUROENDOCRINOL, V20, P82, DOI 10.1111/j.1365-2826.2008.01684.x; Battista N, 2012, MOL CELL ENDOCRINOL, V355, P1, DOI 10.1016/j.mce.2012.01.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cacciola G, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105726; Cobellis G, 2010, BIOL REPROD, V82, P451, DOI 10.1095/biolreprod.109.079210; de Fonseca FR, 2005, ALCOHOL ALCOHOLISM, V40, P2, DOI 10.1093/alcalc/agh110; Garcia MD, 2009, EUR J PHARMACOL, V610, P75, DOI 10.1016/j.ejphar.2009.03.021; El-Talatini MR, 2010, FERTIL STERIL, V93, P1989, DOI 10.1016/j.fertnstert.2008.12.033; El-Talatini MR, 2009, HUM REPROD, V24, P1989, DOI 10.1093/humrep/dep065; El-Talatini MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004579; Fezza Filomena, 2008, V49, P101, DOI 10.1007/978-1-4020-8831-5_4; Francavilla F, 2009, ENDOCRINOLOGY, V150, P4692, DOI 10.1210/en.2009-0057; Gebeh AK, 2012, J CLIN ENDOCR METAB, V97, P2827, DOI 10.1210/jc.2012-1780; Gervasi MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016993; Gervasi MG, 2009, REPRODUCTION, V137, P403, DOI 10.1530/REP-08-0204; Gualtieri R, 2005, REPRODUCTION, V129, P51, DOI 10.1530/rep.1.00374; Guo Y, 2005, J BIOL CHEM, V280, P23429, DOI 10.1074/jbc.C500168200; Ho WSV, 2008, BRIT J PHARMACOL, V155, P837, DOI 10.1038/bjp.2008.324; Hunter RHF, 2008, MOL REPROD DEV, V75, P167, DOI 10.1002/mrd.20776; Hunter RHF, 2012, BIOL REV, V87, P244, DOI 10.1111/j.1469-185X.2011.00196.x; IRELAND JJ, 1980, J DAIRY SCI, V63, P155, DOI 10.3168/jds.S0022-0302(80)82901-8; Jonsson KO, 2001, BRIT J PHARMACOL, V133, P1263, DOI 10.1038/sj.bjp.0704199; Killian GJ, 2004, ANIM REPROD SCI, V82-3, P141, DOI 10.1016/j.anireprosci.2004.04.028; Klinger Francesca G, 2006, J Exp Clin Assist Reprod, V3, P3, DOI 10.1186/1743-1050-3-3; Lam PMW, 2008, ANAL BIOCHEM, V380, P195, DOI 10.1016/j.ab.2008.05.033; Lambert DM, 1999, CURR MED CHEM, V6, P757; Lambert DM, 2002, CURR MED CHEM, V9, P663, DOI 10.2174/0929867023370707; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Maccarrone M, 2002, MOL HUM REPROD, V8, P188, DOI 10.1093/molehr/8.2.188; Maccarrone M, 2001, J IMMUNOL, V166, P7183, DOI 10.4049/jimmunol.166.12.7183; Maccarrone M, 2005, J CELL SCI, V118, P4393, DOI 10.1242/jcs.02536; Maccarrone M, 2000, EUR J BIOCHEM, V267, P2991; Maccarrone M, 2000, LANCET, V355, P1326, DOI 10.1016/S0140-6736(00)02115-2; Maccarrone M, 2003, J BIOL CHEM, V278, P32726, DOI 10.1074/jbc.M302123200; Maccarrone M, 2002, BLOOD, V100, P4040, DOI 10.1182/blood-2002-05-1444; Maccarrone M, 2010, TRENDS BIOCHEM SCI, V35, P601, DOI 10.1016/j.tibs.2010.05.008; Marczylo TH, 2009, ANAL BIOCHEM, V384, P106, DOI 10.1016/j.ab.2008.08.040; McFarland MJ, 2004, PHARMACOL THERAPEUT, V104, P117, DOI 10.1016/j.pharmthera.2004.07.008; Osycka-Salut C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030671; PARRISH JJ, 1989, BIOL REPROD, V40, P1020, DOI 10.1095/biolreprod40.5.1020; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Rossato M, 2005, J CLIN ENDOCR METAB, V90, P984, DOI 10.1210/jc.2004-1287; Schuel H, 2002, CHEM PHYS LIPIDS, V121, P211, DOI 10.1016/S0009-3084(02)00158-5; Schuel H, 2002, MOL REPROD DEV, V63, P376, DOI 10.1002/mrd.90021; Schuel H, 2006, J CLIN INVEST, V116, P2087, DOI 10.1172/JCI29424; Sordelli MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018368; Suarez SS, 2008, INT J DEV BIOL, V52, P455, DOI 10.1387/ijdb.072527ss; Sun XF, 2008, MOL CELL ENDOCRINOL, V286, pS3, DOI 10.1016/j.mce.2008.01.002; Sun YX, 2004, BIOCHEM J, V380, P749, DOI 10.1042/BJ20040031; Talevi R, 2001, BIOL REPROD, V64, P491, DOI 10.1095/biolreprod64.2.491; Vercelli CA, 2009, REPROD BIOMED ONLINE, V18, P824, DOI 10.1016/S1472-6483(10)60033-8; Wang HB, 2006, ENDOCR REV, V27, P427, DOI 10.1210/er.2006-0006; Wang HB, 2006, AAPS J, V8, pE425; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; Yanagimachi R, 1994, PHYSL REPRODUCTION, V1, P189	58	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72521	10.1371/journal.pone.0072521	http://dx.doi.org/10.1371/journal.pone.0072521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977311	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200073
J	Li, QH; Kawamura, K; Yang, S; Okamoto, S; Kobayashi, H; Tada, Y; Sekine, I; Takiguchi, Y; Shingyouji, M; Tatsumi, K; Shimada, H; Hiroshima, K; Tagawa, M				Li, Quanhai; Kawamura, Kiyoko; Yang, Shan; Okamoto, Shinya; Kobayashi, Hiroshi; Tada, Yuji; Sekine, Ikuo; Takiguchi, Yuichi; Shingyouji, Masato; Tatsumi, Koichiro; Shimada, Hideaki; Hiroshima, Kenzo; Tagawa, Masatoshi			Interferon-beta Produces Synergistic Combinatory Anti-Tumor Effects with Cisplatin or Pemetrexed on Mesothelioma Cells	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; I INTERFERON; GENE-TRANSFER; P53; APOPTOSIS; TRIAL; SENSITIVITY; ALPHA/BETA; MECHANISMS; PATHWAYS	Interferons (IFNs) have been tested for the therapeutic effects in various types of malignancy, but mechanisms of the anti-tumors effects and the differential biological activities among IFN members are dependent on respective cell types. In this study, we examined growth inhibitory activities of type I and III IFNs on 5 kinds of human mesothelioma cells bearing wild-type p53 gene, and showed that type I IFNs but not type III IFNs decreased the cell viabilities. Moreover, growth inhibitory activities and up-regulated expression levels of the major histocompatibility complexes class I antigens were greater with IFN-beta than with IFN-alpha treatments. Cell cycle analyses demonstrated that type I IFNs increased S-and G2/M-phase populations, and subsequently sub-G1-phase fractions. The cell cycle changes were also greater with IFN-beta than IFN-alpha treatments, and these data collectively showed that IFN-beta had stronger biological activities than IFN-alpha in mesothelioma. Type I IFNs-treated cells increased p53 expression and the phosphorylation levels, and activated apoptotic pathways. A combinatory use of IFN-beta and cisplatin or pemetrexed, both of which are the current first-line chemotherapeutic agents for mesothelioma, produced synergistic anti-tumor effects, which were also evidenced by increased sub-G1-phase fractions. These data demonstrated firstly to our knowledge that IFN-beta produced synergistic anti-tumor effects with cisplatin or pemetrexed on mesothelioma through up-regulated p53 expression.	[Li, Quanhai; Kawamura, Kiyoko; Yang, Shan; Tagawa, Masatoshi] Chiba Canc Ctr, Res Inst, Div Pathol & Cell Therapy, Chiba 2608717, Japan; [Li, Quanhai; Yang, Shan; Tagawa, Masatoshi] Chiba Univ, Grad Sch Med, Dept Mol Biol & Oncol, Chiba, Japan; [Okamoto, Shinya; Kobayashi, Hiroshi] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Chiba, Japan; [Tada, Yuji; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Japan; [Sekine, Ikuo; Takiguchi, Yuichi] Chiba Univ, Grad Sch Med, Dept Med Oncol, Chiba, Japan; [Shingyouji, Masato] Chiba Canc Ctr, Res Inst, Div Thorac Dis, Chiba 2608717, Japan; [Shimada, Hideaki] Toho Univ, Dept Surg, Sch Med, Tokyo, Japan; [Hiroshima, Kenzo] Tokyo Womens Med Univ, Dept Pathol, Yachiyo Med Ctr, Yachiyo, Japan	Chiba Cancer Center; Chiba University; Chiba University; Chiba University; Chiba University; Chiba Cancer Center; Toho University; Tokyo Women's Medical University	Tagawa, M (corresponding author), Chiba Canc Ctr, Res Inst, Div Pathol & Cell Therapy, 666-2 Nitonacho, Chiba 2608717, Japan.	mtagawa@chiba-cc.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Nichias Corporation; Grants-in-Aid for Scientific Research [23591136] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Nichias Corporation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Grant-in-Aid for Research on seeds for Publicly Essential Drugs and Medical Devices from the Ministry of Health, Labor and Welfare of Japan, and a Grant-in-aid from the Nichias Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carbone M, 2002, SEMIN ONCOL, V29, P2, DOI 10.1053/sonc.2002.30227; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Fujie H, 2011, CANCER SCI, V102, P1977, DOI 10.1111/j.1349-7006.2011.02079.x; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Giovannetti E, 2007, BRIT J CANCER, V96, P769, DOI 10.1038/sj.bjc.6603639; Halme M, 1999, BRIT J CANCER, V80, P1781, DOI 10.1038/sj.bjc.6690597; KE Y, 1989, AM J PATHOL, V134, P979; La QH, 2010, EUR J CANCER, V46, P180, DOI 10.1016/j.ejca.2009.10.002; Lee AY, 2007, CANCER-AM CANCER SOC, V109, P1454, DOI 10.1002/cncr.22552; Li MC, 2009, J LEUKOCYTE BIOL, V86, P23, DOI [10.1189/JLB.1208761, 10.1189/jlb.1208761]; Li Q, 2012, CANCER GENE THER, V19, P218, DOI 10.1038/cgt.2011.86; Lu XH, 2001, CLIN CANCER RES, V7, P2114; Metintas M, 1999, CHEST, V116, P391, DOI 10.1378/chest.116.2.391; Parra HS, 2001, CANCER, V92, P650, DOI 10.1002/1097-0142(20010801)92:3<650::AID-CNCR1366>3.0.CO;2-0; Pokrovskaja K, 2005, J INTERF CYTOK RES, V25, P799, DOI 10.1089/jir.2005.25.799; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Sandoval R, 2004, J BIOL CHEM, V279, P32275, DOI 10.1074/jbc.M313830200; Sangfelt O, 1999, ONCOGENE, V18, P2798, DOI 10.1038/sj.onc.1202609; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Sterman DH, 2007, CLIN CANCER RES, V13, P4456, DOI 10.1158/1078-0432.CCR-07-0403; Sterman DH, 2011, AM J RESP CRIT CARE, V184, P1395, DOI 10.1164/rccm.201103-0554CR; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Vannucchi S, 2005, ONCOGENE, V24, P2536, DOI 10.1038/sj.onc.1208403; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Yang TY, 2013, MOL CARCINOGEN, V52, P183, DOI 10.1002/mc.21842; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x; Zucali PA, 2011, CANCER TREAT REV, V37, P543, DOI 10.1016/j.ctrv.2011.01.001	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72709	10.1371/journal.pone.0072709	http://dx.doi.org/10.1371/journal.pone.0072709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977343	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200081
J	Nakamura, K; Kawabata, H				Nakamura, Koyo; Kawabata, Hideaki			I Choose, Therefore I Like: Preference for Faces Induced by Arbitrary Choice	PLOS ONE			English	Article							COGNITIVE-DISSONANCE REDUCTION; FACIAL ATTRACTIVENESS; EVOLUTIONARY PSYCHOLOGY; SELECTIVE ATTENTION; ATTITUDE-CHANGE; DECISIONS; BEAUTY; JUDGMENTS; DISLIKING; REFLECTS	Behavioral choice alters one's preference rather than simply reflecting it. This effect to fit preferences with past choice, is known as "choice-induced preference change.'' After making a choice between two equally attractive options, one tends to rate the chosen option better than they initially did and/or the unchosen option worse. The present study examined how behavioral choice changes subsequent preference, using facial images for the choice options as well as blind choice techniques. Participants rated their facial preference for each face, and chose between two equally preferred faces and subsequently rated their facial preference. Results from four experiments demonstrated that randomly chosen faces were more preferred only after participants were required to choose "a preferred face,'' (in Experiment 1) but not "an unpreferred face,'' (in Experiment 2) or "a rounder face'' (in Experiment 3). Further, preference change was still observed after participants were informed that choices were actually random (in Experiment 4). Our findings provide new and important implications characterizing the conditions under which random choice changes preference, and show that people are tempted to make a biased evaluation even after they know that they did not make the choice for themselves.	[Nakamura, Koyo; Kawabata, Hideaki] Keio Univ, Dept Psychol, Minato Ku, Tokyo, Japan	Keio University	Kawabata, H (corresponding author), Keio Univ, Dept Psychol, Minato Ku, Tokyo, Japan.	kawabata@flet.keio.ac.jp		Nakamura, Koyo/0000-0002-9506-1644	Ministry of Education, Science, and Culture, Japan [24680029]	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Grant-in-Aid for Scientific Research (No. 24680029) of the Ministry of Education, Science, and Culture, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Alos-Ferrer C, 2012, J EXP SOC PSYCHOL, V48, P1336, DOI 10.1016/j.jesp.2012.07.004; Ariely D, 2008, TRENDS COGN SCI, V12, P13, DOI 10.1016/j.tics.2007.10.008; Aronson E., 1968, THEORIES COGNITIVE C, P5; Beasley RK, 2001, POLIT PSYCHOL, V22, P521, DOI 10.1111/0162-895X.00252; BEM DJ, 1967, PSYCHOL REV, V74, P183, DOI 10.1037/h0024835; BREHM JW, 1956, J ABNORM SOC PSYCH, V52, P384, DOI 10.1037/h0041006; Chen MK, 2010, J PERS SOC PSYCHOL, V99, P573, DOI 10.1037/a0020217; Chen MK, 2008, 1669 YAL U COW FDN R; Coppin G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037857; Coppin G, 2010, PSYCHOL SCI, V21, P489, DOI 10.1177/0956797610364115; Dittrich K, 2012, COGNITION EMOTION, V26, P193, DOI 10.1080/02699931.2011.570313; Egan LC, 2007, PSYCHOL SCI, V18, P978, DOI 10.1111/j.1467-9280.2007.02012.x; Egan LC, 2010, J EXP SOC PSYCHOL, V46, P204, DOI 10.1016/j.jesp.2009.08.014; Elliott R, 1998, J NEUROSCI, V18, P4697; Fenske MJ, 2006, CURR DIR PSYCHOL SCI, V15, P312, DOI 10.1111/j.1467-8721.2006.00459.x; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Fink B, 2002, CURR DIR PSYCHOL SCI, V11, P154, DOI 10.1111/1467-8721.00190; Gawronski B, 2007, J EXP SOC PSYCHOL, V43, P221, DOI 10.1016/j.jesp.2006.04.001; Herr PM, 2004, J CONSUM RES, V30, P588, DOI 10.1086/380291; Izuma K, 2010, P NATL ACAD SCI USA, V107, P22014, DOI 10.1073/pnas.1011879108; Jarcho JM, 2011, SOC COGN AFFECT NEUR, V6, P460, DOI 10.1093/scan/nsq054; Johnston VS, 2006, TRENDS COGN SCI, V10, P9, DOI 10.1016/j.tics.2005.11.003; Kim H, 2007, P NATL ACAD SCI USA, V104, P18253, DOI 10.1073/pnas.0703101104; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Lieberman MD, 2001, PSYCHOL SCI, V12, P135, DOI 10.1111/1467-9280.00323; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Nakamura K, 1998, NEUROREPORT, V9, P753, DOI 10.1097/00001756-199803090-00035; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; Pittinsky TL, 2011, CULT DIVERS ETHN MIN, V17, P134, DOI 10.1037/a0023806; Raymond JE, 2003, PSYCHOL SCI, V14, P537, DOI 10.1046/j.0956-7976.2003.psci_1462.x; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Sharot T, 2012, PSYCHOL SCI, V23, P1123, DOI 10.1177/0956797612438733; Sharot T, 2010, PSYCHOL SCI, V21, P1231, DOI 10.1177/0956797610379235; Sharot T, 2010, J NEUROSCI, V30, P9209, DOI 10.1523/JNEUROSCI.4770-09.2010; Sharot T, 2009, J NEUROSCI, V29, P3760, DOI 10.1523/JNEUROSCI.4972-08.2009; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Simon D, 2004, PSYCHOL SCI, V15, P331, DOI 10.1111/j.0956-7976.2004.00678.x; Zeki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003556	40	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72071	10.1371/journal.pone.0072071	http://dx.doi.org/10.1371/journal.pone.0072071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	207BA	23977211	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200057
J	Hochhauser, E; Avlas, O; Fallach, R; Bachmetov, L; Zemel, R; Pappo, O; Shainberg, A; Ben Ari, Z				Hochhauser, Edith; Avlas, Orna; Fallach, Reut; Bachmetov, Larissa; Zemel, Romy; Pappo, Orit; Shainberg, Asher; Ben Ari, Ziv			Bone Marrow and Nonbone Marrow Toll Like Receptor 4 Regulate Acute Hepatic Injury Induced by Endotoxemia	PLOS ONE			English	Article							GENE-EXPRESSION; MOLECULAR-MECHANISMS; KUPFFER CELLS; MURINE LIVER; KAPPA-B; LIPOPOLYSACCHARIDE; TLR4; MICE; HEPATOCYTES; CYTOKINE	Background: Toll-like receptors (TLRs) are expressed in immune cells and hepatocytes. We examined whether hepatic Toll-like receptor 4 (TLR4) is involved in the acute hepatic injury caused by the administration of lipopolysaccharide (LPS) (septic shock model). Methods: Wild type (WT), TLR4-deficient and chimera mice underwent myeloablative bone marrow transplantation to dissociate between TLR4 expression in the liver or in the immune-hematopoietic system. Mice were injected with LPS and sacrificed 4 hours later. Results: Compared to TLR4 deficient mice, WT mice challenged with LPS displayed increased serum liver enzymes and hepatic cellular inflammatory infiltrate together with increased serum and hepatic levels of interleukin 1 beta (IL-1 beta), tumor necrosis factor alpha (TNF alpha), Up-regulation of hepatic mRNA encoding TLR4, I kappa B and c-jun expressions. TLR4 mutant mice transplanted with WT bone marrow were more protected than WT chimeric mice bearing TLR4 mutant hemopoietic cells from LPS, as seen by IL-1 beta and TNF alpha levels. We then used hepatocytes (Huh7) and macrophages from monocytic cell lines to detect TLR mRNA expression. Macrophages expressed a significantly higher level of TLR4 mRNA and TLR2 (more than 3000- and 8000-fold respectively) compared with the hepatocyte cell line. LPS administration induced TLR4 activation in a hepatocyte cell line in a dose dependent manner while TLR2 mRNA hardly changed. Conclusions: These results suggest that TLR4 activation of hepatocytes participate in the immediate response to LPS induced hepatic injury. However, in this response, the contribution of TLR4 on bone marrow derived cells is more significant than those of the hepatocytes. The absence of the TLR4 gene plays a pivotal role in reducing hepatic LPS induced injury.	[Hochhauser, Edith; Avlas, Orna; Fallach, Reut; Bachmetov, Larissa; Zemel, Romy] Rabin Med Ctr, Felsenstein Med Res Ctr, Petah Tiqwa, Israel; [Avlas, Orna; Shainberg, Asher] Bar Ilan Univ, Goldschmied Med Diagnost Res Ctr, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Pappo, Orit] Chaim Sheba Med Ctr, Dept Histopathol, Ramat Gan, Israel; [Ben Ari, Ziv] Chaim Sheba Med Ctr, Liver Dis Ctr, Ramat Gan, Israel; [Hochhauser, Edith; Bachmetov, Larissa; Zemel, Romy; Pappo, Orit; Ben Ari, Ziv] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Bar Ilan University; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Ben Ari, Z (corresponding author), Chaim Sheba Med Ctr, Liver Dis Ctr, Ramat Gan, Israel.	Ziv.Ben-Ari@sheba.health.gov.il						Ackerman Z, 2008, DIGEST DIS SCI, V53, P777, DOI 10.1007/s10620-007-9911-4; Baumgarten G, 2001, J INFECT DIS, V183, P1617, DOI 10.1086/320712; Ben Ari Z, 2012, CELL PHYSIOL BIOCHEM, V29, P41, DOI 10.1159/000337585; Ben-Ari Z, 2012, CELL PHYSIOL BIOCHEM, V30, P489, DOI 10.1159/000341432; Fallach R, 2010, J MOL CELL CARDIOL, V48, P1236, DOI 10.1016/j.yjmcc.2010.02.020; Gal-Tanamy M, 2011, HEPATOLOGY, V54, P1570, DOI 10.1002/hep.24575; Guguen-Guillouzo C, 2010, METHODS MOL BIOL, V640, P1, DOI 10.1007/978-1-60761-688-7_1; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jirillo E, 2002, J ENDOTOXIN RES, V8, P319, DOI 10.1179/096805102125000641; Liu SB, 2002, INFECT IMMUN, V70, P3433, DOI 10.1128/IAI.70.7.3433-3442.2002; Matsumura T, 2000, J INTERF CYTOK RES, V20, P915, DOI 10.1089/10799900050163299; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Ojaniemi M, 2006, IMMUNOL LETT, V102, P158, DOI 10.1016/j.imlet.2005.08.009; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pearl-Yafe M, 2007, EXP HEMATOL, V35, P1601, DOI 10.1016/j.exphem.2007.07.010; Qureshi ST, 1999, TRENDS GENET, V15, P291, DOI 10.1016/S0168-9525(99)01782-5; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Shen XD, 2007, LIVER TRANSPLANT, V13, P1435, DOI 10.1002/lt.21251; Shiratori Y, 1998, DIGEST DIS SCI, V43, P1737, DOI 10.1023/A:1018879502520; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Takamura M, 2007, LIFE SCI, V80, P1335, DOI 10.1016/j.lfs.2006.12.034; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; Tsutsui H, 2003, CURR MOL MED, V3, P545, DOI 10.2174/1566524033479618; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Werling D, 2003, VET IMMUNOL IMMUNOP, V91, P1, DOI 10.1016/S0165-2427(02)00228-3	28	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e73041	10.1371/journal.pone.0073041	http://dx.doi.org/10.1371/journal.pone.0073041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977376	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000117
J	Spicer, R; Tisdale-Orr, T; Talavera, C				Spicer, Rachel; Tisdale-Orr, Tracy; Talavera, Christian			Auxin-Responsive DR5 Promoter Coupled with Transport Assays Suggest Separate but Linked Routes of Auxin Transport during Woody Stem Development in Populus	PLOS ONE			English	Article							SECONDARY VASCULAR TRANSITION; HIGH-THROUGHPUT METHOD; POLAR AUXIN; QUANTITATIVE-ANALYSIS; BETA-GLUCURONIDASE; PATTERN-FORMATION; XYLEM DEVELOPMENT; LEAF DEVELOPMENT; ARABIDOPSIS; PLANT	Polar auxin transport (PAT) is a major determinant of plant morphology and internal anatomy with important roles in vascular patterning, tropic growth responses, apical dominance and phyllotactic arrangement. Woody plants present a highly complex system of vascular development in which isolated bundles of xylem and phloem gradually unite to form concentric rings of conductive tissue. We generated several transgenic lines of hybrid poplar (Populus tremuia x alba) with the auxin-responsive DR5 promoter driving GUS expression in order to visualize an auxin response during the establishment of secondary growth. Distinct GUS expression in the cambial zone and developing xylem-side derivatives supports the current view of this tissue as a major stream of basipetal PAT. However, we also found novel sites of GUS expression in the primary xylem parenchyma lining the outer perimeter of the pith. Strands of primary xylem parenchyma depart the stem as a leaf trace, and showed GUS expression as long as the leaves to which they were connected remained attached (i.e., until just prior to leaf abscission). Tissue composed of primary xylem parenchyma strands contained measurable levels of free indole-3-acetic acid (IAA) and showed basipetal transport of radiolabeled auxin (3 H-IAA) that was both significantly faster than diffusion and highly sensitive to the PAT inhibitor NPA. Radiolabeled auxin was also able to move between the primary xylem parenchyma in the interior of the stem and the basipetal stream in the cambial zone, an exchange that was likely mediated by ray parenchyma cells. Our results suggest that (a) channeling of leaf-derived IAA first delineates isolated strands of pre-procambial tissue but then later shifts to include basipetal transport through the rapidly expanding xylem elements, and (b) the transition from primary to secondary vascular development is gradual, with an auxin response preceding the appearance of a unified and radially-organized vascular cambium.	[Spicer, Rachel] Connecticut Coll, Dept Bot, New London, CT 06320 USA; [Tisdale-Orr, Tracy] Rowland Inst Harvard, Cambridge, MA USA; [Talavera, Christian] Eurofins Eaton Analyt Inc, Gas Chromatog Dept, Monrovia, CA USA	Connecticut College	Spicer, R (corresponding author), Connecticut Coll, Dept Bot, New London, CT 06320 USA.	rspicer@conncoll.edu			Rowland Institute at Harvard; NSF [NSF DMR 1005022]	Rowland Institute at Harvard; NSF(National Science Foundation (NSF))	Funding for this research was provided by the Rowland Institute at Harvard in the form of a Rowland Junior Fellowship to R. Spicer as well as internal funding to support experimental work (e. g., equipment, supplies, support staff). C. Talavera was supported by the NSF-funded joint REU programs of the Materials Research Science and Engineering Center (MRSEC) and the Nanoscale Science and Engineering Center (NSEC) at Harvard University (NSF DMR 1005022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold T, 2004, NEW PHYTOL, V164, P157, DOI 10.1111/j.1469-8137.2004.01157.x; Avery GS, 1937, AM J BOT, V24, P51, DOI 10.2307/2436958; Baker D, 2000, ABA J, V86, P48; Barkawi LS, 2008, ANAL BIOCHEM, V372, P177, DOI 10.1016/j.ab.2007.08.009; Barkawi LS, 2010, NAT PROTOC, V5, P1609, DOI 10.1038/nprot.2010.118; Barnett J.R., 1981, XYLEM CELL DEV, P47; Beeckman T., 1994, Plant Molecular Biology Reporter, V12, P37, DOI 10.1007/BF02668662; Bishopp A, 2011, CURR BIOL, V21, P927, DOI 10.1016/j.cub.2011.04.049; Bishopp A, 2011, CURR BIOL, V21, P917, DOI 10.1016/j.cub.2011.04.017; Bjorklund S, 2007, PLANT J, V52, P499, DOI 10.1111/j.1365-313X.2007.03250.x; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Cambridge AP, 1996, PLANTA, V199, P583, DOI 10.1007/BF00195190; Carraro N, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00017; COHEN JD, 1986, PLANT PHYSIOL, V80, P14, DOI 10.1104/pp.80.1.14; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; DIGBY J, 1966, ANN BOT-LONDON, V30, P607, DOI 10.1093/oxfordjournals.aob.a084100; Esau, 1965, VASCULAR DIFFERENTIA; Esau Katherine, 1943, BOT REV, V9, P125, DOI 10.1007/BF02872466; FORD H, 1982, BIOL J LINN SOC, V17, P361, DOI 10.1111/j.1095-8312.1982.tb02027.x; FOSKET DE, 1968, P NATL ACAD SCI USA, V59, P1089, DOI 10.1073/pnas.59.4.1089; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Han KH, 2000, PLANT CELL REP, V19, P315, DOI 10.1007/s002990050019; Hellgren JM, 2004, PLANT PHYSIOL, V135, P212, DOI 10.1104/pp.104.038927; Holl W, 1975, TRANSPORT PLANTS, P432; Holl W, 2000, CELL MOL BIOL WOOD F; Ibanes M, 2009, P NATL ACAD SCI USA, V106, P13630, DOI 10.1073/pnas.0906416106; JACOBS M, 1988, SCIENCE, V241, P346, DOI 10.1126/science.241.4863.346; JACOBS WP, 1958, SCIENCE, V128, P1084, DOI 10.1126/science.128.3331.1084; JACOBS WP, 1957, AM J BOT, V44, P823, DOI 10.2307/2438903; JACOBS WP, 1952, AM J BOT, V39, P301, DOI 10.2307/2438258; JACOBS WP, 1954, AM NAT, V88, P327, DOI 10.1086/281841; Jager CE, 2007, PLANTA, V226, P361, DOI 10.1007/s00425-007-0487-1; JEFFERSON RA, 1987, EMBO J, V6, P3901; Junghans U, 2006, PLANT CELL ENVIRON, V29, P1519, DOI 10.1111/j.1365-3040.2006.01529.x; Junghans U, 2004, PLANT BIOLOGY, V6, P22, DOI 10.1055/s-2003-44712; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kojima K, 2002, PLANT GROWTH REGUL, V37, P249, DOI 10.1023/A:1020857004069; Kramer EM, 2002, J THEOR BIOL, V216, P147, DOI 10.1006/jtbi.2002.2551; Kramer EM, 2008, SCIENCE, V320, P1610, DOI 10.1126/science.1156130; LACHAUD S, 1984, PLANTA, V161, P207, DOI 10.1007/BF00982914; LACHAUD S, 1982, CAN J BOT, V60, P869, DOI 10.1139/b82-112; LARSON PR, 1979, AM J BOT, V66, P452, DOI 10.2307/2442399; LARSON PR, 1975, AM J BOT, V62, P1084, DOI 10.2307/2442125; LARSON PR, 1980, ANN BOT-LONDON, V46, P757, DOI 10.1093/oxfordjournals.aob.a085973; LARSON PR, 1976, AM J BOT, V63, P1332, DOI 10.2307/2441842; LARSON PR, 1972, PLANTA, V107, P301, DOI 10.1007/BF00386392; LARSON PR, 1974, WOOD SCI TECHNOL, V8, P11; LARSON PR, 1981, IAWA BULL, V2, P25, DOI 10.1163/22941932-90000390; LARSON PR, 1976, AM J BOT, V63, P369, DOI 10.2307/2441583; LARSON PR, 1977, PLANTA, V134, P241, DOI 10.1007/BF00384188; Larson PR., 1994, VASCULAR CAMBIUM DEV, DOI [10.1007/978-3-642-78466-8, DOI 10.1007/978-3-642-78466-8]; Lewis DR, 2009, NAT PROTOC, V4, P437, DOI 10.1038/nprot.2009.1; Ljung K, 2005, PLANT CELL, V17, P1090, DOI 10.1105/tpc.104.029272; Ljung K, 2001, PLANT J, V28, P465, DOI 10.1046/j.1365-313X.2001.01173.x; Morris DA, 2004, PLANT HORMONES: BIOSYNTHESIS, SIGNAL TRANSDUCTION, ACTION, P437; MORRIS DA, 1978, J EXP BOT, V29, P147, DOI 10.1093/jxb/29.1.147; NORMANLY J, 2010, COLD SPRING HARB PER, V2, P1; Paponov IA, 2005, TRENDS PLANT SCI, V10, P170, DOI 10.1016/j.tplants.2005.02.009; Quaedvlieg NEM, 1998, PLANT MOL BIOL, V38, P861, DOI 10.1023/A:1006182623165; Reid AE, 2011, J LABELLED COMPD RAD, V54, P433, DOI 10.1002/jlcr.1894; SACHS T, 1981, ADV BOT RES, V9, P151, DOI 10.1016/S0065-2296(08)60351-1; SACHS T, 1991, DEVELOPMENT, P83; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; SAUTER JJ, 1994, TREES-STRUCT FUNCT, V8, P297, DOI 10.1007/BF00202674; SAUTER JJ, 1986, PLANTA, V168, P377, DOI 10.1007/BF00392363; Sauter JJ, 2000, CELL MOL BIOL WOOD F, P71; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Scarpella E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001511; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Schrader J, 2003, P NATL ACAD SCI USA, V100, P10096, DOI 10.1073/pnas.1633693100; Schrader J, 2004, PLANT J, V40, P173, DOI 10.1111/j.1365-313X.2004.02199.x; Spicer R, 2007, PLANT CELL ENVIRON, V30, P934, DOI 10.1111/j.1365-3040.2007.01677.x; Spicer R, 2001, TREES-STRUCT FUNCT, V15, P222, DOI 10.1007/s004680100093; Spicer R, 2010, NEW PHYTOL, V186, P577, DOI 10.1111/j.1469-8137.2010.03236.x; SUNDBERG B, 1990, PLANT PHYSIOL, V93, P1295, DOI 10.1104/pp.93.4.1295; SUNDBERG B, 1987, PHYSIOL PLANTARUM, V71, P163, DOI 10.1111/j.1399-3054.1987.tb02862.x; Sundberg B, 1998, PHYSIOL PLANTARUM, V104, P22, DOI 10.1034/j.1399-3054.1998.1040104.x; SUNDBERG B, 1994, PLANT PHYSIOL, V106, P469, DOI 10.1104/pp.106.2.469; THOMPSON NP, 1966, PLANT PHYSIOL, V41, P673, DOI 10.1104/pp.41.4.673; Tuominen H, 1997, PLANT PHYSIOL, V115, P577, DOI 10.1104/pp.115.2.577; Uggla C, 1998, PLANT PHYSIOL, V117, P113, DOI 10.1104/pp.117.1.113; Uggla C, 1996, P NATL ACAD SCI USA, V93, P9282, DOI 10.1073/pnas.93.17.9282; Uggla C, 2001, PLANT PHYSIOL, V125, P2029, DOI 10.1104/pp.125.4.2029; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; van Bel AJE, 2000, EXPTL BIOL REV, P85; VANBEL AJE, 1990, J EXP BOT, V41, P631, DOI 10.1093/jxb/41.6.631; Zazimalova E, 2010, COLD SPRING HARB PER, V2, P1	89	19	19	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72499	10.1371/journal.pone.0072499	http://dx.doi.org/10.1371/journal.pone.0072499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977308	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000099
J	Ferrarini, M; Steimberg, N; Ponzoni, M; Belloni, D; Berenzi, A; Girlanda, S; Caligaris-Cappio, F; Mazzoleni, G; Ferrero, E				Ferrarini, Marina; Steimberg, Nathalie; Ponzoni, Maurilio; Belloni, Daniela; Berenzi, Angiola; Girlanda, Stefania; Caligaris-Cappio, Federico; Mazzoleni, Giovanna; Ferrero, Elisabetta			Ex-Vivo Dynamic 3-D Culture of Human Tissues in the RCCS (TM) Bioreactor Allows the Study of Multiple Myeloma Biology and Response to Therapy	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; BONE-MARROW; SIMULATED MICROGRAVITY; CANCER DEVELOPMENT; MALIGNANT BREAST; ANGIOGENESIS; BORTEZOMIB; MODEL; INHIBITOR; 3D	Three-dimensional (3-D) culture models are emerging as invaluable tools in tumor biology, since they reproduce tissue-specific structural features and cell-cell interactions more accurately than conventional 2-D cultures. Multiple Myeloma, which depends on myeloma cell-Bone Marrow microenvironment interactions for development and response to drugs, may particularly benefit from such an approach. An innovative 3-D dynamic culture model based on the use of the RCCS (TM) Bioreactor was developed to allow long-term culture of myeloma tissue explants. This model was first validated with normal and pathological explants, then applied to tissues from myeloma patients. In all cases, histological examination demonstrated maintenance of viable myeloma cells inside their native microenvironment, with an overall well preserved histo-architecture including bone lamellae and vessels. This system was then successfully applied to evaluate the cytotoxic effects exerted by the proteasome inhibitor Bortezomib not only on myeloma cells but also on angiogenic vessels. Moreover, as surrogate markers of specialized functions expressed by myeloma cells and microenvironment, beta 2 microglobulin, VEGF and Angiopoietin-2 levels, as well as Matrix Metalloproteases activity, were evaluated in supernatants from 3D cultures and their levels reflected the effects of Bortezomib treatment. Notably, determination of beta 2 microglobulin levels in supernatants from Bortezomib-treated samples and in patients'sera following Bortezomib-based therapies disclosed an overall concordance in the response to the drug ex vivo and in vivo. Our findings indicate, as a proof of principle, that 3-D, RCCS (TM) bioreactor-based culture of tissue explants can be exploited for studying myeloma biology and for a pre-clinical approach to patient-targeted therapy.	[Ferrarini, Marina; Belloni, Daniela; Caligaris-Cappio, Federico; Ferrero, Elisabetta] Ist Sci San Raffaele, Dept Oncol, I-20132 Milan, Italy; [Steimberg, Nathalie; Mazzoleni, Giovanna] Univ Brescia, Sch Med, Lab Tissue Engn, Dept Clin & Expt Sci, Brescia, Italy; [Ponzoni, Maurilio] Ist Sci San Raffaele, Pathol Unit, I-20132 Milan, Italy; [Berenzi, Angiola] Univ Brescia, Sch Med, Dept Clin & Expt Sci, Inst Pathol Anat, Brescia, Italy; [Girlanda, Stefania] Ist Sci San Raffaele, Bone Marrow Transplantat Unit, I-20132 Milan, Italy; [Caligaris-Cappio, Federico] Univ Vita Salute San Raffaele, Sch Med, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Brescia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Brescia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Ferrarini, M (corresponding author), Ist Sci San Raffaele, Dept Oncol, I-20132 Milan, Italy.	ferrarini.marina@hsr.it; ferrero.elisabetta@hsr.it	Steimberg, Nathalie/P-7559-2014; Belloni, Daniela/AAN-6718-2020; Mazzoleni, Giovanna/AAC-8220-2021; Ferrarini, Marina/AAO-1548-2020; Mazzoleni, Giovanna/H-1299-2017	Steimberg, Nathalie/0000-0001-7695-0991; Belloni, Daniela/0000-0002-3487-4203; Mazzoleni, Giovanna/0000-0002-9433-1649; Mazzoleni, Giovanna/0000-0002-9433-1649; Ferrarini, Marina/0000-0003-1015-9632; Ferrero, Elisabetta/0000-0003-2571-933X	AIRC [9965]; European Union [LSHB-CT-2006-037168 (EXERA)]; Bosh S.p.A.	AIRC(Fondazione AIRC per la ricerca sul cancro); European Union(European Commission); Bosh S.p.A.	This work was supported by AIRC-Special Program Molecular Clinical Oncology AIRC 5x1000 project No 9965 (to FCC), by European Union Grant LSHB-CT-2006-037168 (EXERA) to GM and by research funding from Bosh S.p.A. to EF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anargyrou K, 2008, LEUKEMIA LYMPHOMA, V49, P677, DOI 10.1080/10428190701861686; Becker JL, 2013, NAT REV CANCER, V13, P315, DOI 10.1038/nrc3507; Belloni D, 2010, EXP CELL RES, V316, P1010, DOI 10.1016/j.yexcr.2009.11.005; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Bolkun L, 2012, ADV MED SCI, P18; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Calimeri T, 2011, LEUKEMIA, V25, P707, DOI 10.1038/leu.2010.300; Colla S, 2010, LEUKEMIA, V24, P1967, DOI 10.1038/leu.2010.193; Cosmi F, 2009, J MECH BEHAV BIOMED, V2, P164, DOI 10.1016/j.jmbbm.2008.06.004; de Bovenkamp MV, 2007, TOXICOL IN VITRO, V21, P545, DOI 10.1016/j.tiv.2006.12.009; Ferrarini M, 2011, CURR MED CHEM, V18, P5185, DOI 10.2174/092986711798184316; Ferreira C. M. S., 2013, INTECH, P39, DOI DOI 10.5772/56515; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Girlanda S, 2005, CANCER RES, V65, P7502, DOI 10.1158/0008-5472.CAN-05-0731; Gumieiro DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057424; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hose D, 2009, BLOOD, V114, P128, DOI 10.1182/blood-2008-10-184226; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Hussein MA, 2002, CURR OPIN ONCOL, V14, P31, DOI 10.1097/00001622-200201000-00006; Joshi S, 2011, CLIN BIOCHEM, V44, P590, DOI 10.1016/j.clinbiochem.2011.01.010; Kirshner J, 2008, BLOOD, V112, P2935, DOI 10.1182/blood-2008-02-142430; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Mastro AM, 2009, CANCER RES, V69, P4097, DOI 10.1158/0008-5472.CAN-08-4437; Mazzoleni G, 2010, ALTEX, V27, P321; Mazzoleni G., 2012, CONTINUUM HLTH RISK, P161; Mazzoleni G, 2009, GENES NUTR, V4, P13, DOI 10.1007/s12263-008-0107-0; Mitsiades CS, 2007, J CELL BIOCHEM, V101, P950, DOI 10.1002/jcb.21213; Nerini-Molteni S, 2008, BRIT J HAEMATOL, V141, P494, DOI 10.1111/j.1365-2141.2008.07066.x; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pruneri G, 2002, BRIT J HAEMATOL, V118, P817, DOI 10.1046/j.1365-2141.2002.03654.x; Rajkumar SV, 2011, NAT REV CLIN ONCOL, V8, P479, DOI 10.1038/nrclinonc.2011.63; Roccaro AM, 2006, CANCER RES, V66, P184, DOI 10.1158/0008-5472.CAN-05-1195; Schumacher K, 2007, TISSUE ENG, V13, P197, DOI 10.1089/ten.2006.0046; Steimberg N, 2010, ARTECH HSE METH BIOE, P205; Storti P, 2011, LEUKEMIA, V25, P527, DOI 10.1038/leu.2010.270; Terpos E, 2012, INT J CANCER, V130, P735, DOI 10.1002/ijc.26062; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tsirakis G, 2011, EUR J HISTOCHEM, V55, P113, DOI 10.4081/ejh.2011.e21; Vacca A, 2006, LEUKEMIA, V20, P193, DOI 10.1038/sj.leu.2404067; Vacca A, 2003, BLOOD, V102, P3340, DOI 10.1182/blood-2003-04-1338; Vacca A, 2001, ACTA HAEMATOL-BASEL, V106, P162, DOI 10.1159/000046612; Veschini L, 2007, BLOOD, V109, P2565, DOI 10.1182/blood-2006-06-032664; Veschini L, 2011, FASEB J, V25, P3906, DOI 10.1096/fj.11-182410; Vickers AEM, 2004, CHEM-BIOL INTERACT, V150, P87, DOI 10.1016/j.cbi.2004.09.005; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zdzisinska B, 2008, LEUKEMIA RES, V32, P1763, DOI 10.1016/j.leukres.2008.04.001; Zocchi MR, 1996, EUR J IMMUNOL, V26, P759, DOI 10.1002/eji.1830260406	49	63	66	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71613	10.1371/journal.pone.0071613	http://dx.doi.org/10.1371/journal.pone.0071613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23990965	gold, Green Submitted, Green Published			2022-12-25	WOS:000324228800011
J	Lavine, JS; King, AA; Andreasen, V; Bjornstad, ON				Lavine, Jennie S.; King, Aaron A.; Andreasen, Viggo; Bjornstad, Ottar N.			Immune Boosting Explains Regime-Shifts in Prevaccine-Era Pertussis Dynamics	PLOS ONE			English	Article							TRANSMISSION; VACCINATION; INFERENCE; INTERFERENCE; EPIDEMIOLOGY; POPULATIONS; INFECTIONS; ENGLAND; MEASLES; IMPACT	Understanding the biological mechanisms underlying episodic outbreaks of infectious diseases is one of mathematical epidemiology's major goals. Historic records are an invaluable source of information in this enterprise. Pertussis (whooping cough) is a re-emerging infection whose intermittent bouts of large multiannual epidemics interspersed between periods of smaller-amplitude cycles remain an enigma. It has been suggested that recent increases in pertussis incidence and shifts in the age-distribution of cases may be due to diminished natural immune boosting. Here we show that a model that incorporates this mechanism can account for a unique set of pre-vaccine-era data from Copenhagen. Under this model, immune boosting induces transient bursts of large amplitude outbreaks. In the face of mass vaccination, the boosting model predicts larger and more frequent outbreaks than do models with permanent or passively-waning immunity. Our results emphasize the importance of understanding the mechanisms responsible for maintaining immune memory for pertussis epidemiology.	[Lavine, Jennie S.; King, Aaron A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Lavine, Jennie S.; King, Aaron A.; Andreasen, Viggo; Bjornstad, Ottar N.] NIH, Fogarty Int Ctr, Bethesdsa, MD USA; [King, Aaron A.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [King, Aaron A.] Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA; [Andreasen, Viggo] Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark; [Bjornstad, Ottar N.] Penn State Univ, Dept Entomol & Biol, University Pk, PA 16802 USA	University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Roskilde University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	King, AA (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	kingaa@umich.edu	King, Aaron A/B-8092-2012	King, Aaron A/0000-0001-6159-3207; Andreasen, Viggo/0000-0001-8152-3898	Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, U.S. Department of Homeland Security; Fogarty International Center, U.S. National Institutes of Health; National Institutes of Health [1-R01-AI-101155-01]; Danish Medical Research Council [272-06-0430]; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101155] Funding Source: NIH RePORTER	Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, U.S. Department of Homeland Security; Fogarty International Center, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by the Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, U.S. Department of Homeland Security and Fogarty International Center, U.S. National Institutes of Health, and by grants from the National Institutes of Health (grant #1-R01-AI-101155-01 to AAK), the Danish Medical Research Council (grant #272-06-0430 to VA), and the Bill & Melinda Gates Foundation (to ONB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen V, 2011, VACCINE, V29, pB49, DOI 10.1016/j.vaccine.2011.03.061; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], INFECT DIS HUMANS DY; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Brennan M, 2000, J INFECT DIS, V181, P210, DOI 10.1086/315192; Broutin H, 2005, AM J EPIDEMIOL, V161, P1159, DOI 10.1093/aje/kwi141; Broutin H, 2010, P ROY SOC B-BIOL SCI, V277, P3239, DOI 10.1098/rspb.2010.0994; Burnham KP, 2002, MULTIMODEL INFERENCE; Carmona R., 1998, PRACTICAL TIME FREQU; Carmona R, 2010, RWAVE TIME FREQUENCY; Cattaneo LA, 1996, J INFECT DIS, V173, P1256, DOI 10.1093/infdis/173.5.1256; CLARKSON JA, 1985, INT J EPIDEMIOL, V14, P153, DOI 10.1093/ije/14.1.153; Crowcroft NS, 2003, LANCET INFECT DIS, V3, P413, DOI 10.1016/S1473-3099(03)00669-8; De Greeff S, 2009, EPIDEMIOL INFECT, P1; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; GRENFELL BT, 1989, PROC R SOC SER B-BIO, V236, P213, DOI 10.1098/rspb.1989.0022; Hallander HO, 2009, APMIS, V117, P912, DOI 10.1111/j.1600-0463.2009.02554.x; He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151; Hethcote HW, 1999, MATH COMPUT MODEL, V30, P29, DOI 10.1016/S0895-7177(99)00196-X; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; Ionides EL, 2011, ANN STAT, V39, P1776, DOI 10.1214/11-AOS886; Johansson B, 1946, DANSKE SYGDOMS DODSA; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; King A.A., 2010, POMP STAT INFERENCE; Lavine J, 2010, VACCINE, V29, P11, DOI 10.1016/j.vaccine.2010.10.029; Lavine JS, 2012, VACCINE, V30, P544, DOI 10.1016/j.vaccine.2011.11.065; Lavine JS, 2011, P NATL ACAD SCI US; McCullagh P., 1998, GEN LINEAR MODELS, V37; Metcalf CJE, 2009, P ROY SOC B-BIOL SCI, V276, P4111, DOI 10.1098/rspb.2009.1058; Mooi F, 2010, INFECTION; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Rohani P, 2002, AM NAT, V159, P469, DOI 10.1086/339467; Rohani P, 2003, NATURE, V422, P885, DOI 10.1038/nature01542; Rohani P, 1998, P ROY SOC B-BIOL SCI, V265, P2033, DOI 10.1098/rspb.1998.0537; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Saemann-Ischenko G, 2001, EUR J CLIN MICROBIOL, V20, P850, DOI 10.1007/s10096-001-0639-3; Tanaka M, 2003, JAMA-J AM MED ASSOC, V290, P2968, DOI 10.1001/jama.290.22.2968; Teunis PFM, 2002, EPIDEMIOL INFECT, V129, P479, DOI 10.1017/S0950268802007896; VONKONIG CHW, 1995, LANCET, V346, P1326, DOI 10.1016/S0140-6736(95)92343-8; Wearing HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000647; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Wood SN, 2010, NATURE, V466, P1102, DOI 10.1038/nature09319	43	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72086	10.1371/journal.pone.0072086	http://dx.doi.org/10.1371/journal.pone.0072086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991047	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800044
J	Cheng, YL; Wang, YJ; Kao, WY; Chen, PH; Huo, TL; Huang, YH; Lan, KH; Su, CW; Chan, WL; Lin, HC; Lee, FY; Wu, JC				Cheng, Yuan-Lung; Wang, Yuan-Jen; Kao, Wei-Yu; Chen, Ping-Hsien; Huo, Teh-la; Huang, Yi-Hsiang; Lan, Keng-Hsin; Su, Chien-Wei; Chan, Wan-Leong; Lin, Han-Chieh; Lee, Fa-Yauh; Wu, Jaw-Ching			Inverse Association between Hepatitis B Virus Infection and Fatty Liver Disease: A Large-Scale Study in Populations Seeking for Check-Up	PLOS ONE			English	Article							BODY-MASS INDEX; ALANINE AMINOTRANSFERASE LEVEL; RISK-FACTORS; METABOLIC SYNDROME; HBSAG SEROCLEARANCE; SURFACE-ANTIGEN; PREVALENCE; STEATOSIS; IMPACT; EPIDEMIOLOGY	Background: Although many studies have attempted to clarify the association between hepatitis B virus (HBV) infection and fatty liver disease, no prior studies have emphasized the relationship of HBV and fatty liver regarding different demographics of age and body mass index (BMI). Aim: To investigate the correlation of HBV and fatty liver in the different demographics of age and BMI. Methods: We enrolled consecutive subjects who had received health check-up services at the Taipei Veterans General Hospital from 2002 to 2009 and ultrasonography was used to diagnose fatty liver according to the practice guidelines of the American Gastroenterological Association. Results: Among the 33,439 subjects enrolled in this study, fatty liver was diagnosed in 43.9% of the population and 38.9% of patients with chronic HBV infection. Multivariate analysis showed that BMI, age, waist circumference, systolic blood pressure, fasting glucose, cholesterol, alanine aminotransferase (ALT) levels, and platelet counts were positively associated, while hepatitis B surface antigen (HBsAg) positivity was inversely associated with fatty liver, especially for subjects with BMI>22.4 kg/m(2) and age>50 years. On the contrary, HBV infection was positively correlated with the presence of elevated serum ALT levels in subjects with fatty liver disease regardless of their age and BMI. Conclusions: Metabolic factors are important determinants for the prevalence of fatty liver. Patients with HBV infection were inversely associated with fatty liver disease than the general population, especially in older and obese patients. Furthermore, metabolic factors and HBV infection were associated with elevated serum ALT levels in fatty liver disease.	[Cheng, Yuan-Lung; Huo, Teh-la; Huang, Yi-Hsiang; Lan, Keng-Hsin; Su, Chien-Wei; Lin, Han-Chieh; Lee, Fa-Yauh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Wang, Yuan-Jen; Chan, Wan-Leong] Taipei Vet Gen Hosp, Dept Med, Div Healthcare & Serv, Taipei, Taiwan; [Wang, Yuan-Jen; Kao, Wei-Yu; Chen, Ping-Hsien; Lan, Keng-Hsin; Su, Chien-Wei; Chan, Wan-Leong; Lin, Han-Chieh; Lee, Fa-Yauh] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Kao, Wei-Yu] Taipei Med Univ Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Chen, Ping-Hsien] Taipei Vet Gen Hosp, Endoscopy Ctr Diag & Treatment, Taipei, Taiwan; [Huo, Teh-la; Lan, Keng-Hsin] Natl Yang Ming Univ, Dept Pharmacol, Taipei 112, Taiwan; [Huo, Teh-la; Lan, Keng-Hsin] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Huang, Yi-Hsiang; Su, Chien-Wei; Wu, Jaw-Ching] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Wu, Jaw-Ching] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Medical University Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Su, CW (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan.	cwsu2@vghtpe.gov.tw; jcwu@vghtpe.gov.tw	Su, Chien-Wei/C-1521-2012; Su, Chien-Wei/AHC-8307-2022	Su, Chien-Wei/0000-0003-3889-7004; Su, Chien-Wei/0000-0003-3889-7004; Cheng, Yuan-Lung/0000-0002-8384-3315; Huang, Yi-Hsiang/0000-0001-5241-5425				Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chen CH, 2007, J GASTROEN HEPATOL, V22, P1482, DOI 10.1111/j.1440-1746.2006.04615.x; Chiang CH, 2013, INT J OBESITY, V37, P410, DOI 10.1038/ijo.2012.63; Chu CM, 2007, INT J OBESITY, V31, P871, DOI 10.1038/sj.ijo.0803479; Chuang SC, 2010, CANCER EPIDEM BIOMAR, V19, P1261, DOI 10.1158/1055-9965.EPI-09-1297; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Haring R, 2009, HEPATOLOGY, V50, P1403, DOI 10.1002/hep.23135; Hershko C, 2009, BLOOD, V114, P1, DOI 10.1182/blood-2009-04-216101; Hou XH, 2011, J GASTROEN HEPATOL, V26, P722, DOI 10.1111/j.1440-1746.2010.06509.x; Hsu CS, 2012, J VIRAL HEPATITIS, V19, pE48, DOI 10.1111/j.1365-2893.2011.01535.x; Huang KW, 2013, COLORECTAL IN PRESS; Jan CF, 2006, INT J OBESITY, V30, P794, DOI 10.1038/sj.ijo.0803204; Jin X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034198; JOSEPH AEA, 1991, CLIN RADIOL, V43, P26, DOI 10.1016/S0009-9260(05)80350-2; Kao WY, 2013, BRIT J CLIN IN PRESS; Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028; Koehler EM, 2013, CLIN GASTRO IN PRESS; Lee IC, 2011, CLIN NUTR, V30, P647, DOI 10.1016/j.clnu.2011.05.001; Lee JY, 2007, J HEPATOL, V47, P239, DOI 10.1016/j.jhep.2007.02.007; Liu CJ, 2012, J GASTROEN HEPATOL, V27, P1555, DOI 10.1111/j.1440-1746.2012.07222.x; Liu J, 2010, GASTROENTEROLOGY, V139, P474, DOI 10.1053/j.gastro.2010.04.048; Machado MV, 2011, J GASTROEN HEPATOL, V26, P1361, DOI 10.1111/j.1440-1746.2011.06801.x; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Na TY, 2009, HEPATOLOGY, V49, P1122, DOI 10.1002/hep.22740; Nascimento ACM, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/695950; Peng DD, 2008, J GASTROEN HEPATOL, V23, P1082, DOI 10.1111/j.1440-1746.2008.05478.x; Sgro C, 2002, HEPATOLOGY, V36, P451, DOI 10.1053/jhep.2002.34857; Shi JP, 2008, J GASTROEN HEPATOL, V23, P1419, DOI 10.1111/j.1440-1746.2008.05531.x; Su CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066457; Su CW, 2009, J CLIN GASTROENTEROL, V43, P876, DOI 10.1097/MCG.0b013e31818980ac; Su CW, 2013, J GASTROENT IN PRESS; Tai DI, 2010, AM J GASTROENTEROL, V105, P1102, DOI 10.1038/ajg.2009.669; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wang CC, 2008, J GASTROEN HEPATOL, V23, P779, DOI 10.1111/j.1440-1746.2007.05216.x; Wong GLH, 2009, GUT, V58, P111, DOI 10.1136/gut.2008.157735; Wong VWS, 2012, J HEPATOL, V56, P533, DOI 10.1016/j.jhep.2011.09.013; Wu WC, 2012, ALIMENT PHARM THER, V36, P560, DOI 10.1111/j.1365-2036.2012.05224.x; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Yu MW, 2008, J CLIN ONCOL, V26, P5576, DOI 10.1200/JCO.2008.16.1075; Yuen MF, 2008, GASTROENTEROLOGY, V135, P1192, DOI 10.1053/j.gastro.2008.07.008; Yun JW, 2009, LIVER INT, V29, P878, DOI 10.1111/j.1478-3231.2009.01976.x; Zhang Z, 2012, J GASTROEN HEPATOL, V27, P1858, DOI 10.1111/j.1440-1746.2012.07268.x	44	59	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72049	10.1371/journal.pone.0072049	http://dx.doi.org/10.1371/journal.pone.0072049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991037	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470700027
J	Liang, X; Wen, JQ; Ni, L; Zhong, JH; Qi, RF; Zhang, LJ; Lu, GM				Liang, Xue; Wen, Jiqiu; Ni, Ling; Zhong, Jianhui; Qi, Rongfeng; Zhang, Long Jiang; Lu, Guang Ming			Altered Pattern of Spontaneous Brain Activity in the Patients with End-Stage Renal Disease: A Resting-State Functional MRI Study with Regional Homogeneity Analysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SOCIAL ANXIETY DISORDER; COGNITIVE FUNCTION; HEPATIC-ENCEPHALOPATHY; HEMODIALYSIS-PATIENTS; ALZHEIMERS-DISEASE; CONNECTIVITY MRI; IMPAIRMENT; NETWORK; ATTENTION	Purpose: To investigate the pattern of spontaneous neural activity in patients with end-stage renal disease (ESRD) with and without neurocognitive dysfunction using resting-state functional magnetic resonance imaging (rs-fMRI) with a regional homogeneity (ReHo) algorithm. Materials and Methods: rs-fMRI data were acquired in 36 ESRD patients (minimal nephro-encephalopathy [MNE], n = 19, 13 male, 37+/-12.07 years; non-nephro-encephalopathy [non-NE], n = 17, 11 male, 38+/-12.13 years) and 20 healthy controls (13 male, 7 female, 36+/-10.27 years). Neuropsychological (number connection test type A [NCT-A], digit symbol test [DST]) and laboratory tests were performed in all patients. The Kendall's coefficient of concordance (KCC) was used to measure the regional homogeneity for each subject. The regional homogeneity maps were compared using ANOVA tests among MNE, non-NE, and healthy control groups and post hoc t-tests between each pair in a voxel-wise way. A multiple regression analysis was performed to evaluate the relationships between ReHo index and NCT-A, DST scores, serum creatinine and urea levels, disease and dialysis duration. Results: Compared with healthy controls, both MNE and non-NE patients showed decreased ReHo in the multiple areas of bilateral frontal, parietal and temporal lobes. Compared with the non-NE, MNE patients showed decreased ReHo in the right inferior parietal lobe (IPL), medial frontal cortex (MFC) and left precuneus (PCu). The NCT-A scores and serum urea levels of ESRD patients negatively correlated with ReHo values in the frontal and parietal lobes, while DST scores positively correlated with ReHo values in the bilateral PCC/precuneus, MFC and inferior parietal lobe (IPL) (all P<0.05, AlphaSim corrected). No significant correlations were found between any regional ReHo values and disease duration, dialysis duration and serum creatinine values in ESRD patients (all P>0.05, AlphaSim corrected). Conclusion: Diffused decreased ReHo values were found in both MNE and non-NE patients. The progressively decreased ReHo in the default mode network (DMN), frontal and parietal lobes might be trait-related in MNE. The ReHo analysis may be potentially valuable for elucidating neurocognitive abnormalities of ESRD patients and detecting the development from non-NE to MNE.	[Liang, Xue; Ni, Ling; Qi, Rongfeng; Zhang, Long Jiang; Lu, Guang Ming] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Imaging, Nanjing 210008, Jiangsu, Peoples R China; [Liang, Xue] Xuzhou Med Coll, Sch Med Imaging, Xuzhou, Peoples R China; [Wen, Jiqiu] Nanjing Univ, Sch Med, Jinling Hosp, Dept Nephrol, Nanjing 210008, Jiangsu, Peoples R China; [Zhong, Jianhui] Univ Rochester, Sch Med & Dent, Dept Imaging Sci, Rochester, NY USA	Nanjing University; Xuzhou Medical University; Nanjing University; University of Rochester	Zhang, LJ (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Imaging, Nanjing 210008, Jiangsu, Peoples R China.	kevinzhlj@163.com; cjr.luguangming@vip.163.com	Zhong, Jianhui/AAE-6061-2020		Natural Scientific Foundation of China [30700194, 81230032, 81101039]; Natural Scientific Foundation of Jiangsu province, China [BK2007572]; China Postdoctoral Science Foundation of Jiangsu Province [100283C]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Scientific Foundation of Jiangsu province, China; China Postdoctoral Science Foundation of Jiangsu Province(China Postdoctoral Science Foundation)	Funding provided by the Natural Scientific Foundation of China [Grant NoS. 30700194 and 81230032 for Long Jiang Zhang; Grant No. 81101039 for Gang Zheng], the Natural Scientific Foundation of Jiangsu province, China [Grant No. BK2007572 for Long Jiang Zhang], and China Postdoctoral Science Foundation of Jiangsu Province (Grant No. 100283C for Gang Zheng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KM, 2009, NEUROPSYCHOLOGICAL A; Altmann P, 2007, KIDNEY INT, V71, P252, DOI 10.1038/sj.ki.5001932; Bajaj JS, 2009, HEPATOLOGY, V50, P2014, DOI 10.1002/hep.23216; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chen CL, 2007, AM J NEURORADIOL, V28, P68; Chen HJ, 2012, EUR J RADIOL, V81, P2463, DOI 10.1016/j.ejrad.2011.10.008; Fazekas G, 1996, NUCL MED COMMUN, V17, P603, DOI 10.1097/00006231-199607000-00011; GEISSLER A, 1995, RADIOLOGY, V194, P693, DOI 10.1148/radiology.194.3.7862964; GILLI P, 1983, CLIN NEPHROL, V19, P188; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hailpern SM, 2007, J AM SOC NEPHROL, V18, P2205, DOI 10.1681/ASN.2006101165; Harciarek M, 2012, J INT NEUROPSYCH SOC, V18, P162, DOI 10.1017/S1355617711001445; HIRAKATA H, 1992, AM J PHYSIOL, V262, pF737, DOI 10.1152/ajprenal.1992.262.5.F737; Jassal SV, 2008, INT UROL NEPHROL, V40, P849, DOI 10.1007/s11255-008-9375-2; Kim HS, 2011, NEUROREHABILITATION, V29, P111, DOI 10.3233/NRE-2011-0684; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liu Y, 2008, NEUROPSYCHOLOGIA, V46, P1648, DOI 10.1016/j.neuropsychologia.2008.01.027; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; LYNCH JC, 1977, J NEUROPHYSIOL, V40, P362, DOI 10.1152/jn.1977.40.2.362; Madero M, 2008, SEMIN DIALYSIS, V21, P29, DOI 10.1111/j.1525-139X.2007.00384.x; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Ni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042016; OKADA J, 1991, NEURORADIOLOGY, V33, P524, DOI 10.1007/BF00588046; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Pliskin NH, 1996, KIDNEY INT, V49, P1435, DOI 10.1038/ki.1996.202; POSNER MI, 1984, J NEUROSCI, V4, P1863; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; Qiu CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P47, DOI 10.1016/j.pscychresns.2011.01.010; Raphael KL, 2012, AM J NEPHROL, V35, P49, DOI 10.1159/000334872; Ronco C, 2002, CONTRIB NEPHROL, V137, P1; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tononi G, 1998, NEUROIMAGE, V7, P133, DOI 10.1006/nimg.1997.0313; Tryc AB, 2011, NEPHROL DIAL TRANSPL, V26, P2635, DOI 10.1093/ndt/gfq729; Tullberg M, 2004, NEUROLOGY, V63, P246, DOI 10.1212/01.WNL.0000130530.55104.B5; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Williams MA, 2004, AM J KIDNEY DIS, V43, P705, DOI 10.1053/j.ajkd.2003.12.031; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang LJ, 2012, RADIOLOGY, V265, P528, DOI 10.1148/radiol.12120185; Zhang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042824; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zhong Y, 2011, EPILEPSY RES, V97, P83, DOI 10.1016/j.eplepsyres.2011.07.007	48	34	48	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e71507	10.1371/journal.pone.0071507	http://dx.doi.org/10.1371/journal.pone.0071507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23990958	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470700017
J	Roppenser, B; Kwon, H; Canadien, V; Xu, RS; Devreotes, PN; Grinstein, S; Brumell, JH				Roppenser, Bernhard; Kwon, Hyunwoo; Canadien, Veronica; Xu, Risheng; Devreotes, Peter N.; Grinstein, Sergio; Brumell, John H.			Multiple Host Kinases Contribute to Akt Activation during Salmonella Infection	PLOS ONE			English	Article							INOSITOL POLYPHOSPHATE MULTIKINASE; EPITHELIAL-CELLS; CONTAINING VACUOLES; ACTIN CYTOSKELETON; PHOSPHORYLATION; TYPHIMURIUM; SOPB; AKT/PKB; INVASION; PATHWAY	SopB is a type 3 secreted effector with phosphatase activity that Salmonella employs to manipulate host cellular processes, allowing the bacteria to establish their intracellular niche. One important function of SopB is activation of the pro-survival kinase Akt/protein kinase B in the infected host cell. Here, we examine the mechanism of Akt activation by SopB during Salmonella infection. We show that SopB-mediated Akt activation is only partially sensitive to PI3-kinase inhibitors LY294002 and wortmannin in HeLa cells, suggesting that Class I PI3-kinases play only a minor role in this process. However, depletion of PI(3,4) P-2/PI(3-5) P-3 by expression of the phosphoinositide 3-phosphatase PTEN inhibits Akt activation during Salmonella invasion. Therefore, production of PI(3,4) P-2/PI(3-5) P-3 appears to be a necessary event for Akt activation by SopB and suggests that non-canonical kinases mediate production of these phosphoinositides during Salmonella infection. We report that Class II PI3-kinase beta isoform, IPMK and other kinases identified from a kinase screen all contribute to Akt activation during Salmonella infection. In addition, the kinases required for SopB-mediated activation of Akt vary depending on the type of infected host cell. Together, our data suggest that Salmonella has evolved to use a single effector, SopB, to manipulate a remarkably large repertoire of host kinases to activate Akt for the purpose of optimizing bacterial replication in its host.	[Roppenser, Bernhard; Canadien, Veronica; Grinstein, Sergio; Brumell, John H.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Kwon, Hyunwoo; Brumell, John H.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Xu, Risheng] Johns Hopkins Med Sch, Dept Neurosci, Baltimore, MD USA; [Devreotes, Peter N.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA; [Grinstein, Sergio; Brumell, John H.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Grinstein, Sergio] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Brumell, John H.] Hosp Sick Children, Sickkids IBD Ctr, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Brumell, JH (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	john.brumell@sickkids.ca			Austrian Science Fund; Canadian Association for Gastroenterology; Crohn's and Colitis Foundation of Canada; Canadian Institutes of Health Research (MOP) [93634]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028007, R01GM028007, R01GM034933] Funding Source: NIH RePORTER	Austrian Science Fund(Austrian Science Fund (FWF)); Canadian Association for Gastroenterology; Crohn's and Colitis Foundation of Canada; Canadian Institutes of Health Research (MOP)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	BR was supported by the Austrian Science Fund. HK was supported by a summer studentship from the Canadian Association for Gastroenterology and Crohn's and Colitis Foundation of Canada. This work was supported by an operating grant from the Canadian Institutes of Health Research (MOP#93634) (to JHB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bakowski MA, 2007, CELL MICROBIOL, V9, P2839, DOI 10.1111/j.1462-5822.2007.01000.x; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Chua BT, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-131; Cooper KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022260; Cuevas B, 1999, J BIOL CHEM, V274, P27583, DOI 10.1074/jbc.274.39.27583; Dai SP, 2007, TRAFFIC, V8, P1365, DOI 10.1111/j.1600-0854.2007.00613.x; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Frederick JP, 2005, P NATL ACAD SCI USA, V102, P8454, DOI 10.1073/pnas.0503706102; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Guo JP, 2011, J BIOL CHEM, V286, P37389, DOI 10.1074/jbc.M111.287433; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Huang YH, 2006, RES MICROBIOL, V157, P206, DOI 10.1016/j.resmic.2005.11.005; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Kim S, 2011, CELL METAB, V13, P215, DOI 10.1016/j.cmet.2011.01.007; Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200; Koul D, 2005, MOL CANCER THER, V4, P1681, DOI 10.1158/1535-7163.MCT-05-0258; Leibiger IB, 2010, BIOCHEM BIOPH RES CO, V396, P111, DOI 10.1016/j.bbrc.2010.02.174; Liu XS, 2011, J BIOL CHEM, V286, P35795, DOI 10.1074/jbc.C111.269050; Ma J, 2012, J IMMUNOL, V188, P5337, DOI 10.4049/jimmunol.1102979; Maag D, 2011, P NATL ACAD SCI USA, V108, P1391, DOI 10.1073/pnas.1017831108; Mahajan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009646; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Mao K, 2008, J MOL CELL CARDIOL, V44, P429, DOI 10.1016/j.yjmcc.2007.10.016; Marcus SL, 2002, CELL MICROBIOL, V4, P435, DOI 10.1046/j.1462-5822.2002.00202.x; Marcus SL, 2001, FEBS LETT, V494, P201, DOI 10.1016/S0014-5793(01)02356-0; Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; PANG T, 1995, TRENDS MICROBIOL, V3, P253, DOI 10.1016/S0966-842X(00)88937-4; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Pendaries C, 2006, EMBO J, V25, P1024, DOI 10.1038/sj.emboj.7601001; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Resnick AC, 2005, P NATL ACAD SCI USA, V102, P12783, DOI 10.1073/pnas.0506184102; Rogers LD, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001668; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Siddhanta U, 1998, J CELL BIOL, V143, P1647, DOI 10.1083/jcb.143.6.1647; Steele-Mortimer O, 2000, J BIOL CHEM, V275, P37718, DOI 10.1074/jbc.M008187200; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Suh HS, 2005, J IMMUNOL, V174, P2712, DOI 10.4049/jimmunol.174.5.2712; Tahoun A, 2012, CELL HOST MICROBE, V12, P645, DOI 10.1016/j.chom.2012.10.009; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; Tsolis RM, 1999, ADV EXP MED BIOL, V473, P261; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wasylnka JA, 2008, INFECT IMMUN, V76, P2722, DOI 10.1128/IAI.00152-08; Zhang XL, 1997, J BIOL CHEM, V272, P17756, DOI 10.1074/jbc.272.28.17756; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	49	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e71015	10.1371/journal.pone.0071015	http://dx.doi.org/10.1371/journal.pone.0071015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23990921	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470700008
J	Stanga, Z; Nock, S; Medina-Escobar, P; Nydegger, UE; Risch, M; Risch, L				Stanga, Zeno; Nock, Stefan; Medina-Escobar, Pedro; Nydegger, Urs E.; Risch, Martin; Risch, Lorenz			Factors Other than the Glomerular Filtration Rate That Determine the Serum Beta-2-Microglobulin Level	PLOS ONE			English	Article							BETA-TRACE-PROTEIN; NUTRITIONAL RISK INDEX; CYSTATIN-C LEVELS; RENAL-FUNCTION; KIDNEY-FUNCTION; CORTICOSTEROID-THERAPY; DIAGNOSTIC-ACCURACY; CLINICAL IMPACT; ESTIMATING GFR; CREATININE	Background: beta 2-microglobulin has been increasingly investigated as a diagnostic marker of kidney function and a prognostic marker of adverse outcomes. To date, non-renal determinants of beta 2-microglobulin levels have not been well described. Non-renal determinants are important for the interpretation and appraisal of the diagnostic and prognostic value of any endogenous kidney function marker. Methods: This cross-sectional analysis was performed within the framework of the www.seniorlabor.ch study, which includes subjectively healthy individuals aged >= 60 years. Factors known or suspected to have a non-renal association with kidney function markers were investigated for a non-renal association with serum beta 2-microglobulin. As a marker of kidney function, the Berlin Initiative Study equation 2 for the estimation of the estimated glomerular filtration rate (eGFR(BIS2)) in the elderly was employed. Results: A total of 1302 participants (714 females and 588 males) were enrolled in the study. The use of a multivariate regression model adjusting for age, gender and kidney function (eGFRBIS2) revealed age, male gender, and C-reactive protein level to be positively associated with beta 2-microglobulin levels. In addition, there was an inverse non-renal relationship between systolic blood pressure, total cholesterol and current smoking status. No association with markers of diabetes mellitus, body stature, nutritional risk, thyroid function or calcium and phosphate levels was observed. Conclusions: Serum beta 2-microglobulin levels in elderly subjects are related to several non-renal factors. These non-renal factors are not congruent to those known from other markers (i.e. cystatin C and creatinine) and remind of classical cardiovascular risk factors.	[Stanga, Zeno] Univ Hosp Bern, Div Endocrinol Diabet Clin Nutr, CH-3010 Bern, Switzerland; [Stanga, Zeno] Univ Hosp Bern, Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Stanga, Zeno] Univ Bern, Bern, Switzerland; [Nock, Stefan; Risch, Lorenz] Private Univ, Triesen, Liechtenstein; [Medina-Escobar, Pedro; Nydegger, Urs E.; Risch, Lorenz] Lab Med Zentren Dr Risch, Liebefeld, Switzerland; [Risch, Martin] Kantonsspital, Zent Lab, Chur, Switzerland; [Risch, Lorenz] Med Univ Innsbruck, Div Clin Biochem, A-6020 Innsbruck, Austria	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; Kantonsspital Aarau AG (KSA); Medical University of Innsbruck	Risch, L (corresponding author), Private Univ, Triesen, Liechtenstein.	lorenzrisch@hotmail.com	Risch, Martin/ABG-4783-2020; Risch, Lorenz/D-4629-2011; Stanga, Zeno/AAM-2244-2020	Risch, Lorenz/0000-0003-2692-6699; 				Astor BC, 2013, CURR OPIN NEPHROL HY; Astor BC, 2012, AM J KIDNEY DIS, V59, P653, DOI 10.1053/j.ajkd.2011.11.042; Bianchi C, 2001, RENAL FAILURE, V23, P419, DOI 10.1081/JDI-100104725; Blirup-Jensen S, 2008, SCAND J CLIN LAB INV, V68, P67, DOI 10.1080/00365510802150067; Bokenkamp A, 2007, CLIN CHEM, V53, P2219, DOI 10.1373/clinchem.2007.094946; Bokenkamp A, 2002, CLIN NEPHROL, V58, P417; Bokenkamp A, 2002, CLIN CHEM, V48, P1123; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; CASSUTO JP, 1978, LANCET, V2, P108; Castro J, 2003, CLIN CHIM ACTA, V334, P225, DOI 10.1016/S0009-8981(03)00162-1; Cimerman N, 2000, CLIN CHIM ACTA, V300, P83, DOI 10.1016/S0009-8981(00)00298-9; Curhan G, 2005, CLIN CHEM, V51, P293, DOI 10.1373/clinchem.2004.044388; Delanghe JR, 2011, CLIN CHEM LAB MED, V49, P977, DOI 10.1515/CCLM.2011.167; Donadio C, 2001, J PHARMACEUT BIOMED, V24, P835, DOI 10.1016/S0731-7085(00)00550-1; Donadio C, 2010, AM J PHYSIOL-RENAL, V299, pF1407, DOI 10.1152/ajprenal.00507.2009; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Filler G, 2002, CLIN CHEM, V48, P729; Filler G, 1997, CLIN CHEM, V43, P1077; Finney H, 2001, CLIN CHIM ACTA, V309, P1, DOI 10.1016/S0009-8981(01)00415-6; Fricker M, 2003, KIDNEY INT, V63, P1944, DOI 10.1046/j.1523-1755.2003.00925.x; GUSSOW D, 1987, J IMMUNOL, V139, P3132; Hostetter TH, 2010, CLIN CHEM, V56, P1381, DOI 10.1373/clinchem.2010.147827; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Inker LA, 2011, AM J KIDNEY DIS, V58, P682, DOI 10.1053/j.ajkd.2011.05.019; Juraschek SP, 2013, CLIN J AM SOC NEPHRO, V8, P584, DOI 10.2215/CJN.08700812; Juraschek SP, 2012, CLIN BIOCHEM, V45, P694, DOI 10.1016/j.clinbiochem.2012.02.027; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Kobayashi I, 2010, NEPHROL DIAL TRANSPL, V25, P3361, DOI 10.1093/ndt/gfq211; Kristensen K, 2007, ACTA OBSTET GYN SCAN, V86, P921, DOI 10.1080/00016340701318133; Lamb EJ, 2004, CLIN CHEM, V50, P1848, DOI 10.1373/clinchem.2004.036947; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Manetti L, 2005, CLIN CHIM ACTA, V356, P227, DOI 10.1016/j.cccn.2005.01.022; Manetti L, 2005, J ENDOCRINOL INVEST, V28, P346, DOI 10.1007/BF03347201; Mariani LH, 2012, J AM SOC NEPHROL, V23, P22, DOI 10.1681/ASN.2010070766; Muto H, 2010, INT J HEMATOL, V91, P471, DOI 10.1007/s12185-010-0521-0; Norlund L, 1997, SCAND J CLIN LAB INV, V57, P463, DOI 10.3109/00365519709084595; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Risch C, 2012, INT J LAB HEMATOL, V34, P192, DOI 10.1111/j.1751-553X.2011.01382.x; Risch L, 2005, CLIN CHEM, V51, P2211, DOI 10.1373/clinchem.2005.057075; Risch L, 2001, CLIN CHEM, V47, P2055; Rule AD, 2006, KIDNEY INT, V69, P399, DOI 10.1038/sj.ki.5000073; Schaeffner ES, 2012, ANN INTERN MED, V157, P471, DOI 10.7326/0003-4819-157-7-201210020-00003; Soares AA, 2009, CLIN CHEM LAB MED, V47, P1023, DOI 10.1515/CCLM.2009.263; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stevens LA, 2009, J AM SOC NEPHROL, V20, P2305, DOI 10.1681/ASN.2009020171; Stevens LA, 2009, KIDNEY INT, V75, P652, DOI 10.1038/ki.2008.638; Tangri N, 2012, J AM SOC NEPHROL, V23, P351, DOI 10.1681/ASN.2011070663; Tangri N, 2011, KIDNEY INT, V79, P471, DOI 10.1038/ki.2010.431; TEUFELSBAUER H, 1989, CIRCULATION, V80, P1681, DOI 10.1161/01.CIR.80.6.1681; Thomassen SA, 2002, SPINAL CORD, V40, P524, DOI 10.1038/sj.sc.3101320; VIBERTI GC, 1981, BRIT MED J, V282, P95, DOI 10.1136/bmj.282.6258.95; WALTERS MT, 1989, ANN RHEUM DIS, V48, P905, DOI 10.1136/ard.48.11.905; White CA, 2009, AM J KIDNEY DIS, V54, P922, DOI 10.1053/j.ajkd.2009.06.003; Yamada K, 2008, AM J CLIN NUTR, V87, P106, DOI 10.1093/ajcn/87.1.106	55	29	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72073	10.1371/journal.pone.0072073	http://dx.doi.org/10.1371/journal.pone.0072073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991042	gold, Green Published			2022-12-25	WOS:000324470700029
J	Huang, HT; Maruyama, J; Kitamoto, K				Huang, Hsiang-Ting; Maruyama, Jun-ichi; Kitamoto, Katsuhiko			Aspergillus oryzae AoSO Is a Novel Component of Stress Granules upon Heat Stress in Filamentous Fungi	PLOS ONE			English	Article							MESSENGER-RNA DECAY; P-BODIES; PROCESSING BODIES; TRANSLATION INITIATION; PROTEINS; RECRUITMENT; YEAST; STABILIZATION; DEADENYLATION; SPITZENKORPER	Stress granules are a type of cytoplasmic messenger ribonucleoprotein (mRNP) granule formed in response to the inhibition of translation initiation, which typically occurs when cells are exposed to stress. Stress granules are conserved in eukaryotes; however, in filamentous fungi, including Aspergillus oryzae, stress granules have not yet been defined. For this reason, here we investigated the formation and localization of stress granules in A. oryzae cells exposed to various stresses using an EGFP fusion protein of AoPab1, a homolog of Saccharomyces cerevisiae Pab1p, as a stress granule marker. Localization analysis showed that AoPab1 was evenly distributed throughout the cytoplasm under normal growth conditions, and accumulated as cytoplasmic foci mainly at the hyphal tip in response to stress. AoSO, a homolog of Neurospora crassa SO, which is necessary for hyphal fusion, colocalized with stress granules in cells exposed to heat stress. The formation of cytoplasmic foci of AoSO was blocked by treatment with cycloheximide, a known inhibitor of stress granule formation. Deletion of the Aoso gene had effects on the formation and localization of stress granules in response to heat stress. Our results suggest that AoSO is a novel component of stress granules specific to filamentous fungi. The authors would specially like to thank Hiroyuki Nakano and Kei Saeki for generously providing experimental and insightful opinions.	[Huang, Hsiang-Ting; Maruyama, Jun-ichi; Kitamoto, Katsuhiko] Univ Tokyo, Dept Biotechnol, Tokyo, Japan	University of Tokyo	Kitamoto, K (corresponding author), Univ Tokyo, Dept Biotechnol, Tokyo, Japan.	akitamo@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Novozymes Japan Research Fund	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Novozymes Japan Research Fund	This study was supported in part by a Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by Novozymes Japan Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; AYLMORE RC, 1984, J GEN MICROBIOL, V130, P2975; Bollig F, 2002, EUR J BIOCHEM, V269, P5830, DOI 10.1046/j.1432-1033.2002.03300.x; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 1998, GENE DEV, V12, P3226, DOI 10.1101/gad.12.20.3226; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Engh I, 2007, EUKARYOT CELL, V6, P831, DOI 10.1128/EC.00269-06; Erickson SL, 2011, J CELL SCI, V124, P293, DOI 10.1242/jcs.072140; Escano CS, 2009, EUKARYOT CELL, V8, P296, DOI 10.1128/EC.00197-08; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fleissner A, 2005, EUKARYOT CELL, V4, P920, DOI 10.1128/EC.4.5.920-930.2005; Fleissner A, 2007, EUKARYOT CELL, V6, P84, DOI 10.1128/EC.00268-06; Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; HOWARD RJ, 1981, J CELL SCI, V48, P89; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kitamoto K, 2002, ADV APPL MICROBIOL, V51, P129, DOI 10.1016/S0065-2164(02)51004-2; LaGrandeur T, 1999, RNA, V5, P420, DOI 10.1017/S1355838299981748; Lai JL, 2012, P NATL ACAD SCI USA, V109, P15781, DOI 10.1073/pnas.1207467109; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lu X, 2006, CANCER RES, V66, P1052, DOI 10.1158/0008-5472.CAN-05-3459; Mabashi Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1882, DOI 10.1271/bbb.60052; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; MARKHAM P, 1994, MYCOL RES, V98, P1089, DOI 10.1016/S0953-7562(09)80195-0; Maruyama JI, 2008, BIOTECHNOL LETT, V30, P1811, DOI 10.1007/s10529-008-9763-9; Maruyama J, 2011, METHODS MOL BIOL, V765, P447, DOI 10.1007/978-1-61779-197-0_27; Maruyama J, 2010, BIOCHEM BIOPH RES CO, V391, P868, DOI 10.1016/j.bbrc.2009.11.154; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Muckenthaler M, 1997, RNA, V3, P983; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Nilsson D, 2011, RNA, V17, P120, DOI 10.1261/rna.2268111; Nissan T, 2010, MOL CELL, V39, P773, DOI 10.1016/j.molcel.2010.08.025; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Powley IR, 2009, GENE DEV, V23, P1207, DOI 10.1101/gad.516509; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; Shah KH, 2012, GENETICS IN PRESS, P112; She MP, 2006, NAT STRUCT MOL BIOL, V13, P63, DOI 10.1038/nsmb1033; SHEPHERD VA, 1993, J CELL SCI, V105, P1173; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; Takahashi S, 2011, NUCLEIC ACIDS RES, V39, P3446, DOI 10.1093/nar/gkq1302; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Tsuboi T, 2010, J BIOL CHEM, V285, P33589, DOI 10.1074/jbc.M110.117150; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; van Peer AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005977; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Wilusz CJ, 2001, RNA, V7, P1416; Yamada O, 1997, BIOSCI BIOTECH BIOCH, V61, P1367, DOI 10.1271/bbb.61.1367	73	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72209	10.1371/journal.pone.0072209	http://dx.doi.org/10.1371/journal.pone.0072209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991062	gold, Green Submitted, Green Published			2022-12-25	WOS:000324470100084
J	Outinen, TK; Tervo, L; Makela, S; Huttunen, R; Maenpaa, N; Huhtala, H; Vaheri, A; Mustonen, J; Aittoniemi, J				Outinen, Tuula K.; Tervo, Laura; Makela, Satu; Huttunen, Reetta; Maenpaa, Niina; Huhtala, Heini; Vaheri, Antti; Mustonen, Jukka; Aittoniemi, Janne			Plasma Levels of Soluble Urokinase-Type Plasminogen Activator Receptor Associate with the Clinical Severity of Acute Puumala Hantavirus Infection	PLOS ONE			English	Article							INDUCED NEPHROPATHIA-EPIDEMICA; PREDICTS MORTALITY; HIV-1-INFECTED PATIENTS; RADIOLOGICAL FINDINGS; CEREBROSPINAL-FLUID; BETA(3) INTEGRINS; IMMUNE ACTIVATION; HEMORRHAGIC-FEVER; VIRUS-INFECTION; CELLULAR ENTRY	Objectives: Urokinase-type plasminogen activator receptor is a multifunctional glycoprotein, the expression of which is increased during inflammation. It is known to bind to beta(3)-integrins, which are elementary for the cellular entry of hantaviruses. Plasma soluble form of the receptor (suPAR) levels were evaluated as a predictor of severe Puumala hantavirus (PUUV) infection and as a possible factor involved in the pathogenesis of the disease. Design: A single-centre prospective cohort study. Subjects and Methods: Plasma suPAR levels were measured twice during the acute phase and once during the convalescence in 97 patients with serologically confirmed acute PUUV infection using a commercial enzyme-linked immunosorbent assay (ELISA). Results: The plasma suPAR levels were significantly higher during the acute phase compared to the control values after the hospitalization (median 8.7 ng/ml, range 4.0-18.2 ng/ml vs. median 4.7 ng/ml, range 2.4-12.2 ng/ml, P<0.001). The maximum suPAR levels correlated with several variables reflecting the severity of the disease. There was a positive correlation with maximum leukocyte count (r = 0.475, p<0.001), maximum plasma creatinine concentration (r = 0.378, p<0.001), change in weight during the hospitalization (r = 0.406, p<0.001) and the length of hospitalization (r = 0.325, p = 0.001), and an inverse correlation with minimum platelet count (r = -0.325, p = 0.001) and minimum hematocrit (r = -0.369, p<0.001). Conclusion: Plasma suPAR values are markedly increased during acute PUUV infection and associate with the severity of the disease. The overexpression of suPAR possibly activates beta(3)-integrin in PUUV infection, and thus might be involved in the pathogenesis of the disease.	[Outinen, Tuula K.; Tervo, Laura; Makela, Satu; Huttunen, Reetta; Mustonen, Jukka] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Outinen, Tuula K.; Makela, Satu; Huttunen, Reetta; Maenpaa, Niina; Mustonen, Jukka] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Maenpaa, Niina; Aittoniemi, Janne] Fimlab Labs, Dept Clin Microbiol, Tampere, Finland; [Huhtala, Heini] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Vaheri, Antti] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland	Tampere University; Tampere University Hospital; Tampere University; Tampere University; University of Helsinki	Outinen, TK (corresponding author), Tampere Univ Hosp, Dept Internal Med, Tampere, Finland.	tuula.outinen@uta.fi	Vaheri, Antti/AAV-1523-2020	Tervo, Laura/0000-0001-9474-0285; Outinen, Tuula/0000-0002-2773-4077; Makela, Satu/0000-0001-6967-2401	Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital [9P031, Fimlab X50000]; European Commission Project "Diagnosis and control of rodent-borne viral zoonoses in Europe'' [QLK2-CT-2002-01358]; Sigrid Juselius Foundation; Finnish Kidney Foundation; Orion-Farmos Research Foundation	Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital; European Commission Project "Diagnosis and control of rodent-borne viral zoonoses in Europe''; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Kidney Foundation; Orion-Farmos Research Foundation	This study was financially supported by the Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital (9P031, Fimlab X50000), European Commission Project "Diagnosis and control of rodent-borne viral zoonoses in Europe'' (QLK2-CT-2002-01358), and by grants from the Sigrid Juselius Foundation, the Finnish Kidney Foundation and the Orion-Farmos Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ES, 2011, EUR J CLIN MICROBIOL, V30, P761, DOI 10.1007/s10096-010-1149-y; Berres ML, 2012, J CLIN GASTROENTEROL, V46, P334, DOI 10.1097/MCG.0b013e31822da19d; Braun N, 2010, NEPHROL DIAL TRANSPL, V25, P2997, DOI 10.1093/ndt/gfq118; COSGRIFF TM, 1991, REV INFECT DIS, V13, P97; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Eugen-Olsen J, 2002, INT J TUBERC LUNG D, V6, P686; Garcia-Monco JC, 2002, J NEUROIMMUNOL, V129, P216, DOI 10.1016/S0165-5728(02)00186-8; Gavrilovskaya IN, 1999, J VIROL, V73, P3951, DOI 10.1128/JVI.73.5.3951-3959.1999; Gavrilovskaya IN, 1998, P NATL ACAD SCI USA, V95, P7074, DOI 10.1073/pnas.95.12.7074; HEYMAN P, 2008, EURO SURVEILL, V13; Huttunen R, 2011, J INTERN MED, V270, P32, DOI 10.1111/j.1365-2796.2011.02363.x; Kanerva M, 1998, REV MED VIROL, V8, P67, DOI 10.1002/(SICI)1099-1654(199804/06)8:2&lt;67::AID-RMV217&gt;3.0.CO;2-U; Kanerva M, 1996, CLIN NEPHROL, V46, P369; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10037; LAHDEVIRTA J, 1971, ANN CLIN RES, V3, P1; Laich A, 2002, CLIN CHEM, V48, P579; Laine O, 2012, THROMB RES, V129, P611, DOI 10.1016/j.thromres.2011.11.007; Laine O, 2011, BLOOD COAGUL FIBRIN, V22, P468, DOI 10.1097/MBC.0b013e328346a420; Laine O, 2010, THROMB RES, V126, P154, DOI 10.1016/j.thromres.2010.05.025; Libraty DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035402; Mackow ER, 2009, THROMB HAEMOSTASIS, V102, P1030, DOI 10.1160/TH09-09-0640; Makary P, 2010, EPIDEMIOL INFECT, V138, P1484, DOI 10.1017/S0950268810000087; Makela S, 2004, AM J KIDNEY DIS, V43, P809, DOI 10.1053/j.ajkd.2003.12.044; Molkanen T, 2011, EUR J CLIN MICROBIOL, V30, P1417, DOI 10.1007/s10096-011-1236-8; Mustjoki S, 2000, FEBS LETT, V486, P237, DOI 10.1016/S0014-5793(00)02312-7; MUSTONEN J, 1994, SCAND J INFECT DIS, V26, P7, DOI 10.3109/00365549409008583; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Ostergaard C, 2004, SCAND J INFECT DIS, V36, P14, DOI 10.1080/00365540310017366; Ostrowski SR, 2005, JAIDS-J ACQ IMM DEF, V39, P23, DOI 10.1097/01.qai.0000157950.02076.a6; Ostrowski SR, 2005, J INFECT DIS, V191, P1331, DOI 10.1086/428854; Ostrowski SR, 2004, JAIDS-J ACQ IMM DEF, V35, P337, DOI 10.1097/00126334-200404010-00002; Outinen TK, 2012, EUR J CLIN MICROBIOL, V31, P957, DOI 10.1007/s10096-011-1392-x; Outinen TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031455; Outinen TK, 2011, J MED VIROL, V83, P731, DOI 10.1002/jmv.22018; Outinen TK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-132; Paakkala A, 2007, ACTA RADIOL, V48, P345, DOI 10.1080/02841850701199629; Sane J, 2012, ANN MED, V44, P468, DOI 10.3109/07853890.2011.573500; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; SETTERGREN B, 1989, REV INFECT DIS, V11, P921; Sidenius N, 2000, BLOOD, V96, P4091; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Uusitalo-Seppala R, 2012, J INTERN MED, V272, P247, DOI 10.1111/j.1365-2796.2012.02569.x; Vaheri A, 2013, REV MED VIROL, V23, P35, DOI 10.1002/rmv.1722; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Vapalahti O, 1996, J CLIN MICROBIOL, V34, P119, DOI 10.1128/JCM.34.1.119-125.1996; Yilmaz G, 2011, J CLIN VIROL, V50, P209, DOI 10.1016/j.jcv.2010.11.014; ZAKI SR, 1995, AM J PATHOL, V146, P552	47	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71335	10.1371/journal.pone.0071335	http://dx.doi.org/10.1371/journal.pone.0071335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990945	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470100042
J	Vojvodic, S; Rehan, SM; Anderson, KE				Vojvodic, Svjetlana; Rehan, Sandra M.; Anderson, Kirk E.			Microbial Gut Diversity of Africanized and European Honey Bee Larval Instars	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; APIS-MELLIFERA; BACTERIAL DIVERSITY; POLLEN; IDENTIFICATION; HOMEOSTASIS; SYMBIONTS; PARADIGM; INSECTS; BREAD	The first step in understanding gut microbial ecology is determining the presence and potential niche breadth of associated microbes. While the core gut bacteria of adult honey bees is becoming increasingly apparent, there is very little and inconsistent information concerning symbiotic bacterial communities in honey bee larvae. The larval gut is the target of highly pathogenic bacteria and fungi, highlighting the need to understand interactions between typical larval gut flora, nutrition and disease progression. Here we show that the larval gut is colonized by a handful of bacterial groups previously described from guts of adult honey bees or other pollinators. First and second larval instars contained almost exclusively Alpha 2.2, a core Acetobacteraceae, while later instars were dominated by one of two very different Lactobacillus spp., depending on the sampled site. Royal jelly inhibition assays revealed that of seven bacteria occurring in larvae, only one Neisseriaceae and one Lactobacillus sp. were inhibited. We found both core and environmentally vectored bacteria with putatively beneficial functions. Our results suggest that early inoculation by Acetobacteraceae may be important for microbial succession in larvae. This assay is a starting point for more sophisticated in vitro models of nutrition and disease resistance in honey bee larvae.	[Vojvodic, Svjetlana; Anderson, Kirk E.] Univ Arizona, Dept Ecol & Evolut Biol, Ctr Insect Sci, Tucson, AZ 85721 USA; [Rehan, Sandra M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Anderson, Kirk E.] USDA, Tucson, AZ USA	University of Arizona; University of Pennsylvania; United States Department of Agriculture (USDA)	Vojvodic, S (corresponding author), Univ Arizona, Dept Ecol & Evolut Biol, Ctr Insect Sci, Tucson, AZ 85721 USA.	vojvodic.sv@gmail.com		Vojvodic Kruse, Svjetlana/0000-0003-0660-6540	NIH PERT fellowship through the Center for Insect Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	NIH PERT fellowship through the Center for Insect Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH PERT fellowship to SV through the Center for Insect Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Aween Mohamed Mustafa, 2012, American Journal of Applied Sciences, V9, P807; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Bailey L, 1991, HONEYBEE PATHOLOGY, P2; BATRA LR, 1973, MYCOPATH MYCOL APPL, V49, P13, DOI 10.1007/BF02057445; Beetsma J, 1985, EXPT BEHAV ECOLOGY S, P407; Bilikova K, 2002, FEBS LETT, V528, P125, DOI 10.1016/S0014-5793(02)03272-6; Chouaia B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S2; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crotti E, 2009, ENVIRON MICROBIOL, V11, P3252, DOI 10.1111/j.1462-2920.2009.02048.x; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Disayathanoowat T, 2012, FEMS MICROBIOL ECOL, V79, P273, DOI 10.1111/j.1574-6941.2011.01216.x; Endo A, 2012, INT J SYST EVOL MICR, V62, P500, DOI 10.1099/ijs.0.031054-0; Endo A, 2009, SYST APPL MICROBIOL, V32, P593, DOI 10.1016/j.syapm.2009.08.002; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Evans Jay D., 2006, BMC Ecology, V6, P4, DOI 10.1186/1472-6785-6-4; Fontana R, 2004, PEPTIDES, V25, P919, DOI 10.1016/j.peptides.2004.03.016; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Garcuia MC., 2010, J APIPROD APIMED SCI, V2, P93, DOI DOI 10.3896/1BRAA.02.3.02; GILLIAM M, 1987, J INVERTEBR PATHOL, V49, P70, DOI 10.1016/0022-2011(87)90127-3; GILLIAM M, 1979, APIDOLOGIE, V10, P43, DOI 10.1051/apido:19790106; GILLIAM M, 1971, ANN ENTOMOL SOC AM, V64, P315, DOI 10.1093/aesa/64.1.315; GILLIAM M, 1979, APIDOLOGIE, V10, P269, DOI 10.1051/apido:19790304; GILLIAM M, 1988, MICROBIOS, V55, P95; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gilliam M, 1997, HONEY BEE PESTS PRED, P81; Goodfellow, 1991, NUCL ACID TECHNIQUES, P177; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Janson EM, 2008, EVOLUTION, V62, P997, DOI 10.1111/j.1558-5646.2008.00348.x; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Liu JR, 2008, J AGR FOOD CHEM, V56, P11447, DOI 10.1021/jf802494e; Lundgren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010831; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; McCreadie JW, 2005, OIKOS, V108, P362, DOI 10.1111/j.0030-1299.2005.13417.x; McFrederick QS, 2012, MOL ECOL, V21, P1754, DOI 10.1111/j.1365-294X.2012.05496.x; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Neveling DP, 2012, CURR MICROBIOL, V65, P507, DOI 10.1007/s00284-012-0186-4; Olofsson TC, 2011, APIDOLOGIE, P1; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P209, DOI 10.1051/apido:19660302; Pavel C. I., 2011, Lucrari Stiintifice - Zootehnie si Biotehnologii, Universitatea de Stiinte Agricole si Medicina Veterinara a Banatului Timisoara, V44, P108; Ramadan MF, 2012, J FUNCT FOODS, V4, P39, DOI 10.1016/j.jff.2011.12.007; Rauch S, 2009, APPL ENVIRON MICROB, V75, P3344, DOI 10.1128/AEM.02839-08; Romanelli A, 2011, J PEPT SCI, V17, P348, DOI 10.1002/psc.1316; RUIZARGU.T, 1973, J GEN MICROBIOL, V76, P211, DOI 10.1099/00221287-76-1-211; RUIZARGUESO T, 1975, APPL MICROBIOL, V30, P893, DOI 10.1128/AEM.30.6.893-896.1975; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; Seeley T., 1995, WISDOM HIVE; Shamala TR, 2000, LETT APPL MICROBIOL, V30, P453, DOI 10.1046/j.1472-765X.2000.00746.x; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; SIMPSON J, 1955, Q J MICROSC SCI, V96, P117; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Swofford DL, 2005, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Vasquez A, 2009, APIDOLOGIE, V40, P26, DOI 10.1051/apido:2008063; Vojvodic S, 2011, VET MICROBIOL, V149, P200, DOI 10.1016/j.vetmic.2010.10.001; Winston ML, 1991, BIOL HONEYBEE	66	102	108	5	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72106	10.1371/journal.pone.0072106	http://dx.doi.org/10.1371/journal.pone.0072106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991051	Green Submitted, gold, Green Published			2022-12-25	WOS:000324470100080
J	Wu, YH; Hu, CW; Chien, CW; Chen, YJ; Huang, HC; Juan, HF				Wu, Yi-Hsuan; Hu, Chia-Wei; Chien, Chih-Wei; Chen, Yu-Ju; Huang, Hsuan-Cheng; Juan, Hsueh-Fen			Quantitative Proteomic Analysis of Human Lung Tumor Xenografts Treated with the Ectopic ATP Synthase Inhibitor Citreoviridin	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; APOPTOTIC DEATH; BETA-SUBUNIT; G1 ARREST; CANCER; PROTEIN; GEFITINIB; MUTATIONS; CARCINOMA; EXPRESSION	ATP synthase is present on the plasma membrane of several types of cancer cells. Citreoviridin, an ATP synthase inhibitor, selectively suppresses the proliferation and growth of lung cancer without affecting normal cells. However, the global effects of targeting ectopic ATP synthase in vivo have not been well defined. In this study, we performed quantitative proteomic analysis using isobaric tags for relative and absolute quantitation (iTRAQ) and provided a comprehensive insight into the complicated regulation by citreoviridin in a lung cancer xenograft model. With high reproducibility of the quantitation, we obtained quantitative proteomic profiling with 2,659 proteins identified. Bioinformatics analysis of the 141 differentially expressed proteins selected by their relative abundance revealed that citreoviridin induces alterations in the expression of glucose metabolism-related enzymes in lung cancer. The up-regulation of enzymes involved in gluconeogenesis and storage of glucose indicated that citreoviridin may reduce the glycolytic intermediates for macromolecule synthesis and inhibit cell proliferation. Using comprehensive proteomics, the results identify metabolic aspects that help explain the antitumorigenic effect of citreoviridin in lung cancer, which may lead to a better understanding of the links between metabolism and tumorigenesis in cancer therapy.	[Wu, Yi-Hsuan; Hu, Chia-Wei; Juan, Hsueh-Fen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Dept Life Sci, Taipei 10764, Taiwan; [Chien, Chih-Wei; Chen, Yu-Ju] Acad Sinica, Inst Chem, Taipei, Taiwan; [Huang, Hsuan-Cheng] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Inst Biomed Informat, Taipei 112, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University	Huang, HC (corresponding author), Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Inst Biomed Informat, Taipei 112, Taiwan.	hsuancheng@ym.edu.tw; yukijuan@ntu.edu.tw	Chen, Yu-Ju/E-9481-2015; Huang, Hsuan-Cheng/C-7266-2011	Chen, Yu-Ju/0000-0002-3178-6697; Huang, Hsuan-Cheng/0000-0002-3386-0934; JUAN, HSUEH-FEN/0000-0003-4876-3309	National Science Council, Taiwan [NSC 99-2621-B-002-005-MY3, NSC 99-2621-B-010-001-MY3]; National Taiwan University Cutting-Edge Steering Research Project [102R7602C3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Cutting-Edge Steering Research Project	This work was supported by the National Science Council, Taiwan (NSC 99-2621-B-002-005-MY3, NSC 99-2621-B-010-001-MY3) and National Taiwan University Cutting-Edge Steering Research Project (102R7602C3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal C, 2004, NEOPLASIA, V6, P646, DOI 10.1593/neo.04232; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Carrillo B, 2010, BIOINFORMATICS, V26, P98, DOI 10.1093/bioinformatics/btp610; Chang HY, 2012, CANCER RES, V72, P4696, DOI 10.1158/0008-5472.CAN-12-0567; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; DAS B, 1994, J EXP MED, V180, P273, DOI 10.1084/jem.180.1.273; DATTA S C, 1979, Asian Journal of Pharmaceutical Sciences, V1, P119; DATTA SC, 1981, FOLIA MICROBIOL, V26, P408, DOI 10.1007/BF02927336; DATTA SC, 1981, TOXICON, V19, P217, DOI 10.1016/0041-0101(81)90024-6; El-Sherbiny YM, 2001, ANTICANCER RES, V21, P2393; Ferlay J, 2010, IARC CANCERBASE, V10; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; GAUSE EM, 1981, J BIOL CHEM, V256, P557; GOLD J, 1974, ANN NY ACAD SCI, V230, P103, DOI 10.1111/j.1749-6632.1974.tb14440.x; Han CL, 2008, MOL CELL PROTEOMICS, V7, P1983, DOI 10.1074/mcp.M800068-MCP200; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang TC, 2008, J PROTEOME RES, V7, P1433, DOI 10.1021/pr700742h; HUME DA, 1979, JNCI-J NATL CANCER I, V62, P3; Jackman DM, 2006, CLIN CANCER RES, V12, P3908, DOI 10.1158/1078-0432.CCR-06-0462; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; LALOR PA, 1987, RHEUMATOL INT, V7, P183, DOI 10.1007/BF00541375; Lee MK, 2006, PATHOLOGY, V38, P555, DOI 10.1080/00313020601024029; Leij-Halfwerk S, 2000, AM J CLIN NUTR, V71, P583; Lin W-T, 2005, MASSTRAQ FULLY AUTOM, P157; Lin WT, 2006, J PROTEOME RES, V5, P2328, DOI 10.1021/pr060132c; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mahoney DW, 2011, J PROTEOME RES, V10, P4325, DOI 10.1021/pr2001308; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; NIGAM VN, 1962, CANCER RES, V22, P131; Orazine CL, 2008, J PROTEOME RES, V7, P1542, DOI 10.1021/pr7008516; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2005, J CLIN ONCOL, V23, P2556, DOI 10.1200/JCO.2005.07.799; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Rocha CM, 2010, J PROTEOME RES, V9, P319, DOI 10.1021/pr9006574; Rodriguez-Suarez E, 2010, PROTEOMICS, V10, P1545, DOI 10.1002/pmic.200900255; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; SATRE M, 1980, J BACTERIOL, V142, P768, DOI 10.1128/JB.142.3.768-776.1980; Schnier Joachim B, 2005, BMC Urol, V5, P6, DOI 10.1186/1471-2490-5-6; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Shadforth IP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-145; Singh RP, 2003, CARCINOGENESIS, V24, P555, DOI 10.1093/carcin/24.3.555; Tang HY, 2012, J PROTEOME RES, V11, P678, DOI 10.1021/pr200603h; Treumann A, 2010, EXPERT REV PROTEOMIC, V7, P647, DOI 10.1586/EPR.10.29; van den Bemd GJCM, 2006, MOL CELL PROTEOMICS, V5, P1830, DOI 10.1074/mcp.M500371-MCP200; Vucenik I, 2005, BREAST CANCER RES TR, V91, P35, DOI 10.1007/s10549-004-6456-5; Vucenik I, 2006, NUTR CANCER, V55, P109, DOI 10.1207/s15327914nc5502_1; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P319; Wei YH, 2011, J PROTEOME RES, V10, P161, DOI 10.1021/pr100491e; Whitehead TL, 2005, PROG NUCL MAG RES SP, V47, P165, DOI 10.1016/j.pnmrs.2005.09.001; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	57	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e70642	10.1371/journal.pone.0070642	http://dx.doi.org/10.1371/journal.pone.0070642			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990911	gold, Green Submitted, Green Published			2022-12-25	WOS:000324470100031
J	Weed, DT; Walker, G; De La Fuente, AC; Nazarian, R; Vella, JL; Gomez-Fernandez, CR; Serafini, P				Weed, Donald T.; Walker, Gail; De La Fuente, Adriana C.; Nazarian, Ronen; Vella, Jennifer L.; Gomez-Fernandez, Carmen R.; Serafini, Paolo			FOXP3 Subcellular Localization Predicts Recurrence in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; REGULATORY T-CELLS; PROGNOSTIC VALUE; CANCER; EXPRESSION; SOFTWARE; ANTIBODY; HEAD	Forkhead box protein P3 (FOXP3) expression in tumor infiltrating CD4(+)T cells is generally associated with an intrinsic capacity to suppress tumor immunity. Based on this notion, different studies have evaluated the prognostic value of this maker in cancer but contradictory results have been found. Indeed, even within the same cancer population, the presence of CD4(+)FOXP3(+)T cells has been associated, with either a poor or a good prognosis, or no correlation has beenfound. Here, we demonstrate, in patients with oral squamous cell carcinoma (OSCC), that what really represents a prognostic parameter is not the overall expression of FOXP3 but its intracellular localization. While overallFOXP3 expression in tumor infiltrating CD4(+)T cells does not correlate with tumor recurrence, its intracellular localization within the CD4 cells does: nuclear FOXP3 (nFOXP3) is associated with tumor recurrence within 3 years, while cytoplasmicFOXP3 (cFOXP3) is associated with a lower likelihood of recurrence. Thus, we propose elevated levels of the cFOXP3/nFOXP3 ratio within tumor infiltrating CD4(+)T cells as a predictor of OSCC recurrence.	[Weed, Donald T.; Nazarian, Ronen] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Walker, Gail] Univ Miami, Miller Sch Med, Biostat & Bioinformat Core, Miami, FL 33136 USA; [De La Fuente, Adriana C.; Vella, Jennifer L.; Serafini, Paolo] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Gomez-Fernandez, Carmen R.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Weed, Donald T.; Walker, Gail; Nazarian, Ronen; Gomez-Fernandez, Carmen R.; Serafini, Paolo] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami	Weed, DT (corresponding author), Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA.	dweed@med.miami.edu; pserafini@med.miami.edu	Serafini, Paolo/C-8195-2012	Serafini, Paolo/0000-0002-3651-9176	Flight Attendant Medical Research Institute (FAMRI); Bankhead Coley Pre-SPORE SCC pilot project award; Munilla Family Foundation	Flight Attendant Medical Research Institute (FAMRI); Bankhead Coley Pre-SPORE SCC pilot project award; Munilla Family Foundation	This work was supported by the Flight Attendant Medical Research Institute (FAMRI)'s young investigator award, by the Bankhead Coley Pre-SPORE SCC pilot project award, and by a gift from the Munilla Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no financial/commercial conflicts of interests.	Badoual C, 2006, CLIN CANCER RES, V12, P465, DOI 10.1158/1078-0432.CCR-05-1886; Bragelmann J, 2013, ORAL ONCOL, V49, P525, DOI 10.1016/j.oraloncology.2013.02.003; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Distel LV, 2009, ORAL ONCOL, V45, pE167, DOI 10.1016/j.oraloncology.2009.05.640; Duray A, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/701657; Fox BC, 2008, BLOOD, V111, P3897, DOI 10.1182/blood-2008-01-134148; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kmieciak M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-89; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Law JP, 2009, CYTOM PART A, V75A, P1040, DOI 10.1002/cyto.a.20815; Magg T, 2012, EUR J IMMUNOL, V42, P1627, DOI 10.1002/eji.201141838; Mailer RKW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006104; Marklund L, 2012, CANCER MED-US, V1, P82, DOI 10.1002/cam4.2; Martin F, 2010, ONCOGENE, V29, P4121, DOI 10.1038/onc.2010.174; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Pretscher D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-292; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Serafini P, 2008, CANCER RES, V68, P5439, DOI 10.1158/0008-5472.CAN-07-6621; Smith EL, 2006, IMMUNOLOGY, V119, P203, DOI 10.1111/j.1365-2567.2006.02425.x; Toh B, 2012, IMMUNOL RES, V53, P229, DOI 10.1007/s12026-012-8288-4; de Mendizabal NV, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-114; Vokes Martha S, 2008, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1417s82; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Woo YL, 2008, J CLIN PATHOL, V61, P969, DOI 10.1136/jcp.2008.056200; Zhang YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-4; Zingg U, 2010, EJSO-EUR J SURG ONC, V36, P670, DOI 10.1016/j.ejso.2010.05.012	30	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71908	10.1371/journal.pone.0071908	http://dx.doi.org/10.1371/journal.pone.0071908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977174	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300049
J	Andersen, V; Vogel, U; Godiksen, S; Frenzel, FB; Saebo, M; Hamfjord, J; Kure, E; Vogel, LK				Andersen, Vibeke; Vogel, Ulla; Godiksen, Sine; Frenzel, Franz B.; Saebo, Mona; Hamfjord, Julian; Kure, Elin; Vogel, Lotte K.			Low ABCB1 Gene Expression Is an Early Event in Colorectal Carcinogenesis	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE 1; RISK; POLYMORPHISMS; CANCER; DISEASE; MDR1	The ABCB1/MDR1 gene product ABCB1/P-glycoprotein is implicated in the development of colorectal cancer (CRC). NFKB1 encodes transcription factors regulating expression of a number of genes including ABCB1. We have previously found association between the ABCB1 C-rs3789243-T polymorphism and CRC risk and interactions between the ABCB1 C-rs3789243-T and C3435T polymorphisms and meat intake in relation to CRC risk (Andersen, BMC Cancer, 2009, 9, 407). ABCB1 and NFKB1 mRNA levels were assessed in intestinal tissue from 122 CRC cases, 101 adenoma cases (12 with severe dysplasia, 89 with mild-moderate dysplasia) and from 18 healthy individuals, together with gene polymorphisms in ABCB1 and NFKB1. ABCB1 mRNA levels were highest in the healthy individuals and significantly lower in mild/moderate and severe dysplasia tissue (P<0.05 for both), morphologically normal tissues close to the tumour (P<0.05), morphologically normal tissue at a distance from the tumour (P<0.05) and CRC tissue (P<0.001). Furthermore, ABCB1 mRNA levels were lower in adenomas and carcinomas compared to morphologically normal tissue from the same individuals (P<0.01). The ABCB1 C-rs3789243-T and NFKB1 -94ins/del homozygous variant genotypes were associated with low ABCB1 mRNA levels in morphologically normal sigmoid tissue from adenoma cases (P<0.05 for both). NFKB1 mRNA levels were lower in both tumour and normal tissue from cancer patients (P<0.001) as compared to healthy individuals but we were unable to show association between NFKB1 -94ins/del genotype and NFKB1 mRNA levels. This study suggests that low ABCB1 mRNA levels are an early event in CRC development and that the two polymorphisms affect ABCB1 mRNA levels whereas low NFKB1 mRNA levels occur later in carcinogenesis. Low ABCB1 protein levels may promote colorectal carcinogenesis through increasing intracellular exposure to carcinogenic ABCB1 substrates.	[Andersen, Vibeke] Hosp Southern Jutland, Dept Med, Aabenraa, Denmark; [Andersen, Vibeke] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Andersen, Vibeke] Reg Hosp Viborg, Dept Med, Viborg, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Godiksen, Sine; Frenzel, Franz B.; Vogel, Lotte K.] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark; [Saebo, Mona] Telemark Univ Coll, Fac Arts & Sci, Dept Environm & Hlth Studies, Telemark, Norway; [Hamfjord, Julian; Kure, Elin] Oslo Univ Hosp, Inst Canc Res, Dept Genet, Oslo, Norway	University of Southern Denmark; National Research Centre for the Working Environment; University of Copenhagen; University College of Southeast Norway; University of Oslo	Andersen, V (corresponding author), Hosp Southern Jutland, Dept Med, Aabenraa, Denmark.	vandersen@health.sdu.dk; elin.kure@rr-research.no	Vogel, Ulla/ABC-2212-2020; Vogel, Ulla B/I-5048-2012; Andersen, Vibeke/I-7932-2012	Vogel, Ulla/0000-0001-6807-1524; Vogel, Ulla B/0000-0001-6807-1524; Andersen, Vibeke/0000-0002-0127-2863; Vogel, Lotte K./0000-0001-9920-0982	Familien Erichsens Mindefond; Viborg Regional Hospital; Hospital of Southern Jutland; Norwegian Colorectal Cancer Prevention (NORCCAP) study (Grant from the Norwegian Cancer Society); Norwegian Colorectal Cancer Prevention (NORCCAP) study (Grant from the Department of Health and Social Affairs)	Familien Erichsens Mindefond; Viborg Regional Hospital; Hospital of Southern Jutland; Norwegian Colorectal Cancer Prevention (NORCCAP) study (Grant from the Norwegian Cancer Society); Norwegian Colorectal Cancer Prevention (NORCCAP) study (Grant from the Department of Health and Social Affairs)	"Familien Erichsens Mindefond'', Viborg Regional Hospital (http://www.hospitalsenhedmidt.dk/regionshospitalet+viborg), Hospital of Southern Jutland (http://www.sygehussonderjylland.dk/wm233821) and the Norwegian Colorectal Cancer Prevention (NORCCAP) study (Grants from the Norwegian Cancer Society (http://www.uicc.org/membership/norwegian-cancer-society) and the Department of Health and Social Affairs) have supported the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen V, 2012, ALIMENT PHARM THER, V10; Andersen V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-484; Andersen V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-407; Andersen V, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-18; Campa D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032784; De Iudicibus S, 2008, ANTICANCER RES, V28, P3921; Gondal G, 2005, EUR J CANCER PREV, V14, P373, DOI 10.1097/00008469-200508000-00010; Haenisch S, 2007, PHARMACOGENOMICS J, V7, P56, DOI 10.1038/sj.tpj.6500403; He T, 2011, COLORECTAL DIS, V10, P1318; Johnson RL, 2012, CANC METASTASIS REV; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Kroetz DL, 2003, PHARMACOGENETICS, V13, P481, DOI 10.1097/00008571-200308000-00006; Larsen UL, 2007, SCAND J CLIN LAB INV, V67, P123, DOI 10.1080/00365510600986084; LINN SC, 1995, EUR J CANCER, V31A, P1291, DOI 10.1016/0959-8049(95)00278-Q; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mizutani T, 2008, CURR DRUG METAB, V9, P167, DOI 10.2174/138920008783571756; Ostergaard M, 2009, SCAND J GASTROENTERO, V44, P65, DOI 10.1080/00365520802400826; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Shou WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046295; Skjelbred CF, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-228; Vogel U, 2011, ATHEROSCLEROSIS, V219, P200, DOI 10.1016/j.atherosclerosis.2011.06.018	21	31	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72119	10.1371/journal.pone.0072119	http://dx.doi.org/10.1371/journal.pone.0072119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977225	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700134
J	Ansari, M; Uppugunduri, CRS; Ferrari-Lacraz, S; Bittencourt, H; Gumy-Pause, F; Chalandon, Y; Tiercy, JM; Schechter, T; Gassas, A; Doyle, JD; Dupuis, L; Duval, M; Krajinovic, M; Villard, J				Ansari, Marc; Uppugunduri, Chakradhara Rao S.; Ferrari-Lacraz, Sylvie; Bittencourt, Henrique; Gumy-Pause, Fabienne; Chalandon, Yves; Tiercy, Jean-Marie; Schechter, Tal; Gassas, Adam; Doyle, John D.; Dupuis, Lee; Duval, Michel; Krajinovic, Maja; Villard, Jean			The Clinical Relevance of Pre-Formed Anti-HLA and Anti-MICA Antibodies after Cord Blood Transplantation in Children	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; GRAFT FAILURE; KIDNEY-TRANSPLANTATION; MEDIATED REJECTION; DONOR; RECIPIENTS; ENGRAFTMENT; SERUM; RISK; ALLOANTIBODIES	Preformed anti-HLA antibodies (AHA) are known to be associated with delayed engraftment and reduced overall survival after adult hematopoietic stem cell transplantation. However, limited data is available in pediatric patients. In this study, we explored the role of AHA on clinical outcomes in 70 pediatric patients who received a single unit of HLA mismatch cord blood for hematologic malignancies, immunodeficiencies or metabolic diseases. The presence of AHA was detected in 44% (31/70) of the patients. Preformed class I AHA was associated with an increased occurrence of grade 1-4 acute graft-versus host disease (p<0.05). The presence of anti- major-histocompatibility-complex class I-related chain A antigens (MICA) antibodies was significantly associated with a reduced platelet recovery after transplantation (p<0.05). AHA of class II with the strength of antibody titer measured as the mean fluorescence intensity above 2000 was associated with reduced event-free survival (p<0.05). A reduction of high titer of AHA and anti- MICA antibodies might have to be considered before cord blood transplantation in pediatric patients for better outcomes.	[Ansari, Marc; Uppugunduri, Chakradhara Rao S.; Gumy-Pause, Fabienne; Chalandon, Yves] Univ Hosp Geneva, Dept Pediat, Oncohematol Unit, Geneva, Switzerland; [Ansari, Marc; Uppugunduri, Chakradhara Rao S.; Gumy-Pause, Fabienne] Geneva Med Univ, CANSEARCH Res Ctr, Geneva, Switzerland; [Ferrari-Lacraz, Sylvie; Tiercy, Jean-Marie; Villard, Jean] Univ Hosp Geneva, Div Lab Med, Div Immunol & Allergy, Transplantat Immunol Unit, Geneva, Switzerland; [Ferrari-Lacraz, Sylvie; Tiercy, Jean-Marie; Villard, Jean] Univ Hosp Geneva, Div Lab Med, Div Immunol & Allergy, Swiss Natl Lab Histocompatibil, Geneva, Switzerland; [Bittencourt, Henrique; Duval, Michel] CHU Ste Justine, Dept Pediat, Oncol & Hematol Unit, Montreal, PQ, Canada; [Schechter, Tal; Gassas, Adam; Doyle, John D.; Dupuis, Lee] Univ Toronto, Hosp Sick Children, Div Hematol Oncol, Canada Dept Pharm, Toronto, ON M5G 1X8, Canada; [Ansari, Marc; Krajinovic, Maja] CHU St Justine Res Ctr, Charles Bruneau Canc Ctr, Montreal, PQ, Canada; [Krajinovic, Maja] CHU St Justine, Clin Pharmacol Unit, Montreal, PQ, Canada	University of Geneva; University of Geneva; University of Geneva; Universite de Montreal; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Villard, J (corresponding author), Univ Hosp Geneva, Div Lab Med, Div Immunol & Allergy, Transplantat Immunol Unit, Geneva, Switzerland.	Jean.Villard@hcuge.ch	Rao, Uppugunduri S Chakradhara/V-3266-2017; Chalandon, Yves/AAF-5125-2019; ANSARI, Marc/V-3334-2017	Rao, Uppugunduri S Chakradhara/0000-0002-8928-7049; Chalandon, Yves/0000-0001-9341-8104; ansari, marc/0000-0002-9649-6498; Dupuis, L.Lee/0000-0002-7699-1061	CANSEARCH; Hans Wilsdorf Foundations; Fondation du Centre de Cancerologie Charles-Bruneau	CANSEARCH; Hans Wilsdorf Foundations; Fondation du Centre de Cancerologie Charles-Bruneau	We are thankful to all the patients and their parents who consented to participate in this HSCT study. This investigation was supported by grants from CANSEARCH, Hans Wilsdorf Foundations, and the Fondation du Centre de Cancerologie Charles-Bruneau. We thank Yves Theoret, Samira Mezziani, Catherine Desjean, Marie-France Vachon and Julie Rousseau for their help in this study. We thank Patricia Huezo-Diaz for language corrections and proof reading the manuscript.	Amico P, 2008, TRANSPLANTATION, V85, P1557, DOI 10.1097/TP.0b013e31816f612a; Amico P, 2009, TRANSPLANTATION, V87, P1681, DOI 10.1097/TP.0b013e3181a5e034; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Brunstein CG, 2011, BIOL BLOOD MARROW TR, V17, P1704, DOI 10.1016/j.bbmt.2011.04.013; Cai J, 2006, AM J TRANSPLANT, V6, P2947, DOI 10.1111/j.1600-6143.2006.01560.x; Ciurea SO, 2009, TRANSPLANTATION, V88, P1019, DOI 10.1097/TP.0b013e3181b9d710; Cutler C, 2011, BLOOD, V118, P6691, DOI 10.1182/blood-2011-05-355263; Dalle JH, 2003, BONE MARROW TRANSPL, V32, P647, DOI 10.1038/sj.bmt.1704209; Dupuis LL, 2008, BIOL BLOOD MARROW TR, V14, P576, DOI 10.1016/j.bbmt.2008.03.002; Ferrari-Lacraz S, 2012, TISSUE ANTIGENS, V79, P315, DOI 10.1111/j.1399-0039.2012.01853.x; Gluckman E, 2009, HAEMATOL-HEMATOL J, V94, P451, DOI 10.3324/haematol.2009.005694; Jinushi M, 2003, J IMMUNOL, V170, P1249, DOI 10.4049/jimmunol.170.3.1249; Kataoka K, 2008, BONE MARROW TRANSPL, V42, P129, DOI 10.1038/bmt.2008.83; Lefaucheur C, 2010, J AM SOC NEPHROL, V21, P1398, DOI 10.1681/ASN.2009101065; Leffell MS, 2009, TISSUE ANTIGENS, V74, P494, DOI 10.1111/j.1399-0039.2009.01377.x; Lemy A, 2010, TRANSPLANTATION, V90, P168, DOI 10.1097/TP.0b013e3181e228f7; Loupy A, 2009, AM J TRANSPLANT, V9, P2561, DOI 10.1111/j.1600-6143.2009.02813.x; Menier C, 2002, INT J CANCER, V100, P63, DOI 10.1002/ijc.10460; Mizutani K, 2005, AM J TRANSPLANT, V5, P2265, DOI 10.1111/j.1600-6143.2005.01016.x; Norris PJ, 2009, TRANSFUSION, V49, P243, DOI 10.1111/j.1537-2995.2008.01955.x; Ottinger HD, 2002, TRANSPLANTATION, V73, P1280, DOI 10.1097/00007890-200204270-00016; Parmar S, 2009, BLOOD, V114, P2884, DOI 10.1182/blood-2009-05-223172; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Riethmuller S, 2010, TRANSPLANTATION, V90, P160, DOI 10.1097/TP.0b013e3181e36e08; Ruggeri A, 2012, HAEMATOLOGICA; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Scrucca L, 2010, BONE MARROW TRANSPL, V45, P1388, DOI 10.1038/bmt.2009.359; Spellman S, 2010, BLOOD, V115, P2704, DOI 10.1182/blood-2009-09-244525; Takanashi M, 2008, TRANSFUSION, V48, P791, DOI 10.1111/j.1537-2995.2008.01678.x; Terasaki PI, 2005, TRANSPLANTATION, V80, P1194, DOI 10.1097/01.tp.0000174338.97313.5a; Terasaki PI, 2003, AM J TRANSPLANT, V3, P665, DOI 10.1034/j.1600-6143.2003.00135.x; Tieng V, 2002, P NATL ACAD SCI USA, V99, P2977, DOI 10.1073/pnas.032668099; Uchiyama M, 2010, BONE MARROW TRANSPL, V45, P199, DOI 10.1038/bmt.2009.103; Zou YZ, 2007, NEW ENGL J MED, V357, P1293, DOI 10.1056/NEJMoa067160; Zou YZ, 2009, CURR OPIN ORGAN TRAN, V14, P414, DOI 10.1097/MOT.0b013e32832d835e; Zou YZ, 2002, HUM IMMUNOL, V63, P30, DOI 10.1016/S0198-8859(01)00349-4; Zwirner NW, 2000, HUM IMMUNOL, V61, P917, DOI 10.1016/S0198-8859(00)00162-2	37	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72141	10.1371/journal.pone.0072141	http://dx.doi.org/10.1371/journal.pone.0072141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977232	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700137
J	Aoude, LG; Wadt, K; Bojesen, A; Cruger, D; Borg, A; Trent, JM; Brown, KM; Gerdes, AM; Jonsson, G; Hayward, NK				Aoude, Lauren G.; Wadt, Karin; Bojesen, Anders; Cruger, Dorthe; Borg, Ake; Trent, Jeffrey M.; Brown, Kevin M.; Gerdes, Anne-Marie; Jonsson, Goran; Hayward, Nicholas K.			A BAP1 Mutation in a Danish Family Predisposes to Uveal Melanoma and Other Cancers	PLOS ONE			English	Article							MALIGNANT MESOTHELIOMA; GERMLINE MUTATIONS; TUMORS	Truncating germline mutations in the tumor suppressor gene BRCA-1 associated protein-1 (BAP1) have been reported in families predisposed to developing a wide range of different cancer types including uveal melanoma and cutaneous melanoma. There has also been an association between amelanotic tumor development and germline BAP1 mutation suggesting a possible phenotypic characteristic of BAP1 mutation carriers. Though there have been many types of cancer associated with germline BAP1 mutation, the full spectrum of disease association is yet to be ascertained. Here we describe a Danish family with predominantly uveal melanoma but also a range of other tumor types including lung, neuroendocrine, stomach, and breast cancer; as well as pigmented skin lesions. Whole-exome sequencing identified a BAP1 splice mutation located at c.581-2A>G, which leads to a premature truncation of BAP1 in an individual with uveal melanoma. This mutation was carried by several other family members with melanoma or various cancers. The finding expands on the growing profile of BAP1 as an important uveal and cutaneous melanoma tumor suppressor gene and implicates its involvement in the development of lung, and stomach cancer.	[Aoude, Lauren G.; Hayward, Nicholas K.] Queensland Inst Med Res, Oncogen Lab, Brisbane, Qld 4006, Australia; [Aoude, Lauren G.] Univ Queensland, Brisbane, Qld, Australia; [Wadt, Karin; Gerdes, Anne-Marie] Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Bojesen, Anders; Cruger, Dorthe] Vejle Hosp, Dept Clin Genet, Vejle, Denmark; [Borg, Ake; Jonsson, Goran] Lund Univ, Div Oncol, Dept Clin Sci Lund, Lund, Sweden; [Trent, Jeffrey M.; Brown, Kevin M.] Translat Genom Res Inst, Phoenix, AZ USA; [Brown, Kevin M.] NCI, Lab Translat Genom, Bethesda, MD 20892 USA	QIMR Berghofer Medical Research Institute; University of Queensland; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Lillebaelt Hospital; Lund University; Translational Genomics Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Aoude, LG (corresponding author), Queensland Inst Med Res, Oncogen Lab, Brisbane, Qld 4006, Australia.	lauren.aoude@qimr.edu.au	Jönsson, Göran/D-1212-2014; Bojesen, Anders B/G-6308-2010; hayward, nick/AAV-8802-2020; Aoude, Lauren/C-7484-2014; hayward, nicholas k/C-1367-2015	Aoude, Lauren/0000-0003-1448-3923; hayward, nicholas k/0000-0003-4760-1033; Gerdes, Anne-Marie/0000-0002-0328-3320; Bojesen, Anders/0000-0003-4289-8595	Melanoma Research Alliance; Swedish Cancer Society; Swedish Research Council; Berta Kamprad Foundation; National Health and Medical Research Council (NHMRC) of Australia; Fight for Sight, Denmark; NHMRC Senior Principal Research Fellowship; ANZ Ph.D. scholarship; NATIONAL CANCER INSTITUTE [ZIACP010201] Funding Source: NIH RePORTER	Melanoma Research Alliance; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Berta Kamprad Foundation; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Fight for Sight, Denmark; NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); ANZ Ph.D. scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Melanoma Research Alliance, the Swedish Cancer Society, the Swedish Research Council, the Berta Kamprad Foundation, the National Health and Medical Research Council (NHMRC) of Australia, and the Fight for Sight, Denmark. NKH and LGA receive salary support through a NHMRC Senior Principal Research Fellowship and ANZ Ph.D. scholarship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Busam KJ, 2013, JAMA DERMATOL, V149, P335, DOI 10.1001/jamadermatol.2013.1529; Carbone M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-179; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hoiom V, 2013, GENE CHROMOSOME CANC, V52, P378, DOI 10.1002/gcc.22035; Isager P, 2005, OPHTHAL EPIDEMIOL, V12, P223, DOI 10.1080/09286580591000836; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Njauw CNJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035295; Popova T, 2013, AM J HUM GENET; Ribeiro C, 2013, ANN ONCOL; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Wadt K, 2012, PIGMENT CELL MELANOM; Wiesner T, 2012, J CLIN ONCOL, V30, pE337, DOI 10.1200/JCO.2011.41.2965; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910	17	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72144	10.1371/journal.pone.0072144	http://dx.doi.org/10.1371/journal.pone.0072144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977234	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700139
J	Bai, H; Euring, D; Volmer, K; Janz, D; Polle, A				Bai, Hua; Euring, Dejuan; Volmer, Katharina; Janz, Dennis; Polle, Andrea			The Nitrate Transporter (NRT) Gene Family in Poplar	PLOS ONE			English	Article							CIS-REGULATORY ELEMENTS; ARABIDOPSIS NITRATE; TRANSCRIPTION FACTORS; RESPONSE REGULATORS; CHL1 FUNCTIONS; PROMOTER; NITROGEN; EXPRESSION; THALIANA; PLANTS	Nitrate is an important nutrient required for plant growth. It also acts as a signal regulating plant development. Nitrate is actively taken up and transported by nitrate transporters (NRT), which form a large family with many members and distinct functions. In contrast to Arabidopsis and rice there is little information about the NRT family in woody plants such as Populus. In this study, a comprehensive analysis of the Populus NRT family was performed. Sixty-eight PtNRT1/PTR, 6 PtNRT2, and 5 PtNRT3 genes were identified in the P. trichocarpa genome. Phylogenetic analysis confirmed that the genes of the NRT family are divided into three clades: NRT1/PTR with four subclades, NRT2, and NRT3. Topological analysis indicated that all members of PtNRT1/PTR and PtNRT2 have 8 to 12 trans-membrane domains, whereas the PtNRT3 proteins have no or up to two trans-membrane domains. Four PtNRT3 members were predicted as secreted proteins. Microarray analyses revealed tissue-specific expression patterns of PtNRT genes with distinct clusters of NRTs for roots, for the elongation zone of the apical stem segment and the developing xylem and a further cluster for leaves, bark and wood. A comparison of different poplar species (P. trichocarpa, P. tremula, P. euphratica, P. fremontii x P. angustifolia, and P. x canescens) showed that the tissue-specific patterns of the NRT genes varied to some extent with species. Bioinformatic analysis of putative cis-regulatory elements in the promoter regions of PtNRT family retrieved motifs suggesting the regulation of the NRT genes by N metabolism, by energy and carbon metabolism, and by phytohormones and stress. Multivariate analysis suggested that the combination and abundance of motifs in distinct promoters may lead to tissue-specificity. Our genome wide analysis of the PtNRT genes provides a valuable basis for functional analysis towards understanding the role of nitrate transporters for tree growth.	[Bai, Hua; Euring, Dejuan; Volmer, Katharina; Janz, Dennis; Polle, Andrea] Univ Gottingen, D-37073 Gottingen, Germany	University of Gottingen	Polle, A (corresponding author), Univ Gottingen, D-37073 Gottingen, Germany.	apolle@gwdg.de		Polle, Andrea/0000-0001-8697-6394	German Academic Exchange Service (DAAD); Niedersachsisches Exzellenzcluster "Function Biodiversity Research''	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Niedersachsisches Exzellenzcluster "Function Biodiversity Research''	PhD scholarships were provided by the German Academic Exchange Service (DAAD) to HB and DE and by the Niedersachsisches Exzellenzcluster "Function Biodiversity Research'' to KV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Alvarez JM, 2012, CURR OPIN PLANT BIOL, V15, P185, DOI 10.1016/j.pbi.2012.03.009; Bate N, 1998, PLANT MOL BIOL, V37, P859, DOI 10.1023/A:1006095023050; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Campos-Soriano L, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-90; Cao J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-465; Castro-Rodriguez V, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-119; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chiu CC, 2004, PLANT CELL PHYSIOL, V45, P1139, DOI 10.1093/pcp/pch143; Chopin F, 2007, PLANT CELL, V19, P1590, DOI 10.1105/tpc.107.050542; Couturier J, 2007, NEW PHYTOL, V174, P137, DOI 10.1111/j.1469-8137.2007.01992.x; Crawford NM, 1998, TRENDS PLANT SCI, V3, P389, DOI 10.1016/S1360-1385(98)01311-9; Criscuolo G, 2012, PLANT CELL ENVIRON, V35, P1567, DOI 10.1111/j.1365-3040.2012.02510.x; Dechorgnat J, 2011, J EXP BOT, V62, P1349, DOI 10.1093/jxb/erq409; Dietrich D, 2004, PLANT J, V40, P488, DOI 10.1111/j.1365-313X.2004.02224.x; ELMAYAN T, 1995, TRANSGENIC RES, V4, P388, DOI 10.1007/BF01973757; Fan SC, 2009, PLANT CELL, V21, P2750, DOI 10.1105/tpc.109.067603; Feng HM, 2011, J EXP BOT, V62, P2319, DOI 10.1093/jxb/erq403; Girin T, 2007, PLANT CELL ENVIRON, V30, P1366, DOI 10.1111/j.1365-3040.2007.01712.x; Gojon A, 2011, J EXP BOT, V62, P2299, DOI 10.1093/jxb/erq419; Gowik U, 2004, PLANT CELL, V16, P1077, DOI 10.1105/tpc.019729; GRIFFITHS AJ, 2008, INTRO GENETIC ANAL; Guo FO, 2003, PLANT CELL, V15, P107, DOI 10.1105/tpc.006312; Guo YL, 2013, PLANT J, V73, P941, DOI 10.1111/tpj.12089; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hatorangan Marcelinus Rocky, 2009, Journal of Crop Science and Biotechnology, V12, P25; He JL, 2013, PLANT PHYSIOL, V162, P424, DOI 10.1104/pp.113.215681; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Huang NC, 1999, PLANT CELL, V11, P1381, DOI 10.1105/tpc.11.8.1381; Hwang SY, 1997, OECOLOGIA, V111, P99, DOI 10.1007/s004420050213; Ishikawa S, 2009, PLANT BIOTECHNOL, V26, P197, DOI 10.5511/plantbiotechnology.26.197; Kanno Y, 2012, P NATL ACAD SCI USA, V109, P9653, DOI 10.1073/pnas.1203567109; Katayama H, 2009, BREEDING SCI, V59, P237, DOI 10.1270/jsbbs.59.237; Kechid M, 2013, NEW PHYTOL, V198, P514, DOI 10.1111/nph.12158; Kiba T, 2012, PLANT CELL, V24, P245, DOI 10.1105/tpc.111.092221; Komarova NY, 2008, PLANT PHYSIOL, V148, P856, DOI 10.1104/pp.108.123844; Komarova NY, 2012, TRAFFIC, V13, P1090, DOI 10.1111/j.1600-0854.2012.01370.x; Konishi M, 2010, PLANT J, V63, P269, DOI 10.1111/j.1365-313X.2010.04239.x; Kotur Z, 2012, NEW PHYTOL, V194, P724, DOI 10.1111/j.1469-8137.2012.04094.x; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Li H, 2012, J EXP BOT, V63, P6173, DOI 10.1093/jxb/ers271; Li JY, 2010, PLANT CELL, V22, P1633, DOI 10.1105/tpc.110.075242; Li WB, 2007, PLANT PHYSIOL, V143, P425, DOI 10.1104/pp.106.091223; Lin SH, 2008, PLANT CELL, V20, P2514, DOI 10.1105/tpc.108.060244; Little DY, 2005, P NATL ACAD SCI USA, V102, P13693, DOI 10.1073/pnas.0504219102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd G., 1980, Combined Proceedings, International Plant Propagators' Society, V30, P421; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Migocka M, 2013, PLANT SOIL, V364, P245, DOI 10.1007/s11104-012-1345-x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakamura Y, 2007, TREE PHYSIOL, V27, P503, DOI 10.1093/treephys/27.4.503; Nakashima K, 2006, PHYSIOL PLANTARUM, V126, P62, DOI 10.1111/j.1399-3054.2005.00592.x; Nazoa P, 2003, PLANT MOL BIOL, V52, P689, DOI 10.1023/A:1024899808018; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Oka A, 2002, GENES GENET SYST, V77, P383, DOI 10.1266/ggs.77.383; Okamoto M, 2003, PLANT CELL PHYSIOL, V44, P304, DOI 10.1093/pcp/pcg036; Oliveros JC, 2007, VENNY INTERACTIVE TO; Orsel M, 2002, PLANT PHYSIOL, V129, P886, DOI 10.1104/pp.005280; Orsel M, 2006, PLANT PHYSIOL, V142, P1304, DOI 10.1104/pp.106.085209; Plavcova L, 2013, PLANT CELL ENVIRON, V36, P186, DOI 10.1111/j.1365-3040.2012.02566.x; Plesch G, 2001, PLANT J, V28, P455, DOI 10.1046/j.1365-313X.2001.01166.x; Plett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015289; Polle A, 2013, APPL MICROBIOL BIOT, V97, P5669, DOI 10.1007/s00253-013-4940-8; Rastogi R, 1997, PLANT MOL BIOL, V34, P465, DOI 10.1023/A:1005842812321; Rennenberg H, 2010, PLANT BIOLOGY, V12, P275, DOI 10.1111/j.1438-8677.2009.00309.x; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Shekhawat UKS, 2011, MOL BIOL REP, V38, P4023, DOI 10.1007/s11033-010-0521-4; SHIRSAT A, 1989, MOL GEN GENET, V215, P326, DOI 10.1007/BF00339737; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taniguchi M, 2007, PLANT CELL PHYSIOL, V48, P263, DOI 10.1093/pcp/pcl063; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; Villain P, 1996, J BIOL CHEM, V271, P32593, DOI 10.1074/jbc.271.51.32593; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Wang YY, 2011, PLANT CELL, V23, P1945, DOI 10.1105/tpc.111.083618; Weichert A, 2012, PLANTA, V235, P311, DOI 10.1007/s00425-011-1508-7; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Yanagisawa S, 2004, P NATL ACAD SCI USA, V101, P7833, DOI 10.1073/pnas.0402267101; Yanagisawa S, 2004, PLANT CELL PHYSIOL, V45, P386, DOI 10.1093/pcp/pch055; Ye RJ, 2012, PLANT CELL REP, V31, P1159, DOI 10.1007/s00299-012-1238-8; Yong ZH, 2010, PLANT J, V63, P739, DOI 10.1111/j.1365-313X.2010.04278.x; Zhang ZL, 2004, PLANT PHYSIOL, V134, P1500, DOI 10.1104/pp.103.034967	88	62	68	9	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72126	10.1371/journal.pone.0072126	http://dx.doi.org/10.1371/journal.pone.0072126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977227	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700135
J	Hwang, IY; Park, C; Luong, T; Harrison, KA; Birnbaumer, L; Kehrl, JH				Hwang, Il-Young; Park, Chung; Luong, Thuyvi; Harrison, Kathleen A.; Birnbaumer, Lutz; Kehrl, John H.			The Loss of Gnai2 and Gnai3 in B Cells Eliminates B Lymphocyte Compartments and Leads to a Hyper-IgM Like Syndrome	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; ADENYLYL-CYCLASE; ORGANIZATION; CCR7; MIGRATION; LINEAGE; CXCR5; EXPRESSION; RETENTION; PROTEINS	B lymphocytes are compartmentalized within lymphoid organs. The organization of these compartments depends upon signaling initiated by G-protein linked chemoattractant receptors. To address the importance of the G-proteins Ga-i2 and Ga-i3 in chemoattractant signaling we created mice lacking both proteins in their B lymphocytes. While bone marrow B cell development and egress is grossly intact; mucosal sites, splenic marginal zones, and lymph nodes essentially lack B cells. There is a partial block in splenic follicular B cell development and a 50-60% reduction in splenic B cells, yet normal numbers of splenic T cells. The absence of Ga-i2 and Ga-i3 in B cells profoundly disturbs the architecture of lymphoid organs with loss of B cell compartments in the spleen, thymus, lymph nodes, and gastrointestinal tract. This results in a severe disruption of B cell function and a hyper-IgM like syndrome. Beyond the pro-B cell stage, B cells are refractory to chemokine stimulation, and splenic B cells are poorly responsive to antigen receptor engagement. Ga-i2 and Ga-i3 are therefore critical for B cell chemoattractant receptor signaling and for normal B cell function. These mice provide a worst case scenario of the consequences of losing chemoattractant receptor signaling in B cells.	[Hwang, Il-Young; Park, Chung; Luong, Thuyvi; Harrison, Kathleen A.; Kehrl, John H.] NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Birnbaumer, Lutz] NIEHS, Neurobiol Lab, NIH, Dept Hlth & Human Serv, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kehrl, JH (corresponding author), NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jkehrl@niaid.nih.gov	Kehrl, John/AAE-6292-2019		Intramural Research Program of the National Institutes of Health [National Institute of Allergy and Infectious Diseases]; IRP project [Z01-ES-101643]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101643, Z01ES101643] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health [National Institute of Allergy and Infectious Diseases](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); IRP project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the National Institutes of Health [National Institute of Allergy and Infectious Diseases] and IRP project Z01-ES-101643 (LB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allende ML, 2010, J EXP MED, V207, P1113, DOI 10.1084/jem.20092210; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Cupedo T, 2004, J IMMUNOL, V173, P4889, DOI 10.4049/jimmunol.173.8.4889; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Cyster JG, 2000, IMMUNOL REV, V176, P181; Cyster JG, 2003, IMMUNOL REV, V194, P48, DOI 10.1034/j.1600-065X.2003.00041.x; Dalwadi H, 2003, J IMMUNOL, V170, P1707, DOI 10.4049/jimmunol.170.4.1707; Durandy Anne, 2007, Adv Immunol, V94, P275, DOI 10.1016/S0065-2776(06)94009-7; Egawa T, 2001, IMMUNITY, V15, P323, DOI 10.1016/S1074-7613(01)00185-6; Feng NG, 2006, J IMMUNOL, V176, P5749, DOI 10.4049/jimmunol.176.10.5749; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gatto D, 2011, J IMMUNOL, V187, P4621, DOI 10.4049/jimmunol.1101542; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Geherin SA, 2012, J IMMUNOL, V188, P6027, DOI 10.4049/jimmunol.1102639; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Henderson RB, 2010, J EXP MED, V207, P837, DOI 10.1084/jem.20091489; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hopken UE, 2004, J LEUKOCYTE BIOL, V76, P709, DOI 10.1189/jlb.1203643; Hu SM, 2011, P NATL ACAD SCI USA, V108, pE1035, DOI 10.1073/pnas.1100156108; Hwang IY, 2010, GENES IMMUN, V11, P384, DOI 10.1038/gene.2010.27; Jain M, 2001, AM J PHYSIOL-HEART C, V280, pH569, DOI 10.1152/ajpheart.2001.280.2.H569; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; Kehrl JH, 2004, CRIT REV IMMUNOL, V24, P409; Kehrl JH, 2009, CURR TOP MICROBIOL, V334, P107, DOI 10.1007/978-3-540-93864-4_5; Lougaris V, 2005, IMMUNOL REV, V203, P48, DOI 10.1111/j.0105-2896.2005.00229.x; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; McDonald KG, 2007, AM J PATHOL, V170, P1229, DOI 10.2353/ajpath.2007.060817; Nakagawa R, 2013, J IMMUNOL, V190, P3309, DOI 10.4049/jimmunol.1202766; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; Ohl L, 2003, J EXP MED, V197, P1199, DOI 10.1084/jem.20030169; Pabst O, 2004, J EXP MED, V199, P411, DOI 10.1084/jem.20030996; Park C, 2012, BLOOD, V119, P978, DOI 10.1182/blood-2011-06-364273; Park C, 2009, METHODS MOL BIOL, V571, P199, DOI 10.1007/978-1-60761-198-1_13; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Pineda VV, 2004, NEURON, V41, P153, DOI 10.1016/S0896-6273(03)00813-4; Plummer NW, 2012, P NATL ACAD SCI USA, V109, P21366, DOI 10.1073/pnas.1219810110; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rowland SL, 2010, J EXP MED, V207, P607, DOI 10.1084/jem.20091673; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Sinha RK, 2009, IMMUNITY, V30, P434, DOI 10.1016/j.immuni.2008.12.018; Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Yang J, 2002, J BIOL CHEM, V277, P46035, DOI 10.1074/jbc.M208519200	54	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72596	10.1371/journal.pone.0072596	http://dx.doi.org/10.1371/journal.pone.0072596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977324	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700178
J	Peccoud, J; Labonne, G; Sauvion, N				Peccoud, Jean; Labonne, Gerard; Sauvion, Nicolas			Molecular Test to Assign Individuals within the Cacopsylla pruni Complex	PLOS ONE			English	Article							JUMPING PLANT-LICE; HEMIPTERA; VECTOR; STERNORRHYNCHA; PHYTOPLASMA; PSYLLOIDEA; HOMOPTERA; INSECTS; BIOLOGY	Crop protection requires the accurate identification of disease vectors, a task that can be made difficult when these vectors encompass cryptic species. Here we developed a rapid molecular diagnostic test to identify individuals of Cacopsylla pruni (Scopoli, 1763) (Hemiptera: Psyllidae), the main vector of the European stone fruit yellows phytoplasma. This psyllid encompasses two highly divergent genetic groups that are morphologically similar and that are characterized by genotyping several microsatellite markers, a costly and time-consuming protocol. With the aim of developing species-specific PCR primers, we sequenced the Internal Transcribed Spacer 2 (ITS2) on a collection of C. pruni samples from France and other European countries. ITS2 sequences showed that the two genetic groups represent two highly divergent clades. This enabled us to develop specific primers for the assignment of individuals to either genetic group in a single PCR, based on ITS2 amplicon size. All previously assigned individuals yielded bands of expected sizes, and the PCR proved efficient on a larger sample of 799 individuals. Because none appeared heterozygous at the ITS2 locus (i.e., none produced two bands), we inferred that the genetic groups of C. pruni, whose distribution is partly sympatric, constitute biological species that have not exchanged genes for an extended period of time. Other psyllid species (Cacopsylla, Psylla, Triozidae and Aphalaridae) failed to yield any amplicon. These primers are therefore unlikely to produce false positives and allow rapid assignment of C. pruni individuals to either cryptic species.	[Peccoud, Jean; Labonne, Gerard; Sauvion, Nicolas] INRA, UMR Biol & Genet Interact Plantes Parasites 0325, F-34060 Montpellier, France	INRAE	Sauvion, N (corresponding author), INRA, UMR Biol & Genet Interact Plantes Parasites 0325, Campus Int Baillarguet, F-34060 Montpellier, France.	sauvion@supagro.inra.fr	, Sauvion/X-8928-2018	, Sauvion/0000-0002-1641-5871; Peccoud, Jean/0000-0002-3356-7869	Institut National de la Recherche Agronomique project SDIPS (Speciation & molecular Diagnostic of Insect Pest Species complexes)	Institut National de la Recherche Agronomique project SDIPS (Speciation & molecular Diagnostic of Insect Pest Species complexes)	Jean Peccoud was funded by a post-doc grant from the Institut National de la Recherche Agronomique project SDIPS (Speciation & molecular Diagnostic of Insect Pest Species complexes). This project also funded the sequencing. Exchanges of materials between laboratories were made possible thanks to the COST Action FA0807 (Integrated Management of Phytoplasma Epidemics in Different Crop Systems) (http://www.costphytoplasma.eu/), and a bilateral project France-Turkey (PHC BOSPHORE-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J.C, 2000, PHYLOGEOGRAPHY HIST, DOI DOI 10.2307/J.CTV1NZFGJ7; BURCKHARDT D, 1986, B ENTOMOL RES, V76, P119, DOI 10.1017/S0007485300015340; BURCKHARDT D, 1989, J NAT HIST, V23, P643, DOI 10.1080/00222938900770371; Burckhardt D, 2012, ZOOTAXA, P1; Campbell Bruce C., 1994, Insect Molecular Biology, V3, P73, DOI 10.1111/j.1365-2583.1994.tb00154.x; Carraro L, 2004, ACTA HORTIC, P449, DOI 10.17660/ActaHortic.2004.657.72; Drummond AJ, 2010, GENEIOUS V5; Farris RE, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.2601; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hodkinson I, 2009, J NAT HIST, V43, P65, DOI 10.1080/00222930802354167; HODKINSON ID, 1974, B ENTOMOL RES, V64, P325, DOI 10.1017/S0007485300031217; Hodkinson ID, 1984, IOBC WPRS B, V7, P32; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; Liu D, 2006, ENTOMOL EXP APPL, V118, P177, DOI 10.1111/j.1570-7458.2006.00383.x; Mifsud D, 2002, J NAT HIST, V36, P1887, DOI 10.1080/00222930110048909; Milligan BG, 1998, MOL GENETIC ANAL POP, P43; Ouvrard D, 2013, PSYL LIST WORLD PSYL; Ouvrard D, 2010, SYST ENTOMOL, V35, P172, DOI 10.1111/j.1365-3113.2009.00499.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING LAB MANU; Sauvion N, 2007, B INSECTOL, V60, P185; Sauvion N, 2009, MOL ECOL RESOUR, V9, P1196, DOI 10.1111/j.1755-0998.2009.02604.x; Shcherbakov D. Y., 2007, Russian Entomological Journal, V16, P47; Steffek R., 2012, Bulletin OEPP, V42, P191, DOI 10.1111/epp.2567; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; White I.M., 1985, Bulletin of the British Museum (Natural History) Entomology, V50, P153	28	20	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72454	10.1371/journal.pone.0072454	http://dx.doi.org/10.1371/journal.pone.0072454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977301	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700171
J	Quarantelli, M; Salvatore, E; Giorgio, SMD; Filla, A; Cervo, A; Russo, CV; Cocozza, S; Massarelli, M; Brunetti, A; De Michele, G				Quarantelli, Mario; Salvatore, Elena; Giorgio, Sara Maria Delle Acque; Filla, Alessandro; Cervo, Amedeo; Russo, Cinzia Valeria; Cocozza, Sirio; Massarelli, Marco; Brunetti, Arturo; De Michele, Giuseppe			Default-Mode Network Changes in Huntington's Disease: An Integrated MRI Study of Functional Connectivity and Morphometry	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RESTING STATE FMRI; PARKINSONS-DISEASE; IMAGE REGISTRATION; PREFRONTAL CORTEX; BRAIN ACTIVITY; BASAL GANGLIA; DYSFUNCTION; DEACTIVATION; MOTION	Previous MRI studies of functional connectivity in pre-symptomatic mutation carriers of Huntington's disease (HD) have shown dysfunction of the Default-Mode Network (DMN). No data however are currently available on the DMN alterations in the symptomatic stages of the disease, which are characterized by cortical atrophy involving several DMN nodes. We assessed DMN integrity and its possible correlations with motor and cognitive symptoms in 26 symptomatic HD patients as compared to 22 normal volunteers, by analyzing resting state functional MRI data, using the Precuneal Cortex/Posterior Cingulate Cortices (PC/PCC) as seed, controlling at voxel level for the effect of atrophy by co-varying for gray matter volume. Direct correlation with PC/PCC was decreased, without correlation with atrophy, in the ventral medial prefrontal cortex (including anterior cingulate and subgenual cortex), right dorso-medial prefrontal cortex, and in the right inferior parietal cortex (mainly involving the angular gyrus). Negative correlations with PC/PCC were decreased bilaterally in the inferior parietal cortices, while a cluster in the right middle occipital gyrus presented increased correlation with PC/PCC. DMN changes in the ventral medial prefrontal cortex significantly correlated with the performance at the Stroop test (p = .0002). Widespread DMN changes, not correlating with the atrophy of the involved nodes, are present in symptomatic HD patients, and correlate with cognitive disturbances.	[Quarantelli, Mario] CNR, Biostruct & Bioimaging Inst, Naples, Italy; [Salvatore, Elena; Filla, Alessandro; Russo, Cinzia Valeria; Massarelli, Marco; De Michele, Giuseppe] Univ Naples Federico II, Dept Neurosci Reprod Sci & Odontostomatol, Naples, Italy; [Giorgio, Sara Maria Delle Acque; Cervo, Amedeo; Cocozza, Sirio; Brunetti, Arturo] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II; University of Naples Federico II	Quarantelli, M (corresponding author), CNR, Biostruct & Bioimaging Inst, Naples, Italy.	quarante@unina.it	Brunetti, Arturo/AAE-5261-2019; Russo, Cinzia Valeria/AAA-8341-2021; Quarantelli, Mario/A-6154-2009; Lang, Steven/AAE-8102-2021; Cocozza, Sirio/ABD-1161-2020	Brunetti, Arturo/0000-0001-7057-3494; Russo, Cinzia Valeria/0000-0003-0345-8319; Quarantelli, Mario/0000-0001-7836-454X; Lang, Steven/0000-0003-1669-9146; Cocozza, Sirio/0000-0002-0300-5160; Cervo, Amedeo/0000-0002-5839-9929; SALVATORE, Elena/0000-0003-1493-5133	European Huntington's Disease Network (Euro-HD)	European Huntington's Disease Network (Euro-HD)	The authors would like to thank all patients and families for participation to the study, and the European Huntington's Disease Network (Euro-HD) for the support.	Ardekani BA, 2001, MAGN RESON IMAGING, V19, P959, DOI 10.1016/S0730-725X(01)00418-0; Argyelan M, 2008, J NEUROSCI, V28, P10687, DOI 10.1523/JNEUROSCI.2933-08.2008; Arnulf I, 2008, CURR OPIN NEUROL, V21, P472, DOI 10.1097/WCO.0b013e328305044d; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Benton AL., 1983, MULTILINGUAL APHASIA; Bluhm R, 2009, PSYCHIAT CLIN NEUROS, V63, P754, DOI 10.1111/j.1440-1819.2009.02030.x; Bohanna I, 2011, NEUROBIOL DIS, V42, P475, DOI 10.1016/j.nbd.2011.02.010; Braskie MN, 2011, HUM BRAIN MAPP, V32, P947, DOI 10.1002/hbm.21081; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Casanova R, 2007, NEUROIMAGE, V34, P137, DOI 10.1016/j.neuroimage.2006.09.011; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Clark VP, 2002, NEUROREPORT, V13, P703, DOI 10.1097/00001756-200204160-00033; Coste CP, 2011, CEREB CORTEX, V21, P2612, DOI 10.1093/cercor/bhr050; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Deckel AW, 2002, BRAIN RES, V939, P76, DOI 10.1016/S0006-8993(02)02550-7; Deckel AW, 2001, J NEUROSCI RES, V64, P99, DOI 10.1002/jnr.1057; Delaveau P, 2010, EUR NEUROPSYCHOPHARM, V20, P784, DOI 10.1016/j.euroneuro.2010.07.001; DELONG MR, 2000, PRINCIPLES NEURAL SC, P853; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; Duan XJ, 2012, NEUROIMAGE, V60, P1280, DOI 10.1016/j.neuroimage.2012.01.047; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Frackowiak RSJ, 1997, HUMAN BRAIN FUNCTION, Vxiii; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Georgiou-Karistianis N, 2007, NEUROPSYCHOLOGIA, V45, P1791, DOI 10.1016/j.neuropsychologia.2006.12.023; Helmich RC, 2010, CEREB CORTEX, V20, P1175, DOI 10.1093/cercor/bhp178; Hobbs NZ, 2011, MOVEMENT DISORD, V26, P1684, DOI 10.1002/mds.23747; Ille R, 2011, J PSYCHIATR NEUROSCI, V36, P383, DOI 10.1503/jpn.100143; Kassubek J, 2005, CEREB CORTEX, V15, P846, DOI 10.1093/cercor/bhh185; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kloppel S, 2009, BRAIN, V132, P1624, DOI 10.1093/brain/awp081; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Ligot N, 2011, J CEREBR BLOOD F MET, V31, P41, DOI 10.1038/jcbfm.2010.186; Liu B, 2010, J NEUROSCI, V30, P64, DOI 10.1523/JNEUROSCI.3941-09.2010; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marchand WR, 2007, NEUROIMAGE, V38, P538, DOI 10.1016/j.neuroimage.2007.07.036; Marrakchi-Kacem L, 2010, LECT NOTES COMPUT SC, V6362, P217; Minzenberg MJ, 2011, PSYCHOPHARMACOLOGY, V215, P23, DOI 10.1007/s00213-010-2111-5; Nagano-Saito A, 2008, J NEUROSCI, V28, P3697, DOI 10.1523/JNEUROSCI.3921-07.2008; Nagano-Saito A, 2009, NEUROSCI LETT, V458, P1, DOI 10.1016/j.neulet.2009.04.025; Orth M, 2011, J NEUROL NEUROSUR PS, V82, P1409, DOI 10.1136/jnnp.2010.209668; Paulsen JS, 2004, AM J NEURORADIOL, V25, P1715; Politis M, 2011, HUM BRAIN MAPP, V32, P258, DOI 10.1002/hbm.21008; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Reading SAJ, 2004, ANN NEUROL, V55, P879, DOI 10.1002/ana.20121; Ribai P, 2007, ARCH NEUROL-CHICAGO, V64, P813, DOI 10.1001/archneur.64.6.813; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Rosas HD, 2010, NEUROIMAGE, V49, P2995, DOI 10.1016/j.neuroimage.2009.10.015; Rosas HD, 2005, NEUROLOGY, V65, P745, DOI 10.1212/01.wnl.0000174432.87383.87; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Saft C, 2008, NEUROPSYCHOLOGIA, V46, P1279, DOI 10.1016/j.neuropsychologia.2007.12.002; Sambataro F, 2013, SCHIZOPHRENIA BULL, V39, P206, DOI 10.1093/schbul/sbr128; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Stokes PRA, 2011, NEUROPSYCHOPHARMACOL, V36, P763, DOI 10.1038/npp.2010.210; Thiruvady DR, 2007, J NEUROL NEUROSUR PS, V78, P127, DOI 10.1136/jnnp.2006.098368; Tian LX, 2007, NEUROIMAGE, V36, P684, DOI 10.1016/j.neuroimage.2007.03.044; Tomasi D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006102; TREISMAN A, 1969, NATURE, V222, P437, DOI 10.1038/222437a0; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Unschuld PG, 2012, PSYCHIAT RES-NEUROIM, V203, P166, DOI 10.1016/j.pscychresns.2012.01.002; Unschuld PG, 2012, NEUROSCI LETT, V514, P204, DOI 10.1016/j.neulet.2012.02.095; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; van Eimeren T, 2009, ARCH NEUROL-CHICAGO, V66, P877, DOI 10.1001/archneurol.2009.97; VANDIJK JG, 1986, HUM GENET, V73, P235, DOI 10.1007/BF00401235; VANHOESEN GW, 1993, NEUROBIOLOGY CINGULA, P345; Wechsler D., 1981, WECHSLER ADULT INTEL; Wolf RC, 2008, EXP NEUROL, V213, P137, DOI 10.1016/j.expneurol.2008.05.017; Wolf RC, 2007, BRAIN, V130, P2845, DOI 10.1093/brain/awm210; Wolf RC, 2012, EXP NEUROL, V237, P191, DOI 10.1016/j.expneurol.2012.06.014; Wolf RC, 2012, HUM BRAIN MAPP, V33, P2161, DOI 10.1002/hbm.21348; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023; Zimbelman JL, 2007, J INT NEUROPSYCH SOC, V13, P758, DOI 10.1017/S1355617707071214	88	36	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72159	10.1371/journal.pone.0072159	http://dx.doi.org/10.1371/journal.pone.0072159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977239	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700143
J	Simard, JC; Cesaro, A; Chapeton-Montes, J; Tardif, M; Antoine, F; Girard, D; Tessier, PA				Simard, Jean-Christophe; Cesaro, Annabelle; Chapeton-Montes, Julie; Tardif, Melanie; Antoine, Francis; Girard, Denis; Tessier, Philippe A.			S100A8 and S100A9 Induce Cytokine Expression and Regulate the NLRP3 Inflammasome via ROS-Dependent Activation of NF-kappa B	PLOS ONE			English	Article							URATE MONOHYDRATE CRYSTALS; REACTIVE OXYGEN; RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; NEUTROPHIL RECRUITMENT; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; IMMUNE-RESPONSES; CROHNS-DISEASE; BOWEL-DISEASE	S100A8 and S100A9 are cytoplasmic proteins expressed by phagocytes. High concentrations of these proteins have been correlated with various inflammatory conditions, including autoimmune diseases such as rheumatoid arthritis and Crohn's disease, as well as autoinflammatory diseases. In the present study, we examined the effects of S100A8 and S100A9 on the secretion of cytokines and chemokines from PBMCs. S100A8 and S100A9 induced the secretion of cytokines such as IL-6, IL-8, and IL-1 beta. This secretion was associated with the activation and translocation of the transcription factor NF-kappa B. Inhibition studies using antisense RNA and the pharmacological agent BAY-117082 confirmed the involvement of NF-kappa B in IL-6, IL-8, and IL-1 beta secretion. S100A8- and S100A9-mediated activation of NF-kappa B, the NLR family, pyrin domain-containing 3 (NLRP3) protein, and pro-IL-1 beta expression was dependent on the generation of reactive oxygen species. This effect was synergistically enhanced by ATP, a known inflammasome activator. These results suggest that S100A8 and S100A9 enhance the inflammatory response by inducing cytokine secretion of PBMCs.	[Simard, Jean-Christophe; Antoine, Francis; Girard, Denis] Univ Quebec, Inst Natl Rech Sci, Inst Armand Frappier, Lab Rech Inflammat Granulocytes, Laval, PQ, Canada; [Cesaro, Annabelle; Chapeton-Montes, Julie; Tardif, Melanie; Tessier, Philippe A.] Univ Laval, Ctr Rech CHU Quebec, Quebec City, PQ, Canada; [Cesaro, Annabelle; Chapeton-Montes, Julie; Tardif, Melanie; Tessier, Philippe A.] Univ Laval, Fac Med, Quebec City, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); Laval University; Laval University	Tessier, PA (corresponding author), Univ Laval, Ctr Rech CHU Quebec, Quebec City, PQ, Canada.	Philippe.Tessier@crchul.ulaval.ca	Cesaro, Annabelle/AAX-3177-2020		Fonds de la Recherche en Sante du Quebec (FRSQ); Canadian Institutes of Health Research	Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a studentship to JCS from the Fonds de la Recherche en Sante du Quebec (FRSQ) and a grant from the Canadian Institutes of Health Research to PAT and DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral FA, 2012, ARTHRITIS RHEUM-US, V64, P474, DOI 10.1002/art.33355; Anceriz N, 2007, BIOCHEM BIOPH RES CO, V354, P84, DOI 10.1016/j.bbrc.2006.12.203; Averill MM, 2012, ARTERIOSCL THROM VAS, V32, P223, DOI 10.1161/ATVBAHA.111.236927; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; BERNTZEN HB, 1989, J RHEUMATOL, V16, P1416; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BRUN JG, 1994, J RHEUMATOL, V21, P733; Cesaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045478; Chang KA, 2012, NEURODEGENER DIS, V10, P27, DOI 10.1159/000333781; Cheneval D, 1998, J BIOL CHEM, V273, P17846, DOI 10.1074/jbc.273.28.17846; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Ennaciri J, 2009, J IMMUNOL, V183, P5261, DOI 10.4049/jimmunol.0900109; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Foell D, 2008, J PATHOL, V216, P183, DOI 10.1002/path.2394; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; He Q, 2012, ASIAN PAC J CANCER P, V13, P1365, DOI 10.7314/APJCP.2012.13.4.1365; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hornung V, 2010, EUR J IMMUNOL, V40, P620, DOI 10.1002/eji.200940185; Jiang YG, 2012, BIOCHEM BIOPH RES CO, V425, P121, DOI 10.1016/j.bbrc.2012.07.011; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kallberg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034207; Kane D, 2003, ARTHRITIS RHEUM, V48, P1676, DOI 10.1002/art.10988; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kessel C., 2012, CLIN IMMUNOL; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lim SY, 2009, J LEUKOCYTE BIOL, V86, P577, DOI 10.1189/jlb.1008608; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Loser K, 2010, NAT MED; Loukili N, 2010, J BIOL CHEM, V285, P15746, DOI 10.1074/jbc.M110.103259; LUGERING N, 1995, EUR J CLIN INVEST, V25, P659, DOI 10.1111/j.1365-2362.1995.tb01982.x; LUGERING N, 1995, DIGESTION, V56, P406, DOI 10.1159/000201267; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Miki H, 2012, J BIOCHEM, V151, P255, DOI 10.1093/jb/mvs006; Newton RA, 1998, J IMMUNOL, V160, P1427; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perregaux DG, 1998, AM J PHYSIOL-CELL PH, V275, pC1538, DOI 10.1152/ajpcell.1998.275.6.C1538; Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Robinson MJ, 2002, J BIOL CHEM, V277, P3658, DOI 10.1074/jbc.M102950200; Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50; Rubartelli A, 2012, J LEUKOCYTE BIOL, V92, P951, DOI 10.1189/jlb.0512265; Ryan KA, 2004, INFECT IMMUN, V72, P2123, DOI 10.1128/IAI.72.4.2123-2130.2004; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Ryckman C, 2004, J LEUKOCYTE BIOL, V76, P433, DOI 10.1189/jlb.0603294; Ryckman C, 2003, ARTHRITIS RHEUM-US, V48, P2310, DOI 10.1002/art.11079; Sampson B, 2002, LANCET, V360, P1742, DOI 10.1016/S0140-6736(02)11683-7; Samuel JM, 2008, CYTOKINE, V42, P256, DOI 10.1016/j.cyto.2008.02.008; SCHMID KW, 1995, HUM PATHOL, V26, P334, DOI 10.1016/0046-8177(95)90067-5; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schumann RR, 1998, BLOOD, V91, P577, DOI 10.1182/blood.V91.2.577.577_577_584; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Simard JC, 2011, J IMMUNOL, V186, P3622, DOI 10.4049/jimmunol.1002956; Simard JC, 2010, J LEUKOCYTE BIOL, V87, P905, DOI 10.1189/jlb.1009676; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; van Lent PLEM, 2012, ARTHRITIS RHEUM-US, V64, P1466, DOI 10.1002/art.34315; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Youm YH, 2011, ENDOCRINOLOGY, V152, P4039, DOI 10.1210/en.2011-1326	73	166	168	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72138	10.1371/journal.pone.0072138	http://dx.doi.org/10.1371/journal.pone.0072138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977231	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000323425700136
J	Winkler, PA; Ekenstedt, KJ; Occelli, LM; Frattaroli, AV; Bartoe, JT; Venta, PJ; Petersen-Jones, SM				Winkler, Paige A.; Ekenstedt, Kari J.; Occelli, Laurence M.; Frattaroli, Anton V.; Bartoe, Joshua T.; Venta, Patrick J.; Petersen-Jones, Simon M.			A Large Animal Model for CNGB1 Autosomal Recessive Retinitis Pigmentosa	PLOS ONE			English	Article							PROGRESSIVE RETINAL ATROPHY; NUCLEOTIDE-GATED CHANNELS; THERAPY RESTORES VISION; ACID-RICH PROTEIN; GENE-THERAPY; BETA-SUBUNIT; CATION CHANNEL; NONSENSE MUTATION; CANINE MODEL; ROD	Retinal dystrophies in dogs are invaluable models of human disease. Progressive retinal atrophy (PRA) is the canine equivalent of retinitis pigmentosa (RP). Similar to RP, PRA is a genetically heterogenous condition. We investigated PRA in the Papillon breed of dog using homozygosity mapping and haplotype construction of single nucleotide polymorphisms within a small family group to identify potential positional candidate genes. Based on the phenotypic similarities between the PRA-affected Papillons, mouse models and human patients, CNGB1 was selected as the most promising positional candidate gene. CNGB1 was sequenced and a complex mutation consisting of the combination of a one basepair deletion and a 6 basepair insertion was identified in exon 26 (c.2387delA;2389_2390insAGCTAC) leading to a frameshift and premature stop codon. Immunohistochemistry (IHC) of pre-degenerate retinal sections from a young affected dog showed absence of labeling using a C-terminal CNGB1 antibody. Whereas an antibody directed against the N-terminus of the protein, which also recognizes the glutamic acid rich proteins arising from alternative splicing of the CNGB1 transcript (upstream of the premature stop codon), labeled rod outer segments. CNGB1 combines with CNGA1 to form the rod cyclic nucleotide gated channel and previous studies have shown the requirement of CNGB1 for normal targeting of CNGA1 to the rod outer segment. In keeping with these previous observations, IHC showed a lack of detectable CNGA1 protein in the rod outer segments of the affected dog. A population study did not identify the CNGB1 mutation in PRA-affected dogs in other breeds and documented that the CNGB1 mutation accounts for similar to 70% of cases of Papillon PRA in our PRA-affected canine DNA bank. CNGB1 mutations are one cause of autosomal recessive RP making the CNGB1 mutant dog a valuable large animal model of the condition.	[Winkler, Paige A.; Occelli, Laurence M.; Bartoe, Joshua T.; Venta, Patrick J.; Petersen-Jones, Simon M.] Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Winkler, Paige A.; Venta, Patrick J.; Petersen-Jones, Simon M.] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Ekenstedt, Kari J.] Univ Wisconsin, Dept Anim & Food Sci, River Falls, WI 54022 USA; [Frattaroli, Anton V.] Michigan State Univ, E Lansing, MI 48824 USA; [Venta, Patrick J.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; University of Wisconsin System; Michigan State University; Michigan State University	Petersen-Jones, SM (corresponding author), Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA.	Peter315@cvm.msu.edu	Petersen-Jones, Simon/B-3822-2018	Petersen-Jones, Simon/0000-0002-7410-2304	Papillon Club of America; Myers-Dunlap Endowment for Canine Health	Papillon Club of America; Myers-Dunlap Endowment for Canine Health	Funding provided by the Papillon Club of America and the Myers-Dunlap Endowment for Canine Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aguirre GD, 2006, COLD SPRING HARB MON, V44, P291; Annear MJ, 2011, GENE THER, V18, P53, DOI 10.1038/gt.2010.111; Ardell MD, 2000, GENE, V245, P311, DOI 10.1016/S0378-1119(00)00023-8; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bareil C, 2001, HUM GENET, V108, P328, DOI 10.1007/s004390100496; Becirovic E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008969; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; BERSON EL, 1991, AM J OPHTHALMOL, V111, P614, DOI 10.1016/S0002-9394(14)73708-0; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; CLEMENTS PJM, 1993, CURR EYE RES, V12, P861, DOI 10.3109/02713689309020391; Colville CA, 1996, J BIOL CHEM, V271, P32968, DOI 10.1074/jbc.271.51.32968; COOK NJ, 1989, J BIOL CHEM, V264, P6996; Dekomien G, 2000, CYTOGENET CELL GENET, V90, P261, DOI 10.1159/000056785; Downs LL, 2012, TRAV GENRE SOC, P169; Downs LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021452; Gearhart PM, 2010, ARCH OPHTHALMOL-CHIC, V128, P1442, DOI 10.1001/archophthalmol.2010.210; Goldstein O, 2010, GENOMICS, V96, P362, DOI 10.1016/j.ygeno.2010.09.003; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; GUM GG, 1984, AM J VET RES, V45, P1166; Hakanson Nils, 1995, Veterinary and Comparative Ophthalmology, V5, P83; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Jacobson SG, 2006, MOL THER, V13, P1074, DOI 10.1016/j.ymthe.2006.03.005; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koch S, 2012, HUM MOL GENET, V21, P4486, DOI 10.1093/hmg/dds290; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; Kondo H, 2004, INVEST OPHTH VIS SCI, V45, P4433, DOI 10.1167/iovs.04-0544; Kukekova AV, 2009, MAMM GENOME, V20, P109, DOI 10.1007/s00335-008-9163-4; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maubaret CG, 2011, INVEST OPHTH VIS SCI, V52, P9304, DOI 10.1167/iovs.11-8372; Michalakis S, 2006, J BIOL CHEM, V281, P35156, DOI 10.1074/jbc.M606409200; Michalakis S, 2011, J NEUROSCI, V31, P133, DOI 10.1523/JNEUROSCI.4735-10.2011; Mowat FM, 2013, GENE THER, V20, P545, DOI 10.1038/gt.2012.63; Mowat FM, 2012, ARVO M, V53, P1928; Mowat FM, 2008, MOL VIS, V14, P2518; Narfstrom K, 1998, AM J VET RES, V59, P221; Narfstrom K, 2003, INVEST OPHTH VIS SCI, V44, P1663, DOI 10.1167/iovs.02-0595; Narfstrom Kristina, 1999, Veterinary Ophthalmology, V2, P67; Pentia DC, 2006, J BIOL CHEM, V281, P5500, DOI 10.1074/jbc.M507488200; Petersen-Jones SM, 1998, EYE, V12, P566, DOI 10.1038/eye.1998.146; Petersen-Jones SM, 1999, INVEST OPHTH VIS SCI, V40, P1637; Petit L, 2012, MOL THER, V20, P2019, DOI 10.1038/mt.2012.134; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritter LM, 2011, J NEUROSCI, V31, P11231, DOI 10.1523/JNEUROSCI.2875-11.2011; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Shuart NG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1466; Simpson DA, 2011, J MED GENET, V48, P145, DOI 10.1136/jmg.2010.083568; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; SUGIMOTO Y, 1991, P NATL ACAD SCI USA, V88, P3116, DOI 10.1073/pnas.88.8.3116; Trudeau MC, 2002, NEURON, V34, P197, DOI 10.1016/S0896-6273(02)00647-5; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; WHITLEY RD, 1988, VET MED-US, V83, P50; Wiesner B, 1998, J CELL BIOL, V142, P473, DOI 10.1083/jcb.142.2.473; Zangerl B, 2006, GENOMICS, V88, P551, DOI 10.1016/j.ygeno.2006.07.007; Zhang Y, 2009, J CELL SCI, V122, P1192, DOI 10.1242/jcs.042531; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhu L, 2004, J BIOL CHEM, V279, P53828, DOI 10.1074/jbc.M408472200	68	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72229	10.1371/journal.pone.0072229	http://dx.doi.org/10.1371/journal.pone.0072229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977260	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700153
J	An, Y; Kang, QQ; Zhao, YF; Hu, XX; Li, N				An, Yang; Kang, Qianqian; Zhao, Yaofeng; Hu, Xiaoxiang; Li, Ning			Lats2 Modulates Adipocyte Proliferation and Differentiation via Hippo Signaling	PLOS ONE			English	Article							ORGAN SIZE CONTROL; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; PPAR-GAMMA; PROMOTER HYPERMETHYLATION; 3T3-L1 PREADIPOCYTES; TRANSCRIPTION FACTOR; CONTACT INHIBITION; NEGATIVE REGULATOR; GENE-EXPRESSION	First identified in Drosophila and highly conserved in mammals, the Hippo pathway controls organ size. Lats2 is one of the core kinases of the Hippo pathway and plays major roles in cell proliferation by interacting with the downstream transcriptional cofactors YAP and TAZ. Although the function of the Hippo pathway and Lats2 is relatively well understood in several tissues and organs, less is known about the function of Lats2 and Hippo signaling in adipose development. Here, we show that Lats2 is an important modulator of adipocyte proliferation and differentiation via Hippo signaling. Upon activation, Lats2 phosphorylates YAP and TAZ, leading to their retention in the cytoplasm, preventing them from activating the transcription factor TEAD in the nucleus. Because TAZ remains in the cytoplasm, PPAR gamma regains its transcriptional activity. Furthermore, cytoplasmic TAZ acts as an inhibitor of Wnt signaling by suppressing DVL2, thereby preventing beta-catenin from entering the nucleus to stimulate TCF/LEF transcriptional activity. The above effects contribute to the phenotype of repressed proliferation and accelerated differentiation in adipocytes. Thus, Lats2 regulates the balance between proliferation and differentiation during adipose development. Interestingly, our study provides evidence that Lats2 not only negatively modulates cell proliferation but also positively regulates cell differentiation.	[An, Yang; Kang, Qianqian; Zhao, Yaofeng; Hu, Xiaoxiang; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Hu, XX (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	huxx@cau.edu.cn; ninglcau@cau.edu.cn			National Transgenic Breeding Project of China [2011ZX08009, 2009ZX08009]; Major State Basic Research Development Program of China [2009CB941603]	National Transgenic Breeding Project of China; Major State Basic Research Development Program of China(National Basic Research Program of China)	This work was supported by the National Transgenic Breeding Project of China (No. 2011ZX08009 and 2009ZX08009), and the Major State Basic Research Development Program of China (No. 2009CB941603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Codelia VA, 2012, CELL, V150, P669, DOI 10.1016/j.cell.2012.07.020; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; GIMBLE JM, 1995, J CELL BIOCHEM, V58, P393, DOI 10.1002/jcb.240580312; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grimaldi PA, 2001, PROG LIPID RES, V40, P269, DOI 10.1016/S0163-7827(01)00005-4; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Guo XM, 2000, GENE, V251, P45, DOI 10.1016/S0378-1119(00)00192-X; He Q, 2012, BIOCHEM BIOPH RES CO, V419, P573, DOI 10.1016/j.bbrc.2012.02.074; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Huang C, 2006, BIOCHEM BIOPH RES CO, V348, P571, DOI 10.1016/j.bbrc.2006.07.095; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang Z, 2006, NEUROSCI RES, V56, P450, DOI 10.1016/j.neures.2006.09.006; Lean MEJ, 2000, P NUTR SOC, V59, P331, DOI 10.1017/S0029665100000379; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; Liu QY, 2010, BMB REP, V43, P97, DOI 10.5483/BMBRep.2010.43.2.097; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Matsui Y, 2008, CIRC RES, V103, P1309, DOI 10.1161/CIRCRESAHA.108.180042; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park SK, 2004, DIABETES, V53, P2757, DOI 10.2337/diabetes.53.11.2757; Peng YQ, 2012, MOL CELL BIOCHEM, V367, P165, DOI 10.1007/s11010-012-1329-4; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Zhang T, 2001, CANCER RES, V61, P8664; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	58	46	49	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72042	10.1371/journal.pone.0072042	http://dx.doi.org/10.1371/journal.pone.0072042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977200	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200053
J	Lehmann, D; Mfune, JKE; Gewers, E; Cloete, J; Brain, C; Voigt, CC				Lehmann, David; Mfune, John Kazgeba Elijah; Gewers, Erick; Cloete, Johann; Brain, Conrad; Voigt, Christian Claus			Dietary Plasticity of Generalist and Specialist Ungulates in the Namibian Desert: A Stable Isotopes Approach	PLOS ONE			English	Article							NATURAL-ABUNDANCE; CARBON-ISOTOPE; PRIOR INFORMATION; C-4 PLANTS; NITROGEN; WATER; DISCRIMINATION; GRADIENT; VALUES; UNCERTAINTY	Desert ungulates live in adverse ecosystems that are particularly sensitive to degradation and global climate change. Here, we asked how two ungulate species with contrasting feeding habits, grazing gemsbok (Oryx g. gazella) and browsing springbok (Antidorcas marsupialis), respond to an increase in food availability during a pronounced rain period. We used a stable isotope approach to delineate the feeding habits of these two ungulates in the arid Kunene Region of Namibia. Our nineteen months field investigation included two time periods of drought when food availability for ungulates was lowest and an intermediate period with extreme, unusual rainfalls. We documented thirteen isotopically distinct food sources in the isotopic space of the study area. Our results indicated a relatively high dietary plasticity of gemsbok, which fed on a mixture of plants, including more than 30% of C3 plants during drought periods, but almost exclusively on C4 and CAM plant types when food was plentiful. During drought periods, the inferred gemsbok diets also consisted of up to 25% of Euphorbia damarana; an endemic CAM plant that is rich in toxic secondary plant compounds. In contrast, springbok were generalists, feeding on a higher proportion of C3 than C4/CAM plants, irrespective of environmental conditions. Our results illustrate two dietary strategies in gemsbok and springbok which enable them to survive and coexist in the hostile Kunene arid ecosystem.	[Lehmann, David; Voigt, Christian Claus] Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany; [Mfune, John Kazgeba Elijah] Univ Namibia UNAM, Dept Biol Sci, Windhoek, Namibia; [Cloete, Johann; Brain, Conrad] Wilderness Safaris Namibia, Windhoek, Namibia	Leibniz Institut fur Zoo und Wildtierforschung	Lehmann, D (corresponding author), Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany.	lehmann@izw-berlin.de			Leibniz Institute for Zoo and Wildlife Research IZW (Grenoble, France)	Leibniz Institute for Zoo and Wildlife Research IZW (Grenoble, France)	Funding came from the Leibniz Institute for Zoo and Wildlife Research IZW Institutional Budget and Private donations (SoS Apero le Bar, Sylvain Attard, 65 Cours Jean Jaures, 38000 Grenoble, France; +33 4 76 25 25 25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 1986, OECOLOGIA, V69, P395, DOI 10.1007/BF00377062; AMUNDSON R, 1994, J ARID ENVIRON, V28, P265, DOI 10.1016/S0140-1963(05)80048-5; Aranibar JN, 2008, J ARID ENVIRON, V72, P326, DOI 10.1016/j.jaridenv.2007.06.007; Aranibar JN, 2004, GLOBAL CHANGE BIOL, V10, P359, DOI 10.1111/j.1365-2486.2003.00698.x; Aranibar JN, 2003, J ARID ENVIRON, V54, P345, DOI 10.1006/jare.2002.1094; Arsenault R, 2002, OIKOS, V97, P313, DOI 10.1034/j.1600-0706.2002.970301.x; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; BENDER MM, 1971, PHYTOCHEMISTRY, V10, P1239, DOI 10.1016/S0031-9422(00)84324-1; BIGALKE R C, 1972, Zoologica Africana, V7, P333; Borgnia M, 2010, SMALL RUMINANT RES, V88, P44, DOI 10.1016/j.smallrumres.2009.11.009; Bothma J, 2002, GAME RANCH MANAGEMEN, P201; Bruyns PV, 2011, TAXON, V60, P1717, DOI 10.1002/tax.606016; Cain JW, 2006, WILDLIFE SOC B, V34, P570, DOI 10.2193/0091-7648(2006)34[570:MOTAWB]2.0.CO;2; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cerling TE, 2003, J MAMMAL, V84, P456, DOI 10.1644/1545-1542(2003)084&lt;0456:DOEABB&gt;2.0.CO;2; Codron D, 2007, S AFR J WILDL RES, V37, P117, DOI 10.3957/0379-4369-37.2.117; COOPER SM, 1986, OECOLOGIA, V68, P446, DOI 10.1007/BF01036753; COOPER SM, 1988, OECOLOGIA, V75, P336, DOI 10.1007/BF00376934; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Digital Atlas of Namibia, 2002, DIG ATL NAM; Duncan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051490; Eloff F. C., 1962, Koedoe, VNo. 5, P128; Gagnon M, 2000, J MAMMAL, V81, P490, DOI 10.1644/1545-1542(2000)081&lt;0490:DPIEAB&gt;2.0.CO;2; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Gordon IJ, 1996, FUNCT ECOL, V10, P219, DOI 10.2307/2389846; Handley LL, 1999, AUST J PLANT PHYSIOL, V26, P185, DOI 10.1071/PP98146; HANLEY TA, 1982, J RANGE MANAGE, V35, P152, DOI 10.2307/3898380; Hartman G, 2010, OECOLOGIA, V162, P837, DOI 10.1007/s00442-009-1514-7; HOFMANN R R, 1972, Mammalia, V36, P226, DOI 10.1515/mamm.1972.36.2.226; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Holdo RM, 2009, AM NAT, V173, P431, DOI 10.1086/597229; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Kerley GIH, 2003, BIOL CONSERV, V112, P169, DOI 10.1016/S0006-3207(02)00426-3; Kerley GIH, 2010, FUNCT ECOL, V24, P670, DOI 10.1111/j.1365-2435.2009.01675.x; Knight MH, 1991, THESIS U PRETORIA; Korol RL, 1999, TREE PHYSIOL, V19, P551; LAGORY MK, 1985, J WILDLIFE MANAGE, V49, P120, DOI 10.2307/3801855; Le Houerou HN, 2002, ARID LAND RES MANAG, V16, P1, DOI 10.1080/153249802753365296; Liu WG, 2005, GLOBAL CHANGE BIOL, V11, P1094, DOI 10.1111/j.1365-2486.2005.00969.x; Luske BL, 2009, AFR J ECOL, V47, P509, DOI 10.1111/j.1365-2028.2008.00973.x; Ma JY, 2007, J ARID ENVIRON, V69, P365, DOI 10.1016/j.jaridenv.2006.11.002; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; NAGY KA, 1994, J MAMMAL, V75, P860, DOI 10.2307/1382468; NOBEL PS, 1991, NEW PHYTOL, V119, P183, DOI 10.1111/j.1469-8137.1991.tb01022.x; Odadi WO, 2011, SCIENCE, V333, P1753, DOI 10.1126/science.1208468; OSMOND CB, 1978, ANNU REV PLANT PHYS, V29, P379, DOI 10.1146/annurev.pp.29.060178.002115; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Parnell A., 2011, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Phillips DL, 2012, J MAMMAL, V93, P342, DOI 10.1644/11-MAMM-S-158.1; Prins HHT, 2006, AFR J ECOL, V44, P186, DOI 10.1111/j.1365-2028.2006.00619.x; Rivals F, 2011, QUATERN INT, V245, P279, DOI 10.1016/j.quaint.2010.08.001; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Skinner J.D., 1996, TRANSVAAL MUSEUM MON, V10; Slater C, 2001, RAPID COMMUN MASS SP, V15, P1270, DOI 10.1002/rcm.328; Stapelberg FH, 2008, S AFR J WILDL RES, V38, P82, DOI 10.3957/0379-4369-38.1.82; SUTOH M, 1987, Radioisotopes, V36, P74, DOI 10.3769/radioisotopes.36.2_74; Swap RJ, 2004, GLOBAL CHANGE BIOL, V10, P350, DOI 10.1111/j.1365-2486.2003.00702.x; TIESZEN LL, 1979, OECOLOGIA, V37, P337, DOI 10.1007/BF00347910; VAN ZYL J. H. M., 1965, ZOOL AFRICANA, V1, P55; Voigt CC, 2003, J EXP BIOL, V206, P1419, DOI 10.1242/jeb.00274; VORSTER F, 1996, THESIS U PRETORIA PR; Ward EJ, 2010, ENVIRON SCI TECHNOL, V44, P4645, DOI 10.1021/es100053v; West JB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P1, DOI 10.1007/978-90-481-3354-3; Williamson D., 1988, P114	71	17	17	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72190	10.1371/journal.pone.0072190	http://dx.doi.org/10.1371/journal.pone.0072190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977249	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200062
J	Gach, JS; Quendler, H; Tong, T; Narayan, KM; Du, SX; Whalen, RG; Binley, JM; Forthal, DN; Poignard, P; Zwick, MB				Gach, Johannes S.; Quendler, Heribert; Tong, Tommy; Narayan, Kristin M.; Du, Sean X.; Whalen, Robert G.; Binley, James M.; Forthal, Donald N.; Poignard, Pascal; Zwick, Michael B.			A Human Antibody to the CD4 Binding Site of gp120 Capable of Highly Potent but Sporadic Cross Clade Neutralization of Primary HIV-1	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; PROXIMAL EXTERNAL REGION; IMMUNOGLOBULIN G1 B12; ENVELOPE GLYCOPROTEIN; VACCINE DESIGN; PARTICLES BEARING; STRUCTURAL BASIS; CELL RESPONSES; RECOGNITION	Primary isolates of HIV-1 resist neutralization by most antibodies to the CD4 binding site (CD4bs) on gp120 due to occlusion of this site on the trimeric spike. We describe 1F7, a human CD4bs monoclonal antibody that was found to be exceptionally potent against the HIV-1 primary isolate JR-FL. However, 1F7 failed to neutralize a patient-matched primary isolate, JR-CSF even though the two isolates differ by <10% in gp120 at the protein level. In an HIV-1 cross clade panel (n = 157), 1F7 exhibited moderate breadth, but occasionally achieved considerable potency. In binding experiments using monomeric gp120s of select resistant isolates and domain-swap chimeras between JR-FL and JR-CSF, recognition by 1F7 was limited by sequence polymorphisms involving at least the C2 region of Env. Putative N-linked glycosylation site (PNGS) mutations, notably at position 197, allowed 1F7 to neutralize JR-CSF potently without improving binding to the cognate, monomeric gp120. In contrast, flow cytometry experiments using the same PNGS mutants revealed that 1F7 binding is enhanced on cognate trimeric Env. BN-PAGE mobility shift experiments revealed that 1F7 is sensitive to the diagnostic mutation D368R in the CD4 binding loop of gp120. Our data on 1F7 reinforce how exquisitely targeted CD4bs antibodies must be to achieve cross neutralization of two closely related primary isolates. High-resolution analyses of trimeric Env that show the orientation of glycans and polymorphic elements of the CD4bs that affect binding to antibodies like 1F7 are desirable to understand how to promote immunogenicity of more conserved elements of the CD4bs.	[Gach, Johannes S.; Quendler, Heribert; Poignard, Pascal; Zwick, Michael B.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Gach, Johannes S.; Forthal, Donald N.] Univ Calif Irvine, Div Infect Dis, Irvine, CA USA; [Tong, Tommy; Binley, James M.] Torrey Pines Inst Mol Studies, San Diego, CA USA; [Narayan, Kristin M.; Du, Sean X.; Whalen, Robert G.] Altravax Inc, Sunnyvale, CA USA; [Poignard, Pascal] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA	Scripps Research Institute; University of California System; University of California Irvine; Torrey Pines Institute for Molecular Studies, California; International AIDS Vaccine Initiative; Scripps Research Institute	Gach, JS (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	jgach@uci.edu; zwick@scripps.edu	poignard, pascal/AAB-4613-2020; poignard, pascal/N-6678-2013	Poignard, Pascal/0000-0002-0021-7192; Gach, Johannes/0000-0002-5043-5710	Austrian Science Fund [J2845-B13, J2917]; National Institutes of Health (NIH) [R01AI084136, P01AI056375, AI93278, AI58763, AI84714, AI77381, AI56375]; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD-VIMC grant) [38619]; Torrey Pines Institute's AIDS and Infectious Disease Science Center; Neutralizing Antibody Consortium of the International AIDS Vaccine Initiative (IAVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI077381, R01AI058763, R01AI093278, R56AI058763, R21AI077381, R21AI084714, P01AI056375, R01AI100790, R33AI084714] Funding Source: NIH RePORTER	Austrian Science Fund(Austrian Science Fund (FWF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD-VIMC grant); Torrey Pines Institute's AIDS and Infectious Disease Science Center; Neutralizing Antibody Consortium of the International AIDS Vaccine Initiative (IAVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Austrian Science Fund grants (J2845-B13 to JSG) and (J2917 to HQ), National Institutes of Health (NIH) (R01AI084136 to DNF, P01AI056375 to RGW, AI93278, AI58763 and AI84714 to JMB; AI77381 and AI56375 to MBZ), the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD-VIMC grant number 38619 to JMB), and the Torrey Pines Institute's AIDS and Infectious Disease Science Center (JMB) and the Neutralizing Antibody Consortium of the International AIDS Vaccine Initiative (IAVI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012; Bansal GP, 2010, CURR OPIN MOL THER, V12, P39; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Cavacini L, 2003, AIDS, V17, P685, DOI 10.1097/00002030-200303280-00006; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Crooks ET, 2008, VIROLOGY, V377, P364, DOI 10.1016/j.virol.2008.04.045; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; Crooks Emma T., 2005, Human Antibodies, V14, P101; Douagi I, 2010, J VIROL, V84, P1683, DOI 10.1128/JVI.01896-09; Du SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020927; Forsell MNE, 2009, CURR OPIN HIV AIDS, V4, P380, DOI 10.1097/COH.0b013e32832edc19; Fouts TR, 1998, AIDS RES HUM RETROV, V14, P591, DOI 10.1089/aid.1998.14.591; Gach JS, 2011, CURR TOP MED CHEM, V11, P2997; Gach JS, 2010, J BIOL CHEM, V285, P1122, DOI 10.1074/jbc.M109.058792; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Herrera C, 2006, VIROLOGY, V351, P121, DOI 10.1016/j.virol.2006.03.003; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; HO DD, 1991, J VIROL, V65, P489, DOI 10.1128/JVI.65.1.489-493.1991; Hoxie JA, 2010, ANNU REV MED, V61, P135, DOI 10.1146/annurev.med.60.042507.164323; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; Kunert R, 1998, AIDS RES HUM RETROV, V14, P1115, DOI 10.1089/aid.1998.14.1115; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Leaman DP, 2010, J VIROL, V84, P3382, DOI 10.1128/JVI.02363-09; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Narayan KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052732; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Pietzsch J, 2010, J EXP MED; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; POSNER MR, 1991, J IMMUNOL, V146, P4325; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scheid JF, 2011, SCIENCE; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tong T, 2012, J VIROL, V86, P3574, DOI 10.1128/JVI.06938-11; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Watkins David I, 2010, Top HIV Med, V18, P35; Wu L, 2009, J VIROL, V83, P5077, DOI 10.1128/JVI.02600-08; Wu SR, 2010, P NATL ACAD SCI USA, V107, P18844, DOI 10.1073/pnas.1007227107; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu XL, 2009, J VIROL, V83, P10892, DOI 10.1128/JVI.01142-09; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zwick MB, 2003, J VIROL, V77, P6965, DOI 10.1128/JVI.77.12.6965-6978.2003; Zwick MB, 2003, J VIROL, V77, P5863, DOI 10.1128/JVI.77.10.5863-5876.2003; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	75	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72054	10.1371/journal.pone.0072054	http://dx.doi.org/10.1371/journal.pone.0072054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991039	Green Published, gold			2022-12-25	WOS:000324228800041
J	Schupbach, J; Gebhardt, MD; Scherrer, AU; Bisset, LR; Niederhauser, C; Regenass, S; Yerly, S; Aubert, V; Suter, F; Pfister, S; Martinetti, G; Andreutti, C; Klimkait, T; Brandenberger, M; Gunthard, HF				Schuepbach, Joerg; Gebhardt, Martin D.; Scherrer, Alexandra U.; Bisset, Leslie R.; Niederhauser, Christoph; Regenass, Stephan; Yerly, Sabine; Aubert, Vincent; Suter, Franziska; Pfister, Stefan; Martinetti, Gladys; Andreutti, Corinne; Klimkait, Thomas; Brandenberger, Marcel; Guenthard, Huldrych F.		Swiss HIV Cohort Study	Simple Estimation of Incident HIV Infection Rates in Notification Cohorts Based on Window Periods of Algorithms for Evaluation of Line-Immunoassay Result Patterns	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; EARLY ANTIRETROVIRAL THERAPY; CAPTURE ENZYME-IMMUNOASSAY; NATURAL POLYMORPHISMS; ANTIBODIES; SEROCONVERSION; SPECIFICITY; SENSITIVITY; INHIBITORS; DIVERSITY	Background: Tests for recent infections (TRIs) are important for HIV surveillance. We have shown that a patient's antibody pattern in a confirmatory line immunoassay (Inno-Lia) also yields information on time since infection. We have published algorithms which, with a certain sensitivity and specificity, distinguish between incident (<=12 months) and older infection. In order to use these algorithms like other TRIs, i.e., based on their windows, we now determined their window periods. Methods: We classified Inno-Lia results of 527 treatment-naive patients with HIV-1 infection <=12 months according to incidence by 25 algorithms. The time after which all infections were ruled older, i.e. the algorithm's window, was determined by linear regression of the proportion ruled incident in dependence of time since infection. Window-based incident infection rates (IIR) were determined utilizing the relationship 'Prevalence = Incidence x Duration' in four annual cohorts of HIV-1 notifications. Results were compared to performance-based IIR also derived from Inno-Lia results, but utilizing the relationship 'incident = true incident + false incident' and also to the IIR derived from the BED incidence assay. Results: Window periods varied between 45.8 and 130.1 days and correlated well with the algorithms' diagnostic sensitivity (R-2 = 0.962; P<0.0001). Among the 25 algorithms, the mean window-based IIR among the 748 notifications of 2005/06 was 0.457 compared to 0.453 obtained for performance-based IIR with a model not correcting for selection bias. Evaluation of BED results using a window of 153 days yielded an IIR of 0.669. Window-based IIR and performance-based IIR increased by 22.4% and respectively 30.6% in 2008, while 2009 and 2010 showed a return to baseline for both methods. Conclusions: IIR estimations by window-and performance-based evaluations of Inno-Lia algorithm results were similar and can be used together to assess IIR changes between annual HIV notification cohorts.	[Schuepbach, Joerg; Bisset, Leslie R.; Yerly, Sabine] Univ Zurich, Inst Med Virol, Swiss Natl Ctr Retroviruses, Zurich, Switzerland; [Gebhardt, Martin D.] Swiss Fed Off Publ Hlth, Bern, Switzerland; [Scherrer, Alexandra U.; Guenthard, Huldrych F.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Niederhauser, Christoph] Swiss Red Cross, Blood Transfus Serv, Bern, Switzerland; [Regenass, Stephan] Univ Zurich Hosp, Clin Immunol, CH-8091 Zurich, Switzerland; [Yerly, Sabine] Univ Hosp Geneva, Virol Lab, Geneva, Switzerland; [Aubert, Vincent] Univ Lausanne Hosp, Serv Immunol & Allergy, Univ Hosp Ctr, Lausanne, Switzerland; [Suter, Franziska] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Pfister, Stefan] Inst Dr Viollier AG, Basel, Switzerland; [Martinetti, Gladys] Ente Osped Cantonale, Microbiol Serv, Bellinzona, Switzerland; [Andreutti, Corinne] Clin Source, Lausanne, Switzerland; [Klimkait, Thomas] Univ Basel, Inst Med Microbiol, Basel, Switzerland; [Brandenberger, Marcel] Labor Synlab Luzern, Luzern, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University of Basel	Schupbach, J (corresponding author), Univ Zurich, Inst Med Virol, Swiss Natl Ctr Retroviruses, Zurich, Switzerland.	schupbach.jorg@virology.uzh.ch	gunthard, huldrych f/F-1724-2011; Kummer, Juerg/B-3322-2011; Schüpbach, Jörg/G-4209-2016	gunthard, huldrych f/0000-0002-1142-6723; Schüpbach, Jörg/0000-0002-8074-5891; Klimkait, Thomas/0000-0003-4945-6511	Swiss National Science Foundation [33CS30_134277, 324730_130865]; Swiss HIV Cohort Research Foundation (SHCS) [560]; Innogenetics NV, Ghent (Belgium); Swiss Federal Office of Public Health (SFOPH) [07.005822, 09.001294, 10.001983, 11.005726]; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss HIV Cohort Research Foundation (SHCS); Innogenetics NV, Ghent (Belgium); Swiss Federal Office of Public Health (SFOPH); University of Zurich	This study has been conducted partially in the framework of the Swiss HIV Cohort Study (SHCS), supported by the Swiss National Science Foundation (grant # 33CS30_134277). In addition, the study was funded jointly by grants from the Swiss HIV Cohort Research Foundation (SHCS project # 560) and from Innogenetics NV, Ghent (Belgium). The latter provided the required Inno-Lia HIV I/II Score kits free of charge. The Swiss National Center for Retroviruses also received support for its work by contracts 07.005822, 09.001294, 10.001983 and 11.005726 with the Swiss Federal Office of Public Health (SFOPH). The Zurich Primary HIV Infection (ZPHI) Study was supported in part by the Swiss National Science Foundation (grant # 324730_130865 to HFG) and by the University of Zurich's Cinical Research Priority Program (CRPP) "Viral infectious diseases: Zurich Primary HIV Infection Study". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, B BAG, P1022; Barin F, 2006, J MED VIROL, V78, pS13, DOI 10.1002/jmv.20600; Barnighausen T, 2010, EPIDEMIOLOGY, V21, P685, DOI 10.1097/EDE.0b013e3181e9e978; Binley JM, 1997, J VIROL, V71, P2799, DOI 10.1128/JVI.71.4.2799-2809.1997; BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; CHARGELEGUE D, 1995, J INFECT DIS, V172, P897, DOI 10.1093/infdis/172.3.897; CHARGELEGUE D, 1993, AIDS, V7, pS87, DOI 10.1097/00002030-199311002-00017; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Gianella S, 2011, ANTIVIR THER, V16, P535, DOI 10.3851/IMP1776; Hecht FM, 2002, AIDS, V16, P1119, DOI 10.1097/00002030-200205240-00005; Hladik W, 2012, AIDS RES HUM RETROV, V28, P95, DOI [10.1089/aid.2010.0347, 10.1089/AID.2010.0347]; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; LANGE JMA, 1988, ANN MED INTERNE, V139, P80; Le Vu S, 2008, EUROSURVEILLANCE, P13; Lindback S, 2000, AIDS, V14, P2283, DOI 10.1097/00002030-200010200-00009; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; Masciotra S, 2011, J CLIN VIROL, V52, pS17, DOI 10.1016/j.jcv.2011.09.011; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; McDougal JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014748; McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a; McWalter TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007368; Murphy G, 2008, EUROSURVEILLANCE, V1, P13; Ntemgwa M, 2007, ANTIMICROB AGENTS CH, V51, P604, DOI 10.1128/AAC.00870-06; Parekh BS, 2005, INDIAN J MED RES, V121, P510; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Park SY, 2011, AIDS, V25, pF13, DOI 10.1097/QAD.0b013e328349f089; Parreira R, 2006, AIDS RES HUM RETROV, V22, P1178, DOI 10.1089/aid.2006.22.1178; POLLET DE, 1991, CLIN CHEM, V37, P1700; Ragonnet-Cronin M, 2012, J INFECT DIS, V206, P756, DOI 10.1093/infdis/jis411; Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349, DOI 10.1097/00126334-200307010-00009; Reid P, 2005, VIROLOGY, V336, P251, DOI 10.1016/j.virol.2005.03.030; Rieder P, 2011, CLIN INFECT DIS, V53, P1271, DOI 10.1093/cid/cir725; Rieder P, 2010, AIDS, V24, P1177, DOI 10.1097/QAD.0b013e328338e4de; Rusert P, 2005, J VIROL, V79, P8454, DOI 10.1128/JVI.79.13.8454-8469.2005; Schmid A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013310; Schupbach J, 2007, PLOS MED, V4, P1921, DOI 10.1371/journal.pmed.0040343; Schupbach J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-88; Schupbach J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-254; Suligoi B, 2002, J CLIN MICROBIOL, V40, P4015, DOI 10.1128/JCM.40.11.4015-4020.2002; Tuaillon E, 2004, JAIDS-J ACQ IMM DEF, V37, P1543, DOI 10.1097/00126334-200412150-00001; WALTHER L, 1995, CLIN DIAGN VIROL, V4, P67, DOI 10.1016/0928-0197(94)00057-2; Welte A, 2010, EUROSURVEILLANCE, V15, P18; Wilson KM, 2004, AIDS, V18, P2253, DOI 10.1097/00002030-200411190-00005	45	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71662	10.1371/journal.pone.0071662	http://dx.doi.org/10.1371/journal.pone.0071662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23990968	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000324228800012
J	Jintaridth, P; Tungtrongchitr, R; Preutthipan, S; Mutirangura, A				Jintaridth, Pornrutsami; Tungtrongchitr, Rungsunn; Preutthipan, Sangchai; Mutirangura, Apiwat			Hypomethylation of Alu Elements in Post-Menopausal Women with Osteoporosis	PLOS ONE			English	Article							DNA HYPOMETHYLATION; LINE-1 METHYLATION; OXIDATIVE STRESS; HIP FRACTURE; RISK-FACTORS; BONE-MASS; ASSOCIATION; GENE; INSTABILITY; EXPRESSION	A decrease in genomic methylation commonly occurs in aging cells; however, whether this epigenetic modification leads to age-related phenotypes has not been evaluated. Alu elements are the major interspersed repetitive DNA elements in humans that lose DNA methylation in aging individuals. Alu demethylation in blood cells starts at approximately 40 years of age, and the degree of Alu hypomethylation increases with age. Bone mass is lost with aging, particularly in menopausal women with lower body mass. Consequently, osteoporosis is commonly found in thin postmenopausal women. Here, we correlated the Alu methylation level of blood cells with bone density in 323 postmenopausal women. Alu hypomethylation was associated with advanced age and lower bone mass density, (P<0.05). The association between the Alu methylation level and bone mass was independent of age, body mass, and body fat, with an odds ratio [1] = 0.4316 (0.2087-0.8927). Individuals of the same age with osteopenia, osteoporosis, and a high body mass index have lower Alu methylation levels (P = 0.0005, 0.003, and <= 0.0001, respectively). Finally, when comparing individuals with the same age and body mass, Alu hypomethylation was observed in individuals with lower bone mass (P<0.0001). In conclusion, there are positive correlations between Alu hypomethylation in blood cells and several age-related phenotypes in bone and body fat. Therefore, reduced global methylation may play a role in the systemic senescence process. Further evaluation of Alu hypomethylation may clarify the epigenetic regulation of osteoporosis in post-menopausal women.	[Jintaridth, Pornrutsami; Tungtrongchitr, Rungsunn] Mahidol Univ Bangkok, Fac Trop Med, Dept Trop Nutr & Food Sci, Bangkok, Thailand; [Preutthipan, Sangchai] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Obstet & Gynecol, Bangkok 10700, Thailand; [Mutirangura, Apiwat] Chulalongkorn Univ, Fac Med, Ctr Excellence Mol Genet Canc & Human Dis, Dept Anat, Bangkok 10330, Thailand	Mahidol University; Mahidol University; Chulalongkorn University	Jintaridth, P (corresponding author), Mahidol Univ Bangkok, Fac Trop Med, Dept Trop Nutr & Food Sci, Bangkok, Thailand.	pornrutsami.jin@mahidol.ac.th; apiwat.mutirangura@gmail.com			Thailand Research Fund [MRG 5480131]; Faculty of Tropical Medicine; Research Chair Grant; National Science and Technology Development Agency, Thailand	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Tropical Medicine; Research Chair Grant; National Science and Technology Development Agency, Thailand	Pornrutsami Jintaridth is supported by Thailand Research Fund Grant MRG 5480131 and the Faculty of Tropical Medicine Grants 2011 and 2012. Apiwat Mutirangura is supported by the Research Chair Grant 2011, the National Science and Technology Development Agency, Thailand.	Antoniades L, 2003, RHEUMATOLOGY, V42, P791, DOI 10.1093/rheumatology/keg227; Aporntewan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017934; Baek KH, 2010, CALCIFIED TISSUE INT, V87, P226, DOI 10.1007/s00223-010-9393-9; Batzer MA, 1999, NAT REV, V3, P370; Bocheva Georgeta, 2011, Interdiscip Toxicol, V4, P167, DOI 10.2478/v10102-011-0026-6; Burwell RG, 2011, SCOLIOSIS; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Cho NY, 2007, J PATHOL, V211, P269, DOI 10.1002/path.2106; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Day JK, 2002, J NUTR, V132, p2419S, DOI 10.1093/jn/132.8.2419S; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; DeLaet CEDH, 1997, BRIT MED J, V315, P221, DOI 10.1136/bmj.315.7102.221; Donkena KV, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/302051; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Espallargues M, 2001, OSTEOPOROSIS INT, V12, P811, DOI 10.1007/s001980170031; Harvey N, 2008, PRIMER METABOLIC BON, P198; Huang QY, 2006, MOL GENET METAB, V88, P295, DOI 10.1016/j.ymgme.2006.04.009; Intarasunanont P, 2012, ENV HLTH, V11; Javaid MK, 2004, J BONE MINER RES, V19, P56, DOI 10.1359/JBMR.0301211; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; Kitazawa R, 2007, MOL ENDOCRINOL, V21, P148, DOI 10.1210/me.2006-0205; Kitkumthorn N, 2012, ASIAN PAC J CANCER P, V13, P4469, DOI 10.7314/APJCP.2012.13.9.4469; Kitkumthorn N, 2011, CLIN EPIGENETICS, V2, P315, DOI 10.1007/s13148-011-0032-8; Kitkumthorn N, 2012, CLIN CHIM ACTA, V413, P869, DOI 10.1016/j.cca.2012.01.024; Kongruttanachok N, 2010, MOL CANCER, V9, DOI [10.1186/1476-4598-1189-1170, DOI 10.1186/1476-4598-1189-1170]; Kung Annie W. C., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P26; Lambertini E, 2002, J ENDOCRINOL, V172, P683, DOI 10.1677/joe.0.1720683; Li CCY, 2011, PLOS GENET, V7, DOI [10.1371/journal.pgen.1001380, 10.1371/journal.pgen.1002196]; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Ongphiphadhanakul Boonsong, 2002, Clin Calcium, V12, P822; Patchsung M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037009; Piyathilake CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054544; Pobsook T, 2011, CLIN CHIM ACTA, V412, P314, DOI 10.1016/j.cca.2010.10.030; Pongchaiyakul Chatlert, 2008, Journal of the Medical Association of Thailand, V91, P261; Potocki L, 2012, BIOCHIMIE, V94, P2013, DOI 10.1016/j.biochi.2012.05.026; RIBOT C, 1992, CLIN ENDOCRINOL, V36, P225, DOI 10.1111/j.1365-2265.1992.tb01436.x; Sanchez-Rodriguez MA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-124; Schurman SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045728; Subramanyam MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054018; Tromp AM, 2000, OSTEOPOROSIS INT, V11, P134, DOI 10.1007/PL00004174; Vijg J, 2013, ANNU REV PHYSIOL, V75, P645, DOI 10.1146/annurev-physiol-030212-183715; Villagra A, 2002, J CELL BIOCHEM, V85, P112, DOI 10.1002/jcb.10113; Wangsri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045292; Wong CCY, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12226	46	49	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e70386	10.1371/journal.pone.0070386	http://dx.doi.org/10.1371/journal.pone.0070386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990903	gold, Green Submitted, Green Published			2022-12-25	WOS:000324470100024
J	Wang, X; Liu, J; Ouyang, YY; Fang, M; Gao, H; Liu, LG				Wang, Xia; Liu, Jun; Ouyang, Yingying; Fang, Min; Gao, Hui; Liu, Liegang			The Association between the Pro12Ala Variant in the PPAR gamma 2 Gene and Type 2 Diabetes Mellitus and Obesity in a Chinese Population	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA-2; BODY-MASS INDEX; CORONARY-HEART-DISEASE; PPAR-GAMMA; INSULIN SENSITIVITY; WAIST CIRCUMFERENCE; RISK-FACTORS; POLYMORPHISM; SUBSTITUTION; OVERWEIGHT	Background: Conflicting results have been reported on the association of the Pro12Ala polymorphism of the PPAR gamma 2 gene with the risk of type 2 diabetes or obesity. Methods and Findings: A total of 3146 subjects with 1145 cases of type 2 diabetes and 2001 healthy controls were included in the study. Genomic DNA was obtained from blood samples and the screening for the gene polymorphisms was done using an allelic discrimination assay-by-design TaqMan method. Overall, the Ala allele frequency was 5.6% in control subjects and 3.9% in diabetes subjects (P = 0.023). We found a statistically significant association of carriers of the Ala allele with greater homoeostasis model assessment of beta cell function index in all subjects (P = 0.046). After controlling for confounders, carriers of the Ala allele had a decreased risk of diabetes compared with noncarriers [odds ratio (OR) 0.64, 95% confidence interval (CI) 0.49-0.83; P = 0.001]. A beneficial effect of the Ala allele was also observed for obesity (OR 0.64, 95% CI 0.42-0.96; P = 0.030). Conclusion: Our results suggested that the presence of the Ala allele may contribute to improved insulin secretory capacity and may confer protection from type 2 diabetes and obesity in the Chinese population.	[Wang, Xia] Shandong Univ, Sch Publ Hlth, Dept Maternal & Child Hlth Care, Jinan 250100, Peoples R China; [Wang, Xia; Liu, Jun; Ouyang, Yingying; Fang, Min; Gao, Hui; Liu, Liegang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Nutr, Wuhan 430074, Peoples R China; [Wang, Xia; Liu, Jun; Ouyang, Yingying; Fang, Min; Gao, Hui; Liu, Liegang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China	Shandong University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, LG (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Nutr, Wuhan 430074, Peoples R China.	lgliu@mails.tjmu.edu.cn			Shandong Province Natural Science Foundation of China [ZR2010HM123]	Shandong Province Natural Science Foundation of China	This study was supported by Shandong Province Natural Science Foundation of China (ZR2010HM123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Z, 2008, ACTA ACAD MED MILITA, V8, P012; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Badii R, 2008, ACTA DIABETOL, V45, P15, DOI 10.1007/s00592-007-0013-8; Beamer BA, 1998, DIABETES, V47, P1806, DOI 10.2337/diabetes.47.11.1806; Huguenin GVB, 2010, BRIT J NUTR, V104, P488, DOI 10.1017/S0007114510000851; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Clement K, 2000, INT J OBESITY, V24, P391, DOI 10.1038/sj.ijo.0801191; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Dong Chun-ping, 2008, Zhonghua Yixue Yichuanxue Zazhi, V25, P447; Douglas JA, 2001, DIABETES, V50, P886, DOI 10.2337/diabetes.50.4.886; Dubois M, 2000, DIABETOLOGIA, V43, P1165, DOI 10.1007/s001250051508; Ek J, 1999, DIABETOLOGIA, V42, P892, DOI 10.1007/s001250051243; Ek J, 2001, DIABETOLOGIA, V44, P1170, DOI 10.1007/s001250100629; Franck N, 2012, BLOOD PRESSURE, V21, P122, DOI 10.3109/08037051.2011.623349; Gouda HN, 2010, AM J EPIDEMIOL, V171, P645, DOI 10.1093/aje/kwp450; Guo Wu-Lan, 2011, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V33, P593; Guoying W, 2002, CHINESE J DIABETES, V2, P002; He M, 2001, INT J OBESITY, V25, P748, DOI 10.1038/sj.ijo.0801612; Hegele RA, 2000, J CLIN ENDOCR METAB, V85, P2014, DOI 10.1210/jc.85.5.2014; Herman WH, 2012, DIABETES CARE, V35, P943, DOI 10.2337/dc12-0298; Ho JSK, 2012, DIABETES RES CLIN PR, V97, P483, DOI 10.1016/j.diabres.2012.03.012; Ito E, 2004, BIOCHEM BIOPH RES CO, V324, P810, DOI 10.1016/j.bbrc.2004.08.238; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Jin M, 2007, J MED SCI YANBIAN U, V1, P002; Kao WHL, 2003, DIABETES, V52, P1568, DOI 10.2337/diabetes.52.6.1568; Koch M, 1999, DIABETOLOGIA, V42, P758, DOI 10.1007/s001250051225; Li SX, 2003, DIABETES, V52, P1265, DOI 10.2337/diabetes.52.5.1265; Lindi V, 2001, DIABETOLOGIA, V44, P925; Liu F, 2009, CHINESE J ARTERIOSCL, V2, P021; Ludovico O, 2007, OBESITY, V15, P1076, DOI 10.1038/oby.2007.617; Mancini FP, 1999, DIABETES, V48, P1466, DOI 10.2337/diabetes.48.7.1466; Masud S, 2003, J MED GENET, V40, P773, DOI 10.1136/jmg.40.10.773; Masugi J, 2000, BIOCHEM BIOPH RES CO, V268, P178, DOI 10.1006/bbrc.2000.2096; Mori H, 2001, DIABETES, V50, P891, DOI 10.2337/diabetes.50.4.891; PARZER S, 1991, BIOCHEM J, V273, P229, DOI 10.1042/bj2730229; Pischon T, 2005, ARTERIOSCL THROM VAS, V25, P1654, DOI 10.1161/01.ATV.0000171993.78135.7e; Radha V, 2006, DIABETES CARE, V29, P1046, DOI 10.2337/dc05-1473; Razquin C, 2011, MOL NUTR FOOD RES, V55, P136, DOI 10.1002/mnfr.201000445; Rhee EJ, 2006, ARCH MED RES, V37, P86, DOI 10.1016/j.arcmed.2005.04.008; Ristow M, 1998, NEW ENGL J MED, V339, P953, DOI 10.1056/NEJM199810013391403; Song FF, 2007, CLIN SCI, V112, P599, DOI 10.1042/CS20060323; Stefan N, 2001, DIABETES, V50, P1143, DOI 10.2337/diabetes.50.5.1143; Stumvoll M, 2002, DIABETES, V51, P2341, DOI 10.2337/diabetes.51.8.2341; Swarbrick MM, 2001, EUR J ENDOCRINOL, V144, P277, DOI 10.1530/eje.0.1440277; Tai ES, 2004, J LIPID RES, V45, P674, DOI 10.1194/jlr.M300363-JLR200; Wang Chuanxian, 2004, Wei Sheng Yan Jiu, V33, P317; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wildman RP, 2004, AM J CLIN NUTR, V80, P1129, DOI 10.1093/ajcn/80.5.1129; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Yamamoto Y, 2002, METABOLISM, V51, P1407, DOI 10.1053/meta.2002.35586; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; Zietz B, 2002, EXP CLIN ENDOCR DIAB, V110, P60, DOI 10.1055/s-2002-23487	54	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71985	10.1371/journal.pone.0071985	http://dx.doi.org/10.1371/journal.pone.0071985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991018	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100068
J	Matsuda, S; Liu, H; Kouzuma, A; Watanabe, K; Hashimoto, K; Nakanishi, S				Matsuda, Shoichi; Liu, Huan; Kouzuma, Atsushi; Watanabe, Kazuya; Hashimoto, Kazuhito; Nakanishi, Shuji			Electrochemical Gating of Tricarboxylic Acid Cycle in Electricity-Producing Bacterial Cells of Shewanella	PLOS ONE			English	Article							ELECTRON-TRANSPORT; SUCCINATE-DEHYDROGENASE; GENE; PHOSPHORYLATION; PATHWAYS; BEHAVIOR; SYSTEM; SIGNAL	Energy-conversion systems mediated by bacterial metabolism have recently attracted much attention, and therefore, demands for tuning of bacterial metabolism are increasing. It is widely recognized that intracellular redox atmosphere which is generally tuned by dissolved oxygen concentration or by appropriate selection of an electron acceptor for respiration is one of the important factors determining the bacterial metabolism. In general, electrochemical approaches are valuable for regulation of redox-active objects. However, the intracellular redox conditions are extremely difficult to control electrochemically because of the presence of insulative phospholipid bilayer membranes. In the present work, the limitation can be overcome by use of the bacterial genus Shewanella, which consists of species that are able to respire via cytochromes abundantly expressed in their outer-membrane with solid-state electron acceptors, including anodes. The electrochemical characterization and the gene expression analysis revealed that the activity of tricarboxylic acid (TCA) cycle in Shewanella cells can be reversibly gated simply by changing the anode potential. Importantly, our present results for Shewanella cells cultured in an electrochemical system under poised potential conditions showed the opposite relationship between the current and electron acceptor energy level, and indicate that this unique behavior originates from deactivation of the TCA cycle in the (over-)oxidative region. Our result obtained in this study is the first demonstration of the electrochemical gating of TCA cycle of living cells. And we believe that our findings will contribute to a deeper understanding of redox-dependent regulation systems in living cells, in which the intracellular redox atmosphere is a critical factor determining the regulation of various metabolic and genetic processes.	[Matsuda, Shoichi; Hashimoto, Kazuhito] Univ Tokyo, Dept Appl Chem, Tokyo, Japan; [Watanabe, Kazuya; Hashimoto, Kazuhito; Nakanishi, Shuji] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Liu, Huan; Kouzuma, Atsushi; Watanabe, Kazuya; Hashimoto, Kazuhito; Nakanishi, Shuji] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, HASHIMOTO Light Energy Convers Project, Tokyo, Japan; [Kouzuma, Atsushi; Watanabe, Kazuya] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 19203, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Tokyo University of Pharmacy & Life Sciences	Hashimoto, K (corresponding author), Univ Tokyo, Dept Appl Chem, Tokyo, Japan.	hashimoto@light.t.u-tokyo.ac.jp; nakanishi@light.t.u-tokyo.ac.jp	Kouzuma, Atsushi/M-4559-2019; HASHIMOTO, Kazuhito/C-5011-2012; Liu, Huan/B-5625-2013; MATSUDA, Shoichi/C-6100-2016	Kouzuma, Atsushi/0000-0002-5076-3810; HASHIMOTO, Kazuhito/0000-0002-8384-8749; Liu, Huan/0000-0001-9009-7122; Nakanishi, Shuji/0000-0002-3313-2689	Exploratory Research for Advanced Technology program of the Japan Science and Technology Agency	Exploratory Research for Advanced Technology program of the Japan Science and Technology Agency	This work was financially supported by the Exploratory Research for Advanced Technology program of the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKRELL BAC, 1993, FEBS LETT, V326, P92, DOI 10.1016/0014-5793(93)81768-U; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Hirst J, 1996, J AM CHEM SOC, V118, P5031, DOI 10.1021/ja9534361; Hunt KA, 2010, J BACTERIOL, V192, P3345, DOI 10.1128/JB.00090-10; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Kouzuma A, 2010, APPL ENVIRON MICROB, V76, P4151, DOI 10.1128/AEM.00117-10; Liu HA, 2011, CHEM COMMUN, V47, P3870, DOI 10.1039/c0cc05028h; Liu HA, 2010, CHEMSUSCHEM, V3, P1253, DOI 10.1002/cssc.201000213; Nakamura R, 2009, ANGEW CHEM INT EDIT, V48, P1606, DOI 10.1002/anie.200804917; NEALSON KH, 1992, APPL ENVIRON MICROB, V58, P439, DOI 10.1128/AEM.58.2.439-443.1992; Oh JI, 2000, EMBO J, V19, P4237, DOI 10.1093/emboj/19.16.4237; Okamoto A, 2013, P NATL ACAD SCI USA, V110, P7856, DOI 10.1073/pnas.1220823110; Peng L, 2010, BIOSENS BIOELECTRON, V25, P2530, DOI 10.1016/j.bios.2010.03.039; Pershad HR, 1999, BBA-BIOENERGETICS, V1412, P262, DOI 10.1016/S0005-2728(99)00066-3; Quastel JH, 1963, METABOLIC INHIBITORS, V2; SUCHETA A, 1992, NATURE, V356, P361, DOI 10.1038/356361a0; Tang YJ, 2007, J BACTERIOL, V189, P894, DOI 10.1128/JB.00926-06	21	28	30	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72901	10.1371/journal.pone.0072901	http://dx.doi.org/10.1371/journal.pone.0072901			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977370	gold, Green Published, Green Submitted			2022-12-25	WOS:000324527300103
J	Chao, HH; Hu, S; Ide, JS; Uchio, E; Zhang, S; Rose, M; Concato, J; Li, CSR				Chao, Herta H.; Hu, Sien; Ide, Jaime S.; Uchio, Edward; Zhang, Sheng; Rose, Michal; Concato, John; Li, Chiang-shan R.			Effects of Androgen Deprivation on Cerebral Morphometry in Prostate Cancer Patients - An Exploratory Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GREY-MATTER VOLUME; QUALITY-OF-LIFE; COGNITIVE FUNCTION; ALZHEIMER-DISEASE; OLDER MEN; FREE TESTOSTERONE; BRAIN STRUCTURE; SPATIAL MEMORY; ELDERLY-MEN	Background: Androgen deprivation therapy (ADT) is a common treatment for non-metastatic, low-risk prostate cancer, but a potential side effect of ADT is impaired brain functioning. Previous work with functional magnetic resonance imaging (MRI) demonstrated altered prefrontal cortical activations in cognitive control, with undetectable changes in behavioral performance. Given the utility of brain imaging in identifying the potentially deleterious effects of ADT on brain functions, the current study examined the effects of ADT on cerebral structures using high resolution MRI and voxel-based morphometry (VBM). Methods: High resolution T1 weighted image of the whole brain were acquired at baseline and six months after ADT for 12 prostate cancer patients and 12 demographically matched non-exposed control participants imaged at the same time points. Brain images were segmented into gray matter, white matter and cerebral ventricles using the VBM toolbox as implemented in Statistical Parametric Mapping 8. Results: Compared to baseline scan, prostate cancer patients undergoing ADT showed decreased gray matter volume in frontopolar cortex, dorsolateral prefrontal cortex and primary motor cortex, whereas the non-exposed control participants did not show such changes. In addition, the decrease in gray matter volume of the primary motor cortex showed a significant correlation with longer reaction time to target detection in a working memory task. Conclusions: ADT can affect cerebral gray matter volumes in prostate cancer patients. If replicated, these results may facilitate future studies of cognitive function and quality of life in men receiving ADT, and can also help clinicians weigh the benefits and risks of hormonal therapy in the treatment of prostate cancer.	[Chao, Herta H.; Rose, Michal; Concato, John] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Chao, Herta H.; Rose, Michal; Concato, John] Yale Univ, Sch Med, Yale Comprehens Canc Ctr, New Haven, CT 06510 USA; [Chao, Herta H.; Rose, Michal; Concato, John] VA Connecticut Healthcare Syst, Med Serv, West Haven, CT USA; [Hu, Sien; Zhang, Sheng; Li, Chiang-shan R.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Ide, Jaime S.] Fed Univ Sao Paolo, Dept Sci & Technol, Salo Paolo, Brazil; [Uchio, Edward] Tower Res, Los Angeles, CA USA; [Concato, John] VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, West Haven, CT USA; [Li, Chiang-shan R.] Yale Univ, Sch Med, Deparment Neurobiol, New Haven, CT USA; [Li, Chiang-shan R.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University	Chao, HH (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	herta.chao@yale.edu	Li, Chiang-Shan Ray/J-2813-2016; Ide, Jaime/B-6615-2014	Li, Chiang-Shan Ray/0000-0002-9393-1212; Ide, Jaime/0000-0002-7223-1102	NIH [R03CA138121]; Yale Cancer Center/Connecticut Challenge Survivorship pilot award; VA Urology Research Sectional Funding; NATIONAL CANCER INSTITUTE [R03CA138121] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Cancer Center/Connecticut Challenge Survivorship pilot award; VA Urology Research Sectional Funding; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH grant R03CA138121 to H.H.C., a Yale Cancer Center/Connecticut Challenge Survivorship pilot award, and VA Urology Research Sectional Funding. The funding agencies had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Alibhai SMH, 2006, CRIT REV ONCOL HEMAT, V60, P201, DOI 10.1016/j.critrevonc.2006.06.006; Alibhai SMH, 2010, J CLIN ONCOL, V28, P5030, DOI 10.1200/JCO.2010.30.8742; Almeida OP, 2004, PSYCHONEUROENDOCRINO, V29, P1071, DOI 10.1016/j.psyneuen.2003.11.002; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Azad N, 2003, J CLIN ENDOCR METAB, V88, P3064, DOI 10.1210/jc.2002-020632; Bryant DM, 2011, J NEUROSCI, V31, P6654, DOI 10.1523/JNEUROSCI.5899-10.2011; Castellon SA, 2005, BREAST CANCER RES TR, V92, P199, DOI 10.1007/s10549-005-5342-0; Chao HH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-371; Cherrier MM, 2007, PSYCHONEUROENDOCRINO, V32, P72, DOI 10.1016/j.psyneuen.2006.10.008; Cherrier MM, 2005, NEUROLOGY, V64, P2063, DOI 10.1212/01.WNL.0000165995.98986.F1; Cherrier MM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-1; Dal Pra A, 2010, CURR ONCOL, V17, P219; Eberling JL, 2004, NEUROIMAGE, V21, P364, DOI 10.1016/j.neuroimage.2003.08.037; Esper P, 1997, UROLOGY, V50, P920, DOI 10.1016/S0090-4295(97)00459-7; Ferguson RJ, 2007, J CLIN ONCOL, V25, P3866, DOI 10.1200/JCO.2007.10.8639; First M. B., 2002, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forbes EE, 2010, J AM ACAD CHILD PSY, V49, P162, DOI 10.1016/j.jaac.2009.11.006; Green HJ, 2002, BJU INT, V90, P427, DOI 10.1046/j.1464-410X.2002.02917.x; Hermans EJ, 2010, NEUROIMAGE, V52, P277, DOI 10.1016/j.neuroimage.2010.04.019; Itti E, 2006, J CLIN ENDOCR METAB, V91, P1423, DOI 10.1210/jc.2005-1596; Jenkins VA, 2005, BJU INT, V96, P48, DOI 10.1111/j.1464-410X.2005.05565.x; Joly F, 2006, J UROLOGY, V176, P2443, DOI 10.1016/j.juro.2006.07.151; Kenny AM, 2004, J GERONTOL A-BIOL, V59, P75; Lu PH, 2006, ARCH NEUROL-CHICAGO, V63, P177, DOI 10.1001/archneur.63.2.nct50002; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Meng MV, 2002, UROLOGY, V60, P7, DOI 10.1016/S0090-4295(02)01560-1; Moffat SD, 2007, NEUROBIOL AGING, V28, P914, DOI 10.1016/j.neurobiolaging.2006.04.001; Moffat SD, 2004, NEUROLOGY, V62, P188, DOI 10.1212/WNL.62.2.188; Mueller SC, 2011, NEUROSCIENCE, V197, P225, DOI 10.1016/j.neuroscience.2011.09.022; Mueller SC, 2011, INT J NEUROPSYCHOPH, V14, P445, DOI 10.1017/S1461145710001136; Neufang S, 2009, CEREB CORTEX, V19, P464, DOI 10.1093/cercor/bhn100; Peper JS, 2009, PSYCHONEUROENDOCRINO, V34, P332, DOI 10.1016/j.psyneuen.2008.09.012; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Salminen E, 2003, BRIT J CANCER, V89, P971, DOI 10.1038/sj.bjc.6601235; Shahinian VB, 2005, CANCER-AM CANCER SOC, V103, P1615, DOI 10.1002/cncr.20955; Silverman DHS, 2007, BREAST CANCER RES TR, V103, P303, DOI 10.1007/s10549-006-9380-z; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; van Wingen GA, 2009, NEUROPSYCHOPHARMACOL, V34, P539, DOI [10.1038/npp.2008.2, 10.1038/sj.npp.2008.2]; Witte AV, 2010, NEUROIMAGE, V49, P1205, DOI 10.1016/j.neuroimage.2009.09.046; Zhang Y, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.09.025	42	55	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72032	10.1371/journal.pone.0072032	http://dx.doi.org/10.1371/journal.pone.0072032			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977199	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700123
J	Min, KJ; Lee, JK; Lee, S; Kim, MK				Min, Kyung-Jin; Lee, Jae-Kwan; Lee, Sanghoon; Kim, Mi Kyung			Alcohol Consumption and Viral Load Are Synergistically Associated with CIN1	PLOS ONE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; HUMAN-PAPILLOMAVIRUS INFECTION; HPV-POSITIVE WOMEN; NATURAL-HISTORY; GENETIC POLYMORPHISMS; IMMUNE-SYSTEM; CANCER; RISK; SMOKING; TRACT	Purpose: We investigated the association between alcohol consumption and risk of cervical intraepithelial neoplasia (CIN) and cervical cancer, and determined whether these associations were modified by human papillomavirus (HPV) viral load in high-risk HPV-positive women participating in the Korean HPV cohort study (KHPV). Methods: Among the women recruited in the KHPV (n = 1,243) from March 2006 to December 2009, we analyzed normal cytology (n = 581) as control group, CIN1 (n = 299), CIN2/3 (n = 161), or cervical cancer (n = 202). Multinomial logistic analysis was performed to estimate multivariate-adjusted odds ratios (OR). Results: Alcohol drinkers had an increased risk of CIN1 (OR = 2.18, 95% CI 1.22-3.89) compared with non-drinkers after adjusting for potential confounders. Subjects with more frequent alcohol consumption had a higher risk of CIN1 (p for linear trend <0.0001). Higher ethanol consumption was associated with an increased risk of CIN1 (p for linear trend = 0.0001). We also observed a synergistic effect between HPV viral load and alcohol consumption: drinkers with a high HPV viral load (>= 100 RLU/PC) were associated with a significantly increased risk of CIN1 (OR = 19.1; 95% CI, 6.60-55.3, interaction p<0.001). There were no associations between alcohol drinking and CIN2/3 or cervical cancer. Conclusions: HPV viral load and alcohol was associated with the risk of CIN1 among high-risk HPV-positive women. This is the first demonstration that alcohol is an independent and combined risk factor of CIN1.	[Min, Kyung-Jin] Inha Univ Hosp, Dept Obstet & Gynecol, Inchon, South Korea; [Lee, Jae-Kwan; Lee, Sanghoon] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea; [Kim, Mi Kyung] Natl Canc Ctr, Div Canc Epidemiol & Management, Carcinogenesis Branch, Goyang, South Korea	Inha University; Inha University Hospital; Korea University; Korea University Medicine (KU Medicine); National Cancer Center - Korea (NCC)	Kim, MK (corresponding author), Natl Canc Ctr, Div Canc Epidemiol & Management, Carcinogenesis Branch, Goyang, South Korea.	alrud@ncc.re.kr		LEE, Jae Kwan/0000-0003-3101-6403; Min, Kyung-Jin/0000-0002-5783-4968	Korea National Cancer Center [NCC-1110320, NCC-1310361]	Korea National Cancer Center	This study was supported by a grant-in-aid from the Korea National Cancer Center (grant no. NCC-1110320, NCC-1310361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso I, 2007, AM J OBSTET GYNECOL, V197, DOI [10.1016/j.ajog.2007.01.023, DOI 10.1016/J.AJ0G.2007.01.023]; AUBORN KJ, 1991, INT J CANCER, V49, P867, DOI 10.1002/ijc.2910490611; Baraona E, 2001, ALCOHOL CLIN EXP RES, V25, P502, DOI 10.1097/00000374-200104000-00004; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; CHAN WK, 1989, J VIROL, V63, P3261, DOI 10.1128/JVI.63.8.3261-3269.1989; Collins S, 2010, EUR J CANCER, V46, P405, DOI 10.1016/j.ejca.2009.09.015; Curado MP, 2009, CURR OPIN ONCOL, V21, P194, DOI 10.1097/CCO.0b013e32832a68ca; Davidson B, 1997, PATHOL RES PRACT, V193, P491, DOI 10.1016/S0344-0338(97)80102-1; Druesne-Pecollo N, 2009, LANCET ONCOL, V10, P173, DOI 10.1016/S1470-2045(09)70019-1; GAVALER JS, 1993, ALCOHOL CLIN EXP RES, V17, P786, DOI 10.1111/j.1530-0277.1993.tb00842.x; Gill J, 2000, ALCOHOL ALCOHOLISM, V35, P417, DOI 10.1093/alcalc/35.5.417; Goodman MT, 2000, CANCER-AM CANCER SOC, V89, P376, DOI 10.1002/1097-0142(20000715)89:2&lt;376::AID-CNCR24&gt;3.0.CO;2-O; Goral J, 2008, ALCOHOL, V42, P237, DOI 10.1016/j.alcohol.2008.02.003; Gronbaek M, 2009, J INTERN MED, V265, P407, DOI 10.1111/j.1365-2796.2009.02082.x; Hjartaker A, 2010, EUR J CANCER PREV, V19, P1, DOI 10.1097/CEJ.0b013e328333fb3a; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Hong JH, 2010, INT J GYNECOL CANCER, V20, P1011, DOI 10.1111/IGC.0b013e3181e513e5; Huang Y, 2008, INT J GYNECOL CANCER, V18, P755, DOI 10.1111/j.1525-1438.2007.01092.x; Hwang JH, 2010, INT J GYNECOL CANCER, V20, P398, DOI 10.1111/IGC.0b013e3181d02ff2; Hwang JH, 2010, CANCER CAUSE CONTROL, V21, P51, DOI 10.1007/s10552-009-9433-9; *INT AG RES CANC, 1988, IARC MON EV CARC RIS, V44; International Agency for Research on Cancer, 2012, IARC MON EV CARC R B, V100 B; Jensen KE, 2011, ACTA OBSTET GYN SCAN, V90, P459, DOI 10.1111/j.1600-0412.2010.01066.x; Jin M, 2013, ANN ONCOL, V24, P807, DOI 10.1093/annonc/mds508; Jung En-Joo, 2012, J Prev Med Public Health, V45, P301, DOI 10.3961/jpmph.2012.45.5.301; Kim MK, 2010, CANCER CAUSE CONTROL, V21, P2295, DOI 10.1007/s10552-010-9656-9; Kim Yong Mi, 2008, J Gynecol Oncol, V19, P113, DOI 10.3802/jgo.2008.19.2.113; LICCIARDONE JC, 1989, INT J EPIDEMIOL, V18, P533, DOI 10.1093/ije/18.3.533; Lorincz AT, 2002, LANCET, V360, P228, DOI 10.1016/S0140-6736(02)09463-1; Luhn P, 2013, GYNECOL ONCOL, V128, P265, DOI 10.1016/j.ygyno.2012.11.003; MARSHALL JR, 1983, JNCI-J NATL CANCER I, V70, P847; Matsumoto K, 2003, BRIT J CANCER, V89, P831, DOI 10.1038/sj.bjc.6601220; Nova E, 2012, P NUTR SOC, V71, P307, DOI 10.1017/S0029665112000171; Pelucchi C, 2008, EUR J CANCER PREV, V17, P340, DOI 10.1097/CEJ.0b013e3282f75e91; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Richardson DB, 2009, AM J EPIDEMIOL, V169, P756, DOI 10.1093/aje/kwn411; ROTHMAN KJ, 1980, AM J EPIDEMIOL, V112, P467, DOI 10.1093/oxfordjournals.aje.a113015; Schlecht NF, 2003, INT J CANCER, V103, P519, DOI 10.1002/ijc.10846; Seitz HK, 2004, INT J CANCER, V108, P483, DOI 10.1002/ijc.11600; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stentella P, 1998, EUR J GYNAECOL ONCOL, V19, P466; Syrjanen K, 2007, EUR J EPIDEMIOL, V22, P723, DOI 10.1007/s10654-007-9180-8; Thygesen LC, 2009, ALCOHOL ALCOHOLISM, V44, P387, DOI 10.1093/alcalc/agp034; Tolstrup J, 2006, ACTA OBSTET GYN SCAN, V85, P1114, DOI 10.1080/00016340600677027; Tong SY, 2010, CANCER CAUSE CONTROL, V21, P23, DOI 10.1007/s10552-009-9430-z; Wheeler CM, 2008, OBSTET GYN CLIN N AM, V35, P519, DOI 10.1016/j.ogc.2008.09.006; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Yokoyama A, 2005, ALCOHOL, V35, P175, DOI 10.1016/j.alcohol.2005.04.003	48	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72142	10.1371/journal.pone.0072142	http://dx.doi.org/10.1371/journal.pone.0072142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977233	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700138
J	Shi, XL; Yang, JJ; Zhu, HY; Ye, L; Feng, MQ; Li, JY; Huang, H; Tao, Q; Ye, D; Sun, LHK; Sun, BNC; Sun, CRY; Han, GZ; Liu, YY; Yao, MH; Zhou, P; Ju, DW				Shi, Xunlong; Yang, Jianjun; Zhu, Haiyan; Ye, Li; Feng, Meiqing; Li, Jiyang; Huang, Hai; Tao, Qun; Ye, Dan; Sun, Lee-Hwei K.; Sun, Bill N. C.; Sun, Cecily R. Y.; Han, Guizhen; Liu, Yuanyuan; Yao, Minghui; Zhou, Pei; Ju, Dianwen			Pharmacokinetics and Pharmacodynamics of Recombinant Human EPO-Fc Fusion Protein In Vivo	PLOS ONE			English	Article							HUMAN-ERYTHROPOIETIN; ANEMIA; ALPHA; THERAPY; VITRO	In this study, the in vivo pharmacokinetics and pharmacodynamics of a novel recombinant human erythropoietin (rhEPO) Fc fusion protein, rhEPO-Fc, were studied in both rodents and rhesus monkeys. Animal models of anemia induced by irradiation, cyclophosphamide and partial renal ablation were used to evaluate therapeutic effects of rhEPO-Fc. We have demonstrated that serum half-life of rhEPO-Fc was 29.5 to 38.9 h at doses of 8, 25, 80 mu g/kg in rhesus monkeys and 35.5 to 43.5 h at doses of 16, 50, 160 mu g/kg in rats. In anemia animal models, rhEPO-Fc dose-dependently (7.5-30.0 mu g/kg in mice, 5.4-21.4 mu g/kg in rats and 5.0-10.0 mu g/kg in rhesus monkeys) increased reticulocyte level, followed by an increase of RBC count, hemoglobin and hematocrit levels. At reduced intervention frequency of weekly treatments, rhEPO-Fc showed similar hematopoietic effects as compared with rhEPO given three times a week. These results indicated that rhEPO-Fc could potentially be used in treatment of anemia and warrants future clinical trials.	[Shi, Xunlong; Zhu, Haiyan; Ye, Li; Feng, Meiqing; Li, Jiyang; Huang, Hai; Zhou, Pei; Ju, Dianwen] Fudan Univ, Sch Pharm, Dept Biosynth, Shanghai 200433, Peoples R China; [Yang, Jianjun; Tao, Qun; Ye, Dan] Shanghai Meiye Biotech Inst, Shanghai, Peoples R China; [Sun, Lee-Hwei K.; Sun, Bill N. C.; Sun, Cecily R. Y.] PharMab Shanghai Inc, Shanghai, Peoples R China; [Han, Guizhen; Liu, Yuanyuan; Yao, Minghui] Fudan Univ, Sch Med, Dept Pharmacol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Ju, DW (corresponding author), Fudan Univ, Sch Pharm, Dept Biosynth, Shanghai 200433, Peoples R China.	dianwenju@fudan.edu.cn	liu, yuanyuan/GWZ-5838-2022; zhu, xueqiong/U-1320-2019; shi, xunlong/AAF-9803-2020; yang, jian/HIK-0188-2022		Shanghai Science and Technology Funds [11431920104, 09XD1421800]; National Science and Technology Major Project for Drug Discovery of Ministry of Science and Technology of China [2011ZX09102-001-27]; Shanghai Meiye Biotech Institute, Shanghai, China; PharMab (Shanghai), Inc., China	Shanghai Science and Technology Funds; National Science and Technology Major Project for Drug Discovery of Ministry of Science and Technology of China; Shanghai Meiye Biotech Institute, Shanghai, China; PharMab (Shanghai), Inc., China	This work was supported by Shanghai Science and Technology Funds (11431920104, 09XD1421800) and National Science and Technology Major Project for Drug Discovery of Ministry of Science and Technology of China (2011ZX09102-001-27). This study was also supported by Shanghai Meiye Biotech Institute, Shanghai, China and PharMab (Shanghai), Inc., China. The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of manuscript.	ABELS RI, 1992, SEMIN ONCOL, V19, P29; Adamson JW, 2001, ANEMIA POLYCYTHEMIA, P348; Amann K, 2002, KIDNEY INT, V62, P877, DOI 10.1046/j.1523-1755.2002.00518.x; Brezski RJ, 2011, MABS-AUSTIN, V3, P558, DOI 10.4161/mabs.3.6.18119; Colella P, 2011, HUM MOL GENET, V20, P2251, DOI 10.1093/hmg/ddr115; Dalle B, 2001, BLOOD, V97, P3776, DOI 10.1182/blood.V97.12.3776; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Elliott S, 2004, EXP HEMATOL, V32, P1146, DOI 10.1016/j.exphem.2004.08.004; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; Fukuma S, 2012, AM J KIDNEY DIS, V59, P108, DOI 10.1053/j.ajkd.2011.07.014; Goldenberg MM, 1999, CLIN THER, V21, P75, DOI 10.1016/S0149-2918(00)88269-7; HENRY DH, 1992, ANN INTERN MED, V117, P739, DOI 10.7326/0003-4819-117-9-739; Hoffbrand AV., 2016, ESSENTIAL HAEMATOLOG, V7th; Jolling K, 2004, J PHARM SCI-US, V93, P3027, DOI 10.1002/jps.20200; Joy MS, 2002, ANN PHARMACOTHER, V36, P1183; Joyeux-Faure M, 2007, J PHARMACOL EXP THER, V323, P759, DOI 10.1124/jpet.107.127357; Kochendoerfer GG, 2003, SCIENCE, V299, P884, DOI 10.1126/science.1079085; Macdougall IC, 2012, AM J KIDNEY DIS, V59, P444, DOI 10.1053/j.ajkd.2011.11.013; Macdougall IC, 2001, NEPHROL DIAL TRAN S3, P4; Nelius T, 2010, MED ONCOL, V27, P363, DOI 10.1007/s12032-009-9218-8; Shanafelt TD, 2007, CANCER-AM CANCER SOC, V109, P2291, DOI 10.1002/cncr.22662; Sharples EJ, 2006, CURR OPIN PHARMACOL, V6, P184, DOI 10.1016/j.coph.2006.01.003; Silva M, 1996, BLOOD, V88, P1576, DOI 10.1182/blood.V88.5.1576.1576; Stuben G, 2003, INT J RADIAT ONCOL, V55, P1358, DOI 10.1016/S0360-3016(03)00012-9; Sullivan TA, 2012, EXP EYE RES, V96, P36, DOI 10.1016/j.exer.2012.01.006; Sun Lee-Hwei K, Unite states patent, Patent No. [6900292B2, 6900292]; Sytkowski AJ, 1998, P NATL ACAD SCI USA, V95, P1184, DOI 10.1073/pnas.95.3.1184; Sytkowski AJ, 1999, J BIOL CHEM, V274, P24773, DOI 10.1074/jbc.274.35.24773; Wang YJ, 2010, J CONTROL RELEASE, V145, P306, DOI 10.1016/j.jconrel.2010.04.021; Way JC, 2005, PROTEIN ENG DES SEL, V18, P111, DOI 10.1093/protein/gzi021; Wong VK, 2003, SKIN THERAPY LETT, V8, P7; Xu WX, 2013, CANCER RES, V73, P3075, DOI 10.1158/0008-5472.CAN-12-2357; Yang JJ, 2007, CHINA BIOTECHNOL, V27, P6; [张欣 ZHANG Xin], 2007, [中国新药杂志, Chinese Journal New Drugs], V16, P196	34	9	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72673	10.1371/journal.pone.0072673	http://dx.doi.org/10.1371/journal.pone.0072673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977338	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700185
J	Wang, S; He, GL; Yang, Y; Liu, Y; Diao, RY; Sheng, K; Liu, XH; Xu, WM				Wang, Shan; He, Guolin; Yang, Yue; Liu, Ying; Diao, Ruiying; Sheng, Kai; Liu, Xinghui; Xu, Wenming			Reduced Expression of Enac in Placenta Tissues of Patients with Severe Preeclampsia Is Related to Compromised Trophoblastic Cell Migration and Invasion during Pregnancy	PLOS ONE			English	Article							EPITHELIAL SODIUM-CHANNEL; SUBUNIT; HYPERTENSION	The purpose of the study is to investigate the expression of epithelial sodium channel (ENaC) in normal pregnancy and severe preeclampsia placenta and to explore the underlying mechanism of the relationship between the altered ENaC expression and onset of preeclampsia. Reverse transcription polymerase chain reaction (RT-PCR) and Western blot were used to check epithelial sodium channel subunits expression in mRNA and protein level in first term and full term placental tissue. ENaC alpha specific RNAi were used to knockdown ENaC expression and cell invasion and migration assay were used to check whether reduced expression of ENaC can compromise trophoblast cell function. The result showed that ENaC alpha was highly expressed in first term placental trophoblast cells; while EnaC beta was highly expressed in full term placenta. Knockdown ENaC alpha expression by using small interfering RNA reduced the invasive and migration abilities of HTR-8/SVneo cell. Real time-PCR and Western blot analysis showed that the expression levels of ENaC beta were also significantly lower in severe preeclampsia compared with normal pregnancy. It is concluded that the ENaC played an important role in trophoblast cell invasion and migration. Reduced expression and activity of epithelial sodium channel in trophoblast cells may be involved in the pathogenesis of preeclampsia.	[Wang, Shan; He, Guolin; Yang, Yue; Sheng, Kai; Liu, Xinghui] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Peoples R China; [Wang, Shan; He, Guolin; Yang, Yue; Liu, Ying; Sheng, Kai; Xu, Wenming] Sichuan Univ, West China Univ Hosp 2, Chinese Univ Hong Kong, Joint Lab Reprod Med, Chengdu 610064, Peoples R China; [Wang, Shan; Xu, Wenming] Sichuan Univ, West China Univ Hosp 2, Minist Educ, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Chengdu 610064, Peoples R China; [Diao, Ruiying] Peking Univ, Shenzhen Hosp, Shenzhen Key Lab Male Reprod & Genet, Shenzhen, Peoples R China	Sichuan University; Chinese University of Hong Kong; Sichuan University; Sichuan University; Peking University	Liu, XH (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Peoples R China.	xinghuiliu@163.com; wenmingx@gmail.com			National Basic Research Program of China [2012CB944903]; Natural Sciences Foundation of China [81270709]; Ministry of Education Program for New Century Excellent Talents in University [NCET-12-0382]	National Basic Research Program of China(National Basic Research Program of China); Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education Program for New Century Excellent Talents in University	This work was supported by the National Basic Research Program of China (2012CB944903); Natural Sciences Foundation of China (81270709), and the Ministry of Education Program for New Century Excellent Talents in University (NCET-12-0382). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bubien JK, 2010, J BIOL CHEM, V285, P23527, DOI 10.1074/jbc.R109.025049; del Monaco S, 2006, MEDICINA-BUENOS AIRE, V66, P31; del Monaco SM, 2009, J MEMBRANE BIOL, V232, P1, DOI 10.1007/s00232-009-9206-0; Fisher Susan J, 2004, Reprod Biol Endocrinol, V2, P53, DOI 10.1186/1477-7827-2-53; Gambling L, 2004, KIDNEY INT, V65, P1774, DOI 10.1111/j.1523-1755.2004.00593.x; Gennari-Moser C, 2011, ENDOCRINOLOGY, V152, P263, DOI 10.1210/en.2010-0525; Hirota Y, 2010, NAT MED, V16, P529, DOI 10.1038/nm0510-529; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Lyall F, 2005, PLACENTA, V26, pS31, DOI 10.1016/j.placenta.2005.02.010; Marino GI, 2012, PLACENTA; Mick VE, 2001, MOL ENDOCRINOL, V15, P575, DOI 10.1210/me.15.4.575; Rayner BL, 2003, J HYPERTENS, V21, P921, DOI 10.1097/00004872-200305000-00016; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Salker MS, 2011, NAT MED, V17, P1509, DOI 10.1038/nm.2498; Sargent IL, 2007, J REPROD IMMUNOL, V76, P40, DOI 10.1016/j.jri.2007.03.009; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Wareing M, 2011, PLACENTA, V32, pS203, DOI 10.1016/j.placenta.2010.12.022	18	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72153	10.1371/journal.pone.0072153	http://dx.doi.org/10.1371/journal.pone.0072153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977235	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700140
J	Zeng, GQ; Yi, H; Zhang, PF; Li, XH; Hu, R; Li, MY; Li, C; Qu, JQ; Deng, XM; Xiao, ZQ				Zeng, Gu-Qing; Yi, Hong; Zhang, Peng-Fei; Li, Xin-Hui; Hu, Rong; Li, Mao-Yu; Li, Cui; Qu, Jia-Quan; Deng, Xingming; Xiao, Zhi-Qiang			The Function and Significance of SELENBP1 Downregulation in Human Bronchial Epithelial Carcinogenic Process	PLOS ONE			English	Article							SELENIUM-BINDING PROTEIN-1; CANCER PREVENTION; EXPRESSION; LUNG; IDENTIFICATION; BIOMARKERS; DAMAGE; HSP56	Background: Our quantitative proteomic study showed that selenium-binding protein 1 (SELENBP1) was progressively decreased in human bronchial epithelial carcinogenic process. However, there is little information on expression and function of SELENBP1 during human lung squamous cell cancer (LSCC) carcinogenesis. Methods: iTRAQ-tagging combined with 2D LC-MS/MS analysis was used to identify differentially expressed proteins in the human bronchial epithelial carcinogenic process. SELENBP1, member of selenoproteins family and progressively downregulated in this process, was selected to further study. Both Western blotting and immunohistochemistry were performed to detect SELENBP1 expression in independent sets of tissues of bronchial epithelial carcinogenesis, and ability of SELENBP1 for discriminating NBE (normal bronchial epithelium) from preneoplastic lesions from invasive LSCC was evaluated. The effects of SELENBP1 downregulation on the susceptibility of benzo(a) pyrene (B[a]P)-induced human bronchial epithelial cell transformation were determined. Results: 102 differentially expressed proteins were identified by quantitative proteomics, and SELENBP1 was found and confirmed being progressively decreased in the human bronchial epithelial carcinogenic process. The sensitivity and specificity of SELENBP1 were 80% and 79% in discriminating NBE from preneoplastic lesions, 79% and 82% in discriminating NBE from invasive LSCC, and 77% and 71% in discriminating preneoplastic lesions from invasive LSCC, respectively. Furthermore, knockdown of SELENBP1 in immortalized human bronchial epithelial cell line 16HBE cells significantly increased the efficiency of B[a] P-induced cell transformation. Conclusions: The present data shows for the first time that decreased SELENBP1 is an early event in LSCC, increases B[a]P-induced human bronchial epithelial cell transformation, and might serve as a novel potential biomarker for early detection of LSCC.	[Zeng, Gu-Qing; Yi, Hong; Zhang, Peng-Fei; Li, Xin-Hui; Hu, Rong; Li, Mao-Yu; Li, Cui; Qu, Jia-Quan; Xiao, Zhi-Qiang] Cent S Univ, Xiangya Hosp, Chinese Minist Hlth, Key Lab Canc Prote, Changsha, Hunan, Peoples R China; [Zeng, Gu-Qing] Univ South China, Sch Nursing, Hengyang, Hunan, Peoples R China; [Deng, Xingming] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Deng, Xingming] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Central South University; University of South China; Emory University; Emory University	Deng, XM (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA.	xdeng4@emory.edu; zqxiao2001@hotmail.com			National Natural Science Foundation of China [81230053, 81172559, 81272959]; National Basic Research Program of China [2013CB910502]; Hunan Provincial Natural Science Foundation of China [12JJ6080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	This research program was supported by National Natural Science Foundation of China (81230053, 81172559, 81272959), National Basic Research Program of China (2013CB910502) and Hunan Provincial Natural Science Foundation of China (12JJ6080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUERBACH O, 1979, NEW ENGL J MED, V300, P381, DOI 10.1056/NEJM197902223000801; Behne D, 2001, ANNU REV NUTR, V21, P453, DOI 10.1146/annurev.nutr.21.1.453; Chen GA, 2004, J PATHOL, V202, P321, DOI 10.1002/path.1524; Cheng AL, 2008, CLIN CANCER RES, V14, P435, DOI 10.1158/1078-0432.CCR-07-1215; El-Bayoumy K, 2001, MUTAT RES-FUND MOL M, V475, P123, DOI 10.1016/S0027-5107(01)00075-6; Feng XP, 2010, CANCER RES, V70, P3450, DOI 10.1158/0008-5472.CAN-09-4099; Fischer J, 2006, Z EVANGEL ETHIK, V50, P1; Greenberg AK, 2002, RESPIR RES, V3, DOI 10.1186/rr170; Hoffmann D, 1997, PREV MED, V26, P427, DOI 10.1006/pmed.1997.0183; Howe HL, 2001, J NATL CANCER I, V93, P824, DOI 10.1093/jnci/93.11.824; Huang KC, 2006, INT J CANCER, V118, P2433, DOI 10.1002/ijc.21671; Jeong JY, 2009, BIOCHEM BIOPH RES CO, V379, P583, DOI 10.1016/j.bbrc.2008.12.110; Klein EA, 2004, ANN NY ACAD SCI, V1031, P234, DOI 10.1196/annals.1331.023; Li TH, 2008, MOL NUTR FOOD RES, V52, P1289, DOI 10.1002/mnfr.200700331; Osada H, 2002, ONCOGENE, V21, P7421, DOI 10.1038/sj.onc.1205802; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Pohl NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007774; Porat A, 2000, J BIOL CHEM, V275, P14457, DOI 10.1074/jbc.275.19.14457; Qi YM, 2010, J BIOL CHEM, V285, P33010, DOI 10.1074/jbc.M110.137406; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; Schrauzer GN, 2009, CRIT REV BIOTECHNOL, V29, P10, DOI 10.1080/07388550802658048; Seo YR, 2002, ONCOGENE, V21, P3663, DOI 10.1038/sj.onc.1205468; Travis WD, 1999, HISTOLOGICAL TYPING; VIRTAMO J, 1987, CANCER, V60, P145, DOI 10.1002/1097-0142(19870715)60:2<145::AID-CNCR2820600203>3.0.CO;2-U; Wu M, 2010, J BIOL CHEM, V285, P12055, DOI 10.1074/jbc.M109.088781; Yang L, 2004, BRIT J CANCER, V90, P2157, DOI 10.1038/sj.bjc.6601813; Yang MH, 1998, CANCER RES, V58, P3150; Zeng GQ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013946	28	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71865	10.1371/journal.pone.0071865	http://dx.doi.org/10.1371/journal.pone.0071865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977169	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700110
J	Lin, PI; Kuo, PH; Chen, CH; Wu, JY; Gau, SSF; Wu, YY; Liu, SK				Lin, Ping-I; Kuo, Po-Hsiu; Chen, Chia-Hsiang; Wu, Jer-Yuarn; Gau, Susan S-F.; Wu, Yu-Yu; Liu, Shih-Kai			Runs of Homozygosity Associated with Speech Delay in Autism in a Taiwanese Han Population: Evidence for the Recessive Model	PLOS ONE			English	Article							GENE-GENE INTERACTION; SPECTRUM DISORDERS; INTERSTITIAL DELETION; JACOBSEN SYNDROME; CANDIDATE GENES; CHILDREN; GENOME; VARIANTS; ALLELES; LOCI	Runs of homozygosity (ROH) may play a role in complex diseases. In the current study, we aimed to test if ROHs are linked to the risk of autism and related language impairment. We analyzed 546,080 SNPs in 315 Han Chinese affected with autism and 1,115 controls. ROH was defined as an extended homozygous haplotype spanning at least 500 kb. Relative extended haplotype homozygosity (REHH) for the trait-associated ROH region was calculated to search for the signature of selection sweeps. Totally, we identified 676 ROH regions. An ROH region on 11q22.3 was significantly associated with speech delay (corrected p = 1.73 x 10(-8)). This region contains the NPAT and ATM genes associated with ataxia telangiectasia characterized by language impairment; the CUL5 (culin 5) gene in the same region may modulate the neuronal migration process related to language functions. These three genes are highly expressed in the cerebellum. No evidence for recent positive selection was detected on the core haplotypes in this region. The same ROH region was also nominally significantly associated with speech delay in another independent sample (p = 0.037; combinatorial analysis Stouffer's z trend = 0.0005). Taken together, our findings suggest that extended recessive loci on 11q22.3 may play a role in language impairment in autism. More research is warranted to investigate if these genes influence speech pathology by perturbing cerebellar functions.	[Lin, Ping-I] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Lin, Ping-I; Gau, Susan S-F.] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Kuo, Po-Hsiu; Gau, Susan S-F.] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chen, Chia-Hsiang; Gau, Susan S-F.] Natl Taiwan Univ, Dept Psychiat, Coll Med, Taipei 10764, Taiwan; [Chen, Chia-Hsiang] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Taiwan; [Wu, Jer-Yuarn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Wu, Jer-Yuarn] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Gau, Susan S-F.] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Grad Inst Clin Med, Dept Psychol, Taipei 10764, Taiwan; [Gau, Susan S-F.] Natl Taiwan Univ, Sch Occupat Therapy, Taipei 10764, Taiwan; [Wu, Yu-Yu] Chang Gung Univ, Coll Med, Linkou Med Ctr, Dept Psychiat,Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Liu, Shih-Kai] Taoyuan Mental Hosp, Dept Hlth, Dept Child & Adolescent Psychiat, Tao Yuan, Taiwan	Cincinnati Children's Hospital Medical Center; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan; National Taiwan University; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University	Gau, SSF (corresponding author), Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan.	gaushufe@ntu.edu.tw	Gau, Susan Shur-Fen/P-4726-2017; Wu, Jer-Yuarn/S-7010-2018; Lin, Ping-I (Daniel)/O-2613-2015; Chen, Chia-Hsiang/E-3939-2010	Gau, Susan Shur-Fen/0000-0002-2718-8221; Lin, Ping-I/0000-0002-9739-7184; Kuo, Po-Hsiu/0000-0003-0365-3587; Chen, Chia-Hsiang/0000-0002-8232-2403	National Science Council [NSC96-3112-B-002-033, NSC97-3112-B-002-009, NSC98-3112-B-002-004, NSC 99-3112-B-002-036]; National Taiwan University [10R81918-03, 101R892103, 102R892103]; National Taiwan University Hospital [NTUH101-N2017]; Academia Sinica [40-05-GMM]; National Center for Genome Medicine at Academia Sinica (NCGM) of National Core Facility Program for Biotechnology (NCFPB) [NSC-101-2319-B-001-001]; Translational Resource Center for Genomic Medicine (TRC) of National Research Program for Biopharmaceuticals (NRPB) [NSC-101-2325-B-001-035]; National Science Council, Taiwan; National Institute of Mental Health [1U24MH081810]; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810] Funding Source: NIH RePORTER	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); National Taiwan University Hospital(National Taiwan University); Academia Sinica(Academia Sinica - Taiwan); National Center for Genome Medicine at Academia Sinica (NCGM) of National Core Facility Program for Biotechnology (NCFPB); Translational Resource Center for Genomic Medicine (TRC) of National Research Program for Biopharmaceuticals (NRPB); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was mainly supported by grants from National Science Council (NSC96-3112-B-002-033, NSC97-3112-B-002-009, NSC98-3112-B-002-004, and NSC 99-3112-B-002-036), National Taiwan University (AIM for Top University Excellent Research Project: 10R81918-03, 101R892103, 102R892103), and National Taiwan University Hospital (NTUH101-N2017) and partially supported by Academia Sinica Genomic Medicine Multicenter Study (Academia Sinica 40-05-GMM) and National Center for Genome Medicine at Academia Sinica (NCGM, NSC-101-2319-B-001-001) of National Core Facility Program for Biotechnology (NCFPB) and Translational Resource Center for Genomic Medicine (TRC, NSC-101-2325-B-001-035) of National Research Program for Biopharmaceuticals (NRPB), National Science Council, Taiwan. The authors gratefully acknowledge the resources provided by the AGRE consortium and the participating AGRE families. AGRE is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to Clara M. Lajonchere (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon M, 2002, AM J HUM GENET, V70, P60, DOI 10.1086/338241; Anney R, 2012, HUM MOL GENET, V21, P4781, DOI 10.1093/hmg/dds301; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Ashley-Koch AE, 2007, PSYCHIAT GENET, V17, P221, DOI 10.1097/YPG.0b013e32809c2f75; Berg JS, 2007, GENET MED, V9, P427, DOI 10.1097/GIM.0b013e3180986192; Burnside RD, 2009, AM J MED GENET A, V149A, P1516, DOI 10.1002/ajmg.a.32906; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; Casey JP, 2012, HUM GENET, V131, P565, DOI 10.1007/s00439-011-1094-6; Cheung J, 2001, GENOMICS, V78, P7, DOI 10.1006/geno.2001.6651; Chun S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002240; da Silva MAS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014023; Depienne C, 2007, J MED GENET, V44, P452, DOI 10.1136/jmg.2006.047092; Devlin B, 2004, AM J MED GENET B, V126B, P46, DOI 10.1002/ajmg.b.20125; Devlin B, 2011, BRAIN RES, V1380, P78, DOI 10.1016/j.brainres.2010.11.026; Feng L, 2007, GENE DEV, V21, P2717, DOI 10.1101/gad.1604207; Gabis L, 2008, J CHILD NEUROL, V23, P766, DOI 10.1177/0883073808315423; Gau SSF, 2010, PSYCHIAT CLIN NEUROS, V64, P70, DOI 10.1111/j.1440-1819.2009.02034.x; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Grossfeld PD, 2004, AM J MED GENET A, V129A, P51, DOI 10.1002/ajmg.a.30090; Guerin A, 2012, AM J MED GENET A, V158A, P2551, DOI 10.1002/ajmg.a.35621; Guerreiro MM, 2002, NEUROLOGY, V59, P245, DOI 10.1212/WNL.59.2.245; Horelli-Kuitunen N, 1999, AM J MED GENET, V86, P416, DOI 10.1002/(SICI)1096-8628(19991029)86:5<416::AID-AJMG4>3.0.CO;2-S; Keller MC, 2012, PLOS GENET, V8, P425, DOI 10.1371/journal.pgen.1002656; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Kini U, 2010, AM J MED GENET A, V152A, P1383, DOI 10.1002/ajmg.a.33435; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Lin PI, 2012, RES DEV DISABIL, V33, P1533, DOI 10.1016/j.ridd.2012.03.004; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Ma DQ, 2010, AM J MED GENET B, V153B, P477, DOI 10.1002/ajmg.b.31003; Manolakos E, 2009, MOL CYTOGENET, V2, DOI 10.1186/1755-8166-2-26; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Nalls MA, 2009, NEUROGENETICS, V10, P183, DOI 10.1007/s10048-009-0182-4; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Perez Castillo A, 1989, AN ESP PEDIATR, V30, P242; Poot M, 2010, NEUROGENETICS, V11, P81, DOI 10.1007/s10048-009-0205-1; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Ramoz N, 2008, AM J MED GENET B, V147B, P1152, DOI 10.1002/ajmg.b.30739; RUTTER M, 1970, SEMIN PSYCHIAT, V2, P435; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Simo S, 2010, J NEUROSCI, V30, P5668, DOI 10.1523/JNEUROSCI.0035-10.2010; Singh AS, 2013, PROG NEURO-PSYCHOPH, V45, P131, DOI 10.1016/j.pnpbp.2013.04.015; Spence SJ, 2006, AM J MED GENET B, V141B, P591, DOI 10.1002/ajmg.b.30329; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; VENTER A, 1992, J CHILD PSYCHOL PSYC, V33, P489, DOI 10.1111/j.1469-7610.1992.tb00887.x; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vinck A, 2011, DEV NEUROREHABIL, V14, P315, DOI 10.3109/17518423.2011.603368; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wang LL, 2010, CURR PHARM DESIGN, V16, P1313, DOI 10.2174/138161210791034030; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Zhang H, 2002, MOL PSYCHIATR, V7, P1012, DOI 10.1038/sj.mp.4001124	58	18	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72056	10.1371/journal.pone.0072056	http://dx.doi.org/10.1371/journal.pone.0072056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977206	gold, Green Published, Green Submitted			2022-12-25	WOS:000323570200054
J	Oumata, N; Nguyen, PH; Beringue, V; Soubigou, F; Pang, YH; Desban, N; Massacrier, C; Morel, Y; Paturel, C; Contesse, MA; Bouaziz, S; Sanyal, S; Galons, H; Blondel, M; Voisset, C				Oumata, Nassima; Phu Hai Nguyen; Beringue, Vincent; Soubigou, Flavie; Pang, Yanhong; Desban, Nathalie; Massacrier, Catherine; Morel, Yannis; Paturel, Carine; Contesse, Marie-Astrid; Bouaziz, Serge; Sanyal, Suparna; Galons, Herve; Blondel, Marc; Voisset, Cecile			The Toll-Like Receptor Agonist Imiquimod Is Active against Prions	PLOS ONE			English	Article							PROTEIN-FOLDING ACTIVITY; 23S RIBOSOMAL-RNA; YEAST-BASED ASSAY; MAMMALIAN PRIONS; NEURODEGENERATIVE DISEASES; 5-PERCENT CREAM; SCREENING ASSAY; SCRAPIE AGENT; IN-VIVO; DRUGS	Using a yeast-based assay, a previously unsuspected antiprion activity was found for imiquimod (IQ), a potent Toll-like receptor 7 (TLR7) agonist already used for clinical applications. The antiprion activity of IQ was first detected against yeast prions [PSI+] and [URE3], and then against mammalian prion both ex vivo in a cell-based assay and in vivo in a transgenic mouse model for prion diseases. In order to facilitate structure-activity relationship studies, we conducted a new synthetic pathway which provides a more efficient means of producing new IQ chemical derivatives, the activity of which was tested against both yeast and mammalian prions. The comparable antiprion activity of IQ and its chemical derivatives in the above life forms further emphasizes the conservation of prion controlling mechanisms throughout evolution. Interestingly, this study also demonstrated that the antiprion activity of IQ and IQ-derived compounds is independent from their ability to stimulate TLRs. Furthermore, we found that IQ and its active chemical derivatives inhibit the protein folding activity of the ribosome (PFAR) in vitro.	[Oumata, Nassima; Galons, Herve] Univ Paris 05, INSERM, U1022, Lab Chim Organ 2, Paris, France; [Phu Hai Nguyen; Soubigou, Flavie; Contesse, Marie-Astrid; Blondel, Marc; Voisset, Cecile] Univ Bretagne Occidentale, Fac Med & Sci Sante, INSERM, UMR1078, F-29269 Brest, France; [Phu Hai Nguyen; Soubigou, Flavie; Contesse, Marie-Astrid; Blondel, Marc; Voisset, Cecile] Etab Francais Sang EFS Bretagne, Bretagne, France; [Phu Hai Nguyen; Soubigou, Flavie; Contesse, Marie-Astrid; Blondel, Marc; Voisset, Cecile] Hop Morvan, Lab Genet Mol, CHRU Brest, Brest, France; [Beringue, Vincent] INRA, Virol Immunol Mol UR892, Jouy En Josas, France; [Pang, Yanhong; Sanyal, Suparna] Uppsala Univ, Dept Cell & Mol Biol, BMC, Uppsala, Sweden; [Desban, Nathalie] CNRS, UPS2682, Prot Phosphorylat & Dis Lab, Roscoff, France; [Massacrier, Catherine; Morel, Yannis; Paturel, Carine] Innate Pharma, Marseille, France; [Bouaziz, Serge] Univ Paris 05, Lab Cristallog & RMN Biol, CNRS, UMR 8015, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Uppsala University; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Blondel, M (corresponding author), Univ Bretagne Occidentale, Fac Med & Sci Sante, INSERM, UMR1078, F-29269 Brest, France.	marc.blondel@univ-brest.fr; cecile.voisset@univ-brest.fr	morel, yves/C-4757-2017; Voisset, Cecile/AAK-1636-2020; bouaziz, serge/C-1401-2014; Bouaziz, Serge/ABA-8712-2020; Blondel, Marc/AAJ-9049-2020	Bouaziz, Serge/0000-0001-7792-8307; Blondel, Marc/0000-0003-4897-2995; Pang, Yanhong/0000-0002-5167-4174; Voisset, Cecile/0000-0001-7505-1927	Agence Nationale de la Recherche "blanche" from the French government; Contrat Jeune Chercheur from Institut National de la Sante et de la Recherche Medicale; SSF-Dalen (Sweden-France Bilateral Collaboration) Program	Agence Nationale de la Recherche "blanche" from the French government(French National Research Agency (ANR)); Contrat Jeune Chercheur from Institut National de la Sante et de la Recherche Medicale; SSF-Dalen (Sweden-France Bilateral Collaboration) Program	This work was supported by an Agence Nationale de la Recherche "blanche" from the French government, a Contrat Jeune Chercheur from Institut National de la Sante et de la Recherche Medicale and the SSF-Dalen (Sweden-France Bilateral Collaboration) Program (to MB & SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer F, 2004, J VIROL, V78, P482, DOI 10.1128/JVI.78.1.482-490.2004; Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855; Bach S, 2006, METHODS, V39, P72, DOI 10.1016/j.ymeth.2006.04.005; Barret A, 2003, J VIROL, V77, P8462, DOI 10.1128/JVI.77.15.8462-8469.2003; Beringue V, 2000, J VIROL, V74, P5432, DOI 10.1128/JVI.74.12.5432-5440.2000; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Chattopadhyay S, 1996, P NATL ACAD SCI USA, V93, P8284, DOI 10.1073/pnas.93.16.8284; Collins SJ, 2002, ANN NEUROL, V52, P503, DOI 10.1002/ana.10336; Couplan E, 2011, P NATL ACAD SCI USA, V108, P11989, DOI 10.1073/pnas.1101478108; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Das Debasis, 2008, Biotechnology Journal, V3, P999, DOI 10.1002/biot.200800098; Dirikoc S, 2007, J NEUROSCI, V27, P9537, DOI 10.1523/JNEUROSCI.1942-07.2007; Dos Reis S, 2011, BIOCHIMIE, V93, P1047, DOI 10.1016/j.biochi.2011.03.002; Ederth J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn992; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, PRION, V3, P74, DOI 10.4161/pri.3.2.8754; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Khier S, 2010, EUR J PHARM SCI, V39, P23, DOI 10.1016/j.ejps.2009.10.006; Kim Y, 2009, J MED CHEM, V52, P2098, DOI 10.1021/jm801659w; Klingenstein R, 2006, J NEUROCHEM, V98, P748, DOI 10.1111/j.1471-4159.2006.03889.x; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; Lacarrubba F, 2011, J DERMATOL TREAT, V22, P353, DOI 10.3109/09546634.2010.548503; Langevin C, 2011, NEUROBIOL DIS, V41, P219, DOI 10.1016/j.nbd.2010.09.010; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Lefrere JJ, 2009, TRANSFUSION, V49, P797, DOI 10.1111/j.1537-2995.2008.02044.x; Miller G, 2009, SCIENCE, V326, P1337, DOI 10.1126/science.326.5958.1338; Miller RL, 1999, INT J IMMUNOPHARMACO, V21, P1, DOI 10.1016/S0192-0561(98)00068-X; Naddaka V, 2008, US Patent, Patent No. 7323568; Peinador C, 1997, TETRAHEDRON, V53, P8269, DOI 10.1016/S0040-4020(97)00492-4; Sanyal SC, 2002, EUR J BIOCHEM, V269, P3856, DOI 10.1046/j.1432-1033.2002.03085.x; Schofer H, 2007, BRIT J DERMATOL, V157, P52, DOI 10.1111/j.1365-2133.2007.08274.x; Serra-Guillen C, 2012, J AM ACAD DERMATOL, V66, pE131, DOI 10.1016/j.jaad.2011.11.933; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Torres A, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-7; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002174; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Vilotte JL, 2001, J VIROL, V75, P5977, DOI 10.1128/JVI.75.13.5977-5984.2001; Voisset Cecile, 2009, Infectious Disorders - Drug Targets, V9, P31; Voisset Cecile, 2008, Biotechnology Journal, V3, P1033, DOI 10.1002/biot.200800134; Zagon IS, 2008, EXP BIOL MED, V233, P968, DOI 10.3181/0802-RM-58	41	24	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72112	10.1371/journal.pone.0072112	http://dx.doi.org/10.1371/journal.pone.0072112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977222	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200059
J	Wang, ZG; Yang, GJ; Nie, P; Fu, JH; Wang, XF; Liu, D				Wang, Zhenguang; Yang, Guangjie; Nie, Pei; Fu, Junhua; Wang, Xufu; Liu, Dan			Dynamical Observation on Biological Progression of VX2 Liver Tumors to Identify the Optimal Time for Intervention in Animal Models	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; ARTERIAL EMBOLIZATION; RABBIT LIVER; IMPLANTATION; METASTASIS; INJECTION; INFUSION; EFFICACY	Purpose: Based on practice guideline of "management of hepatocellular carcinoma (HCC): update" published by American Association for the Study of Liver Diseases (AASLD) and "Barcelona Clinic Liver Cancer staging system (BCLC)," this study investigated how to enroll the optimal VX2 liver tumor model for HCC researches by dynamically observing the biological progression of the tumor. Materials: Thirty-two healthy New Zealand white rabbits were implanted VX2 liver tumor by cell suspension method (n=24) and tissue fragment method (n=8). All the rabbits underwent CT scans on day 7, 14, 21 and 28 after implantation to observe the size of the tumors, the time when metastases and ascites occurred and the survival time. Appropriate intervention times were estimated corresponding to different clinical HCC stages by using tumor diameter-time curve. Results: The VX2 liver tumors grew rapidly within 28 days after implantation. And the tumors in the cell suspension group grew faster than those of the tissue fragment group. The appropriate intervention time corresponding to very early stage, early stage and intermediate stage were <11 days, 11-16.9 days and >16.9 days, respectively in the cell suspension group, and <19.9 days, 19.9-25.5 days and >25.5 days, respectively in the tissue fragment group. Conclusion: Preclinical animal research needs to improve on different levels to yield best predictions for human patients. Researchers should seek for an individualized proposal to select optimal VX2 liver tumor models for their experiments. This approach may lead to a more accurate determination of therapeutic outcomes.	[Wang, Zhenguang; Yang, Guangjie] Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao 266071, Peoples R China; [Nie, Pei] Shandong Univ, Shandong Med Imaging Res Inst, Dept CT, Jinan 250100, Peoples R China; [Fu, Junhua] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Intervent Med, Qingdao 266071, Peoples R China; [Wang, Xufu] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Nucl Med, Qingdao 266071, Peoples R China; [Liu, Dan] Laigang Hosp, Dept Radiol, Laiwu, Peoples R China; [Wang, Zhenguang; Yang, Guangjie] Shandong Univ, Qilu Hosp, Dept Nucl Med, Jinan 250100, Peoples R China	Qingdao University; Shandong University; Qingdao University; Qingdao University; Shandong University	Yang, GJ (corresponding author), Qingdao Univ, Coll Med, Affiliated Hosp, PET CT Room, Qingdao 266071, Peoples R China.	yangguangj@yahoo.com.cn						Achen MG, 2005, CANCER CELL, V7, P121, DOI 10.1016/j.ccr.2005.01.017; Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411; Bridges JFP, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-32; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2002, HEPATOLOGY, V35, P519, DOI 10.1053/jhep.2002.32089; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cao W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061583; Chen JH, 2004, LAB ANIM-UK, V38, P79, DOI 10.1258/00236770460734434; Gupta S, 2011, CARDIOVASC INTER RAD, V34, P1021, DOI 10.1007/s00270-011-0154-6; Hou Y, 2012, CELL RES, V22, P259, DOI 10.1038/cr.2011.139; Huo TI, 2007, AM J GASTROENTEROL, V102, P1920, DOI 10.1111/j.1572-0241.2007.01370.x; Ishii H, 1996, CANCER, V77, P1792; IZUMI B, 1986, CANCER RES, V46, P4167; KAKIZOE S, 1987, CANCER-AM CANCER SOC, V59, P310, DOI 10.1002/1097-0142(19870115)59:2<310::AID-CNCR2820590224>3.0.CO;2-S; Lencioni RA, 2003, RADIOLOGY, V228, P235, DOI 10.1148/radiol.2281020718; Liapi E, 2011, J NUCL MED, V52, P225, DOI 10.2967/jnumed.110.083162; Lin WY, 2002, J VET MED SCI, V64, P649, DOI 10.1292/jvms.64.649; Livraghi T, 2003, RADIOLOGY, V226, P441, DOI 10.1148/radiol.2262012198; Martic-Kehl MI, 2012, EUR J NUCL MED MOL I, V39, P1492, DOI 10.1007/s00259-012-2175-z; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Minami Y, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/104685; Morisco F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059658; Ohtani O, 2008, ANAT REC, V291, P643, DOI 10.1002/ar.20681; OKADA M, 1995, BRIT J CANCER, V71, P518, DOI 10.1038/bjc.1995.103; Ravoori MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062371; Roosen A, 2012, BJU INT, V109, P6, DOI 10.1111/j.1464-410X.2011.10494.x; Sano B, 2002, SURG TODAY, V32, P503, DOI 10.1007/s005950200085; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Sonoda A, 2011, CARDIOVASC INTER RAD, V34, P1272, DOI 10.1007/s00270-011-0156-4; Sonoda A, 2011, ONCOLOGY-BASEL, V80, P92, DOI 10.1159/000328763; Tang ZY, 2001, WORLD J GASTROENTERO, V7, P445; Toyohara J, 2011, ANN NUCL MED, V25, P717, DOI 10.1007/s12149-011-0531-x; Wang Y, 2011, J VASC INTERV RADIOL, V22, P1606, DOI 10.1016/j.jvir.2011.08.005; Wright KC, 2011, RADIOLOGY, V260, P718, DOI 10.1148/radiol.11101868; Yu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017926; Zhong JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058082	37	7	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e74327	10.1371/journal.pone.0074327	http://dx.doi.org/10.1371/journal.pone.0074327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977399	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200097
J	Viola, M; Bartolini, B; Vigetti, D; Karousou, E; Moretto, P; Deleonibus, S; Sawamura, T; Wight, TN; Hascall, VC; De Luca, G; Passi, A				Viola, Manuela; Bartolini, Barbara; Vigetti, Davide; Karousou, Evgenia; Moretto, Paola; Deleonibus, Sara; Sawamura, Tatsuya; Wight, Thomas N.; Hascall, Vincent C.; De Luca, Giancarlo; Passi, Alberto			Oxidized Low Density Lipoprotein (LDL) Affects Hyaluronan Synthesis in Human Aortic Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SYNTHASE 2; CHONDROITIN SULFATE; CHOLESTEROL; ACCUMULATION; EXPRESSION; RECEPTOR; MONOCYTE; ATHEROSCLEROSIS; PROLIFERATION	Thickening of the vessel in response to high low density lipoprotein( s) (LDL) levels is a hallmark of atherosclerosis, characterized by increased hyaluronan (HA) deposition in the neointima. Human native LDL trapped within the arterial wall undergoes modifications such as oxidation (oxLDL). The aim of our study is to elucidate the link between internalization of oxLDL and HA production in vitro, using human aortic smooth muscle cells. LDL were used at an effective protein concentration of 20-50 mu g/ml, which allowed 80% cell viability. HA content in the medium of untreated cells was 28.9 +/- 3.7 nmol HA-disaccharide/cell and increased after oxLDL treatment to 53.9 +/- 5.6. OxLDL treatments doubled the transcripts of HA synthase HAS2 and HAS3. Accumulated HA stimulated migration of aortic smooth muscle cells and monocyte adhesiveness to extracellular matrix. The effects induced by oxLDL were inhibited by blocking LOX-1 scavenger receptor with a specific antibody (10 mu g/ml). The cholesterol moiety of LDL has an important role in HA accumulation because cholesterol-free oxLDL failed to induce HA synthesis. Nevertheless, cholesterol-free oxLDL and unmodified cholesterol (20 mu g/ml) induce only HAS3 transcription, whereas 22, oxysterol affects both HAS2 and HAS3. Moreover, HA deposition was associated with higher expression of endoplasmic reticulum stress markers (CHOP and GRP78). Our data suggest that HA synthesis can be induced in response to specific oxidized sterol-related species delivered through oxLDL.	[Viola, Manuela; Bartolini, Barbara; Vigetti, Davide; Karousou, Evgenia; Moretto, Paola; Deleonibus, Sara; De Luca, Giancarlo; Passi, Alberto] Univ Insubria, Dipartimento Sci Chirurg & Morfol, I-21100 Varese, Italy; [Sawamura, Tatsuya] Natl Cerebral & Cardiovasc Ctr, Dept Vasc Physiol, Suita, Osaka 5658565, Japan; [Wight, Thomas N.] Benaroya Res Inst Virginia Mason, Hope Heart Matrix Biol Program, Seattle, WA 98101 USA; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	University of Insubria; National Cerebral & Cardiovascular Center - Japan; Benaroya Research Institute; Virginia Mason Medical Center; Cleveland Clinic Foundation	Passi, A (corresponding author), Univ Insubria, Dipartimento Sci Chirurg & Morfol, Via JH Dunant 5, I-21100 Varese, Italy.	alberto.passi@uninsubria.it	passi, alberto g/A-1752-2018; Sawamura, Tatsuya/E-7103-2010; Viola, Manuela/B-7120-2011	passi, alberto g/0000-0003-3328-3089; Viola, Manuela/0000-0002-0634-6390; vigetti, davide/0000-0002-6339-8453	PRIN	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by a grant from PRIN 2009 (to E. K.).	Albertini R, 1997, FEBS LETT, V403, P154, DOI 10.1016/S0014-5793(97)00043-4; Badimon L, 2012, ANN NY ACAD SCI, V1254, P18, DOI 10.1111/j.1749-6632.2012.06480.x; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Chang MY, 2012, J BIOL CHEM, V287, P14122, DOI 10.1074/jbc.M111.324988; Chang MY, 2006, ARTERIOSCL THROM VAS, V26, P494, DOI 10.1161/01.ATV.0000200135.61362.27; Christian AE, 1997, J LIPID RES, V38, P2264; Colgan SM, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001742; Dickhout JG, 2011, FASEB J, V25, P576, DOI 10.1096/fj.10-159319; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goyal T, 2012, CURR ATHERO IN PRESS; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Karousou EG, 2004, ELECTROPHORESIS, V25, P2919, DOI 10.1002/elps.200406034; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Kataoka H, 1999, CIRCULATION, V99, P3110, DOI 10.1161/01.CIR.99.24.3110; Khalil MF, 2004, ARTERIOSCL THROM VAS, V24, P2211, DOI 10.1161/01.ATV.0000147163.54024.70; Kolodgie FD, 2002, ARTERIOSCL THROM VAS, V22, P1642, DOI 10.1161/01.ATV.0000034021.92658.4C; Kultti A, 2010, J BIOL CHEM, V285, P22899, DOI 10.1074/jbc.M109.088435; Lee S, 2012, EXP CELL RES, V318, P2128, DOI 10.1016/j.yexcr.2012.06.012; Leonarduzzi G, 2012, FREE RADICAL BIO MED, V52, P19, DOI 10.1016/j.freeradbiomed.2011.09.031; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Llorente-Cortes V, 2000, ARTERIOSCL THROM VAS, V20, P1572, DOI 10.1161/01.ATV.20.6.1572; Lu JJ, 2011, ANTIOXID REDOX SIGN, V15, P2301, DOI 10.1089/ars.2010.3792; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Merrilees MJ, 2011, ARTERIOSCL THROM VAS, V31, P1309, DOI 10.1161/ATVBAHA.111.225573; Mitra S, 2011, CARDIOVASC DRUG THER, V25, P419, DOI 10.1007/s10557-011-6341-5; Morello F, 2009, ATHEROSCLEROSIS, V207, P38, DOI 10.1016/j.atherosclerosis.2009.04.001; Moriwaki H, 1998, ARTERIOSCL THROM VAS, V18, P1541, DOI 10.1161/01.ATV.18.10.1541; Nagy N, 2010, CIRCULATION, V122, P2313, DOI 10.1161/CIRCULATIONAHA.110.972653; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; REYNOLDS GD, 1985, AM J PATHOL, V121, P200; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Sakr SW, 2008, J BIOL CHEM, V283, P36195, DOI 10.1074/jbc.M807772200; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005; Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804; Steck TL, 2010, TRENDS CELL BIOL, V20, P680, DOI 10.1016/j.tcb.2010.08.007; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Vigetti D, 2008, J BIOL CHEM, V283, P4448, DOI 10.1074/jbc.M709051200; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Vigetti D, 2012, J BIOL CHEM, V287, P35544, DOI 10.1074/jbc.M112.402347; Vigetti D, 2011, J BIOL CHEM, V286, P34497, DOI 10.1074/jbc.M111.266312; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Vijayagopal P, 1996, ATHEROSCLEROSIS, V127, P195, DOI 10.1016/S0021-9150(96)05954-0; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Yoshida H, 2010, CLIN CHIM ACTA, V411, P1875, DOI 10.1016/j.cca.2010.08.038	58	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29595	29603		10.1074/jbc.M113.508341	http://dx.doi.org/10.1074/jbc.M113.508341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23979132	hybrid, Green Published			2022-12-25	WOS:000330615300035
J	Kumar, A; Torii, T; Ishino, Y; Muraoka, D; Yoshimura, T; Togayachi, A; Narimatsu, H; Ikenaka, K; Hitoshi, S				Kumar, Akhilesh; Torii, Tomohiro; Ishino, Yugo; Muraoka, Daisuke; Yoshimura, Takeshi; Togayachi, Akira; Narimatsu, Hisashi; Ikenaka, Kazuhiro; Hitoshi, Seiji			The Lewis X-related alpha 1,3-Fucosyltransferase, Fut10, Is Required for the Maintenance of Stem Cell Populations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Embryonic Stem Cell; Glycobiology; Glycosyltransferases; HPLC; Neural Stem Cell; Bisecting N-Glycans; Stemness	CENTRAL-NERVOUS-SYSTEM; EMBRYONIC ANTIGEN; PROGENITOR CELLS; N-GLYCANS; MOUSE; OLIGOSACCHARIDES; BRAIN; MICE; DIFFERENTIATION; DISAPPEARANCE	Lewis X (Le(X), Gal1-4(Fuc1-3)GlcNAc) is a carbohydrate epitope that is present at the nonreducing terminus of sugar chains of glycoproteins and glycolipids, and is abundantly expressed in several stem cell populations. Le(X) antigen can be used in conjunction with fluorescence-activated cell sorting to isolate neurosphere-forming neural stem cells (NSCs) from embryonic mouse brains. However, its function in the maintenance and differentiation of stem cells remains largely unknown. In this study, we examined mice deficient for fucosyltransferase 9 (Fut9), which is thought to synthesize most, if not all, of the Le(X) moieties in the brain. We found that the number of NSCs was increased in the brain of Fut9(-/-) embryos, suggesting that Fut9-synthesized Le(X) is dispensable for the maintenance of NSCs. Another 1,3-fucosyltransferase gene, fucosyltransferase 10 (Fut10), is expressed in the ventricular zone of the embryonic brain. Overexpression of Fut10 enhanced the self-renewal of NSCs. Conversely, suppression of Fut10 expression induced the differentiation of NSCs and embryonic stem cells. In addition, knockdown of Fut10 expression in the cortical ventricular zone of the embryonic brain by in utero electroporation of Fut10-miRNAs impaired the radial migration of neural precursor cells. Our data suggest that Fut10 is involved in a unique 1,3-fucosyltransferase activity with stringent substrate specificity, and that this activity is required to maintain stem cells in an undifferentiated state.	[Kumar, Akhilesh; Torii, Tomohiro; Ishino, Yugo; Muraoka, Daisuke; Yoshimura, Takeshi; Ikenaka, Kazuhiro; Hitoshi, Seiji] Grad Univ Adv Studies, Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Okazaki, Aichi 4448787, Japan; [Kumar, Akhilesh; Torii, Tomohiro; Ishino, Yugo; Muraoka, Daisuke; Yoshimura, Takeshi; Ikenaka, Kazuhiro; Hitoshi, Seiji] Grad Univ Adv Studies, Sch Life Sci, Dept Physiol Sci, Okazaki, Aichi 4448787, Japan; [Togayachi, Akira; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Glycogene Funct Team, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan; [Hitoshi, Seiji] Shiga Univ Med Sci, Dept Integrat Physiol, Otsu, Shiga 5202192, Japan	Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; National Institute of Advanced Industrial Science & Technology (AIST); Shiga University of Medical Science	Hitoshi, S (corresponding author), Shiga Univ Med Sci, Dept Integrat Physiol, Otsu, Shiga 5202192, Japan.	shitoshi-tky@umin.ac.jp	Togayachi, Akira/M-4144-2018; Narimatsu, Hisashi/M-4757-2018	Togayachi, Akira/0000-0003-3600-9149; Narimatsu, Hisashi/0000-0002-8402-133X; Torii, Tomohiro/0000-0002-0039-923X; Yoshimura, Takeshi/0000-0002-0316-8082	Ministry of Education, Culture, Sports, Science and Technology of Japan [21650092, 20019032]; Sankyo Foundation of Life Science; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [24770138] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sankyo Foundation of Life Science; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Exploratory Research (21650092) (to S. H.) and Scientific Research on Priority Area (20019032) (to K. I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and grants from the Sankyo Foundation of Life Science and the Astellas Foundation for Research on Metabolic Disorders (to S. H.).	ALLENDOERFER KL, 1995, MOL CELL NEUROSCI, V6, P381, DOI 10.1006/mcne.1995.1029; Baboval T, 2002, MAMM GENOME, V13, P538, DOI 10.1007/s00335-001-2152-5; BIRD JM, 1984, DEV BIOL, V104, P449, DOI 10.1016/0012-1606(84)90101-5; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; GOOI HC, 1981, NATURE, V292, P156, DOI 10.1038/292156a0; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hitoshi S, 2011, NEUROGENESIS IN THE ADULT BRAIN II: CLINICAL IMPLICATIONS, P189, DOI 10.1007/978-4-431-53945-2_10; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kudo T, 2004, MOL CELL BIOL, V24, P4221, DOI 10.1128/MCB.24.10.4221-4228.2004; Kudo T, 2002, J BIOL CHEM, V277, P47724, DOI 10.1074/jbc.M205839200; Kudo T, 2007, GLYCOBIOLOGY, V17, P1, DOI 10.1093/glycob/cwl047; Masae N, 2006, DEV BIOL, V297, P262, DOI 10.1016/j.ydbio.2006.05.017; Mollicone R, 2009, J BIOL CHEM, V284, P4723, DOI 10.1074/jbc.M809312200; MURAMATSU T, 1988, BIOCHIMIE, V70, P1587, DOI 10.1016/0300-9084(88)90294-5; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nishihara S, 2003, GLYCOBIOLOGY, V13, P445, DOI 10.1093/glycob/cwg048; Nishihara S, 1999, FEBS LETT, V462, P289, DOI 10.1016/S0014-5793(99)01549-5; Patnaik S. K., 2007, NATURE PRECEDINGS; Rebbaa A, 1996, J NEUROCHEM, V67, P2265; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roos C, 2002, J BIOL CHEM, V277, P3168, DOI 10.1074/jbc.m107927200; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Tanabe K, 2006, ANAL BIOCHEM, V348, P324, DOI 10.1016/j.ab.2005.10.035; Toumadje A, 2003, IN VITRO CELL DEV-AN, V39, P449; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; Yagi H, 2012, J BIOL CHEM, V287, P24356, DOI 10.1074/jbc.M112.365643; YAMAMOTO M, 1985, P NATL ACAD SCI USA, V82, P3045, DOI 10.1073/pnas.82.9.3045; Yan LY, 1997, GLYCOCONJUGATE J, V14, P45, DOI 10.1023/A:1018508914551; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Yoshimura T, 2012, ANAL BIOCHEM, V423, P253, DOI 10.1016/j.ab.2012.01.023	31	18	19	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28859	28868		10.1074/jbc.M113.469403	http://dx.doi.org/10.1074/jbc.M113.469403			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23986452	hybrid, Green Published			2022-12-25	WOS:000330298800038
J	Caetano-Anolles, G; Wang, ML; Caetano-Anolles, D				Caetano-Anolles, Gustavo; Wang, Minglei; Caetano-Anolles, Derek			Structural Phylogenomics Retrodicts the Origin of the Genetic Code and Uncovers the Evolutionary Impact of Protein Flexibility	PLOS ONE			English	Article							TRANSFER-RNA-SYNTHETASES; NONRIBOSOMAL PEPTIDE-SYNTHESIS; AMINO-ACID-COMPOSITION; SECONDARY STRUCTURE; CYCLODIPEPTIDE SYNTHASES; MOLECULAR EVOLUTION; AEROBIC METABOLISM; EDITING MECHANISM; QUALITY-CONTROL; ACCEPTOR STEM	The genetic code shapes the genetic repository. Its origin has puzzled molecular scientists for over half a century and remains a long-standing mystery. Here we show that the origin of the genetic code is tightly coupled to the history of aminoacyl-tRNA synthetase enzymes and their interactions with tRNA. A timeline of evolutionary appearance of protein domain families derived from a structural census in hundreds of genomes reveals the early emergence of the 'operational' RNA code and the late implementation of the standard genetic code. The emergence of codon specificities and amino acid charging involved tight coevolution of aminoacyl-tRNA synthetases and tRNA structures as well as episodes of structural recruitment. Remarkably, amino acid and dipeptide compositions of single-domain proteins appearing before the standard code suggest archaic synthetases with structures homologous to catalytic domains of tyrosyl-tRNA and seryl-tRNA synthetases were capable of peptide bond formation and aminoacylation. Results reveal that genetics arose through coevolutionary interactions between polypeptides and nucleic acid cofactors as an exacting mechanism that favored flexibility and folding of the emergent proteins. These enhancements of phenotypic robustness were likely internalized into the emerging genetic system with the early rise of modern protein structure.	[Caetano-Anolles, Gustavo; Wang, Minglei; Caetano-Anolles, Derek] Univ Illinois, Dept Crop Sci, Evolutionary Bioinformat Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Caetano-Anolles, G (corresponding author), Univ Illinois, Dept Crop Sci, Evolutionary Bioinformat Lab, Urbana, IL 61801 USA.	gca@illinois.edu		Caetano-Anolles, Gustavo/0000-0001-5854-4121	National Science Foundation [MCB-0749836, OISE-1132791]; CREES-United States Department of Agriculture; Office Of Internatl Science &Engineering [1132791] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); CREES-United States Department of Agriculture; Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported in part by National Science Foundation grants MCB-0749836 and OISE-1132791 and CREES-United States Department of Agriculture (all to GCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailor MH, 2010, SCIENCE, V327, P202, DOI 10.1126/science.1181085; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bilgin T, 2013, J MOL EVOL, V76, P343, DOI 10.1007/s00239-013-9564-1; Bilokapic S, 2006, EMBO J, V25, P2498, DOI 10.1038/sj.emboj.7601129; Boniecki MT, 2012, J BIOL CHEM, V287, P11285, DOI 10.1074/jbc.C111.325795; Bonnefond L, 2011, P NATL ACAD SCI USA, V108, P3912, DOI 10.1073/pnas.1019480108; Caetano-Anolles D, 2011, J MOL EVOL, V72, P14, DOI 10.1007/s00239-010-9400-9; Caetano-Anolles G, 2003, GENOME RES, V13, P1563, DOI 10.1101/gr.1161903; Caetano-Anolles G, 2002, NUCLEIC ACIDS RES, V30, P2575, DOI 10.1093/nar/30.11.2575; Caetano-Anolles G, 2002, J MOL EVOL, V54, P333, DOI 10.1007/s00239-001-0048-3; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Caetano-Anolles G, 2013, J MOL MICROB BIOTECH, V23, P152, DOI 10.1159/000346551; Caetano-Anolles G, 2012, J MOL EVOL, V74, P1, DOI 10.1007/s00239-011-9480-1; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Caetano-Anolles K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059300; CAETANOANOLLES G, 2010, EVOLUTIONARY GENOMIC, P431; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Chao FA, 2013, NAT CHEM BIOL, V9, P81, DOI [10.1038/NCHEMBIO.1138, 10.1038/nchembio.1138]; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; CUSACK S, 1991, NUCLEIC ACIDS RES, V19, P3489, DOI 10.1093/nar/19.13.3489; Danchin A, 2007, PROTEOMICS, V7, P875, DOI 10.1002/pmic.200600442; David LA, 2011, NATURE, V469, P93, DOI 10.1038/nature09649; de Pouplana LR, 2001, TRENDS BIOCHEM SCI, V26, P591, DOI 10.1016/S0968-0004(01)01932-6; de Pouplana LR, 2001, CELL, V104, P191, DOI 10.1016/S0092-8674(01)00204-5; Debes C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002861; Delarue M, 2007, RNA, V13, P161, DOI 10.1261/rna.257607; DEPINNA MCC, 1991, CLADISTICS, V7, P367; DIGIULIO M, 1992, J THEOR BIOL, V159, P199; Dupont CL, 2010, P NATL ACAD SCI USA, V107, P10567, DOI 10.1073/pnas.0912491107; Eichert A, 2011, BIOCHEM BIOPH RES CO, V412, P532, DOI 10.1016/j.bbrc.2011.07.030; Ekman D, 2010, J MOL BIOL, V396, P396, DOI 10.1016/j.jmb.2009.11.053; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Farris JS, 2008, CLADISTICS, V24, P89; FERSHT AR, 1980, BIOCHEMISTRY-US, V19, P5520, DOI 10.1021/bi00565a009; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P1250, DOI 10.1021/bi00574a021; Forslund K, 2008, MOL BIOL EVOL, V25, P254, DOI 10.1093/molbev/msm254; Fournier GP, 2011, ORIGINS LIFE EVOL B, V41, P621, DOI 10.1007/s11084-011-9261-2; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Goncearenco A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-75; Gondry M, 2009, NAT CHEM BIOL, V5, P414, DOI 10.1038/nchembio.175; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Guerler A, 2008, PROTEIN SCI, V17, P1374, DOI 10.1110/ps.035469.108; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Hale SP, 1997, SCIENCE, V276, P1250, DOI 10.1126/science.276.5316.1250; Harish A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032776; HARTMAN H, 1975, ORIGINS LIFE EVOL B, V6, P423, DOI 10.1007/BF01130344; Heard SB, 1996, EVOLUTION, V50, P2141, DOI 10.1111/j.1558-5646.1996.tb03604.x; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ikehara K, 2005, CHEM REC, V5, P107, DOI 10.1002/tcr.20037; Jakschitz TAE, 2012, CHEM SOC REV, V41, P5484, DOI 10.1039/c2cs35073d; Jakubowski H, 2005, AMINOACYL TRNA SYNTH, P354; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KACSER H, 1984, J MOL EVOL, V20, P38, DOI 10.1007/BF02101984; KHARCHENKO E P, 1976, Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, V12, P280; Kim KM, 2012, STRUCTURE, V20, P67, DOI 10.1016/j.str.2011.11.003; Kim KM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-140; Kim KM, 2010, MOL BIOL EVOL, V27, P1710, DOI 10.1093/molbev/msq106; LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366; Li L, 2011, J BIOL CHEM, V286, P10387, DOI 10.1074/jbc.M110.198929; Lienau EK, 2006, SYST BIOL, V55, P441, DOI 10.1080/10635150600697416; Lienau EK, 2009, ACTA BIOTHEOR, V57, P187, DOI 10.1007/s10441-008-9066-5; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Mittenthal Jay, 2012, Frontiers in Genetics, V3, P147, DOI [10.3389/fgene.2012.00147, 10.3389/fgene.2012.00172]; Mocibob M, 2010, P NATL ACAD SCI USA, V107, P14585, DOI 10.1073/pnas.1007470107; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Nasir A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-156; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Parker ET, 2011, P NATL ACAD SCI USA, V108, P5526, DOI 10.1073/pnas.1019191108; Pham Y, 2010, J BIOL CHEM, V285, P38590, DOI 10.1074/jbc.M110.136911; Reynolds NM, 2010, NAT REV MICROBIOL, V8, P849, DOI 10.1038/nrmicro2472; Riddle DS, 1997, NAT STRUCT BIOL, V4, P805, DOI 10.1038/nsb1097-805; Rodin AS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-14; Rodin SN, 2008, HEREDITY, V100, P341, DOI 10.1038/sj.hdy.6801086; Rodin SN, 1997, P NATL ACAD SCI USA, V94, P5183, DOI 10.1073/pnas.94.10.5183; RODIN SN, 1995, ORIGINS LIFE EVOL B, V25, P565, DOI 10.1007/BF01582025; Roy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007813; Saito MA, 2012, STRUCTURE, V20, P1, DOI 10.1016/j.str.2011.12.006; Sauguet L, 2011, NUCLEIC ACIDS RES, V39, P4475, DOI 10.1093/nar/gkr027; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; Shitivelband S, 2005, J MOL BIOL, V348, P513, DOI 10.1016/j.jmb.2005.02.023; Sober E, 2004, SYST BIOL, V53, P644, DOI 10.1080/10635150490468657; Sobolevsky Y, 2013, J BIOMOL STRUCT DYN, V31, P1293, DOI 10.1080/07391102.2012.735623; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; Sun FJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000018; Sun FJ, 2008, J MOL EVOL, V66, P21, DOI 10.1007/s00239-007-9050-8; Sun FJ, 2007, TRENDS GENET, V23, P26, DOI 10.1016/j.tig.2006.11.005; Sun FJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-153; Sun FJ, 2009, J MOL EVOL, V69, P430, DOI 10.1007/s00239-009-9264-z; Sun FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002799; SUN FJ, 2010, EVOLUTIONARY BIOINFO, P329; Suzuki T, 1997, EMBO J, V16, P1122, DOI 10.1093/emboj/16.5.1122; Taylor WR, 2007, CURR OPIN STRUC BIOL, V17, P354, DOI 10.1016/j.sbi.2007.06.002; Terada T, 2002, NAT STRUCT BIOL, V9, P257, DOI 10.1038/nsb777; Trifonov EN, 2009, CURR OPIN STRUC BIOL, V19, P335, DOI 10.1016/j.sbi.2009.03.007; Vasil'eva IA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P247, DOI 10.1134/S0006297907030029; Venditti C, 2006, SYST BIOL, V55, P637, DOI 10.1080/10635150600865567; Vetting MW, 2010, NAT CHEM BIOL, V6, P797, DOI 10.1038/NCHEMBIO.440; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang M, 2007, GENOME RES, V17, P1572, DOI 10.1101/gr.6454307; Wang ML, 2011, MOL BIOL EVOL, V28, P567, DOI 10.1093/molbev/msq232; Wang ML, 2009, STRUCTURE, V17, P66, DOI 10.1016/j.str.2008.11.008; Webster AJ, 2003, SCIENCE, V301, P478, DOI 10.1126/science.1083202; Wolf YI, 1999, GENOME RES, V9, P689; Wong JTF, 2005, BIOESSAYS, V27, P416, DOI 10.1002/bies.20208; Yadavalli SS, 2012, ADV PROTEIN CHEM STR, V86, P1, DOI 10.1016/B978-0-12-386497-0.00001-3; YCAS M, 1974, J THEOR BIOL, V44, P145, DOI 10.1016/S0022-5193(74)80035-4; Ye JQ, 2004, BBA-BIOENERGETICS, V1659, P1, DOI 10.1016/j.bbabio.2004.06.003; Zhao MW, 2005, EMBO J, V24, P1430, DOI 10.1038/sj.emboj.7600618; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070; ZULL JE, 1990, TRENDS BIOCHEM SCI, V15, P257, DOI 10.1016/0968-0004(90)90048-G	121	37	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72225	10.1371/journal.pone.0072225	http://dx.doi.org/10.1371/journal.pone.0072225			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991065	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470100086
J	Lin, YC; Tsai, PH; Lin, CY; Cheng, CH; Lin, TH; Lee, KPH; Huang, KY; Chen, SH; Hwang, JJ; Kandaswami, CC; Lee, MT				Lin, Yo-Chuen; Tsai, Pei-Hsun; Lin, Chun-Yu; Cheng, Chia-Hsiung; Lin, Tsung-Han; Lee, Kevin P. H.; Huang, Kai-Yun; Chen, Shih-Hsun; Hwang, Jiuan-Jiuan; Kandaswami, Chithan C.; Lee, Ming-Ting			Impact of Flavonoids on Matrix Metalloproteinase Secretion and Invadopodia Formation in Highly Invasive A431-III Cancer Cells	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; SRC SUBSTRATE; EMS1 GENE; CORTACTIN; DEGRADATION; QUERCETIN; PODOSOMES; LUTEOLIN; ACTIN; INHIBITORS	Metastasis is a major cause of mortality in cancer patients. Invadopodia are considered to be crucial structures that allow cancer cells to penetrate across the extracellular matrix (ECM) by using matrix metalloproteinases (MMPs). Previously, we isolated a highly invasive A431-III subline from parental A431 cells by Boyden chamber assay. The A431-III cells possess higher invasive and migratory abilities, elevated levels of MMP-9 and an enhanced epithelial-mesenchymal transition (EMT) phenotype. In this study, we discovered that A431-III cells had an increased potential to form invadopodia and an improved capacity to degrade ECM compared with the original A431 cells. We also observed enhanced phosphorylation levels of cortactin and Src in A431-III cells; these phosphorylated proteins have been reported to be the main regulators of invadopodia formation. Flavonoids, almost ubiquitously distributed in food plants and plant food products, have been documented to exhibit anti-tumor properties. Therefore, it was of much interest to explore the effects of flavonoid antioxidants on the metastatic activity of A431-III cells. Exposure of A431-III cells to two potent dietary flavonoids, namely luteolin (Lu) and quercetin (Qu), caused inhibition of invadopodia formation and decrement in ECM degradation. We conclude that Lu and Qu attenuate the phosphorylation of cortactin and Src in A431-III cells. As a consequence, there ensues a disruption of invadopodia generation and the suppression of MMP secretion. These changes, in concert, bring about a reduction in metastasis.	[Lin, Yo-Chuen; Tsai, Pei-Hsun; Lin, Chun-Yu; Lin, Tsung-Han; Lee, Ming-Ting] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Cheng, Chia-Hsiung] Taipei Med Univ, Coll Med, Dept Biochem, Taipei, Taiwan; [Lee, Kevin P. H.] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Huang, Kai-Yun; Lee, Ming-Ting] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Chen, Shih-Hsun] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Hwang, Jiuan-Jiuan] Natl Yang Ming Univ, Inst Physiol, Taipei 112, Taiwan; [Kandaswami, Chithan C.] Castle Hills Hlth, Lewisville, TX USA	National Taiwan University; Taipei Medical University; Taipei Medical University; Academia Sinica - Taiwan; Johns Hopkins University; National Yang Ming Chiao Tung University	Lee, MT (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan.	mtlee@gate.sinica.edu.tw	Cheng, Chia-Hsiung/A-6044-2019	Cheng, Chia-Hsiung/0000-0003-0307-9650	Taiwan Academia Sinica Thematic Project [AS-96-TP-B06]	Taiwan Academia Sinica Thematic Project	This work was supported in part by Taiwan Academia Sinica Thematic Project (AS-96-TP-B06 to MTL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ammer Amanda Gatesman, 2009, J Cancer Sci Ther, V1, P52; Angers-Loustau A, 2004, MOL CANCER RES, V2, P595; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Byun S, 2010, CANCER RES, V70, P2415, DOI 10.1158/0008-5472.CAN-09-4093; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; CHEN WT, 1989, J EXP ZOOL, V251, P167, DOI 10.1002/jez.1402510206; CHEN WT, 1985, NATURE, V316, P156, DOI 10.1038/316156a0; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Courtneidge SA, 2005, COLD SH Q B, V70, P167, DOI 10.1101/sqb.2005.70.014; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Huang YT, 1999, BRIT J PHARMACOL, V128, P999, DOI 10.1038/sj.bjp.0702879; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanadaswami C, 2005, IN VIVO, V19, P895; KANDASWAMI C, 1992, ANTI-CANCER DRUG, V3, P525, DOI 10.1097/00001813-199210000-00013; Kao WT, 2008, ANTICANCER RES, V28, P2109; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Lin CY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-87; Lin CY, 2011, CANCER SCI, V102, P815, DOI 10.1111/j.1349-7006.2011.01861.x; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Lin YS, 2011, CANCER SCI, V102, P1829, DOI 10.1111/j.1349-7006.2011.02035.x; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Liotta L A, 1990, Semin Cancer Biol, V1, P99; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Mannello F, 2005, CURR CANCER DRUG TAR, V5, P285, DOI 10.2174/1568009054064615; Middleton E, 2000, PHARMACOL REV, V52, P673; Muralidharan-Chari V, 2009, CANCER RES, V69, P2201, DOI 10.1158/0008-5472.CAN-08-1301; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Rodrigo JP, 2000, CLIN CANCER RES, V6, P3177; Russo GL, 2007, BIOCHEM PHARMACOL, V74, P533, DOI 10.1016/j.bcp.2007.02.014; Russo M, 2010, BRIT J CANCER, V103, P642, DOI 10.1038/sj.bjc.6605794; Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; SCHUURING E, 1993, MOL CELL BIOL, V13, P2891, DOI 10.1128/MCB.13.5.2891; SCHUURING E, 1995, GENE, V159, P83, DOI 10.1016/0378-1119(94)00562-7; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076	54	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71903	10.1371/journal.pone.0071903	http://dx.doi.org/10.1371/journal.pone.0071903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991004	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100063
J	Smith, MA; Blankman, E; Deakin, NO; Hoffman, LM; Jensen, CC; Turner, CE; Beckerle, MC				Smith, Mark A.; Blankman, Elizabeth; Deakin, Nicholas O.; Hoffman, Laura M.; Jensen, Christopher C.; Turner, Christopher E.; Beckerle, Mary C.			LIM Domains Target Actin Regulators Paxillin and Zyxin to Sites of Stress Fiber Strain	PLOS ONE			English	Article							FOCAL ADHESION LOCALIZATION; CELL-MIGRATION; INTEGRIN ADHESOME; PROTEINS; KINASE; FAMILY; FORCE; HIC-5; RECRUITMENT; MEMBERS	Contractile actomyosin stress fibers are critical for maintaining the force balance between the interior of the cell and its environment. Consequently, the actin cytoskeleton undergoes dynamic mechanical loading. This results in spontaneous, stochastic, highly localized strain events, characterized by thinning and elongation within a discrete region of stress fiber. Previous work showed the LIM-domain adaptor protein, zyxin, is essential for repair and stabilization of these sites. Using live imaging, we show paxillin, another LIM-domain adaptor protein, is also recruited to stress fiber strain sites. Paxillin recruitment to stress fiber strain sites precedes zyxin recruitment. Zyxin and paxillin are each recruited independently of the other. In cells lacking paxillin, actin recovery is abrogated, resulting in slowed actin recovery and increased incidence of catastrophic stress fiber breaks. For both paxillin and zyxin, the LIM domains are necessary and sufficient for recruitment. This work provides further evidence of the critical role of LIM-domain proteins in responding to mechanical stress in the actin cytoskeleton.	[Smith, Mark A.; Hoffman, Laura M.; Jensen, Christopher C.; Beckerle, Mary C.] Univ Utah, Dept Biol, Salt Lake City, UT USA; [Blankman, Elizabeth; Beckerle, Mary C.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA; [Deakin, Nicholas O.; Turner, Christopher E.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Beckerle, MC (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT USA.	Mary.Beckerle@hci.utah.edu			National Institutes of Health (NIH) [GM50877]; NIH [CA 163296]; NATIONAL CANCER INSTITUTE [R01CA163296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050877] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding to MCB from National Institutes of Health (NIH) GM50877 and to CET from NIH CA 163296. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Colombelli J, 2009, J CELL SCI, V122, P1665, DOI 10.1242/jcs.042986; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Drees B, 2000, J BIOL CHEM, V275, P22503, DOI 10.1074/jbc.M001698200; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Fujita H, 1998, J BIOL CHEM, V273, P26516, DOI 10.1074/jbc.273.41.26516; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Guo WH, 2007, MOL BIOL CELL, V18, P4519, DOI 10.1091/mbc.E07-06-0582; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; Hoffman LM, 2012, MOL BIOL CELL, V23, P1846, DOI 10.1091/mbc.E11-12-1057; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kim-Kaneyama J, 2005, J CELL SCI, V118, P937, DOI 10.1242/jcs.01683; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Li B, 2001, J BIOL CHEM, V276, P33328, DOI 10.1074/jbc.M100789200; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Nishiya N, 1999, J BIOL CHEM, V274, P9847, DOI 10.1074/jbc.274.14.9847; Nix DA, 2001, J BIOL CHEM, V276, P34759, DOI 10.1074/jbc.M102820200; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Reinhard M, 1999, J BIOL CHEM, V274, P13410, DOI 10.1074/jbc.274.19.13410; SADLER I, 1992, J CELL BIOL, V119, P1573, DOI 10.1083/jcb.119.6.1573; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035; Smith MA, 2010, DEV CELL, V19, P365, DOI 10.1016/j.devcel.2010.08.008; Thomas SM, 1999, J CELL SCI, V112, P181; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; TURNER CE, 1994, J CELL SCI, V107, P1583; Uemura A, 2011, BIOPHYS J, V101, P1069, DOI 10.1016/j.bpj.2011.08.001; Webb DJ, 2005, J CELL SCI, V118, P4925, DOI 10.1242/jcs.02563; WENG ZG, 1993, J BIOL CHEM, V268, P14956; Yi JS, 2002, J BIOL CHEM, V277, P9580, DOI 10.1074/jbc.M106922200; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858	43	54	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e69378	10.1371/journal.pone.0069378	http://dx.doi.org/10.1371/journal.pone.0069378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990882	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100009
J	Chmielarz, P; Kusmierczyk, J; Parlato, R; Schutz, G; Nalepa, I; Kreiner, G				Chmielarz, Piotr; Kusmierczyk, Justyna; Parlato, Rosanna; Schuetz, Guenther; Nalepa, Irena; Kreiner, Grzegorz			Inactivation of Glucocorticoid Receptor in Noradrenergic System Influences Anxiety- and Depressive-Like Behavior in Mice	PLOS ONE			English	Article							IMMOBILIZATION STRESS; LOCUS-COERULEUS; EXPRESSION; NEURONS; BRAIN; NOREPINEPHRINE; CORTICOSTERONE; TRANSPORTER; RESPONSES; NUCLEUS	The aim of this study was to investigate whether conditional inactivation of the glucocorticoid receptors (GRs) in noradrenergic neurons affects animal behavior in mice. Selective ablation of GRs in the noradrenergic system was achieved using the Cre/loxP approach. We crossed transgenic mice expressing the Cre recombinase under the dopamine beta-hydroxylase (DBH) promoter with animals harboring the floxed GR gene. The resulting GR(DBHCre) mutant mice exhibited no alterations in terms of normal cage behavior, weight gain, spatial memory or spontaneous locomotor activity, regardless of gender. To assess depressive- and anxiety-like behaviors we performed the Tail Suspension Test and the Light-Dark Box Test. While male mutant animals did not show any alternations in both tests, female GR(DBHCre) mutants displayed depressive- and anxiety-like behavior. Additionally, male GR(DBHCre) mice were exposed to chronic restraint stress but still exhibited immobility times and anxiety statuses similar to those of non-stressed animals while stressed control mice clearly revealed depressive- and anxiety-like phenotype. Thus, in males the effects of the mutation were precipitated only after chronic restraint stress procedure. Our data reveal a possible gender-dependent role of GRs in the noradrenergic system in anxiety- and depressive-like behavior in mice.	[Chmielarz, Piotr; Kusmierczyk, Justyna; Nalepa, Irena; Kreiner, Grzegorz] Polish Acad Sci, Inst Pharmacol, Dept Brain Biochem, Krakow, Poland; [Parlato, Rosanna; Schuetz, Guenther] German Canc Res Ctr, DKFZ ZMBH Alliance, Dept Mol Biol Cell 1, Heidelberg, Germany; [Parlato, Rosanna] Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany; [Parlato, Rosanna] Univ Ulm, Inst Appl Physiol, D-89069 Ulm, Germany	Polish Academy of Sciences; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ulm University	Kreiner, G (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Brain Biochem, Krakow, Poland.	kreiner@if-pan.krakow.pl	Parlato, Rosanna/AAH-4429-2020; Nalepa, Irena/AAA-2594-2021; Parlato, Rosanna/G-8768-2015; Chmielarz, Piotr/AAG-8172-2019	Parlato, Rosanna/0000-0001-6682-9645; Nalepa, Irena/0000-0002-7821-0206; Kusmierczyk, Justyna/0000-0002-6464-5620; Kreiner, Grzegorz/0000-0003-3719-2889; Chmielarz, Piotr/0000-0001-8935-8591	DeMeTer [POIG.01.01.02-12-004/09-00]; European Regional Development Fund	DeMeTer; European Regional Development Fund(European Commission)	This study was supported by grant POIG.01.01.02-12-004/09-00 (DeMeTer) financed by the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Cecchi M, 2002, NEUROPHARMACOLOGY, V43, P1139, DOI 10.1016/S0028-3908(02)00292-7; Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Chourbaji S, 2008, BRAIN RES REV, V57, P554, DOI 10.1016/j.brainresrev.2007.04.008; Cox BM, 2011, BEHAV BRAIN RES, V220, P106, DOI 10.1016/j.bbr.2011.01.038; Dalla C, 2005, NEUROSCIENCE, V135, P703, DOI 10.1016/j.neuroscience.2005.06.068; Dalla C, 2010, BASIC CLIN PHARMACOL, V106, P226, DOI 10.1111/j.1742-7843.2009.00516.x; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; deAngelis L, 1996, N-S ARCH PHARMACOL, V354, P379; Haller J, 2002, BRAIN RES BULL, V58, P279, DOI 10.1016/S0361-9230(02)00789-X; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; ITOH J, 1990, PSYCHOPHARMACOLOGY, V101, P27, DOI 10.1007/BF02253713; Jedema HP, 2008, EUR J NEUROSCI, V27, P2433, DOI 10.1111/j.1460-9568.2008.06208.x; JHANWARUNIYAL M, 1986, BRAIN RES, V368, P404, DOI 10.1016/0006-8993(86)90591-3; Joo Y, 2009, NEUROSCI LETT, V461, P121, DOI 10.1016/j.neulet.2009.06.025; Juszczak GR, 2006, PHARMACOL BIOCHEM BE, V85, P332, DOI 10.1016/j.pbb.2006.08.016; KITADA Y, 1983, NEUROPHARMACOLOGY, V22, P1055, DOI 10.1016/0028-3908(83)90024-2; Kruk-Slomka M, 2012, PHARMACOL REP, V64, P1066, DOI 10.1016/S1734-1140(12)70904-0; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; LIPOSITS Z, 1986, HISTOCHEMISTRY, V85, P95, DOI 10.1007/BF00491754; Makino S, 2002, BRAIN RES, V943, P216, DOI 10.1016/S0006-8993(02)02647-1; McEwen BS, 2000, PROG BRAIN RES, V122, P25; MORILAK DA, 1985, J NEUROSCI, V5, P1300; Parlato R, 2007, DEVELOPMENT, V134, P1663, DOI 10.1242/dev.02838; Parlato R, 2009, ENDOCRINOLOGY, V150, P1775, DOI 10.1210/en.2008-1107; Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005; SHARMA AC, 1992, BIOL PSYCHIAT, V16, P117, DOI DOI 10.1016/0278-5846(92)90014-6.PUBMED:1557503; Sun ZW, 2010, J NEUROCHEM, V113, P105, DOI 10.1111/j.1471-4159.2010.06587.x; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5	30	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72632	10.1371/journal.pone.0072632	http://dx.doi.org/10.1371/journal.pone.0072632			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977333	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300093
J	Costa, PS; Santos, NC; Cunha, P; Palha, JA; Sousa, N				Costa, Patricio Soares; Santos, Nadine Correia; Cunha, Pedro; Palha, Joana Almeida; Sousa, Nuno			The Use of Bayesian Latent Class Cluster Models to Classify Patterns of Cognitive Performance in Healthy Ageing	PLOS ONE			English	Article							MINI-MENTAL-STATE; OLDER-ADULTS; AGE; EDUCATION; RESERVE; MEMORY; DIAGNOSIS; PROFILES; DECLINE	The main focus of this study is to illustrate the applicability of latent class analysis in the assessment of cognitive performance profiles during ageing. Principal component analysis (PCA) was used to detect main cognitive dimensions (based on the neurocognitive test variables) and Bayesian latent class analysis (LCA) models (without constraints) were used to explore patterns of cognitive performance among community-dwelling older individuals. Gender, age and number of school years were explored as variables. Three cognitive dimensions were identified: general cognition (MMSE), memory (MEM) and executive (EXEC) function. Based on these, three latent classes of cognitive performance profiles (LC1 to LC3) were identified among the older adults. These classes corresponded to stronger to weaker performance patterns (LC1>LC2>LC3) across all dimensions; each latent class denoted the same hierarchy in the proportion of males, age and number of school years. Bayesian LCA provided a powerful tool to explore cognitive typologies among healthy cognitive agers.	[Costa, Patricio Soares; Santos, Nadine Correia; Cunha, Pedro; Palha, Joana Almeida; Sousa, Nuno] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Costa, Patricio Soares; Santos, Nadine Correia; Cunha, Pedro; Palha, Joana Almeida; Sousa, Nuno] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal; [Cunha, Pedro] Ctr Hosp Alto Ave EPE, Guimaraes, Portugal	Universidade do Minho	Sousa, N (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	njcsousa@ecsaude.uminho.pt	Cunha, Pedro/AAE-6732-2019; Cunha, Pedro G/K-6743-2014; Sousa, Nuno JC/N-9137-2017; Sousa, Nuno/C-2782-2009; Costa, Patrício/A-3072-2013; Palha, Joana Almeida/C-2745-2009; Santos, Nadine Correia/AAC-2873-2019; Santos, Nadine/K-7431-2015	Cunha, Pedro/0000-0002-8518-4130; Cunha, Pedro G/0000-0002-8518-4130; Sousa, Nuno JC/0000-0002-8755-5126; Costa, Patrício/0000-0002-1201-9177; Palha, Joana Almeida/0000-0002-8866-368X; Santos, Nadine/0000-0001-8110-7173	European Commission FP7 initiative [HEALTH-F2-2010-259772]; SwitchBox post-doctoral fellowship	European Commission FP7 initiative; SwitchBox post-doctoral fellowship	The study is integrated in the "Maintaining health in old age through homeostasis (SWITCHBOX)" collaborative project funded by the European Commission FP7 initiative (grant HEALTH-F2-2010-259772). NS and JAP are main team members of the European consortium SWITCHBOX (http://www.switchbox-online.eu/). NCS is supported by a SwitchBox post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle JL, 2009, AMOS 18 USERS GUIDE; Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P495, DOI 10.1016/S0887-6177(99)00040-2; Baltes PB, 1990, SUCCESSFUL AGING PER; BRAYNE C, 1990, AGE AGEING, V19, P91, DOI 10.1093/ageing/19.2.91; Breslau N, 2005, ARCH GEN PSYCHIAT, V62, P1343, DOI 10.1001/archpsyc.62.12.1343; Buschke H, 1995, J Int Neuropsychol Soc, V1, P483; Chung H, 2004, AM STAT, V58, P152, DOI 10.1198/0003130043286; Eshghi A., 2011, J DATA SCI, V9, P271, DOI [10.6339/JDS.201104_09(2).0009, DOI 10.6339/JDS.201104_09(2).0009]; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Formann AK, 2003, BIOMETRICS, V59, P189, DOI 10.1111/1541-0420.00023; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Gelman A., 2004, BAYESIAN DATA ANAL; Goh JO, 2012, PSYCHOL AGING, V27, P707, DOI 10.1037/a0026715; Goncalves L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040633; Graffar M., 1956, COURRIER, V6, P455; Greendale GA, 2011, OBSTET GYN CLIN N AM, V38, P519, DOI 10.1016/j.ogc.2011.05.007; Gur Raquel E, 2002, Dialogues Clin Neurosci, V4, P197; Haughton D, 2009, AM STAT, V63, P81, DOI 10.1198/tast.2009.0016; Hilborn JV, 2009, J CLIN EXP NEUROPSYC, V31, P412, DOI 10.1080/13803390802232659; Hybels CF, 2009, AM J GERIAT PSYCHIAT, V17, P387, DOI 10.1097/JGP.0b013e31819431ff; Kaplan D, 2004, SAGE HDB QUANTITATIV; Lambe P, 2011, MED EDUC, V45, P308, DOI 10.1111/j.1365-2923.2010.03897.x; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Molloy D W, 1997, Int Psychogeriatr, V9 Suppl 1, P87, DOI 10.1017/S1041610297004754; Paulo AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024553; R Core Team, 2012, R LANG ENV STAT COMP; Salthouse TA, 2010, J INT NEUROPSYCH SOC, V16, P754, DOI 10.1017/S1355617710000706; Salthouse TA, 2010, NEUROPSYCHOLOGY, V24, P273, DOI 10.1037/a0017284; Santos NC, 2013, AGE, V35, P1983, DOI 10.1007/s11357-012-9482-y; Schmand B, 1997, PSYCHOL MED, V27, P1337, DOI 10.1017/S0033291797005461; Schumacher F.R., 2007, BMC P, V1, pS112; Small GW, 2002, BMJ-BRIT MED J, V324, P1502, DOI 10.1136/bmj.324.7352.1502; St Clair-Thompson HL, 2010, EUR J COGN PSYCHOL, V22, P286, DOI 10.1080/09541440902771299; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Strauss E, 2006, COMPENDIUM NEUROPSYC; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; van Exel E, 2001, J NEUROL NEUROSUR PS, V71, P29, DOI 10.1136/jnnp.71.1.29; Vance DE, 2008, J NEUROSCI NURS, V40, P241, DOI 10.1097/01376517-200808000-00008; Vermunt, 2005, DMA RES COUNCIL J; Vermunt J. K., 2002, ADV LATENT CLASS ANA; Wechsler D., 1997, WECHSLER ADULT INTEL; Wilson RS, 2009, NEUROLOGY, V72, P460, DOI 10.1212/01.wnl.0000341782.71418.6c; Yang FM, 2009, PSYCHOSOMATICS, V50, P248, DOI 10.1176/appi.psy.50.3.248	44	31	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71940	10.1371/journal.pone.0071940	http://dx.doi.org/10.1371/journal.pone.0071940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219RU	23977183	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300054
J	Gao, F; Chen, D; Hu, QS; Wang, GH				Gao, Feng; Chen, Dong; Hu, Qingsong; Wang, Guanghui			Rotenone Directly Induces BV2 Cell Activation via the p38 MAPK Pathway	PLOS ONE			English	Article							NF-KAPPA-B; PARKINSONS-DISEASE; MICROGLIAL ACTIVATION; DOPAMINERGIC-NEURONS; NEURODEGENERATION; NEUROINFLAMMATION; INFLAMMATION; MECHANISMS; ETIOLOGY; MPTP	Parkinson's disease (PD) is the second most common neurodegenerative disease. Although its pathogenesis is still unclear, increasing evidence suggests that mitochondrial dysfunction induced by environmental toxins, such as mitochondrial complex I inhibitors, plays a significant role in the disease process. The microglia in PD brains are highly activated, and inflammation is also an essential element in PD pathogenesis. However, the means by which these toxins activate microglia is still unclear. In the present study, we found that rotenone, a mitochondrial complex I inhibitor, could directly activate microglia via the nuclear factor kappa B (NF-kappa B) signaling pathway, thereby inducing significantly increased expression of inflammatory cytokines. We further observed that rotenone induced caspase-1 activation and mature IL-1 beta release, both of which are strictly dependent on p38 mitogen-activated protein kinase (MAPK). The activation of p38 is associated with the presence of reactive oxygen species (ROS) produced by rotenone. Removal of these ROS abrogated the activation of the microglia. Therefore, our data suggest that the environmental toxin rotenone can directly activate microglia through the p38 MAPK pathway.	[Gao, Feng; Wang, Guanghui] Univ Sci & Technol China, Chinese Acad Sci, Lab Mol Neuropathol, Key Lab Brain Funct & Dis, Hefei 230026, Peoples R China; [Gao, Feng; Wang, Guanghui] Univ Sci & Technol China, Chinese Acad Sci, Sch Life Sci, Hefei 230026, Peoples R China; [Chen, Dong; Hu, Qingsong; Wang, Guanghui] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Lab Mol Neuropathol, Suzhou, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Soochow University - China	Gao, F (corresponding author), Univ Sci & Technol China, Chinese Acad Sci, Lab Mol Neuropathol, Key Lab Brain Funct & Dis, Hefei 230026, Peoples R China.	peakg@mail.ustc.edu.cn; wghui@ustc.edu.cn	Wang, Guanghui/U-3979-2017	Wang, Guanghui/0000-0001-8551-6468	National High-tech Research and Development program of China 973-projects [2011CB504102]; National Natural Sciences Foundation of China [91132723]	National High-tech Research and Development program of China 973-projects(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	Funding came from the National High-tech Research and Development program of China 973-projects (2011CB504102) http://www.973.gov.cn/English/Index.aspx and the National Natural Sciences Foundation of China (No. 91132723) http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; England Jr AC, 1998, NEW ENGL J MED, V265, P837; Gao HM, 2003, FASEB J, V17, P1957, DOI 10.1096/fj.03-0203fje; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hu QS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002946; Kuwahara I, 2006, AM J PHYSIOL-LUNG C, V291, pL407, DOI 10.1152/ajplung.00471.2005; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Manthripragada AD, 2011, NEUROEPIDEMIOLOGY, V36, P155, DOI 10.1159/000325653; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Miller RL, 2009, NEUROCHEM RES, V34, P55, DOI 10.1007/s11064-008-9656-2; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Phani Sudarshan, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS207, DOI 10.1016/S1353-8020(11)70064-5; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tian LP, 2012, CURR MOL MED, V12, P1005; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Vroon A, 2007, EXP GERONTOL, V42, P762, DOI 10.1016/j.exger.2007.04.010; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Zhou F, 2007, NEUROPSYCHOPHARMACOL, V32, P2570, DOI 10.1038/sj.npp.1301381	31	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72046	10.1371/journal.pone.0072046	http://dx.doi.org/10.1371/journal.pone.0072046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977201	Green Submitted, gold, Green Published			2022-12-25	WOS:000324527300059
J	Gautam, P; Nair, SC; Ramamoorthy, K; Swamy, CVB; Nagaraj, R				Gautam, Poonam; Nair, Sudha C.; Ramamoorthy, Kalidoss; Swamy, Cherukuvada V. Brahmendra; Nagaraj, Ramakrishnan			Analysis of Human Blood Plasma Proteome from Ten Healthy Volunteers from Indian Population	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; PROTEINS; DISEASE; EXPRESSION; DIVERSITY; BIOMARKER; CELLS	Analysis of any mammalian plasma proteome is a challenge, particularly by mass spectrometry, due to the presence of albumin and other abundant proteins which can mask the detection of low abundant proteins. As detection of human plasma proteins is valuable in diagnostics, exploring various workflows with minimal fractionation prior to mass spectral analysis, is required in order to study population diversity involving analysis in a large cohort of samples. Here, we used 'reference plasma sample', a pool of plasma from 10 healthy individuals from Indian population in the age group of 25-60 yrs including 5 males and 5 females. The 14 abundant proteins were immunodepleted from plasma and then evaluated by three different workflows for proteome analysis using a nanoflow reverse phase liquid chromatography system coupled to a LTQ Orbitrap Velos mass spectrometer. The analysis of reference plasma sample a) without prefractionation, b) after prefractionation at peptide level by strong cation exchange chromatography and c) after prefractionation at protein level by sodium dodecyl sulfate polyacrylamide gel electrophoresis, led to the identification of 194, 251 and 342 proteins respectively. Together, a comprehensive dataset of 517 unique proteins was achieved from all the three workflows, including 271 proteins with high confidence identified by >= 2 unique peptides in any of the workflows or identified by single peptide in any of the two workflows. A total of 70 proteins were common in all the three workflows. Some of the proteins were unique to our study and could be specific to Indian population. The high-confidence dataset obtained from our study may be useful for studying the population diversity, in discovery and validation process for biomarker identification.	[Gautam, Poonam; Nair, Sudha C.; Ramamoorthy, Kalidoss; Swamy, Cherukuvada V. Brahmendra; Nagaraj, Ramakrishnan] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Gautam, P (corresponding author), Indian Council Med Res, Natl Inst Pathol, New Delhi, India.	gautamp@icmr.org.in; nraj@ccmb.res.in			CSIR [NWP04]	CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by CSIR Network Project NWP04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altelaar AFM, 2011, CURR OPIN CHEM BIOL, V16, P1; Anderson NL, 2010, CLIN CHEM, V56, P177, DOI 10.1373/clinchem.2009.126706; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Cabre A, 2007, J INTERN MED, V262, P496, DOI 10.1111/j.1365-2796.2007.01849.x; Chait BT, 2011, ANNU REV BIOCHEM, V80, P239, DOI 10.1146/annurev-biochem-110810-095744; Clinton GM, 1996, P NATL ACAD SCI USA, V93, P316, DOI 10.1073/pnas.93.1.316; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cromwell William C, 2009, Curr Cardiol Rep, V11, P468; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Farrah T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006353; Gibson DS, 2012, J PROTEOMICS, V75, P5479, DOI 10.1016/j.jprot.2012.06.024; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Hortin GL, 2008, CLIN CHEM, V54, P1608, DOI 10.1373/clinchem.2008.108175; Nedelkov D, 2004, ANAL CHEM, V76, P1733, DOI 10.1021/ac035105+; Nedelkov D, 2005, P NATL ACAD SCI USA, V102, P10852, DOI 10.1073/pnas.0500426102; Nedelkov D, 2008, PROTEOMICS, V8, P779, DOI 10.1002/pmic.200700501; Nedelkov D, 2006, MOL CELL PROTEOMICS, V5, P1811, DOI 10.1074/mcp.R600006-MCP200; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Schenk S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-41; Surinova S, 2011, J PROTEOME RES, V10, P5, DOI 10.1021/pr1008515; Takenaka K, 2005, LIFE SCI, V77, P3231, DOI 10.1016/j.lfs.2005.05.048; Walldius G, 2004, J INTERN MED, V255, P188, DOI 10.1046/j.1365-2796.2003.01276.x; Yang XR, 2008, CLIN CANCER RES, V14, P3850, DOI 10.1158/1078-0432.CCR-07-4338	25	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72584	10.1371/journal.pone.0072584	http://dx.doi.org/10.1371/journal.pone.0072584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977322	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300089
J	Nic-Can, GI; Lopez-Torres, A; Barredo-Pool, F; Wrobel, K; Loyola-Vargas, VM; Rojas-Herrera, R; De-la-Pena, C				Nic-Can, Geovanny I.; Lopez-Torres, Adolfo; Barredo-Pool, Felipe; Wrobel, Kazimierz; Loyola-Vargas, Victor M.; Rojas-Herrera, Rafael; De-la-Pena, Clelia			New Insights into Somatic Embryogenesis: LEAFY COTYLEDON1, BABY BOOM1 and WUSCHEL-RELATED HOMEOBOX4 Are Epigenetically Regulated in Coffea canephora	PLOS ONE			English	Article							ARABIDOPSIS LEAFY COTYLEDON1; DNA-METHYLATION; EXPRESSION DYNAMICS; HISTONE METHYLATION; PLANT; GENES; CELLS; TRANSCRIPTION; DIFFERENTIATION; TRIMETHYLATION	Plant cells have the capacity to generate a new plant without egg fertilization by a process known as somatic embryogenesis (SE), in which differentiated somatic cells can form somatic embryos able to generate a functional plant. Although there have been advances in understanding the genetic basis of SE, the epigenetic mechanism that regulates this process is still unknown. Here, we show that the embryogenic development of Coffea canephora proceeds through a crosstalk between DNA methylation and histone modifications during the earliest embryogenic stages of SE. We found that low levels of DNA methylation, histone H3 lysine 9 dimethylation (H3K9me2) and H3K27me3 change according to embryo development. Moreover, the expression of LEAFY COTYLEDON1 (LEC1) and BABY BOOM1 (BBM1) are only observed after SE induction, whereas WUSCHEL-RELATED HOMEOBOX4 (WOX4) decreases its expression during embryo maturation. Using a pharmacological approach, it was found that 5-Azacytidine strongly inhibits the embryogenic response by decreasing both DNA methylation and gene expression of LEC1 and BBM1. Therefore, in order to know whether these genes were epigenetically regulated, we used Chromatin Immunoprecipitation (ChIP) assays. It was found that WOX4 is regulated by the repressive mark H3K9me2, while LEC1 and BBM1 are epigenetically regulated by H3K27me3. We conclude that epigenetic regulation plays an important role during somatic embryogenic development, and a molecular mechanism for SE is proposed.	[Nic-Can, Geovanny I.; Rojas-Herrera, Rafael] Univ Autonoma Yucatan, Merida, Yucatan, Mexico; [Loyola-Vargas, Victor M.] Ctr Invest Cient Yucatan, Unidad Bioquim & Biol Mol Plantas, Merida, Yucatan, Mexico; [Lopez-Torres, Adolfo; Wrobel, Kazimierz] Univ Guanajuato, Fac Quim, Guanajuato, Mexico; [Barredo-Pool, Felipe; De-la-Pena, Clelia] Ctr Invest Cient Yucatan, Unidad Biotecnol, Merida, Yucatan, Mexico	Universidad Autonoma de Yucatan; Centro de Investigacion Cientifica de Yucatan; Universidad de Guanajuato; Centro de Investigacion Cientifica de Yucatan	De-la-Pena, C (corresponding author), Ctr Invest Cient Yucatan, Unidad Biotecnol, Merida, Yucatan, Mexico.	clelia@cicy.mx	Nic-Can, Geovanny/P-9273-2019; Lopez-Torres, Adolfo/ABE-9271-2021; Loyola-Vargas, Victor M/Q-8255-2016; Nic-Can, Geovanny I./C-9300-2016; Rojas Herrera, Rafael Antonio/HHS-2493-2022	Nic-Can, Geovanny/0000-0001-8003-7716; Lopez-Torres, Adolfo/0000-0003-0826-170X; Rojas Herrera, Rafael Antonio/0000-0001-8551-2336; Wrobel, Kazimierz/0000-0003-4357-3178; De-la-Pena, Clelia/0000-0002-9093-9489	L'OREAL-UNESCO-AMC; CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA (CONACYT) [213451, Conacyt 178149, 157014]	L'OREAL-UNESCO-AMC; CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	These studies were supported by L'OREAL-UNESCO-AMC and CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA (CONACYT), grants 213451 to GN, Conacyt 178149 to CD and 157014 to VMLV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Arizaga S, 2002, AM J BOT, V89, P632, DOI 10.3732/ajb.89.4.632; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Borrell B, 2012, NATURE, V483, P264, DOI 10.1038/483264a; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Bouyer D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002014; Bruce TJA, 2007, PLANT SCI, V173, P603, DOI 10.1016/j.plantsci.2007.09.002; Chakrabarty D, 2003, PLANT SCI, V165, P61, DOI 10.1016/S0168-9452(03)00127-4; Costas C, 2011, BBA-GENE REGUL MECH, V1809, P379, DOI 10.1016/j.bbagrm.2011.03.005; De Smet I, 2010, PLANT J, V61, P959, DOI 10.1111/j.1365-313X.2010.04143.x; De-la-Pena C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-203; De-La-Pena C, 2012, MOL PLANT PATHOL, V13, P388, DOI 10.1111/j.1364-3703.2011.00757.x; Ding Y, 2007, PLANT CELL, V19, P9, DOI 10.1105/tpc.106.048124; Echevarria-Machado I, 2005, MOL BIOTECHNOL, V31, P129, DOI 10.1385/MB:31:2:129; Elo A, 2009, SEMIN CELL DEV BIOL, V20, P1097, DOI 10.1016/j.semcdb.2009.09.009; Exner V, 2008, CURR OPIN PLANT BIOL, V11, P64, DOI 10.1016/j.pbi.2007.10.004; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fraga HPF, 2012, PLANT CELL REP, V31, P2165, DOI 10.1007/s00299-012-1327-8; Gambino G, 2011, J EXP BOT, V62, P1089, DOI 10.1093/jxb/erq349; Garcia-Aguilar M, 2010, PLANT CELL, V22, P3249, DOI 10.1105/tpc.109.072181; Grafi G, 2004, DEV BIOL, V268, P1, DOI 10.1016/j.ydbio.2003.12.027; Grafi G, 2007, DEV BIOL, V306, P838, DOI 10.1016/j.ydbio.2007.03.023; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Ji JB, 2010, PLANT PHYSIOL, V152, P1346, DOI 10.1104/pp.109.149641; Junker A, 2012, PLANT J, V71, P427, DOI 10.1111/j.1365-313X.2012.04999.x; Karami Omid, 2009, J Chem Biol, V2, P177, DOI 10.1007/s12154-009-0028-4; Koltunow AM, 2003, ANNU REV PLANT BIOL, V54, P547, DOI 10.1146/annurev.arplant.54.110901.160842; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lafos M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002040; Laux T, 1996, DEVELOPMENT, V122, P87; Lee HS, 2003, P NATL ACAD SCI USA, V100, P2152, DOI 10.1073/pnas.0437909100; Leljak-Levanic D, 2009, PROPAG ORNAM PLANTS, V9, P3; Li W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002243; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; LOSCHIAVO F, 1989, THEOR APPL GENET, V77, P325, DOI 10.1007/BF00305823; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Loyola-Vargas VM., 2008, MOL BIOMETHODS HDB, P875, DOI [10.1007/978-1-60327-375-6_50, DOI 10.1007/978-1-60327-375-6_50, DOI 10.1007/978-1-60327-375-6]; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Malik MR, 2007, PLANT PHYSIOL, V144, P134, DOI 10.1104/pp.106.092932; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Meijon M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-10; Miguel C, 2011, J EXP BOT, V62, P3713, DOI 10.1093/jxb/err155; Mondego JMC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-30; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nic-Can Geovanny I, 2012, Methods Mol Biol, V877, P313, DOI 10.1007/978-1-61779-818-4_24; Noceda C, 2009, TREES-STRUCT FUNCT, V23, P1285, DOI 10.1007/s00468-009-0370-8; Passarinho P, 2008, PLANT MOL BIOL, V68, P225, DOI 10.1007/s11103-008-9364-y; Privat I, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-5; Quiroz-Figueroa Francisco, 2006, Methods Mol Biol, V318, P111; Ricardi MM, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-11; Ruiz-Garcia L, 2005, PLANTA, V222, P301, DOI 10.1007/s00425-005-1524-6; Santos D, 2002, PLANT CELL TISS ORG, V70, P155, DOI 10.1023/A:1016369921067; Schmidt EDL, 1997, DEVELOPMENT, V124, P2049; Srinivasan C, 2007, PLANTA, V225, P341, DOI 10.1007/s00425-006-0358-1; Suer S, 2011, PLANT CELL, V23, P3247, DOI 10.1105/tpc.111.087874; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; TAYLOR RL, 1967, CAN J BOTANY, V45, P1553, DOI 10.1139/b67-159; Tokuji Y, 2011, PLANT CELL TISS ORG, V106, P289, DOI 10.1007/s11240-011-9920-z; van der Graaff E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-248; Viejo M, 2010, SEX PLANT REPROD, V23, P315, DOI 10.1007/s00497-010-0145-9; Vogel G, 2005, SCIENCE, V309, P86, DOI 10.1126/science.309.5731.86; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-165; Weinhofer I, 2012, PLOS GENET, V6; Xiao WY, 2006, PLANT CELL, V18, P805, DOI 10.1105/tpc.105.038836; Xu L, 2008, MOL CELL BIOL, V28, P1348, DOI 10.1128/MCB.01607-07; Xu ML, 2004, THEOR APPL GENET, V109, P899, DOI 10.1007/s00122-004-1717-6; Yamamoto N, 2005, J PLANT PHYSIOL, V162, P47, DOI 10.1016/j.jplph.2004.05.013; Yang XY, 2010, CRIT REV PLANT SCI, V29, P36, DOI 10.1080/07352680903436291; Zeng FC, 2007, GENOMICS, V90, P620, DOI 10.1016/j.ygeno.2007.07.007; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62; ZIMMERMAN JL, 1993, PLANT CELL, V5, P1411, DOI 10.1105/tpc.5.10.1411	75	90	97	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72160	10.1371/journal.pone.0072160	http://dx.doi.org/10.1371/journal.pone.0072160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977240	Green Submitted, gold, Green Published			2022-12-25	WOS:000324527300069
J	Thacker, WC				Thacker, William Carlisle			Can Hydrographic Data Provide Evidence That the Rate of Oceanic Uptake of Anthropogenic CO2 Is Increasing?	PLOS ONE			English	Article								Predictions of the rate of accumulation of anthropogenic carbon dioxide in the Pacific Ocean near 32 degrees S and 150 degrees W based on the P16 surveys of 1991 and 2005 and on the P06 surveys of 1992 and 2003 underestimate the amount found in the P06 survey of 2009-2010, suggesting an increasing uptake rate. Assuming the accumulation rate to be constant over the two decades, analyses using all five surveys lead to upward revision of the rates based only on the first four. On the other hand, accumulation rates estimated for 2003-2010 are significantly greater than those for 1991-2003, again suggesting an increasing uptake rate. In addressing this question it is important to acknowledge the limitations of the repeat hydrography and consequent uncertainties of estimated accumulation rates.	[Thacker, William Carlisle] Univ Miami, Miami, FL USA; [Thacker, William Carlisle] NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA	University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML)	Thacker, WC (corresponding author), Univ Miami, Miami, FL USA.	cthacker@rsmas.miami.edu	Thacker, Carlisle C/I-3813-2013	Thacker, Carlisle C/0000-0002-9285-8826	Physical Oceanography Division of National Oceanic and Atmospheric Administration's Atlantic Oceanographic and Meteorological Laboratory; Office of Naval Research Award [N00014-101-0498]	Physical Oceanography Division of National Oceanic and Atmospheric Administration's Atlantic Oceanographic and Meteorological Laboratory; Office of Naval Research Award(Office of Naval Research)	This work has been supported by the Physical Oceanography Division of National Oceanic and Atmospheric Administration's Atlantic Oceanographic and Meteorological Laboratory and by the Office of Naval Research Award N00014-101-0498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Feely R. A., 2008, ORNLCDIAC155 US DEP, DOI 10.3334/CDIAC/00002; Johnson KM, 2001, ORNLCDIAC132 US DEP; Rubin S, 1998, ORNLCDIAC109 US DEP; Takahashi T, 1995, ORNLCDIAC86 US DEP E; Thacker WC, 2012, MAR CHEM, V132, P44, DOI 10.1016/j.marchem.2012.02.004; Uchida H., 2005, WHP P6 A10 I3 I4 REV; Wanninkhof R, 2010, TECHNICAL REPORT	7	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71920	10.1371/journal.pone.0071920	http://dx.doi.org/10.1371/journal.pone.0071920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977179	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300053
J	Blacklock, K; Verkhivker, GM				Blacklock, Kristin; Verkhivker, Gennady M.			Differential Modulation of Functional Dynamics and Allosteric Interactions in the Hsp90-Cochaperone Complexes with p23 and Aha1: A Computational Study	PLOS ONE			English	Article							HSP90 MOLECULAR CHAPERONE; TRANSFER-RNA SYNTHETASE; ESCHERICHIA-COLI HSP90; N-TERMINAL DOMAIN; CONFORMATIONAL DYNAMICS; ENERGY LANDSCAPES; TYROSINE PHOSPHORYLATION; PROTEIN STRUCTURES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS	Allosteric interactions of the molecular chaperone Hsp90 with a large cohort of cochaperones and client proteins allow for molecular communication and event coupling in signal transduction networks. The integration of cochaperones into the Hsp90 system is driven by the regulatory mechanisms that modulate the progression of the ATPase cycle and control the recruitment of the Hsp90 clientele. In this work, we report the results of computational modeling of allosteric regulation in the Hsp90 complexes with the cochaperones p23 and Aha1. By integrating protein docking, biophysical simulations, modeling of allosteric communications, protein structure network analysis and the energy landscape theory we have investigated dynamics and stability of the Hsp90-p23 and Hsp90-Aha1 interactions in direct comparison with the extensive body of structural and functional experiments. The results have revealed that functional dynamics and allosteric interactions of Hsp90 can be selectively modulated by these cochaperones via specific targeting of the regulatory hinge regions that could restrict collective motions and stabilize specific chaperone conformations. The protein structure network parameters have quantified the effects of cochaperones on conformational stability of the Hsp90 complexes and identified dynamically stable communities of residues that can contribute to the strengthening of allosteric interactions. According to our results, p23-mediated changes in the Hsp90 interactions may provide "molecular brakes'' that could slow down an efficient transmission of the inter-domain allosteric signals, consistent with the functional role of p23 in partially inhibiting the ATPase cycle. Unlike p23, Aha1-mediated acceleration of the Hsp90-ATPase cycle may be achieved via modulation of the equilibrium motions that facilitate allosteric changes favoring a closed dimerized form of Hsp90. The results of our study have shown that Aha1 and p23 can modulate the Hsp90-ATPase activity and direct the chaperone cycle by exerting the precise control over structural stability, global movements and allosteric communications in Hsp90.	[Blacklock, Kristin; Verkhivker, Gennady M.] Chapman Univ, Schmid Coll Sci & Technol, Sch Computat Sci, Orange, CA USA; [Blacklock, Kristin; Verkhivker, Gennady M.] Chapman Univ, Schmid Coll Sci & Technol, Crean Sch Hlth & Life Sci, Orange, CA USA; [Verkhivker, Gennady M.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Chapman University System; Chapman University; Chapman University System; Chapman University; University of California System; University of California San Diego	Verkhivker, GM (corresponding author), Chapman Univ, Schmid Coll Sci & Technol, Sch Computat Sci, Orange, CA USA.	verkhivk@chapman.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471	Chapman University	Chapman University	This work is supported by funding from Chapman University. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 2007, CURR OPIN STRUC BIOL, V17, P633, DOI 10.1016/j.sbi.2007.09.011; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Bhattacharyya M, 2011, BIOCHEMISTRY-US, V50, P6225, DOI 10.1021/bi200306u; Bhattacharyya M, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-27; Bhattacharyya M, 2010, PROTEINS, V78, P506, DOI 10.1002/prot.22573; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Chen B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-156; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Colombo G, 2008, P NATL ACAD SCI USA, V105, P7976, DOI 10.1073/pnas.0802879105; Csermely P, 2012, CURR PROTEIN PEPT SC, V13, P19, DOI 10.2174/138920312799277992; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Csermely P, 2008, TRENDS BIOCHEM SCI, V33, P569, DOI 10.1016/j.tibs.2008.09.006; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Cunningham CN, 2012, PROTEIN SCI, V21, P1162, DOI 10.1002/pro.2103; Daily MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000293; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Didenko T, 2012, BBA-MOL CELL RES, V1823, P636, DOI 10.1016/j.bbamcr.2011.11.009; Dixit A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037605; Dixit A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002179; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Echtenkamp FJ, 2012, BBA-MOL CELL RES, V1823, P668, DOI 10.1016/j.bbamcr.2011.08.011; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104; Ferreiro DU, 2011, P NATL ACAD SCI USA, V108, P3499, DOI 10.1073/pnas.1018980108; Forafonov F, 2008, MOL CELL BIOL, V28, P3446, DOI 10.1128/MCB.02246-07; Gaiser AM, 2010, J BIOL CHEM, V285, P40921, DOI 10.1074/jbc.M110.131086; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Ghosh A, 2008, BIOCHEMISTRY-US, V47, P11398, DOI 10.1021/bi8007559; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P15711, DOI 10.1073/pnas.0704459104; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Graf C, 2009, EMBO J, V28, P602, DOI 10.1038/emboj.2008.306; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Hartson S. D., 2011, BIOCHIM BIOPHYS ACTA, V1823, P656; Haupt A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-38; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8; Hollup SM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-52; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Jackson SE, 2013, TOP CURR CHEM, V328, P155, DOI 10.1007/128_2012_356; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Karagoz GE, 2011, P NATL ACAD SCI USA, V108, P580, DOI 10.1073/pnas.1011867108; Keskin O, 2000, BIOPHYS J, V78, P2093, DOI 10.1016/S0006-3495(00)76756-7; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Lee CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019961; Lee CT, 2012, EMBO J, V31, P1518, DOI 10.1038/emboj.2012.37; Li J, 2013, NAT STRUCT MOL BIOL, V20, P326, DOI 10.1038/nsmb.2502; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li WF, 2011, P NATL ACAD SCI USA, V108, P3504, DOI 10.1073/pnas.1018983108; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Luccioli S, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046008; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makhnevych T, 2012, BBA-MOL CELL RES, V1823, P674, DOI 10.1016/j.bbamcr.2011.09.001; Mandel AK, 2011, METHODS MOL BIOL, V787, P75, DOI 10.1007/978-1-61779-295-3_6; Martinez-Yamout MA, 2006, J BIOL CHEM, V281, P14457, DOI 10.1074/jbc.M601759200; Matts RL, 2011, ACS CHEM BIOL, V6, P800, DOI 10.1021/cb200052x; Matts RL, 2011, BIOORGAN MED CHEM, V19, P684, DOI 10.1016/j.bmc.2010.10.029; Mayer MP, 2002, MOL CELL, V10, P1255, DOI 10.1016/S1097-2765(02)00793-1; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; Meyer P, 2004, EMBO J, V23, P1402, DOI 10.1038/sj.emboj.7600141; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Millson SH, 2004, CELL STRESS CHAPERON, V9, P359, DOI 10.1379/CSC-29R1.1; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Mollapour M, 2011, MOL CELL, V41, P672, DOI 10.1016/j.molcel.2011.02.011; Mollapour M, 2010, MOL CELL, V37, P333, DOI 10.1016/j.molcel.2010.01.005; Morishima Y, 2003, J BIOL CHEM, V278, P48754, DOI 10.1074/jbc.M309814200; Morra G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002433; Morra G, 2010, J CHEM THEORY COMPUT, V6, P2978, DOI 10.1021/ct100334n; Morra G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000323; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Okazaki K, 2006, P NATL ACAD SCI USA, V103, P11844, DOI 10.1073/pnas.0604375103; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piazza F, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026001; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rader AJ, 2011, MOL BIOSYST, V7, P464, DOI 10.1039/c0mb00054j; Ratzke C, 2010, P NATL ACAD SCI USA, V107, P16101, DOI 10.1073/pnas.1000916107; Ratzke C, 2012, J MOL BIOL, V423, P462, DOI 10.1016/j.jmb.2012.07.026; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Retzlaff M, 2009, EMBO REP, V10, P1147, DOI 10.1038/embor.2009.153; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2003, J BIOL CHEM, V278, P10328, DOI 10.1074/jbc.M213094200; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Rohl A, 2013, TRENDS BIOCHEM SCI, V38, P253, DOI 10.1016/j.tibs.2013.02.003; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Seifert C, 2012, BIOPHYS J, V103, P2195, DOI 10.1016/j.bpj.2012.09.008; Sharma K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014654; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Soroka J, 2012, MOL CELL, V45, P517, DOI 10.1016/j.molcel.2011.12.031; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Street TO, 2012, J MOL BIOL, V415, P3, DOI 10.1016/j.jmb.2011.10.038; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; Sukhwal A, 2011, ACTA CRYSTALLOGR D, V67, P429, DOI 10.1107/S0907444911007062; Sun L, 2012, BBA-MOL CELL RES, V1823, P1092, DOI 10.1016/j.bbamcr.2012.03.014; Sutto L, 2007, P NATL ACAD SCI USA, V104, P19825, DOI 10.1073/pnas.0709922104; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Theodoraki MA, 2012, BBA-MOL CELL RES, V1823, P683, DOI 10.1016/j.bbamcr.2011.08.006; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Tsaytler PA, 2009, CELL STRESS CHAPERON, V14, P629, DOI 10.1007/s12192-009-0115-z; van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Verkhivker GM, 2009, CURR TOP MED CHEM, V9, P1369, DOI 10.2174/156802609789895700; Vijayabaskar MS, 2010, BIOPHYS J, V99, P3704, DOI 10.1016/j.bpj.2010.08.079; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966; Xu WP, 2012, MOL CELL, V47, P434, DOI 10.1016/j.molcel.2012.05.015; Yang LW, 2006, NUCLEIC ACIDS RES, V34, pW24, DOI 10.1093/nar/gkl084; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhang MH, 2008, EMBO J, V27, P2789, DOI 10.1038/emboj.2008.190; Zhang MH, 2010, MOL CELL, V39, P269, DOI 10.1016/j.molcel.2010.05.010; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2007, ADV EXP MED BIOL, V594, P27; Zhuravlev PI, 2010, Q REV BIOPHYS, V43, P295, DOI 10.1017/S0033583510000119; Zurawska A, 2010, BBA-MOL CELL RES, V1803, P575, DOI 10.1016/j.bbamcr.2010.03.002	142	34	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71936	10.1371/journal.pone.0071936	http://dx.doi.org/10.1371/journal.pone.0071936			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977182	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700115
J	Cabalzar, K; Pelzer, C; Wolf, A; Lenz, G; Iwaszkiewicz, J; Zoete, V; Hailfinger, S; Thome, M				Cabalzar, Katrin; Pelzer, Christiane; Wolf, Annette; Lenz, Georg; Iwaszkiewicz, Justyna; Zoete, Vincent; Hailfinger, Stephan; Thome, Margot			Monoubiquitination and Activity of the Paracaspase MALT1 Requires Glutamate 549 in the Dimerization Interface	PLOS ONE			English	Article							NF-KAPPA-B; MULTIORGAN INFLAMMATION; PROTEASE ACTIVITY; IN-VITRO; LYMPHOMA; RELB; ACTIVATION; BCL10; CLEAVAGE; TARGETS	The mucosa-associated lymphoid tissue protein-1 (MALT1, also known as paracaspase) is a protease whose activity is essential for the activation of lymphocytes and the growth of cells derived from human diffuse large B-cell lymphomas of the activated B-cell subtype (ABC DLBCL). Crystallographic approaches have shown that MALT1 can form dimers via its protease domain, but why dimerization is relevant for the biological activity of MALT1 remains largely unknown. Using a molecular modeling approach, we predicted Glu 549 (E549) to be localized within the MALT1 dimer interface and thus potentially relevant. Experimental mutation of this residue into alanine (E549A) led to a complete impairment of MALT1 proteolytic activity. This correlated with an impaired capacity of the mutant to form dimers of the protease domain in vitro, and a reduced capacity to promote NF-kappa B activation and transcription of the growth-promoting cytokine interleukin-2 in antigen receptor-stimulated lymphocytes. Moreover, this mutant could not rescue the growth of ABC DLBCL cell lines upon MALT1 silencing. Interestingly, the MALT1 mutant E549A was unable to undergo monoubiquitination, which we identified previously as a critical step in MALT1 activation. Collectively, these findings suggest a model in which E549 at the dimerization interface is required for the formation of the enzymatically active, monoubiquitinated form of MALT1.	[Cabalzar, Katrin; Pelzer, Christiane; Hailfinger, Stephan; Thome, Margot] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Wolf, Annette; Lenz, Georg] Charite Univ Med Berlin, Mol Canc Res Ctr, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany; [Iwaszkiewicz, Justyna; Zoete, Vincent] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Lausanne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Swiss Institute of Bioinformatics	Thome, M (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	Margot.ThomeMiazza@unil.ch	Lenz, Georg/I-6844-2012; Thome, Margot/F-8167-2011	Thome, Margot/0000-0002-5656-2139; Iwaszkiewicz, Justyna/0000-0003-3494-589X	Swiss National Science Foundation; Swiss Cancer League; foundations Pierre Mercier and Emma Muschamp; German Research Foundation; Deutsche Krebshilfe; Boehringer Ingelheim Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; foundations Pierre Mercier and Emma Muschamp; German Research Foundation(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Boehringer Ingelheim Foundation(Boehringer Ingelheim)	This work was supported by grants from the Swiss National Science Foundation (M.T.), the Swiss Cancer League (M.T.), the foundations Pierre Mercier and Emma Muschamp (M.T.), the German Research Foundation (G.L.) and the Deutsche Krebshilfe (G.L.). K.C. was supported by a PhD fellowship from the Boehringer Ingelheim Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chao Y, 2005, PLOS BIOL, V3, P1079, DOI 10.1371/journal.pbio.0030183; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Ferch U, 2009, J EXP MED, V206, P2313, DOI 10.1084/jem.20091167; Fontan L, 2012, CANCER CELL, V22, P812, DOI 10.1016/j.ccr.2012.11.003; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Hachmann J, 2012, BIOCHEM J, V443, P287, DOI 10.1042/BJ20120035; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Hailfinger S, 2009, P NATL ACAD SCI USA, V106, P19946, DOI 10.1073/pnas.0907511106; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Keller N, 2009, STRUCTURE, V17, P438, DOI 10.1016/j.str.2008.12.019; Lenz G, 2008, SCIENCE; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Marienfeld R, 2001, ONCOGENE, V20, P8142, DOI 10.1038/sj.onc.1204884; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; McAllister-Lucas LM, 2011, CLIN CANCER RES, V17, P6623, DOI 10.1158/1078-0432.CCR-11-0467; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Nagel D, 2012, CANCER CELL, V22, P825, DOI 10.1016/j.ccr.2012.11.002; Neal JW, 2002, J BIOL CHEM, V277, P49776, DOI 10.1074/jbc.M207913200; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Pelzer C, 2013, NAT IMMUNOL, V14, P337, DOI 10.1038/ni.2540; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Roschitzki-Voser H, 2012, PROTEIN EXPRES PURIF, V84, P236, DOI 10.1016/j.pep.2012.05.009; Rosebeck S, 2011, CELL CYCLE, V10, P2485, DOI 10.4161/cc.10.15.16923; Rosebeck S, 2011, SCIENCE, V331, P468, DOI 10.1126/science.1198946; Rueda D, 2007, J IMMUNOL, V178, P4373, DOI 10.4049/jimmunol.178.7.4373; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Snipas SJ, 2004, BIOL CHEM, V385, P1093, DOI 10.1515/BC.2004.142; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Thome M, 2008, NAT REV IMMUNOL, V8, P495, DOI 10.1038/nri2338; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weih F, 1996, J IMMUNOL, V157, P3974; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wiesmann C, 2012, J MOL BIOL, V419, P4, DOI 10.1016/j.jmb.2012.02.018; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105; Yu JW, 2011, P NATL ACAD SCI USA, V108, P21004, DOI 10.1073/pnas.1111708108	53	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72051	10.1371/journal.pone.0072051	http://dx.doi.org/10.1371/journal.pone.0072051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977204	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700127
J	Parise, E; Csibra, G				Parise, Eugenio; Csibra, Gergely			Neural Responses to Multimodal Ostensive Signals in 5-Month-Old Infants	PLOS ONE			English	Article							DIRECTED SPEECH; SOCIAL-INTERACTION; RECOGNITION MEMORY; BRAIN; GAZE; COMMUNICATION; PERCEPTION; INTENTION; MOTHERESE; BIRTH	Infants' sensitivity to ostensive signals, such as direct eye contact and infant-directed speech, is well documented in the literature. We investigated how infants interpret such signals by assessing common processing mechanisms devoted to them and by measuring neural responses to their compounds. In Experiment 1, we found that ostensive signals from different modalities display overlapping electrophysiological activity in 5-month-old infants, suggesting that these signals share neural processing mechanisms independently of their modality. In Experiment 2, we found that the activation to ostensive signals from different modalities is not additive to each other, but rather reflects the presence of ostension in either stimulus stream. These data support the thesis that ostensive signals obligatorily indicate to young infants that communication is directed to them.	[Parise, Eugenio; Csibra, Gergely] Cent European Univ, Cognit Dev Ctr, Budapest, Hungary	Central European University	Parise, E (corresponding author), Cent European Univ, Cognit Dev Ctr, Budapest, Hungary.	eugenioparise@tiscali.it	Parise, Eugenio/ABD-9940-2021; Parise, Eugenio/ABC-3974-2021; Csibra, Gergely/C-4345-2008	Parise, Eugenio/0000-0003-4836-6370; Parise, Eugenio/0000-0003-4836-6370; Csibra, Gergely/0000-0002-7044-3056	European Research Council Advanced Investigator Grant [249519]	European Research Council Advanced Investigator Grant(European Research Council (ERC))	This work was supported by a European Research Council Advanced Investigator Grant (no. 249519, OSTREFCOM) to Gergely Csibra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigelow AE, 1998, INFANT BEHAV DEV, V21, P149, DOI 10.1016/S0163-6383(98)90060-1; COLOMBO J, 1995, MERRILL PALMER QUART, V41, P104; COOPER RP, 1990, CHILD DEV, V61, P1584, DOI 10.2307/1130766; Csibra G, 2000, SCIENCE, V290, P1582, DOI 10.1126/science.290.5496.1582; Deligianni F, 2011, DEV PSYCHOL, V47, P1499, DOI 10.1037/a0025659; Enrici I, 2011, J COGNITIVE NEUROSCI, V23, P2415, DOI 10.1162/jocn.2010.21594; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; FERNALD A, 1985, INFANT BEHAV DEV, V8, P181, DOI 10.1016/S0163-6383(85)80005-9; Gergely C, 2010, MIND LANG, V25, P141; Grossmann T, 2008, P ROY SOC B-BIOL SCI, V275, P2803, DOI 10.1098/rspb.2008.0986; Grossmann T, 2007, SOC COGN AFFECT NEUR, V2, P284, DOI 10.1093/scan/nsm025; Grossmann T, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00201; Halit H, 2004, J CHILD PSYCHOL PSYC, V45, P1228, DOI 10.1111/j.1469-7610.2004.00321.x; Kampe KKW, 2003, J NEUROSCI, V23, P5258; MANDEL DR, 1995, PSYCHOL SCI, V6, P314, DOI 10.1111/j.1467-9280.1995.tb00517.x; Naoi N, 2012, NEUROIMAGE, V59, P1735, DOI 10.1016/j.neuroimage.2011.07.093; PAPOUSEK M, 1990, INFANT BEHAV DEV, V13, P539, DOI 10.1016/0163-6383(90)90022-Z; Parise E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014208; Pascalis O, 1998, J EXP PSYCHOL LEARN, V24, P249, DOI 10.1037/0278-7393.24.1.249; Reynolds GD, 2005, DEV PSYCHOL, V41, P598, DOI 10.1037/0012-1649.41.4.598; Saito Y, 2007, ARCH DIS CHILD-FETAL, V92, pF113, DOI 10.1136/adc.2006.097949; Saito Y, 2007, EARLY HUM DEV, V83, P225, DOI 10.1016/j.earlhumdev.2006.05.017; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Senju A, 2008, CURR BIOL, V18, P668, DOI 10.1016/j.cub.2008.03.059; Stoyanova RS, 2010, PSYCHOL SCI, V21, P1765, DOI 10.1177/0956797610388812; Tallon-Baudry C, 1999, CLIN NEUROPHYSIOL, V110, P660, DOI 10.1016/S1388-2457(98)00008-X; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838; Webb SJ, 2005, DEVELOPMENTAL SCI, V8, P605, DOI 10.1111/j.1467-7687.2005.00452.x; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; Zangl R, 2007, INFANCY, V11, P31, DOI 10.1207/s15327078in1101_2	30	40	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72360	10.1371/journal.pone.0072360	http://dx.doi.org/10.1371/journal.pone.0072360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	205ER	23977289	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000323425700166
J	Subramanian, V; Moorleghen, JJ; Balakrishnan, A; Howatt, DA; Chishti, AH; Uchida, HA				Subramanian, Venkateswaran; Moorleghen, Jessica J.; Balakrishnan, Anju; Howatt, Deborah A.; Chishti, Athar H.; Uchida, Haruhito A.			Calpain-2 Compensation Promotes Angiotensin II-Induced Ascending and Abdominal Aortic Aneurysms in Calpain-1 Deficient Mice	PLOS ONE			English	Article							ATHEROSCLEROTIC LESIONS; SYSTEM; HYPERTENSION; CALPASTATIN; INFUSION; INHIBITION; RECEPTOR; REVEALS; SMOKING; PROTEIN	Background and Objective: Recently, we demonstrated that angiotensin II (AngII)-infusion profoundly increased both aortic protein and activity of calpains, calcium-activated cysteine proteases, in mice. In addition, pharmacological inhibition of calpain attenuated AngII-induced abdominal aortic aneurysm (AA) in mice. Recent studies have shown that AngII infusion into mice leads to aneurysmal formation localized to the ascending aorta. However, the precise functional contribution of calpain isoforms (-1 or -2) in AngII-induced abdominal AA formation is not known. Similarly, a functional role of calpain in AngII-induced ascending AA remains to be defined. Using BDA-410, an inhibitor of calpains, and calpain-1 genetic deficient mice, we examined the relative contribution of calpain isoforms in AngII-induced ascending and abdominal AA development. Methodology/Results: To investigate the relative contribution of calpain-1 and -2 in development of AngII-induced AAs, male LDLr -/- mice that were either calpain-1 +/+ or -/- were fed a saturated fat-enriched diet and infused with AngII (1,000 ng/kg/min) for 4 weeks. Calpain-1 deficiency had no significant effect on body weight or blood pressure during AngII infusion. Moreover, calpain-1 deficiency showed no discernible effects on AngII-induced ascending and abdominal AAs. Interestingly, AngII infusion induced increased expression of calpain-2 protein, thus compensating for total calpain activity in aortas of calpain-1 deficient mice. Oral administration of BDA-410, a calpain inhibitor, along with AngII-infusion significantly attenuated AngII-induced ascending and abdominal AA formation in both calpain-1 +/+ and -/- mice as compared to vehicle administered mice. Furthermore, BDA-410 administration attenuated AngII-induced aortic medial hypertrophy and macrophage accumulation. Western blot and immunostaining analyses revealed BDA-410 administration attenuated AngII-induced C-terminal fragmentation of filamin A, an actin binding cytoskeletal protein in aorta. Conclusion: Calpain-2 compensates for loss of calpain-1, and both calpain isoforms are involved in AngII-induced aortic aneurysm formation in mice.	[Subramanian, Venkateswaran; Moorleghen, Jessica J.; Balakrishnan, Anju; Howatt, Deborah A.] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Chishti, Athar H.] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Sackler Sch Program Physiol, Boston, MA 02111 USA; [Chishti, Athar H.] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Sackler Sch Program Pharmacol, Boston, MA 02111 USA; [Chishti, Athar H.] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Sackler Sch Program Microbiol, Boston, MA 02111 USA; [Uchida, Haruhito A.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008530, Japan	University of Kentucky; Tufts University; Tufts University; Tufts University; Okayama University	Subramanian, V (corresponding author), Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA.	venkat.subramanian@uky.edu		Subramanian, Venkateswaran/0000-0002-1183-7717	National Institutes of Health (NIH) [HL80100, HL89517]; American Heart Association [13BGIA14560001]; NIH COBRE (Centres of Scientific Research Excellence) on obesity and cardiovascular disease [P20RR021954]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080100, R01HL089517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH COBRE (Centres of Scientific Research Excellence) on obesity and cardiovascular disease; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by the National Institutes of Health (NIH) HL80100, HL89517, a Beginning Grant-in Aid from American Heart Association (13BGIA14560001 to VS) and a pilot project grant (to VS) from NIH COBRE (Centres of Scientific Research Excellence) on obesity and cardiovascular disease (P20RR021954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Barisione C, 2006, J VASC SURG, V44, P372, DOI 10.1016/j.jvs.2006.04.047; Cassis LA, 2007, ARTERIOSCL THROM VAS, V27, P380, DOI 10.1161/01.ATV.0000254680.71485.92; Cassis LA, 2009, AM J PHYSIOL-HEART C, V296, pH1660, DOI 10.1152/ajpheart.00028.2009; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2005, METHODS, V36, P129, DOI 10.1016/j.ymeth.2004.11.008; Daugherty A, 2004, CIRCULATION, V110, P3849, DOI 10.1161/01.CIR.0000150540.54220.C4; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Daugherty A., 2009, JOVE, P2, DOI [10.3791/1291, DOI 10.3791/1291]; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guo DC, 2006, ANN NY ACAD SCI, V1085, P339, DOI 10.1196/annals.1383.013; Isselbacher EM, 2005, CIRCULATION, V111, P816, DOI 10.1161/01.CIR.0000154569.08857.7A; JEREMY RW, 1994, AM J CARDIOL, V74, P369, DOI 10.1016/0002-9149(94)90405-7; Kim D, 2010, 8 INT RES S MARF SYN; Kuchay SM, 2007, MOL CELL BIOL, V27, P6038, DOI 10.1128/MCB.00522-07; Letavernier E, 2008, CIRC RES, V102, P720, DOI 10.1161/CIRCRESAHA.107.160077; Li XR, 2007, MOL BIOCHEM PARASIT, V155, P26, DOI 10.1016/j.molbiopara.2007.05.004; Lofvenberg L, 1999, FEBS LETT, V443, P89, DOI 10.1016/S0014-5793(98)01697-4; Lu Hong, 2007, V139, P77; MURACHI T, 1989, BIOCHEM INT, V18, P263; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Pilop C, 2009, CIRCULATION, V120, P983, DOI 10.1161/CIRCULATIONAHA.108.843516; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Sato K, 2011, J NEUROCHEM, V117, P504, DOI 10.1111/j.1471-4159.2011.07222.x; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Subramanian V, 2012, J CARDIOVASC PHARM, V59, P66, DOI 10.1097/FJC.0b013e318235d5ea; Takano J, 2011, MOL CELL BIOL, V31, P4097, DOI 10.1128/MCB.05189-11; Tedesco MM, 2009, ARTERIOSCL THROM VAS, V29, P1452, DOI 10.1161/ATVBAHA.109.187757; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; Vardulaki KA, 2000, BRIT J SURG, V87, P195, DOI 10.1046/j.1365-2168.2000.01353.x; Wong DR, 2007, AM J EPIDEMIOL, V165, P838, DOI 10.1093/aje/kwk063	36	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72214	10.1371/journal.pone.0072214	http://dx.doi.org/10.1371/journal.pone.0072214			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977256	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700149
J	Liu, J; Copland, DA; Horie, S; Wu, WK; Chen, M; Xu, YH; Morgan, BP; Mack, M; Xu, HP; Nicholson, LB; Dick, AD				Liu, Jian; Copland, David A.; Horie, Shintaro; Wu, Wei-Kang; Chen, Mei; Xu, Yunhe; Morgan, B. Paul; Mack, Matthias; Xu, Heping; Nicholson, Lindsay B.; Dick, Andrew D.			Myeloid Cells Expressing VEGF and Arginase-1 Following Uptake of Damaged Retinal Pigment Epithelium Suggests Potential Mechanism That Drives the Onset of Choroidal Angiogenesis in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COMPLEMENT FACTOR B; MACULAR DEGENERATION; FRACTALKINE RECEPTOR; OXIDATIVE STRESS; BRUCHS MEMBRANE; MACROPHAGES; ACTIVATION; INFLAMMATION; NEOVASCULARIZATION	Whilst data recognise both myeloid cell accumulation during choroidal neovascularisation (CNV) as well as complement activation, none of the data has presented a clear explanation for the angiogenic drive that promotes pathological angiogenesis. One possibility that is a pre-eminent drive is a specific and early conditioning and activation of the myeloid cell infiltrate. Using a laser-induced CNV murine model, we have identified that disruption of retinal pigment epithelium (RPE) and Bruch's membrane resulted in an early recruitment of macrophages derived from monocytes and microglia, prior to angiogenesis and contemporaneous with lesional complement activation. Early recruited CD11b(+) cells expressed a definitive gene signature of selective inflammatory mediators particularly a pronounced Arg-1 expression. Accumulating macrophages from retina and peripheral blood were activated at the site of injury, displaying enhanced VEGF expression, and notably prior to exaggerated VEGF expression from RPE, or earliest stages of angiogenesis. All of these initial events, including distinct VEGF (+) Arg-1(+) myeloid cells, subsided when CNV was established and at the time RPE-VEGF expression was maximal. Depletion of inflammatory CCR2-positive monocytes confirmed origin of infiltrating monocyte Arg-1 expression, as following depletion Arg-1 signal was lost and CNV suppressed. Furthermore, our in vitro data supported a myeloid cell uptake of damaged RPE or its derivatives as a mechanism generating VEGF (+) Arg-1(+) phenotype in vivo. Our results reveal a potential early driver initiating angiogenesis via myeloid-derived VEGF drive following uptake of damaged RPE and deliver an explanation of why CNV develops during any of the stages of macular degeneration and can be explored further for therapeutic gain.	[Liu, Jian; Copland, David A.; Horie, Shintaro; Wu, Wei-Kang; Xu, Yunhe; Nicholson, Lindsay B.; Dick, Andrew D.] Univ Bristol, Sch Clin Sci, Unit Ophthalmol, Bristol, Avon, England; [Chen, Mei; Xu, Heping] Queens Univ Belfast, Ctr Vis & Vasc Sci, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Morgan, B. Paul] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Mack, Matthias] Univ Hosp, Dept Internal Med 2, Regensburg, Germany; [Nicholson, Lindsay B.; Dick, Andrew D.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England	University of Bristol; Queens University Belfast; Cardiff University; University of Regensburg; University of Bristol	Dick, AD (corresponding author), Univ Bristol, Sch Clin Sci, Unit Ophthalmol, Bristol, Avon, England.	a.dick@bristol.ac.uk	Xu, Heping/A-4430-2008; Copland, David/AAE-5334-2020; Copland, David/AAG-2368-2019	Xu, Heping/0000-0003-4000-931X; Copland, David/0000-0002-2257-4270; Dick, Andrew/0000-0002-0742-3159	Dunhill Medical Trust (UK)	Dunhill Medical Trust (UK)(Dunhill Medical Trust)	Supported by Dunhill Medical Trust (UK). http://www.dunhillmedical.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrashev RI, 2008, CAN J MICROBIOL, V54, P977, DOI 10.1139/W08-091; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; Brouckaert G, 2004, MOL BIOL CELL, V15, P1089, DOI 10.1091/mbc.E03-09-0668; Bruhl H, 2007, ARTHRITIS RHEUM, V56, P2975, DOI 10.1002/art.22854; Caldwell RB, 2010, BRAIN RES BULL, V81, P303, DOI 10.1016/j.brainresbull.2009.08.025; Camelo S, 2012, ANGIOGENESIS, V15, P609, DOI 10.1007/s10456-012-9290-0; Campos M, 2006, INVEST OPHTH VIS SCI, V47, P5163, DOI 10.1167/iovs.06-0156; Cao XG, 2011, PATHOL INT, V61, P528, DOI 10.1111/j.1440-1827.2011.02695.x; Chen M, 2008, INVEST OPHTH VIS SCI, V49, P3699, DOI 10.1167/iovs.07-1522; Chen M, 2012, AM J PATHOL, V180, P235, DOI 10.1016/j.ajpath.2011.09.020; Chen M, 2008, EXP EYE RES, V87, P543, DOI 10.1016/j.exer.2008.09.005; Cherepanoff S, 2010, BRIT J OPHTHALMOL, V94, P918, DOI 10.1136/bjo.2009.165563; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Copland DA, 2007, AM J PATHOL, V171, P580, DOI 10.2353/ajpath.2007.070272; Cruz-Guilloty F, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/503725; Csaky KG, 2004, EXP EYE RES, V78, P1107, DOI 10.1016/j.exer.2004.01.010; Dick AD, 2012, OPHTHALMIC RES, V48, P43, DOI 10.1159/000335982; Dou Y, 2012, CELL RES, V22, P1022, DOI 10.1038/cr.2012.10; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Ebrahimi KB, 2011, J LIPIDS, V2011, DOI 10.1155/2011/802059; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Forrester JV, 2010, IMMUNOL REV, V234, P282, DOI 10.1111/j.0105-2896.2009.00873.x; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; He LZ, 2013, AM J PATHOL, V182, P2407, DOI 10.1016/j.ajpath.2013.02.032; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Ishibashi T, 1997, GRAEF ARCH CLIN EXP, V235, P159, DOI 10.1007/BF00941723; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jonas JB, 2010, ARCH OPHTHALMOL-CHIC, V128, P1281, DOI 10.1001/archophthalmol.2010.227; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kent D, 2003, MOL VIS, V9, P747; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Khera TK, 2010, FEBS J, V277, P2754, DOI 10.1111/j.1742-4658.2010.07692.x; Kinnunen K, 2012, ACTA OPHTHALMOL, V90, P299, DOI 10.1111/j.1755-3768.2011.02179.x; Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X; Liu J, 2011, J BIOL CHEM, V286, P20991, DOI 10.1074/jbc.M111.226266; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Medina RJ, 2011, MOL MED, V17, P1045, DOI 10.2119/molmed.2011.00129; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mellen MA, 2008, CELL DEATH DIFFER, V15, P1279, DOI 10.1038/cdd.2008.40; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nicholson E, 2009, J NEUROIMMUNOL, V215, P25, DOI 10.1016/j.jneuroim.2009.07.009; Oh H, 1999, INVEST OPHTH VIS SCI, V40, P1891; Ohnaka M, 2011, INVEST OPHTH VIS SCI, V52, P1493, DOI 10.1167/iovs.10-5516; Ohsawa K, 2000, J CELL SCI, V113, P3073; Petrovski G, 2011, AUTOPHAGY, V7, P321, DOI 10.4161/auto.7.3.14583; Ramos MA, 1998, ARTERIOSCL THROM VAS, V18, P1188, DOI 10.1161/01.ATV.18.7.1188; Reich B, 2013, KIDNEY INT; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Sene A, 2013, CELL METAB, V17, P549, DOI 10.1016/j.cmet.2013.03.009; Skeie JM, 2009, EYE, V23, P747, DOI 10.1038/eye.2008.206; Suzuki M, 2012, J CELL SCI, V125, P2407, DOI 10.1242/jcs.097683; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; van Hecke MV, 2005, DIABETOLOGIA, V48, P1300, DOI 10.1007/s00125-005-1799-y; Wang JY, 2009, J CELL PHYSIOL, V220, P119, DOI 10.1002/jcp.21742; Whitcup SM, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/348092; Wu WK, 2010, IMMUNOBIOLOGY, V215, P796, DOI 10.1016/j.imbio.2010.05.025; Xie P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028933; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001	68	39	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72935	10.1371/journal.pone.0072935	http://dx.doi.org/10.1371/journal.pone.0072935			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977372	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000323570200092
J	Tibaldi, L; Leyman, S; Nicolas, A; Notebaert, S; Dewulf, M; Ngo, TH; Zuany-Amorim, C; Amzallag, N; Bernard-Pierrot, I; Sastre-Garau, X; Thery, C				Tibaldi, Lorenzo; Leyman, Shirley; Nicolas, Andre; Notebaert, Sofie; Dewulf, Melissa; Thu Hoa Ngo; Zuany-Amorim, Claudia; Amzallag, Nathalie; Bernard-Pierrot, Isabelle; Sastre-Garau, Xavier; Thery, Clotilde			New Blocking Antibodies Impede Adhesion, Migration and Survival of Ovarian Cancer Cells, Highlighting MFGE8 as a Potential Therapeutic Target of Human Ovarian Carcinoma	PLOS ONE			English	Article							HUMAN-BREAST-TUMORS; MONOCLONAL-ANTIBODIES; APOPTOTIC CELLS; GROWTH; PROTEIN; MFG-E8/LACTADHERIN; IDENTIFICATION; ANTIGENS; LINKS	Milk Fat Globule -EGF -factor VIII (MFGE8), also called lactadherin, is a secreted protein, which binds extracellularly to phosphatidylserine and to alpha v beta 3 and alpha v beta 5 integrins. On human and mouse cells expressing these integrins, such as endothelial cells, phagocytes and some tumors, MFGE8/lactadherin has been shown to promote survival, epithelial to mesenchymal transition and phagocytosis. A protumoral function of MFGE8 has consequently been documented for a few types of human cancers, including melanoma, a subtype of breast cancers, and bladder carcinoma. Inhibiting the functions of MFGE8 could thus represent a new type of therapy for human cancers. Here, we show by immunohistochemistry on a collection of human ovarian cancers that MFGE8 is overexpressed in 45% of these tumors, and we confirm that it is specifically overexpressed in the triple-negative subtype of human breast cancers. We have established new in vitro assays to measure the effect of MFGE8 on survival, adhesion and migration of human ovarian and triple-negative breast cancer cell lines. Using these assays, we could identify new MFGE8-specific monoclonal antibodies, which efficiently blocked these three tumor-promoting effects of MFGE8. Our results suggest future use of MFGE8-blocking antibodies as new anti-cancer therapeutics in subgroups of ovarian carcinoma, and triple-negative breast carcinoma patients.	[Tibaldi, Lorenzo; Dewulf, Melissa; Amzallag, Nathalie; Bernard-Pierrot, Isabelle; Thery, Clotilde] Inst Curie, Ctr Rech, Paris, France; [Tibaldi, Lorenzo; Dewulf, Melissa; Amzallag, Nathalie; Thery, Clotilde] INSERM, U932, Paris, France; [Leyman, Shirley; Notebaert, Sofie; Thu Hoa Ngo; Zuany-Amorim, Claudia] ThromboGenics NV, Heverlee, Belgium; [Nicolas, Andre; Sastre-Garau, Xavier] Inst Curie, Dept Tumor Biol, Paris, France; [Bernard-Pierrot, Isabelle] CNRS, UMR144, Paris, France; [Thery, Clotilde] CBT 507 IGR Curie, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Thery, C (corresponding author), INSERM, U932, Paris, France.	clotilde.thery@curie.fr	thery, clotilde/F-6373-2013	thery, clotilde/0000-0001-8294-6884; Sastre-Garau, Xavier/0000-0001-5992-2083	Institut Curie; INSERM; Association pour La Recherche contre le Cancer	Institut Curie; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour La Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by Institut Curie, INSERM, Association pour La Recherche contre le Cancer, a prize from Fondation de France, and a two-years collaboration contract between Institut Curie, INSERM, and ThromboGenics NV, Leuven, Belgium (www.thrombogenics.com). ThromboGenics NV outlined the strategy for antibody generation, performed the mice immunization, checked the specificity of the new anti-human MFGE8 antibodies, sequenced their variable regions, and participated in the design of the tests for selection of the lead candidate antibodies.	Bu HF, 2007, J CLIN INVEST, V117, P3673, DOI 10.1172/JCI31841; Carrascosa C, 2012, ONCOGENE, V31, P1521, DOI 10.1038/onc.2011.356; CERIANI RL, 1988, CANCER RES, V48, P4664; CERIANI RL, 1982, P NATL ACAD SCI-BIOL, V79, P5420, DOI 10.1073/pnas.79.17.5420; CERIANI RL, 1987, CANCER RES, V47, P532; COUTO JR, 1995, CANCER RES, V55, P1717; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Fens MHAM, 2008, BLOOD, V111, P4542, DOI 10.1182/blood-2007-06-094763; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; IMAI S, 1990, ONCOLOGY, V47, P177; Jinushi M, 2008, CANCER RES, V68, P8889, DOI 10.1158/0008-5472.CAN-08-2147; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108; Jinushi M, 2009, J EXP MED, V206, P1317, DOI 10.1084/jem.20082614; LAROCCA D, 1991, CANCER RES, V51, P4994; PETERSON JA, 1995, CANCER RES, V55, pS5847; R Development Core Team, 2012, R LANG ENV STAT COMP; Shojaei F, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-26; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Sugano G, 2011, ONCOGENE, V30, P642, DOI 10.1038/onc.2010.446; Veron P, 2005, BLOOD CELL MOL DIS, V35, P81, DOI 10.1016/j.bcmd.2005.05.001; Yang CW, 2011, CANCER RES, V71, P937, DOI 10.1158/0008-5472.CAN-10-1471	24	34	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72708	10.1371/journal.pone.0072708	http://dx.doi.org/10.1371/journal.pone.0072708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977342	gold, Green Published, Green Submitted			2022-12-25	WOS:000323570200080
J	Alghaeed, Z; Reilly, JJ; Chastin, SFM; Martin, A; Davies, G; Paton, JY				Alghaeed, Zubaida; Reilly, John J.; Chastin, Sebastien F. M.; Martin, Anne; Davies, Gwyneth; Paton, James Y.			The Influence of Minimum Sitting Period of the ActivPAL (TM) on the Measurement of Breaks in Sitting in Young Children	PLOS ONE			English	Article							HABITUAL SEDENTARY BEHAVIOR; CARDIOVASCULAR-DISEASE; OBJECTIVE MEASUREMENT; PRESCHOOL-CHILDREN; PHYSICAL-ACTIVITY; REFERENCE CURVES; TIME; POSTURE; ACTIGRAPH; AGREEMENT	Background: Sitting time and breaks in sitting influence cardio-metabolic health. New monitors (e. g. activPAL (TM)) may be more accurate for measurement of sitting time and breaks in sitting although how to optimize measurement accuracy is not yet clear. One important issue is the minimum sitting/upright period (MSUP) to define a new posture. Using the activPAL (TM), we investigated the effect of variations in MSUP on total sitting time and breaks in sitting, and also determined the criterion validity of different activPAL (TM) settings for both constructs. Methods: We varied setting of MSUP in 23 children (mean (SD) age 4.5 y (0.7)) who wore activPAL (TM) (24 hr/d) for 5-7 d. We first studied activPAL (TM) using the default setting of 10 s MSUP and then reduced this to 5 s, 2 s and 1 s. In a second study, in a convenience sample of 30 pre-school children (mean age 4.1 y (SD 0.5)) we validated the activPAL (TM) measures of sitting time and breaks in sitting at different MSUP settings against direct observation. Results: Comparing settings of 10, 5, 2 and 1 s, there were no significant differences in sitting time (6.2 hr (1.0), 6.3 hr (1.0), 6.4 hr (1.0) and 6.3 hr (1.6), respectively) between settings but there were significant increases in the apparent number of breaks - (8(3), 14(2), 21(4) and 28 (6)/h) at 10, 5, 2 and 1 s settings, respectively. In comparison with direct observation, a 2 s setting had the smallest error relative to direct observation (95% limits of agreement: -14 to +17 sitting bouts/hr, mean difference 1.83, p = 0.2). Conclusion: With activPAL (TM), breaks in sitting, but not total sitting time, are highly sensitive to the setting of MSUP, with 2 s optimal for young children. The MSUP to define a new posture will need to be empirically determined if accurate measurements of number of breaks in sitting are to be obtained.	[Alghaeed, Zubaida; Davies, Gwyneth; Paton, James Y.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland; [Reilly, John J.] Univ Strathclyde, Phys Act Hlth Grp, Glasgow, Lanark, Scotland; [Chastin, Sebastien F. M.] Glasgow Caledonian Univ, Sch Hlth & Social Care, Glasgow G4 0BA, Lanark, Scotland; [Martin, Anne] Univ Edinburgh, Inst Sport PE & Hlth Sci, Edinburgh, Midlothian, Scotland; [Davies, Gwyneth] Imperial Coll London, Natl Heart & Lung Inst, London, England	University of Glasgow; University of Strathclyde; Glasgow Caledonian University; University of Edinburgh; Imperial College London	Paton, JY (corresponding author), Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland.	james.paton@glasgow.ac.uk	Chastin, Sebastien/ABF-1455-2020; Davies, Gwyneth/AAE-9574-2020	Chastin, Sebastien/0000-0003-1421-9348; Davies, Gwyneth/0000-0001-7937-2728; Martin, Anne/0000-0003-1614-6525				BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chastin SFM, 2010, GAIT POSTURE, V31, P82, DOI 10.1016/j.gaitpost.2009.09.002; Chastin SFM, 2010, MOVEMENT DISORD, V25, P2114, DOI 10.1002/mds.23146; Chastin SFM, 2012, AGE AGEING, V41, P111, DOI 10.1093/ageing/afr075; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Davies G, 2012, PHYSIOL MEAS, V33, P1913, DOI 10.1088/0967-3334/33/11/1913; Davies G, 2012, MED SCI SPORT EXER, V44, P761, DOI 10.1249/MSS.0b013e31823b1dc7; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Harrington DM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-120; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kwon S, 2012, MED SCI SPORT EXER, V44, P1075, DOI 10.1249/MSS.0b013e318245ca20; Lanningham-Foster LM, 2005, MED SCI SPORT EXER, V37, P1800, DOI 10.1249/01.mss.0000175050.03506.bf; Lyden K, 2012, MED SCI SPORT EXER, V44, P2243, DOI 10.1249/MSS.0b013e318260c477; Martin A, 2011, PEDIATR EXERC SCI, V23, P468, DOI 10.1123/pes.23.4.468; Mitchell JA, 2012, MED SCI SPORT EXER, V44, P1081, DOI 10.1249/MSS.0b013e3182446c65; Oliver M, 2010, PREV MED, V51, P357, DOI 10.1016/j.ypmed.2010.08.010; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Ridgers ND, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-15	22	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71854	10.1371/journal.pone.0071854	http://dx.doi.org/10.1371/journal.pone.0071854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977163	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000323221500108
J	Kinder, M; Greenplate, AR; Grugan, KD; Soring, KL; Heeringa, KA; McCarthy, SG; Bannish, G; Perpetua, M; Lynch, F; Jordan, RE; Strohl, WR; Brezski, RJ				Kinder, Michelle; Greenplate, Allison R.; Grugan, Katharine D.; Soring, Keri L.; Heeringa, Katharine A.; McCarthy, Stephen G.; Bannish, Gregory; Perpetua, Meredith; Lynch, Frank; Jordan, Robert E.; Strohl, William R.; Brezski, Randall J.			Engineered Protease-resistant Antibodies with Selectable Cell-killing Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-GAMMA-RI; ANTI-CD20 MONOCLONAL-ANTIBODY; IMMUNE EFFECTOR FUNCTION; IGG BINDING-SITE; IN-VITRO; MATRIX METALLOPROTEINASES; THERAPEUTIC ACTIVITY; RECEPTOR; CLEAVAGE; AFFINITY	Molecularly engineered antibodies with fit-for-purpose properties will differentiate next generation antibody therapeutics from traditional IgG1 scaffolds. One requirement for engineering the most appropriate properties for a particular therapeutic area is an understanding of the intricacies of the target microenvironment in which the antibody is expected to function. Our group and others have demonstrated that proteases secreted by invasive tumors and pathological microorganisms are capable of cleaving human IgG1, the most commonly adopted isotype among monoclonal antibody therapeutics. Specific cleavage in the lower hinge of IgG1 results in a loss of Fc-mediated cell-killing functions without a concomitant loss of antigen binding capability or circulating antibody half-life. Proteolytic cleavage in the hinge region by tumor-associated or microbial proteases is postulated as a means of evading host immune responses, and antibodies engineered with potent cell-killing functions that are also resistant to hinge proteolysis are of interest. Mutation of the lower hinge region of an IgG1 resulted in protease resistance but also resulted in a profound loss of Fc-mediated cell-killing functions. In the present study, we demonstrate that specific mutations of the C(H)2 domain in conjunction with lower hinge mutations can restore and sometimes enhance cell-killing functions while still retaining protease resistance. By identifying mutations that can restore either complement-or Fc gamma receptor-mediated functions on a protease-resistant scaffold, we were able to generate a novel protease-resistant platform with selective cell-killing functionality.	[Kinder, Michelle; Greenplate, Allison R.; Grugan, Katharine D.; Soring, Keri L.; Heeringa, Katharine A.; McCarthy, Stephen G.; Jordan, Robert E.; Strohl, William R.; Brezski, Randall J.] Janssen Res & Dev LLC, Biol Res, Spring House, PA 19477 USA; [Bannish, Gregory; Perpetua, Meredith] Huntingdon Life Sci, E Millstone, NJ 08873 USA; [Lynch, Frank] QualTek Mol Labs, Newtown, PA 18940 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Brezski, RJ (corresponding author), Janssen Res & Dev LLC, 1400 McKean Rd, Spring House, PA 19477 USA.	rbrezski@its.jnj.com	Greenplate, Allison/F-7360-2015	Greenplate, Allison/0000-0002-2614-3072; Strohl, William/0000-0002-8271-6875; Brezski, Randall/0000-0003-4028-4741				Adams GP, 2001, CANCER RES, V61, P4750; Anderson DR, 1997, BIOCHEM SOC T, V25, P705, DOI 10.1042/bst0250705; Ang KK, 2002, CANCER RES, V62, P7350; Armour KL, 1999, EUR J IMMUNOL, V29, P2613, DOI 10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J; Beers SA, 2008, BLOOD, V112, P4170, DOI 10.1182/blood-2008-04-149161; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Brezski RJ, 2008, J IMMUNOL, V181, P3183, DOI 10.4049/jimmunol.181.5.3183; Brezski RJ, 2011, MABS-AUSTIN, V3, P558, DOI 10.4161/mabs.3.6.18119; Brezski RJ, 2010, MABS-AUSTIN, V2, P212, DOI 10.4161/mabs.2.3.11780; Brezski RJ, 2009, P NATL ACAD SCI USA, V106, P17864, DOI 10.1073/pnas.0904174106; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; BURTON DR, 1988, MOL IMMUNOL, V25, P1175, DOI 10.1016/0161-5890(88)90153-8; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Cooper JB, 2009, HEAD NECK-J SCI SPEC, V31, P1086, DOI 10.1002/hed.21109; Cragg MS, 2003, BLOOD, V101, P1045, DOI 10.1182/blood-2002-06-1761; Dall'Acqua WF, 2006, J IMMUNOL, V177, P1129, DOI 10.4049/jimmunol.177.2.1129; Di Gaetano N, 2003, J IMMUNOL, V171, P1581, DOI 10.4049/jimmunol.171.3.1581; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; DUNCAN AR, 1988, NATURE, V332, P563, DOI 10.1038/332563a0; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Fan XJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3240; Gearing AJH, 2002, IMMUNOL LETT, V81, P41, DOI 10.1016/S0165-2478(01)00333-9; Golay J, 2006, HAEMATOL-HEMATOL J, V91, P176; Gong Q, 2005, J IMMUNOL, V174, P817, DOI 10.4049/jimmunol.174.2.817; Grugan KD, 2012, J IMMUNOL, V189, P5457, DOI 10.4049/jimmunol.1201889; Guentsch A, 2013, J PERIODONTAL RES, V48, P458, DOI 10.1111/jre.12027; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; HULETT MD, 1994, J BIOL CHEM, V269, P15287; Idusogie EE, 2001, J IMMUNOL, V166, P2571, DOI 10.4049/jimmunol.166.4.2571; JEFFERIS R, 1968, NATURE, V219, P646, DOI 10.1038/219646b0; JEFFERIS R, 1990, MOL IMMUNOL, V27, P1237, DOI 10.1016/0161-5890(90)90027-W; Jefferis R, 2007, EXPERT OPIN BIOL TH, V7, P1401, DOI 10.1517/14712598.7.9.1401; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Johansson BP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001692; Johansson N, 1997, AM J PATHOL, V151, P499; Jung ST, 2010, P NATL ACAD SCI USA, V107, P604, DOI 10.1073/pnas.0908590107; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; LUND J, 1991, J IMMUNOL, V147, P2657; Moore GL, 2010, MABS-AUSTIN, V2, P181, DOI 10.4161/mabs.2.2.11158; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Nandakumar KS, 2008, TRENDS IMMUNOL, V29, P173, DOI 10.1016/j.it.2008.01.007; Nandakumar KS, 2007, ARTHRITIS RHEUM-US, V56, P3253, DOI 10.1002/art.22930; Natsume A, 2008, CANCER RES, V68, P3863, DOI 10.1158/0008-5472.CAN-07-6297; Natsume A, 2008, DRUG DES DEV THER, V3, P7; Natsume A, 2009, CANCER SCI, V100, P2411, DOI 10.1111/j.1349-7006.2009.01327.x; Nesspor TC, 2012, J MOL RECOGNIT, V25, P147, DOI 10.1002/jmr.2155; Ngo CV, 2007, INT J CANCER, V120, P1261, DOI 10.1002/ijc.22426; Niwa R, 2004, CLIN CANCER RES, V10, P6248, DOI 10.1158/1078-0432.CCR-04-0850; Oflazoglu E, 2009, BRIT J CANCER, V100, P113, DOI 10.1038/sj.bjc.6604812; Oganesyan V, 2008, MOL IMMUNOL, V45, P1872, DOI 10.1016/j.molimm.2007.10.042; PARTRIDGE LJ, 1986, MOL IMMUNOL, V23, P1365, DOI 10.1016/0161-5890(86)90022-2; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; REFF ME, 1994, BLOOD, V83, P435; Reichert JM, 2010, MABS-AUSTIN, V2, P695, DOI 10.4161/mabs.2.6.13603; Richards JO, 2008, MOL CANCER THER, V7, P2517, DOI 10.1158/1535-7163.MCT-08-0201; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Ryan MH, 2008, MOL IMMUNOL, V45, P1837, DOI 10.1016/j.molimm.2007.10.043; SANDERS LAM, 1995, INFECT IMMUN, V63, P73, DOI 10.1128/IAI.63.1.73-81.1995; Sazinsky SL, 2008, P NATL ACAD SCI USA, V105, P20167, DOI 10.1073/pnas.0809257105; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Stavenhagen JB, 2007, CANCER RES, V67, P8882, DOI 10.1158/0008-5472.CAN-07-0696; Strohl WR, 2009, CURR OPIN BIOTECH, V20, P685, DOI 10.1016/j.copbio.2009.10.011; Strohl WR, 2012, WOODH PUB SER BIOMED, P1, DOI 10.1533/9781908818096; Tamm A, 1996, J BIOL CHEM, V271, P3659; TAO MH, 1989, J IMMUNOL, V143, P2595; Teeling JL, 2006, J IMMUNOL, V177, P362, DOI 10.4049/jimmunol.177.1.362; TURNER M W, 1970, Clinical and Experimental Immunology, V7, P603; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Vincents B, 2004, BIOCHEMISTRY-US, V43, P15540, DOI 10.1021/bi048284d; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; von Pawel-Rammingen U, 2012, J INNATE IMMUN, V4, P132, DOI 10.1159/000332940; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wines BD, 2000, J IMMUNOL, V164, P5313, DOI 10.4049/jimmunol.164.10.5313; WOOF JM, 1986, MOL IMMUNOL, V23, P319, DOI 10.1016/0161-5890(86)90059-3; Yan BX, 2012, J BIOL CHEM, V287, P5891, DOI 10.1074/jbc.M111.311811; Yee AMF, 2000, CLIN INFECT DIS, V30, P25, DOI 10.1086/313588	80	25	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30843	30854		10.1074/jbc.M113.486142	http://dx.doi.org/10.1074/jbc.M113.486142			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	23986451	Green Published, hybrid			2022-12-25	WOS:000330778900005
J	Lee, JW; Kim, JH				Lee, Jin-Wook; Kim, Jae-Hong			Activation of the Leukotriene B-4 Receptor 2-Reactive Oxygen Species (BLT2-ROS) Cascade following Detachment Confers Anoikis Resistance in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cancer; Cancer Biology; NADPH Oxidase; Prostate Cancer; Anokis Resistance	FACTOR-KAPPA-B; REDOX REGULATION; CARCINOMA-CELLS; PRO-SURVIVAL; INHIBITION; PATHWAY; GROWTH; OVEREXPRESSION; EXPRESSION; APOPTOSIS	Background: Despite the critical role of anoikis resistance in prostate cancer progression, the molecular mechanism causing anoikis resistance remains unclear. Results: BLT2 protects prostate cancer cells against anoikis via a NOX-ROS-NF-B-linked pathway. Conclusion: Activation of the BLT2-linked pathway following cell detachment confers anoikis resistance. Significance: Our findings suggest BLT2 as a key regulator of anoikis resistance in prostate cancer cells. The majority of prostate cancer-related deaths are associated with advanced and metastatic malignancies. Although anoikis resistance has been recognized as one of the hallmarks of metastatic prostate malignancies, the molecular events that cause anoikis resistance are poorly understood. In this study, we found that the detachment of PC-3 prostate cancer cells caused a time-dependent increase in the expression level of the leukotriene B-4 receptor-2 (BLT2) and that BLT2 played a critical role in establishing anoikis resistance in these cells. Blocking BLT2 with the pharmacological inhibitor LY255283 or with RNAi knockdown clearly abolished anoikis resistance and resulted in severe apoptotic death. Additionally, we demonstrated that the activation of NADPH oxidase (NOX) and subsequent generation of reactive oxygen species (ROS) were downstream of BLT2 signaling and led to the activation of NF-B, thus establishing anoikis resistance during cell detachment. Furthermore, we observed that the ectopic expression of BLT2 in normal prostate PWR-1E cells rendered the cells resistant to anoikis and apparently diminished apoptotic cell death following detachment. Taken together, our results suggest that BLT2-NOX-ROS-NF-B cascade induction during detachment confers a novel mechanism of anoikis resistance in prostate cancer cells and potentially contributes to prostate cancer progression.	[Lee, Jin-Wook; Kim, Jae-Hong] Korea Univ, Coll Life Sci & Biotechnol, Seoul 136701, South Korea	Korea University	Kim, JH (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, 5-1 Anam Dong, Seoul 136701, South Korea.	jhongkim@korea.ac.kr	Kim, Jae-Hong/B-2530-2009	Kim, Jae-Hong/0000-0002-8019-0208	Bio & Medical Technology Development Program Grant [2012M3A9C5048709]; National Research Foundation [2012R1A2A2A01044526]; Ministry of Science, Information and Communication Technologies (ICT) and Future Planning, Republic of Korea; National Research and Development Program for Cancer Control Grant [1220020]; Ministry for Health and Welfare, Republic of Korea; Korea University [G1300090]	Bio & Medical Technology Development Program Grant; National Research Foundation; Ministry of Science, Information and Communication Technologies (ICT) and Future Planning, Republic of Korea; National Research and Development Program for Cancer Control Grant; Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea University	This work was supported by Bio & Medical Technology Development Program Grant 2012M3A9C5048709, Basic Science Research Program Grant 2012R1A2A2A01044526 through the National Research Foundation funded by the Ministry of Science, Information and Communication Technologies (ICT) and Future Planning, Republic of Korea, and the National Research and Development Program for Cancer Control Grant 1220020, Ministry for Health and Welfare, Republic of Korea. This work was also supported by Korea University Grant G1300090.	Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Chamulitrat W, 2003, ONCOGENE, V22, P6045, DOI 10.1038/sj.onc.1206654; Chell SD, 2006, CANCER RES, V66, P3106, DOI 10.1158/0008-5472.CAN-05-3702; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Cho KJ, 2011, MOL CELLS, V32, P1, DOI 10.1007/s10059-011-1021-7; Cho KJ, 2010, J IMMUNOL, V185, P6329, DOI 10.4049/jimmunol.1001213; Choi JA, 2008, FREE RADICAL BIO MED, V44, P624, DOI 10.1016/j.freeradbiomed.2007.10.041; Choi JA, 2010, CARCINOGENESIS, V31, P543, DOI 10.1093/carcin/bgp203; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Ghosh J, 2003, BIOCHEM BIOPH RES CO, V307, P342, DOI 10.1016/S0006-291X(03)01201-4; Giannoni E, 2008, CELL DEATH DIFFER, V15, P867, DOI 10.1038/cdd.2008.3; Giannoni E, 2009, ONCOGENE, V28, P2074, DOI 10.1038/onc.2009.77; Greene ER, 2011, PROSTAG OTH LIPID M, V96, P27, DOI 10.1016/j.prostaglandins.2011.08.004; Hennig R, 2008, BRIT J CANCER, V99, P1064, DOI 10.1038/sj.bjc.6604655; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim EY, 2010, FREE RADICAL BIO MED, V49, P1072, DOI 10.1016/j.freeradbiomed.2010.06.023; Kim GY, 2010, J IMMUNOL, V184, P3946, DOI 10.4049/jimmunol.0901735; Kim GY, 2009, ARTERIOSCL THROM VAS, V29, P915, DOI 10.1161/ATVBAHA.109.185793; Kim HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043223; Kim SH, 2011, CANCER RES, V71, P7010, DOI 10.1158/0008-5472.CAN-11-1262; Krishnamoorthy S, 2011, CANCER METAST REV, V30, P613, DOI 10.1007/s10555-011-9309-9; Kumar S, 2011, MOL CELL BIOL, V31, P4036, DOI 10.1128/MCB.01342-10; Larre S, 2008, PROSTAG OTH LIPID M, V87, P14, DOI 10.1016/j.prostaglandins.2008.05.001; Lee JW, 2012, BIOCHEM BIOPH RES CO, V420, P428, DOI 10.1016/j.bbrc.2012.03.012; Lee SK, 2000, MOL ENDOCRINOL, V14, P915, DOI 10.1210/me.14.6.915; McCabe NP, 2006, PROSTATE, V66, P779, DOI 10.1002/pros.20360; Michael J Morgan, 2011, Cell Research, V21, P103; Neiva KG, 2009, NEOPLASIA, V11, P583, DOI 10.1593/neo.09266; Nie DT, 2003, CLIN EXP METASTAS, V20, P657, DOI 10.1023/A:1027302408187; Nie DT, 2001, CANCER METAST REV, V20, P195, DOI 10.1023/A:1015579209850; Oyoshi MK, 2012, IMMUNITY, V37, P747, DOI 10.1016/j.immuni.2012.06.018; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Pidgeon GP, 2003, CANCER RES, V63, P4258; Pidgeon GP, 2002, CANCER RES, V62, P2721; Rennebeck G, 2005, CANCER RES, V65, P11230, DOI 10.1158/0008-5472.CAN-05-2763; Rocconi RP, 2008, REPROD SCI, V15, P321, DOI 10.1177/1933719108316390; Rungtabnapa P, 2011, AM J PHYSIOL-CELL PH, V300, pC235, DOI 10.1152/ajpcell.00249.2010; Ryu HC, 2010, J INVEST DERMATOL, V130, P1095, DOI 10.1038/jid.2009.436; Sakamoto S, 2010, MOL ASPECTS MED, V31, P205, DOI 10.1016/j.mam.2010.02.001; Schneider C, 2011, CANCER METAST REV, V30, P277, DOI 10.1007/s10555-011-9310-3; Seo JM, 2012, J BIOL CHEM, V287, P13840, DOI 10.1074/jbc.M111.317131; Tager AM, 2003, PROSTAG LEUKOTR ESS, V69, P123, DOI 10.1016/S0952-3278(03)00073-5; Terada LS, 2011, CANCER CELL, V19, P297, DOI 10.1016/j.ccr.2011.02.019; Toruner M, 2006, J BIOL CHEM, V281, P8686, DOI 10.1074/jbc.M512178200; Woo CH, 2006, BIOCHEM BIOPH RES CO, V351, P972, DOI 10.1016/j.bbrc.2006.10.154; Yan SR, 2005, ONCOGENE, V24, P6482, DOI 10.1038/sj.onc.1208810; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yoo MH, 2004, ONCOGENE, V23, P9259, DOI 10.1038/sj.onc.1208151; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018	49	35	35	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30054	30063		10.1074/jbc.M113.481283	http://dx.doi.org/10.1074/jbc.M113.481283			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986446	hybrid, Green Published			2022-12-25	WOS:000329868100006
J	Chapman, MA; Mandel, JR; Burke, JM				Chapman, Mark A.; Mandel, Jennifer R.; Burke, John M.			Sequence Validation of Candidates for Selectively Important Genes in Sunflower	PLOS ONE			English	Article							DNA POLYMORPHISM; EVOLUTION; DOMESTICATION; DIVERSITY; WILD; MICROSATELLITES; GENETICS; SORGHUM; MAIZE; SCAN	Analyses aimed at identifying genes that have been targeted by past selection provide a powerful means for investigating the molecular basis of adaptive differentiation. In the case of crop plants, such studies have the potential to not only shed light on important evolutionary processes, but also to identify genes of agronomic interest. In this study, we test for evidence of positive selection at the DNA sequence level in a set of candidate genes previously identified in a genome-wide scan for genotypic evidence of selection during the evolution of cultivated sunflower. In the majority of cases, we were able to confirm the effects of selection in shaping diversity at these loci. Notably, the genes that were found to be under selection via our sequence-based analyses were devoid of variation in the cultivated sunflower gene pool. This result confirms a possible strategy for streamlining the search for adaptively-important loci process by pre-screening the derived population to identify the strongest candidates before sequencing them in the ancestral population.	[Chapman, Mark A.; Mandel, Jennifer R.; Burke, John M.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Burke, JM (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	jmburke@uga.edu	Chapman, Mark/E-5260-2011; Burke, John M/A-3502-2013	Chapman, Mark/0000-0002-7151-723X; Burke, John M/0000-0002-1412-5539; Mandel, Jennifer/0000-0003-3539-2991	U.S. Department of Agriculture, National Institute of Food and Agriculture [2008-35300-19263]; National Science Foundation [DBI-0820451]	U.S. Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF))	This work was funded in part by the U.S. Department of Agriculture (www.usda.gov) National Institute of Food and Agriculture (grant number 2008-35300-19263) and the National Science Foundation (http://www.nsf.gov) Plant Genome Research Program (grant number DBI-0820451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Burke JM, 2007, CURR OPIN GENET DEV, V17, P525, DOI 10.1016/j.gde.2007.09.003; Cai HW, 2002, THEOR APPL GENET, V104, P1217, DOI 10.1007/s00122-001-0819-7; Casa AM, 2005, THEOR APPL GENET, V111, P23, DOI 10.1007/s00122-005-1952-5; Chapman MA, 2012, THEOR APPL GENET, V125, P897, DOI 10.1007/s00122-012-1881-z; Chapman MA, 2008, PLANT CELL, V20, P2931, DOI 10.1105/tpc.108.059808; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1992, TRENDS GENET, V8, P302, DOI 10.1016/0168-9525(92)90261-2; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Feder ME, 2003, NAT REV GENET, V4, P651, DOI 10.1038/nrg1128; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Hamblin MT, 2006, GENETICS, V173, P953, DOI 10.1534/genetics.105.054312; Hammer K., 1984, KULTURPFLANZE, V32, P11, DOI [DOI 10.1007/BF02098682, 10.1007/BF02098682]; HUDSON RR, 1987, GENETICS, V116, P153; Koinange EMK, 1996, CROP SCI, V36, P1037, DOI 10.2135/cropsci1996.0011183X003600040037x; Kolkman JM, 2007, GENETICS, V177, P457, DOI 10.1534/genetics.107.074054; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Liu AZ, 2006, GENETICS, V173, P321, DOI 10.1534/genetics.105.051110; Mandel JR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003378; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, PRIMER3 WWW GEN USER; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Schlotterer C, 2005, MOL B INT U, P55, DOI 10.1007/0-387-27651-3_5; Schlotterer C, 2002, CURR OPIN GENET DEV, V12, P683, DOI 10.1016/S0959-437X(02)00349-0; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Tang SX, 2003, THEOR APPL GENET, V106, P990, DOI 10.1007/s00122-002-1127-6; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Vielle-Calzada JP, 2009, SCIENCE, V326, P1078, DOI 10.1126/science.1178437; Vigouroux Y, 2002, P NATL ACAD SCI USA, V99, P9650, DOI 10.1073/pnas.112324299; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weber AL, 2008, GENETICS, V180, P1221, DOI 10.1534/genetics.108.090134; Wood HM, 2008, MOL ECOL, V17, P3123, DOI 10.1111/j.1365-294X.2008.03755.x; Wright SI, 2004, GENETICS, V168, P1071, DOI 10.1534/genetics.104.026500; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	42	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71941	10.1371/journal.pone.0071941	http://dx.doi.org/10.1371/journal.pone.0071941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991009	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000324228800026
J	Lesniak, D; Sabri, S; Xu, YX; Graham, K; Bhatnagar, P; Suresh, M; Abdulkarim, B				Lesniak, David; Sabri, Siham; Xu, Yaoxian; Graham, Kathryn; Bhatnagar, Pravin; Suresh, Mavanur; Abdulkarim, Bassam			Spontaneous Epithelial-Mesenchymal Transition and Resistance to HER-2-Targeted Therapies in HER-2-Positive Luminal Breast Cancer	PLOS ONE			English	Article							CELL-LINES; STEM-CELLS; TRASTUZUMAB RESISTANCE; GENE-EXPRESSION; PHENOTYPE; HERCEPTIN; BETA-1-INTEGRIN; CHEMOTHERAPY; CONTRIBUTES; SURVIVAL	Resistance to trastuzumab, a rationally designed HER-2-targeting antibody, remains a major hurdle in the management of HER-2-positive breast cancer. Preclinical studies suggest the mechanisms of trastuzumab resistance are numerous. Unfortunately, the majority of these studies are based around HER-2-positive (HER-2+) luminal cell lines. The role of epithelial to mesenchymal transition (EMT), a genetic program that confers a basal phenotype, may represent a novel mechanism of escape for HER-2+ luminal cells from trastuzumab treatment. Here we investigated this possibility using a model of clonal selection in HER-2+ luminal breast cancer cells. Following a random isolation and expansion of "colony clusters" from SKBR-3 cell lines, several colony clusters underwent a spontaneous EMT in-vitro. In addition to expression of conventional EMT markers, all mesenchymal colony clusters displayed a predominant CD44+/CD24- phenotype with decreased HER-2 expression and elevated levels of a beta 1-integrin isoform with a high degree of N-glycosylation. Treatment with a beta 1-integrin function-blocking antibody, AIIB2, preferentially decreased the N-glycosylated form of beta 1-integrin, impaired mammosphere formation and restored epithelial phenotype in mesenchymal colony clusters. Using this model we provide the first clear evidence that resistance to trastuzumab (and lapatinib) can occur spontaneously as HER-2+ cells shift from a luminal to a basal/mesenchymal phenotype following EMT. While the major determinant of trastuzumab resistance in mesenchymal colony clusters is likely the down regulation of the HER-2 protein, our evidence suggests that multiple factors may contribute, including expression of N-glycosylated beta 1-integrin.	[Lesniak, David; Graham, Kathryn] Cross Canc Inst, Dept Expt Oncol, Edmonton, AB T6G 1Z2, Canada; [Lesniak, David; Graham, Kathryn] Univ Alberta, Edmonton, AB, Canada; [Sabri, Siham; Xu, Yaoxian; Abdulkarim, Bassam] McGill Univ, Dept Radiat Oncol, Res Inst, Ctr Hlth, Montreal, PQ H3A 2T5, Canada; [Bhatnagar, Pravin; Suresh, Mavanur] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada	University of Alberta; University of Alberta; McGill University; University of Alberta	Abdulkarim, B (corresponding author), McGill Univ, Dept Radiat Oncol, Res Inst, Ctr Hlth, Montreal, PQ H3A 2T5, Canada.	bassam.abdulkarim@mcgill.ca	Sabri, Siham/K-1101-2015	Sabri, Siham/0000-0001-5792-689X	Terry Fox Research Institute; Alberta Innovates Health Solutions; Canadian Institute for Health Research	Terry Fox Research Institute; Alberta Innovates Health Solutions; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a research grant from the Terry Fox Research Institute. DL is supported by MD/PhD studentships from Alberta Innovates Health Solutions, and the Canadian Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoudjit F, 2001, ONCOGENE, V20, P4995, DOI 10.1038/sj.onc.1204554; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chahal M, 2010, NEURO-ONCOLOGY, V12, P822, DOI 10.1093/neuonc/noq017; Cordes N, 2006, ONCOGENE, V25, P1378, DOI 10.1038/sj.onc.1209164; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Diermeier S, 2005, EXP CELL RES, V304, P604, DOI 10.1016/j.yexcr.2004.12.008; Dua R, 2010, BREAST CANCER RES TR, V122, P685, DOI 10.1007/s10549-009-0592-x; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Granovsky M, 2000, NAT MED, V6, P306; Huang C, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2936; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Koninki K, 2010, CANCER LETT, V294, P211, DOI 10.1016/j.canlet.2010.02.002; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Lesniak D, 2009, CANCER RES, V69, P8620, DOI 10.1158/0008-5472.CAN-09-1591; Li M, 2010, J BIOSCIENCES, V35, P665, DOI 10.1007/s12038-010-0073-8; Liu H, 2008, HUM PATHOL, V39, P167, DOI 10.1016/j.humpath.2007.06.012; Lower EE, 2009, BREAST CANCER RES TR, V113, P301, DOI 10.1007/s10549-008-9931-6; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maschler S, 2005, ONCOGENE, V24, P2032, DOI 10.1038/sj.onc.1208423; Morrow PKH, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2324; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Oliveras-Ferraros C, 2012, CELL CYCLE, V11, P4020, DOI 10.4161/cc.22225; Oliveras-Ferraros C, 2010, BIOCHEM BIOPH RES CO, V397, P27, DOI 10.1016/j.bbrc.2010.05.041; Paik S, 2008, NEW ENGL J MED, V358, P1409, DOI 10.1056/NEJMc0801440; Park SY, 2010, CLIN CANCER RES, V16, P876, DOI 10.1158/1078-0432.CCR-09-1532; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Polyak K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003244; Pontier SM, 2009, J CELL SCI, V122, P207, DOI 10.1242/jcs.040394; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rakha EA, 2010, BREAST CANCER RES TR, V120, P293, DOI 10.1007/s10549-010-0746-x; Reim F, 2009, CANCER RES, V69, P8058, DOI 10.1158/0008-5472.CAN-09-0834; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Santinelli A, 2008, INT J CANCER, V122, P999, DOI 10.1002/ijc.23051; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Skottman H, 2006, STEM CELLS, V24, P151, DOI 10.1634/stemcells.2004-0189; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stockholm D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000394; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Tanner M, 2004, MOL CANCER THER, V3, P1585; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wang LY, 2007, J CELL BIOCHEM, V100, P230, DOI 10.1002/jcb.21071; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Yen TY, 2012, J PROTEOME RES, V11, P656, DOI 10.1021/pr201041j; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x	50	37	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71987	10.1371/journal.pone.0071987	http://dx.doi.org/10.1371/journal.pone.0071987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991019	Green Submitted, gold, Green Published			2022-12-25	WOS:000324228800033
J	Xiao, FF; Ma, JZ; Amos, CI				Xiao, Feifei; Ma, Jianzhong; Amos, Christopher I.			A Unified Framework Integrating Parent-of-Origin Effects for Association Study	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; GENETIC-LINKAGE; VARIANTS; FAMILIES; MODEL	Genetic imprinting is the most well-known cause for parent-of-origin effect (POE) whereby a gene is differentially expressed depending on the parental origin of the same alleles. Genetic imprinting is related to several human disorders, including diabetes, breast cancer, alcoholism, and obesity. This phenomenon has been shown to be important for normal embryonic development in mammals. Traditional association approaches ignore this important genetic phenomenon. In this study, we generalize the natural and orthogonal interactions (NOIA) framework to allow for estimation of both main allelic effects and POEs. We develop a statistical (Stat-POE) model that has the orthogonal estimates of parameters including the POEs. We conducted simulation studies for both quantitative and qualitative traits to evaluate the performance of the statistical and functional models with different levels of POEs. Our results showed that the newly proposed Stat-POE model, which ensures orthogonality of variance components if Hardy-Weinberg Equilibrium (HWE) or equal minor and major allele frequencies is satisfied, had greater power for detecting the main allelic additive effect than a Func-POE model, which codes according to allelic substitutions, for both quantitative and qualitative traits. The power for detecting the POE was the same for the Stat-POE and Func-POE models under HWE for quantitative traits.	[Xiao, Feifei; Ma, Jianzhong] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Amos, Christopher I.] Dartmouth Coll, Dept Community & Family Med, Geisel Sch Med, Lebanon, NH 03756 USA	University of Texas System; UTMD Anderson Cancer Center; Dartmouth College	Amos, CI (corresponding author), Dartmouth Coll, Dept Community & Family Med, Geisel Sch Med, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Christopher.I.Amos@Dartmouth.edu	Xiao, Feifei/K-2438-2014; Xiao, Feifei/AAD-9539-2021		Cancer Prevention and Research Institute of Texas [RP100443]; NIH [U19CA148127, R01CA134682]; NATIONAL CANCER INSTITUTE [R01CA134682, U19CA148127] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research has been supported by Cancer Prevention and Research Institute of Texas RP100443, NIH U19CA148127 and R01CA134682. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth HE, 2011, GENET EPIDEMIOL, V35, P19, DOI 10.1002/gepi.20547; Alvarez-Castro JM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000062; Alvarez-Castro JM, 2007, GENETICS, V176, P1151, DOI 10.1534/genetics.106.067348; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; Belonogova NM, 2010, EUR J HUM GENET, V18, P379, DOI 10.1038/ejhg.2009.167; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Dong CH, 2005, AM J HUM GENET, V76, P427, DOI 10.1086/428438; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Feng R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028909; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gorlova OY, 2007, HUM GENET, V122, P159, DOI 10.1007/s00439-007-0387-2; Guo YF, 2006, J CLIN ENDOCR METAB, V91, P4001, DOI 10.1210/jc.2006-0549; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Liu T, 2007, GENOMICS, V90, P276, DOI 10.1016/j.ygeno.2007.04.004; Ma JZ, 2012, HUM HERED, V73, P185, DOI 10.1159/000339906; Maher B, 2006, NATURE, V456, P7218; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Shete S, 2002, AM J HUM GENET, V70, P751, DOI 10.1086/338931; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Wang CG, 2012, BRIEF BIOINFORM, V13, P34, DOI 10.1093/bib/bbr023; Wyszynski DF, 1999, GENET EPIDEMIOL, V17, pS409; Zeng ZB, 2005, GENETICS, V169, P1711, DOI 10.1534/genetics.104.035857; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1	25	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72208	10.1371/journal.pone.0072208	http://dx.doi.org/10.1371/journal.pone.0072208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991061	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800051
J	Sand-Dejmek, J; Ehrnstrom, R; Berglund, P; Andersson, T; Ryden, L				Sand-Dejmek, Janna; Ehrnstrom, Roy; Berglund, Pontus; Andersson, Tommy; Ryden, Lisa			The Prognostic Significance of Wnt-5a Expression in Primary Breast Cancer Is Extended to Premenopausal Women	PLOS ONE			English	Article							MIGRATION; INVASION; PROTEIN; ROLES	Wnt-5a protein expression in primary tumors from unselected breast cancer patients has revealed a tumor suppressive function of the protein. However, in vitro experiments on human breast cancer cells have reported contradictory results, indicating both a tumor suppressive and promoting functions of Wnt-5a. This could be due to various functions of Wnt-5a in different subgroups of patients. The unselected cohorts analyzed to date for Wnt-5a protein expression contained few premenopausal patients. The aim of the present investigation was to evaluate the prognostic significance of Wnt-5a protein expression in a cohort of premenopausal women with comprehensive data on biomarkers, molecular subtypes and long-term outcome. In a randomized trial of adjuvant tamoxifen versus no adjuvant treatment, 564 premenopausal primary breast cancer patients were included. The median follow-up time was 14 years. A tumor tissue array was constructed and 361 samples were evaluated for Wnt-5a reactivity by immunohistochemistry. The primary end-point was recurrence-free survival. Wnt-5a protein expression was reduced or lost in 146/361 of tumors and correlated to younger age, estrogen receptor (ER) negativity and triple-negative phenotype. Wnt-5a was a prognostic factor in the whole cohort (p = 0.003). In patients with ER-positive tumors, Wnt-5a was an independent positive prognostic marker (HR 0.51 95% CI: 0.33-0.78 p = 0.002) and HER2 a negative prognostic marker (HR 2.84 95% CI: 1.51-5.31, p = 0.001) in a Cox multivariate analysis adjusted for standard prognostic markers and tamoxifen treatment. In the ER-negative subset, Wnt-5a added no prognostic information. In a subgroup analysis, Wnt-5a was significantly associated with better prognosis in patients with Luminal A tumors (p = 0.04). Conclusively, our results suggest that loss of Wnt-5a is a valuable prognostic marker in premenopausal breast cancer patients in particular in patients with ER-positive tumors and out-performed conventional prognostic factors in this subset of patients.	[Sand-Dejmek, Janna; Berglund, Pontus; Andersson, Tommy] Lund Univ, Skane Univ Hosp, Dept Lab Med, Malmo, Sweden; [Sand-Dejmek, Janna] Lund Univ, Skane Univ Hosp, Dept Clin Sci Malmo, Malmo, Sweden; [Ehrnstrom, Roy] Lund Univ, Dept Lab Med Malmo, Skane Univ Hosp, Malmo, Sweden; [Ryden, Lisa] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Sand-Dejmek, J (corresponding author), Lund Univ, Skane Univ Hosp, Dept Lab Med, Malmo, Sweden.	jannasd@gmail.com		Andersson, Tommy/0000-0003-4032-5769	Swedish Cancer Foundation; Swedish Research Council; Soderberg Foundations; Malmo University Hospital Cancer Foundation; Gunnar Nilsson's Cancer Foundation; BioCare program at Lund University; Berta Kamprad Foundation; SUS Research Foundation; Percy Falk Foundation; Swedish Society of Medicine; Skane County Council's Research and Development Foundation; Governmental Funding of Clinical Research within the national health services (ALF)	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberg Foundations; Malmo University Hospital Cancer Foundation; Gunnar Nilsson's Cancer Foundation; BioCare program at Lund University; Berta Kamprad Foundation; SUS Research Foundation; Percy Falk Foundation; Swedish Society of Medicine; Skane County Council's Research and Development Foundation; Governmental Funding of Clinical Research within the national health services (ALF)	The study was supported by grants from the Swedish Cancer Foundation, the Swedish Research Council, Soderberg Foundations, Malmo University Hospital Cancer Foundation, Gunnar Nilsson's Cancer Foundation, the BioCare program at Lund University, Berta Kamprad Foundation, SUS Research Foundation, Percy Falk Foundation, Swedish Society of Medicine, Skane County Council's Research and Development Foundation, and by Governmental Funding of Clinical Research within the national health services (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Brennan DJ, 2006, CLIN CANCER RES, V12, P6421, DOI 10.1158/1078-0432.CCR-06-0480; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Dejmek J, 2005, CLIN CANCER RES, V11, P520; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Jansson M, 2001, J CELL SCI, V114, P2043; Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106; Jiang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058329; Jirstrom K, 2005, J CLIN PATHOL, V58, P1135, DOI 10.1136/jcp.2005.027185; Jonsson M, 2002, CANCER RES, V62, P409; Khaja ASS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026539; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Leris ACA, 2005, ANTICANCER RES, V25, P731; Liu XH, 2008, DIGEST LIVER DIS, V40, P560, DOI 10.1016/j.dld.2007.12.011; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Millar EKA, 2011, BRIT J CANCER, V105, P272, DOI 10.1038/bjc.2011.228; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; Safholm A, 2008, CLIN CANCER RES, V14, P6556, DOI 10.1158/1078-0432.CCR-08-0711; Turner NC, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a421; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644	25	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e70890	10.1371/journal.pone.0070890	http://dx.doi.org/10.1371/journal.pone.0070890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23990917	Green Submitted, gold, Green Published			2022-12-25	WOS:000324470700006
J	Wassmer, S; Beddaoui, M; Rajai, P; Munger, R; Tsilfidis, C				Wassmer, Sarah; Beddaoui, Margaret; Rajai, Payman; Munger, Rejean; Tsilfidis, Catherine			A Focus on the Optical Properties of the Regenerated Newt Lens	PLOS ONE			English	Article							METAMORPHOSIS; EYE	Lens regeneration studies in the adult newt suggest that molecular aspects of lens regeneration are complete within 5 weeks of lentectomy. However, very little is known about the optical properties of the regenerated lens. In an aquatic environment, the lens accounts for almost all of the refractive power of the eye, and thus, a fully functional lens is critical. We compared the optical properties of 9- and 26-week regenerated lenses in the red spotted newt, Notophthalmus viridescens, with the original lenses removed from the same eyes. At 9 weeks, the regenerated lenses are smaller than the original lenses and are histologically immature, with a lower density of lens proteins. The 9 week lenses have greater light transmission, but significantly reduced focal length and refractive index than the original lenses. This suggests that following 9 weeks of regeneration, the lenses have not recovered the functionality of the original lens. By 26 weeks, the transmission of light in the more mature lens is reduced, but the optical parameters of the lens have recovered enough to allow functional vision.	[Wassmer, Sarah; Beddaoui, Margaret; Rajai, Payman; Munger, Rejean; Tsilfidis, Catherine] Ottawa Hosp Res Inst, Vis Res Program, Ottawa, ON, Canada; [Wassmer, Sarah; Beddaoui, Margaret; Tsilfidis, Catherine] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Rajai, Payman; Munger, Rejean] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; [Munger, Rejean; Tsilfidis, Catherine] Univ Ottawa, Dept Ophthalmol, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Tsilfidis, C (corresponding author), Ottawa Hosp Res Inst, Vis Res Program, Ottawa, ON, Canada.	ctsilfidis@ohri.ca	Rajai, Payman/P-5598-2019	Rajai, Payman/0000-0002-3382-2364	Natural Sciences and Engineering Research Council of Canada (NSERCC) [171259]	Natural Sciences and Engineering Research Council of Canada (NSERCC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work in this manuscript was supported by a Natural Sciences and Engineering Research Council of Canada (NSERCC) grant to CT (Grant # 171259). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Call Mindy K., 2005, Anatomical Record Part B:The New Anatomist, V287, P42, DOI 10.1002/ar.b.20084; Colucci VL, 1891, MEM REGALE ACCAD S 5, V1, P167; Eguchi G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1389; Grogg MW, 2006, SEMIN CELL DEV BIOL, V17, P753, DOI 10.1016/j.semcdb.2006.10.001; Henry JJ, 2010, PROG RETIN EYE RES, V29, P543, DOI 10.1016/j.preteyeres.2010.07.002; Hoshino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025140; Inoue T, 2012, DEV DYNAM, V241, P1575, DOI 10.1002/dvdy.23854; Kroger RHH, 2001, VISION RES, V41, P549, DOI 10.1016/S0042-6989(00)00283-2; Land MF, 2012, OPHTHAL PHYSL OPT, V32, P449, DOI 10.1111/j.1475-1313.2012.00941.x; Litzenger T, 2002, ENCY LIFE SCI; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; REYER RW, 1954, Q REV BIOL, V29, P1, DOI 10.1086/399936; Sato T, 1940, ARCH ENTWICKLUNGSMEC, V140, P570; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Sione LS, 1941, ANAT RECORD, V79, P333, DOI 10.1002/ar.1090790306; SIVAK JG, 1983, J COMP PHYSIOL, V150, P329, DOI 10.1007/BF00605022; SIVAK JG, 1980, CAN J ZOOL, V58, P2059, DOI 10.1139/z80-282; STONE LS, 1953, J EXP ZOOL, V124, P435, DOI 10.1002/jez.1401240304; Tsonis PA, 2008, CELL MOL LIFE SCI, V65, P41, DOI 10.1007/s00018-007-7429-8; Wolff G., 1895, REGEN URODELENLINSE, V1, P380; Yamada T, 1977, Monogr Dev Biol, V13, P1; Yumana T., 1967, P247	23	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e70845	10.1371/journal.pone.0070845	http://dx.doi.org/10.1371/journal.pone.0070845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23990914	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470700005
J	Duan, HB; Deng, YM; Wang, XH; Xu, CF				Duan, Haibin; Deng, Yimin; Wang, Xiaohua; Xu, Chunfang			Small and Dim Target Detection via Lateral Inhibition Filtering and Artificial Bee Colony Based Selective Visual Attention	PLOS ONE			English	Article							ABC OPTIMIZATION ALGORITHM; SEARCH; MODEL	This paper proposed a novel bionic selective visual attention mechanism to quickly select regions that contain salient objects to reduce calculations. Firstly, lateral inhibition filtering, inspired by the limulus' ommateum, is applied to filter low-frequency noises. After the filtering operation, we use Artificial Bee Colony (ABC) algorithm based selective visual attention mechanism to obtain the interested object to carry through the following recognition operation. In order to eliminate the camera motion influence, this paper adopted ABC algorithm, a new optimization method inspired by swarm intelligence, to calculate the motion salience map to integrate with conventional visual attention. To prove the feasibility and effectiveness of our method, several experiments were conducted. First the filtering results of lateral inhibition filter were shown to illustrate its noise reducing effect, then we applied the ABC algorithm to obtain the motion features of the image sequence. The ABC algorithm is proved to be more robust and effective through the comparison between ABC algorithm and popular Particle Swarm Optimization (PSO) algorithm. Except for the above results, we also compared the classic visual attention mechanism and our ABC algorithm based visual attention mechanism, and the experimental results of which further verified the effectiveness of our method.	[Duan, Haibin; Deng, Yimin; Xu, Chunfang] Beihang Univ, Sch Automat Sci & Elect Engn, State Key Lab Virtual Real Technol & Syst, Beijing, Peoples R China; [Duan, Haibin; Deng, Yimin; Wang, Xiaohua] Beihang Univ, Sci & Technol Aircraft Control Lab, Beijing, Peoples R China	Beihang University; Beihang University	Duan, HB (corresponding author), Beihang Univ, Sch Automat Sci & Elect Engn, State Key Lab Virtual Real Technol & Syst, Beijing, Peoples R China.	hbduan@buaa.edu.cn			Natural Science Foundation of China (NSFC) [61273054, 60975072, 60604009]; National Key Basic Research Program of China [2013CB035503]; National High Technology Research and Development Program of China (863 Program) [2011AA040902]; Program for New Century Excellent Talents in University of China [NCET-10-0021]; Top-Notch Young Talents Program of China [2012]; Fundamental Research Funds for the Central Universities of China [YWF-12-LZGF-059]; Innovation Foundation of BUAA for PhD Graduates [302953]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); Top-Notch Young Talents Program of China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Innovation Foundation of BUAA for PhD Graduates	This work was partially supported by Natural Science Foundation of China (NSFC) under grant #61273054, #60975072 and #60604009, National Key Basic Research Program of China under grant #2013CB035503, National High Technology Research and Development Program of China (863 Program) under grant #2011AA040902, Program for New Century Excellent Talents in University of China under grant #NCET-10-0021, Top-Notch Young Talents Program of China under grant #2012, Fundamental Research Funds for the Central Universities of China under grant #YWF-12-LZGF-059, and Innovation Foundation of BUAA for PhD Graduates under grant #302953. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basturk B., 2006, IEEE SWARM INT S, P12; Duan HB, 2010, INT J NEURAL SYST, V20, P39, DOI 10.1142/S012906571000222X; Duan Haibin, 2011, BIOINSPIRED COMPUTAT; Dusan Teodorovic F., 2005, ADV METHODS TRANSP, P51; Elazary L, 2010, VISION RES, V50, P1338, DOI 10.1016/j.visres.2010.01.002; Fathian M, 2007, APPL MATH COMPUT, V190, P1502, DOI 10.1016/j.amc.2007.02.029; Gao G, 2009, IEEE T GEOSCI REMOTE, V47, P1685, DOI 10.1109/TGRS.2008.2006504; Gu YF, 2010, IEEE GEOSCI REMOTE S, V7, P469, DOI 10.1109/LGRS.2009.2039192; Hartline HK, 1938, AM J PHYSIOL, V121, P400, DOI 10.1152/ajplegacy.1938.121.2.400; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Karaboga D, 2008, APPL SOFT COMPUT, V8, P687, DOI 10.1016/j.asoc.2007.05.007; Karaboga D., 2007, SIGNAL PROCESSING CO, P1, DOI [DOI 10.1109/SIU.2007.4298679, 10.1109/SIU.2007.4298679]; Karaboga D, 2007, LECT NOTES ARTIF INT, V4617, P318; Karaboga D, 2007, LECT NOTES COMPUT SC, V4529, P789, DOI 10.1007/978-3-540-72950-1_77; Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x; Karaboga N, 2009, J FRANKLIN I, V346, P328, DOI 10.1016/j.jfranklin.2008.11.003; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Lee K, 2005, IEEE T NEURAL NETWOR, V16, P910, DOI 10.1109/TNN.2005.851787; Malanowski M, 2012, IEEE T GEOSCI REMOTE, V50, P3502, DOI 10.1109/TGRS.2011.2181521; Marques RCP, 2009, IEEE T SYST MAN CY C, V39, P214, DOI 10.1109/TSMCC.2008.2006685; Miao J, 2010, IEEE T AUTON MENT DE, V2, P196, DOI 10.1109/TAMD.2010.2053365; Mundhenk TN, 2005, BIOL CYBERN, V93, P188, DOI 10.1007/s00422-005-0577-8; Qi SX, 2013, IEEE GEOSCI REMOTE S, V10, P495, DOI 10.1109/LGRS.2012.2211094; Siagian C, 2007, NEUROMORPHIC ENG, V1, P1; Singh A, 2009, APPL SOFT COMPUT, V9, P625, DOI 10.1016/j.asoc.2008.09.001; Sun YQ, 2007, OPTICAL ENG, V46, P116; Xu CF, 2010, PATTERN RECOGN LETT, V31, P1759, DOI 10.1016/j.patrec.2009.11.018; Xu CF, 2010, AEROSP SCI TECHNOL, V14, P535, DOI 10.1016/j.ast.2010.04.008; Yu C, 2009, IEEE T AUTON MENT DE, V1, P141, DOI 10.1109/TAMD.2009.2031513; Yu YL, 2012, IEEE T AUTON MENT DE, V4, P87, DOI 10.1109/TAMD.2011.2163513; Zhang B, 2007, IEEE AERO EL SYS MAG, V22, P20, DOI 10.1109/MAES.2007.4301021; Zi F, 2007, ICEMI 2007: PROCEEDINGS OF 2007 8TH INTERNATIONAL CONFERENCE ON ELECTRONIC MEASUREMENT & INSTRUMENTS, VOL II, P701	33	25	29	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72035	10.1371/journal.pone.0072035	http://dx.doi.org/10.1371/journal.pone.0072035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991033	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470100074
J	Labonne, J; Vignon, M; Prevost, E; Lecomte, F; Dodson, JJ; Kaeuffer, R; Aymes, JC; Jarry, M; Gaudin, P; Davaine, P; Beall, E				Labonne, Jacques; Vignon, Matthias; Prevost, Etienne; Lecomte, Frederic; Dodson, Julian J.; Kaeuffer, Renaud; Aymes, Jean-Christophe; Jarry, Marc; Gaudin, Philippe; Davaine, Patrick; Beall, Edward			Invasion Dynamics of a Fish-Free Landscape by Brown Trout (Salmo trutta)	PLOS ONE			English	Article							CLIMATE-CHANGE; METAPOPULATION DYNAMICS; ATLANTIC SALMON; BIOLOGICAL INVASIONS; KERGUELEN ISLANDS; DISPERSAL; IMPACTS; EVOLUTION; MODEL; RATES	Metapopulation dynamics over the course of an invasion are usually difficult to grasp because they require large and reliable data collection, often unavailable. The invasion of the fish-free freshwater ecosystems of the remote sub-Antarctic Kerguelen Islands following man-made introductions of brown trout (Salmo trutta) in the 1950's is an exception to this rule. Benefiting from a full long term environmental research monitoring of the invasion, we built a Bayesian dynamic metapopulation model to analyze the invasion dynamics of 85 river systems over 51 years. The model accounted for patch size (river length and connections to lakes), alternative dispersal pathways between rivers, temporal trends in dynamics, and uncertainty in colonization date. The results show that the model correctly represents the observed pattern of invasion, especially if we assume a coastal dispersal pathway between patches. Landscape attributes such as patch size influenced the colonization function, but had no effect on propagule pressure. Independently from patch size and distance between patches, propagule pressure and colonization function were not constant through time. Propagule pressure increased over the course of colonization, whereas the colonization function decreased, conditional on propagule pressure. The resulting pattern of this antagonistic interplay is an initial rapid invasion phase followed by a strong decrease in the invasion rate. These temporal trends may be due to either adaptive processes or environmental gradients encountered along the colonization front. It was not possible to distinguish these two hypotheses. Because invasibility of Kerguelen Is. freshwater ecosystems is very high due to the lack of a pre-existing fish fauna and minimal human interference, our estimates of invasion dynamics represent a blueprint for the potential of brown trout invasiveness in pristine environments. Our conclusions shed light on the future of polar regions where, because of climate change, fish-free ecosystems become increasingly accessible to invasion by fish species.	[Labonne, Jacques; Prevost, Etienne; Aymes, Jean-Christophe; Gaudin, Philippe; Davaine, Patrick; Beall, Edward] INRA, UMR 1224, ECOBIOP, St Pee Sur Nivelle, France; [Vignon, Matthias; Jarry, Marc] UPPA, UMR 1224, ECOBIOP, St Pee Sur Nivelle, France; [Lecomte, Frederic] Minist Ressources Nat & Faune Quebec, Quebec City, PQ, Canada; [Dodson, Julian J.] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Kaeuffer, Renaud] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; [Kaeuffer, Renaud] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	INRAE; Universite de Pau et des Pays de l'Adour; Universite de Pau et des Pays de l'Adour; Laval University; McGill University; McGill University	Labonne, J (corresponding author), INRA, UMR 1224, ECOBIOP, St Pee Sur Nivelle, France.	labonne@st-pee.inra.fr	Lecomte, Frederic/AAN-7766-2021; Vignon, Matthias/N-1122-2019	Vignon, Matthias/0000-0001-9222-8966; Lecomte, Frederic/0000-0002-8845-1249; Aymes, Jean-Christophe/0000-0002-1181-3010; Labonne, Jacques/0000-0001-5953-3029	French Polar Institute (IPEV)	French Polar Institute (IPEV)	This study is a part of the SALMEVOL-1041 research program supported by the French Polar Institute (IPEV http://http://www.institut-polaire.fr/) for data collection and logistic support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, QUANTITATIVE ECOLOGY; Ayllon F, 2004, AQUACULTURE, V230, P81, DOI 10.1016/S0044-8486(03)00435-6; Berthier E, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001192; Bonduriansky R, 2011, AM NAT, V178, P729, DOI 10.1086/662665; Bromwich DH, 2013, NAT GEOSCI, V6, P139, DOI [10.1038/NGEO1671, 10.1038/ngeo1671]; Carlton JT, 1996, BIOL CONSERV, V78, P97, DOI 10.1016/0006-3207(96)00020-1; Chapman DS, 2007, J ANIM ECOL, V76, P36, DOI 10.1111/j.1365-2656.2006.01172.x; Chown SL, 2012, SCIENCE, V337, P158, DOI 10.1126/science.1222821; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Correa C, 2012, ECOL APPL, V22, P828, DOI 10.1890/11-1174.1; Davaine P., 1982, CNFRA, P399; DELETTRE YR, 1978, REV ECOL BIOL SOL, V15, P475; Elton C. S., 1958, ECOLOGY INVASIONS AN; Facon B, 2006, AM NAT, V168, P769, DOI 10.1086/508669; Fausch KD, 2008, BIOL INVASIONS, V10, P685, DOI 10.1007/s10530-007-9162-5; Frenot Y, 2005, BIOL REV, V80, P45, DOI 10.1017/S1464793104006542; FRENOT Y, 1993, OECOLOGIA, V95, P140, DOI 10.1007/BF00649517; Friedland KD, 2012, POLAR BIOL, V35, P593, DOI 10.1007/s00300-011-1105-z; Gay C, 1981, COM NATL FRANC RECH, V47, P43; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Graham CT, 2009, J FISH BIOL, V74, P1143, DOI 10.1111/j.1095-8649.2009.02180.x; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Habit E, 2012, DIVERS DISTRIB, V18, P1153, DOI 10.1111/j.1472-4642.2012.00906.x; Hanski I., 1999, METAPOPULATION ECOLO; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Hendry AP, 2007, FUNCT ECOL, V21, P455, DOI 10.1111/j.1365-2435.2007.01240.x; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hinzman LD, 2005, CLIMATIC CHANGE, V72, P251, DOI 10.1007/s10584-005-5352-2; Hocking MD, 2011, SCIENCE, V331, P1609, DOI 10.1126/science.1201079; Hof AR, 2012, DIVERS DISTRIB, V18, P554, DOI 10.1111/j.1472-4642.2011.00876.x; Holt RD, 2011, AM NAT, V178, pS6, DOI 10.1086/661784; Jarry M, 1998, ACTA BIOTHEOR, V46, P253, DOI 10.1023/A:1001789211146; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Jonsson N, 2004, J FISH BIOL, V64, P241, DOI 10.1111/j.1095-8649.2004.00269.x; Knutsen JA, 2001, J FISH BIOL, V59, P533, DOI 10.1111/j.1095-8649.2001.tb02359.x; Korsu K, 2007, P NATL ACAD SCI USA, V104, P9725, DOI 10.1073/pnas.0610719104; KRUEGER CC, 1991, CAN J FISH AQUAT SCI, V48, P66, DOI 10.1139/f91-305; Lamy T, 2012, MOL ECOL, V21, P1394, DOI 10.1111/j.1365-294X.2012.05478.x; Lapointe NWR, 2012, BIOL INVASIONS, V14, P1931, DOI 10.1007/s10530-012-0204-2; Lebouvier M, 2011, BIOL INVASIONS, V13, P1195, DOI 10.1007/s10530-011-9946-5; Lecomte F, 2013, POLAR BIOL, V36, P457, DOI 10.1007/s00300-012-1281-5; Lenda M, 2010, J BIOGEOGR, V37, P1824, DOI 10.1111/j.1365-2699.2010.02344.x; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Lyse AA, 1998, J FISH BIOL, V52, P923, DOI 10.1111/j.1095-8649.1998.tb00593.x; McDowall RM, 2008, FISH FISH, V9, P208, DOI 10.1111/j.1467-2979.2008.00271.x; McIntosh AR, 2010, NEW ZEAL J ECOL, V34, P195; Middlemas SJ, 2009, J FISH BIOL, V74, P639, DOI 10.1111/j.1095-8649.2008.02154.x; Milner AM, 2009, HYDROL PROCESS, V23, P62, DOI 10.1002/hyp.7197; Nolte AW, 2011, MOL ECOL, V20, P1803, DOI 10.1111/j.1365-294X.2011.05083.x; North A, 2011, EVOLUTION, V65, P79, DOI 10.1111/j.1558-5646.2010.01107.x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Peterson BJ, 2002, SCIENCE, V298, P2171, DOI 10.1126/science.1077445; Rikardsen AH, 2005, J FISH BIOL, V66, P1163, DOI 10.1111/j.0022-1112.2005.00655.x; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Tannerfeldt M, 2002, OECOLOGIA, V132, P213, DOI 10.1007/s00442-002-0967-8; Todd CD, 2008, GLOBAL CHANGE BIOL, V14, P958, DOI 10.1111/j.1365-2486.2007.01522.x; Travis JMJ, 2010, J EVOLUTION BIOL, V23, P2656, DOI 10.1111/j.1420-9101.2010.02123.x; Travis JMJ, 2009, J THEOR BIOL, V259, P151, DOI 10.1016/j.jtbi.2009.03.008; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Westley PAH, 2011, DIVERS DISTRIB, V17, P566, DOI 10.1111/j.1472-4642.2011.00751.x; Wojtenka J., 1982, COM NATL FRANC RECH, V51, P413; Young KA, 2010, ANIM CONSERV, V13, P399, DOI 10.1111/j.1469-1795.2010.00354.x	62	13	13	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71052	10.1371/journal.pone.0071052	http://dx.doi.org/10.1371/journal.pone.0071052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990925	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100037
J	Pohl, A; Anders, S; Schulte-Ruther, M; Mathiak, K; Kircher, T				Pohl, Anna; Anders, Silke; Schulte-Ruether, Martin; Mathiak, Klaus; Kircher, Tilo			Positive Facial Affect - An fMRI Study on the Involvement of Insula and Amygdala	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; EMOTIONAL RESPONSES; ANTERIOR INSULA; BROCAS AREA; IMITATION; EXPRESSIONS; METAANALYSIS; ACTIVATION; BRAIN; MECHANISMS	Imitation of facial expressions engages the putative human mirror neuron system as well as the insula and the amygdala as part of the limbic system. The specific function of the latter two regions during emotional actions is still under debate. The current study investigated brain responses during imitation of positive in comparison to non-emotional facial expressions. Differences in brain activation of the amygdala and insula were additionally examined during observation and execution of facial expressions. Participants imitated, executed and observed happy and non-emotional facial expressions, as well as neutral faces. During imitation, higher right hemispheric activation emerged in the happy compared to the non-emotional condition in the right anterior insula and the right amygdala, in addition to the pre-supplementary motor area, middle temporal gyrus and the inferior frontal gyrus. Region-of-interest analyses revealed that the right insula was more strongly recruited by (i) imitation and execution than by observation of facial expressions, that (ii) the insula was significantly stronger activated by happy than by non-emotional facial expressions during observation and imitation and that (iii) the activation differences in the right amygdala between happy and non-emotional facial expressions were increased during imitation and execution, in comparison to sole observation. We suggest that the insula and the amygdala contribute specifically to the happy emotional connotation of the facial expressions depending on the task. The pattern of the insula activity might reflect increased bodily awareness during active execution compared to passive observation and during visual processing of the happy compared to non-emotional facial expressions. The activation specific for the happy facial expression of the amygdala during motor tasks, but not in the observation condition, might reflect increased autonomic activity or feedback from facial muscles to the amygdala.	[Pohl, Anna; Mathiak, Klaus] Rheinisch Westfal Tech Hsch Aachen Univ, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Pohl, Anna] Rheinisch Westfal Tech Hsch Aachen Univ, Cent Serv Facil Funct Imaging, Interdisciplinary Ctr Clin Res, Aachen, Germany; [Pohl, Anna; Schulte-Ruether, Martin; Mathiak, Klaus] Julich Aachen Res Alliance Translat Brain Med, Julich, Germany; [Pohl, Anna] Rheinisch Westfal Tech Hsch Aachen Univ, Dept Neurol, Aachen, Germany; [Anders, Silke] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Schulte-Ruether, Martin; Mathiak, Klaus] Res Ctr Julich, Inst Neurosci & Med, Julich, Germany; [Schulte-Ruether, Martin] Rheinisch Westfal Tech Hsch Aachen Univ, Child Neuropsychol Sect, Dept Child & Adolescent Psychiat, Aachen, Germany; [Kircher, Tilo] Univ Marburg, Dept Psychiat & Psychotherapy, Marburg, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; University of Lubeck; Helmholtz Association; Research Center Julich; RWTH Aachen University; Philipps University Marburg	Pohl, A (corresponding author), Rheinisch Westfal Tech Hsch Aachen Univ, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany.	anpohl@ukaachen.de	, Martin/F-4784-2013; Kircher, Tilo/AAT-6480-2020; Pohl, Anna/ACD-5340-2022	, Martin/0000-0002-7198-9923; Kircher, Tilo/0000-0002-2514-2625; Pohl, Anna/0000-0002-3761-5768	Federal Ministry of Education and Research [BMBF] [FKZ 01GW0751]; Interdisciplinary Centre for Clinical Research of the Medical faculty of the RWTH Aachen University [IZKF] [N2-6]	Federal Ministry of Education and Research [BMBF](Federal Ministry of Education & Research (BMBF)); Interdisciplinary Centre for Clinical Research of the Medical faculty of the RWTH Aachen University [IZKF]	This study was funded by the Federal Ministry of Education and Research [BMBF, FKZ 01GW0751] and the Interdisciplinary Centre for Clinical Research of the Medical faculty of the RWTH Aachen University [IZKF, N2-6]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELMANN PK, 1989, ANNU REV PSYCHOL, V40, P249, DOI 10.1146/annurev.ps.40.020189.001341; Anders S, 2004, HUM BRAIN MAPP, V23, P200, DOI 10.1002/hbm.20048; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J., 2003, HUMAN BRAIN FUNCTION; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Bien N, 2009, CEREB CORTEX, V19, P2338, DOI 10.1093/cercor/bhn251; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Caspers S, 2006, NEUROIMAGE, V33, P430, DOI 10.1016/j.neuroimage.2006.06.054; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Chen YH, 2009, NEUROIMAGE, V47, P1921, DOI 10.1016/j.neuroimage.2009.04.093; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 2002, COGNITION EMOTION, V16, P449, DOI 10.1080/02699930143000356; Dyck M, 2010, NEUROIMAGE; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ekman P, 1978, FACIAL ACTION CODING; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; Heiser M, 2003, EUR J NEUROSCI, V17, P1123, DOI 10.1046/j.1460-9568.2003.02530.x; Hennenlotter A, 2005, NEUROIMAGE, V26, P581, DOI 10.1016/j.neuroimage.2005.01.057; Hennenlotter A, 2009, CEREB CORTEX, V19, P537, DOI 10.1093/cercor/bhn104; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jabbi M, 2008, EMOTION, V8, P775, DOI 10.1037/a0014194; Keysers C, 2006, PROG BRAIN RES, V156, P379, DOI 10.1016/S0079-6123(06)56021-2; Kircher T., 2012, SOCIAL COGNITIVE AFF; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Kuhn S, 2010, SOC NEUROSCI-UK, V5, P384, DOI 10.1080/17470911003633750; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee Thomas E. Jr., 2006, Mammalian Species, P1; Lee TW, 2008, CEREB CORTEX, V18, P104, DOI 10.1093/cercor/bhm035; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Makuuchi M, 2005, CEREB CORTEX, V15, P563, DOI 10.1093/cercor/bhh157; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mathiak KA, 2012, MAGN RESON MATER PHY, V25, P177, DOI 10.1007/s10334-011-0285-4; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; Molenberghs P, 2009, NEUROSCI BIOBEHAV R, V33, P975, DOI 10.1016/j.neubiorev.2009.03.010; Montgomery KJ, 2008, J COGNITIVE NEUROSCI, V20, P1866, DOI 10.1162/jocn.2008.20127; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Stel M, 2010, BRIT J PSYCHOL, V101, P311, DOI 10.1348/000712609X465424; van der Gaag C, 2007, SOC NEUROSCI-UK, V2, P179, DOI 10.1080/17470910701376878; van der Gaag C, 2007, SOC COGN AFFECT NEUR, V2, P93, DOI 10.1093/scan/nsm002; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Williamson RA, 2010, DEV PSYCHOL, V46, P57, DOI 10.1037/a0017473; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039	55	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e69886	10.1371/journal.pone.0069886	http://dx.doi.org/10.1371/journal.pone.0069886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990890	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100015
J	Walther, C; Schweinberger, SR; Kovacs, G				Walther, Christian; Schweinberger, Stefan R.; Kovacs, Gyula			Adaptor Identity Modulates Adaptation Effects in Familiar Face Identification and Their Neural Correlates	PLOS ONE			English	Article							PERCEPTUAL ADAPTATION; VISUAL-ADAPTATION; TEMPORAL CORTEX; BRAIN RESPONSE; SHAPE; RECOGNITION; SELECTIVITY; REPETITION; ACCOUNT; N250R	Adaptation-related aftereffects (AEs) show how face perception can be altered by recent perceptual experiences. Along with contrastive behavioural biases, modulations of the early event-related potentials (ERPs) were typically reported on categorical levels. Nevertheless, the role of the adaptor stimulus per se for face identity-specific AEs is not completely understood and was therefore investigated in the present study. Participants were adapted to faces (S1s) varying systematically on a morphing continuum between pairs of famous identities (identities A and B), or to Fourier phase-randomized faces, and had to match the subsequently presented ambiguous faces (S2s; 50/50% identity A/B) to one of the respective original faces. We found that S1s identical with or near to the original identities led to strong contrastive biases with more identity B responses following A adaptation and vice versa. In addition, the closer S1s were to the 50/50% S2 on the morphing continuum, the smaller the magnitude of the AE was. The relation between S1s and AE was, however, not linear. Additionally, stronger AEs were accompanied by faster reaction times. Analyses of the simultaneously recorded ERPs revealed categorical adaptation effects starting at 100 ms post-stimulus onset, that were most pronounced at around 125-240 ms for occipito-temporal sites over both hemispheres. S1-specific amplitude modulations were found at around 300-400 ms. Response-specific analyses of ERPs showed reduced voltages starting at around 125 ms when the S1 biased perception in a contrastive way as compared to when it did not. Our results suggest that face identity AEs do not only depend on physical differences between S1 and S2, but also on perceptual factors, such as the ambiguity of S1. Furthermore, short-term plasticity of face identity processing might work in parallel to object-category processing, and is reflected in the first 400 ms of the ERP.	[Walther, Christian; Schweinberger, Stefan R.; Kovacs, Gyula] Univ Jena, DFG Res Unit Person Percept, Jena, Germany; [Walther, Christian] Univ Regensburg, Inst Psychol, D-93053 Regensburg, Germany; [Schweinberger, Stefan R.] Univ Jena, Dept Gen Psychol & Cognit Neurosci, Jena, Germany; [Kovacs, Gyula] Univ Jena, Inst Psychol, Jena, Germany; [Kovacs, Gyula] Budapest Univ Technol & Econ, Dept Cognit Sci, Budapest, Hungary	Friedrich Schiller University of Jena; University of Regensburg; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Budapest University of Technology & Economics	Walther, C (corresponding author), Univ Jena, DFG Res Unit Person Percept, Jena, Germany.	christian.walther@uni-jena.de	Kovacs, Gyula/E-4781-2010; Schweinberger, Stefan/A-1860-2009	Schweinberger, Stefan/0000-0001-5762-0188	Deutsche Forschungsgemeinschaft (DFG) [KO 3918/1-1, Ko 3918/2-1]; funding programme Open Access Publishing	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); funding programme Open Access Publishing	This work was supported by the Deutsche Forschungsgemeinschaft (DFG; URL: http://www.dfg.de) with grants to GK (KO 3918/1-1, Ko 3918/2-1) and within the funding programme Open Access Publishing (URL: http://oa.uni-regensburg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amihai I, 2011, EXP BRAIN RES, V209, P193, DOI 10.1007/s00221-011-2546-x; Anstis S, 1998, TRENDS COGN SCI, V2, P111, DOI 10.1016/S1364-6613(98)01142-5; Banko EM, 2011, J NEUROSCI, V31, P2663, DOI 10.1523/JNEUROSCI.2725-10.2011; BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; Bindemann M, 2008, PSYCHOPHYSIOLOGY, V45, P535, DOI 10.1111/j.1469-8986.2008.00663.x; Burkhardt A, 2010, NEUROPSYCHOLOGIA, V48, P3743, DOI 10.1016/j.neuropsychologia.2010.08.016; Clifford CWG, 2000, P ROY SOC B-BIOL SCI, V267, P1705, DOI 10.1098/rspb.2000.1198; Cziraki C, 2010, J NEUROPHYSIOL, V103, P1410, DOI 10.1152/jn.00582.2009; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Furl N, 2007, NEUROIMAGE, V37, P300, DOI 10.1016/j.neuroimage.2007.04.057; Ganis G, 2012, NEUROIMAGE, V62, P1563, DOI 10.1016/j.neuroimage.2012.05.043; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Harris A, 2007, CEREB CORTEX, V17, P63, DOI 10.1093/cercor/bhj124; Hills PJ, 2010, J EXP PSYCHOL HUMAN, V36, P876, DOI 10.1037/a0018731; Hole G, 2011, COGNITION, V119, P216, DOI 10.1016/j.cognition.2011.01.011; Jaquet E, 2007, Q J EXP PSYCHOL, V60, P1457, DOI 10.1080/17470210701467870; Jenkins R, 2006, PSYCHOL SCI, V17, P506, DOI 10.1111/j.1467-9280.2006.01736.x; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kaufmann JM, 2012, BIOL PSYCHOL, V89, P21, DOI 10.1016/j.biopsycho.2011.08.011; Kloth N, 2010, J COGNITIVE NEUROSCI, V22, P2345, DOI 10.1162/jocn.2009.21329; Kloth N, 2008, J VISION, V8, DOI 10.1167/8.11.4; Kovacs G, 2006, CEREB CORTEX, V16, P742, DOI 10.1093/cercor/bhj020; Kovacs G, 2008, NEUROIMAGE, V43, P156, DOI 10.1016/j.neuroimage.2008.06.042; Kovacs G, 2007, VISION RES, V47, P3141, DOI 10.1016/j.visres.2007.08.019; Laurence S, 2011, PERCEPTION, V40, P450, DOI 10.1068/p6774; Leopold DA, 2005, P ROY SOC B-BIOL SCI, V272, P897, DOI 10.1098/rspb.2004.3022; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Megreya AM, 2006, MEM COGNITION, V34, P865, DOI 10.3758/BF03193433; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; Oruc I, 2011, P ROY SOC B-BIOL SCI, V278, P2591, DOI 10.1098/rspb.2010.2480; Philiastides MG, 2006, J NEUROSCI, V26, P8965, DOI 10.1523/JNEUROSCI.1655-06.2006; Rhodes G, 2004, CURR BIOL, V14, P2119, DOI 10.1016/j.cub.2004.11.053; Rhodes G, 2007, VISION RES, V47, P2291, DOI 10.1016/j.visres.2007.05.012; Rhodes G, 2010, VISION RES, V50, P963, DOI 10.1016/j.visres.2010.03.003; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Schulz C, 2012, NEUROIMAGE, V63, P491, DOI 10.1016/j.neuroimage.2012.06.080; Schulz C, 2012, NEUROPSYCHOLOGIA, V50, P2426, DOI 10.1016/j.neuropsychologia.2012.06.013; Schweinberger S. R, 2011, OXFORD HDB FACE PERC, P345, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0018; Schweinberger SR, 2004, NEUROREPORT, V15, P1501, DOI 10.1097/01.wnr.0000131675.00319.42; Schweinberger SR, 2002, COGNITIVE BRAIN RES, V14, P398, DOI 10.1016/S0926-6410(02)00142-8; Schweinberger SR, 2002, NEUROPSYCHOLOGIA, V40, P2057, DOI 10.1016/S0028-3932(02)00050-7; Schweinberger SR, 2010, VISION RES, V50, P2570, DOI 10.1016/j.visres.2010.08.017; Theodoni P, 2011, J NEUROSCI, V31, P234, DOI 10.1523/JNEUROSCI.2757-10.2011; Thierry G, 2007, NAT NEUROSCI, V10, P505, DOI 10.1038/nn1864; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Walther C, 2013, CORTEX, V49, P1963, DOI 10.1016/j.cortex.2012.08.012; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Yamashita JA, 2005, J EXP PSYCHOL HUMAN, V31, P420, DOI 10.1037/0096-1523.31.3.420; Zimmer M, 2011, Q J EXP PSYCHOL, V64, P533, DOI 10.1080/17470218.2010.501964	52	7	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e70525	10.1371/journal.pone.0070525	http://dx.doi.org/10.1371/journal.pone.0070525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218YW	23990908	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100028
J	Chen, LL; Zhu, JM; Li, YH; Lu, J; Gao, L; Xu, HB; Fan, MW; Yang, XL				Chen, Liulin; Zhu, Junming; Li, Yuhong; Lu, Jie; Gao, Li; Xu, Huibi; Fan, Mingwen; Yang, Xiangliang			Enhanced Nasal Mucosal Delivery and Immunogenicity of Anti-Caries DNA Vaccine through Incorporation of Anionic Liposomes in Chitosan/DNA Complexes	PLOS ONE			English	Article							INTRANASAL IMMUNIZATION; MOLECULAR-WEIGHT; CELLULAR UPTAKE; IN-VITRO; NANOPARTICLES; INFLUENZA; IMPROVEMENT; MEMBRANE; TOXICITY; IMMUNITY	The design of optimized nanoparticles offers a promising strategy to enable DNA vaccines to cross various physiological barriers for eliciting a specific and protective mucosal immunity via intranasal administration. Here, we reported a new designed nanoparticle system through incorporating anionic liposomes (AL) into chitosan/DNA (CS/DNA) complexes. With enhanced cellular uptake, the constructed AL/CS/DNA nanoparticles can deliver the anti-caries DNA vaccine pGJA-P/VAX into nasal mucosa. TEM results showed the AL/CS/DNA had a spherical structure. High DNA loading ability and effective DNA protection against nuclease were proved by gel electrophoresis. The surface charge of the AL/CS/DNA depended strongly on pH environment, enabling the intracellular release of loaded DNA via a pH-mediated manner. In comparison to the traditional CS/DNA system, our new design rendered a higher transfection efficiency and longer residence time of the AL/CS/DNA at nasal mucosal surface. These outstanding features enable the AL/CS/DNA to induce a significantly (p<0.01) higher level of secretory IgA (SIgA) than the CS/DNA in animal study, and a longer-term mucosal immunity. On the other hand, the AL/CS/DNA exhibited minimal cytotoxicity. These results suggest that the developed nanoparticles offer a potential platform for DNA vaccine packaging and delivery for more efficient elicitation of mucosal immunity.	[Chen, Liulin; Zhu, Junming; Lu, Jie; Gao, Li; Xu, Huibi; Yang, Xiangliang] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Natl Engn Res Ctr Nanomed, Wuhan 430074, Peoples R China; [Li, Yuhong; Fan, Mingwen] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed Engn, Wuhan 430072, Peoples R China	Huazhong University of Science & Technology; Wuhan University	Fan, MW (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed Engn, Wuhan 430072, Peoples R China.	kqyywjtx@public.wh.hb.cn; yangxl@mail.hust.edu.cn	li, Yu/HCI-9086-2022; Li, yu/HHZ-5236-2022; li, yu/HGL-9518-2022		Science and Technology Supporting Plan Foundation of China [NCET-06-0615]	Science and Technology Supporting Plan Foundation of China	This study was supported by grant NCET-06-0615 from the Science and Technology Supporting Plan Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita H, 2009, BIOMATERIALS, V30, P2940, DOI 10.1016/j.biomaterials.2009.02.009; ARAMAKI Y, 1993, PHARM RES-DORDR, V10, P1228, DOI 10.1023/A:1018936806278; Barackman JD, 1999, INFECT IMMUN, V67, P4276, DOI 10.1128/IAI.67.8.4276-4279.1999; Bot A, 2002, MICROBES INFECT, V4, P511, DOI 10.1016/S1286-4579(02)01566-6; Chae SY, 2005, J CONTROL RELEASE, V109, P330, DOI 10.1016/j.jconrel.2005.09.040; Chavanpatil MD, 2006, J NANOSCI NANOTECHNO, V6, P2651, DOI 10.1166/jnn.2006.443; Csaba N, 2009, ADV DRUG DELIVER REV, V61, P140, DOI 10.1016/j.addr.2008.09.005; Debin A, 2002, VACCINE, V20, P2752, DOI 10.1016/S0264-410X(02)00191-3; Douglas KL, 2006, J CONTROL RELEASE, V115, P354, DOI 10.1016/j.jconrel.2006.08.021; England RJA, 1999, CLIN OTOLARYNGOL, V24, P67, DOI 10.1046/j.1365-2273.1999.00223.x; Fan MW, 2002, J DENT RES, V81, P784, DOI 10.1177/0810784; Filion MC, 1997, BBA-BIOMEMBRANES, V1329, P345, DOI 10.1016/S0005-2736(97)00126-0; Fillion P, 2001, BBA-BIOMEMBRANES, V1515, P44, DOI 10.1016/S0005-2736(01)00392-3; Guo JH, 2004, J DENT RES, V83, P266; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Hagenaars N, 2010, J CONTROL RELEASE, V144, P17, DOI 10.1016/j.jconrel.2010.01.027; Hamman JH, 2002, INT J PHARMACEUT, V232, P235, DOI 10.1016/S0378-5173(01)00914-0; He P, 1998, INT J PHARMACEUT, V166, P75, DOI 10.1016/S0378-5173(98)00027-1; Illum L, 1998, PHARM RES-DORDR, V15, P1326; Illum L, 2007, J PHARM SCI-US, V96, P473, DOI 10.1002/jps.20718; Jepson MA, 2004, ADV DRUG DELIVER REV, V56, P511, DOI 10.1016/j.addr.2003.10.018; Jia R, 2006, VACCINE, V24, P5192, DOI 10.1016/j.vaccine.2006.03.090; Khatri K, 2008, VACCINE, V26, P2225, DOI 10.1016/j.vaccine.2008.02.058; Khatri K, 2008, INT J PHARMACEUT, V354, P235, DOI 10.1016/j.ijpharm.2007.11.027; Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029; Lee PW, 2010, BIOMATERIALS, V31, P2425, DOI 10.1016/j.biomaterials.2009.11.100; Liao ZX, 2010, BIOMATERIALS, V31, P8780, DOI 10.1016/j.biomaterials.2010.07.086; Lin YH, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105102; Liu C, 2008, VACCINE, V26, P6685, DOI 10.1016/j.vaccine.2008.08.041; Liu GX, 2009, VACCINE, V27, P2940, DOI 10.1016/j.vaccine.2009.03.009; Liu MA, 1997, P NATL ACAD SCI USA, V94, P10496, DOI 10.1073/pnas.94.20.10496; Mansouri S, 2006, BIOMATERIALS, V27, P2060, DOI 10.1016/j.biomaterials.2005.09.020; Nam HY, 2009, J CONTROL RELEASE, V135, P259, DOI 10.1016/j.jconrel.2009.01.018; Natsume H, 1999, INT J PHARM, V185, P1, DOI 10.1016/S0378-5173(99)00100-3; Nguyen DN, 2009, ADV MATER, V21, P847, DOI 10.1002/adma.200801478; Palumbo RN, 2012, J CONTROL RELEASE, V157, P86, DOI 10.1016/j.jconrel.2011.08.037; Peng SF, 2009, BIOMATERIALS, V30, P1797, DOI 10.1016/j.biomaterials.2008.12.019; Raghuwanshi D, 2012, MOL PHARMACEUT, V9, P946, DOI 10.1021/mp200553x; Sanden T, 2010, P NATL ACAD SCI USA, V107, P4129, DOI 10.1073/pnas.0908671107; Schaffer DV, 2000, BIOTECHNOL BIOENG, V67, P598, DOI 10.1002/(SICI)1097-0290(20000305)67:5<598::AID-BIT10>3.0.CO;2-G; Slutter B, 2010, MOL PHARMACEUT, V7, P2207, DOI 10.1021/mp100210g; Srinivasan C, 2009, J CONTROL RELEASE, V71, P445; Szoka FC, 1997, ADV DRUG DELIVER REV, V24, P291, DOI 10.1016/S0169-409X(96)00470-X; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; van der Lubben IM, 2001, ADV DRUG DELIVER REV, V52, P139, DOI 10.1016/S0169-409X(01)00197-1; Vaughan K, 2005, VACCINE, V23, P2928, DOI 10.1016/j.vaccine.2004.10.046; WANG B, 1993, P NATL ACAD SCI USA, V90, P4156, DOI 10.1073/pnas.90.9.4156; Wang DQ, 2004, J CLIN VIROL, V31, pS99, DOI 10.1016/j.jcv.2004.09.013; Wang X, 2008, VACCINE, V26, P5135, DOI 10.1016/j.vaccine.2008.03.088; Xu QA, 2006, J DENT RES, V85, P915, DOI 10.1177/154405910608501008; Xu QA, 2005, CARIES RES, V39, P422, DOI 10.1159/000086851; Zhou XF, 2008, BIOMATERIALS, V29, P111, DOI 10.1016/j.biomaterials.2007.09.007	52	30	34	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71953	10.1371/journal.pone.0071953	http://dx.doi.org/10.1371/journal.pone.0071953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977186	Green Submitted, gold, Green Published			2022-12-25	WOS:000324527300056
J	Pierce, LR; Willey, JC; Palsule, VV; Yeo, J; Shepherd, BS; Crawford, EL; Stepien, CA				Pierce, Lindsey R.; Willey, James C.; Palsule, Vrushalee V.; Yeo, Jiyoun; Shepherd, Brian S.; Crawford, Erin L.; Stepien, Carol A.			Accurate Detection and Quantification of the Fish Viral Hemorrhagic Septicemia virus (VHSv) with a Two-Color Fluorometric Real-Time PCR Assay	PLOS ONE			English	Article							QUANTITATIVE RT-PCR; POLYMERASE CHAIN-REACTION; GREAT-LAKES; MOLECULAR DIAGNOSIS; RAPID DETECTION; PERFORMANCE; VALIDATION; USA; DIVERSITY; GENOTYPE	Viral Hemorrhagic Septicemia virus (VHSv) is one of the world's most serious fish pathogens, infecting >80 marine, freshwater, and estuarine fish species from Eurasia and North America. A novel and especially virulent strain - IVb - appeared in the Great Lakes in 2003, has killed many game fish species in a series of outbreaks in subsequent years, and shut down interstate transport of baitfish. Cell culture is the diagnostic method approved by the USDA-APHIS, which takes a month or longer, lacks sensitivity, and does not quantify the amount of virus. We thus present a novel, easy, rapid, and highly sensitive real-time quantitative reverse transcription PCR (qRT-PCR) assay that incorporates synthetic competitive template internal standards for quality control to circumvent false negative results. Results demonstrate high signal-to-analyte response (slope = 1.00 +/- 0.02) and a linear dynamic range that spans seven orders of magnitude (R-2 = 0.99), ranging from 6 to 6,000,000 molecules. Infected fishes are found to harbor levels of virus that range to 1,200,000 VHSv molecules/10(6) actb1 molecules with 1,000 being a rough cut-off for clinical signs of disease. This new assay is rapid, inexpensive, and has significantly greater accuracy than other published qRT-PCR tests and traditional cell culture diagnostics.	[Pierce, Lindsey R.; Palsule, Vrushalee V.; Stepien, Carol A.] Univ Toledo, Lake Erie Ctr, Great Lakes Genet Genom Lab, Toledo, OH 43606 USA; [Pierce, Lindsey R.; Palsule, Vrushalee V.; Stepien, Carol A.] Univ Toledo, Dept Environm Sci, Toledo, OH 43606 USA; [Willey, James C.; Yeo, Jiyoun; Crawford, Erin L.] Univ Toledo, Dept Med, Toledo, OH 43606 USA; [Shepherd, Brian S.] Univ Wisconsin, ARS, USDA, Sch Freshwater Sci, Milwaukee, WI 53201 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Milwaukee	Stepien, CA (corresponding author), Univ Toledo, Lake Erie Ctr, Great Lakes Genet Genom Lab, 2801 W Bancroft St, Toledo, OH 43606 USA.	carol.stepien@utoledo.edu	Stepien, Carol Ann/GWU-8631-2022; A.Stepien, Carol/AAW-5270-2020; Stepien, Carol A./A-7898-2011	Stepien, Carol A./0000-0002-5544-4333	NOAA Ohio Sea Grant [R/LR-015]; USDA-NIFA (CSREES) [2008-38927-19156, 2009-38927-20043, 2010-38927-21048]; USDA-ARS CRIS project [3655-31320-002-00D, 58-3655-9-748 A01, R21 CA 138397]; NSF [GK-12 #DGE-0742395]; NSF-DDIG [1110495]; Direct For Biological Sciences [1110495] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1034791] Funding Source: National Science Foundation	NOAA Ohio Sea Grant; USDA-NIFA (CSREES); USDA-ARS CRIS project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NSF(National Science Foundation (NSF)); NSF-DDIG(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the following grants: NOAA Ohio Sea Grant #R/LR-015 (to CAS, JCW), USDA-NIFA (CSREES) #2008-38927-19156, #2009-38927-20043, #2010-38927-21048 (to CAS, JCW), USDA-ARS CRIS project #3655-31320-002-00D, under the specific cooperative agreement #58-3655-9-748 A01 (to CAS, JCW, BSS), R21 CA 138397 (to JCW), NSF GK-12 #DGE-0742395 (to CAS), and NSF-DDIG #1110495 (to LRP, CAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammayappan A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-171; [Anonymous], 2012, LANG ENV STAT COMP; [Anonymous], 2011, VIR HEM SEPT VIR; [Anonymous], 2004, 815B04001 EPA; Bain MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010156; Brunson R., 1989, AM FISH SOC FISH HLT, V17, P3; Chai Z, 2013, ARCH VIROL, V158, P407, DOI 10.1007/s00705-012-1504-7; Chico V, 2006, J VIROL METHODS, V132, P154, DOI 10.1016/j.jviromet.2005.10.005; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COUTLEE F, 1991, MOL CELL PROBE, V5, P241, DOI 10.1016/0890-8508(91)90046-M; Cutrin JM, 2009, J VIROL METHODS, V162, P155, DOI 10.1016/j.jviromet.2009.07.033; Ellis JS, 2002, REV MED VIROL, V12, P375, DOI 10.1002/rmv.370; Elsayed E, 2006, J FISH DIS, V29, P611, DOI 10.1111/j.1365-2761.2006.00755.x; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Faisal M, 2012, VIRUSES-BASEL, V4, P734, DOI 10.3390/v4050734; Faisal M, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-2; Food and Drug Adminitration, 2010, GUID IND FO IN PRESS; Gagne N, 2007, J FISH DIS, V30, P213, DOI 10.1111/j.1365-2761.2007.00802.x; Garver KA, 2011, DIS AQUAT ORGAN, V95, P97, DOI 10.3354/dao02344; Gelderblom HC, 2006, ANTIVIR THER, V11, P95; Goodwin AE, 2011, DIS AQUAT ORGAN, V94, P173, DOI 10.3354/dao02328; Hawley LM, 2008, DIS AQUAT ORGAN, V82, P171, DOI 10.3354/dao01998; Hope KM, 2010, J AQUAT ANIM HEALTH, V22, P50, DOI 10.1577/H09-028.1; Hopper K, 1989, FISH HLTH SECT AM FI, V17, P1; Huggett Jim F, 2008, BMC Res Notes, V1, P70, DOI 10.1186/1756-0500-1-70; International Organization for Standardization, 2005, 22174 BS EN ISO; Jonstrup SP, 2013, J FISH DIS, V36, P9, DOI 10.1111/j.1365-2761.2012.01416.x; Liu ZX, 2008, J VIROL METHODS, V149, P103, DOI 10.1016/j.jviromet.2007.12.017; Lopez-Vazquez C, 2006, J VIROL METHODS, V133, P167, DOI 10.1016/j.jviromet.2005.10.033; Matejusova I, 2008, DIS AQUAT ORGAN, V80, P137, DOI 10.3354/dao01911; Meyers Theodore R., 1995, Annual Review of Fish Diseases, V5, P3, DOI 10.1016/0959-8030(95)00002-X; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Olesen NJ, 2013, MANUAL DIAGNOSTIC TE, P347; Park S, 2011, BIOTECHNOL ADV, V29, P830, DOI 10.1016/j.biotechadv.2011.06.017; Pasche JS, 2013, PLANT DIS, V97, P608, DOI 10.1094/PDIS-06-12-0554-RE; Phelps NBD, 2012, J AQUAT ANIM HEALTH, V24, P238, DOI 10.1080/08997659.2012.711268; Pierce LR, 2013, J VIROL METHODS, V189, P129, DOI 10.1016/j.jviromet.2013.01.006; Pierce LR, 2012, MOL PHYLOGENET EVOL, V63, P327, DOI 10.1016/j.ympev.2011.12.024; Rao JR, 2006, MOL DIAGNOSTICS CURR; Rosauer DR, 2011, AQUACULTURE, V317, P58, DOI 10.1016/j.aquaculture.2011.03.037; Schumacher W, 2007, J CLIN VIROL, V38, P304, DOI 10.1016/j.jcv.2006.12.022; Shabir GA, 2003, J CHROMATOGR A, V987, P57, DOI 10.1016/S0021-9673(02)01536-4; Shaperclaus W, 1938, FISCHEREI ZEITUNG, V41, P267; Sokal RR, 1995, BIOMETRY; Swanson P, 2006, J VIROL METHODS, V134, P237, DOI 10.1016/j.jviromet.2006.01.012; Takano R, 2000, B EUR ASSOC FISH PAT, V20, P186; Thompson TM, 2011, DIS AQUAT ORGAN, V96, P29, DOI 10.3354/dao02362; U.S. Fish and Wildlife Service and American Fisheries Society-Fish Health Section, 2010, AM FISH SOC FISH HLT; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Willey JC, 1998, AM J RESP CELL MOL, V19, P6, DOI 10.1165/ajrcmb.19.1.3076; Winton Jr, 2002, REV M T FIS, V3, P49	51	12	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71851	10.1371/journal.pone.0071851	http://dx.doi.org/10.1371/journal.pone.0071851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977162	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300046
J	Arguello, JR; Sellanes, C; Lou, YR; Raguso, RA				Arguello, J. Roman; Sellanes, Carolina; Lou, Yann Ru; Raguso, Robert A.			Can Yeast (S. cerevisiae) Metabolic Volatiles Provide Polymorphic Signaling?	PLOS ONE			English	Article							HOST RACE FORMATION; POPULATION-STRUCTURE; GENETIC-VARIATION; FLORAL SCENT; DROSOPHILA; PLANTS; ECOLOGY; ODOR; ARABIDOPSIS; CHEMISTRY	Chemical signaling between organisms is a ubiquitous and evolutionarily dynamic process that helps to ensure mate recognition, location of nutrients, avoidance of toxins, and social cooperation. Evolutionary changes in chemical communication systems progress through natural variation within the organism generating the signal as well as the responding individuals. A promising yet poorly understood system with which to probe the importance of this variation exists between D. melanogaster and S. cerevisiae. D. melanogaster relies on yeast for nutrients, while also serving as a vector for yeast cell dispersal. Both are outstanding genetic and genomic models, with Drosophila also serving as a preeminent model for sensory neurobiology. To help develop these two genetic models as an ecological model, we have tested if - and to what extent - S. cerevisiae is capable of producing polymorphic signaling through variation in metabolic volatiles. We have carried out a chemical phenotyping experiment for 14 diverse accessions within a common garden random block design. Leveraging genomic sequences for 11 of the accessions, we ensured a genetically broad sample and tested for phylogenetic signal arising from phenotypic dataset. Our results demonstrate that significant quantitative differences for volatile blends do exist among S. cerevisiae accessions. Of particular ecological relevance, the compounds driving the blend differences (acetoin, 2-phenyl ethanol and 3-methyl-1-butanol) are known ligands for D. melanogasters chemosensory receptors, and are related to sensory behaviors. Though unable to correlate the genetic and volatile measurements, our data point clear ways forward for behavioral assays aimed at understanding the implications of this variation.	[Arguello, J. Roman] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Sellanes, Carolina] Univ Repul, Fac Quim, Lab Ecol Quim, Montevideo, Uruguay; [Lou, Yann Ru] Cornell Univ, Dept Plant Biol, Ithaca, NY USA; [Raguso, Robert A.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University; Universidad de la Republica, Uruguay; Cornell University; Cornell University	Arguello, JR (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	jacob.arguello@unil.ch; rar229@cornell.edu		Arguello, J. Roman/0000-0001-7353-6023; Lou, Yann-Ru/0000-0002-4716-4323	Cornell 3CPG postdoctoral grant; US National Science Foundation [DEB-0746106]; Direct For Biological Sciences [0746106] Funding Source: National Science Foundation	Cornell 3CPG postdoctoral grant; US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	JRA was supported by a Cornell 3CPG postdoctoral grant. Chemical analyses were supported by US National Science Foundation award DEB-0746106 to RAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2004, IDENTIFICATION ESSEN, V3rd ed.; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; BARKER JSF, 1981, AUST J BIOL SCI, V34, P613, DOI 10.1071/BI9810613; Becher PG, 2012, FUNCT ECOL, V26, P822, DOI 10.1111/j.1365-2435.2012.02006.x; Becher PG, 2010, J CHEM ECOL, V36, P599, DOI 10.1007/s10886-010-9794-2; Begon M., 1982, Genetics and Biology of Drosophila, V3b, P345; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; BUSH GL, 1969, EVOLUTION, V23, P237, DOI 10.1111/j.1558-5646.1969.tb03508.x; Carter D, 2008, SACCHAROMYCES GENOME; Chess SKR, 2008, AM J BOT, V95, P1652, DOI 10.3732/ajb.0800118; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Coyne JA, 2004, SPECIATION, V37; D'Alessandro M, 2006, ANALYST, V131, P24, DOI 10.1039/b507589k; DACUNHA AB, 1951, EVOLUTION, V5, P97, DOI 10.1111/j.1558-5646.1951.tb02766.x; Darwin C., 1859, ORIGIN SPECIES MEANS; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dobzhansky T., 1937; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; El-Sayed AM, 2005, J AGR FOOD CHEM, V53, P953, DOI 10.1021/jf048521j; Falush D, 2003, GENETICS, V164, P1567; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; FOGLEMAN JC, 1982, OECOLOGIA, V52, P187, DOI 10.1007/BF00363835; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Goodrich KR, 2006, INT J PLANT SCI, V167, P33, DOI 10.1086/498351; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hansson BS, 2010, CHEMOECOLOGY, V20, P51, DOI 10.1007/s00049-009-0033-7; Harmon LJ, 2010, EVOLUTION, V64, P2173, DOI 10.1111/j.1558-5646.2010.00973.x; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; Huang J, 2003, PLANTA, V217, P767, DOI 10.1007/s00425-003-1039-y; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jurgens A, 2009, FUNCT ECOL, V23, P875, DOI 10.1111/j.1365-2435.2009.01626.x; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; LAPOINTE FJ, 1995, J CLASSIF, V12, P265, DOI 10.1007/BF03040858; LINDSAY SL, 1958, AM NAT, V92, P279, DOI 10.1086/282036; Linn C, 2003, P NATL ACAD SCI USA, V100, P11490, DOI 10.1073/pnas.1635049100; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Majetic CJ, 2010, S AFR J BOT, V76, P632, DOI 10.1016/j.sajb.2010.07.006; Malausa T, 2005, SCIENCE, V308, P258, DOI 10.1126/science.1107577; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Montell C, 2005, PFLUG ARCH EUR J PHY, V451, P19, DOI 10.1007/s00424-005-1426-2; Olsson S, 2006, J COMP PHYSIOL A, V192, P279, DOI 10.1007/s00359-005-0069-2; Ortiz-Castro R, 2009, PLANT SIGNAL BEHAV, V4, P701, DOI 10.4161/psb.4.8.9047; Peakall R, 2010, NEW PHYTOL, V188, P437, DOI 10.1111/j.1469-8137.2010.03308.x; PHAFF HJ, 1956, ECOLOGY, V37, P533, DOI 10.2307/1930176; Pichersky E, 2007, TRENDS BIOTECHNOL, V25, P105, DOI 10.1016/j.tibtech.2007.01.002; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2012, R LANG ENV STAT COMP; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Ramdya P, 2010, TRENDS GENET, V26, P307, DOI 10.1016/j.tig.2010.04.004; Ranganathan Y, 2010, PLANT BIOLOGY, V12, P735, DOI 10.1111/j.1438-8677.2009.00278.x; Ray A, 2008, PLOS BIOL, V6, P1069, DOI 10.1371/journal.pbio.0060125; Reuter M, 2007, CURR BIOL, V17, pR81, DOI 10.1016/j.cub.2006.11.059; Richgels PK, 2012, CHEM SENSES, V37, P229, DOI 10.1093/chemse/bjr097; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Scanes K. T., 1998, South African Journal for Enology and Viticulture, V19, P17; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Schaefer HM, 2011, PLANT-ANIMAL COMMUNICATION, P1, DOI 10.1093/acprof:osobl/9780199563609.001.0001; SCHREIER P, 1976, Z LEBENSM UNTERS FOR, V162, P279, DOI 10.1007/BF01113310; SHIHATA AMEA, 1952, EVOLUTION, V6, P325, DOI 10.2307/2405417; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; STARMER WT, 1976, MICROB ECOL, V3, P11, DOI 10.1007/BF02011450; STARMER WT, 1986, J CHEM ECOL, V12, P1037, DOI 10.1007/BF01638995; Steck K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00361; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Svensson GP, 2005, AM J BOT, V92, P1624, DOI 10.3732/ajb.92.10.1624; van Dam NM, 2008, PLANT BIOLOGY, V10, P29, DOI 10.1055/s-2007-964961; Walsh BD., 1867, J HORT, V2, P338; Wang J, 2005, PLANT J, V44, P606, DOI 10.1111/j.1365-313X.2005.02552.x; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Williams A, 1981, Z LEBENSMITTELUNTERS, V172; WILLIAMS A T R, 1977, Journal of Agricultural and Food Chemistry, V25, P756, DOI 10.1021/jf60212a040; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Yee TW, 2010, J STAT SOFTW, V32, P1; Yee TW, 1996, J ROY STAT SOC B MET, V58, P481; Zheng SJ, 2008, PLANT PHYSIOL, V146, P812, DOI 10.1104/pp.107.111542; Zhu JW, 2003, J CHEM ECOL, V29, P899, DOI 10.1023/A:1022931816351	88	27	27	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e70219	10.1371/journal.pone.0070219	http://dx.doi.org/10.1371/journal.pone.0070219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990899	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700006
J	Bernfur, K; Larsson, O; Larsson, C; Gustavsson, N				Bernfur, Katja; Larsson, Olaf; Larsson, Christer; Gustavsson, Niklas			Relative Abundance of Integral Plasma Membrane Proteins in Arabidopsis Leaf and Root Tissue Determined by Metabolic Labeling and Mass Spectrometry	PLOS ONE			English	Article							GENE ENCODES; ARABINOGALACTAN PROTEINS; DIFFERENTIAL EXPRESSION; SNARE PROTEIN; REVEALS; FAMILY; QUANTITATION; PROTEOMICS; THALIANA; ATPASE	Metabolic labeling of proteins with a stable isotope (N-15) in intact Arabidopsis plants was used for accurate determination by mass spectrometry of differences in protein abundance between plasma membranes isolated from leaves and roots. In total, 703 proteins were identified, of which 188 were predicted to be integral membrane proteins. Major classes were transporters, receptors, proteins involved in membrane trafficking and cell wall-related proteins. Forty-one of the integral proteins, including nine of the 13 isoforms of the PIP (plasma membrane intrinsic protein) aquaporin subfamily, could be identified by peptides unique to these proteins, which made it possible to determine their relative abundance in leaf and root tissue. In addition, peptides shared between isoforms gave information on the proportions of these isoforms. A comparison between our data for protein levels and corresponding data for mRNA levels in the widely used database Genevestigator showed an agreement for only about two thirds of the proteins. By contrast, localization data available in the literature for 21 of the 41 proteins show a much better agreement with our data, in particular data based on immunostaining of proteins and GUS-staining of promoter activity. Thus, although mRNA levels may provide a useful approximation for protein levels, detection and quantification of isoform-specific peptides by proteomics should generate the most reliable data for the proteome.	[Bernfur, Katja; Larsson, Christer] Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, Lund, Sweden; [Larsson, Olaf] Huddinge Univ Hosp, Mutat Anal Facil, Clin Res Ctr, Novum, Stockholm, Sweden; [Gustavsson, Niklas] Novo Nordisk AS, Malov, Denmark	Lund University; Karolinska Institutet; Novo Nordisk	Bernfur, K (corresponding author), Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, Lund, Sweden.	katja.bernfur@biochemistry.lu.se			Swedish Foundation for Strategic Research	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by a grant from the Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsson, 1986, PARTITION CELL PARTI; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Alexandersson E, 2004, PLANT CELL PHYSIOL, V45, P1543, DOI 10.1093/pcp/pch209; Arango M, 2003, PLANTA, V216, P355, DOI 10.1007/s00425-002-0856-8; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dormann P, 2000, PLANT PHYSIOL BIOCH, V38, P789, DOI 10.1016/S0981-9428(00)01186-4; Enami K, 2009, PLANT CELL PHYSIOL, V50, P280, DOI 10.1093/pcp/pcn197; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Hakoyama T, 2012, PLANT PHYSIOL, V160, P897, DOI 10.1104/pp.112.200782; Hayashi S, 2008, PLANT CELL PHYSIOL, V49, P1522, DOI 10.1093/pcp/pcn120; Hem S, 2007, BIOCHEM BIOPH RES CO, V363, P375, DOI 10.1016/j.bbrc.2007.08.177; Hirayama T, 1997, PLANT MOL BIOL, V34, P175, DOI 10.1023/A:1005885230896; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Iino M, 2007, PHYTOCHEMISTRY, V68, P1664, DOI 10.1016/j.phytochem.2007.04.002; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; JOHANSSON F, 1994, PHYSIOL PLANTARUM, V92, P389; Johansson I, 1996, PLANT CELL, V8, P1181, DOI 10.1105/tpc.8.7.1181; Johnson KL, 2003, PLANT PHYSIOL, V133, P1911, DOI 10.1104/pp.103.031237; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kim DY, 2007, PLANT J, V50, P207, DOI 10.1111/j.1365-313X.2007.03044.x; Klahre U, 1998, PLANT CELL, V10, P1677, DOI 10.1105/tpc.10.10.1677; Kline KG, 2010, ANNU REV BIOPHYS, V39, P291, DOI 10.1146/annurev.biophys.093008.131339; KORNER LE, 1985, PLANT PHYSIOL, V79, P72, DOI 10.1104/pp.79.1.72; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSSON C, 1994, METHOD ENZYMOL, V228, P451; Li Y, 2008, GENOMICS, V92, P488, DOI 10.1016/j.ygeno.2008.08.011; MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x; Marmagne A, 2007, MOL CELL PROTEOMICS, V6, P1980, DOI 10.1074/mcp.M700099-MCP200; Maurel C, 2009, CURR OPIN PLANT BIOL, V12, P690, DOI 10.1016/j.pbi.2009.09.002; Monneuse JM, 2011, PROTEOMICS, V11, P1789, DOI 10.1002/pmic.201000660; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nilsson R, 2010, MOL CELL PROTEOMICS, V9, P368, DOI 10.1074/mcp.M900289-MCP200; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Pagny G, 2012, NEW PHYTOL, V196, P873, DOI 10.1111/j.1469-8137.2012.04289.x; Santoni V, 2003, BIOCHEM J, V373, P289, DOI 10.1042/BJ20030159; Schapire AL, 2008, PLANT CELL, V20, P3374, DOI 10.1105/tpc.108.063859; Sedbrook JC, 2002, PLANT CELL, V14, P1635, DOI 10.1105/tpc.002360; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Suwastika IN, 2008, CELL STRUCT FUNCT, V33, P185, DOI 10.1247/csf.08024; Tao YZ, 2004, PLANT SCI, V167, P743, DOI 10.1016/j.plantsci.2004.05.012; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Varet A, 2003, PLANT PHYSIOL, V132, P2023, DOI 10.1104/pp.103.020438; Whiteman SA, 2008, PLANT J, V56, P146, DOI 10.1111/j.1365-313X.2008.03578.x; Zhang JW, 2008, J EXP BOT, V59, P2979, DOI 10.1093/jxb/ern156; Zhang P, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003152	47	9	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71206	10.1371/journal.pone.0071206	http://dx.doi.org/10.1371/journal.pone.0071206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990937	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700028
J	Mullins, JC; Garofolo, G; Van Ert, M; Fasanella, A; Lukhnova, L; Hugh-Jones, ME; Blackburn, JK				Mullins, Jocelyn C.; Garofolo, Giuliano; Van Ert, Matthew; Fasanella, Antonio; Lukhnova, Larisa; Hugh-Jones, Martin E.; Blackburn, Jason K.			Ecological Niche Modeling of Bacillus anthracis on Three Continents: Evidence for Genetic-Ecological Divergence?	PLOS ONE			English	Article							UNITED-STATES; FRANCISELLA-TULARENSIS; SPECIES DISTRIBUTIONS; MOLECULAR EVOLUTION; ENVIRONMENTAL DATA; KAZAKSTAN; MATTER; SHIFT; PREDICTION; DIVERSITY	We modeled the ecological niche of a globally successful Bacillus anthracis sublineage in the United States, Italy and Kazakhstan to better understand the geographic distribution of anthrax and potential associations between regional populations and ecology. Country-specific ecological-niche models were developed and reciprocally transferred to the other countries to determine if pathogen presence could be accurately predicted on novel landscapes. Native models accurately predicted endemic areas within each country, but transferred models failed to predict known occurrences in the outside countries. While the effects of variable selection and limitations of the genetic data should be considered, results suggest differing ecological associations for the B. anthracis populations within each country and may reflect niche specialization within the sublineage. Our findings provide guidance for developing accurate ecological niche models for this pathogen; models should be developed regionally, on the native landscape, and with consideration to population genetics. Further genomic analysis will improve our understanding of the genetic-ecological dynamics of B. anthracis across these countries and may lead to more refined predictive models for surveillance and proactive vaccination programs. Further studies should evaluate the impact of variable selection of native and transferred models.	[Mullins, Jocelyn C.; Van Ert, Matthew; Blackburn, Jason K.] Univ Florida, Dept Geog, Spatial Epidemiol & Ecol Res Lab, Gainesville, FL 32611 USA; [Garofolo, Giuliano] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Teramo, Italy; [Garofolo, Giuliano; Fasanella, Antonio] Ist Zooprofilatt Sperimentale Puglia & Basilicata, Anthrax Reference Inst Italy, Foggia, Italy; [Van Ert, Matthew; Blackburn, Jason K.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Lukhnova, Larisa] Kazakh Sci Ctr Quarantine & Zoonot Dis, Anthrax Lab, Alma Ata, Kazakhstan; [Hugh-Jones, Martin E.] Louisiana State Univ, Sch Coast & Environm, Dept Environm Sci, Baton Rouge, LA 70803 USA	State University System of Florida; University of Florida; IZS Dell'abruzzo E Del Molise Giuseppe Caporale; IZS Puglia e Basilicata; State University System of Florida; University of Florida; Aikimbayev's Kazakh Scientific Centre for Quarantine & Zoonotic Diseases; Kazakh Scientific Research Institute of Plant Protection & Quarantine of Zh.Zhienbaev; Louisiana State University System; Louisiana State University	Blackburn, JK (corresponding author), Univ Florida, Dept Geog, Spatial Epidemiol & Ecol Res Lab, Gainesville, FL 32611 USA.	jkblackburn@ufl.edu	Lukhnova, Larissa/ABE-5682-2021; Blackburn, Jason/AAV-9445-2020; Garofolo, Giuliano/B-8551-2016	Blackburn, Jason/0000-0003-0928-4831; Garofolo, Giuliano/0000-0001-7017-3888; Luhnova, Larisa/0000-0002-5818-8021	U.S. Defense Threat Reduction Agency (DTRA) through the Biological Threat Reduction Program in Kazakhstan; Emerging Pathogens Institute at the University of Florida; Department of Homeland Security; College of Humanities and Social Sciences at California State University Fullerton	U.S. Defense Threat Reduction Agency (DTRA) through the Biological Threat Reduction Program in Kazakhstan; Emerging Pathogens Institute at the University of Florida; Department of Homeland Security(United States Department of Homeland Security (DHS)); College of Humanities and Social Sciences at California State University Fullerton	This work was partially supported by the U.S. Defense Threat Reduction Agency (DTRA) through the Biological Threat Reduction Program in Kazakhstan. Field efforts in the US were partially funded by the Emerging Pathogens Institute at the University of Florida, the Department of Homeland Security, and the College of Humanities and Social Sciences at California State University Fullerton. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Aikembayev AM, 2010, EMERG INFECT DIS, V16, P789, DOI 10.3201/eid1605.091427; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Beyer W, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001534; Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103; Blackburn JK, 2010, J WILDLIFE DIS, V46, P918, DOI 10.7589/0090-3558-46.3.918; Blackburn JK, 2006, EVALUATING SPATIAL E; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Carrel MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008631; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fasanella A, 2005, J CLIN MICROBIOL, V43, P3398, DOI 10.1128/JCM.43.7.3398-3401.2005; Fisher MC, 2005, PLOS PATHOG, V1, P159, DOI 10.1371/journal.ppat.0010020; Garofolo Giuliano, 2011, BMC Res Notes, V4, P273, DOI 10.1186/1756-0500-4-273; Gonzalez Sergio C., 2011, BMC Ecology, V11, P20, DOI 10.1186/1472-6785-11-20; Hay SI, 2006, ADV PARASIT, V62, P37, DOI 10.1016/S0065-308X(05)62002-7; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holt RD, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P259; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Hugh-Jones ME, 2002, REV SCI TECH OIE, V21, P359, DOI 10.20506/rst.21.2.1336; Jimenez-Valverde A, 2009, BIODIVERS INFORM, V6; Joyner TA, 2010, ECOLOGICAL NICHE MOD; Joyner TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009596; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kenefic LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004813; Kracalik IT, 2012, GEOSPATIAL HEALTH, V7, P111, DOI 10.4081/gh.2012.110; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; McNyset KM, 2005, ECOL FRESHW FISH, V14, P243, DOI 10.1111/j.1600-0633.2005.00101.x; Mukherjee A, 2012, BIOCONTROL SCI TECHN, V22, P447, DOI 10.1080/09583157.2012.664616; Mukherjee A, 2011, BIOL INVASIONS, P1; Mullins Jocelyn, 2011, BMC Ecology, V11, P32, DOI 10.1186/1472-6785-11-32; Nakazawa Y, 2007, VECTOR-BORNE ZOONOT, V7, P529, DOI 10.1089/vbz.2007.0125; Nakazawa Y, 2010, AM J TROP MED HYG, V82, P912, DOI 10.4269/ajtmh.2010.09-0354; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Peterson AT, 2011, ECOLOGICAL NICHES GE; Rice NH, 2003, BIOL J LINN SOC, V80, P369, DOI 10.1046/j.1095-8312.2003.00242.x; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; Rodder D, 2010, NATURWISSENSCHAFTEN, V97, P781, DOI 10.1007/s00114-010-0694-7; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Simonson TS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-71; Smith KL, 2000, J CLIN MICROBIOL, V38, P3780, DOI 10.1128/JCM.38.10.3780-3784.2000; Sternbach G, 2003, J EMERG MED, V24, P463, DOI 10.1016/S0736-4679(03)00079-9; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; VAN NESS GLENN, 1956, JOUR AMER VET MED ASSOC, V128, P7; VANNESS GB, 1971, SCIENCE, V172, P1303, DOI 10.1126/science.172.3990.1303; Woods CW, 2004, AM J TROP MED HYG, V71, P48, DOI 10.4269/ajtmh.2004.71.48	55	40	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72451	10.1371/journal.pone.0072451	http://dx.doi.org/10.1371/journal.pone.0072451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977300	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700170
J	Nii-Trebi, NI; Ibe, S; Barnor, JS; Ishikawa, K; Brandful, JAM; Ofori, SB; Yamaoka, S; Ampofo, WK; Sugiura, W				Nii-Trebi, Nicholas I.; Ibe, Shiro; Barnor, Jacob S.; Ishikawa, Koichi; Brandful, James A. M.; Ofori, Sampson B.; Yamaoka, Shoji; Ampofo, William K.; Sugiura, Wataru			HIV-1 Drug-Resistance Surveillance among Treatment-Experienced and -Naive Patients after the Implementation of Antiretroviral Therapy in Ghana	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; IDENTIFICATION; AFRICA	Background: Limited HIV-1 drug-resistance surveillance has been carried out in Ghana since the implementation of antiretroviral therapy (ART). This study sought to provide data on the profile of HIV-1 drug resistance in ART-experienced and newly diagnosed individuals in Ghana. Methods: Samples were collected from 101 HIV-1-infected patients (32 ART-experienced cases with virological failure and 69 newly diagnosed ART-naive cases, including 11 children), in Koforidua, Eastern region of Ghana, from February 2009 to January 2010. The pol gene sequences were analyzed by in-house HIV-1 drug-resistance testing. Results: The most prevalent HIV-1 subtype was CRF02_AG (66.3%, 67/101) followed by unique recombinant forms (25.7%, 26/101). Among 31 ART-experienced adults, 22 (71.0%) possessed at least one drug-resistance mutation, and 14 (45.2%) had two-class-resistance to nucleoside and non-nucleoside reverse-transcriptase inhibitors used in their first ART regimen. Importantly, the number of accumulated mutations clearly correlated with the duration of ART. The most prevalent mutation was lamivudine-resistance M184V (n = 12, 38.7%) followed by efavirenz/nevirapine-resistance K103N (n = 9, 29.0%), and zidovudine/stavudine-resistance T215Y/F (n = 6, 19.4%). Within the viral protease, the major nelfinavir-resistance mutation L90M was found in one case. No transmitted HIV-1 drug-resistance mutation was found in 59 ART-naive adults, but K103N and G190S mutations were observed in one ART-naive child. Conclusions: Despite expanding accessibility to ART in Eastern Ghana, the prevalence of transmitted HIV-1 drug resistance presently appears to be low. As ART provision with limited options is scaled up nationwide in Ghana, careful monitoring of transmitted HIV-1 drug resistance is necessary.	[Nii-Trebi, Nicholas I.] Univ Ghana, Sch Allied Hlth Sci, Dept Med Lab Sci, Accra, Ghana; [Ibe, Shiro; Sugiura, Wataru] Natl Hosp Org Nagoya Med Ctr, Clin Res Ctr, Dept Infect & Immunol, Nagoya, Aichi, Japan; [Barnor, Jacob S.; Brandful, James A. M.; Ampofo, William K.] Univ Ghana, Noguchi Mem Inst Med Res, Dept Virol, Accra, Ghana; [Ishikawa, Koichi] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Ofori, Sampson B.] Koforidua Reg Hosp, Dept Med, Koforidua, Ghana; [Yamaoka, Shoji] Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Tokyo, Japan; [Sugiura, Wataru] Nagoya Univ, Grad Sch Med, Dept AIDS Res, Nagoya, Aichi 4648601, Japan	University of Ghana; Nagoya Medical Center; University of Ghana; National Institute of Infectious Diseases (NIID); Tokyo Medical & Dental University (TMDU); Nagoya University	Sugiura, W (corresponding author), Natl Hosp Org Nagoya Med Ctr, Clin Res Ctr, Dept Infect & Immunol, Nagoya, Aichi, Japan.	wsugiura@nnh.hosp.go.jp			Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Tokyo Medical and Dental University; Ministry of Health, Labour and Welfare of Japan [H22-AIDS-004]; HIV Research Trust, United Kingdom	Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Tokyo Medical and Dental University; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); HIV Research Trust, United Kingdom	This study was supported by a grant of the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan to the University of Ghana; the Tokyo Medical and Dental University; a Grant-in-Aid for AIDS Research from the Ministry of Health, Labour and Welfare of Japan (H22-AIDS-004); and a grant from the HIV Research Trust, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampofo William K, 2009, Ghana Med J, V43, P142; Barnor J, 2011, 6 IAS C HIV PATH TRE; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Chiba-Mizutani T, 2007, J CLIN MICROBIOL, V45, P477, DOI 10.1128/JCM.01708-06; Delgado E, 2008, JAIDS-J ACQ IMM DEF, V48, P599, DOI 10.1097/QAI.0b013e3181806c0e; Fischetti L, 2004, J MED VIROL, V73, P158, DOI 10.1002/jmv.20070; Frentz D, 2012, AIDS REV, V14, P17; Ghana AIDS Commission, 2012, GHAN COUNTR AIDS PRO; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Meloni ST, 2004, J VIROL, V78, P12438, DOI 10.1128/JVI.78.22.12438-12445.2004; National HIV/AIDS/STI Control Programme, 2008, GUID ANT THER GHAN; Pacold M, 2010, AIDS RES HUM RETROV, V26, P1291, DOI 10.1089/aid.2010.0042; Redd AD, 2011, J CLIN MICROBIOL, V49, P2859, DOI 10.1128/JCM.00804-11; Sagoe KWC, 2007, J CLIN VIROL, V40, P163, DOI 10.1016/j.jcv.2007.07.016; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; UNAIDS, 2011, UNAIDS WORLD AIDS DA; Vidal N, 2006, AIDS RES HUM RETROV, V22, P182, DOI 10.1089/aid.2006.22.182; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Whitcomb JM, 2003, J INFECT DIS, V188, P992, DOI 10.1086/378281	23	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71972	10.1371/journal.pone.0071972	http://dx.doi.org/10.1371/journal.pone.0071972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977189	gold, Green Submitted, Green Published			2022-12-25	WOS:000323425700119
J	Qiu, DJ; Huang, LM; Liu, S; Zhang, H; Lin, SJ				Qiu, Dajun; Huang, Liangmin; Liu, Sheng; Zhang, Huan; Lin, Senjie			Apical Groove Type and Molecular Phylogeny Suggests Reclassification of Cochlodinium geminatum as Polykrikos geminatum	PLOS ONE			English	Article							SP-NOV DINOPHYCEAE; COMB. NOV; GYMNODINIUM-AUREOLUM; DINOFLAGELLATE; ULTRASTRUCTURE; MORPHOLOGY; GENUS; AMPHIDINIUM; DYNAMICS; BLOOM	Traditionally Cocholodinium and Gymnodinium sensu lato clade are distinguished based on the cingulum turn number, which has been increasingly recognized to be inadequate for Gymnodiniales genus classification. This has been improved by the combination of the apical groove characteristics and molecular phylogeny, which has led to the erection of several new genera (Takayama, Akashiwo, Karenia, and Karlodinium). Taking the apical groove characteristics and molecular phylogeny combined approach, we reexamined the historically taxonomically uncertain species Cochlodinium geminatum that formed massive blooms in Pearl River Estuary, China, in recent years. Samples were collected from a bloom in 2011 for morphological, characteristic pigment, and molecular analyses. We found that the cingulum in this species wraps around the cell body about 1.2 turns on average but can appear under the light microscopy to be >1.5 turns after the cells have been preserved. The shape of its apical groove, however, was stably an open-ended anticlockwise loop of kidney bean shape, similar to that of Polykrikos. Furthermore, the molecular phylogenetic analysis using 18S rRNA-ITS-28S rRNA gene cistron we obtained in this study also consistently placed this species closest to Polykrikos within the Gymnodinium sensu stricto clade and set it far separated from the clade of Cochlodinium. These results suggest that this species should be transferred to Polykrikos as Polykrikos geminatum. Our results reiterate the need to use the combination of apical groove morphology and molecular phylogeny for the classification of species within the genus of Cochlodinium and other Gymnodiniales lineages.	[Qiu, Dajun; Huang, Liangmin; Liu, Sheng; Lin, Senjie] Chinese Acad Sci, CAS Key Lab Trop Marine Bioresources & Ecol, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Zhang, Huan; Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; University of Connecticut	Qiu, DJ (corresponding author), Chinese Acad Sci, CAS Key Lab Trop Marine Bioresources & Ecol, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China.	djqiu@scsio.ac.cn; senjie.lin@uconn.edu	Lin, Senjie/A-7466-2011; zhang, yaqun/J-8478-2014; Qiu, Dajun/D-3045-2017; Qiu, Dajun/I-5944-2019; Guo, chentao/G-7320-2016	Qiu, Dajun/0000-0003-2315-3432; Qiu, Dajun/0000-0003-2315-3432; 	National Science Foundation of China [41129001, 41130855, 41006067]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Science Foundation of China (41129001, 41130855, 41006067) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Attaran-Fariman G, 2007, PHYCOLOGIA, V46, P644, DOI 10.2216/07-05.1; Calado AJ, 2005, PHYCOLOGIA, V44, P112, DOI 10.2216/0031-8884(2005)44[112:OTFDPI]2.0.CO;2; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; de Salas MF, 2003, J PHYCOL, V39, P1233, DOI 10.1111/j.0022-3646.2003.03-019.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Fraga S, 1995, PHYCOLOGIA, V34, P514, DOI 10.2216/i0031-8884-34-6-514.1; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; HALLEGRAEFF GM, 2010, ALGAE AUSTR PHYTOPLA, P145; Handy SM, 2008, HARMFUL ALGAE, V7, P599, DOI 10.1016/j.hal.2007.12.018; Hansen G, 2004, PROTIST, V155, P271, DOI 10.1078/1434461041844231; Hansen G, 2000, J PHYCOL, V36, P394, DOI 10.1046/j.1529-8817.2000.99172.x; Hansen G, 2007, PHYCOL RES, V55, P25, DOI 10.1111/j.1440-1835.2006.00442.x; HOPPENRATH M, 2009, KLEINE SERCKENERG 49, V49, P52235; Hoppenrath M, 2007, PROTIST, V158, P209, DOI 10.1016/j.protis.2006.12.001; Hoppenrath M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-116; Hoppenrath M, 2010, EUR J PROTISTOL, V46, P29, DOI 10.1016/j.ejop.2009.08.003; [胡俊 Hu Jun], 2011, [海洋科学, Marine Sciences], V35, P19; Iwataki M, 2010, J EUKARYOT MICROBIOL, V57, P308, DOI 10.1111/j.1550-7408.2010.00491.x; Iwataki Mitsunori, 2006, Japanese Journal of Phycology, V54, P77; Jorgensen MF, 2004, PHYCOL RES, V52, P284; Jorgensen MF, 2004, J PHYCOL, V40, P351, DOI 10.1111/j.1529-8817.2004.03131.x; Lin SJ, 2006, APPL ENVIRON MICROB, V72, P5626, DOI 10.1128/AEM.00586-06; Lin S, 2009, APPL ENVIRON MICROB, V75, P1279, DOI 10.1128/AEM.01578-08; Matsuoka K, 2009, REV PALAEOBOT PALYNO, V154, P79, DOI 10.1016/j.revpalbo.2008.12.013; Murray S, 2007, PHYCOL RES, V55, P176, DOI 10.1111/j.1440-1835.2007.00460.x; Ou Lin-jian, 2010, JOURNAL OF TROPICAL OCEANOGRAPHY, V29, P57; Qiu DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029398; REES AJJ, 1991, PHYCOLOGIA, V30, P90, DOI 10.2216/i0031-8884-30-1-90.1; Schutt F., 1895, ERG PLANKTON EXP, V4, P1, DOI DOI 10.3390/IJERPH10105146; SCHUTT F, 1896, DIENATURLICHEN PFL B, P31; Shen PP, 2012, HARMFUL ALGAE, V13, P10, DOI 10.1016/j.hal.2011.09.009; Siano R, 2009, PHYCOLOGIA, V48, P44, DOI 10.2216/08-61.1; Sparmann SF, 2008, PROTIST, V159, P383, DOI 10.1016/j.protis.2007.12.002; Steidinger Karen A., 1997, P387, DOI 10.1016/B978-012693018-4/50005-7; TAKAYAMA H, 1985, Bulletin of Plankton Society of Japan, V32, P129; Tang YZ, 2008, J EUKARYOT MICROBIOL, V55, P91, DOI 10.1111/j.1550-7408.2008.00305.x; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183; Yamaguchi A, 2006, PHYCOL RES, V54, P317, DOI 10.1111/j.1440-1835.2006.00438.x	39	19	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71346	10.1371/journal.pone.0071346	http://dx.doi.org/10.1371/journal.pone.0071346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990946	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700038
J	Thongsroy, J; Matangkasombut, O; Thongnak, A; Rattanatanyong, P; Jirawatnotai, S; Mutirangura, A				Thongsroy, Jirapan; Matangkasombut, Oranart; Thongnak, Araya; Rattanatanyong, Prakasit; Jirawatnotai, Siwanon; Mutirangura, Apiwat			Replication-Independent Endogenous DNA Double-Strand Breaks in Saccharomyces cerevisiae Model	PLOS ONE			English	Article							LINE-1 METHYLATION; YEAST; REPAIR; DAMAGE; PROTEINS; CANCER; CELLS	Without exposure to any DNA-damaging agents, non-dividing eukaryotic cells carry endogenous DNA double-strand breaks (EDSBs), or Replication-Independent (RIND)-EDSBs. In human cells, RIND-EDSBs are enriched in the methylated heterochromatic areas of the genome and are repaired by an ATM-dependent non-homologous end-joining pathway (NHEJ). Here, we showed that Saccharomyces cerevisiae similarly possess RIND-EDSBs. Various levels of EDSBs were detected during different phases of the cell cycle, including G0. Using a collection of mutant yeast strains, we investigated various DNA metabolic and DNA repair pathways that might be involved in the maintenance of RIND-EDSB levels. We found that the RIND-EDSB levels increased significantly in yeast strains lacking proteins involved in NHEJ DNA repair and in suppression of heterochromatin formation. RIND-EDSB levels were also upregulated when genes encoding histone deacetylase, endonucleases, topoisomerase, and DNA repair regulators were deleted. In contrast, RIND-EDSB levels were downregulated in the mutants that lack chromatin-condensing proteins, such as the high-mobility group box proteins, and Sir2. Likewise, RIND-EDSB levels were also decreased in human cells lacking HMGB1. Therefore, we conclude that the genomic levels of RIND-EDSBs are evolutionally conserved, dynamically regulated, and may be influenced by genome topology, chromatin structure, and the efficiency of DNA repair systems.	[Thongsroy, Jirapan] Chulalongkorn Univ, Fac Grad Sch, Interdept Program BioMed Sci, Bangkok, Thailand; [Matangkasombut, Oranart] Chulalongkorn Univ, Fac Dent, Dept Microbiol, Bangkok, Thailand; [Matangkasombut, Oranart] Chulalongkorn Univ, Fac Dent, Developing Res Unit Oral Microbiol, Bangkok, Thailand; [Thongnak, Araya; Rattanatanyong, Prakasit; Mutirangura, Apiwat] Chulalongkorn Univ, Fac Med, Dept Anat, Bangkok 10330, Thailand; [Rattanatanyong, Prakasit; Mutirangura, Apiwat] Chulalongkorn Univ, Ctr Excellence Mol Genet Canc & Human Dis, Bangkok, Thailand; [Jirawatnotai, Siwanon] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Jirawatnotai, Siwanon] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Jirawatnotai, Siwanon] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pharmacol, Bangkok 10700, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Mahidol University	Matangkasombut, O (corresponding author), Chulalongkorn Univ, Fac Dent, Dept Microbiol, Bangkok, Thailand.	oranart@gmail.com; mapiwat@chula.ac.th			National Science and Technology Development Agency (NSTDA), Thailand; Four Seasons Hotel Bangkok's 4th Cancer Care charity fun run; Chulalongkorn University under the office of the Higher Education Commission; Thai Red Cross Society; Chulalongkorn University	National Science and Technology Development Agency (NSTDA), Thailand; Four Seasons Hotel Bangkok's 4th Cancer Care charity fun run; Chulalongkorn University under the office of the Higher Education Commission; Thai Red Cross Society; Chulalongkorn University(Chulalongkorn University)	This work was supported by the Discovery-Based Development Grant and the Research Chair Grant 2011 from the National Science and Technology Development Agency (NSTDA), Thailand; by the Four Seasons Hotel Bangkok's 4th Cancer Care charity fun run in coordination with the Thai Red Cross Society; and by Chulalongkorn University under the office of the Higher Education Commission. Funding for the open access charge was provided by Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylon Y, 2004, DNA REPAIR, V3, P797, DOI 10.1016/j.dnarep.2004.04.013; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Burkhart D, 2000, ST COMPAR L, P145; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Kitkumthorn N, 2012, CLIN CHIM ACTA, V413, P869, DOI 10.1016/j.cca.2012.01.024; Kongruttanachok N, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-70; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; NELSON RG, 1979, P NATL ACAD SCI USA, V76, P6515, DOI 10.1073/pnas.76.12.6515; Olive PL, 2005, CYTOM PART A, V66A, P1, DOI 10.1002/cyto.a.20154; Pornthanakasem W, 2008, NUCLEIC ACIDS RES, V36, P3667, DOI 10.1093/nar/gkn261; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Ribeiro GF, 2006, MOL BIOL CELL, V17, P4584, DOI 10.1091/mbc.E06-05-0475; Stillman DJ, 2010, BBA-GENE REGUL MECH, V1799, P175, DOI 10.1016/j.bbagrm.2009.11.010; Sun ZW, 1999, GENETICS, V152, P921; Tsabar M, 2013, CURR OPIN GENET DEV, V23, P166, DOI 10.1016/j.gde.2012.11.015; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Yao XJ, 2010, J CANCER RES CLIN, V136, P677, DOI 10.1007/s00432-009-0706-1; Yoshida K, 2003, J RADIAT RES, V44, P47, DOI 10.1269/jrr.44.47; Zhou J, 2009, NUCLEIC ACIDS RES, V37, P3699, DOI 10.1093/nar/gkp233	21	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72706	10.1371/journal.pone.0072706	http://dx.doi.org/10.1371/journal.pone.0072706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977341	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700186
J	Haslam, M; Gumert, MD; Biro, D; Carvalho, S; Malaivijitnond, S				Haslam, Michael; Gumert, Michael D.; Biro, Dora; Carvalho, Susana; Malaivijitnond, Suchinda			Use-Wear Patterns on Wild Macaque Stone Tools Reveal Their Behavioural History	PLOS ONE			English	Article							LONG-TAILED MACAQUES; ARCHAEOLOGY; RESIDUE; ARTIFACTS; USAGE; SITE	Burmese long-tailed macaques (Macaca fascicularis aurea) are one of a limited number of wild animal species to use stone tools, with their tool use focused on pounding shelled marine invertebrates foraged from intertidal habitats. These monkeys exhibit two main styles of tool use: axe hammering of oysters, and pound hammering of unattached encased foods. In this study, we examined macroscopic use-wear patterns on a sample of 60 wild macaque stone tools from Piak Nam Yai Island, Thailand, that had been collected following behavioural observation, in order to (i) quantify the wear patterns in terms of the types and distribution of use-damage on the stones, and (ii) develop a Use-Action Index (UAI) to differentiate axe hammers from pound hammers by wear patterns alone. We used the intensity of crushing damage on differing surface zones of the stones, as well as stone weight, to produce a UAI that had 92% concordance when compared to how the stones had been used by macaques, as observed independently prior to collection. Our study is the first to demonstrate that quantitative archaeological use-wear techniques can accurately reconstruct the behavioural histories of non-human primate stone tools.	[Haslam, Michael; Carvalho, Susana] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England; [Gumert, Michael D.] Nanyang Technol Univ, Sch Humanities & Social Sci, Div Psychol, Singapore 639798, Singapore; [Biro, Dora] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Malaivijitnond, Suchinda] Chulalongkorn Univ, Dept Biol, Primate Res Unit, Bangkok, Thailand	University of Oxford; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Oxford; Chulalongkorn University	Haslam, M (corresponding author), Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England.	michael.haslam@rlaha.ox.ac.uk	Gumert, Michael D./N-2516-2015	Gumert, Michael D./0000-0002-7464-4525; Carvalho, Susana/0000-0003-4542-3720; Haslam, Michael/0000-0001-8234-7806; Biro, Dora/0000-0002-3408-6274	Centenary Academic Fund of Chulalongkorn University; Academic Research Fund of Nanyang Technological University; Ministry of Education Singapore [RG07/95]; Royal Society University Research Fellowship; European Research Council [283959]	Centenary Academic Fund of Chulalongkorn University; Academic Research Fund of Nanyang Technological University(Nanyang Technological University); Ministry of Education Singapore(Ministry of Education, Singapore); Royal Society University Research Fellowship(Royal Society of London); European Research Council(European Research Council (ERC)European Commission)	This study was financially supported by the Centenary Academic Fund of Chulalongkorn University, the Academic Research Fund of Nanyang Technological University, a Tier 1 Research Grant RG07/95 from the Ministry of Education Singapore awarded to MG, a Royal Society University Research Fellowship awarded to DB, and European Research Council Starting Grant no. 283959 (PRIMARCH) awarded to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; Canale GR, 2009, AM J PRIMATOL, V71, P366, DOI 10.1002/ajp.20648; Carpenter A., 1887, Nature, Vxxxvi, P53; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; Carvalho S, 2009, ANIM COGN, V12, pS103, DOI 10.1007/s10071-009-0271-7; Clarkson C, 2011, J ARCHAEOL SCI, V38, P1062, DOI 10.1016/j.jas.2010.12.001; Cooper JL, 2009, TERRA AUSTRALIS, V30, P207; de la Torre I, 2013, J ARCHAEOL SCI, V40, P313, DOI 10.1016/j.jas.2012.08.007; Elisabetta V, 2013, J ARCHAEOL SCI, V40, P3222, DOI 10.1016/j.jas.2013.03.021; Goren-Inbar N, 2002, P NATL ACAD SCI USA, V99, P2455, DOI 10.1073/pnas.032570499; Gumert M, HUMAN ACTIV IN PRESS; Gumert MD, 2012, AM J PHYS ANTHROPOL, V149, P447, DOI 10.1002/ajpa.22143; Gumert MD, 2011, AM J PRIMATOL, V73, P1239, DOI 10.1002/ajp.20996; Gumert MD, 2009, AM J PRIMATOL, V71, P594, DOI 10.1002/ajp.20694; Haslam M, 2004, J ARCHAEOL SCI, V31, P1715, DOI 10.1016/j.jas.2004.05.006; Haslam M, 2006, J SOC ARCHAEOL, V6, P402, DOI 10.1177/1469605306067851; Haslam M, 2012, ANTIQUITY, V86, P299, DOI 10.1017/S0003598X00062773; Haslam M, 2009, NATURE, V460, P339, DOI 10.1038/nature08188; Hernandez-Aguilar RA, 2007, P NATL ACAD SCI USA, V104, P19210, DOI 10.1073/pnas.0707929104; Hernandez-Aguilar RA, 2009, J HUM EVOL, V57, P350, DOI 10.1016/j.jhevol.2009.03.007; JOULIAN F, 1996, MODELLING EARLY HUMA, P173; Kuzminsky SC, 2012, J ARCHAEOL SCI, V39, P2744, DOI 10.1016/j.jas.2012.04.020; Lombard M, 2005, J HUM EVOL, V48, P279, DOI 10.1016/j.jhevol.2004.11.006; Malaivijitnond S, 2007, AM J PRIMATOL, V69, P227, DOI 10.1002/ajp.20342; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; McGrew WC, 1997, INT J PRIMATOL, V18, P787, DOI 10.1023/A:1026347913888; Mercader J, 2002, SCIENCE, V296, P1452, DOI 10.1126/science.1070268; Mercader J, 2007, P NATL ACAD SCI USA, V104, P3043, DOI 10.1073/pnas.0607909104; Mora R, 2005, J ANTHROPOL ARCHAEOL, V24, P179, DOI 10.1016/j.jaa.2004.12.001; Ottoni EB, 2008, EVOL ANTHROPOL, V17, P171, DOI 10.1002/evan.20185; Pascual-Garrido A, 2012, FOLIA PRIMATOL, V83, P24, DOI 10.1159/000338898; Scheffers A, 2012, HOLOCENE, V22, P1169, DOI 10.1177/0959683612441803; Shumaker R.W., 2011, ANIMAL TOOL BEHAV US; Stewart FA, 2011, J HUM EVOL, V61, P388, DOI 10.1016/j.jhevol.2011.05.005; Visalberghi E, 2007, AM J PHYS ANTHROPOL, V132, P426, DOI 10.1002/ajpa.20546; Whiten A, 2013, NATURE, V498, P303, DOI 10.1038/498303a	36	35	36	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72872	10.1371/journal.pone.0072872	http://dx.doi.org/10.1371/journal.pone.0072872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977365	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200091
J	Liang, CM; Chen, YH; Lu, DW; Chen, JT; Tai, MC				Liang, Chang-Min; Chen, Yi-Hao; Lu, Da-Wen; Chen, Jiann-Torng; Tai, Ming-Cheng			New Continuous Air Pumping Technique to Improve Clinical Outcomes of Descemet-Stripping Automated Endothelial Keratoplasty in Asian Patients with Previous Ahmed Glaucoma Valve Implantation	PLOS ONE			English	Article							GRAFT-SURVIVAL; PREEXISTING GLAUCOMA; RISK-FACTORS; DSAEK; EYES; SURGERY	Background: To evaluate the outcomes of Descemet-stripping automated endothelial keratoplasty (DSAEK) with the use of continuous air pumping technique in Asian eyes with previous Ahmed glaucoma valve implantation. Methods: The DSAEK procedure was modified in that complete air retention of the anterior chamber was maintained for 10 min using continuous air pumping at 30 mm Hg. The primary outcome measurement was graft survival, and postoperative clinical features including, rate of graft detachment, endothelial cell count, intraocular pressure (IOP), surgical time and cup/disc ratio were also recorded. Results: A total of 13 eyes of 13 patients which underwent modified DSAEK and 6 eyes of 6 patients which underwent conventional DSAEK were included. There was a significant difference in graft survival curves between two groups (P = 0.029); the 1-year graft survival rates were estimated as 100% and 66.7% for patients with modified DSAEK and those with traditional DSAEK, respectively. The rate of graft detachment were 0% and 33.3% for the modified DSAEK and conventional DSAEK groups, respectively (P = 0.088). The significantly lowered surgical time for air tamponade was noted in the modified DSAEK group compared to that in the conventional DSAEK group [median (IQR): 10.0 (10.0, 10.0) min vs. 24.5 (22.0, 27.0) min; P<0.001] Postoperatively, patients in the modified DSAEK group had significantly lower IOP as compared to the conventional DSAEK group [12.0 (11.0, 15.0) mm Hg vs. 16.0 (15.0, 18.0) mm Hg; P = 0.047]. Modified DSAEK patients had higher endothelial cell counts as compared to conventional DSAEK patients [2148.0 (1964.0, 2218.0) vs. 1529.0 (713.0, 2014.0)], but the difference did not reach statistical significance (P = 0.072). Conclusions: New continuous air pumping technique in DSAEK can be performed safely and effectively in patients with prior GDDs placement who have corneal failure.	[Liang, Chang-Min; Chen, Yi-Hao; Lu, Da-Wen; Chen, Jiann-Torng; Tai, Ming-Cheng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Ophthalmol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital	Tai, MC (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Ophthalmol, Taipei, Taiwan.	mingtai1966@yahoo.com.tw			Tri-Service General Hospital [TSGH-C102-095, TSGH-C102-098]	Tri-Service General Hospital	This study was supported in part by grants TSGH-C102-095 and TSGH-C102-098 from the Tri-Service General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang M, 2012, CLIN OPHTHALMOL, V6, P537, DOI 10.2147/OPTH.S26343; Anshu A, 2012, OPHTHALMOLOGY, V119, P1982, DOI 10.1016/j.ophtha.2012.04.031; Anshu A, 2012, OPHTHALMOLOGY, V119, P536, DOI 10.1016/j.ophtha.2011.09.019; Ayyala RS, 1998, OPHTHALMOLOGY, V105, P1968, DOI 10.1016/S0161-6420(98)91049-1; Banitt MR, 2010, CURR OPIN OPHTHALMOL, V21, P144, DOI 10.1097/ICU.0b013e3283360b95; Boey PY, 2012, AM J OPHTHALMOL; Esquenazi S, 2010, J GLAUCOMA, V19, P219, DOI 10.1097/IJG.0b013e3181af3202; Goshe JM, 2012, OPHTHALMOLOGY, V119, P1130, DOI 10.1016/j.ophtha.2012.01.012; Guerra FP, 2011, OPHTHALMOLOGY, V118, P2368, DOI 10.1016/j.ophtha.2011.06.002; Ide T, 2009, OPEN OPHTHALMOL J, V3, P1, DOI 10.2174/1874364100903010001; Jangi AA, 2012, CORNEA; Karimian Farid, 2010, J Ophthalmic Vis Res, V5, P205; Kim P, 2012, CORNEA, V31, P172, DOI 10.1097/ICO.0b013e318224820a; Letko E, 2011, OPHTHALMOLOGY, V118, P310, DOI 10.1016/j.ophtha.2010.06.032; Leung EW, 2008, J GLAUCOMA, V17, P350, DOI 10.1097/IJG.0b013e31815c5f4f; Li JY, 2012, OPHTHALMOLOGY; Phillips PM, 2010, CORNEA, V29, P534, DOI 10.1097/ICO.0b013e3181c11bf3; Phillips PM, 2009, CORNEA, V28, P871, DOI 10.1097/ICO.0b013e318199f8d7; Price MO, 2012, OPHTHALMOLOGY; Quek DT, 2011, AM J OPHTHALMOL, V152, P48, DOI 10.1016/j.ajo.2011.01.030; Ratanasit A, 2011, CORNEA, V30, P1414, DOI 10.1097/ICO.0b013e31820ca34b; Riaz KM, 2009, CORNEA, V28, P959, DOI 10.1097/ICO.0b013e31819c4e2c; Tai MC, 2010, J CATARACT REFR SURG, V36, P1758, DOI 10.1016/j.jcrs.2010.05.011; Topouzis F, 1999, AM J OPHTHALMOL, V128, P198, DOI 10.1016/S0002-9394(99)00080-X; Wu EI, 2012, AM J OPHTHALMOL, V153, P949, DOI 10.1016/j.ajo.2011.10.004	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72089	10.1371/journal.pone.0072089	http://dx.doi.org/10.1371/journal.pone.0072089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977215	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200058
J	Viana, AR; Razuk, M; de Freitas, PB; Barela, JA				Viana, Andre R.; Razuk, Milena; de Freitas, Paulo B.; Barela, Jose A.			Sensorimotor Integration in Dyslexic Children under Different Sensory Stimulations	PLOS ONE			English	Article							POSTURAL CONTROL; DEVELOPMENTAL DYSLEXIA; INFORMATION; BALANCE; TOUCH	Dyslexic children, besides difficulties in mastering literacy, also show poor postural control that might be related to how sensory cues coming from different sensory channels are integrated into proper motor activity. Therefore, the aim of this study was to examine the relationship between sensory information and body sway, with visual and somatosensory information manipulated independent and concurrently, in dyslexic children. Thirty dyslexic and 30 non-dyslexic children were asked to stand as still as possible inside of a moving room either with eyes closed or open and either lightly touching a moveable surface or not for 60 seconds under five experimental conditions: (1) no vision and no touch; (2) moving room; (3) moving bar; (4) moving room and stationary touch; and (5) stationary room and moving bar. Body sway magnitude and the relationship between room/bar movement and body sway were examined. Results showed that dyslexic children swayed more than non-dyslexic children in all sensory condition. Moreover, in those trials with conflicting vision and touch manipulation, dyslexic children swayed less coherent with the stimulus manipulation compared to non-dyslexic children. Finally, dyslexic children showed higher body sway variability and applied higher force while touching the bar compared to non-dyslexic children. Based upon these results, we can suggest that dyslexic children are able to use visual and somatosensory information to control their posture and use the same underlying neural control processes as non-dyslexic children. However, dyslexic children show poorer performance and more variability while relating visual and somatosensory information and motor action even during a task that does not require an active cognitive and motor involvement. Further, in sensory conflict conditions, dyslexic children showed less coherent and more variable body sway. These results suggest that dyslexic children have difficulties in multisensory integration because they may suffer from integrating sensory cues coming from multiple sources.	[Viana, Andre R.; Razuk, Milena; de Freitas, Paulo B.; Barela, Jose A.] Univ Cruzeiro Sul, Inst Phys Act & Sport Sci, Grad Program Human Movement Sci, Sao Paulo, Brazil; [Barela, Jose A.] Sao Paulo State Univ, Inst Biosci, Sao Paulo, Brazil	Universidade Cruzeiro do Sul; Universidade Estadual Paulista	Barela, JA (corresponding author), Univ Cruzeiro Sul, Inst Phys Act & Sport Sci, Grad Program Human Movement Sci, Sao Paulo, Brazil.	jose.barela@cruzeirodosul.edu.br	Barela, José A/F-4284-2012; Razuk, Milena/N-6626-2013; de Freitas, Paulo B/E-7175-2011	Barela, José A/0000-0003-0951-254X; de Freitas, Paulo B/0000-0002-0406-041X	Grant Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)/Brazil [2009/16051-8]; Assistantship FAPESP/Brazil [2010/03676-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil [558552/2010-2]	Grant Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)/Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Assistantship FAPESP/Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding provided by Grant Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)/Brazil(corresponding author) #2009/16051-8; Assistantship FAPESP/Brazil (ARV) #2010/03676-7 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil (MR) #558552/2010-2. (http://www.fapesp.br/) (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bair WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040932; Bair WN, 2011, GAIT POSTURE, V34, P183, DOI 10.1016/j.gaitpost.2011.04.007; Barela AMF, 2009, MOTOR CONTROL, V13, P119, DOI 10.1123/mcj.13.2.119; Barela JA, 2003, EXP BRAIN RES, V150, P434, DOI 10.1007/s00221-003-1441-5; Barela JA, 2011, RES DEV DISABIL, V32, P1814, DOI 10.1016/j.ridd.2011.03.011; Brookes RL, 2010, DYSLEXIA, V16, P358, DOI 10.1002/dys.420; Capellini SA, 2010, PROVA AVALIACAO PROC; Fawcett A.J., 2004, ELECT J RES ED PSYCH, V2, P35; Freitas Junior PB, 2004, NEUROSCI LETT, V369, P64, DOI 10.1016/j.neulet.2004.07.075; Geiger G., 2000, CHILD DEV DISABILITI, VXXVI, P73; Horak F, 1996, HDB PHYSIOL 12, V12, P255; Jeka J, 2000, EXP BRAIN RES, V134, P107, DOI 10.1007/s002210000412; Jeka J J, 1998, Motor Control, V2, P13; Jeka JJ, 1997, EXP BRAIN RES, V113, P475, DOI 10.1007/PL00005600; Jeka JJ, 1998, J NEUROPHYSIOL; Legrand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035301; Moe-Nilssen R, 2003, EXP BRAIN RES, V150, P237, DOI 10.1007/s00221-003-1450-4; Moojen S, 2007, CONSCIENCIA FONOLOGI; Nicolson RI, 2002, EXP BRAIN RES, V143, P42, DOI 10.1007/s00221-001-0969-5; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; Patel M, 2010, DYSLEXIA, V16, P162, DOI 10.1002/dys.398; Pozzo T, 2006, NEUROSCI LETT, V403, P211, DOI 10.1016/j.neulet.2006.03.049; Quercia P, 2011, EXP BRAIN RES, V209, P599, DOI 10.1007/s00221-011-2593-3; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Stoffregen TA, 2006, MOTOR CONTROL, V10, P24, DOI 10.1123/mcj.10.1.24; Vieira S, 2009, NEUROSCI LETT, V462, P125, DOI 10.1016/j.neulet.2009.06.093	26	14	14	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72719	10.1371/journal.pone.0072719	http://dx.doi.org/10.1371/journal.pone.0072719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977346	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200083
J	Adamaki, M; Lambrou, GI; Athanasiadou, A; Tzanoudaki, M; Vlahopoulos, S; Moschovi, M				Adamaki, Maria; Lambrou, George I.; Athanasiadou, Anastasia; Tzanoudaki, Marianna; Vlahopoulos, Spiros; Moschovi, Maria			Implication of IRF4 Aberrant Gene Expression in the Acute Leukemias of Childhood	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; REGULATORY FACTOR 4; SEQUENCE BINDING-PROTEIN; CHRONIC MYELOID-LEUKEMIA; CENTER B-CELLS; TRANSCRIPTION FACTOR; MUM1/IRF4 EXPRESSION; INTERFERON; DIFFERENTIATION; TRANSFORMATION	The most frequent targets of genetic alterations in human leukemias are transcription factor genes with essential functions in normal blood cell development. The Interferon Regulatory Factor 4 (IRF4) gene encodes a transcription factor important for key developmental stages of hematopoiesis, with known oncogenic implications in multiple myeloma, adult leukemias and lymphomas. Very few studies have reported an association of IRF4 with childhood malignancy, whereas high transcript levels have been observed in the more mature immunophenotype of ALL. Our aim was to investigate the expression levels of IRF4 in the diagnostic samples of pediatric leukemias and compare them to those of healthy controls, in order to determine aberrant gene expression and whether it extends to leukemic subtypes other than the relatively mature ALL subpopulation. Quantitative real-time RT-PCR methodology was used to investigate IRF4 expression in 58 children with acute leukemias, 4 leukemic cell lines and 20 healthy children. We show that aberrant IRF4 gene expression is implicated in a variety of leukemic subtypes; higher transcript levels appear in the more immature B-common ALL subtype and in T-cell than in B-cell leukemias, with the highest expression levels appearing in the AML group. Interestingly, we show that childhood leukemia, irrespective of subtype or cell maturation stage, is characterised by a minimum of approximately twice the amount of IRF4 gene expression encountered in healthy children. A statistically significant correlation also appeared to exist between high IRF4 expression and relapse. Our results show that ectopic expression of IRF4 follows the reverse expression pattern of what is encountered in normal B-cell development and that there might be a dose-dependency of childhood leukemia for aberrantly expressed IRF4, a characteristic that could be explored therapeutically. It is also suggested that high IRF4 expression might be used as an additional prognostic marker of relapse at diagnosis.	[Adamaki, Maria; Lambrou, George I.; Athanasiadou, Anastasia; Vlahopoulos, Spiros; Moschovi, Maria] Univ Athens, Pediat Hematol Oncol Unit, Dept Pediat 1, Aghia Sofia Childrens Hosp, Athens, Greece; [Tzanoudaki, Marianna] Aghia Sofia Childrens Hosp, Dept Immunol & Histocompatibil, Athens, Greece	National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; The Aghia Sophia Children's Hospital	Adamaki, M (corresponding author), Univ Athens, Pediat Hematol Oncol Unit, Dept Pediat 1, Aghia Sofia Childrens Hosp, Athens, Greece.	madamaki@med.uoa.gr	Vlahopoulos, Spiros/AAK-6362-2020; Vlahopoulos, Spiros A/A-1186-2014; Adamaki, Maria/AAC-3048-2022; Lambrou, George/F-9674-2011	Vlahopoulos, Spiros/0000-0001-6245-3863; Vlahopoulos, Spiros A/0000-0001-6245-3863; MOSCHOVI, MARIA/0000-0002-2982-8501; Lambrou, George/0000-0001-8389-1360				Acquaviva J, 2008, BLOOD, V112, P3798, DOI 10.1182/blood-2007-10-117838; Allan JM, 2010, LEUKEMIA, V24, P877, DOI 10.1038/leu.2009.298; Armstrong SA, 2003, SEMIN HEMATOL, V40, P268, DOI 10.1016/S0037-1963(03)00196-3; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bisig B, 2012, BEST PRACT RES CL HA, V25, P13, DOI 10.1016/j.beha.2012.01.004; Boiers C, 2010, BLOOD, V115, P5061, DOI 10.1182/blood-2009-12-258756; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Chang CC, 2002, BLOOD, V100, P4671, DOI 10.1182/blood-2002-01-0104; Craig F, 2008, LEUKEMIA LYMPHOMA, V49, P273, DOI 10.1080/10428190701760037; De Silva NS, 2012, IMMUNOL REV, V247, P73, DOI 10.1111/j.1600-065X.2012.01113.x; Do TN, 2010, BBA-MOL BASIS DIS, V1802, P292, DOI 10.1016/j.bbadis.2009.10.015; Falini B, 2000, BLOOD, V95, P2084, DOI 10.1182/blood.V95.6.2084; Gabriele L, 2007, CYTOKINE GROWTH F R, V18, P503, DOI 10.1016/j.cytogfr.2007.06.008; Garcia JF, 2006, HAEMATOLOGICA, V91, P467; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Gupta S, 1999, J EXP MED, V190, P1837, DOI 10.1084/jem.190.12.1837; Ito M, 2002, JPN J CANCER RES, V93, P685, DOI 10.1111/j.1349-7006.2002.tb01307.x; Kanno Y, 2005, J INTERF CYTOK RES, V25, P770, DOI 10.1089/jir.2005.25.770; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lambrou GI, 2009, LEUK RES; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; Lehtonen A, 2005, J IMMUNOL, V175, P6570, DOI 10.4049/jimmunol.175.10.6570; Lohoff M, 2004, J EXP MED, V200, P247, DOI 10.1084/jem.20040182; Lu RQ, 2008, TRENDS IMMUNOL, V29, P487, DOI 10.1016/j.it.2008.07.006; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Moorman AV, 2010, LANCET ONCOL, V11, P429, DOI 10.1016/S1470-2045(10)70066-8; Pernis AB, 2002, J INTERF CYTOK RES, V22, P111, DOI 10.1089/107999002753452728; Petridou ET, 2013, CANCER CAUSE CONTROL, V24, P1111, DOI 10.1007/s10552-013-0188-y; Pham-Ledard A, 2010, J INVEST DERMATOL, V130, P816, DOI 10.1038/jid.2009.314; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; PUI CH, 1993, BLOOD, V82, P343; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Schmidt M, 2000, J CLIN ONCOL, V18, P3331, DOI 10.1200/JCO.2000.18.19.3331; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shaffer AL, 2009, CLIN CANCER RES, V15, P2954, DOI 10.1158/1078-0432.CCR-08-1845; Sitwala KV, 2008, INT J CLIN EXP PATHO, V1, P461; Stubbs MC, 2008, LEUKEMIA, V22, P66, DOI 10.1038/sj.leu.2404951; Tsutsumi S, 2003, CANCER RES, V63, P4882; Uckun FM, 1997, BLOOD, V89, P2488; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025812; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Yoshida S, 1999, LEUKEMIA, V13, P1812, DOI 10.1038/sj.leu.2401563	50	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72326	10.1371/journal.pone.0072326	http://dx.doi.org/10.1371/journal.pone.0072326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977280	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000091
J	Newquist, G; Hogan, J; Walker, K; Lamanuzzi, M; Bowser, M; Kidd, T				Newquist, Gunnar; Hogan, Jesse; Walker, Kirsti; Lamanuzzi, Matthew; Bowser, Micah; Kidd, Thomas			Control of Male and Female Fertility by the Netrin Axon Guidance Genes	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; POLYCYSTIC-OVARY-SYNDROME; DROSOPHILA-MELANOGASTER; COMMISSURAL AXONS; CENTRAL COMPLEX; ANCHOR CELL; NEURONS; RECEPTOR; DCC; EXPRESSION	The netrin axon guidance genes have previously been implicated in fertility in C. elegans and in vertebrates. Here we show that adult Drosophila lacking both netrin genes, NetA and NetB, have fertility defects in both sexes together with an inability to fly and reduced viability. NetAB females produce fertilized eggs at a much lower rate than wild type. Oocyte development and ovarian innervation are unaffected in NetAB females, and the reproductive tract appears normal. A small gene, hog, that resides in an intron of NetB does not contribute to the NetAB phenotype. Restoring endogenous NetB expression rescues egg-laying, but additional genetic manipulations, such as restoration of netrin midline expression and inhibition of cell death have no effect on fertility. NetAB males induce reduced egg-laying in wild type females and display mirror movements of their wings during courtship. Measurement of courtship parameters revealed no difference compared to wild type males. Transgenic manipulations failed to rescue male fertility and mirror movements. Additional genetic manipulations, such as removal of the enabled gene, a known suppressor of the NetAB embryonic CNS phenotype, did not improve the behavioral defects. The ability to fly was rescued by inhibition of neuronal cell death and pan-neural NetA expression. Based on our results we hypothesize that the adult fertility defects of NetAB mutants are due to ovulation defects in females and a failure to properly transfer sperm proteins in males, and are likely to involve multiple neural circuits.	[Newquist, Gunnar; Hogan, Jesse; Walker, Kirsti; Lamanuzzi, Matthew; Bowser, Micah; Kidd, Thomas] Univ Nevada, Dept Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Kidd, T (corresponding author), Univ Nevada, Dept Biol, Reno, NV 89557 USA.	tkidd@unr.edu	Kidd, Thomas/AAT-9993-2020	Lamanuzzi, Matthew/0000-0002-3473-1771; Kidd, Thomas/0000-0001-7190-4208	National Science Foundation [IOS-1052555]; National Center for Research Resources [P20RR016464, 5P20RR024210]; National Institute of General Medical Sciences [8 P20 GM103554]; National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464, P20RR024210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103554] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grants from the National Science Foundation IOS-1052555, National Center for Research Resources (P20RR016464, 5P20RR024210) and the National Institute of General Medical Sciences (8 P20 GM103554) from the National Institutes of Health (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes A, 2004, CURR BIOL, V14, P704, DOI 10.1016/j.cub.2004.04.003; Albrecht S, 2011, DEV BIOL, V350, P89, DOI 10.1016/j.ydbio.2010.11.016; Arik Anam J., 2009, BMC Physiology, V9, P15, DOI 10.1186/1472-6793-9-15; Asakura T, 2007, DEV BIOL, V304, P800, DOI 10.1016/j.ydbio.2007.01.028; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Basini G, 2011, MOL CELL ENDOCRINOL, V331, P41, DOI 10.1016/j.mce.2010.08.001; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Cariboni A, 2004, HUM MOL GENET, V13, P2781, DOI 10.1093/hmg/ddh309; Cavaliere V, 1998, DEV DYNAM, V237, P2061; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Deiner MS, 1999, J NEUROSCI, V19, P9900; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Dobens L, 2005, DEV BIOL, V287, P425, DOI 10.1016/j.ydbio.2005.09.019; Dorsten JN, 2008, INT J DEV NEUROSCI, V26, P753, DOI 10.1016/j.ijdevneu.2008.07.004; Ejima A, 2007, COLD SPRING HARB PRO, V2007; Estes KA, 2009, DEV BIOL, V328, P297, DOI 10.1016/j.ydbio.2009.01.034; Fernandes JJ, 2005, DEV BIOL, V277, P493, DOI 10.1016/j.ydbio.2004.09.038; Finger JH, 2002, J NEUROSCI, V22, P10346; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Horn KE, 2013, CELL REP, V3, P173, DOI 10.1016/j.celrep.2012.12.005; HOTTA Y, 1972, NATURE, V240, P527, DOI 10.1038/240527a0; Ilius M, 2007, J NEUROGENET, V21, P321, DOI 10.1080/01677060701693503; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Ko SY, 2012, TRENDS MOL MED, V18, P544, DOI 10.1016/j.molmed.2012.07.001; Kugler JM, 2009, FLY, V3, P15, DOI 10.4161/fly.3.1.7751; Kuzina I, 2011, DEVELOPMENT, V138, P1839, DOI 10.1242/dev.062471; Lara HE, 2002, MICROSC RES TECHNIQ, V59, P495, DOI 10.1002/jemt.10229; Larrieu-Lahargue F, 2012, TRENDS CARDIOVAS MED, V22, P44, DOI 10.1016/j.tcm.2012.06.010; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Levine B, 2010, DEV BIOL, V344, P196, DOI 10.1016/j.ydbio.2010.04.030; Low VF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046999; Maeda A, 2008, J REPROD DEVELOP, V54, P275, DOI 10.1262/jrd.20044; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Manning L, 2012, CELL REP, V2, P1002, DOI 10.1016/j.celrep.2012.09.009; Merz DC, 2001, GENETICS, V158, P1071; Middleton CA, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-17; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Monastirioti M, 2003, DEV BIOL, V264, P38, DOI 10.1016/j.ydbio.2003.07.019; Murakami S, 2010, J COMP NEUROL, V518, P2019, DOI 10.1002/cne.22319; Nair Shatima, 2007, Invertebrate Neuroscience, V7, P137, DOI 10.1007/s10158-007-0048-0; Newquist G, 2013, CELL REP, V3, P595, DOI 10.1016/j.celrep.2013.02.017; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Rezaval C, 2012, CURR BIOL, V22, P1155, DOI 10.1016/j.cub.2012.04.062; Rodriguez-Valentin R, 2006, J CELL PHYSIOL, V209, P183, DOI 10.1002/jcp.20722; Saleem S, 2012, MECH DEVELOP, V129, P177, DOI 10.1016/j.mod.2012.04.002; Scholz H, 1997, MECH DEVELOP, V64, P137; Schwarting GA, 2004, EUR J NEUROSCI, V19, P11, DOI 10.1111/j.1460-9568.2004.03094.x; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SHOREY HH, 1962, SCIENCE, V137, P677, DOI 10.1126/science.137.3531.677; Spradling Allan C., 1993, P1; Srour M, 2010, SCIENCE, V328, P592, DOI 10.1126/science.1186463; Stemerdink C, 1997, DEVELOPMENT, V124, P3787; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Sun JJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00415; Sverrisdottir YB, 2008, AM J PHYSIOL-ENDOC M, V294, pE576, DOI 10.1152/ajpendo.00725.2007; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tayler TD, 2012, P NATL ACAD SCI USA, V109, P20697, DOI 10.1073/pnas.1218246109; TRENT C, 1983, GENETICS, V104, P619; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Wing Sun Lai K, 2011, DEVELOPMENT, V138, P2153, DOI [10.1242/dev.044529, DOI 10.1242/DEV.044529.PUBMED:21558366]; Wolfner M.F., 2007, P183; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; YU Q, 1987, NATURE, V326, P765, DOI 10.1038/326765a0; Ziel JW, 2009, NAT CELL BIOL, V11, P183, DOI 10.1038/ncb1825	71	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72524	10.1371/journal.pone.0072524	http://dx.doi.org/10.1371/journal.pone.0072524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977313	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000101
J	Urzica, EI; Vieler, A; Hong-Hermesdorf, A; Page, MD; Casero, D; Gallaher, SD; Kropat, J; Pellegrini, M; Benning, C; Merchant, SS				Urzica, Eugen I.; Vieler, Astrid; Hong-Hermesdorf, Anne; Page, M. Dudley; Casero, David; Gallaher, Sean D.; Kropat, Janette; Pellegrini, Matteo; Benning, Christoph; Merchant, Sabeeha S.			Remodeling of Membrane Lipids in Iron-starved Chlamydomonas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Algae; Iron; Lipid Metabolism; Plant Biochemistry; Triacylglycerol; Fatty Acid Desaturase	TRIACYLGLYCEROL ACCUMULATION; NITROGEN DEPRIVATION; FATTY-ACIDS; PHOTOSYNTHETIC APPARATUS; THYLAKOID MEMBRANES; GENE-EXPRESSION; REINHARDTII; DEFICIENCY; BIOSYNTHESIS; ARABIDOPSIS	Background: Iron starvation triggers lipid droplet and triacylglycerol (TAG) accumulation in Chlamydomonas reinhardtii. Results: The overall lipid profile shows a decrease in the absolute content of monogalactosyldiacylglycerol (MGDG) and an increase in saturated and monounsaturated fatty acids. Conclusion: Iron starvation has an early and distinct effect on membrane lipids, before onset of chlorosis. Significance: Iron deficiency affects distribution of lipid type as well as fatty acid profile. Chlamydomonas reinhardtii cells exposed to abiotic stresses (e.g. nitrogen, zinc, or phosphorus deficiency) accumulate triacylglycerols (TAG), which are stored in lipid droplets. Here, we report that iron starvation leads to formation of lipid droplets and accumulation of TAGs. This occurs between 12 and 24 h after the switch to iron-starvation medium. C. reinhardtii cells deprived of iron have more saturated fatty acid (FA), possibly due to the loss of function of FA desaturases, which are iron-requiring enzymes with diiron centers. The abundance of a plastid acyl-ACP desaturase (FAB2) is decreased to the same degree as ferredoxin. Ferredoxin is a substrate of the desaturases and has been previously shown to be a major target of the iron deficiency response. The increase in saturated FA (C16:0 and C18:0) is concomitant with the decrease in unsaturated FA (C16:4, C18:3, or C18:4). This change was gradual for diacylglyceryl-N,N,N-trimethylhomoserine (DGTS) and digalactosyldiacylglycerol (DGDG), whereas the monogalactosyldiacylglycerol (MGDG) FA profile remained stable during the first 12 h, whereas MGDG levels were decreasing over the same period of time. These changes were detectable after only 2 h of iron starvation. On the other hand, DGTS and DGDG contents gradually decreased until a minimum was reached after 24-48 h. RNA-Seq analysis of iron-starved C. reinhardtii cells revealed notable changes in many transcripts coding for enzymes involved in FA metabolism. The mRNA abundances of genes coding for components involved in TAG accumulation (diacylglycerol acyltransferases or major lipid droplet protein) were increased. A more dramatic increase at the transcript level has been observed for many lipases, suggesting that major remodeling of lipid membranes occurs during iron starvation in C. reinhardtii.	[Urzica, Eugen I.; Hong-Hermesdorf, Anne; Page, M. Dudley; Gallaher, Sean D.; Kropat, Janette; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Casero, David; Pellegrini, Matteo; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Casero, David; Pellegrini, Matteo; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Vieler, Astrid; Benning, Christoph] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Michigan State University	Urzica, EI (corresponding author), Univ Munster, Inst Plant Biol & Biotechnol, D-48143 Munster, Germany.	eugen.urzica@uni-muenster.de; sabeeha@chem.ucla.edu	Vieler, Astrid/J-2749-2019; Vieler, Astrid/P-5825-2014; Benning, Christoph/Y-2528-2019; Urzica, Eugen I/B-7903-2013; Casero, David/E-7365-2010; Vieler, Astrid/A-7334-2013; Urzica, Eugen Ioan/GXV-9546-2022	Vieler, Astrid/0000-0003-0009-7490; Vieler, Astrid/0000-0003-0009-7490; Benning, Christoph/0000-0001-8585-3667; Casero, David/0000-0002-7347-3330; Vieler, Astrid/0000-0003-0009-7490; Urzica, Eugen Ioan/0000-0002-1028-7442; Gallaher, Sean/0000-0002-9773-6051; Pellegrini, Matteo/0000-0001-9355-9564	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FD02-04ER15529]; Air Force Office of Science Research [FA 9550-10-1-0095, FA9550-08-0165]	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); Air Force Office of Science Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy Grant DE-FD02-04ER15529 (to S. M.) and Air Force Office of Science Research Grants FA 9550-10-1-0095 (to M. P.) and FA9550-08-0165 (to C. B.).	ABADIA A, 1988, PHYSIOL PLANTARUM, V72, P713, DOI 10.1111/j.1399-3054.1988.tb06370.x; Allen MD, 2007, EUKARYOT CELL, V6, P1841, DOI 10.1128/EC.00205-07; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blouin A, 2003, PLANT PHYSIOL BIOCH, V41, P11, DOI 10.1016/S0981-9428(02)00003-7; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Busch A, 2008, PLANT J, V55, P201, DOI 10.1111/j.1365-313X.2008.03490.x; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Chen JCH, 2008, INT J TECHNOL MANAGE, V43, P1; Chen M, 2011, BIORESOURCE TECHNOL, V102, P1649, DOI 10.1016/j.biortech.2010.09.062; Deng XD, 2011, AFR J MICROBIOL RES, V5, P260; Fan JL, 2011, FEBS LETT, V585, P1985, DOI 10.1016/j.febslet.2011.05.018; FISCHER W, 1973, H-S Z PHYSIOL CHEM, V354, P1115, DOI 10.1515/bchm2.1973.354.2.1115; FOLCH J, 1957, J BIOL CHEM, V226, P497; FOX BG, 1993, P NATL ACAD SCI USA, V90, P2486, DOI 10.1073/pnas.90.6.2486; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Hsieh SI, 2013, MOL CELL PROTEOMICS, V12, P65, DOI 10.1074/mcp.M112.021840; HUTNER S. H., 1950, PROC AMER PHIL SOC, V94, P152; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; Kobayashi K, 2013, PLANT J, V73, P250, DOI 10.1111/tpj.12028; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; La Russa M, 2012, J BIOTECHNOL, V162, P13, DOI 10.1016/j.jbiotec.2012.04.006; Li XB, 2012, PLANT CELL, V24, P4670, DOI 10.1105/tpc.112.105106; Li XB, 2012, EUKARYOT CELL, V11, P1451, DOI 10.1128/EC.00268-12; Liu BS, 2013, CURR OPIN BIOTECH, V24, P300, DOI 10.1016/j.copbio.2012.08.008; Hernandez ML, 2012, PLANT PHYSIOL, V160, P215, DOI 10.1104/pp.112.201541; Matthew T, 2009, J BIOL CHEM, V284, P23415, DOI 10.1074/jbc.M109.003541; Merchant SS, 2012, CURR OPIN BIOTECH, V23, P352, DOI 10.1016/j.copbio.2011.12.001; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Miquel M, 1998, PLANT PHYSIOL, V117, P923, DOI 10.1104/pp.117.3.923; Moellering ER, 2010, EUKARYOT CELL, V9, P97, DOI 10.1128/EC.00203-09; MONGE E, 1993, PLANT SOIL, V154, P97, DOI 10.1007/BF00011077; Moore TS, 2001, PLANT PHYSIOL, V125, P423, DOI 10.1104/pp.125.1.423; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Msanne J, 2012, PHYTOCHEMISTRY, V75, P50, DOI 10.1016/j.phytochem.2011.12.007; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Nguyen HM, 2011, PROTEOMICS, V11, P4266, DOI 10.1002/pmic.201100114; NISHIO JN, 1985, PLANT PHYSIOL, V77, P705, DOI 10.1104/pp.77.3.705; Page MD, 2012, PLANT CELL, V24, P2649, DOI 10.1105/tpc.112.098962; Pineau B, 2004, EUR J BIOCHEM, V271, P329, DOI 10.1046/j.1432-1033.2003.03931.x; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; Riekhof WR, 2005, EUKARYOT CELL, V4, P242, DOI 10.1128/EC.4.2.242-252.2005; Riekhof WR, 2003, PLANT PHYSIOL, V133, P864, DOI 10.1104/pp.103.029249; SCHLOSS JA, 1990, MOL GEN GENET, V221, P443, DOI 10.1007/BF00259410; SCHMIDT H, 1990, P NATL ACAD SCI USA, V87, P9477, DOI 10.1073/pnas.87.23.9477; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; STOCKING CR, 1975, PLANT PHYSIOL, V55, P626, DOI 10.1104/pp.55.4.626; Terauchi AM, 2010, PHOTOSYNTH RES, V105, P39, DOI 10.1007/s11120-010-9562-8; TERRY N, 1980, PLANT PHYSIOL, V65, P114, DOI 10.1104/pp.65.1.114; Urzica EI, 2012, PLANT CELL, V24, P3921, DOI 10.1105/tpc.112.102491; WADA H, 1993, J BACTERIOL, V175, P544, DOI 10.1128/JB.175.2.544-547.1993; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Weers PMM, 1997, LIMNOL OCEANOGR, V42, P1584, DOI 10.4319/lo.1997.42.7.1584; Yang WY, 2004, BIOCHEM J, V382, P51, DOI 10.1042/BJ20040254; Yoon K, 2012, PLANT CELL, V24, P3708, DOI 10.1105/tpc.112.100701; Zauner S, 2012, EUKARYOT CELL, V11, P856, DOI 10.1128/EC.00079-12; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795	59	62	64	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30246	30258		10.1074/jbc.M113.490425	http://dx.doi.org/10.1074/jbc.M113.490425			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23983122	Green Published, hybrid			2022-12-25	WOS:000329868100023
J	He, J; Kauffman, WB; Fuselier, T; Naveen, SK; Voss, TG; Hristova, K; Wimley, WC				He, Jing; Kauffman, W. Berkeley; Fuselier, Taylor; Naveen, Somanna K.; Voss, Thomas G.; Hristova, Kalina; Wimley, William C.			Direct Cytosolic Delivery of Polar Cargo to Cells by Spontaneous Membrane-translocating Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENETRATING PEPTIDES; INTERFACIAL ACTIVITY; UPTAKE KINETICS; MECHANISM; TRANSFECTION; ENDOCYTOSIS; EFFICIENCY; BILAYERS; PATHWAYS; SYSTEM	Direct cellular entry of potentially useful polar compounds into cells is prevented by the hydrophobic barrier of the membrane. Toward circumventing this barrier, we used high throughput screening to identify a family of peptides that carry membrane-impermeant cargos across synthetic membranes. Here we characterize the plasma membrane translocation of these peptides with polar cargos under a variety of conditions. The spontaneous membrane-translocating peptides (SMTPs) delivered the zwitterionic, membrane-impermeant dye tetramethylrhodamine (TAMRA) into cells even when the conditions were not permissive for endocytosis. They also delivered the larger, anionic membrane-impermeant dye Alexa Fluor 546 but did not deliver a quantum dot nanoparticle. Under all conditions, the SMTP-cargo filled the cytoplasm with a diffuse, non-punctate fluorescence that was partially excluded from the nucleus. D-Amino acid peptides behaved identically in vitro, ruling out proteolysis as an important factor in the diffuse cellular distribution. Thus, cytosolic delivery of SMTP-cargo conjugates is dominated by direct membrane translocation. This is in sharp contrast to Arg(9)-TAMRA, a representative highly cationic, cell-penetrating peptide, which entered cells only when endocytosis was permitted. Arg(9)-TAMRA triggered large scale endocytosis and did not appreciably escape the endosomal compartments in the 1-h timescales we studied. When injected into mice, SMTP-TAMRA conjugates were found in many tissues even after 2 h. Unconjugated TAMRA was rapidly cleared and did not become systemically distributed. SMTPs are a platform that could improve delivery of many polar compounds to cells, in the laboratory or in the clinic, including those that would otherwise be rejected as drugs because they are membrane-impermeant.	[He, Jing; Kauffman, W. Berkeley; Fuselier, Taylor; Wimley, William C.] Tulane Univ, Sch Med, Dept Biochem, New Orleans, LA 70112 USA; [Naveen, Somanna K.; Voss, Thomas G.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	Tulane University; Tulane University; Johns Hopkins University	Wimley, WC (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	wwimley@tulane.edu	He, Jing/B-2400-2015	Kauffman, William/0000-0003-0571-5403	National Institutes of Health [GM60000]; National Science Foundation Division of Materials Research [1003441, 1003411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Division of Materials Research(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60000 (to W. C. W.). This work was also supported by National Science Foundation Division of Materials Research Grants 1003441 (to W. C. W.) and 1003411 (to K.H.).	Abes S, 2006, J CONTROL RELEASE, V110, P595, DOI 10.1016/j.jconrel.2005.10.026; Aguilera TA, 2009, INTEGR BIOL, V1, P371, DOI 10.1039/b904878b; Bayley H, 2004, MOL MEMBR BIOL, V21, P209, DOI 10.1080/09687680410001716853; Bessodes Michel, 2013, Methods Mol Biol, V948, P67, DOI 10.1007/978-1-62703-140-0_6; Chugh A, 2010, IUBMB LIFE, V62, P183, DOI 10.1002/iub.297; Cruz J, 2013, BIOPHYS J, V104, P2419, DOI 10.1016/j.bpj.2013.04.043; Debart F, 2007, CURR TOP MED CHEM, V7, P727, DOI 10.2174/156802607780487704; Delehanty JB, 2010, INTEGR BIOL-UK, V2, P265, DOI 10.1039/c0ib00002g; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dong M, 2012, CLIN CANCER RES, V18, P1830, DOI 10.1158/1078-0432.CCR-11-2105; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Dupont E, 2011, METHODS MOL BIOL, V683, P21, DOI 10.1007/978-1-60761-919-2_2; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Fazio N, 2010, CANCER TREAT REV, V36, pS87, DOI 10.1016/S0305-7372(10)70026-8; Floren A, 2011, METHODS MOL BIOL, V683, P117, DOI 10.1007/978-1-60761-919-2_9; Fonseca SB, 2009, ADV DRUG DELIVER REV, V61, P953, DOI 10.1016/j.addr.2009.06.001; Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x; Gautam A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-74; Gerlach SL, 2010, BIOPOLYMERS, V94, P617, DOI 10.1002/bip.21435; GIOCONDI MC, 1989, BIOCHEM BIOPH RES CO, V162, P1004, DOI 10.1016/0006-291X(89)90773-0; He J, 2012, ANGEW CHEM INT EDIT, V51, P7150, DOI 10.1002/anie.201202741; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jafari M, 2013, BIOCHEMISTRY-US, V52, P3428, DOI 10.1021/bi4001326; Jarver P, 2010, TRENDS PHARMACOL SCI, V31, P528, DOI 10.1016/j.tips.2010.07.006; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Langel U., 2006, HDB CELL PENETRATING; Lehto T, 2010, J CONTROL RELEASE, V141, P42, DOI 10.1016/j.jconrel.2009.08.028; Longmuir KJ, 2009, INT J PHARMACEUT, V382, P222, DOI 10.1016/j.ijpharm.2009.07.030; Mager I, 2012, BBA-BIOMEMBRANES, V1818, P502, DOI 10.1016/j.bbamem.2011.11.020; Marks JR, 2011, J AM CHEM SOC, V133, P8995, DOI 10.1021/ja2017416; Montrose K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01661; Mukai Y, 2006, BIOL PHARM BULL, V29, P1570, DOI 10.1248/bpb.29.1570; Nakase I, 2012, ACCOUNTS CHEM RES, V45, P1132, DOI 10.1021/ar200256e; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; Palm-Apergi C, 2009, FASEB J, V23, P214, DOI 10.1096/fj.08-110254; Raagel H, 2010, BBA-BIOMEMBRANES, V1798, P2240, DOI 10.1016/j.bbamem.2010.02.013; Rathinakumar R, 2010, FASEB J, V24, P3232, DOI 10.1096/fj.10-157040; Rathinakumar R, 2009, J AM CHEM SOC, V131, P7609, DOI 10.1021/ja8093247; Rausch JM, 2007, BIOCHEMISTRY-US, V46, P12124, DOI 10.1021/bi700978h; Sadler K, 2002, BIOCHEMISTRY-US, V41, P14150, DOI 10.1021/bi026661l; Salomone F, 2012, J CONTROL RELEASE, V163, P293, DOI 10.1016/j.jconrel.2012.09.019; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Tan YX, 2012, J GENE MED, V14, P241, DOI 10.1002/jgm.2609; TSONG TY, 1991, BIOPHYS J, V60, P297, DOI 10.1016/S0006-3495(91)82054-9; Van Overstraeten-Schlogel N, 2012, DRUG DELIV, V19, P112, DOI 10.3109/10717544.2011.649219; Wang S, 2012, J MED CHEM, V55, P2427, DOI 10.1021/jm201743s; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Yandek LE, 2007, BIOPHYS J, V92, P2434, DOI 10.1529/biophysj.106.100198; Yu HJ, 2011, ACS NANO, V5, P9246, DOI 10.1021/nn203503h	52	46	46	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29974	29986		10.1074/jbc.M113.488312	http://dx.doi.org/10.1074/jbc.M113.488312			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23983125	hybrid, Green Published			2022-12-25	WOS:000330615300070
J	Akelo, V; Girde, S; Borkowf, CB; Angira, F; Achola, K; Lando, R; Mills, LA; Thomas, TK; Lecher, SL				Akelo, Victor; Girde, Sonali; Borkowf, Craig B.; Angira, Frank; Achola, Kevin; Lando, Richard; Mills, Lisa A.; Thomas, Timothy K.; Lecher, Shirley Lee			Attitudes toward Family Planning among HIV-Positive Pregnant Women Enrolled in a Prevention of Mother-To-Child Transmission Study in Kisumu, Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CONTRACEPTIVE USE; RURAL UGANDA; UNINTENDED PREGNANCIES; PROSPECTIVE COHORT; SOUTH-AFRICA; CONDOM USE; PREVALENCE; POSTPARTUM; INFECTION	Background: Preventing unintended pregnancies among HIV-positive women through family planning (FP) reduces pregnancy-related morbidity and mortality, decreases the number of pediatric HIV infections, and has also proven to be a cost-effective way to prevent mother-to-child HIV transmission. A key element of a comprehensive HIV prevention agenda, aimed at avoiding unintended pregnancies, is recognizing the attitudes towards FP among HIV-positive women and their spouse or partner. In this study, we analyze FP attitudes among HIV-infected pregnant women enrolled in a PMTCT clinical trial in Western Kenya. Methods and Findings: Baseline data were collected on 522 HIV-positive pregnant women using structured questionnaires. Associations between demographic variables and the future intention to use FP were examined using Fisher's exact tests and permutation tests. Most participants (87%) indicated that they intended to use FP. However, only 8% indicated condoms as a preferred FP method, and 59% of current pregnancies were unintended. Factors associated with positive intentions to use FP were: marital status (p = 0.04), having talked to their spouse or partner about FP (p < 0.001), perceived spouse or partner approval of FP (p, 0.001), previous use of a FP method (p = 0.006), attitude toward the current pregnancy (p = 0.02), disclosure of a sexually transmitted infection (STI) diagnosis (p = 0.03) and ethnic group (p = 0.03). Conclusion: A significant gap exists between future FP intentions and current FP practices. Support and approval by the spouse or partner are key elements of FP intentions. Counseling services should be offered to both members of a couple to increase FP use, especially given the high number of unplanned pregnancies among HIV-positive women. Condoms should be promoted as part of a dual use method for HIV and STI prevention and for contraception. Integration of individual and couple FP services into routine HIV care, treatment and support services is needed in order to avoid unintended pregnancies and to prevent mother-to-child HIV transmission.	[Akelo, Victor; Angira, Frank; Achola, Kevin; Lando, Richard] Kenya Govt Med Res Ctr, Kisumu, Kenya; [Akelo, Victor; Girde, Sonali; Borkowf, Craig B.; Lecher, Shirley Lee] US Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Girde, Sonali] ICF Int, Atlanta, GA USA; [Mills, Lisa A.; Thomas, Timothy K.] US Ctr Dis Control & Prevent, HIV Res Branch, Atlanta, GA USA	Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Lecher, SL (corresponding author), US Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA.	gux5@cdc.gov			Kenya Medical Research Institute (KEMRI) through the US Centers for Disease Control and Prevention (CDC)	Kenya Medical Research Institute (KEMRI) through the US Centers for Disease Control and Prevention (CDC)	Funding for the study was provided by the Kenya Medical Research Institute (KEMRI) through a cooperative agreement with the US Centers for Disease Control and Prevention (CDC). The study design, data collection instruments, data collection, data analysis, decision to publish, and preparation of the manuscript were led by CDC and KEMRI staff based in Atlanta and at the KEMRI/CDC Field Station in Kisumu, Kenya. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the CDC.	Anand A, 2009, AIDS, V23, P1565, DOI 10.1097/QAD.0b013e32832cb10c; Beyeza-Kashesya J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-144; Bii S C, 2008, East Afr Med J, V85, P46; Centers for Disease Control and Prevention DoRH, 2012, UN PREGN PREV; Chersich MF, 2008, INT J GYNECOL OBSTET, V100, P45, DOI 10.1016/j.ijgo.2007.06.053; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Cleland J, 2006, LANCET, V368, P1788, DOI 10.1016/S0140-6736(06)69738-9; Council P, 2003, POP COUNC ANN REP; Crede S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-197; Division of Primary Health Care Ministry of Health Government of Kenya, 2000, FAM PLANN REPR HLTH; Duerr A, 2005, LANCET, V366, P261, DOI 10.1016/S0140-6736(05)66917-6; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Halperin DT, 2009, AIDS, V23, pS123, DOI 10.1097/01.aids.0000363785.73450.5a; Heffron R, 2010, SEX TRANSM DIS, V37, P621, DOI 10.1097/OLQ.0b013e3181e1a162; Heys J, 2009, AIDS, V23, pS37, DOI 10.1097/01.aids.0000363776.76129.fd; Higgins JA, 2012, SEX HEALTH, V9, P73, DOI 10.1071/SH11004; Hladik W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007691; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Hubacher D, 2008, CONTRACEPTION, V78, P73, DOI 10.1016/j.contraception.2008.03.002; Kenya Go, 2009, KEN 2009 POP HOUS CE; Keogh SC, 2009, AIDS, V23, pS27, DOI 10.1097/01.aids.0000363775.68505.f1; Kibuuka H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005164; Kikuchi K, 2011, BIOSCI TRENDS, V5, P255, DOI 10.5582/bst.2011.v5.6.255; King R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-530; Kosgei RJ, 2011, JAIDS-J ACQ IMM DEF, V58, pE121, DOI 10.1097/QAI.0b013e318237ca80; Loutfy MR, 2012, HIV MED, V13, P107, DOI 10.1111/j.1468-1293.2011.00946.x; Maharaj P, 2012, AIDS CARE, V24, P444, DOI 10.1080/09540121.2011.613913; Maticka-Tyndale E, 2012, SEX HEALTH, V9, P59, DOI 10.1071/SH11033; Montgomery CM, 2008, AIDS CARE, V20, P733, DOI 10.1080/09540120701693974; Mutiso S M, 2008, East Afr Med J, V85, P171; Nattabi Barbara, 2011, Confl Health, V5, P18, DOI 10.1186/1752-1505-5-18; Ngubane N, 2008, SAMJ S AFR MED J, V98, P209; Ngure K, 2012, AIDS, V26, P513, DOI 10.1097/QAD.0b013e32834f981c; Phillips SJ, 2012, AIDS; Polis CB, 2013, AIDS, V27, P493, DOI 10.1097/QAD.0b013e32835ad539; Polis CB, 2011, CONTRACEPTION, V83, P549, DOI 10.1016/j.contraception.2010.10.002; Reynolds HW, 2008, SEX TRANSM INFECT, V84, pII49, DOI 10.1136/sti.2008.030049; Reynolds HW, 2005, SEX TRANSM INFECT, V81, P184, DOI 10.1136/sti.2004.012013; Rutenberg N, 2005, STUD FAMILY PLANN, V36, P235, DOI 10.1111/j.1728-4465.2005.00064.x; Subramanian Laura, 2008, Afr J Reprod Health, V12, P45; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; UNAIDS, 2012, REP GLOB AIDS EP 201; UNAIDS, 2012, WOM NEED ACC DUAL PR; UNAIDS, 2011, UNAIDS 1 2011 2015 S; United Nations Department of Economic and Social Affairs PD, 2011, 2011 UPD MDG DAT UNM; USAID, 2006, ISS BRIEF ADD FAM PL; Wand H, 2012, AIDS, V26, P375, DOI 10.1097/QAD.0b013e32834f990f; Wanyenze RK, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-35; World Health Organization Unicef AIDS, 2007, GUID GLOB SCAL UP PR	49	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e66593	10.1371/journal.pone.0066593	http://dx.doi.org/10.1371/journal.pone.0066593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215RU	23990868	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800002
J	Kadera, BE; Li, LY; Toste, PA; Wu, NP; Adams, C; Dawson, DW; Donahue, TR				Kadera, Brian E.; Li, Luyi; Toste, Paul A.; Wu, Nanping; Adams, Curtis; Dawson, David W.; Donahue, Timothy R.			MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis	PLOS ONE			English	Article							II COLON-CANCER; STELLATE CELLS; EXPRESSION; GENE; PATTERNS; SURVIVAL; INVASION; MIR-21; PROLIFERATION; STROMA	Introduction: Pancreatic ductal adenocarcinoma (PDAC) is projected to rise to the second leading cause of U. S. cancer-related deaths by 2020. Novel therapeutic targets are desperately needed. MicroRNAs (miRs) are small noncoding RNAs that function by suppressing gene expression and are dysregulated in cancer. miR-21 is overexpressed in PDAC tumor cells (TC) and is associated with decreased survival, chemoresistance and invasion. Dysregulation of miR regulatory networks in PDAC tumor-associated fibroblasts (TAFs) have not been previously described. In this study, we show that miR-21 expression in TAFs promotes TC invasion. Methods: In-situ hybridization for miR-21 was performed on the 153 PDAC patient UCLA tissue microarray and 23 patient-matched lymph node metastases. Stromal and TC histoscores were correlated with clinicopathologic parameters by univariate and multivariate Cox regression. miR-21 positive cells were further characterized by immunofluorescence for mesenchymal/epithelial markers. For in vitro studies, TAFs were isolated from freshly resected human PDAC tumors by the outgrowth method. miR-21 was overexpressed/inhibited in fibroblasts and then co-cultured with GFP-MiaPaCa TCs to assess TC invasion in modified Boyden chambers. Results: miR-21 was upregulated in TAFs of 78% of tumors, and high miR-21 significantly correlated with decreased overall survival (P = 0.04). Stromal miR-21 expression was also significantly associated with lymph node invasion (P = 0.004), suggesting that it is driving TC spread. Co-immunofluorescence revealed that miR-21 colocalized with peritumoral fibroblasts expressing alpha-smooth muscle actin. Moreover, expression of miR-21 in primary TAFs correlated with miR-21 in TAFs from patient-matched LN metastases; evidence that PDAC tumor cells induce TAFs to express miR-21. miR-21 expression in TAFs and TCs promotes invasion of TCs and is inhibited with anti-miR-21. Conclusions: miR-21 expression in PDAC TAFs is associated with decreased overall survival and promotes TC invasion. Anti-miR-21 may represent a novel therapeutic strategy for dual targeting of both tumor and stroma in PDAC.	[Kadera, Brian E.; Li, Luyi; Toste, Paul A.; Wu, Nanping; Adams, Curtis; Donahue, Timothy R.] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Surg, Dept Surg, Los Angeles, CA 90095 USA; [Dawson, David W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Donahue, Timothy R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Dawson, David W.; Donahue, Timothy R.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Donahue, Timothy R.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Donahue, TR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Surg, Dept Surg, Los Angeles, CA 90095 USA.	tdonahue@mednet.ucla.edu	Dawson, David/I-5917-2014	Kadera, Brian/0000-0002-5133-8656	Hirshberg Foundation; Concern Foundation; Oppenheimer Foundation; California Institute for Regenerative Medicine [TG2-01169]; CURE; Stop Cancer Foundation; Susan E. Riley Foundation; Gerald S. Levey Surgical Research Award	Hirshberg Foundation; Concern Foundation; Oppenheimer Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); CURE; Stop Cancer Foundation; Susan E. Riley Foundation; Gerald S. Levey Surgical Research Award	This work was supported by the Hirshberg Foundation (http://www.pancreatic.org), Concern Foundation (http://www.concernfoundation.org), Oppenheimer Foundation (http://oppenheimer.healthsciences.ucla.edu), California Institute for Regenerative Medicine TG2-01169 (http://www.cirm.ca.gov), CURE (http://www.cure.med.ucla.edu), Stop Cancer Foundation (www.stopcancer.org), Susan E. Riley Foundation and the Gerald S. Levey Surgical Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIG 2013, P1, DOI DOI 10.1017/CB09781107415324.004; Kovochich AN, 2013, CANCER-AM CANCER SOC, V119, P529, DOI 10.1002/cncr.27725; Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Brentnall TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030219; Bronnum H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056280; Cameron JL, 2006, ANN SURG, V244, P10, DOI 10.1097/01.sla.0000217673.04165.ea; Campbell I, 2011, J PATHOL, V223, P450, DOI 10.1002/path.2842; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Donahue TR, 2012, CLIN CANCER RES, V18, P1352, DOI 10.1158/1078-0432.CCR-11-1539; du Rieu MC, 2010, CLIN CHEM, V56, P603, DOI 10.1373/clinchem.2009.137364; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Giovannetti E, 2010, CANCER RES, V70, P4528, DOI 10.1158/0008-5472.CAN-09-4467; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Huang M, 2002, J CLIN INVEST, V109, P931, DOI 10.1172/JCI200214685; Hwang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010630; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Kjaer-Frifeldt S, 2012, BRIT J CANCER, V107, P1169, DOI 10.1038/bjc.2012.365; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Laghi L, 2002, ONCOGENE, V21, P4301, DOI 10.1038/sj.onc.1205533; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; Martinez-Rocha L, 2013, AQUAC RES, V44, P847, DOI 10.1111/j.1365-2109.2011.03083.x; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Sabatel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016979; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477	48	126	131	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e71978	10.1371/journal.pone.0071978	http://dx.doi.org/10.1371/journal.pone.0071978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991015	gold, Green Submitted, Green Published			2022-12-25	WOS:000324470700022
J	Zhang, HM; Zhou, QC				Zhang, Hongmei; Zhou, Quancheng			Tyrosinase Inhibitory Effects and Antioxidative Activities of Saponins from Xanthoceras Sorbifolia Nutshell	PLOS ONE			English	Article							TRITERPENOID SAPONINS; MUSHROOM TYROSINASE; ENERGY PLANTS; MECHANISM; EXTRACTS; CHINA; ACID	Certain saponins are bioactive compounds with anticancer, antivirus and antioxidant activities. This paper discussed inhibitory effects of saponins from Xanthoceras Sorbifolia on tyrosinase, through the research of the rate of tyrosinase catalyzed L-DOPA oxidation. The inhibition rate of tyrosinase activity presented non-linear changes with the saponins concentration. The rate reached 52.0% when the saponins concentration was 0.96 mg/ml. Antioxidant activities of saponins from Xanthoceras Sorbifolia were evaluated by using hydroxyl and superoxide radical scavenging assays. The hydroxyl radical scavenging effects of the saponins were 15.5-68.7%, respectively at the concentration of 0.18-2.52 mg/ml. The superoxide radical scavenging activity reduced from 96.6% to 7.05% with the time increasing at the concentration of 1.44 mg/ml. All the above antioxidant evaluation indicated that saponins from Xanthoceras Sorbifolia exhibited good antioxidant activity in a concentration-dependent manner.	[Zhang, Hongmei; Zhou, Quancheng] Shandong Univ Technol, Sch Agr Engn & Food Sci, Zibo, Shandong, Peoples R China	Shandong University of Technology	Zhou, QC (corresponding author), Shandong Univ Technol, Sch Agr Engn & Food Sci, Zibo, Shandong, Peoples R China.	zhouquancheng@126.com						Bi LL, 2012, FITOTERAPIA, V83, P234, DOI 10.1016/j.fitote.2011.11.002; Chan PK, 2007, BIOCHEM PHARMACOL, V73, P341, DOI 10.1016/j.bcp.2006.10.007; Chen LJ, 2010, J NAT MED-TOKYO, V64, P114, DOI 10.1007/s11418-009-0376-y; Chen X.D., 2007, FOOD RES DEV, V128, P20; Cheng W. M., 2001, CHINESE TRADITIONAL, V32, P199; Dahl M. K., 1978, J DAIRY SCI, V61, P400; [段玉清 Duan Yuqing], 2004, [食品科学, Food Science], V25, P169; Han P, 2008, FOOD CHEM, V107, P797, DOI 10.1016/j.foodchem.2007.08.084; Heo SJ, 2005, BIORESOURCE TECHNOL, V96, P1613, DOI 10.1016/j.biortech.2004.07.013; Huang KF, 2005, FOOD CHEM, V89, P583, DOI 10.1016/j.foodchem.2004.03.022; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Lau SS, 2001, CHEM RES TOXICOL, V14, P25, DOI 10.1021/tx000161g; Li XF, 2010, ENVIRON MANAGE, V46, P579, DOI 10.1007/s00267-010-9443-0; Li Z. - R., 2005, AGR TECHNOLOGY, V25, P4; [刘新霞 LIU Xinxia], 2007, [中草药, Chinese Traditional and Herbal Drugs], V38, P1859; Madinez MV, 1995, TRENDS FOOD SCI TECH, V6, P195; Nerya O, 2003, J AGR FOOD CHEM, V51, P1201, DOI 10.1021/jf020935u; Nie W, 2009, SEP PURIF TECHNOL, V65, P243, DOI 10.1016/j.seppur.2008.10.042; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Scott MC, 2002, J CELL SCI, V115, P2349; Shao HB, 2008, BIOMASS BIOENERG, V32, P283, DOI 10.1016/j.biombioe.2007.10.001; Singh N, 2004, FOOD CHEM, V85, P611, DOI 10.1016/j.foodchem.2003.07.003; Tapondjou LA, 2011, CARBOHYD RES, V346, P2699, DOI 10.1016/j.carres.2011.09.014; Wang H.D., 1998, CHIN WILD PLANT RESO, V17, P13; Wang Z. - S., 2002, SPECIAL EC ANIMAL PL, V11, P29; Xie LP, 2003, INT J BIOCHEM CELL B, V35, P1658, DOI 10.1016/S1357-2725(03)00006-2; Yang Y, 2006, NUTR RES, V26, P369, DOI 10.1016/j.nutres.2006.06.014; Zu YG, 2009, EUR FOOD RES TECHNOL, V229, P43, DOI 10.1007/s00217-009-1024-1	29	8	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e70090	10.1371/journal.pone.0070090	http://dx.doi.org/10.1371/journal.pone.0070090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990897	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100020
J	Feller, S; Teucher, B; Kaaks, R; Boeing, H; Vigl, M				Feller, Silke; Teucher, Birgit; Kaaks, Rudolf; Boeing, Heiner; Vigl, Matthaeus			Life Satisfaction and Risk of Chronic Diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; POSITIVE AFFECT; PSYCHOLOGICAL-FACTORS; GENDER-DIFFERENCES; BREAST-CANCER; EPIC-GERMANY; HEALTH; MORTALITY; DEPRESSION; HAPPINESS	Objective: The aim of the study was to examine the prospective association between life satisfaction and risk of type 2 diabetes mellitus, myocardial infarction, stroke, and cancer. Previous studies suggested that psychosocial factors may affect the development of chronic diseases but the impact of positive attitudes, in particular life satisfaction, is yet to be determined. Methods: The analysis included 50,358 participants of the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study in Potsdam and Heidelberg. Life satisfaction was assessed in a baseline interview and incident cases of chronic diseases were identified and verified during follow-up. Hazard ratios were calculated using Cox proportional hazards regression models that were systematically multivariable-adjusted for established risk factors and prevalent diseases. Results: During an average of 8 years of follow-up 2,293 cases of cancer, 1,840 cases of type 2 diabetes mellitus, 440 cases of stroke, and 562 cases of myocardial infarction were observed. Women who were unsatisfied with life at baseline showed in all models a significantly increased risk of cancer (HR: 1.45; 95% CI: 1.18-1.78) and stroke (HR: 1.69; 95% CI: 1.05-2.73) as well as an increased risk of type 2 diabetes mellitus by trend across categories (p-trend=0.04) compared to women very satisfied with life. In men, a relationship between life satisfaction and stroke was found but did not persist after consideration of lifestyle factors and prevalent diseases. No significant association was observed between life satisfaction and risk of myocardial infarction. Conclusions: The results of this study suggest that reduced life satisfaction is related to the development of chronic diseases-particularly in women and partly mediated by established risk factors.	[Feller, Silke; Boeing, Heiner; Vigl, Matthaeus] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Teucher, Birgit; Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; German Cancer Research Center (DKFZ)	Feller, S (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany.	silke.feller@dife.de	Teucher, Birgit/J-6380-2015		German Federal Ministry of Education and Research (BMBF) [01ER0808]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The project was funded by the German Federal Ministry of Education and Research (BMBF) under the promotional reference 01ER0808; URL: http://www.bmbf.de/en/index.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann E, 1999, GESUNDHEITSWESEN, V61, P138; Bergmann MM, 1999, ANN NUTR METAB, V43, P225, DOI 10.1159/000012789; Boehm JK, 2011, HEALTH PSYCHOL, V30, P259, DOI 10.1037/a0023124; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; Chalmers J, 1999, CLIN EXP HYPERTENS, V21, P1009; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Cuijpers P, 2002, J AFFECT DISORDERS, V72, P227, DOI 10.1016/S0165-0327(01)00413-X; Dalton SO, 2002, EUR J CANCER, V38, P1313, DOI 10.1016/S0959-8049(02)00099-0; Davidson KW, 2010, EUR HEART J, V31, P1065, DOI 10.1093/eurheartj/ehp603; Denton M, 2004, SOC SCI MED, V58, P2585, DOI 10.1016/j.socscimed.2003.09.008; Diener E, 2003, ANNU REV PSYCHOL, V54, P403, DOI 10.1146/annurev.psych.54.101601.145056; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; Dolan P, 2006, FINAL REPORT DEFRA; Dorak M. Tevfik, 2012, Frontiers in Genetics, V3, P268, DOI 10.3389/fgene.2012.00268; Fujita F, 2005, J PERS SOC PSYCHOL, V88, P158, DOI 10.1037/0022-3514.88.1.158; Garssen B, 2004, CLIN PSYCHOL REV, V24, P315, DOI 10.1016/j.cpr.2004.01.002; Gonzalez CA, 2006, PUBLIC HEALTH NUTR, V9, P124, DOI 10.1079/PHN2005934; Grad FP, 2002, B WORLD HEALTH ORGAN, V80, P981; Grant N, 2009, INT J BEHAV MED, V16, P259, DOI 10.1007/s12529-009-9032-x; Guven C, 2009, SOEPPAPERS MULTIDISC, P198; Haberland J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-52; Hansen JD, 2010, INT J CARDIOL, V145, P603, DOI 10.1016/j.ijcard.2010.08.059; Howell R., 2007, HEALTH PSYCHOL REV, V1, P83, DOI [DOI 10.1080/17437190701492486, 10.1080/17437190701492486]; Howell RT, 2009, EVID-BASED MENT HEAL, V12, P41, DOI 10.1136/ebmh.12.2.41; Koivumaa-Honkanen H, 2004, PSYCHOL MED, V34, P221, DOI 10.1017/S0033291703001089; Koivumaa-Honkanen H, 2002, ACTA PSYCHIAT SCAND, V105, P444, DOI 10.1034/j.1600-0447.2002.01287.x; Koivumaa-Honkanen H, 2001, AM J PSYCHIAT, V158, P433, DOI 10.1176/appi.ajp.158.3.433; Koivumaa-Honkanen H, 2000, AM J EPIDEMIOL, V152, P983, DOI 10.1093/aje/152.10.983; Koizumi M, 2008, J EPIDEMIOL, V18, P191, DOI 10.2188/jea.JE2007388; Lacruz ME, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-579; Lillberg K, 2002, CANCER CAUSE CONTROL, V13, P191, DOI 10.1023/A:1014306231709; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Lopez M, 2010, CLIN TER, V161, P69; Lucas RE, 2007, J RES PERS, V41, P1091, DOI 10.1016/j.jrp.2006.11.005; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; McSweeney JC, 2003, CIRCULATION, V108, P2619, DOI 10.1161/01.CIR.0000097116.29625.7C; Meyer MR, 2011, ACTA PHYSIOL, V203, P259, DOI 10.1111/j.1748-1716.2010.02237.x; Nabi H, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a118; Ostir GV, 2001, PSYCHOSOM MED, V63, P210, DOI 10.1097/00006842-200103000-00003; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peled R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-245; Pouwer F, 2010, DISCOV MED, V9, P112; Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rugulies R, 2002, AM J PREV MED, V23, P51, DOI 10.1016/S0749-3797(02)00439-7; Schimmack U, 2005, J PERS SOC PSYCHOL, V89, P395, DOI 10.1037/0022-3514.89.3.395; Schimmack U, 2002, J PERS, V70, P345, DOI 10.1111/1467-6494.05008; Schraub S, 2009, REV EPIDEMIOL SANTE, V57, P113, DOI 10.1016/j.respe.2008.12.012; Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1561, DOI 10.1016/j.jacc.2009.04.098; SHIN DC, 1978, SOC INDIC RES, V5, P475, DOI 10.1007/BF00352944; Shirai K, 2009, CIRCULATION, V120, P956, DOI 10.1161/CIRCULATIONAHA.108.834176; Steptoe A, 2005, P NATL ACAD SCI USA, V102, P6508, DOI 10.1073/pnas.0409174102; Stewart-Brown S, 1998, BMJ-BRIT MED J, V317, P1608, DOI 10.1136/bmj.317.7173.1608; Tamres LK, 2002, PERS SOC PSYCHOL REV, V6, P2, DOI 10.1207/S15327957PSPR0601_1; Tanno K, 2009, J PSYCHOSOM RES, V67, P67, DOI 10.1016/j.jpsychores.2008.10.018; Thode N, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P296, DOI 10.1007/s00103-004-1004-3; Tindle HA, 2009, CIRCULATION, V120, P656, DOI 10.1161/CIRCULATIONAHA.108.827642; Veenhoven R, 2008, J HAPPINESS STUD, V9, P449, DOI 10.1007/s10902-006-9042-1; Wakai K, 2007, CANCER CAUSE CONTROL, V18, P259, DOI 10.1007/s10552-006-0111-x; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Ylostalo PV, 2003, J DENT RES, V82, P194, DOI 10.1177/154405910308200309	64	49	50	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e73462	10.1371/journal.pone.0073462	http://dx.doi.org/10.1371/journal.pone.0073462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219RU	23977388	Green Submitted, Green Published, gold			2022-12-25	WOS:000324527300108
J	Feng, H; Chen, P; Zhao, F; Nassal, M; Hu, KH				Feng, Hui; Chen, Ping; Zhao, Fei; Nassal, Michael; Hu, Kanghong			Evidence for Multiple Distinct Interactions between Hepatitis B Virus P Protein and Its Cognate RNA Encapsidation Signal during Initiation of Reverse Transcription	PLOS ONE			English	Article							STEM-LOOP STRUCTURE; DNA-SYNTHESIS; TYROSINE RESIDUE; TERMINAL PROTEIN; PRECORE REGION; STRAND DNA; SEQUENCE; REPLICATION; EPSILON; POLYMERASE	Replication of hepatitis B virus (HBV) via protein-primed reverse transcription is initiated by binding of the viral P protein to the conserved epsilon stem-loop on the pregenomic (pg) RNA. This triggers encapsidation of the complex and the epsilon-templated synthesis of a short P protein-linked DNA oligonucleotide (priming) for subsequent minus-strand DNA extension. epsilon consists of a lower and upper stem, a bulge containing the priming template, and an apical loop. The nonhelical subelements are considered important for DNA synthesis and pgRNA packaging whereas the role of the upper stem is not well characterized. Priming itself could until recently not be addressed because in vitro generated HBV P - epsilon complexes showed no activity. Focussing on the four A residues at the base and tip of the upper epsilon stem and the two U residues in the loop we first investigated the impact of 24 mutations on viral DNA accumulation in transfected cells. While surprisingly many mutations were tolerated, further analyzing the negatively acting mutations, including in a new cell-free priming system, revealed divergent position-related impacts on pgRNA packaging, priming activity and possibly initiation site selection. This genetic separability implies that the epsilon RNA undergoes multiple distinct interactions with P protein as pgRNA encapsidation and replication initiation progress, and that the strict conservation of e in nature may reflect its optimal adaptation to comply with all of them. The data further define the most attractive mutants for future studies, including as decoys for interference with HBV replication.	[Feng, Hui; Chen, Ping; Zhao, Fei; Hu, Kanghong] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Nassal, Michael] Univ Hosp Freiburg, Dept Internal Med II Mol Biol, Freiburg, Germany; [Hu, Kanghong] Hubei Univ Technol, Biomed Ctr, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; University of Freiburg; Hubei University of Technology	Nassal, M (corresponding author), Univ Hosp Freiburg, Dept Internal Med II Mol Biol, Freiburg, Germany.	nassal2@ukl.uni-freiburg.de; hukgh@wh.iov.cn	Nassal, Michael/U-4529-2019; Hu, Kanghong/AAL-3011-2020	Nassal, Michael/0000-0003-2204-9158; 	National Major Science and Technology Special Projects for Infectious Diseases of China [2012ZX10004503-008, 2012ZX10001006-002, 2012ZX10002006-002]; Deutsche Forschungsgemeinschaft [DFG Na 154/7-3]	National Major Science and Technology Special Projects for Infectious Diseases of China; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by grants from the National Major Science and Technology Special Projects for Infectious Diseases of China (2012ZX10004503-008, 2012ZX10001006-002, 2012ZX10002006-002). Initial experiments were in part supported by the Deutsche Forschungsgemeinschaft (DFG Na 154/7-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham TM, 2007, J VIROL, V81, P11577, DOI 10.1128/JVI.01414-07; Abraham TM, 2006, J VIROL, V80, P4380, DOI 10.1128/JVI.80.9.4380-4387.2006; BARTENSCHLAGER R, 1992, EMBO J, V11, P3413, DOI 10.1002/j.1460-2075.1992.tb05420.x; Beck J, 2003, J BIOL CHEM, V278, P36128, DOI 10.1074/jbc.M301069200; Beck J, 1998, MOL CELL BIOL, V18, P6265, DOI 10.1128/MCB.18.11.6265; Beck J, 1997, J VIROL, V71, P4971, DOI 10.1128/JVI.71.7.4971-4980.1997; Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Beck J, 2011, J VIROL, V85, P7742, DOI 10.1128/JVI.00482-11; Boregowda RK, 2011, J VIROL, V85, P7754, DOI 10.1128/JVI.00483-11; Cao F, 2005, J VIROL, V79, P10164, DOI 10.1128/JVI.79.16.10164-10170.2005; FALLOWS DA, 1995, J VIROL, V69, P3067, DOI 10.1128/JVI.69.5.3067-3073.1995; Feng H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027862; Flodell S, 2002, NUCLEIC ACIDS RES, V30, P4803, DOI 10.1093/nar/gkf603; Flodell S, 2006, NUCLEIC ACIDS RES, V34, P4449, DOI 10.1093/nar/gkl582; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gold L., 2012, COLD SPRING HARB PER, V4; Homs M, 2011, NUCLEIC ACIDS RES, V39, P8457, DOI 10.1093/nar/gkr451; Hu JM, 2006, J VIROL, V80, P2141, DOI 10.1128/JVI.80.5.2141-2150.2006; Hu JM, 1996, P NATL ACAD SCI USA, V93, P1060, DOI 10.1073/pnas.93.3.1060; Hu JM, 1997, EMBO J, V16, P59, DOI 10.1093/emboj/16.1.59; Hu JM, 2002, J VIROL, V76, P269, DOI 10.1128/JVI.76.1.269-279.2002; Hu KH, 2004, NUCLEIC ACIDS RES, V32, P4377, DOI 10.1093/nar/gkh772; Jones SA, 2012, J VIROL, V86, P5134, DOI 10.1128/JVI.07137-11; Kim HY, 2004, VIROLOGY, V322, P22, DOI 10.1016/j.virol.2004.01.009; KNAUS T, 1993, NUCLEIC ACIDS RES, V21, P3967, DOI 10.1093/nar/21.17.3967; LANFORD RE, 1995, J VIROL, V69, P4431, DOI 10.1128/JVI.69.7.4431-4439.1995; Lisi V, 2007, RNA, V13, P1537, DOI 10.1261/rna.597507; LOK ASF, 1994, P NATL ACAD SCI USA, V91, P4077, DOI 10.1073/pnas.91.9.4077; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 1996, J VIROL, V70, P2764, DOI 10.1128/JVI.70.5.2764-2773.1996; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nassal M, 2009, FUTURE VIROL, V4, P55, DOI 10.2217/17460794.4.1.55; Oropeza CE, 2007, VIROLOGY, V359, P371, DOI 10.1016/j.virol.2006.08.036; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; POLLACK JR, 1993, J VIROL, V67, P3254, DOI 10.1128/JVI.67.6.3254-3263.1993; POLLACK JR, 1994, J VIROL, V68, P5579, DOI 10.1128/JVI.68.9.5579-5587.1994; RIEGER A, 1995, NUCLEIC ACIDS RES, V23, P3909, DOI 10.1093/nar/23.19.3909; Schaaf SG, 1999, J BIOL CHEM, V274, P37787, DOI 10.1074/jbc.274.53.37787; Schmid B, 2011, J VIROL, V85, P9300, DOI 10.1128/JVI.05005-11; Schudoma C, 2010, NUCLEIC ACIDS RES, V38, P970, DOI 10.1093/nar/gkp1010; Stahl M, 2007, J VIROL, V81, P13354, DOI 10.1128/JVI.01196-07; Stahl M, 2007, NUCLEIC ACIDS RES, V35, P6124, DOI 10.1093/nar/gkm628; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Sun DX, 2010, J HEPATOL, V52, P817, DOI 10.1016/j.jhep.2009.10.038; Taouji S, 2012, NEW BIOTECHNOL, V29, P550, DOI 10.1016/j.nbt.2011.11.017; Tavis JE, 1996, J VIROL, V70, P5741, DOI 10.1128/JVI.70.9.5741-5750.1996; TAVIS JE, 1994, J VIROL, V68, P3536, DOI 10.1128/JVI.68.6.3536-3543.1994; WANG GH, 1994, J VIROL, V68, P8437, DOI 10.1128/JVI.68.12.8437-8442.1994; WANG GH, 1992, CELL, V71, P663, DOI 10.1016/0092-8674(92)90599-8; Wang YX, 2012, J VIROL, V86, P10079, DOI 10.1128/JVI.00816-12; WEBER M, 1994, J VIROL, V68, P2994, DOI 10.1128/JVI.68.5.2994-2999.1994; WEEKS KM, 1993, SCIENCE, V261, P1574, DOI 10.1126/science.7690496; World Health Organization (WHO), 2008, HEP B FACT SHEET 204; Zhou Jiehua, 2012, Frontiers in Genetics, V3, P234, DOI 10.3389/fgene.2012.00234; ZOULIM F, 1994, J VIROL, V68, P6, DOI 10.1128/JVI.68.1.6-13.1994; Zoulim F, 2009, GASTROENTEROLOGY, V137, P1593, DOI 10.1053/j.gastro.2009.08.063	56	9	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72798	10.1371/journal.pone.0072798	http://dx.doi.org/10.1371/journal.pone.0072798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977352	Green Submitted, Green Published, gold			2022-12-25	WOS:000324527300096
J	Robbins, J; Passmore, GM; Abogadie, FC; Reilly, JM; Brown, DA				Robbins, Jon; Passmore, Gayle M.; Abogadie, Fe C.; Reilly, Joanne M.; Brown, David A.			Effects of KCNQ2 Gene Truncation on M-Type Kv7 Potassium Currents	PLOS ONE			English	Article							FAMILIAL NEONATAL CONVULSIONS; CYSTEINE-MODIFYING REAGENT; K+ CHANNELS; MAMMALIAN-CELLS; KCNQ2/KCNQ3; EPILEPSY; MOUSE; EXPRESSION; SUBUNIT; NEURONS	The KCNQ2 gene product, Kv7.2, is a subunit of the M-channel, a low-threshold voltage-gated K+ channel that regulates mammalian and human neuronal excitability. Spontaneous mutations one of the KCNQ2 genes cause disorders of neural excitability such as Benign Familial Neonatal Seizures. However there appear to be no reports in which both human KCNQ2 genes are mutated. We therefore asked what happens to M-channel function when both KCNQ2 genes are disrupted. We addressed this using sympathetic neurons isolated from mice in which the KCNQ2 gene was truncated at a position corresponding to the second transmembrane domain of the Kv7.2 protein. Since homozygote KCNQ2-/- mice die postnatally, experiments were largely restricted to neurons from late embryos. Quantitative PCR revealed an absence of KCNQ2 mRNA in ganglia from KCNQ2-/- embryos but 100-120% increase of KCNQ3 and KCNQ5 mRNAs; KCNQ2+/- ganglia showed similar to 30% less KCNQ2 mRNA than wild-type (+/+) ganglia but 40-50% more KCNQ3 and KCNQ5 mRNA. Neurons from KCNQ2-/- embryos showed a complete absence of M-current, even after applying the Kv7 channel enhancer, retigabine. Neurons from heterozygote KCNQ2+/- embryos had similar to 60% reduced M-current. In contrast, M-currents in neurons from adult KCNQ2+/- mice were no smaller than those in neurons from wild-type mice. Measurements of tetraethylammonium block did not indicate an increased expression of Kv7.5-containing subunits, implying a compensatory increase in Kv7.2 expression from the remaining KCNQ2 gene. We conclude that mouse embryonic M-channels have an absolute requirement for Kv7.2 subunits for functionality, that the reduced M-channel activity in heterozygote KCNQ2+/- mouse embryos results primarily from a gene-dosage effect, and that there is a compensatory increase in Kv7.2 expression in adult mice.	[Passmore, Gayle M.; Abogadie, Fe C.; Reilly, Joanne M.; Brown, David A.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Robbins, Jon] Kings Coll London, Wolfson Ctr Age Related Dis, London, England; [Abogadie, Fe C.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia	University of London; University College London; University of London; King's College London; Royal Melbourne Institute of Technology (RMIT)	Robbins, J (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London, England.	jon.robbins@kcl.ac.uk	Robbins, Jonathan/A-8661-2008; Brown, David A/J-9019-2012	Robbins, Jonathan/0000-0003-1907-0714; 	UK Medical Research Council [G0500194]; Wellcome Trust [WT081706]; European Union [LSHM - CT - 2004 - 503038]; Medical Research Council [G0500194] Funding Source: researchfish; MRC [G0500194] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the UK Medical Research Council (G0500194), The Wellcome Trust (WT081706) and the European Union (LSHM - CT - 2004 - 503038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bal M, 2008, J BIOL CHEM, V283, P30668, DOI 10.1074/jbc.M805216200; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Choveau FS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00397; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; Hadley JK, 2003, J NEUROSCI, V23, P5012; Hadley JK, 2000, BRIT J PHARMACOL, V129, P413, DOI 10.1038/sj.bjp.0703086; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Hill AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000317; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Hunter J, 2006, NEUROBIOL DIS, V24, P194, DOI 10.1016/j.nbd.2006.06.011; Jensen HS, 2005, MOL BRAIN RES, V139, P52, DOI 10.1016/j.molbrainres.2005.05.007; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; Li Y, 2004, J NEUROSCI, V24, P5079, DOI 10.1523/JNEUROSCI.0882-04.2004; Maljevic S, 2008, J PHYSIOL-LONDON, V586, P1791, DOI 10.1113/jphysiol.2008.150656; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Otto JF, 2006, J NEUROSCI, V26, P2053, DOI 10.1523/JNEUROSCI.1575-05.2006; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Passmore GM, 2003, J NEUROSCI, V23, P7227, DOI 10.1523/JNEUROSCI.23-18-07227.2003; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Roche JP, 2002, BRIT J PHARMACOL, V137, P1173, DOI 10.1038/sj.bjp.0704989; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Selyanko AA, 2001, J PHYSIOL-LONDON, V534, P15, DOI 10.1111/j.1469-7793.2001.00015.x; Selyanko AA, 1999, J NEUROSCI, V19, P7742; Singh NA, 2003, BRAIN, V126, P2726, DOI 10.1093/brain/awg286; Singh NA, 2008, J PHYSIOL-LONDON, V586, P3405, DOI 10.1113/jphysiol.2008.154971; Soldovieri MV, 2011, PHYSIOLOGY, V26, P365, DOI 10.1152/physiol.00009.2011; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Zaika O, 2008, BIOPHYS J, V95, P5121, DOI 10.1529/biophysj.108.137604; Zhang J, 2012, NEURON, V76, P1133, DOI 10.1016/j.neuron.2012.10.019	40	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71809	10.1371/journal.pone.0071809	http://dx.doi.org/10.1371/journal.pone.0071809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977150	gold, Green Published, Green Submitted			2022-12-25	WOS:000324527300040
J	Han, CE; Yoo, SW; Seo, SW; Na, DL; Seong, JK				Han, Cheol E.; Yoo, Sang Wook; Seo, Sang Won; Na, Duk L.; Seong, Joon-Kyung			Cluster-Based Statistics for Brain Connectivity in Correlation with Behavioral Measures	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; CLINICAL DEMENTIA; FUNCTIONAL CONNECTIVITY; HIERARCHICAL ORGANIZATION; DISCONNECTION SYNDROMES; SPATIAL STATISTICS; PERMUTATION TESTS; CORTICAL NETWORKS; TRACTOGRAPHY; SCALE	Graph theoretical approaches have successfully revealed abnormality in brain connectivity, in particular, for contrasting patients from healthy controls. Besides the group comparison analysis, a correlational study is also challenging. In studies with patients, for example, finding brain connections that indeed deepen specific symptoms is interesting. The correlational study is also beneficial since it does not require controls, which are often difficult to find, especially for old-age patients with cognitive impairment where controls could also have cognitive deficits due to normal ageing. However, one of the major difficulties in such correlational studies is too conservative multiple comparison correction. In this paper, we propose a novel method for identifying brain connections that are correlated with a specific cognitive behavior by employing cluster-based statistics, which is less conservative than other methods, such as Bonferroni correction, false discovery rate procedure, and extreme statistics. Our method is based on the insight that multiple brain connections, rather than a single connection, are responsible for abnormal behaviors. Given brain connectivity data, we first compute a partial correlation coefficient between every edge and the behavioral measure. Then we group together neighboring connections with strong correlation into clusters and calculate their maximum sizes. This procedure is repeated for randomly permuted assignments of behavioral measures. Significance levels of the identified sub-networks are estimated from the null distribution of the cluster sizes. This method is independent of network construction methods: either structural or functional network can be used in association with any behavioral measures. We further demonstrated the efficacy of our method using patients with subcortical vascular cognitive impairment. We identified sub-networks that are correlated with the disease severity by exploiting diffusion tensor imaging techniques. The identified sub-networks were consistent with the previous clinical findings having valid significance level, while other methods did not assert any significant findings.	[Han, Cheol E.; Seong, Joon-Kyung] Korea Univ, Dept Biomed Engn, Seoul, South Korea; [Yoo, Sang Wook] Korea Adv Inst Sci & Technol, Dept Comp Sci, Taejon 305701, South Korea; [Seo, Sang Won; Na, Duk L.] Sungkyunkwan Univ Med, Dept Neurol, Seoul, South Korea; [Seo, Sang Won; Na, Duk L.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea	Korea University; Korea Advanced Institute of Science & Technology (KAIST); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Seong, JK (corresponding author), Korea Univ, Dept Biomed Engn, Seoul, South Korea.	jkseong@korea.ac.kr	Na, Duk Lyul/C-9598-2011	Yoo, Sang Wook/0000-0002-5404-4397; Han, Cheol/0000-0002-9994-6861	National Research Foundation of Korea (NRF); Korea government (MSIP) [2010-0028631]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education [2012-004157]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2010-0028631) and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2012-004157). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Andersson JLR, 2007, NONLINEAR OPTIMISATI; Andersson JLR, 2007, NONLINEAR REGISTRATI; Aralasmak A, 2006, J COMPUT ASSIST TOMO, V30, P695, DOI 10.1097/01.rct.0000226397.43235.8b; Bai F, 2012, J NEUROSCI, V32, P4307, DOI 10.1523/JNEUROSCI.5061-11.2012; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERG L, 1988, ANN NEUROL, V23, P477, DOI 10.1002/ana.410230509; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; BURKE WJ, 1988, ARCH NEUROL-CHICAGO, V45, P31, DOI 10.1001/archneur.1988.00520250037015; Chui HC, 2007, NEUROL CLIN, V25, P717, DOI 10.1016/j.ncl.2007.04.003; Crofts JJ, 2011, NEUROIMAGE, V54, P161, DOI 10.1016/j.neuroimage.2010.08.032; Crofts JJ, 2009, J R SOC INTERFACE, V6, P411, DOI 10.1098/rsif.2008.0484; Cui Y, 2012, NEUROIMAGE, V59, P1209, DOI 10.1016/j.neuroimage.2011.08.013; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Echtermeyer Christoph, 2011, Front Neuroinform, V5, P10, DOI 10.3389/fninf.2011.00010; Echtermeyer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015765; EDGINGTON ES, 1964, J PSYCHOL, V57, P445, DOI 10.1080/00223980.1964.9916711; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Freeman L. C., 1977, SOCIOMETRY, V35; Friston K, 1996, ARNMD SERIES, V73, P421; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GESCHWIN.N, 1965, BRAIN, V88, P585, DOI 10.1093/brain/88.3.585; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gleich DF, 2009, THESIS STANFORD U SA, P134; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hayasaka S, 2004, NEUROIMAGE, V23, P54, DOI 10.1016/j.neuroimage.2004.04.035; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; Hayashi Y, 2012, J NEUROSURG, V117, P839, DOI 10.3171/2012.8.JNS12348; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hilgetag CC, 2004, NEUROINFORMATICS, V2, P353, DOI 10.1385/NI:2:3:353; Hilgetag CC, 2000, PHILOS T R SOC B, V355, P71, DOI 10.1098/rstb.2000.0550; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kay S, 1986, BR J PSYCHIAT; Kim TH, 2010, PSYCHIAT INVEST, V7, P102, DOI 10.4306/pi.2010.7.2.102; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Lee JH, 2011, NEUROLOGY, V77, P18, DOI 10.1212/WNL.0b013e318221acee; Leritz EC, 2011, NEUROIMAGE, V54, P2659, DOI 10.1016/j.neuroimage.2010.10.050; Li H, 2010, NEUROIMAGE, V49, P1249, DOI 10.1016/j.neuroimage.2009.08.017; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Liao Y, 2013, J PSYCHIATR NEUROSCI, V38, P49, DOI 10.1503/jpn.110180; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Ludbrook J, 1998, AM STAT, V52, P127, DOI 10.2307/2685470; Lynch CA, 2006, DEMENT GERIATR COGN, V21, P40, DOI 10.1159/000089218; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 1999, ANAT REC, V257, P102; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; O'Donnell LJ, 2007, IEEE T MED IMAGING, V26, P1562, DOI 10.1109/TMI.2007.906785; Palva S, 2012, TRENDS COGN SCI, V16, P219, DOI 10.1016/j.tics.2012.02.004; Park J.H, 1989, J KOREAN NEUROPSYCHI, V28, P508; Paulesu E, 1996, BRAIN, V119, P143, DOI 10.1093/brain/119.1.143; Pereira AC, 2012, NEUROLOGY, V79, P290, DOI 10.1212/WNL.0b013e31825fdf73; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; POLINE JB, 1993, J CEREBR BLOOD F MET, V13, P425, DOI 10.1038/jcbfm.1993.57; Rahman N.A., 1968, COURSE THEORETICAL S; Raz E, 2010, RADIOLOGY, V257, P448, DOI 10.1148/radiol.10100626; Rentz DM, 2010, ANN NEUROL, V67, P353, DOI 10.1002/ana.21904; Romano A, 2009, EUR RADIOL, V19, P2798, DOI 10.1007/s00330-009-1483-6; Shu N, 2011, CEREB CORTEX, V21, P2565, DOI 10.1093/cercor/bhr039; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; SPORNS O, 2011, NETWORKS BRAIN, P412; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Verstraete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024239; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang QF, 2012, NEUROIMAGE, V59, P1085, DOI 10.1016/j.neuroimage.2011.09.035; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Witwer BP, 2002, J NEUROSURG, V97, P568, DOI 10.3171/jns.2002.97.3.0568; YOUNG MP, 1992, NATURE, V358, P152, DOI 10.1038/358152a0; Zalesky A., 2010, NEUROIMAGE; Zalesky A, 2012, NEUROIMAGE, V60, P1055, DOI 10.1016/j.neuroimage.2012.01.068; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018	107	29	32	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72332	10.1371/journal.pone.0072332	http://dx.doi.org/10.1371/journal.pone.0072332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977281	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700165
J	Horsburgh, KA; Prost, S; Gosling, A; Stanton, JA; Rand, C; Matisoo-Smith, EA				Horsburgh, K. Ann; Prost, Stefan; Gosling, Anna; Stanton, Jo-Ann; Rand, Christy; Matisoo-Smith, Elizabeth A.			The Genetic Diversity of the Nguni Breed of African Cattle (Bos spp.): Complete Mitochondrial Genomes of Haplogroup T1	PLOS ONE			English	Article							EUROPEAN CATTLE; SOUTHERN AFRICA; ORIGINS; TAURINE; INDICUS; TAURUS; DOMESTICATION; POPULATIONS; INFERENCE; DATE	Domesticated cattle were commonplace in northern Africa by about 7,000 years ago. Archaeological evidence, however, suggests they were not established in southern Africa until much later, no earlier than 2,000 years ago. Genetic reconstructions have started to shed light on the movement of African cattle, but efforts have been frustrated by a lack of data south of Ethiopia and the nature of the mitochondrial haplogroup T1 which is almost fixed across the continent. We sequenced 35 complete mitochondrial genomes from a South African herd of Nguni cattle, a breed historically associated with Bantu speaking farmers who were among the first to bring cattle to southern Africa. As expected, all individuals in the study were found to be members of haplogroup T1. Only half of the sub-haplogroups of T1 (T1a-T1f) are represented in our sample and the overwhelming majority (94%) in this study belong to subhaplogroup T1b. A previous study of African cattle found frequencies of T1b of 27% in Egypt and 69% in Ethiopia. These results are consistent with serial multiple founder effects significantly shaping the gene pool as cattle were moved from north to south across the continent. Interestingly, these mitochondrial data give no indication that the impacts of the founder effects were ameliorated by gene flow from recently introduced Indian cattle breeds.	[Horsburgh, K. Ann; Prost, Stefan; Gosling, Anna; Stanton, Jo-Ann; Rand, Christy; Matisoo-Smith, Elizabeth A.] Univ Otago, Dept Anat, Dunedin, New Zealand; Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, ZA-2050 Johannesburg, Gauteng Provinc, South Africa; [Prost, Stefan] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Horsburgh, K. Ann; Prost, Stefan; Matisoo-Smith, Elizabeth A.] Univ Otago, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand	University of Otago; University of Witwatersrand; University of California System; University of California Berkeley; University of Otago	Horsburgh, KA (corresponding author), Univ Otago, Dept Anat, Dunedin, New Zealand.	horsburgh@otago.ac.nz	Stanton, Jo-Ann L/C-6621-2009; Gosling, Anna/AAA-2590-2019; Horsburgh, K. Ann/B-9369-2016	Stanton, Jo-Ann L/0000-0001-8139-4694; Gosling, Anna/0000-0003-3151-3346; Horsburgh, K. Ann/0000-0003-0959-8013; Prost, Stefan/0000-0002-6229-3596; Matisoo-Smith, Elizabeth/0000-0002-3500-8307; Rand, Christy/0000-0003-1617-6089	Royal Society of New Zealand Marsden Grant [11-UOO-138]	Royal Society of New Zealand Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ))	This work was funded by a Royal Society of New Zealand Marsden Grant (11-UOO-138) to KAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; Ambrose SH, 1998, J ARCHAEOL SCI, V25, P377, DOI 10.1006/jasc.1997.0277; Anderung C, 2007, ANIM GENET, V38, P595, DOI 10.1111/j.1365-2052.2007.01663.x; [Anonymous], 2000, ORIGINS DEV AFRICAN; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BONFIGLIO S, 2012, PLOS ONE, V7; Bradley DG, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P273; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Caramelli D., 2006, HUM EVOL, V21, P107; Clutton-Brock J, 1989, WALKING LARDER PATTE, P200; Cymbron T, 1999, P ROY SOC B-BIOL SCI, V266, P597, DOI 10.1098/rspb.1999.0678; Dadi H, 2009, ANIM GENET, V40, P556, DOI 10.1111/j.1365-2052.2009.01866.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, RAMBAUT TRACE V1 4; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dunne J, 2012, NATURE, V486, P390, DOI 10.1038/nature11186; Freeman AR, 2004, MOL ECOL, V13, P3477, DOI 10.1111/j.1365-294X.2004.02311.x; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Hanotte O, 2000, MOL ECOL, V9, P387, DOI 10.1046/j.1365-294x.2000.00858.x; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Ho SYW, 2008, BIOL LETTERS, V4, P370, DOI 10.1098/rsbl.2008.0073; Huffman T.N., 2007, HDB IRON AGE; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacHugh DE, 1997, GENETICS, V146, P1071; Mack R., 1970, Tropical Animal Health and Production, V2, P210, DOI 10.1007/BF02356441; Marshall F., 2000, ORIGIN DEV AFRICAN L, P191; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Mitchell P, 2002, ARCHAEOLOGY SO AFRIC; Orton J, 2013, ANTIQUITY, V87, P108, DOI 10.1017/S0003598X00048651; Payne W.J.A., 1997, TROPICAL CATTLE ORIG; Robertshaw P, 2010, J ARCHAEOL SCI, V37, P1898, DOI 10.1016/j.jas.2010.02.016; Sadr K, 2003, J AFR HIST, V44, P195, DOI 10.1017/S0021853702008393; Sadr K, 1998, AFR ARCHAEOL REV, V15, P101, DOI [10.1023/A:1022158701778, DOI 10.1023/A:1022158701778]; Sadr K, 2008, J AFRICAN ARCHAEOLOG, V4, P235; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Shaw T, 1977, HUNTERS GATHERERS 1S, P69; Smith A. B., 1980, SAHARA NILE, P489; Smith A. B., 1986, AFR ARCHAEOL REV, V4, P197; Smith AB, 2006, CAMBRIDGE MONOGRAPHS; Smith AB, 2008, SOUTH AFR HUMANIT, V20, P49; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; van Vuure C, 2005, RETRACING AUROCHS HI; Williamson K., 2000, AFRICAN LANGUAGES IN, P11; Wood M., 2000, S AFRICAN ARCHAEOLOG, V8, P78	47	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71956	10.1371/journal.pone.0071956	http://dx.doi.org/10.1371/journal.pone.0071956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977187	Green Published, gold			2022-12-25	WOS:000323425700117
J	Lai, MA; Quarles, EK; Lopez-Yglesias, AH; Zhao, XD; Hajjar, AM; Smith, KD				Lai, Marvin A.; Quarles, Ellen K.; Lopez-Yglesias, Americo H.; Zhao, Xiaodan; Hajjar, Adeline M.; Smith, Kelly D.			Innate Immune Detection of Flagellin Positively and Negatively Regulates Salmonella Infection	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; TOLL-LIKE RECEPTOR-5; BACTERIAL FLAGELLIN; GENE-EXPRESSION; INFLAMMASOME RECEPTORS; ATTENUATED PHENOTYPE; IN-VIVO; MICE; INTERLEUKIN-1-BETA; RECOGNITION	Salmonella enterica serovar Typhimurium is a flagellated bacterium and one of the leading causes of gastroenteritis in humans. Bacterial flagellin is required for motility and also a prime target of the innate immune system. Innate immune recognition of flagellin is mediated by at least two independent pathways, TLR5 and Naip5-Naip6/NlrC4/Caspase-1. The functional significance of each of the two independent flagellin recognition systems for host defense against wild type Salmonella infection is complex, and innate immune detection of flagellin contributes to both protection and susceptibility. We hypothesized that efficient modulation of flagellin expression in vivo permits Salmonella to evade innate immune detection and limit the functional role of flagellin-specific host innate defenses. To test this hypothesis, we used Salmonella deficient in the anti-sigma factor flgM, which overproduce flagella and are attenuated in vivo. In this study we demonstrate that flagellin recognition by the innate immune system is responsible for the attenuation of flgM(-) S. Typhimurium, and dissect the contribution of each flagellin recognition pathway to bacterial clearance and inflammation. We demonstrate that caspase-1 controls mucosal and systemic infection of flgM(-) S. Typhimurium, and also limits intestinal inflammation and injury. In contrast, TLR5 paradoxically promotes bacterial colonization in the cecum and systemic infection, but attenuates intestinal inflammation. Our results indicate that Salmonella evasion of caspase-1 dependent flagellin recognition is critical for establishing infection and that evasion of TLR5 and caspase-1 dependent flagellin recognition helps Salmonella induce intestinal inflammation and establish a niche in the inflamed gut.	[Lai, Marvin A.; Quarles, Ellen K.; Lopez-Yglesias, Americo H.; Zhao, Xiaodan; Smith, Kelly D.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Hajjar, Adeline M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Smith, KD (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kelsmith@uw.edu		Hajjar, Adeline/0000-0002-4838-8070; Quarles, Ellen/0000-0002-7160-3939	Public Health Service, National Research Service Award, from the National Institute of General Medical Sciences [T32 GM07270]; U.S. NIH [5R01AI084803, 5R01AI062859]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062859, R01AI084803, T32AI007140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	Public Health Service, National Research Service Award, from the National Institute of General Medical Sciences; U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Marvin A. Lai was supported in part by Public Health Service, National Research Service Award, T32 GM07270, from the National Institute of General Medical Sciences. The work is supported by U.S. NIH grants 5R01AI084803 and 5R01AI062859 (KDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams P, 2001, PROTEOMICS, V1, P597, DOI 10.1002/1615-9861(200104)1:4<597::AID-PROT597>3.0.CO;2-P; Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; ALPERS CE, 1991, AM J PATHOL, V139, P855; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; BAUMLER AJ, 1994, INFECT IMMUN, V62, P1623; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Ciacci-Woolwine F, 1998, INFECT IMMUN, V66, P1127, DOI 10.1128/IAI.66.3.1127-1134.1998; Cummings LA, 2005, J IMMUNOL, V174, P7929, DOI 10.4049/jimmunol.174.12.7929; Cummings LA, 2006, MOL MICROBIOL, V61, P795, DOI 10.1111/j.1365-2958.2006.05271.x; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hoek JB, 2002, ALCOHOL, V27, P63, DOI 10.1016/S0741-8329(02)00215-X; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Karlinsey JE, 2007, METHOD ENZYMOL, V421, P199, DOI 10.1016/S0076-6879(06)21016-4; Kinnebrew MA, 2010, J INFECT DIS, V201, P534, DOI 10.1086/650203; Koblansky AA, 2013, IMMUNITY, V38, P119, DOI 10.1016/j.immuni.2012.09.016; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; KUTSUKAKE K, 1994, MOL GEN GENET, V243, P605, DOI 10.1007/BF00279569; KUTSUKAKE K, 1994, J BACTERIOL, V176, P3598, DOI 10.1128/JB.176.12.3598-3605.1994; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Maloy SR., 1996, GENETIC ANAL PATHOGE; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; SCHMITT CK, 1994, J BACTERIOL, V176, P368, DOI 10.1128/JB.176.2.368-377.1994; Schmitt CK, 1996, FEMS MICROBIOL LETT, V135, P281, DOI 10.1016/0378-1097(95)00467-X; Schmitt CK, 1996, J BACTERIOL, V178, P2911, DOI 10.1128/jb.178.10.2911-2915.1996; Smith K, 2003, POETRY REV, V93, P5; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2008, CELL MICROBIOL, V10, P1166, DOI 10.1111/j.1462-5822.2008.01118.x; Steiner TS, 2007, INFECT IMMUN, V75, P545, DOI 10.1128/IAI.01506-06; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; Tomoyasu T, 2003, MOL MICROBIOL, V48, P443, DOI 10.1046/j.1365-2958.2003.03437.x; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vijay-Kumar M, 2008, INFECT IMMUN, V76, P1276, DOI 10.1128/IAI.01491-07; Wyant TL, 1999, INFECT IMMUN, V67, P3619, DOI 10.1128/IAI.67.7.3619-3624.1999; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	50	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72047	10.1371/journal.pone.0072047	http://dx.doi.org/10.1371/journal.pone.0072047			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977202	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700125
J	Schonmann, RH; Vicente, R; Caticha, N				Schonmann, Roberto H.; Vicente, Renato; Caticha, Nestor			Altruism Can Proliferate through Population Viscosity despite High Random Gene Flow	PLOS ONE			English	Article							KIN SELECTION; INCLUSIVE FITNESS; HAMILTONS RULE; ISLAND MODEL; EVOLUTION; COOPERATION; DEMOGRAPHY	The ways in which natural selection can allow the proliferation of cooperative behavior have long been seen as a central problem in evolutionary biology. Most of the literature has focused on interactions between pairs of individuals and on linear public goods games. This emphasis has led to the conclusion that even modest levels of migration would pose a serious problem to the spread of altruism through population viscosity in group structured populations. Here we challenge this conclusion, by analyzing evolution in a framework which allows for complex group interactions and random migration among groups. We conclude that contingent forms of strong altruism that benefits equally all group members, regardless of kinship and without greenbeard effects, can spread when rare under realistic group sizes and levels of migration, due to the assortment of genes resulting only from population viscosity. Our analysis combines group-centric and gene-centric perspectives, allows for arbitrary strength of selection, and leads to extensions of Hamilton's rule for the spread of altruistic alleles, applicable under broad conditions.	[Schonmann, Roberto H.] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA; [Vicente, Renato] Univ Sao Paulo, Inst Matemat & Estat, Dept Appl Math, Sao Paulo, Brazil; [Caticha, Nestor] Univ Sao Paulo, Inst Fis, Dept Fis Geral, BR-01498 Sao Paulo, Brazil	University of California System; University of California Los Angeles; Universidade de Sao Paulo; Universidade de Sao Paulo	Schonmann, RH (corresponding author), Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA.	rhs@math.ucla.edu	Vicente, Renato/B-2347-2008; Vicente, Renato/X-8205-2019	Vicente, Renato/0000-0003-0671-9895; Vicente, Renato/0000-0003-0671-9895	CNPq [480476/2009-8]; Center for Natural and Artificial Information Processing Systems of the University of Sao Paulo (NAP CNAIPS-USP)	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Center for Natural and Artificial Information Processing Systems of the University of Sao Paulo (NAP CNAIPS-USP)	This project was partially supported by CNPq, under grant 480476/2009-8 and by the Center for Natural and Artificial Information Processing Systems of the University of Sao Paulo (NAP CNAIPS-USP). No additional external funding has been received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot P, 2011, NATURE, V471, pE1, DOI [10.1038/nature09831, 10.1038/nature09835]; AOKI K, 1982, EVOLUTION, V36, P832, DOI [10.2307/2407896, 10.1111/j.1558-5646.1982.tb05449.x]; Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Aviles L, 2002, P NATL ACAD SCI USA, V99, P14268, DOI 10.1073/pnas.212408299; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bergmuller R, 2007, BEHAV PROCESS, V76, P61, DOI 10.1016/j.beproc.2007.07.001; Bourke AFG, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199231157.001.0001; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Chuang JS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.57; CROW JF, 1982, P NATL ACAD SCI-BIOL, V79, P2628, DOI 10.1073/pnas.79.8.2628; Davies NB, 2012, INTRO BEHAV ECOLOGY; Foster KR, 2009, COLD SH Q B, V74, P403, DOI 10.1101/sqb.2009.74.041; Frank S. A., 1998, FDN SOCIAL EVOLUTION, DOI DOI 10.1515/9780691206820; Gardner A, 2006, J EVOLUTION BIOL, V19, P1707, DOI 10.1111/j.1420-9101.2006.01104.x; Gardner A, 2011, J EVOLUTION BIOL, V24, P1020, DOI 10.1111/j.1420-9101.2011.02236.x; Gardner A, 2010, EVOLUTION, V64, P25, DOI 10.1111/j.1558-5646.2009.00842.x; GOODNIGHT KF, 1992, AM NAT, V140, P1028, DOI 10.1086/285454; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Hamilton M.B., 2009, POPULATION GENETICS; Hamilton W. D., 1975, BIOSOCIAL ANTHR, P133; Hartl DL, 2007, PRINCIPLES POPULATIO, V6.4; Hauert C, 2006, J THEOR BIOL, V239, P195, DOI 10.1016/j.jtbi.2005.08.040; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; JOSHI NV, 1987, J GENET, V66, P69, DOI 10.1007/BF02934456; Kerr B, 2004, TRENDS ECOL EVOL, V19, P135, DOI 10.1016/j.tree.2003.10.004; Kerr B, 2002, BIOL PHILOS, V17, P477, DOI 10.1023/A:1020504900646; KIMURA M, 1983, P NATL ACAD SCI-BIOL, V80, P6317, DOI 10.1073/pnas.80.20.6317; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Lehmann L, 2007, P NATL ACAD SCI USA, V104, P6736, DOI 10.1073/pnas.0700662104; Lehmann L, 2010, PHILOS T R SOC B, V365, P2599, DOI 10.1098/rstb.2010.0138; Leigh EG, 2010, J EVOLUTION BIOL, V23, P6, DOI 10.1111/j.1420-9101.2009.01876.x; LEIGH EG, 1983, P NATL ACAD SCI-BIOL, V80, P2985, DOI 10.1073/pnas.80.10.2985; Lessard S, 2009, J MATH BIOL, V59, P659, DOI 10.1007/s00285-008-0248-1; MATESSI C, 1976, THEOR POPUL BIOL, V9, P360, DOI 10.1016/0040-5809(76)90053-8; Maynard Smith, 1998, EVOL GENET; MAYO DG, 1987, PHILOS SCI, V54, P515, DOI 10.1086/289403; McElreath R., 2007, MATH MODELS SOCIAL E; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Ohtsuki H, 2010, EVOLUTION, V64, P3344, DOI 10.1111/j.1558-5646.2010.01117.x; Okasha S., 2006, EVOLUTION LEVELS SEL, DOI [10.1093/acprof:oso/9780199267972.001.0001, DOI 10.1093/ACPROF:OSO/9780199267972.001.0001]; QUELLER DC, 1992, AM NAT, V139, P540, DOI 10.1086/285343; Rankin DJ, 2009, EVOLUTION, V63, P1913, DOI 10.1111/j.1558-5646.2009.00656.x; Refard D, 2013, P R SOC B, V280; ROUSSET F, 2004, GENETIC STRUCTURE SE; Roze D, 2008, THEOR POPUL BIOL, V73, P529, DOI 10.1016/j.tpb.2008.03.002; Rutte C, 2007, PLOS BIOL, V5, P1421, DOI 10.1371/journal.pbio.0050196; Schonmann RH, 2012, ARXIV12091412V1; Simon B, 2012, J THEOR BIOL, V299, P55, DOI 10.1016/j.jtbi.2011.07.014; SMITH J. M., 1964, Nature, V201, P1145, DOI 10.1038/2011145a0; Smith J, 2010, SCIENCE, V328, P1700, DOI 10.1126/science.1189675; SMITH JM, 1976, Q REV BIOL, V51, P277, DOI 10.1086/409311; Szathmary E, 1995, MAJOR TRANSITIONS EV; Taylor PD, 1996, J THEOR BIOL, V180, P27, DOI 10.1006/jtbi.1996.0075; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; Traulsen A, 2010, EVOLUTION, V64, P316, DOI 10.1111/j.1558-5646.2009.00899.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Veelen M, 2009, J THEOR BIOL, V259, P589, DOI 10.1016/j.jtbi.2009.04.019; Wenseleers Tom, 2010, P132; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; West SA, 2011, EVOL HUM BEHAV, V32, P231, DOI 10.1016/j.evolhumbehav.2010.08.001; Williams G. C., 1966, P307; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809	68	9	9	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72043	10.1371/journal.pone.0072043	http://dx.doi.org/10.1371/journal.pone.0072043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23991035	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700124
J	Jiang, LZ; Huang, Y; Deng, M; Liu, T; Lai, WB; Ye, X				Jiang, Liangzhen; Huang, Yan; Deng, Min; Liu, Ting; Lai, Wenbin; Ye, Xin			Polo-Like Kinase 1 Inhibits the Activity of Positive Transcription Elongation Factor of RNA Pol II b (P-TEFb)	PLOS ONE			English	Article							BROMODOMAIN PROTEIN BRD4; POLYMERASE-II; CYCLIN T1; DEPENDENT TRANSCRIPTION; HIV-1 TAT; TERMINAL DOMAIN; IN-VITRO; MITOTIC PROGRESSION; HIGH-AFFINITY; BOX DOMAIN	Polo-like kinase 1 (Plk1) is a highly conserved Ser/Thr kinase in eukaryotes and plays a critical role in various aspects of the cell cycle. Plk1 exerts its multiple functions by phosphorylating its substrates. In this study, we found that Plk1 can interact with cyclin T1/Cdk9 complex-the main form of the positive transcription elongation complex b (P-TEFb), and its C-terminal polo-box domain is responsible for the binding. Further analysis indicated that Plk1 could phosphorylate cyclin T1 at Ser564 and inhibit the kinase activity of cyclin T1/Cdk9 complex on phosphorylation of the C-terminal domain (CTD) of RNA polymerase II. By taking the approach of luciferase assay, we demonstrated that over-expression of both wild type Plk1 and constitutively active form of Plk1 inhibits the P-TEFb dependent HIV-1 LTR transcription, while knockdown of Plk1 increases the HIV-1 LTR transcription. Consistently, the data from the HIV-1 pseudovirus reporter assay indicated that Plk1 blocks the gene expression of HIV-1 pseudovirus. Taken together, our results revealed that Plk1 negatively regulates the RNA polymerase II-dependent transcription through inhibiting the activity of cyclin T1/Cdk9 complex.	[Jiang, Liangzhen; Huang, Yan; Deng, Min; Liu, Ting; Lai, Wenbin; Ye, Xin] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Ctr Mol Immunol, Beijing, Peoples R China; [Jiang, Liangzhen; Huang, Yan; Deng, Min; Liu, Ting; Lai, Wenbin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, X (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Ctr Mol Immunol, Beijing, Peoples R China.	yex@im.ac.cn			Ministry of Science and Technology of China [2012CB519003, 2011CB504705, 2011CB504802]; National Natural Science Foundation of China [81272272]; Chinese Academy of Sciences [KSCX2-EW-J-6]; Innovative Research Group of the National Natural Science Foundation of China [81021003]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Innovative Research Group of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China (2012CB519003, 2011CB504705, 2011CB504802), the National Natural Science Foundation of China (81272272) and Chinese Academy of Sciences Innovation projects (KSCX2-EW-J-6). Xin Ye is a principal investigator of the Innovative Research Group of the National Natural Science Foundation of China (Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoulitchev S, 1998, GENE DEV, V12, P3541, DOI 10.1101/gad.12.22.3541; Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bahassi E, 2011, EXP BIOL MED, V236, P648, DOI 10.1258/ebm.2011.011011; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Cho SY, 2009, EMBO J, V28, P1407, DOI 10.1038/emboj.2009.99; Deng M, 2009, J BIOL CHEM, V284, P7875, DOI 10.1074/jbc.M807827200; Devaiah BN, 2012, P NATL ACAD SCI USA, V109, P6927, DOI 10.1073/pnas.1120422109; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Fairley JA, 2012, MOL CELL, V45, P541, DOI 10.1016/j.molcel.2011.11.030; Fu JHJ, 2007, MOL CELL BIOL, V27, P4641, DOI 10.1128/MCB.00857-06; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; Garber ME, 2000, MOL CELL BIOL, V20, P6958, DOI 10.1128/MCB.20.18.6958-6969.2000; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; GOTTESFELD JM, 1994, SCIENCE, V263, P81, DOI 10.1126/science.8272869; Grohmann D, 2011, RES MICROBIOL, V162, P10, DOI 10.1016/j.resmic.2010.09.002; Hintermair C, 2012, EMBO J, V31, P2784, DOI 10.1038/emboj.2012.123; Hoque M, 2003, MOL CELL BIOL, V23, P1688, DOI 10.1128/MCB.23.5.1688-1702.2003; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; JOHNSON TC, 1965, J CELL BIOL, V27, P565, DOI 10.1083/jcb.27.3.565; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Leresche A, 1996, EXP CELL RES, V229, P282, DOI 10.1006/excr.1996.0373; Liu T, 2011, J BIOL CHEM, V286, P36352, DOI 10.1074/jbc.M111.250175; Lowery DM, 2004, CELL CYCLE, V3, P128; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rizkallah R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015928; Segil N, 1996, GENE DEV, V10, P2389, DOI 10.1101/gad.10.19.2389; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sunagawa Y, 2010, J BIOL CHEM, V285, P9556, DOI 10.1074/jbc.M109.070458; Taube R, 2002, MOL CELL BIOL, V22, P321, DOI 10.1128/MCB.22.1.321-331.2002; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wang WS, 2009, J MED VIROL, V81, P536, DOI 10.1002/jmv.21404; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; ZAWEL L, 1993, COLD SPRING HARB SYM, V58, P187, DOI 10.1101/SQB.1993.058.01.023; Zhang F, 2003, GENE DEV, V17, P748, DOI 10.1101/gad.1068203; Zhou MS, 2006, J VIROL, V80, P4781, DOI 10.1128/JVI.80.10.4781-4791.2006; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	47	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72289	10.1371/journal.pone.0072289	http://dx.doi.org/10.1371/journal.pone.0072289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977272	gold, Green Published, Green Submitted			2022-12-25	WOS:000323570200067
J	Supaphon, P; Phongpaichit, S; Rukachaisirikul, V; Sakayaroj, J				Supaphon, Preuttiporn; Phongpaichit, Souwalak; Rukachaisirikul, Vatcharin; Sakayaroj, Jariya			Antimicrobial Potential of Endophytic Fungi Derived from Three Seagrass Species: Cymodocea serrulata, Halophila ovalis and Thalassia hemprichii	PLOS ONE			English	Article							NATURAL-PRODUCTS; ANTIBACTERIAL; METABOLITES; PLANTS; DERIVATIVES	Endophytic fungi from three commonly found seagrasses in southern Thailand were explored for their ability to produce antimicrobial metabolites. One hundred and sixty endophytic fungi derived from Cymodocea serrulata (Family Cymodoceaceae), Halophila ovalis and Thalassia hemprichii (Family Hydrocharitaceae) were screened for production of antimicrobial compounds by a colorimetric broth microdilution test against ten human pathogenic microorganisms including Staphylococcus aureus ATCC 25923, a clinical isolate of methicillin-resistant S. aureus, Escherichia coli ATCC 25923, Pseudomonas aeruginosa ATCC 27853, Candida albicans ATCC 90028 and NCPF 3153, Cryptococcus neoformans ATCC 90112 and ATCC 90113 and clinical isolates of Microsporum gypseum and Penicillium marneffei. Sixty-nine percent of the isolates exhibited antimicrobial activity against at least one test strain. Antifungal activity was more pronounced than antibacterial activity. Among the active fungi, seven isolates including Hypocreales sp. PSU-ES26 from C. serrulata, Trichoderma spp. PSU-ES8 and PSU-ES38 from H. ovalis, and Penicillium sp. PSU-ES43, Fusarium sp. PSU-ES73, Stephanonectria sp. PSU-ES172 and an unidentified endophyte PSU-ES190 from T. hemprichii exhibited strong antimicrobial activity against human pathogens with minimum inhibitory concentrations (MIC) of less than 10 mu g/ml. The inhibitory extracts at concentrations of 4 times their MIC destroyed the targeted cells as observed by scanning electron microscopy. These results showed the antimicrobial potential of extracts from endophytic fungi from seagrasses.	[Supaphon, Preuttiporn; Phongpaichit, Souwalak] Prince Songkla Univ, Dept Microbiol, Fac Sci, Hat Yai, Songkhla, Thailand; [Supaphon, Preuttiporn; Phongpaichit, Souwalak] Prince Songkla Univ, Nat Prod Res Ctr Excellence, Fac Sci, Hat Yai, Songkhla, Thailand; [Rukachaisirikul, Vatcharin] Prince Songkla Univ, Dept Chem, Fac Sci, Hat Yai, Songkhla, Thailand; [Rukachaisirikul, Vatcharin] Prince Songkla Univ, Ctr Excellence Innovat Chem, Fac Sci, Hat Yai, Songkhla, Thailand; [Sakayaroj, Jariya] Natl Ctr Genet Engn & Biotechnol, Klongluang, Pathumthani, Thailand	Prince of Songkla University; Prince of Songkla University; Prince of Songkla University; Prince of Songkla University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Phongpaichit, S (corresponding author), Prince Songkla Univ, Dept Microbiol, Fac Sci, Hat Yai, Songkhla, Thailand.	souwalak.p@psu.ac.th	Rukachaisirikul, Vatcharin/AAX-8587-2020		Thailand Research Fund (TRF) [RTA5480002, PHD/0052/2550]; Prince of Songkla University	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Prince of Songkla University	This work was supported by the Thailand Research Fund (TRF) Senior Research Scholar (Grant no. RTA5480002, the Center of Excellence for Innovationin Chemistry (PERCH-CIC) and Graduate School, Prince of Songkla University. PS is grateful to the TRF through the Royal Golden Jubilee Ph.D. Program (Grant no. PHD/0052/2550) and Prince of Songkla University for scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adulyanukosol K, 2007, MAR BIOL, V151, P1887, DOI 10.1007/s00227-007-0619-y; Alva P, 2002, FUNG DIVERS RES SER, V7, P167; Aly AH, 2010, FUNGAL DIVERS, V41, P1, DOI 10.1007/s13225-010-0034-4; Arunpanichlert J, 2012, PHYTOCHEM LETT, V5, P604, DOI 10.1016/j.phytol.2012.06.004; Arunpanichlert J, 2011, ARCH PHARM RES, V34, P1633, DOI 10.1007/s12272-011-1007-1; Arunpanichlert J, 2010, CHEM PHARM BULL, V58, P1033, DOI 10.1248/cpb.58.1033; Bhadury P, 2006, J IND MICROBIOL BIOT, V33, P325, DOI 10.1007/s10295-005-0070-3; Buatong J, 2011, WORLD J MICROB BIOT, V27, P3005, DOI 10.1007/s11274-011-0765-8; Bushmann PJ, 2006, J EXP MAR BIOL ECOL, V331, P41, DOI 10.1016/j.jembe.2005.10.005; Clinical and Laboratory Standards Institute (CLSI), 2002, M27MA2 CLSI; Clinical and Laboratory Standards Institute (CLSI), 2002, M7A4 CLSI; CLSI/Clinical a.L.S. Institute, 2002, M38A CLSI; Devarajan PT, 2002, INDIAN J MAR SCI, V31, P73; Engel S, 2006, MAR BIOL, V149, P991, DOI 10.1007/s00227-006-0264-x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GHISALBERTI EL, 1991, SOIL BIOL BIOCHEM, V23, P1011, DOI 10.1016/0038-0717(91)90036-J; HALL T, 2005, BIOEDIT; He GC, 2004, J NAT PROD, V67, P1084, DOI 10.1021/np0498859; Jirge S. S., 2010, International Journal of Research in Ayurveda and Pharmacy (IJRAP), V1, P55, DOI 10.4103/0974-7788.59946; Kumar CS, 2008, WORLD J MICROB BIOT, V24, P1989, DOI 10.1007/s11274-008-9695-5; Lucas EMF, 2007, BRAZ J MICROBIOL, V38, P785, DOI 10.1590/S1517-83822007000400036; Menez EG, 1983, SMITHSONIAN CONTRIB, P1; Nicoletti R, 2007, MYCOPATHOLOGIA, V163, P295, DOI 10.1007/s11046-007-9015-x; Owen Noel L., 2004, Science Progress, V87, P79, DOI 10.3184/003685004783238553; Petit P, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue4-fulltext-9; Phongpaichit S, 2006, FEMS IMMUNOL MED MIC, V48, P367, DOI 10.1111/j.1574-695X.2006.00155.x; Qi SH, 2008, BOT MAR, V51, P441, DOI 10.1515/BOT.2008.054; Rancic A, 2006, ENVIRON TOXICOL PHAR, V22, P80, DOI 10.1016/j.etap.2005.12.003; Ravikumar S, 2011, INDIAN J SCI TECHNOL, V4, P98, DOI [10.17485/ijst/2011/v4i2/29941, DOI 10.17485/IJST/2011/V4I2/29941]; Redkin SC, 1996, ENDOPHYTIC FUNGI GRA, P223; Ross C, 2008, AQUAT BOT, V88, P134, DOI 10.1016/j.aquabot.2007.09.003; Sakayaroj J, 2010, FUNGAL DIVERS, V42, P27, DOI 10.1007/s13225-009-0013-9; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Schulz B, 2002, MYCOL RES, V106, P996, DOI 10.1017/S0953756202006342; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Trisuwan K, 2010, TETRAHEDRON, V66, P4484, DOI 10.1016/j.tet.2010.04.073; Vicente MF, 2001, J APPL MICROBIOL, V91, P806, DOI 10.1046/j.1365-2672.2001.01447.x; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wilson W., 1998, ISOLATION ENDOPHYTES, P4; Wiyakrutta S, 2004, WORLD J MICROB BIOT, V20, P265, DOI 10.1023/B:WIBI.0000023832.27679.a8; Won KJ, 2012, TOX SCI, V126, P289, DOI [10.1093/toxsci/kfs010. PubMed: 22262564., DOI 10.1093/T0XSCI/KFS010.PUBMED:22262564]; Zhao K, 2011, CURR MICROBIOL, V62, P182, DOI 10.1007/s00284-010-9685-3	44	53	58	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72520	10.1371/journal.pone.0072520	http://dx.doi.org/10.1371/journal.pone.0072520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977310	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200072
J	Kubohara, Y; Kikuchi, H; Matsuo, Y; Oshima, Y; Homma, Y				Kubohara, Yuzuru; Kikuchi, Haruhisa; Matsuo, Yusuke; Oshima, Yoshiteru; Homma, Yoshimi			Mitochondria Are the Target Organelle of Differentiation-Inducing Factor-3, an Anti-Tumor Agent Isolated from Dictyostelium Discoideum	PLOS ONE			English	Article							SUPPRESSES CELL-GROWTH; HUMAN LEUKEMIA K562; FACTOR-I; STRUCTURAL REQUIREMENTS; INTRACELLULAR-PH; CYCLIN D1; MORPHOGEN; MURINE; DIF-1; PROLIFERATION	Differentiation-inducing factor-3 (DIF-3), found in the cellular slime mold Dictyostelium discoideum, and its derivatives such as butoxy-DIF-3 (Bu-DIF-3) are potent anti-tumor agents. However, the precise mechanisms underlying the actions of DIF-3 remain to be elucidated. In this study, we synthesized a green fluorescent derivative of DIF-3, BODIPY-DIF-3, and a control fluorescent compound, Bu-BODIPY (butyl-BODIPY), and investigated how DIF-like molecules behave in human cervical cancer HeLa cells by using both fluorescence and electron microscopy. BODIPY-DIF-3 at 5-20 mu M suppressed cell growth in a dose-dependent manner, whereas Bu-BODIPY had minimal effect on cell growth. When cells were incubated with BODIPY-DIF-3 at 20 mu M, it penetrated cell membranes within 0.5 h and localized mainly in mitochondria, while Bu-BODIPY did not stain the cells. Exposure of cells for 1-3 days to DIF-3, Bu-DIF-3, BODIPY-DIF-3, or CCCP (a mitochondrial uncoupler) induced substantial mitochondrial swelling, suppressing cell growth. When added to isolated mitochondria, DIF-3, Bu-DIF-3, and BOIDPY-DIF-3, like CCCP, dose-dependently promoted the rate of oxygen consumption, but Bu-BODIPY did not. Our results suggest that these bioactive DIF-like molecules suppress cell growth, at least in part, by disturbing mitochondrial activity. This is the first report showing the cellular localization and behavior of DIF-like molecules in mammalian tumor cells.	[Kubohara, Yuzuru] Gunma Univ, Dept Mol & Cellular Biol, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan; [Kikuchi, Haruhisa; Matsuo, Yusuke; Oshima, Yoshiteru] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Nat Prod Chem, Aoba Ku, Sendai, Miyagi 980, Japan; [Homma, Yoshimi] Fukushima Med Univ, Sch Med, Dept Biomol Sci, Inst Biomed Sci, Fukushima, Japan	Gunma University; Tohoku University; Fukushima Medical University	Kubohara, Y (corresponding author), Gunma Univ, Dept Mol & Cellular Biol, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan.	kubohara@showa.gunma-u.ac.jp	Kikuchi, Haruhisa/AAC-3758-2019	Kikuchi, Haruhisa/0000-0001-6938-0185	Ministry of Education, Culture, Sports, Science and Technology of Japan [24590110, 23710247]; Adaptable and Seamless Technology Transfer Program (A-STEP) of the Japan Science and Technology Agency [AS232Z00488G]; Joint Research Program of the Institute for Molecular and Cellular Regulation, Gunma University [11018]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Adaptable and Seamless Technology Transfer Program (A-STEP) of the Japan Science and Technology Agency; Joint Research Program of the Institute for Molecular and Cellular Regulation, Gunma University	This work was supported in part by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jsps.go.jp/english/index.html) (to YK and YO: No. 24590110, and to HK: No. 23710247), Adaptable and Seamless Technology Transfer Program (A-STEP) of the Japan Science and Technology Agency (http://www.jst.go.jp/EN/index.html) (to YK: No. AS232Z00488G), and the Joint Research Program of the Institute for Molecular and Cellular Regulation, Gunma University (http://www.imcr.gunma-u.ac.jp/en/) (to YK, HK, and YO: No. 11018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaishi E, 2004, EUR J PHARMACOL, V485, P21, DOI 10.1016/j.ejphar.2003.11.041; Armstrong JS, 2006, BRIT J PHARMACOL, V147, P239, DOI 10.1038/sj.bjp.0706556; ASAHI KI, 1995, BIOCHEM BIOPH RES CO, V208, P1036, DOI 10.1006/bbrc.1995.1438; Asai T, 1998, INT J CANCER, V76, P418, DOI 10.1002/(SICI)1097-0215(19980504)76:3<418::AID-IJC21>3.3.CO;2-E; DJIAN P, 1985, J CELL PHYSIOL, V124, P554, DOI 10.1002/jcp.1041240327; El Debs BW, 2011, J BIOMOL SCREEN, V16, P818, DOI 10.1177/1087057111414898; Gokan N, 2005, BIOCHEM PHARMACOL, V70, P676, DOI 10.1016/j.bcp.2005.06.002; Gottlieb E, 2002, P NATL ACAD SCI USA, V99, P12801, DOI 10.1073/pnas.202477599; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Kabuyama Y, 2010, AM J PHYSIOL-CELL PH, V298, pC107, DOI 10.1152/ajpcell.00231.2009; Kanai M, 2003, ONCOGENE, V22, P548, DOI 10.1038/sj.onc.1206109; Kay RR, 1999, SEMIN CELL DEV BIOL, V10, P577, DOI 10.1006/scdb.1999.0341; KAY RR, 1989, DEVELOPMENT, V107, P81; Kikuchi H, 2005, J ORG CHEM, V70, P8854, DOI 10.1021/jo051352x; Kikuchi H, 2004, BIOORGAN MED CHEM, V12, P3203, DOI 10.1016/j.bmc.2004.04.001; Kikuchi H, 2006, LIFE SCI, V80, P160, DOI 10.1016/j.lfs.2006.08.034; Kikuchi H, 2010, TETRAHEDRON, V66, P6000, DOI 10.1016/j.tet.2010.06.029; Kroemer G, 2002, BIOCHIMIE, V84, P103, DOI 10.1016/S0300-9084(02)01382-2; KUBOHARA Y, 1995, FEBS LETT, V359, P119, DOI 10.1016/0014-5793(95)00022-2; Kubohara Y, 1999, EUR J PHARMACOL, V381, P57, DOI 10.1016/S0014-2999(99)00548-8; Kubohara Y, 1997, BIOCHEM BIOPH RES CO, V236, P418, DOI 10.1006/bbrc.1997.6964; Kuwayama H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006658; Lena A, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-13; Matsuda T, 2010, J PHARMACOL SCI, V112, P320, DOI 10.1254/jphs.09348FP; Miwa Y, 2000, CIRC RES, V86, P68, DOI 10.1161/01.RES.86.1.68; MORRIS HR, 1988, BIOCHEM J, V249, P903, DOI 10.1042/bj2490903; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; NEWELL K, 1992, BRIT J CANCER, V66, P311, DOI 10.1038/bjc.1992.262; NEWELL KJ, 1989, CANCER RES, V49, P4477; Sekimoto T, 2010, MOL CELL, V37, P79, DOI 10.1016/j.molcel.2009.12.015; SHAULSKY G, 1995, P NATL ACAD SCI USA, V92, P5660, DOI 10.1073/pnas.92.12.5660; Shimizu K, 2004, CANCER RES, V64, P2568, DOI 10.1158/0008-5472.CAN-03-3551; SONDAK VK, 1987, INT J CELL CLONING, V5, P191; Takahashi-Yanaga F, 2003, J BIOL CHEM, V278, P9663, DOI 10.1074/jbc.M205768200; Takahashi-Yanaga F, 2006, J BIOL CHEM, V281, P38489, DOI 10.1074/jbc.M605205200; Tanaka S, 2012, TOXICOL LETT, V211, P312, DOI 10.1016/j.toxlet.2012.04.015; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551	38	20	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72118	10.1371/journal.pone.0072118	http://dx.doi.org/10.1371/journal.pone.0072118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977224	gold, Green Submitted, Green Published			2022-12-25	WOS:000323378000079
J	Schiepek, G; Tominschek, I; Heinzel, S; Aigner, M; Dold, M; Unger, A; Lenz, G; Windischberger, C; Moser, E; Ploderl, M; Lutz, J; Meindl, T; Zaudig, M; Pogarell, O; Karch, S				Schiepek, Guenter; Tominschek, Igor; Heinzel, Stephan; Aigner, Martin; Dold, Markus; Unger, Annemarie; Lenz, Gerhard; Windischberger, Christian; Moser, Ewald; Ploederl, Martin; Lutz, Juergen; Meindl, Thomas; Zaudig, Michael; Pogarell, Oliver; Karch, Susanne			Discontinuous Patterns of Brain Activation in the Psychotherapy Process of Obsessive-Compulsive Disorder: Converging Results from Repeated fMRI and Daily Self-Reports	PLOS ONE			English	Article							GLUCOSE METABOLIC-RATE; CEREBRAL-BLOOD-FLOW; BEHAVIOR-THERAPY; SYMPTOM PROVOCATION; NONLINEAR DYNAMICS; ANTERIOR CINGULATE; SUDDEN GAINS; DSM-III; CONNECTIVITY; DEPRESSION	This study investigates neuronal activation patterns during the psychotherapeutic process, assuming that change dynamics undergo critical instabilities and discontinuous transitions. An internet-based system was used to collect daily self-assessments during inpatient therapies. A dynamic complexity measure was applied to the resulting time series. Critical phases of the change process were indicated by the maxima of the varying complexity. Repeated functional magnetic resonance imaging (fMRI) measurements were conducted over the course of the therapy. The study was realized with 9 patients suffering from obsessive-compulsive disorder (subtype: washing/contamination fear) and 9 matched healthy controls. For symptom-provocative stimulation individualized pictures from patients' personal environments were used. The neuronal responses to these disease-specific pictures were compared to the responses during standardized disgust-provoking and neutral pictures. Considerably larger neuronal changes in therapy-relevant brain areas (cingulate cortex/supplementary motor cortex, bilateral dorsolateral prefrontal cortex, bilateral insula, bilateral parietal cortex, cuneus) were observed during critical phases (order transitions), as compared to non-critical phases, and also compared to healthy controls. The data indicate that non-stationary changes play a crucial role in the psychotherapeutic process supporting self-organization and complexity models of therapeutic change.	[Schiepek, Guenter; Ploederl, Martin] Paracelsus Med Univ, Christian Doppler Univ Hosp, Inst Synerget & Psychotherapy Res, Salzburg, Austria; [Tominschek, Igor; Zaudig, Michael] Clin Psychosomat Med, Munich, Germany; [Heinzel, Stephan] Psychiat Univ Hosp St Hedwig, Berlin, Germany; [Aigner, Martin; Dold, Markus; Unger, Annemarie; Lenz, Gerhard] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria; [Windischberger, Christian; Moser, Ewald] Med Univ Vienna, Ctr Med Phys & Biomed Engn, MR Ctr Excellence, Vienna, Austria; [Ploederl, Martin] Paracelsus Med Univ, Christian Doppler Univ Hosp, Dept Suicide Prevent, Salzburg, Austria; [Lutz, Juergen; Meindl, Thomas] Ludwig Maximilians Univ Munchen, Inst Clin Radiol, Munich, Germany; [Pogarell, Oliver; Karch, Susanne] Ludwig Maximilians Univ Munchen, Dept Psychiat & Psychotherapy, Munich, Germany	Paracelsus Private Medical University; Medical University of Vienna; Medical University of Vienna; Paracelsus Private Medical University; University of Munich; University of Munich	Schiepek, G (corresponding author), Paracelsus Med Univ, Christian Doppler Univ Hosp, Inst Synerget & Psychotherapy Res, Salzburg, Austria.	guenter.schiepek@ccsys.de	Moser, Ewald/B-3666-2013; Plöderl, Martin/N-9701-2015	Moser, Ewald/0000-0001-8278-9583; Plöderl, Martin/0000-0003-4659-9314; Windischberger, Christian/0000-0002-9944-0190; Dold, Markus/0000-0001-8914-2192; Dold, Markus/0000-0002-0266-0083	Austrian National Bank [11931]; German Society of Systemic and Family Therapy; German Systemic Society	Austrian National Bank; German Society of Systemic and Family Therapy; German Systemic Society	This study was supported by the Austrian National Bank, Grant No. 11931; the German Society of Systemic and Family Therapy, and the German Systemic Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz JS, 2009, LANCET, V374, P491, DOI 10.1016/S0140-6736(09)60240-3; Aigner M, 2005, PSYCHIAT RES-NEUROIM, V140, P173, DOI 10.1016/j.pscychresns.2005.03.002; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; Beck AT., 1996, BECK DEPRESSION INVE; Buchheim A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033745; Bussmann JBJ, 2009, EUR PSYCHOL, V14, P142, DOI 10.1027/1016-9040.14.2.142; Bystritsky A, 2012, J PSYCHIATR RES, V46, P428, DOI 10.1016/j.jpsychires.2011.10.013; Crino R, 2005, AM J PSYCHIAT, V162, P876, DOI 10.1176/appi.ajp.162.5.876; Demal U, 2011, KLIN PSYCHOL KRANKEN, P97; EATON WW, 1989, ACTA PSYCHIAT SCAND, V79, P163, DOI 10.1111/j.1600-0447.1989.tb08584.x; Ebner-Priemer UW, 2009, PSYCHOL ASSESSMENT, V21, P463, DOI 10.1037/a0017075; Eddy KT, 2004, CLIN PSYCHOL REV, V24, P1011, DOI 10.1016/j.cpr.2004.08.004; Eickhoff SB, 2011, CLIN EEG NEUROSCI, V42, P107, DOI 10.1177/155005941104200211; Eisen JL, 2001, COMPR PSYCHIAT, V42, P494, DOI 10.1053/comp.2001.27898; Franke GH, 2002, SCL 90 R GERMAN VERS; Freyer T, 2011, PSYCHOL MED, V41, P207, DOI 10.1017/S0033291710000309; Friedlander L, 2006, CLIN PSYCHOL REV, V26, P32, DOI 10.1016/j.cpr.2005.06.010; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Greisberg S, 2003, CLIN PSYCHOL REV, V23, P95, DOI 10.1016/S0272-7358(02)00232-5; Gumz A, 2012, PSYCHOTHER RES, V22, P26, DOI 10.1080/10503307.2011.622313; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; HAKEN H, 2004, SYNERGETICS INTRO AD; Haken H, 2010, SYNERGETIK PSYCHOL; Hand I, 1991, VERHALTENSTHERAPIE, V1, P223, DOI DOI 10.1159/000257972; Hayes AM, 2007, CLIN PSYCHOL REV, V27, P715, DOI 10.1016/j.cpr.2007.01.008; Ilardi SS, 1999, CLIN PSYCHOL-SCI PR, V6, P295, DOI 10.1093/clipsy/6.3.295; Jaafari N, 2011, PSYCHOPATHOLOGY, V44, P272, DOI 10.1159/000323607; KARNO M, 1988, ARCH GEN PSYCHIAT, V45, P1094, DOI 10.1001/archpsyc.1988.01800360042006; Kasess CH, 2008, NEUROIMAGE, V40, P828, DOI 10.1016/j.neuroimage.2007.11.040; Kasess CH, 2010, NEUROIMAGE, V49, P3065, DOI 10.1016/j.neuroimage.2009.11.037; Kelly MAR, 2005, BEHAV RES THER, V43, P703, DOI 10.1016/j.brat.2004.06.002; Kelso S., 1995, DYNAMIC PATTERNS SEL; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kobak KA, 1998, PSYCHOPHARMACOLOGY, V136, P205, DOI 10.1007/s002130050558; Kowalik ZJ, 1997, PSYCHOTHER RES, V7, P197, DOI 10.1080/10503309712331331973; Kuelz AK, 2004, BIOL PSYCHOL, V65, P185, DOI 10.1016/j.biopsycho.2003.07.007; Kwon JS, 2009, EXPERT REV NEUROTHER, V9, P255, DOI 10.1586/14737175.9.2.255; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; Linehan M., 2014, DBT SKILLS TRAINING; Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564; Mataix-Cols D, 2005, AM J PSYCHIAT, V162, P228, DOI 10.1176/appi.ajp.162.2.228; Mataix-Cols D, 2009, PSYCHIAT RES, V168, P238, DOI 10.1016/j.psychres.2008.05.007; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; MCGUIRE PK, 1994, BRIT J PSYCHIAT, V164, P459, DOI 10.1192/bjp.164.4.459; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Meyer-Lindenberg A, 2002, P NATL ACAD SCI USA, V99, P10948, DOI 10.1073/pnas.162114799; Nabeyama M, 2008, PSYCHIAT RES-NEUROIM, V163, P236, DOI 10.1016/j.pscychresns.2007.11.001; Nakao T, 2005, BIOL PSYCHIAT, V57, P901, DOI 10.1016/j.biopsych.2004.12.039; Nakatani E, 2003, PSYCHIAT RES-NEUROIM, V124, P113, DOI 10.1016/S0925-4927(03)00069-6; R Development Core Team, 2012, R LANG ENV STAT COMP; RAUCH SL, 1994, ARCH GEN PSYCHIAT, V51, P62; Rengachary J, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00029, 10.3389/fnhum.2011.00069]; Rosa-Alcazar AI, 2008, CLIN PSYCHOL REV, V28, P1310, DOI 10.1016/j.cpr.2008.07.001; Rosenthal R., 2000, CONTRASTS EFFECT SIZ; Rotge JY, 2008, J PSYCHIATR NEUROSCI, V33, P405; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Saxena S, 2009, MOL PSYCHIATR, V14, P197, DOI 10.1038/sj.mp.4002134; Schienle A, 2005, INT J PSYCHOPHYSIOL, V57, P69, DOI 10.1016/j.ijpsycho.2004.12.013; SCHIEPEK G., 2009, ENCY COMPLEXITY SYST, P7991, DOI [10.1007/978-0-387-30440-3_472, DOI 10.1007/978-0-387-30440-3_472]; Schiepek G, 2012, Z PSYCHOSOM MED PSYC, V58, P257, DOI 10.13109/zptm.2012.58.3.257; Schiepek G, 2009, EUR REV, V17, P331, DOI 10.1017/S1062798709000763; Schiepek G, 2010, BIOL CYBERN, V102, P197, DOI 10.1007/s00422-009-0362-1; Schiepek G, 2009, WORLD J BIOL PSYCHIA, V10, P658, DOI 10.1080/15622970802311829; Schlosser RGM, 2010, HUM BRAIN MAPP, V31, P1834, DOI 10.1002/hbm.20980; Schnell K, 2007, J PSYCHIATR RES, V41, P837, DOI 10.1016/j.jpsychires.2006.08.011; Schwartz JM, 1996, ARCH GEN PSYCHIAT, V53, P109; Simon D, 2010, PSYCHOPHYSIOLOGY, V47, P728, DOI 10.1111/j.1469-8986.2010.00980.x; Sladky R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050050; Stern DN, 1998, INT J PSYCHOANAL, V79, P903; Stiles WB, 2003, J CONSULT CLIN PSYCH, V71, P14, DOI 10.1037/0022-006X.71.1.14; Stulz N, 2007, J CONSULT CLIN PSYCH, V75, P864, DOI 10.1037/0022-006X.75.6.864; Tass PA, 2007, INT J PSYCHOPHYSIOL, V64, P53, DOI 10.1016/j.ijpsycho.2006.07.013; Tass PA, 2012, RESTOR NEUROL NEUROS, V30, P137, DOI 10.3233/RNN-2012-110218; Timulak L, 2010, PSYCHOL PSYCHOTHER-T, V83, P421, DOI 10.1348/147608310X499404; Tominschek I, 2007, ZWANGSSTORUNGEN SYST; Tschacher W, 2000, PSYCHOTHER RES, V10, P296, DOI 10.1093/ptr/10.3.296; van den Heuvel OA, 2005, ARCH GEN PSYCHIAT, V62, P301, DOI 10.1001/archpsyc.62.3.301; van den Heuvel OA, 2004, PSYCHIAT RES-NEUROIM, V132, P225, DOI 10.1016/j.pscychresns.2004.06.007; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Yucel M, 2007, ARCH GEN PSYCHIAT, V64, P946, DOI 10.1001/archpsyc.64.8.946	84	38	39	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71863	10.1371/journal.pone.0071863	http://dx.doi.org/10.1371/journal.pone.0071863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977168	Green Published, gold			2022-12-25	WOS:000323378000072
J	Sckolnick, M; Krementsova, EB; Warshaw, DM; Trybus, KM				Sckolnick, Maria; Krementsova, Elena B.; Warshaw, David M.; Trybus, Kathleen M.			More Than Just a Cargo Adapter, Melanophilin Prolongs and Slows Processive Runs of Myosin Va	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAND-OVER-HAND; MELANOSOME TRANSPORT; SECRETORY GRANULES; STRUCTURAL BASIS; BINDING DOMAIN; GLOBULAR TAIL; LINKS RAB27A; DYNAMICS; ACTIN; ORGANELLE	Myosin Va (myoVa) is a molecular motor that processively transports cargo along actin tracks. One well studied cargo in vivo is the melanosome, a pigment organelle that is moved first by kinesin on microtubules and then handed off to myoVa for transport in the actin-rich dendritic periphery of melanocytes. Melanophilin (Mlph) is the adapter protein that links Rab27a-melanosomes to myoVa. Using total internal reflection fluorescence microscopy and quantum dot-labeled full-length myoVa, we show at the single-molecule level that Mlph increases the number of processively moving myoVa motors by 17-fold. Surprisingly, myoVa-Mlph moves similar to 4-fold slower than myoVa alone and with twice the run length. These two changes greatly increase the time spent on actin, a property likely to enhance the transfer of melanosomes to the adjacent keratinocyte. In contrast to the variable stepping pattern of full-length myoVa, the myoVa-Mlph complex shows a normal gating pattern between the heads typical of a fully active motor and consistent with a cargo-dependent activation mechanism. The Mlph-dependent changes in myoVa depend on a positively charged cluster of amino acids in the actin binding domain of Mlph, suggesting that Mlph acts as a "tether" that links the motor to the track. Our results provide a molecular explanation for the uncharacteristically slow speed of melanosome movement by myoVa in vivo. More generally, these data show that proteins that link motors to cargo can modify motor properties to enhance their biological role.	[Sckolnick, Maria; Krementsova, Elena B.; Warshaw, David M.; Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	University of Vermont	Trybus, KM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	kathleen.trybus@uvm.edu			National Institutes of Health [GM078097, GM094229, T32HL07647]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078097, R01GM094229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM078097 (to K. M. T.) and GM094229 (to D. M. W.), and Training Grant T32HL07647 (to M. S.).	Armstrong JM, 2012, P NATL ACAD SCI USA, V109, pE218, DOI 10.1073/pnas.1109709109; Arnold DB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.283pe49; Brozzi F, 2012, TRAFFIC, V13, P54, DOI 10.1111/j.1600-0854.2011.01301.x; Brunstein M, 2009, BIOPHYS J, V97, P1548, DOI 10.1016/j.bpj.2009.06.048; Clemen AEM, 2005, BIOPHYS J, V88, P4402, DOI 10.1529/biophysj.104.053504; Fukuda M, 2004, J CELL SCI, V117, P583, DOI 10.1242/jcs.00891; Fukuda M, 2002, J BIOL CHEM, V277, P43096, DOI 10.1074/jbc.M203862200; Geething NC, 2007, J BIOL CHEM, V282, P21518, DOI 10.1074/jbc.M701932200; Huang JD, 1998, GENETICS, V148, P1963; Huet S, 2012, J NEUROSCI, V32, P2564, DOI 10.1523/JNEUROSCI.2724-11.2012; Hume AN, 2006, MOL BIOL CELL, V17, P4720, DOI 10.1091/mbc.E06-05-0457; Hume AN, 2011, BIOCHEM SOC T, V39, P1191, DOI 10.1042/BST0391191; Kad NM, 2008, J BIOL CHEM, V283, P17477, DOI 10.1074/jbc.M800539200; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Kukimoto-Niino M, 2008, STRUCTURE, V16, P1478, DOI 10.1016/j.str.2008.07.014; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Lambert J, 1998, BIOCHEM BIOPH RES CO, V252, P329, DOI 10.1006/bbrc.1998.9644; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Lopes VS, 2007, TRAFFIC, V8, P486, DOI 10.1111/j.1600-0854.2007.00548.x; Lu HL, 2010, J BIOL CHEM, V285, P42068, DOI 10.1074/jbc.M110.180265; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Nagashima K, 2002, FEBS LETT, V517, P233, DOI 10.1016/S0014-5793(02)02634-0; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Pylypenko O, 2012, P NATL ACAD SCI USA, V109, P5555, DOI 10.1073/pnas.1202494109; Rogers SL, 1998, CURR BIOL, V8, P161, DOI 10.1016/S0960-9822(98)70063-6; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Snyder GE, 2004, BIOPHYS J, V87, P1776, DOI 10.1529/biophysj.103.036897; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Wang J, 1999, J BIOL CHEM, V274, P28542, DOI 10.1074/jbc.274.40.28542; Warshaw DM, 2005, BIOPHYS J, V88, pL30, DOI 10.1529/biophysj.105.061903; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Wu XF, 2001, J CELL SCI, V114, P1091; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Wu XS, 2005, J CELL BIOL, V171, P201, DOI 10.1083/jcb.200503028; Wu XF, 2006, FEBS LETT, V580, P5863, DOI 10.1016/j.febslet.2006.09.047	47	29	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29313	29322		10.1074/jbc.M113.476929	http://dx.doi.org/10.1074/jbc.M113.476929			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23979131	hybrid, Green Published			2022-12-25	WOS:000330615300011
J	Chang, JLYF; Wang, C; Liu, JC; Huang, YQ; Jin, CL; Yang, CF; Hai, B; Liu, F; D'Souza, RN; McKeehan, WL; Wang, F				Chang, Julia Yu Fong; Wang, Cong; Liu, Junchen; Huang, Yanqing; Jin, Chengliu; Yang, Chaofeng; Hai, Bo; Liu, Fei; D'Souza, Rena N.; McKeehan, Wallace L.; Wang, Fen			Fibroblast Growth Factor Signaling Is Essential for Self-renewal of Dental Epithelial Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Fibroblast Growth Factor (FGF); Fibroblast Growth Factor Receptor (FGFR); Stem Cells; Tooth; Wnt Signaling	MOUSE INCISORS; TOOTH MORPHOGENESIS; MULTILINEAGE DIFFERENTIATION; IN-VITRO; WNT; GENERATION; PROGENITORS; EXPRESSION; NICHE; IDENTIFICATION	A constant supply of epithelial cells from dental epithelial stem cell (DESC) niches in the cervical loop (CL) enables mouse incisors to grow continuously throughout life. Elucidation of the cellular and molecular mechanisms underlying this unlimited growth potential is of broad interest for tooth regenerative therapies. Fibroblast growth factor (FGF) signaling is essential for the development of mouse incisors and for maintenance of the CL during prenatal development. However, how FGF signaling in DESCs controls the self-renewal and differentiation of the cells is not well understood. Herein, we report that FGF signaling is essential for self-renewal and the prevention of cell differentiation of DESCs in the CL as well as in DESC spheres. Inhibiting the FGF signaling pathway decreased proliferation and increased apoptosis of the cells in DESC spheres. Suppressing FGFR or its downstream signal transduction pathways diminished Lgr5-expressing cells in the CL and promoted cell differentiation both in DESC spheres and the CL. Furthermore, disruption of the FGF pathway abrogated Wnt signaling to promote Lgr5 expression in DESCs both in vitro and in vivo. This study sheds new light on understanding the mechanism by which the homeostasis, expansion, and differentiation of DESCs are regulated.	[Chang, Julia Yu Fong; Wang, Cong; Liu, Junchen; Huang, Yanqing; Jin, Chengliu; Yang, Chaofeng; McKeehan, Wallace L.; Wang, Fen] Texas A&M Univ, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA; [Chang, Julia Yu Fong; D'Souza, Rena N.] Texas A&M Univ, Dept Biomed Sci, Baylor Coll Dent, Dallas, TX 75246 USA; [Wang, Cong] Wenzhou Med Univ, Coll Pharm, Wenzhou 325000, Zhejiang, Peoples R China; [Hai, Bo; Liu, Fei] Texas A&M Univ, Coll Med, Dept Mol & Cellular Med, Bryan, TX 77807 USA	Texas A&M University System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Wenzhou Medical University; Texas A&M University System; Texas A&M University College Station	Chang, JLYF (corresponding author), Univ Washington, Sch Dent, Oral & Maxillofacial Surg Oral Pathol Div, Seattle, WA 98195 USA.	jyfchang@uw.edu; fwang@ibt.tamhsc.edu		CHANG, JULIA YU-FONG/0000-0002-3880-3787; Liu, Fei/0000-0002-7398-2274; Liu, Junchen/0000-0003-2765-9780; D'Souza, Rena/0000-0002-1505-5173; Huang, Yanqing/0000-0001-7275-3333	National Institutes of Health [K08DE020883, T32DE018380, CA096824, CA140388]; John S. Dunn Research Foundation; Cancer Prevention and Research Institution of Texas [CPRIT 110555]; NATIONAL CANCER INSTITUTE [R01CA096824, P50CA140388, R56CA096824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE023106, K08DE020883, T32DE018380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John S. Dunn Research Foundation; Cancer Prevention and Research Institution of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants K08DE020883 (to J. Y. F. C.), T32DE018380 (R. N. D.), CA096824 (to F. W.), and CA140388 (to W. L. M. and F. W.). This work was also supported by the John S. Dunn Research Foundation (to W. L. M.) and the Cancer Prevention and Research Institution of Texas Grant CPRIT 110555 (to F. W. and W. L. M.).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Chang JYF, 2013, STEM CELL RES, V11, P990, DOI 10.1016/j.scr.2013.06.008; Charles C, 2011, DEVELOPMENT, V138, P4063, DOI 10.1242/dev.069195; Chen G, 2012, STEM CELLS, V30, P623, DOI 10.1002/stem.1021; Chen JQ, 2009, DEV BIOL, V334, P174, DOI 10.1016/j.ydbio.2009.07.015; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fujimori S, 2010, DEV BIOL, V348, P97, DOI 10.1016/j.ydbio.2010.09.009; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Handrigan GR, 2010, DEV BIOL, V348, P130, DOI 10.1016/j.ydbio.2010.09.003; Handrigan GR, 2010, DEVELOPMENT, V137, P3545, DOI 10.1242/dev.052415; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Harada H, 2002, DEVELOPMENT, V129, P1533; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Ille F, 2005, CELL MOL LIFE SCI, V62, P1100, DOI 10.1007/s00018-005-4552-2; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; Kettunen P, 2000, DEV DYNAM, V219, P322, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1062>3.0.CO;2-J; Kettunen P, 1998, DEV GENET, V22, P374, DOI 10.1002/(SICI)1520-6408(1998)22:4<374::AID-DVG7>3.0.CO;2-3; Kettunen P, 1998, DEV DYNAM, V211, P256, DOI 10.1002/(SICI)1097-0177(199803)211:3<256::AID-AJA7>3.0.CO;2-G; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Kratochwil K, 2002, GENE DEV, V16, P3173, DOI 10.1101/gad.1035602; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Levenstein ME, 2008, STEM CELLS, V26, P3099, DOI 10.1634/stemcells.2007-1056; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lin YS, 2007, GENESIS, V45, P554, DOI 10.1002/dvg.20327; Lin YS, 2009, DEV DYNAM, V238, P324, DOI 10.1002/dvdy.21778; Liu F, 2010, J DENT RES, V89, P909, DOI 10.1177/0022034510370090; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; MCKEEHAN WL, 2009, HDB CELL SIGNALING, P253; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Parsa S, 2010, DEVELOPMENT, V137, P3743, DOI 10.1242/dev.051672; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Shi FX, 2012, J NEUROSCI, V32, P9639, DOI 10.1523/JNEUROSCI.1064-12.2012; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Suomalainen M, 2010, DEV DYNAM, V239, P364, DOI 10.1002/dvdy.22106; Takamori K, 2008, J DENT RES, V87, P238, DOI 10.1177/154405910808700307; Trokovic R, 2003, EMBO J, V22, P1811, DOI 10.1093/emboj/cdg169; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Wang XP, 2009, DEVELOPMENT, V136, P1939, DOI 10.1242/dev.033803; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zhang YY, 2008, DEVELOPMENT, V135, P775, DOI 10.1242/dev.009910	56	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28952	28961		10.1074/jbc.M113.506873	http://dx.doi.org/10.1074/jbc.M113.506873			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23979135	Green Published, hybrid			2022-12-25	WOS:000330298800050
J	Kim, JA; Kim, Y; Kwon, BM; Han, DC				Kim, Joo Ae; Kim, Youngmi; Kwon, Byoung-Mog; Han, Dong Cho			The Natural Compound Cantharidin Induces Cancer Cell Death through Inhibition of Heat Shock Protein 70 (HSP70) and Bcl-2-associated Athanogene Domain 3 (BAG3) Expression by Blocking Heat Shock Factor 1 (HSF1) Binding to Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Bcl-2 Family Proteins; Cancer Therapy; Drug Screening; Heat Shock Protein; PP2A	PROTEIN PHOSPHATASE 2A; NON-ONCOGENE ADDICTION; BH3 MIMETIC ABT-737; NF-KAPPA-B; TUMOR-SUPPRESSOR; SIGNALING PATHWAYS; BCL-2 PROTEINS; OKADAIC ACID; APOPTOSIS; STRESS	Heat shock factor 1 (HSF1) enhances the survival of cancer cells under various stresses. The knock-out of HSF1 impairs cancer formation and progression, suggesting that HSF1 is a promising therapeutic target. To identify inhibitors of HSF1 activity, we performed cell-based screening with a library of marketed and experimental drugs and identified cantharidin as an HSF1 inhibitor. Cantharidin is a potent antitumor agent from traditional Chinese medicine. Cantharidin inhibited heat shock-induced luciferase activity with an IC50 of 4.2 m. In contrast, cantharidin did not inhibit NF-B luciferase reporter activity, demonstrating that cantharidin is not a general transcription inhibitor. When the HCT-116 colorectal cancer cells were exposed to heat shock in the presence of cantharidin, the induction of HSF1 downstream target proteins, such as HSP70 and BAG3 (Bcl-2-associated athanogene domain 3), was suppressed. HSP70 and its co-chaperone BAG3 have been reported to protect cells from apoptosis by stabilizing anti-apoptotic Bcl-2 family proteins. As expected, treating HCT-116 cancer cells with cantharidin significantly decreased the amounts of BCL-2, BCL-x(L), and MCL-1 protein and induced apoptotic cell death. Chromatin immunoprecipitation analysis showed that cantharidin inhibited the binding of HSF1 to the HSP70 promoter and subsequently blocked HSF1-dependent p-TEFb recruitment. Therefore, the p-TEFb-dependent phosphorylation of the C-terminal domain of RNA polymerase II was blocked, arresting transcription at the elongation step. Protein phosphatase 2A inhibition with PP2CA siRNA or okadaic acid did not block HSF1 activity, suggesting that cantharidin inhibits HSF1 in a protein phosphatase 2A-independent manner. We show for the first time that cantharidin inhibits HSF1 transcriptional activity.	[Kim, Joo Ae; Kim, Youngmi; Kwon, Byoung-Mog; Han, Dong Cho] Korea Res Inst Biosci & Biotechnol, Biomed Genom Res Ctr, Taejon 305806, South Korea; [Kim, Joo Ae; Kim, Youngmi; Kwon, Byoung-Mog; Han, Dong Cho] Univ Sci & Technol, Taejon 305806, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kwon, BM (corresponding author), 111 Gwahangno, Taejon 305806, South Korea.	kwonbm@kribb.re.kr; dchan@kribb.re.kr			National Chemical Genomics Research Program NRF [2011-0018688]; KRIBB Research Initiative Program; Bio & Medical Technology Development Program of the National Research Foundation; Korean Government [2012M3A9C404877]	National Chemical Genomics Research Program NRF; KRIBB Research Initiative Program; Bio & Medical Technology Development Program of the National Research Foundation; Korean Government(Korean Government)	This work was supported by the National Chemical Genomics Research Program NRF Grant 2011-0018688, the KRIBB Research Initiative Program, and the Bio & Medical Technology Development Program of the National Research Foundation funded by Korean Government Grant 2012M3A9C404877.	Akgul C, 2000, FEBS LETT, V478, P72, DOI 10.1016/S0014-5793(00)01809-3; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boiani M, 2013, J BIOL CHEM, V288, P6980, DOI 10.1074/jbc.M112.414177; Chang CC, 2008, FOOD CHEM TOXICOL, V46, P3116, DOI 10.1016/j.fct.2008.06.084; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Deng LP, 2013, CURR MED CHEM, V20, P159, DOI 10.2174/092986713804806711; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; EPSTEIN WL, 1958, ARCH DERMATOL, V77, P508, DOI 10.1001/archderm.1958.01560050014003; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Huang WW, 2011, INT J ONCOL, V38, P1067, DOI 10.3892/ijo.2011.922; Jacobs AT, 2009, J BIOL CHEM, V284, P9176, DOI 10.1074/jbc.M808656200; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Keuling AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006651; KINGSTON RE, 1986, MOL CELL BIOL, V6, P3180, DOI 10.1128/MCB.6.9.3180; KINGSTON RE, 1984, NATURE, V312, P280, DOI 10.1038/312280a0; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Lee JH, 2002, J BIOL CHEM, V277, P18411, DOI 10.1074/jbc.M201368200; Li W, 2011, CANCER LETT, V304, P117, DOI 10.1016/j.canlet.2011.02.009; Li W, 2010, CANCER SCI, V101, P1226, DOI 10.1111/j.1349-7006.2010.01523.x; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Lin XH, 1998, P NATL ACAD SCI USA, V95, P14693, DOI 10.1073/pnas.95.25.14693; Lis JT, 2000, GENE DEV, V14, P792; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Matsuoka Y, 2003, BRIT J PHARMACOL, V138, P1303, DOI 10.1038/sj.bjp.0705182; Mitra A, 2012, ONCOGENE, V31, P4472, DOI 10.1038/onc.2011.623; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Rocchi P, 2005, CANCER RES, V65, P11083, DOI 10.1158/0008-5472.CAN-05-1840; Sagawa M, 2008, CANCER SCI, V99, P1820, DOI 10.1111/j.1349-7006.2008.00872.x; Sanchez-Serrano I, 2006, NAT REV DRUG DISCOV, V5, P107, DOI 10.1038/nrd1959; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Solit DB, 2008, DRUG DISCOV TODAY, V13, P38, DOI 10.1016/j.drudis.2007.10.007; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Stanhill A, 2006, ONCOGENE, V25, P1485, DOI 10.1038/sj.onc.1209193; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; SZATROWSKI TP, 1991, CANCER RES, V51, P794; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Van Hoof C, 2004, CANCER CELL, V5, P105, DOI 10.1016/S1535-6108(04)00027-3; Walter G, 2012, CELL CYCLE, V11, P451, DOI 10.4161/cc.11.3.19057; Wang CC, 2000, TOXICOLOGY, V147, P77, DOI 10.1016/S0300-483X(00)00185-2; WANG GS, 1989, J ETHNOPHARMACOL, V26, P147, DOI 10.1016/0378-8741(89)90062-7; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yan Y, 1997, J BIOL CHEM, V272, P15220, DOI 10.1074/jbc.272.24.15220; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yoon YJ, 2011, J BIOL CHEM, V286, P1737, DOI 10.1074/jbc.M110.179440	55	69	69	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28713	28726		10.1074/jbc.M113.488346	http://dx.doi.org/10.1074/jbc.M113.488346			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23983126	Green Published, hybrid			2022-12-25	WOS:000330298800025
J	Kobayashi, N; Hanaoka, M; Droma, Y; Ito, M; Katsuyama, Y; Kubo, K; Ota, M				Kobayashi, Nobumitsu; Hanaoka, Masayuki; Droma, Yunden; Ito, Michiko; Katsuyama, Yoshihiko; Kubo, Keishi; Ota, Masao			Polymorphisms of the Tissue Inhibitor of Metalloproteinase 3 Gene Are Associated with Resistance to High-Altitude Pulmonary Edema (HAPE) in a Japanese Population: A Case Control Study Using Polymorphic Microsatellite Markers	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; NITRIC-OXIDE; ADAPTATION; EPITHELIUM; BINDING; SYSTEM; TIMP3	Introduction: High-altitude pulmonary edema (HAPE) is a hypoxia-induced, life-threatening, high permeability type of edema attributable to pulmonary capillary stress failure. Genome-wide association analysis is necessary to better understand how genetics influence the outcome of HAPE. Materials and Methods: DNA samples were collected from 53 subjects susceptible to HAPE (HAPE-s) and 67 elite Alpinists resistant to HAPE (HAPE-r). The genome scan was carried out using 400 polymorphic microsatellite markers throughout the whole genome in all subjects. In addition, six single nucleotide polymorphisms (SNPs) of the gene encoding the tissue inhibitor of metalloproteinase 3 (TIMP3) were genotyped by Taqman (R) SNP Genotyping Assays. Results: The results were analyzed using case-control comparisons. Whole genome scanning revealed that allele frequencies in nine markers were statistically different between HAPE-s and HAPE-r subjects. The SNP genotyping of the TIMP3 gene revealed that the derived allele C of rs130293 was associated with resistance to HAPE [odds ratio (OR) = 0.21, P = 0.0012) and recessive inheritance of the phenotype of HAPE-s (P = 0.0012). A haplotype CAC carrying allele C of rs130293 was associated with resistance to HAPE. Discussion: This genome-wide association study revealed several novel candidate genes associated with susceptibility or resistance to HAPE in a Japanese population. Among those, the minor allele C of rs130293 (C/T) in the TIMP3 gene was linked to resistance to HAPE; while, the ancestral allele T was associated with susceptibility to HAPE.	[Kobayashi, Nobumitsu; Hanaoka, Masayuki; Droma, Yunden; Ito, Michiko; Kubo, Keishi] Shinshu Univ, Sch Med, Dept Internal Med 1, Matsumoto, Nagano 390, Japan; [Kobayashi, Nobumitsu; Ota, Masao] Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan; [Katsuyama, Yoshihiko] Shinshu Univ Hosp, Dept Pharm, Matsumoto, Nagano, Japan	Shinshu University; Shinshu University; Shinshu University	Ota, M (corresponding author), Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan.	otamasao@shinshu-u.ac.jp		Ota, Masao/0000-0002-6400-5658	Japan Society for the Promotion of Science [22590853]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a Grant-in-Aid for Scientific Research (C), No. 22590853, from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Cremona G, 2002, LANCET, V359, P303, DOI 10.1016/S0140-6736(02)07496-2; Droma Y, 2002, CIRCULATION, V106, P826, DOI 10.1161/01.CIR.0000024409.30143.70; Duplain H, 2000, AM J RESP CRIT CARE, V162, P221, DOI 10.1164/ajrccm.162.1.9908039; Eisenhut Michael, 2006, J Inflamm (Lond), V3, P5, DOI 10.1186/1476-9255-3-5; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs JSR, 1999, ADV EXP MED BIOL, V474, P81; Gueders MM, 2006, EUR J PHARMACOL, V533, P133, DOI 10.1016/j.ejphar.2005.12.082; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hackett P, 2002, JAMA-J AM MED ASSOC, V287, P2275, DOI 10.1001/jama.287.17.2275; Hanaoka M, 1998, CIRCULATION, V97, P1124, DOI 10.1161/01.CIR.97.12.1124; Hanaoka M, J APPL PHYSL, V94, P1836; Hotta J, 2004, CHEST, V126, P825, DOI 10.1378/chest.126.3.825; HULTGREN H, 1962, BRIT HEART J, V24, P95; KOBAYASHI T, 1987, CHEST, V92, P814, DOI 10.1378/chest.92.5.814; Koreth J, 1996, J PATHOL, V178, P239, DOI 10.1002/(SICI)1096-9896(199603)178:3<239::AID-PATH506>3.0.CO;2-5; Lee MH, 2007, J BIOL CHEM, V282, P6887, DOI 10.1074/jbc.M610490200; Loffek S, 2011, EUR RESPIR J, V38, P191, DOI 10.1183/09031936.00146510; Lorenzo VF, 2009, BLOOD CELL MOL DIS, V43, P221, DOI 10.1016/j.bcmd.2009.04.006; Luo YJ, 2012, RESPIRATION, V84, P155, DOI 10.1159/000336625; Lynch M, 2003, MOL BIOL EVOL, V20, P563, DOI 10.1093/molbev/msg068; Mairbaurl H, 2003, J APPL PHYSIOL, V95, P1843, DOI 10.1152/japplphysiol.01156.2002; Mairbaurl H, 2003, AM J RESP CRIT CARE, V167, P862, DOI 10.1164/rccm.200208-864OC; Mortimer H, 2004, PHARMACOL THERAPEUT, V101, P183, DOI 10.1016/j.pharmthera.2003.11.003; MURPHY G, 1992, AM J RESP CELL MOL, V7, P120, DOI 10.1165/ajrcmb/7.2.120; Nemes S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-56; Ohashi J, 2003, J HUM GENET, V48, P487, DOI 10.1007/s10038-003-0058-7; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Qi Y, 2009, CLIN CHIM ACTA, V405, P17, DOI 10.1016/j.cca.2009.03.056; Sartori C, 2004, EUR RESPIR J, V23, P916, DOI 10.1183/09031936.04.00115304; SAVOUREY G, 1995, AVIAT SPACE ENVIR MD, V66, P963; Scherrer U, 2010, PROG CARDIOVASC DIS, V52, P485, DOI 10.1016/j.pcad.2010.02.004; SCOGGIN CH, 1977, NEW ENGL J MED, V297, P1269, DOI 10.1056/NEJM197712082972309; Stohr H, 1995, GENOME RES, V5, P483, DOI 10.1101/gr.5.5.483; VOCK P, 1989, RADIOLOGY, V170, P661, DOI 10.1148/radiology.170.3.2916019; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; WEST JB, 1992, INT J SPORTS MED, V13, pS54, DOI 10.1055/s-2007-1024594; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277	40	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e71993	10.1371/journal.pone.0071993	http://dx.doi.org/10.1371/journal.pone.0071993			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991023	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470700025
J	Almendro-Vedia, VG; Monroy, F; Cao, FJ				Almendro-Vedia, Victor G.; Monroy, Francisco; Cao, Francisco J.			Mechanics of Constriction during Cell Division: A Variational Approach	PLOS ONE			English	Article							GROWTH; MODELS; FORCE; CURVATURE; DYNAMICS; SHAPE; RING	During symmetric division cells undergo large constriction deformations at a stable midcell site. Using a variational approach, we investigate the mechanical route for symmetric constriction by computing the bending energy of deformed vesicles with rotational symmetry. Forces required for constriction are explicitly computed at constant area and constant volume, and their values are found to be determined by cell size and bending modulus. For cell-sized vesicles, considering typical bending modulus of kappa similar to 10k(B)T, we calculate constriction forces in the range 0.1-1pN. The instability of symmetrical constriction is shown and quantified with a characteristic coefficient of the order of -50k(B)T, thus evidencing that cells need a robust mechanism to stabilize constriction at midcell.	[Almendro-Vedia, Victor G.; Cao, Francisco J.] Univ Complutense, Dept Fis Atom Mol & Nucl, E-28040 Madrid, Spain; [Almendro-Vedia, Victor G.; Monroy, Francisco] Univ Complutense, Dept Quim Fis 1, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Cao, FJ (corresponding author), Univ Complutense, Dept Fis Atom Mol & Nucl, Ave Complutense S-N, E-28040 Madrid, Spain.	vgavedia@fis.ucm.es; monroy@quim.ucm.es; francao@fis.ucm.es	Cao, Francisco J./B-7794-2008; Almendro-Vedia, Victor G./R-3757-2019; Monroy, Francisco/N-2763-2013	Cao, Francisco J./0000-0003-1611-913X; Almendro-Vedia, Victor G./0000-0002-7297-1901; Monroy, Francisco/0000-0001-6455-3083	Ministerio de Ciencia e Innovacion; Ministerio de Economia y Competitividad (Spain) [FIS 2010-17440, FIS2009-14650-C02-01, FIS2012-35723]; Consolider Ingenio en Nanociencia Molecular [CSD2007-0010]; Comunidad Autonoma de Madrid (Spain) [S2009MAT-1507]; Ministerio de Educacion Cultura y Deporte (Spain) through Becas de Colaboracion program	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad (Spain)(Spanish Government); Consolider Ingenio en Nanociencia Molecular; Comunidad Autonoma de Madrid (Spain)(Comunidad de Madrid); Ministerio de Educacion Cultura y Deporte (Spain) through Becas de Colaboracion program	This work was supported by Ministerio de Ciencia e Innovacion and Ministerio de Economia y Competitividad (Spain) under grants FIS 2010-17440 to FJC and FIS2009-14650-C02-01, FIS2012-35723, Consolider Ingenio en Nanociencia Molecular CSD2007-0010, and S2009MAT-1507 from Comunidad Autonoma de Madrid (Spain) to FM. VGAV acknowledges support from Ministerio de Educacion Cultura y Deporte (Spain) through Becas de Colaboracion program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2010, MOL BIOL CELL; Albertson R, 2005, TRENDS CELL BIOL, V15, P92, DOI 10.1016/j.tcb.2004.12.008; Arriaga LR, 2010, J PHYS CHEM B, V114, P4509, DOI 10.1021/jp9118953; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Bernander R, 2000, TRENDS MICROBIOL, V8, P278, DOI 10.1016/S0966-842X(00)01760-1; Boal D. H., 2002, MECH CELL; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Budin I, 2011, P NATL ACAD SCI USA, V108, P5249, DOI 10.1073/pnas.1100498108; BURDETT IDJ, 1974, J BACTERIOL, V119, P1039, DOI 10.1128/JB.119.3.1039-1056.1974; Burgess DR, 2005, TRENDS CELL BIOL, V15, P156, DOI 10.1016/j.tcb.2005.01.006; CANHAM PB, 1970, J THEOR BIOL, V26, P61, DOI 10.1016/S0022-5193(70)80032-7; CAO LG, 1990, J CELL BIOL, V110, P1089, DOI 10.1083/jcb.110.4.1089; Chen IA, 2009, CURR BIOL, V19, pR327, DOI 10.1016/j.cub.2009.03.002; DEULING HJ, 1976, J PHYS-PARIS, V37, P1335, DOI 10.1051/jphys:0197600370110133500; Elsgoltz L, 1977, CLASSICAL DYNAMICS P; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Evans E.A., 1980, MECH THERMODYNAMICS; EVANS EA, 1974, BIOPHYS J, V14, P923, DOI 10.1016/S0006-3495(74)85959-X; Field C, 1999, CURR OPIN CELL BIOL, V11, P68, DOI 10.1016/S0955-0674(99)80009-X; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FINKELSTEIN A, 1976, J GEN PHYSIOL, V68, P127, DOI 10.1085/jgp.68.2.127; Formula Gauss-Bonnet, 2013, DIFFERENTIAL EQUATIO; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Hanczyc MM, 2004, CURR OPIN CHEM BIOL, V8, P660, DOI 10.1016/j.cbpa.2004.10.002; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Horger I, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031922; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Kim HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020252; Kutalik Z, 2005, INT J FOOD MICROBIOL, V105, P177, DOI 10.1016/j.ijfoodmicro.2005.04.026; Lan GH, 2007, P NATL ACAD SCI USA, V104, P16110, DOI 10.1073/pnas.0702925104; Liu AP, 2008, NAT PHYS, V4, P789, DOI 10.1038/nphys1071; Lopez-Montero I, 2012, BBA, V1828, P687; Lopez-Montero I, 2010, CHEM PHYS LIPIDS, V163, P56, DOI 10.1016/j.chemphyslip.2009.10.002; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Maddox AS, 2007, DEV CELL, V12, P827, DOI 10.1016/j.devcel.2007.02.018; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; MORRE DJ, 1975, ANNU REV PLANT PHYS, V26, P441, DOI 10.1146/annurev.pp.26.060175.002301; Moseley JB, 2010, CELL, V142, P189, DOI 10.1016/j.cell.2010.07.004; Niven GW, 2008, APPL ENVIRON MICROB, V74; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Reshes G, 2008, BIOPHYS J, V94, P251, DOI 10.1529/biophysj.107.104398; Sandre O, 1999, P NATL ACAD SCI USA, V96, P10591, DOI 10.1073/pnas.96.19.10591; Sedzinski J, 2011, NATURE, V476, P462, DOI 10.1038/nature10286; SEIFERT U, 1991, PHYS REV A, V44, P1182, DOI 10.1103/PhysRevA.44.1182; Seifert U, 1995, HDB BIOL PHYS, VI; Surovtsev IV, 2009, J THEOR BIOL, V260, P422, DOI 10.1016/j.jtbi.2009.06.001; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Thornton S, 2003, CLASSICAL DYNAMICS P; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Weiss P, 1962, MOLECULAR CONTROL CE, P1; Woldringh CL, 2010, BACTERIAL CHROMATIN, P71, DOI 10.1007/978-90-481-3473-1_5; Wu LJ, 2012, NAT REV MICROBIOL, V10, P8, DOI 10.1038/nrmicro2671	57	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e69750	10.1371/journal.pone.0069750	http://dx.doi.org/10.1371/journal.pone.0069750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990888	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100013
J	Ndondoki, C; Brou, H; Timite-Konan, M; Oga, M; Amani-Bosse, C; Menan, H; Ekouevi, D; Leroy, V				Ndondoki, Camille; Brou, Hermann; Timite-Konan, Marguerite; Oga, Maxime; Amani-Bosse, Clarisse; Menan, Herve; Ekouevi, Didier; Leroy, Valeriane			Universal HIV Screening at Postnatal Points of Care: Which Public Health Approach for Early Infant Diagnosis in Cote d'Ivoire?	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; ANTIRETROVIRAL THERAPY; INFECTION; PROGRAM; CHILDREN; ACCEPTABILITY; FACILITIES; MORTALITY; SERVICES; OUTCOMES	Background: Universal HIV pediatric screening offered at postnatal points of care (PPOC) is an entry point for early infant diagnosis (EID). We assessed the parents' acceptability of this approach in Abidjan, Cote d'Ivoire. Methods: In this cross-sectional study, trained counselors offered systematic HIV screening to all children aged 6-26 weeks attending PPOC in three community health centers with existing access to HAART during 2008, as well as their parents/ caregivers. HIV-testing acceptability was measured for parents and children; rapid HIV tests were used for parents. Both parents' consent was required according to the Ivorian Ethical Committee to perform a HIV test on HIV-exposed children. Free HIV care was offered to those who were diagnosed HIV-infected. Findings: We provided 3,013 HIV tests for infants and their 2,986 mothers. While 1,731 mothers (58%) accepted the principle of EID, only 447 infants had formal parental consent 15%; 95% confidence interval (CI): [14%-16%]. Overall, 1,817 mothers (61%) accepted to test for HIV, of whom 81 were HIV-infected (4.5%; 95% CI: [3.5%-5.4%]). Among the 81 HIV-exposed children, 42 (52%) had provided parental consent and were tested: five were HIV-infected (11.9%; 95% CI: [2.1%-21.7%]). Only 46 fathers (2%) came to diagnose their child. Parental acceptance of EID was strongly correlated with prenatal self-reported HIV status: HIV-infected mothers were six times more likely to provide EID parental acceptance than mothers reporting unknown or negative prenatal HIV status (aOR: 5.9; 95% CI: [3.3-10.6], p = 0.0001). Conclusions: Although the principle of EID was moderately accepted by mothers, fathers' acceptance rate remained very low. Routine HIV screening of all infants was inefficient for EID at a community level in Abidjan in 2008. Our results suggest the need of focusing on increasing the PMTCT coverage, involving fathers and tracing children issued from PMTCT programs in low HIV prevalence countries.	[Ndondoki, Camille; Ekouevi, Didier; Leroy, Valeriane] Univ Bordeaux Victor Segalen, INSERM, ISPED, Ctr Rech Epidemiol & Biostat,U897, Bordeaux, France; [Brou, Hermann; Timite-Konan, Marguerite; Oga, Maxime; Amani-Bosse, Clarisse; Menan, Herve; Ekouevi, Didier] Projet Pedi Test ANRS 12165, Programme PACCI, Abidjan, Cote Ivoire; [Timite-Konan, Marguerite] CHU Yopougon, Serv Pediat, Abidjan, Cote Ivoire; [Menan, Herve] Lab Virol CeDRes, Abidjan, Cote Ivoire	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Leroy, V (corresponding author), Univ Bordeaux Victor Segalen, INSERM, ISPED, Ctr Rech Epidemiol & Biostat,U897, Bordeaux, France.	Valeriane.Leroy@isped.u-bordeaux2.fr	Leroy, Valeriane/AAO-5175-2020; Leroy, Valeriane/F-8129-2013; EKOUEVI, Didier K/E-7960-2014; Leroy, Valeriane/GQB-1102-2022	Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616	French Agence Nationale de Recherches sur le Sida et les Hepatites virales (ANRS) [12165]	French Agence Nationale de Recherches sur le Sida et les Hepatites virales (ANRS)(ANRSFrench National Research Agency (ANR))	The primary sponsor of the PEDITEST ANRS 12165 Study was the French Agence Nationale de Recherches sur le Sida et les Hepatites virales (ANRS). CN is doctoral fellow of the French charity SIDACTION. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaky MF, 2010, B WORLD HEALTH ORGAN, V88, P490, DOI 10.2471/BLT.09.068015; [Anonymous], 2010, CHILDR AIDS 5 STOCKT, P52; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Braun M, 2011, J ACQUIR IMMUNE DEFI; Braun M, 2009, MAL 5 IAS C HIV PATH; Braun M, 2011, JAIDS-J ACQ IMM DEF, V56, pE122, DOI 10.1097/QAI.0b013e31820a7f2f; Brou H, 2007, PLOS MED, V4, P1912, DOI 10.1371/journal.pmed.0040342; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Desgrees-du-Lou A, 2002, AIDS BEHAV; Dow A, 2009, MAL 5 IAS C HIV PATH; Dube Q, 2012, B WORLD HEALTH ORGAN, V90, P699, DOI 10.2471/BLT.11.100776; Eisenhut M, 2009, INT J STD AIDS, V20, P506, DOI 10.1258/ijsa.2008.008506; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2007, COUNTR SIT AN; Kankasa C, 2009, JAIDS-J ACQ IMM DEF, V51, P202, DOI 10.1097/QAI.0b013e31819c173f; Kellerman S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000285; Lofgren SM, 2009, AIDS, V23, P2459, DOI 10.1097/QAD.0b013e328331f702; McCollum ED, 2012, SUPERIOR UPTAKE OUTC; Menzies NA, 2009, PEDIATR INFECT DIS J, V28, P819, DOI 10.1097/INF.0b013e3181a3954b; Ministere de Lutte contre le SIDA, 2007, ENQ IND SID COT IV; Ministere de Lutte contre le SIDA, 2007, ENQ IND SID COT IV; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nuwagaba-Biribonwoha H, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-44; Oga M, 2009, ATTITUDES PRACTICES; Oga MA, 2011, JAIDS-J ACQ IMM DEF, V57, pS16, DOI 10.1097/QAI.0b013e31821fd487; Penazzato M, 2009, WHAT IS AVAILABLE EA; PEPFAR, 2007, US PRES EM PLAN AIDS; Perez F, 2006, JAIDS-J ACQ IMM DEF, V41, P514, DOI 10.1097/01.qai.0000191285.70331.a0; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Stringer EM, 2010, JAMA-J AM MED ASSOC, V304, P293, DOI 10.1001/jama.2010.990; Tejiokem MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021840; UNAIDS, 2011, WORLD REF DAY 2019 H; *UNAIDS WHO, 2009, 2009 AIDS EP UPD; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wanyenze RK, 2010, TROP MED INT HEALTH, V15, P113, DOI 10.1111/j.1365-3156.2009.02417.x; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization, 2010, ANT THER HIV INF INF; World Health Organization (WHO), 2008, REP WHO TECHN REF GR; Yesiga-Tumushabe J, 2009, 5 IAS C HIV PATH TRE	40	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e67996	10.1371/journal.pone.0067996	http://dx.doi.org/10.1371/journal.pone.0067996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990870	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100002
J	Hsiao, JHT; Fu, YH; Hill, AF; Halliday, GM; Kim, WS				Hsiao, Jen-Hsiang T.; Fu, YuHong; Hill, Andrew F.; Halliday, Glenda M.; Kim, Woojin Scott			Elevation in Sphingomyelin Synthase Activity Is Associated with Increases in Amyloid-Beta Peptide Generation	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; APOLIPOPROTEIN-E; COMMON VARIANTS; GAMMA-SECRETASE; IN-VITRO; CHOLESTEROL; METABOLISM; ACCUMULATION; CERAMIDE	A pathological hallmark of Alzheimer's disease (AD) is the presence of amyloid-beta peptide (A beta) plaques in the brain. A beta is derived from a sequential proteolysis of the transmenbrane amyloid precursor protein (APP), a process which is dependent on the distribution of lipids present in the plasma membrane. Sphingomyelin is a major membrane lipid, however its role in APP processing is unclear. Here, we assessed the expression of sphingomyelin synthase (SGMS1; the gene responsible for sphingomyelin synthesis) in human brain and found that it was significantly elevated in the hippocampus of AD brains, but not in the cerebellum. Secondly, we assessed the impact of altering SGMS activity on A beta generation. Inhibition of SGMS activity significantly reduced the level of A beta in a dose- and time dependent manner. The decrease in A beta level occurred without changes in APP expression or cell viability. These results when put together indicate that SGMS activity impacts on APP processing to produce A beta and it could be a contributing factor in A beta pathology associated with AD.	[Hsiao, Jen-Hsiang T.; Fu, YuHong; Halliday, Glenda M.; Kim, Woojin Scott] Neurosci Res Australia, Sydney, NSW, Australia; [Hill, Andrew F.] Univ Melbourne, Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Hill, Andrew F.] Mental Hlth Res Inst Victoria, Parkville, Vic, Australia; [Halliday, Glenda M.; Kim, Woojin Scott] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	Neuroscience Research Australia; University of Melbourne; University of New South Wales Sydney	Kim, WS (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	w.kim@unsw.edu.au	Halliday, Glenda M/E-8555-2011; Hill, Andrew F./AAH-2854-2020; Fu, YuHong/AAC-8160-2022; Fu, YuHong/O-6819-2014; Hill, Andrew F/B-4527-2009; Hill, Andrew F./GZL-4124-2022	Halliday, Glenda M/0000-0003-0422-8398; Hill, Andrew F/0000-0001-5581-2354; Hill, Andrew F./0000-0001-5581-2354	National Health and Medical Research Council of Australia (NHMRC); NHMRC; University of New South Wales; Neuroscience Research Australia; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism [NIAAA R24AA012725]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R28AA012725] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of New South Wales; Neuroscience Research Australia; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the National Health and Medical Research Council of Australia (NHMRC). GMH is a NHMRC Senior Principal Research Fellow. Brain tissues were received from the Sydney Brain Bank and from the New South Wales Tissue Resource Centre at the University of Sydney which are supported by the NHMRC, the University of New South Wales, Neuroscience Research Australia, Schizophrenia Research Institute and the National Institute of Alcohol Abuse and Alcoholism (NIAAA R24AA012725). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, NEUROBIOL AGING, V18, pS1, DOI [10.1016/S0197-4580(97)00057-2, DOI 10.1016/S0197-4580(97)00057-2.PUBMED:9330978]; Bales KR, 2000, NEUROBIOL AGING, V21, P427, DOI 10.1016/S0197-4580(00)00143-3; BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Chan SL, 2008, J NEUROCHEM, V106, P793, DOI 10.1111/j.1471-4159.2008.05433.x; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fabelo N, 2012, J NEUROPATH EXP NEUR, V71, P868, DOI 10.1097/NEN.0b013e31826be03c; Foley P, 2010, BBA-MOL CELL BIOL L, V1801, P750, DOI 10.1016/j.bbalip.2010.05.004; Glaros EN, 2005, J BIOL CHEM, V280, P24515, DOI 10.1074/jbc.M413862200; Gregory GC, 2006, NEUROBIOL AGING, V27, P387, DOI 10.1016/j.neurobiolaging.2005.03.011; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Hoetzl S, 2007, J NEUROCHEM, V103, P3, DOI 10.1111/j.1471-4159.2007.04721.x; Hojjati MR, 2006, J LIPID RES, V47, P673, DOI 10.1194/jlr.D500040-JLR200; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim WS, 2013, J NEUROSCI, V33, P4387, DOI 10.1523/JNEUROSCI.4165-12.2013; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Li HY, 2010, BBA-MOL CELL BIOL L, V1801, P887, DOI 10.1016/j.bbalip.2010.05.012; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nixon RA, 2004, AM J PATHOL, V164, P757, DOI 10.1016/S0002-9440(10)63163-X; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Tamboli IY, 2011, J NEUROSCI, V31, P1837, DOI 10.1523/JNEUROSCI.2954-10.2011; Tamboli IY, 2005, J BIOL CHEM, V280, P28110, DOI 10.1074/jbc.M414525200; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Ward RV, 2000, BIOCHEM J, V348, P137, DOI 10.1042/0264-6021:3480137; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Wing DR, 2001, ANAL BIOCHEM, V298, P207, DOI 10.1006/abio.2001.5393; Xu Q, 2004, J BIOL CHEM, V279, P25511, DOI 10.1074/jbc.M311256200	37	9	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e74016	10.1371/journal.pone.0074016	http://dx.doi.org/10.1371/journal.pone.0074016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977395	Green Published, gold			2022-12-25	WOS:000324527300111
J	Lin, RJ; He, JW; Chung, LY; Lee, JD; Wang, JJ; Yen, CM				Lin, Rong-Jyh; He, Jie-Wen; Chung, Li-Yu; Lee, June-Der; Wang, Jiun-Jye; Yen, Chuan-Min			Angiostrongylus cantonensis (Nematode: Metastrongiloidea): In Vitro Cultivation of Infective Third-Stage Larvae to Fourth-Stage Larvae	PLOS ONE			English	Article							AMINO-ACID-CONCENTRATIONS; CEREBROSPINAL-FLUID; INVITRO CULTIVATION; STAGE LARVAE; MENINGITIS	The present study to attempt to cultivate Angiostrongylus cantonensis from third-stage larvae (AcL3) to fourth-stage larvae (AcL4) in vitro in defined complete culture medium that contained with Minimum Essential Medium Eagle (MEM), supplemented amino acid (AA), amine (AM), fatty acid (FA), carbohydrate (CA) and 20% fetal calf serum (FCS) was successful. When AcL3 were cultured in the defined complete culture medium at 37 degrees C in a 5% CO2 atmosphere, the larvae began to develop to AcL4 after 30 days of cultivation, and were enclosed within the sheaths of the third molts of the life cycle. Under these conditions, the larvae developed uniformly and reached to the fourth-stage 36 days. The morphology of AcL3 develop to AcL4 were recording and analyzing. Then comparison of A. cantonensis larval morphology and development between in vitro cultivation in defined complete culture medium and in vivo cultivation in infective BALB/c mice. The larvae that had been cultivated in vitro were smaller than AcL4 of infective BALB/c mice. However the AcL3 that were cultured using defined incomplete culture medium (MEM plus 20% FCS with AA+AM, FA, CA, AA+AM+FA, FA+CA, CA+AA+AM or not) did not adequately survive and develop. Accordingly, the inference is made that only the defined complete medium enable AcL3 develop to AcL4 in vitro. Some nematodes have been successfully cultured into mature worms but only a few researches have been made to cultivate A. cantonensis in vitro. The present study is the first to have succeeded in developing AcL3 to AcL4 by in vitro cultivation. Finally, the results of in vitro cultivation studies herein contribute to improving media for the effective development and growth of A. cantonensis. The gap in the A. cantonensis life cycle when the larvae are cultivated in vitro from third-stage larvae to fourth-stage larvae can thus be solved.	[Lin, Rong-Jyh; He, Jie-Wen; Chung, Li-Yu; Lee, June-Der; Wang, Jiun-Jye; Yen, Chuan-Min] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Parasitol, Kaohsiung, Taiwan; [He, Jie-Wen; Yen, Chuan-Min] Kaohsiung Med Univ, Coll Med, Inst Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University	Yen, CM (corresponding author), Kaohsiung Med Univ, Coll Med, Sch Med, Dept Parasitol, Kaohsiung, Taiwan.	chmiye@kmu.edu.tw		, Lee/0000-0002-7105-0326; Yen, Chuan-Min/0000-0003-1306-6941; Lin lin, Rong-Jyh rong shi/0000-0001-9321-5278	National Science Council, Taiwan [NSC84-2331-B037-045]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council, Taiwan NSC84-2331-B037-045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALICATA J. E., 1965, Adv. Parasit., V3, P223, DOI 10.1016/S0065-308X(08)60366-8; ASH LR, 1970, J PARASITOL, V56, P249, DOI 10.2307/3277651; BHAIBULAYA M, 1975, INT J PARASITOL, V5, P7, DOI 10.1016/0020-7519(75)90091-0; Bisseru B., 1971, SE Asian J trop Med pub Hlth, V2, P523; Chye SM, 2004, CLIN CHEM, V50, P51, DOI 10.1373/clinchem.2003.020867; CORSTON RN, 1981, J NEUROL NEUROSUR PS, V44, P791, DOI 10.1136/jnnp.44.9.791; COURDURIER J, 1968, Bulletin de la Societe de Pathologie Exotique, V61, P254; Douvres FW, 1987, METHODS CULTIVATING, P318; Guilhon J, 1973, C R Acad Hebd Seances Acad Sci D, V676, P857; Hansen E. L., 1978, Methods of cultivating parasites in vitro., P227; HATA H, 1990, EXP PARASITOL, V70, P476, DOI 10.1016/0014-4894(90)90132-V; HATA H, 1993, J VET MED SCI, V55, P345, DOI 10.1292/jvms.55.345; HEIBLIM DI, 1978, ARCH NEUROL-CHICAGO, V35, P765, DOI 10.1001/archneur.1978.00500350069015; Hwang K P, 1991, Southeast Asian J Trop Med Public Health, V22 Suppl, P194; Klivenyi P, 1997, ACTA NEUROL SCAND, V95, P96, DOI 10.1111/j.1600-0404.1997.tb00076.x; LAMERS KJB, 1987, CLIN CHIM ACTA, V167, P135, DOI 10.1016/0009-8981(87)90366-4; Moreau JP, 1972, ANN PARASITOLOGIE, V47, P525; PAZZAGLI A, 1970, NEUROLOGY, V20, P783, DOI 10.1212/WNL.20.8.783; Shih PC, 2007, J HELMINTHOL, V81, P1, DOI 10.1017/S0022149X07182353; Taylor A. E. R., 1968, P377; Taylor AER, 1968, CULTIVATION PARASITE; UGA S, 1982, Japanese Journal of Parasitology, V31, P59; UGA S, 1983, J HELMINTHOL, V57, P297, DOI 10.1017/S0022149X00010981; Wang QP, 2012, EUR J CLIN MICROBIOL, V31, P389, DOI 10.1007/s10096-011-1328-5; WEINSTEIN P, 1963, AM J TROP MED HYG, V12, P358, DOI 10.4269/ajtmh.1963.12.358	25	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72084	10.1371/journal.pone.0072084	http://dx.doi.org/10.1371/journal.pone.0072084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977214	Green Submitted, Green Published, gold			2022-12-25	WOS:000324527300061
J	Mussil, B; Suspene, R; Aynaud, MM; Gauvrit, A; Vartanian, JP; Wain-Hobson, S				Mussil, Bianka; Suspene, Rodolphe; Aynaud, Marie-Ming; Gauvrit, Anne; Vartanian, Jean-Pierre; Wain-Hobson, Simon			Human APOBEC3A Isoforms Translocate to the Nucleus and Induce DNA Double Strand Breaks Leading to Cell Stress and Death	PLOS ONE			English	Article							HISTONE H2AX PHOSPHORYLATION; HUMAN-IMMUNODEFICIENCY-VIRUS; BASE EXCISION-REPAIR; BOX-BINDING PROTEIN; CYTIDINE DEAMINASES; POLY(ADP-RIBOSE) POLYMERASE; RETROVIRAL RESTRICTION; GENOMIC INSTABILITY; DAMAGE CHECKPOINT; GAMMA-H2AX FOCI	Human APOBEC3 enzymes deaminate single stranded DNA. At least five can deaminate mitochondrial DNA in the cytoplasm, while three can deaminate viral DNA in the nucleus. However, only one, APOBEC3A, can hypermutate genomic DNA. We analysed the distribution and function of the two APOBEC3A isoforms p1 and p2 in transfected cell lines. Both can translocate to the nucleus and hypermutate CMYC DNA and induce DNA double strand breaks as visualized by the detection of (c) H2AX or Chk2. APOBEC3A induced G1 phase cell cycle arrest and triggered several members of the intrinsic apoptosis pathway. Activation of purified human CD4+ T lymphocytes with PHA, IL2 and interferon a resulted in C-> T hypermutation of genomic DNA and double stranded breaks suggesting a role for APOBEC3A in pro-inflammatory conditions. As chronic inflammation underlies many diseases including numerous cancers, it is possible that APOBEC3A induction may generate many of the lesions typical of a cancer genome.	[Mussil, Bianka; Suspene, Rodolphe; Aynaud, Marie-Ming; Gauvrit, Anne; Vartanian, Jean-Pierre; Wain-Hobson, Simon] Inst Pasteur, Mol Retrovirol Unit, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wain-Hobson, S (corresponding author), Inst Pasteur, Mol Retrovirol Unit, Paris, France.	simon.wain-hobson@pasteur.fr		Vartanian, Jean-Pierre/0000-0001-8079-8814	La Ligue pour la Recherche contre le Cancer; Institut National pour la Recherche contre le cancer (INCa) [2009-1-PL BIO- 14-IP-1]	La Ligue pour la Recherche contre le Cancer; Institut National pour la Recherche contre le cancer (INCa)	This work was supported by grants from La Ligue pour la Recherche contre le Cancer and the Institut National pour la Recherche contre le cancer (INCa). The Molecular Retrovirology Unit is an "equipe labelisee de la Ligue pour la Recherche contre le Cancer". Funding for the open access charge was from Institut National pour la Recherche contre le cancer (INCa), 2009-1-PL BIO- 14-IP-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1999, ONCOGENE, V18, P5268, DOI 10.1038/sj.onc.1202997; Ahn JY, 2000, CANCER RES, V60, P5934; Argyris EG, 2007, VIROLOGY, V367, P440, DOI 10.1016/j.virol.2007.06.010; Aynaud MM, 2012, J BIOL CHEM, V287, P39182, DOI 10.1074/jbc.M112.372722; Bennett P, 2008, FREE RADICAL BIO MED, V45, P1352, DOI 10.1016/j.freeradbiomed.2008.08.007; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Biebricher CK, 2005, VIRUS RES, V107, P117, DOI 10.1016/j.virusres.2004.11.002; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bohr VA, 2005, MUTAT RES-FUND MOL M, V577, P252, DOI 10.1016/j.mrfmmm.2005.03.021; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cann KL, 2007, BIOCHEM CELL BIOL, V85, P663, DOI 10.1139/O07-135; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Chehab NH, 2000, GENE DEV, V14, P278; CHIANG SY, 1994, BIOCHEMISTRY-US, V33, P7033, DOI 10.1021/bi00189a003; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Coker HA, 2007, DNA REPAIR, V6, P235, DOI 10.1016/j.dnarep.2006.10.001; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Delker RK, 2009, NAT IMMUNOL, V10, P1147, DOI 10.1038/ni.1799; Deniaud E, 2006, ONCOGENE, V25, P7096, DOI 10.1038/sj.onc.1209696; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Garrod KR, 2012, CELL REP, V2, P1438, DOI 10.1016/j.celrep.2012.10.015; Gorbunova V, 2005, MECH AGEING DEV, V126, P621, DOI 10.1016/j.mad.2005.02.008; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Green DR, 2000, METHOD ENZYMOL, V322, P15; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Henry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030036; Henry M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004277; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; Imam SZ, 2006, NEUROBIOL AGING, V27, P1129, DOI 10.1016/j.neurobiolaging.2005.06.002; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Karlsson KH, 2004, RADIAT RES, V161, P517, DOI 10.1667/RR3171; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Katyal S, 2008, MECH AGEING DEV, V129, P483, DOI 10.1016/j.mad.2008.03.008; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Komatsu A, 2008, INT J ONCOL, V33, P261, DOI 10.3892/ijo_00000005; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kovalchuk AL, 2002, P NATL ACAD SCI USA, V99, P1509, DOI 10.1073/pnas.022643999; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Leatherbarrow EL, 2006, INT J RADIAT BIOL, V82, P111, DOI 10.1080/09553000600599783; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Love RP, 2012, J BIOL CHEM, V287, P30812, DOI 10.1074/jbc.M112.393181; Mahieux R, 2005, J GEN VIROL, V86, P2489, DOI 10.1099/vir.0.80973-0; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Nakamura AJ, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-6; Nakamura AJ, 2009, CELL CYCLE, V8, P2324, DOI 10.4161/cc.8.15.9311; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Okazaki Il-mi, 2007, Adv Immunol, V94, P245, DOI 10.1016/S0065-2776(06)94008-5; Okeoma CM, 2009, J VIROL, V83, P3486, DOI 10.1128/JVI.02347-08; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Ooms M, 2012, J VIROL, V86, P6097, DOI 10.1128/JVI.06570-11; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Petit V, 2009, PHILOS T R SOC B, V364, P705, DOI 10.1098/rstb.2008.0272; Pillai SK, 2012, P NATL ACAD SCI USA, V109, P3035, DOI 10.1073/pnas.1111573109; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sanchez-Martinez S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038190; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Sedelnikova OA, 2006, CELL CYCLE, V5, P2909, DOI 10.4161/cc.5.24.3569; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shinohara M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00806; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Suspene R, 2013, EFFICIENT D IN PRESS; Suspene R, 2011, J VIROL, V85, P7594, DOI 10.1128/JVI.00290-11; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Tanaka T, 2007, CELL CYCLE, V6, P371, DOI 10.4161/cc.6.3.3835; Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V341, P314, DOI 10.1016/j.bbrc.2005.12.192; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; Turelli P, 2008, J VIROL, V82, P6585, DOI 10.1128/JVI.00216-08; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Wang FX, 2008, J GEN VIROL, V89, P722, DOI 10.1099/vir.0.83530-0; WANG ZG, 1988, J BACTERIOL, V170, P1082, DOI 10.1128/jb.170.3.1082-1091.1988; Warters RL, 2005, J INVEST DERMATOL, V124, P807, DOI 10.1111/j.0022-202X.2005.23674.x; Wijesinghe P, 2012, NUCLEIC ACIDS RES, V40, P9206, DOI 10.1093/nar/gks685; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Yang N, 2004, DNA REPAIR, V3, P1323, DOI 10.1016/j.dnarep.2004.04.014; Yu T, 2006, DNA REPAIR, V5, P935, DOI 10.1016/j.dnarep.2006.05.040; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang P, 2010, ACTA BIOCH BIOPH SIN, V42, P440, DOI 10.1093/abbs/gmq040; Zhang TW, 2013, HUM MOL GENET, V22, P1262, DOI 10.1093/hmg/dds513; Zhang XB, 1999, ARCH PATHOL LAB MED, V123, P921; Zhang XB, 1998, BIOCHEM BIOPH RES CO, V248, P18, DOI 10.1006/bbrc.1998.8906; Zhang XB, 1997, ANN CLIN LAB SCI, V27, P260; Zuba-Surma EK, 2007, FOLIA HISTOCHEM CYTO, V45, P279	121	60	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e73641	10.1371/journal.pone.0073641	http://dx.doi.org/10.1371/journal.pone.0073641			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977391	Green Submitted, Green Published, gold			2022-12-25	WOS:000324527300110
J	McMahan, CD; Chakrabarty, P; Sparks, JS; Smith, WL; Davis, MP				McMahan, Caleb D.; Chakrabarty, Prosanta; Sparks, John S.; Smith, Wm. Leo; Davis, Matthew P.			Temporal Patterns of Diversification across Global Cichlid Biodiversity (Acanthomorpha: Cichlidae)	PLOS ONE			English	Article							PERCIFORMES CICHLIDAE; ADAPTIVE RADIATION; LUMBRERA FORMATION; LAKE VICTORIA; EVOLUTION; BIOGEOGRAPHY; PHYLOGENY; AFRICAN; TELEOSTEI; EOCENE	The contrasting distribution of species diversity across the major lineages of cichlids makes them an ideal group for investigating macroevolutionary processes. In this study, we investigate whether different rates of diversification may explain the disparity in species richness across cichlid lineages globally. We present the most taxonomically robust time-calibrated hypothesis of cichlid evolutionary relationships to date. We then utilize this temporal framework to investigate whether both species-rich and depauperate lineages are associated with rapid shifts in diversification rates and if exceptional species richness can be explained by clade age alone. A single significant rapid rate shift increase is detected within the evolutionary history of the African subfamily Pseudocrenilabrinae, which includes the haplochromins of the East African Great Lakes. Several lineages from the subfamilies Pseudocrenilabrinae (Australotilapiini, Oreochromini) and Cichlinae (Heroini) exhibit exceptional species richness given their clade age, a net rate of diversification, and relative rates of extinction, indicating that clade age alone is not a sufficient explanation for their increased diversity. Our results indicate that the Neotropical Cichlinae includes lineages that have not experienced a significant rapid burst in diversification when compared to certain African lineages (rift lake). Neotropical cichlids have remained comparatively understudied with regard to macroevolutionary patterns relative to African lineages, and our results indicate that of Neotropical lineages, the tribe Heroini may have an elevated rate of diversification in contrast to other Neotropical cichlids. These findings provide insight into our understanding of the diversification patterns across taxonomically disparate lineages in this diverse clade of freshwater fishes and one of the most species-rich families of vertebrates.	[McMahan, Caleb D.; Chakrabarty, Prosanta] Louisiana State Univ, Dept Biol Sci, LSU Museum Nat Sci Ichthyol, Baton Rouge, LA 70803 USA; [Sparks, John S.] Amer Museum Nat Hist, Dept Ichthyol, Div Vertebrate Zool, New York, NY 10024 USA; [Smith, Wm. Leo; Davis, Matthew P.] Field Museum, Div Fishes, Chicago, IL USA	Louisiana State University System; Louisiana State University; American Museum of Natural History (AMNH); Field Museum of Natural History (Chicago)	McMahan, CD (corresponding author), Louisiana State Univ, Dept Biol Sci, LSU Museum Nat Sci Ichthyol, Baton Rouge, LA 70803 USA.	cmcmah2@lsu.edu	Chakrabarty, Prosanta/E-3307-2010		NSF [DEB 0716155, DEB 0732642, DEB 1060869, DEB 0910081, DEB 0916695, DEB 1258141, DEB 1311408, IOS 0749943]; Direct For Biological Sciences [0749943] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF grants DEB 0716155, DEB 0732642, and DEB 1060869 to WLS, DEB 0910081 to MPD, DEB 0916695 to PC, DEB 1258141 to MPD and WLS, DEB 1311408 to CDM, and IOS 0749943 to JSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Arratia Gloria, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P9; Azuma Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-215; Chakrabarty P, 2005, COPEIA, P359, DOI 10.1643/CG-04-089R2; Chakrabarty P, 2004, FISH FISH, V5, P97, DOI 10.1111/j.1467-2979.2004.00148.x; Clabaut C, 2007, EVOLUTION, V61, P560, DOI 10.1111/j.1558-5646.2007.00045.x; Day JJ, 2013, SYST BIOL, V62, P351, DOI 10.1093/sysbio/syt001; Day JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001730; Deutsch JC, 1997, BIOL J LINN SOC, V62, P1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eschmeyer WN, 2012, CATALOG FISHES; Farias IP, 2000, J EXP ZOOL, V288, P76, DOI 10.1002/(SICI)1097-010X(20000415)288:1&lt;76::AID-JEZ8&gt;3.0.CO;2-P; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hulsey CD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-279; Kaiser TM, 2006, Z DEUT GESELLS GEOWI, V157, P99; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kullander S.O., 2003, CHECK LIST FRESHWATE, P605; Loh YHE, 2013, MOL BIOL EVOL, V30, P906, DOI 10.1093/molbev/mss326; Lopez-Fernandez H, 2005, MOL PHYLOGENET EVOL, V34, P227, DOI 10.1016/j.ympev.2004.09.004; Lopez-Fernandez H, 2013, EVOLUTION, V67, P1321, DOI 10.1111/evo.12038; Lopez-Fernandez H, 2010, MOL PHYLOGENET EVOL, V55, P1070, DOI 10.1016/j.ympev.2010.02.020; Maddison WP, 2009, MESQUITE MODULAR SYS; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Malabarba MC, 2006, J VERTEBR PALEONTOL, V26, P267, DOI 10.1671/0272-4634(2006)26[267:PAANFC]2.0.CO;2; Malabarba MC, 2010, J VERTEBR PALEONTOL, V30, P341, DOI 10.1080/02724631003618348; Miya M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-58; Moyle RG, 2009, P NATL ACAD SCI USA, V106, P1863, DOI 10.1073/pnas.0809861105; Murray AM, 2001, BIOL J LINN SOC, V74, P517, DOI 10.1006/bijl.2001.0599; Muschick M, 2012, CURR BIOL, V22, P2362, DOI 10.1016/j.cub.2012.10.048; Nelson JS, 1984, FISHES WORLD; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perez PA, 2010, NEOTROP ICHTHYOL, V8, P631, DOI 10.1590/S1679-62252010000300008; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rabosky Daniel L., 2006, Evolutionary Bioinformatics Online, V2, P257; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; Rambaut A, 2010, TRACER V1 4; Ruber L, 2001, J EVOLUTION BIOL, V14, P325, DOI 10.1046/j.1420-9101.2001.00269.x; Salzburger W, 2002, SYST BIOL, V51, P113, DOI 10.1080/106351502753475907; Salzburger W, 2004, NATURWISSENSCHAFTEN, V91, P277, DOI 10.1007/s00114-004-0528-6; Schwarzer J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-186; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2002, P ROY SOC B-BIOL SCI, V269, P491, DOI 10.1098/rspb.2001.1906; Seehausen O, 2004, P ROY SOC B-BIOL SCI, V271, P1345, DOI 10.1098/rspb.2004.2737; Smith WL, 2008, CLADISTICS, V24, P625, DOI 10.1111/j.1096-0031.2008.00210.x; Sparks JS, 2008, B AM MUS NAT HIST, P5; Sparks JS, 2004, CLADISTICS, V20, P501, DOI 10.1111/j.1096-0031.2004.00038.x; Stiassny M.L.J., 1991, CICHLID FISHES BEHAV, P1; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060	52	61	62	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71162	10.1371/journal.pone.0071162	http://dx.doi.org/10.1371/journal.pone.0071162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990936	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700025
J	Davis, D; Koornstra, W; Fagrouch, Z; Verschoor, EJ; Heeney, JL; Bogers, WMJM				Davis, David; Koornstra, Wim; Fagrouch, Zahra; Verschoor, Ernst J.; Heeney, Jonathan L.; Bogers, Willy M. J. M.			In Vitro Neutralization of Low Dose Inocula at Physiological Concentrations of a Monoclonal Antibody Which Protects Macaques against SHIV Challenge	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; EXTENDED INCUBATION PHASES; T-CELL-LINE; RHESUS MACAQUES; MUCOSAL TRANSMISSION; CORECEPTOR USAGE; HIV-1SF2 GP120; SIMIAN AIDS; ENVELOPE; HIV	Background: Passive transfer of antibodies can be protective in the simian human immunodeficiency virus (SHIV) - rhesus macaque challenge model. The human monoclonal antibody IgG1 b12 neutralizes human immunodeficiency type 1 (HIV-1) in vitro and protects against challenge by SHIV. Our hypothesis is that neutralizing antibodies can only completely inactivate a relatively small number of infectious virus. Methods And Findings: We have used GHOST cell assays to quantify individual infectious events with HIV-1(SF162) and its SHIV derivatives: the relatively neutralization sensitive SHIVSF162P4 isolate and the more resistant SHIVSF162P3. A plot of the number of fluorescent GHOST cells with increasing HIV-1(SF162) dose is not linear. It is likely that with high-dose inocula, infection with multiple virus produces additive fluorescence in individual cells. In studies of the neutralization kinetics of IgG1 b12 against these isolates, events during the absorption phase of the assay, as well as the incubation phase, determine the level of neutralization. It is possible that complete inactivation of a virus is limited to the time it is exposed on the cell surface. Assays can be modified so that neutralization of these very low doses of virus can be quantified. A higher concentration of antibody is required to neutralize the same dose of resistant SHIVSF162P3 than the sensitive SHIVSF162P4. In the absence of selection during passage, the density of the CCR5 co-receptor on the GHOST cell surface is reduced. Changes in the CD4 : CCR5 density ratio influence neutralization. Conclusions: Low concentrations of IgG1 b12 completely inactivate small doses of the neutralization resistant SHIVSF162P3. Assays need to be modified to quantify this effect. Results from modified assays may predict protection following repeated low-dose shiv challenges in rhesus macaques. It should be possible to induce this level of antibody by vaccination so that modified assays could predict the outcome of human trials.	[Davis, David; Koornstra, Wim; Fagrouch, Zahra; Verschoor, Ernst J.; Heeney, Jonathan L.; Bogers, Willy M. J. M.] Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands; [Heeney, Jonathan L.] Univ Cambridge, Lab Viral Zoonot, Cambridge, England	University of Cambridge	Davis, D (corresponding author), Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands.	davis@bprc.nl		Heeney, Jonathan/0000-0003-2702-1621	Dutch Government; European Commission [012168, 012183]	Dutch Government; European Commission(European CommissionEuropean Commission Joint Research Centre)	Research was supported by the Dutch Government and grants from the European Commission: Sixth Framework Programme Lifescihealth-3 Specific Targeted Research Projects 012168 and 012183. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balfe P, 2004, VIROLOGY, V318, P267, DOI 10.1016/j.virol.2003.09.022; Barnett SW, 2010, J VIROL, V84, P5975, DOI 10.1128/JVI.02533-09; Barnetta SW, 2008, AIDS, V22, P339, DOI 10.1097/QAD.0b013e3282f3ca57; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bogers WMJM, 2008, VIROLOGY, V382, P217, DOI 10.1016/j.virol.2008.09.016; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Cecilia D, 1998, J VIROL, V72, P6988, DOI 10.1128/JVI.72.9.6988-6996.1998; CHENGMAYER C, 1988, ANN NEUROL, V23, pS58, DOI 10.1002/ana.410230716; CHENGMAYER C, 1988, P NATL ACAD SCI USA, V85, P2815, DOI 10.1073/pnas.85.8.2815; CHENGMAYER C, 1989, P NATL ACAD SCI USA, V86, P8575, DOI 10.1073/pnas.86.21.8575; Cherpelis S, 2001, IMMUNOL LETT, V79, P47, DOI 10.1016/S0165-2478(01)00265-6; Davis D, 2006, J MED VIROL, V78, P864, DOI 10.1002/jmv.20635; Davis D, 2004, VACCINE, V22, P747, DOI 10.1016/j.vaccine.2003.08.031; Davis D, 2003, J MED VIROL, V71, P332, DOI 10.1002/jmv.10490; Davis D, 2001, J MED VIROL, V64, P207, DOI 10.1002/jmv.1038; Davis D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028974; DeVico A, 2007, P NATL ACAD SCI USA, V104, P17477, DOI 10.1073/pnas.0707399104; Donners H, 2003, VACCINE, V22, P104, DOI 10.1016/S0264-410X(03)00530-9; Donners H, 2003, J MED VIROL, V69, P173, DOI 10.1002/jmv.10288; Ellenberger D, 2006, VIROLOGY, V352, P216, DOI 10.1016/j.virol.2006.04.005; Haigwood NL, 2004, AIDS REV, V6, P187; Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Ho SH, 2007, J VIROL, V81, P8621, DOI 10.1128/JVI.00759-07; Hsu M, 2005, JAIDS-J ACQ IMM DEF, V40, P383, DOI 10.1097/01.qai.0000184857.39318.4f; Hsu M, 2003, J MED PRIMATOL, V32, P211, DOI 10.1034/j.1600-0684.2003.00027.x; Hsu M, 2003, J VIROL, V77, P989, DOI 10.1128/JVI.77.2.989-998.2003; KLIKS SC, 1993, P NATL ACAD SCI USA, V90, P11518, DOI 10.1073/pnas.90.24.11518; Kraft Z, 2007, J VIROL, V81, P6402, DOI 10.1128/JVI.00424-07; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Leutenegger CM, 2001, AIDS RES HUM RETROV, V17, P243, DOI 10.1089/088922201750063160; LUCIW PA, 1995, P NATL ACAD SCI USA, V92, P7490, DOI 10.1073/pnas.92.16.7490; Mascola JR, 2003, J VIROL, V77, P10348, DOI 10.1128/JVI.77.19.10348-10356.2003; Mascola JR, 2003, CURR MOL MED, V3, P209, DOI 10.2174/1566524033479799; Moldt B, 2012, J VIROL, V86, P6189, DOI 10.1128/JVI.00491-12; Morner A, 1999, J VIROL, V73, P2343; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Polacino P, 2008, J MED PRIMATOL, V37, P13, DOI 10.1111/j.1600-0684.2008.00325.x; Robbins J B, 1996, Adv Exp Med Biol, V397, P169; Ruprecht Ruth M., 2009, V525, P559, DOI 10.1007/978-1-59745-554-1_31; Shedlock DJ, 2009, NAT REV IMMUNOL, V9, P717, DOI 10.1038/nri2636; SHIODA T, 1992, P NATL ACAD SCI USA, V89, P9434, DOI 10.1073/pnas.89.20.9434; Stamatatos L, 2000, AIDS RES HUM RETROV, V16, P981, DOI 10.1089/08892220050058407; Stamatatos L, 1998, J VIROL, V72, P7840, DOI 10.1128/JVI.72.10.7840-7845.1998; Tan RCH, 1999, J MED PRIMATOL, V28, P164, DOI 10.1111/j.1600-0684.1999.tb00265.x; Tsai L, 2007, VIROLOGY, V362, P207, DOI 10.1016/j.virol.2006.12.024; VANDERGRIEND RJ, 1985, BLOOD, V65, P1002; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xu R, 2006, AIDS RES HUM RETROV, V22, P1022, DOI 10.1089/aid.2006.22.1022; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	56	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72702	10.1371/journal.pone.0072702	http://dx.doi.org/10.1371/journal.pone.0072702			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977339	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200078
J	Fan, LX; Liu, GB; Wang, F; Geissen, V; Ritsema, CJ				Fan, Liangxin; Liu, Guobin; Wang, Fei; Geissen, Violette; Ritsema, Coen J.			Factors Affecting Domestic Water Consumption in Rural Households upon Access to Improved Water Supply: Insights from the Wei River Basin, China	PLOS ONE			English	Article							PATH-COEFFICIENT ANALYSIS; DEVELOPING-COUNTRIES; SENSITIVITY-ANALYSIS; USE PATTERNS; BEHAVIOR; STORAGE; HOME	Comprehensively understanding water consumption behavior is necessary to design efficient and effective water use strategies. Despite global efforts to identify the factors that affect domestic water consumption, those related to domestic water use in rural regions have not been sufficiently studied, particularly in villages that have gained access to improved water supply. To address this gap, we investigated 247 households in eight villages in the Wei River Basin where three types of improved water supply systems are implemented. Results show that domestic water consumption in liters per capita per day was significantly correlated with water supply pattern and vegetable garden area, and significantly negatively correlated with family size and age of household head. Traditional hygiene habits, use of water appliances, and preference for vegetable gardening remain dominant behaviors in the villages with access to improved water supply. Future studies on rural domestic water consumption should pay more attention to user lifestyles (water appliance usage habits, outdoor water use) and cultural backgrounds (age, education).	[Fan, Liangxin; Liu, Guobin; Wang, Fei] Northwest A&F Univ, Coll Nat Resources & Environm, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China; [Fan, Liangxin] Henan Polytech Univ, Sch Surveying & Land Informat Engn, Jiaozuo, Peoples R China; [Liu, Guobin; Wang, Fei] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Peoples R China; [Liu, Guobin; Wang, Fei] Minist Educ, Yangling, Peoples R China; [Geissen, Violette; Ritsema, Coen J.] Univ Wageningen & Res Ctr, Soil Sci Ctr, Alterra, Wageningen, Netherlands	Northwest A&F University - China; Henan Polytechnic University; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Wageningen University & Research	Liu, GB (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China.	gbliu@ms.iswc.ac.cn	/J-8497-2013	/0000-0002-5213-4399	External Cooperation Program of the Chinese Academy of Sciences [GJHZ1018]; Netherlands Organization for Scientific Research (NWO) [OND1339291]; National Sciences Foundation of China Project [41201566]	External Cooperation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Sciences Foundation of China Project	Funding for this work included China-Netherlands Joint Scientific Thematic Research Programme (JSTP) supported by the External Cooperation Program of the Chinese Academy of Sciences (GJHZ1018) and Netherlands Organization for Scientific Research (NWO, OND1339291); the National Sciences Foundation of China Project (No. 41201566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkemik KA, 2012, ENERG ECON, V34, P865, DOI 10.1016/j.eneco.2012.04.002; Andey SP, 2009, WATER RESOUR MANAG, V23, P2555, DOI 10.1007/s11269-008-9396-8; Arbues F., 2003, J SOC EC, V32, P81, DOI 10.1016/S1053-5357(03)00005-2; Arouna A, 2010, WATER RESOUR MANAG, V24, P1381, DOI 10.1007/s11269-009-9504-4; Avants SK, 2000, J SUBST ABUSE, V11, P215, DOI 10.1016/S0899-3289(00)00022-5; Campbell H.E., 2004, REV POLICY RES, V21, P637, DOI [10.1111/j.1541-1338.2004.00099.x, DOI 10.1111/J.1541-1338.2004.00099.X]; Chadha M.L., 2003, FOOD NUTR AGR, V32, P17; Chu-Agor ML, 2012, ECOL MODEL, V224, P33, DOI 10.1016/j.ecolmodel.2011.10.021; Collins J, 2003, CARROTS STICKS SERMO; Corral-Verdugo V, 2002, ENVIRON MANAGE, V30, P527, DOI 10.1007/s00267-002-2599-5; Fan LX, 2013, RESOUR CONSERV RECY, V74, P45, DOI 10.1016/j.resconrec.2013.02.017; Gazzinelli, 1998, Cad Saude Publica, V14, P265, DOI 10.1590/S0102-311X1998000200011; Gregory GD, 2003, J APPL SOC PSYCHOL, V33, P1261, DOI 10.1111/j.1559-1816.2003.tb01949.x; Gu MX, 2009, J WATER RESOUR WATER, V20, P153; Guler M, 2001, EUR J AGRON, V14, P161, DOI 10.1016/S1161-0301(00)00086-1; Jacob GA, 2013, J BEHAV THER EXP PSY, V44, P61, DOI 10.1016/j.jbtep.2012.07.006; Jorgensen B, 2009, J ENVIRON MANAGE, V91, P227, DOI 10.1016/j.jenvman.2009.08.009; Keshavarzi AR, 2006, WATER RES, V40, P1173, DOI 10.1016/j.watres.2006.01.021; Korkut ZKI, 1993, S DUR WHEAT ITS PROD; Krantz H., 2005, THESIS LINKOPING U S; Lockie S, 2004, APPETITE, V43, P135, DOI 10.1016/j.appet.2004.02.004; Loh M., 2003, DOMESTIC WATER USE S; Machingambi M, 2003, PHYS CHEM EARTH, V28, P1039, DOI 10.1016/j.pce.2003.08.045; Makoni FS, 2004, PHYS CHEM EARTH, V29, P1291, DOI 10.1016/j.pce.2004.09.013; Martin N, 1999, POPULATION HOUSEHOLD; Martinez-Espineira R, 2004, APPL ECON, V36, P1697, DOI 10.1080/0003684042000218570; Mendola M, 2012, J INT DEV, V24, P102, DOI 10.1002/jid.1684; MINTZ ED, 1995, JAMA-J AM MED ASSOC, V273, P948, DOI 10.1001/jama.273.12.948; MWRC (The Ministry of Water Resources of China), 2012, SAF DRINK WAT; NBSC (National Bureau of Statistics of China), 2012, STAT YB CHIN; Nyong AO, 2001, J ARID ENVIRON, V49, P387, DOI 10.1006/jare.2000.0736; Qiao Z, 2009, ECON LETT, V102, P161, DOI 10.1016/j.econlet.2008.12.010; Renwick ME, 2000, J ENVIRON ECON MANAG, V40, P37, DOI 10.1006/jeem.1999.1102; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Saltelli A., 2004, SENSITIVITY ANAL PRA, V1, DOI 10.1002/0470870958; Shen Dajun, 2006, ACCESS WATER SANITAT; Shove E, 2010, ESRC EC SOC RES COUN; Sobsey MD, 2003, WATER SCI TECHNOL, V47, P221, DOI 10.2166/wst.2003.0199; Syme GJ, 2004, LANDSCAPE URBAN PLAN, V68, P121, DOI 10.1016/j.landurbplan.2003.08.002; UNDP, 2012, MILL DEV GOALS REP; Vairavamoorthy K, 2008, PHYS CHEM EARTH, V33, P330, DOI 10.1016/j.pce.2008.02.008; Wardell JD, 2012, ADDICT BEHAV, V37, P435, DOI 10.1016/j.addbeh.2011.12.004; WHO UNICEF, 2012, PROGR DRINK WAT SAN; Woods PSA, 2003, PREV VET MED, V61, P339, DOI 10.1016/S0167-5877(03)00162-4; World Bank (WB), 2012, WORLD DEV IND; Yu SW, 2012, ENERG CONVERS MANAGE, V53, P142, DOI 10.1016/j.enconman.2011.08.015; [张文洲 Zhang Wenzhou], 2005, [水资源与水工程学报, Journal of Water Resources and Water Engineering], V16, P75	47	40	40	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71977	10.1371/journal.pone.0071977	http://dx.doi.org/10.1371/journal.pone.0071977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	207BA	23977190	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200050
J	Zhang, ZR; Chu, WF; Song, BL; Gooz, M; Zhang, JN; Yu, CJ; Jiang, S; Baldys, A; Gooz, P; Steele, S; Owsianik, G; Nilius, B; Komlosi, P; Bell, PD				Zhang, Zhi-Ren; Chu, Wen-Feng; Song, Binlin; Gooz, Monika; Zhang, Jia-Ning; Yu, Chang-Jiang; Jiang, Shuai; Baldys, Aleksander; Gooz, Pal; Steele, Stacy; Owsianik, Grzegorz; Nilius, Bernd; Komlosi, Peter; Bell, P. Darwin			TRPP2 and TRPV4 Form an EGF-Activated Calcium Permeable Channel at the Apical Membrane of Renal Collecting Duct Cells	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; GROWTH-FACTOR RECEPTOR; CATION CHANNEL; MUTANT MICE; PKD2; INHIBITION; PERMEATION; RESTORES; GENE; CAT1	Objective: Regulation of apical calcium entry is important for the function of principal cells of the collecting duct. However, the molecular identity and the regulators of the transporter/channel, which is responsible for apical calcium entry and what factors regulate the calcium conduction remain unclear. Methods and Results: We report that endogenous TRPP2 and TRPV4 assemble to form a 23-pS divalent cation-permeable non-selective ion channel at the apical membrane of renal principal cells of the collecting duct. TRPP2\TRPV4 channel complex was identified by patch-clamp, immunofluorescence and co-immunprecipitation studies in both principal cells that either possess normal cilia (cilia (+)) or in which cilia are absent (cilia (-)). This channel has distinct biophysical and pharmacological and regulatory profiles compared to either TRPP2 or TRPV4 channels. The rate of occurrence detected by patch clamp was higher in cilia (-) compared to cilia (+) cells. In addition, shRNA knockdown of TRPP2 increased the prevalence of TRPV4 channel activity while knockdown of TRPV4 resulted in TRPP2 activity and knockdown of both proteins vastly decreased the 23-pS channel activity. Epidermal growth factor (EGF) stimulated TRPP2\TRPV4 channel through the EGF receptor (EGFR) tyrosine kinase-dependent signaling. With loss of cilia, apical EGF treatment resulted in 64-fold increase in channel activity in cilia (-) but not cilia (+) cells. In addition EGF increased cell proliferation in cilia (-) cell that was dependent upon TRPP2\TRPV4 channel mediated increase in intracellular calcium. Conclusion: We conclude that in the absence of cilia, an EGF activated TRPP2\TRPV4 channel may play an important role in increased cell proliferation and cystogenesis.	[Bell, P. Darwin] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA; [Zhang, Zhi-Ren; Chu, Wen-Feng; Song, Binlin; Gooz, Monika; Baldys, Aleksander; Gooz, Pal; Steele, Stacy; Komlosi, Peter; Bell, P. Darwin] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Zhang, Zhi-Ren; Chu, Wen-Feng; Song, Binlin; Zhang, Jia-Ning; Yu, Chang-Jiang; Jiang, Shuai] Harbin Med Univ, Educ Minist Myocardial Ischemia & Treatment, Affiliated Hosp 2, Dept Pharm,Key Labs,Dept Pharmacol, Harbin, Peoples R China; [Zhang, Zhi-Ren; Chu, Wen-Feng; Song, Binlin; Zhang, Jia-Ning; Yu, Chang-Jiang; Jiang, Shuai] Harbin Med Univ, Educ Minist Myocardial Ischemia & Treatment, Affiliated Hosp 2, Dept Cardiol,Key Labs,Dept Pharmacol, Harbin, Peoples R China; [Owsianik, Grzegorz; Nilius, Bernd] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Ion Channel Res, Louvain, Belgium	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Harbin Medical University; Harbin Medical University; KU Leuven	Zhang, ZR (corresponding author), Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA.	zhirenz@yahoo.com; Bellpd@musc.edu	Yu, Changjiang/AAJ-9219-2021; Komlosi, Peter/H-5475-2019; Yu, Changjiang/N-2467-2019	Komlosi, Peter/0000-0002-5284-8877; Jiang, Shuai/0000-0003-1235-6269	Key Project of Chinese National Program for Fundamental Research and Development (973 Program) [2012CB517803]; National Natural Science Foundation, China [81070217, 30871007]; Key Project National Science Foundation of Heilongjiang, China [ZD200807-01]; Heilongjiang Educational Committee, China [1154HZ11]; Veterans Affairs Merit Grant; National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDKD) [DK074038]; NIH/NIDDK [RO1 DK32032]; Dialysis Clinic, Inc. (DCI) [C-2618A]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038] Funding Source: NIH RePORTER	Key Project of Chinese National Program for Fundamental Research and Development (973 Program)(National Basic Research Program of China); National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Key Project National Science Foundation of Heilongjiang, China; Heilongjiang Educational Committee, China; Veterans Affairs Merit Grant(US Department of Veterans Affairs); National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDKD); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Dialysis Clinic, Inc. (DCI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Key Project of Chinese National Program for Fundamental Research and Development (973 Program, 2012CB517803) National Natural Science Foundation, China (# 81070217 & # 30871007), Key Project National Science Foundation of Heilongjiang, China (# ZD200807-01) and Grant from Heilongjiang Educational Committee, China (# 1154HZ11) to ZRZ and by Veterans Affairs Merit Grant, National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDKD) DK074038, NIH/NIDDK RO1 DK32032 and a Grant from the Dialysis Clinic, Inc. (DCI) # C-2618A to PDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; de Groot T, 2009, J AM SOC NEPHROL, V20, P1693, DOI 10.1681/ASN.2008080873; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; GRANTHAM JJ, 1994, AM J KIDNEY DIS, V23, P210, DOI 10.1016/S0272-6386(12)80974-7; Haugh Jason M, 2002, Mol Interv, V2, P292, DOI 10.1124/mi.2.5.292; Kobori T, 2009, J BIOL CHEM, V284, P35507, DOI 10.1074/jbc.M109.060228; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Ma R, 2005, MOL CELL BIOL, V25, P8285, DOI 10.1128/MCB.25.18.8285-8298.2005; MERRITT JE, 1989, J BIOL CHEM, V264, P1522; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Nagao S, 2008, KIDNEY INT, V73, P269, DOI 10.1038/sj.ki.5002629; Nilius B, 2000, J PHYSIOL-LONDON, V527, P239, DOI 10.1111/j.1469-7793.2000.00239.x; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Park EY, 2009, J BIOL CHEM, V284, P7214, DOI 10.1074/jbc.M805890200; Richards WG, 1998, J CLIN INVEST, V101, P935, DOI 10.1172/JCI2071; Sala-Rabanal M, 2012, J BIOL CHEM, V287, P8746, DOI 10.1074/jbc.M111.336131; Siroky BJ, 2006, AM J PHYSIOL-RENAL, V290, pF1320, DOI 10.1152/ajprenal.00463.2005; Sorkin A, 2001, BIOCHEM SOC T, V29, P480, DOI 10.1042/BST0290480; Stewart AP, 2010, BIOPHYS J, V99, P790, DOI 10.1016/j.bpj.2010.05.012; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Voets T, 2001, J BIOL CHEM, V276, P47767, DOI 10.1074/jbc.C100607200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Wilson SJ, 2006, BBA-MOL BASIS DIS, V1762, P647, DOI 10.1016/j.bbadis.2006.04.006; Yamaguchi T, 2006, J AM SOC NEPHROL, V17, P178, DOI 10.1681/ASN.2005060645; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Yoo KH, 2008, BMB REP, V41, P593, DOI 10.5483/BMBRep.2008.41.8.593; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Zhang P, 2009, HUM MOL GENET, V18, P1238, DOI 10.1093/hmg/ddp024; Zhang ZR, 2000, BIOPHYS J, V79, P298, DOI 10.1016/S0006-3495(00)76292-8; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2	36	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e73424	10.1371/journal.pone.0073424	http://dx.doi.org/10.1371/journal.pone.0073424			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977387	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200095
J	Wang, L; Zhou, DS; Mao, PY; Zhang, YQ; Hou, J; Hu, Y; Li, J; Hou, SJ; Yang, RF; Wang, RH; Qiu, JF				Wang, Li; Zhou, Dongsheng; Mao, Panyong; Zhang, Yiquan; Hou, Jun; Hu, Yan; Li, Jin; Hou, Shaojie; Yang, Ruifu; Wang, Runhua; Qiu, Jingfu			Cell Density- and Quorum Sensing-Dependent Expression of Type VI Secretion System 2 in Vibrio parahaemolyticus	PLOS ONE			English	Article							BIOFILM FORMATION; HARVEYI; CHOLERAE; VIRULENCE; LUXR; PROMOTER; PATHOGEN; APHA; INTEGRATION; VULNIFICUS	Background: Vibrio parahaemolyticus AphA and OpaR are the two master quorum sensing (QS) regulators that are abundantly expressed at low cell density (LCD) and high cell density (HCD), respectively, with a feature of reciprocally gradient production of them with transition between LCD and HCD. The type VI secretion system 2 (T6SS2) gene cluster can be assigned into three putative operons, namely VPA1027-1024, VPA1043-1028, and VPA1044-1046. T6SS2 contributes to adhesion of V. parahaemolyticus to host cells. Methodology/Principal Findings: OpaR box-like sequences were found within the upstream promoter regions of all the above three operons, while none of AphA box-like elements could be identified for them. The subsequent primer extension, LacZ fusion, electrophoretic mobility shift, and DNase I footprinting assays disclosed that OpaR bound to the promoter regions of these three operons to stimulate their transcription, while AphA negatively regulated their transcription most likely through acting on OpaR. This regulation led to a gradient increase of T6SS2 transcription with transition from LCD to HCD. Conclusions/Significance: V. parahaemolyticus OpaR and AphA positively and negatively regulate T6SS2 expression, respectively, leading to a gradient elevation of T6SS2 expression with transition from LCD to HCD. T6SS2 genes are thus assigned as the QS regulon members in V. parahaemolyticus.	[Wang, Li; Wang, Runhua; Qiu, Jingfu] Chongqing Med Univ, Sch Publ Hlth, Chongqing, Peoples R China; [Zhou, Dongsheng; Zhang, Yiquan; Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhou, Dongsheng; Mao, Panyong; Hou, Jun; Hu, Yan; Li, Jin; Hou, Shaojie] Beijing 302 Hosp, Beijing, Peoples R China	Chongqing Medical University; Beijing Institute of Microbiology & Epidemiology; Fifth Medical Center of Chinese PLA General Hospital	Qiu, JF (corresponding author), Chongqing Med Univ, Sch Publ Hlth, Chongqing, Peoples R China.	jfqiu@126.com	Zhang, Yiquan/AAP-3311-2021; Yang, Ruifu/A-2273-2011	Zhang, Yiquan/0000-0003-3935-4079; Yang, Ruifu/0000-0003-3219-7269; Zhou, Dongsheng/0000-0003-3827-5969	National Natural Science Foundation of China [31170127, 31071093, 31170129]; National Key Program for Infectious Disease of China [2013ZX10004216]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Program for Infectious Disease of China	National Natural Science Foundation of China (31170127, 31071093, and 31170129) and the National Key Program for Infectious Disease of China (2013ZX10004216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews GP, 1996, INFECT IMMUN, V64, P2180, DOI 10.1128/IAI.64.6.2180-2187.1996; Broberg CA, 2011, MICROBES INFECT, V13, P992, DOI 10.1016/j.micinf.2011.06.013; Camara M, 2002, NAT GENET, V32, P217, DOI 10.1038/ng1002-217; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Defoirdt T, 2008, ISME J, V2, P19, DOI 10.1038/ismej.2007.92; Gode-Potratz CJ, 2011, J BACTERIOL, V193, P4224, DOI 10.1128/JB.00432-11; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Hiyoshi H, 2010, INFECT IMMUN, V78, P1772, DOI 10.1128/IAI.01051-09; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Ishikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006734; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Khajanchi BK, 2009, MICROBIOL-SGM, V155, P3518, DOI 10.1099/mic.0.031575-0; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Lesic B, 2009, MICROBIOL-SGM, V155, P2845, DOI 10.1099/mic.0.029082-0; Lin BC, 2010, ENV MICROBIOL REP, V2, P81, DOI 10.1111/j.1758-2229.2009.00100.x; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; Ma LZ, 2012, SCI WORLD J, DOI 10.1100/2012/982140; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; McCarter LL, 1998, J BACTERIOL, V180, P3166, DOI 10.1128/JB.180.12.3166-3173.1998; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Rutherford ST, 2011, GENE DEV, V25, P397, DOI 10.1101/gad.2015011; Salomon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061086; Sana TG, 2012, J BIOL CHEM, V287, P27095, DOI 10.1074/jbc.M112.376368; Shao Y, 2012, MOL MICROBIOL, V83, P599, DOI 10.1111/j.1365-2958.2011.07959.x; Sheng LL, 2012, ARCH MICROBIOL, V194, P379, DOI 10.1007/s00203-011-0780-z; SWARTZMAN E, 1992, J BACTERIOL, V174, P7490, DOI 10.1128/jb.174.22.7490-7493.1992; Teng SW, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.30; Tsou AM, 2010, INFECT IMMUN, V78, P461, DOI 10.1128/IAI.00590-09; Tu KC, 2008, MOL MICROBIOL, V70, P896, DOI 10.1111/j.1365-2958.2008.06452.x; Tu KC, 2007, GENE DEV, V21, P221, DOI 10.1101/gad.1502407; Tu KC, 2010, MOL CELL, V37, P567, DOI 10.1016/j.molcel.2010.01.022; van Kessel JC, 2013, J BACTERIOL, V195, P436, DOI 10.1128/JB.01998-12; Wang L, 2013, INT J FOOD MICROBIOL, V160, P245, DOI 10.1016/j.ijfoodmicro.2012.11.004; Waters CM, 2006, GENE DEV, V20, P2754, DOI 10.1101/gad.1466506; Yeung P S Marie, 2004, Foodborne Pathog Dis, V1, P74, DOI 10.1089/153531404323143594; Yu Y, 2012, ARCH MICROBIOL, V194, P827, DOI 10.1007/s00203-012-0816-z; Zhang WP, 2011, ARCH MICROBIOL, V193, P351, DOI 10.1007/s00203-011-0680-2; Zheng J, 2010, P NATL ACAD SCI USA, V107, P21128, DOI 10.1073/pnas.1014998107	41	24	29	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e73363	10.1371/journal.pone.0073363	http://dx.doi.org/10.1371/journal.pone.0073363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977385	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000119
J	Kang, XL; Liu, G; Liu, YF; Xu, QQ; Zhang, M; Fang, MY				Kang, Xiaolong; Liu, Gang; Liu, Yufang; Xu, Qinqin; Zhang, Ming; Fang, Meiying			Transcriptome Profile at Different Physiological Stages Reveals Potential Mode for Curly Fleece in Chinese Tan Sheep	PLOS ONE			English	Article							RNA-SEQ; HAIR-FOLLICLES; GENE; IDENTIFICATION; EXPRESSION; WNT; PATHWAY; ANAGEN; GENOME; SKIN	Tan sheep (Ovis aries), a Chinese indigenous breed, has special curly fleece after birth, especially at one month old. However, this unique phenotype disappears gradually with age and the underlying reasons of trait evolvement are still unknown. In this study, skin transcriptome data was used to study this issue. In total 51,215 transcripts including described transcripts and transfrags were identified. Pathway analysis of the top 100 most highly expressed transcripts, which included TCHH and keratin gene family members, such as KRT25, KRT5, KRT71, KRT14 and others, showed pathways known to be relevant to hair/fleece development and function. Six hundred differentially expressed (DE) transcripts were detected at two different physiological ages (one-month-old with curly fleece and 48-month-old without curly fleece) and were categorized into three major functional groups: cellular component, molecular function, and biological process. The top six functional categories included cell, cell part, cellular process, binding, intracellular, metabolic process. The detected differentially expressed genes were particularly involved in signal, signal peptide, disulfide bond, glycoprotein and secreted terms, respectively. Further splicing isoform analysis showed that the metallothionein 3 isoform was up-regulated in Tan lamb skin, indicating that it may be related to the conformation of curly fleece in Chinese Tan lamb. The hair-related important differentially expressed genes (SPINK4, FGF21, ESR alpha, EphA3, NTNG1 and GPR110) were confirmed by qPCR analysis. We deduced that the differences existed in expressed transcripts, splice isoforms and GO categories between the two different physiological stages, which might constitute the major reasons for explaining the trait evolvement of curly fleece in Chinese Tan sheep. This study provides some clues for elucidating the molecular mechanism of fleece change with age in Chinese Tan sheep, as well as supplying some potential values for understanding human hair disorder and texture changes.	[Kang, Xiaolong; Liu, Gang; Liu, Yufang; Xu, Qinqin; Fang, Meiying] China Agr Univ, Dept Anim Genet & Breeding, Natl Engn Lab Anim Breeding, MOA Lab Anim Genet & Breeding,Coll Anim Sci & Tec, Beijing 100094, Peoples R China; [Kang, Xiaolong] Ningxia Univ, Coll Agr, Yinchuan, Peoples R China; [Zhang, Ming] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	China Agricultural University; Ningxia University; Washington State University	Fang, MY (corresponding author), China Agr Univ, Dept Anim Genet & Breeding, Natl Engn Lab Anim Breeding, MOA Lab Anim Genet & Breeding,Coll Anim Sci & Tec, Beijing 100094, Peoples R China.	meiying@cau.edu.cn	Kang, Xiaolong/ADG-5490-2022		Natural Science Foundation of China (NSFC) [31072002]; State Major Research Program of China [2011ZX08009-001-003]; Program for New Century Excellent Talents in University [NCET-11-0480]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); State Major Research Program of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by Natural Science Foundation of China (NSFC, Grant 31072002), State Major Research Program of China (2011ZX08009-001-003), and Program for New Century Excellent Talents in University (NCET-11-0480). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2004, J INVEST DERMATOL, V123, P417, DOI 10.1111/j.0022-202X.2004.23307.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bawden CS, 2001, J INVEST DERMATOL, V116, P157, DOI 10.1046/j.1523-1747.2001.00215.x; Bejsovec A, 2000, CURR BIOL, V10, pR919, DOI 10.1016/S0960-9822(00)00852-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Cox LA, 2012, J PHYSIOL-LONDON, V590, P2873, DOI 10.1113/jphysiol.2011.222398; Cui Z, 1962, CHINA ANIM HUSB VET, V4, P1; Fang Y, 2010, ASIAN J ANIM VET ADV, V5, P34; FIETZ MJ, 1993, J CELL BIOL, V121, P855, DOI 10.1083/jcb.121.4.855; Geng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062704; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Guenzi E, 2001, EMBO J, V20, P5568, DOI 10.1093/emboj/20.20.5568; Jager M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-158; Kawano M, 2005, J INVEST DERMATOL, V124, P877, DOI 10.1111/j.0022-202X.2005.23693.x; Kikkawa Y, 2003, GENETICS, V165, P721; Kurek D, 2007, DEVELOPMENT, V134, P261, DOI 10.1242/dev.02721; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lu TA, 1986, J GANSU AGR U, V3, P14; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Midorikawa T, 2004, J DERMATOL SCI, V36, P25, DOI 10.1016/j.jdermsci.2004.05.001; Mikkola ML, 2008, CYTOKINE GROWTH F R, V19, P219, DOI 10.1016/j.cytogfr.2008.04.008; Nakatake Y, 2001, BBA-GENE STRUCT EXPR, V1517, P460, DOI 10.1016/S0167-4781(00)00302-X; Oh HS, 1996, P NATL ACAD SCI USA, V93, P12525, DOI 10.1073/pnas.93.22.12525; Okano J, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397273; PACKMAN S, 1987, J CLIN INVEST, V79, P1338, DOI 10.1172/JCI112959; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Ren HX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-411; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Saito H, 2003, PIGM CELL RES, V16, P261, DOI 10.1034/j.1600-0749.2003.00039.x; Sammeth M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000147; Schroder N, 2006, GASTROENTEROLOGY, V130, P902, DOI 10.1053/j.gastro.2005.12.025; Sharov AA, 2011, J INVEST DERMATOL, V131, P257, DOI 10.1038/jid.2010.279; Shimomura Y, 2008, NAT GENET, V40, P335, DOI 10.1038/ng.100; Thibaut S, 2005, INT J DERMATOL, V44, P2, DOI 10.1111/j.1365-4632.2005.02798.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wei ZQ, 2003, CHINA HERBIVORE SCI, V1, P57; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045830; Xu T, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/269191; Yamada Y, 2008, J DERMATOL SCI, V52, P178, DOI 10.1016/j.jdermsci.2008.05.007; Yang LJ, 2010, J NINGXIA U NAT SCI, V31; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang R, 2010, J AGR SCI, V31, P27	48	54	60	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71763	10.1371/journal.pone.0071763	http://dx.doi.org/10.1371/journal.pone.0071763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23990983	gold, Green Submitted, Green Published			2022-12-25	WOS:000324228800018
J	Mummert, A; Weiss, H				Mummert, Anna; Weiss, Howard			Get the News Out Loudly and Quickly: The Influence of the Media on Limiting Emerging Infectious Disease Outbreaks	PLOS ONE			English	Article							BEHAVIORAL-CHANGES; SPREAD	During outbreaks of infectious diseases with high morbidity and mortality, individuals closely follow media reports of the outbreak. Many will attempt to minimize contacts with other individuals in order to protect themselves from infection and possibly death. This process is called social distancing. Social distancing strategies include restricting socializing and travel, and using barrier protections. We use modeling to show that for short-term outbreaks, social distancing can have a large influence on reducing outbreak morbidity and mortality. In particular, public health agencies working together with the media can significantly reduce the severity of an outbreak by providing timely accounts of new infections and deaths. Our models show that the most effective strategy to reduce infections is to provide this information as early as possible, though providing it well into the course of the outbreak can still have a significant effect. However, our models for long-term outbreaks indicate that reporting historic infection data can result in more infections than with no reporting at all. We examine three types of media influence and we illustrate the media influence with a simulated outbreak of a generic emerging infectious disease in a small city. Social distancing can never be complete; however, for a spectrum of outbreaks, we show that leaving isolation ( stopping applying social distancing measures) for up to 4 hours each day has modest effect on the overall morbidity and mortality.	[Mummert, Anna] Marshall Univ, Dept Math, Huntington, WV 25755 USA; [Weiss, Howard] Georgia Inst Technol, Dept Math, Atlanta, GA 30332 USA	Marshall University; University System of Georgia; Georgia Institute of Technology	Mummert, A (corresponding author), Marshall Univ, Dept Math, Huntington, WV 25755 USA.	mummerta@marshall.edu			MUAdvance Faculty Fellowship Award	MUAdvance Faculty Fellowship Award	Both authors were supported through the MUAdvance Faculty Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2010, J INFECT DIS, V201, P491, DOI 10.1086/650396; Altman LK, 2003, NY TIMES; ANDERSON R M, 1991; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Blendon RJ, 2004, CLIN INFECT DIS, V38, P925, DOI 10.1086/382355; Center for Disease Control and Prevention, COND STDS FACT SHEET; Cui JG, 2008, J DYN DIFFER EQU, V20, P31, DOI 10.1007/s10884-007-9075-0; d'Onofrio A, 2007, THEOR POPUL BIOL, V71, P301, DOI 10.1016/j.tpb.2007.01.001; Del Valle S, 2005, MATH BIOSCI, V195, P228, DOI 10.1016/j.mbs.2005.03.006; Eichelberger L, 2007, SOC SCI MED, V65, P1284, DOI 10.1016/j.socscimed.2007.04.022; Epstein JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003955; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Kiss IZ, 2010, MATH BIOSCI, V225, P1, DOI 10.1016/j.mbs.2009.11.009; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Poletti P, 2009, J THEOR BIOL, V260, P31, DOI 10.1016/j.jtbi.2009.04.029; Reluga TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000793; Tanaka MM, 2002, THEOR POPUL BIOL, V62, P111, DOI 10.1006/tpbi.2002.1585; Tracht SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009018; Weiss Howard, 2009, MATH INTRO POPULATIO	19	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71692	10.1371/journal.pone.0071692	http://dx.doi.org/10.1371/journal.pone.0071692			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23990974	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800014
J	Bourget, R; Chaumont, L; Sapoukhina, N				Bourget, Romain; Chaumont, Loic; Sapoukhina, Natalia			Timing of Pathogen Adaptation to a Multicomponent Treatment	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; EVOLUTIONARY EPIDEMIOLOGY; POPULATION-GENETICS; DRUG-RESISTANCE; DYNAMICS; FITNESS; VACCINATION; DURABILITY; VIRUS; GENES	The sustainable use of multicomponent treatments such as combination therapies, combination vaccines/chemicals, and plants carrying multigenic resistance requires an understanding of how their population-wide deployment affects the speed of the pathogen adaptation. Here, we develop a stochastic model describing the emergence of a mutant pathogen and its dynamics in a heterogeneous host population split into various types by the management strategy. Based on a multi-type Markov birth and death process, the model can be used to provide a basic understanding of how the life-cycle parameters of the pathogen population, and the controllable parameters of a management strategy affect the speed at which a pathogen adapts to a multicomponent treatment. Our results reveal the importance of coupling stochastic mutation and migration processes, and illustrate how their stochasticity can alter our view of the principles of managing pathogen adaptive dynamics at the population level. In particular, we identify the growth and migration rates that allow pathogens to adapt to a multicomponent treatment even if it is deployed on only small proportions of the host. In contrast to the accepted view, our model suggests that treatment durability should not systematically be identified with mutation cost. We show also that associating a multicomponent treatment with defeated monocomponent treatments can be more durable than associating it with intermediate treatments including only some of the components. We conclude that the explicit modelling of stochastic processes underlying evolutionary dynamics could help to elucidate the principles of the sustainable use of multicomponent treatments in population-wide management strategies intended to impede the evolution of harmful populations.	[Bourget, Romain; Chaumont, Loic] Univ Angers, Lab Angevin Rech Math LAREMA, Angers, France; [Bourget, Romain; Sapoukhina, Natalia] INRA, IRHS, UMR1345, Beaucouze, France; [Bourget, Romain; Sapoukhina, Natalia] AgroCampus Ouest, UMR1345, IRHS, Angers, France; [Bourget, Romain; Sapoukhina, Natalia] Univ Angers, UMR1345, IRHS, Angers, France	Universite d'Angers; INRAE; Institut Agro; Agrocampus Ouest; Universite d'Angers; Universite d'Angers	Bourget, R (corresponding author), Univ Angers, Lab Angevin Rech Math LAREMA, Angers, France.	bourget@math.univ-angers.fr			Region Pays de la Loire (MODEMAVE project); SPE Department of INRA	Region Pays de la Loire (MODEMAVE project)(Region Pays de la Loire); SPE Department of INRA	Funding for this research was provided by Region Pays de la Loire (MODEMAVE project) and by SPE Department of INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L.J.S., 2010, INTRO STOCHASTIC PRO; ANDERSON N, 1988, AUST VET J, V65, P62, DOI 10.1111/j.1751-0813.1988.tb07355.x; Ayme V, 2006, MOL PLANT MICROBE IN, V19, P557, DOI 10.1094/MPMI-19-0557; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Berkhoff EGM, 2006, VACCINE, V24, P6594, DOI 10.1016/j.vaccine.2006.05.051; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P12106, DOI 10.1073/pnas.94.22.12106; Boni MF, 2008, VACCINE, V26, pC8, DOI 10.1016/j.vaccine.2008.04.011; Bourget R, 2012, EXPONENTIALITY 1 PAS; Bourget R., 2013, THESIS U ANGERS; Carrasco P, 2007, J VIROL METHODS, V139, P181, DOI 10.1016/j.jviromet.2006.09.020; Carriere Y, 2001, P ROY SOC B-BIOL SCI, V268, P1475, DOI 10.1098/rspb.2001.1689; Castle MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040941; Collingham YC, 2000, ECOL APPL, V10, P131, DOI 10.1890/1051-0761(2000)010[0131:IOHFAP]2.0.CO;2; Cuevas JM, 2005, J GEN VIROL, V86, P435, DOI 10.1099/vir.0.80359-0; D'Agata EMC, 2007, J THEOR BIOL, V249, P487, DOI 10.1016/j.jtbi.2007.08.011; Day T, 2012, EVOLUTION, V66, P1582, DOI 10.1111/j.1558-5646.2011.01533.x; Debarre F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000337; Dieckmann, 2005, PURSUIT VIRULENCE MA, DOI 10.1038/s41396-021-00911-3; Ethier S.N., 2005, MARKOV PROCESSES CHA, V2nd; Fabre F, 2012, NEW PHYTOL, V193, P1064, DOI 10.1111/j.1469-8137.2011.04019.x; Fabre F, 2009, VIRUS RES, V141, P140, DOI 10.1016/j.virusres.2008.11.021; Gandon S, 2007, J R SOC INTERFACE, V4, P803, DOI 10.1098/rsif.2006.0207; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Handel A, 2006, PLOS COMPUT BIOL, V2, P1262, DOI 10.1371/journal.pcbi.0020137; Hermsen R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248104; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Hooper JW, 2000, VIROLOGY, V266, P329, DOI 10.1006/viro.1999.0096; Kelly JD, 2003, FIELD CROP RES, V82, P135, DOI 10.1016/S0378-4290(03)00034-0; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Labbe P, 2009, GENETICS, V182, P303, DOI 10.1534/genetics.109.101444; Lannou C, 1997, THEOR APPL GENET, V94, P991, DOI 10.1007/s001220050506; Leach JE, 2001, ANNU REV PHYTOPATHOL, V39, P187, DOI 10.1146/annurev.phyto.39.1.187; Lipsitch M, 1997, ANTIMICROB AGENTS CH, V41, P363, DOI 10.1128/AAC.41.2.363; MacLean RC, 2010, NAT REV GENET, V11, P405, DOI 10.1038/nrg2778; MASSAD E, 1993, INT J BIOMED COMPUT, V33, P65, DOI 10.1016/0020-7101(93)90060-J; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; MICHEAHAMZEHPOUR M, 1986, AM J MED, V80, P138, DOI 10.1016/0002-9343(86)90491-2; Michelmore R, 2008, EUR J PLANT PATHOL, V122, P19, DOI 10.1007/s10658-008-9305-2; MUNDT CC, 1990, PHYTOPATHOLOGY, V80, P221, DOI 10.1094/Phyto-80-221; Novozhilov AS, 2006, BRIEF BIOINFORM, V7, P70, DOI 10.1093/bib/bbk006; Ohtsuki A, 2006, J THEOR BIOL, V238, P780, DOI 10.1016/j.jtbi.2005.06.030; Otten W, 2004, NEW PHYTOL, V163, P125, DOI 10.1111/j.1469-8137.2004.01086.x; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Read AF, 2007, EVOLUTION HLTH DIS; Restif O, 2006, P ROY SOC B-BIOL SCI, V273, P409, DOI 10.1098/rspb.2005.3335; Reuter GEH., 1961, P 4 BERK S MATH STAT, P421; Rhodes TD, 2005, J VIROL, V79, P1666, DOI 10.1128/JVI.79.3.1666-1677.2005; Rice SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007130; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Sapoukhina N, 2009, THEOR ECOL, V2, P229, DOI 10.1007/s12080-009-0045-5; Scherer A, 2002, BRIT MED BULL, V62, P187, DOI 10.1093/bmb/62.1.187; Suzuki SU, 2011, J THEOR BIOL, V276, P117, DOI 10.1016/j.jtbi.2011.02.002; Trindade S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000578; van den Bosch F, 2003, PHYTOPATHOLOGY, V93, P616, DOI 10.1094/PHYTO.2003.93.5.616; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; zur Wiesch PA, 2011, LANCET INFECT DIS, V11, P236, DOI 10.1016/S1473-3099(10)70264-4	57	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71926	10.1371/journal.pone.0071926	http://dx.doi.org/10.1371/journal.pone.0071926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991006	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100065
J	Kim, M; Kwon, TH; Jung, SM; Cho, SH; Jin, SY; Park, NH; Kim, CG; Kim, JS				Kim, Misoon; Kwon, Tae-Hyung; Jung, Su-Mi; Cho, Seung-Hak; Jin, Seon Yeong; Park, Nyun-Ho; Kim, Choong-Gon; Kim, Jong-Shik			Antibiotic Resistance of Bacteria Isolated from the Internal Organs of Edible Snow Crabs	PLOS ONE			English	Article							CLASS 1 INTEGRON; CHIONOECETES-OPILIO; GENES; PREVALENCE; FISH; DATABASE; CHICKEN; LEVEL	Antibiotic resistance and microbiota within edible snow crabs are important for the Chionoecetes (snow crab) fishing industry. We investigated these parameters using culture methods and antibiotic susceptibility tests with six internal organs from three species of Chionoecetes. Each sample revealed many unexpected microbial species within Chionoecetes internal organs. On the basis of 16S rRNA sequence analysis of 381 isolates, the most abundant genera identified in Chionoecetes opilio were Acinetobacter spp. (24%), Bacillus spp. (4%), Pseudomonas spp. (34%), Stenotrophomonas spp. (28%), and Agreia spp. (11%). In Chionoecetes sp. crabs, Acinetobacter spp. (23%), Bacillus spp. (12%), and Psychrobacter spp. (20%) were most prevalent, while Agreia spp. (11%), Bacillus spp. (31%), Microbacterium spp. (10%), Rhodococcus spp. (12%), and Agrococcus spp. (6%) were most abundant in C. japonicus. Our antibiotic resistance test found resistance to all nine antibiotics tested in 19, 14, and two of the isolates from C. opilio, Chionoecetes sp., and, C. japonicus respectively. Our results are the first to show that microbes with antibiotic resistance are widely distributed throughout the internal organs of natural snow crabs.	[Kim, Misoon; Kwon, Tae-Hyung; Jin, Seon Yeong; Park, Nyun-Ho; Kim, Choong-Gon; Kim, Jong-Shik] Gyeongbuk Inst Marine Bioind, Uljin Gun, Gyeongbuk, South Korea; [Jung, Su-Mi; Cho, Seung-Hak] Korea Natl Inst Hlth, Div Enter Bacterial Infect, Ctr Infect Dis, Cheongwon Gun, Chungcheongbuk, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease	Kim, JS (corresponding author), Gyeongbuk Inst Marine Bioind, Uljin Gun, Gyeongbuk, South Korea.	jskim@gimb.or.kr			Gyeongsangbuk-Do Province; Uljin-Gun's research grant	Gyeongsangbuk-Do Province; Uljin-Gun's research grant	This work was supported by the Gyeongsangbuk-Do Province and Uljin-Gun's research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Bakri MM, 2009, EMERG INFECT DIS, V15, P817, DOI 10.3201/eid1505.081186; Benhalima K, 2001, HYDROBIOLOGIA, V449, P261, DOI 10.1023/A:1017523404792; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Chun Y. Y., 2009, J KOR FISH SOC, V4, P119; Clinical and Laboratory Standards Institute, 2012, M07A9 CLIN LAB STAND; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Depardieu F, 2004, J CLIN MICROBIOL, V42, P5857, DOI 10.1128/JCM.42.12.5857-5860.2004; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; EKLUND MW, 1965, APPL MICROBIOL, V13, P985, DOI 10.1128/AEM.13.6.985-990.1965; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Ghosh Koushik, 2010, Proceedings of the Zoological Society (Calcutta), V63, P13, DOI 10.1007/s12595-010-0002-8; Gibreel A, 2004, MICROB DRUG RESIST, V10, P98, DOI 10.1089/1076629041310127; Gillings MR, 2009, APPL ENVIRON MICROB, V75, P6002, DOI 10.1128/AEM.01033-09; Glenn LM, 2012, MICROB DRUG RESIST, V18, P453, DOI 10.1089/mdr.2011.0224; Hogan D, 2002, CURR OPIN MICROBIOL, V5, P472, DOI 10.1016/S1369-5274(02)00357-0; HOSKIN GP, 1983, APPL ENVIRON MICROB, V46, P499, DOI 10.1128/AEM.46.2.499-500.1983; Kim Sung Han, 2010, Korean Journal of Fisheries and Aquatic Sciences, V43, P670; Kim WJ, 2012, J SHELLFISH RES, V31, P49, DOI 10.2983/035.031.0106; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lim YS, 2001, J AQUACULT, V14, P51; Lucarelli C, 2010, J CLIN MICROBIOL, V48, P2103, DOI 10.1128/JCM.01371-09; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P44, DOI 10.1111/j.1574-6976.2008.00142.x; Martineau F, 2000, ANTIMICROB AGENTS CH, V44, P231, DOI 10.1128/AAC.44.2.231-238.2000; Mary P, 2000, MICROB ECOL, V39, P322; Nawaz M, 2012, INT J FOOD MICROBIOL, V155, P179, DOI 10.1016/j.ijfoodmicro.2012.02.002; Okanlawon BM, 2010, AFR J BIOTECHNOL, V9, P2129; Ozaktas T, 2012, WATER RES, V46, P6382, DOI 10.1016/j.watres.2012.09.010; Prabu D, 2013, INDIAN J MED RES, V137, P164; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sajjad A, 2011, APPL ENVIRON MICROB, V77, P335, DOI 10.1128/AEM.02142-10; Sanbongi Y, 2004, ANTIMICROB AGENTS CH, V48, P2244, DOI 10.1128/AAC.48.6.2244-2250.2004; SCHABERG DR, 1991, AM J MED, V91, pS72, DOI 10.1016/0002-9343(91)90346-Y; Schuwerack PMM, 2001, J INVERTEBR PATHOL, V77, P269, DOI 10.1006/jipa.2001.5023; Schwaiger K, 2012, INT J FOOD MICROBIOL, V154, P206, DOI 10.1016/j.ijfoodmicro.2011.12.014; Schwaiger K, 2011, INT J FOOD MICROBIOL, V148, P191, DOI 10.1016/j.ijfoodmicro.2011.06.001; Shah SQA, 2012, ENVIRON SCI TECHNOL, V46, P8672, DOI 10.1021/es3018607; Soge OO, 2006, J ANTIMICROB CHEMOTH, V58, P1048, DOI 10.1093/jac/dkl370; Su HC, 2011, J ENVIRON MONITOR, V13, P3229, DOI 10.1039/c1em10634a; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thaller MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008989; Verner-Jeffreys DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008388; White T., 1990, PCR PROTOCOLS GUIDE, P315; Yoon Y.Y., 2003, J KOREAN SOC MARINE, V6, P68	49	17	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e70887	10.1371/journal.pone.0070887	http://dx.doi.org/10.1371/journal.pone.0070887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990916	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100034
J	Mundt, F; Nilsonne, G; Arslan, S; Csuros, K; Hillerdal, G; Yildirim, H; Metintas, M; Dobra, K; Hjerpe, A				Mundt, Filip; Nilsonne, Gustav; Arslan, Sertac; Csuros, Karola; Hillerdal, Gunnar; Yildirim, Huseyin; Metintas, Muzaffer; Dobra, Katalin; Hjerpe, Anders			Hyaluronan and N-ERC/Mesothelin as Key Biomarkers in a Specific Two-Step Model to Predict Pleural Malignant Mesothelioma	PLOS ONE			English	Article							MEGAKARYOCYTE POTENTIATING FACTOR; SOLUBLE MESOTHELIN; OSTEOPONTIN LEVELS; SERUM MESOTHELIN; FAMILY PROTEINS; UP-REGULATION; ELISA SYSTEM; DIAGNOSIS; EFFUSIONS; UTILITY	Purpose: Diagnosis of malignant mesothelioma is challenging. The first available diagnostic material is often an effusion and biochemical analysis of soluble markers may provide additional diagnostic information. This study aimed to establish a predictive model using biomarkers from pleural effusions, to allow early and accurate diagnosis. Patients and Methods: Effusions were collected prospectively from 190 consecutive patients at a regional referral centre. Hyaluronan, N-ERC/mesothelin, C-ERC/mesothelin, osteopontin, syndecan-1, syndecan-2, and thioredoxin were measured using ELISA and HPLC. A predictive model was generated and validated using a second prospective set of 375 effusions collected consecutively at a different referral centre. Results: Biochemical markers significantly associated with mesothelioma were hyaluronan (odds ratio, 95% CI: 8.82, 4.82-20.39), N-ERC/mesothelin (4.81, 3.19-7.93), CERC/mesothelin (3.58, 2.43-5.59) and syndecan-1 (1.34, 1.03-1.77). A two-step model using hyaluronan and N-ERC/mesothelin, and combining a threshold decision rule with logistic regression, yielded good discrimination with an area under the ROC curve of 0.99 (95% CI: 0.97-1.00) in the model generation dataset and 0.83 (0.74-0.91) in the validation dataset, respectively. Conclusions: A two-step model using hyaluronan and N-ERC/mesothelin predicts mesothelioma with high specificity. This method can be performed on the first available effusion and could be a useful adjunct to the morphological diagnosis of mesothelioma.	[Mundt, Filip; Csuros, Karola; Dobra, Katalin; Hjerpe, Anders] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Nilsonne, Gustav] Karolinska Inst, Stockholm Brain Inst, Stockholm, Sweden; [Nilsonne, Gustav] Karolinska Inst, Osher Inst Integrat Med, Dept Clin Neurosci, Stockholm, Sweden; [Nilsonne, Gustav] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Arslan, Sertac; Yildirim, Huseyin; Metintas, Muzaffer] Eskisehir Osmangazi Univ, Fac Med, Dept Chest Dis, Eskisehir, Turkey; [Hillerdal, Gunnar] Karolinska Univ Hosp, Thorax, Dept Lung Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Stockholm University; Eskisehir Osmangazi University; Karolinska Institutet; Karolinska University Hospital	Mundt, F (corresponding author), Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden.	filip.mundt@ki.se		Nilsonne, Gustav/0000-0001-5273-0150	Swedish Heart-Lung Foundation; AFA Insurance; Nordic Mesothelioma Fund	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); AFA Insurance; Nordic Mesothelioma Fund	This study was funded by the Swedish Heart-Lung Foundation, AFA Insurance and the Nordic Mesothelioma Fund. AFA is a non-profit insurance company, jointly owned by the Swedish Labour Organization and the Swedish Employers Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman C, 2009, MED CLIN-BARCELONA, V133, P449, DOI 10.1016/j.medcli.2008.11.047; Cappia S, 2008, AM J CLIN PATHOL, V130, P58, DOI 10.1309/TWCQV536WWRNEU51; Creaney J, 2008, J THORAC ONCOL, V3, P851, DOI 10.1097/JTO.0b013e318180477b; Creaney J, 2007, THORAX, V62, P569, DOI 10.1136/thx.2006.068114; Creaney J, 2011, LUNG CANCER, V74, P55, DOI 10.1016/j.lungcan.2011.02.007; DAVID G, 1992, J CELL BIOL, V118, P961, DOI 10.1083/jcb.118.4.961; Davies HE, 2009, AM J RESP CRIT CARE, V180, P437, DOI 10.1164/rccm.200811-1729OC; Dejmek A, 2005, DIAGN CYTOPATHOL, V32, P160, DOI 10.1002/dc.20202; Fedarko NS, 2001, CLIN CANCER RES, V7, P4060; Flores-Staino C, 2010, LUNG CANCER, V68, P39, DOI 10.1016/j.lungcan.2009.05.004; FREBOURG T, 1987, CANCER, V59, P2104, DOI 10.1002/1097-0142(19870615)59:12<2104::AID-CNCR2820591224>3.0.CO;2-I; Grigoriu B, 2009, CLIN BIOCHEM, V42, P1046, DOI 10.1016/j.clinbiochem.2009.03.007; Grigoriu BD, 2007, CLIN CANCER RES, V13, P2928, DOI 10.1158/1078-0432.CCR-06-2144; Gulyas M, 2003, J PATHOL, V199, P479, DOI 10.1002/path.1312; Harrell F, RMS REGRESSION MODEL; Hellstrom I, 2006, CANCER EPIDEM BIOMAR, V15, P1014, DOI 10.1158/1055-9965.EPI-05-0334; HJERPE A, 1986, CLIN CHEM, V32, P952; Hollevoet K, 2011, J THORAC ONCOL, V6, P1930, DOI 10.1097/JTO.0b013e3182272294; Hollevoet K, 2010, AM J RESP CRIT CARE, V181, P620, DOI 10.1164/rccm.200907-1020OC; Iwahori K, 2008, LUNG CANCER, V62, P45, DOI 10.1016/j.lungcan.2008.02.012; Kahlos K, 2001, INT J CANCER, V95, P198, DOI 10.1002/1097-0215(20010520)95:3<198::AID-IJC1034>3.0.CO;2-F; Kao SCH, 2011, PATHOLOGY, V43, P201, DOI 10.1097/PAT.0b013e3283445e67; L-R Monica, 2012, OPTIMALCUTPOINTS COM; MARTENSSON G, 1994, CANCER, V73, P1406, DOI 10.1002/1097-0142(19940301)73:5<1406::AID-CNCR2820730515>3.0.CO;2-I; Metintas M, 2010, ARCH ENVIRON OCCUP H, V65, P86, DOI 10.1080/19338240903390305; Mohr S, 2004, BIOCHIMIE, V86, P13, DOI 10.1016/j.biochi.2003.11.008; Moschos C, 2009, RESPIROLOGY, V14, P716, DOI 10.1111/j.1440-1843.2009.01536.x; NURMINEN M, 1994, CLIN CHEM, V40, P777; Ostroff RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046091; Pantazopoulos I, 2013, EUR RESPIR J, V41, P706, DOI 10.1183/09031936.00226111; Pass HI, 2008, ANN THORAC SURG, V85, P265, DOI 10.1016/j.athoracsur.2007.07.042; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; PETTERSSON T, 1988, CHEST, V94, P1037, DOI 10.1378/chest.94.5.1037; Rihn BH, 2000, FEBS LETT, V480, P95, DOI 10.1016/S0014-5793(00)01913-X; Rizopoulos D., **DATA OBJECT**; Robinson BWS, 2003, LANCET, V362, P1612, DOI 10.1016/S0140-6736(03)14794-0; Saqi A, 2005, DIAGN CYTOPATHOL, V33, P65, DOI 10.1002/dc.20297; Scherpereel A, 2010, EUR RESPIR J, V35, P479, DOI [10.3779/j.issn.1009-3419.2010.10.14, 10.1183/09031936.00063109]; Scherpereel A, 2006, AM J RESP CRIT CARE, V173, P1155, DOI 10.1164/rccm.200511-1789OC; Segal A, 2013, PATHOLOGY, V45, P44, DOI 10.1097/PAT.0b013e32835bc848; Seidel C, 2004, J PHARMACEUT BIOMED, V34, P797, DOI 10.1016/S0731-7085(03)00569-7; Shiomi K, 2006, CANCER SCI, V97, P928, DOI 10.1111/j.1349-7006.2006.00246.x; SPIEGELHALTER DJ, 1986, STAT MED, V5, P421, DOI 10.1002/sim.4780050506; Sterman DH, 2005, RESPIROLOGY, V10, P266, DOI 10.1111/j.1440-1843.2005.00714.x; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Sun XJ, 2000, DIFFERENTIATION, V66, P181, DOI 10.1111/j.1432-0436.2000.660404.x; Tabata C, 2011, ANTIOXID REDOX SIGNA; Team RDC, 2021, R LANG ENV STAT COMP; Thylen A, 2001, CANCER, V92, P1224, DOI 10.1002/1097-0142(20010901)92:5<1224::AID-CNCR1441>3.0.CO;2-U; Vordermark D, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-207; Welker L, 2007, VIRCHOWS ARCH, V450, P455, DOI 10.1007/s00428-007-0375-x; Yamada S, 2011, CLIN CHEM LAB MED	53	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72030	10.1371/journal.pone.0072030	http://dx.doi.org/10.1371/journal.pone.0072030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991032	Green Submitted, gold, Green Published			2022-12-25	WOS:000324470100073
J	Nair, KL; Jagadeeshan, S; Nair, SA; Kumar, GSV				Nair, Lekha K.; Jagadeeshan, Sankar; Nair, Asha S.; Kumar, G. S. Vinod			Folic Acid Conjugated delta-Valerolactone-Poly(ethylene glycol) Based Triblock Copolymer as a Promising Carrier for Targeted Doxorubicin Delivery	PLOS ONE			English	Article							DRUG-DELIVERY; POLYMER MICELLES; IMAGING AGENTS; NANOPARTICLES; CELLS; LIPOSOMES; EXPRESSION; PEPTIDE; TPGS	The aim of this study is to test the hypothesis that the newly synthesized poly(delta-valerolactone)/poly(ethylene glycol)/poly(delta-valerolactone) (VEV) copolymer grafted with folic acid would impart targetability and further enhance the anti-tumor efficacy of doxorubicin (DOX). Here, folic acid conjugated VEV (VEV-FOL) was synthesized by a modified esterification method and characterized using IR and NMR. DOX loaded VEV-FOL micelles were synthesized using a novel solvent evaporation method and were obtained with a mean diameter of 97 nm with high encapsulation efficiency and sustained in vitro release profile. Comparative studies of polymer micelles with and without folate for cellular uptake and cytotoxicity were done on folate receptor-positive breast cancer cell line, MDAMB231. The intracellular uptake tests showed significant increase in folate micellar uptake when compared to non-folate-mediated micelles. MTT assay followed by apoptosis assays clearly indicated that folate decorated micelles showed significantly better cytotoxicity (IC50 = 0.014 mu M) and efficiency to induce apoptosis than other treated groups. Moreover, a significant G2/M arrest was induced by DOX loaded VEV-FOL micelles at a concentration where free drug failed to show any activity. Thus, our results show that the folic acid-labeled VEV copolymer is a promising biomaterial with controlled and sustainable tumor targeting ability for anticancer drugs which can open new frontiers in the area of targeted chemotherapy.	[Nair, Lekha K.; Jagadeeshan, Sankar; Nair, Asha S.; Kumar, G. S. Vinod] Rajiv Gandhi Ctr Biotechnol, Poojappura, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Kumar, GSV (corresponding author), Rajiv Gandhi Ctr Biotechnol, Poojappura, Kerala, India.	gsvinod@rgcb.res.in	JAGADEESHAN, SANKAR/S-8384-2019	JAGADEESHAN, SANKAR/0000-0002-3778-8757	Council of Scientific and Industrial Research, New Delhi, India	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	LNK sincerely acknowledges Council of Scientific and Industrial Research, New Delhi, India, for providing research fellowship and the authors' gratefully acknowledge National Institute of Interdisciplinary Sciences and Technology, Kerala, India, for NMR studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2009, BIOMATERIALS, V30, P5737, DOI 10.1016/j.biomaterials.2009.07.008; BARLOGIE B, 1976, CANCER RES, V36, P1975; Dilnawaz F, 2010, BIOMATERIALS, V31, P3694, DOI 10.1016/j.biomaterials.2010.01.057; DiPaola RS, 2002, CLIN CANCER RES, V8, P3311; Fritzer M, 1996, BIOCHEM PHARMACOL, V51, P489, DOI 10.1016/0006-2952(95)02225-2; Gabizon A, 2003, CLIN CANCER RES, V9, P6551; Kakudo T, 2004, BIOCHEMISTRY-US, V43, P5618, DOI 10.1021/bi035802w; Kang KW, 2010, NANOMED-NANOTECHNOL, V6, P210, DOI 10.1016/j.nano.2009.12.006; Kikuchi A, 1996, BIOCHEM BIOPH RES CO, V227, P666, DOI 10.1006/bbrc.1996.1566; Kim SY, 2007, MACROMOL RES, V15, P646, DOI 10.1007/BF03218945; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Lee JB, 2012, INT J CANCER, V131, pE781, DOI 10.1002/ijc.27361; Lee K, 2010, BIOMATERIALS, V31, P6530, DOI 10.1016/j.biomaterials.2010.04.046; Liu SQ, 2007, BIOMATERIALS, V28, P1423, DOI 10.1016/j.biomaterials.2006.11.013; Liu YT, 2010, BIOMATERIALS, V31, P330, DOI 10.1016/j.biomaterials.2009.09.036; Matteucci C, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.58; Meier R, 2010, RADIOLOGY, V255, P527, DOI 10.1148/radiol.10090050; Nair KL, 2012, J APPL POLYM SCI, V124, P2030, DOI 10.1002/app.35229; Nair K Lekha, 2011, Int J Nanomedicine, V6, P1685, DOI 10.2147/IJN.S20165; Nair KL, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-42; Nasongkla N, 2006, NANO LETT, V6, P2427, DOI 10.1021/nl061412u; O'Loughlin C, 2000, EUR J CANCER, V36, P1149, DOI 10.1016/S0959-8049(00)00071-X; Ohara Y, 2012, INT J CANCER, V131, P2402, DOI 10.1002/ijc.27502; Park EK, 2005, BIOMATERIALS, V26, P1053, DOI 10.1016/j.biomaterials.2004.04.008; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Reddy JA, 2005, CURR PHARM BIOTECHNO, V6, P131, DOI 10.2174/1389201053642376; Sapra Puja, 2005, Current Drug Delivery, V2, P369, DOI 10.2174/156720105774370159; Shmeeda H, 2006, MOL CANCER THER, V5, P818, DOI 10.1158/1535-7163.MCT-05-0543; Sudimack J, 2000, ADV DRUG DELIVER REV, V41, P147, DOI 10.1016/S0169-409X(99)00062-9; Tanaka K, 2010, INT J PHARMACEUT, V396, P229, DOI 10.1016/j.ijpharm.2010.06.028; Tao XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049304; Wang S, 1998, J CONTROL RELEASE, V53, P39, DOI 10.1016/S0168-3659(97)00236-8; Wu J, 2006, INT J PHARMACEUT, V316, P148, DOI 10.1016/j.ijpharm.2006.02.027; Zeng FQ, 2006, BIOCONJUGATE CHEM, V17, P399, DOI 10.1021/bc050350g; Zhang ZP, 2007, BIOMATERIALS, V28, P1889, DOI 10.1016/j.biomaterials.2006.12.018; Zhao HZ, 2008, INT J PHARMACEUT, V349, P256, DOI 10.1016/j.ijpharm.2007.07.040; Zhao HZ, 2009, J BIOMED MATER RES A, V91A, P505, DOI 10.1002/jbm.a.32220	37	16	16	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e70697	10.1371/journal.pone.0070697	http://dx.doi.org/10.1371/journal.pone.0070697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990912	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100032
J	Nakanishi, Y; Yanagisawa, T; Shin, D; Fukuma, R; Chen, C; Kambara, H; Yoshimura, N; Hirata, M; Yoshimine, T; Koike, Y				Nakanishi, Yasuhiko; Yanagisawa, Takufumi; Shin, Duk; Fukuma, Ryohei; Chen, Chao; Kambara, Hiroyuki; Yoshimura, Natsue; Hirata, Masayuki; Yoshimine, Toshiki; Koike, Yasuharu			Prediction of Three-Dimensional Arm Trajectories Based on ECoG Signals Recorded from Human Sensorimotor Cortex	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; ELECTROCORTICOGRAPHIC SIGNALS; MOVEMENT TRAJECTORIES; CORTICAL CONTROL; PROSTHETIC ARM; CHRONIC STROKE; EEG; COMMUNICATION	Brain-machine interface techniques have been applied in a number of studies to control neuromotor prostheses and for neurorehabilitation in the hopes of providing a means to restore lost motor function. Electrocorticography (ECoG) has seen recent use in this regard because it offers a higher spatiotemporal resolution than non-invasive EEG and is less invasive than intracortical microelectrodes. Although several studies have already succeeded in the inference of computer cursor trajectories and finger flexions using human ECoG signals, precise three-dimensional (3D) trajectory reconstruction for a human limb from ECoG has not yet been achieved. In this study, we predicted 3D arm trajectories in time series from ECoG signals in humans using a novel preprocessing method and a sparse linear regression. Average Pearson's correlation coefficients and normalized root-mean-square errors between predicted and actual trajectories were 0.44 similar to 0.73 and 0.18 similar to 0.42, respectively, confirming the feasibility of predicting 3D arm trajectories from ECoG. We foresee this method contributing to future advancements in neuroprosthesis and neurorehabilitation technology.	[Nakanishi, Yasuhiko; Shin, Duk; Chen, Chao; Kambara, Hiroyuki; Yoshimura, Natsue; Koike, Yasuharu] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan; [Yanagisawa, Takufumi; Hirata, Masayuki; Yoshimine, Toshiki] Osaka Univ, Sch Med, Dept Neurosurg, Osaka, Japan; [Yanagisawa, Takufumi; Fukuma, Ryohei] ATR Computat Neurosci Labs, Kyoto, Japan; [Yanagisawa, Takufumi] Osaka Univ, Div Funct Diagnost Sci, Grad Sch Med, Osaka, Japan	Tokyo Institute of Technology; Osaka University; Osaka University	Shin, D (corresponding author), Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan.	shinduk@cns.pi.titech.ac.jp	Kambara, Hiroyuki/E-4546-2014; LUO, JINGJING/AAZ-6697-2021; Koike, Yasuharu/E-9150-2014; NAKANISHI, Yasuhiko/E-4594-2014; Shin, Duk/G-9620-2011; Yoshimura, Natsue/E-7087-2014	LUO, JINGJING/0000-0002-3222-1276; Koike, Yasuharu/0000-0002-8169-0044; Yoshimura, Natsue/0000-0002-7495-9113; Chen, Chao/0000-0001-7358-4332	Japan Society for the Promotion of Science (JSPS) [22390275, 23390347, 24700419]; Grants-in-Aid for Scientific Research [23390347] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI grants (22390275, 23390347, and 24700419) from the Japan Society for the Promotion of Science (JSPS). A part of this study was the result of "Brain Machine Interface Development" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball T, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016006; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; Blankertz B, 2003, IEEE T NEUR SYS REH, V11, P127, DOI 10.1109/TNSRE.2003.814456; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P147, DOI 10.1109/TNSRE.2006.875557; Broetz D, 2010, NEUROREHAB NEURAL RE, V24, P674, DOI 10.1177/1545968310368683; Buch E, 2008, STROKE, V39, P910, DOI 10.1161/STROKEAHA.107.505313; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Chestek CA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026002; Chin CM, 2007, J NEURAL ENG, V4, P146, DOI 10.1088/1741-2560/4/2/014; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Gunduz A, 2009, NEURAL NETWORKS, V22, P1257, DOI 10.1016/j.neunet.2009.06.036; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Kennedy PR, 2004, IEEE T NEUR SYS REH, V12, P339, DOI 10.1109/TNSRE.2004.834629; Koike Y, 2006, NEUROSCI RES, V55, P146, DOI 10.1016/j.neures.2006.02.012; Kubanek J, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066001; Leuthardt EC, 2006, IEEE T NEUR SYS REH, V14, P194, DOI 10.1109/TNSRE.2006.875536; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Leuthardt EC, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036004; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Nambu I, 2009, NEUROIMAGE, V47, P628, DOI 10.1016/j.neuroimage.2009.04.050; PFURTSCHELLER G, 1994, NEUROSCI LETT, V174, P93, DOI 10.1016/0304-3940(94)90127-9; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Sato M, 2001, NEURAL COMPUT, V13, P1649, DOI 10.1162/089976601750265045; Schalk G, 2008, J NEURAL ENG, V5, P75, DOI 10.1088/1741-2560/5/1/008; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shimoda K, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036015; Shin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047992; Shindo K, 2011, J REHABIL MED, V43, P951, DOI 10.2340/16501977-0859; Soekadar SR, 2011, IEEE T NEUR SYS REH, V19, P542, DOI 10.1109/TNSRE.2011.2166809; Stark E, 2007, J NEUROSCI, V27, P8387, DOI 10.1523/JNEUROSCI.1321-07.2007; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Ting Jo-Anne, 2008, Neural Netw, V21, P1112, DOI 10.1016/j.neunet.2008.06.012; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; Watanabe H, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036006; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; WOLPAW JR, 1991, ELECTROEN CLIN NEURO, V78, P252, DOI 10.1016/0013-4694(91)90040-B; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; Yanagisawa T, 2012, ANN NEUROL, V71, P353, DOI 10.1002/ana.22613; Yanagisawa T, 2009, NEUROIMAGE, V45, P1099, DOI 10.1016/j.neuroimage.2008.12.069; Yoshimura N, 2012, NEUROIMAGE, V59, P1324, DOI 10.1016/j.neuroimage.2011.08.029	49	63	63	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72085	10.1371/journal.pone.0072085	http://dx.doi.org/10.1371/journal.pone.0072085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991046	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100077
J	Wong, MCS; Lee, A; Ngai, KLK; Chor, JCY; Chan, PKS				Wong, Martin C. S.; Lee, Albert; Ngai, Karry L. K.; Chor, Josette C. Y.; Chan, Paul K. S.			Knowledge, Attitude, Practice and Barriers on Vaccination against Human Papillomavirus Infection: A Cross-Sectional Study among Primary Care Physicians in Hong Kong	PLOS ONE			English	Article							PARTICLE VACCINE; SUSTAINED EFFICACY; HPV VACCINATION; YOUNG-WOMEN; PREVENTION; TYPE-18; GYNECOLOGISTS	This study explored the knowledge, attitude, practice and barriers to prescribe human papillomavirus (HPV) vaccines among private primary care physicians in Hong Kong. A self-administered questionnaire survey was conducted by sending letters to doctors who had joined a vaccination program for school girls. From 720 surveys sent, 444 (61.7%) completed questionnaires were returned and analyzed. For knowledge, few responded to questions accurately on the prevalence of cervical HPV (27.9%) and genital wart infection (13.1%) among sexually active young women in Hong Kong, and only 44.4% correctly answered the percentage of cervical cancers caused by HPV. For attitude, most agreed that HPV vaccination should be fully paid by the Government (68.3%) as an important public health strategy. Vaccination against HPV was perceived as more important than those for genital herpes (52.2%) and Chlamydia (50.1%) for adolescent health, and the majority selected adolescents aged 12-14 years as the ideal group for vaccination. Gardasil (R) (30.9%) and Cervarix (R) (28.0%) were almost equally preferred. For practice, the factors influencing the choice of vaccine included strength of vaccine protection (61.1%), long-lasting immunity (56.8%) and good antibody response (55.6%). The most significant barriers to prescribe HPV vaccines consisted of parental refusal due to safety concerns (48.2%), and their practice of advising vaccination was mostly affected by local Governmental recommendations (78.7%). A substantial proportion of physicians had recommended HPV vaccines for their female clients/patients aged 18-26 years for protection of cervical cancer (83.8%) or both cervical cancer and genital warts (85.5%). The knowledge on HPV infection was low among physicians in Hong Kong. Prescription of HPV vaccine was hindered by the perceived parental concerns and was mostly relied on Governmental recommendations. Educational initiatives should be targeted towards both physicians and parents, and the Government should consider full subsidy to enhance vaccine uptake rate.	[Wong, Martin C. S.; Lee, Albert; Chor, Josette C. Y.] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Ngai, Karry L. K.; Chan, Paul K. S.] Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, PKS (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	paulkschan@cuhk.edu.hk	Wong, Martin/L-4568-2014; Chan, Paul KS/J-9360-2013	Wong, Martin/0000-0001-7706-9370; Chan, Paul KS/0000-0002-6360-4608	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	A Lee has received support from GlaxoSmithKline to conduct educational activities. PKS Chan has received support for attending academic conferences from GlaxoSmithKline. This study was partly supported by an unrestricted educational grant from GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2007, VACCINE, V25, P3007, DOI 10.1016/j.vaccine.2007.01.016; Centers for Disease Control and Prevention, 2012, CDCS ADV COMM REC HU; Chan PKS, 2012, CRIT REV CL LAB SCI, V49, P117, DOI 10.3109/10408363.2012.707174; Chan PKS, 2012, INT J CANCER, V131, P692, DOI 10.1002/ijc.26404; Chan PKS, 2009, J MED VIROL, V81, P1635, DOI 10.1002/jmv.21575; Chan ZCY, 2011, ASIAN PAC J CANCER P, V12, P1095; Daley MF, 2006, PEDIATRICS, V118, P2280, DOI 10.1542/peds.2006-1946; Daley MF, 2010, PEDIATRICS, V126, P425, DOI 10.1542/peds.2009-3500; Dinh TA, 2007, J ADOLESCENT HEALTH, V40, P559, DOI 10.1016/j.jadohealth.2007.02.003; Dixon E, 2011, THESIS GEORGIA SO U; Duval B, 2007, VACCINE, V25, P7841, DOI 10.1016/j.vaccine.2007.08.041; Franco EL, 2005, VACCINE, V23, P2388, DOI 10.1016/j.vaccine.2005.01.016; Franco MFE, 2011, THESIS U CHESTER; Garland S, 2008, VACCINE, V26, P5435, DOI 10.1016/j.vaccine.2008.07.077; Gerend MA, 2007, SEX TRANSM DIS, V34, P468, DOI 10.1097/01.olq.0000245915.38315.bd; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Huey NL, 2009, PREV CHRONIC DIS, V6; Jaspan DM, 2008, J LOW GENIT TRACT DI, V12, P118, DOI 10.1097/LGT.0b013e31815d9639; Lee A, 2012, 50 ANN MULT C HONG K; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Ogilvie GS, 2007, CAN MED ASSOC J, V177, P1506, DOI 10.1503/cmaj.071022; Raley Janice C, 2004, Infect Dis Obstet Gynecol, V12, P127, DOI 10.1080/10647440400020661; Riedesel J M, 2005, J Pediatr Adolesc Gynecol, V18, P391, DOI 10.1016/j.jpag.2005.09.004; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Schiffman M, 2003, ARCH PATHOL LAB MED, V127, P930; Tan J, 2010, AUST NZ J OBSTET GYN, V50, P472, DOI 10.1111/j.1479-828X.2010.01205.x; Trottier H, 2005, VACCINE, V24, pS1; *US FDA, 2006, FDA LIC NEW VACC PRE; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Zimet GD, 2000, SEX TRANSM DIS, V27, P49, DOI 10.1097/00007435-200001000-00010	33	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71827	10.1371/journal.pone.0071827	http://dx.doi.org/10.1371/journal.pone.0071827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990994	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100057
J	Lewandowska, D; ten Have, S; Hodge, K; Tillemans, V; Lamond, AI; Brown, JWS				Lewandowska, Dominika; ten Have, Sara; Hodge, Kelly; Tillemans, Vinciane; Lamond, Angus I.; Brown, John W. S.			Plant SILAC: Stable-Isotope Labelling with Amino Acids of Arabidopsis Seedlings for Quantitative Proteomics	PLOS ONE			English	Article							STRESS-RESPONSIVE PROTEINS; CELL-CULTURE; PEPTIDE IDENTIFICATION; THALIANA; SALT; SALINITY; GENES; MOUSE	Stable Isotope Labelling by Amino acids in Cell culture (SILAC) is a powerful technique for comparative quantitative proteomics, which has recently been applied to a number of different eukaryotic organisms. Inefficient incorporation of labelled amino acids in cell cultures of Arabidopsis thaliana has led to very limited use of SILAC in plant systems. We present a method allowing, for the first time, efficient labelling with stable isotope-containing arginine and lysine of whole Arabidopsis seedlings. To illustrate the utility of this method, we have combined the high labelling efficiency (>95%) with quantitative proteomics analyses of seedlings exposed to increased salt concentration. In plants treated for 7 days with 80 mM NaCl, a relatively mild salt stress, 215 proteins were identified whose expression levels changed significantly compared to untreated seedling controls. The 92 up-regulated proteins included proteins involved in abiotic stress responses and photosynthesis, while the 123 down-regulated proteins were enriched in proteins involved in reduction of oxidative stress and other stress responses, respectively. Efficient labelling of whole Arabidopsis seedlings by this modified SILAC method opens new opportunities to exploit the genetic resources of Arabidopsis and analyse the impact of mutations on quantitative protein dynamics in vivo.	[Lewandowska, Dominika; Tillemans, Vinciane; Brown, John W. S.] James Hutton Inst, Dundee, Scotland; [Lewandowska, Dominika; Brown, John W. S.] James Hutton Inst, Div Plant Sci, Coll Life Sci, Univ Dundee, Dundee, Scotland; [ten Have, Sara; Hodge, Kelly; Lamond, Angus I.] Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland	James Hutton Institute; James Hutton Institute; University of Dundee; University of Dundee	Brown, JWS (corresponding author), James Hutton Inst, Dundee, Scotland.	j.w.s.brown@dundee.ac.uk		Lamond, Angus/0000-0001-6204-6045	Wellcome Trust [073980/Z/03/Z, 083524/Z/07/Z, 97945/B/11/Z]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G024979/1, BB/K013661/1]; Scottish Government Rural and Environment Science and Analytical Services division (RESAS); Fonds de la Recherche Scientifique - FNRS, Belgium; Biotechnology and Biological Sciences Research Council [BB/K013661/1, BB/G024979/1] Funding Source: researchfish; BBSRC [BB/G024979/1, BB/K013661/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government Rural and Environment Science and Analytical Services division (RESAS); Fonds de la Recherche Scientifique - FNRS, Belgium(Fonds de la Recherche Scientifique - FNRS); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Wellcome Trust (073980/Z/03/Z, 083524/Z/07/Z and 97945/B/11/Z), from the Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G024979/1 and BB/K013661/1]; and the Scottish Government Rural and Environment Science and Analytical Services division (RESAS). V.T. was supported by the Fonds de la Recherche Scientifique - FNRS, Belgium. A.I.L is a Wellcome Trust Principal Research fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bicho CC, 2010, MOL CELL PROTEOMICS, V9, P1567, DOI 10.1074/mcp.M110.000208; Bindschedler LV, 2008, PHYTOCHEMISTRY, V69, P1962, DOI 10.1016/j.phytochem.2008.04.007; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Engelsberger WR, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-14; Fredens J, 2011, NAT METHODS, V8, P845, DOI [10.1038/NMETH.1675, 10.1038/nmeth.1675]; Gong ZZ, 2001, PLANT PHYSIOL, V126, P363, DOI 10.1104/pp.126.1.363; Gouw JW, 2010, MOL CELL PROTEOMICS, V9, P11, DOI 10.1074/mcp.R900001-MCP200; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P1697, DOI 10.1074/mcp.M500190-MCP200; Hebeler R, 2008, MOL CELL PROTEOMICS, V7, P108, DOI 10.1074/mcp.M700340-MCP200; Jander G, 2009, ARABIDOPSIS BOOK, V7, pe0121; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; Kaffarnik FAR, 2009, MOL CELL PROTEOMICS, V8, P145, DOI 10.1074/mcp.M800043-MCP200; Kim JK, 2005, BIOSCI BIOTECH BIOCH, V69, P1331, DOI 10.1271/bbb.69.1331; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Laganowsky A, 2009, J PROTEOMICS, V72, P397, DOI 10.1016/j.jprot.2009.01.024; Lanquar V, 2007, PROTEOMICS, V7, P750, DOI 10.1002/pmic.200600791; Larance M, 2011, NAT METHODS, V8, P849, DOI [10.1038/NMETH.1679, 10.1038/nmeth.1679]; Mastrobuoni G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-215; Mukherjee AK, 2010, J PROTEOMICS, V73, P709, DOI 10.1016/j.jprot.2009.10.005; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Ndimba BK, 2005, PROTEOMICS, V5, P4185, DOI 10.1002/pmic.200401282; Nelson CJ, 2007, PROTEOMICS, V7, P1279, DOI 10.1002/pmic.200600832; Oliveros JC, 2007, VENNY INTERACTIVE TO; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pang QY, 2010, J PROTEOME RES, V9, P2584, DOI 10.1021/pr100034f; Schaff JE, 2008, PLANT J, V56, P840, DOI 10.1111/j.1365-313X.2008.03639.x; Schutz W, 2011, PLANT CELL, V23, P1701, DOI 10.1105/tpc.110.082016; Semane B, 2010, J PLANT PHYSIOL, V167, P247, DOI 10.1016/j.jplph.2009.09.015; Simpson PJ, 2009, J MOL BIOL, V392, P465, DOI 10.1016/j.jmb.2009.07.023; Slocum RD, 2005, PLANT PHYSIOL BIOCH, V43, P729, DOI 10.1016/j.plaphy.2005.06.007; Van Hoof D, 2007, NAT METHODS, V4, P677, DOI 10.1038/nmeth0907-677	38	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72207	10.1371/journal.pone.0072207	http://dx.doi.org/10.1371/journal.pone.0072207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977254	Green Submitted, Green Published, gold			2022-12-25	WOS:000324527300072
J	Puri, S; Garcia-Nunez, A; Hebrok, M; Cano, DA				Puri, Sapna; Garcia-Nunez, Alejandro; Hebrok, Matthias; Cano, David A.			Elimination of Von Hippel-Lindau Function Perturbs Pancreas Endocrine Homeostasis in Mice	PLOS ONE			English	Article							ALPHA-CELLS; GLUCAGON-SECRETION; BETA-CELLS; IN-VIVO; INSULIN-SECRETION; GENE-EXPRESSION; GLUCOSE; REGULATOR; HYPOXIA; STABILIZATION	Mutations in the human homolog of the Vhlh gene [encoding the von-Hippel Lindau (VHL) protein] lead to tumor development. In mice, depletion of Vhlh in pancreatic beta-cells causes perturbed glucose homeostasis, but the role of this gene in other pancreatic cells is poorly understood. To investigate the function of VHL/HIF pathway in pancreatic cells, we inactivated Vhlh in the pancreatic epithelium as well as in the endocrine and exocrine lineages. Our results show that embryonic depletion of Vhlh within the pancreatic epithelium causes postnatal lethality due to severe hypoglycemia. The hypoglycemia is recapitulated in mice with endocrine-specific removal of Vhlh, while animals with loss of Vhlh predominantly in the exocrine compartment survive to adulthood with no overt defects in glucose metabolism. Mice with hypoglycemia display diminished insulin release in response to elevated glucose. Significantly, the glucagon response is impaired both in vivo (circulating glucagon levels) as well as in an in vitro secretion assay in isolated islets. Hypoxia also impairs glucagon secretion in a glucagon-expressing cell line in culture. Our results reveal a novel role for the hypoxia/HIF pathway in islet hormone secretion and maintenance of the fine balance that allows for the establishment of normoglycemia.	[Puri, Sapna; Hebrok, Matthias] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA USA; [Garcia-Nunez, Alejandro; Cano, David A.] Univ Seville, Hosp Univ Virgen Rocio, CSIC, Serv Endocrinol & Nutr,Inst Biomed Sevilla, Seville, Spain	University of California System; University of California San Francisco; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Cano, DA (corresponding author), Univ Seville, Hosp Univ Virgen Rocio, CSIC, Serv Endocrinol & Nutr,Inst Biomed Sevilla, Seville, Spain.	dcano-ibis@us.es	Garcia Nuñez, Alejandro/ABG-2122-2020; Cano, David A./B-8013-2015	Garcia Nuñez, Alejandro/0000-0002-0090-9930; Cano, David A./0000-0001-6264-3288	Leona M. and Harry B. Helmsley Charitable Trust; National Institutes of Health (NIH) [R01 DK60533]; Andalusian Regional Government [P08-CVI-3727]; "Ramon y Cajal" program [RYC-2006-001071]; Spanish Ministry of Science and Innovation [SAF2008-02469, SAF2011-26805]; Andalusian Regional Ministry of Health [PI-0250/2008]; NIH [DK60533]; Juvenile Diabetes Research Foundation; imaging and islet cores of the UCSF Diabetes and Endocrinology Research Center (DERC) NIH [P30DK63720]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060533, P30DK063720] Funding Source: NIH RePORTER	Leona M. and Harry B. Helmsley Charitable Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Andalusian Regional Government; "Ramon y Cajal" program(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Andalusian Regional Ministry of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); imaging and islet cores of the UCSF Diabetes and Endocrinology Research Center (DERC) NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SP was supported by a grant from the Leona M. and Harry B. Helmsley Charitable Trust and a grant from the National Institutes of Health (NIH) (R01 DK60533). AGN was supported by a fellowship from the Andalusian Regional Government (P08-CVI-3727). DAC was supported by the "Ramon y Cajal" program (RYC-2006-001071) and grants (SAF2008-02469 and SAF2011-26805) from the Spanish Ministry of Science and Innovation and the Andalusian Regional Ministry of Health (PI-0250/2008). Work in MH's laboratory was supported by grants from the NIH (DK60533) and a Scholar Award from the Juvenile Diabetes Research Foundation. Image acquisition and islet isolation were supported by the imaging and islet cores of the UCSF Diabetes and Endocrinology Research Center (DERC) NIH grant P30DK63720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloch K, 2012, HISTOCHEM CELL BIOL, V137, P801, DOI 10.1007/s00418-012-0925-4; Cano DA, 2006, GASTROENTEROLOGY, V131, P1856, DOI 10.1053/j.gastro.2006.10.050; Cantley J, 2010, DIABETES OBES METAB, V12, P159, DOI 10.1111/j.1463-1326.2010.01276.x; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Ernst SJ, 2009, ENDOCRINOLOGY, V150, P1132, DOI 10.1210/en.2008-0991; Fraker CA, 2009, BIOL CELL, V101, P431, DOI 10.1042/BC20080178; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hancock AS, 2010, MOL ENDOCRINOL, V24, P1605, DOI 10.1210/me.2010-0120; Hayashi Y, 2009, MOL ENDOCRINOL, V23, P1990, DOI 10.1210/me.2009-0296; Heinis M, 2009, DIABETES; Heiser PW, 2008, GASTROENTEROLOGY, V135, P1288, DOI 10.1053/j.gastro.2008.06.089; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Jermendy A, 2011, DIABETOLOGIA, V54, P594, DOI 10.1007/s00125-010-2036-x; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Lacraz G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006963; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Puri S, 2009, DIABETES, V58, P433, DOI 10.2337/db08-0749; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; Schonhoff SE, 2004, DEV BIOL, V270, P443, DOI 10.1016/j.ydbio.2004.03.013; Shah YM, 2008, GASTROENTEROLOGY, V134, P2036, DOI 10.1053/j.gastro.2008.03.009; Shen HCJ, 2010, ENDOCRINOLOGY, V151, P4024, DOI 10.1210/en.2009-1251; Shen HCJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004897; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Song JH, 2010, GENESIS, V48, P628, DOI 10.1002/dvg.20672; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908	36	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72213	10.1371/journal.pone.0072213	http://dx.doi.org/10.1371/journal.pone.0072213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977255	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300073
J	Yang, L; Munck, M; Swaminathan, K; Kapinos, LE; Noegel, AA; Neumann, S				Yang, Liu; Munck, Martina; Swaminathan, Karthic; Kapinos, Larisa E.; Noegel, Angelika A.; Neumann, Sascha			Mutations in LMNA Modulate the Lamin A - Nesprin-2 Interaction and Cause LINC Complex Alterations	PLOS ONE			English	Article							FAMILIAL PARTIAL LIPODYSTROPHY; STEROL REGULATORY ELEMENT; DREIFUSS MUSCULAR-DYSTROPHY; NUCLEAR-MEMBRANE PROTEIN; A-TYPE LAMINS; DILATED CARDIOMYOPATHY; METABOLIC SYNDROME; BINDING-SITE; HELA-CELLS; A/C GENE	Background: In eukaryotes the genetic material is enclosed by a continuous membrane system, the nuclear envelope (NE). Along the NE specific proteins assemble to form meshworks and mutations in these proteins have been described in a group of human diseases called laminopathies. Laminopathies include lipodystrophies, muscle and cardiac diseases as well as metabolic or progeroid syndromes. Most laminopathies are caused by mutations in the LMNAgene encoding lamins A/C. Together with Nesprins (Nuclear Envelope Spectrin Repeat Proteins) they are core components of the LINC complex (Linker of Nucleoskeleton and Cytoskeleton). The LINC complex connects the nucleoskeleton and the cytoskeleton and plays a role in the transfer of mechanically induced signals along the NE into the nucleus, and its components have been attributed functions in maintaining nuclear and cellular organization as well as signal transduction. Results: Here we narrowed down the interaction sites between lamin A and Nesprin-2 to aa 403-425 in lamin A and aa 6146-6347 in Nesprin-2. Laminopathic mutations in and around the involved region of lamin A (R401C, G411D, G413C, V415I, R419C, L421P, R427G, Q432X) modulate the interaction with Nesprin-2 and this may contribute to the disease phenotype. The most notable mutation is the lamin A mutation Q432X that alters LINC complex protein assemblies and causes chromosomal and transcription factor rearrangements. Conclusion: Mutations in Nesprin-2 and lamin A are characterised by complex genotype phenotype relations. Our data show that each mutation in LMNAanalysed here has a distinct impact on the interaction among both proteins that substantially explains how distinct mutations in widely expressed genes lead to the formation of phenotypically different diseases.	[Yang, Liu; Munck, Martina; Swaminathan, Karthic; Noegel, Angelika A.; Neumann, Sascha] Univ Cologne, Fac Med, Inst Biochem 1, D-50931 Cologne, Germany; [Yang, Liu; Munck, Martina; Swaminathan, Karthic; Noegel, Angelika A.; Neumann, Sascha] Univ Cologne, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany; [Yang, Liu; Munck, Martina; Swaminathan, Karthic; Noegel, Angelika A.; Neumann, Sascha] Univ Cologne, Fac Med, Cologne Cluster Cellular Stress Responses Aging A, D-50931 Cologne, Germany; [Kapinos, Larisa E.] Univ Basel, Biozentrum, Basel, Switzerland; [Kapinos, Larisa E.] Univ Basel, Nanosci Inst, Basel, Switzerland	University of Cologne; University of Cologne; University of Cologne; University of Basel; University of Basel	Noegel, AA (corresponding author), Univ Cologne, Fac Med, Inst Biochem 1, D-50931 Cologne, Germany.	noegel@uni-koeln.de; neumanns@uni-koeln.de		Swaminathan, Karthic/0000-0002-0981-7549; Kapinos, Larisa E./0000-0001-6101-0876	Center for Molecular Medicine, University of Cologne; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases; China Scholarship Council (CSC)	Center for Molecular Medicine, University of Cologne; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases; China Scholarship Council (CSC)(China Scholarship Council)	The work was supported by the Center for Molecular Medicine, University of Cologne, the Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases. LY is supported by a fellowship from the China Scholarship Council (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Bechert K, 2003, EXP CELL RES, V286, P75, DOI 10.1016/S0014-4827(03)00104-6; Bertrand AT, 2011, BIOCHEM SOC T, V39, P1687, DOI 10.1042/BST20110670; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brauch KM, 2009, AM J CARDIOL, V103, P1426, DOI 10.1016/j.amjcard.2009.01.354; Broers JLV, 1999, J CELL SCI, V112, P3463; Capanni C, 2005, HUM MOL GENET, V14, P1489, DOI 10.1093/hmg/ddi158; Capanni C, 2003, EXP CELL RES, V291, P122, DOI 10.1016/S0014-4827(03)00395-1; Caron M, 2007, CELL DEATH DIFFER, V14, P1759, DOI 10.1038/sj.cdd.4402197; Chambliss AB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01087; Clements L, 2000, BIOCHEM BIOPH RES CO, V267, P709, DOI 10.1006/bbrc.1999.2023; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Decaudain A, 2007, J CLIN ENDOCR METAB, V92, P4835, DOI 10.1210/jc.2007-0654; Dessalle K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050878; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Dutour A, 2011, HUM MOL GENET, V20, P3779, DOI 10.1093/hmg/ddr294; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guillet-Deniau I, 2002, DIABETES, V51, P1722, DOI 10.2337/diabetes.51.6.1722; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Haque WA, 2003, DIABETES CARE, V26, P1350, DOI 10.2337/diacare.26.5.1350; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Ho CY, 2012, J CELL SCI, V125, P2087, DOI 10.1242/jcs.087288; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hubner S, 2006, J CELL BIOCHEM, V98, P810, DOI 10.1002/jcb.20791; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Kandert S, 2007, HUM MOL GENET, V16, P2944, DOI 10.1093/hmg/ddm255; Kapinos LE, 2010, J MOL BIOL, V396, P719, DOI 10.1016/j.jmb.2009.12.001; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; Lu W, 2012, CELL MOL LIFE SCI; Lu WS, 2008, BBA-MOL CELL RES, V1783, P2415, DOI 10.1016/j.bbamcr.2008.09.001; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Maraldi NM, 2011, J CELL BIOCHEM, V112, P979, DOI 10.1002/jcb.22992; Mariappan I, 2007, BIOCHEM BIOPH RES CO, V355, P981, DOI 10.1016/j.bbrc.2007.02.060; Mellad JA, 2011, CURR OPIN CELL BIOL, V23, P47, DOI 10.1016/j.ceb.2010.11.006; Moller DV, 2009, EUR J HEART FAIL, V11, P1031, DOI 10.1093/eurjhf/hfp134; Neumann S, 2010, J BIOL CHEM, V285, P34932, DOI 10.1074/jbc.M110.119651; Paradisi M, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-27; Rajgor D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040098; Rashmi RN, 2012, NUCLEUS-PHILA, V3, P172, DOI 10.4161/nucl.19090; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Simpson JG, 2008, BIOCHEM SOC T, V36, P1359, DOI 10.1042/BST0361359; Stierle VN, 2003, BIOCHEMISTRY-US, V42, P4819, DOI 10.1021/bi020704g; Sylvius N, 2008, EXP CELL RES, V314, P2362, DOI 10.1016/j.yexcr.2008.04.017; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; Taranum Surayya, 2012, Int J Cell Biol, V2012, P736524, DOI 10.1155/2012/736524; Taranum S, 2012, EUR J CELL BIOL, V91, P614, DOI 10.1016/j.ejcb.2012.03.003; Vigouroux C, 2001, J CELL SCI, V114, P4459; Vytopil M, 2002, NEUROMUSCULAR DISORD, V12, P958, DOI 10.1016/S0960-8966(02)00178-5; WANG XD, 1993, J BIOL CHEM, V268, P14497; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Wang Z, 2010, BIOINFORMATICS, V26, P882, DOI 10.1093/bioinformatics/btq058; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Williams C, 2012, SCIENCE, V338, P1209, DOI 10.1126/science.1228633; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Zaremba-Czogalla M, 2011, CELL MOL BIOL LETT, V16, P114, DOI 10.2478/s11658-010-0038-9; Zhen YY, 2002, J CELL SCI, V115, P3207	68	31	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71850	10.1371/journal.pone.0071850	http://dx.doi.org/10.1371/journal.pone.0071850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977161	gold, Green Submitted, Green Published			2022-12-25	WOS:000324527300045
J	Barbieri, NL; de Oliveira, AL; Tejkowski, TM; Pavanelo, DB; Rocha, DA; Matter, LB; Callegari-Jacques, SM; de Brito, BG; Horn, F				Barbieri, Nicolle Lima; de Oliveira, Aline Luisa; Tejkowski, Thiago Moreira; Pavanelo, Daniel Brisotto; Rocha, Debora Assumpcao; Matter, Leticia Beatriz; Callegari-Jacques, Sidia Maria; de Brito, Benito Guimaraes; Horn, Fabiana			Genotypes and Pathogenicity of Cellulitis Isolates Reveal Traits That Modulate APEC Virulence	PLOS ONE			English	Article							AVIAN ESCHERICHIA-COLI; URINARY-TRACT-INFECTION; ANTIMICROBIAL RESISTANCE; MOLECULAR CHARACTERIZATION; CHI-7122 O78K80H9; BROILER-CHICKENS; DNA-SEQUENCE; STRAINS; GENES; PLASMID	We characterized 144 Escherichia coli isolates from severe cellulitis lesions in broiler chickens from South Brazil. Analysis of susceptibility to 15 antimicrobials revealed frequencies of resistance of less than 30% for most antimicrobials except tetracycline (70%) and sulphonamides (60%). The genotyping of 34 virulence-associated genes revealed that all the isolates harbored virulence factors related to adhesion, iron acquisition and serum resistance, which are characteristic of the avian pathogenic E. coli (APEC) pathotype. ColV plasmid-associated genes (cvi/cva, iroN, iss, iucD, sitD, traT, tsh) were especially frequent among the isolates (from 66.6% to 89.6%). According to the Clermont method of ECOR phylogenetic typing, isolates belonged to group D (47.2%), to group A (27.8%), to group B2 (17.4%) and to group B1 (7.6%); the group B2 isolates contained the highest number of virulence-associated genes. Clonal relationship analysis using the ARDRA method revealed a similarity level of 57% or higher among isolates, but no endemic clone. The virulence of the isolates was confirmed in vivo in one-day-old chicks. Most isolates (72.9%) killed all infected chicks within 7 days, and 65 isolates (38.1%) killed most of them within 24 hours. In order to analyze differences in virulence among the APEC isolates, we created a pathogenicity score by combining the times of death with the clinical symptoms noted. By looking for significant associations between the presence of virulence-associated genes and the pathogenicity score, we found that the presence of genes for invasins ibeA and gimB and for group II capsule KpsMTII increased virulence, while the presence of pic decreased virulence. The fact that ibeA, gimB and KpsMTII are characteristic of neonatal meningitis E. coli (NMEC) suggests that genes of NMEC in APEC increase virulence of strains.	[Barbieri, Nicolle Lima; de Oliveira, Aline Luisa; Pavanelo, Daniel Brisotto; Rocha, Debora Assumpcao; Matter, Leticia Beatriz; Horn, Fabiana] Univ Fed Rio Grande do Sul, Dept Biofis, Porto Alegre, RS, Brazil; [Tejkowski, Thiago Moreira; de Brito, Benito Guimaraes] Inst Pesquisas Vet Desiderio Finamor, Eldorado Do Sul, RS, Brazil; [Matter, Leticia Beatriz] Univ Reg Integrada Alto Uruguai & Missoes, Dept Ciencias Saude, Santo Angelo, RS, Brazil; [Callegari-Jacques, Sidia Maria] Univ Fed Rio Grande do Sul, Dept Estat, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Regional Integrada do Alto Uruguai e das Missoes (URI); Universidade Federal do Rio Grande do Sul	Horn, F (corresponding author), Univ Fed Rio Grande do Sul, Dept Biofis, Porto Alegre, RS, Brazil.	fabiana.horn@ufrgs.br	Callegari-Jacques, Sidia M/H-1774-2016; Barbieri, Nicolle Lima/L-6477-2013; Horn, Fabiana/K-9637-2013; Barbieri, Nicolle/AAB-3223-2020; Pavanelo, Daniel Brisotto/AAG-2890-2019; de Oliveira, Aline Luisa/ABA-8787-2021; Lima Barbieri, Nicolle/L-6477-2013	Barbieri, Nicolle Lima/0000-0002-8223-6580; Lima Barbieri, Nicolle/0000-0001-8641-7592; Pavanelo, Daniel/0000-0001-7104-0761; CALLEGARI JACQUES, SIDIA M./0000-0002-2489-2539; Assumpcao Rocha, Debora/0000-0002-2524-076X	CNPq (MAPA, Brazil) [578364/2008-5]; CNPq studentship (RHAE) [573367/2008-6]; CNPq Ph.D. studentship	CNPq (MAPA, Brazil); CNPq studentship (RHAE); CNPq Ph.D. studentship	This work was partially supported by CNPq (MAPA 578364/2008-5, Brazil). T.M.T. was the recipient of a CNPq studentship (RHAE 573367/2008-6), and N.L.B. held a CAPES Master Degree studentship (Ministry of Education, Brazil) and is currently supported by a CNPq Ph.D. studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PERF STAND ANT SUSC; Anton AI, 1998, J MOL EVOL, V47, P62, DOI 10.1007/PL00006363; Barbieri NL, 2012, AVIAN DIS, V56, P436, DOI 10.1637/9921-090811-Case.1; Blanco JE, 1997, J CLIN MICROBIOL, V35, P2184, DOI 10.1128/JCM.35.8.2184-2185.1997; Bonacorsi S, 2003, J INFECT DIS, V187, P1895, DOI 10.1086/375347; Chen X, 2012, AFR J MICROBIOL RES, V6, P1001, DOI [10.5897/AJMR11.1220, 10.5897/AJMR-11-1220]; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clinical and Laboratory Standards Institute, 2020, M100 CLSI, V30th; Cormican M, 2001, J ANTIMICROB CHEMOTH, V48, P587, DOI 10.1093/jac/48.4.587; de Brito BG, 2003, INFECT IMMUN, V71, P4175, DOI 10.1128/IAI.71.7.4175-4177.2003; Dho-Moulin M, 1999, VET RES, V30, P299; Dziva F, 2008, AVIAN PATHOL, V37, P355, DOI 10.1080/03079450802216652; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; Fallavena LCB, 2000, AVIAN PATHOL, V29, P557, DOI 10.1080/03079450020016797; GarciaMartinez J, 1996, FEMS IMMUNOL MED MIC, V14, P231, DOI 10.1016/0928-8244(96)00037-5; Germon P, 2005, MICROBIOL-SGM, V151, P1179, DOI 10.1099/mic.0.27809-0; Gyles Carlton L., 2008, Animal Health Research Reviews, V9, P149, DOI 10.1017/S1466252308001552; Heimer SR, 2004, INFECT IMMUN, V72, P593, DOI 10.1128/IAI.72.1.593-597.2004; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Horn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041031; Jeffrey JS, 2002, AVIAN DIS, V46, P48, DOI 10.1637/0005-2086(2002)046[0048:VFOECF]2.0.CO;2; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Li GW, 2011, INFECT IMMUN, V79, P1951, DOI 10.1128/IAI.01230-10; Li GW, 2005, INFECT IMMUN, V73, P2818, DOI 10.1128/IAI.73.5.2818-2827.2005; Mellata M, 2010, INFECT IMMUN, V78, P1528, DOI 10.1128/IAI.00981-09; Mellata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004232; Mora A, 2010, APPL ENVIRON MICROB, V76, P6991, DOI 10.1128/AEM.01112-10; Moulin-Schouleur M, 2006, J CLIN MICROBIOL, V44, P3484, DOI 10.1128/JCM.00548-06; Ngeleka M, 1996, INFECT IMMUN, V64, P3118, DOI 10.1128/IAI.64.8.3118-3126.1996; Norton RA, 1997, AVIAN DIS, V41, P422, DOI 10.2307/1592198; Ozawa M, 2008, AVIAN DIS, V52, P392, DOI 10.1637/8193-120907-Reg; PEIGHAMBARI SM, 1995, AVIAN DIS, V39, P116, DOI 10.2307/1591990; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; ROSENBERGER JK, 1985, AVIAN DIS, V29, P1094, DOI 10.2307/1590464; Sayah RS, 2005, APPL ENVIRON MICROB, V71, P1394, DOI 10.1128/AEM.71.3.1394-1404.2005; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Schouler C, 2012, J CLIN MICROBIOL, V50, P1673, DOI 10.1128/JCM.05057-11; Schroeder CM, 2002, EMERG INFECT DIS, V8, P1409, DOI 10.3201/eid0812.0200770; Skyberg JA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-24; Up JP, 2003, NEW ANIMAL DRUG EVAL; VIDOTTO MC, 1990, AVIAN DIS, V34, P531, DOI 10.2307/1591241; WOOLEY RE, 1992, AVIAN DIS, V36, P679, DOI 10.2307/1591764; Yang HC, 2004, J CLIN MICROBIOL, V42, P3483, DOI 10.1128/JCM.42.8.3483-3489.2004; Zhao LX, 2009, MICROBIOL-SGM, V155, P1634, DOI 10.1099/mic.0.024869-0; Zhao SH, 2005, VET MICROBIOL, V107, P215, DOI 10.1016/j.vetmic.2005.01.021	49	37	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72322	10.1371/journal.pone.0072322	http://dx.doi.org/10.1371/journal.pone.0072322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977279	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700164
J	Chappell, TM; Beaudoin, ALP; Kennedy, GG				Chappell, Thomas M.; Beaudoin, Amanda L. P.; Kennedy, George G.			Interacting Virus Abundance and Transmission Intensity Underlie Tomato Spotted Wilt Virus Incidence: An Example Weather-Based Model for Cultivated Tobacco	PLOS ONE			English	Article							FRANKLINIELLA-FUSCA THYSANOPTERA; ACIBENZOLAR-S-METHYL; INTEGRATED MANAGEMENT; THRIPS THYSANOPTERA; WEED HOSTS; TOSPOVIRUS; PEPPER; SPREAD; OCCIDENTALIS; EPIDEMIOLOGY	Through a modeling approach, we investigated weather factors that affect the summer incidence of Tomato spotted wilt virus (TSWV), a virus vectored exclusively by thrips, in cultivated tobacco. Aspects of thrips and plant biology that affect disease spread were treated as functions of weather, leading to a model of disease incidence informed by thrips and plant biology, and dependent on weather input variables. We found that disease incidence during the summer was influenced by weather affecting thrips activity during the preceding year, especially during a time when thrips transmit TSWV to and from the plant hosts that constitute the virus' natural reservoir. We identified an interaction between spring precipitation and earlier weather affecting thrips, relating this to virus abundance and transmission intensity as interacting factors affecting disease incidence. Throughout, weather is the basic driver of epidemiology in the system, and our findings allowed us to detect associations between atypically high- or low-incidence years and the local climatic deviations from normal weather patterns, brought about by El Nino Southern Oscillation transitions.	[Chappell, Thomas M.; Beaudoin, Amanda L. P.; Kennedy, George G.] N Carolina State Univ, Coll Agr & Life Sci, Dept Entomol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Chappell, TM (corresponding author), N Carolina State Univ, Coll Agr & Life Sci, Dept Entomol, Raleigh, NC 27695 USA.	tmchappe@ncsu.edu			USDA CSREES Risk Avoidance and Mitigation Program [RF330-411-3843858]	USDA CSREES Risk Avoidance and Mitigation Program(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by USDA CSREES Risk Avoidance and Mitigation Program Grant #RF330-411-3843858. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAMBERLIN JR, 1992, ENVIRON ENTOMOL, V21, P121, DOI 10.1093/ee/21.1.121; Chatzivassiliou EK, 2008, PLANT DIS, V92, P1012, DOI 10.1094/PDIS-92-7-1012; Cherry K, 2009, PLANT DIS MANAGEMENT, V3, pFC084, DOI [10.1094/PDMR03, DOI 10.1094/PDMR03]; Coutts BA, 2005, ANN APPL BIOL, V146, P95, DOI 10.1111/j.1744-7348.2005.04033.x; Coutts BA, 2004, ANN APPL BIOL, V145, P231, DOI 10.1111/j.1744-7348.2004.tb00379.x; Csinos AS, 2001, PLANT DIS, V85, P292, DOI 10.1094/PDIS.2001.85.3.292; GETZ WM, 1982, ANNU REV ENTOMOL, V27, P447, DOI 10.1146/annurev.en.27.010182.002311; Gitaitis RD, 1998, PLANT DIS, V82, P752, DOI 10.1094/PDIS.1998.82.7.752; Groves RL, 2001, PHYTOPATHOLOGY, V91, P891, DOI 10.1094/PHYTO.2001.91.9.891; Groves RL, 2003, J ECON ENTOMOL, V96, P1, DOI 10.1603/0022-0493-96.1.1; Groves RL, 2002, PLANT DIS, V86, P573, DOI 10.1094/PDIS.2002.86.6.573; Groves RL, 2001, CROP PROT, V20, P439, DOI 10.1016/S0261-2194(00)00171-X; Hagan A. K., 1990, Plant Disease, V74, P615, DOI 10.1094/PD-74-0615B; HOBBS HA, 1993, PLANT DIS, V77, P797, DOI 10.1094/PD-77-0797; Holt J, 1997, J APPL ECOL, V34, P793, DOI 10.2307/2404924; Jeger MJ, 1998, IMA J MATH APPL MED, V15, P1; Kahn ND, 2005, J ECON ENTOMOL, V98, P1810, DOI 10.1603/0022-0493-98.6.1810; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; LOWRY VK, 1992, ANN ENTOMOL SOC AM, V85, P744, DOI 10.1093/aesa/85.6.744; Madden L.V., 1983, P159; MADDEN LV, 1990, RES POPUL ECOL, V32, P47, DOI 10.1007/BF02512589; Madden LV, 2000, PHYTOPATHOLOGY, V90, P576, DOI 10.1094/PHYTO.2000.90.6.576; Martins AS, 1997, FISH RES, V30, P217, DOI 10.1016/S0165-7836(96)00566-8; McPhaden MJ, 2004, B AM METEOROL SOC, V85, P677, DOI 10.1175/BAMS-85-5-677; Melton TA, 2004, FLUECURED TOBACCO; Mila AL, 2011, PHYTOPATHOLOGY, V101, P462, DOI 10.1094/PHYTO-05-10-0146; Mila AL, 2009, 2009 FLUE CURED TOBA, P140; Momol MT, 2004, PLANT DIS, V88, P882, DOI 10.1094/PDIS.2004.88.8.882; Morsello SC, 2010, ENTOMOL EXP APPL, P134; Morsello SC, 2009, ENTOMOL EXP APPL, V130, P138, DOI 10.1111/j.1570-7458.2008.00801.x; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; Pappu HR, 2000, CROP PROT, V19, P349, DOI 10.1016/S0261-2194(00)00028-4; Pappu SS, 1998, PLANT DIS, V82, P351, DOI 10.1094/PDIS.1998.82.3.351C; Reitz SR, 2003, J ECON ENTOMOL, V96, P1201, DOI 10.1603/0022-0493-96.4.1201; Riley DG, 2004, J ECON ENTOMOL, V97, P1648, DOI 10.1603/0022-0493-97.5.1648; Spence N. J., 2001, Biotic interactions in plant-pathogen associations, P15, DOI 10.1079/9780851995120.0015; STINNER RE, 1974, CAN ENTOMOL, V106, P519, DOI 10.4039/Ent106519-5; Stroup W.W., 2012, GEN LINEAR MIXED MOD; Ullman D.E., 1992, Advances in Disease Vector Research, V9, P195; Ullman DE, 2002, ADV BOT RES, V36, P113, DOI 10.1016/S0065-2296(02)36061-0	40	20	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e73321	10.1371/journal.pone.0073321	http://dx.doi.org/10.1371/journal.pone.0073321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977384	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700196
J	Henry, LG; Aruni, W; Sandberg, L; Fletcher, HM				Henry, Leroy G.; Aruni, Wilson; Sandberg, Lawrence; Fletcher, Hansel M.			Protective Role of the PG1036-PG1037-PG1038 Operon in Oxidative Stress in Porphyromonas gingivalis W83	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; IRON PROTOPORPHYRIN IX; DNA-DAMAGE; HYDROGEN-PEROXIDE; FUSOBACTERIUM-NUCLEATUM; CYSTEINE PROTEINASES; CELL-ADHESION; FREE-RADICALS; GENE; GINGIPAINS	As an anaerobe, Porphyromonas gingivalis is significantly affected by the harsh inflammatory environment of the periodontal pocket during initial colonization and active periodontal disease. We reported previously that the repair of oxidative stress-induced DNA damage involving 8-oxo-7,8-dihydroguanine (8-oxoG) may occur by an undescribed mechanism in P. gingivalis. DNA affinity fractionation identified PG1037, a conserved hypothetical protein, among other proteins, that were bound to the 8-oxoG lesion. PG1037 is part of the uvrA-PG1037-pcrA operon in P. gingivalis which is known to be upregulated under H2O2 induced stress. A PCR-based linear transformation method was used to inactivate the uvrA and pcrA genes by allelic exchange mutagenesis. Several attempts to inactivate PG1037 were unsuccessful. Similar to the wild-type when plated on Brucella blood agar, the uvrA and pcrA-defective mutants were black-pigmented and beta-hemolytic. These isogenic mutants also had reduced gingipain activities and were more sensitive to H2O2 and UV irradiation compared to the parent strain. Additionally, glycosylase assays revealed that 8-oxoG repair activities were similar in both wild-type and mutant P. gingivalis strains. Several proteins, some of which are known to have oxidoreducatse activity, were shown to interact with PG1037. The purified recombinant PG1037 protein could protect DNA from H2O2-induced damage. Collectively, these findings suggest that the uvrA-PG1037-pcrA operon may play an important role in hydrogen peroxide stress-induced resistance in P. gingivalis.	[Henry, Leroy G.; Aruni, Wilson; Fletcher, Hansel M.] Loma Linda Univ, Sch Med, Div Microbiol & Mol Genet, Loma Linda, CA 92350 USA; [Sandberg, Lawrence] Loma Linda Univ, Sch Med, Div Biochem, Loma Linda, CA USA	Loma Linda University; Loma Linda University	Fletcher, HM (corresponding author), Loma Linda Univ, Sch Med, Div Microbiol & Mol Genet, Loma Linda, CA 92350 USA.	Hfletcher@llu.edu	WILSON, ARUNI/AAU-1908-2020	Aruni, Wilson/0000-0002-9208-0153	Public Health Services from NIDCR [DE13664, DE019730, DE022508, DE022724]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022508, R56DE013664, R01DE019730, R21DE022724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013664] Funding Source: NIH RePORTER	Public Health Services from NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Public Health Services grants DE13664, DE019730, DE022508, and DE022724 from NIDCR (to HMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaibou H, 2001, INFECT IMMUN, V69, P325, DOI 10.1128/IAI.69.1.325-335.2001; Abaibou H, 2000, ORAL MICROBIOL IMMUN, V15, P40, DOI 10.1034/j.1399-302x.2000.150107.x; Amano A, 2007, FRONT BIOSCI, V12, P3965, DOI 10.2741/2363; [Anonymous], 2015, NAT REV IMMUNOL, DOI [DOI 10.1902/jop.2009.097001, DOI 10.1038/nri3785]; Augusto-Pinto Luiz, 2003, Genet Mol Res, V2, P77; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; BEAMAN L, 1984, ANNU REV MICROBIOL, V38, P27; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; Brochu V, 2001, ORAL MICROBIOL IMMUN, V16, P79, DOI 10.1034/j.1399-302x.2001.016002079.x; Chapple ILC, 1996, J CLIN PATHOL-CL MOL, V49, pM247; Chene P, 2008, BIOCHEM SYST ECOL, V36, P101, DOI 10.1016/j.bse.2007.08.001; Darveau RP, 2012, J DENT RES, V91, P816, DOI 10.1177/0022034512453589; Dashper SG, 2004, ORAL MICROBIOL IMMUN, V19, P50, DOI 10.1046/j.0902-0055.2003.00113.x; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; delaMorena ML, 1996, GENE, V177, P23, DOI 10.1016/0378-1119(96)00264-8; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Diaz PI, 2004, ORAL MICROBIOL IMMUN, V19, P137, DOI 10.1111/j.0902-0055.2004.00120.x; Diaz PI, 2002, MICROBIOL-SGM, V148, P467, DOI 10.1099/00221287-148-2-467; Dou Y, 2010, FEMS MICROBIOL LETT, V312, P24, DOI 10.1111/j.1574-6968.2010.02093.x; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Fowler RG, 2003, DNA REPAIR, V2, P159, DOI 10.1016/S1568-7864(02)00193-3; Genco CA, 2001, MOL MICROBIOL, V39, P1, DOI 10.1046/j.1365-2958.2001.02231.x; Gralnick JA, 2003, J BIOL CHEM, V278, P20708, DOI 10.1074/jbc.M301577200; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Gros L, 2002, ONCOGENE, V21, P8905, DOI 10.1038/sj.onc.1206005; Hanna MN, 2001, J BACTERIOL, V183, P5964, DOI 10.1128/JB.183.20.5964-5973.2001; Henry LG, 2008, J BACTERIOL, V190, P7985, DOI 10.1128/JB.00919-08; Higdon R, 2005, OMICS, V9, P364, DOI 10.1089/omi.2005.9.364; Higdon R, 2007, BIOINFORMATICS, V23, P277, DOI 10.1093/bioinformatics/btl595; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Imlay JA, 2002, ADV MICROB PHYSIOL, V46, P111, DOI 10.1016/S0065-2911(02)46003-1; Jang HJ, 2009, ENVIRON SCI TECHNOL, V43, P9465, DOI 10.1021/es902255q; Johnson NA, 2004, J BACTERIOL, V186, P7697, DOI 10.1128/JB.186.22.7697-7703.2004; Klein BA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-578; Kuramitsu HK, 1998, ORAL MICROBIOL IMMUN, V13, P263, DOI 10.1111/j.1399-302X.1998.tb00706.x; Lewis JP, 1999, J BACTERIOL, V181, P4905, DOI 10.1128/JB.181.16.4905-4913.1999; Liu PF, 2003, DNA REPAIR, V2, P199, DOI 10.1016/S1568-7864(02)00198-2; Lu AL, 2001, CELL BIOCHEM BIOPHYS, V35, P141, DOI 10.1385/CBB:35:2:141; Makarova KS, 2002, TRENDS BIOCHEM SCI, V27, P384, DOI 10.1016/S0968-0004(02)02140-0; Marnett LJ, 2002, TOXICOLOGY, V181, P219, DOI 10.1016/S0300-483X(02)00448-1; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; McKenzie RME, 2012, MICROBIOL-SGM, V158, P2465, DOI 10.1099/mic.0.056416-0; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Mol CD, 1999, ANNU REV BIOPH BIOM, V28, P101, DOI 10.1146/annurev.biophys.28.1.101; Morita R, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/179594; NAKAYAMA K, 1994, J BACTERIOL, V176, P1939, DOI 10.1128/jb.176.7.1939-1943.1994; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Petit MA, 1998, MOL MICROBIOL, V29, P261, DOI 10.1046/j.1365-2958.1998.00927.x; Potempa J, 1998, J BIOL CHEM, V273, P21648, DOI 10.1074/jbc.273.34.21648; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 1999, MOL CLONING LAB MANU; SANCAR A, 1983, CELL, V33, P249, DOI 10.1016/0092-8674(83)90354-9; SCHUBERT J, 1991, FREE RADICAL BIO MED, V11, P545, DOI 10.1016/0891-5849(91)90135-P; Sekiguchi M, 2002, ONCOGENE, V21, P8895, DOI 10.1038/sj.onc.1206023; Shankar J, 2008, GENE, V410, P223, DOI 10.1016/j.gene.2007.12.015; Sheets SA, 2005, INFECT IMMUN, V73, P1543, DOI 10.1128/IAI.73.3.1543-1552.2005; Sheets SM, 2008, FRONT BIOSCI-LANDMRK, V13, P3215; Sheets SM, 2006, INFECT IMMUN, V74, P5667, DOI 10.1128/IAI.01140-05; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Smalley JW, 2000, FEMS MICROBIOL LETT, V183, P159, DOI 10.1111/j.1574-6968.2000.tb08951.x; Smalley JW, 1998, BIOCHEM J, V331, P681, DOI 10.1042/bj3310681; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stivers JT, 2001, ARCH BIOCHEM BIOPHYS, V396, P1, DOI 10.1006/abbi.2001.2605; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Sztukowska M, 2002, MOL MICROBIOL, V44, P479, DOI 10.1046/j.1365-2958.2002.02892.x; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Ueshima J, 2003, INFECT IMMUN, V71, P1170, DOI 10.1128/IAI.71.3.1170-1178.2003; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Van Houten B, 2005, MUTAT RES-FUND MOL M, V577, P92, DOI 10.1016/j.mrfmmm.2005.03.013; Vanterpool E, 2005, INFECT IMMUN, V73, P1357, DOI 10.1128/IAI.73.3.1357-1366.2005; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wienkoop S, 2006, J EXP BOT, V57, P1529, DOI 10.1093/jxb/erj157; Yang W, 2008, CELL RES, V18, P184, DOI 10.1038/cr.2007.116; Zhang LB, 2007, J IMMUNOL METHODS, V321, P80, DOI 10.1016/j.jim.2007.01.009	78	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e69645	10.1371/journal.pone.0069645	http://dx.doi.org/10.1371/journal.pone.0069645			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990885	Green Submitted, gold, Green Published			2022-12-25	WOS:000323425700005
J	Xu, XB; Yin, LL; Ying, QC; Song, HM; Xue, DW; Lai, TF; Xu, MJ; Shen, B; Wang, HZ; Shi, XQ				Xu, Xiangbin; Yin, Lili; Ying, Qicai; Song, Hongmiao; Xue, Dawei; Lai, Tongfei; Xu, Maojun; Shen, Bo; Wang, Huizhong; Shi, Xuequn			High-Throughput Sequencing and Degradome Analysis Identify miRNAs and Their Targets Involved in Fruit Senescence of Fragaria ananassa	PLOS ONE			English	Article							COENZYME-A REDUCTASE; ARABIDOPSIS-THALIANA; PARALLEL ANALYSIS; PLANT MICRORNAS; SMALL RNAS; TOMATO; BIOGENESIS; EXPRESSION; CLONING; IDENTIFICATION	In non-climacteric fruits, the respiratory increase is absent and no phytohormone is appearing to be critical for their ripening process. They must remain on the parent plant to enable full ripening and be picked at or near the fully ripe stage to obtain the best eating quality. However, huge losses often occur for their quick post-harvest senescence. To understanding the complex mechanism of non-climacteric fruits post-harvest senescence, we constructed two small RNA libraries and one degradome from strawberry fruit stored at 20 degrees C for 0 and 24 h. A total of 88 known and 1224 new candidatemiRNAs, and 103 targets cleaved by 19 known miRNAs families and 55 new candidatemiRNAs were obtained. These targets were associated with development, metabolism, defense response, signaling transduction and transcriptional regulation. Among them, 14 targets, including NAC transcription factor, Auxin response factors (ARF) and Myb transcription factors, cleaved by 6 known miRNA families and 6 predicted candidates, were found to be involved in regulating fruit senescence. The present study provided valuable information for understanding the quick senescence of strawberry fruit, and offered a foundation for studying the miRNA-mediated senescence of non-climacteric fruits.	[Xu, Xiangbin; Yin, Lili; Ying, Qicai; Song, Hongmiao; Xue, Dawei; Lai, Tongfei; Xu, Maojun; Shen, Bo; Wang, Huizhong] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Shi, Xuequn] Hainan Univ, Coll Environm & Plant Protect, Haikou, Peoples R China	Hangzhou Normal University; Hainan University	Song, HM (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	hmsongibcas@126.com; bshen65@hzcnc.com; whz62@163.com; shixuequn@163.com	XUE, Dawei/B-3262-2010; Xue, Dawei/H-2324-2018; SHEN, BO/GOK-2179-2022	XUE, Dawei/0000-0001-9904-7615; Xue, Dawei/0000-0001-9904-7615; SHEN, BO/0000-0003-0490-2071	National Natural Science Foundation of China [31071836]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (31071836). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Phillips L, 2004, TRENDS PLANT SCI, V9, P331, DOI 10.1016/j.tplants.2004.05.004; Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, RNA, V15, P2112, DOI 10.1261/rna.1774909; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Dalmay T, 2010, J INTEGR PLANT BIOL, V52, P388, DOI 10.1111/j.1744-7909.2009.00871.x; Daraselia ND, 1996, PLANT PHYSIOL, V112, P727, DOI 10.1104/pp.112.2.727; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Fitzpatrick CA, 2002, DEVELOPMENT, V129, P4497; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Greene LA, 2007, BBA-MOL BASIS DIS, V1772, P392, DOI 10.1016/j.bbadis.2006.12.003; Guilfoyle TJ, 2001, J PLANT GROWTH REGUL, V20, P281, DOI 10.1007/s003440010026; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kato-Emori S, 2001, MOL GENET GENOMICS, V265, P135, DOI 10.1007/s004380000401; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lanet E, 2009, PLANT CELL, V21, P1762, DOI 10.1105/tpc.108.063412; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024758; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Masselink H, 2001, CANCER LETT, V171, P87, DOI 10.1016/S0304-3835(01)00631-0; Moctezuma E, 2003, J EXP BOT, V54, P2025, DOI 10.1093/jxb/erg214; NARITA JO, 1989, PLANT CELL, V1, P181, DOI 10.1105/tpc.1.2.181; Okada M, 2002, EMBO J, V21, P675, DOI 10.1093/emboj/21.4.675; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang L, 2007, FEBS LETT, V581, P3848, DOI 10.1016/j.febslet.2007.07.010; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029669	45	65	70	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e70959	10.1371/journal.pone.0070959	http://dx.doi.org/10.1371/journal.pone.0070959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990918	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700014
J	Zhang, H; Wang, W; Diao, DM; Cheng, Y; Song, YC; Zhu, K; Dang, CX				Zhang, Hao; Wang, Wei; Diao, Dongmei; Cheng, Yao; Song, Yongchun; Zhu, Kun; Dang, Chengxue			Ratio of Metastatic to Examined Lymph Nodes, a Helpful Staging System and Independent Prognostic Factor of Esophagogastric Junction Cancer	PLOS ONE			English	Article							GASTRIC-CARCINOMA; ADENOCARCINOMA; CLASSIFICATION; CARDIA; ESOPHAGEAL; SURVIVAL; SURGERY	Background: The incidence of the esophagogastric junction cancer is growing rapidly. The purpose of this study is to clarify the outcome of the ratio between metastatic and examined lymph nodes in esophagogastric junction cancer patients with or without 7 examined lymph nodes. Methods: A total of 3,481 patients who underwent operation are identified from the Surveillance, Epidemiology, and End Results database. Different lymph nodes resected groups are analyzed to test the lymph nodes ratio factor. Results: There are 2522 patients with 7 or more lymph nodes resected and 959 patients with less than 7 lymph nodes resected. Lymph nodes ratio and lymph node involvement are independent prognostic factors. But the lymph nodes ratio categories have a better prognostic value than the lymph node involvement categories. Compared with lymph node involvement categories, lymph nodes ratio categories represent patients with more homogeneous overall survival rate. Conclusions: This study defines that the lymph nodes ratio is an independent prognostic factor for esophagogastric junction cancer. The lymph nodes ratio can prevent stage migration and may be a helpful system to predict the prognosis of esophagogastric junction cancer patients.	[Zhang, Hao; Wang, Wei; Diao, Dongmei; Cheng, Yao; Song, Yongchun; Zhu, Kun; Dang, Chengxue] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Oncol, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Dang, CX (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Oncol, Xian 710049, Shaanxi, Peoples R China.	dangchengxue@yahoo.com.cn	diao, dongmei/HGD-6807-2022					Bando E, 2002, ANN SURG ONCOL, V9, P775, DOI 10.1245/ASO.2002.10.011; Berger AC, 2005, J CLIN ONCOL, V23, P8706, DOI 10.1200/JCO.2005.02.8852; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; de Manzoni G, 2002, BRIT J CANCER, V87, P171, DOI 10.1038/sj.bjc.6600432; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Dresner SM, 2001, SURGERY, V129, P103, DOI 10.1067/msy.2001.110024; Dutkowski P, 2002, HEPATO-GASTROENTEROL, V49, P176; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fang WL, 2009, ANN SURG ONCOL, V16, P3237, DOI 10.1245/s10434-009-0636-9; Gao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035021; Groth SS, 2010, J THORAC CARDIOV SUR, V139, P612, DOI 10.1016/j.jtcvs.2009.07.017; Hasegawa S, 2010, GASTRIC CANCER, V13, P63, DOI 10.1007/s10120-010-0555-2; Hasegawa S, 2009, WORLD J SURG, V33, P95, DOI 10.1007/s00268-008-9740-4; Herrera LJ, 2010, ANN SURG ONCOL, V17, P676, DOI 10.1245/s10434-009-0824-7; Hosokawa Y, 2012, ANN SURG ONCOL, V19, P677, DOI 10.1245/s10434-011-1983-x; Inoue K, 2002, ANN SURG ONCOL, V9, P27, DOI 10.1245/aso.2002.9.1.27; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Marchet A, 2007, ANN SURG, V245, P543, DOI 10.1097/01.sla.0000250423.43436.e1; Okabayashi T, 2000, CANCER, V89, P2555, DOI 10.1002/1097-0142(20001215)89:12<2555::AID-CNCR6>3.0.CO;2-R; OKUSA T, 1990, SURG GYNECOL OBSTET, V170, P488; Rice TW, 2010, ANN SURG ONCOL, V17, P1721, DOI 10.1245/s10434-010-1024-1; Siewert JR, 2000, ANN SURG, V232, P353; Siewert JR, 1996, DIS ESOPHAGUS, V9, P173, DOI DOI 10.1093/DOTE/9.4.278; Xu DZ, 2009, ANN SURG ONCOL, V16, P319, DOI 10.1245/s10434-008-0240-4; Yoon SS, 2009, ONCOLOGIST, V14, P871, DOI 10.1634/theoncologist.2009-0070; Zhang ZX, 1998, INT J RADIAT ONCOL, V42, P929, DOI 10.1016/S0360-3016(98)00280-6	26	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e73238	10.1371/journal.pone.0073238	http://dx.doi.org/10.1371/journal.pone.0073238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977381	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700194
J	Krueger, WS; Khuntirat, B; Yoon, IK; Blair, PJ; Chittagarnpitch, M; Putnam, SD; Supawat, K; Gibbons, RV; Bhuddari, D; Pattamadilok, S; Sawanpanyalert, P; Heil, GL; Gray, GC				Krueger, Whitney S.; Khuntirat, Benjawan; Yoon, In-Kyu; Blair, Patrick J.; Chittagarnpitch, Malinee; Putnam, Shannon D.; Supawat, Krongkaew; Gibbons, Robert V.; Bhuddari, Darunee; Pattamadilok, Sirima; Sawanpanyalert, Pathom; Heil, Gary L.; Gray, Gregory C.			Prospective Study of Avian Influenza Virus Infections among Rural Thai Villagers	PLOS ONE			English	Article							A H5N1 VIRUS; SWINE WORKERS; UNITED-STATES; SURVEILLANCE; PNEUMONIA; OUTBREAKS; POULTRY; ASSAYS; RISK; PCR	Background: In 2008, 800 rural Thai adults living within Kamphaeng Phet Province were enrolled in a prospective cohort study of zoonotic influenza transmission. Serological analyses of enrollment sera suggested this cohort had experienced subclinical avian influenza virus (AIV) infections with H9N2 and H5N1 viruses. Methods: After enrollment, participants were contacted weekly for 24mos for acute influenza-like illnesses (ILI). Cohort members confirmed to have influenza A infections were enrolled with their household contacts in a family transmission study involving paired sera and respiratory swab collections. Cohort members also provided sera at 12 and 24 months after enrollment. Serologic and real-time RT-PCR assays were performed against avian, swine, and human influenza viruses. Results: Over the 2 yrs of follow-up, 81 ILI investigations in the cohort were conducted; 31 (38%) were identified as influenza A infections by qRT-PCR. Eighty-three household contacts were enrolled; 12 (14%) reported ILIs, and 11 (92%) of those were identified as influenza infections. A number of subjects were found to have slightly elevated antibodies against avian-like A/Hong Kong/1073/1999(H9N2) virus: 21 subjects (2.7%) at 12-months and 40 subjects (5.1%) at 24-months. Among these, two largely asymptomatic acute infections with H9N2 virus were detected by >4-fold increases in annual serologic titers (final titers 1: 80). While controlling for age and influenza vaccine receipt, moderate poultry exposure was significantly associated with elevated H9N2 titers (adjusted OR = 2.3; 95% CI, 1.04-5.2) at the 24-month encounter. One subject had an elevated titer (1: 20) against H5N1 during follow-up. Conclusions: From 2008-10, evidence for AIV infections was sparse among this rural population. Subclinical H9N2 AIV infections likely occurred, but serological results were confounded by antibody cross-reactions. There is a critical need for improved serological diagnostics to more accurately detect subclinical AIV infections in humans.	[Krueger, Whitney S.; Heil, Gary L.; Gray, Gregory C.] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32610 USA; [Krueger, Whitney S.; Heil, Gary L.; Gray, Gregory C.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Khuntirat, Benjawan; Yoon, In-Kyu; Gibbons, Robert V.; Bhuddari, Darunee] Armed Forces Res Inst Med Sci, US Army Med Component, Bangkok 10400, Thailand; [Blair, Patrick J.] Naval Med Res Unit 2, Singapore, Singapore; [Blair, Patrick J.] Off Def Cooperat, Singapore, Singapore; [Chittagarnpitch, Malinee; Supawat, Krongkaew; Pattamadilok, Sirima; Sawanpanyalert, Pathom] Minist Publ Hlth, Natl Inst Hlth, Bangkok, Thailand; [Putnam, Shannon D.] USN, Hlth Res Ctr, San Diego, CA 92152 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Ministry of Public Health - Thailand; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC)	Gray, GC (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32610 USA.	gcgray@phhp.ufl.edu	Gray, Gregory C./ABF-1298-2020	Gray, Gregory/0000-0002-4628-5908	US Armed Forces Health Surveillance Center - Global Emerging Infections Surveillance Operations; National Institute of Allergy and Infectious Diseases [R01 AI068803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068803] Funding Source: NIH RePORTER	US Armed Forces Health Surveillance Center - Global Emerging Infections Surveillance Operations; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the US Armed Forces Health Surveillance Center - Global Emerging Infections Surveillance Operations (multiple grants to GCG, PJB, SDP, and IU) and National Institute of Allergy and Infectious Diseases (R01 AI068803 to GCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, BIOL INFL; Baggett HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048609; Beaudoin AL, 2012, TRANSBOUND EMERG DIS; Buchy P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010864; Buranathai C, 2007, AVIAN DIS, V51, P194, DOI 10.1637/7594-040306R.1; CAPUANO A, 2007, INFLUENZA RESP VIRUS; Cauchemez S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003061; Chaichoune K, 2009, J GEN VIROL, V90, P216, DOI 10.1099/vir.0.005660-0; Chokephaibulkit K, 2004, PEDIATR INFECT DIS J, V23, P793; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Gill JS, 2006, EMERG INFECT DIS, V12, P1284, DOI 10.3201/eid1708.060492; Gray GC, 2007, EMERG INFECT DIS, V13, P1871, DOI 10.3201/eid1312.061323; Gray GC, 2008, INFLUENZA OTHER RESP, V2, P61, DOI 10.1111/j.1750-2659.2008.00041.x; Katz MA, 2007, VACCINE, V25, P3827, DOI 10.1016/j.vaccine.2007.01.109; Kayali G, 2008, J CLIN VIROL, V43, P73, DOI 10.1016/j.jcv.2008.04.013; Khuntirat BP, 2011, CLIN INFECT DIS, V53, pE107, DOI 10.1093/cid/cir525; Lee MS, 2001, J VIROL METHODS, V97, P13, DOI 10.1016/S0166-0934(01)00301-9; Lerdsamran H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016164; Myers KP, 2007, CLIN INFECT DIS, V45, P4, DOI 10.1086/518579; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; Nguyen DC, 2005, J VIROL, V79, P4201, DOI 10.1128/JVI.79.7.4201-4212.2005; Olsen SJ, 2006, LANCET INFECT DIS, V6, P757, DOI 10.1016/S1473-3099(06)70639-9; Prachayangprecha S, 2011, JPN J INFECT DIS, V64, P377; Ramirez A, 2006, EMERG INFECT DIS, V12, P997, DOI 10.3201/eid1206.051576; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Siengsanan J, 2009, J WILDLIFE DIS, V45, P740, DOI 10.7589/0090-3558-45.3.740; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Tiensin T, 2007, AVIAN DIS, V51, P182, DOI 10.1637/7635-042806R.1; Tiensin T, 2005, EMERG INFECT DIS, V11, P1664, DOI 10.3201/eid1111.050608; Tiensin T, 2007, J INFECT DIS, V196, P1679, DOI 10.1086/522007; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; WHO, 2010, CUM NUMB CONF HUM CA; Wisedchanwet T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-131; World Health Organization, 2009, ASS SEV INFL PAND	35	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72196	10.1371/journal.pone.0072196	http://dx.doi.org/10.1371/journal.pone.0072196			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977250	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200063
J	Do, HT; Bruelle, C; Tselykh, T; Jalonen, P; Korhonen, L; Lindholm, D				Hai Thi Do; Bruelle, Celine; Tselykh, Timofey; Jalonen, Pilvi; Korhonen, Laura; Lindholm, Dan			Reciprocal Regulation of Very Low Density Lipoprotein Receptors (VLDLRs) in Neurons by Brain-derived Neurotrophic Factor (BDNF) and Reelin INVOLVEMENT OF THE E3 LIGASE Mylip/Idol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAJAL-RETZIUS CELLS; RAT HIPPOCAMPUS; GLUTAMATERGIC SYNAPSES; DEPENDENT REGULATION; SYNAPTIC PLASTICITY; NEURITE OUTGROWTH; SIGNALING PATHWAY; APOPTOSIS PROTEIN; LINKED INHIBITOR; MESSENGER-RNA	BDNF positively influences various aspects of neuronal migration, maturation, and survival in the developing brain. Reelin in turn mediates inhibitory signals to migrating neuroblasts, which is crucial for brain development. The interplay between BDNF and Reelin signaling in neurodevelopment is not fully understood. We show here that BDNF increased the levels of the Reelin receptor (VLDL receptor (VLDLR)) in hippocampal neurons by increasing gene expression. In contrast, Reelin decreased VLDLRs, which was accompanied by an increase in the levels of the E3 ligase Mylip/Idol in neurons. Down-regulation of Mylip/Idol using shRNAs abrogated the decrease in VLDLRs induced by Reelin. These results show that VLDLRs are tightly regulated in hippocampal neurons by both transcriptional and post-transcriptional mechanisms. The regulation of VLDLR by BDNF and Reelin may affect the migration of neurons and contribute to neurodevelopmental disorders in the nervous system.	[Hai Thi Do; Bruelle, Celine; Tselykh, Timofey; Korhonen, Laura; Lindholm, Dan] Univ Helsinki, Inst Biomed Biochem & Dev Biol, FIN-00290 Helsinki, Finland; [Hai Thi Do; Bruelle, Celine; Tselykh, Timofey; Jalonen, Pilvi; Korhonen, Laura; Lindholm, Dan] Biomedicum 2, Minerva Fdn Inst Med Res, FIN-00290 Helsinki, Finland	University of Helsinki	Lindholm, D (corresponding author), Univ Helsinki, Inst Biomed Biochem & Dev Biol, Haartmaninkatu 8, FIN-00290 Helsinki, Finland.	dan.lindholm@helsinki.fi	Lindholm, Dan/B-3777-2014; Korhonen, Laura/AAW-3256-2020	Korhonen, Laura/0000-0002-1837-5930	Finska Lakaresallskapet; Sigrid Juselius Foundation; Liv och Halsa; Magnus Ehrnrooth; Minerva Foundation; Academy of Finland	Finska Lakaresallskapet; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Liv och Halsa; Magnus Ehrnrooth; Minerva Foundation; Academy of Finland(Academy of Finland)	This work was supported by Finska Lakaresallskapet, the Sigrid Juselius Foundation, Liv och Halsa, Magnus Ehrnrooth, the Minerva Foundation, and the Academy of Finland.	Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; BERZAGHI MD, 1993, J NEUROSCI, V13, P3818; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Bornhauser BC, 2003, J BIOL CHEM, V278, P35412, DOI 10.1074/jbc.M306271200; Bornhauser BC, 2003, FEBS LETT, V553, P195, DOI 10.1016/S0014-5793(03)01010-X; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Duit S, 2010, J BIOL CHEM, V285, P4896, DOI 10.1074/jbc.M109.025973; Durakoglugil MS, 2009, P NATL ACAD SCI USA, V106, P15938, DOI 10.1073/pnas.0908176106; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fatemi SH, 2005, BIOL PSYCHIAT, V57, P777, DOI 10.1016/j.biopsych.2004.12.018; Forster E, 2010, EUR J NEUROSCI, V31, P1511, DOI 10.1111/j.1460-9568.2010.07222.x; Gao ZH, 2013, CELL MOL LIFE SCI, V70, P2319, DOI 10.1007/s00018-012-1171-6; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Do HT, 2012, J BIOL CHEM, V287, P12602, DOI 10.1074/jbc.M112.341248; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hyrskyluoto A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.170; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Kairisalo M, 2009, EUR J NEUROSCI, V30, P958, DOI 10.1111/j.1460-9568.2009.06898.x; Korhonen L, 2001, MOL CELL NEUROSCI, V17, P364, DOI 10.1006/mcne.2000.0935; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kreuter R, 1999, J LIPID RES, V40, P376; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Lindholm D, 1996, EUR J NEUROSCI, V8, P1452, DOI 10.1111/j.1460-9568.1996.tb01607.x; Marty S, 1996, J NEUROSCI, V16, P675; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; Olsson PA, 1999, J BIOL CHEM, V274, P36288, DOI 10.1074/jbc.274.51.36288; Putkonen N, 2011, EUR J NEUROSCI, V34, P1212, DOI 10.1111/j.1460-9568.2011.07858.x; Qiu SF, 2007, J NEUROPHYSIOL, V97, P2312, DOI 10.1152/jn.00869.2006; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Ringstedt T, 1998, NEURON, V21, P305, DOI 10.1016/S0896-6273(00)80540-1; Rogers JT, 2011, LEARN MEMORY, V18, P558, DOI 10.1101/lm.2153511; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Scotti E, 2013, MOL CELL BIOL, V33, P1503, DOI 10.1128/MCB.01716-12; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	47	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29613	29620		10.1074/jbc.M113.500967	http://dx.doi.org/10.1074/jbc.M113.500967			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23990472	Green Published, hybrid			2022-12-25	WOS:000330615300037
J	Karasawa, A; Swier, LJYM; Stuart, MCA; Brouwers, J; Helms, B; Poolman, B				Karasawa, Akira; Swier, Lotteke J. Y. M.; Stuart, Marc C. A.; Brouwers, Jos; Helms, Bernd; Poolman, Bert			Physicochemical Factors Controlling the Activity and Energy Coupling of an Ionic Strength-gated ATP-binding Cassette (ABC) Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; OSMOTIC ACTIVATION; BILAYER NANODISCS; PROTEIN; PROP; BETAINE; BETP; RECONSTITUTION; MECHANISM	Cells control their volume through the accumulation of compatible solutes. The bacterial ATP-binding cassette transporter OpuA couples compatible solute uptake to ATP hydrolysis. Here, we study the gating mechanism and energy coupling of OpuA reconstituted in lipid nanodiscs. We show that anionic lipids are essential both for the gating and the energy coupling. The tight coupling between substrate binding on extracellular domains and ATP hydrolysis by cytoplasmic nucleotide-binding domains allows the study of transmembrane signaling in nanodiscs. From the tight coupling between processes at opposite sides of the membrane, we infer that the ATPase activity of OpuA in nanodiscs reflects solute translocation. Intriguingly, the substrate-dependent, ionic strength-gated ATPase activity of OpuA in nanodiscs is at least an order of magnitude higher than in lipid vesicles (i.e. with identical membrane lipid composition, ionic strength, and nucleotide and substrate concentrations). Even with the chemical components the same, the lateral pressure (profile) of the nanodiscs will differ from that of the vesicles. We thus propose that membrane tension limits translocation in vesicular systems. Increased macromolecular crowding does not activate OpuA but acts synergistically with ionic strength, presumably by favoring gating interactions of like-charged surfaces via excluded volume effects.	[Karasawa, Akira; Swier, Lotteke J. Y. M.; Stuart, Marc C. A.; Poolman, Bert] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; [Karasawa, Akira; Swier, Lotteke J. Y. M.; Stuart, Marc C. A.; Poolman, Bert] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biophys Chem, Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; [Karasawa, Akira; Swier, Lotteke J. Y. M.; Stuart, Marc C. A.; Poolman, Bert] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Brouwers, Jos; Helms, Bernd] Univ Utrecht, Dept Pharmaceut Sci, NL-3508 TD Utrecht, Netherlands	University of Groningen; University of Groningen; University of Groningen; Utrecht University	Poolman, B (corresponding author), Univ Groningen, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.poolman@rug.nl	Institute, Zernike/W-7033-2019; Karasawa, Akira/ABF-4128-2021; Karasawa, Akira/ABC-9782-2021; Brouwers, Jos F/AAH-1444-2019; Stuart, Marc/B-6274-2008	Brouwers, Jos F/0000-0003-2924-3279; Stuart, Marc/0000-0003-0667-6338	Netherlands Organization for Scientific Research (NWO) [700.56.302, 728.011.104]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Netherlands Organization for Scientific Research (NWO) Top-Subsidy Grant 700.56.302 and ChemThem "Chemical Biology" Grant 728.011.104.	Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; Alvarez FJD, 2010, J AM CHEM SOC, V132, P9513, DOI 10.1021/ja104047c; Bao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034836; Bayburt TH, 2006, ARCH BIOCHEM BIOPHYS, V450, P215, DOI 10.1016/j.abb.2006.03.013; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; Boldog T, 2006, P NATL ACAD SCI USA, V103, P11509, DOI 10.1073/pnas.0604988103; Bolen D W, 2001, Methods Mol Biol, V168, P17; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Brown MF, 2012, BIOCHEMISTRY-US, V51, P9782, DOI 10.1021/bi301332v; Culham DE, 2003, BIOCHEMISTRY-US, V42, P410, DOI 10.1021/bi0264364; Culham DE, 2008, BIOCHEMISTRY-US, V47, P8176, DOI 10.1021/bi800794z; Culham DE, 2012, J BIOL CHEM, V287, P27813, DOI 10.1074/jbc.M112.387936; Dalal K, 2012, P NATL ACAD SCI USA, V109, P4104, DOI 10.1073/pnas.1117783109; Dalal K, 2009, J BIOL CHEM, V284, P7897, DOI 10.1074/jbc.M808305200; Damodaran S, 2012, LANGMUIR, V28, P9475, DOI 10.1021/la300953n; DRIESSEN AJM, 1988, BIOCHEMISTRY-US, V27, P865, DOI 10.1021/bi00403a005; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Inagaki S, 2012, J MOL BIOL, V417, P95, DOI 10.1016/j.jmb.2012.01.023; Ishmukhametov R, 2010, EMBO J, V29, P3911, DOI 10.1038/emboj.2010.259; Karasawa A, 2011, J BIOL CHEM, V286, P37280, DOI 10.1074/jbc.M111.284059; Kawai T, 2011, FEBS LETT, V585, P3533, DOI 10.1016/j.febslet.2011.10.015; Keates RAB, 2010, BIOCHEMISTRY-US, V49, P8847, DOI 10.1021/bi101281f; Li MS, 2011, P NATL ACAD SCI USA, V108, P9390, DOI 10.1073/pnas.1104824108; Mahmood NABN, 2006, J BIOL CHEM, V281, P29830, DOI 10.1074/jbc.M604907200; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; Mors K, 2013, BBA-BIOMEMBRANES, V1828, P1222, DOI 10.1016/j.bbamem.2012.12.011; Nicklisch SCT, 2012, BBA-BIOMEMBRANES, V1818, P359, DOI 10.1016/j.bbamem.2011.10.021; Parsegian VA, 2000, P NATL ACAD SCI USA, V97, P3987, DOI 10.1073/pnas.97.8.3987; Patzlaff JS, 2003, J BIOL CHEM, V278, P29546, DOI 10.1074/jbc.M304796200; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Perez C, 2011, EMBO J, V30, P1221, DOI 10.1038/emboj.2011.46; Racher KI, 2001, BIOCHEMISTRY-US, V40, P7324, DOI 10.1021/bi002331u; Ranaghan MJ, 2011, J AM CHEM SOC, V133, P18318, DOI 10.1021/ja2070957; Reid C, 1997, BIOPHYS J, V72, P1022, DOI 10.1016/S0006-3495(97)78754-X; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Ritchie TK, 2011, J BIOL CHEM, V286, P39489, DOI 10.1074/jbc.M111.284554; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; SHAPIRO AB, 1995, J BIOL CHEM, V270, P16167, DOI 10.1074/jbc.270.27.16167; Shaw AW, 2007, J BIOL CHEM, V282, P6556, DOI 10.1074/jbc.M607973200; Spitzer JJ, 2005, TRENDS BIOCHEM SCI, V30, P536, DOI 10.1016/j.tibs.2005.08.002; Tokuriki N, 2004, PROTEIN SCI, V13, P125, DOI 10.1110/ps.03288104; Tsatskis Y, 2005, J BIOL CHEM, V280, P41387, DOI 10.1074/jbc.M508362200; van der Heide T, 2001, EMBO J, V20, P7022, DOI 10.1093/emboj/20.24.7022; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wolters JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010361; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Ziegler C, 2010, MOL MICROBIOL, V78, P13, DOI 10.1111/j.1365-2958.2010.07332.x	50	22	22	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29862	29871		10.1074/jbc.M113.499327	http://dx.doi.org/10.1074/jbc.M113.499327			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23979139	hybrid, Green Published			2022-12-25	WOS:000330615300059
J	Yang, ZH; Tsuchiya, H; Zhang, YX; Hartnett, ME; Wang, L				Yang, Zhihong; Tsuchiya, Hiroyuki; Zhang, Yuxia; Hartnett, M. Elizabeth; Wang, Li			MicroRNA-433 Inhibits Liver Cancer Cell Migration by Repressing the Protein Expression and Function of cAMP Response Element-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Liver Cancer; MicroRNA; Post-translational Modification; Translation Regulation; HCC	SMALL HETERODIMER PARTNER; HEPATOCELLULAR-CARCINOMA; SHP INHIBITION; ERR-GAMMA; CREB; MIR-433; MIR-127; GROWTH; PROLIFERATION; ACTIVATION	We show for the first time that potent microRNA-433 (miR-433) inhibition of expression of the cAMP response element-binding protein CREB1 represses hepatocellular carcinoma (HCC) cell migration. We identified a miR-433 seed match region in human and mouse CREB1 3-UTRs. Overexpression of miR-433 markedly decreased human CREB1 3-UTR reporter activity, and the inhibitory effect of miR-433 was alleviated upon mutation of its binding site. Ectopic expression of miR-433 reduced CREB1 protein levels in a variety of human and mouse cancer cells, including HeLa, Hepa1, Huh7, and HepG2. Human CREB1 protein levels in highly invasive MHCC97H cells were diminished by expression of miR-433 but were induced by miR-433 antagomir (anti-miR-433). The expression of mouse CREB1 protein negatively correlated with miR-433 levels in nuclear receptor Shp(-/-) liver tissues and liver tumors compared with wild-type mice. miR-433 exhibited a significant repression of MHCC97H cell migration, which was reversed by anti-miR-433. Overexpressing miR-433 inhibited focus formation dramatically, demonstrating that miR-433 may exert a tumor suppressor function. Knockdown of CREB1 by siRNAs impeded MHCC97H cell migration and invasion and antagonized the effect of anti-miR-433. Interestingly, CREB1 siRNA decreased MHCC97H cell proliferation, which was not influenced by anti-miR-433. Overexpressing CREB1 decreased the inhibitory activity of miR-433. The CpG islands surrounding miR-433 were hypermethylated, and the DNA methylation agent 5-aza-2-deoxycytidine, but not the histone deacetylase inhibitor trichostatin A, drastically stimulated the expression of miR-433 and miR-127 in HCC cells. The latter is clustered with miR-433. The results reveal a critical role of miR-433 in mediating HCC cell migration via CREB1.	[Yang, Zhihong; Tsuchiya, Hiroyuki; Zhang, Yuxia; Wang, Li] Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84132 USA; [Yang, Zhihong; Tsuchiya, Hiroyuki; Zhang, Yuxia; Wang, Li] Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84132 USA; [Yang, Zhihong; Hartnett, M. Elizabeth] Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Wang, L (corresponding author), Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84132 USA.	l.wang@hsc.utah.edu			National Institutes of Health [P30 CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY014800, R01EY017011, R01EY015130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge the use of core facilities (Cell Imaging Core) supported by National Institutes of Health Grant P30 CA042014 to the Huntsman Cancer Institute.	Abramovitch R, 2004, CANCER RES, V64, P1338, DOI 10.1158/0008-5472.CAN-03-2089; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; De Cesare D, 1999, TRENDS BIOCHEM SCI, V24, P281, DOI 10.1016/S0968-0004(99)01414-0; Estep M, 2010, ALIMENT PHARM THER, V32, P487, DOI 10.1111/j.1365-2036.2010.04366.x; Fimia GM, 1999, NATURE, V398, P165, DOI 10.1038/18237; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Kovach SJ, 2006, J CELL PHYSIOL, V206, P411, DOI 10.1002/jcp.20474; Lin X, 2013, LEUKEMIA, V27, P344, DOI 10.1038/leu.2012.224; Luo HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-82; Pigazzi M, 2009, CANCER RES, V69, P2471, DOI 10.1158/0008-5472.CAN-08-3404; Simon D, 2010, HUM MOL GENET, V19, P2015, DOI 10.1093/hmg/ddq083; Siu YT, 2007, FEBS J, V274, P3224, DOI 10.1111/j.1742-4658.2007.05884.x; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006880; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Song GS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003574; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang W, 2012, WORLD J GASTROENTERO, V18, P5442, DOI 10.3748/wjg.v18.i38.5442; Yang ZH, 2012, BIOCHEM BIOPH RES CO, V417, P744, DOI 10.1016/j.bbrc.2011.12.027; Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342; Zhang YX, 2011, BIOCHEM BIOPH RES CO, V416, P135, DOI 10.1016/j.bbrc.2011.11.011; Zhang YX, 2011, J BIOL CHEM, V286, P29635, DOI 10.1074/jbc.M111.253039; Zhang YX, 2011, FEBS LETT, V585, P1269, DOI 10.1016/j.febslet.2011.03.059; Zhou TF, 2010, J BIOL CHEM, V285, P24871, DOI 10.1074/jbc.M110.133280	28	82	89	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28893	28899		10.1074/jbc.M113.502682	http://dx.doi.org/10.1074/jbc.M113.502682			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23979134	hybrid, Green Published			2022-12-25	WOS:000330298800041
J	Cheng, H; Li, LL; Cheng, SY; Cao, FL; Xu, F; Yuan, HH; Wu, CH				Cheng Hua; Li Linling; Cheng Shuiyuan; Cao Fuliang; Xu Feng; Yuan Honghui; Wu Conghua			Molecular Cloning and Characterization of Three Genes Encoding Dihydroflavonol-4-Reductase from Ginkgo biloba in Anthocyanin Biosynthetic Pathway	PLOS ONE			English	Article							5-AMINOLEVULINIC ACID; FLAVONOID BIOSYNTHESIS; CHALCONE SYNTHASE; EXPRESSION; 4-REDUCTASE; INDUCTION; REDUCTASE; LIGHT	Dihydroflavonol-4-reductase (DFR, EC1.1.1.219) catalyzes a key step late in the biosynthesis of anthocyanins, condensed tannins (proanthocyanidins), and other flavonoids important to plant survival and human nutrition. Three DFR cDNA clones (designated GbDFRs) were isolated from the gymnosperm Ginkgo biloba. The deduced GbDFR proteins showed high identities to other plant DFRs, which form three distinct DFR families. Southern blot analysis showed that the three GbDFRs each belong to a different DFR family. Phylogenetic tree analysis revealed that the GbDFRs share the same ancestor as other DFRs. The expression of the three recombinant GbDFRs in Escherichia coli showed that their actual protein sizes were in agreement with predictions from the cDNA sequences. The recombinant proteins were purified and their activity was analyzed; both GbDFR1 and GbDFR3 could catalyze dihydroquercetin conversion to leucocyanidin, while GbDFR2 catalyzed dihydrokaempferol conversion to leucopelargonidin. qRT-PCR showed that the GbDFRs were expressed in a tissue-specific manner, and transcript accumulation for the three genes was highest in young leaves and stamens. These transcription patterns were in good agreement with the pattern of anthocyanin accumulation in G. biloba. The expression profiles suggested that GbDFR1 and GbDFR2 are mainly involved in responses to plant hormones, environmental stress and damage. During the annual growth cycle, the GbDFRs were significantly correlated with anthocyanin accumulation in leaves. A fitted linear curve showed the best model for relating GbDFR2 and GbDFR3 with anthocyanin accumulation in leaves. GbDFR1 appears to be involved in environmental stress response, while GbDFR3 likely has primary functions in the synthesis of anthocyanins. These data revealed unexpected properties and differences in three DFR proteins from a single species.	[Cheng Hua; Li Linling; Cheng Shuiyuan; Xu Feng; Yuan Honghui; Wu Conghua] Econ Forest Germplasm Improvement & Comprehens Ut, Huanggang, Hubei, Peoples R China; [Cheng Hua; Li Linling; Cheng Shuiyuan; Yuan Honghui; Wu Conghua] Huanggang Normal Univ, Coll Chem & Life Sci, Huanggang, Peoples R China; [Cheng Hua; Cheng Shuiyuan; Cao Fuliang] Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Peoples R China	Huanggang Normal University; Nanjing Forestry University	Cheng, SY (corresponding author), Econ Forest Germplasm Improvement & Comprehens Ut, Huanggang, Hubei, Peoples R China.	s_y_cheng@sina.com	Xu, Feng/L-8097-2019	Xu, Feng/0000-0003-3212-6284	Natural Science Foundation of China [31270717/C161101]; Economic Forest Germplasm Improvement and Comprehensive Utilization of Resources of Hubei Key Laboratories [2013000203, 2011BH0030]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Economic Forest Germplasm Improvement and Comprehensive Utilization of Resources of Hubei Key Laboratories	This work was supported by the Natural Science Foundation of China (31270717/C161101) and the Economic Forest Germplasm Improvement and Comprehensive Utilization of Resources of Hubei Key Laboratories (2013000203, 2011BH0030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awada MA, 2001, SCI HORTIC-AMSTERDAM, V88, P289, DOI 10.1016/S0304-4238(00)00215-6; Bashandy T, 2009, MOL PLANT, V2, P249, DOI 10.1093/mp/ssn065; Cancan Z, 2010, EFFECTS ENV FACTORS; Cheng H, 2011, PLANT CELL REP, V30, P49, DOI 10.1007/s00299-010-0943-4; Cheng SY, 2009, J MED PLANTS RES, V3, P1248; Cheng Shui-yuan, 2005, Journal of Plant Resources and Environment, V14, P20; Cheng ShuiYuan, 2004, Journal of Fruit Science, V21, P116; Cheng ShuiYuan, 2001, Scientia Silvae Sinicae, V37, P31; Cheng ShuiYuan, 2004, Scientia Silvae Sinicae, V40, P45; El-Kereamy A, 2003, PHYSIOL PLANTARUM, V119, P175, DOI 10.1034/j.1399-3054.2003.00165.x; Feng X, 2008, CLONING EXPRESSION G; Fofana B, 2002, PHYSIOL MOL PLANT P, V61, P121, DOI 10.1016/S0885-5765(02)90420-0; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Guo J, 2010, PLANT GROWTH REGUL, V62, P1, DOI 10.1007/s10725-010-9472-y; Hayat S., 2007, Salicylic acid: a plant hormone, P1; Hotta Y, 1997, PLANT GROWTH REGUL, V22, P109, DOI 10.1023/A:1005883930727; Huang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030364; HUITS HSM, 1994, PLANT J, V6, P295, DOI 10.1046/j.1365-313X.1994.06030295.x; Jaakola L, 2010, PLANT CELL ENVIRON, V33, P1239, DOI 10.1111/j.1365-3040.2010.02154.x; Johnson ET, 1999, PLANT J, V19, P81, DOI 10.1046/j.1365-313X.1999.00502.x; Johnson ET, 2001, PLANT J, V25, P325, DOI 10.1046/j.1365-313x.2001.00962.x; Kim S, 2005, THEOR APPL GENET, V110, P588, DOI 10.1007/s00122-004-1882-7; Li H, 2012, MICROCHIM ACTA, V179, P123, DOI 10.1007/s00604-012-0873-7; Liew CF, 1998, PLANT SCI, V135, P161, DOI 10.1016/S0168-9452(98)00071-5; Liu GuangDe, 2009, Scientia Agricultura Sinica, V42, P55; Liu J, 2006, PLANT PHYSL COMMUNIC, V41, P715; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Martens S, 2003, BIOCHEM ENG J, V14, P227, DOI 10.1016/S1369-703X(02)00224-3; Martens S, 2002, FEBS LETT, V531, P453, DOI 10.1016/S0014-5793(02)03583-4; Meer I, 1993, REGULATION GEN PHENY; MEYER P, 1987, NATURE, V330, P677, DOI 10.1038/330677a0; MURRAY JR, 1991, PLANT PHYSIOL, V97, P343, DOI 10.1104/pp.97.1.343; Nakatsuka A, 2003, PLANT SCI, V165, P759, DOI 10.1016/S0168-9452(03)00254-1; Nishihara E, 2003, J PLANT PHYSIOL, V160, P1085, DOI 10.1078/0176-1617-00991; Ostergaard L, 2001, PLANT SCI, V160, P463, DOI 10.1016/S0168-9452(00)00407-6; Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Shimada N, 2005, J EXP BOT, V56, P2573, DOI 10.1093/jxb/eri251; Singh K, 2009, PLANT BIOTECHNOL REP, V3, P95, DOI 10.1007/s11816-008-0079-y; SKRIVER K, 1990, PLANT CELL, V2, P503, DOI 10.1105/tpc.2.6.503; Smith JV, 2004, APPL MICROBIOL BIOT, V64, P465, DOI 10.1007/s00253-003-1527-9; STAFFORD HA, 1985, PLANT PHYSIOL, V78, P791, DOI 10.1104/pp.78.4.791; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang LK, 2009, NEW PHYTOL, V181, P576, DOI 10.1111/j.1469-8137.2008.02692.x; van Beek TA, 2002, J CHROMATOGR A, V967, P21, DOI 10.1016/S0021-9673(02)00172-3; VON WETTSTEIN D, 1995, PLANT CELL, V7, P1039, DOI 10.1105/tpc.7.7.1039; Wang LJ, 2004, PHYSIOL PLANTARUM, V121, P258, DOI 10.1111/j.0031-9317.2004.00319.x; Wang QingJu, 2008, Scientia Silvae Sinicae, V44, P45; [王燕 Wang Yan], 2002, [湖北农业科学, Hubei agricultural sciences], V0, P103; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; Williams CA, 2004, NAT PROD REP, V21, P539, DOI 10.1039/b311404j; Winkel-Shirley B, 2001, PLANT PHYSIOL, V127, P1399, DOI 10.1104/pp.127.4.1399; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Xie DY, 2004, PLANT PHYSIOL, V134, P979, DOI 10.1104/pp.103.030221; Xu F, 2008, MOL CELLS, V26, P536; Xu F, 2008, AFR J BIOTECHNOL, V7, P721; Xu F, 2012, MOL BIOL REP, V39, P2285, DOI 10.1007/s11033-011-0978-9; Yoshida K, 2010, J PLANT RES, V123, P801, DOI 10.1007/s10265-010-0325-6	60	42	50	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72017	10.1371/journal.pone.0072017	http://dx.doi.org/10.1371/journal.pone.0072017			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991027	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800036
J	Duehrkop, C; Banz, Y; Spirig, R; Miescher, S; Nolte, MW; Spycher, M; Smith, RAG; Sacks, SH; Rieben, R				Duehrkop, Claudia; Banz, Yara; Spirig, Rolf; Miescher, Sylvia; Nolte, Marc W.; Spycher, Martin; Smith, Richard A. G.; Sacks, Steven H.; Rieben, Robert			C1 Esterase Inhibitor Reduces Lower Extremity Ischemia/Reperfusion Injury and Associated Lung Damage	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; SYSTEMIC INFLAMMATORY RESPONSE; FOLLOW INTESTINAL ISCHEMIA; LIMB ISCHEMIA; PLASMA KALLIKREIN; ENDOTHELIAL GLYCOCALYX; HEREDITARY ANGIOEDEMA; COMPLEMENT INHIBITOR; LEUKOCYTE ADHESION; SKELETAL-MUSCLE	Background: Ischemia/reperfusion injury of lower extremities and associated lung damage may result from thrombotic occlusion, embolism, trauma, or surgical intervention with prolonged ischemia and subsequent restoration of blood flow. This clinical entity is characterized by high morbidity and mortality. Deprivation of blood supply leads to molecular and structural changes in the affected tissue. Upon reperfusion inflammatory cascades are activated causing tissue injury. We therefore tested preoperative treatment for prevention of reperfusion injury by using C1 esterase inhibitor (C1 INH). Methods and Findings: Wistar rats systemically pretreated with C1 INH (n = 6), APT070 (a membrane-targeted myristoylated peptidyl construct derived from human complement receptor 1, n = 4), vehicle (n = 7), or NaCl (n = 8) were subjected to 3h hind limb ischemia and 24h reperfusion. The femoral artery was clamped and a tourniquet placed under maintenance of a venous return. C1 INH treated rats showed significantly less edema in muscle (P < 0.001) and lung and improved muscle viability (P < 0.001) compared to controls and APT070. C1 INH prevented up-regulation of bradykinin receptor b1 (P < 0.05) and VE-cadherin (P < 0.01), reduced apoptosis (P < 0.001) and fibrin deposition (P < 0.01) and decreased plasma levels of pro-inflammatory cytokines, whereas deposition of complement components was not significantly reduced in the reperfused muscle. Conclusions: C1 INH reduced edema formation locally in reperfused muscle as well as in lung, and improved muscle viability. C1 INH did not primarily act via inhibition of the complement system, but via the kinin and coagulation cascade. APT070 did not show beneficial effects in this model, despite potent inhibition of complement activation. Taken together, C1 INH might be a promising therapy to reduce peripheral ischemia/reperfusion injury and distant lung damage in complex and prolonged surgical interventions requiring tourniquet application.	[Duehrkop, Claudia; Banz, Yara; Rieben, Robert] Univ Bern, Dept Clin Res, Bern, Switzerland; [Duehrkop, Claudia] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Banz, Yara] Univ Bern, Inst Pathol, Bern, Switzerland; [Spirig, Rolf; Miescher, Sylvia; Spycher, Martin] CSL Behring AG, Bern, Switzerland; [Nolte, Marc W.] CSL Behring GmbH, Marburg, Germany; [Smith, Richard A. G.; Sacks, Steven H.] Kings Coll London, Sch Med Guys, Div Transplantat Immunol & Mucosal Biol, MRC Ctr Transplantat, London WC2R 2LS, England	University of Bern; University of Bern; University of Bern; CSL; CSL; University of London; King's College London	Rieben, R (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.	robert.rieben@dkf.unibe.ch	Rieben, Robert/D-7044-2017	Rieben, Robert/0000-0003-4179-8891; Sacks, Steven/0000-0001-6361-9095	Swiss National Science Foundation [32003B-135272]; CSL Behring GmbH, Bern, Switzerland; Medical Research Council [G0600698, G1001197, G0600892, MR/J006742/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10142] Funding Source: researchfish; MRC [G0600698, G0600892, G1001197] Funding Source: UKRI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CSL Behring GmbH, Bern, Switzerland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Swiss National Science Foundation (32003B-135272) and CSL Behring GmbH, Bern, Switzerland. No additional external funding was received for this study. The funders had no role in data collection and analysis, but were involved in study design, decision to publish and in preparation of the manuscript.	Austinat M, 2009, STROKE, V40, P285, DOI 10.1161/STROKEAHA.108.526673; Banz Y, 2007, CARDIOVASC RES, V76, P482, DOI 10.1016/j.cardiores.2007.07.016; Bianchi C, 2001, CIRCULATION, V104, pI319; Bork K, 2006, AM J MED, V119, P267, DOI 10.1016/j.amjmed.2005.09.064; BRAY MA, 1981, BRIT J PHARMACOL, V72, P483, DOI 10.1111/j.1476-5381.1981.tb11000.x; Brown EW, 2002, BLOOD COAGUL FIBRIN, V13, P711, DOI 10.1097/00001721-200212000-00007; Cai SH, 2005, J IMMUNOL, V174, P6462, DOI 10.4049/jimmunol.174.10.6462; Cai SH, 2003, J IMMUNOL, V171, P4786, DOI 10.4049/jimmunol.171.9.4786; Chong AJ, 2003, ANN THORAC SURG, V75, pS649, DOI 10.1016/S0003-4975(02)04691-X; COLMAN RW, 1969, BIOCHEM BIOPH RES CO, V35, P273, DOI 10.1016/0006-291X(69)90278-2; COOPER NR, 1985, ADV IMMUNOL, V37, P151, DOI 10.1016/S0065-2776(08)60340-5; De Simoni MG, 2003, J CEREBR BLOOD F MET, V23, P232, DOI 10.1097/01.WCB.0000046146.31247.A1; Dick F, 2008, CIRCULATION, V118, P1920, DOI 10.1161/CIRCULATIONAHA.108.787754; Edagawa M, 1999, TRANSPLANTATION, V67, P944, DOI 10.1097/00007890-199904150-00003; Eefting F, 2004, CARDIOVASC RES, V61, P414, DOI 10.1016/j.cardiores.2003.12.023; Ege T, 2004, J INT MED RES, V32, P124, DOI 10.1177/147323000403200204; Fu JR, 2006, BIOCHEM BIOPH RES CO, V349, P504, DOI 10.1016/j.bbrc.2006.08.065; GADALETA D, 1994, ANN NY ACAD SCI, V723, P470, DOI 10.1111/j.1749-6632.1994.tb36780.x; GOLDSMITH GH, 1978, J CLIN INVEST, V62, P54, DOI 10.1172/JCI109113; Gouverneur M, 2006, J INTERN MED, V259, P393, DOI 10.1111/j.1365-2796.2006.01625.x; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hashimoto N, 2004, J HEART LUNG TRANSPL, V23, P606, DOI 10.1016/S1053-2498(03)00297-3; Heijnen BHM, 2006, CLIN EXP IMMUNOL, V143, P15, DOI 10.1111/j.1365-2249.2005.02958.x; Heydenreich N, 2012, STROKE, V43, P2457, DOI 10.1161/STROKEAHA.112.660340; Horstick G, 1997, CIRCULATION, V95, P701, DOI 10.1161/01.CIR.95.3.701; Hsieh CH, 2008, J IMMUNOL, V181, P2806, DOI 10.4049/jimmunol.181.4.2806; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Inderbitzin D, 2004, EUR SURG RES, V36, P142, DOI 10.1159/000077255; Kao MC, 2011, J SURG RES, V171, pE97, DOI 10.1016/j.jss.2011.03.028; Kemp M, 2004, BRIT J ANAESTH, V93, P63, DOI 10.1093/bja/aeh148; Kulik L, 2009, J IMMUNOL, V182, P5363, DOI 10.4049/jimmunol.0803980; Kunschak M, 1998, TRANSFUSION, V38, P540, DOI 10.1046/j.1537-2995.1998.38698326333.x; LANDERMAN NS, 1962, J ALLERGY, V33, P330, DOI 10.1016/0021-8707(62)90032-1; Li R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037195; Liao YH, 2012, J AM COLL CARDIOL, V59, P420, DOI 10.1016/j.jacc.2011.10.863; Lu F, 2012, CARDIOVASC PATHOL; McMullen ME, 2006, IMMUNOBIOLOGY, V211, P759, DOI 10.1016/j.imbio.2006.06.011; Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; Nielsen EW, 2002, SCAND J IMMUNOL, V56, P588, DOI 10.1046/j.1365-3083.2002.01173.x; OKADA Y, 1994, STROKE, V25, P1847, DOI 10.1161/01.STR.25.9.1847; Pedersen ED, 2004, CLIN EXP IMMUNOL, V137, P117, DOI 10.1111/j.1365-2249.2004.02489.x; PUNCH J, 1991, J TRAUMA, V31, P760, DOI 10.1097/00005373-199106000-00005; Ravindran S, 2004, THROMB HAEMOSTASIS, V92, P1277, DOI 10.1160/TH04-01-0008; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Schoots LG, 2004, CRIT CARE MED, V32, P1375, DOI 10.1097/01.CCM.0000128567.57761.E9; SEEKAMP A, 1993, AM J PATHOL, V143, P453; Smith GP, 2001, MOL IMMUNOL, V38, P249, DOI 10.1016/S0161-5890(01)00047-5; Smith RAG, 2002, BIOCHEM SOC T, V30, P1037, DOI 10.1042/bst0301037; Souza DG, 2005, BRIT J PHARMACOL, V145, P1027, DOI 10.1038/sj.bjp.0706286; Souza DG, 2004, J IMMUNOL, V172, P2542, DOI 10.4049/jimmunol.172.4.2542; Stallone R J, 1969, Ann Thorac Surg, V7, P539; Swiss Academy of Medical Sciences, 1997, Altern Lab Anim, V25, P379; Toomayan GA, 2003, MICROSURG, V23, P561, DOI 10.1002/micr.10210; Weiser MR, 1996, J EXP MED, V183, P2343, DOI 10.1084/jem.183.5.2343; Witherow FN, 2001, CIRCULATION, V104, P2177, DOI 10.1161/hc4301.098252; Yassin MMI, 2002, WORLD J SURG, V26, P115, DOI 10.1007/s00268-001-0169-2; Zeerleder S, 2011, SEMIN THROMB HEMOST, V37, P362, DOI 10.1055/s-0031-1276585; Zhang M, 2006, J EXP MED, V203, P141, DOI 10.1084/jem.20050390	59	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72059	10.1371/journal.pone.0072059	http://dx.doi.org/10.1371/journal.pone.0072059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991040	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800042
J	Thomsen, R; Daugaard, TF; Holm, IE; Nielsen, AL				Thomsen, Rune; Daugaard, Tina F.; Holm, Ida E.; Nielsen, Anders Lade			Alternative mRNA Splicing from the Glial Fibrillary Acidic Protein (GFAP) Gene Generates Isoforms with Distinct Subcellular mRNA Localization Patterns in Astrocytes	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; RADIAL GLIA; VENTRICULAR ZONE; CELLS; IDENTIFICATION; BRAIN; DELTA; VISUALIZATION; PROGENITORS	The intermediate filament network of astrocytes includes Glial fibrillary acidic protein (Gfap) as a major component. Gfap mRNA is alternatively spliced resulting in generation of different protein isoforms where Gfap alpha is the most predominant isoform. The Gfap delta isoform is expressed in proliferating neurogenic astrocytes of the developing human brain and in the adult human and mouse brain. Here we provide a characterization of mouse Gfap delta mRNA and Gfap delta protein. RT-qPCR analysis showed that Gfap delta mRNA and Gfap alpha mRNA expression is coordinately increased in the post-natal period. Immunohistochemical staining of developing mouse brain samples showed that Gfap delta is expressed in the sub-ventricular zones in accordance with the described localization in the developing and adult human brain. Immunofluorescence analysis verified incorporation of Gfap delta into the Gfap intermediate filament network and overlap in Gfap delta and Gfap alpha subcellular localization. Subcellular mRNA localization studies identified different localization patterns of Gfap delta and Gfap alpha mRNA in mouse primary astrocytes. A larger fraction of Gfap alpha mRNA showed mRNA localization to astrocyte protrusions compared to Gfap delta mRNA. The differential mRNA localization patterns were dependent on the different 3'-exon sequences included in Gfap delta and Gfap alpha mRNA. The presented results show that alternative Gfap mRNA splicing results in isoform-specific mRNA localization patterns with resulting different local mRNA concentration ratios which have potential to participate in subcellular region-specific intermediate filament dynamics during brain development, maintenance and in disease.	[Thomsen, Rune; Daugaard, Tina F.; Nielsen, Anders Lade] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Holm, Ida E.] Reg Hosp Randers, Expt Neuropathol Lab, Dept Pathol, Randers, Denmark; [Nielsen, Anders Lade] Aarhus Univ, Ctr Integrat Sequencing, iSEQ, Aarhus, Denmark; [Nielsen, Anders Lade] Aarhus Univ, Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH)	Nielsen, AL (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	aln@hum-gen.au.dk	Nielsen, Anders Lade L/Q-9604-2016	Nielsen, Anders Lade L/0000-0003-4372-9961; Daugaard, Tina Fuglsang/0000-0003-0320-3076; Thomsen, Rune/0000-0002-9969-6567	Lundbeck Foundation; Fonden til Laegevidenskabens Fremme; NANONET COST [BM1002]; Faculty of Health Sciences, Aarhus University, Denmark	Lundbeck Foundation(Lundbeckfonden); Fonden til Laegevidenskabens Fremme; NANONET COST(European Cooperation in Science and Technology (COST)); Faculty of Health Sciences, Aarhus University, Denmark	This project is funded by grants from the Lundbeck Foundation, Fonden til Laegevidenskabens Fremme, and NANONET COST [BM1002]. RT is a recipient of a PhD fellowship from the Faculty of Health Sciences, Aarhus University, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Andreiuolo F, 2009, NEUROPATHOLOGY, V29, P31, DOI 10.1111/j.1440-1789.2008.00936.x; ANTANITUS DS, 1976, BRAIN RES, V103, P613, DOI 10.1016/0006-8993(76)90464-9; Aquino DA, 1996, DEV BRAIN RES, V91, P1, DOI 10.1016/0165-3806(95)00146-8; Blechingberg J, 2007, NUCLEIC ACIDS RES, V35, P7636, DOI 10.1093/nar/gkm931; Blechingberg J, 2007, GLIA, V55, P497, DOI 10.1002/glia.20475; BOVOLENTA P, 1984, DEV BIOL, V102, P248, DOI 10.1016/0012-1606(84)90189-1; Boyd SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033565; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Condorelli DF, 1999, J NEUROSCI RES, V56, P219, DOI 10.1002/(SICI)1097-4547(19990501)56:3<219::AID-JNR1>3.0.CO;2-2; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; DeAzevedo LC, 2003, J NEUROBIOL, V55, P288, DOI 10.1002/neu.10205; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; Gomi H, 2010, BRAIN RES, V1312, P156, DOI 10.1016/j.brainres.2009.11.025; Gotz M, 2002, BRAIN RES BULL, V57, P777, DOI 10.1016/S0361-9230(01)00777-8; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Honig LS, 1996, CEREB CORTEX, V6, P794, DOI 10.1093/cercor/6.6.794; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251; Leonard BW, 2009, J COMP NEUROL, V515, P269, DOI 10.1002/cne.22040; Liu XX, 2006, GLIA, V54, P394, DOI 10.1002/glia.20392; Mamber C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052659; Medrano S, 2001, J COMP NEUROL, V430, P56, DOI 10.1002/1096-9861(20010129)430:1<56::AID-CNE1014>3.0.CO;2-Y; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Middeldorp J, 2010, DEVELOPMENT, V137, P313, DOI 10.1242/dev.041632; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Mili S, 2009, TRENDS CELL BIOL, V19, P156, DOI 10.1016/j.tcb.2009.02.001; Nielsen AL, 2004, J BIOL CHEM, V279, P41537, DOI 10.1074/jbc.M406601200; Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; SARTHY PV, 1989, MOL CELL BIOL, V9, P4556, DOI 10.1128/MCB.9.10.4556; Shav-Tal Y, 2005, J CELL SCI, V118, P4077, DOI 10.1242/jcs.02543; Singh R, 2003, GENOMICS, V82, P185, DOI 10.1016/S0888-7543(03)00106-X; Sundholm-Peters NL, 2004, J NEUROCYTOL, V33, P153, DOI 10.1023/B:NEUR.0000029654.70632.3a; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Thomsen R, 2011, GLIA, V59, P1782, DOI 10.1002/glia.21223; Thomsen Rune, 2010, J Bioinform Comput Biol, V8, P885, DOI 10.1142/S0219720010004963; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; van den Berge SA, 2010, AGING CELL, V9, P313, DOI 10.1111/j.1474-9726.2010.00556.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511	50	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72110	10.1371/journal.pone.0072110	http://dx.doi.org/10.1371/journal.pone.0072110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991052	Green Published, gold, Green Submitted			2022-12-25	WOS:000324228800046
J	Horino, S; Uchiyama, T; So, T; Nagashima, H; Sun, S; Sato, M; Asao, A; Haji, Y; Sasahara, Y; Candotti, F; Tsuchiya, S; Kure, S; Sugamura, K; Ishii, N				Horino, Satoshi; Uchiyama, Toru; So, Takanori; Nagashima, Hiroyuki; Sun, Shu-lan; Sato, Miki; Asao, Atsuko; Haji, Yoichi; Sasahara, Yoji; Candotti, Fabio; Tsuchiya, Shigeru; Kure, Shigeo; Sugamura, Kazuo; Ishii, Naoto			Gene Therapy Model of X-linked Severe Combined Immunodeficiency Using a Modified Foamy Virus Vector	PLOS ONE			English	Article							INTERLEUKIN-2-RECEPTOR GAMMA-CHAIN; TRANSCRIPTION START REGIONS; MOUSE MODEL; LONG-TERM; HEMATOPOIETIC-CELLS; REPOPULATING CELLS; RETROVIRAL VECTORS; STEM-CELLS; INTEGRATION; TRANSDUCTION	X-linked severe combined immunodeficiency (SCID-X1) is an inherited genetic immunodeficiency associated with mutations in the common cytokine receptor gamma chain (gamma c) gene, and characterized by a complete defect of T and natural killer (NK) cells. Gene therapy for SCID-X1 using conventional retroviral (RV) vectors carrying the gamma c gene results in the successful reconstitution of T cell immunity. However, the high incidence of vector-mediated T cell leukemia, caused by vector insertion near or within cancer-related genes has been a serious problem. In this study, we established a gene therapy model of mouse SCID-X1 using a modified foamy virus (FV) vector expressing human gamma c. Analysis of vector integration in a human T cell line demonstrated that the FV vector integration sites were significantly less likely to be located within or near transcriptional start sites than RV vector integration sites. To evaluate the therapeutic efficacy, bone marrow cells from gamma c-knockout (gamma c-KO) mice were infected with the FV vector and transplanted into gamma c-KO mice. Transplantation of the FV-treated cells resulted in the successful reconstitution of functionally active T and B cells. These data suggest that FV vectors can be effective and may be safer than conventional RV vectors for gene therapy for SCID-X1.	[Horino, Satoshi; So, Takanori; Nagashima, Hiroyuki; Sun, Shu-lan; Asao, Atsuko; Haji, Yoichi; Ishii, Naoto] Tohoku Univ, Dept Microbiol & Immunol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Horino, Satoshi; Uchiyama, Toru; Sato, Miki; Haji, Yoichi; Tsuchiya, Shigeru; Kure, Shigeo] Tohoku Univ, Dept Pediat, Grad Sch Med, Sendai, Miyagi 980, Japan; [Candotti, Fabio] NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Sugamura, Kazuo] Miyagi Canc Ctr, Natori, Miyagi 9811293, Japan	Tohoku University; Tohoku University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Miyagi Cancer Center	Ishii, N (corresponding author), Tohoku Univ, Dept Microbiol & Immunol, Grad Sch Med, Sendai, Miyagi 980, Japan.	ishiin@med.tohoku.ac.jp	So, Takanori/R-6175-2019; Asao, Atsuko/AAC-4576-2019; Nagashima, Hiroyuki/AAL-3128-2021	So, Takanori/0000-0003-3004-8526; Asao, Atsuko/0000-0003-3578-4127; Ishii, Naoto/0000-0002-0549-8245; Nagashima, Hiroyuki/0000-0001-8405-6746; Horino, Satohi/0000-0002-8385-4962; UCHIYAMA, TORU/0000-0001-9610-0900; Candotti, Fabio/0000-0001-6399-6042	Ministry of Education, Science, Sports and Culture of Japan [24659487, 24390118]; Japan Society for the Promotion of Science; Japan Science and Technology Agency [111020001010004100]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000121, ZIAHG000122] Funding Source: NIH RePORTER	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported in part by a grant-in-aid (#24659487 and #24390118) for scientific research on priority areas from the Ministry of Education, Science, Sports and Culture of Japan, a grant-in-aid for scientific research on priority areas from the Japan Society for the Promotion of Science, and grants (#111020001010004100) from the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ARIMA N, 1992, J EXP MED, V176, P1265, DOI 10.1084/jem.176.5.1265; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Bauer TR, 2008, NAT MED, V14, P93, DOI 10.1038/nm1695; Beard BC, 2007, HUM GENE THER, V18, P423, DOI 10.1089/hum.2007.011; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Cavazzana-Calvo M, 2007, J CLIN INVEST, V117, P1456, DOI 10.1172/JCI30953; Chatziandreou I, 2011, EXP HEMATOL, V39, P643, DOI 10.1016/j.exphem.2011.03.003; Fischer A, 2010, NAT IMMUNOL, V11, P457, DOI 10.1038/ni0610-457; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Haddad E, 1998, BLOOD, V91, P3646; Huston MW, 2011, MOL THER, V19, P1867, DOI 10.1038/mt.2011.127; ISHII N, 1994, J IMMUNOL, V153, P1310; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Josephson NC, 2004, HUM GENE THER, V15, P87, DOI 10.1089/10430340460732481; Kume A, 2002, BONE MARROW TRANSPL, V30, P113, DOI 10.1038/sj.bmt.1703613; Laufs S, 2004, MOL THER, V10, P874, DOI 10.1016/j.ymthe.2004.08.001; Leurs C, 2003, HUM GENE THER, V14, P509, DOI 10.1089/104303403764539305; Modlich U, 2009, MOL THER, V17, P1919, DOI 10.1038/mt.2009.179; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Morianos I, 2012, GENE THER, V19, P303, DOI 10.1038/gt.2011.98; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; Otsu M, 2000, HUM GENE THER, V11, P2051, DOI 10.1089/10430340050143462; Otsu M, 2001, BLOOD, V97, P1618, DOI 10.1182/blood.V97.6.1618; Russell DW, 1996, J VIROL, V70, P217, DOI 10.1128/JVI.70.1.217-222.1996; Si Y, 2008, BLOOD, V112, P4458, DOI 10.1182/blood-2007-07-102947; Stirnnagel K, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-45; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Trobridge G, 2002, MOL THER, V6, P321, DOI 10.1006/mthe.2002.0672; Trobridge GD, 2006, P NATL ACAD SCI USA, V103, P1498, DOI 10.1073/pnas.0510046103; Uchiyama T, 2012, MOL THER, V20, P1270, DOI 10.1038/mt.2011.282; Vassilopoulos G, 2001, BLOOD, V98, P604, DOI 10.1182/blood.V98.3.604; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Zhang F, 2007, BLOOD, V110, P1448, DOI 10.1182/blood-2006-12-060814; Zhu NX, 2006, J BIOL CHEM, V281, P14711, DOI 10.1074/jbc.M513810200	36	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71594	10.1371/journal.pone.0071594	http://dx.doi.org/10.1371/journal.pone.0071594			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990961	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100048
J	Li, C; Wen, TF; Yan, LN; Li, B; Yang, JY; Xu, MQ; Wang, WT; Wei, YG				Li, Chuan; Wen, Tian-Fu; Yan, Lu-Nan; Li, Bo; Yang, Jia-Ying; Xu, Ming-Qing; Wang, Wen-Tao; Wei, Yong-Gang			Scoring Selection Criteria Including Total Tumour Volume and Pretransplant Percentage of Lymphocytes to Predict Recurrence of Hepatocellular Carcinoma after Liver Transplantation	PLOS ONE			English	Article							INTRAGRAFT GENE-EXPRESSION; LIVING DONOR; MICROVASCULAR INVASION; MILAN CRITERIA; ANTITUMOR IMMUNITY; RATIO; IMPACT; RESECTION; SURVIVAL; SIZE	Aim: The selection criteria for patients with hepatocellular carcinoma (HCC) to undergo liver transplantation should accurately predict posttransplant recurrence while not denying potential beneficiaries. In the present study, we attempted to identify risk factors associated with posttransplant recurrence and to expand the selection criteria. Patients and Methods: Adult patients with HCC who underwent liver transplantation between November 2004 and September 2012 at our centre were recruited into the current study (N = 241). Clinical and pathological data were retrospectively reviewed. Patients who died during the perioperative period or died of non-recurrence causes were excluded from this study (N = 25). All potential risk factors were analysed using uni- and multi-variate analyses. Results: Sixty-one recipients of 216 qualified patients suffered from recurrence. Similar recurrence-free and long-term survival rates were observed between living donor liver transplant recipients (N = 60) and deceased donor liver transplant recipients (N = 156). Total tumour volume (TTV) and preoperative percentage of lymphocytes (L%) were two independent risk factors in the multivariate analysis. We propose a prognostic score model based on these two risk factors. Patients within our criteria achieved a similar recurrence-free survival to patients within the Milan criteria. Seventy-one patients who were beyond the Milan criteria but within our criteria also had comparable survival to patients within the Milan criteria. Conclusions: TTV and L% are two risk factors that contribute to posttransplant recurrence. Selection criteria based on these two factors, which are proposed by our study, expanded the Milan criteria without increasing the risk of posttransplant recurrence.	[Li, Chuan; Wen, Tian-Fu; Yan, Lu-Nan; Li, Bo; Yang, Jia-Ying; Xu, Ming-Qing; Wang, Wen-Tao; Wei, Yong-Gang] Sichuan Univ, Div Liver Transplantat, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University	Wen, TF (corresponding author), Sichuan Univ, Div Liver Transplantat, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China.	ccwentianfu@sohu.com			National Science and Technology Major Project of China [2012ZX10002-016, 2012ZX10002-017]	National Science and Technology Major Project of China	This work was supported by a grant from the National Science and Technology Major Project of China (2012ZX10002-016 and 2012ZX10002-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataide EC, 2011, TRANSPL P, V43, P1362, DOI 10.1016/j.transproceed.2011.02.032; Burra P, 2013, LIVER TRANSPLANT, V19, P122, DOI 10.1002/lt.23574; Chen TM, 2012, J GASTROEN HEPATOL, V27, P553, DOI 10.1111/j.1440-1746.2011.06910.x; Di Sandro S, 2009, TRANSPL P, V41, P1283, DOI 10.1016/j.transproceed.2009.03.022; Dumitra TC, 2013, TRANSPLANTATION, V95, P228, DOI 10.1097/TP.0b013e31827743d7; Duvoux C, 2012, GASTROENTEROLOGY, V143, P986, DOI 10.1053/j.gastro.2012.05.052; Eto M, 2008, CLIN CANCER RES, V14, P2833, DOI 10.1158/1078-0432.CCR-07-1742; Fisher RA, 2007, AM J TRANSPLANT, V7, P1601, DOI 10.1111/j.1600-6143.2007.01802.x; Gomez D, 2008, WORLD J SURG, V32, P1757, DOI 10.1007/s00268-008-9552-6; Grant RC, 2013, CLIN TRANSPLANT, V27, P140, DOI 10.1111/ctr.12031; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Jiang SM, 2009, LIVER TRANSPLANT, V15, P1043, DOI 10.1002/lt.21797; Lee HH, 2005, TRANSPL P, V37, P1251, DOI 10.1016/j.transproceed.2005.01.018; Liang WH, 2012, LIVER TRANSPLANT, V18, P1226, DOI 10.1002/lt.23490; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Lo CM, 2007, BRIT J SURG, V94, P78, DOI 10.1002/bjs.5528; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Man K, 2003, LIVER TRANSPLANT, V9, P425, DOI 10.1053/jlts.2003.50066; Man K, 2003, ANN SURG, V237, P256, DOI 10.1097/00000658-200302000-00015; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Moon JI, 2012, TRANSPL P, V44, P487, DOI 10.1016/j.transproceed.2011.11.009; Motomura T, 2013, J HEPATOL, V58, P58, DOI 10.1016/j.jhep.2012.08.017; Nemes B, 2011, TRANSPL P, V43, P1272, DOI 10.1016/j.transproceed.2011.03.077; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Roayaie S, 2009, GASTROENTEROLOGY, V137, P850, DOI 10.1053/j.gastro.2009.06.003; Shah SA, 2007, J GASTROINTEST SURG, V11, P464, DOI 10.1007/s11605-006-0033-7; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Toso C, 2008, LIVER TRANSPLANT, V14, P1107, DOI 10.1002/lt.21484; Wang HT, 2012, INT J CANCER, V130, P2892, DOI 10.1002/ijc.26339; Wang R., 2013, HEPATOLOGY; Western CE, 2012, GUT, V61, pA192, DOI 10.1136/gutjnl-2012-302514c.22; Wittnich C, 2004, TRANSPL P, V36, P1485, DOI 10.1016/j.transproceed.2004.05.055; Wu Y, 2010, INT J CANCER, V126, P2373, DOI 10.1002/ijc.24932; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563; Zhang L, 2012, MOL BIOL REP, V39, P5085, DOI 10.1007/s11033-011-1304-2	36	12	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72235	10.1371/journal.pone.0072235	http://dx.doi.org/10.1371/journal.pone.0072235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991069	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100089
J	Park, Y; Lee, K; Ziegler, TR; Martin, GS; Hebbar, G; Vidakovic, B; Jones, DP				Park, Youngja; Lee, Kichun; Ziegler, Thomas R.; Martin, Greg S.; Hebbar, Gautam; Vidakovic, Brani; Jones, Dean P.			Multifractal Analysis for Nutritional Assessment	PLOS ONE			English	Article							BLOOD GLUTATHIONE SYNTHESIS; FRACTAL DYNAMICS; PEAK ALIGNMENT; NMR SIGNALS; DISEASE; VARIABILITY; PHYSIOLOGY; PLASMA; ADULTS; STATE	The concept of multifractality is currently used to describe self-similar and complex scaling properties observed in numerous biological signals. Fractals are geometric objects or dynamic variations which exhibit some degree of similarity (irregularity) to the original object in a wide range of scales. This approach determines irregularity of biologic signal as an indicator of adaptability, the capability to respond to unpredictable stress, and health. In the present work, we propose the application of multifractal analysis of wavelet-transformed proton nuclear magnetic resonance (H-1 NMR) spectra of plasma to determine nutritional insufficiency. For validation of this method on H-1 NMR signal of human plasma, standard deviation from classical statistical approach and Hurst exponent (H), left slope and partition function from multifractal analysis were extracted from H-1 NMR spectra to test whether multifractal indices could discriminate healthy subjects from unhealthy, intensive care unit patients. After validation, the multifractal approach was applied to spectra of plasma from a modified crossover study of sulfur amino acid insufficiency and tested for associations with blood lipids. The results showed that standard deviation and H, but not left slope, were significantly different for sulfur amino acid sufficiency and insufficiency. Quadratic discriminant analysis of H, left slope and the partition function showed 78% overall classification accuracy according to sulfur amino acid status. Triglycerides and apolipoprotein C3 were significantly correlated with a multifractal model containing H, left slope, and standard deviation, and cholesterol and high-sensitivity C-reactive protein were significantly correlated to H. In conclusion, multifractal analysis of H-1 NMR spectra provides a new approach to characterize nutritional status.	[Park, Youngja; Martin, Greg S.; Jones, Dean P.] Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; [Park, Youngja] Korea Univ, Coll Pharm, Sejong City, South Korea; [Lee, Kichun] Hanyang Univ, Dept Ind Engn, Seoul 133791, South Korea; [Ziegler, Thomas R.; Hebbar, Gautam] Emory Univ, Dept Med, Div Endocrinol Metab & Lipids, Atlanta, GA 30322 USA; [Vidakovic, Brani] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Jones, Dean P.] Emory Univ, Dept Med, Clin Biomarkers Lab, Atlanta, GA 30322 USA	Emory University; Korea University; Hanyang University; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University	Lee, K (corresponding author), Hanyang Univ, Dept Ind Engn, Seoul 133791, South Korea.	skylee@hanyang.ac.kr; dpjones@emory.edu	Martin, Greg/B-4085-2009	Martin, Greg/0000-0002-9684-7593; Park, Youngja/0000-0002-1310-148X	National Institutes of Health [ES012929, ES009047, DK066008, DK55850, K24 RR023356]; Emory University General Clinical Research Center [M01 RR00039/UL1 RR025008]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039, K24RR023356] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055850, R03DK066008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009047, R03ES012929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by National Institutes of Health grants ES012929, ES009047 and DK066008 (DPJ); DK55850 and K24 RR023356 (TRZ); and the Emory University General Clinical Research Center grant M01 RR00039/UL1 RR025008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral LAN, 1999, COMPUT PHYS COMMUN, V121, P126, DOI 10.1016/S0010-4655(99)00295-7; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Ciuciu P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00186; Forshed J, 2003, ANAL CHIM ACTA, V487, P189, DOI 10.1016/S0003-2670(03)00570-1; Gao JB, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016117; Go YM, 2005, CIRCULATION, V111, P2973, DOI 10.1161/CIRCULATIONAHA.104.515155; GO YM, 2008, BIOCHIM BIOPHYS ACTA, V1780, P1273, DOI DOI 10.1016/J.BBAGEN.2008.01.011; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GOLDBERGER AL, 1987, YALE J BIOL MED, V60, P421; Goncalves P, 1998, P 32 AS C SIGN SYST, V1, P287; Hampson KM, 2012, J MOD OPTIC, V59, P1056, DOI 10.1080/09500340.2012.683826; Hampson KM, 2011, BIOMED OPT EXPRESS, V2, P464, DOI 10.1364/BOE.2.000464; Hausdorff JM, 2009, MOVEMENT DISORD, V24, P1688, DOI 10.1002/mds.22554; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Havlin S, 1999, PHYSICA A, V274, P99, DOI 10.1016/S0378-4371(99)00333-7; Hu J, 2010, ANN BIOMED ENG, V38, P854, DOI 10.1007/s10439-009-9863-2; Hu J, 2009, CHAOS, V19, DOI 10.1063/1.3152007; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Jones DP, 2011, NUTRITION, V27, P199, DOI 10.1016/j.nut.2010.01.014; Jones DP, 2004, FASEB J, V18, P1246, DOI 10.1096/fj.03-0971fje; Jung Yoon Young, 2010, J Data Sci, V8, P1; Lee GC, 2004, ANAL CHIM ACTA, V513, P413, DOI 10.1016/j.aca.2004.02.068; Lyons J, 2001, CRIT CARE MED, V29, P870, DOI 10.1097/00003246-200104000-00036; Lyons J, 2000, P NATL ACAD SCI USA, V97, P5071, DOI 10.1073/pnas.090083297; MacIntosh RE, 2008, ACTA CYTOL, V52, P530, DOI 10.1159/000325593; Mandelbrot B.B, 1977, FRACTALS FORM CHANCE; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Martin GS, 2005, CRIT CARE MED, V33, P1681, DOI 10.1097/01.CCM.0000171539.47006.02; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; Mutihac R, 2010, ROM REP PHYS, V62, P801; Park Y, 2011, J NUTR, V141, P1424, DOI 10.3945/jn.111.138875; Park Y, 2010, J NUTR, V140, P760, DOI 10.3945/jn.109.116764; Park Y, 2009, AM J PHYSIOL-REG I, V297, pR202, DOI 10.1152/ajpregu.90757.2008; Payne DNR, 2002, PEDIATR PULM, V33, P356, DOI 10.1002/ppul.10081; Peng CK, 2002, ANN BIOMED ENG, V30, P683, DOI 10.1114/1.1481053; Raguso CA, 2000, AM J CLIN NUTR, V71, P491; Ramirez-Cobo P, 2013, COMPUT STAT DATA AN, V58, P71, DOI 10.1016/j.csda.2011.09.009; Shimizu Y, 2004, NEUROIMAGE, V22, P1195, DOI 10.1016/j.neuroimage.2004.03.007; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Thurner S, 2003, PHYSICA A, V326, P511, DOI 10.1016/S0378-4371(03)00279-6; Vidakovic B., 1999, STAT MODELING WAVELE; Wendt H, 2009, SIGNAL PROCESS, V89, P1100, DOI 10.1016/j.sigpro.2008.12.015; Zhang J, 2012, PHYSICA A, V388, P4407	44	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e69000	10.1371/journal.pone.0069000	http://dx.doi.org/10.1371/journal.pone.0069000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990878	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100007
J	Ding, V; Lew, QJ; Chu, KL; Natarajan, S; Rajasegaran, V; Gurumurthy, M; Choo, ABH; Chao, SH				Ding, Vanessa; Lew, Qiao Jing; Chu, Kai Ling; Natarajan, Subaashini; Rajasegaran, Vikneswari; Gurumurthy, Meera; Choo, Andre B. H.; Chao, Sheng-Hao			HEXIM1 Induces Differentiation of Human Pluripotent Stem Cells	PLOS ONE			English	Article							POLYMERASE-II TRANSCRIPTION; RNA-POLYMERASE; P-TEFB; HEXAMETHYLENE BISACETAMIDE; NEURAL DIFFERENTIATION; GENE-EXPRESSION; IPS CELLS; 7SK RNA; IDENTIFICATION; ELONGATION	Hexamethylene bisacetamide inducible protein 1 (HEXIM1) is best known as the inhibitor of positive transcription elongation factor b (P-TEFb), which is composed of cyclin-dependent kinase 9 (CDK9)/cyclin T1. P-TEFb is an essential regulator for the transcriptional elongation by RNA polymerase II. A genome-wide study using human embryonic stem cells shows that most mRNA synthesis is regulated at the stage of transcription elongation, suggesting a possible role for P-TEFb/HEXIM1 in the gene regulation of stem cells. In this report, we detected a marked increase in HEXIM1 protein levels in the differentiated human pluripotent stem cells (hPSCs) induced by LY294002 treatment. Since no changes in CDK9 and cyclin T1 were observed in the LY294002-treated cells, increased levels of HEXIM1 might lead to inhibition of P-TEFb activity. However, treatment with a potent P-TEFb inhibiting compound, flavopiridol, failed to induce hPSC differentiation, ruling out the possible requirement for P-TEFb kinase activity in hPSC differentiation. Conversely, differentiation was observed when hPSCs were incubated with hexamethylene bisacetamide, a HEXIM1 inducing reagent. The involvement of HEXIM1 in the regulation of hPSCs was further supported when overexpression of HEXIM1 concomitantly induced hPSC differentiation. Collectively, our study demonstrates a novel role of HEXIM1 in regulating hPSC fate through a P-TEFb-independent pathway.	[Ding, Vanessa; Natarajan, Subaashini; Choo, Andre B. H.] ASTAR, Bioproc Technol Inst, Stem Cell Grp, Singapore, Singapore; [Lew, Qiao Jing; Chu, Kai Ling; Rajasegaran, Vikneswari; Gurumurthy, Meera; Chao, Sheng-Hao] ASTAR, Bioproc Technol Inst, Express Engn Grp, Singapore, Singapore; [Choo, Andre B. H.] Natl Univ Singapore, Fac Engn, Dept Bioengn, Singapore 117548, Singapore; [Chao, Sheng-Hao] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore; National University of Singapore	Chao, SH (corresponding author), ASTAR, Bioproc Technol Inst, Express Engn Grp, Singapore, Singapore.	jimmy_chao@bti.a-star.edu.sg		Choo, Andre/0000-0001-9648-0755	Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work is supported by funding from the Agency for Science, Technology and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; Blagosklonny MV, 2004, CELL CYCLE, V3, P1537, DOI 10.4161/cc.3.12.1278; Chan KKK, 2008, STEM CELLS DEV, V17, P825, DOI 10.1089/scd.2008.0233; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chao SH, 2003, MOL CELL BIOL, V23, P831, DOI 10.1128/MCB.23.3.831-841.2003; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Choo A, 2006, J BIOTECHNOL, V122, P130, DOI 10.1016/j.jbiotec.2005.09.008; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; COELHO CND, 1993, DIFFERENTIATION, V52, P129, DOI 10.1111/j.1432-0436.1993.tb00623.x; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Czudnochowski N, 2010, J MOL BIOL, V395, P28, DOI 10.1016/j.jmb.2009.10.055; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dey A, 2007, CELL CYCLE, V6, P1856, DOI 10.4161/cc.6.15.4556; Dey A, 2008, CELL CYCLE, V7, P3759, DOI 10.4161/cc.7.23.7213; Ding V, 2006, BIOTECHNOL LETT, V28, P491, DOI 10.1007/s10529-006-0005-8; Ding VMY, 2010, J CELL PHYSIOL, V225, P417, DOI 10.1002/jcp.22214; DZIADEK M, 1978, J EMBRYOL EXP MORPH, V43, P289; FIBACH E, 1977, CANCER RES, V37, P440; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Galatioto J, 2010, J CELL SCI, V123, P3789, DOI 10.1242/jcs.073387; Gherghiceanu M, 2011, J CELL MOL MED, V15, P2539, DOI 10.1111/j.1582-4934.2011.01417.x; GRANA X, 1994, P NATL ACAD SCI USA, V91, P3834, DOI 10.1073/pnas.91.9.3834; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gurumurthy M, 2008, J MOL BIOL, V378, P302, DOI 10.1016/j.jmb.2008.02.055; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Kusuhara M, 1999, BIOMED RES-TOKYO, V20, P273, DOI 10.2220/biomedres.20.273; Lau J, 2009, CELL CYCLE, V8, P2247, DOI 10.4161/cc.8.14.9015; Lew QJ, 2012, J BIOL CHEM, V287, P36443, DOI 10.1074/jbc.M112.374157; Lew QJ, 2011, CELL CYCLE, V10, P1978, DOI 10.4161/cc.10.12.15859; LI HS, 1994, DEV BIOL, V162, P181, DOI 10.1006/dbio.1994.1077; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARKS PA, 1994, P NATL ACAD SCI USA, V91, P10251, DOI 10.1073/pnas.91.22.10251; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Morali OG, 2000, DEV BIOL, V227, P133, DOI 10.1006/dbio.2000.9875; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ouchida R, 2003, GENES CELLS, V8, P95, DOI 10.1046/j.1365-2443.2003.00618.x; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Schulte A, 2005, J BIOL CHEM, V280, P24968, DOI 10.1074/jbc.M501431200; Shimizu N, 2005, P NATL ACAD SCI USA, V102, P8555, DOI 10.1073/pnas.0409863102; Snir M, 2003, AM J PHYSIOL-HEART C, V285, pH2355, DOI 10.1152/ajpheart.00020.2003; Song B, 2012, STEM CELL RES, V8, P259, DOI 10.1016/j.scr.2011.12.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Wittmann BM, 2003, CANCER RES, V63, P5151; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang SX, 2005, J BIOL CHEM, V280, P19115, DOI 10.1074/jbc.M413793200	61	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72823	10.1371/journal.pone.0072823	http://dx.doi.org/10.1371/journal.pone.0072823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977357	gold, Green Published			2022-12-25	WOS:000324527300100
J	Cui, MQ; Wang, TK; Xu, J; Ke, YH; Du, XY; Yuan, XT; Wang, ZJ; Gong, CL; Zhuang, YB; Lei, SS; Su, X; Wang, XS; Huang, LY; Zhong, ZJ; Peng, GN; Yuan, J; Chen, ZL; Wang, YF				Cui, Mingquan; Wang, Tongkun; Xu, Jie; Ke, Yuehua; Du, Xinying; Yuan, Xitong; Wang, Zhoujia; Gong, Chunli; Zhuang, Yubin; Lei, Shuangshuang; Su, Xiao; Wang, Xuesong; Huang, Liuyu; Zhong, Zhijun; Peng, Guangneng; Yuan, Jing; Chen, Zeliang; Wang, Yufei			Impact of Hfq on Global Gene Expression and Intracellular Survival in Brucella melitensis	PLOS ONE			English	Article							RNA CHAPERONE HFQ; OUTER-MEMBRANE PROTEIN; ENVELOPE STRESS-RESPONSE; IV SECRETION SYSTEM; HEAT-SHOCK RESPONSE; HOST FACTOR-I; ESCHERICHIA-COLI; STATIONARY-PHASE; ACID-RESISTANCE; REGULATORY RNAS	Brucella melitensis is a facultative intracellular bacterium that replicates within macrophages. The ability of brucellae to survive and multiply in the hostile environment of host macrophages is essential to its virulence. The RNA-binding protein Hfq is a global regulator that is involved in stress resistance and pathogenicity. Here we demonstrate that Hfq is essential for stress adaptation and intracellular survival in B. melitensis. A B. melitensis hfq deletion mutant exhibits reduced survival under environmental stresses and is attenuated in cultured macrophages and mice. Microarray-based transcriptome analyses revealed that 359 genes involved in numerous cellular processes were dysregulated in the hfq mutant. From these same samples the proteins were also prepared for proteomic analysis to directly identify Hfq-regulated proteins. Fifty-five proteins with significantly affected expression were identified in the hfq mutant. Our results demonstrate that Hfq regulates many genes and/or proteins involved in metabolism, virulence, and stress responses, including those potentially involved in the adaptation of Brucella to the oxidative, acid, heat stress, and antibacterial peptides encountered within the host. The dysregulation of such genes and/or proteins could contribute to the attenuated hfq mutant phenotype. These findings highlight the involvement of Hfq as a key regulator of Brucella gene expression and facilitate our understanding of the role of Hfq in environmental stress adaptation and intracellular survival of B. melitensis.	[Cui, Mingquan; Wang, Tongkun; Xu, Jie; Ke, Yuehua; Du, Xinying; Yuan, Xitong; Wang, Zhoujia; Gong, Chunli; Zhuang, Yubin; Lei, Shuangshuang; Su, Xiao; Wang, Xuesong; Huang, Liuyu; Yuan, Jing; Chen, Zeliang; Wang, Yufei] Acad Mil Med Sci, Inst Dis Control & Prevent, Dept Infect Dis Control, Beijing, Peoples R China; [Cui, Mingquan; Zhuang, Yubin; Lei, Shuangshuang; Zhong, Zhijun; Peng, Guangneng] Sichuan Agr Univ, Coll Vet Med, Yaan, Peoples R China; [Wang, Tongkun] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Sichuan Agricultural University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Yuan, J (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Dept Infect Dis Control, Beijing, Peoples R China.	yuanjing6216@163.com; zeliangchen@yahoo.com; yufeiwang21@yahoo.com		Cui, Mingquan/0000-0003-3375-6747	National Natural Science Foundation of China [31000041, 81171530]; Beijing Natural Science Foundation of China [6122030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This study was supported by the National Natural Science Foundation of China (31000041, 81171530) and Beijing Natural Science Foundation of China (6122030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ES, 2009, INFECT IMMUN, V77, P3466, DOI 10.1128/IAI.00444-09; Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Barra-Bily L, 2010, J BACTERIOL, V192, P1719, DOI 10.1128/JB.01429-09; Boigegrain RA, 2004, INFECT IMMUN, V72, P5693, DOI 10.1128/IAI.72.10.5693-5703.2004; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; BOWDEN RA, 1995, J MED MICROBIOL, V43, P344, DOI 10.1099/00222615-43-5-344; Brown L, 1996, J BACTERIOL, V178, P3763, DOI 10.1128/jb.178.13.3763-3770.1996; Caro-Hernandez P, 2007, INFECT IMMUN, V75, P4050, DOI 10.1128/IAI.00486-07; Caswell CC, 2013, INFECT IMMUN, V81, P1040, DOI 10.1128/IAI.01097-12; Caswell CC, 2012, MOL MICROBIOL, V85, P345, DOI 10.1111/j.1365-2958.2012.08117.x; Caswell CC, 2012, J BACTERIOL, V194, P3, DOI 10.1128/JB.05623-11; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Delory M, 2006, J BACTERIOL, V188, P7707, DOI 10.1128/JB.00644-06; Delpino AV, 2006, MICROBES INFECT, V8, P1203, DOI 10.1016/j.micinf.2005.11.008; Delrue RM, 2005, CELL MICROBIOL, V7, P1151, DOI 10.1111/j.1462-5822.2005.00543.x; DelVecchio VG, 2002, VET MICROBIOL, V90, P587, DOI 10.1016/S0378-1135(02)00238-9; DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398; DETEJADA GM, 1993, J BACTERIOL, V175, P5273; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Edmonds MD, 2002, RES VET SCI, V72, P235, DOI 10.1053/rvsc.2002.0555; Edmonds MD, 2001, AM J VET RES, V62, P1461, DOI 10.2460/ajvr.2001.62.1461; ELZER PH, 1994, INFECT IMMUN, V62, P4135, DOI 10.1128/IAI.62.10.4135-4139.1994; Fantappie L, 2009, INFECT IMMUN, V77, P1842, DOI 10.1128/IAI.01216-08; Ferooz J, 2011, MICROBIOL-SGM, V157, P1263, DOI 10.1099/mic.0.044875-0; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; Folichon M, 2003, NUCLEIC ACIDS RES, V31, P7302, DOI 10.1093/nar/gkg915; FRANZE MT, 1968, NATURE, V219, P588, DOI 10.1038/219588a0; Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x; Gajiwala KS, 2000, J MOL BIOL, V295, P605, DOI 10.1006/jmbi.1999.3347; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Gao MS, 2010, MOL PLANT MICROBE IN, V23, P355, DOI 10.1094/MPMI-23-4-0355; Gee JM, 2005, INFECT IMMUN, V73, P2873, DOI 10.1128/IAI.73.5.2873-2880.2005; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; GUTIERREZ C, 1991, J MOL BIOL, V220, P959, DOI 10.1016/0022-2836(91)90366-E; Halling S M, 1998, Microb Comp Genomics, V3, P21, DOI 10.1089/omi.1.1998.3.21; JIANG XS, 1993, CELL IMMUNOL, V151, P309, DOI 10.1006/cimm.1993.1241; Kaufmann SHE, 2011, IMMUNOL REV, V240, P5, DOI 10.1111/j.1600-065X.2010.01001.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Leonard S, 2007, J BACTERIOL, V189, P131, DOI 10.1128/JB.00712-06; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; LIN JS, 1992, INFECT IMMUN, V60, P2425, DOI 10.1128/IAI.60.6.2425-2431.1992; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Martinez A, 1997, J BACTERIOL, V179, P5188, DOI 10.1128/jb.179.16.5188-5194.1997; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Meibom KL, 2009, INFECT IMMUN, V77, P1866, DOI 10.1128/IAI.01496-08; MORENO E, 1990, J BACTERIOL, V172, P3569, DOI 10.1128/jb.172.7.3569-3576.1990; Moriyon I, 1998, Int Microbiol, V1, P19; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Pfeiffer V, 2007, MOL MICROBIOL, V66, P1174, DOI 10.1111/j.1365-2958.2007.05991.x; RafieKolpin M, 1996, INFECT IMMUN, V64, P5274, DOI 10.1128/IAI.64.12.5274-5283.1996; REST RF, 1975, J BACTERIOL, V122, P139, DOI 10.1128/JB.122.1.139-144.1975; Robertson GT, 1999, MOL MICROBIOL, V34, P690, DOI 10.1046/j.1365-2958.1999.01629.x; Roop RM, 2003, ANNU REV MICROBIOL, V57, P57, DOI 10.1146/annurev.micro.57.030502.090803; Saikolappan S, 2011, TUBERCULOSIS, V91, pS119, DOI 10.1016/j.tube.2011.10.021; Schiano CA, 2010, INFECT IMMUN, V78, P2034, DOI 10.1128/IAI.01046-09; Shao CL, 2012, J PROTEOME RES, V11, P4465, DOI 10.1021/pr3002244; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Steele KH, 2010, J BACTERIOL, V192, P4912, DOI 10.1128/JB.00231-10; STRAUS DB, 1987, NATURE, V329, P348, DOI 10.1038/329348a0; Taminiau B, 2002, INFECT IMMUN, V70, P3004, DOI 10.1128/IAI.70.6.3004-3011.2002; Teixeira-Gomes AP, 2000, INFECT IMMUN, V68, P2954, DOI 10.1128/IAI.68.5.2954-2961.2000; Thompson KM, 2007, J BACTERIOL, V189, P4243, DOI 10.1128/JB.00020-07; Torres-Quesada O, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-71; Valderas MW, 2005, VET MICROBIOL, V107, P307, DOI 10.1016/j.vetmic.2005.01.018; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Vogel J, 2009, MOL MICROBIOL, V71, P1, DOI 10.1111/j.1365-2958.2008.06505.x; Vytvytska O, 2000, GENE DEV, V14, P1109; Wang YF, 2011, VET MICROBIOL, V151, P354, DOI 10.1016/j.vetmic.2011.03.031; Wang YF, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0005368, 10.1371/journal.pone.0007401]; Waterman SR, 1996, MOL MICROBIOL, V21, P925, DOI 10.1046/j.1365-2958.1996.00058.x; Wilusz CJ, 2013, RNA BIOL, V10, P592, DOI 10.4161/rna.23695; Zhang JB, 2013, MICROBIOL IMMUNOL, V57, P502, DOI 10.1111/1348-0421.12065; Zhong ZJ, 2012, J MICROBIOL, V50, P567, DOI 10.1007/s12275-012-2022-8	82	34	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71933	10.1371/journal.pone.0071933	http://dx.doi.org/10.1371/journal.pone.0071933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977181	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700114
J	Redler, A; Di Rocco, G; Giannotti, D; Frezzotti, F; Bernieri, MG; Ceccarelli, S; D'Amici, S; Vescarelli, E; Mitterhofer, AP; Angeloni, A; Marchese, C				Redler, Adriano; Di Rocco, Giorgio; Giannotti, Domenico; Frezzotti, Francesca; Bernieri, Maria Giulia; Ceccarelli, Simona; D'Amici, Sirio; Vescarelli, Enrica; Mitterhofer, Anna Paola; Angeloni, Antonio; Marchese, Cinzia			Fibroblast Growth Factor Receptor-2 Expression in Thyroid Tumor Progression: Potential Diagnostic Application	PLOS ONE			English	Article							FACTOR-I FGF-1; CANCER; CARCINOMA; CELLS; MELANOMA; 2-IIIB; OVEREXPRESSION; RESTORATION; INHIBITION; FGFR-1	Fibroblast growth factor receptor-2 (FGFR-2) plays an important role in tumorigenesis. In thyroid cancer it has been observed a FGFR-2 down-modulation, but the role of this receptor has not been yet clarified. Therefore, we decided to examine the expression of both FGFR-2 isoform, FGFR-2-IIIb and FGFR-2-IIIc, in different histological thyroid variants such as hyperplasia, follicular adenoma and papillary carcinoma. Immunohistochemistry and quantitative Real-Time PCR analyses were performed on samples of hyperplasia, follicular adenoma and papillary carcinoma, compared with normal thyroid tissue. Thyroid hyperplasia did not show statistically significant reduction in FGFR-2 protein and mRNA levels. Interestingly, in both follicular adenoma and papillary carcinoma samples we observed a strongly reduced expression of both FGFR-2 isoforms. We speculate that FGFR-2 down-modulation might be an early event in thyroid carcinogenesis. Furthermore, we suggest the potential use of FGFR-2 as an early marker for thyroid cancer diagnosis.	[Redler, Adriano; Di Rocco, Giorgio; Giannotti, Domenico; Frezzotti, Francesca] Univ Roma La Sapienza, Dept Surg Sci, I-00185 Rome, Italy; [Bernieri, Maria Giulia] Univ Roma La Sapienza, Dept Radiol Sci Oncol & Anat Pathol, I-00185 Rome, Italy; [Ceccarelli, Simona; D'Amici, Sirio; Vescarelli, Enrica; Marchese, Cinzia] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Mitterhofer, Anna Paola] Univ Roma La Sapienza, Dept Clin Med, I-00185 Rome, Italy; [Angeloni, Antonio] Univ Roma La Sapienza, Dept Mol Med, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Ceccarelli, S (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy.	simona.ceccarelli@uniroma1.it	Marchese, Cinzia/J-1323-2018; Ceccarelli, Simona/J-4086-2018; Mitterhofer, Anna Paola/I-7180-2012; Angeloni, Antonio/J-9392-2018	Ceccarelli, Simona/0000-0001-8789-7719; Angeloni, Antonio/0000-0003-4969-9548; Mitterhofer, Anna Paola/0000-0002-0132-386X; MARCHESE, CINZIA/0000-0002-9280-8917	Sapienza University of Rome, Italy [prot. C26A117TS5]	Sapienza University of Rome, Italy	This work was partially supported by grants from Sapienza University of Rome, Italy (Ateneo 2011 - prot. C26A117TS5). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NU, 1997, MELANOMA RES, V7, P299, DOI 10.1097/00008390-199708000-00004; ASA SL, 2000, THYROID CANC DIAGNOS, P39; Brierley JD, 2001, PROGNOSTIC FACTORS C, P195; Eggo MC, 2003, MOL CELL ENDOCRINOL, V213, P47, DOI 10.1016/j.mce.2003.10.034; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Ezzat S, 2005, CLIN CANCER RES, V11, P1336; Gartside MG, 2009, MOL CANCER RES, V7, P41, DOI 10.1158/1541-7786.MCR-08-0021; Giri D, 1999, CLIN CANCER RES, V5, P1063; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Hughes SE, 1997, J HISTOCHEM CYTOCHEM, V45, P1005, DOI 10.1177/002215549704500710; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kondo T, 2007, CANCER RES, V67, P5461, DOI 10.1158/0008-5472.CAN-06-4477; Kondo T, 2007, CLIN CANCER RES, V13, P4713, DOI 10.1158/1078-0432.CCR-07-0618; MARCHESE C, 1995, J EXP MED, V182, P1369, DOI 10.1084/jem.182.5.1369; Matsubara A, 1998, CANCER RES, V58, P1509; MORRISON RS, 1994, J NEURO-ONCOL, V18, P207, DOI 10.1007/BF01328955; Myoken Y, 1996, J PATHOL, V178, P429; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Oltean S, 2006, P NATL ACAD SCI USA, V103, P14116, DOI 10.1073/pnas.0603090103; Onose H, 1999, EUR J ENDOCRINOL, V140, P169, DOI 10.1530/eje.0.1400169; Revest JM, 2001, DEV BIOL, V231, P47, DOI 10.1006/dbio.2000.0144; Ricol D, 1999, ONCOGENE, V18, P7234, DOI 10.1038/sj.onc.1203186; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; SAVAGNER P, 1994, MOL BIOL CELL, V5, P851, DOI 10.1091/mbc.5.8.851; Shingu K, 1998, ENDOCR J, V45, P35, DOI 10.1507/endocrj.45.35; St Bernard R, 2005, ENDOCRINOLOGY, V146, P1145, DOI 10.1210/en.2004-1134; Thompson SD, 1998, J CLIN ENDOCR METAB, V83, P1336, DOI 10.1210/jc.83.4.1336; Yasumoto H, 2004, PROSTATE, V61, P236, DOI 10.1002/pros.20093; Yoshimura N, 1998, CLIN IMMUNOL IMMUNOP, V89, P28, DOI 10.1006/clin.1998.4551	29	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72224	10.1371/journal.pone.0072224	http://dx.doi.org/10.1371/journal.pone.0072224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977259	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700152
J	Bhattacharjee, P; Bhattacharyya, D				Bhattacharjee, Payel; Bhattacharyya, Debasish			Factor V Activator from Daboia russelli russelli Venom Destabilizes beta-Amyloid Aggregate, the Hallmark of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aggregation; Amyloid; Neurodegenerative Diseases; Peptides; Toxins; Russell's Viper Venom Factor V Activator	BLOOD-BRAIN-BARRIER; DRUG DISCOVERY; PEPTIDE; OLIGOMERS; FIBRILLOGENESIS; NEUROTOXICITY; CLEARANCE; TOXICITY; THERAPY; MODEL	Formation of plaque by fibrils of -amyloid (A) peptide in the brain is the characteristic feature of Alzheimer disease (AD). Inhibition of the process of aggregate formation from A-monomer and destabilization of the aggregate could be useful for prevention and propagation of the disease respectively. Russell's viper venom (RVV) contains protein(s) that destabilize A aggregates as revealed from the thioflavin T assay. The active component was identified as factor V activator (RVV-V). Among the possible mechanisms of destabilization, RVV-V-mediated proteolysis was ruled out from mass spectrometric data and the thioflavin T assay. The alternate hypothesis that small peptides derived from RVV-V destabilize the aggregate is better supported by experimental results. Six small peptides were synthesized using RVV-V as the template, and three unrelated peptides were synthesized to serve as controls. Destabilization of A aggregate by these peptides was studied using spectrofluorometric assays, atomic force microscopy, transmission electron microscopy, and confocal microscopy. Among the peptides, CTNIF and the mixture of the six peptides were most potent in converting the aggregates to the monomeric state and thus, preventing cytotoxicity in SH-SY5Y human neuroblastoma cells. The control peptides failed to show similar effects. Moreover, some of these peptides are stable in blood for 24 h. Therefore, these venom-derived peptides offer an encouraging opportunity to prevent amyloidosis and may provide information to combat AD.	[Bhattacharjee, Payel; Bhattacharyya, Debasish] Indian Inst Chem Biol, Council Sci & Ind Res, Div Struct Biol & Bioinformat, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bhattacharyya, D (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Div Struct Biol & Bioinformat, 4 Raja SC Mullick Rd, Kolkata 700032, India.	payel.iicb@gmail.com; debasish@iicb.res.in			Department of Science and Technology, Cognition Science Initiative [SR/CSI/07/2009(G)]; Council of Scientific and Industrial Research Network [miND BSC0115]; University Grants Commission-National Eligibility Test fellowship	Department of Science and Technology, Cognition Science Initiative(Department of Science & Technology (India)); Council of Scientific and Industrial Research Network; University Grants Commission-National Eligibility Test fellowship	This work was supported by the Department of Science and Technology, Cognition Science Initiative, Project SR/CSI/07/2009(G) and Council of Scientific and Industrial Research Network Project miND BSC0115.; Supported by a University Grants Commission-National Eligibility Test fellowship.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Adessi C, 2003, J BIOL CHEM, V278, P13905, DOI 10.1074/jbc.M211976200; Bellesia G, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216103; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bett CK, 2010, ACS CHEM NEUROSCI, V1, P608, DOI 10.1021/cn100045q; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; DeVries HE, 1997, PHARMACOL REV, V49, P143; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Feng Y, 2009, NEUROTOXICOLOGY, V30, P986, DOI 10.1016/j.neuro.2009.08.013; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Gestwicki JE, 2004, SCIENCE, V306, P865, DOI 10.1126/science.1101262; Gordon DJ, 2002, J PEPT RES, V60, P37, DOI 10.1034/j.1399-3011.2002.11002.x; Hawaes C. A., 2009, DRUG DEVELOP RES, V70, P111; Huang THJ, 2000, J MOL BIOL, V297, P73, DOI 10.1006/jmbi.2000.3559; KISIEL W, 1981, METHOD ENZYMOL, V80, P275; Koren J, 2009, J CELL MOL MED, V13, P619, DOI 10.1111/j.1582-4934.2008.00557.x; Kuznetsova I. M., 2012, PLOS ONE, V7; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Marsh NA, 1998, BLOOD COAGUL FIBRIN, V9, P395, DOI 10.1097/00001721-199807000-00001; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Pearson HA, 2006, J PHYSIOL-LONDON, V575, P5, DOI 10.1113/jphysiol.2006.111203; Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Shaw C., 2009, BIOCH SOC, V31, P34; SHEARMAN MS, 1995, J NEUROCHEM, V65, P218, DOI 10.1046/j.1471-4159.1995.65010218.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Strober W., 1997, CURRENT PROTOCOLS IM; TOKUNAGA F, 1988, J BIOL CHEM, V263, P17471; Tsai IH, 1996, TOXICON, V34, P99, DOI 10.1016/0041-0101(95)00114-X; Van Dam D, 2006, NAT REV DRUG DISCOV, V5, P956, DOI 10.1038/nrd2075; Westermann Jan-Christoph, 2008, V494, P87, DOI 10.1007/978-1-59745-419-3_6; Witt KA, 2006, AAPS J, V8, pE76, DOI 10.1208/aapsj080109	39	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30559	30570		10.1074/jbc.M113.511410	http://dx.doi.org/10.1074/jbc.M113.511410			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986449	Green Published, hybrid			2022-12-25	WOS:000329868100057
J	Hoppenbrouwers, SS; Nazeri, A; de Jesus, DR; Stirpe, T; Felsky, D; Schutter, DJLG; Daskalakis, ZJ; Voineskos, AN				Hoppenbrouwers, Sylco S.; Nazeri, Arash; de Jesus, Danilo R.; Stirpe, Tania; Felsky, Daniel; Schutter, Dennis J. L. G.; Daskalakis, Zafiris J.; Voineskos, Aristotle N.			White Matter Deficits in Psychopathic Offenders and Correlation with Factor Structure	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; CRIMINAL PSYCHOPATHS; SHIPLEY-INSTITUTE; CONDUCT DISORDER; LIVING-SCALE; ABNORMALITIES; BEHAVIOR; AMYGDALA; REWARD; BOYS	Psychopathic offenders show a persistent pattern of emotional unresponsivity to the often horrendous crimes they perpetrate. Recent studies have related psychopathy to alterations in white matter. Therefore, diffusion tensor imaging followed by tract-based spatial statistics (TBSS) analysis in 11 psychopathic offenders matched to 11 healthy controls was completed. Fractional anisotropy was calculated within each voxel and comparisons were made between groups using a permutation test. Any clusters of white matter voxels different between groups were submitted to probabilistic tractography. Significant differences in fractional anisotropy were found between psychopathic offenders and healthy controls in three main white matter clusters. These three clusters represented two major networks: an amygdalo-prefrontal network, and a striato-thalamo-frontal network. The interpersonal/affective component of the PCL-R correlated with white matter deficits in the orbitofrontal cortex and frontal pole whereas the antisocial component correlated with deficits in the striato-thalamo-frontal network. In addition to replicating earlier work concerning disruption of an amygdala-prefrontal network, we show for the first time that white matter integrity in a striato-thalamo-frontal network is disrupted in psychopathic offenders. The novelty of our findings lies in the two dissociable white matter networks that map directly onto the two major factors of psychopathy.	[Hoppenbrouwers, Sylco S.; Schutter, Dennis J. L. G.] Univ Utrecht, Dept Expt Psychol, Utrecht, Netherlands; [Hoppenbrouwers, Sylco S.] Forens Psychiat Ctr Oldenkotte, Rekken, Gelderland, Netherlands; [Nazeri, Arash; de Jesus, Danilo R.; Felsky, Daniel; Daskalakis, Zafiris J.; Voineskos, Aristotle N.] Ctr Addict & Mental Hlth, Dept Psychiat, Toronto, ON, Canada; [Stirpe, Tania] Correct Serv Canada, Dept Psychol, Toronto, ON, Canada	Utrecht University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Voineskos, AN (corresponding author), Ctr Addict & Mental Hlth, Dept Psychiat, Toronto, ON, Canada.	aristotle.voineskos@camh.ca	Voineskos, Aristotle/J-5014-2013; Daskalakis, Zafiris J/J-5503-2013	Daskalakis, Zafiris J/0000-0001-9502-0538; Voineskos, Aristotle/0000-0003-0156-0395; Felsky, Daniel/0000-0003-1831-9848; Nazeri, Arash/0000-0001-6983-0641	CIHR; APA (APIRE) AstraZeneca; NWO [452-07-012]; Young Minds in Psychiatry Award; Constance and Stephen Lieber through a National Alliance for Research on Schizophrenia and Depression Lieber Young Investigator award; Neuronetics; Aspect Medical Inc.	CIHR(Canadian Institutes of Health Research (CIHR)); APA (APIRE) AstraZeneca(AstraZeneca); NWO(Netherlands Organization for Scientific Research (NWO)); Young Minds in Psychiatry Award; Constance and Stephen Lieber through a National Alliance for Research on Schizophrenia and Depression Lieber Young Investigator award; Neuronetics; Aspect Medical Inc.	This work was supported by a CIHR Clinician Scientist Award (ZJD, ANV), by APA (APIRE) AstraZeneca, by NWO Innovational Research Grant (452-07-012) (DS), by Young Minds in Psychiatry Award (ANV), and Constance and Stephen Lieber through a National Alliance for Research on Schizophrenia and Depression Lieber Young Investigator award (ZJD). ZJD has received external funding through Neuronetics and Aspect Medical Inc. and travel support through Pfizer, Inc. All other authors report no biomedical financial interests or potential conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2011, BRAIN, V134, P2025, DOI 10.1093/brain/awr119; Barkataki I, 2006, BEHAV BRAIN RES, V169, P239, DOI 10.1016/j.bbr.2006.01.009; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; Bjork JM, 2012, BIOL PSYCHOL, V89, P408, DOI 10.1016/j.biopsycho.2011.12.003; Blair RJR, 2008, PHILOS T R SOC B, V363, P2557, DOI 10.1098/rstb.2008.0027; Blair RJR, 2007, TRENDS COGN SCI, V11, P387, DOI 10.1016/j.tics.2007.07.003; Boccardi M, 2013, INT J LAW PSYCHIAT, V36, P157, DOI 10.1016/j.ijlp.2013.01.008; Boccardi M, 2011, PSYCHIAT RES-NEUROIM, V193, P85, DOI 10.1016/j.pscychresns.2010.12.013; Boccardi M, 2010, HUM BRAIN MAPP, V31, P438, DOI 10.1002/hbm.20877; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Buckholtz JW, 2010, NAT NEUROSCI, V13, P419, DOI 10.1038/nn.2510; Cima M, 2010, SOC COGN AFFECT NEUR, V5, P59, DOI 10.1093/scan/nsp051; Coenen VA, 2011, NEUROSCI BIOBEHAV R, V35, P1971, DOI 10.1016/j.neubiorev.2010.12.009; Craig MC, 2009, MOL PSYCHIATR, V14, P946, DOI 10.1038/mp.2009.40; De Brito SA, 2011, MOL PSYCHIATR, V16, P476, DOI 10.1038/mp.2010.74; De Brito SA, 2009, BRAIN, V132, P843, DOI 10.1093/brain/awp011; Ducharme S, 2011, BIOL PSYCHIAT, V70, P283, DOI 10.1016/j.biopsych.2011.03.015; Finger EC, 2011, AM J PSYCHIAT, V168, P152, DOI 10.1176/appi.ajp.2010.10010129; Finger EC, 2012, PSYCHIAT RES-NEUROIM, V202, P239, DOI 10.1016/j.pscychresns.2011.11.002; First MB, 2002, STRUCTURED CLIN INTE; Gao Y, 2010, AM J PSYCHIAT, V167, P56, DOI 10.1176/appi.ajp.2009.09040499; Gatzke-Kopp LM, 2009, J ABNORM PSYCHOL, V118, P203, DOI 10.1037/a0014378; Glenn AL, 2012, BIOL PSYCHIAT, V72, P817, DOI 10.1016/j.biopsych.2012.04.027; Glenn AL, 2010, BIOL PSYCHIAT, V67, P52, DOI 10.1016/j.biopsych.2009.06.018; Hare R. D., 2003, MANUAL HARE PSYCHOPA; Hare RD, 2008, ANNU REV CLIN PSYCHO, V4, P217, DOI 10.1146/annurev.clinpsy.3.022806.091452; Heimer L, 2006, NEUROSCI BIOBEHAV R, V30, P126, DOI 10.1016/j.neubiorev.2005.06.006; Intrator J, 1997, BIOL PSYCHIAT, V42, P96, DOI 10.1016/S0006-3223(96)00290-9; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kiehl KA, 2001, BIOL PSYCHIAT, V50, P677, DOI 10.1016/S0006-3223(01)01222-7; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koenigs M, 2012, SOC COGN AFFECT NEUR, V7, P708, DOI 10.1093/scan/nsr048; Motzkin JC, 2011, J NEUROSCI, V31, P17348, DOI 10.1523/JNEUROSCI.4215-11.2011; Muller JL, 2008, PSYCHIAT RES-NEUROIM, V163, P213, DOI 10.1016/j.pscychresns.2007.08.010; Munro GES, 2007, NEUROSCI LETT, V418, P149, DOI 10.1016/j.neulet.2007.03.017; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Rush Benjamin, 1812, MED INQUIRIES OBSERV; Schiffer B, 2011, ARCH GEN PSYCHIAT, V68, P1039, DOI 10.1001/archgenpsychiatry.2011.61; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Soderstrom H, 2002, PSYCHIAT RES-NEUROIM, V114, P81, DOI 10.1016/S0925-4927(02)00006-9; Sundram F, 2012, CORTEX, V48, P216, DOI 10.1016/j.cortex.2011.06.005; TAMKIN AS, 1987, J CLIN PSYCHOL, V43, P138, DOI 10.1002/1097-4679(198701)43:1<138::AID-JCLP2270430122>3.0.CO;2-M; Veit R, 2010, NEUROIMAGE, V49, P3365, DOI 10.1016/j.neuroimage.2009.11.040; Voineskos AN, 2012, NEUROBIOL AGING; WEISS JL, 1991, J CLIN PSYCHOL, V47, P558, DOI 10.1002/1097-4679(199107)47:4<558::AID-JCLP2270470414>3.0.CO;2-W; Yang YL, 2009, ARCH GEN PSYCHIAT, V66, P986, DOI 10.1001/archgenpsychiatry.2009.110	53	37	38	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72375	10.1371/journal.pone.0072375	http://dx.doi.org/10.1371/journal.pone.0072375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977291	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300083
J	Barisic-Jager, E; Krecioch, I; Hosiner, S; Antic, S; Dorner, S				Barisic-Jaeger, Elisabeth; Krecioch, Izabela; Hosiner, Stefanie; Antic, Sanja; Dorner, Silke			HPat a Decapping Activator Interacting with the miRNA Effector Complex	PLOS ONE			English	Article							MESSENGER-RNA DECAY; TRANSLATIONAL REPRESSION; GW182 PROTEINS; MEDIATED DEADENYLATION; CCR4-NOT DEADENYLASE; HUMAN-CELLS; DROSOPHILA; DEGRADATION; ARGONAUTE; IDENTIFICATION	Animal miRNAs commonly mediate mRNA degradation and/or translational repression by binding to their target mRNAs. Key factors for miRNA-mediated mRNA degradation are the components of the miRNA effector complex (AGO1 and GW182) and the general mRNA degradation machinery (deadenylation and decapping enzymes). The CCR4-NOT1 complex required for the deadenylation of target mRNAs is directly recruited to the miRNA effector complex. However, it is unclear whether the following decapping step is only a consequence of deadenylation occurring independent of the miRNA effector complex or e.g. decapping activators can get recruited to the miRNA effector complex. In this study we performed split-affinity purifications in Drosophila cells and provide evidence for the interaction of the decapping activator HPat with the miRNA effector complex. Furthermore, in knockdown analysis of various mRNA degradation factors we demonstrate the importance of NOT1 for this interaction. This suggests that deadenylation and/or the recruitment of NOT1 protein precedes the association of HPat with the miRNA effector complex. Since HPat couples deadenylation and decapping, the recruitment of HPat to the miRNA effector complex provides a mechanism to commit the mRNA target for degradation.	[Barisic-Jaeger, Elisabeth; Krecioch, Izabela; Hosiner, Stefanie; Antic, Sanja; Dorner, Silke] Univ Vienna, Dept Microbiol Immunbiol & Genet, Max F Perutz Labs, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Dorner, S (corresponding author), Univ Vienna, Dept Microbiol Immunbiol & Genet, Max F Perutz Labs, Vienna, Austria.	silke.dorner@univie.ac.at		Krecioch, Izabela/0000-0002-3629-8123; Dorner, Silke/0000-0002-7471-6015	Austrian Science Fund (FWF) [V63-B17, P21488-B09]; Vienna Science and Technology Fund (WWTF) [LS09-044]; Austrian Science Fund (FWF) [P 21488] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Vienna Science and Technology Fund (WWTF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund (FWF, http://www.fwf.ac.at): V63-B17, P21488-B09 to SD; and the Vienna Science and Technology Fund (WWTF, http://www.wwtf.at): LS09-044 to SD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Braun JE, 2012, NAT STRUCT MOL BIOL, V19, P1324, DOI 10.1038/nsmb.2413; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Dorner S, 2006, P NATL ACAD SCI USA, V103, P11880, DOI 10.1073/pnas.0605210103; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Haas G, 2010, J CELL BIOL, V189, P289, DOI 10.1083/jcb.200910141; Halbeisen RE, 2009, METHODS, V48, P306, DOI 10.1016/j.ymeth.2009.04.003; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Huntzinger E, 2013, NUCLEIC ACIDS RES, V41, P978, DOI 10.1093/nar/gks1078; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Jager E, 2010, RNA BIOL, V7, P381; Jinek M, 2010, NAT STRUCT MOL BIOL, V17, P238, DOI 10.1038/nsmb.1768; Kozlov G, 2010, J BIOL CHEM, DOI [10.1074/jbc.M1109.089540, DOI 10.1074/JBC.M1109.089540]; Kuzuoglu-Ozturk D, 2012, NUCLEIC ACIDS RES, V40, P5651, DOI 10.1093/nar/gks218; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Nissan T, 2010, MOL CELL, V39, P773, DOI 10.1016/j.molcel.2010.08.025; Ozgur S, 2010, MOL CELL BIOL, V30, P4308, DOI 10.1128/MCB.00429-10; Piao XH, 2010, MOL CELL BIOL, V30, P1486, DOI 10.1128/MCB.01481-09; Pilkington GR, 2008, MOL CELL BIOL, V28, P1298, DOI 10.1128/MCB.00936-07; Pradhan SJ, 2012, J CELL SCI, V125, P6105, DOI 10.1242/jcs.113043; Scheller N, 2007, BBA-MOL CELL RES, V1773, P1786, DOI 10.1016/j.bbamcr.2007.08.009; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; Temme C, 2010, RNA, V16, P1356, DOI 10.1261/rna.2145110; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014	46	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71860	10.1371/journal.pone.0071860	http://dx.doi.org/10.1371/journal.pone.0071860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977167	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700109
J	Gentry, SN; Jackson, TL				Gentry, Sara N.; Jackson, Trachette L.			A Mathematical Model of Cancer Stem Cell Driven Tumor Initiation: Implications of Niche Size and Loss of Homeostatic Regulatory Mechanisms	PLOS ONE			English	Article							HEMATOPOIETIC STEM; SELF-RENEWAL; MUTATION ACQUISITION; PROLIFERATION; DIFFERENTIATION; CARCINOGENESIS; HYPOTHESIS; STRATEGIES; HALLMARKS; DYNAMICS	Hierarchical organized tissue structures, with stem cell driven cell differentiation, are critical to the homeostatic maintenance of most tissues, and this underlying cellular architecture is potentially a critical player in the development of a many cancers. Here, we develop a mathematical model of mutation acquisition to investigate how deregulation of the mechanisms preserving stem cell homeostasis contributes to tumor initiation. A novel feature of the model is the inclusion of both extrinsic and intrinsic chemical signaling and interaction with the niche to control stem cell self-renewal. We use the model to simulate the effects of a variety of types and sequences of mutations and then compare and contrast all mutation pathways in order to determine which ones generate cancer cells fastest. The model predicts that the sequence in which mutations occur significantly affects the pace of tumorigenesis. In addition, tumor composition varies for different mutation pathways, so that some sequences generate tumors that are dominated by cancerous cells with all possible mutations, while others are primarily comprised of cells that more closely resemble normal cells with only one or two mutations. We are also able to show that, under certain circumstances, healthy stem cells diminish due to the displacement by mutated cells that have a competitive advantage in the niche. Finally, in the event that all homeostatic regulation is lost, exponential growth of the cancer population occurs in addition to the depletion of normal cells. This model helps to advance our understanding of how mutation acquisition affects mechanisms that influence cell-fate decisions and leads to the initiation of cancers.	[Gentry, Sara N.; Jackson, Trachette L.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Jackson, TL (corresponding author), Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA.	tjacks@umich.edu			James S. McDonnell Foundation [220020079/SCS]	James S. McDonnell Foundation	The is work was partially supported by Grant #: 220020079/SCS from the James S. McDonnell Foundation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkowitz JL, 2002, BLOOD, V100, P2665, DOI 10.1182/blood-2002-03-0822; Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Andersen LK, 2001, J THEOR BIOL, V209, P113, DOI 10.1006/jtbi.2000.2255; Ashkenazi R, 2008, NEOPLASIA, V10, P1170, DOI 10.1593/neo.08572; Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; BARRETT JC, 1993, ENVIRON HEALTH PERSP, V100, P9, DOI 10.2307/3431516; Beckman RA, 2006, P NATL ACAD SCI USA, V103, P14140, DOI 10.1073/pnas.0606271103; Behbod F, 2005, CARCINOGENESIS, V26, P703, DOI 10.1093/carcin/bgh293; Bernard S, 2003, J THEOR BIOL, V223, P283, DOI 10.1016/S0022-5193(03)00090-0; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Clarke MF, 2005, CANCER CHEMOTH PHARM, V56, pS64, DOI 10.1007/s00280-005-0097-1; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2005, NAT GENET, V37, P1027, DOI 10.1038/ng1005-1027; Colijn C, 2005, J THEOR BIOL, V237, P117, DOI 10.1016/j.jtbi.2005.03.033; delasAlas MM, 1997, J NATL CANCER I, V89, P1537, DOI 10.1093/jnci/89.20.1537; DEMETRI GD, 1991, BLOOD, V78, P2791; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Enderling H, 2011, PROG BIOPHYS MOL BIO, V106, P391, DOI 10.1016/j.pbiomolbio.2011.03.007; Flynn CM, 2007, BLOOD, V109, P2688, DOI 10.1182/blood-2006-07-021980; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Galderisi U, 2005, CELL DEATH DIFFER, P1; Ganguly R, 2006, CELL PROLIFERAT, V39, P3, DOI 10.1111/j.1365-2184.2006.00369.x; Gentry SN, 2009, MATH MODEL NAT PHENO, V4, P156, DOI 10.1051/mmnp/20094307; Haapala K, 2007, HUM PATHOL, V38, P474, DOI 10.1016/j.humpath.2006.09.008; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He Y, 2007, CANCER RES, V67, P8188, DOI 10.1158/0008-5472.CAN-07-0418; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Tello JI, 2013, MATH BIOSCI ENG, V10, P263, DOI 10.3934/mbe.2013.10.263; Komarova NL, 2003, CANCER RES, V63, P6635; Leder K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014366; Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; Li ZX, 2006, TRENDS BIOCHEM SCI, V31, P589, DOI 10.1016/j.tibs.2006.08.001; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Loeb KR, 2000, CARCINOGENESIS, V21, P379, DOI 10.1093/carcin/21.3.379; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Michor F, 2004, CELL CYCLE, V3, P358; Mohle R, 2007, SEMIN HEMATOL, V44, P193, DOI 10.1053/j.seminhematol.2007.04.006; Molina-Pena R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026233; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Passier R, 2003, CARDIOVASC RES, V58, P324, DOI 10.1016/S0008-6363(02)00770-8; Rahman M, 2011, NEUROSURGERY, V68, P531, DOI 10.1227/NEU.0b013e3181ff9eb5; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rodriguez-Brenes I, 2011, PNAS, V18; Saeidpour S, 2013, INT J LIFESC BT PHAR, V2, P30; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; Spencer SL, 2004, J THEOR BIOL, V231, P515, DOI 10.1016/j.jtbi.2004.07.006; Stochat E, 2002, B MATH BIOL, V64, P861; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; TOMLINSON IPM, 1995, P NATL ACAD SCI USA, V92, P11130, DOI 10.1073/pnas.92.24.11130; Vainstein V, 2012, J THEOR BIOL, V298, P32, DOI 10.1016/j.jtbi.2011.12.016; Voloshyna I, 2008, CANCER RES, V68, P1197, DOI 10.1158/0008-5472.CAN-07-5163; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wodarz D, 2007, J THEOR BIOL, V245, P449, DOI 10.1016/j.jtbi.2006.10.013; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568	62	35	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71128	10.1371/journal.pone.0071128	http://dx.doi.org/10.1371/journal.pone.0071128			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990931	gold, Green Submitted, Green Published			2022-12-25	WOS:000323425700018
J	Touyarot, K; Bonhomme, D; Roux, P; Alfos, S; Lafenetre, P; Richard, E; Higueret, P; Pallet, V				Touyarot, Katia; Bonhomme, Damien; Roux, Pascale; Alfos, Serge; Lafenetre, Pauline; Richard, Emmanuel; Higueret, Paul; Pallet, Veronique			A Mid-Life Vitamin A Supplementation Prevents Age-Related Spatial Memory Deficits and Hippocampal Neurogenesis Alterations through CRABP-I	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ACID-BINDING PROTEIN; RETINOIC ACID; ADULT NEUROGENESIS; DENTATE GYRUS; NUCLEAR RECEPTORS; HYPO-EXPRESSION; MESSENGER-RNA; CELLS; DIFFERENTIATION	Age-related memory decline including spatial reference memory is considered to begin at middle-age and coincides with reduced adult hippocampal neurogenesis. Moreover, a dysfunction of vitamin A hippocampal signalling pathway has been involved in the appearance of age-related memory deficits but also in adult hippocampal neurogenesis alterations. The present study aims at testing the hypothesis that a mid-life vitamin A supplementation would be a successful strategy to prevent age-related memory deficits. Thus, middle-aged Wistar rats were submitted to a vitamin A enriched diet and were tested 4 months later in a spatial memory task. In order to better understand the potential mechanisms mediating the effects of vitamin A supplementation on hippocampal functions, we studied different aspects of hippocampal adult neurogenesis and evaluated hippocampal CRABP-I expression, known to modulate differentiation processes. Here, we show that vitamin A supplementation from middle-age enhances spatial memory and improves the dendritic arborisation of newborn immature neurons probably resulting in a better survival and neuronal differentiation in aged rats. Moreover, our results suggest that hippocampal CRABP-I expression which controls the intracellular availability of retinoic acid (RA), may be an important regulator of neuronal differentiation processes in the aged hippocampus. Thus, vitamin A supplementation from middle-age could be a good strategy to maintain hippocampal plasticity and functions.	[Touyarot, Katia; Bonhomme, Damien; Roux, Pascale; Alfos, Serge; Lafenetre, Pauline; Higueret, Paul; Pallet, Veronique] Univ Bordeaux, UMR 1286, Bordeaux, France; [Touyarot, Katia; Bonhomme, Damien; Roux, Pascale; Alfos, Serge; Lafenetre, Pauline; Higueret, Paul; Pallet, Veronique] INRA, UMR 1286, Bordeaux, France; [Richard, Emmanuel] INSERM, U1035, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Touyarot, K (corresponding author), Univ Bordeaux, UMR 1286, Bordeaux, France.	katia.touyarot@enscbp.fr		ALFOS, Serge/0000-0001-7092-4370	University of Bordeaux 1; University of Bordeaux 2; Conseil Regional d'Aquitaine; French National Institute Of Food Processing (INRA)	University of Bordeaux 1; University of Bordeaux 2; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); French National Institute Of Food Processing (INRA)	This work was supported by University of Bordeaux 1 and Bordeaux 2, the Conseil Regional d'Aquitaine and the French National Institute Of Food Processing (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Arfaoui A, 2012, ANN ANAT; Arfaoui Asma, 2009, Pak J Biol Sci, V12, P939, DOI 10.3923/pjbs.2009.939.948; AzaisBraesco V, 1995, BBA-LIPID LIPID MET, V1259, P271, DOI 10.1016/0005-2760(95)00173-5; BIESALSKI HK, 1983, INT J VITAM NUTR RES, V53, P130; Bizon JL, 2003, EUR J NEUROSCI, V18, P215, DOI 10.1046/j.1460-9568.2003.02733.x; Bizon JL, 2004, AGING CELL, V3, P227, DOI 10.1111/j.1474-9728.2004.00099.x; BLOMHOFF R, 1994, NUTR REV, V52, P13; Bonnet E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003487; Borel P, 1998, J GERONTOL A-BIOL, V53, pB133, DOI 10.1093/gerona/53A.2.B133; BOYLAN JF, 1991, J CELL BIOL, V112, P965, DOI 10.1083/jcb.112.5.965; BOYLAN JF, 1992, J BIOL CHEM, V267, P21486; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; Corcoran JPT, 2004, EUR J NEUROSCI, V20, P896, DOI 10.1111/j.1460-9568.2004.03563.x; Crandall J, 2004, P NATL ACAD SCI USA, V101, P5111, DOI 10.1073/pnas.0306336101; deGroot CPGM, 1996, EUR J CLIN NUTR, V50, pS32; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Drapeau E, 2007, J NEUROSCI, V27, P6037, DOI 10.1523/JNEUROSCI.1031-07.2007; Driscoll I, 2006, NEUROSCIENCE, V139, P1173, DOI 10.1016/j.neuroscience.2006.01.040; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Dyall SC, 2010, J NEUROSCI RES, V88, P2091, DOI 10.1002/jnr.22390; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Enderlin V, 1997, NEUROSCI LETT, V229, P125, DOI 10.1016/S0304-3940(97)00424-2; Erickson CA, 2003, EXP GERONTOL, V38, P61, DOI 10.1016/S0531-5565(02)00160-2; Etchamendy N, 2003, BEHAV BRAIN RES, V145, P37, DOI 10.1016/S0166-4328(03)00099-8; Etchamendy N, 2001, J NEUROSCI, V21, P6423, DOI 10.1523/JNEUROSCI.21-16-06423.2001; Feart C, 2005, EUR J ENDOCRINOL, V152, P449, DOI 10.1530/eje.1.01858; Feart C, 2005, NEUROBIOL AGING, V26, P729, DOI 10.1016/j.neurobiolaging.2004.06.004; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; GIGUERE V, 1990, METHOD ENZYMOL, V189, P223; Goodman AB, 2003, P NATL ACAD SCI USA, V100, P2901, DOI 10.1073/pnas.0437937100; Goodman AB, 2006, J CELL PHYSIOL, V209, P598, DOI 10.1002/jcp.20784; Goodman T, 2012, HIPPOCAMPUS; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Husson M, 2006, NEUROBIOL DIS, V23, P1, DOI 10.1016/j.nbd.2006.01.008; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Koehl M, 2011, EUR J NEUROSCI, V33, P1101, DOI 10.1111/j.1460-9568.2011.07609.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002; Lemaire V, 2006, BIOL PSYCHIAT, V59, P786, DOI 10.1016/j.biopsych.2005.11.009; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; MADEN M, 1988, NATURE, V335, P733, DOI 10.1038/335733a0; Maden M, 2002, NAT REV NEUROSCI, V3, P843, DOI 10.1038/nrn963; Marlatt MW, 2012, DEV NEUROBIOL, V72, P943, DOI 10.1002/dneu.22009; McCaffery P, 2000, CYTOKINE GROWTH F R, V11, P233, DOI 10.1016/S1359-6101(00)00002-2; McCaffery P, 2006, J NEUROBIOL, V66, P780, DOI 10.1002/neu.20237; McCaffery PJ, 2003, EUR J NEUROSCI, V18, P457, DOI 10.1046/j.1460-9568.2003.02765.x; Mingaud F, 2008, J NEUROSCI, V28, P279, DOI 10.1523/JNEUROSCI.4065-07.2008; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Nyffeler M, 2010, NEUROBIOL AGING, V31, P1956, DOI 10.1016/j.neurobiolaging.2008.10.014; Olson CR, 2010, MOL NUTR FOOD RES, V54, P489, DOI 10.1002/mnfr.200900246; ONG DE, 1994, NUTR REV, V52, P24, DOI 10.1111/j.1753-4887.1994.tb01383.x; Penniston KL, 2006, AM J CLIN NUTR, V83, P191; PEREZCASTRO AV, 1989, P NATL ACAD SCI USA, V86, P8813, DOI 10.1073/pnas.86.22.8813; Piatti VC, 2006, NEUROSCIENTIST, V12, P463, DOI 10.1177/1073858406293538; Polidori MC, 2004, J ALZHEIMERS DIS, V6, P185; Pujadas L, 2010, J NEUROSCI, V30, P4636, DOI 10.1523/JNEUROSCI.5284-09.2010; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; Rinaldi P, 2003, NEUROBIOL AGING, V24, P915, DOI 10.1016/S0197-4580(03)00031-9; Ross AC, 2009, CRIT REV FOOD SCI, V49, P708, DOI 10.1080/10408390903098749; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Shimazu K, 2006, LEARN MEMORY, V13, P307, DOI 10.1101/lm.76006; Singer BH, 2011, P NATL ACAD SCI USA, V108, P5437, DOI 10.1073/pnas.1015425108; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Tronel S, 2010, P NATL ACAD SCI USA, V107, P7963, DOI 10.1073/pnas.0914613107; Uhrig M, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-38; van der Loo B, 2004, J CARDIOVASC PHARM, V43, P26, DOI 10.1097/00005344-200401000-00005; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Wilson LJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-138; Zainuddin MSA, 2012, BRIT MED BULL, V103, P89, DOI 10.1093/bmb/lds021; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhang YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036772	81	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72101	10.1371/journal.pone.0072101	http://dx.doi.org/10.1371/journal.pone.0072101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977218	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700132
J	Zhang, XF; Shen, WK; Dong, XM; Fan, JP; Liu, LX; Gao, X; Kernstine, KH; Zhong, L				Zhang, Xufei; Shen, Weike; Dong, Xiaomin; Fan, Jiangping; Liu, Lixia; Gao, Xu; Kernstine, Kemp H.; Zhong, Li			Identification of Novel Autoantibodies for Detection of Malignant Mesothelioma	PLOS ONE			English	Article							BREAST-CANCER; LUNG-CANCER; PLEURAL-MESOTHELIOMA; MICROARRAY; EXPRESSION; SERUM; GENE; BIOMARKERS; MARKERS; PROGRESSION	Background: The malignant mesothelioma (MM) survival rate has been hampered by the lack of efficient and accurate early detection methods. The immune system may detect the early changes of tumor progression by responding with tumor-associated autoantibody production. Hence, in this study, we translated the humoral immune response to cancer proteins into a potential blood test for MM. Methodology/Principal Findings: A T7 phage MM cDNA library was constructed using MM tumor tissues and biopanned for tumor-associated antigens (TAAs) using pooled MM patient and normal serum samples. About 1008 individual phage TAA clones from the biopanned library were subjected to protein microarray construction and tested with 53 MM and 52 control serum samples as a training group. Nine candidate autoantibody markers were selected from the training group using Tclass system and logistic regression statistical analysis, which achieved 94.3% sensitivity and 90.4% specificity with an AUC value of 0.89 in receiver operating characteristic analysis. The classifier was further evaluated with 50 patient and 50 normal serum samples as an independent blind validation, and the sensitivity of 86.0% and the specificity of 86.0% were obtained with an AUC of 0.82. Sequencing and BLASTN analysis of the classifier revealed that five of these nine candidate markers were found to have strong homology to cancer related proteins (PDIA6, MEG3, SDCCAG3, IGHG3, IGHG1). Conclusions/Significance: Our results indicated that using a panel of 9 autoantibody markers presented a promising accuracy for MM detection. Although the results need further validation in high-risk groups, they provided the potentials in developing a serum-based assay for MM diagnosis.	[Zhang, Xufei; Shen, Weike; Dong, Xiaomin; Fan, Jiangping; Liu, Lixia; Zhong, Li] Hebei Univ, Coll Life Sci, Dept Cell Biol, Baoding, Hebei, Peoples R China; [Gao, Xu] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Kernstine, Kemp H.] UT Southwestern Med Ctr, Div Thorac Surg, Dallas, TX USA; [Zhong, Li] Western Univ Hlth Sci, Dept Basic Med Sci, Pomona, CA USA	Hebei University; University System of Ohio; University of Cincinnati; University of Texas System; University of Texas Southwestern Medical Center Dallas; Western University of Health Sciences	Zhong, L (corresponding author), Hebei Univ, Coll Life Sci, Dept Cell Biol, Baoding, Hebei, Peoples R China.	lzhong@westernu.edu			National Institutes of Health [CA137570]; NSFC [81071795, 81272444]; NATIONAL CANCER INSTITUTE [R21CA137570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by National Institutes of Health grant CA137570 (L. Zhong) and NSFC grant #81071795 and #81272444, http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Amati M, 2008, CANCER EPIDEM BIOMAR, V17, P163, DOI 10.1158/1055-9965.EPI-07-0607; Amin W, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-236; Aziz T, 2002, EUR J CARDIO-THORAC, V22, P298, DOI 10.1016/S1010-7940(02)00273-7; Beyer HL, 2007, CLIN CHEM, V53, P666, DOI 10.1373/clinchem.2006.079327; BIELEFELDTOHMANN H, 1994, CANCER IMMUNOL IMMUN, V39, P347, DOI 10.1007/BF01534421; Billings C G, 2000, Monaldi Arch Chest Dis, V55, P151; Bin Amer SM, 2008, SAUDI MED J, V29, P507; BOUTIN C, 1993, CANCER, V72, P394, DOI 10.1002/1097-0142(19930715)72:2<394::AID-CNCR2820720214>3.0.CO;2-5; Brockmann JG, 2000, CLIN CANCER RES, V6, P4249; Chapman CJ, 2008, THORAX, V63, P228, DOI 10.1136/thx.2007.083592; Creaney J, 2001, BRIT J CANCER, V84, P52, DOI 10.1054/bjoc.2000.1529; Creaney J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026515; Creaney J, 2009, CURR OPIN PULM MED, V15, P366, DOI 10.1097/MCP.0b013e32832b98eb; DAVIS MR, 1992, INT J CANCER, V52, P881, DOI 10.1002/ijc.2910520609; Gennaro V, 2000, Epidemiol Prev, V24, P213; Hagemann N, 2012, ONCOGENE; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Heffner JE, 2000, CHEST, V117, P79, DOI 10.1378/chest.117.1.79; Heffner JE, 2008, MAYO CLIN PROC, V83, P235, DOI 10.4065/83.2.235; Hua JP, 2006, EURASIP J BIOINFORM, DOI 10.1155/BSB/2006/43056; Ismail-Khan Roohi, 2006, Cancer Control, V13, P255; Iwahori K, 2008, LUNG CANCER, V62, P45, DOI 10.1016/j.lungcan.2008.02.012; Jager D, 2001, CANCER RES, V61, P2055; Jaklitsch MT, 2001, WORLD J SURG, V25, P210, DOI 10.1007/s002680020021; Kamp DW, 2009, TRANSL RES, V153, P143, DOI 10.1016/j.trsl.2009.01.004; Kimura T, 2004, BIOCHEM J, V382, P169, DOI 10.1042/BJ20040116; Laessig D, 2007, ANTICANCER RES, V27, P1963; Ledet EM, 2012, PROSTATE; Li WJ, 2005, BREAST CANCER RES, V7, DOI 10.1186/bcr1295; Li XY, 2011, PANCREAS, V40, P753, DOI 10.1097/MPA.0b013e318213d51b; Lin HS, 2007, CANCER EPIDEM BIOMAR, V16, P2396, DOI 10.1158/1055-9965.EPI-07-0318; MAGNANI C, 1995, OCCUP ENVIRON MED, V52, P362, DOI 10.1136/oem.52.6.362; Mott FE, 2012, OCHSNER J, V12, P70; Musk AW, 2004, LUNG CANCER, V45, pS21, DOI 10.1016/j.lungcan.2004.04.010; Neri M, 2003, LUNG CANCER-J IASLC, V39, P165, DOI 10.1016/S0169-5002(02)00449-X; Neznanov N, 2005, DNA CELL BIOL, V24, P777, DOI 10.1089/dna.2005.24.777; Ostroff RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046091; Pan B, 2013, MOL BIOL REP, V40, P27, DOI 10.1007/s11033-012-1944-x; Pin C, 2006, APPL MICROBIOL BIOT, V72, P852, DOI 10.1007/s00253-006-0536-x; Qian F, 2005, INT J MOL MED, V15, P137; Remmelink M, 2005, INT J ONCOL, V26, P247; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Robinson C, 2000, AM J RESP CELL MOL, V22, P550, DOI 10.1165/ajrcmb.22.5.3930; Portal JAR, 2009, MED CLIN-BARCELONA, V133, P464, DOI 10.1016/j.medcli.2009.06.018; Scanlan M J, 2001, Cancer Immun, V1, P4; Serao NVL, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-49; So CK, 2004, CLIN CANCER RES, V10, P19, DOI 10.1158/1078-0432.CCR-03-0160; Sorensen BS, 2009, RADIOTHER ONCOL, V92, P443, DOI 10.1016/j.radonc.2009.05.019; Sugita Y, 2004, CANCER RES, V64, P2199, DOI 10.1158/0008-5472.CAN-03-3070; Sun SY, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-13; Tan EM, 2001, J CLIN INVEST, V108, P1411, DOI 10.1172/JCI200114451; van der Bij S, 2011, BRIT J CANCER, V104, P1325, DOI 10.1038/bjc.2011.104; Volkmann M, 2002, ONCOLOGY-BASEL, V63, P297, DOI 10.1159/000065472; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; Wuju L, 2002, BIOINFORMATICS, V18, P325, DOI 10.1093/bioinformatics/18.2.325; Xiao T, 2005, MOL CELL PROTEOMICS, V4, P1480, DOI 10.1074/mcp.M500055-MCP200; Yamabuki T, 2007, CANCER RES, V67, P2517, DOI 10.1158/0008-5472.CAN-06-3369; Ying L, 2013, MOL BIOSYST; Zhang B, 2012, BIOMARKERS, V17, P372, DOI 10.3109/1354750X.2012.680609; Zhang X, 2003, J CLIN ENDOCR METAB, V88, P5119, DOI 10.1210/jc.2003-030222; Zhao YL, 2008, BIOCHEM BIOPH RES CO, V372, P346, DOI 10.1016/j.bbrc.2008.05.046; Zhong L, 2005, AM J RESP CRIT CARE, V172, P1308, DOI 10.1164/rccm.200505-830OC; Zhong L, 2006, J THORAC ONCOL, V1, P513, DOI 10.1097/01243894-200607000-00003	63	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72458	10.1371/journal.pone.0072458	http://dx.doi.org/10.1371/journal.pone.0072458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977302	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700172
J	Marrachelli, VG; Mastronardi, ML; Sarr, M; Soleti, R; Leonetti, D; Martinez, MC; Andriantsitohaina, R				Marrachelli, Vannina Gonzalez; Mastronardi, Maria Letizia; Sarr, Mamadou; Soleti, Raffaella; Leonetti, Daniela; Martinez, Maria Carmen; Andriantsitohaina, Ramaroson			Sonic Hedgehog Carried by Microparticles Corrects Angiotensin II-Induced Hypertension and Endothelial Dysfunction in Mice	PLOS ONE			English	Article							VASCULAR DYSFUNCTION; ANGIOGENESIS; OXIDASES	Microparticles are small fragments of the plasma membrane generated after cell stimulation. We recently showed that Sonic hedgehog (Shh) is present in microparticles generated from activated/apoptotic human T lymphocytes and corrects endothelial injury through nitric oxide (NO) release. This study investigates whether microparticles bearing Shh correct angiotensin II-induced hypertension and endothelial dysfunction in mice. Male Swiss mice were implanted with osmotic minipumps delivering angiotensin II (0.5 mg/kg/day) or NaCl (0.9%). Systolic blood pressure and heart rate were measured daily during 21 days. After 7 day of minipump implantation, mice received i.v. injections of microparticles (10 mu g/ml) or i.p. Shh receptor antagonist cyclopamine (10 mg/kg/2 days) during one week. Angiotensin II induced a significant rise in systolic blood pressure without affecting heart rate. Microparticles reversed angiotensin II-induced hypertension, and cyclopamine prevented the effects of microparticles. Microparticles completely corrected the impairment of acetylcholine-and flow-induced relaxation in vessels from angiotensin II-infused mice. The improvement of endothelial function induced by microparticles was completely prevented by cyclopamine treatment. Moreover, microparticles alone did not modify NO and O-2(center dot)-production in aorta, but significantly increased NO and reduced O-2(center dot)-productions in aorta from angiotensin II-treated mice, and these effects were blocked by cyclopamine. Altogether, these results show that microparticles bearing Shh correct angiotensin II-induced hypertension and endothelial dysfunction in aorta through a mechanism associated with Shh-induced NO production and reduction of oxidative stress. These microparticles may represent a new therapeutic approach in cardiovascular diseases associated with decreased NO production.	[Marrachelli, Vannina Gonzalez; Mastronardi, Maria Letizia; Sarr, Mamadou; Soleti, Raffaella; Leonetti, Daniela; Martinez, Maria Carmen; Andriantsitohaina, Ramaroson] LUNAM Univ, Angers, France; [Marrachelli, Vannina Gonzalez; Mastronardi, Maria Letizia; Sarr, Mamadou; Soleti, Raffaella; Leonetti, Daniela; Martinez, Maria Carmen; Andriantsitohaina, Ramaroson] Inst Natl Sante & Rech Med, U1063, Angers, France; [Leonetti, Daniela; Andriantsitohaina, Ramaroson] CHU Angers, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Andriantsitohaina, R (corresponding author), LUNAM Univ, Angers, France.	ramaroson.andriantsitohaina@univ-angers.fr	soleti, raffaella/AAC-1678-2021; marrachelli, vannina G/L-6041-2014; SOLETI, RAFFAELLA/ABB-5455-2020; ANDRIANTSITOHAINA, Ramaroson/H-5286-2018	marrachelli, vannina G/0000-0002-4097-3312; SOLETI, RAFFAELLA/0000-0002-0271-0490; Martinez, M Carmen/0000-0003-3897-7397; andriantsitohaina, ramaroson/0000-0002-4770-3585	Agence Nationale pour la Recherche [ANR-07-PHYSIO-010-01]; Region Pays de la Loire [CIMATH-2]; INSERM; Universite d'Angers; Societe Francaise de Hypertension Arterielle	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Region Pays de la Loire(Region Pays de la Loire); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite d'Angers; Societe Francaise de Hypertension Arterielle	This work was funded by grants from Agence Nationale pour la Recherche [ANR-07-PHYSIO-010-01]; Region Pays de la Loire [CIMATH-2]; INSERM; and Universite d'Angers. VGM and MLM are recipients of postdoctoral fellowship from Universite d'Angers and Societe Francaise de Hypertension Arterielle, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2007, FASEB J, V21, P2735, DOI 10.1096/fj.07-8079com; Benameur T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012688; Cao J, 2012, HYPERTENSION, V60, P467, DOI 10.1161/HYPERTENSIONAHA.112.193805; Martinez MC, 2006, BLOOD, V108, P3012, DOI 10.1182/blood-2006-04-019109; Martinez MC, 2011, CIRC RES, V109, P110, DOI 10.1161/CIRCRESAHA.110.233049; Martinez MC, 2011, TRENDS PHARMACOL SCI, V32, P659, DOI 10.1016/j.tips.2011.06.005; Martinez-Revelles S, 2013, ANTIOXID REDOX SIGN, V18, P51, DOI 10.1089/ars.2011.4335; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Schiffrin EL, 2010, MOL INTERV, V10, P354, DOI 10.1124/mi.10.6.4; Soleti R, 2012, FREE RADICAL BIO MED, V53, P2159, DOI 10.1016/j.freeradbiomed.2012.09.021; Soleti R, 2009, CARCINOGENESIS, V30, P580, DOI 10.1093/carcin/bgp030; Sturza A, 2013, HYPERTENSION, V62, P140, DOI 10.1161/HYPERTENSIONAHA.113.01314; Wu JH, 2010, INVEST OPHTH VIS SCI, V51, P2986, DOI 10.1167/iovs.09-4151	13	21	23	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72861	10.1371/journal.pone.0072861	http://dx.doi.org/10.1371/journal.pone.0072861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977364	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200090
J	Rinne, P; Penttinen, AM; Nordlund, W; Ahotupa, M; Savontaus, E				Rinne, Petteri; Penttinen, Anna-Maija; Nordlund, Wendy; Ahotupa, Markku; Savontaus, Eriika			alpha-MSH Analogue Attenuates Blood Pressure Elevation in DOCA-Salt Hypertensive Mice	PLOS ONE			English	Article							MELANOCYTE-STIMULATING HORMONE; RECEPTOR; RAT; NATRIURESIS; MODULATION; EXPRESSION; RESPONSES	Melanocyte-stimulating hormones, alpha-, beta- and gamma-MSH, regulate important physiological functions including energy homeostasis, inflammation and sodium metabolism. Previous studies have shown that alpha-MSH increases sodium excretion and promotes vascular function in rodents, but it is unexplored whether these characteristics of alpha-MSH could translate into therapeutic benefits in the treatment of hypertension. Therefore, we first assessed the diuretic and natriuretic properties of the stable alpha-MSH analogue [Nle(4), D-Phe(7)]-alpha-MSH (NDP-alpha-MSH) and investigated whether it has protective effects in deoxycorticosterone acetate (DOCA)-salt hypertensive mice. Adult male C57Bl/6N mice were subjected to DOCA-salt treatment and randomized to receive intraperitoneal injections of either saline as vehicle or NDP-alpha-MSH (0.3 mg/kg/day for 14 days) starting 7 days after the DOCA-salt treatment. Systemic hemodynamics, serum and urine electrolytes, and oxidative stress markers were assessed in control sham-operated and DOCA-salt mice. NDP-alpha-MSH elicited marked diuretic and natriuretic responses that were reversible with the MC3/4 receptor antagonist SHU9119. Chronic NDP-alpha-MSH treatment attenuated blood pressure elevation in DOCA-salt mice without affecting the blood pressure of normotensive control animals. Owing to the enhanced sodium excretion, NDP-alpha-MSH-treated mice were protected from DOCA-salt-induced hypernatremia. DOCA-salt treatment mildly increased oxidative stress at the tissue level, but NDP-alpha-MSH had no significant effects on the oxidative stress markers. In conclusion, treatment with NDP-alpha-MSH increases urinary sodium excretion and protects against DOCA-salt-induced hypertension. These findings point to the potential future use of alpha-MSH analogues in the treatment of hypertension.	[Rinne, Petteri; Penttinen, Anna-Maija; Nordlund, Wendy; Savontaus, Eriika] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Rinne, Petteri; Penttinen, Anna-Maija; Nordlund, Wendy; Savontaus, Eriika] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland; [Ahotupa, Markku] Univ Turku, Dept Biochem & Food Chem, FIN-20014 Turku, Finland; [Savontaus, Eriika] Turku Univ Hosp, Clin Pharmacol Unit, FIN-20520 Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku	Rinne, P (corresponding author), Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland.	pperin@utu.fi	Rinne, Petteri/N-7099-2019	Savontaus, Eriika/0000-0003-3421-0367	Academy of Finland; Finnish Funding Agency for Technology and Innovation; Finnish Cultural Foundation; Finnish Foundation for Cardiovascular Research	Academy of Finland(Academy of Finland); Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Foundation for Cardiovascular Research	This work was supported by grants from the Academy of Finland (ES), the Finnish Funding Agency for Technology and Innovation (ES), the Finnish Cultural Foundation (PR), and the Finnish Foundation for Cardiovascular Research (PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzani C, 2001, J PHARMACOL EXP THER, V297, P1082; Beswick RA, 2001, HYPERTENSION, V38, P1107, DOI 10.1161/hy1101.093423; Chen XW, 1997, AM J PHYSIOL-REG I, V272, pR1946, DOI 10.1152/ajpregu.1997.272.6.R1946; Colombo G, 2005, J IMMUNOL, V175, P3391, DOI 10.4049/jimmunol.175.5.3391; Cope G, 2012, CLIN EXP PHARM PHYSL; Forstermann U, 2011, BRIT J PHARMACOL, V164, P213, DOI 10.1111/j.1476-5381.2010.01196.x; Gatti S, 2012, EXP NEUROL, V234, P230, DOI 10.1016/j.expneurol.2011.12.039; Giuliani D, 2007, BRIT J PHARMACOL, V150, P595, DOI 10.1038/sj.bjp.0707115; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; HRADEC J, 1979, ENDOCRINOL EXP, V13, P145; Humphreys MH, 2004, AM J PHYSIOL-REG I, V286, pR417, DOI 10.1152/ajpregu.00365.2003; Kathpalia PP, 2011, PEPTIDES, V32, P1068, DOI 10.1016/j.peptides.2011.02.006; Kolgazi M, 2007, J APPL TOXICOL, V27, P183, DOI 10.1002/jat.1191; Kuo JJ, 2004, HYPERTENSION, V43, P370, DOI 10.1161/01.HYP.0000111836.54204.93; Lindskog A, 2010, J AM SOC NEPHROL, V21, P1290, DOI 10.1681/ASN.2009101025; LYMANGROVER JR, 1985, ENDOCRINOLOGY, V116, P1227, DOI 10.1210/endo-116-3-1227; Manning RD, 2003, ACTA PHYSIOL SCAND, V179, P243, DOI 10.1046/j.0001-6772.2003.01204.x; Matsumura K, 2002, BRAIN RES, V948, P145, DOI 10.1016/S0006-8993(02)03045-7; Ni XP, 2006, J HYPERTENS, V24, P2239, DOI 10.1097/01.hjh.0000249702.49854.fa; Ni XP, 2006, AM J PHYSIOL-REG I, V290, pR560, DOI 10.1152/ajpregu.00279.2005; Ni XP, 1998, AM J PHYSIOL-REG I, V274, pR931, DOI 10.1152/ajpregu.1998.274.4.R931; Obst M, 2004, KIDNEY INT, V65, P2268, DOI 10.1111/j.1523-1755.2004.00646.x; ORIAS R, 1972, ENDOCRINOLOGY, V90, P700, DOI 10.1210/endo-90-3-700; Rinne P, 2008, PEPTIDES, V29, P1943, DOI 10.1016/j.peptides.2008.06.012; Rinne P, 2013, CARDIOVASC RES, V97, P360, DOI 10.1093/cvr/cvs335; Ruohonen ST, 2009, NEUROENDOCRINOLOGY, V89, P351, DOI 10.1159/000188602; SCHENK J, 1992, J PHARMACOL TOX MET, V27, P161, DOI 10.1016/1056-8719(92)90036-Z; SHIRASAKI Y, 1988, J PHARMACOL EXP THER, V245, P53; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Ugwu SO, 1997, BIOPHARM DRUG DISPOS, V18, P259, DOI 10.1002/(SICI)1099-081X(199704)18:3<259::AID-BDD20>3.0.CO;2-X; VANDEVOORDE J, 1986, AM J PHYSIOL, V250, pH711, DOI 10.1152/ajpheart.1986.250.5.H711	31	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72857	10.1371/journal.pone.0072857	http://dx.doi.org/10.1371/journal.pone.0072857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977363	Green Submitted, Green Published, gold			2022-12-25	WOS:000323570200089
J	Kapina, MA; Rubakova, EI; Majorov, KB; Logunova, NN; Apt, AS				Kapina, Marina A.; Rubakova, Elvira I.; Majorov, Konstantin B.; Logunova, Nadezhda N.; Apt, Alexander S.			Capacity of Lung Stroma to Educate Dendritic Cells Inhibiting Mycobacteria-Specific T-Cell Response Depends upon Genetic Susceptibility to Tuberculosis	PLOS ONE			English	Article							HOMEOSTASIS; INDUCTION; MURINE; MICE; DIFFERENTIATION; GRANULOMA; ANTIGENS; IMMATURE; MATURE	The balance between activation and inhibition of local immune responses in affected tissues during prolonged chronic infections is important for host protection. There is ample evidence that regulatory, tolerogenic dendritic cells (DC) are developed and present in tissues and inhibit overwhelming inflammatory reactions. Also, it was firmly established that stromal microenvironment of many organs is able to induce development of immature regulatory DC (DCreg), an essential element of a general immune regulatory network. However, direct experimental data demonstrating inhibition of immune responses by stroma-instructed immature DCreg in infectious models are scarce, and virtually nothing is known about functioning of this axis of immunity during tuberculosis (TB) infection. In this study, we demonstrate that lung stromal cells are capable of supporting the development in culture of immature CD11b(+)CD11c(low)CD103(-) DCreg from lineage-negative (lin(-)) bone marrow precursors. DCreg developed on lung stroma isolated from mice of genetically TB-hyper-susceptible I/St and relatively resistant B6 inbred strains inhibited proliferative response of mycobacteria-specific CD4(+) T-cell lines a dose-dependent manner. Importantly, the inhibitory activity of B6 DCreg was substantially higher than that of I/St Dcreg. Moreover, when the donors of stromal cells were chronically infected with virulent mycobacteria, the capacity to instruct inhibitory DCreg was retained in B6, but further diminished in I/St stromal cells. DCreg-provided suppression was mediated by a few soluble mediators, including PGE(2), NO and IL-10. The content of CD4(+)Foxp3(+) Treg cells in the mediastinal, lung-draining lymph nodes at the advanced stages of chronic infection did not change in I/St, but increased 2-fold in B6 mice, and lung pathology was much more pronounced in the former mice. Taken together, these data provide genetic evidence that the capacity to maintain populations of regulatory cells during M. tuberculosis infection is a part of the host protective strategy.	[Kapina, Marina A.; Rubakova, Elvira I.; Majorov, Konstantin B.; Logunova, Nadezhda N.; Apt, Alexander S.] Cent Inst TB, Immunogenet Lab, Moscow, Russia		Apt, AS (corresponding author), Cent Inst TB, Immunogenet Lab, Moscow, Russia.	asapt@aha.ru	Majorov, Konstantin Borisovich/AIE-6667-2022	Apt, Alexander/0000-0002-3683-3085	Russian Foundation for Basic Research [12-04-00013, 12-04-00173]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The work was financially supported by the Russian Foundation for Basic Research grants 12-04-00013 (to ASA) and 12-04-00173 (to NNL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamias G, 2012, CYTOKINE, V59, P451, DOI 10.1016/j.cyto.2012.06.014; Belkaid Y, 2008, IMMUNITY, V29, P362, DOI 10.1016/j.immuni.2008.08.005; BILYK N, 1991, IMMUNOLOGY, V74, P645; Cooper AM, 2009, CURR OPIN IMMUNOL, V21, P378, DOI 10.1016/j.coi.2009.06.004; D'Avila H, 2008, CELL MICROBIOL, V10, P2589, DOI 10.1111/j.1462-5822.2008.01233.x; del Rio ML, 2010, IMMUNOL REV, V234, P268, DOI 10.1111/j.0105-2896.2009.00874.x; Kautz-Neu K, 2011, J EXP MED, V208, P885, DOI 10.1084/jem.20102318; Kondratieva E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010515; Leepiyasakulchai C, 2012, INFECT IMMUN, V80, P1128, DOI 10.1128/IAI.05552-11; Li Q, 2008, EUR J IMMUNOL, V38, P2751, DOI 10.1002/eji.200838542; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Majorov KB, 2003, INFECT IMMUN, V71, P697, DOI 10.1128/IAI.71.2.697-707.2003; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; MIGLIORINI P, 1991, J IMMUNOL METHODS, V139, P107, DOI 10.1016/0022-1759(91)90357-L; Ottenhoff THM, 2012, INT J TUBERC LUNG D, V16, P1424, DOI 10.5588/ijtld.12.0479; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Owens BMJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00262; Pichugin AV, 1998, CLIN EXP IMMUNOL, V111, P316; Radaeva TV, 2008, TUBERCULOSIS, V88, P576, DOI 10.1016/j.tube.2008.05.003; Reece ST, 2012, CURR OPIN MICROBIOL, V15, P63, DOI 10.1016/j.mib.2011.10.006; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Smith KA, 2011, J IMMUNOL, V186, P7098, DOI 10.4049/jimmunol.1003636; Smits HH, 2005, TRENDS IMMUNOL, V26, P123, DOI 10.1016/j.it.2005.01.002; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stumbles PA, 2010, METHODS MOL BIOL, V595, P249, DOI 10.1007/978-1-60761-421-0_17; Svensson M, 2004, IMMUNITY, V21, P805, DOI 10.1016/j.immuni.2004.10.012; Svensson M, 2006, TRENDS IMMUNOL, V27, P580, DOI 10.1016/j.it.2006.10.006; Tang H, 2006, BLOOD, V108, P1189, DOI 10.1182/blood-2006-01-007187; Torrado E, 2011, TRENDS IMMUNOL, V32, P66, DOI 10.1016/j.it.2010.12.001; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130; Zhou ZP, 2010, STEM CELLS, V28, P620, DOI 10.1002/stem.301	35	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72773	10.1371/journal.pone.0072773	http://dx.doi.org/10.1371/journal.pone.0072773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977351	Green Submitted, gold, Green Published			2022-12-25	WOS:000323378000114
J	Carchman, EH; Whelan, S; Loughran, P; Mollen, K; Stratamirovic, S; Shiva, S; Rosengart, MR; Zuckerbraun, BS				Carchman, Evie H.; Whelan, Sean; Loughran, Patricia; Mollen, Kevin; Stratamirovic, Sladjana; Shiva, Sruti; Rosengart, Matthew R.; Zuckerbraun, Brian S.			Experimental sepsis-induced mitochondrial biogenesis is dependent on autophagy, TLR4, and TLR9 signaling in liver	FASEB JOURNAL			English	Article						lipopolysaccharide; Toll-like receptor 4; VPS34; peroxisome proliferator-activated receptor-gamma coactivator; PGC-1 alpha	NITRIC-OXIDE; IN-VITRO; INFLAMMATORY RESPONSES; ADAPTIVE IMMUNITY; INNATE; DNA; FAILURE; MICE; HEPATOCYTES; ACTIVATION	Organ injury in sepsis is initially characterized by dysfunction without cell death and structural damage, and thus with the ability to recover organ function. Adaptive metabolic responses to sepsis can prevent bioenergetic failure and death. These studies were aimed at investigating the influence of sepsis on mitochondrial homeostasis, focusing on removal of dysfunctional mitochondria and restitution of a healthy mitochondrial population. These data demonstrate decreased hepatic oxidative phosphorylation by 31 +/- 11% following murine cecal ligation and puncture (CLP) at 8 h and 34 +/- 9% following LPS treatment in vitro at 12 h (P<0.05). In addition, there was a loss of mitochondrial membrane potential. Mitochondrial density and number initially decreased (relative area per micrograph of 64 +/- 10% at baseline vs. 39 +/- 13% at 8 h following LPS; P<0.05) and was associated with an increase in autophagy and mitophagy. CLP-induced markers of mitochondrial biogenesis and mitochondrial number and density recovered over time. Furthermore, these data suggest that mitochondrial biogenesis was dependent on an autophagy and mitochondrial DNA/Toll-like receptor 9 (TLR9) signaling pathway. These results suggest that hepatocyte survival and maintenance of function in sepsis is dependent on a mitochondrial homeostasis pathway marked by mitophagy and biogenesis.	[Carchman, Evie H.; Whelan, Sean; Loughran, Patricia; Mollen, Kevin; Stratamirovic, Sladjana; Rosengart, Matthew R.; Zuckerbraun, Brian S.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Shiva, Sruti] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; [Shiva, Sruti; Zuckerbraun, Brian S.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA USA; [Carchman, Evie H.; Loughran, Patricia; Stratamirovic, Sladjana; Zuckerbraun, Brian S.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Zuckerbraun, BS (corresponding author), F1200PUH,200 Lothrop St, Pittsburgh, PA 15213 USA.	zuckerbraunbs@upmc.edu	Loughran, Patricia/AAB-1184-2021	Mollen, Kevin/0000-0001-7629-2722	U.S. National Institutes of Health [R01 GM082830, GM082852]; U.S. Veterans Affairs Merit Award [1I01BX000566]; U.S. Department of Defense grant [DM102439]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082830, R01GM082852] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000566] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Veterans Affairs Merit Award; U.S. Department of Defense grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work is supported by U.S. National Institutes of Health grants R01 GM082830 (B.S.Z.) and GM082852 (M. R. R.), U.S. Veterans Affairs Merit Award 1I01BX000566 (B.S.Z.), and U.S. Department of Defense grant DM102439 (B.S.Z.). Author contributions: E. H. C. and B.S.Z., study concept and design; E. H. C., S. P. W., and P. L., acquisition of data; E. H. C., M. R. R., S.Sh., K. P. M., and B.S.Z., analysis and interpretation of data; E. H. C., S. P. M., and B.S.Z., drafting of the manuscript; E. H. C. and B.S.Z., critical revision of the manuscript for important intellectual content and statistical analysis; B.S.Z., acquisition of funding; S.St., technical support. The authors declare no conflicts of interest.	Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Bertin S, 2008, MOL CELL PROTEOMICS, V7, P2311, DOI 10.1074/mcp.M800100-MCP200; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328; Creery D, 2002, CRIT CARE MED, V30, P483; Crouser ED, 2002, CRIT CARE MED, V30, P276, DOI 10.1097/00003246-200202000-00002; Delgado M, 2009, IMMUNOL REV, V227, P189, DOI 10.1111/j.1600-065X.2008.00725.x; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Erusalimsky JD, 2007, ARTERIOSCL THROM VAS, V27, P2524, DOI 10.1161/ATVBAHA.107.151167; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gramignoli R, 2012, CELL TRANSPLANT, V21, P1245, DOI 10.3727/096368911X600939; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Lancel S, 2009, J PHARMACOL EXP THER, V329, P641, DOI 10.1124/jpet.108.148049; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; McBride HM, 2008, J CELL BIOL, V183, P757, DOI 10.1083/jcb.200810184; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Piantadosi CA, 2012, BBA-GEN SUBJECTS, V1820, P712, DOI 10.1016/j.bbagen.2011.03.008; Piantadosi CA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207738; Plitas G, 2008, J EXP MED, V205, P1277, DOI 10.1084/jem.20080162; Reynolds CM, 2009, FREE RADICAL BIO MED, V46, P564, DOI 10.1016/j.freeradbiomed.2008.11.007; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Singer M, 2004, LANCET, V364, P545, DOI 10.1016/S0140-6736(04)16815-3; Stolz DB, 2002, HEPATOLOGY, V36, P81, DOI 10.1053/jhep.2002.33716; Waltz P, 2011, AUTOPHAGY, V7, P315, DOI 10.4161/auto.7.3.14044; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Watanabe E, 2009, LAB INVEST, V89, P549, DOI 10.1038/labinvest.2009.8; WEST MA, 1985, INFECT IMMUN, V49, P563, DOI 10.1128/IAI.49.3.563-570.1985; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	36	52	65	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4703	4711		10.1096/fj.13-229476	http://dx.doi.org/10.1096/fj.13-229476			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23982147	Green Published			2022-12-25	WOS:000329999000006
J	Zhou, J; Ye, SQ; Fujiwara, T; Manolagas, SC; Zhao, HB				Zhou, Jian; Ye, Shiqiao; Fujiwara, Toshifumi; Manolagas, Stavros C.; Zhao, Haibo			Steap4 Plays a Critical Role in Osteoclastogenesis in Vitro by Regulating Cellular Iron/Reactive Oxygen Species (ROS) Levels and cAMP Response Element-binding Protein (CREB) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Iron Metabolism; Mitochondria; Osteoclast; Oxidative Stress	FORKHEAD-BOX-O; OXIDATIVE STRESS; BONE LOSS; PROSTATE-CANCER; DOWN-REGULATION; ADIPOSE-TISSUE; IRON OVERLOAD; BETA-CATENIN; CRUCIAL ROLE; DIFFERENTIATION	Background: Iron uptake through the transferrin-dependent pathway is essential for osteoclast differentiation. Results: Knocking down the expression of Steap4, an endosomal ferrireductase, inhibits osteoclast formation and decreases cellular iron and ROS production. Conclusion: Steap4 regulates cellular iron metabolism during osteoclast differentiation. Significance: This work provides new insights into the molecular mechanisms regulating cellular iron metabolism in osteoclast lineage cells. Iron is essential for osteoclast differentiation, and iron overload in a variety of hematologic diseases is associated with excessive bone resorption. Iron uptake by osteoclast precursors via the transferrin cycle increases mitochondrial biogenesis, reactive oxygen species production, and activation of cAMP response element-binding protein, a critical transcription factor downstream of receptor activator of NF-B-ligand-induced calcium signaling. These changes are required for the differentiation of osteoclast precursors to mature bone-resorbing osteoclasts. However, the molecular mechanisms regulating cellular iron metabolism in osteoclasts remain largely unknown. In this report, we provide evidence that Steap4, a member of the six-transmembrane epithelial antigen of prostate (Steap) family proteins, is an endosomal ferrireductase with a critical role in cellular iron utilization in osteoclasts. Specifically, we show that Steap4 is the only Steap family protein that is up-regulated during osteoclast differentiation. Knocking down Steap4 expression in vitro by lentivirus-mediated short hairpin RNAs inhibits osteoclast formation and decreases cellular ferrous iron, reactive oxygen species, and the activation of cAMP response element-binding protein. These results demonstrate that Steap4 is a critical enzyme for cellular iron uptake and utilization in osteoclasts and, thus, indispensable for osteoclast development and function.	[Zhao, Haibo] Univ Arkansas Med Sci, Ctr Osteoporosis & Bone Metab Dis, Div Endocrinol & Metab, Dept Internal Med, Little Rock, AR 72205 USA; Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Zhao, HB (corresponding author), Univ Arkansas Med Sci, Ctr Osteoporosis & Bone Metab Dis, Div Endocrinol & Metab, Dept Internal Med, 4301 W Markham St,Slot 587, Little Rock, AR 72205 USA.	hzhao@uams.edu	Zhao, Haibo/ABG-9729-2021; Ye, Shiqiao/N-2873-2015	Ye, Shiqiao/0000-0003-1529-7102; ZHAO, HAIBO/0000-0003-0836-7555	NIAMS; NIA, National Institutes of Health [AR055694, AR062012, P01 AG13918]; University of Arkansas for Medical Sciences Tobacco Settlement Funds by the Arkansas Biosciences Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062012, R03AR055694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Arkansas for Medical Sciences Tobacco Settlement Funds by the Arkansas Biosciences Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by NIAMS and NIA, National Institutes of Health Grants AR055694, AR062012, and P01 AG13918. This work was also partially supported by University of Arkansas for Medical Sciences Tobacco Settlement Funds provided by the Arkansas Biosciences Institute.	Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Arner P, 2008, J CLIN ENDOCR METAB, V93, P2249, DOI 10.1210/jc.2008-0206; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chen CY, 2012, BBA-MOL CELL RES, V1823, P1459, DOI 10.1016/j.bbamcr.2012.01.003; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexcr.2004.07.035; Haidar R, 2011, BONE, V48, P425, DOI 10.1016/j.bone.2010.10.173; Helfrich MH, 2003, MICROSC RES TECHNIQ, V61, P514, DOI 10.1002/jemt.10375; Hubert RS, 1999, P NATL ACAD SCI USA, V96, P14523, DOI 10.1073/pnas.96.25.14523; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Kim H, 2013, CELL METAB, V17, P249, DOI 10.1016/j.cmet.2013.01.002; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; Kirstein B, 2006, J CELL BIOCHEM, V98, P1085, DOI 10.1002/jcb.20835; Knutson MD, 2007, NUTR REV, V65, P335, DOI 10.1301/nr.2007.jul.335-340; Korkmaz CG, 2005, ONCOGENE, V24, P4934, DOI 10.1038/sj.onc.1208677; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Li GF, 2012, OSTEOPOROSIS INT, V23, P2403, DOI 10.1007/s00198-012-1982-1; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Petrat F, 1999, HEPATOLOGY, V29, P1171, DOI 10.1002/hep.510290435; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; RYAN TP, 1992, CRIT REV TOXICOL, V22, P119, DOI 10.3109/10408449209146308; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tsay J, 2010, BLOOD, V116, P2582, DOI 10.1182/blood-2009-12-260083; Wang L, 2010, CANCER RES, V70, P5818, DOI 10.1158/0008-5472.CAN-09-4697; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Ye S., 2011, PLOS ONE, V6; Zhang CM, 2008, ACTA PHARMACOL SIN, V29, P587, DOI 10.1111/j.1745-7254.2008.00793.x; Zhao HB, 2001, J BIOL CHEM, V276, P39295, DOI 10.1074/jbc.M010999200	47	59	61	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30064	30074		10.1074/jbc.M113.478750	http://dx.doi.org/10.1074/jbc.M113.478750			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23990467	Green Published, hybrid			2022-12-25	WOS:000329868100007
J	Ludwig, CF; Ullrich, F; Leisle, L; Stauber, T; Jentsch, TJ				Ludwig, Carmen F.; Ullrich, Florian; Leisle, Lilia; Stauber, Tobias; Jentsch, Thomas J.			Common Gating of Both CLC Transporter Subunits Underlies Voltage-dependent Activation of the 2Cl(-)/1H(+) Exchanger ClC-7/Ostm1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anion Transport; Chloride Transport; Gating; Ion Channels; Lysosomal Storage Disease; Albers-Schonberg Disease; Antiport; Split-channel	CHLORIDE CHANNEL FUNCTION; COMPLEMENTARY FRAGMENTS; CYTOPLASMIC DOMAIN; TORPEDO-MARMORATA; REQUIRES OSTM1; POINT MUTATION; BETA-SUBUNIT; CBS DOMAINS; C-TERMINUS; OSTEOPETROSIS	CLC anion transporters form dimers that function either as Cl- channels or as electrogenic Cl-/H+ exchangers. CLC channels display two different types of gates, protopore gates that open and close the two pores of a CLC dimer independently of each other and common gates that act on both pores simultaneously. ClC-7/Ostm1 is a lysosomal 2Cl(-)/1H(+) exchanger that is slowly activated by depolarization. This gating process is drastically accelerated by many CLCN7 mutations underlying human osteopetrosis. Making use of some of these mutants, we now investigate whether slow voltage activation of plasma membrane-targeted ClC-7/Ostm1 involves protopore or common gates. Voltage activation of wild-type ClC-7 subunits was accelerated by co-expressing an excess of ClC-7 subunits carrying an accelerating mutation together with a point mutation rendering these subunits transport-deficient. Conversely, voltage activation of a fast ClC-7 mutant could be slowed by co-expressing an excess of a transport-deficient mutant. These effects did not depend on whether the accelerating mutation localized to the transmembrane part or to cytoplasmic cystathionine--synthase (CBS) domains of ClC-7. Combining accelerating mutations in the same subunit did not speed up gating further. No currents were observed when ClC-7 was truncated after the last intramembrane helix. Currents and slow gating were restored when the C terminus was co-expressed by itself or fused to the C terminus of the -subunit Ostm1. We conclude that common gating underlies the slow voltage activation of ClC-7. It depends on the CBS domain-containing C terminus that does not require covalent binding to the membrane domain of ClC-7.	[Ludwig, Carmen F.; Ullrich, Florian; Leisle, Lilia; Stauber, Tobias; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Ludwig, Carmen F.; Ullrich, Florian; Leisle, Lilia; Stauber, Tobias; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Jentsch, Thomas J.] Charite, NeuroCure Cluster Excellence, D-10117 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jentsch, TJ (corresponding author), FMP MDC, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de	Ullrich, Florian/AAA-6043-2019; Stauber, Tobias/E-4005-2010	Ullrich, Florian/0000-0002-1153-2040; Stauber, Tobias/0000-0003-0727-6109; Jentsch, Thomas/0000-0002-3509-2553	Deutsche Forschungsgemeinschaft [JE164/7, JE164/9, SFB740 TP C5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in part, by grants from the Deutsche Forschungsgemeinschaft (JE164/7, JE164/9, and SFB740 TP C5).	Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; BAUER CK, 1991, P NATL ACAD SCI USA, V88, P11052, DOI 10.1073/pnas.88.24.11052; Bennetts B, 2012, J BIOL CHEM, V287, P25808, DOI 10.1074/jbc.M111.327551; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Cederholm JM, 2010, INT J BIOCHEM CELL B, V42, P1182, DOI 10.1016/j.biocel.2010.04.004; Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Chen MF, 2001, J GEN PHYSIOL, V118, P23, DOI 10.1085/jgp.118.1.23; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; de Santiago JA, 2005, J GEN PHYSIOL, V126, P591, DOI 10.1085/jgp.200509310; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Elvington SM, 2009, EMBO J, V28, P3090, DOI 10.1038/emboj.2009.259; Estevez R, 2004, J PHYSIOL-LONDON, V557, P363, DOI 10.1113/jphysiol.2003.058453; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Fong PY, 1998, AM J PHYSIOL-CELL PH, V274, pC966, DOI 10.1152/ajpcell.1998.274.4.C966; Frattini A, 2003, J BONE MINER RES, V18, P1740, DOI 10.1359/jbmr.2003.18.10.1740; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Jeworutzki E, 2012, NEURON, V73, P951, DOI 10.1016/j.neuron.2011.12.039; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; Li XH, 2000, J BIOL CHEM, V275, P35994, DOI 10.1074/jbc.M002712200; Lin YW, 1999, J GEN PHYSIOL, V114, P1, DOI 10.1085/jgp.114.1.1; Lisal J, 2008, NAT STRUCT MOL BIOL, V15, P805, DOI 10.1038/nsmb.1466; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Ludewig U, 1997, BIOPHYS J, V73, P789, DOI 10.1016/S0006-3495(97)78111-6; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Ma L, 2008, BIOCHEM J, V413, P61, DOI 10.1042/BJ20071489; Ma LL, 2011, BIOCHEM J, V436, P415, DOI 10.1042/BJ20102153; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; Markovic S, 2007, STRUCTURE, V15, P715, DOI 10.1016/j.str.2007.04.013; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; Mo L, 2004, AM J PHYSIOL-CELL PH, V286, pC79, DOI 10.1152/ajpcell.00009.2003; Neagoe I, 2010, J BIOL CHEM, V285, P21689, DOI 10.1074/jbc.M110.125971; Pusch M, 1995, NEURON, V15, P1455, DOI 10.1016/0896-6273(95)90023-3; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; SchmidtRose T, 1997, J BIOL CHEM, V272, P20515, DOI 10.1074/jbc.272.33.20515; Stauber T, 2012, COMPR PHYSIOL, V2, P1701, DOI 10.1002/cphy.c110038; Stauber T, 2013, ANNU REV PHYSIOL, V75, P453, DOI 10.1146/annurev-physiol-030212-183702; Stauber T, 2010, J BIOL CHEM, V285, P34537, DOI 10.1074/jbc.M110.162545; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Traverso S, 2006, J GEN PHYSIOL, V127, P51, DOI 10.1085/jgp.200509340; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Wu WP, 2006, BIOCHEM J, V395, P89, DOI 10.1042/BJ20050966; Yusef YR, 2006, J PHYSIOL-LONDON, V572, P173, DOI 10.1113/jphysiol.2005.102392; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	59	28	30	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28611	28619		10.1074/jbc.M113.509364	http://dx.doi.org/10.1074/jbc.M113.509364			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23983121	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000330298800017
J	Zhou, JJ; Chen, YQ; Liu, Y; Shi, SF; Wang, SX; Li, XY; Zhang, H; Wang, HY				Zhou, Jingjing; Chen, Yuqing; Liu, Ying; Shi, Sufang; Wang, Suxia; Li, Xueying; Zhang, Hong; Wang, Haiyan			Urinary Uromodulin Excretion Predicts Progression of Chronic Kidney Disease Resulting from IgA Nephropathy	PLOS ONE			English	Article							TAMM-HORSFALL PROTEIN; GLOMERULAR-FILTRATION-RATE; OXFORD CLASSIFICATION; GLYCOPROTEIN; EXPRESSION; PATHOGENESIS; MUTATIONS; EQUATION	Background: Uromodulin, or Tamm-Horsfall protein, is the most abundant urinary protein in healthy individuals. Recent studies have suggested that uromodulin may play a role in chronic kidney diseases. We examined an IgA nephropathy cohort to determine whether uromodulin plays a role in the progression of IgA nephropathy. Methods: A total of 344 IgA nephropathy patients were involved in this study. Morphological changes were evaluated with the Oxford classification of IgA nephropathy. Enzyme Linked Immunosorbent Assay (ELISA) measured the urinary uromodulin level on the renal biopsy day. Follow up was done regularly on 185 patients. Time-average blood pressure, time-average proteinuria, estimated glomerular filtration rate (eGFR) and eGFR decline rate were caculated. Association between the urinary uromodulin level and the eGFR decline rate was analyzed with SPSS 13.0. Results: We found that lower baseline urinary uromodulin levels (P = 0.03) and higher time-average proteinuria (P = 0.04) were risk factors for rapid eGFR decline in a follow-up subgroup of the IgA nephropathy cohort. Urinary uromodulin level was correlated with tubulointerstitial lesions (P = 0.016). Patients that had more tubular atrophy/interstitial fibrosis on the surface had lower urinary uromodulin levels (P = 0.02). Conclusions: Urinary uromodulin level is associated with interstitial fibrosis/tubular atrophy and contributes to eGFR decline in IgA nephropathy.	[Zhou, Jingjing; Chen, Yuqing; Liu, Ying; Shi, Sufang; Zhang, Hong; Wang, Haiyan] Peking Univ, Hosp 1, Div Renal, Dept Med, Beijing 100871, Peoples R China; [Wang, Suxia] Peking Univ, Hosp 1, Lab Electron Microscopy, Beijing 100871, Peoples R China; [Li, Xueying] Peking Univ, Hosp 1, Dept Stat, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Chen, YQ (corresponding author), Peking Univ, Hosp 1, Div Renal, Dept Med, Beijing 100871, Peoples R China.	cyq@bjmu.edu.cn			Chinese 985 project from the government [NCET-10-0186/BMU 20110156]	Chinese 985 project from the government	Funding of this work is a grant of the Chinese 985 project (NCET-10-0186/BMU 20110156) from the government. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Barrett J, 2011, SEMIN NEPHROL, V31, P349, DOI 10.1016/j.semnephrol.2011.06.006; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chakraborty J, 2004, UROL RES, V32, P79, DOI 10.1007/s00240-003-0374-6; Dulawa J, 1998, J HUM HYPERTENS, V12, P635, DOI 10.1038/sj.jhh.1000680; El-Achkar TM, 2008, AM J PHYSIOL-RENAL, V295, pF534, DOI 10.1152/ajprenal.00083.2008; Floege J, 2011, AM J KIDNEY DIS, V58, P992, DOI 10.1053/j.ajkd.2011.05.033; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Kreft B, 2002, INFECT IMMUN, V70, P2650, DOI 10.1128/IAI.70.5.2650-2656.2002; Lau WH, 2008, INT J BIOL SCI, V4, P215; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; MAZZUCHI N, 1974, J LAB CLIN MED, V84, P771; MCKENZIE JK, 1964, AUSTRALAS ANN MED, V13, P32, DOI 10.1111/imj.1964.13.1.32; OLLIERHARTMANN MP, 1984, NEPHRON, V38, P163, DOI 10.1159/000183300; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Prajczer S, 2010, NEPHROL DIAL TRANSPL, V25, P1896, DOI 10.1093/ndt/gfp748; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; RINDLER MJ, 1990, J BIOL CHEM, V265, P20784; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; SCHWARTZ RH, 1973, TRANSPLANTATION, V16, P83, DOI 10.1097/00007890-197308000-00001; Scolari F, 2004, AM J KIDNEY DIS, V44, P987, DOI 10.1053/j.ajkd.2004.08.021; Sejdiu I, 2008, SCAND J UROL NEPHROL, V42, P168, DOI 10.1080/00365590701644691; SOBEL JD, 1985, J INFECT DIS, V152, P653, DOI 10.1093/infdis/152.3.653; TAMM I, 1950, P SOC EXP BIOL MED, V74, P108, DOI 10.3181/00379727-74-17825; Tsai CY, 2000, NEPHRON, V85, P207, DOI 10.1159/000045663; Zaucke F, 2010, HUM MOL GENET, V19, P1985, DOI 10.1093/hmg/ddq077	31	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e71023	10.1371/journal.pone.0071023	http://dx.doi.org/10.1371/journal.pone.0071023			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23990922	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470700009
J	Matsunaga, M; Bai, Y; Yamakawa, K; Toyama, A; Kashiwagi, M; Fukuda, K; Oshida, A; Sanada, K; Fukuyama, S; Shinoda, J; Yamada, J; Sadato, N; Ohira, H				Matsunaga, Masahiro; Bai, Yu; Yamakawa, Kaori; Toyama, Asako; Kashiwagi, Mitsuyoshi; Fukuda, Kazuyuki; Oshida, Akiko; Sanada, Kazue; Fukuyama, Seisuke; Shinoda, Jun; Yamada, Jitsuhiro; Sadato, Norihiro; Ohira, Hideki			Brain-Immune Interaction Accompanying Odor-Evoked Autobiographic Memory	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSES; ORBITOFRONTAL CORTEX; ASSOCIATION; EMOTION; STRESS; REDISTRIBUTION; METAANALYSIS; CYTOKINES; CIRCUITS; CUES	The phenomenon in which a certain smell evokes a specific memory is known as the Proust phenomenon. Odor-evoked autobiographic memories are more emotional than those elicited by other sensory stimuli. The results of our previous study indicated that odor-evoked autobiographic memory accompanied by positive emotions has remarkable effects on various psychological and physiological activities, including the secretion of cytokines, which are immune-signaling molecules that modulate systemic inflammation. In this study, we aimed to clarify the neural substrates associated with the interaction between odor-evoked autobiographic memory and peripheral circulating cytokines. We recruited healthy male and female volunteers and investigated the association between brain responses and the concentration of several cytokines in the plasma by using positron emission tomography (PET) recordings when an autographic memory was evoked in participants by asking them to smell an odor that was nostalgic to them. Participants experienced positive emotions and autobiographic memories when nostalgic odors were presented to them. The levels of peripheral proinflammatory cytokines, such as the tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma), were significantly reduced after experiencing odor-evoked autobiographic memory. Subtraction analysis of PET images indicated that the medial orbitofrontal cortex (mOFC) and precuneus/posterior cingulate cortex (PCC) were significantly activated during experiences of odor-evoked autobiographic memory. Furthermore, a correlation analysis indicated that activities of the mOFC and precuneus/PCC were negatively correlated with IFN-gamma concentration. These results indicate that the neural networks including the precuneus/PCC and mOFC might regulate the secretion of peripheral proinflammatory cytokines during the experience of odor-evoked autobiographic memories accompanied with positive emotions.	[Matsunaga, Masahiro] Aichi Med Univ, Dept Hlth & Psychosocial Med, Sch Med, Aichi, Japan; [Bai, Yu; Yamakawa, Kaori; Toyama, Asako; Ohira, Hideki] Nagoya Univ, Grad Sch Environm Studies, Dept Psychol, Nagoya, Aichi 4648601, Japan; [Kashiwagi, Mitsuyoshi; Oshida, Akiko; Sanada, Kazue] Kao Corp, Kansei Sci Res Labs, Tokyo, Japan; [Fukuda, Kazuyuki] Kao Corp, Perfumery Dev Res Labs, Tokyo, Japan; [Fukuyama, Seisuke; Shinoda, Jun; Yamada, Jitsuhiro] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Gifu, Japan; [Sadato, Norihiro] Natl Inst Physiol Sci, Div Cerebral Integrat, Dept Cerebral Res, Aichi, Japan	Aichi Medical University; Nagoya University; KAO Corporation; KAO Corporation; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Matsunaga, M (corresponding author), Aichi Med Univ, Dept Hlth & Psychosocial Med, Sch Med, Aichi, Japan.	matsunag@aichi-med-u.ac.jp	YAMAKAWA, Kaori/ABC-8782-2020	Sadato, Norihiro/0000-0002-9786-3907	Japan Society for the Promotion of Science [22700683]; Grants-in-Aid for Scientific Research [25284003] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (22700683 to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aggleton J, 1986, EMOTION THEORY RES E, P281; Arshamian A, 2013, NEUROPSYCHOLOGIA, V51, P123, DOI 10.1016/j.neuropsychologia.2012.10.023; Bandler R, 2000, BRAIN RES BULL, V53, P95, DOI 10.1016/S0361-9230(00)00313-0; Bosch JA, 2005, PSYCHOSOM MED, V67, P366, DOI 10.1097/01.psy.0000160469.00312.8e; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Chakrabarti B, 2006, EUR J NEUROSCI, V23, P1944, DOI 10.1111/j.1460-9568.2006.04697.x; Diekhof EK, 2012, NEUROPSYCHOLOGIA, V50, P1252, DOI 10.1016/j.neuropsychologia.2012.02.007; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Gottfried JA, 2005, BRAIN RES REV, V50, P287, DOI 10.1016/j.brainresrev.2005.08.004; Herz RS, 2002, AM J PSYCHOL, V115, P21, DOI 10.2307/1423672; HERZ RS, 1995, CHEM SENSES, V20, P517, DOI 10.1093/chemse/20.5.517; Herz RS, 2004, NEUROPSYCHOLOGIA, V42, P371, DOI 10.1016/j.neuropsychologia.2003.08.009; Herz RS, 1998, ANN NY ACAD SCI, V855, P670, DOI 10.1111/j.1749-6632.1998.tb10643.x; Irwin LN, 2012, BRAIN RES, V1489, P1, DOI 10.1016/j.brainres.2012.10.034; Kimura K, 2007, BRAIN BEHAV IMMUN, V21, P921, DOI 10.1016/j.bbi.2007.03.004; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maes M, 2011, NEUROENDOCRINOL LETT, V32, P7; Matsunaga M, 2011, JPN SOC PSYCHOSOMAT, V51, P135; Matsunaga M, 2008, BRAIN BEHAV IMMUN, V22, P408, DOI 10.1016/j.bbi.2007.09.008; Matsunaga M, 2011, NEUROENDOCRINOL LETT, V32, P774; Matsunaga M, 2011, NEUROENDOCRINOL LETT, V32, P458; Ohira H, 2006, NEUROIMAGE, V29, P721, DOI 10.1016/j.neuroimage.2005.08.047; Ohira H, 2008, NEUROIMAGE, V39, P500, DOI 10.1016/j.neuroimage.2007.08.017; Ohira H, 2009, NEUROIMAGE, V47, P897, DOI 10.1016/j.neuroimage.2009.04.088; PANDYA DN, 1981, EXP BRAIN RES, V42, P319, DOI 10.1007/BF00237497; Price JL, 2005, J COMP NEUROL, V493, P132, DOI 10.1002/cne.20750; Proust M., 1919, COTE CHEZ SWANN; Raduner S, 2006, J BIOL CHEM, V281, P14192, DOI 10.1074/jbc.M601074200; Schuyler BS, 2012, SOC COGN AFFECT NEUR; Willander J, 2007, MEM COGNITION, V35, P1659, DOI 10.3758/BF03193499; Willander J, 2006, PSYCHON B REV, V13, P240, DOI 10.3758/BF03193837; Xu HP, 2007, J LEUKOCYTE BIOL, V82, P532, DOI 10.1189/jlb.0307159; Yamakawa K, 2009, BIOL PSYCHOL, V82, P25, DOI 10.1016/j.biopsycho.2009.05.001	33	26	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72523	10.1371/journal.pone.0072523	http://dx.doi.org/10.1371/journal.pone.0072523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977312	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300087
J	Rusciano, G; Capriglione, P; Pesce, G; Del Prete, S; Cennamo, G; Di Cave, D; Cerulli, L; Sasso, A				Rusciano, Giulia; Capriglione, Paola; Pesce, Giuseppe; Del Prete, Salvatore; Cennamo, Gilda; Di Cave, David; Cerulli, Luciano; Sasso, Antonio			Raman Microspectroscopy Analysis in the Treatment of Acanthamoeba Keratitis	PLOS ONE			English	Article							RED-BLOOD-CELLS; LIVING CELLS; SPECTROSCOPY; TWEEZERS; TOOL; FUSARIUM	Acanthamoeba keratitis is a rare but serious corneal disease, often observed in contact lens wearers. Clinical treatment of infected patients frequently involves the use of polyhexamethylene biguanide (PHMB), a polymer used as a disinfectant and antiseptic, which is toxic also for the epithelial cells of the cornea. Prompt and effective diagnostic tools are hence highly desiderable for both starting early therapy and timely suspension of the treatment. In this work we use Raman microspectroscopy to analyse in vitro a single Acanthamoeba cell in cystic phase. In particular, we investigate the effect of PHMB at the single-cell level, providing useful information on both the underlying biochemical mechanism and the time frame for Acanthamoeba eradication in ocular infections. Furthermore, we demonstrate that Raman spectroscopy, in conjunction with standard multivariate analysis methods, allows discriminating between live and dead Acanthamoebas, which is fundamental to optimizing patients' treatment.	[Rusciano, Giulia; Capriglione, Paola; Pesce, Giuseppe; Sasso, Antonio] Univ Naples Federico II, Dipartimento Fis, Naples, Italy; [Del Prete, Salvatore; Cennamo, Gilda] Univ Naples Federico II, Dipartimento Neurosci & Sci Riprodutt & Odontosto, Naples, Italy; [Di Cave, David; Cerulli, Luciano] Univ Roma Tor Vergata, Dipartimento Med Sperimentale & Chirurg, Rome, Italy; [Sasso, Antonio] Ist Nazl Ottica, CNR, Pozzuoli, Italy	University of Naples Federico II; University of Naples Federico II; University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR)	Rusciano, G (corresponding author), Univ Naples Federico II, Dipartimento Fis, Complesso Univ Monte S Angelo, Naples, Italy.	giulia.rusciano@unina.it	Rusciano, Giulia/A-2079-2010; Del Prete, Salvatore/AAC-7867-2020; Pesce, Giuseppe/B-9618-2009; Del Prete, Salvatore/AAW-7149-2021; Pesce, Giuseppe/AAX-8652-2020	Rusciano, Giulia/0000-0002-7152-5352; Pesce, Giuseppe/0000-0002-2806-9769; Del Prete, Salvatore/0000-0001-6004-7781; Sasso, Antonio/0000-0003-3591-3531	MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca)	MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR))	This work was funded by MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajito K, 2001, TRAC-TREND ANAL CHEM, V20, P255, DOI 10.1016/S0165-9936(01)00060-7; Chan JW, 2006, BIOPHYS J, V90, P648, DOI 10.1529/biophysj.105.066761; Choo-Smith LP, 2002, BIOPOLYMERS, V67, P1; De Luca AC, 2007, HAEMATOL-HEMATOL J, V92, P174; De Luca AC, 2008, OPT EXPRESS, V16, P7943, DOI 10.1364/OE.16.007943; Dingari NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032406; Erckens RJ, 2001, LASER MED SCI, V16, P236, DOI 10.1007/PL00011360; Ferraro J.R., 1994, INTRO RAMAN SPECTROS; Hanlon EB, 2000, PHYS MED BIOL, V45, pR1, DOI 10.1088/0031-9155/45/2/201; Kaur H, 2007, CORNEA, V26, P212, DOI 10.1097/ICO.0b013e31802eb136; Khan AO, 2007, OPHTHALMOLOGY, V114, P395, DOI 10.1016/j.ophtha.2006.08.023; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; Kumar R, 2002, CLIN INFECT DIS, V35, P434, DOI 10.1086/341487; Larkin DF, 1992, OPHTHALMOLOGY, V99, P85; Lasch P., 2008, BIOMEDICAL VIBRATION; Lim N, 2008, AM J OPHTHALMOL, V145, P130, DOI 10.1016/j.ajo.2007.08.040; Lin HC, 2009, ACTA OPHTHALMOL, V87, P199, DOI 10.1111/j.1755-3768.2008.01192.x; Martens HA, 1998, VALIDATION VERIFICAT; Notingher I, 2006, EXPERT REV MED DEVIC, V3, P215, DOI 10.1586/17434440.3.2.215; PUPPELS GJ, 1991, EXP CELL RES, V195, P361, DOI 10.1016/0014-4827(91)90385-8; Rusciano G, 2010, METHODS, V51, P27, DOI 10.1016/j.ymeth.2009.12.009; Rusciano G, 2008, SENSORS-BASEL, V8, P7818, DOI 10.3390/s8127818; Salzer R, 2000, FRESEN J ANAL CHEM, V366, P712, DOI 10.1007/s002160051565; Sansanayudh W, 2008, BRIT J OPHTHALMOL, V92, P720, DOI 10.1136/bjo.2007.134171; Schaumberg DA, 1998, CORNEA, V17, P3, DOI 10.1097/00003226-199801000-00001; Schrader B., 1995, INFRARED RAMAN SPECT, P411, DOI 10.1002/9783527615438.ch05; Schroeder JM, 2001, J CLIN MICROBIOL, V39, P1903, DOI 10.1128/JCM.39.5.1903-1911.2001; Seal DV, 2003, EYE, V17, P893, DOI 10.1038/sj.eye.6700563; Thomas GJ, 1999, ANNU REV BIOPH BIOM, V28, P1, DOI 10.1146/annurev.biophys.28.1.1; Verrier S, 2004, BIOPOLYMERS, V74, P157, DOI 10.1002/bip.20063; Wood BR, 2007, ANAL BIOANAL CHEM, V387, P1691, DOI 10.1007/s00216-006-0881-8	31	23	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72127	10.1371/journal.pone.0072127	http://dx.doi.org/10.1371/journal.pone.0072127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977228	Green Submitted, gold, Green Published			2022-12-25	WOS:000324527300065
J	Yi, F; Zhang, XH; Yang, CR; Li, BM				Yi, Feng; Zhang, Xue-Han; Yang, Charles R.; Li, Bao-ming			Contribution of Dopamine D1/5 Receptor Modulation of Post-Spike/Burst Afterhyperpolarization to Enhance Neuronal Excitability of Layer V Pyramidal Neurons in Prepubertal Rat Prefrontal Cortex	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTION-POTENTIAL REPOLARIZATION; INTRINSIC MEMBRANE-PROPERTIES; ACTIVATED CATION CURRENT; LONG-TERM POTENTIATION; CA2+ CHANNELS; CORTICAL-NEURONS; I-H; SLOW AFTERHYPERPOLARIZATION; PERSISTENT ACTIVITY	Dopamine (DA) receptors in the prefrontal cortex (PFC) modulate both synaptic and intrinsic plasticity that may contribute to cognitive processing. However, the ionic basis underlying DA actions to enhance neuronal plasticity in PFC remains ill-defined. Using whole-cell patch-clamp recordings in layer V-VI pyramidal cells in prepubertal rat PFC, we showed that DA, via activation of D1/5, but not D2/3/4, receptors suppress a Ca2+-dependent, apamin-sensitive K+ channel that mediates post-spike/burst afterhyperpolarization (AHP) to enhance neuronal excitability of PFC neurons. This inhibition is not dependent on HCN channels. The D1/5 receptor activation also enhanced an afterdepolarizing potential (ADP) that follows the AHP. Additional single-spike analyses revealed that DA or D1/5 receptor activation suppressed the apamin-sensitive post-spike mAHP, further contributing to the increase in evoked spike firing to enhance the neuronal excitability. Taken together, the D1/5 receptor modulates intrinsic mechanisms that amplify a long depolarizing input to sustain spike firing outputs in pyramidal PFC neurons.	[Yi, Feng; Zhang, Xue-Han; Li, Bao-ming] Fudan Univ, Inst Neurobiol, Shanghai 200433, Peoples R China; [Yi, Feng; Zhang, Xue-Han; Li, Bao-ming] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Yang, Charles R.] Shanghai Chempartner Co Ltd, CNS Pharmacol & Ion Channel, Shanghai, Peoples R China; [Li, Bao-ming] Nanchang Univ, Inst Life Sci, Ctr Neuropsychiat Dis, Nanchang, Peoples R China	Fudan University; Fudan University; Nanchang University	Li, BM (corresponding author), Fudan Univ, Inst Neurobiol, Shanghai 200433, Peoples R China.	bmli@ncu.edu.cn	Yi, Feng/O-9034-2019	Yi, Feng/0000-0002-0049-742X	Ministry of Science and Technology of China [2006CB500807, 2010CBA00406]; National Natural Science Foundation of China [30990263, 30821002]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants to Bao-Ming Li from the Ministry of Science and Technology of China (2006CB500807; 2010CBA00406) and the National Natural Science Foundation of China (30990263; 30821002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel HJ, 2004, J NEUROPHYSIOL, V91, P324, DOI 10.1152/jn.00583.2003; Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Azouz R, 1996, J PHYSIOL-LONDON, V492, P211, DOI 10.1113/jphysiol.1996.sp021302; Bacci A, 2005, TRENDS NEUROSCI, V28, P602, DOI 10.1016/j.tins.2005.08.007; Bandyopadhyay S, 2005, J NEUROPHYSIOL, V93, P864, DOI 10.1152/jn.00922.2004; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Berger T, 2003, J NEUROPHYSIOL, V90, P2428, DOI 10.1152/jn.00377.2003; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Ceci A, 1999, NEUROSCIENCE, V93, P107, DOI 10.1016/S0306-4522(99)00123-2; Chen L, 2007, J NEUROPHYSIOL, V97, P2448, DOI 10.1152/jn.00317.2006; CONSTANTI A, 1993, NEUROSCIENCE, V56, P887, DOI 10.1016/0306-4522(93)90135-3; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; Di Pietro NC, 2011, BIOL PSYCHIAT, V69, P1204, DOI 10.1016/j.biopsych.2010.08.007; Disterhoft JF, 2006, TRENDS NEUROSCI, V29, P587, DOI 10.1016/j.tins.2006.08.005; Dong Y, 2004, J NEUROSCI, V24, P3077, DOI 10.1523/JNEUROSCI.4715-03.2004; Dong Y, 2003, J NEUROSCI, V23, P2686; Durstewitz D, 2002, NEURAL NETWORKS, V15, P561, DOI 10.1016/S0893-6080(02)00049-7; Durstewitz D, 2010, NEURON, V66, P438, DOI 10.1016/j.neuron.2010.03.029; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Gamelli AE, 2011, HIPPOCAMPUS, V21, P133, DOI 10.1002/hipo.20728; GEIJOBARRIENTOS E, 1995, EUR J NEUROSCI, V7, P358, DOI 10.1111/j.1460-9568.1995.tb00331.x; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gorelova N, 2002, J NEUROPHYSIOL, V88, P3150, DOI 10.1152/jn.00335.2002; Gorelova N, 2001, MECH DOPAMINE ACTIVA; Gorelova NA, 2000, J NEUROPHYSIOL, V84, P75, DOI 10.1152/jn.2000.84.1.75; Gulledge AT, 1998, J NEUROSCI, V18, P9139; Gulledge AT, 2001, J NEUROPHYSIOL, V86, P586, DOI 10.1152/jn.2001.86.2.586; Henze DA, 2000, J NEUROPHYSIOL, V84, P2799, DOI 10.1152/jn.2000.84.6.2799; Kisilevsky AE, 2008, NEURON, V58, P557, DOI 10.1016/j.neuron.2008.03.002; Lavin A, 2005, J NEUROSCI, V25, P5013, DOI 10.1523/JNEUROSCI.0557-05.2005; Lavin A, 2001, NEUROSCIENCE, V104, P335, DOI 10.1016/S0306-4522(01)00096-3; Lee JCF, 2005, J NEUROPHYSIOL, V93, P2012, DOI 10.1152/jn.01017.2004; LESLIE CA, 1991, DEV BRAIN RES, V62, P109, DOI 10.1016/0165-3806(91)90195-O; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; Marzo A, 2010, NEUROSCIENCE, V169, P74, DOI 10.1016/j.neuroscience.2010.04.046; Maurice N, 2001, J NEUROSCI, V21, P2268, DOI 10.1523/JNEUROSCI.21-07-02268.2001; Molineux ML, 2008, J NEUROPHYSIOL, V100, P2684, DOI 10.1152/jn.90427.2008; Moore AR, 2011, BRAIN RES, V1370, P1, DOI 10.1016/j.brainres.2010.10.111; Muller A, 2007, J NEUROSCI, V27, P483, DOI 10.1523/JNEUROSCI.3816-06.2007; Murchison D, 2007, AGING CELL, V6, P297, DOI 10.1111/j.1474-9726.2007.00293.x; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Oh MM, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.002.2010; Onn SP, 2003, J PHARMACOL EXP THER, V306, P870, DOI 10.1124/jpet.103.050062; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Pedarzani P, 1995, J NEUROPHYSIOL, V74, P2749, DOI 10.1152/jn.1995.74.6.2749; PENITSORIA J, 1987, BRAIN RES, V425, P263, DOI 10.1016/0006-8993(87)90509-9; Phillips AG, 2004, J NEUROSCI, V24, P547, DOI 10.1523/JNEUROSCI.4653-03.2004; Ping HX, 1999, J NEUROPHYSIOL, V81, P977, DOI 10.1152/jn.1999.81.3.977; Ranjan R, 1998, BIOPHYS J, V74, P1850, DOI 10.1016/S0006-3495(98)77895-6; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rosenkranz JA, 2006, J NEUROSCI, V26, P3229, DOI 10.1523/JNEUROSCI.4333-05.2006; Rotaru DC, 2007, J PHYSIOL-LONDON, V581, P981, DOI 10.1113/jphysiol.2007.130864; Satake T, 2008, BRAIN RES, V1229, P47, DOI 10.1016/j.brainres.2008.06.098; Schiller Y, 2004, J NEUROPHYSIOL, V92, P862, DOI 10.1152/jn.00972.2003; Seamans J. K., 2010, Society for Neuroscience Abstract Viewer and Itinerary Planner, V40; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 1997, J NEUROSCI, V17, P5936; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Seong HJ, 2012, J NEUROSCI, V32, P10516, DOI 10.1523/JNEUROSCI.1367-12.2012; Shah M, 2000, J NEUROPHYSIOL, V83, P2554, DOI 10.1152/jn.2000.83.5.2554; SMILEY JF, 1994, P NATL ACAD SCI USA, V91, P5720, DOI 10.1073/pnas.91.12.5720; STANZIONE P, 1984, NEUROSCIENCE, V13, P1105, DOI 10.1016/0306-4522(84)90291-4; Stefani MR, 2006, J NEUROSCI, V26, P8810, DOI 10.1523/JNEUROSCI.1656-06.2006; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; THOMPSON SM, 1985, J NEUROSCI, V5, P817; Thurley K, 2008, J NEUROPHYSIOL, V99, P2985, DOI 10.1152/jn.01098.2007; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; Tseng KY, 2005, CEREB CORTEX, V15, P49, DOI 10.1093/cercor/bhh107; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Vogalis F, 2003, EUR J NEUROSCI, V18, P3155, DOI 10.1111/j.1460-9568.2003.03040.x; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; Wilson CJ, 2006, J NEUROPHYSIOL, V95, P196, DOI 10.1152/jn.00630.2005; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wu JP, 2005, J NEUROSCI, V25, P6322, DOI 10.1523/JNEUROSCI.1405-05.2005; Xu J, 2005, REV NEUROSCIENCE, V16, P311; Yamamoto R, 2007, J NEUROPHYSIOL, V98, P984, DOI 10.1152/jn.00204.2007; Yang CR, 1996, J NEUROSCI, V16, P1922; Yanovsky Y, 2005, NEUROSCIENCE, V136, P1027, DOI 10.1016/j.neuroscience.2005.08.026; Young CE, 2004, J NEUROSCI, V24, P8, DOI 10.1523/JNEUROSCI.1650-03.2004; Yue CY, 2005, J NEUROSCI, V25, P9704, DOI 10.1523/JNEUROSCI.1621-05.2005	87	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71880	10.1371/journal.pone.0071880	http://dx.doi.org/10.1371/journal.pone.0071880			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977170	Green Submitted, Green Published, gold			2022-12-25	WOS:000324527300048
J	Muller, MF; Florian, S; Pommer, S; Osterhoff, M; Esworthy, RS; Chu, FF; Brigelius-Flohe, R; Kipp, AP				Mueller, Mike F.; Florian, Simone; Pommer, Stefanie; Osterhoff, Martin; Esworthy, R. Steven; Chu, Fong-Fong; Brigelius-Flohe, Regina; Kipp, Anna P.			Deletion of Glutathione Peroxidase-2 Inhibits Azoxymethane-Induced Colon Cancer Development	PLOS ONE			English	Article							MOUSE MODEL; GPX2; EXPRESSION; MICE; SELENIUM; CARCINOGENESIS; SELENOPROTEINS; INFLAMMATION; APOPTOSIS; CELLS	The selenoprotein glutathione peroxidase-2 (GPx2) appears to have a dual role in carcinogenesis. While it protected mice from colon cancer in a model of inflammation-triggered carcinogenesis (azoxymethane and dextran sodium sulfate treatment), it promoted growth of xenografted tumor cells. Therefore, we analyzed the effect of GPx2 in a mouse model mimicking sporadic colorectal cancer (azoxymethane-treatment only). GPx2-knockout (KO) and wild-type (WT) mice were adjusted to an either marginally deficient (-Se), adequate (+Se), or supranutritional (++Se) selenium status and were treated six times with azoxymethane (AOM) to induce tumor development. In the -Se and ++Se groups, the number of tumors was significantly lower in GPx2-KO than in respective WT mice. On the +Se diet, the number of dysplastic crypts was reduced in GPx2-KO mice. This may be explained by more basal and AOM-induced apoptotic cell death in GPx2-KO mice that eliminates damaged or pre-malignant epithelial cells. In WT dysplastic crypts GPx2 was up-regulated in comparison to normal crypts which might be an attempt to suppress apoptosis. In contrast, in the +Se groups tumor numbers were similar in both genotypes but tumor size was larger in GPx2-KO mice. The latter was associated with an inflammatory and tumor-promoting environment as obvious from infiltrated inflammatory cells in the intestinal mucosa of GPx2-KO mice even without any treatment and characterized as low-grade inflammation. In WT mice the number of tumors tended to be lowest in +Se compared to -Se and ++Se feeding indicating that selenium might delay tumorigenesis only in the adequate status. In conclusion, the role of GPx2 and presumably also of selenium depends on the cancer stage and obviously on the involvement of inflammation.	[Mueller, Mike F.; Florian, Simone; Pommer, Stefanie; Brigelius-Flohe, Regina; Kipp, Anna P.] German Inst Human Nutr Potsdam Rehbrucke, Dept Biochem Micronutrients, Nuthetal, Germany; [Osterhoff, Martin] German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, Nuthetal, Germany; [Esworthy, R. Steven; Chu, Fong-Fong] Beckman Res Inst City Hope, Dept Radiat Biol, Duarte, CA USA	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); City of Hope; Beckman Research Institute of City of Hope	Kipp, AP (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Biochem Micronutrients, Nuthetal, Germany.	annakipp@dife.de	Esworthy, Steve/AAN-3152-2020	Esworthy, Steve/0000-0002-4111-3349; Kipp, Anna Patricia/0000-0002-3307-1038	German Research Foundation [Br 778/8-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation (Br 778/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banning A, 2008, ANTIOXID REDOX SIGN, V10, P1491, DOI 10.1089/ars.2008.2047; Banning A, 2008, CANCER RES, V68, P9746, DOI 10.1158/0008-5472.CAN-08-1321; Barrett CW, 2013, CANCER RES, V73, P1245, DOI 10.1158/0008-5472.CAN-12-3150; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; Bocher M, 1997, J IMMUNOL METHODS, V208, P191, DOI 10.1016/S0022-1759(97)00149-X; Bousserouel S, 2010, INT J ONCOL, V36, P1485, DOI 10.3892/ijo_00000635; Brigelius-Flohe R, 2002, METHOD ENZYMOL, V347, P101; Carlson BA, 2012, CARCINOGENESIS, V33, P1806, DOI 10.1093/carcin/bgs230; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; Duckworth CA, 2009, GASTROENTEROLOGY, V136, P943, DOI 10.1053/j.gastro.2008.11.036; Esworthy RS, 2000, AM J PHYSIOL-GASTR L, V279, pG426, DOI 10.1152/ajpgi.2000.279.2.G426; Esworthy RS, 2005, J NUTR, V135, P740, DOI 10.1093/jn/135.4.740; Esworthy RS, 2001, AM J PHYSIOL-GASTR L, V281, pG848, DOI 10.1152/ajpgi.2001.281.3.G848; Florian S, 2001, FREE RADICAL RES, V35, P655, DOI 10.1080/10715760100301181; Florian S, 2010, FREE RADICAL BIO MED, V49, P1694, DOI 10.1016/j.freeradbiomed.2010.08.029; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hawkes WC, 2009, BIOL TRACE ELEM RES, V131, P229, DOI 10.1007/s12011-009-8367-0; Hirose Y, 1996, JPN J CANCER RES, V87, P575, DOI 10.1111/j.1349-7006.1996.tb00262.x; Hong MY, 1999, CELL GROWTH DIFFER, V10, P749; Hrdina J, 2009, J NUTR BIOCHEM, V20, P638, DOI 10.1016/j.jnutbio.2008.06.009; Hu Y, 2005, INT J CANCER, V115, P561, DOI 10.1002/ijc.20876; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; Ishikawa TO, 2010, CARCINOGENESIS, V31, P729, DOI 10.1093/carcin/bgq002; Kipp A, 2007, BIOL CHEM, V388, P1027, DOI 10.1515/BC.2007.137; Kipp A, 2009, MOL NUTR FOOD RES, V53, P1561, DOI 10.1002/mnfr.200900105; Kipp AP, 2012, BBA-GEN SUBJECTS, V1820, P1588, DOI 10.1016/j.bbagen.2012.05.016; Krehl S, 2012, CARCINOGENESIS, V33, P620, DOI 10.1093/carcin/bgr288; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lu YP, 1997, CANCER RES, V57, P1468; Mork H, 2000, NUTR CANCER, V37, P108, DOI 10.1207/S15327914NC3701_14; Murawaki Y, 2008, CANCER LETT, V259, P218, DOI 10.1016/j.canlet.2007.10.019; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Perse M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/473964; Qiu W, 2009, CANCER RES, V69, P4999, DOI 10.1158/0008-5472.CAN-09-0262; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; SCHRAUZER GN, 1977, BIOINORG CHEM, V7, P23, DOI 10.1016/S0006-3061(00)80126-X; Schwitalla S, 2013, CANCER CELL, V23, P93, DOI 10.1016/j.ccr.2012.11.014; Singh P, 2000, GASTROENTEROLOGY, V119, P162, DOI 10.1053/gast.2000.8527; Tsuji PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050574; Wataru AA, 2003, TOXICOL LETT, V144, P213, DOI 10.1016/S0378-4274(03)00221-2; Xia YM, 2005, AM J CLIN NUTR, V81, P829, DOI 10.1093/ajcn/81.4.829; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Yoo MH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001112; Yoshimi N, 2004, CANCER SCI, V95, P792, DOI 10.1111/j.1349-7006.2004.tb02183.x	47	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72055	10.1371/journal.pone.0072055	http://dx.doi.org/10.1371/journal.pone.0072055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977205	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700128
J	Rohe, M; Hartl, D; Fjorback, AN; Klose, J; Willnow, TE				Rohe, Michael; Hartl, Daniela; Fjorback, Anja Nawarecki; Klose, Joachim; Willnow, Thomas E.			SORLA-Mediated Trafficking of TrkB Enhances the Response of Neurons to BDNF	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; ANTEROGRADE TRANSPORT; SIGNALING PATHWAYS; TRANSGENIC MICE; BRAIN; PROTEIN; DISEASE; RECEPTOR; HUNTINGTIN; PATHOLOGY	Stimulation of neurons with brain-derived neurotrophic factor (BDNF) results in robust induction of SORLA, an intracellular sorting receptor of the VPS10P domain receptor gene family. However, the relevance of SORLA for BDNF-induced neuronal responses has not previously been investigated. We now demonstrate that SORLA is a sorting factor for the tropomyosin-related kinase receptor B (TrkB) that facilitates trafficking of this BDNF receptor between synaptic plasma membranes, post-synaptic densities, and cell soma, a step critical for neuronal signal transduction. Loss of SORLA expression results in impaired neuritic transport of TrkB and in blunted response to BDNF in primary neurons; and it aggravates neuromotoric deficits caused by low BDNF activity in a mouse model of Huntington's disease. Thus, our studies revealed a key role for SORLA in mediating BDNF trophic signaling by regulating the intracellular location of TrkB.	[Rohe, Michael; Willnow, Thomas E.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Hartl, Daniela; Klose, Joachim] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Fjorback, Anja Nawarecki] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Aarhus University	Rohe, M (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	michael.rohe@mdc-berlin.de; willnow@mdc-berlin.de		Willnow, Thomas/0000-0001-9515-7921				ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Andersen OS, 2005, J GEN PHYSIOL, V125, P1, DOI 10.1085/jgp.200409233; Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; BIEDLER JL, 1973, CANCER RES, V33, P2643; Cardinaux JR, 1997, MOL BRAIN RES, V51, P220, DOI 10.1016/S0169-328X(97)00241-6; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Conner JM, 1997, J NEUROSCI, V17, P2295; Dodson SE, 2008, J NEUROSCI, V28, P12877, DOI 10.1523/JNEUROSCI.4582-08.2008; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; Fjorback AW, 2012, J NEUROSCI, V32, P1467, DOI 10.1523/JNEUROSCI.2272-11.2012; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Inamura N, 2005, J NEUROCHEM, V95, P1438, DOI 10.1111/j.1471-4159.2005.03466.x; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rohe M, 2008, J BIOL CHEM, V283, P14826, DOI 10.1074/jbc.M710574200; Rohe M, 2011, J PROTEOME RES, V10, P1459, DOI 10.1021/pr101008p; Rohe M, 2009, J NEUROSCI, V29, P15472, DOI 10.1523/JNEUROSCI.3960-09.2009; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Spires TL, 2004, EUR J NEUROSCI, V19, P2799, DOI 10.1111/j.0953-816X.2004.03374.x; Vaegter CB, 2011, NAT NEUROSCI, V14, P54, DOI 10.1038/nn.2689; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Zabel Claus, 2009, V519, P311, DOI 10.1007/978-1-59745-281-6_20; Zabel Claus, 2009, V519, P171, DOI 10.1007/978-1-59745-281-6_11; Zabel C, 2009, MOL CELL PROTEOMICS, V8, P720, DOI 10.1074/mcp.M800277-MCP200	32	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72164	10.1371/journal.pone.0072164	http://dx.doi.org/10.1371/journal.pone.0072164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977241	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000323425700144
J	Marin, MM; Leder, H				Marin, Manuela M.; Leder, Helmut			Examining Complexity across Domains: Relating Subjective and Objective Measures of Affective Environmental Scenes, Paintings and Music	PLOS ONE			English	Article							PERCEIVED FRAGRANCE COMPLEXITY; VISUAL COMPLEXITY; AESTHETIC PREFERENCE; SEX-DIFFERENCES; GENDER-DIFFERENCES; PERSONALITY STYLE; EMOTIONAL STIMULI; ART; FAMILIARITY; AROUSAL	Subjective complexity has been found to be related to hedonic measures of preference, pleasantness and beauty, but there is no consensus about the nature of this relationship in the visual and musical domains. Moreover, the affective content of stimuli has been largely neglected so far in the study of complexity but is crucial in many everyday contexts and in aesthetic experiences. We thus propose a cross-domain approach that acknowledges the multidimensional nature of complexity and that uses a wide range of objective complexity measures combined with subjective ratings. In four experiments, we employed pictures of affective environmental scenes, representational paintings, and Romantic solo and chamber music excerpts. Stimuli were pre-selected to vary in emotional content (pleasantness and arousal) and complexity (low versus high number of elements). For each set of stimuli, in a between-subjects design, ratings of familiarity, complexity, pleasantness and arousal were obtained for a presentation time of 25 s from 152 participants. In line with Berlyne's collative-motivation model, statistical analyses controlling for familiarity revealed a positive relationship between subjective complexity and arousal, and the highest correlations were observed for musical stimuli. Evidence for a mediating role of arousal in the complexity-pleasantness relationship was demonstrated in all experiments, but was only significant for females with regard to music. The direction and strength of the linear relationship between complexity and pleasantness depended on the stimulus type and gender. For environmental scenes, the root mean square contrast measures and measures of compressed file size correlated best with subjective complexity, whereas only edge detection based on phase congruency yielded equivalent results for representational paintings. Measures of compressed file size and event density also showed positive correlations with complexity and arousal in music, which is relevant for the discussion on which aspects of complexity are domain-specific and which are domain-general.	[Marin, Manuela M.; Leder, Helmut] Univ Vienna, Dept Basic Psychol Res & Res Methods, Vienna, Austria	University of Vienna	Marin, MM (corresponding author), Univ Vienna, Dept Basic Psychol Res & Res Methods, Vienna, Austria.	manuela.marin@univie.ac.at	Marin, Manuela M/G-8693-2012; Marin, Manuela M./Q-4496-2017	Marin, Manuela M./0000-0002-9657-1507				Abramov I, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-21; Aksentijevic A, 2012, THEOR PSYCHOL, V22, P572, DOI 10.1177/0959354311423435; Alais D, 2010, SEEING PERCEIVING, V23, P3, DOI 10.1163/187847510X488603; BARRON F, 1952, J PERS, V20, P385, DOI 10.1111/j.1467-6494.1952.tb01116.x; Barron F, 1952, J PSYCHOL, V33, P199, DOI 10.1080/00223980.1952.9712830; Bates E, 2003, PSYCHON B REV, V10, P344, DOI 10.3758/BF03196494; Baumgartner T, 2006, BRAIN RES, V1075, P151, DOI 10.1016/j.brainres.2005.12.065; Beauvois MW, 2007, MUSIC PERCEPT, V24, P247, DOI 10.1525/MP.2007.24.3.247; Berlyne D.E., 1974, STUDIES NEW EXPT AES, P175; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; Berlyne D.E., 1960, CONFLICT AROUSAL CUR, DOI [10.1037/11164-000, DOI 10.1037/11164-000]; BERLYNE DE, 1970, PERCEPT PSYCHOPHYS, V8, P279, DOI 10.3758/BF03212593; BERLYNE DE, 1966, CAN J PSYCHOLOGY, V20, P125, DOI 10.1037/h0082931; BERLYNE DE, 1968, CAN J PSYCHOLOGY, V22, P376, DOI 10.1037/h0082777; BERLYNE DE, 1963, CAN J PSYCHOLOGY, V17, P274, DOI 10.1037/h0092883; Bermpohl F, 2006, NEUROIMAGE, V30, P588, DOI 10.1016/j.neuroimage.2005.09.040; Birkhoff GD, 1933, AESTHETIC MEASURE; Boolos G.S., 2002, COMPUTABILITY LOGIC; Boon JP, 2011, NONLIN DYNAM PSYCHOL, V15, P265; Bradley MM, 2007, PSYCHOPHYSIOLOGY, V44, P364, DOI 10.1111/j.1469-8986.2007.00520.x; Bradley MM, 2011, PSYCHOPHYSIOLOGY, V48, P1543, DOI 10.1111/j.1469-8986.2011.01223.x; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Bragg B. W. E., 1974, STUDIES NEW EXPT AES, P91; Brody LR, 2009, HDB EMOTIONS, P395; BURKE MJ, 1990, PERCEPT MOTOR SKILL, V71, P687, DOI 10.2466/pms.1990.71.2.687; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Casti J., 2003, ART COMPLEXITY; Cavalcante A., 2011, P 21 ANN C JAP NEUR, P2011; Cela-Conde CJ, 2009, P NATL ACAD SCI USA, V106, P3847, DOI 10.1073/pnas.0900304106; Chamorro-Premuzic T, 2010, PSYCHOL AESTHET CREA, V4, P196, DOI 10.1037/a0019211; Chatterjee A., 2004, B PSYCHOL ARTS, V4, P56, DOI DOI 10.1037/E514602010-003; Chikhman V, 2012, PERCEPTION, V41, P631, DOI 10.1068/p6987; Cilibrasi R, 2004, COMPUT MUSIC J, V28, P49, DOI 10.1162/0148926042728449; Clore G. L., 2010, HDB EMOTIONS, P628; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; Crozier J. B., 1974, STUDIES NEW EXPT AES, V10, P27; Cupchik G. C., 1988, EMPIRICAL STUDIES AR, V6, P171, DOI [10.2190/FLM8-6NQ7-N5WM-WLLT, DOI 10.2190/FLM8-6NQ7-N5WM-WLLT]; CUPCHIK GC, 1995, POETICS, V23, P177, DOI 10.1016/0304-422X(94)00014-W; Cupchik GC., 1988, EMPIR STUD ARTS, V6, P1, DOI [10.2190/5YN3-J3P8-FWHY-UDB3, DOI 10.2190/5YN3-J3P8-FWHY-UDB3]; DAY H, 1967, PERCEPT PSYCHOPHYS, V2, P281, DOI 10.3758/BF03211042; Donderi DC, 2006, PSYCHOL BULL, V132, P73, DOI 10.1037/0033-2909.132.1.73; Donderi DC, 2005, DISPLAYS, V26, P71, DOI 10.1016/j.displa.2005.02.002; Donderi DC, 2006, PERCEPTION, V35, P823, DOI 10.1068/p5249; Eerola T, 2011, J NEW MUSIC RES, V40, P349, DOI 10.1080/09298215.2011.602195; Eerola Tuomas, 2006, PSYCHOL MUSIC, V34, P337, DOI DOI 10.1177/0305735606064842; Eisenberg J, 2003, CREATIVITY RES J, V15, P287, DOI 10.1207/S15326934CRJ152&3_19; EISENMAN R, 1964, J PSYCHOL, V58, P375, DOI 10.1080/00223980.1964.9916759; Eysenck HJ, 1941, PSYCHOL REV, V48, P83, DOI 10.1037/h0062483; EYSENCK HJ, 1970, BRIT J PSYCHOL, V61, P65, DOI 10.1111/j.2044-8295.1970.tb02802.x; FARLEY FH, 1980, B PSYCHONOMIC SOC, V15, P194; Feist G. J., 2004, EMPIR STUD ARTS, V22, P77, DOI [10.2190/Y7CA-TBY6-V7LR-76GK, DOI 10.2190/Y7CA-TBY6-V7LR-76GK]; Fernandez D, 2008, PERCEPTION, V37, P1098, DOI 10.1068/p5814; Forsythe A, 2011, BRIT J PSYCHOL, V102, P49, DOI 10.1348/000712610X498958; Forsythe A, 2003, BEHAV RES METH INS C, V35, P334, DOI 10.3758/BF03202562; Forsythe A, 2008, BEHAV RES METHODS, V40, P116, DOI 10.3758/BRM.40.1.116; Forsythe A, 2009, LECT NOTES ARTIF INT, V5639, P158, DOI 10.1007/978-3-642-02728-4_17; Furnham A, 2001, PERS INDIV DIFFER, V31, P997, DOI 10.1016/S0191-8869(00)00202-6; Gabrielsson A, 2001, MUSIC SCI, V5, P123, DOI 10.1177/10298649020050S105; Gard MG, 2007, EMOTION, V7, P429, DOI 10.1037/1528-3542.7.2.429; Gartus A, 2011, PERCEPTION S206, V40; Gibson E, 1998, COGNITION, V68, P1, DOI 10.1016/S0010-0277(98)00034-1; Gonzalez RC, 2003, IGITAL IMAGE PROCESS; Graham DJ, 2008, SPATIAL VISION, V21, P149, DOI 10.1163/156856808782713771; Hager M, 2012, PSYCHOL AESTHET CREA, V6, P320, DOI 10.1037/a0028776; Hagtvedt H., 2008, EMPIR STUD ARTS, V26, P197, DOI DOI 10.2190/EM.26.2.D; Hayes AF, 2010, MULTIVAR BEHAV RES, V45, P627, DOI 10.1080/00273171.2010.498290; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; HEYDUK RG, 1975, PERCEPT PSYCHOPHYS, V17, P84, DOI 10.3758/BF03204003; HOLM S, 1979, SCAND J STAT, V6, P65; Imamoglu C, 2000, J ENVIRON PSYCHOL, V20, P5, DOI 10.1006/jevp.1999.0155; Jacobsen T, 2002, PERCEPT MOTOR SKILL, V95, P755, DOI 10.2466/PMS.95.7.755-766; JELLINEK JS, 1979, J SOC COSMET CHEM, V30, P253; JELLINEK JS, 1983, J SOC COSMET CHEM, V34, P83; Kaplan S., 1982, COGNITION ENV FUNCTI; Keller Peter E, 2011, Adv Cogn Psychol, V7, P142, DOI 10.2478/v10053-008-0094-0; Kettunen J, 1998, BIOL PSYCHOL, V48, P209, DOI 10.1016/S0301-0511(98)00017-9; Konecni V. J., 2010, HDB MUSIC EMOTION TH, P697; Konecni VJ, 1976, AM J PSYCHOL, V91, P133; Koole S, 2009, COGNITION EMOTION, V23, P4, DOI 10.1080/02699930802619031; Kovesi P., 2003, AUSTR PATT REC SOC C; Kovesi P., 1999, VIDERE J COMPUT VIS, V1, P1; Kreibig SD, 2012, MOTIVATION AFFECTS C, P93; KREITLER S, 1974, HUM DEV, V17, P54, DOI 10.1159/000271333; Kreutz G, 2008, MUSIC PERCEPT, V26, P57, DOI 10.1525/MP.2008.26.1.57; KRUPINSKI E, 1988, B PSYCHONOMIC SOC, V26, P355, DOI 10.3758/BF03337681; Lacey J.I., 1963, EXPRESSION EMOTIONS, P161; Lang PJ, 2005, INT AFFECTIVE PICTUR, pA; Lartillot O, 2008, ST CLASS DAT ANAL, P261, DOI 10.1007/978-3-540-78246-9_31; Leder H, 2004, BRIT J PSYCHOL, V95, P489, DOI 10.1348/0007126042369811; Leder H, 2012, PSYCHOL AESTHET CREA, V6, P2, DOI 10.1037/a0026396; LI M, 1997, INTRO KOLMOGOROV COM; Lin Y-C., 2011, VISUAL ARTS RES, V37, P30, DOI [10.5406/visuartsrese.37.1.0030, DOI 10.5406/VISUARTSRESE.37.1.0030]; Lithari C, 2010, BRAIN TOPOGR, V23, P27, DOI 10.1007/s10548-009-0130-5; Logeswaran N, 2009, NEUROSCI LETT, V455, P129, DOI 10.1016/j.neulet.2009.03.044; Londei A, 2003, P 5 TRIENN ESCOM C, P200; Marin MM, 2012, EMOTION, V12, P618, DOI 10.1037/a0025020; Martindale, 1988, FDN AESTHETICS ART A; MARTINDALE C, 1990, AM J PSYCHOL, V103, P53, DOI 10.2307/1423259; MARTINDALE C, 1989, MUSIC PERCEPT, V6, P431; MARTINDALE C, 1984, J MIND BEHAV, V5, P49; Mauch M, 2011, P 12 INT C MUS INF R; Mauss IB, 2005, EMOTION, V5, P175, DOI 10.1037/1528-3542.5.2.175; McDermott JH, 2012, NEUROSCIENCE OF PREFERENCE AND CHOICE: COGNITIVE AND NEURAL MECHANISMS, P227, DOI 10.1016/B978-0-12-381431-9.00020-6; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Messinger SM, 1998, J PSYCHOL, V132, P558, DOI 10.1080/00223989809599288; Meyers-Levy J, 2010, J CONSUM PSYCHOL, V20, P495, DOI 10.1016/j.jcps.2010.06.006; Mielby LH, 2012, FOOD QUAL PREFER, V26, P188, DOI 10.1016/j.foodqual.2012.04.014; MUNSINGER H, 1964, PSYCHOL MONOGR, V78, P1; Myers L, 2006, SPEARMAN CORRELATION, DOI 101002/0471667196ess5050pub2; Nadal M., 2010, EMPIR STUD ARTS, V28, P173, DOI 10.2190/EM.28.2.d; Nater UM, 2006, INT J PSYCHOPHYSIOL, V62, P300, DOI 10.1016/j.ijpsycho.2006.05.011; NEPERUD RW, 1988, LEONARDO, V21, P305, DOI 10.2307/1578660; NICKI RM, 1975, CAN J PSYCHOL, V29, P237, DOI 10.1037/h0082029; North A. C., 1995, PSYCHOMUSICOLOGY, V14, P77, DOI DOI 10.1037/H0094090; Orr MG, 2005, MUSIC PERCEPT, V22, P583, DOI 10.1525/mp.2005.22.4.583; OSBORNE JW, 1970, PSYCHON SCI, V19, P69, DOI 10.3758/BF03337424; Osgood C.E., 1957, MEASUREMENT MEANING; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pandey S., 2010, J SOC SOC WORK RES, V1, P28, DOI [10.5243/jsswr.2010.2, DOI 10.5243/JSSWR.2010.2]; Parncutt R., 2006, CULTURE COMMUNICATIO, P725; Pearce MT, 2006, MUSIC PERCEPT, V23, P377, DOI 10.1525/mp.2006.23.5.377; Pearce MT, 2010, NEUROIMAGE, V50, P302, DOI 10.1016/j.neuroimage.2009.12.019; PELI E, 1990, J OPT SOC AM A, V7, P2032, DOI 10.1364/JOSAA.7.002032; Rentfrow PJ, 2011, J PERS SOC PSYCHOL, V100, P1139, DOI 10.1037/a0022406; Rentfrow PJ, 2003, J PERS SOC PSYCHOL, V84, P1236, DOI 10.1037/0022-3514.84.6.1236; Rosenthal Robert., 1991, META ANALYTIC PROCED; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell P., 1982, CURR PSYCHOL RES REV, V2, P195, DOI [DOI 10.1007/BF03186760, 10.1007/BF03186760]; SAKLOFSKE DH, 1975, PERCEPT MOTOR SKILL, V41, P813, DOI 10.2466/pms.1975.41.3.813; Schafer T, 2011, MUSIC PERCEPT, V29, P37, DOI 10.1525/MP.2011.29.1.37; Schafer T, 2010, PSYCHOL AESTHET CREA, V4, P223, DOI 10.1037/a0018374; Scherer K.R., 1984, APPROACHES EMOTION, P293; SCHOOLER C, 1984, INTELLIGENCE, V8, P259, DOI 10.1016/0160-2896(84)90011-4; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Sharp C, 2006, J CHILD PSYCHOL PSYC, V47, P143, DOI 10.1111/j.1469-7610.2005.01464.x; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Silverman I, 1992, ADAPTED MIND EVOLUTI, P487; Silvia P.J., 2005, EMPIR STUD ARTS, V23, P119, DOI [10.2190/12AV-AH2P-MCEH-289E, DOI 10.2190/12AV-AH2P-MCEH-289E, https://doi.org/10.2190/12AV-AH2P-MCEH-289E]; Silvia PJ, 2005, REV GEN PSYCHOL, V9, P342, DOI 10.1037/1089-2680.9.4.342; Smith J., 2001, EMPIRICAL STUDIES AR, V19, P229, DOI [10.2190/5MQM-59JH-X21R-JN5J, DOI 10.2190/5MQM-59JH-X21R-JN5J]; SMITH JD, 1990, COGNITION, V34, P279, DOI 10.1016/0010-0277(90)90007-7; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Solomonoff R. J., 1986, UNCERTAINTY ARTIFICI, P473; STECK L, 1975, J EXP PSYCHOL HUMAN, V104, P170; Storbeck J, 2008, SOC PERSONAL PSYCHOL, V2, P1824, DOI 10.1111/j.1751-9004.2008.00138.x; Streich S, 2007, THESIS U POMPEU FABR; Tan Ed, 2000, HDB EMOTIONS, P116; TAYLOR RE, 1964, J PSYCHOL, V57, P239, DOI 10.1080/00223980.1964.9916693; Thayer RE, 1989, BIOPSYCHOLOGY MOOD A; Trochidis K, 2011, P 8 SOUND MUS COMP C; Vartanian O., 2007, AESTHETICS INNOVATIO, P429; Vettehen PH, 2008, COMMUN RES, V35, P319, DOI 10.1177/0093650208315960; VITZ PC, 1964, J EXP PSYCHOL, V68, P176, DOI 10.1037/h0043402; VITZ PC, 1966, J EXP PSYCHOL, V71, P74, DOI 10.1037/h0022619; WOHLWILL JF, 1968, PERCEPT PSYCHOPHYS, V4, P307, DOI 10.3758/BF03210521; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494; Zentner Marcel, 2010, HDB MUSIC EMOTION TH, P187; Zhang DS, 2004, PATTERN RECOGN, V37, P1, DOI 10.1016/j.patcog.2003.07.008	162	71	72	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72412	10.1371/journal.pone.0072412	http://dx.doi.org/10.1371/journal.pone.0072412			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	207BA	23977295	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200069
J	Peron, C; Gremillet, D				Peron, Clara; Gremillet, David			Tracking through Life Stages: Adult, Immature and Juvenile Autumn Migration in a Long-Lived Seabird	PLOS ONE			English	Article							CORYS SHEARWATER; CALONECTRIS-DIOMEDEA; CLIMATE; AREAS; SEA; AGE; CONSERVATION; RECRUITMENT; MOVEMENTS; FISHERIES	Seasonal long-distance migration is likely to be experienced in a contrasted manner by juvenile, immature and adult birds, leading to variations in migratory routes, timing and behaviour. We provide the first analysis of late summer movements and autumn migration in these three life stages, which were tracked concurrently using satellite tags, geolocators or GPS recorders in a long-ranging migratory seabird, the Scopoli's shearwater (formerly named Cory's shearwater, Calonectris diomedea) breeding on two French Mediterranean islands. During the late breeding season, immatures foraged around their colony like breeding adults, but they were the only group showing potential prospecting movements around non-natal colonies. Global migration routes were broadly comparable between the two populations and the three life stages, with all individuals heading towards the Atlantic Ocean through the strait of Gibraltar and travelling along the West African coast, up to 8000 km from their colony. However, detailed comparison of timing, trajectory and oceanographic conditions experienced by the birds revealed remarkable age-related differences. Compared to adults and immatures, juveniles made a longer stop-over in the Balearic Sea (10 days vs 4 days in average), showed lower synchrony in crossing the Gibraltar strait, had more sinuous pathways and covered longer daily distances (240 km.d(-1) vs 170 km.d(-1)). Analysis of oceanographic habitats along migratory routes revealed funnelling selection of habitat towards coastal and more productive waters with increasing age. Younger birds may have reduced navigational ability and learn progressively fine-scale migration routes towards the more profitable travelling and wintering areas. Our study demonstrates the importance of tracking long-lived species through the stages, to better understand migratory behavior and assess differential exposure to at-sea threats. Shared distribution between life stages and populations make Scopoli's shearwaters particularly vulnerable to extreme mortality events in autumn and winter. Such knowledge is key for the conservation of critical marine habitats.	[Peron, Clara; Gremillet, David] CNRS, UMR 5175, CEFE, Montpellier, France; [Gremillet, David] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; National Research Foundation - South Africa; University of Cape Town	Peron, C (corresponding author), CNRS, UMR 5175, CEFE, Montpellier, France.	clara.peron@cefe.cnrs.fr	Gremillet, David/W-1946-2018	Gremillet, David/0000-0002-7711-9398	French Marine Protected Areas Agency	French Marine Protected Areas Agency	This study was funded by the French Marine Protected Areas Agency: "Programme PACOMM, Natura2000 en mer" administered by Aurore Sterckeman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyev Vsevolod, 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P227; Agostini VN, 2002, FISH OCEANOGR, V11, P129, DOI 10.1046/j.1365-2419.2002.00201.x; Akesson S, 2005, J NAVIGATION, V58, P365, DOI 10.1017/S0373463305003401; Alderman R, 2010, MAR ECOL PROG SER, V405, P271, DOI 10.3354/meps08590; Alerstam T, 1990, BIRD MIGRATION; Anselme L., 2012, CORYS SHEARWATER CAL; Aristegui J, 2009, PROG OCEANOGR, V83, P33, DOI 10.1016/j.pocean.2009.07.031; Belda EJ, 2001, BIOL CONSERV, V98, P357, DOI 10.1016/S0006-3207(00)00178-6; Bestley S, 2008, J ANIM ECOL, V77, P1223, DOI 10.1111/j.1365-2656.2008.01437.x; Binet D, 1997, OCEANOL ACTA, V20, P177; BirdLife International, 2012, IUCN IUCN RED LIST T; Boulinier T, 1996, J AVIAN BIOL, V27, P252, DOI 10.2307/3677230; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Dias MP, 2011, P ROY SOC B-BIOL SCI, V278, P1786, DOI 10.1098/rspb.2010.2114; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Fieberg J, 2001, ECOL LETT, V4, P244, DOI 10.1046/j.1461-0248.2001.00202.x; Field IC, 2005, OECOLOGIA, V142, P127, DOI 10.1007/s00442-004-1704-2; Fort J, 2012, FRONT ECOL ENVIRON, V10, P237, DOI 10.1890/110194; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Gomez-Diaz E, 2009, MAR ECOL PROG SER, V382, P197, DOI 10.3354/meps07974; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Granadeiro JP, 1998, ANIM BEHAV, V56, P1169, DOI 10.1006/anbe.1998.0827; Gschweng M, 2008, P ROY SOC B-BIOL SCI, V275, P2887, DOI 10.1098/rspb.2008.0575; Hake M, 2003, OIKOS, V103, P385, DOI 10.1034/j.1600-0706.2003.12145.x; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Jenouvrier S, 2009, GLOBAL CHANGE BIOL, V15, P268, DOI 10.1111/j.1365-2486.2008.01715.x; Jenouvrier S, 2008, OIKOS, V117, P620, DOI 10.1111/j.0030-1299.2008.16394.x; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jorge PE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022433; Kochert MN, 2011, CONDOR, V113, P89, DOI 10.1525/cond.2011.090243; LEOPOLD MF, 1993, HYDROBIOLOGIA, V258, P197, DOI 10.1007/BF00006197; Louzao M, 2009, MAR ECOL PROG SER, V391, P183, DOI 10.3354/meps08124; Louzao M, 2006, ECOL APPL, V16, P1683, DOI 10.1890/1051-0761(2006)016[1683:OHOAEM]2.0.CO;2; Mansfield KL, 2009, MAR BIOL, V156, P2555, DOI 10.1007/s00227-009-1279-x; Igual JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004826; Marques PAM, 2009, ACTA ETHOL, V12, P87, DOI 10.1007/s10211-009-0060-y; MARTIN K, 1995, AM ZOOL, V35, P340; Martinez-Abrain A, 2002, ICES J MAR SCI, V59, P529, DOI 10.1006/jmsc.2001.1175; McConnell B, 2002, J ANIM ECOL, V71, P65, DOI 10.1046/j.0021-8790.2001.00576.x; Mueller HC, 2000, WILSON BULL, V112, P214, DOI 10.1676/0043-5643(2000)112[0214:AASDIT]2.0.CO;2; NEVITT GA, 1995, NATURE, V376, P680, DOI 10.1038/376680ao; Newton I, 2007, IBIS, V149, P453, DOI 10.1111/j.1474-919X.2007.00704.x; Newton I., 2010, BIRD MIGRATION; Nichols J., 2001, DISPERSAL; Oro D, 1997, ICES J MAR SCI, V54, P695, DOI 10.1006/jmsc.1997.0246; Peron C, 2012, P ROY SOC B-BIOL SCI, V279, P2515, DOI 10.1098/rspb.2011.2705; Phillips RA, 2006, BIOL CONSERV, V129, P336, DOI 10.1016/j.biocon.2005.10.046; Phillips RA, 2005, ECOLOGY, V86, P2386, DOI 10.1890/04-1885; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; POLIS GA, 1984, AM NAT, V123, P541, DOI 10.1086/284221; PORTER JM, 1987, J ANIM ECOL, V56, P675, DOI 10.2307/5076; R Development Core Team, 2011, R LANG ENV STAT COMP; Rabouam C, 1998, AUK, V115, P483; Ramos R, 2013, NATURE, V496, P300, DOI 10.1038/496300a; Rao JS, 1967, SANKHYA B, V28; Reich KJ, 2007, BIOL LETTERS, V3, P712, DOI 10.1098/rsbl.2007.0394; Ristow D, 2000, CONDOR, V102, P696, DOI 10.1650/0010-5422(2000)102[0696:STOCSS]2.0.CO;2; Rodriguez A, 2009, DIVERS DISTRIB, V15, P1010, DOI 10.1111/j.1472-4642.2009.00600.x; Ruffino L, 2009, BIOL INVASIONS, V11, P1631, DOI 10.1007/s10530-008-9394-z; SABATES A, 1990, MAR ECOL PROG SER, V59, P75, DOI 10.3354/meps059075; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Sangster G, 2012, IBIS, V154, P874, DOI 10.1111/j.1474-919X.2012.01273.x; Sara M, 1993, P 2 MED SEAB S MEDMA, P213; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shillinger GL, 2012, MAR ECOL PROG SER, V457, P165, DOI 10.3354/meps09816; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Thorup K, 2003, P ROY SOC B-BIOL SCI, V270, pS8, DOI 10.1098/rsbl.2003.0014; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Trebilco R, 2008, BIOL CONSERV, V141, P2942, DOI 10.1016/j.biocon.2008.07.027; Ueta M, 2002, AUK, V119, P832; Votier SC, 2008, J ANIM ECOL, V77, P974, DOI 10.1111/j.1365-2656.2008.01421.x; Votier SC, 2011, MAR BIOL, V158, P355, DOI 10.1007/s00227-010-1563-9; WARHAM J, 1990, PETRELS THEIR ECOLOG; Weimerskirch H, 2006, J AVIAN BIOL, V37, P23, DOI 10.1111/j.2006.0908-8857.03675.x; Wilson R.P., 1992, P131; WITHAM R, 1980, AM ZOOL, V20, P525	79	94	95	0	179	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72713	10.1371/journal.pone.0072713	http://dx.doi.org/10.1371/journal.pone.0072713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977344	gold, Green Published, Green Submitted			2022-12-25	WOS:000323570200082
J	Ruisu, K; Kask, K; Meier, R; Saare, M; Raid, R; Veraksits, A; Karis, A; Tonissoo, T; Pooga, M				Ruisu, Katrin; Kask, Keiu; Meier, Riho; Saare, Merly; Raid, Raivo; Veraksits, Alar; Karis, Alar; Tonissoo, Tambet; Pooga, Margus			Ablation of RIC8A Function in Mouse Neurons Leads to a Severe Neuromuscular Phenotype and Postnatal Death	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; HETEROTRIMERIC G-PROTEINS; G-ALPHA-I; RIC-8 SYNEMBRYN; ASYMMETRIC DIVISION; DROSOPHILA RIC-8; MITOTIC SPINDLE; PLASMA-MEMBRANE; NERVOUS-SYSTEM; KNOCKOUT MICE	Resistance to inhibitors of cholinesterase 8 (RIC8) is a guanine nucleotide exchange factor required for the intracellular regulation of G protein signalling. RIC8 activates different G alpha subunits via non-canonical pathway, thereby amplifying and prolonging the G protein mediated signal. In order to circumvent the embryonic lethality associated with the absence of RIC8A and to study its role in the nervous system, we constructed Ric8a conditional knockout mice using Cre/loxP technology. Introduction of a synapsin I promoter driven Cre transgenic mouse strain (SynCre) into the floxed Ric8a (Ric8a(F/F)) background ablated RIC8A function in most differentiated neuron populations. Mutant SynCre(+/-)Ric8lac(Z/F) mice were born at expected Mendelian ratio, but they died in early postnatal age (P4-P6). The mutants exhibited major developmental defects, like growth retardation and muscular weakness, impaired coordination and balance, muscular spasms and abnormal heart beat. Histological analysis revealed that the deficiency of RIC8A in neurons caused skeletal muscle atrophy and heart muscle hypoplasia, in addition, the sinoatrial node was misplaced and its size reduced. However, we did not observe gross morphological changes in brains of SynCre(+)/-Ric8alac(Z/F) mutants. Our results demonstrate that in mice the activity of RIC8A in neurons is essential for survival and its deficiency causes a severe neuromuscular phenotype.	[Ruisu, Katrin; Kask, Keiu; Meier, Riho; Saare, Merly; Raid, Raivo; Karis, Alar; Tonissoo, Tambet; Pooga, Margus] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Veraksits, Alar] Univ Tartu, Dept Physiol, Inst Biomed & Translat Med, EE-50090 Tartu, Estonia	University of Tartu; University of Tartu	Ruisu, K (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	katrin86@ut.ee; tambet.tonissoo@ut.ee	Tõnissoo, Tambet/G-6064-2016; Tõnissoo, Tambet/G-2323-2017; Kask, Keiu/G-6330-2016; Pooga, Margus/A-8575-2011	Kask, Keiu/0000-0002-0629-2601; Pooga, Margus/0000-0003-4532-4087	Estonian Science foundation [ETF8427]; Estonian Ministry of Education and Research [SF0180019s11]	Estonian Science foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	The work was supported by grants ETF8427 from the Estonian Science foundation and SF0180019s11 from the Estonian Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amoureux MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032216; Bowerman M, 2012, NEUROMUSCULAR DISORD, V22, P263, DOI 10.1016/j.nmd.2011.09.007; Cells J., 1998, CELL BIOL LAB HDB; Chan P, 2011, J BIOL CHEM, V286, P19932, DOI 10.1074/jbc.M110.163675; Couwenbergs C, 2004, CURR BIOL, V14, P1871, DOI 10.1016/j.cub.2004.09.059; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Durham D, 2002, BRADYCARDIAS CRIT CA, V4, P54; Fenech C, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.011.2009; Ferguson SM, 2004, P NATL ACAD SCI USA, V101, P8762, DOI 10.1073/pnas.0401667101; Gabay M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002223; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Hasue F, 2005, NEUROSCIENCE, V130, P349, DOI 10.1016/j.neuroscience.2004.09.036; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3269, DOI 10.1073/pnas.95.6.3269; Klattenhoff C, 2003, J CELL PHYSIOL, V195, P151, DOI 10.1002/jcp.10300; Land C, 2008, BEST PRACT RES CL EN, V22, P107, DOI 10.1016/j.beem.2007.09.005; Ma S, 2012, J NEUROSCI, V32, P14979, DOI 10.1523/JNEUROSCI.1282-12.2012; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Miller KG, 2000, GENETICS, V156, P1649; Mitchell ML, 2001, MODERN PATHOL, V14, P14, DOI 10.1038/modpathol.3880251; Mocholi E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019236; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Nishimura A, 2006, GENES CELLS, V11, P487, DOI 10.1111/j.1365-2443.2006.00959.x; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Street KA, 2005, DNA CELL BIOL, V24, P133, DOI 10.1089/dna.2005.24.133; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2004, METHOD ENZYMOL, V390, P377; Thomas CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023197; Tonissoo T, 2006, BEHAV BRAIN RES, V167, P42, DOI 10.1016/j.bbr.2005.08.025; Tonissoo T, 2003, GENE EXPR PATTERNS, V3, P591, DOI 10.1016/S1567-133X(03)00119-4; Tonissoo T, 2010, DEV DYNAM, V239, P3404, DOI 10.1002/dvdy.22480; TRIFFITT JT, 1987, ACTA ORTHOP SCAND, V58, P673, DOI 10.3109/17453678709146514; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Wang LM, 2011, J BIOL CHEM, V286, P31055, DOI 10.1074/jbc.M111.253427; Wang SC, 2007, BIOCHEM J, V406, P383, DOI 10.1042/BJ20070512; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	45	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e74031	10.1371/journal.pone.0074031	http://dx.doi.org/10.1371/journal.pone.0074031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977396	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200096
J	Ock, S; Ahn, J; Lee, SH; Kang, H; Offermanns, S; Ahn, HY; Jo, YS; Shong, M; Cho, BY; Jo, D; Abel, ED; Lee, TJ; Park, WJ; Lee, IK; Kim, J				Ock, Sangmi; Ahn, Jihyun; Lee, Seok Hong; Kang, Hyun; Offermanns, Stefan; Ahn, Hwa Young; Jo, Young Suk; Shong, Minho; Cho, Bo Youn; Jo, Daewoong; Abel, E. Dale; Lee, Tae Jin; Park, Woo Jin; Lee, In-Kyu; Kim, Jaetaek			IGF-1 receptor deficiency in thyrocytes impairs thyroid hormone secretion and completely inhibits TSH-stimulated goiter	FASEB JOURNAL			English	Article						MCT8; T-4; hypertrophy; proliferation	GROWTH-FACTOR-I; THYROTROPIN; CELLS; ASSOCIATION; EXPRESSION; ABSENCE	Although thyroid-stimulating hormone (TSH) is known to be a major regulator of thyroid hormone biosynthesis and thyroid growth, insulin-like growth factor 1 (IGF-1) is required for mediating thyrocyte growth in concert with TSH in vitro. We generated mice with thyrocyte-selective ablation of IGF-1 receptor (TIGF1RKO) to explore the role of IGF-1 receptor signaling on thyroid function and growth. In 5-wk-old TIGF1RKO mice, serum thyroxine (T-4) concentrations were decreased by 30% in concert with a 43% down-regulation of the monocarboxylate transporter 8 (MCT8), which is involved in T-4 secretion. Despite a 3.5-fold increase in circulating concentrations of TSH, thyroid architecture and size were normal. Furthermore, thyrocyte area was increased by 40% in WT thyroids after 10 d TSH injection, but this effect was absent in TSH-injected TIGF1RKO mice. WT mice treated with methimazole and sodium perchlorate for 2 or 6 wk exhibited pronounced goiter development (2.0 and 5.4-fold, respectively), but in TIGF1RKO mice, goiter development was completely abrogated. These data reveal an essential role for IGF-1 receptor signaling in the regulation of thyroid function and TSH-stimulated goitrogenesis.	[Ock, Sangmi; Ahn, Jihyun; Lee, Seok Hong; Ahn, Hwa Young; Cho, Bo Youn; Kim, Jaetaek] Chung Ang Univ, Dept Internal Med, Div Endocrinol & Metab, Seoul 156755, South Korea; [Kang, Hyun] Chung Ang Univ, Dept Anesthesiol, Seoul 156755, South Korea; [Lee, Tae Jin] Chung Ang Univ, Dept Pathol, Coll Med, Seoul 156755, South Korea; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany; [Jo, Young Suk; Shong, Minho] Chungnam Natl Univ Hosp, Res Ctr Endocrine & Metab Dis, Dept Internal Med, Taejon, South Korea; [Jo, Daewoong] Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37212 USA; [Abel, E. Dale] Univ Utah, Sch Med, Program Mol Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT USA; [Park, Woo Jin] Gwangju Inst Sci & Technol, Global Res Lab, Kwangju, South Korea; [Park, Woo Jin] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Div Endocrinol & Metab, Taegu, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu, South Korea	Chung Ang University; Chung Ang University; Chung Ang University; Chung Ang University Hospital; Max Planck Society; Chungnam National University; Chungnam National University Hospital; Vanderbilt University; Utah System of Higher Education; University of Utah; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Kyungpook National University; Kyungpook National University; Kyungpook National University	Kim, J (corresponding author), Chung Ang Univ, Dept Internal Med, Div Endocrinol & Metab, 224-1 Heuk Seok Dong, Seoul 156755, South Korea.	jtkim@cau.ac.kr	Lee, In-Kyu/AAR-6374-2021; Ahn, Jihyun/AAH-9110-2020; Kang, Hyun/AAE-7872-2020; Kim, Jaetaek/AAE-7147-2020; /H-7803-2012; Offermanns, Stefan/L-3313-2017	Kang, Hyun/0000-0003-2844-5880; Kim, Jaetaek/0000-0001-5247-0408; Offermanns, Stefan/0000-0001-8676-6805; shong, minho/0000-0002-0247-7115; Abel, E. Dale/0000-0001-5290-0738	Korea Healthcare Technology RD Project [A084811, A101749]; Korea Ministry of Health and Welfare; Basic Science Research Program through the National Research Foundation, Ministry of Education, Republic of Korea [2012R1A1A2043642]	Korea Healthcare Technology RD Project; Korea Ministry of Health and Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); Basic Science Research Program through the National Research Foundation, Ministry of Education, Republic of Korea	The authors thank Dr. Samuel Refetoff (University of Chicago) for T<INF>4</INF> and TSH measurements. This study was supported by grants of the Korea Healthcare Technology R&D Project (A084811 to J.K.; A101749 to W.J.P and J.K.), Korea Ministry of Health and Welfare, and by grants of the Basic Science Research Program through the National Research Foundation (2012R1A1A2043642 to J.A.), Ministry of Education, Republic of Korea. The authors declare no conflicts of interest.	Belfiore A, 1999, BIOCHIMIE, V81, P403, DOI 10.1016/S0300-9084(99)80088-1; Bidey SP, 1999, J ENDOCRINOL, V160, P321, DOI 10.1677/joe.0.1600321; Brewer C, 2007, CANCER RES, V67, P8002, DOI 10.1158/0008-5472.CAN-07-2471; Cadoret A, 2005, INT J CANCER, V114, P668, DOI 10.1002/ijc.20805; Cheung NW, 1996, J CLIN ENDOCR METAB, V81, P1179, DOI 10.1210/jc.81.3.1179; Cheung NW, 1997, CLIN ENDOCRINOL, V46, P545, DOI 10.1046/j.1365-2265.1997.1680985.x; Clement S, 2001, ENDOCRINOLOGY, V142, P5131, DOI 10.1210/en.142.12.5131; Derwahl M, 1999, J CLIN ENDOCR METAB, V84, P829, DOI 10.1210/jc.84.3.829; Di Cosmo C, 2010, J CLIN INVEST, V120, P3377, DOI 10.1172/JCI42113; DORMITZER PR, 1989, AM J PHYS ANTHROPOL, V78, P527, DOI 10.1002/ajpa.1330780408; Dumitrescu AM, 2006, ENDOCRINOLOGY, V147, P4036, DOI 10.1210/en.2006-0390; Eggo MC, 1990, GROWTH FACTORS, V2, P99, DOI 10.3109/08977199009071497; FIELD JB, 1973, J CLIN INVEST, V52, P2404, DOI 10.1172/JCI107430; Frittitta L, 1999, CANCER-AM CANCER SOC, V85, P492, DOI 10.1002/(SICI)1097-0142(19990115)85:2<492::AID-CNCR30>3.0.CO;2-I; Graf H., 2012, WERNER INGBARS THYRO, P635; Kasagi K, 1999, THYROID, V9, P791, DOI 10.1089/thy.1999.9.791; Kero J, 2007, J CLIN INVEST, V117, P2399, DOI 10.1172/JCI30380; Kim J, 2008, MOL ENDOCRINOL, V22, P2531, DOI 10.1210/me.2008-0265; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Kogai T, 1997, ENDOCRINOLOGY, V138, P2227, DOI 10.1210/en.138.6.2227; LEMOINE NR, 1989, BRIT J CANCER, V60, P897, DOI 10.1038/bjc.1989.387; Liao XH, 2011, ENDOCRINOLOGY, V152, P1180, DOI 10.1210/en.2010-0900; Maia AL, 2011, J ENDOCRINOL, V209, P283, DOI 10.1530/JOE-10-0481; Marians RC, 2002, P NATL ACAD SCI USA, V99, P15776, DOI 10.1073/pnas.242322099; Medeiros-Neto G, 2012, MED CLIN N AM, V96, P351, DOI 10.1016/j.mcna.2012.01.010; Misaki T., 1998, J CLIN ENDOCR METAB, V66, P1227; Missero C, 1998, MOL CELL ENDOCRINOL, V140, P37, DOI 10.1016/S0303-7207(98)00027-6; MIYAKAWA M, 1988, J CLIN ENDOCR METAB, V67, P973, DOI 10.1210/jcem-67-5-973; Muller K, 2011, MOL ENDOCRINOL, V25, P1867, DOI 10.1210/me.2011-0065; Nishimura M, 2008, DRUG METAB PHARMACOK, V23, P22, DOI 10.2133/dmpk.23.22; Ock S, 2011, ENDOCR J, V58, P1013, DOI 10.1507/endocrj.EJ11-0007; Ramsden JD, 2005, ENDOCRINOLOGY, V146, P2895, DOI 10.1210/en.2005-0168; Santisteban P., 2012, WERNER INGBARS THYRO, P4; Smith VE, 2012, ENDOCRINOLOGY, V153, P3526, DOI 10.1210/en.2011-2030; TAKAHASHI S, 1990, ENDOCRINOLOGY, V126, P736, DOI 10.1210/endo-126-2-736; TODE B, 1989, J CLIN ENDOCR METAB, V69, P639, DOI 10.1210/jcem-69-3-639; Trajkovic M, 2007, J CLIN INVEST, V117, P627, DOI 10.1172/JCI28253; Tsui S, 2008, J IMMUNOL, V181, P4397, DOI 10.4049/jimmunol.181.6.4397; Volzke H, 2007, J CLIN ENDOCR METAB, V92, P4039, DOI 10.1210/jc.2007-0816; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1099, DOI 10.1210/endo-114-4-1099; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Yeager N, 2007, CANCER RES, V67, P959, DOI 10.1158/0008-5472.CAN-06-3524	42	28	31	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4899	4908		10.1096/fj.13-231381	http://dx.doi.org/10.1096/fj.13-231381			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23982142				2022-12-25	WOS:000329999000024
J	Taft, MH; Behrmann, E; Munske-Weidemann, LC; Thiel, C; Raunser, S; Manstein, DJ				Taft, Manuel H.; Behrmann, Elmar; Munske-Weidemann, Lena-Christin; Thiel, Claudia; Raunser, Stefan; Manstein, Dietmar J.			Functional Characterization of Human Myosin-18A and Its Interaction with F-actin and GOLPH3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cytoskeleton; Myosin; Protein Domains; Protein-Protein Interactions	PDZ-CONTAINING MYOSIN; KINETIC MECHANISM; MYSPDZ MYO18A; BINDING SITE; SALT-BRIDGE; MOTOR; DOMAIN; MUSCLE; IDENTIFICATION; COMPLEX	Background: Class-18A myosins share a unique N-terminal extension comprising a PDZ module and a KE-rich region. Results: Human myosin-18A binds F-actin via its motor domain in a nucleotide-dependent manner and via the KE-rich region, modulated by direct interaction between the PDZ module and GOLPH3. Conclusion: Myosin-18A binds F-actin and recruits interaction partners to the cytoskeleton. Significance: This work establishes a molecular basis for myosin-18A mediated membrane-cytoskeleton interplay. Molecular motors of the myosin superfamily share a generic motor domain region. They commonly bind actin in an ATP-sensitive manner, exhibit actin-activated ATPase activity, and generate force and movement in this interaction. Class-18 myosins form heavy chain dimers and contain protein interaction domains located at their unique N-terminal extension. Here, we characterized human myosin-18A molecular function in the interaction with nucleotides, F-actin, and its putative binding partner, the Golgi-associated phosphoprotein GOLPH3. We show that myosin-18A comprises two actin binding sites. One is located in the KE-rich region at the start of the N-terminal extension and appears to mediate ATP-independent binding to F-actin. The second actin-binding site resides in the generic motor domain and is regulated by nucleotide binding in the absence of intrinsic ATP hydrolysis competence. This core motor domain displays its highest actin affinity in the ADP state. Electron micrographs of myosin-18A motor domain-decorated F-actin filaments show a periodic binding pattern independent of the nucleotide state. We show that the PDZ module mediates direct binding of myosin-18A to GOLPH3, and this interaction in turn modulates the actin binding properties of the N-terminal extension. Thus, myosin-18A can act as an actin cross-linker with multiple regulatory modulators that targets interacting proteins or complexes to the actin-based cytoskeleton.	[Taft, Manuel H.; Munske-Weidemann, Lena-Christin; Thiel, Claudia; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Behrmann, Elmar; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany	Hannover Medical School; Max Planck Society	Taft, MH (corresponding author), Hannover Med Sch, Inst Biophys Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Taft.Manuel@MH-Hannover.de	Manstein, Dietmar J./AAG-2640-2019; Behrmann, Elmar/I-5808-2015; Raunser, Stefan/AHE-1573-2022; Taft, Manuel/O-1396-2019; Taft, Manuel H/T-2508-2017; Manstein, Dietmar J. J/M-1034-2013	Manstein, Dietmar J./0000-0003-0763-0147; Behrmann, Elmar/0000-0001-6794-3669; Taft, Manuel/0000-0001-5853-8629; Taft, Manuel H/0000-0001-5853-8629; Manstein, Dietmar J. J/0000-0003-0763-0147; Raunser, Stefan/0000-0001-9373-3016	Deutsche Forschungsgemeinschaft [MA 1081/19-1, RA 1781/1-1]; Fonds der Chemischen Industrie [684052]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by Deutsche Forschungsgemeinschaft Grants MA 1081/19-1 (to D. J. M.) and RA 1781/1-1 (to S. R.), Fonds der Chemischen Industrie Grant 684052 (to E. B.), and the Max Planck Society (to S. R. and E. B.).	BAGSHAW CR, 1975, FEBS LETT, V58, P197, DOI 10.1016/0014-5793(75)80258-4; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Diensthuber RP, 2011, FEBS LETT, V585, P767, DOI 10.1016/j.febslet.2011.01.042; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Dose AC, 2007, J BIOL CHEM, V282, P216, DOI 10.1074/jbc.M605964200; Dose AC, 2008, BIOCHEMISTRY-US, V47, P2485, DOI 10.1021/bi7021574; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Furch M, 1999, J MOL BIOL, V290, P797, DOI 10.1006/jmbi.1999.2921; Furusawa T, 2000, BIOCHEM BIOPH RES CO, V270, P67, DOI 10.1006/bbrc.2000.2377; Guzik-Lendrum S, 2013, J BIOL CHEM, V288, P9532, DOI 10.1074/jbc.M112.441238; Guzik-Lendrum S, 2011, J BIOL CHEM, V286, P21755, DOI 10.1074/jbc.M111.218669; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Heissler SM, 2011, J BIOL CHEM, V286, P21191, DOI 10.1074/jbc.M110.212290; Hsu RM, 2010, MOL BIOL CELL, V21, P287, DOI 10.1091/mbc.E09-03-0232; Isogawa Y, 2005, BIOCHEMISTRY-US, V44, P6190, DOI 10.1021/bi0475931; Khromov A, 1998, BIOPHYS J, V75, P1926, DOI 10.1016/S0006-3495(98)77633-7; Kliche W, 2001, EMBO J, V20, P40, DOI 10.1093/emboj/20.1.40; KRISANDA JM, 1983, AM J PHYSIOL, V244, pC385, DOI 10.1152/ajpcell.1983.244.5.C385; Kurzawa SE, 1996, J MUSCLE RES CELL M, V17, P669, DOI 10.1007/BF00154061; Langer W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-676; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; Lowey S, 2007, J MOL BIOL, V371, P902, DOI 10.1016/j.jmb.2007.05.080; Matsui K, 2011, J PROTEOME RES, V10, P3983, DOI 10.1021/pr200577d; Mori K, 2005, BIOCHEM BIOPH RES CO, V326, P491, DOI 10.1016/j.bbrc.2004.11.058; Mori K, 2003, J BIOCHEM, V133, P405, DOI 10.1093/jb/mvg053; Nalavadi V, 2005, J BIOL CHEM, V280, P38957, DOI 10.1074/jbc.M507161200; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Onishi H, 1998, P NATL ACAD SCI USA, V95, P6653, DOI 10.1073/pnas.95.12.6653; Ponomarev MA, 2000, BIOCHEMISTRY-US, V39, P4527, DOI 10.1021/bi992420a; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; ROTH K, 1991, MAGNET RESON MED, V22, P505, DOI 10.1002/mrm.1910220258; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Senisterra GA, 2006, J BIOMOL SCREEN, V11, P940, DOI 10.1177/1087057106294699; Struchholz S, 2009, J BIOL CHEM, V284, P3663, DOI 10.1074/jbc.M808338200; Taft MH, 2008, J BIOL CHEM, V283, P26902, DOI 10.1074/jbc.M802957200; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Ussowicz M, 2012, CANCER GENET-NY, V205, P261, DOI 10.1016/j.cancergen.2012.02.006; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; Walz C, 2005, LEUKEMIA, V19, P1005, DOI 10.1038/sj.leu.2403712; Waz C, 2009, GENE CHROMOSOME CANC, V48, P179, DOI 10.1002/gcc.20629; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Yang CH, 2005, J BIOL CHEM, V280, P34447, DOI 10.1074/jbc.M505229200; Zolkiewski M, 1996, BIOPHYS CHEM, V59, P365, DOI 10.1016/0301-4622(95)00129-8	46	44	50	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30029	30041		10.1074/jbc.M113.497180	http://dx.doi.org/10.1074/jbc.M113.497180			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23990465	hybrid, Green Published			2022-12-25	WOS:000329868100004
J	Arya, S; Sethi, D; Singh, S; Hade, MD; Singh, V; Raju, P; Chodisetti, SB; Verma, D; Varshney, GC; Agrewala, JN; Dikshit, KL				Arya, Swati; Sethi, Deepti; Singh, Sandeep; Hade, Mangesh Dattu; Singh, Vijender; Raju, Preeti; Chodisetti, Sathi Babu; Verma, Deepshikha; Varshney, Grish C.; Agrewala, Javed N.; Dikshit, Kanak L.			Truncated Hemoglobin, HbN, Is Post-translationally Modified in Mycobacterium tuberculosis and Modulates Host-Pathogen Interactions during Intracellular Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; GENE-EXPRESSION; OXYGEN-BINDING; IN-VITRO; MACROPHAGES; CELL; PROTEINS; RESPONSES; SURVIVAL; MANNOSE	Mycobacterium tuberculosis (Mtb) is a phenomenally successful human pathogen having evolved mechanisms that allow it to survive within the hazardous environment of macrophages and establish long term, persistent infection in the host against the control of cell-mediated immunity. One such mechanism is mediated by the truncated hemoglobin, HbN, of Mtb that displays a potent O-2-dependent nitric oxide dioxygenase activity and protects its host from the toxicity of macrophage-generated nitric oxide (NO). Here we demonstrate for the first time that HbN is post-translationally modified by glycosylation in Mtb and remains localized on the cell membrane and the cell wall. The glycan linkage in the HbN was identified as mannose. The elevated expression of HbN in Mtb and M. smegmatis facilitated their entry within the macrophages as compared with isogenic control cells, and mutation in the glycan linkage of HbN disrupted this effect. Additionally, HbN-expressing cells exhibited higher survival within the THP-1 and mouse peritoneal macrophages, simultaneously increasing the intracellular level of proinflammatory cytokines IL-6 and TNF-alpha and suppressing the expression of co-stimulatory surface markers CD80 and CD86. These results, thus, suggest the involvement of HbN in modulating the host-pathogen interactions and immune system of the host apart from protecting the bacilli from nitrosative stress inside the activated macrophages, consequently driving cells toward increased infectivity and intracellular survival.	[Arya, Swati; Sethi, Deepti; Singh, Sandeep; Hade, Mangesh Dattu; Singh, Vijender; Raju, Preeti; Chodisetti, Sathi Babu; Verma, Deepshikha; Varshney, Grish C.; Agrewala, Javed N.; Dikshit, Kanak L.] CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Dikshit, KL (corresponding author), CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India.		Hade, Mangesh/AAF-7217-2019; Agrewala, Javed Naim/AAS-8449-2021; Hade, Mangesh/ABD-8535-2021; Chodisetti, Sathi Babu/H-3239-2018	Hade, Mangesh/0000-0002-5937-9049; Chodisetti, Sathi Babu/0000-0001-7473-9420; Singh, Sandeep/0000-0001-9322-2929	European Commission; CSIR [SIP10, BSC0210]; Department of Biotechnology	European Commission(European CommissionEuropean Commission Joint Research Centre); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology	This work was supported by the European Commission under the FP7 program on health and CSIR Supra-institutional Project Grants SIP10 and BSC0210. This work was also supported by CSIR and the Department of Biotechnology (to S. A., D. S., and S.S.).	Agrewala JN, 1998, J IMMUNOL, V160, P1067; Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; Balkhi MY, 2004, J LEUKOCYTE BIOL, V75, P874, DOI 10.1189/jlb.1003476; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Cowley SC, 2001, GENE, V264, P225, DOI 10.1016/S0378-1119(01)00336-5; Craney A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019421; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Dahl JL, 2001, INFECT IMMUN, V69, P4295, DOI 10.1128/IAI.69.7.4295-4302.2001; Dutta NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028958; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Fimereli Danai K., 2012, Artificial Intelligence: Theories and Applications. Proceedings 7th Hellenic Conference on AI, SETN 2012, P285, DOI 10.1007/978-3-642-30448-4_36; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Gao Q, 2005, MICROBIOL-SGM, V151, P5, DOI 10.1099/mic.0.27539-0; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; Giffin MM, 2012, J BACTERIOL, V194, P1045, DOI 10.1128/JB.05914-11; Gonzalez-Zamnorano M, 2009, J PROTEOME RES, V8, P721, DOI 10.1021/pr800756a; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; Herrmann JL, 2000, FEBS LETT, V473, P358, DOI 10.1016/S0014-5793(00)01553-2; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; Khan N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002676; Koo MS, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-2; Lama A, 2006, FEBS LETT, V580, P4031, DOI 10.1016/j.febslet.2006.06.037; Lama A, 2009, J BIOL CHEM, V284, P14457, DOI 10.1074/jbc.M807436200; Manca C, 1999, J IMMUNOL, V162, P6740; Mendelson M, 2005, TUBERCULOSIS, V85, P407, DOI 10.1016/j.tube.2005.08.004; Michell SL, 2003, J BIOL CHEM, V278, P16423, DOI 10.1074/jbc.M207959200; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Neyrolles O, 2011, TUBERCULOSIS, V91, P187, DOI 10.1016/j.tube.2011.01.002; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Pawaria S, 2008, APPL ENVIRON MICROB, V74, P3512, DOI 10.1128/AEM.02663-07; Pawaria S, 2007, MICROB PATHOGENESIS, V42, P119, DOI 10.1016/j.micpath.2006.12.001; Ragas A, 2007, J BIOL CHEM, V282, P5133, DOI 10.1074/jbc.M610183200; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Suvas S, 2002, J BIOL CHEM, V277, P7766, DOI 10.1074/jbc.M105902200; Wei J, 2000, J BACTERIOL, V182, P377, DOI 10.1128/JB.182.2.377-384.2000; WHO, 2008, TUB FACTS	49	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29987	29999		10.1074/jbc.M113.507301	http://dx.doi.org/10.1074/jbc.M113.507301			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23983123	Green Published, hybrid			2022-12-25	WOS:000330615300071
J	Feurdean, A; Bhagwat, SA; Willis, KJ; Birks, HJB; Lischke, H; Hickler, T				Feurdean, Angelica; Bhagwat, Shonil A.; Willis, Katherine J.; Birks, H. John B.; Lischke, Heike; Hickler, Thomas			Tree Migration-Rates: Narrowing the Gap between Inferred Post-Glacial Rates and Projected Rates	PLOS ONE			English	Article							PICEA-ABIES; FAGUS-SYLVATICA; PLANT MIGRATION; GLACIAL REFUGIA; DISPERSAL; CLIMATE; EUROPE; POPULATION; SPREAD; VEGETATION	Faster-than-expected post-glacial migration rates of trees have puzzled ecologists for a long time. In Europe, post-glacial migration is assumed to have started from the three southern European peninsulas (southern refugia), where large areas remained free of permafrost and ice at the peak of the last glaciation. However, increasing palaeobotanical evidence for the presence of isolated tree populations in more northerly microrefugia has started to change this perception. Here we use the Northern Eurasian Plant Macrofossil Database and palaeoecological literature to show that post-glacial migration rates for trees may have been substantially lower (60-260 m yr(-1)) than those estimated by assuming migration from southern refugia only (115-550 m yr(-1)), and that early-successional trees migrated faster than mid-and late-successional trees. Post-glacial migration rates are in good agreement with those recently projected for the future with a population dynamical forest succession and dispersal model, mainly for early-successional trees and under optimal conditions. Although migration estimates presented here may be conservative because of our assumption of uniform dispersal, tree migration-rates clearly need reconsideration. We suggest that small outlier populations may be a key factor in understanding past migration rates and in predicting potential future range-shifts. The importance of outlier populations in the past may have an analogy in the future, as many tree species have been planted beyond their natural ranges, with a more beneficial microclimate than their regional surroundings. Therefore, climate-change-induced range-shifts in the future might well be influenced by such microrefugia.	[Feurdean, Angelica; Hickler, Thomas] Senckenberg Res Inst, Frankfurt, Germany; [Feurdean, Angelica; Hickler, Thomas] Nat Hist Museum, Frankfurt, Germany; [Feurdean, Angelica; Hickler, Thomas] Biodivers & Climate Res Ctr, Frankfurt, Germany; [Feurdean, Angelica] Romanian Acad Emil Racovita, Inst Speleol, Cluj Napoca, Romania; [Bhagwat, Shonil A.; Birks, H. John B.] Open Univ, Dept Geog, Milton Keynes MK7 6AA, Bucks, England; [Bhagwat, Shonil A.] Univ Oxford, Sch Geog & Environm, Oxford, England; [Bhagwat, Shonil A.; Willis, Katherine J.] Univ Oxford, Dept Zool, Biodivers Inst, Long Term Ecol Lab, Oxford OX1 3PS, England; [Bhagwat, Shonil A.; Willis, Katherine J.] Univ Oxford, Dept Zool, Biodivers Inst, Oxford Martin Inst, Oxford OX1 3PS, England; [Willis, Katherine J.; Birks, H. John B.] Univ Bergen, Dept Biol, Bergen, Norway; [Birks, H. John B.] UCL, Environm Change Res Ctr, London, England; [Lischke, Heike] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland; [Hickler, Thomas] Senckenberg Gesell Nat Forsch, Frankfurt, Germany; [Hickler, Thomas] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); Emil Racovita Institute of Speleology; Open University - UK; University of Oxford; University of Oxford; University of Oxford; University of Bergen; University of London; University College London; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt	Feurdean, A (corresponding author), Senckenberg Res Inst, Frankfurt, Germany.	angelica.feurdean@senckenberg.de	Hickler, Thomas/S-6287-2016; Lischke, Heike/J-5719-2013; Birks, John B/C-3103-2008	Hickler, Thomas/0000-0002-4668-7552; Lischke, Heike/0000-0003-4284-5194; Birks, John B/0000-0002-5891-9859; Feurdean, Angelica/0000-0002-2497-3005; Willis, Katherine/0000-0002-6763-2489	National Environment Research Council [NE/D001578/1]; German Research Foundation [FE-1096/2-1]; Biodiversity and Climate Research Center; Swiss National Science foundation [315230_122434]	National Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); German Research Foundation(German Research Foundation (DFG)); Biodiversity and Climate Research Center; Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission)	The macrofossil database was funded through National Environment Research Council grant number NE/D001578/1, awarded to MEE and KJW. AF and TH acknowledge funding from the German Research Foundation (grant FE-1096/2-1), TH from the Biodiversity and Climate Research Center, and HL from the Swiss National Science foundation (grant 315230_122434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JRM, 2010, QUATERNARY SCI REV, V29, P2604, DOI 10.1016/j.quascirev.2010.05.031; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Bhagwat SA, 2008, J BIOGEOGR, V35, P464, DOI 10.1111/j.1365-2699.2007.01861.x; Bialozyt R, 2012, J BIOGEOGR, V39, P665, DOI 10.1111/j.1365-2699.2011.02665.x; Binney HA, 2009, QUATERNARY SCI REV, V28, P2445, DOI 10.1016/j.quascirev.2009.04.016; Birks HJB, 2008, PLANT ECOL DIVERS, V1, P147, DOI 10.1080/17550870802349146; BIRKS HJB, 1989, J BIOGEOGR, V16, P503, DOI 10.2307/2845208; Blockley SPE, 2012, QUATERNARY SCI REV, V36, P2, DOI 10.1016/j.quascirev.2011.09.017; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; Feurdean A, 2007, REV PALAEOBOT PALYNO, V145, P305, DOI 10.1016/j.revpalbo.2006.12.004; Feurdean A, 2012, J BIOGEOGR, V39, P258, DOI 10.1111/j.1365-2699.2011.02605.x; Giesecke T, 2005, QUATERNARY SCI REV, V24, P2495, DOI 10.1016/j.quascirev.2005.03.002; Giesecke T, 2004, J BIOGEOGR, V31, P1523, DOI 10.1111/j.1365-2699.2004.01095.x; Giesecke T, 2007, J BIOGEOGR, V34, P118, DOI 10.1111/j.1365-2699.2006.01580.x; Helmisaari H, 1989, IIASA WORKING PAPERS, V89-65; Hickler T, 2012, GLOBAL ECOL BIOGEOGR, V21, P50, DOI 10.1111/j.1466-8238.2010.00613.x; Higgins SI, 2003, J ECOL, V91, P341, DOI 10.1046/j.1365-2745.2003.00781.x; Huntley B., 1983, ATLAS PRESENT POLLEN; Kullman L, 2002, J ECOL, V90, P68, DOI 10.1046/j.0022-0477.2001.00630.x; Kunes P, 2008, J BIOGEOGR, V35, P2223, DOI 10.1111/j.1365-2699.2008.01974.x; Lischke H, 2006, ECOL MODEL, V199, P409, DOI 10.1016/j.ecolmodel.2005.11.046; Lischke H, 2006, ECOL MODEL, V198, P341, DOI 10.1016/j.ecolmodel.2006.05.005; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Meier ES, 2012, GLOBAL ECOL BIOGEOGR, V21, P164, DOI 10.1111/j.1466-8238.2011.00669.x; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Naughton F, 2009, EARTH PLANET SC LETT, V284, P329, DOI 10.1016/j.epsl.2009.05.001; Normand S, 2011, P ROY SOC B-BIOL SCI, V278, P3644, DOI 10.1098/rspb.2010.2769; Ohlemuller R, 2012, GLOBAL ECOL BIOGEOGR, V21, P152, DOI 10.1111/j.1466-8238.2011.00674.x; Ordonez A, 2013, ECOL LETT, V16, P773, DOI 10.1111/ele.12110; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; RITCHIE JC, 1986, J BIOGEOGR, V13, P527, DOI 10.2307/2844816; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Svenning JC, 2008, J ECOL, V96, P1117, DOI 10.1111/j.1365-2745.2008.01422.x; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; Svenning JC, 2007, GLOBAL ECOL BIOGEOGR, V16, P234, DOI 10.1111/j.1466-8238.2006.00280.x; Terhurne-Berson R, 2004, VEG HIST ARCHAEOBOT, V13, P257, DOI 10.1007/s00334-004-0049-4; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tzedakis PC, 2002, SCIENCE, V297, P2044, DOI 10.1126/science.1073083; Valiranta M, 2011, J BIOGEOGR, V38, P922, DOI 10.1111/j.1365-2699.2010.02448.x; Van der Veken S, 2008, FRONT ECOL ENVIRON, V6, P212, DOI 10.1890/070063; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002; Willis KJ, 2000, QUATERNARY RES, V53, P203, DOI 10.1006/qres.1999.2119	47	95	96	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71797	10.1371/journal.pone.0071797	http://dx.doi.org/10.1371/journal.pone.0071797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23990991	Green Published, Green Accepted, gold			2022-12-25	WOS:000324228800020
J	Ghosh-Roy, S; Das, D; Chowdhury, D; Smerdon, MJ; Chaudhuri, RN				Ghosh-Roy, Sounak; Das, Dhiman; Chowdhury, Debarati; Smerdon, Michael J.; Chaudhuri, Ronita Nag			Rad26, the Transcription-Coupled Repair Factor in Yeast, Is Required for Removal of Stalled RNA Polymerase-II following UV Irradiation	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; B GENE; CHROMATIN; HOMOLOG; COMPLEX; PROTEIN; SUBPATHWAYS; INHIBITION	Transcription coupled nucleotide excision repair (TCR) is a major pathway responsible for removal of helix distorting DNA lesions from transcriptionally active regions of the genome. Rad26, a key factor of the TCR pathway, is known to play a role during early steps of TCR. Here, we show that Rad26-mediated TCR is not absolutely dependent on active transcription elongation in budding yeast. As per our results, RAD26-deleted cells show enhanced UV sensitivity compared to wild type cells under conditions where transcription elongation is inhibited. The increased UV sensitivity observed in RAD26-deleted cells, however, is not due to reduced expression of the major NER-responsive genes. Interestingly, transcription of the constitutively expressed RPB2 gene is adversely affected in RAD26-deleted cells during UV-induced DNA damage repair. In consonance, chromatin immunoprecipitation analysis showed that unlike in wild type, in RAD26-deleted cells no significant reduction in RNA polymerase II occupancy occurs during nucleotide excision repair in the transcriptionally active loci like, RPB2, PYK1 and RPL2B. These results collectively indicate that removal of RNAPII during DNA damage repair following UV irradiation is dependent on Rad26.	[Ghosh-Roy, Sounak; Das, Dhiman; Chowdhury, Debarati; Chaudhuri, Ronita Nag] St Xaviers Coll, Dept Biotechnol, Kolkata, India; [Smerdon, Michael J.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	St. Xavier's College Kolkata; Washington State University	Chaudhuri, RN (corresponding author), St Xaviers Coll, Dept Biotechnol, Kolkata, India.	ronita_7@yahoo.co.in	Ghosh Roy, Sounak/Y-3505-2018	Ghosh Roy, Sounak/0000-0002-2045-0370	National Institutes of Health from the National Institute of Environmental Health Sciences [ES004106]; Science and Engineering Research Board (Department of Science and Technology, India) [SR/FT/LS-145/2009]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004106] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Environmental Health Sciences; Science and Engineering Research Board (Department of Science and Technology, India)(Department of Science & Technology (India)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The initial phase of this work was supported by National Institutes of Health grant ES004106 from the National Institute of Environmental Health Sciences to MJS and partly funded by Science and Engineering Research Board (Department of Science and Technology, India) grant SR/FT/LS-145/2009 to RNC. Contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Bucheli M, 2004, MOL MICROBIOL, V52, P1653, DOI 10.1111/j.1365-2958.2004.04081.x; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Ding B, J BIOL CHEM, V285, P5317; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Guzder SN, 1996, J BIOL CHEM, V271, P18314, DOI 10.1074/jbc.271.31.18314; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; HANAWALT PC, 1992, ANN NY ACAD SCI, V663, P17, DOI 10.1111/j.1749-6632.1992.tb38644.x; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Jansen LET, 2000, EMBO J, V19, P6498, DOI 10.1093/emboj/19.23.6498; Laine JP, 2006, TRENDS GENET, V22, P430, DOI 10.1016/j.tig.2006.06.006; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Lee SK, 2001, MOL CELL BIOL, V21, P8651, DOI 10.1128/MCB.21.24.8651-8656.2001; Li SH, 2006, J BIOL CHEM, V281, P36643, DOI 10.1074/jbc.M604885200; Li SS, 2004, J BIOL CHEM, V279, P14418, DOI 10.1074/jbc.M312004200; Li SS, 2002, J BIOL CHEM, V277, P44651, DOI 10.1074/jbc.M206623200; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; LJUNGMAN M, 1995, NUCLEIC ACIDS RES, V23, P1782, DOI 10.1093/nar/23.10.1782; Malik S, NUCL ACIDS RES, V40, P3348; Malik S, NUCL ACIDS RES, V38, P1461; Nag R, 2008, NUCL ACIDS RES; Nag R, NUCL ACIDS RES, V38, P1450; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Pereira LA, 2003, GENE, V315, P1, DOI 10.1016/S0378-1119(03)00714-5; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Selby CP, 1997, J BIOL CHEM, V272, P1885, DOI 10.1074/jbc.272.3.1885; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1995, J BIOL CHEM, V270, P4890, DOI 10.1074/jbc.270.9.4890; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; SWEDER KS, 1992, P NATL ACAD SCI USA, V89, P10696, DOI 10.1073/pnas.89.22.10696; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Tijsterman M, 1997, P NATL ACAD SCI USA, V94, P8027, DOI 10.1073/pnas.94.15.8027; Tornaletti S, 1999, J BIOL CHEM, V274, P24124, DOI 10.1074/jbc.274.34.24124; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a	40	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72090	10.1371/journal.pone.0072090	http://dx.doi.org/10.1371/journal.pone.0072090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991048	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100078
J	Schunck, H; Lavik, G; Desai, DK; Grosskopf, T; Kalvelage, T; Loscher, CR; Paulmier, A; Contreras, S; Siegel, H; Holtappels, M; Rosenstiel, P; Schilhabel, MB; Graco, M; Schmitz, RA; Kuypers, MMM; LaRoche, J				Schunck, Harald; Lavik, Gaute; Desai, Dhwani K.; Grosskopf, Tobias; Kalvelage, Tim; Loescher, Carolin R.; Paulmier, Aurelien; Contreras, Sergio; Siegel, Herbert; Holtappels, Moritz; Rosenstiel, Philip; Schilhabel, Markus B.; Graco, Michelle; Schmitz, Ruth A.; Kuypers, Marcel M. M.; LaRoche, Julie			Giant Hydrogen Sulfide Plume in the Oxygen Minimum Zone off Peru Supports Chemolithoautotrophy	PLOS ONE			English	Article							ANAEROBIC AMMONIUM OXIDATION; SULFATE-REDUCTION; NITROUS-OXIDE; AUTOTROPHIC DENITRIFICATION; PELAGIC REDOXCLINES; CYTOCHROME CBB(3); MICROBIAL ECOLOGY; UPWELLING REGION; ANOXIC WATERS; SULFUR CYCLE	In Eastern Boundary Upwelling Systems nutrient-rich waters are transported to the ocean surface, fuelling high photoautotrophic primary production. Subsequent heterotrophic decomposition of the produced biomass increases the oxygen-depletion at intermediate water depths, which can result in the formation of oxygen minimum zones (OMZ). OMZs can sporadically accumulate hydrogen sulfide (H2S), which is toxic to most multicellular organisms and has been implicated in massive fish kills. During a cruise to the OMZ off Peru in January 2009 we found a sulfidic plume in continental shelf waters, covering an area >5500 km(2), which contained similar to 2.2 x 10(4) tons of H2S. This was the first time that H2S was measured in the Peruvian OMZ and with similar to 440 km(3) the largest plume ever reported for oceanic waters. We assessed the phylogenetic and functional diversity of the inhabiting microbial community by high-throughput sequencing of DNA and RNA, while its metabolic activity was determined with rate measurements of carbon fixation and nitrogen transformation processes. The waters were dominated by several distinct gamma-, delta- and epsilon-proteobacterial taxa associated with either sulfur oxidation or sulfate reduction. Our results suggest that these chemolithoautotrophic bacteria utilized several oxidants (oxygen, nitrate, nitrite, nitric oxide and nitrous oxide) to detoxify the sulfidic waters well below the oxic surface. The chemolithoautotrophic activity at our sampling site led to high rates of dark carbon fixation. Assuming that these chemolithoautotrophic rates were maintained throughout the sulfidic waters, they could be representing as much as similar to 30% of the photoautotrophic carbon fixation. Postulated changes such as eutrophication and global warming, which lead to an expansion and intensification of OMZs, might also increase the frequency of sulfidic waters. We suggest that the chemolithoautotrophically fixed carbon may be involved in a negative feedback loop that could fuel further sulfate reduction and potentially stabilize the sulfidic OMZ waters.	[Schunck, Harald; Desai, Dhwani K.; Grosskopf, Tobias; LaRoche, Julie] GEOMAR Helmholtz Ctr Ocean Res Kiel, Res Div Marine Biogeochem, Kiel, Germany; [Schunck, Harald; Loescher, Carolin R.; Schmitz, Ruth A.] Univ Kiel, Inst Gen Microbiol, Kiel, Germany; [Lavik, Gaute; Kalvelage, Tim; Paulmier, Aurelien; Contreras, Sergio; Holtappels, Moritz; Kuypers, Marcel M. M.] Max Planck Inst Marine Microbiol, Dept Biogeochem, Bremen, Germany; [Desai, Dhwani K.; LaRoche, Julie] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Grosskopf, Tobias] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England; [Paulmier, Aurelien] Inst Dev Res, Lab Studies Geophys & Spatial Oceanog, Toulouse, France; [Paulmier, Aurelien; Graco, Michelle] Inst Mar Peru, Direcc Invest Oceanog, Callao, Peru; [Contreras, Sergio] Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA; [Siegel, Herbert] Leibniz Inst Balt Sea Res Warnemunde, Rostock, Germany; [Rosenstiel, Philip; Schilhabel, Markus B.] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel; Max Planck Society; Dalhousie University; University of Exeter; Institut de Recherche pour le Developpement (IRD); Instituto del Mar del Peru; University of Minnesota System; University of Minnesota Duluth; Leibniz Institut fur Ostseeforschung Warnemunde; University of Kiel	LaRoche, J (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Res Div Marine Biogeochem, Kiel, Germany.	julie.laroche@dal.ca	Holtappels, Moritz/ABC-7901-2020; Desai, Dhwani/AAA-4237-2020; PAULMIER, Aurélien/U-7521-2017; Contreras, Sergio/I-1858-2014; Lavik, Gaute/F-6578-2013; LaRoche, Julie/A-1109-2010; Rosenstiel, Philip/A-5137-2009; Löscher, Carolin/AAB-3701-2019	Desai, Dhwani/0000-0002-1447-5360; PAULMIER, Aurélien/0000-0002-4128-7824; Contreras, Sergio/0000-0001-7192-6810; Rosenstiel, Philip/0000-0002-9692-8828; Holtappels, Moritz/0000-0003-3682-1903; Graco, Michelle Ivette/0000-0002-6193-3256; Schmitz-Streit, Ruth Anne/0000-0002-6788-0829; LaRoche, Julie/0000-0003-4809-6411; Loscher, Carolin/0000-0002-2044-6849	WGL-PAKT project 'REAL' (Leibniz Association); Max Planck Society; Helmholtz Association; German Research Association	WGL-PAKT project 'REAL' (Leibniz Association); Max Planck Society(Max Planck SocietyFoundation CELLEX); Helmholtz Association(Helmholtz Association); German Research Association(German Research Foundation (DFG))	Funding was provided by the WGL-PAKT project 'REAL' (Leibniz Association), the Max Planck Society and the Helmholtz Association. The Cluster of Excellence "The Future Ocean" provided structural support. This work is a contribution of the Collaborative Research Centre 754 "climate - biogeochemistry interactions in the tropical oceans'' (www.sfb754.de), which is supported by the German Research Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT DB, 1995, DEEP-SEA RES PT I, V42, P1239, DOI 10.1016/0967-0637(95)00042-5; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Brettar I, 2006, APPL ENVIRON MICROB, V72, P1364, DOI 10.1128/AEM.72.2.1364-1372.2006; BRETTAR I, 1991, MAR ECOL PROG SER, V77, P157, DOI 10.3354/meps077157; Bruchert V, 2003, GEOCHIM COSMOCHIM AC, V67, P4505, DOI 10.1016/S0016-7037(03)00275-8; BRYSCH K, 1987, ARCH MICROBIOL, V148, P264, DOI 10.1007/BF00456703; Burtt J.L., 1852, AM J SCI, V2, P433; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; Copenhagen, 1953, INVESTIGATIONAL REPO, V14, P1; Dalsgaard T, 2012, LIMNOL OCEANOGR, V57, P1331, DOI 10.4319/lo.2012.57.5.1331; Desai DK, 2013, BIOINFORMATICS, V29, P790, DOI 10.1093/bioinformatics/bts721; Desai Dhwani K., 2011, Advances in Bioinformatics, V2011, P743782, DOI 10.1155/2011/743782; DETMER AE, 1993, MAR ECOL PROG SER, V99, P197, DOI 10.3354/meps099197; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; DUGDALE RC, 1977, DEEP-SEA RES, V24, P601, DOI 10.1016/0146-6291(77)90530-6; Emery KO, 1955, ESSAYS NATURAL SCI H, P299; Farias L, 2009, BIOGEOSCIENCES, V6, P3053, DOI 10.5194/bg-6-3053-2009; FENNEL W, 1995, J MARINE SYST, V6, P313, DOI 10.1016/0924-7963(94)00031-6; Finster K, 1998, APPL ENVIRON MICROB, V64, P119; Forte E, 2001, EUR J BIOCHEM, V268, P6486, DOI 10.1046/j.0014-2956.2001.02597.x; FOSSING H, 1990, CONT SHELF RES, V10, P355, DOI 10.1016/0278-4343(90)90056-R; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; FRIEDERICH GE, 1987, DEEP-SEA RES, V34, P1049, DOI 10.1016/0198-0149(87)90052-5; Fuchs BM, 2005, AQUAT MICROB ECOL, V39, P145, DOI 10.3354/ame039145; Fussel J, 2012, ISME J, V6, P1200, DOI 10.1038/ismej.2011.178; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Glaubitz S, 2010, FEMS MICROBIOL ECOL, V74, P32, DOI 10.1111/j.1574-6941.2010.00944.x; Glaubitz S, 2009, ENVIRON MICROBIOL, V11, P326, DOI 10.1111/j.1462-2920.2008.01770.x; Grasshoff K, 1999, METHODS SEAWATER ANA; GREGG MC, 1986, J PHYS OCEANOGR, V16, P856, DOI 10.1175/1520-0485(1986)016<0856:OOPMAN>2.0.CO;2; Grote J, 2007, APPL ENVIRON MICROB, V73, P7155, DOI 10.1128/AEM.00466-07; Grote J, 2012, P NATL ACAD SCI USA, V109, P506, DOI 10.1073/pnas.1111262109; Grote J, 2008, APPL ENVIRON MICROB, V74, P7546, DOI 10.1128/AEM.01186-08; Gruber N., 2004, OCEAN CARBON CYCLE C, P97, DOI DOI 10.1007/978-1-4020-2087-2_4; Hamersley MR, 2007, LIMNOL OCEANOGR, V52, P923, DOI 10.4319/lo.2007.52.3.0923; Hamukuaya H, 1998, S AFR J MARINE SCI, V19, P57; Hannig M, 2007, LIMNOL OCEANOGR, V52, P1336, DOI 10.4319/lo.2007.52.4.1336; Hart T. J., 1960, Discovery Reports, V31, P123; Hayes MK, 2006, LIMNOL OCEANOGR, V51, P280, DOI 10.4319/lo.2006.51.1.0280; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Holtappels M, 2011, METHOD ENZYMOL, V486, P223, DOI [10.1016/S0076-6879(11)86010-6, 10.1016/B978-0-12-381294-0.00010-9]; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jensen MM, 2008, LIMNOL OCEANOGR, V53, P23, DOI 10.4319/lo.2008.53.1.0023; Jensen MM, 2011, ISME J, V5, P1660, DOI 10.1038/ismej.2011.44; Jeroschewski P, 1996, ANAL CHEM, V68, P4351, DOI 10.1021/ac960091b; JORGENSEN BB, 1991, DEEP-SEA RES, V38, pS1083; JORGENSEN BB, 1982, PHILOS T R SOC B, V298, P543, DOI 10.1098/rstb.1982.0096; Jost G, 2008, LIMNOL OCEANOGR, V53, P14, DOI 10.4319/lo.2008.53.1.0014; Jost G, 2010, FEMS MICROBIOL ECOL, V71, P226, DOI 10.1111/j.1574-6941.2009.00798.x; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/NGEO1739, 10.1038/ngeo1739]; Kalvelage T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029299; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kuwahara H, 2007, CURR BIOL, V17, P881, DOI 10.1016/j.cub.2007.04.039; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2007, P NATL ACAD SCI USA, V104, P7104, DOI 10.1073/pnas.0611081104; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; Lavin P, 2010, ENV MICROBIOL REP, V2, P728, DOI 10.1111/j.1758-2229.2010.00167.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LUTHER GW, 1991, DEEP-SEA RES, V38, pS1121, DOI 10.1016/S0198-0149(10)80027-5; Meyer B, 2007, MICROBIOL-SGM, V153, P3478, DOI 10.1099/mic.0.2007/008250-0; Meyer B, 2007, MICROBIOL-SGM, V153, P2026, DOI 10.1099/mic.0.2006/003152-0; Montecino V, 2009, PROG OCEANOGR, V83, P65, DOI 10.1016/j.pocean.2009.07.041; Nakagawa S, 2008, FEMS MICROBIOL ECOL, V65, P1, DOI 10.1111/j.1574-6941.2008.00502.x; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Newton ILG, 2007, SCIENCE, V315, P998, DOI 10.1126/science.1138438; Niggemann J, 2005, COMPOSITION DEGRADAT; Ohde T, 2007, CONT SHELF RES, V27, P744, DOI 10.1016/j.csr.2006.11.016; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Shao MF, 2010, APPL MICROBIOL BIOT, V88, P1027, DOI 10.1007/s00253-010-2847-1; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Siegel H, 2007, CONT SHELF RES, V27, P258, DOI 10.1016/j.csr.2006.10.003; SOROKIN YI, 1995, HYDROBIOLOGIA, V308, P61, DOI 10.1007/BF00037788; Stevens H, 2008, ENVIRON MICROBIOL, V10, P1244, DOI 10.1111/j.1462-2920.2007.01539.x; Stewart FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037118; Stewart FJ, 2011, BIOCHEM SOC T, V39, P1859, DOI 10.1042/BST20110708; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Stolper DA, 2010, P NATL ACAD SCI USA, V107, P18755, DOI 10.1073/pnas.1013435107; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Strittmatter AW, 2009, ENVIRON MICROBIOL, V11, P1038, DOI 10.1111/j.1462-2920.2008.01825.x; Sunamura M, 2004, APPL ENVIRON MICROB, V70, P1190, DOI 10.1128/AEM.70.2.1190-1198.2004; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; Ulloa O, 2012, P NATL ACAD SCI USA, V109, P15996, DOI 10.1073/pnas.1205009109; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; VANDEROOST J, 1994, FEMS MICROBIOL LETT, V121, P1, DOI 10.1016/0378-1097(94)90137-6; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309; Walter S, 2006, BIOGEOSCIENCES, V3, P607, DOI 10.5194/bg-3-607-2006; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; WARD BB, 1989, DEEP-SEA RES, V36, P1031, DOI 10.1016/0198-0149(89)90076-9; Weeks SJ, 2002, NATURE, V415, P493, DOI 10.1038/415493b; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002; Wright JJ, 2012, NAT REV MICROBIOL, V10, P381, DOI 10.1038/nrmicro2778; WYRTKI K, 1962, DEEP-SEA RES, V9, P11, DOI 10.1016/0011-7471(62)90243-7; Yamamoto M, 2010, ENVIRON MICROBIOL, V12, P1144, DOI 10.1111/j.1462-2920.2010.02155.x; Zamora LM, 2012, BIOGEOSCIENCES, V9, P5007, DOI 10.5194/bg-9-5007-2012; ZHANG JZ, 1993, DEEP-SEA RES PT I, V40, P1023, DOI 10.1016/0967-0637(93)90088-K	113	124	127	4	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e68661	10.1371/journal.pone.0068661	http://dx.doi.org/10.1371/journal.pone.0068661			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990875	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000324470100006
J	van Dijk, MT; van Wingen, GA; van Lammeren, A; Blom, RM; de Kwaasteniet, BP; Scholte, HS; Denys, D				van Dijk, Milenna T.; van Wingen, Guido A.; van Lammeren, Anouk; Blom, Rianne M.; de Kwaasteniet, Bart P.; Scholte, H. Steven; Denys, Damiaan			Neural Basis of Limb Ownership in Individuals with Body Integrity Identity Disorder	PLOS ONE			English	Article							VENTRAL PREMOTOR CORTEX; MULTISENSORY BRAIN; RUBBER HAND; STIMULATION; TACTILE; APOTEMNOPHILIA; EMBODIMENT; ACTIVATION; MECHANISMS; AMPUTATION	Our body feels like it is ours. However, individuals with body integrity identity disorder (BIID) lack this feeling of ownership for distinct limbs and desire amputation of perfectly healthy body parts. This extremely rare condition provides us with an opportunity to study the neural basis underlying the feeling of limb ownership, since these individuals have a feeling of disownership for a limb in the absence of apparent brain damage. Here we directly compared brain activation between limbs that do and do not feel as part of the body using functional MRI during separate tactile stimulation and motor execution experiments. In comparison to matched controls, individuals with BIID showed heightened responsivity of a large somatosensory network including the parietal cortex and right insula during tactile stimulation, regardless of whether the stimulated leg felt owned or alienated. Importantly, activity in the ventral premotor cortex depended on the feeling of ownership and was reduced during stimulation of the alienated compared to the owned leg. In contrast, no significant differences between groups were observed during the performance of motor actions. These results suggest that altered somatosensory processing in the premotor cortex is associated with the feeling of disownership in BIID, which may be related to altered integration of somatosensory and proprioceptive information.	[van Dijk, Milenna T.; van Wingen, Guido A.; van Lammeren, Anouk; Blom, Rianne M.; de Kwaasteniet, Bart P.; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [van Wingen, Guido A.; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Brain Imaging Ctr, NL-1105 AZ Amsterdam, Netherlands; [Scholte, H. Steven] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Denys, Damiaan] Netherlands Inst Neurosci, Amsterdam, Netherlands; [van Dijk, Milenna T.] NYU, Sch Med, Sackler Inst Grad Biomed Sci, New York, NY USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); New York University	van Wingen, GA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	guidovanwingen@gmail.com	van Wingen, Guido/AAK-8462-2021; Scholte, H.Steven/ABD-1737-2020	van Wingen, Guido/0000-0003-3076-5891; Scholte, H.Steven/0000-0002-9839-1788				Arzy S, 2006, ARCH NEUROL-CHICAGO, V63, P1022, DOI 10.1001/archneur.63.7.1022; Baier B, 2008, STROKE, V39, P486, DOI 10.1161/STROKEAHA.107.495606; Bekrater-Bodmann R, 2011, J NEUROSCI, V31, P9443, DOI 10.1523/JNEUROSCI.2302-11.2011; Blom RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034702; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brang D, 2008, NEUROREPORT, V19, P1305, DOI 10.1097/WNR.0b013e32830abc4d; Burton H, 1999, CEREB CORTEX, V9, P662, DOI 10.1093/cercor/9.7.662; Critchley M., 1953, PARIETAL LOBES; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; First MB, 2005, PSYCHOL MED, V35, P919, DOI 10.1017/S0033291704003320; Gentile G, 2011, J NEUROPHYSIOL, V105, P910, DOI 10.1152/jn.00840.2010; Gerstmann J, 1942, ARCH NEURO PSYCHIATR, V48, P890, DOI 10.1001/archneurpsyc.1942.02290120042003; Giummarra MJ, 2008, NEUROSCI BIOBEHAV R, V32, P143, DOI 10.1016/j.neubiorev.2007.07.001; Giummarra MJ, 2011, NEUROPSYCHOL REV, V21, P320, DOI 10.1007/s11065-011-9184-8; HAMMEKE TA, 1994, NEUROSURGERY, V35, P677, DOI 10.1227/00006123-199410000-00014; Hilti LM, 2013, BRAIN, V136, P318, DOI 10.1093/brain/aws316; Kammers MPM, 2009, J COGNITIVE NEUROSCI, V21, P1311, DOI 10.1162/jocn.2009.21095; Karnath HO, 2010, BRAIN STRUCT FUNCT, V214, P411, DOI 10.1007/s00429-010-0250-4; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; McGeoch PD, 2011, J NEUROL NEUROSUR PS, V82, P1314, DOI 10.1136/jnnp-2011-300224; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Ramachandran VS, 2007, MED HYPOTHESES, V69, P250, DOI 10.1016/j.mehy.2006.12.013; Ryan CJ, 2009, NEUROETHICS-NETH, V2, P21, DOI 10.1007/s12152-008-9026-4; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Taylor KS, 2009, HUM BRAIN MAPP, V30, P1947, DOI 10.1002/hbm.20641; Tomassini V, 2007, J NEUROSCI, V27, P10259, DOI 10.1523/JNEUROSCI.2144-07.2007; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Vallar G, 2009, EXP BRAIN RES, V192, P533, DOI 10.1007/s00221-008-1562-y; Yetkin FZ, 1996, AM J NEURORADIOL, V17, P95; Zeller D, 2011, J NEUROSCI, V31, P4852, DOI 10.1523/JNEUROSCI.5154-10.2011	34	39	39	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72212	10.1371/journal.pone.0072212	http://dx.doi.org/10.1371/journal.pone.0072212			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991064	Green Submitted, gold, Green Published			2022-12-25	WOS:000324470100085
J	Vergallo, C; Piccoli, C; Romano, A; Panzarini, E; Serra, A; Manno, D; Dini, L				Vergallo, Cristian; Piccoli, Claudia; Romano, Alberto; Panzarini, Elisa; Serra, Antonio; Manno, Daniela; Dini, Luciana			Magnetostatic Field System for Uniform Cell Cultures Exposure	PLOS ONE			English	Article							STATIC MAGNETIC-FIELDS; MT; APOPTOSIS; GROWTH; DNA; DIFFERENTIATION; LEUKEMIA; CANCER; ASSAY	The aim of the present work has been the design and the realization of a Magnetostatic Field System for Exposure of Cell cultures (MaFiSEC) for the uniform and the reproducible exposure of cell cultures to static magnetic fields (SMFs) of moderate magnetic induction. Experimental and computer-simulated physical measurements show that MaFiSEC: i) generates a SMF with magnetic induction that can be chosen in the range of 3 to 20 mT; ii) allows the uniform SMF exposure of cells growing in adhesion and in suspension; iii) is cheap and easy to use. The efficacy and reproducibility of MaFiSEC has been tested by comparing the biological effects exerted on isolated human lymphocytes by 72 h of exposure to a magnet (i.e. Neodymium Magnetic Disk, NMD) placed under the culture Petri dish. Lymphocytes morphology, viability, cell death, oxidative stress and lysosomes activity were the parameters chosen to evaluate the SMF biological effects. The continuous exposure of cells to a uniform SMF, achieved with MaFiSEC, allows highly reproducible biochemical and morphological data.	[Vergallo, Cristian; Piccoli, Claudia; Romano, Alberto; Panzarini, Elisa; Manno, Daniela; Dini, Luciana] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy; [Serra, Antonio] Univ Salento, Dept Mat Sci, Lecce, Italy	University of Salento; University of Salento	Dini, L (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy.	luciana.dini@unisalento.it	Manno, Daniela/F-2745-2017; Serra, Antonio/B-3676-2014; Vergallo, Cristian/J-4303-2019	Manno, Daniela/0000-0002-5843-8772; Serra, Antonio/0000-0003-3380-7751; Vergallo, Cristian/0000-0002-0264-4753; Panzarini, Elisa/0000-0003-4219-4272				Amara S, 2007, PHYS MED BIOL, V52, P889, DOI 10.1088/0031-9155/52/4/002; BAEHNER RL, 1976, BLOOD, V48, P309; Chionna A, 2005, BIOELECTROMAGNETICS, V26, P275, DOI 10.1002/bem.20081; Chionna A, 2003, EUR J HISTOCHEM, V47, P299, DOI 10.4081/840; Dini L, 2005, MICRON, V36, P195, DOI 10.1016/j.micron.2004.12.009; Dini L., 2003, European Journal of Histochemistry, V47, P265; Dini L, 2010, EXP BIOL MED, V235, P1432, DOI 10.1258/ebm.2010.010122; Dini L, 2009, BIOELECTROMAGNETICS, V30, P352, DOI 10.1002/bem.20474; Henry Steven L, 2008, Eplasty, V8, pe40; Ishisaka, 2000, Pathophysiology, V7, P149, DOI 10.1016/S0928-4680(00)00043-2; Jajte J, 2001, J OCCUP HEALTH, V43, P379, DOI 10.1539/joh.43.379; Kheifets LI, 2001, BIOELECTROMAGNETICS, pS120, DOI 10.1002/1521-186X(2001)22:5+<::AID-BEM1028>3.0.CO;2-Y; Kubinyi G, 2010, BIOELECTROMAGNETICS, V31, P488, DOI 10.1002/bem.20577; Laszlo J, 2007, BIOELECTROMAGNETICS, V28, P615, DOI 10.1002/bem.20341; Meshkini Azadeh, 2009, IRANIAN BIOMEDICAL JOURNAL, V13, P35; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Repacholi MH, 1999, BIOELECTROMAGNETICS, V20, P133, DOI 10.1002/(SICI)1521-186X(1999)20:3<133::AID-BEM1>3.0.CO;2-O; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Rosen AD, 2003, CELL BIOCHEM BIOPHYS, V39, P163, DOI 10.1385/CBB:39:2:163; Rosen AD, 2009, BIOELECTROMAGNETICS, V30, P114, DOI 10.1002/bem.20452; Rumbaut RE, 2008, AM J PHYSIOL-HEART C, V294, pH19, DOI 10.1152/ajpheart.01342.2007; Sarimov R, 2005, BIOELECTROMAGNETICS, V26, P631, DOI 10.1002/bem.20146; Saunders R, 2005, PROG BIOPHYS MOL BIO, V87, P225, DOI 10.1016/j.pbiomolbio.2004.09.001; Shen JF, 2007, NEUROSCI LETT, V415, P164, DOI 10.1016/j.neulet.2007.01.015; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; SLADOWSKI D, 1993, J IMMUNOL METHODS, V157, P203, DOI 10.1016/0022-1759(93)90088-O; Sullivan K, 2011, BIOELECTROMAGNETICS, V32, P140, DOI 10.1002/bem.20624; Tenuzzo B, 2009, TISSUE CELL, V41, P169, DOI 10.1016/j.tice.2008.09.004; Tenuzzo B, 2006, BIOELECTROMAGNETICS, V27, P560, DOI 10.1002/bem.20252; Waliszewski P, 1999, J PHOTOCH PHOTOBIO B, V52, P137, DOI 10.1016/S1011-1344(99)90000-3; Wartenberg D, 2001, BIOELECTROMAGNETICS, pS86, DOI 10.1002/1521-186X(2001)22:5+<::AID-BEM1026>3.0.CO;2-3; Yamashita K, 2001, ELECTR ENG JPN, V137, P36, DOI 10.1002/eej.1078; Yano A, 2001, BIOELECTROMAGNETICS, V22, P194, DOI 10.1002/bem.38; Zmyslony M, 2000, MUTAT RES-FUND MOL M, V453, P89, DOI 10.1016/S0027-5107(00)00094-4	34	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72341	10.1371/journal.pone.0072341	http://dx.doi.org/10.1371/journal.pone.0072341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977284	gold, Green Published, Green Submitted			2022-12-25	WOS:000324527300081
J	Hrabovszky, E; Borsay, BA; Racz, K; Herczeg, L; Ciofi, P; Bloom, SR; Ghatei, MA; Dhillo, WS; Liposits, Z				Hrabovszky, Erik; Borsay, Beata A.; Racz, Kalman; Herczeg, Laszlo; Ciofi, Philippe; Bloom, Stephen R.; Ghatei, Mohammad A.; Dhillo, Waljit S.; Liposits, Zsolt			Substance P Immunoreactivity Exhibits Frequent Colocalization with Kisspeptin and Neurokinin B in the Human Infundibular Region	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; MONKEY MACACA-MULATTA; MESSENGER RIBONUCLEIC-ACIDS; PITUITARY-GONADAL AXIS; ARCUATE NUCLEUS; GENE-EXPRESSION; POSTMENOPAUSAL WOMEN; ANTERIOR-PITUITARY; PULSE-GENERATOR; KISS1 NEURONS	Neurons synthesizing neurokinin B (NKB) and kisspeptin (KP) in the hypothalamic arcuate nucleus represent important upstream regulators of pulsatile gonadotropin-releasing hormone (GnRH) neurosecretion. In search of neuropeptides co-expressed in analogous neurons of the human infundibular nucleus (Inf), we have carried out immunohistochemical studies of the tachykinin peptide Substance P (SP) in autopsy samples from men (21-78 years) and postmenopausal (53-83 years) women. Significantly higher numbers of SP-immunoreactive (IR) neurons and darker labeling were observed in the Inf of postmenopausal women than in age-matched men. Triple-immunofluorescent studies localized SP immunoreactivity to considerable subsets of KP-IR and NKB-IR axons and perikarya in the infundibular region. In postmenopausal women, 25.1% of NKB-IR and 30.6% of KP-IR perikarya contained SP and 16.5% of all immunolabeled cell bodies were triple-labeled. Triple-, double-and single-labeled SP-IR axons innervated densely the portal capillaries of the infundibular stalk. In quadruple-labeled sections, these axons formed occasional contacts with GnRH-IR axons. Presence of SP in NKB and KP neurons increases the functional complexity of the putative pulse generator network. First, it is possible that SP modulates the effects of KP and NKB in axo-somatic and axo-dendritic afferents to GnRH neurons. Intrinsic SP may also affect the activity and/or neuropeptide release of NKB and KP neurons via autocrine/paracrine actions. In the infundibular stalk, SP may influence the KP and NKB secretory output via additional autocrine/paracrine mechanisms or regulate GnRH neurosecretion directly. Finally, possible co-release of SP with KP and NKB into the portal circulation could underlie further actions on adenohypophysial gonadotrophs.	[Hrabovszky, Erik; Borsay, Beata A.; Liposits, Zsolt] Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary; [Borsay, Beata A.; Racz, Kalman; Herczeg, Laszlo] Univ Debrecen, Fac Med, Dept Forens Med, H-4012 Debrecen, Hungary; [Ciofi, Philippe] Neuroctr Magendie, INSERM, U862, Bordeaux, France; [Bloom, Stephen R.; Ghatei, Mohammad A.; Dhillo, Waljit S.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Invest Med, London, England; [Liposits, Zsolt] Pazmany Peter Catholic Univ, Fac Informat Technol, Dept Neurosci, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Debrecen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Imperial College London	Hrabovszky, E (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary.	hrabovszky.erik@koki.hu	Liposits, Zsolt/K-8145-2019; Ciofi, Philippe/N-7009-2017	Ciofi, Philippe/0000-0001-6339-9977; Dhillo, Waljit/0000-0001-5950-4316; Hrabovszky, Erik/0000-0001-6927-0015; Liposits, Zsolt/0000-0002-3508-2750	National Science Foundation of Hungary [OTKA K83710, K100722]; National Development Agency [BONUS HU 08/2-2011-0006]; European Community's Seventh Framework Programme (FP7) [245009]; Medical Research Council [G1000455, G0701679, G0000566] Funding Source: researchfish; National Institute for Health Research [CDF-2009-02-05] Funding Source: researchfish; MRC [G1000455, G0000566, G0701679] Funding Source: UKRI	National Science Foundation of Hungary; National Development Agency; European Community's Seventh Framework Programme (FP7); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research leading to these results has received funding from the National Science Foundation of Hungary (OTKA K83710, K100722), the National Development Agency (BONUS HU 08/2-2011-0006) and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no245009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN ER, 1990, ENDOCRINOLOGY, V126, P330, DOI 10.1210/endo-126-1-330; Burke MC, 2006, J COMP NEUROL, V498, P712, DOI 10.1002/cne.21086; CONTI F, 1992, J COMP NEUROL, V322, P136, DOI 10.1002/cne.903220111; COSLOVSKY R, 1985, ENDOCRINOLOGY, V117, P2198, DOI 10.1210/endo-117-5-2198; CUELLO AC, 1979, P NATL ACAD SCI USA, V76, P3532, DOI 10.1073/pnas.76.7.3532; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; Dhillo WS, 2005, J CLIN ENDOCR METAB, V90, P6609, DOI 10.1210/jc.2005-1468; Dudas B, 2002, J CLIN ENDOCR METAB, V87, P2946, DOI 10.1210/jc.87.6.2946; Dufourny L, 1999, NEUROSCI RES, V33, P223, DOI 10.1016/S0168-0102(99)00009-7; Duval P, 1998, J NEUROENDOCRINOL, V10, P823; Eckersell CB, 1997, NEUROSCIENCE, V80, P473, DOI 10.1016/S0306-4522(97)00072-9; Goodman RL, 2007, ENDOCRINOLOGY, V148, P5752, DOI 10.1210/en.2007-0961; Gottsch ML, 2011, ENDOCRINOLOGY, V152, P4298, DOI 10.1210/en.2011-1521; HABER S, 1981, NEUROSCIENCE, V6, P1291, DOI 10.1016/0306-4522(81)90188-3; Herbison AE, 1998, ENDOCR REV, V19, P302, DOI 10.1210/edrv.19.3.0332; HOKFELT T, 1978, P NATL ACAD SCI USA, V75, P1013, DOI 10.1073/pnas.75.2.1013; Hopman AHN, 1998, J HISTOCHEM CYTOCHEM, V46, P771, DOI 10.1177/002215549804600611; Hrabovszky E, 2007, J CLIN ENDOCR METAB, V92, P2827, DOI 10.1210/jc.2006-2819; Hrabovszky E, 2010, EUR J NEUROSCI, V31, P1984, DOI 10.1111/j.1460-9568.2010.07239.x; Hrabovszky E, 2012, ENDOCRINOLOGY, V153, P4978, DOI 10.1210/en.2012-1545; Hrabovszky Erik, 2011, Front Endocrinol (Lausanne), V2, P80, DOI 10.3389/fendo.2011.00080; Lasaga M, 2011, PEPTIDES, V32, P1972, DOI 10.1016/j.peptides.2011.07.009; Lehman MN, 2010, ENDOCRINOLOGY, V151, P3479, DOI 10.1210/en.2010-0022; LIPOSITS Z, 1984, NEUROSCIENCE, V13, P513, DOI 10.1016/0306-4522(84)90245-8; MAI JK, 1986, NEUROSCIENCE, V17, P709, DOI 10.1016/0306-4522(86)90041-2; Mittelman-Smith MA, 2012, ENDOCRINOLOGY, V153, P2800, DOI 10.1210/en.2012-1045; Molnar CS, 2012, ENDOCRINOLOGY, V153, P5428, DOI 10.1210/en.2012-1739; Navarro VM, 2011, ENDOCRINOLOGY, V152, P4265, DOI 10.1210/en.2011-1143; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; Navarro VM, 2013, ANN M END SOC CA US; Ohkura S, 2009, J NEUROENDOCRINOL, V21, P813, DOI 10.1111/j.1365-2826.2009.01909.x; Okamura H, 2010, J NEUROENDOCRINOL, V22, P825, DOI 10.1111/j.1365-2826.2010.02037.x; Ortega HH, 2006, REPROD DOMEST ANIM, V41, P204, DOI 10.1111/j.1439-0531.2006.00669.x; Pennefather JN, 2004, LIFE SCI, V74, P1445, DOI 10.1016/j.lfs.2003.09.039; PRIEST CA, 1995, MOL BRAIN RES, V28, P61, DOI 10.1016/0169-328X(94)00184-G; Ramaswamy S, 2008, ENDOCRINOLOGY, V149, P4387, DOI 10.1210/en.2008-0438; Ramaswamy S, 2010, ENDOCRINOLOGY, V151, P4494, DOI 10.1210/en.2010-0223; RANCE NE, 1994, NEUROENDOCRINOLOGY, V60, P337, DOI 10.1159/000126768; RANCE NE, 1991, ENDOCRINOLOGY, V128, P2239, DOI 10.1210/endo-128-5-2239; Rometo AM, 2008, J NEUROENDOCRINOL, V20, P1376, DOI 10.1111/j.1365-2826.2008.01796.x; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Shibata M, 2007, J NEUROENDOCRINOL, V19, P432, DOI 10.1111/j.1365-2826.2007.01549.x; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010; Zimmer A, 1998, P NATL ACAD SCI USA, V95, P2630, DOI 10.1073/pnas.95.5.2630	44	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72369	10.1371/journal.pone.0072369	http://dx.doi.org/10.1371/journal.pone.0072369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977290	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000323425700167
J	Janse, M; de Rooij, BJF; van Hoek, B; van den Berg, AP; Porte, RJ; Blokzijl, H; Coenraad, MJ; Hepkema, BG; Schaapherder, AF; Ringers, J; Weersma, RK; Verspaget, HW				Janse, Marcel; de Rooij, Bert-Jan F.; van Hoek, Bart; van den Berg, Arie P.; Porte, Robert J.; Blokzijl, Hans; Coenraad, Minneke J.; Hepkema, Bouke G.; Schaapherder, Alexander F.; Ringers, Jan; Weersma, Rinse K.; Verspaget, Hein W.			Recipient's Genetic R702W NOD2 Variant Is Associated with an Increased Risk of Bacterial Infections after Orthotopic Liver Transplantation	PLOS ONE			English	Article							CROHNS-DISEASE; NOD2/CARD15; MUTATIONS; DONOR; GUT; SUSCEPTIBILITY; POLYMORPHISMS; PERITONITIS; MORTALITY; BARRIER	Introduction: Orthotopic liver transplantation (OLT) is accompanied by a significant postoperative infection risk. Immunosuppression to prevent rejection increases the susceptibility to infections, mainly by impairing the adaptive immune system. Genetic polymorphisms in the lectin complement pathway of the donor have recently been identified as important risk determinants of clinically significant bacterial infection (CSI) after OLT. Another genetic factor involved in innate immunity is NOD2, which was reported to be associated with increased risk of spontaneous bacterial peritonitis in cirrhotic patients. Methods: We assessed association of three genetic NOD2 variants (R702W, G908R and 3020insC) with increased risk of CSI after OLT. 288 OLT recipient-donor pairs from two tertiary referral centers were genotyped for the three NOD2 variants. The probability of CSI in relation to NOD2 gene variants was determined with cumulative incidence curves and log-rank analysis. Results: The R702W NOD2 variant in the recipient was associated with CSI after OLT. Eight out of 15 (53.3%) individuals with a mutated genotype compared to 80/273 (29.3%) with wild type genotype developed CSI (p=0.027, univariate cox regression), illustrated by a higher frequency of CSI after OLT over time (p=0.0003, log rank analysis). Multivariate analysis (including the donor lectin complement pathway profile) showed independence of this R702W NOD2 association from other risk factors (HR 2.0; p=0.04). The other NOD2 variants, G908R and 3020insC, in the recipient were not associated with CSI. There was no association with CSI after OLT for any of the NOD2 variants in the donor. Conclusion: The mutated NOD2 R702W genotype in the recipient is independently associated with an increased risk of bacterial infections after liver transplantation, indicating a predisposing role for this genetic factor impairing the recipient's innate immune system.	[Janse, Marcel; van den Berg, Arie P.; Blokzijl, Hans; Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Janse, Marcel; van den Berg, Arie P.; Porte, Robert J.; Blokzijl, Hans; Hepkema, Bouke G.; Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [de Rooij, Bert-Jan F.; van Hoek, Bart; Coenraad, Minneke J.; Verspaget, Hein W.] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands; [Porte, Robert J.] Univ Groningen, Univ Med Ctr Groningen, Dept Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands; [Hepkema, Bouke G.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Schaapherder, Alexander F.; Ringers, Jan] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands	University of Groningen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Verspaget, HW (corresponding author), Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands.	H.W.Verspaget@lumc.nl	van Hoek, Bart/AAU-8953-2020; Coenraad, Minneke/AAU-1684-2020; Weersma, Rinse/ABE-3807-2021; Ringers, Jan/Q-8382-2016	Coenraad, Minneke/0000-0002-3434-4421; Ringers, Jan/0000-0001-5007-7354; van Hoek, Bart/0000-0001-6527-764X	Netherlands Organization for Scientific Research [90.700.281]; Netherlands Organisation for Health Research and Development [AGIKO 2010/15659/]; Dutch Digestive Foundation [WO 07-18]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch Digestive Foundation	RKW is supported by a clinical fellowship grant (90.700.281) from the Netherlands Organization for Scientific Research. BJFdR is supported by grants from The Netherlands Organisation for Health Research and Development (AGIKO 2010/15659/) and the Dutch Digestive Foundation (WO 07-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenrodt B, 2010, HEPATOLOGY, V51, P1327, DOI 10.1002/hep.23440; Blair JE, 2005, LIVER TRANSPLANT, V11, P1452, DOI 10.1002/lt.20624; Bouwman LH, 2005, GASTROENTEROLOGY, V129, P408, DOI 10.1053/j.gastro.2005.06.049; Braun JP, 2007, J INT MED RES, V35, P72, DOI 10.1177/147323000703500107; Brenmoehl J, 2007, INTENS CARE MED, V33, P1541, DOI 10.1007/s00134-007-0722-z; de Rooij BJF, 2010, HEPATOLOGY, V52, P1100, DOI 10.1002/hep.23782; Demetris AJ, 1997, HEPATOLOGY, V25, P658; Derikx JPM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003954; Dutkowski P, 2010, GASTROENTEROLOGY, V138, P802, DOI 10.1053/j.gastro.2010.01.030; Fishbein T, 2008, GUT, V57, DOI 10.1136/gut.2007.133322; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Holler E, 2006, BLOOD, V107, P4189, DOI 10.1182/blood-2005-09-3741; Holler E, 2004, BLOOD, V104, P889, DOI 10.1182/blood-2003-10-3543; Hugot JP, 2007, AM J GASTROENTEROL, V102, P1259, DOI 10.1111/j.1572-0241.2007.01149.x; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Janse M, 2011, GUT, V60, P877, DOI 10.1136/gut.2009.196238; Krueger B, 2007, TRANSPL INT, V20, P600, DOI 10.1111/j.1432-2277.2007.00486.x; Lee SO, 2011, LIVER TRANSPLANT, V17, P1081, DOI 10.1002/lt.22327; Nguyen Y, 2010, BLOOD, V115, P3625, DOI 10.1182/blood-2009-09-243840; Ningappa M, 2011, AM J GASTROENTEROL, V106, P157, DOI 10.1038/ajg.2010.322; Nischalke HD, 2011, J HEPATOL, V55, P1010, DOI 10.1016/j.jhep.2011.02.022; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Roedder S, 2011, GENOME MED, V3, DOI 10.1186/gm253; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; van Hoek B, 2012, BEST PRACT RES CL GA, V26, P61, DOI 10.1016/j.bpg.2012.01.004; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632	30	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72617	10.1371/journal.pone.0072617	http://dx.doi.org/10.1371/journal.pone.0072617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977330	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700182
J	Li, SJ; Li, Y; Cui, SC; Qi, Y; Zhao, JJ; Liu, XY; Xu, P; Chen, XH				Li, Shu-Jing; Li, Ya; Cui, Shi-chao; Qi, Yao; Zhao, Jing-Jing; Liu, Xiao-Yan; Xu, Ping; Chen, Xian-Hua			Splicing Factor Transformer-2 beta (Tra2 beta) Regulates the Expression of Regulator of G Protein Signaling 4 (RGS4) Gene and Is Induced by Morphine	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEINS; OPIOID-RECEPTOR GENE; MESSENGER-RNA LEVELS; SR PROTEINS; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; SUBCELLULAR-LOCALIZATION; DIFFERENTIAL MODULATION; NUCLEAR-LOCALIZATION; PERIAQUEDUCTAL GRAY	Regulator of G protein signaling 4 (RGS4) is a critical modulator of G protein-coupled receptor (GPCR)-mediated signaling and plays important roles in many neural process and diseases. Particularly, drug-induced alteration in RGS4 protein levels is associated with acute and chronic effects of drugs of abuse. However, the precise mechanism underlying the regulation of RGS4 expression is largely unknown. Here, we demonstrated that the expression of RGS4 gene was subject to regulation by alternative splicing of the exon 6. Transformer-2 beta (Tra2 beta), an important splicing factor, bound to RGS4 mRNA and increased the relative level of RGS4-1 mRNA isoform by enhancing the inclusion of exon 6. Meanwhile, Tra2 beta increased the expression of full-length RGS4 protein. In rat brain, Tra2 beta was co-localized with RGS4 in multiple opioid action-related brain regions. In addition, the acute and chronic morphine treatment induced alteration in the expression level of Tra2 beta in rat locus coerulus (LC) in parallel to that of RGS4 proteins. It suggests that induction of this splicing factor may contribute to the change of RGS4 level elicited by morphine. Taken together, the results provide the evidence demonstrating the function of Tra2 beta as a new mediator in opioid-induced signaling pathway via regulating RGS4 expression.	[Li, Shu-Jing; Li, Ya; Cui, Shi-chao; Qi, Yao; Zhao, Jing-Jing; Liu, Xiao-Yan; Xu, Ping; Chen, Xian-Hua] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Li, Shu-Jing; Li, Ya; Cui, Shi-chao; Qi, Yao; Zhao, Jing-Jing; Liu, Xiao-Yan; Xu, Ping; Chen, Xian-Hua] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Dept Neurobiol, Shanghai 200433, Peoples R China; [Li, Shu-Jing; Chen, Xian-Hua] Fudan Univ, Shanghai Med Coll, Lab Genom Physiol, Shanghai 200433, Peoples R China; [Li, Shu-Jing; Chen, Xian-Hua] Fudan Univ, Shanghai Med Coll, Inst Brain Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Chen, XH (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China.	xhchen@fudan.edu.cn		Li, Shujing/0000-0003-2793-3065	National Foundation of Natural Sciences of China [30770661, 30971464, 81030020]; Shanghai Leading Academic Discipline Project [B111]	National Foundation of Natural Sciences of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by grants from the National Foundation of Natural Sciences of China (No. 30770661, 30971464,81030020), and the Shanghai Leading Academic Discipline Project (No. B111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benderska N, 2010, BBA-GENE REGUL MECH, V1799, P448, DOI 10.1016/j.bbagrm.2010.01.003; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bishop GB, 2002, NEUROBIOL DIS, V10, P334, DOI 10.1006/nbdi.2002.0518; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Chatterjee TK, 2000, J BIOL CHEM, V275, P29660, DOI 10.1074/jbc.M000330200; Chatterjee TK, 2003, J BIOL CHEM, V278, P30261, DOI 10.1074/jbc.M212687200; Chatterjee TK, 1997, J BIOL CHEM, V272, P15481, DOI 10.1074/jbc.272.24.15481; Chen XH, 2004, CELL BIOL INT, V28, P791, DOI 10.1016/j.cellbi.2004.07.009; Chen XH, 2003, CELL BIOL INT, V27, P491, DOI 10.1016/S1065-6995(03)00072-6; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; D'Souza I, 2006, J BIOL CHEM, V281, P2460, DOI 10.1074/jbc.M505809200; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; Ding L, 2007, GENE, V401, P46, DOI 10.1016/j.gene.2007.07.002; Emilsson L, 2006, SYNAPSE, V59, P173, DOI 10.1002/SYN.20226; Erdely HA, 2006, SYNAPSE, V59, P472, DOI 10.1002/syn.20265; Erdely HA, 2004, EUR J NEUROSCI, V19, P3125, DOI 10.1111/j.0953-816X.2004.03364.x; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; FU XD, 1995, RNA, V1, P663; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; Gold SJ, 2003, EUR J NEUROSCI, V17, P971, DOI 10.1046/j.1460-9568.2003.02529.x; Gold SJ, 1997, J NEUROSCI, V17, P8024; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Granneman JG, 1998, MOL PHARMACOL, V54, P687; Graveley BR, 1998, MOL CELL, V1, P765, DOI 10.1016/S1097-2765(00)80076-3; Grillet N, 2003, J NEUROSCI, V23, P10613; Gris P, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-33; GUIMARAES APC, 1994, BRAIN RES, V647, P220, DOI 10.1016/0006-8993(94)91321-8; Han MH, 2010, BIOL PSYCHIAT, V67, P761, DOI 10.1016/j.biopsych.2009.08.041; HELMSTETTER FJ, 1994, J NEUROSCI, V14, P7099; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hooks SB, 2008, BIOCHEM PHARMACOL, V75, P76, DOI 10.1016/j.bcp.2007.07.045; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Itoh M, 2006, J NEUROCHEM, V99, P1505, DOI 10.1111/j.1471-4159.2006.04220.x; Jiang ZH, 2003, J BIOL CHEM, V278, P18997, DOI 10.1074/jbc.M301800200; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Kiryu-Seo S, 1998, MOL BRAIN RES, V62, P220, DOI 10.1016/S0169-328X(98)00255-1; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; LaneLadd SB, 1997, J NEUROSCI, V17, P7890; Larminie C, 2004, MOL BRAIN RES, V122, P24, DOI 10.1016/j.molbrainres.2003.11.014; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Leontiadis LJ, 2009, CELL SIGNAL, V21, P1218, DOI 10.1016/j.cellsig.2009.03.013; Lerner TN, 2012, NEURON, V73, P347, DOI 10.1016/j.neuron.2011.11.015; Li SJ, 2013, J BIOL CHEM, V288, P8898, DOI 10.1074/jbc.M113.456715; Liang YB, 2005, FEBS J, V272, P791, DOI 10.1111/j.1742-4658.2004.04516.x; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; MATSUO N, 1995, J BIOL CHEM, V270, P28216, DOI 10.1074/jbc.270.47.28216; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Moyer RA, 2011, NEUROPSYCHOPHARMACOL, V36, P753, DOI 10.1038/npp.2010.208; Muma NA, 2003, SYNAPSE, V47, P58, DOI 10.1002/syn.10153; Ni YG, 1999, J NEUROSCI, V19, P3674; Pan YX, 2005, DNA CELL BIOL, V24, P736, DOI 10.1089/dna.2005.24.736; Paspalas CD, 2009, CEREB CORTEX, V19, P2145, DOI 10.1093/cercor/bhn235; Rahman Z, 1999, J NEUROSCI, V19, P2016; RASMUSSEN K, 1990, J NEUROSCI, V10, P2308; Rivero G, 2012, NEUROPHARMACOLOGY, V62, P1044, DOI 10.1016/j.neuropharm.2011.10.015; Saito M, 2003, ALCOHOL, V29, P39, DOI 10.1016/S0741-8329(02)00322-1; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Schwendt M, 2006, J NEUROCHEM, V96, P1606, DOI 10.1111/j.1471-4159.2006.03669.x; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Suzuki T, 1997, PHARMACOL BIOCHEM BE, V57, P293, DOI 10.1016/S0091-3057(96)00319-X; Talbot JN, 2010, J NEUROCHEM, V112, P1026, DOI 10.1111/j.1471-4159.2009.06519.x; TOLLE TR, 1994, NEUROSCIENCE, V58, P305, DOI 10.1016/0306-4522(94)90037-X; Tosetti P, 2003, J PHYSIOL-LONDON, V549, P157, DOI 10.1113/jphysiol.2002.034439; Wang Q, 2009, J BIOL CHEM, V284, P18357, DOI 10.1074/jbc.M109.015453; Wang ZH, 2011, NEUROCHEM RES, V36, P1027, DOI 10.1007/s11064-011-0443-0; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Xie GX, 2005, J MOL BIOL, V353, P1081, DOI 10.1016/j.jmb.2005.09.040; Xie GX, 2005, ANESTH ANALG, V100, P1034, DOI 10.1213/01.ANE.0000147711.51122.4B; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009	76	43	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72220	10.1371/journal.pone.0072220	http://dx.doi.org/10.1371/journal.pone.0072220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977258	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700151
J	Satarian, L; Javan, M; Kiani, S; Hajikaram, M; Mirnajafi-Zadeh, J; Baharvand, H				Satarian, Leila; Javan, Mohammad; Kiani, Sahar; Hajikaram, Maryam; Mirnajafi-Zadeh, Javad; Baharvand, Hossein			Engrafted Human Induced Pluripotent Stem Cell-Derived Anterior Specified Neural Progenitors Protect the Rat Crushed Optic Nerve	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; FUNCTIONAL RECOVERY; DIFFERENTIATION; SURVIVAL; TRANSPLANTATION; GENERATION; INJURY; MODEL; DEGENERATION; INTEGRATION	Background: Degeneration of retinal ganglion cells (RGCs) is a common occurrence in several eye diseases. This study examined the functional improvement and protection of host RGCs in addition to the survival, integration and neuronal differentiation capabilities of anterior specified neural progenitors (NPs) following intravitreal transplantation. Methodology/Principal Findings: NPs were produced under defined conditions from human induced pluripotent stem cells (hiPSCs) and transplanted into rats whose optic nerves have been crushed (ONC). hiPSCs were induced to differentiate into anterior specified NPs by the use of Noggin and retinoic acid. The hiPSC-NPs were labeled by green fluorescent protein or a fluorescent tracer 1,19 -dioctadecyl-3,3,39,39-tetramethylindocarbocyanine perchlorate (DiI) and injected two days after induction of ONC in hooded rats. Functional analysis according to visual evoked potential recordings showed significant amplitude recovery in animals transplanted with hiPSC-NPs. Retrograde labeling by an intra-collicular DiI injection showed significantly higher numbers of RGCs and spared axons in ONC rats treated with hiPSC-NPs or their conditioned medium (CM). The analysis of CM of hiPSC-NPs showed the secretion of ciliary neurotrophic factor, basic fibroblast growth factor, and insulin-like growth factor. Optic nerve of cell transplanted groups also had increased GAP43 immunoreactivity and myelin staining by FluoroMyelin (TM) which imply for protection of axons and myelin. At 60 days post-transplantation hiPSC-NPs were integrated into the ganglion cell layer of the retina and expressed neuronal markers. Conclusions/Significance: The transplantation of anterior specified NPs may improve optic nerve injury through neuroprotection and differentiation into neuronal lineages. These NPs possibly provide a promising new therapeutic approach for traumatic optic nerve injuries and loss of RGCs caused by other diseases.	[Satarian, Leila; Javan, Mohammad; Mirnajafi-Zadeh, Javad] Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran; [Kiani, Sahar; Hajikaram, Maryam; Baharvand, Hossein] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Stem Cells & Dev Biol, Tehran, Iran; [Baharvand, Hossein] Univ Sci & Culture, ACECR, Dept Dev Biol, Tehran, Iran	Tarbiat Modares University; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR)	Javan, M (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran.	mjavan@modares.ac.ir; baharvand@royaninstitute.org	Mirnajafi-Zadeh, Javad/W-5379-2019; Kiani, Sahar/AAO-3557-2020; Satarian, Leila/M-3835-2017; Javan, Mohammad/C-6758-2008; Mirnajafi-Zadeh, Javad/AAD-4822-2022	Mirnajafi-Zadeh, Javad/0000-0003-3946-9052; Kiani, Sahar/0000-0001-7779-9998; Satarian, Leila/0000-0002-5068-5031; Javan, Mohammad/0000-0003-2045-6171; 	Royan Institute Research Affairs [199]; Tarbiat Modares University	Royan Institute Research Affairs; Tarbiat Modares University	The authors are thankful to Royan Institute Research Affairs for providing facilities and support for performing the experiments (grant #199). The project also received support from Tarbiat Modares University as a PhD dissertation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharvand H, 2010, METHODS MOL BIOL, V584, P425, DOI 10.1007/978-1-60761-369-5_23; Banin E, 2006, STEM CELLS, V24, P246, DOI 10.1634/stemcells.2005-0009; Bull ND, 2008, INVEST OPHTH VIS SCI, V49, P3449, DOI 10.1167/iovs.08-1770; Carr AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008152; Chen MF, 2010, INVEST OPHTH VIS SCI, V51, P5970, DOI 10.1167/iovs.09-4504; Dhara SK, 2008, J CELL BIOCHEM, V105, P633, DOI 10.1002/jcb.21891; Hanke J, 2002, ANN ANAT, V184, P113, DOI 10.1016/S0940-9602(02)80002-4; Hellstrom M, 2011, CURR GENE THER, V11, P116, DOI 10.2174/156652311794940746; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Inoue Y, 2007, EXP EYE RES, V85, P234, DOI 10.1016/j.exer.2007.04.007; Jagatha B, 2009, BIOCHEM BIOPH RES CO, V380, P230, DOI 10.1016/j.bbrc.2009.01.038; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P960, DOI 10.1167/iovs.09-3884; Khurgel M, 1996, GLIA, V16, P351, DOI 10.1002/(SICI)1098-1136(199604)16:4<351::AID-GLIA7>3.0.CO;2-2; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Klassen HJ, 2003, CYTOKINE, V22, P101, DOI 10.1016/S1043-4666(03)00120-0; Ko ML, 2001, NEUROSCI LETT, V305, P139, DOI 10.1016/S0304-3940(01)01830-4; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kokkinaki M, 2011, STEM CELLS, V29, P825, DOI 10.1002/stem.635; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; Logan A, 2006, BRAIN, V129, P490, DOI 10.1093/brain/awh706; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Meyer JS, 2006, STEM CELLS, V24, P274, DOI 10.1634/stemcells.2005-0059; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Mozafari S, 2010, BRAIN RES, V1351, P50, DOI 10.1016/j.brainres.2010.07.026; Mu XQ, 2004, SEMIN CELL DEV BIOL, V15, P115, DOI 10.1016/j.semcdb.2003.09.009; Nemati S, 2011, STEM CELLS DEV, V20, P503, DOI 10.1089/scd.2010.0143; Niapour A, 2012, CELL TRANSPLANT, V21, P827, DOI 10.3727/096368911X593163; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z; Parameswaran S, 2010, STEM CELLS, V28, P695, DOI 10.1002/stem.320; Paxinos G., 2007, RAT BRAIN STEREOTAXI, VVol. 6; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Polentes J, 2012, CELL TRANSPLANT, V21, P2587, DOI 10.3727/096368912X653228; Pouya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027925; SABEL BA, 1993, NEUROPSYCHOBIOLOGY, V28, P62, DOI 10.1159/000119001; Salehi H, 2012, STEM CELL RES, V8, P120, DOI 10.1016/j.scr.2011.08.008; SAUTTER J, 1993, EUR J NEUROSCI, V5, P680, DOI 10.1111/j.1460-9568.1993.tb00533.x; Schmeer C, 2002, EUR J NEUROSCI, V15, P637, DOI 10.1046/j.1460-9568.2002.01893.x; Shaham O, 2012, PROG RETIN EYE RES, V31, P351, DOI 10.1016/j.preteyeres.2012.04.002; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TANSLEY K, 1946, J EXP BIOL, V22, P221; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Totonchi M, 2010, INT J DEV BIOL, V54, P877, DOI 10.1387/ijdb.092903mt; Tucker BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018992; West EL, 2008, EXP EYE RES, V86, P601, DOI 10.1016/j.exer.2008.01.004; Yang QT, 2012, J TRAUMA ACUTE CARE, V72, P1350, DOI 10.1097/TA.0b013e3182493c70; Young MJ, 2000, MOL CELL NEUROSCI, V16, P197, DOI 10.1006/mcne.2000.0869	48	29	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71855	10.1371/journal.pone.0071855	http://dx.doi.org/10.1371/journal.pone.0071855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977164	gold, Green Published			2022-12-25	WOS:000323425700107
J	Toque, HA; Nunes, KP; Yao, L; Xu, ZM; Kondrikov, D; Su, YC; Webb, RC; Caldwell, RB; Caldwell, RW				Toque, Haroldo A.; Nunes, Kenia P.; Yao, Lin; Xu, Zhimin; Kondrikov, Dmitry; Su, Yunchao; Webb, R. Clinton; Caldwell, Ruth B.; Caldwell, R. William			Akita Spontaneously Type 1 Diabetic Mice Exhibit Elevated Vascular Arginase and Impaired Vascular Endothelial and Nitrergic Function	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CORPORA CAVERNOSA; CORPUS CAVERNOSUM; MEDIATED DILATION; OXIDATIVE STRESS; BLOOD-PRESSURE; POSTTRANSLATIONAL MODIFICATION; UP-REGULATION; DYSFUNCTION; EXPRESSION	Background: Elevated arginase (Arg) activity is reported to be involved in diabetes-induced vascular endothelial dysfunction. It can reduce L-arginine availability to nitric oxide (NO) synthase (NOS) and NO production. Akita mice, a genetic non-obese type 1 diabetes model, recapitulate human diabetes. We determined the role of Arg in a time-course of diabetes-associated endothelial dysfunction in aorta and corpora cavernosa (CC) from Akita mice. Methods and Results: Endothelium-dependent relaxation, Arg and NOS activity, and protein expression levels of Arg and constitutive NOS were assessed in aortas and CC from Akita and non-diabetic wild type (WT) mice at 4, 12 and 24 wks of age. Systolic blood pressure (SBP) was assessed by tail cuff. In aorta and CC, Akita mice exhibited a progressive impairment of vascular endothelial and nitrergic function increased Arg activity and expression (Arg1 in aorta and both Arg1 and Arg2 in CC) compared with that of age-matched WT mice. Treatment of aorta and CC from Akita mice with an Arg inhibitor (BEC or ABH) reduced diabetes-induced elevation of Arg activity and restored endothelial and nitrergic function. Reduced levels of phospho-eNOS at Ser(1177) (in aorta and CC) and nNOS expression (in CC) were observed in Akita mice at 12 and 24 wks. Akita mice also had decreased NOS activity in aorta and CC at 12 and 24 wks that was restored by BEC treatment. Further, Akita mice exhibited moderately increased SBP at 24 wks and increased sensitivity to PE-induced contractions in aorta and sympathetic nerve stimulation in CC at 12 and 24 wks. Conclusions: Over 24 wks of diabetes in Akita mice, both aortic and cavernosal tissues exhibited increased Arg activity/expression, contributing to impaired endothelial and nitrergic function and reduced NO production. Our findings demonstrate involvement of Arg activity in diabetes-induced impairment of vascular function in Akita mouse.	[Toque, Haroldo A.; Yao, Lin; Kondrikov, Dmitry; Su, Yunchao; Webb, R. Clinton; Caldwell, R. William] Georgia Regents Univ, Dept Pharmacol & Toxicol, Augusta, GA USA; [Nunes, Kenia P.; Webb, R. Clinton; Caldwell, R. William] Georgia Regents Univ, Dept Physiol, Augusta, GA USA; [Xu, Zhimin; Caldwell, Ruth B.] Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Toque, HA (corresponding author), Georgia Regents Univ, Dept Pharmacol & Toxicol, Augusta, GA USA.	hflorestoque@gru.edu	Xu, Zhimin/L-9853-2013	Caldwell, Ruth/0000-0003-0168-0354; Nunes, Kenia/0000-0002-4838-7617	American Heart Association (Southeast Affiliate) [7990086]; National Institutes of Health [HL-70215, EY-11766]; NATIONAL EYE INSTITUTE [R01EY011766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088261, R01HL070215] Funding Source: NIH RePORTER	American Heart Association (Southeast Affiliate)(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Haroldo A. Toque is funded by a postdoctoral fellowship (7990086) from the American Heart Association (Southeast Affiliate). This study was supported by the National Institutes of Health grants HL-70215 and EY-11766 to RWC and RBC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akingba AG, 2001, MOL UROL, V5, P189, DOI 10.1089/10915360152745885; Angulo J, 2010, J SEX MED, V7, P758, DOI 10.1111/j.1743-6109.2009.01587.x; Bachetti T, 2004, J MOL CELL CARDIOL, V37, P515, DOI 10.1016/j.yjmcc.2004.05.004; Bagnost T, 2008, J HYPERTENS, V26, P1110, DOI 10.1097/HJH.0b013e3282fcc357; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Bivalacqua TJ, 2001, BIOCHEM BIOPH RES CO, V283, P923, DOI 10.1006/bbrc.2001.4874; Bivalacqua TJ, 2004, P NATL ACAD SCI USA, V101, P9121, DOI 10.1073/pnas.0400520101; Chandra S, 2012, BRIT J PHARMACOL, V165, P506, DOI 10.1111/j.1476-5381.2011.01584.x; Cohen RA, 2010, J CARDIOVASC PHARM, V55, P308, DOI 10.1097/FJC.0b013e3181d89670; Cox JD, 1999, NAT STRUCT BIOL, V6, P1043; Demougeot C, 2005, J HYPERTENS, V23, P971, DOI 10.1097/01.hjh.0000166837.78559.93; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; El-Bassossy HM, 2012, VASC PHARMACOL, V57, P194, DOI 10.1016/j.vph.2012.01.001; Escrig A, 2002, BIOL REPROD, V66, P185, DOI 10.1095/biolreprod66.1.185; Federici M, 2002, CIRCULATION, V106, P466, DOI 10.1161/01.CIR.0000023043.02648.51; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08; Hayashi K, 2006, BIOL PHARM BULL, V29, P1110, DOI 10.1248/bpb.29.1110; Hein TW, 2003, FASEB J, V17, P2328, DOI 10.1096/fj.03-0115fje; Ishizaka M, 2007, VASC PHARMACOL, V47, P272, DOI 10.1016/j.vph.2007.08.001; Kanie N, 2000, GEN PHARMACOL-VASC S, V35, P311, DOI 10.1016/S0306-3623(02)00115-5; Kazuyama E, 2009, MOL CELL BIOCHEM, V332, P95, DOI 10.1007/s11010-009-0178-2; Kim JH, 2009, J APPL PHYSIOL, V107, P1249, DOI 10.1152/japplphysiol.91393.2008; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75, DOI 10.1152/ajpendo.2001.280.1.E75; Matsumoto T, 2003, AM J PHYSIOL-HEART C, V285, pH283, DOI 10.1152/ajpheart.00954.2002; Ming XF, 2004, CIRCULATION, V110, P3708, DOI 10.1161/01.CIR.0000142867.26182.32; Morris SM, 2011, DIABETES, V60, P3015, DOI 10.2337/db11-0901; Mumenthaler SM, 2008, INT J ONCOL, V32, P357; Musicki B, 2005, J SEX MED, V2, P347, DOI 10.1111/j.1743-6109.2005.20349.x; Musicki B, 2009, J ANDROL, V30, P352, DOI 10.2164/jandrol.108.006999; Nacci C, 2009, ENDOCRINOLOGY, V150, P849, DOI 10.1210/en.2008-1069; Nangle MR, 2003, DIABETES, V52, P2396, DOI 10.2337/diabetes.52.9.2396; Nascimento NRF, 2006, P NATL ACAD SCI USA, V103, P218, DOI 10.1073/pnas.0509779103; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Romero MJ, 2012, AM J PHYSIOL-HEART C, V302, pH159, DOI 10.1152/ajpheart.00774.2011; Ryoo S, 2008, CIRC RES, V102, P923, DOI 10.1161/CIRCRESAHA.107.169573; Sakai Y, 2004, J UROLOGY, V172, P369, DOI 10.1097/01.ju.0000121691.06417.40; Sankaralingam S, 2010, CARDIOVASC RES, V85, P194, DOI 10.1093/cvr/cvp277; Santhanam L, 2008, J APPL PHYSIOL, V105, P1632, DOI 10.1152/japplphysiol.90627.2008; Taubert D, 2004, DIABETOLOGIA, V47, P2059, DOI 10.1007/s00125-004-1586-1; Thengchaisri N, 2006, ARTERIOSCL THROM VAS, V26, P2035, DOI 10.1161/01.ATV.0000233334.24805.62; Toque HA, 2011, J SEX MED, V8, P722, DOI 10.1111/j.1743-6109.2010.02098.x; Toque HA, 2010, J SEX MED, V7, P3857, DOI 10.1111/j.1743-6109.2010.01996.x; Wei LH, 2001, P NATL ACAD SCI USA, V98, P9260, DOI 10.1073/pnas.161294898; White AR, 2006, HYPERTENSION, V47, P245, DOI 10.1161/01.HYP.0000198543.34502.d7; Yang XQ, 2009, CLIN EXP PHARMACOL P, V36, P764, DOI 10.1111/j.1440-1681.2009.05145.x; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang CH, 2004, HYPERTENSION, V44, P935, DOI 10.1161/01.HYP.0000146907.82869.f2; Zhang CH, 2001, FASEB J, V15, P1264, DOI 10.1096/fj.00-0681fje	52	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72277	10.1371/journal.pone.0072277	http://dx.doi.org/10.1371/journal.pone.0072277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977269	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700159
J	Oh, CM; Jung, KW; Won, YJ; Shin, A; Kong, HJ; Jun, JK; Park, SY				Oh, Chang-Mo; Jung, Kyu-Won; Won, Young-Joo; Shin, Aesun; Kong, Hyun-Joo; Jun, Jae Kwan; Park, Sang-yoon			Trends in the Incidence of In Situ and Invasive Cervical Cancer by Age Group and Histological Type in Korea from 1993 to 2009	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS PREVALENCE; SCREENING-PROGRAM; UNITED-STATES; ADENOCARCINOMA; WOMEN; COUNTRIES; MORTALITY; SURVIVAL; TESTS	Objective: Our study aims to describe changes in carcinoma in situ (CIS) and invasive cervical carcinoma (ICC) in Korean women diagnosed between 1993 and 2009. Methods: All cases of CIS and invasive cervical carcinoma diagnosed from 1993 to 2009 in the Korean National Cancer Incidence database were analyzed. Age-standardized rates (ASRs) and annual percent changes (APCs) in incidence rates were compared according to age and histological type. Additionally, we used Korea National Health and Nutrition Examination Survey (KNHANES) to know the association between screening rate for cervical cancer and incidence rate of cervical cancer. Results: Between 1993 and 2009, 72,240 cases of ICC were reported in Korea. Total incidence rate of ICC was 14.7 per 100,000 females. ASRs of ICC declined 3.8% per year, from 19.3 per 100,000 in 1993 to 10.5 per 100,000 in 2009. Although the overall incidence rate of adenocarcinoma remained stable, invasive squamous cell carcinoma showed a decreasing trend (APC -4.2%). For women aged 60-79 years, ASRs for squamous cell carcinoma increased from 1993 to 2001, and decreased from 2001 to 2009 (APC: -4.6%). Total 62,300 cases of CIS were diagnosed from 1993 to 2009. Total incidence rate of CIS was 12.2 per 100,000 females. ASRs of CIS increased 5.7% per year, from 7.5 per 100,000 in 1993 to 19.0 per 100,000 in 2009. Adenocarcinoma in situ increased 13.2% per year. There was a strong positive correlation between screening rate for cervical cancer and incidence rate for CIS (p-value = 0.03) whereas screening rate showed a strong negative correlation with incidence rate for squamous ICC (p-value = 0.04). Conclusions: The increasing trend in CIS, coupled with a decreasing trend in ICC, suggests the important role of cervix cancer screening. The incidence of adenocarcinoma showed a plateau, but the incidence of adenocarcinoma in situ showed an increasing trend.	[Oh, Chang-Mo; Jung, Kyu-Won; Won, Young-Joo; Shin, Aesun; Kong, Hyun-Joo] Natl Canc Ctr, Natl Canc Control Inst, Canc Registrat & Stat Branch, Goyang, South Korea; [Shin, Aesun] Natl Canc Ctr, Res Inst, Mol Epidemiol Branch, Goyang, South Korea; [Jun, Jae Kwan] Natl Canc Ctr, Natl Canc Control Inst, Canc Early Detect Branch, Goyang, South Korea; [Park, Sang-yoon] Natl Canc Ctr Hosp, Natl Canc Ctr, Ctr Gynecol Canc, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Jung, KW (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Canc Registrat & Stat Branch, Goyang, South Korea.	ara@ncc.re.kr	Shin, Aesun/E-9145-2014	Shin, Aesun/0000-0002-6426-1969	National Cancer Center Grant [NCC-1310220]	National Cancer Center Grant	This work was supported by the National Cancer Center Grant (NCC-1310220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, CANC INCIDENCE 5 CON; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Arbyn M, 2011, INT J CANCER, V128, P1899, DOI 10.1002/ijc.25525; Bae JH, 2008, J MICROBIOL BIOTECHN, V18, P788; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P677, DOI 10.1158/1055-9965.EPI-04-0569; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Bulk S, 2005, INT J CANCER, V113, P1005, DOI 10.1002/ijc.20678; Canfell K, 2006, MED J AUSTRALIA, V185, P482, DOI 10.5694/j.1326-5377.2006.tb00661.x; Chen YY, 2009, BRIT J CANCER, V101, P174, DOI 10.1038/sj.bjc.6605139; Chung HH, 2007, INT J GYNECOL CANCER, V17, P595, DOI 10.1111/j.1525-1438.2007.00824.x; Chung HH, 2006, INT J GYNECOL CANCER, V16, P1833, DOI 10.1111/j.1525-1438.2006.00708.x; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; Ferlay J, 2010, GLOBOCAN 2008 CANC I; Fritz A, 2000, INT CLASSIFICATION D; Han MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035469; Howlader N, 2011, SEER CANC STAT REV 1; Jung KW, 2009, CANCER RES TREAT, V44, P11; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kim Y, 2011, ASIAN PAC J CANCER P, V12, P725; Kim YT, 2009, J GYNECOL ONCOL, V20, P1, DOI 10.3802/jgo.2009.20.1.1; Lee K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-144; Lee YH, 2012, J GYNECOL ONCOL, V23, P16, DOI 10.3802/jgo.2012.23.1.16; Liu S, 2001, INT J GYNECOL CANCER, V11, P24, DOI 10.1046/j.1525-1438.2001.011001024.x; Liu SL, 2001, CAN MED ASSOC J, V164, P1151; Maucort-Boulch D, 2008, CANCER EPIDEM BIOMAR, V17, P717, DOI 10.1158/1055-9965.EPI-07-2691; MITCHELL H, 1995, BRIT J CANCER, V71, P894, DOI 10.1038/bjc.1995.172; National Cancer Institute, 2013, JOINP REGR PROGR VER; Park EC, 2010, NATL CANC CONTROL PR; Park KJ, 2009, ARCH PATHOL LAB MED, V133, P729, DOI 10.1043/1543-2165-133.5.729; Renshaw AA, 2004, ARCH PATHOL LAB MED, V128, P153; Sasieni P, 2009, INT J CANCER, V125, P525, DOI 10.1002/ijc.24410; Schoolland M, 2002, CANCER CYTOPATHOL, V96, P330, DOI 10.1002/cncr.10886; Shin HR, 2003, INT J CANCER, V103, P413, DOI 10.1002/ijc.10825; Smith HO, 2000, GYNECOL ONCOL, V78, P97, DOI 10.1006/gyno.2000.5826; Ward KK, 2012, GYNECOL ONCOL, V126, P330, DOI 10.1016/j.ygyno.2012.05.035; Yang L, 2004, BRIT J CANCER, V90, P2157, DOI 10.1038/sj.bjc.6601813	38	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72012	10.1371/journal.pone.0072012	http://dx.doi.org/10.1371/journal.pone.0072012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977194	Green Submitted, Green Published, gold			2022-12-25	WOS:000323570200052
J	Peebles, KC; Horsman, H; Tzeng, YC				Peebles, Karen C.; Horsman, Helen; Tzeng, Yu-Chieh			The Influence of Tobacco Smoking on the Relationship between Pressure and Flow in the Middle Cerebral Artery in Humans	PLOS ONE			English	Article							CIGARETTE-SMOKING; BLOOD-FLOW; RHO-KINASE; ISCHEMIC-STROKE; IN-VIVO; AUTOREGULATION; NICOTINE; VELOCITY; RISK; CIRCULATION	Background: Cigarette smoking is associated with an increased risk of stroke but the mechanism is unclear. The study examined whether acute and chronic cigarette smoking alters the dynamic relationship between blood pressure and cerebral blood flow. We hypothesised that acute and chronic smoking would result in a cerebral circulation that was less capable of buffering against dynamic fluctuations in blood pressure. Further, these changes would be accompanied by a reduction in baroreflex sensitivity, which is reduced after smoking (acute smoking). Methods: We recruited 17 non-smokers and 15 habitual smokers (13 +/- 5 pack years). Continuous measurements of mean cerebral blood flow velocity (transcranial Doppler ultrasound), blood pressure (finger photoplethysmography) and heart rate enabled transfer function analysis of the dynamic relationship between pressure and flow (gain, normalised gain, phase and coherence) and baroreflex sensitivity during supine rest before and after smoking a single cigarette (acute smoking). Results: There were no between-group differences in gain, phase or coherence before acute smoking. However, both groups showed a reduction in gain and coherence, associated with a reduction in baroreflex sensitivity, and increase in phase after acute smoking. Conclusions: Contrary to our hypothesis, these findings suggest that in the face of a reduction in baroreflex sensitivity acute smoking may potentially improve the ability of the cerebral circulation to buffer against changes in blood pressure. However, chronic smoking did not alter the dynamic relationship between blood pressure and cerebral blood flow velocity. These results have implications on understanding mechanisms for attenuating stroke risk.	[Peebles, Karen C.; Horsman, Helen; Tzeng, Yu-Chieh] Univ Otago, Cardiovasc Syst Lab, Wellington, New Zealand; [Peebles, Karen C.; Horsman, Helen; Tzeng, Yu-Chieh] Univ Otago, Ctr Translat Physiol, Wellington, New Zealand; [Peebles, Karen C.] Univ Otago, Dept Physiol, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Tzeng, YC (corresponding author), Univ Otago, Cardiovasc Syst Lab, Wellington, New Zealand.	shieak.tzeng@otago.ac.nz		Peebles, Karen/0000-0002-9694-9127	National Heart Foundation Fellowship (NZ); New Zealand Health Research Council [11/125]	National Heart Foundation Fellowship (NZ); New Zealand Health Research Council(Health Research Council of New Zealand)	KCP was supported by a National Heart Foundation Fellowship (NZ). This project was supported by a New Zealand Health Research Council grant awarded to YCT (Ref 11/125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosio E, 2006, EUR J CLIN INVEST, V36, P320, DOI 10.1111/j.1365-2362.2006.01628.x; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Bhat VM, 2008, STROKE, V39, P2439, DOI 10.1161/STROKEAHA.107.510073; Byrd GD, 2005, J CHROMATOGR SCI, V43, P133, DOI 10.1093/chromsci/43.3.133; Campese VM, 2004, AM J PHYSIOL-HEART C, V287, pH695, DOI 10.1152/ajpheart.00619.2003; CRUICKSHANK JM, 1989, J HUM HYPERTENS, V3, P443; CRYER PE, 1976, NEW ENGL J MED, V295, P573, DOI 10.1056/NEJM197609092951101; DEMPSEY RJ, 1992, STROKE, V23, P693, DOI 10.1161/01.STR.23.5.693; Failla M, 1997, J HYPERTENS, V15, P1659, DOI 10.1097/00004872-199715120-00069; Gerhardt U, 1999, J AUTON PHARMACOL, V19, P105, DOI 10.1046/j.1365-2680.1999.00123.x; Gerzanich V, 2001, CIRC RES, V88, P359, DOI 10.1161/01.RES.88.3.359; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; Hawkins BT, 2004, BRAIN RES, V1027, P48, DOI 10.1016/j.brainres.2004.08.043; Iida M, 1998, STROKE, V29, P1656, DOI 10.1161/01.STR.29.8.1656; Immink RV, 2005, STROKE, V36, P2595, DOI 10.1161/01.STR.0000189624.06836.03; ISAAC PF, 1972, NATURE, V236, P308, DOI 10.1038/236308a0; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KUBOTA K, 1983, STROKE, V14, P720, DOI 10.1161/01.STR.14.5.720; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Kurth T, 2003, STROKE, V34, P1151, DOI 10.1161/01.STR.0000065200.93070.32; Lipman RD, 2003, HYPERTENSION, V42, P481, DOI 10.1161/01.HYP.0000091370.83602.E6; Mancia G, 1997, AM J PHYSIOL-HEART C, V273, pH1555, DOI 10.1152/ajpheart.1997.273.3.H1555; Moppett IK, 2004, BRIT J ANAESTH, V93, P710, DOI 10.1093/bja/aeh205; Morioka C, 1997, PSYCHOPHARMACOLOGY, V131, P220, DOI 10.1007/s002130050287; Narkiewicz K, 1998, CIRCULATION, V98, P528, DOI 10.1161/01.CIR.98.6.528; Noma K, 2005, ARTERIOSCL THROM VAS, V25, P2630, DOI 10.1161/01.ATV.0000189304.32725.bd; Noma K, 2003, HYPERTENSION, V41, P1102, DOI 10.1161/01.HYP.0000067062.92836.9E; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Panerai RB, 2006, AM J PHYSIOL-HEART C, V291, pH251, DOI 10.1152/ajpheart.01348.2005; Panerai RB, 2009, PHILOS T R SOC A, V367, P1319, DOI 10.1098/rsta.2008.0264; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Peebles KC, 2008, J APPL PHYSIOL, V105, P1060, DOI 10.1152/japplphysiol.90613.2008; ROGERS RL, 1983, JAMA-J AM MED ASSOC, V250, P2796, DOI 10.1001/jama.250.20.2796; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Silvestrini M, 1996, J CEREBR BLOOD F MET, V16, P746, DOI 10.1097/00004647-199607000-00027; SKINHOJ E, 1973, J APPL PHYSIOL, V35, P820, DOI 10.1152/jappl.1973.35.6.820; Terborg C, 2002, J NEUROL SCI, V205, P15, DOI 10.1016/S0022-510X(02)00308-8; Tsuchiya M, 2002, CIRCULATION, V105, P1155, DOI 10.1161/hc1002.105935; Tzeng YC, 2011, J PHYSIOL-LONDON, V589, P3263, DOI 10.1113/jphysiol.2011.206953; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zhang R, 2009, J PHYSIOL-LONDON, V587, P2567, DOI 10.1113/jphysiol.2008.168302	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72624	10.1371/journal.pone.0072624	http://dx.doi.org/10.1371/journal.pone.0072624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977332	gold, Green Submitted, Green Published			2022-12-25	WOS:000323378000106
J	Bosmann, M; Grailer, JJ; Ruemmler, R; Russkamp, NF; Zetoune, FS; Sarma, JV; Standiford, TJ; Ward, PA				Bosmann, Markus; Grailer, Jamison J.; Ruemmler, Robert; Russkamp, Norman F.; Zetoune, Firas S.; Sarma, J. Vidya; Standiford, Theodore J.; Ward, Peter A.			Extracellular histones are essential effectors of C5aR-and C5L2-mediated tissue damage and inflammation in acute lung injury	FASEB JOURNAL			English	Article						complement; cytotoxic factors	COMPLEMENT FRAGMENTS C5A; RECEPTOR C5AR; ANAPHYLATOXIN; C5L2; EXPRESSION; TRAPS; PATHOGENESIS; MEDIATORS; CELLS; DEATH	We investigated how complement activation promotes tissue injury and organ dysfunction during acute inflammation. Three models of acute lung injury (ALI) induced by LPS, IgG immune complexes, or C5a were used in C57BL/6 mice, all models requiring availability of both C5a receptors (C5aR and C5L2) for full development of ALI. Ligation of C5aR and C5L2 with C5a triggered the appearance of histones (H3 and H4) in bronchoalveolar lavage fluid (BALF). BALF from humans with ALI contained H4 histone. Histones were absent in control BALF from healthy volunteers. In mice with ALI, in vivo neutralization of H4 with IgG antibody reduced the intensity of ALI. Neutrophil depletion in mice with ALI markedly reduced H4 presence in BALF and was highly protective. The direct lung damaging effects of extracellular histones were demonstrated by airway administration of histones into mice and rats (Sprague-Dawley), which resulted in ALI that was C5a receptor-independent, and associated with intense inflammation, PMN accumulation, damage/destruction of alveolar epithelial cells, together with release into lung of cytokines/chemokines. High-resolution magnetic resonance imaging demonstrated lung damage, edema and consolidation in histone-injured lungs. These studies confirm the destructive C5a-dependent effects in lung linked to appearance of extracellular histones.	[Bosmann, Markus; Ruemmler, Robert] Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Bosmann, Markus] Univ Med Ctr, Dept Hematol & Oncol, Mainz, Germany; [Grailer, Jamison J.; Ruemmler, Robert; Russkamp, Norman F.; Zetoune, Firas S.; Sarma, J. Vidya; Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Standiford, Theodore J.] Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine Rd, Ann Arbor, MI 48109 USA.	pward@umich.edu		Bosmann, Markus/0000-0003-2773-1033	U.S. National Institutes of Health (NIH) [GM-29507, GM-61656, NHLBI-T32-HL007517-29]; Deutsche Forschungsgemeinschaft [571701, BO 3482/1-1, BO 3482/3-1]; German Federal Ministry of Education and Research [BMBF 01EO1003]; Marie Curie Career Integration grant of the European Union [334486]; Boehringer Ingelheim Fonds; NIH [P50CA093990]; NATIONAL CANCER INSTITUTE [P50CA093990] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007517, P50HL074024, P50HL060289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061656, R37GM029507, R01GM029507] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Marie Curie Career Integration grant of the European Union; Boehringer Ingelheim Fonds(Boehringer Ingelheim); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants GM-29507 and GM-61656 (P. A. W.) and NHLBI-T32-HL007517-29 (J.J.G.) from the U.S. National Institutes of Health (NIH), along with the Deutsche Forschungsgemeinschaft (project 571701, BO 3482/1-1, BO 3482/3-1, M. B.), the German Federal Ministry of Education and Research (BMBF 01EO1003, M. B.), a Marie Curie Career Integration grant of the European Union (project 334486, M. B.) and the Boehringer Ingelheim Fonds (N.F.R., R. R). The authors are responsible for the content of this publication. The authors declare no conflicts of interest. The authors thank Dr. Ralph Lydic and William Filbey for help with the whole-body plethysmography, Lisa K. Johnson and Dorothy Sorenson for technical assistance with the histopathology, and Amanda Welton for technical assistance with the MRI studies (all from the University of Michigan). The authors thank the Department of Radiology at the University of Michigan for the use of the Center for Molecular Imaging, which is supported in part by NIH grant P50CA093990. The authors thank Beverly Schumann, Sue Scott, and Robin Kunkel for excellent staff support.	Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Allam R, 2012, J AM SOC NEPHROL, V23, P1375, DOI 10.1681/ASN.2011111077; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327; Bosmann M., 2012, FASEB J; Bosmann M, 2013, EUR J IMMUNOL, V43, P1907, DOI 10.1002/eji.201243075; Bosmann M, 2012, J IMMUNOL, V188, P5086, DOI 10.4049/jimmunol.1102914; Bosmann M, 2012, FASEB J, V26, P1640, DOI 10.1096/fj.11-199216; Bosmann M, 2012, ADV EXP MED BIOL, V946, P147, DOI 10.1007/978-1-4614-0106-3_9; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Dunkelberger J, 2012, J IMMUNOL, V188, P4032, DOI 10.4049/jimmunol.1103141; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Friggeri A, 2012, MOL MED, V18, P825, DOI 10.2119/molmed.2012.00005; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gao HW, 2006, ANNU REV PATHOL-MECH, V1, P215, DOI 10.1146/annurev.pathol.1.110304.100155; Garcia CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064443; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Goss CH, 2003, CRIT CARE MED, V31, P1607, DOI 10.1097/01.CCM.0000063475.65751.1D; Gotts JE, 2011, CRIT CARE CLIN, V27, P719, DOI 10.1016/j.ccc.2011.04.004; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; HIRSCH JG, 1958, J EXP MED, V108, P925, DOI 10.1084/jem.108.6.925; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Kanse SM, 2012, J IMMUNOL, V188, P2858, DOI 10.4049/jimmunol.1103029; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Kwan WH, 2013, J EXP MED, V210, P257, DOI 10.1084/jem.20121525; Lalli PN, 2008, BLOOD, V112, P1759, DOI 10.1182/blood-2008-04-151068; LARSEN GL, 1980, AM J PATHOL, V100, P179; Lee DY, 2009, J INVEST DERMATOL, V129, P2489, DOI 10.1038/jid.2009.106; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P214, DOI 10.1513/pats.200504-031AC; Martin TR, 2011, CRIT CARE CLIN, V27, P735, DOI 10.1016/j.ccc.2011.05.013; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; MONESTIER M, 1993, MOL IMMUNOL, V30, P1069, DOI 10.1016/0161-5890(93)90153-3; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Paine R, 2012, CRIT CARE MED, V40, P90, DOI 10.1097/CCM.0b013e31822d7bf0; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riedemann NC, 2002, J IMMUNOL, V168, P1919, DOI 10.4049/jimmunol.168.4.1919; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Sun L, 2009, FASEB J, V23, P3808, DOI 10.1096/fj.09-133694; Ward PA, 2003, EUR RESPIR J, V22, p22S, DOI 10.1183/09031936.03.00000703a; WARREN JS, 1989, J CLIN INVEST, V84, P1873, DOI 10.1172/JCI114374; WEBSTER RO, 1982, J CLIN INVEST, V70, P1177, DOI 10.1172/JCI110716; WETSEL RA, 1995, IMMUNOL LETT, V44, P183, DOI 10.1016/0165-2478(94)00212-A; Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang X, 2010, J IMMUNOL, V185, P6741, DOI 10.4049/jimmunol.1000892	66	149	158	0	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					5010	5021		10.1096/fj.13-236380	http://dx.doi.org/10.1096/fj.13-236380			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23982144	Green Published, Green Submitted			2022-12-25	WOS:000329999000034
J	Kogawa, M; Hisatake, K; Atkins, GJ; Findlay, DM; Enoki, Y; Sato, T; Gray, PC; Kanesaki-Yatsuka, Y; Anderson, PH; Wada, S; Kato, N; Fukuda, A; Katayama, S; Tsujimoto, M; Yoda, T; Suda, T; Okazaki, Y; Matsumoto, M				Kogawa, Masakazu; Hisatake, Koji; Atkins, Gerald J.; Findlay, David M.; Enoki, Yuichiro; Sato, Tsuyoshi; Gray, Peter C.; Kanesaki-Yatsuka, Yukiko; Anderson, Paul H.; Wada, Seiki; Kato, Naoki; Fukuda, Aya; Katayama, Shigehiro; Tsujimoto, Masafumi; Yoda, Tetsuya; Suda, Tatsuo; Okazaki, Yasushi; Matsumoto, Masahito			The Paired-box Homeodomain Transcription Factor Pax6 Binds to the Upstream Region of the TRAP Gene Promoter and Suppresses Receptor Activator of NF-kappa B Ligand (RANKL)-induced Osteoclast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-PHOSPHATASE GENE; TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE; C-FOS; TERMINAL DIFFERENTIATION; BONE-RESORPTION; MICE; RANKL; EXPRESSION; CELLS	Osteoclast formation is regulated by balancing between the receptor activator of nuclear factor-kappa B ligand (RANKL) expressed in osteoblasts and extracellular negative regulatory cytokines such as interferon-gamma (IFN-gamma) and interferon-beta (IFN-beta), which can suppress excessive bone destruction. However, relatively little is known about intrinsic negative regulatory factors in RANKL-mediated osteoclast differentiation. Here, we show the paired-box homeodomain transcription factor Pax6 acts as a negative regulator of RANKL-mediated osteoclast differentiation. Electrophoretic mobility shift and reporter assays found that Pax6 binds endogenously to the proximal region of the tartrate acid phosphatase (TRAP) gene promoter and suppresses nuclear factor of activated T cells c1 (NFATc1)-induced TRAP gene expression. Introduction of Pax6 retrovirally into bone marrow macrophages attenuates RANKL-induced osteoclast formation. Moreover, we found that the Groucho family member co-repressor Grg6 contributes to Pax6-mediated suppression of the TRAP gene expression induced by NFATc1. These results suggest that Pax6 interferes with RANKL-mediated osteoclast differentiation together with Grg6. Our results demonstrate that the Pax6 pathway constitutes a new aspect of the negative regulatory circuit of RANKL-RANK signaling in osteoclastogenesis and that the augmentation of Pax6 might therefore represent a novel target to block pathological bone resorption.	[Kogawa, Masakazu; Hisatake, Koji; Fukuda, Aya; Matsumoto, Masahito] Saitama Med Univ, Res Ctr Genom Med, Dept Biol Mol, Hidaka City, Saitama 3501241, Japan; [Kogawa, Masakazu; Wada, Seiki; Katayama, Shigehiro] Saitama Med Univ, Res Ctr Genom Med, Dept Endocrinol & Diabet, Hidaka City, Saitama 3501241, Japan; [Enoki, Yuichiro; Sato, Tsuyoshi; Yoda, Tetsuya] Saitama Med Univ, Res Ctr Genom Med, Dept Oral & Maxillofacial Surg, Hidaka City, Saitama 3501241, Japan; [Kato, Naoki] Saitama Med Univ, Res Ctr Genom Med, Dept Orthopaed Surg, Hidaka City, Saitama 3501241, Japan; [Kanesaki-Yatsuka, Yukiko; Suda, Tatsuo; Okazaki, Yasushi; Matsumoto, Masahito] Saitama Med Univ, Div Funct Genom & Syst Med, Res Ctr Genom Med, Hidaka City, Saitama 3501241, Japan; [Kogawa, Masakazu; Atkins, Gerald J.; Findlay, David M.] Univ Adelaide, Discipline Orthopaed & Trauma, Adelaide, SA 5000, Australia; [Hisatake, Koji; Fukuda, Aya] Univ Tsukuba, Fac Med, Lab Gene Regulat, Tsukuba, Ibaraki 3050006, Japan; [Gray, Peter C.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Anderson, Paul H.] Univ Adelaide, Sch Pharm & Med Sci, Div Hlth Sci, Adelaide, SA 5000, Australia; [Tsujimoto, Masafumi] Teikyo Heisei Univ, Fac Pharmaceut Sci, Tokyo 1648530, Japan	Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; University of Adelaide; University of Tsukuba; Salk Institute; University of Adelaide	Matsumoto, M (corresponding author), Saitama Med Univ, Div Funct Genom & Syst Med, Res Ctr Genom Med, 1397-1 Yamane, Hidaka City, Saitama 3501241, Japan.	masam@saitama-med.ac.jp	Matsumoto, Masahito/AGS-0755-2022; Anderson, Paul H/F-4198-2013	Anderson, Paul H/0000-0002-8685-3252; Atkins, Gerald/0000-0002-3123-9861; Okazaki, Yasushi/0000-0003-3241-5502; Hisatake, Koji/0000-0002-5795-3115	MEXT; JSPS KAKENHI Grant [25462380]; Kanzawa Medical Research; Kowa Life Science Foundation; Life Science; Japan Diabetes Foundations; Clayton Medical Research Foundation, Inc.; Cancer Center Core Grant [P30 CA014195-38]; Ochiai Memorial Awards; Maruki Memorial Awards; Saitama Medical University Internal Research Grant [11B-08]; Kawano Masanori Memorial Foundation for the promotion of Pediatrics; Grants-in-Aid for Scientific Research [25460354] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kanzawa Medical Research; Kowa Life Science Foundation; Life Science; Japan Diabetes Foundations; Clayton Medical Research Foundation, Inc.; Cancer Center Core Grant; Ochiai Memorial Awards; Maruki Memorial Awards; Saitama Medical University Internal Research Grant(Saitama Medical University); Kawano Masanori Memorial Foundation for the promotion of Pediatrics(Kawano Masanori Memorial Foundation for Promotion of Pediatrics); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by MEXT and JSPS KAKENHI Grant 25462380, grants from the Kanzawa Medical Research, the Kowa Life Science Foundation, the Life Science, the Japan Diabetes Foundations (to M. M.), the Clayton Medical Research Foundation, Inc. (to P. C. G.), Cancer Center Core Grant P30 CA014195-38 (to P. C. G.), Ochiai Memorial Awards (2001 and 2007), Maruki Memorial Awards (to M. M.), Saitama Medical University Internal Research Grant 11B-08 (to M. M.), "Support Project of Strategic Research Center in Private Universities" from MEXT and a grant from Kawano Masanori Memorial Foundation for the promotion of Pediatrics (to M. M.).	Abu-Amer Y, 2001, J CLIN INVEST, V107, P1375, DOI 10.1172/JCI10530; Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Cai Y, 2003, EMBO J, V22, P5522, DOI 10.1093/emboj/cdg536; Castori M, 2009, AM J MED GENET A, V149A, P1768, DOI 10.1002/ajmg.a.32960; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Conway SJ, 2000, CARDIOVASC RES, V47, P314, DOI 10.1016/S0008-6363(00)00098-5; Dang JJ, 2001, MOL CELL BIOL, V21, P5935, DOI 10.1128/MCB.21.17.5935-5945.2001; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Elvenes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024659; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Hasson P, 2006, BRIT J CANCER, V94, P771, DOI 10.1038/sj.bjc.6603019; Hayman AR, 1996, DEVELOPMENT, V122, P3151; Hikata T, 2009, BLOOD, V113, P2202, DOI 10.1182/blood-2008-06-162594; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Horowitz MC, 2004, J IMMUNOL, V173, P6583, DOI 10.4049/jimmunol.173.11.6583; HOTH CF, 1993, AM J HUM GENET, V52, P455; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kralova J, 2002, GENE, V286, P271, DOI 10.1016/S0378-1119(02)00425-0; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; Linderson Y, 2004, EMBO REP, V5, P291, DOI 10.1038/sj.embor.7400089; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; Luchin A, 2000, J BONE MINER RES, V15, P451, DOI 10.1359/jbmr.2000.15.3.451; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Mansouri A, 1996, DEVELOPMENT, V122, P831; Marcal N, 2005, MOL CELL BIOL, V25, P10916, DOI 10.1128/MCB.25.24.10916-10929.2005; Matsumoto M, 2000, FEBS LETT, V486, P23, DOI 10.1016/S0014-5793(00)02231-6; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Matsumoto M, 2001, J BIOL CHEM, V276, P33086, DOI 10.1074/jbc.M104299200; Matsumoto M, 1999, BIOL CHEM, V380, P699, DOI 10.1515/BC.1999.087; Moreno JL, 2003, BLOOD, V102, P1078, DOI 10.1182/blood-2002-11-3437; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Pfeffer PL, 1998, DEVELOPMENT, V125, P3063; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Torres MA, 1996, DEVELOPMENT, V122, P3381; WALLIN J, 1994, DEVELOPMENT, V120, P1109; Wang WF, 2004, DEV BIOL, V270, P364, DOI 10.1016/j.ydbio.2004.03.003; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Wolf G, 2010, MOL ENDOCRINOL, V24, P2331, DOI 10.1210/me.2009-0220; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329	63	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31299	31312		10.1074/jbc.M113.461848	http://dx.doi.org/10.1074/jbc.M113.461848			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	23990468	Green Published, hybrid			2022-12-25	WOS:000330778900047
J	Kurita, S; Yamada, T; Rikitsu, E; Ikeda, W; Takai, Y				Kurita, Souichi; Yamada, Tomohiro; Rikitsu, Etsuko; Ikeda, Wataru; Takai, Yoshimi			Binding between the Junctional Proteins Afadin and PLEKHA7 and Implication in the Formation of Adherens Junction in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE NECTIN; E-CADHERIN; TIGHT JUNCTIONS; CYTOPLASMIC DOMAIN; ALPHA-CATENIN; MDCK CELLS; POLARITY; COMPLEX; ROLES; ACTIN	Adherens junction (AJ) is a specialized cell-cell junction structure that plays a role in mechanically connecting adjacent cells to resist strong contractile forces and to maintain tissue structure, particularly in the epithelium. AJ is mainly comprised of cell adhesion molecules cadherin and nectin and their associating cytoplasmic proteins including beta-catenin, alpha-catenin, p120(ctn), and afadin. Our series of studies have revealed that nectin first forms cell-cell adhesion and then recruits cadherin to form AJ. The recruitment of cadherin by nectin is mediated by the binding of alpha-catenin and p120(ctn) to afadin. Recent studies showed that PLEKHA7 binds to p120(ctn), which is associated with E-cadherin, and maintains the integrity of AJ in epithelial cells. In this study, we showed that PLEKHA7 bound to afadin in addition to p120(ctn) and was recruited to the nectin-3 alpha-based cell-cell adhesion site in a manner dependent on afadin, but not on p120(ctn). The binding of PLEKHA7 to afadin was required for the proper formation of AJ, but not for the formation of tight junction, in EpH4 mousemammarygland epithelial cells. These results indicate that PLEKHA7 plays a cooperative role with nectin and afadin in the proper formation of AJ in epithelial cells.	[Kurita, Souichi; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 6500017, Japan; [Kurita, Souichi; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Pathogenet Signaling, Dept Biochem & Mol Biol, Kobe, Hyogo 6500047, Japan; [Yamada, Tomohiro; Rikitsu, Etsuko; Ikeda, Wataru] KAN Res Inst Inc, Kobe, Hyogo 6500047, Japan; [Takai, Yoshimi] Japan Sci & Technol Agcy JST, CREST, Kobe, Hyogo 6500047, Japan	Kobe University; Kobe University; KAN Research Institute; Japan Science & Technology Agency (JST)	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Pathogenet Signaling, Dept Biochem & Mol Biol,Chuo Ku, 1-5-6 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	ytakai@med.kobe-u.ac.jp	Ikeda, Wataru/V-8531-2019	Ikeda, Wataru/0000-0002-6907-9058	Global Centers of Excellence Program; Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency; Naito Foundation; Sagawa Foundation; Yasuda Medical Foundation	Global Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Naito Foundation(Naito Memorial Foundation); Sagawa Foundation; Yasuda Medical Foundation	This work was supported by the Global Centers of Excellence Program "Global Center for Education and Research in Integrative Membrane Biology" and the Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan, by grants-in-aid from the Japan Society for the Promotion of Science, by the Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency, and by grants from the Naito Foundation, the Sagawa Foundation, and the Yasuda Medical Foundation.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Honda T, 2003, GENES CELLS, V8, P51, DOI 10.1046/j.1365-2443.2003.00616.x; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; Ikenouchi J, 2012, J BIOL CHEM, V287, P9525, DOI 10.1074/jbc.M111.327064; KINCH MS, 1995, J CELL BIOL, V130, P461, DOI 10.1083/jcb.130.2.461; Kuramitsu K, 2008, GENES CELLS, V13, P797, DOI 10.1111/j.1365-2443.2008.01206.x; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Miyahara M, 2000, J BIOL CHEM, V275, P613, DOI 10.1074/jbc.275.1.613; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; Ohnishi H, 2004, J BIOL CHEM, V279, P46014, DOI 10.1074/jbc.M402616200; Okamoto R, 2005, GENES CELLS, V10, P435, DOI 10.1111/j.1365-2443.2005.00846.x; Ooshio' T, 2007, J CELL SCI, V120, P2352, DOI 10.1242/jcs.03470; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pulimeno P, 2011, J BIOL CHEM, V286, P16743, DOI 10.1074/jbc.M111.230862; Pulimeno P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012207; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Sakisaka T, 1999, ONCOGENE, V18, P1609, DOI 10.1038/sj.onc.1202451; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Yamada A, 2006, ONCOGENE, V25, P5085, DOI 10.1038/sj.onc.1209525; Zhang L, 2011, J BIOL CHEM, V286, P16879, DOI 10.1074/jbc.M110.186932	42	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29356	29368		10.1074/jbc.M113.453464	http://dx.doi.org/10.1074/jbc.M113.453464			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23990464	hybrid, Green Published			2022-12-25	WOS:000330615300015
J	Mak, CH; Pham, P; Afif, SA; Goodman, MF				Mak, Chi H.; Phuong Pham; Afif, Samir A.; Goodman, Myron F.			A Mathematical Model for Scanning and Catalysis on Single-stranded DNA, Illustrated with Activation-induced Deoxycytidine Deaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSINE DEAMINASE; CLUSTERED MUTATIONS; CYTIDINE DEAMINASE; PROTEIN; AID; DIFFUSION; SEARCH; REPAIR; TRANSLOCATION; TRANSCRIPTION	We formulated a master equation-based mathematical model to analyze random scanning and catalysis for enzymes that act on single-stranded DNA (ssDNA) substrates. Catalytic efficiencies and intrinsic scanning distances are deduced from the distribution of positions and gap lengths between a series of catalytic events occurring over time, which are detected as point mutations in a lacZ alpha-based reporter sequence containing enzyme target motifs. Mathematical analysis of the model shows how scanning motions become separable from the catalysis when the proper statistical properties of the mutation pattern are used to interpret the readouts. Two-point correlations between all catalytic events determine intrinsic scanning distances, whereas gap statistics between mutations determine their catalytic efficiencies. Applying this model to activation-induced deoxycytidine deaminase (AID), which catalyzes C -> U deaminations processively on ssDNA, we have established that deaminations of AGC hot motifs occur at a low rate, similar to 0.03 s(-1), and low efficiency, similar to 3%. AID performs random bidirectional movements for an average distance of 6.2 motifs, at a rate of about 15 nucleotides per second, and "dwells" at a motif site for 2.7s while bound >4 min to the same DNA molecule. These results provide new and important insights on how AID may be optimized for generating mutational diversity in Ig genes, and we discuss how the properties of AID acting freely on a "naked" ssDNA relate to the constrained action of AID during transcription-dependent somatic hypermutation and class-switch recombination.	[Mak, Chi H.; Goodman, Myron F.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Mak, Chi H.] Univ So Calif, Ctr Appl Math Sci, Los Angeles, CA 90089 USA; [Phuong Pham; Afif, Samir A.; Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Mak, CH (corresponding author), Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA.	cmak@usc.edu; mgoodman@usc.edu			National Institutes of Health [ES13192, GM21422]; National Science Foundation [CHE-0713981]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES013192, R01ES013192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021422, R37GM021422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES13192 and GM21422 (to M. F. G.). This work was also supported by National Science Foundation Grant CHE-0713981 (to C.H.M.).	Benichou O, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198101; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Canugovi C, 2009, FASEB J, V23, P34, DOI 10.1096/fj.08-115352; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Condamin S, 2007, NATURE, V450, P77, DOI 10.1038/nature06201; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Coppey M, 2004, BIOPHYS J, V87, P1640, DOI 10.1529/biophysj.104.045773; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Doi M., 1986, THEORY POLYM DYNAMIC, V1st ed.; FISHER ME, 1984, J STAT PHYS, V34, P667, DOI 10.1007/BF01009436; Flory P. J, 1953, PRINCIPLES POLYM CHE; Gardiner C. W., 1994, HDB STOCHASTIC METHO, P236; Gorman J, 2008, NAT STRUCT MOL BIOL, V15, P768, DOI 10.1038/nsmb.1441; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Halford SE, 2001, BIOCHEM SOC T, V29, P363, DOI 10.1042/BST0290363; Hu T, 2006, BIOPHYS J, V90, P2731, DOI 10.1529/biophysj.105.078162; Jaszczur M, 2013, CELL MOL LIFE SCI, V70, P3089, DOI 10.1007/s00018-012-1212-1; Lada AG, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-47; Lomholt MA, 2009, P NATL ACAD SCI USA, V106, P8204, DOI 10.1073/pnas.0903293106; LORING RF, 1982, CHEM PHYS, V70, P139, DOI 10.1016/0301-0104(82)85114-8; Marcovitz A, 2011, P NATL ACAD SCI USA, V108, P17957, DOI 10.1073/pnas.1109594108; Meester R., 2008, NATURAL INTRO PROBAB, P137; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2011, J BIOL CHEM, V286, P24931, DOI 10.1074/jbc.M111.241208; Porecha RH, 2008, P NATL ACAD SCI USA, V105, P10791, DOI 10.1073/pnas.0801612105; Press W.H, 2007, NUMERICAL RECIPES C, P82; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Schonhoft JD, 2012, NAT CHEM BIOL, V8, P205, DOI 10.1038/nchembio.764; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; Shen HM, 2005, MOL CELL BIOL, V25, P10815, DOI 10.1128/MCB.25.24.10815-10821.2005; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Storb U, 2009, CELL CYCLE, V8, P3097, DOI 10.4161/cc.8.19.9658; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	47	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29786	29795		10.1074/jbc.M113.506550	http://dx.doi.org/10.1074/jbc.M113.506550			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23979486	Green Published, hybrid			2022-12-25	WOS:000330615300053
J	Wu, F; Guo, LL; Jakubowski, A; Su, LH; Li, WC; Bonner-Weir, S; Burkly, LC				Wu, Fei; Guo, Lili; Jakubowski, Aniela; Su, Lihe; Li, Wan-Chun; Bonner-Weir, Susan; Burkly, Linda C.			TNF-Like Weak Inducer of Apoptosis (TWEAK) Promotes Beta Cell Neogenesis from Pancreatic Ductal Epithelium in Adult Mice	PLOS ONE			English	Article							HOMEODOMAIN PROTEIN IDX-1; GLUCAGON-LIKE PEPTIDE-1; ISLET NEOGENESIS; PROGENITOR CELLS; ENDOCRINE-CELLS; TRANSGENIC MICE; MOUSE PANCREAS; IN-VITRO; REGENERATION; GROWTH	Aim/Hypothesis: The adult mammalian pancreas has limited ability to regenerate in order to restore adequate insulin production from multipotent progenitors, the identity and function of which remain poorly understood. Here we test whether the TNF family member TWEAK (TNF-like weak inducer of apoptosis) promotes beta-cell neogenesis from proliferating pancreatic ductal epithelium in adult mice. Methods: C57Bl/6J mice were treated with Fc-TWEAK and pancreas harvested at different time points for analysis by histology and immunohistochemistry. For lineage tracing, 4 week old double transgenic mice CAII-CreER (TM) : R26R-eYFP were implanted with tamoxifen pellet, injected with Fc-TWEAK or control Ig twice weekly and analyzed at day 18 for TWEAK-induced duct cell progeny by costaining for insulin and YFP. The effect of TWEAK on pancreatic regeneration was determined by pancytokeratin immunostaining of paraffin embedded sections from wildtype and TWEAK receptor (Fn14) deficient mice after Px. Results: TWEAK stimulates proliferation of ductal epithelial cells through its receptor Fn14, while it has no mitogenic effect on pancreatic alpha- or beta-cells or acinar cells. Importantly, TWEAK induces transient expression of endogenous Ngn3, a master regulator of endocrine cell development, and induces focal ductal structures with characteristics of regeneration foci. In addition, we identify by lineage tracing TWEAK-induced pancreatic beta-cells derived from pancreatic duct epithelial cells. Conversely, we show that Fn14 deficiency delays formation of regenerating foci after Px and limits their expansion. Conclusions/Interpretation: We conclude that TWEAK is a novel factor mediating pancreatic b-cell neogenesis from ductal epithelium in normal adult mice.	[Wu, Fei; Jakubowski, Aniela; Su, Lihe; Burkly, Linda C.] Biogen Idec Inc, Dept Immunobiol, Cambridge, MA USA; [Guo, Lili; Li, Wan-Chun; Bonner-Weir, Susan] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol,Dept Med, Boston, MA 02115 USA	Biogen; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Burkly, LC (corresponding author), Biogen Idec Inc, Dept Immunobiol, Cambridge, MA USA.	linda.burkly@biogenidec.com	Li, Wan-Chun/AAY-9929-2020	Bonner-Weir, Susan/0000-0003-4682-0656	Juvenile Diabetes Research Foundation (JDRF) [15-2007-1060]; National Institutes of Health NIDDK [P30 DK36836]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Juvenile Diabetes Research Foundation (JDRF) Grant 15-2007-1060 and National Institutes of Health NIDDK P30 DK36836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; BONNERWEIR S, 1983, J CLIN INVEST, V71, P1544, DOI 10.1172/JCI110910; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Campbell S, 2006, J IMMUNOL, V176, P1889, DOI 10.4049/jimmunol.176.3.1889; Chicheportiche Y, 2002, ARTHRITIS RES, V4, P126, DOI 10.1186/ar388; GAYTAN F, 1994, J ANDROL, V15, P558; Geutskens SB, 2005, J LEUKOCYTE BIOL, V78, P845, DOI 10.1189/jlb.1004624; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; GU DL, 1993, DEVELOPMENT, V118, P33; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Herrera PL, 2002, ENDOCRINE, V19, P267, DOI 10.1385/ENDO:19:3:267; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Li M, 2003, PANCREAS, V27, P345, DOI 10.1097/00006676-200311000-00013; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; Lipsett M, 2002, DIABETES, V51, P1834, DOI 10.2337/diabetes.51.6.1834; Lu Y, 2009, REGUL PEPTIDES, V157, P25, DOI 10.1016/j.regpep.2009.05.011; Michaelson JS, 2011, MABS-AUSTIN, V3, P362, DOI 10.4161/mabs.3.4.16090; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Nakayama M, 2002, J IMMUNOL, V168, P734, DOI 10.4049/jimmunol.168.2.734; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Reinert RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033529; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; SCOPSI L, 1986, J HISTOCHEM CYTOCHEM, V34, P1469, DOI 10.1177/34.11.2877024; Sharma A, 1999, DIABETES, V48, P507, DOI 10.2337/diabetes.48.3.507; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Suarez-Pinzon WL, 2008, DIABETES, V57, P3281, DOI 10.2337/db08-0688; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Wagner M, 2008, AM J PHYSIOL-GASTR L, V294, pG1139, DOI 10.1152/ajpgi.00338.2007; Wang GS, 2005, LAB INVEST, V85, P675, DOI 10.1038/labinvest.3700259; WANG RN, 1995, DIABETOLOGIA, V38, P1405, DOI 10.1007/BF00400600; WANG TC, 1993, J CLIN INVEST, V92, P1349, DOI 10.1172/JCI116708; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yamamoto K, 2000, DIABETES, V49, P2021, DOI 10.2337/diabetes.49.12.2021; Yatoh S, 2007, DIABETES, V56, P1802, DOI 10.2337/db06-1670; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhou J, 2002, J CELL PHYSIOL, V192, P304, DOI 10.1002/jcp.10143; ZHOU Q, 2008, NATURE	47	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72132	10.1371/journal.pone.0072132	http://dx.doi.org/10.1371/journal.pone.0072132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991053	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800047
J	Hadrup, N; Taxvig, C; Pedersen, M; Nellemann, C; Hass, U; Vinggaard, AM				Hadrup, Niels; Taxvig, Camilla; Pedersen, Mikael; Nellemann, Christine; Hass, Ulla; Vinggaard, Anne Marie			Concentration Addition, Independent Action and Generalized Concentration Addition Models for Mixture Effect Prediction of Sex Hormone Synthesis In Vitro	PLOS ONE			English	Article							ADRENOCORTICAL CARCINOMA-CELLS; FUNGICIDE PROCHLORAZ; MALE-RAT; TOXICITY; STEROIDOGENESIS; TESTOSTERONE; CHEMICALS; EXPOSURE; ANTIANDROGENS; CONTAMINANTS	Humans are concomitantly exposed to numerous chemicals. An infinite number of combinations and doses thereof can be imagined. For toxicological risk assessment the mathematical prediction of mixture effects, using knowledge on single chemicals, is therefore desirable. We investigated pros and cons of the concentration addition (CA), independent action (IA) and generalized concentration addition (GCA) models. First we measured effects of single chemicals and mixtures thereof on steroid synthesis in H295R cells. Then single chemical data were applied to the models; predictions of mixture effects were calculated and compared to the experimental mixture data. Mixture 1 contained environmental chemicals adjusted in ratio according to human exposure levels. Mixture 2 was a potency adjusted mixture containing five pesticides. Prediction of testosterone effects coincided with the experimental Mixture 1 data. In contrast, antagonism was observed for effects of Mixture 2 on this hormone. The mixtures contained chemicals exerting only limited maximal effects. This hampered prediction by the CA and IA models, whereas the GCA model could be used to predict a full dose response curve. Regarding effects on progesterone and estradiol, some chemicals were having stimulatory effects whereas others had inhibitory effects. The three models were not applicable in this situation and no predictions could be performed. Finally, the expected contributions of single chemicals to the mixture effects were calculated. Prochloraz was the predominant but not sole driver of the mixtures, suggesting that one chemical alone was not responsible for the mixture effects. In conclusion, the GCA model seemed to be superior to the CA and IA models for the prediction of testosterone effects. A situation with chemicals exerting opposing effects, for which the models could not be applied, was identified. In addition, the data indicate that in non-potency adjusted mixtures the effects cannot always be accounted for by single chemicals.	[Hadrup, Niels; Taxvig, Camilla; Nellemann, Christine; Hass, Ulla; Vinggaard, Anne Marie] Tech Univ Denmark, Natl Food Inst, Div Toxicol & Risk Assessment, Soborg, Denmark; [Pedersen, Mikael] Tech Univ Denmark, Natl Food Inst, Div Food Chem, Soborg, Denmark	Technical University of Denmark; Technical University of Denmark	Hadrup, N (corresponding author), Tech Univ Denmark, Natl Food Inst, Div Toxicol & Risk Assessment, Soborg, Denmark.	nilha@food.dtu.dk	Taxvig, Camilla/C-6871-2016	Taxvig, Camilla/0000-0001-7985-2676; Hadrup, Niels/0000-0002-1188-445X; Pedersen, Mikael/0000-0001-6540-4805; Hass, Ulla/0000-0001-5309-167X; Nellemann, Christine/0000-0002-4692-5127; Vinggaard, Anne Marie/0000-0002-6822-3572	Ministry of Food, Agriculture and Fisheries of Denmark; Danish Veterinary and Food Administration; European Commission [212502]	Ministry of Food, Agriculture and Fisheries of Denmark; Danish Veterinary and Food Administration; European Commission(European CommissionEuropean Commission Joint Research Centre)	The Ministry of Food, Agriculture and Fisheries of Denmark and the Danish Veterinary and Food Administration are acknowledged for their financial support. In addition, this study was supported by a grant from the European Commission, 7th Framework Programme, CONTAMED (Contaminant mixtures and human reproductive health - novel strategies for health impact and risk assessment of endocrine disrupters), grant agreement number 212502. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhaus T, 2004, ENVIRON SCI TECHNOL, V38, P6363, DOI 10.1021/es0497678; BARDSLEY WG, 1978, J THEOR BIOL, V72, P321, DOI 10.1016/0022-5193(78)90096-6; BIRD IM, 1993, ENDOCRINOLOGY, V133, P1555, DOI 10.1210/en.133.4.1555; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Blystone CR, 2007, TOXICOL SCI, V97, P512, DOI 10.1093/toxsci/kfm055; Blystone CR, 2007, TOXICOL SCI, V97, P65, DOI 10.1093/toxsci/kfm004; Chedrese PJ, 2001, REPROD TOXICOL, V15, P693, DOI 10.1016/S0890-6238(01)00172-1; Christiansen S, 2012, INT J ANDROL, V35, P303, DOI 10.1111/j.1365-2605.2011.01242.x; Churchill JE, 2001, ARCH ENVIRON HEALTH, V56, P157, DOI 10.1080/00039890109604068; Faust M, 2003, AQUAT TOXICOL, V63, P43, DOI 10.1016/S0166-445X(02)00133-9; Goforth HW, 2012, NEUROL CLIN, V30, P277, DOI 10.1016/j.ncl.2011.09.015; Hass U, 2012, REPROD TOXICOL, V34, P261, DOI 10.1016/j.reprotox.2012.05.090; Hecker M, 2007, ENVIRON SCI POLLUT R, V14, P23, DOI 10.1065/espr2007.03.402; HEINDEL JJ, 1995, FUND APPL TOXICOL, V25, P9, DOI 10.1006/faat.1995.1035; HERMENS J, 1984, AQUAT TOXICOL, V5, P143, DOI 10.1016/0166-445X(84)90005-5; Higley EB, 2010, ENVIRON SCI POLLUT R, V17, P1137, DOI 10.1007/s11356-009-0285-3; Hotchkiss AK, 2004, BIOL REPROD, V71, P1852, DOI 10.1095/biolreprod.104.031674; Howard GJ, 2010, ENVIRON HEALTH PERSP, V118, P666, DOI 10.1289/ehp.0901312; Howard GJ, 2009, J THEOR BIOL, V259, P469, DOI 10.1016/j.jtbi.2009.03.030; Kjaerstad MB, 2010, INT J ANDROL, V33, P425, DOI 10.1111/j.1365-2605.2009.01034.x; KONEMANN H, 1981, TOXICOLOGY, V19, P229, DOI 10.1016/0300-483X(81)90132-3; Laier P, 2006, TOXICOL APPL PHARM, V213, P160, DOI 10.1016/j.taap.2005.10.013; Mortensen SK, 2007, ANAL CHIM ACTA, V586, P217, DOI 10.1016/j.aca.2006.10.016; O'Connor JC, 2002, TOXICOL SCI, V69, P92, DOI 10.1093/toxsci/69.1.92; Ohlsson A, 2009, TOXICOL LETT, V191, P174, DOI 10.1016/j.toxlet.2009.08.020; Olmstead AW, 2005, INTEGR ENVIRON ASSES, V1, P114, DOI 10.1897/IEAM_2004-005R.1; Quignot N, 2012, TOXICOL IN VITRO, V26, P107, DOI 10.1016/j.tiv.2011.11.004; Rijk JCW, 2012, CHEM RES TOXICOL, V25, P1720, DOI 10.1021/tx3001779; Rossi GP, 2011, J HYPERTENS, V29, P2295, DOI 10.1097/HJH.0b013e32834c465d; Sanderson JT, 2002, TOXICOL APPL PHARM, V182, P44, DOI 10.1006/taap.2002.9420; Taxvig C, 2008, INT J ANDROL, V31, P170, DOI 10.1111/j.1365-2605.2007.00838.x; Taxvig C, 2007, TOXICOL SCI, V100, P464, DOI 10.1093/toxsci/kfm227; Vinggaard AM, 2005, TOXICOL SCI, V85, P886, DOI 10.1093/toxsci/kfi150; Wilson VS, 2009, TOXICOL LETT, V186, P73, DOI 10.1016/j.toxlet.2008.12.017; Woodruff TJ, 2011, ENVIRON HEALTH PERSP, V119, P878, DOI 10.1289/ehp.1002727; Ye LP, 2011, MOLECULES, V16, P9983, DOI 10.3390/molecules16129983; Zhang XW, 2011, TOXICOL SCI, V121, P320, DOI 10.1093/toxsci/kfr061	37	61	62	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e70490	10.1371/journal.pone.0070490	http://dx.doi.org/10.1371/journal.pone.0070490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23990906	Green Published, gold			2022-12-25	WOS:000324470700003
J	Keller, J; Rulseh, AM; Komarek, A; Latnerova, I; Rusina, R; Brozova, H; Vymazal, J				Keller, Jiri; Rulseh, Aaron M.; Komarek, Arnost; Latnerova, Iva; Rusina, Robert; Brozova, Hana; Vymazal, Josef			New Non-Linear Color Look-Up Table for Visualization of Brain Fractional Anisotropy Based on Normative Measurements - Principals and First Clinical Use	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; DIFFUSION; REGION; TRACT	Fractional anisotropy (FA) is the most commonly used quantitative measure of diffusion in the brain. Changes in FA have been reported in many neurological disorders, but the implementation of diffusion tensor imaging (DTI) in daily clinical practice remains challenging. We propose a novel color look-up table (LUT) based on normative data as a tool for screening FA changes. FA was calculated for 76 healthy volunteers using 12 motion-probing gradient directions (MPG), a subset of 59 subjects was additionally scanned using 30 MPG. Population means and 95% prediction intervals for FA in the corpus callosum, frontal gray matter, thalamus and basal ganglia were used to create the LUT. Unique colors were assigned to inflection points with continuous ramps between them. Clinical use was demonstrated on 17 multiple system atrophy (MSA) patients compared to 13 patients with Parkinson disease (PD) and 17 healthy subjects. Four blinded radiologists classified subjects as MSA/non-MSA. Using only the LUT, high sensitivity (80%) and specificity (84%) were achieved in differentiating MSA subjects from PD subjects and controls. The LUTs generated from 12 and 30 MPG were comparable and accentuate FA abnormalities.	[Keller, Jiri] Charles Univ Prague, Fac Med 3, Dept Neurol, Prague, Czech Republic; [Keller, Jiri; Rulseh, Aaron M.; Latnerova, Iva; Vymazal, Josef] Na Homolce Hosp, Dept Radiol, Prague, Czech Republic; [Komarek, Arnost] Charles Univ Prague, Fac Math & Phys, Dept Probabil & Math Stat, Prague, Czech Republic; [Rusina, Robert] Thomayer Hosp, Dept Neurol, Prague, Czech Republic; [Rusina, Robert; Brozova, Hana] Fac Med 1, Dept Neurol, Prague, Czech Republic; [Rusina, Robert; Brozova, Hana] Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Rusina, Robert; Brozova, Hana] Gen Univ Hosp Prague, Prague, Czech Republic	Charles University Prague; Na Homolce Hospital; Charles University Prague; Thomayer Hospital; Charles University Prague; Charles University Prague; General University Hospital Prague	Keller, J (corresponding author), Charles Univ Prague, Fac Med 3, Dept Neurol, Prague, Czech Republic.	keller.public+plosone@gmail.com	Keller, Jiří/AAE-4791-2019; Brozova, Hana/AAM-9717-2021; Komarek, Arnost/A-5534-2012; Rulseh, Aaron/D-3924-2015	Keller, Jiří/0000-0002-6799-7840; Brozova, Hana/0000-0003-3383-7117; Komarek, Arnost/0000-0001-8778-3762; Rulseh, Aaron/0000-0002-8332-4419	Interni grantova agentura Ministerstva zdravotnictvi (IGA MZCR) [NT11328, NT12094]; Research Project Charles University in Prague; PRVOUK P34; Research Goal MSM [0021620849]	Interni grantova agentura Ministerstva zdravotnictvi (IGA MZCR); Research Project Charles University in Prague; PRVOUK P34; Research Goal MSM	This study was supported by grants Interni grantova agentura Ministerstva zdravotnictvi (IGA MZCR) NT11328, NT12094, Research Project Charles University in Prague, PRVOUK P34, and Research Goal MSM 0021620849. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, PACKAGE LME4 LINEAR; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Bozzali M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048079; Chan LL, 2007, J NEUROL NEUROSUR PS, V78, P1383, DOI 10.1136/jnnp.2007.121525; Douaud G, 2009, NEUROIMAGE, V46, P958, DOI 10.1016/j.neuroimage.2009.03.044; Giuliani NR, 2005, SCHIZOPHR RES, V74, P135, DOI 10.1016/j.schres.2004.08.019; Harrison DM, 2011, NEUROLOGY, V76, P179, DOI 10.1212/WNL.0b013e318206ca61; Ibrahim I, 2009, NEUROENDOCRINOL LETT, V30, P39; Jolapara M, 2010, NEURORADIOLOGY; Keller J, 2010, ISMRM ESMRMB JOINT A; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Llufriu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037167; Mitelman SA, 2009, SCHIZOPHR RES, V114, P144, DOI 10.1016/j.schres.2009.07.021; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J; Palmer SL, 2002, AM J NEURORADIOL, V23, P1088; Peters BD, 2010, J PSYCHIATR RES, V44, P993, DOI 10.1016/j.jpsychires.2010.05.003; Preti MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035856; R Development Core Team R, 2009, R LANG ENV STAT COMP; Rasband W., 2006, IMAGEJ; Rulseh AM, 2013, J MAGN RESON IMAGING, V38, P1103, DOI 10.1002/jmri.24065; Sharma KR, 2012, JOURNAL OF NEUROIMAG; Shiga K, 2005, J NEUROL, V252, P589, DOI 10.1007/s00415-005-0708-0; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Taoka T, 2007, NEUROIMAGE, V37, P387, DOI 10.1016/j.neuroimage.2007.05.028; Tha KK, 2010, RADIOLOGY, V255, P563, DOI 10.1148/radiol.10090988; Van Camp N, 2012, NEUROBIOL AGING, V33, P945, DOI 10.1016/j.neurobiolaging.2010.07.001; Weiss Kenneth L, 2002, Radiographics, V22, pe3; WEISS KL, 1987, AM J ROENTGENOL, V149, P825, DOI 10.2214/ajr.149.4.825; Xu JS, 2010, NEUROPSYCHOPHARMACOL, V35, P1541, DOI 10.1038/npp.2010.25; Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045476	32	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e71431	10.1371/journal.pone.0071431	http://dx.doi.org/10.1371/journal.pone.0071431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23990954	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470700016
J	Erickson, CE; Gul, R; Blessing, CP; Nguyen, J; Liu, T; Pulakat, L; Bastepe, M; Jackson, EK; Andresen, BT				Erickson, Catherine E.; Gul, Rukhsana; Blessing, Christopher P.; Jenny Nguyen; Liu, Tammy; Pulakat, Lakshmi; Bastepe, Murat; Jackson, Edwin K.; Andresen, Bradley T.			The beta-blocker Nebivolol Is a GRK/beta-arrestin Biased Agonist	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; EPIDERMAL GROWTH-FACTOR; NITRIC-OXIDE PRODUCTION; ADRENERGIC BLOCKERS; ENDOTHELIAL-CELLS; RAT AORTA; CARVEDILOL; BINDING; EGF; BETA(3)-ADRENOCEPTOR	Nebivolol, a third generation beta-adrenoceptor (beta-AR) antagonist (beta-blocker), causes vasodilation by inducing nitric oxide (NO) production. The mechanism via which nebivolol induces NO production remains unknown, resulting in the genesis of much of the controversy regarding the pharmacological action of nebivolol. Carvedilol is another beta-blocker that induces NO production. A prominent pharmacological mechanism of carvedilol is biased agonism that is independent of G alpha(s) and involves G protein-coupled receptor kinase (GRK)/beta-arrestin signaling with downstream activation of the epidermal growth factor receptor (EGFR) and extracellular signal-regulated kinase (ERK). Due to the pharmacological similarities between nebivolol and carvedilol, we hypothesized that nebivolol is also a GRK/beta-arrestin biased agonist. We tested this hypothesis utilizing mouse embryonic fibroblasts (MEFs) that solely express beta(2)-ARs, and HL-1 cardiac myocytes that express beta(1)- and beta(2)-ARs and no detectable beta(3)-ARs. We confirmed previous reports that nebivolol does not significantly alter cAMP levels and thus is not a classical agonist. Moreover, in both cell types, nebivolol induced rapid internalization of beta-ARs indicating that nebivolol is also not a classical beta-blocker. Furthermore, nebivolol treatment resulted in a time-dependent phosphorylation of ERK that was indistinguishable from carvedilol and similar in duration, but not amplitude, to isoproterenol. Nebivolol-mediated phosphorylation of ERK was sensitive to propranolol (non-selective beta-AR-blocker), AG1478 (EGFR inhibitor), indicating that the signaling emanates from beta-ARs and involves the EGFR. Furthermore, in MEFs, nebivolol-mediated phosphorylation of ERK was sensitive to pharmacological inhibition of GRK2 as well as siRNA knockdown of beta-arrestin 1/2. Additionally, nebivolol induced redistribution of beta-arrestin 2 from a diffuse staining pattern into more intense punctate spots. We conclude that nebivolol is a beta(2)-AR, and likely beta(1)-AR, GRK/beta-arrestin biased agonist, which suggests that some of the unique clinically beneficial effects of nebivolol may be due to biased agonism at beta(1)- and/or beta(2)-ARs.	[Erickson, Catherine E.; Gul, Rukhsana; Blessing, Christopher P.; Pulakat, Lakshmi] Univ Missouri, Dept Internal Med, Columbia, MO USA; [Pulakat, Lakshmi] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA; [Pulakat, Lakshmi; Andresen, Bradley T.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA; [Erickson, Catherine E.; Gul, Rukhsana; Pulakat, Lakshmi] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Gul, Rukhsana] King Saud Univ, Coll Med, Obes Res Ctr, Riyadh 11461, Saudi Arabia; [Bastepe, Murat] Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Boston, MA 02114 USA; [Bastepe, Murat] Harvard Univ, Sch Med, Boston, MA USA; [Jackson, Edwin K.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Jenny Nguyen; Liu, Tammy; Andresen, Bradley T.] Western Univ Hlth Sci, Dept Pharmaceut Sci, Pomona, CA USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; King Saud University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western University of Health Sciences	Andresen, BT (corresponding author), Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA.	bandresen@westernu.edu	Gul, Rukhsana/ABG-8259-2020; Bastepe, Murat/GQQ-3389-2022	Gul, Rukhsana/0000-0003-0454-864X; Andresen, Bradley/0000-0002-3948-7456; Bastepe, Murat/0000-0002-2643-3504; Jackson, Edwin/0000-0002-8101-6009	Life Science Mission Enhancement Fund from UM-Columbia; National Institutes of Health [R01 DK073911, HL109002, DK091190, HL069846, DK068575, DK079307]; University of Missouri; Western University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109002, R01HL069846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091190, R01DK068575, P30DK079307] Funding Source: NIH RePORTER	Life Science Mission Enhancement Fund from UM-Columbia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Missouri; Western University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by the Life Science Mission Enhancement Fund from UM-Columbia to LP, as well as research grants from the National Institutes of Health R01 DK073911 to MB; HL109002, DK091190, HL069846, DK068575, and DK079307 to EKJ. Internal funds from the University of Missouri and Western University to BTA were also used to conduct these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso RA, 2006, AM J HYPERTENS, V19, P419, DOI 10.1016/j.amjhyper.2005.11.011; Andresen Bradley T., 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P92; Andresen BT, 2010, METHOD ENZYMOL, V484, P631, DOI [10.1016/S0076-6879(10)84031-5, 10.1016/B978-0-12-381298-8.00031-9]; Bastepe M, 2002, MOL ENDOCRINOL, V16, P1912, DOI 10.1210/me.2002-0054; BOWMAN AJ, 1994, BRIT J CLIN PHARMACO, V38, P199, DOI 10.1111/j.1365-2125.1994.tb04342.x; Brixius K, 2001, BRIT J PHARMACOL, V133, P1330, DOI 10.1038/sj.bjp.0704188; Broeders MAW, 2000, CIRCULATION, V102, P677, DOI 10.1161/01.CIR.102.6.677; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; COCKCROFT JR, 1995, J PHARMACOL EXP THER, V274, P1067; de Groot AA, 2003, J CARDIOVASC PHARM, V42, P232, DOI 10.1097/00005344-200308000-00012; Dessy C, 2005, CIRCULATION, V112, P1198, DOI 10.1161/CIRCULATIONAHA.104.532960; DiNicolantonio JJ, 2012, EXPERT REV CARDIOVAS, V10, P13, DOI [10.1586/erc.11.166, 10.1586/ERC.11.166]; Escano CS, 2008, J PHARMACOL EXP THER, V324, P34, DOI 10.1124/jpet.107.126300; Feng MG, 2012, AM J PHYSL RENAL PHY; Frazier EP, 2011, EUR J PHARMACOL, V654, P86, DOI 10.1016/j.ejphar.2010.11.036; Garbin U, 2007, PHARMACOL RES, V56, P515, DOI 10.1016/j.phrs.2007.09.015; Gosgnach W, 2001, J CARDIOVASC PHARM, V38, P191, DOI 10.1097/00005344-200108000-00004; Hamdani N, 2009, N-S ARCH PHARMACOL, V379, P403, DOI 10.1007/s00210-009-0392-1; Iino M, 2002, J MED CHEM, V45, P2150, DOI 10.1021/jm010093a; Kim IM, 2008, P NATL ACAD SCI USA, V105, P14555, DOI 10.1073/pnas.0804745105; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LONNQVIST F, 1993, BRIT J PHARMACOL, V110, P929; Matsushita Mayumi, 2006, Journal of Smooth Muscle Research, V42, P217, DOI 10.1540/jsmr.42.217; Mehta VB, 2008, GROWTH FACTORS, V26, P301, DOI 10.1080/08977190802393596; NAMIKI A, 1990, EUR J PHARMACOL, V180, P247, DOI 10.1016/0014-2999(90)90308-S; Niclauss N, 2006, N-S ARCH PHARMACOL, V374, P99, DOI 10.1007/s00210-006-0104-z; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; PAUWELS PJ, 1989, EUR J PHARM-MOLEC PH, V172, P471, DOI 10.1016/0922-4106(89)90030-8; PAUWELS PJ, 1991, BIOCHEM PHARMACOL, V42, P1683, DOI 10.1016/0006-2952(91)90502-V; PAUWELS PJ, 1988, MOL PHARMACOL, V34, P843; Pierce KL, 2001, J BIOL CHEM, V276, P23155, DOI 10.1074/jbc.M101303200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Price A, 2013, HYPERTENSION, V61, P1263, DOI 10.1161/HYPERTENSIONAHA.113.01302; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rakesh K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000769; Rautureau Y, 2002, BRIT J PHARMACOL, V137, P153, DOI 10.1038/sj.bjp.0704867; Ren J, 2008, J PHARMACOL EXP THER, V325, P920, DOI 10.1124/jpet.108.137752; RUFFOLO RR, 1990, EUR J CLIN PHARMACOL, V38, pS82, DOI 10.1007/BF01409471; Seibold A, 1998, J BIOL CHEM, V273, P7637, DOI 10.1074/jbc.273.13.7637; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; STAEHELIN M, 1983, J BIOL CHEM, V258, P3496; THOMPSON JE, 1994, BIOCHEMISTRY-US, V33, P7408, DOI 10.1021/bi00189a047; Tilley DG, 2011, CIRC RES, V109, P217, DOI 10.1161/CIRCRESAHA.110.231225; Tzingounis AV, 2010, P NATL ACAD SCI USA, V107, P21028, DOI 10.1073/pnas.1004169107; VANDEWATER A, 1988, J CARDIOVASC PHARM, V11, P552, DOI 10.1097/00005344-198805000-00007; Veverka A, 2007, VASC HEALTH RISK MAN, V3, P647; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Xiao K, 2010, PROCNATLACADSCIUSA; Ye HM, 2013, HYPERTENSION, V61, P1008, DOI 10.1161/HYPERTENSIONAHA.111.00892; Zhou Y, 2009, MICROVASC RES, V78, P78, DOI 10.1016/j.mvr.2009.04.006	51	49	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71980	10.1371/journal.pone.0071980	http://dx.doi.org/10.1371/journal.pone.0071980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977191	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300057
J	Burke, LS; Hyland, PL; Pfeiffer, RM; Prescott, J; Wheeler, W; Mirabello, L; Savage, SA; Burdette, L; Yeager, M; Chanock, S; De Vivo, I; Tucker, MA; Goldstein, AM; Yang, XHR				Burke, Laura S.; Hyland, Paula L.; Pfeiffer, Ruth M.; Prescott, Jennifer; Wheeler, William; Mirabello, Lisa; Savage, Sharon A.; Burdette, Laurie; Yeager, Meredith; Chanock, Stephen; De Vivo, Immaculata; Tucker, Margaret A.; Goldstein, Alisa M.; Yang, Xiaohong R.			Telomere Length and the Risk of Cutaneous Malignant Melanoma in Melanoma-Prone Families with and without CDKN2A Mutations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LOCUS; VARIANTS; CANCER; P16(INK4A); SIZE	Introduction: Recent evidence suggests a link between constitutional telomere length (TL) and cancer risk. Previous studies have suggested that longer telomeres were associated with an increased risk of melanoma and larger size and number of nevi. The goal of this study was to examine whether TL modified the risk of melanoma in melanoma-prone families with and without CDKN2A germline mutations. Materials and Methods: We measured TL in blood DNA in 119 cutaneous malignant melanoma (CMM) cases and 208 unaffected individuals. We also genotyped 13 tagging SNPs in TERT. Results: We found that longer telomeres were associated with an increased risk of CMM (adjusted OR = 2.81, 95% CI = 1.02-7.72, P = 0.04). The association of longer TL with CMM risk was seen in CDKN2A- cases but not in CDKN2A+ cases. Among CMM cases, the presence of solar injury was associated with shorter telomeres (P = 0.002). One SNP in TERT, rs2735940, was significantly associated with TL (P = 0.002) after Bonferroni correction. Discussion: Our findings suggest that TL regulation could be variable by CDKN2A mutation status, sun exposure, and pigmentation phenotype. Therefore, TL measurement alone may not be a good marker for predicting CMM risk.	[Burke, Laura S.; Hyland, Paula L.; Pfeiffer, Ruth M.; Mirabello, Lisa; Savage, Sharon A.; Tucker, Margaret A.; Goldstein, Alisa M.; Yang, Xiaohong R.] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Rockville, MD USA; [Hyland, Paula L.] NCI, Canc Prevent Fellowship Program, Off Directors, NIH,US Dept HHS, Rockville, MD USA; [Prescott, Jennifer; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Prescott, Jennifer; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Prescott, Jennifer; De Vivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Prescott, Jennifer; De Vivo, Immaculata] Harvard Univ, Sch Med, Boston, MA USA; [Wheeler, William] Informat Management Serv Inc, Rockville, MD USA; [Burdette, Laurie; Yeager, Meredith; Chanock, Stephen] NCI, Core Genotyping Facil, SAIC Frederick Inc, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Information Management Services, Inc.; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Yang, XHR (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Rockville, MD USA.	royang@mail.nih.gov	Yeager, Meredith/AAA-5322-2020; Savage, Sharon/AAB-5160-2019; Savage, Sharon A/B-9747-2015; Tucker, Margaret A/B-4297-2015; Mirabello, Lisa/H-5594-2018	Savage, Sharon/0000-0001-6006-0740; Savage, Sharon A/0000-0001-6006-0740; De Vivo, Immaculata/0000-0002-7185-7402	Cancer Prevention Fellowship Program; Center for Cancer Training, National Cancer Institute, Bethesda, United States of America; Health and Social Care, Northern Ireland, United Kingdom	Cancer Prevention Fellowship Program; Center for Cancer Training, National Cancer Institute, Bethesda, United States of America; Health and Social Care, Northern Ireland, United Kingdom	Paula Hyland was funded by the Cancer Prevention Fellowship Program, the Center for Cancer Training, National Cancer Institute, Bethesda, United States of America and the Health and Social Care, Northern Ireland, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; Bataille V, 2007, CANCER EPIDEM BIOMAR, V16, P1499, DOI 10.1158/1055-9965.EPI-07-0152; Bishop DT, 2002, J NATL CANCER I, V94, P894, DOI 10.1093/jnci/94.12.894; Bodelon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052466; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Eliason MJ, 2006, J INVEST DERMATOL, V126, P660, DOI 10.1038/sj.jid.5700094; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; Goldstein AM, 2004, HUM MUTAT, V23, P630, DOI 10.1002/humu.9247; Goldstein AM, 2000, J NATL CANCER I, V92, P1006, DOI 10.1093/jnci/92.12.1006; Goldstein AM, 2005, CANCER EPIDEM BIOMAR, V14, P2208, DOI 10.1158/1055-9965.EPI-05-0321; Goldstein AM, 2001, ARCH DERMATOL, V137, P1493; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Gu JA, 2011, CANCER PREV RES, V4, P514, DOI 10.1158/1940-6207.CAPR-11-0063; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Jenkins NC, 2011, ONCOGENE, V30, P265, DOI 10.1038/onc.2010.419; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lan Q, 2009, CLIN CANCER RES, V15, P7429, DOI 10.1158/1078-0432.CCR-09-0845; Law MH, 2012, J INVEST DERMATOL, V132, P485, DOI 10.1038/jid.2011.322; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; Liu J, 2011, CANCER-AM CANCER SOC, V117, P4247, DOI 10.1002/cncr.26015; Mangino M, 2009, J MED GENET, V46, P451, DOI 10.1136/jmg.2008.064956; Muller HK, 2008, PHOTOCHEM PHOTOBIOL, V84, P47, DOI 10.1111/j.1751-1097.2007.00246.x; Murnane JP, 2012, MUTAT RES-FUND MOL M, V730, P28, DOI 10.1016/j.mrfmmm.2011.04.008; Nan HM, 2011, CANCER RES, V71, P6758, DOI 10.1158/0008-5472.CAN-11-1988; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Pfeiffer RM, 2001, BIOMETRIKA, V88, P933, DOI 10.1093/biomet/88.4.933; Radpour R, 2010, MODERN PATHOL, V23, P763, DOI 10.1038/modpathol.2009.195; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Sarkar-Agrawal P, 2004, JNCI-J NATL CANCER I, V96, P1790, DOI 10.1093/jnci/djh307; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Tucker MA, 2009, HEMATOL ONCOL CLIN N, V23, P383, DOI 10.1016/j.hoc.2009.03.010; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	39	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71121	10.1371/journal.pone.0071121	http://dx.doi.org/10.1371/journal.pone.0071121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990928	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700016
J	Clop, A; Bertoni, A; Spain, SL; Simpson, MA; Pullabhatla, V; Tonda, R; Hundhausen, C; Di Meglio, P; De Jong, P; Hayday, AC; Nestle, FO; Barker, JN; Bell, RJA; Capon, F; Trembath, RC				Clop, Alex; Bertoni, Anna; Spain, Sarah L.; Simpson, Michael A.; Pullabhatla, Venu; Tonda, Raul; Hundhausen, Christian; Di Meglio, Paola; De Jong, Pieter; Hayday, Adrian C.; Nestle, Frank O.; Barker, Jonathan N.; Bell, Robert J. A.; Capon, Francesca; Trembath, Richard C.			An In-Depth Characterization of the Major Psoriasis Susceptibility Locus Identifies Candidate Susceptibility Alleles within an HLA-C Enhancer Element	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; EXPRESSION; POLYMORPHISM; ARTHRITIS; RESPONSES; PATHWAYS; SEQUENCE; PSORS1; MHC	Psoriasis is an immune-mediated skin disorder that is inherited as a complex genetic trait. Although genome-wide association scans (GWAS) have identified 36 disease susceptibility regions, more than 50% of the genetic variance can be attributed to a single Major Histocompatibility Complex (MHC) locus, known as PSORS1. Genetic studies indicate that HLA-C is the strongest PSORS1 candidate gene, since markers tagging HLA-Cw*0602 consistently generate the most significant association signals in GWAS. However, it is unclear whether HLA-Cw*0602 is itself the causal PSORS1 allele, especially as the role of SNPs that may affect its expression has not been investigated. Here, we have undertaken an in-depth molecular characterization of the PSORS1 interval, with a view to identifying regulatory variants that may contribute to disease susceptibility. By analysing high-density SNP data, we refined PSORS1 to a 179 kb region encompassing HLA-C and the neighbouring HCG27 pseudogene. We compared multiple MHC sequences spanning this refined locus and identified 144 candidate susceptibility variants, which are unique to chromosomes bearing HLA-Cw*0602. In parallel, we investigated the epigenetic profile of the critical PSORS1 interval and uncovered three enhancer elements likely to be active in T lymphocytes. Finally we showed that nine candidate susceptibility SNPs map within a HLA-C enhancer and that three of these variants co-localise with binding sites for immune-related transcription factors. These data indicate that SNPs affecting HLA-Cw*0602 expression are likely to contribute to psoriasis susceptibility and highlight the importance of integrating multiple experimental approaches in the investigation of complex genomic regions such as the MHC.	[Clop, Alex; Bertoni, Anna; Spain, Sarah L.; Simpson, Michael A.; Pullabhatla, Venu; Hundhausen, Christian; Di Meglio, Paola; Nestle, Frank O.; Barker, Jonathan N.; Capon, Francesca; Trembath, Richard C.] Kings Coll London, Div Genet & Mol Med, London, England; [Tonda, Raul] CRAG, Cerdanyola Del Valles, Spain; [De Jong, Pieter] Childrens Hosp Oakland, BACPAC Resources Ctr, Oakland, CA USA; [Hayday, Adrian C.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London, England; [Bell, Robert J. A.] Univ Calif San Francisco, Dept Neurosurg, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Trembath, Richard C.] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England	University of London; King's College London; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of London; King's College London; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of London; Queen Mary University London	Capon, F (corresponding author), Kings Coll London, Div Genet & Mol Med, London, England.	francesca.capon@kcl.ac.uk; vp-health@qmul.ac.uk	Clop, Alex/D-1519-2009; Tonda, Raul/I-1606-2015; Clop, Alex/AAH-9231-2021; Simpson, Michael/F-4737-2011; Capon, Francesca/F-4763-2011; Spain, Sarah/G-1968-2010	Clop, Alex/0000-0001-9238-2728; Tonda, Raul/0000-0001-7893-2404; Clop, Alex/0000-0001-9238-2728; Simpson, Michael/0000-0002-8539-8753; Capon, Francesca/0000-0003-2432-5793; Trembath, Richard/0000-0003-0550-3400; Spain, Sarah/0000-0002-7591-8364; HAYDAY, ADRIAN/0000-0002-9495-5793; Barker, Jonathan/0000-0002-9030-183X; Di Meglio, Paola/0000-0002-2066-7780	Department of Health via the National Institute of Health Research (NIHR) comprehensive Biomedical Research Centre award; Medical Research Council [G0000934, G0601387]; Wellcome Trust [068545/Z/02]; UK National Blood Service; National Psoriasis Foundation USA; Generation Trust; KCL; UCSF; King's College London; King's College Hospital NHS Foundation Trust;  [NPF127]; MRC [G0000934, G0601387] Funding Source: UKRI; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish	Department of Health via the National Institute of Health Research (NIHR) comprehensive Biomedical Research Centre award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); UK National Blood Service; National Psoriasis Foundation USA; Generation Trust; KCL; UCSF; King's College London(General Electric); King's College Hospital NHS Foundation Trust; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors acknowledge the use of BRC Core Facilities provided by the financial support from the Department of Health via the National Institute of Health Research (NIHR,www.nihr.ac.uk/) comprehensive Biomedical Research Centre award to Guy's and St Thomas NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The British 1958 Birth Cohort DNA collection was funded by Medical Research Council (www.mrc.ac.uk) grant G0000934 and Wellcome Trust (www.wellcome.ac.uk) grant 068545/Z/02, and the UK National Blood Service controls by the Wellcome Trust. This work was supported by the Medical Research Council (grant G0601387 to RCT, JNB, FON and AH), the National Psoriasis Foundation USA (www.psoriasis.org; Discovery grant to FC) and Prime Minister's Initiative 2 (PMI2)/partnership NPF127, for UK-US partnership between KCL and UCSF. AB's studentship was funded by The Generation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Capon F, 2002, J INVEST DERMATOL, V118, P745, DOI 10.1046/j.1523-1747.2002.01749.x; Capon F, 2004, HUM MOL GENET; Capon F, 2012, J INVEST DERMATOL, V132, P915, DOI 10.1038/jid.2011.395; Carlen L, 2007, J INVEST DERMATOL, V127, P342, DOI 10.1038/sj.jid.5700549; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Helms C, 2005, HUM GENET, V118, P466, DOI 10.1007/s00439-005-0048-2; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Hundhausen C, 2012, J INVEST DERMATOL, V132, P635, DOI 10.1038/jid.2011.378; Johnson DR, 2003, J IMMUNOL, V170, P1894, DOI 10.4049/jimmunol.170.4.1894; Karnowski A, 2012, J EXP MED, V209, P2049, DOI 10.1084/jem.20111504; Knight J, 2012, HUM MOL GENET, V21, P5185, DOI 10.1093/hmg/dds344; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liao HT, 2008, J RHEUMATOL, V35, P891; Mallon E, 1999, J INVEST DERMATOL, V113, P693, DOI 10.1046/j.1523-1747.1999.00724.x; McLaren PJ, 2012, HUM MOL GENET, V21, P4334, DOI 10.1093/hmg/dds226; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Rodriguez-Rodero S, 2007, EUR J IMMUNOL, V37, P1938, DOI 10.1002/eji.200737031; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Tervaniemi MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049920; Thompson JD, 2002, CURR PROTOC BIOINFOR; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Veal CD, 2002, AM J HUM GENET, V71, P554, DOI 10.1086/342289; Xu WD, 2012, AUTOIMMUN REV, V11, P918, DOI 10.1016/j.autrev.2012.08.011	37	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71690	10.1371/journal.pone.0071690	http://dx.doi.org/10.1371/journal.pone.0071690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990973	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700084
J	Huang, CCY; Ko, ML; Ko, GYP				Huang, Cathy Chia-Yu; Ko, Michael Lee; Ko, Gladys Yi-Ping			A New Functional Role for Mechanistic/Mammalian Target of Rapamycin Complex 1 (mTORC1) in the Circadian Regulation of L-Type Voltage-Gated Calcium Channels in Avian Cone Photoreceptors	PLOS ONE			English	Article							CALCINEURIN PHOSPHATASE-ACTIVITY; MAMMALIAN TARGET; MESSENGER-RNA; IMMUNOSUPPRESSANT FK506; RETINOMOTOR MOVEMENTS; AXON REGENERATION; SYNAPTIC RIBBONS; VERTEBRATE ROD; CYCLOSPORINE-A; T-LYMPHOCYTES	In the retina, the L-type voltage-gated calcium channels (L-VGCCs) are responsible for neurotransmitter release from photoreceptors and are under circadian regulation. Both the current densities and protein expression of L-VGCCs are significantly higher at night than during the day. However, the underlying mechanisms of circadian regulation of L-VGCCs in the retina are not completely understood. In this study, we demonstrated that the mechanistic/mammalian target of rapamycin complex (mTORC) signaling pathway participated in the circadian phase-dependent modulation of L-VGCCs. The activities of the mTOR cascade, from mTORC1 to its downstream targets, displayed circadian oscillations throughout the course of a day. Disruption of mTORC1 signaling dampened the L-VGCC current densities, as well as the protein expression of L-VGCCs at night. The decrease of L-VGCCs at night by mTORC1 inhibition was in part due to a reduction of L-VGCC alpha 1 subunit translocation from the cytosol to the plasma membrane. Finally, we showed that mTORC1 was downstream of the phosphatidylionositol 3 kinase-protein kinase B (PI3K-AKT) signaling pathway. Taken together, mTORC1 signaling played a role in the circadian regulation of L-VGCCs, in part through regulation of ion channel trafficking and translocation, which brings to light a new functional role for mTORC1: the modulation of ion channel activities.	[Huang, Cathy Chia-Yu; Ko, Michael Lee; Ko, Gladys Yi-Ping] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station	Ko, GYP (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX USA.	gko@cvm.tamu.edu		Huang, Cathy Chia-Yu/0000-0002-4091-5163	National Eye Institute [NIHR01EY017452]; NATIONAL EYE INSTITUTE [R01EY017452] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIHR01EY017452 (National Eye Institute) to G.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER R, 1989, SCIENCE, V243, P391, DOI 10.1126/science.2911751; ADLER R, 1984, J CELL BIOL, V99, P1173, DOI 10.1083/jcb.99.3.1173; Adly MA, 1999, INVEST OPHTH VIS SCI, V40, P2165; Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; BeleckyAdams T, 1996, DEV BIOL, V178, P304, DOI 10.1006/dbio.1996.0220; Besharse JC, 2003, ADV EXP MED BIOL, V533, P157; BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Burnside B, 2001, Prog Brain Res, V131, P477; CAHILL GM, 1995, PROG RETIN EYE RES, V14, P267, DOI 10.1016/1350-9462(94)00001-Y; Cao R, 2011, NEUROSCIENCE, V181, P79, DOI 10.1016/j.neuroscience.2011.03.005; Cao RF, 2008, MOL CELL NEUROSCI, V38, P312, DOI 10.1016/j.mcn.2008.03.005; Cao RF, 2010, J NEUROSCI, V30, P6302, DOI 10.1523/JNEUROSCI.5482-09.2010; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; CLARDY J, 1995, P NATL ACAD SCI USA, V92, P56, DOI 10.1073/pnas.92.1.56; DUMONT FJ, 1990, J IMMUNOL, V144, P251; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; FERRARI S, 1994, CRIT REV BIOCHEM MOL, V29, P385, DOI 10.3109/10409239409083485; FINDLAY JA, 1980, CAN J CHEM, V58, P579, DOI 10.1139/v80-090; Firth SI, 2001, CLIN EXP OPHTHALMOL, V29, P183, DOI 10.1046/j.1442-9071.2001.00401.x; Fox TE, 2012, INVEST OPHTH VIS SCI, V53, P7257, DOI 10.1167/iovs.11-7626; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; GLEASON E, 1992, VISUAL NEUROSCI, V8, P315, DOI 10.1017/S0952523800005058; Green CB, 2004, J BIOL RHYTHM, V19, P91, DOI 10.1177/0748730404263002; Haque R, 2002, NEUROREPORT, V13, P2247, DOI 10.1097/00001756-200212030-00016; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang CCY, 2012, J CELL BIOCHEM, V113, P911, DOI 10.1002/jcb.23419; Hull C, 2006, J NEUROPHYSIOL, V96, P2025, DOI 10.1152/jn.00364.2006; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Johnson JE, 2007, MOL VIS, V13, P887; Karaganis SP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-206; Kersten FFJ, 2010, INVEST OPHTH VIS SCI, V51, P2338, DOI 10.1167/iovs.09-4650; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Ko GYP, 2004, J NEUROSCI, V24, P1296, DOI 10.1523/JNEUROSCI.3560-03.2004; Ko GYP, 2003, J NEUROSCI, V23, P3145; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; Ko ML, 2007, J NEUROCHEM, V103, P784, DOI 10.1111/j.1471-4159.2007.04816.x; Ko ML, 2009, J NEUROCHEM, V108, P1607, DOI 10.1111/j.1471-4159.2009.05931.x; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; KORENBROT JI, 1995, CELL CALCIUM, V18, P285, DOI 10.1016/0143-4160(95)90025-X; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; Krizaj D, 2002, FRONT BIOSCI-LANDMRK, V7, pD2023, DOI 10.2741/krizaj; la Fleur SE, 2001, DIABETES, V50, P1237, DOI 10.2337/diabetes.50.6.1237; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; Leibinger M, 2012, NEUROBIOL DIS, V46, P314, DOI 10.1016/j.nbd.2012.01.004; Lhuillier L, 2002, J NEUROPHYSIOL, V88, P954, DOI 10.1152/jn.2002.88.2.954; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LIU XY, 2012, PLOS ONE, V134, DOI DOI 10.1371/J0URNAL.P0NE.0050602.PUBMED:23189207; Menger GJ, 2005, VISUAL NEUROSCI, V22, P203, DOI 10.1017/S0952523805222083; MOORE RY, 1983, FED PROC, V42, P2783; Morgans CW, 1999, EUR J NEUROSCI, V11, P2989, DOI 10.1046/j.1460-9568.1999.00719.x; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; PIERCE ME, 1993, NEURON, V10, P579, DOI 10.1016/0896-6273(93)90161-J; PIERCE ME, 1985, J GEN PHYSIOL, V86, P671, DOI 10.1085/jgp.86.5.671; Proud CG, 2009, BIOCHEM SOC T, V37, P227, DOI 10.1042/BST0370227; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Shi L, 2009, J BIOL CHEM, V284, P3966, DOI 10.1074/jbc.M806333200; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; TANAKA H, 1987, J AM CHEM SOC, V109, P5031, DOI 10.1021/ja00250a050; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Wei T, 2012, J NEUROSCI, V32, P6981, DOI 10.1523/JNEUROSCI.6432-11.2012; Wu XH, 2004, J BIOL CHEM, V279, P9167, DOI 10.1074/jbc.M312397200; Yu DY, 2006, IUBMB LIFE, V58, P429, DOI 10.1080/15216540600791555; Zheng XZ, 2010, CURR BIOL, V20, P1203, DOI 10.1016/j.cub.2010.05.027; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	90	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e73315	10.1371/journal.pone.0073315	http://dx.doi.org/10.1371/journal.pone.0073315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977383	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700195
J	Lin, F; Ye, JL; Wang, HG; Zhang, AJ; Zhao, BG				Lin, Feng; Ye, Jianling; Wang, Huaguang; Zhang, Aijun; Zhao, Boguang			Host Deception: Predaceous Fungus, Esteya vermicola, Entices Pine Wood Nematode by Mimicking the Scent of Pine Tree for Nutrient	PLOS ONE			English	Article							BURSAPHELENCHUS-XYLOPHILUS; BIOLOGICAL-CONTROL; MONOCHAMUS-ALTERNATUS; TRAPPING FUNGI; CATTLE; ATTRACTION; VOLATILES; GENUS	Background: A nematophagous fungus, Esteya vermicola, is recorded as the first endoparasitic fungus of pine wood nematode (PWN), Bursaphelenchus xylophilus, in last century. E. vermicola exhibited high infectivity toward PWN in the laboratory conditions and conidia spraying of this fungus on Japanese red pine, Pinus densiflora, seedlings in the field protected the pine trees from pine wilt disease to some extent, indicating that it is a potential bio-control agent against PWN. Previous research had demonstrated that the living fungal mycelia of E. vermicola continuously produced certain volatile organic compounds (VOCs), which were responsible for the PWN attraction. However, identity of these VOCs remains unknown. Methodology/Principal Findings: In this study, we report the identification of alpha-pinene, beta-pinene, and camphor produced by living mycelia of E. vermicola, the same volatile compounds emitted from PWN host pine tree, as the major VOCs for PWN attraction using gas chromatography-mass spectrometry (GC-MS). In addition, we also confirmed the host deception behavior of E. vermicola to PWN by using synthetic VOCs in a straightforward laboratory bioassay. Conclusions/Significance: This research result has demonstrated that the endoparasitic nematophagous fungus, E. vermicola, mimics the scent of PWN host pine tree to entice PWN for the nutrient. The identification of the attractive VOCs emitted from the fungus E. vermicola is of significance in better understanding parasitic mechanism of the fungus and the co-evolution in the two organisms and will aid management of the pine wilt disease.	[Lin, Feng; Ye, Jianling; Wang, Huaguang; Zhao, Boguang] Nanjing Forestry Univ, Dept Forest Protect, Nanjing, Jiangsu, Peoples R China; [Ye, Jianling] Jiangsu Entry Exit Inspect & Quarantine Bur, Anim Plant & Food Inspect Ctr, Nanjing, Jiangsu, Peoples R China; [Zhang, Aijun] ARS, Invas Insect Biocontrol & Behav Lab, USDA, Beltsville, MD USA	Nanjing Forestry University; United States Department of Agriculture (USDA)	Zhao, BG (corresponding author), Nanjing Forestry Univ, Dept Forest Protect, Nanjing, Jiangsu, Peoples R China.	zhbg596@126.com			Chinese Ministry of Forestry [201004003]	Chinese Ministry of Forestry	This work was supported by a project from the Chinese Ministry of Forestry (2010) No. 201004003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa T., 2008, PINE WILT DIS, P123, DOI [10.1007/978-4-431-75655-2_13, DOI 10.1007/978-4-431-75655-2_13]; Assis RCL, 2012, EXP PARASITOL, V132, P373, DOI 10.1016/j.exppara.2012.08.013; Fan JT, 2007, ANN FOREST SCI, V64, P67, DOI 10.1051/forest:2006089; Gomes APS, 1999, BRAZ J MED BIOL RES, V32, P79, DOI 10.1590/S0100-879X1999000100012; GRONVOLD J, 1993, VET PARASITOL, V48, P311, DOI 10.1016/0304-4017(93)90165-J; GRONVOLD J, 1993, PARASITOL TODAY, V9, P137, DOI 10.1016/0169-4758(93)90179-J; JANSSON HB, 1979, J GEN MICROBIOL, V112, P89, DOI 10.1099/00221287-112-1-89; Kaplan I, 2008, ECOLOGY, V89, P392, DOI 10.1890/07-0471.1; Liou JY, 1999, MYCOL RES, V103, P242, DOI 10.1017/S0953756298006984; Nichols WJ, 2010, J CHEM ECOL, V36, P1140, DOI 10.1007/s10886-010-9855-6; Nordbring-Hertz B, 2001, ELS, DOI [10.1038/npg.els.0004293, DOI 10.1038/NPG.ELS.0004293]; Southey J.F., 1986, LAB METHODS WORKING; Takeuchi Y, 2006, NEMATOLOGY, V8, P869, DOI 10.1163/156854106779799295; Wang CY, 2008, J MICROBIOL, V46, P380, DOI 10.1007/s12275-007-0122-7; Wang CY, 2011, BIOCONTROL, V56, P91, DOI 10.1007/s10526-010-9302-1; Wang CY, 2010, CURR MICROBIOL, V60, P387, DOI 10.1007/s00284-009-9556-y; Wang Z, 2011, BIOCONTROL SCI TECHN, V21, P387, DOI 10.1080/09583157.2011.552971; Yun JE, 2012, J AGR FOOD CHEM, V60, P7392, DOI 10.1021/jf302484m; Zhao LL, 2007, J CHEM ECOL, V33, P1207, DOI 10.1007/s10886-007-9289-y	19	13	13	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71676	10.1371/journal.pone.0071676	http://dx.doi.org/10.1371/journal.pone.0071676			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990972	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700083
J	Mir, SA; Nagy-Szakal, D; Dowd, SE; Szigeti, RG; Smith, CW; Kellermayer, R				Mir, Sabina A.; Nagy-Szakal, Dorottya; Dowd, Scot E.; Szigeti, Reka G.; Smith, C. Wayne; Kellermayer, Richard			Prenatal Methyl-Donor Supplementation Augments Colitis in Young Adult Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; FOLIC-ACID SUPPLEMENTATION; DEXTRAN SULFATE SODIUM; EARLY-LIFE; DEVELOPMENTAL ORIGINS; GENE-EXPRESSION; MURINE COLITIS; PREGNANT RATS; MICROBIOTA; BACTERIA	Inflammatory bowel diseases (IBD) have become highly prevalent in developed countries. Environmentally triggered exaggerated immune responses against the intestinal microbiome are thought to mediate the disorders. The potential dietary origins of the disease group have been implicated. However, the effects of environmental influences on prenatal developmental programming in respect to orchestrating postnatal microbiome composition and predilection towards mammalian colitis have not been examined. We tested how transient prenatal exposure to methyl donor micronutrient (MD) supplemented diets may impact predilection towards IBD in a murine dextran sulfate sodium (DSS) colitis model. Prenatal MD supplementation was sufficient to modulate colonic mucosal Ppara expression (3.2 fold increase; p=0.022) and worsen DSS colitis in young adulthood. The prenatal dietary exposure shifted the postnatal colonic mucosal and cecal content microbiomes. Transfer of the gut microbiome from prenatally MD supplemented young adult animals into germ free mice resulted in increased colitis susceptibility in the recipients compared to controls. Therefore, the prenatal dietary intervention induced the postnatal nurturing of a colitogenic microbiome. Our results show that prenatal nutritional programming can modulate the mammalian host to harbor a colitogenic microbiome. These findings may be relevant for the nutritional developmental origins of IBD.	[Mir, Sabina A.; Nagy-Szakal, Dorottya; Kellermayer, Richard] Texas Childrens Hosp, Baylor Coll Med, Sect Pediat Gastroenterol Hepatol & Nutr, ARS Childrens Nutr Res Ctr,Dept Pediat,Dept Agr, Houston, TX 77030 USA; [Dowd, Scot E.] MR DNA Mol Res, Shallowater, TX USA; [Szigeti, Reka G.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Smith, C. Wayne] Baylor Coll Med, Dept Pediat, Infect Dis Sect, ARS Childrens Nutr Res Ctr,Dept Agr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Kellermayer, R (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Sect Pediat Gastroenterol Hepatol & Nutr, ARS Childrens Nutr Res Ctr,Dept Pediat,Dept Agr, Houston, TX 77030 USA.	kellerma@bcm.edu	Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427	Broad Medical Research Program; Broad Foundation [IBD-0252]; Child Health Research Career Development Agency of the Baylor College of Medicine (NIH) [5K12 HD041648]; Public Health Service grant [DK56338]; Texas Medical Center Digestive Diseases Center; USDA/ARS [6250-51000-046]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD041648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	Broad Medical Research Program; Broad Foundation; Child Health Research Career Development Agency of the Baylor College of Medicine (NIH); Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); Texas Medical Center Digestive Diseases Center; USDA/ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Richard Kellermayer was supported in part by the Broad Medical Research Program, the Broad Foundation (IBD-0252); the Child Health Research Career Development Agency of the Baylor College of Medicine (NIH # 5K12 HD041648); and a Public Health Service grant DK56338, funding the Texas Medical Center Digestive Diseases Center. Smith C. Wayne was supported by USDA/ARS 6250-51000-046. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert EJ, 2008, J LEUKOCYTE BIOL, V83, P833, DOI 10.1189/jlb.0807557; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Azuma YT, 2010, INT IMMUNOPHARMACOL, V10, P1261, DOI 10.1016/j.intimp.2010.07.007; Beard CM, 2011, MED HYPOTHESES, V77, P15, DOI 10.1016/j.mehy.2011.03.013; Dolinoy DC, 2008, ENVIRON MOL MUTAGEN, V49, P4, DOI 10.1002/em.20366; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gismera CS, 2008, WORLD J GASTROENTERO, V14, P5491, DOI 10.3748/wjg.14.5491; Halfvarson J, 2011, INFLAMM BOWEL DIS, V17, P6, DOI 10.1002/ibd.21295; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Harris RA, 2013, EPIGENETICS-US, V8, P157, DOI 10.4161/epi.23438; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Kellermayer R, 2012, CAN J GASTROENTEROL, V26, P909, DOI 10.1155/2012/526408; Kellermayer R, 2012, J PEDIATR GASTR NUTR, V55, P243, DOI 10.1097/MPG.0b013e3182617c16; Kellermayer R, 2010, HUM MOL GENET, V19, P2168, DOI 10.1093/hmg/ddq095; Kitajima S, 2000, EXP ANIM TOKYO, V49, P9, DOI 10.1538/expanim.49.9; Kleessen B, 2002, SCAND J GASTROENTERO, V37, P1034, DOI 10.1080/003655202320378220; Kronman MP, 2012, PEDIATRICS, V130, pE794, DOI 10.1542/peds.2011-3886; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Lee CH, 2011, PROC SPIE, V8285, DOI 10.1117/12.914442; Lee JW, 2007, GASTROENTEROLOGY, V133, P108, DOI 10.1053/j.gastro.2007.03.113; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Lucke K, 2006, J MED MICROBIOL, V55, P617, DOI 10.1099/jmm.0.46198-0; Lytle C, 2005, INFLAMM BOWEL DIS, V11, P231, DOI 10.1097/01.MIB.0000160805.46235.eb; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; Mohapatra SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010215; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; Nagy-Szakal D, 2013, J PEDIATR GASTR NUTR, V56, P544, DOI 10.1097/MPG.0b013e3182769748; Nagy-Szakal D, 2012, GUT MICROBES, V3, P426, DOI 10.4161/gmic.20697; Nagy-Szakal D, 2011, GUT MICROBES, V2, P178, DOI 10.4161/gmic.2.3.16107; Noor SO, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-134; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Ouyang Q, 2005, CURR OPIN GASTROEN, V21, P408; PERRET V, 1977, GUT, V18, P382, DOI 10.1136/gut.18.5.382; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Pfefferle PI, 2010, J ALLERGY CLIN IMMUN, V125, P108, DOI 10.1016/j.jaci.2009.09.019; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Rouge C, 2010, ANAEROBE, V16, P362, DOI 10.1016/j.anaerobe.2010.06.002; Saemann MD, 2002, WIEN KLIN WOCHENSCHR, V114, P289; Sartor RB, 2011, MUCOSAL IMMUNOL, V4, P127, DOI 10.1038/mi.2010.87; Sartor R Balfour, 2007, Curr Gastroenterol Rep, V9, P497; Schaible TD, 2011, HUM MOL GENET, V20, P1687, DOI 10.1093/hmg/ddr044; Sepulveda AR, 2010, GASTROENTEROLOGY, V138, P1836, DOI 10.1053/j.gastro.2009.12.042; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Takahashi K, 2011, J BIOL CHEM, V286, P35755, DOI 10.1074/jbc.M111.271007; van Hoffen E, 2009, ALLERGY, V64, P484, DOI 10.1111/j.1398-9995.2008.01765.x; Veenema AH, 2008, ENDOCRINOLOGY, V149, P2727, DOI 10.1210/en.2007-1469; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang QZ, 2012, J PEDIATR SURG, V47, P241, DOI 10.1016/j.jpedsurg.2011.09.064; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Waterland RA, 2006, J PEDIATR-US, V149, pS137, DOI 10.1016/j.jpeds.2006.06.064; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Waterland RA, 2009, HORM RES, V71, P13, DOI 10.1159/000178030; Whitrow MJ, 2009, AM J EPIDEMIOL, V170, P1486, DOI 10.1093/aje/kwp315; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Yin L, 2011, MUCOSAL IMMUNOL, V4, P409, DOI 10.1038/mi.2010.83; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]	62	21	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e73162	10.1371/journal.pone.0073162	http://dx.doi.org/10.1371/journal.pone.0073162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977377	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700192
J	Richter, F; Liebig, T; Guenzi, E; Herrmann, A; Scheurich, P; Pfizenmaier, K; Kontermann, RE				Richter, Fabian; Liebig, Timo; Guenzi, Eric; Herrmann, Andreas; Scheurich, Peter; Pfizenmaier, Klaus; Kontermann, Roland E.			Antagonistic TNF Receptor One-Specific Antibody (ATROSAB): Receptor Binding and In Vitro Bioactivity	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MOLECULAR-CLONING; SOLUBLE TNF; RHEUMATOID-ARTHRITIS; SELECTIVE-INHIBITION; MUTANT TNF; ALPHA; LYMPHOTOXIN; THERAPY; EXPRESSION	Background: Selective inhibition of TNFR1 signaling holds the potential to greatly reduce the pro-inflammatory activity of TNF, while leaving TNFR2 untouched, thus allowing for cell survival and tissue homeostasis. ATROSAB is a humanized antagonistic anti-TNFR1 antibody developed for the treatment of inflammatory diseases. Methodology/Principal Findings: The epitope of ATROSAB resides in the N-terminal region of TNFR1 covering parts of CRD1 and CRD2. By site-directed mutagenesis, we identified Arg68 and His69 of TNFR1 as important residues for ATROSAB binding. ATROSAB inhibited binding of I-125-labeled TNF to HT1080 in the subnanomolar range. Furthermore, ATROSAB inhibited release of IL-6 and IL-8 from HeLa and HT1080 cells, respectively, induced by TNF or lymphotoxin alpha (LT alpha). Different from an agonistic antibody (Htr-9), which binds to a region close to the ATROSAB epitope but elicits strong TNFR1 activation, ATROSAB showed a negligible induction of IL-6 and IL-8 production over a broad concentration range. We further verified that ATROSAB, comprising mutations within the Fc region known to abrogate complement fixation and antibody-mediated cellular effector functions, indeed lacks binding activity for C1q, Fc gamma RI (CD64), Fc gamma RIIB (CD32b), and Fc gamma RIII (CD16) disabling ADCC and CDC. Conlusions/Significance: The data corroborate ATROSAB's unique function as a TNFR1-selective antagonist efficiently blocking both TNF and LT alpha action. In agreement with recent studies of TNFR1 complex formation and activation, we suggest a model of the underlying mechanism of TNFR1 inhibition by ATROSAB.	[Richter, Fabian; Scheurich, Peter; Pfizenmaier, Klaus; Kontermann, Roland E.] Univ Stuttgart, Inst Zellbiol & Immunol, D-70174 Stuttgart, Germany; [Liebig, Timo] Celonic AG, Basel, Switzerland; [Guenzi, Eric; Herrmann, Andreas] Baliopharm AG, Basel, Switzerland	University of Stuttgart	Kontermann, RE (corresponding author), Univ Stuttgart, Inst Zellbiol & Immunol, D-70174 Stuttgart, Germany.	roland.kontermann@izi.uni-stuttgart.de	Kontermann, Roland E./F-9263-2014		Bundesministerium fur Bildung und Forschung Select [01GU1102B]	Bundesministerium fur Bildung und Forschung Select(Federal Ministry of Education & Research (BMBF))	Funding from Bundesministerium fur Bildung und Forschung Select 01GU1102B (http://www.bmbf.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armour KL, 1999, EUR J IMMUNOL, V29, P2613, DOI 10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Arntz OJ, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2974; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Branschadel M, 2010, CELL SIGNAL, V22, P404, DOI 10.1016/j.cellsig.2009.10.011; BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Buch MH, 2004, ANN RHEUM DIS, V63, P1344, DOI 10.1136/ard.2003.014878; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Calmon-Hamaty F, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3376; Carter PH, 2001, P NATL ACAD SCI USA, V98, P11879, DOI 10.1073/pnas.211178398; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; de Gannes GC, 2007, ARCH DERMATOL, V143, P223, DOI 10.1001/archderm.143.2.223; Desai SB, 2006, BEST PRACT RES CL RH, V20, P757, DOI 10.1016/j.berh.2006.06.002; ESPEVIK T, 1990, J EXP MED, V171, P415, DOI 10.1084/jem.171.2.415; Fontaine V, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-07-j0001.2002; Gerken M, 2010, BBA-BIOMEMBRANES, V1798, P1081, DOI 10.1016/j.bbamem.2010.02.021; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; GRELL M, 1994, J IMMUNOL, V153, P1963; GRELL M, 1993, LYMPHOKINE CYTOK RES, V12, P143; HIMMLER A, 1990, DNA CELL BIOL, V9, P705, DOI 10.1089/dna.1990.9.705; Huang XW, 2006, CLIN CANCER RES, V12, P2849, DOI 10.1158/1078-0432.CCR-06-0360; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; KAUFMAN EN, 1992, CANCER RES, V52, P4157; Kitagaki M, 2012, J ATHEROSCLER THROMB, V19, P36, DOI 10.5551/jat.9746; Kontermann RE, 2008, J IMMUNOTHER, V31, P225, DOI 10.1097/CJI.0b013e31816a88f9; Kontermann RE, 2009, EXPERT OPIN DRUG DIS, V4, P279, DOI 10.1517/17460440902785167; Krippner-Heidenreich A, 2002, J BIOL CHEM, V277, P44155, DOI 10.1074/jbc.M207399200; KRUPPA G, 1992, J IMMUNOL, V148, P3152; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Lewis AK, 2012, BIOCHEMISTRY-US, V51, P6545, DOI 10.1021/bi3006626; Li FB, 2012, CELL CYCLE, V11, P3343, DOI 10.4161/cc.21842; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; Moore GL, 2010, MABS-AUSTIN, V2, P181, DOI 10.4161/mabs.2.2.11158; Moosmayer D, 1995, Ther Immunol, V2, P31; Nomura T, 2011, J CONTROL RELEASE, V149, P8, DOI 10.1016/j.jconrel.2009.12.015; NYGREN H, 1985, J IMMUNOL METHODS, V85, P87, DOI 10.1016/0022-1759(85)90276-5; Olleros ML, 2009, J INFECT DIS, V199, P1053, DOI 10.1086/597204; Perrier C, 2013, INFLAMM BOWEL DIS, V19, P246, DOI 10.1002/ibd.23023; POWELL MB, 1990, INT IMMUNOL, V2, P539, DOI 10.1093/intimm/2.6.539; Ramos-Casals M, 2007, MEDICINE, V86, P242, DOI 10.1097/MD.0b013e3181441a68; Ranzinger J, 2009, NANO LETT, V9, P4240, DOI 10.1021/nl902429b; Rosenblum H, 2011, AUTOIMMUN REV, V10, P563, DOI 10.1016/j.autrev.2011.04.010; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; Shakoor N, 2002, LANCET, V359, P579, DOI 10.1016/S0140-6736(02)07714-0; Shibata H, 2009, BIOMATERIALS, V30, P6638, DOI 10.1016/j.biomaterials.2009.08.041; Shibata H, 2008, CYTOKINE, V44, P229, DOI 10.1016/j.cyto.2008.07.003; Suen WE, 1997, J EXP MED, V186, P1233, DOI 10.1084/jem.186.8.1233; Sukits SF, 2001, J MOL BIOL, V310, P895, DOI 10.1006/jmbi.2001.4790; Tack CJ, 2009, DIABETOLOGIA, V52, P1442, DOI 10.1007/s00125-009-1381-0; Telliez JB, 2000, J MOL BIOL, V300, P1323, DOI 10.1006/jmbi.2000.3899; THOMA B, 1990, J EXP MED, V172, P1019, DOI 10.1084/jem.172.4.1019; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Van Hauwermeiren F, 2011, CYTOKINE GROWTH F R, V22, P311, DOI 10.1016/j.cytogfr.2011.09.004; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Walls RS, 2008, LANCET INFECT DIS, V8, P601, DOI 10.1016/S1473-3099(08)70227-5; Winkel C, 2012, MATH BIOSCI ENG, V9, P663, DOI 10.3934/mbe.2012.9.663; Zalevsky J, 2007, J IMMUNOL, V179, P1872, DOI 10.4049/jimmunol.179.3.1872; Zettlitz KA, 2010, MABS-AUSTIN, V2, P639, DOI 10.4161/mabs.2.6.13583; Zidi I, 2011, MED ONCOL, V28, P641, DOI 10.1007/s12032-010-9490-7	65	29	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72156	10.1371/journal.pone.0072156	http://dx.doi.org/10.1371/journal.pone.0072156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977237	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700142
J	Saqcena, M; Menon, D; Patel, D; Mukhopadhyay, S; Chow, V; Foster, DA				Saqcena, Mahesh; Menon, Deepak; Patel, Deven; Mukhopadhyay, Suman; Chow, Victor; Foster, David A.			Amino Acids and mTOR Mediate Distinct Metabolic Checkpoints in Mammalian G1 Cell Cycle	PLOS ONE			English	Article							PHOSPHATIDIC-ACID; RESTRICTION POINT; COMPLEX 1; GROWTH; CANCER; TOR; TARGET; PHOSPHORYLATION; PROLIFERATION; PROGRESSION	Objective: In multicellular organisms, cell division is regulated by growth factors (GFs). In the absence of GFs, cells exit the cell cycle at a site in G1 referred to as the restriction point (R) and enter a state of quiescence known as G0. Additionally, nutrient availability impacts on G1 cell cycle progression. While there is a vast literature on G1 cell cycle progression, confusion remains - especially with regard to the temporal location of R relative to nutrient-mediated checkpoints. In this report, we have investigated the relationship between R and a series of metabolic cell cycle checkpoints that regulate passage into S-phase. Methods: We used double-block experiments to order G1 checkpoints that monitor the presence of GFs, essential amino acids (EEAs), the conditionally essential amino acid glutamine, and inhibition of mTOR. Cell cycle progression was monitored by uptake of [H-3]-thymidine and flow cytometry, and analysis of cell cycle regulatory proteins was by Western-blot. Results: We report here that the GF-mediated R can be temporally distinguished from a series of late G1 metabolic checkpoints mediated by EAAs, glutamine, and mTOR - the mammalian/mechanistic target of rapamycin. R is clearly upstream from an EAA checkpoint, which is upstream from a glutamine checkpoint. mTOR is downstream from both the amino acid checkpoints, close to S-phase. Significantly, in addition to GF autonomy, we find human cancer cells also have dysregulated metabolic checkpoints. Conclusion: The data provided here are consistent with a GF-dependent mid-G1 R where cells determine whether it is appropriate to divide, followed by a series of late-G1 metabolic checkpoints mediated by amino acids and mTOR where cells determine whether they have sufficient nutrients to accomplish the task. Since mTOR inhibition arrests cells the latest in G1, it is likely the final arbiter for nutrient sufficiency prior to committing to replicating the genome.	[Saqcena, Mahesh; Menon, Deepak; Patel, Deven; Mukhopadhyay, Suman; Chow, Victor; Foster, David A.] CUNY, Hunter Coll, Dept Biol Sci, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Foster, DA (corresponding author), CUNY, Hunter Coll, Dept Biol Sci, New York, NY 10021 USA.	foster@genectr.hunter.cuny.edu	Mukhopadhyay, Suman/N-3556-2017; Saqcena, Mahesh/U-5973-2017; Patel, Deven/J-4886-2019; Menon, Deepak/S-7899-2019	Mukhopadhyay, Suman/0000-0002-4658-1942; Saqcena, Mahesh/0000-0002-2210-3444; Menon, Deepak/0000-0002-6529-7859	National Cancer Institute [CA46677]; National Center for Research Resources of the National Institutes of Health [RR-03037]; NATIONAL CANCER INSTITUTE [R01CA046677, R29CA046677] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support by National Cancer Institute grant CA46677 is acknowledged. Research Centers in Minority Institutions award RR-03037 from the National Center for Research Resources of the National Institutes of Health, which supports infrastructure and instrumentation in the Biological Sciences Department at Hunter College, is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Blagosklonny MV, 2011, AGING-US, V3, P1130, DOI 10.18632/aging.100422; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Chen KH, 1999, INVEST OPHTH VIS SCI, V40, P2513; Coutant A, 2002, HEPATOLOGY, V36, P1079, DOI 10.1053/jhep.2002.36160; Cross FR, 2011, PHILOS T R SOC B, V366, P3532, DOI 10.1098/rstb.2011.0078; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Foster DA, 2013, TRENDS ENDOCRIN MET, V24, P272, DOI 10.1016/j.tem.2013.02.003; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Loyer P, 1996, J BIOL CHEM, V271, P11484, DOI 10.1074/jbc.271.19.11484; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Platz A, 1996, BRIT J CANCER, V74, P936, DOI 10.1038/bjc.1996.460; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Rialland M, 2002, J CELL SCI, V115, P1435; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; STILES CD, 1979, P NATL ACAD SCI USA, V76, P1279, DOI 10.1073/pnas.76.3.1279; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631; Yellen P, 2011, CELL CYCLE, V10, P3948, DOI 10.4161/cc.10.22.18124; YEN A, 1978, EXP CELL RES, V114, P389, DOI 10.1016/0014-4827(78)90497-4; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365	40	49	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e74157	10.1371/journal.pone.0074157	http://dx.doi.org/10.1371/journal.pone.0074157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977397	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700200
J	Sun, YV; Lazarus, A; Smith, JA; Chuang, YH; Zhao, W; Turner, ST; Kardia, SLR				Sun, Yan V.; Lazarus, Alicia; Smith, Jennifer A.; Chuang, Yu-Hsuan; Zhao, Wei; Turner, Stephen T.; Kardia, Sharon L. R.			Gene-Specific DNA Methylation Association with Serum Levels of C-Reactive Protein in African Americans	PLOS ONE			English	Article							BLOOD-PRESSURE; INFLAMMATION; DISEASE; ATHEROSCLEROSIS; HYPERTENSION; EPIGENETICS; DISCOVERY; PROFILES; RISK	A more thorough understanding of the differences in DNA methylation (DNAm) profiles in populations may hold promise for identifying molecular mechanisms through which genetic and environmental factors jointly contribute to human diseases. Inflammation is a key molecular mechanism underlying several chronic diseases including cardiovascular disease, and it affects DNAm profile on both global and locus-specific levels. To understand the impact of inflammation on the DNAm of the human genome, we investigated DNAm profiles of peripheral blood leukocytes from 966 African American participants in the Genetic Epidemiology Network of Arteriopathy (GENOA) study. By testing the association of DNAm sites on CpG islands of over 14,000 genes with C-reactive protein (CRP), an inflammatory biomarker of cardiovascular disease, we identified 257 DNAm sites in 240 genes significantly associated with serum levels of CRP adjusted for age, sex, body mass index and smoking status, and corrected for multiple testing. Of the significantly associated DNAm sites, 80.5% were hypomethylated with higher CRP levels. The most significant Gene Ontology terms enriched in the genes associated with the CRP levels were immune system process, immune response, defense response, response to stimulus, and response to stress, which are all linked to the functions of leukocytes. While the CRP-associated DNAm may be cell-type specific, understanding the DNAm association with CRP in peripheral blood leukocytes of multi-ethnic populations can assist in unveiling the molecular mechanism of how the process of inflammation affects the risks of developing common disease through epigenetic modifications.	[Sun, Yan V.; Chuang, Yu-Hsuan] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Sun, Yan V.] Emory Univ, Sch Med, Dept Biomed Informat, Atlanta, GA 30322 USA; [Lazarus, Alicia; Smith, Jennifer A.; Zhao, Wei; Kardia, Sharon L. R.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Turner, Stephen T.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA	Emory University; Rollins School Public Health; Emory University; University of Michigan System; University of Michigan; Mayo Clinic	Sun, YV (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.	yvsun@emory.edu	Turner, Stephen/GXM-4654-2022	Zagel, Alicia/0000-0002-9168-1862; Zagel, Alicia/0000-0002-8786-8173; Smith, Jennifer Ann/0000-0002-3575-5468	National Institutes of Health [HL100185, HL100245]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100245, RC1HL100185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL100185 and HL100245. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2010, EPIGENETICS-US, V5; Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Bell CG, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-33; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Boerwinkle E, 2002, HYPERTENSION, V39, P3; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Burrell AM, 2011, DISCOV MED, V11, P187; Chae CU, 2001, HYPERTENSION, V38, P399, DOI 10.1161/01.HYP.38.3.399; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen YA, 2011, GENOMICS, V97, P214, DOI 10.1016/j.ygeno.2010.12.004; Collotta M, 2013, TOXICOLOGY, V307, P35, DOI 10.1016/j.tox.2013.01.017; Daniels PR, 2004, AM J MED, V116, P676, DOI 10.1016/j.amjmed.2003.12.032; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Hage FG, 2007, J AM COLL CARDIOL, V50, P1115, DOI 10.1016/j.jacc.2007.06.012; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Koestler DC, 2012, CANCER EPIDEM BIOMAR, V21, P1293, DOI 10.1158/1055-9965.EPI-12-0361; Kullo IJ, 2005, AM J HYPERTENS, V18, P1123, DOI 10.1016/j.amjhyper.2005.03.730; Lagerstrom MC, 2007, J NEUROCHEM, V100, P1129, DOI 10.1111/j.1471-4159.2006.04281.x; Libby P, 2004, AM J MED, V116, P9, DOI 10.1016/j.amjmed.2004.02.006; Lu CY, 2009, GENE CHROMOSOME CANC, V48, P1057, DOI 10.1002/gcc.20708; Luc G, 2003, ARTERIOSCL THROM VAS, V23, P1255, DOI 10.1161/01.ATV.0000079512.66448.1D; Luo LY, 2001, CLIN CHEM, V47, P237; Ni CW, 2010, BLOOD, V116, pE66, DOI 10.1182/blood-2010-04-278192; Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316; Pankow JS, 2001, ATHEROSCLEROSIS, V154, P681, DOI 10.1016/S0021-9150(00)00586-4; Pogribny IP, 2013, ADV EXP MED BIOL, V754, P215, DOI 10.1007/978-1-4419-9967-2_11; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reiner AP, 2012, AM J HUM GENET, V91, P502, DOI 10.1016/j.ajhg.2012.07.023; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Samols D., 2006, AM J MED, V119, p166., DOI [DOI 10.1016/J.AMJMED.2005.06.057, 10.1016/j.amjmed.2005.06.057]; Shenker NS, 2012, HUM MOL GENET; Smith JA, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-16; Sun YV, 2008, GENET EPIDEMIOL, V32, P350, DOI 10.1002/gepi.20309; Sun YV, 2010, HUM GENET, V127, P651, DOI 10.1007/s00439-010-0810-y; Sun YV, 2013, HUM GENET; Talieri M, 2011, TUMOR BIOL, V32, P737, DOI 10.1007/s13277-011-0175-4; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Uddin M, 2011, PSYCHOL MED, V41, P997, DOI 10.1017/S0033291710001674; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890	45	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e73480	10.1371/journal.pone.0073480	http://dx.doi.org/10.1371/journal.pone.0073480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977389	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700197
J	Kim, S; Beyer, BA; Lewis, C; Nadel, JA				Kim, Suil; Beyer, Brittney A.; Lewis, Courtney; Nadel, Jay A.			Normal CFTR Inhibits Epidermal Growth Factor Receptor-Dependent Pro-Inflammatory Chemokine Production in Human Airway Epithelial Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; TRANSMEMBRANE CONDUCTANCE REGULATOR; PSEUDOMONAS-AERUGINOSA INFECTION; CYSTIC-FIBROSIS AIRWAYS; INTERLEUKIN-8 PRODUCTION; TNF-ALPHA; CYTOKINE SECRETION; SIGNALING CASCADE; IL-8 EXPRESSION	Mutations in cystic fibrosis transmembrane conductance regulator (CFTR) protein cause cystic fibrosis, a disease characterized by exaggerated airway epithelial production of the neutrophil chemokine interleukin (IL)-8, which results in exuberant neutrophilic inflammation. Because activation of an epidermal growth factor receptor (EGFR) signaling cascade induces airway epithelial IL-8 production, we hypothesized that normal CFTR suppresses EGFR-dependent IL-8 production and that loss of CFTR at the surface exaggerates IL-8 production via activation of a pro-inflammatory EGFR cascade. We examined this hypothesis in human airway epithelial (NCI-H292) cells and in normal human bronchial epithelial (NHBE) cells containing normal CFTR treated with a CFTR-selective inhibitor (CFTR-172), and in human airway epithelial (IB3) cells containing mutant CFTR versus isogenic (C38) cells containing wild-type CFTR. In NCI-H292 cells, CFTR-172 induced IL-8 production EGFR-dependently. Pretreatment with an EGFR neutralizing antibody or the metalloprotease TACE inhibitor TAPI-1, or TACE siRNA knockdown prevented CFTR-172-induced EGFR phosphorylation (EGFR-P) and IL-8 production, implicating TACE-dependent EGFR pro-ligand cleavage in these responses. Pretreatment with neutralizing antibodies to I-L1R or to IL-1alpha, but not to IL-1beta, markedly suppressed CFTR-172-induced EGFR-P and IL-8 production, suggesting that binding of IL-1alpha to IL-1R stimulates a TACE-EGFR-IL-8 cascade. Similarly, in NHBE cells, CFTR-172 increased IL-8 production EGFR-, TACE-, and IL-1alpha/IL-1R-dependently. In IB3 cells, constitutive IL-8 production was markedly increased compared to C38 cells. EGFR-P was increased in IB3 cells compared to C38 cells, and exaggerated IL-8 production in the IB3 cells was EGFR-dependent. Activation of TACE and binding of IL-1alpha to IL-1R contributed to EGFR-P and IL-8 production in IB3 cells but not in C38 cells. Thus, we conclude that normal CFTR suppresses airway epithelial IL-8 production that occurs via a stimulatory EGFR cascade, and that loss of normal CFTR activity exaggerates IL-8 production via activation of a pro-inflammatory EGFR cascade.	[Kim, Suil; Beyer, Brittney A.] Oregon Hlth & Sci Univ, Dept Med, Portland Vet Affairs Med Ctr, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Kim, Suil] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Lewis, Courtney; Nadel, Jay A.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Lewis, Courtney; Nadel, Jay A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Nadel, Jay A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; VA Portland Health Care System; Oregon Health & Science University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kim, S (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Portland Vet Affairs Med Ctr, Div Pulm & Crit Care Med, Portland, OR 97201 USA.	kimsui@ohsu.edu			Cystic Fibrosis Foundation Pilot Research Award; Portland VA Research Foundation; Cardiovascular Research Institute	Cystic Fibrosis Foundation Pilot Research Award; Portland VA Research Foundation; Cardiovascular Research Institute	This work was supported by a Cystic Fibrosis Foundation Pilot Research Award (www.cff.org) and Portland VA Research Foundation (www.pvarf.org) grant to SK, and by Cardiovascular Research Institute funding to JN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldallal N, 2002, AM J RESP CRIT CARE, V166, P1248, DOI 10.1164/rccm.200206-627OC; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; BANKSSCHLEGEL SP, 1985, CANCER RES, V45, P1187; Bartling TR, 2009, AM J PHYSIOL-LUNG C, V297, pL35, DOI 10.1152/ajplung.90399.2008; Becker MN, 2004, AM J RESP CRIT CARE, V169, P645, DOI 10.1164/rccm.200207-765OC; Bezzerri V, 2011, J IMMUNOL, V187, P6069, DOI 10.4049/jimmunol.1100821; Bhattacharyya S, 2011, J BIOL CHEM, V286, P11604, DOI 10.1074/jbc.M110.198390; BJORGE JD, 1989, J BIOL CHEM, V264, P4021; Black HR, 1998, AM J RESP CELL MOL, V19, P210, DOI 10.1165/ajrcmb.19.2.3053; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Burgel PR, 2007, THORAX, V62, P153, DOI 10.1136/thx.2006.062190; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; DEAN TP, 1993, PEDIATR RES, V34, P159, DOI 10.1203/00006450-199308000-00010; DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865; Eidelman O, 2001, MOL MED, V7, P523, DOI 10.1007/BF03401858; FLOTTE TR, 1993, J BIOL CHEM, V268, P3781; Hall KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031600; Hardie WD, 1999, PEDIATR DEVEL PATHOL, V2, P415, DOI 10.1007/s100249900144; Hunter MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011598; Hybiske K, 2007, AM J PHYSIOL-LUNG C, V293, pL1250, DOI 10.1152/ajplung.00231.2007; John G, 2010, AM J RESP CELL MOL, V42, P424, DOI 10.1165/rcmb.2008-0408OC; Kelly M, 2010, J PHARMACOL EXP THER, V333, P60, DOI 10.1124/jpet.109.162032; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Kim S, 2011, EXP CELL RES, V317, P2650, DOI 10.1016/j.yexcr.2011.08.023; Kim S, 2011, J IMMUNOL, V186, P3392, DOI 10.4049/jimmunol.1003377; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Kube D, 2001, AM J PHYSIOL-LUNG C, V280, pL493, DOI 10.1152/ajplung.2001.280.3.L493; Kuwahara I, 2006, AM J PHYSIOL-LUNG C, V291, pL407, DOI 10.1152/ajplung.00471.2005; Li J, 2003, AM J PHYSIOL-LUNG C, V284, pL307, DOI 10.1152/ajplung.00086.2002; Liu K, 2008, J BIOL CHEM, V283, P9977, DOI 10.1074/jbc.M710257200; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Maiuri L, 2008, J IMMUNOL, V180, P7697, DOI 10.4049/jimmunol.180.11.7697; Manzer R, 2008, AM J RESP CELL MOL, V38, P318, DOI 10.1165/rcmb.2007-0250OC; Massengale ARD, 1999, AM J RESP CELL MOL, V20, P1073, DOI 10.1165/ajrcmb.20.5.3243; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Nagayama S, 1999, FEBS LETT, V455, P215, DOI 10.1016/S0014-5793(99)00880-7; Nakanaga T, 2007, AM J PHYSIOL-LUNG C, V292, pL1289, DOI 10.1152/ajplung.00356.2006; Olaru F, 2010, J INVEST DERMATOL, V130, P1866, DOI 10.1038/jid.2010.37; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Reiniger N, 2005, INFECT IMMUN, V73, P6822, DOI 10.1128/IAI.73.10.6822-6830.2005; Ribeiro CMP, 2005, J BIOL CHEM, V280, P17798, DOI 10.1074/jbc.M410618200; Richter A, 2002, AM J RESP CELL MOL, V27, P85, DOI 10.1165/ajrcmb.27.1.4789; RIORDAN JR, 1989, SCIENCE, V245, P1066; Salva PS, 1996, PEDIATR PULM, V21, P11, DOI 10.1002/(SICI)1099-0496(199601)21:1<11::AID-PPUL2>3.0.CO;2-T; Shao MXG, 2003, P NATL ACAD SCI USA, V100, P11618, DOI 10.1073/pnas.1534804100; Stecenko AA, 2001, INFLAMMATION, V25, P145, DOI 10.1023/A:1011080229374; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; STRIETER RM, 1989, SCIENCE, V243, P1467, DOI 10.1126/science.2648570; Subauste MC, 2001, INT IMMUNOPHARMACOL, V1, P1229, DOI 10.1016/S1567-5769(01)00063-7; Tabary O, 1998, AM J PATHOL, V153, P921, DOI 10.1016/S0002-9440(10)65633-7; Takeyama K, 2001, AM J RESP CRIT CARE, V163, P511, DOI 10.1164/ajrccm.163.2.2001038; Tang A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037689; Tirouvanziam R, 2002, AM J PHYSIOL-LUNG C, V283, pL445, DOI 10.1152/ajplung.00419.2001; Veit G, 2012, MOL BIOL CELL, V23, P4188, DOI 10.1091/mbc.E12-06-0424; Venkatakrishnan A, 2000, AM J RESP CELL MOL, V23, P396, DOI 10.1165/ajrcmb.23.3.3949; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Wong J, 2007, AM J PHYSIOL-LUNG C, V293, pL1385, DOI 10.1152/ajplung.00207.2007; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; Zhang ZL, 2001, FASEB J, V15, P303	65	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72981	10.1371/journal.pone.0072981	http://dx.doi.org/10.1371/journal.pone.0072981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977375	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200094
J	Lei, L; Li, HX; Yan, FH; Xiao, Y				Lei, Lang; Li, Houxuan; Yan, Fuhua; Xiao, Yin			Hyperlipidemia Impaired Innate Immune Response to Periodontal Pathogen Porphyromonas gingivalis in Apolipoprotein E Knockout Mice	PLOS ONE			English	Article							NF-KAPPA-B; MYELOID CELLS-1 STREM-1; E-DEFICIENT MICE; INFLAMMATORY RESPONSE; HOST-DEFENSE; LIPID RAFTS; LIPOPOLYSACCHARIDE; SERUM; BINDING; TISSUE	A finely-tuned innate immune response plays a pivotal role in protecting host against bacterial invasion during periodontal disease progression. Hyperlipidemia has been suggested to exacerbate periodontal health condition. However, the underlying mechanism has not been addressed. In the present study, we investigated the effect of hyperlipidemia on innate immune responses to periodontal pathogen Porphyromonas gingivalis infection. Apolipoprotein E-deficient and wild-type mice at the age of 20 weeks were used for the study. Peritoneal macrophages were isolated and subsequently used for the study of viable P. gingivalis infection. ApoE(-/-) mice demonstrated inhibited iNOS production and impaired clearance of P. gingivalis in vitro and in vivo; furthermore, ApoE(-/-) mice displayed disrupted cytokine production pattern in response to P. gingivalis, with a decreased production of tumor necrosis factor-alpha, interleukin-6 (IL-6), IL-1 beta and monocyte chemotactic protein-1. Microarray data demonstrated that Toll-like receptor (TLR) and NOD-like receptor (NLR) pathway were altered in ApoE(-/-) mice macrophages; further analysis of pattern recognition receptors (PRRs) demonstrated that expression of triggering receptors on myeloid cells-1 (TREM-1), an amplifier of the TLR and NLR pathway, was decreased in ApoE(-/-) mice macrophages, leading to decreased recruitment of NF-kappa B onto the promoters of the TNF-alpha and IL-6. Our data suggest that in ApoE(-/-) mice hyperlipidemia disrupts the expression of PRRs, and cripples the host's capability to generate sufficient innate immune response to P. gingivalis, which may facilitate immune evasion, subgingival colonization and establishment of P. gingivalis in the periodontal niche.	[Lei, Lang; Li, Houxuan] Fujian Med Univ, Sch & Hosp Stomatol, Fuzhou, Peoples R China; [Yan, Fuhua] Nanjing Univ, Sch Med, Inst & Hosp Stomatol, Nanjing 210008, Jiangsu, Peoples R China; [Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Bone Res Lab, Brisbane, Qld 4001, Australia	Fujian Medical University; Nanjing University; Queensland University of Technology (QUT)	Yan, FH (corresponding author), Nanjing Univ, Sch Med, Inst & Hosp Stomatol, Nanjing 210008, Jiangsu, Peoples R China.	fhyan2005@126.com; yin.xiao@qut.edu.au	Xiao, Yin/AAM-4033-2020	Xiao, Yin/0000-0003-1785-3491	National Natural Science Foundation of China [81170973, 81100760]; Fujian Province Minjiang Scholars Program Research Foundation from School of Stomatology, Fujian Medical University [Minjiaogao (2010) 104]; Innovation Project of Fujian Provincial Bureau of Public Health [2011-CX-26]; Talent Foundation of Institute and Hospital of Stomatology Nanjing University Medical School [2013-02-250]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Province Minjiang Scholars Program Research Foundation from School of Stomatology, Fujian Medical University; Innovation Project of Fujian Provincial Bureau of Public Health; Talent Foundation of Institute and Hospital of Stomatology Nanjing University Medical School	This study was supported by the National Natural Science Foundation of China (grant number 81170973 and 81100760) (http://www.nsfc.gov.cn/), Fujian Province Minjiang Scholars Program Research Foundation (Minjiaogao (2010) 104) from School of Stomatology, Fujian Medical University, Innovation Project of Fujian Provincial Bureau of Public Health (2011-CX-26), and the Talent Foundation of Institute and Hospital of Stomatology Nanjing University Medical School (number 2013-02-250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alayan J, 2006, ORAL MICROBIOL IMMUN, V21, P360, DOI 10.1111/j.1399-302X.2006.00304.x; Ali K, 2005, CIRC RES, V97, P922, DOI 10.1161/01.RES.0000187467.67684.43; Assinger A, 2011, J THROMB HAEMOST, V9, P799, DOI 10.1111/j.1538-7836.2011.04193.x; Awartani F, 2010, J CONT DENT PRACT, V11, P033; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Bisson C, 2012, J CLIN PERIODONTOL, V39, P1141, DOI 10.1111/jcpe.12008; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Bostanci N, 2013, J DENT RES, V92, P161, DOI 10.1177/0022034512470691; Bostanci N, 2011, MOL IMMUNOL, V49, P387, DOI 10.1016/j.molimm.2011.09.012; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chu XH, 1999, CELL TISSUE RES, V296, P331, DOI 10.1007/s004410051293; Cutler Christopher W, 2003, J Int Acad Periodontol, V5, P47; de Bont N, 1999, J LIPID RES, V40, P680; Fentoglu O, 2009, J PERIODONTOL, V80, P267, DOI 10.1902/jop.2009.080104 ; Foey AD, 1998, J IMMUNOL, V160, P920; Ford ES, 2010, INT J CARDIOL, V140, P226, DOI 10.1016/j.ijcard.2008.11.033; Fukada SY, 2008, J DENT RES, V87, P1155, DOI 10.1177/154405910808701207; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Ghosh J, 2012, J LIPID RES, V53, P2560, DOI 10.1194/jlr.M026914; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gyurko R, 2003, INFECT IMMUN, V71, P4917, DOI 10.1128/IAI.71.9.4917-4924.2003; Hajishengallis G, 2013, MOL ORAL MICROBIOL, V28, P239, DOI 10.1111/omi.12021; Hajishengallis G, 2006, INFECT IMMUN, V74, P5658, DOI 10.1128/IAI.00784-06; Hajishengallis G, 2006, CELL MICROBIOL, V8, P1557, DOI 10.1111/j.1462-5822.2006.00730.x; Hajishengallis G, 2012, ADV EXP MED BIOL, V946, P69, DOI 10.1007/978-1-4614-0106-3_5; HAZENBOS WLW, 1994, INFECT IMMUN, V62, P4818, DOI 10.1128/IAI.62.11.4818-4824.1994; He J, 2004, CIRCULATION, V110, P405, DOI 10.1161/01.CIR.0000136583.52681.0D; Jung YS, 2012, DIGEST LIVER DIS, V44, P897, DOI 10.1016/j.dld.2012.05.011; Koter M, 2004, INT J BIOCHEM CELL B, V36, P205, DOI 10.1016/S1357-2725(03)00195-X; Lamster I B, 1992, Curr Opin Dent, V2, P39; Liang S, 2009, MECH AGEING DEV, V130, P538, DOI 10.1016/j.mad.2009.06.006; Liu YW, 2006, CELL SIGNAL, V18, P1492, DOI 10.1016/j.cellsig.2005.12.001; Madan M, 2007, ATHEROSCLEROSIS, V190, P62, DOI 10.1016/j.atherosclerosis.2006.02.026; Madenspacher JH, 2010, J IMMUNOL, V185, P1660, DOI 10.4049/jimmunol.0903501; Maekawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020240; Martens GW, 2008, INFECT IMMUN, V76, P3464, DOI 10.1128/IAI.00037-08; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Morran MP, 2009, ORAL MICROBIOL IMMUN, V24, P331, DOI 10.1111/j.1399-302X.2009.00522.x; Nakarai H, 2011, METABOLISM, V60, P823, DOI 10.1016/j.metabol.2010.07.034; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Nazzal D, 2010, J INFECT DIS, V202, P782, DOI 10.1086/655700; Netea MG, 1998, INFECT IMMUN, V66, P2365, DOI 10.1128/IAI.66.5.2365-2367.1998; Netea MG, 2006, J LEUKOCYTE BIOL, V80, P1454, DOI 10.1189/jlb.1205758; Noack B, 2000, J PERIODONTOL, V71, P898, DOI 10.1902/jop.2000.71.6.898; Ristic-Medic D, 2009, GEN PHYSIOL BIOPHYS, V28, P190; Roger T, 2011, BLOOD, V117, P1205, DOI 10.1182/blood-2010-05-284711; Roselaar SE, 1998, J LIPID RES, V39, P1740; Sato T, 2013, MOD RHEUMATOL; Seres I, 1996, ATHEROSCLEROSIS, V121, P175, DOI 10.1016/0021-9150(95)05714-5; Shamshiev AT, 2007, J EXP MED, V204, P441, DOI 10.1084/jem.20061737; Su LX, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-157; Tomofuji T, 2006, FEBS LETT, V580, P3601, DOI 10.1016/j.febslet.2006.05.041; Triantafilou M, 2004, J CELL SCI, V117, P4007, DOI 10.1242/jcs.01270; Triantafilou M, 2007, CELL MICROBIOL, V9, P2030, DOI 10.1111/j.1462-5822.2007.00935.x; Vaya A, 2008, CLIN HEMORHEOL MICRO, V40, P289, DOI 10.3233/CH-2008-1139; Wang M, 2008, CELL MICROBIOL, V10, P2029, DOI 10.1111/j.1462-5822.2008.01185.x; Wang M, 2007, J IMMUNOL, V179, P2349, DOI 10.4049/jimmunol.179.4.2349; Wang QT, 2007, J CLIN PERIODONTOL, V34, P946, DOI 10.1111/j.1600-051X.2007.01139.x; Wu YP, 2012, CRIT CARE, V16, DOI 10.1186/cc11884; Yu WH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015613; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P; Zhang XY, 2011, AM J PHYSIOL-CELL PH, V301, pC451, DOI 10.1152/ajpcell.00458.2010; Zhou QD, 2009, P NATL ACAD SCI USA, V106, P10740, DOI 10.1073/pnas.0904412106	63	30	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71849	10.1371/journal.pone.0071849	http://dx.doi.org/10.1371/journal.pone.0071849			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977160	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200049
J	Suo, S; Ishiura, S				Suo, Satoshi; Ishiura, Shoichi			Dopamine Modulates Acetylcholine Release via Octopamine and CREB Signaling in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; SEROTONERGIC PATHWAY; NERVOUS-SYSTEM; RECEPTOR; NEURONS; PROTEIN; GENE; EXPRESSION; IDENTIFICATION; INVERTEBRATES	Animals change their behavior and metabolism in response to external stimuli. cAMP response element binding protein (CREB) is a signal-activated transcription factor that enables the coupling of extracellular signals and gene expression to induce adaptive changes. Biogenic amine neurotransmitters regulate CREB and such regulation is important for long-term changes in various nervous system functions, including learning and drug addiction. In Caenorhabditis elegans, the amine neurotransmitter octopamine activates a CREB homolog, CRH-1, in cholinergic SIA neurons, whereas dopamine suppresses CREB activation by inhibiting octopamine signaling in response to food stimuli. However, the physiological role of this activation is unknown. In this study, the effect of dopamine, octopamine, and CREB on acetylcholine signaling was analyzed using the acetylcholinesterase inhibitor aldicarb. Mutants with decreased dopamine signaling exhibited reduced acetylcholine signaling, and octopamine and CREB functioned downstream of dopamine in this regulation. This study demonstrates that the regulation of CREB by amine neurotransmitters modulates acetylcholine release from the neurons of C. elegans.	[Suo, Satoshi; Ishiura, Shoichi] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Tokyo, Japan	University of Tokyo	Suo, S (corresponding author), Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Tokyo, Japan.	suo@bio.c.u-tokyo.ac.jp	soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108	JSPS [23700439, 23115705]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by JSPS Grant-in-Aid for Young Scientists (23700439) and for Scientific Research on Innovative Areas (Systems Molecular Ethology, 23115705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Allen AT, 2011, GENETICS, V188, P579, DOI 10.1534/genetics.111.128512; Amano H, 2011, LEARN MEMORY, V18, P654, DOI 10.1101/lm.2224411; BRENNER S, 1974, GENETICS, V77, P71; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; HERMAN RK, 1985, CELL, V40, P509, DOI 10.1016/0092-8674(85)90199-0; Hyman SE, 1996, NEURON, V16, P901, DOI 10.1016/S0896-6273(00)80111-7; Kauffman AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000372; Kimura KD, 2010, J NEUROSCI, V30, P16365, DOI 10.1523/JNEUROSCI.6023-09.2010; Kimura Y, 2002, EMBO REP, V3, P962, DOI 10.1093/embo-reports/kvf191; LEWIS JA, 1987, J NEUROSCI, V7, P3059; Lints R, 1999, DEVELOPMENT, V126, P5819; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McDonald PW, 2007, J NEUROSCI, V27, P14216, DOI 10.1523/JNEUROSCI.2992-07.2007; Murakami M, 2001, MECH DEVELOP, V109, P27, DOI 10.1016/S0925-4773(01)00507-X; Nishida Y, 2011, EMBO REP, V12, P855, DOI 10.1038/embor.2011.120; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Pujol N, 2000, DEVELOPMENT, V127, P3361; RAND JB, 1984, GENETICS, V106, P227; Riddle D, 1997, C ELEGANS; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Sugiura M, 2005, J NEUROCHEM, V94, P1146, DOI 10.1111/j.1471-4159.2005.03268.x; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Suo S, 2003, J NEUROCHEM, V86, P869, DOI 10.1046/j.1471-4159.2003.01896.x; Suo S, 2006, J NEUROSCI, V26, P10082, DOI 10.1523/JNEUROSCI.0819-06.2006; Suo S, 2009, EMBO J, V28, P2437, DOI 10.1038/emboj.2009.194; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Timbers TA, 2011, BEHAV NEUROSCI, V125, P560, DOI 10.1037/a0024370; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zubenko GS, 2009, AM J MED GENET B, V150B, P12, DOI 10.1002/ajmg.b.30891	37	14	15	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72578	10.1371/journal.pone.0072578	http://dx.doi.org/10.1371/journal.pone.0072578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977320	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200076
J	Zub, K; Fletcher, QE; Szafranska, PA; Konarzewski, M				Zub, Karol; Fletcher, Quinn E.; Szafranska, Paulina A.; Konarzewski, Marek			Male Weasels Decrease Activity and Energy Expenditure in Response to High Ambient Temperatures	PLOS ONE			English	Article							CIRCADIAN ACTIVITY PATTERNS; DISSIPATION LIMIT THEORY; PHYSIOLOGICAL ADJUSTMENTS; LABORATORY MICE; METABOLIC-RATE; NATIONAL-PARK; WOLF ACTIVITY; TRADE-OFFS; ENERGETICS; FOREST	The heat dissipation limit (HDL) hypothesis suggests that the capacity of endotherms to dissipate body heat may impose constraints on their energy expenditure. Specifically, this hypothesis predicts that endotherms should avoid the detrimental consequences of hyperthermia by lowering their energy expenditure and reducing their activity in response to high ambient temperatures (T-a). We used an extensive data set on the daily energy expenditure (DEE, n = 27) and the daily activity time (AT, n = 48) of male weasels (Mustela nivalis) during the spring and summer breeding season to test these predictions. We found that T-a was related in a "hump-shaped" (i.e. convex) manner to AT, DEE, resting metabolic rate (RMR) and metabolic scope (the ratio of DEE to RMR). These results support the HDL hypothesis because in response to warm T(a)s male weasels reduced their AT, DEE, and RMR. Although the activity and energy expenditure of large endotherms are most likely to be constrained in response to warm T(a)s because they are less able to dissipate heat, our results suggest that small endotherms may also experience constraints consistent with the HDL hypothesis.	[Zub, Karol; Szafranska, Paulina A.; Konarzewski, Marek] Mammal Res Inst PAS, Bialowieza, Poland; [Fletcher, Quinn E.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Konarzewski, Marek] Univ Bialystok, Inst Biol, Bialystok, Poland	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; University of Aberdeen; University of Bialystok	Zub, K (corresponding author), Mammal Res Inst PAS, Bialowieza, Poland.	karolzub@zbs.bialowieza.pl; q.fletcher@gmail.com	Konarzewski, Marek/AAR-9952-2020; Zub, Karol/ABG-4802-2020	Konarzewski, Marek/0000-0001-7428-6521; Zub, Karol/0000-0001-7235-2206; Szafranska, Paulina/0000-0001-7914-5664	Polish Committee for Scientific Research (KBN) [3 P04F 05125]	Polish Committee for Scientific Research (KBN)(Polish State Committee for Scientific Research)	This study was supported by the Polish Committee for Scientific Research (KBN) grant 3 P04F 05125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Art T, 2005, LIVEST PROD SCI, V92, P101, DOI 10.1016/j.livprodsci.2004.11.013; BELTRAN JF, 1994, J MAMMAL, V75, P382, DOI 10.2307/1382557; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; CASEY TM, 1979, PHYSIOL ZOOL, V52, P153, DOI 10.1086/physzool.52.2.30152560; CHAPPELL MA, 1980, J MAMMAL, V61, P278, DOI 10.2307/1380049; CHAPPELL MA, 1980, J MAMMAL, V61, P268, DOI 10.2307/1380048; Chappell MA, 2013, J EXP BIOL, V216, P578, DOI 10.1242/jeb.079186; CHOSHNIAK I, 1995, AM J PHYSIOL-REG I, V268, pR1101, DOI 10.1152/ajpregu.1995.268.5.R1101; Curio E., 1976, ETHOLOGY PREDATION; Elgar MA, 1987, FUNCT ECOL, V1, P25, DOI 10.2307/2389354; GARLAND T, 1983, J ZOOL, V199, P157, DOI 10.1111/j.1469-7998.1983.tb02087.x; Gorman ML, 1998, NATURE, V391, P479, DOI 10.1038/35131; Gremillet D, 2012, FUNCT ECOL, V26, P1001, DOI 10.1111/j.1365-2435.2012.02048.x; Guillemette CU, 2009, BIOL LETTERS, V5, P166, DOI 10.1098/rsbl.2008.0592; HALLE S, 1994, MAMMAL REV, V24, P17, DOI 10.1111/j.1365-2907.1994.tb00132.x; Hamel S, 2008, ANIM BEHAV, V75, P217, DOI 10.1016/j.anbehav.2007.04.028; Hammond KA, 1997, NATURE, V386, P457, DOI 10.1038/386457a0; Hayward MW, 2007, AFR J ECOL, V45, P135, DOI 10.1111/j.1365-2028.2006.00686.x; Hilbert DW, 2004, BIOL CONSERV, V116, P367, DOI 10.1016/S0006-3207(03)00230-1; HILL RW, 1972, J APPL PHYSIOL, V33, P261, DOI 10.1152/jappl.1972.33.2.261; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; JEDRZEJEWSKA B, 1998, ECOLOGICAL STUDIES, V135; Jedrzejewski W, 2000, ANN ZOOL FENN, V37, P161; JEDRZEJEWSKI W, 1995, ECOLOGY, V76, P179, DOI 10.2307/1940640; KENAGY GJ, 1989, ECOLOGY, V70, P1834, DOI 10.2307/1938116; King C.M., 2007, NATURAL HIST WEASELS; Koenker R., 2005, QUANTILE REGRESSION, DOI DOI 10.1017/CBO9780511754098; Kolbe JA, 2007, J WILDLIFE MANAGE, V71, P1607, DOI 10.2193/2005-727; Koteja P, 1996, FUNCT ECOL, V10, P675, DOI 10.2307/2390179; Kowalczyk R, 2003, J BIOGEOGR, V30, P463, DOI 10.1046/j.1365-2699.2003.00804.x; KOZLOWSKI S, 1985, J APPL PHYSIOL, V59, P766, DOI 10.1152/jappl.1985.59.3.766; Krol E, 2003, J EXP BIOL, V206, P4267, DOI 10.1242/jeb.00675; Krol E, 2003, J EXP BIOL, V206, P4255, DOI 10.1242/jeb.00674; Krol E, 2007, J EXP BIOL, V210, P4233, DOI 10.1242/jeb.009779; Lane JE, 2010, J ANIM ECOL, V79, P27, DOI 10.1111/j.1365-2656.2009.01592.x; Lane JE, 2009, J ANIM ECOL, V78, P296, DOI 10.1111/j.1365-2656.2008.01502.x; Leger J, 2006, J EXP BIOL, V209, P103, DOI 10.1242/jeb.01964; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; McNab B.K., 1989, P335; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; MCNAB BK, 1986, ECOL MONOGR, V56, P1, DOI 10.2307/2937268; MERKT JR, 1994, P NATL ACAD SCI USA, V91, P12313, DOI 10.1073/pnas.91.25.12313; Munoz-Garcia A, 2005, PHYSIOL BIOCHEM ZOOL, V78, P1039, DOI 10.1086/432852; Nagy KA, 1983, U CALIFORNIA LOS ANG, V12-1417; Ostrowski S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P810, DOI 10.1086/504614; R Development Core Team, 2010, R LANG ENV STAT COMP; Schmidt-Nielsen K., 1972, ANIMALS WORK; Speakman J.R., 1997, DOUBLY LABELLED WATE; Speakman JR, 2011, J EXP BIOL, V214, P230, DOI 10.1242/jeb.048603; Speakman JR, 2010, INTEGR COMP BIOL, V50, P793, DOI 10.1093/icb/icq049; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; SPEAKMAN JR, 1988, PHYSIOL ZOOL, V61, P514, DOI 10.1086/physzool.61.6.30156160; Speakman JR, 2002, J NUTR, V132, p1583S, DOI 10.1093/jn/132.6.1583S; SPEAKMAN JR, 1994, FUNCT ECOL, V8, P336, DOI 10.2307/2389826; TAYLOR CR, 1982, ANNU REV PHYSIOL, V44, P97, DOI 10.1146/annurev.ph.44.030182.000525; Theuerkauf J, 2003, J MAMMAL, V84, P243, DOI 10.1644/1545-1542(2003)084<0243:DPADOW>2.0.CO;2; Theuerkauf J, 2009, ETHOLOGY, V115, P649, DOI 10.1111/j.1439-0310.2009.01653.x; Tinbergen JM, 2000, J ANIM ECOL, V69, P323, DOI 10.1046/j.1365-2656.2000.00395.x; Welcker J, 2010, J ANIM ECOL, V79, P205, DOI 10.1111/j.1365-2656.2009.01626.x; Zhao ZJ, 2011, J EXP BIOL, V214, P988, DOI 10.1242/jeb.049395; Zub K, 2009, P ROY SOC B-BIOL SCI, V276, P1921, DOI 10.1098/rspb.2008.1936; Zub K, 2011, J ANIM ECOL, V80, P259, DOI 10.1111/j.1365-2656.2010.01762.x	62	18	18	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72646	10.1371/journal.pone.0072646	http://dx.doi.org/10.1371/journal.pone.0072646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977336	gold, Green Published, Green Submitted			2022-12-25	WOS:000323570200077
J	Roh, SE; Woo, JA; Lakshmana, MK; Uhlar, C; Ankala, V; Boggess, T; Liu, T; Hong, YH; Mook-Jung, I; Kim, SJ; Kang, DE				Roh, Seung-Eon; Woo, Jung A.; Lakshmana, Madepalli K.; Uhlar, Courtney; Ankala, Vinishaa; Boggess, Taylor; Liu, Tian; Hong, Yun-Hwa; Mook-Jung, Inhee; Kim, Sang Jeong; Kang, David E.			Mitochondrial dysfunction and calcium deregulation by the RanBP9-cofilin pathway	FASEB JOURNAL			English	Article						synapse; axonal transport; amyloid; MTT	AMYLOID PRECURSOR PROTEIN; BETA-INDUCED APOPTOSIS; ALZHEIMERS-DISEASE; CORTICAL-NEURONS; OXIDATIVE DAMAGE; PIVOTAL ROLE; MOUSE MODEL; CELL-DEATH; RANBP9; ACTIN	Mitochondrial dysfunction and synaptic damage are important features of Alzheimer's disease (AD) associated with amyloid beta (A beta) and tau. We reported previously that the scaffolding protein RanBP9, which is overall increased in brains of patients with AD and in mutant APP transgenic mice, simultaneously promotes A beta generation and focal adhesion disruption by accelerating the endocytosis of APP and beta 1-integrin, respectively. Moreover, RanBP9 induces neurodegeneration in vitro and in vivo and mediates A beta-induced neurotoxicity. Here we show in primary hippocampal neurons that RanBP9 potentiates A beta-induced reactive oxygen species (ROS) overproduction, apoptosis, and calcium deregulation. Analyses of calcium-handling measures demonstrate that RanBP9 selectively delays the clearance of cytosolic Ca2+ mediated by the mitochondrial calcium uniporter through a process involving the translocation of cofilin into mitochondria and oxidative mechanisms. Further, RanBP9 retards the anterograde axonal transport of mitochondria in primary neurons and decreases synaptic mitochondrial activity in brain. These data indicate that RanBP9, cofilin, and A beta mimic and potentiate each other to produce mitochondrial dysfunction, ROS overproduction, and calcium deregulation, which leads to neurodegenerative changes reminiscent of those seen in AD.	[Roh, Seung-Eon; Woo, Jung A.; Liu, Tian; Mook-Jung, Inhee; Kang, David E.] Seoul Natl Univ, Coll Med, World Class Univ Neurocyt Program, Seoul, South Korea; [Roh, Seung-Eon; Hong, Yun-Hwa; Kim, Sang Jeong] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Lakshmana, Madepalli K.] Torrey Pines Inst Mol Studies, Neurobiol Sect, Port St Lucie, FL USA; [Uhlar, Courtney; Ankala, Vinishaa; Boggess, Taylor; Kang, David E.] Univ S Florida, Dept Mol Med, Hlth Byrd Alzheimers Inst, Tampa, FL USA	Seoul National University (SNU); Seoul National University (SNU); Torrey Pines Institute for Molecular Studies, Florida; State University System of Florida; University of South Florida	Kang, DE (corresponding author), USF Hlth Byrd Inst, Dept Mol Med, 4001 E Fletcher Ave, Tampa, FL 33613 USA.	dkang@health.usf.edu	Liu, Tian/M-8684-2016; Kang, David E./E-5234-2012	Liu, Tian/0000-0003-3639-7321; Woo, Jung A/0000-0002-9194-1361; Kang, David E./0000-0002-7132-821X; Liu, Tian/0000-0002-6437-8892; Kim, Sang Jeong/0000-0001-8931-3713	U.S. National Institutes of Health/National Institute on Aging [1R01AG033055, 1K02AG031920]; World Class University-Neurocytomics Project from National Research Foundation of Korea (NRF-K); NRF-K [2011-0030737]; NATIONAL INSTITUTE ON AGING [R01AG033055, K02AG031920] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); World Class University-Neurocytomics Project from National Research Foundation of Korea (NRF-K); NRF-K; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Elisabetta Bianchi (Pasteur Institute, Paris, France) for the RanBP9 monoclonal antibody and Dr. Won Kyung Ho (Seoul National University, Seoul, Korea) for helpful discussions. This work was supported in part by U.S. National Institutes of Health/National Institute on Aging grants (1R01AG033055 and 1K02AG031920, D. E. K.), a World Class University-Neurocytomics Project grant from the National Research Foundation of Korea (NRF-K; D. E. K., I.M.-J.), and an NRF-K grant (S.J.K., 2011-0030737). The authors declare no conflicts of interest.	Berkova Z, 2003, CELL CALCIUM, V34, P55, DOI 10.1016/S0143-4160(03)00022-8; Bernstein BW, 2006, AM J PHYSIOL-CELL PH, V291, pC828, DOI 10.1152/ajpcell.00066.2006; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bertrand SJ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-38; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Brocard JB, 2001, J PHYSIOL-LONDON, V531, P793, DOI 10.1111/j.1469-7793.2001.0793h.x; Brown M, 2009, MOD LANG QUART, V70, P1, DOI 10.1215/00267929-2008-025; Calkins MJ, 2011, BBA-MOL BASIS DIS, V1812, P507, DOI 10.1016/j.bbadis.2011.01.007; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Cichon J, 2012, J BIOL CHEM, V287, P3919, DOI 10.1074/jbc.M111.301911; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Davis RC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-10; Distelmaier F, 2009, J MOL MED, V87, P515, DOI 10.1007/s00109-009-0452-5; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Eckert A, 2008, NEURODEGENER DIS, V5, P157, DOI 10.1159/000113689; GOODMAN Y, 1994, BRAIN RES, V654, P171, DOI 10.1016/0006-8993(94)91586-5; Gourlay CW, 2005, BIOCHEM SOC T, V33, P1260, DOI 10.1042/BST0331260; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Kang David E, 2011, Exp Neurobiol, V20, P67, DOI 10.5607/en.2011.20.2.67; Klamt F, 2009, NAT CELL BIOL, V11, P1241, DOI 10.1038/ncb1968; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Lakshmana MK, 2012, FASEB J, V26, P2072, DOI 10.1096/fj.11-196709; Lakshmana MK, 2010, FASEB J, V24, P119, DOI 10.1096/fj.09-136457; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Lee SH, 2012, J NEUROSCI, V32, P5953, DOI 10.1523/JNEUROSCI.0465-12.2012; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Liu T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.203; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Moreira PI, 2001, BIOSCIENCE REP, V21, P789, DOI 10.1023/A:1015536808304; Nilsen J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-74; Numakawa Y, 2006, J NEUROCHEM, V97, P1191, DOI 10.1111/j.1471-4159.2006.03827.x; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Palavicini JP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.183; Pratico D, 2001, LIPIDS, V36, pS45, DOI 10.1007/s11745-001-0681-0; Salgo MG, 1996, ARCH BIOCHEM BIOPHYS, V333, P482, DOI 10.1006/abbi.1996.0418; Toescu EC, 2007, AGING CELL, V6, P265, DOI 10.1111/j.1474-9726.2007.00299.x; Wabnitz GH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.36; Woo JA, 2012, CELL DEATH DIFFER, V19, P1413, DOI 10.1038/cdd.2012.14; Woo JA, 2012, FASEB J, V26, P1672, DOI 10.1096/fj.11-194423; Yan SD, 2005, INT J EXP PATHOL, V86, P161, DOI 10.1111/j.0959-9673.2005.00427.x; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106	44	25	25	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4776	4789		10.1096/fj.13-234765	http://dx.doi.org/10.1096/fj.13-234765			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23982146	Green Published			2022-12-25	WOS:000329999000013
J	Zhou, L; Zhao, XD; Han, YA; Lu, YY; Shang, YL; Liu, CH; Li, T; Jin, ZA; Fan, DM; Wu, KC				Zhou, Lin; Zhao, Xiaodi; Han, Yanan; Lu, Yuanyuan; Shang, Yulong; Liu, Changhao; Li, Ting; Jin, Zhian; Fan, Daiming; Wu, Kaichun			Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis	FASEB JOURNAL			English	Article						DNA methylation; metastasis	TUMOR-SUPPRESSOR; DNA METHYLATION; PROMOTER HYPERMETHYLATION; ABERRANT METHYLATION; CELL-PROLIFERATION; CERVICAL-CANCER; DOWN-REGULATION; GENE; MICRORNAS; RUNX3	Epigenetic changes play significant roles in the development of cancer. UHRF1, as an epigenetic regulator, has been shown to be overexpressed and to coordinate tumor suppressor gene silencing in several cancers. However, the role and underlying mechanism of UHRF1 in gastric cancer (GC) progression remain largely unknown. In this study, we investigated the expression and function of UHRF1 in GC metastasis and explored its upstream regulatory mechanisms at the microRNA level. UHRF1 was overexpressed in GC tissues, especially in metastatic ones, and a high level of UHRF1 expression predicted poor survival. The down-regulation of UHRF1 suppressed GC invasion and metastasis in vitro and in vivo. We identified and verified miR-146a and miR-146b as direct upstream regulators of UHRF1. Furthermore, the restoration of miR-146a/b dramatically reduced the expression of UHRF1 through the direct targeting of its 3'-UTR, and this effect in turn reactivated the slit homologue 3 (Slit3), cadherin 4 (CDH4), and runt-related transcription factor 3 (RUNX3) genes via promoter demethylation. Finally, analyses of miR-146a/b and UHRF1 levels in human GC tissues revealed that miR-146a/b correlated inversely with UHRF1 expression. These findings describe a new mechanism for the regulation of UHRF1 and aberrant DNA hypermethylation in GC. The newly identified miR-146a/b/UHRF1 axis provides insight into the GC metastasis process, and targeting this novel axis represents a therapeutic approach to blocking GC metastasis.	Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian 710032, Peoples R China; Fourth Mil Med Univ, Xijing Hosp, Xijing Hosp Digest Dis, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Fan, DM (corresponding author), Xijing Hosp Digest Dis, State Key Lab Canc Biol, West Changle Rd, Xian 710032, Peoples R China.	daimingfan@fmmu.edu.cn; kaicwu@fmmu.edu.cn	liu, chang/HCI-5413-2022		National Natural Science Foundation of China [81272652, 81172290, 91129723, 81090270, 81090273, 81120108005]; National Key and Basic Research Development Program of China [2010CB529302, 2010CB529306]; National Municipal Science and Technology Project [2009ZX09103-667, 2009ZX09301-009-RC06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key and Basic Research Development Program of China(National Basic Research Program of China); National Municipal Science and Technology Project	This study was supported by combined grants from the National Natural Science Foundation of China (81272652, 81172290, 91129723, 81090270, 81090273, and 81120108005), the National Key and Basic Research Development Program of China (2010CB529302 and 2010CB529306), and the National Municipal Science and Technology Project (2009ZX09103-667 and 2009ZX09301-009-RC06). The authors thank Zheng Chen, Guangbo Tang, Jianhua Dou, and Gui Ren (State Key Laboratory of Cancer Biology) for assistance in tissue sample collection. The authors report no conflicts of interest.	Alhosin M, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-41; Babbio F, 2012, ONCOGENE, V31, P4878, DOI 10.1038/onc.2011.641; Bai FH, 2007, DIGEST DIS SCI, V52, P1571, DOI 10.1007/s10620-006-9570-x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Chen Y, 2011, INT J CANCER, V129, P1586, DOI 10.1002/ijc.25831; Chiba T, 2012, GASTROENTEROLOGY, V143, P550, DOI 10.1053/j.gastro.2012.07.009; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; Daskalos A, 2011, CANCER-AM CANCER SOC, V117, P1027, DOI 10.1002/cncr.25531; Dickinson RE, 2004, BRIT J CANCER, V91, P2071, DOI 10.1038/sj.bjc.6602222; Du CP, 2011, CANCER LETT, V309, P54, DOI 10.1016/j.canlet.2011.05.016; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Gao DC, 2012, CANCER RES, V72, P4883, DOI 10.1158/0008-5472.CAN-12-1223; Garcia AI, 2011, EMBO MOL MED, V3, P279, DOI 10.1002/emmm.201100136; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gigek CO, 2012, EPIGENOMICS-UK, V4, P279, DOI [10.2217/EPI.12.22, 10.2217/epi.12.22]; Gonzalez CA, 2012, INT J CANCER, V130, P745, DOI 10.1002/ijc.26430; Hayashi Y., 2012, GUT; He LJ, 2009, CANCER LETT, V276, P88, DOI 10.1016/j.canlet.2008.10.044; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; Hou ZB, 2012, MOL MED REP, V6, P501, DOI 10.3892/mmr.2012.946; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Jeanblanc M, 2005, ONCOGENE, V24, P7337, DOI 10.1038/sj.onc.1208878; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Li Q, 2011, EPIGENETICS-US, V6, P849, DOI 10.4161/epi.6.7.16314; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Lopez-Serra P, 2012, ONCOGENE, V31, P1609, DOI 10.1038/onc.2011.354; Lu XX, 2012, CANCER-AM CANCER SOC, V118, P5507, DOI 10.1002/cncr.27604; Macaluso M, 2007, CANCER RES, V67, P7731, DOI 10.1158/0008-5472.CAN-07-1476; Miotto E, 2004, CANCER RES, V64, P8156, DOI 10.1158/0008-5472.CAN-04-3000; Narayan G, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-16; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Osada H, 2007, CARCINOGENESIS, V28, P2, DOI 10.1093/carcin/bgl185; Packeisen J, 2002, J CLIN PATHOL, V55, P613, DOI 10.1136/jcp.55.8.613; Paik JH, 2011, CLIN CANCER RES, V17, P4761, DOI 10.1158/1078-0432.CCR-11-0494; Patnaik SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022379; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Sabatino L, 2012, ONCOGENE, V31, P5061, DOI 10.1038/onc.2012.3; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tian RQ, 2011, J BIOL CHEM, V286, P25556, DOI 10.1074/jbc.M111.221564; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Unoki M, 2010, BRIT J CANCER, V103, P217, DOI 10.1038/sj.bjc.6605717; Unoki M, 2009, BRIT J CANCER, V101, P98, DOI 10.1038/sj.bjc.6605123; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang F, 2012, ANN SURG ONCOL, V19, P2753, DOI 10.1245/s10434-011-2194-1; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Wong KY, 2012, CARCINOGENESIS, V33, P1629, DOI 10.1093/carcin/bgs212; Xiao B, 2012, ONCOL REP, V27, P559, DOI 10.3892/or.2011.1514; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156	56	81	91	2	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4929	4939		10.1096/fj.13-233387	http://dx.doi.org/10.1096/fj.13-233387			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23982143				2022-12-25	WOS:000329999000027
J	Kim, MJ; Son, HJ; Song, SH; Jung, M; Kim, Y; Rhyu, MR				Kim, Min Jung; Son, Hee Jin; Song, Seo Hyeon; Jung, Myungji; Kim, Yiseul; Rhyu, Mee-Ra			The TRPA1 Agonist, Methyl Syringate Suppresses Food Intake and Gastric Emptying	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; GUT HORMONE; INSULIN SENSITIVITY; BODY-WEIGHT; RELEASE; GLUCOSE; YY; ACTIVATION; EXPRESSION; SECRETION	Transient receptor potential channel ankryn 1 (TRPA1) expressed in the gastrointestinal tract is associated with gastric motility, gastric emptying, and food intake. In this study, we investigated the effects of methyl syringate, a specific and selective TRPA1 agonist, on food intake, gastric emptying, and gut hormone levels in imprinting control region (ICR) mice. The administration of methyl syringate suppressed cumulative food intake and gastric emptying. In addition, treatment with ruthenium red (RR), a general cation channel blocker, and HC-030031, a selective TRPA1 antagonist, inhibited methyl syringate-induced reduction of food intake and delayed gastric emptying in ICR mice. Methyl syringate also increased plasma peptide YY (PYY) levels, but not glucagon-like peptide-1 (GLP-1) levels. The elevation in PYY was blocked by treatment with RR and HC-030031. The present findings indicate that methyl syringate regulates food intake and gastric emptying through a TRPA1-mediated pathway and, by extension, can contribute to weight suppression.	[Kim, Min Jung; Son, Hee Jin; Song, Seo Hyeon; Jung, Myungji; Kim, Yiseul; Rhyu, Mee-Ra] Korea Food Res Inst, Div Metab & Funct Res, Songnam, Gyeonggi Do, South Korea	Korea Food Research Institute (KFRI)	Rhyu, MR (corresponding author), Korea Food Res Inst, Div Metab & Funct Res, Songnam, Gyeonggi Do, South Korea.	mrrhyu@kfri.re.kr			Korea Food Research Institute [E0131201]	Korea Food Research Institute	This study was supported by Korea Food Research Institute (E0131201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN TE, 1985, GASTROENTEROLOGY, V89, P1070, DOI 10.1016/0016-5085(85)90211-2; Ahren B, 1999, AM J PHYSIOL-ENDOC M, V277, pE996, DOI 10.1152/ajpendo.1999.277.6.E996; Baggio LL, 2004, GASTROENTEROLOGY, V127, P546, DOI 10.1053/j.gastro.2004.04.063; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bassoli A, 2009, BIOORGAN MED CHEM, V17, P1636, DOI 10.1016/j.bmc.2008.12.057; Batterham RL, 2006, CELL METAB, V4, P223, DOI 10.1016/j.cmet.2006.08.001; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bratkovskaya I, 2006, BIOCHEMISTRY-MOSCOW+, V71, P550, DOI 10.1134/S0006297906050130; Challis BG, 2003, BIOCHEM BIOPH RES CO, V311, P915, DOI 10.1016/j.bbrc.2003.10.089; Chaudhri O, 2006, PHILOS T R SOC B, V361, P1187, DOI 10.1098/rstb.2006.1856; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; des Gachons CP, 2011, J NEUROSCI, V31, P999, DOI 10.1523/JNEUROSCI.1374-10.2011; Doihara H, 2009, N-S ARCH PHARMACOL, V380, P353, DOI 10.1007/s00210-009-0435-7; HERRMANN C, 1995, DIGESTION, V56, P117, DOI 10.1159/000201231; HOLST JJ, 1994, GASTROENTEROLOGY, V107, P1848, DOI 10.1016/0016-5085(94)90831-1; Inoue K, 2005, J SCI FOOD AGR, V85, P872, DOI 10.1002/jsfa.1952; Jermnak U, 2012, INT J FOOD MICROBIOL, V153, P339, DOI 10.1016/j.ijfoodmicro.2011.11.023; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Korner J, 2006, OBESITY, V14, P1553, DOI 10.1038/oby.2006.179; Liu CD, 1997, DIS COLON RECTUM, V40, P478, DOI 10.1007/BF02258396; Liu CD, 1996, AM SURGEON, V62, P232; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Meier JJ, 2004, CRIT CARE MED, V32, P848, DOI 10.1097/01.CCM.0000114811.60629.B5; Naslund E, 2007, PHYSIOL BEHAV, V92, P256, DOI 10.1016/j.physbeh.2007.05.017; Nozawa K, 2009, P NATL ACAD SCI USA, V106, P3408, DOI 10.1073/pnas.0805323106; Orskov C, 1996, SCAND J GASTROENTERO, V31, P665, DOI 10.3109/00365529609009147; ORSKOV C, 1994, DIABETES, V43, P535, DOI 10.2337/diabetes.43.4.535; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Purhonen AK, 2008, FEBS LETT, V582, P229, DOI 10.1016/j.febslet.2007.12.005; Ritter RC, 2004, PHYSIOL BEHAV, V81, P249, DOI 10.1016/j.physbeh.2004.02.012; Shintaku K., 2011, BRIT J PHARMACOL, V165, P1476; Son HJ, 2012, ARCH PHARM RES, V35, P2211, DOI 10.1007/s12272-012-1220-6; Terada Y, 2011, J AGR FOOD CHEM, V59, P2627, DOI 10.1021/jf1041646; Tessari P, 2007, DIABETES-METAB RES, V23, P378, DOI 10.1002/dmrr.698; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3853, DOI 10.1210/jc.86.8.3853; Vilsboll T, 2001, DIABETES, V50, P609, DOI 10.2337/diabetes.50.3.609; Vrang N, 2006, AM J PHYSIOL-REG I, V291, pR367, DOI 10.1152/ajpregu.00726.2005; Zhong J, 2011, PFLUG ARCH EUR J PHY, V462, P841, DOI 10.1007/s00424-011-1021-7	40	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71603	10.1371/journal.pone.0071603	http://dx.doi.org/10.1371/journal.pone.0071603			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990963	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100049
J	Komiyama, M; Wada, H; Ura, S; Yamakage, H; Satoh-Asahara, N; Shimatsu, A; Koyama, H; Kono, K; Takahashi, Y; Hasegawa, K				Komiyama, Maki; Wada, Hiromichi; Ura, Shuichi; Yamakage, Hajime; Satoh-Asahara, Noriko; Shimatsu, Akira; Koyama, Hiroshi; Kono, Koichi; Takahashi, Yuko; Hasegawa, Koji			Analysis of Factors That Determine Weight Gain during Smoking Cessation Therapy	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE; DIABETES-MELLITUS; CIGARETTE-SMOKING; TOBACCO SMOKING; NICOTINE; MORTALITY; CHOLESTEROL; OVERWEIGHT; RECEPTOR; SMOKERS	Cigarette smokers are generally known to gain weight after quitting smoking, and such weight gain is thought to contribute to the worsening of glucose tolerance. While smoking cessation therapy such as nicotine replacement is useful to minimize post-cessation weight gain, substantial gain occurs even during the therapy. The purpose of the present study was to identify factors associated with weight gain during smoking cessation therapy. We evaluated 186 patients(132 males and 54 females) who visited our outpatient clinic for smoking cessation, and successfully achieved smoking abstinence. We performed gender-adjusted regression analysis for the rate of BMI increase from the beginning of cessation to 3 months after initiation. Furthermore, we performed multivariate analysis to investigate factors that determine the BMI increase after smoking cessation. The mean BMI significantly (p<0.0001) increased from 23.5 +/- 63.6 kg/m(2) at the initial consultation to 23.9 +/- 63.8 kg/m(2) at 3 months after the start of therapy. There was no significant difference in the extent of BMI increase between nicotine patch and varenicline therapy groups. Factors significantly correlated with the %BMI increase at 3 months after the start of therapy were triglyceride (p = 0.0006, beta a = 0.260), high-density lipoprotein cholesterol (p = 0.0386, beta a = 20.168), daily cigarette consumption (p = 0.0385, beta a = 0.154), and the Fagerstrom Test for Nicotine Dependence (FTND) score (p = 0.0060, beta a = 0.203). Stepwise multivariate analysis demonstrated that triglyceride and the FTND score were the factors determining the post-cessation BMI increase and that the FTND score was the strongest one. The present study demonstrated that smokers with a high FTND score are more likely to gain weight during smoking cessation therapy. Thus, smokers with a high nicotine dependency may require intervention against weight gain in the cessation clinic.	[Komiyama, Maki; Koyama, Hiroshi] Natl Hosp Org Kyoto Med Ctr, Dept Gen Internal Med, Kyoto, Japan; [Wada, Hiromichi; Ura, Shuichi; Hasegawa, Koji] Natl Hosp Org Kyoto Med Ctr, Div Translat Res, Kyoto, Japan; [Yamakage, Hajime; Satoh-Asahara, Noriko; Shimatsu, Akira] Natl Hosp Org Kyoto Med Ctr, Clin Res Inst, Kyoto, Japan; [Komiyama, Maki; Kono, Koichi] Osaka Med Coll, Dept Hyg & Publ Hlth, Osaka, Japan; [Takahashi, Yuko] Nara Womens Univ, Hlth Care Ctr, Nara 630, Japan	Osaka Medical College; Nara Womens University	Hasegawa, K (corresponding author), Natl Hosp Org Kyoto Med Ctr, Div Translat Res, Kyoto, Japan.	koj@kuhp.kyoto-u.ac.jp	TAKAHASHI, Yuko/GYR-2934-2022; Shimatsu, Akira/I-3856-2019	Wada, Hiromichi/0000-0002-8980-224X	National Hospital Organization; Pfizer Health Research Foundation	National Hospital Organization; Pfizer Health Research Foundation	This work was supported in part by a Grant-in-Aid for Clinical Research from the National Hospital Organization and the Pfizer Health Research Foundation (to KH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Arai K, 2001, AM J PHYSIOL-ENDOC M, V280, pE867, DOI 10.1152/ajpendo.2001.280.6.E867; Aubin HJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4439; CARNEY RM, 1984, NEW ENGL J MED, V310, P614, DOI 10.1056/NEJM198403083101002; Chinn S, 2005, LANCET, V365, P1629, DOI 10.1016/S0140-6736(05)66511-7; Clair C, 2013, JAMA-J AM MED ASSOC, V309, P1014, DOI 10.1001/jama.2013.1644; Covey LS, 2011, ARCH INTERN MED, V171, P1956; Critchley J, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003041.PUB2, 10.1002/14651858.CD003041.pub2]; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Ferrara CM, 2001, INT J OBESITY, V25, P1322, DOI 10.1038/sj.ijo.0801716; Filozof C, 2004, Obes Rev, V5, P95, DOI 10.1111/j.1467-789X.2004.00131.x; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; FRANKISH HM, 1995, BRAIN RES, V694, P139, DOI 10.1016/0006-8993(95)00834-D; Gossett LK, 2009, J CLIN LIPIDOL, V3, P372, DOI 10.1016/j.jacl.2009.10.008; GRUNBERG NE, 1985, PHARMACOL BIOCHEM BE, V23, P851, DOI 10.1016/0091-3057(85)90081-4; Hasegawa K., 2008, SMOKING CONTROL SCI, V2, P23; Jo YH, 2002, J NEUROBIOL, V53, P618, DOI 10.1002/neu.10147; Kamaura M, 2011, J EPIDEMIOL, V21, P431, DOI 10.2188/jea.JE20110010; Love SJ, 2011, AM J ADDICTION, V20, P1, DOI 10.1111/j.1521-0391.2010.00091.x; de Morentin PBM, 2012, DIABETES, V61, P807, DOI 10.2337/db11-1079; Mizoue T, 1998, INT J EPIDEMIOL, V27, P984, DOI 10.1093/ije/27.6.984; Moolgavkar SH, 2012, JNCI-J NATL CANCER I, V104, P541, DOI 10.1093/jnci/djs136; Morimoto A, 2012, DIABETES RES CLIN PR, V96, P407, DOI 10.1016/j.diabres.2012.03.007; Oba S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0017061; Okuda N, 2005, ATHEROSCLEROSIS, V178, P371, DOI 10.1016/j.atherosclerosis.2004.09.007; PERKINS KA, 1989, NEW ENGL J MED, V320, P898, DOI 10.1056/NEJM198904063201404; PERKINS KA, 1992, BRIT J ADDICT, V87, P193; Satoh N, 2008, CIRC J, V72, P932, DOI 10.1253/circj.72.932; Sepinwall D, 2004, ADDICT BEHAV, V29, P1809, DOI 10.1016/j.addbeh.2004.04.002; Shimada S, 2011, CIRC J, V75, P185, DOI 10.1253/circj.CJ-10-0335; Sztalryd C, 1996, AM J PHYSIOL-ENDOC M, V270, pE215, DOI 10.1152/ajpendo.1996.270.2.E215; Thorndike AN, 2008, ARCH INTERN MED, V168, P186, DOI 10.1001/archinternmed.2007.60; Tonstad S, 2009, DIABETES RES CLIN PR, V85, P4, DOI 10.1016/j.diabres.2009.04.013; Ukkola O, 2001, INT J OBESITY, V25, P1332, DOI 10.1038/sj.ijo.0801735; Ussher MH, 2008, COCHRANE DB SYST REV, V4; Wada H., 2008, SMOKING CONTROL SCI, V2, P4; Wada H, 2012, J ATHEROSCLER THROMB, V19, P47, DOI 10.5551/jat.9035; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005	39	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72010	10.1371/journal.pone.0072010	http://dx.doi.org/10.1371/journal.pone.0072010			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991026	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100070
J	Uchino, BN; Smith, TW; Carlisle, M; Birmingham, WC; Light, KC				Uchino, Bert N.; Smith, Timothy W.; Carlisle, McKenzie; Birmingham, Wendy C.; Light, Kathleen C.			The Quality of Spouses' Social Networks Contributes to Each Other's Cardiovascular Risk	PLOS ONE			English	Article							CLOSE RELATIONSHIPS; MARITAL QUALITY; STRESSORS; HEALTH; INTERDEPENDENCE; HETEROGENEITY; PREDICTION; MODELS; COUPLE; HOME	Objectives: Although the quality of one's own social relationships has been related to cardiovascular morbidity and mortality, whether a partner's social network quality can similarly influence one's cardiovascular risk is unknown. In this study we tested whether the quality of a partner's social networks influenced one's own ambulatory blood pressure (ABP). Methods: The quality of 94 couples' social networks was determined using a comprehensive model of relationships that separates out social ties that are sources of positivity(supportive), negativity (aversive), and both positivity and negativity (ambivalent). We then utilized statistical models (actor-partner analyses) that allowed us to separate out the links between one's own social network quality on ABP (actor influences), a partner's social network quality on ABP (partner influences), and a couple's network quality combined on ABP (actor X partner interactions). Results: Independent of one's own relationship quality, results showed that an individual's ABP was lower if their spouse had more supportive ties, and higher if a spouse had more aversive and ambivalent ties. In addition, couples' networks in combination were associated with higher ABP but only if both had a low number of supportive ties, or a high number of aversive or ambivalent ties. Conclusions: These data suggest that the social ties of those we have close relationships with may influence our cardiovascular risk and opens new opportunities to capitalize on untapped social resources or to mitigate hidden sources of social strain.	[Uchino, Bert N.; Smith, Timothy W.; Carlisle, McKenzie] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA; [Uchino, Bert N.; Smith, Timothy W.; Carlisle, McKenzie] Univ Utah, Hlth Psychol Program, Salt Lake City, UT USA; [Birmingham, Wendy C.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Light, Kathleen C.] Univ Utah, Dept Anesthesiol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Brigham Young University; Utah System of Higher Education; University of Utah	Uchino, BN (corresponding author), Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA.	bert.uchino@psych.utah.edu			National Heart, Lung, and Blood Institute [R01 HL68862]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068862] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grants R01 HL68862 from the National Heart, Lung, and Blood Institute (Bert N. Uchino, PI). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L.S., 1991, MULTIPLE REGRESSION; Baucom BR, 2009, J CONSULT CLIN PSYCH, V77, P160, DOI 10.1037/a0014405; Beckes L, 2011, SOC PERSONAL PSYCHOL, V5, P976, DOI 10.1111/j.1751-9004.2011.00400.x; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bucholz EM, 2012, ARCH INTERN MED, V172, P1084, DOI 10.1001/archinternmed.2012.2649; CACIOPPO JT, 1995, PSYCHOSOM MED, V57, P154, DOI 10.1097/00006842-199503000-00008; Campbell L, 2002, PERS RELATIONSHIP, V9, P327, DOI 10.1111/1475-6811.00023; Campo RA, 2009, J COMMUNITY PSYCHOL, V37, P471, DOI 10.1002/jcop.20308; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; Cohen J., 1983, APPL MULTIPLE REGRES; Cornwell B, 2012, J MARRIAGE FAM, V74, P229, DOI 10.1111/j.1741-3737.2012.00959.x; Coyne JC, 2001, AM J CARDIOL, V88, P526, DOI 10.1016/S0002-9149(01)01731-3; De Vogli R, 2007, ARCH INTERN MED, V167, P1951, DOI 10.1001/archinte.167.18.1951; Epstein N.B., 2002, ENHANCED COGNITIVE B; Felmlee DH, 2001, SOC FORCES, V79, P1259, DOI 10.1353/sof.2001.0039; GALECKI AT, 1994, COMMUN STAT THEORY, V23, P3105, DOI 10.1080/03610929408831436; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goodwin J, 2007, BLOOD PRESS MONIT, V12, P113, DOI 10.1097/MBP.0b013e3280acab1b; Hodgkinson J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3621; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; House JS, 2001, PSYCHOSOM MED, V63, P273, DOI 10.1097/00006842-200103000-00011; Kearns JN, 2004, J FAM PSYCHOL, V18, P383, DOI 10.1037/0893-3200.18.2.383; Kelley H.H., 1978, INTERPERSONAL RELATI; Kenny D. A., 2006, DYADIC DATA ANAL; KIECOLTGLASER JK, 1991, PSYCHOSOM MED, V53, P345, DOI 10.1097/00006842-199107000-00001; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; MARLER MR, 1988, STAT MED, V7, P697, DOI 10.1002/sim.4780070608; Matthews KA, 2002, ARCH INTERN MED, V162, P309, DOI 10.1001/archinte.162.3.309; MILARDO RM, 1983, J PERS SOC PSYCHOL, V44, P964; Newsom JT, 2003, PSYCHOL AGING, V18, P746, DOI 10.1037/0882-7974.18.4.746; Nezlek JB, 2008, SOC PERSONAL PSYCHOL, V2, P842, DOI 10.1111/j.1751-9004.2007.00059.x; Park T, 2002, STAT MED, V21, P143, DOI 10.1002/sim.949; Pickering TG, 2006, NEW ENGL J MED, V354, P2368, DOI 10.1056/NEJMra060433; Repetti R, 2009, CURR DIR PSYCHOL SCI, V18, P106, DOI 10.1111/j.1467-8721.2009.01618.x; Robles TR, PSYCHOL B; Rusbult CE, 2008, SOC PERSONAL PSYCHOL, V2, P2049, DOI 10.1111/j.1751-9004.2008.00147.x; Sbarra DA, 2011, PERSPECT PSYCHOL SCI, V6, P454, DOI 10.1177/1745691611414724; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Smith TW, 2007, PSYCHOSOM MED, V69, P441, DOI 10.1097/PSY.0b013e3180600a65; Story LB, 2006, J FAM PSYCHOL, V20, P690, DOI 10.1037/0893-3200.20.4.690; Taylor S.E., 2011, OXFORD HDB HLTH PSYC, P189; Uchino BN, 2001, J BEHAV MED, V24, P361, DOI 10.1023/A:1010634902498; Uchino BN, 2004, SOCIAL SUPPORT PHYS; Weiss H. M., 2004, CONSTRUCTING EMA STU	47	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71881	10.1371/journal.pone.0071881	http://dx.doi.org/10.1371/journal.pone.0071881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218YW	23990999	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100059
J	Zhu, J; Feng, XL; Lou, JY; Li, WD; Li, S; Zhu, HX; Yang, L; Zhang, AP; He, L; Li, C				Zhu, Jie; Feng, Xiaolu; Lou, Jingyu; Li, Weidong; Li, Sheng; Zhu, Hongxin; Yang, Lun; Zhang, Aiping; He, Lin; Li, Can			Accurate Quantification of microRNA via Single Strand Displacement Reaction on DNA Origami Motif	PLOS ONE			English	Article							FOLDING DNA; EXPRESSION; MIR-133A; TARGET; ARRAYS; FSCN1; RNA	DNA origami is an emerging technology that assembles hundreds of staple strands and one single-strand DNA into certain nanopattern. It has been widely used in various fields including detection of biological molecules such as DNA, RNA and proteins. MicroRNAs (miRNAs) play important roles in post-transcriptional gene repression as well as many other biological processes such as cell growth and differentiation. Alterations of miRNAs' expression contribute to many human diseases. However, it is still a challenge to quantitatively detect miRNAs by origami technology. In this study, we developed a novel approach based on streptavidin and quantum dots binding complex (STV-QDs) labeled single strand displacement reaction on DNA origami to quantitatively detect the concentration of miRNAs. We illustrated a linear relationship between the concentration of an exemplary miRNA as miRNA-133 and the STV-QDs hybridization efficiency; the results demonstrated that it is an accurate nano-scale miRNA quantifier motif. In addition, both symmetrical rectangular motif and asymmetrical China-map motif were tested. With significant linearity in both motifs, our experiments suggested that DNA Origami motif with arbitrary shape can be utilized in this method. Since this DNA origami-based method we developed owns the unique advantages of simple, time-and-material-saving, potentially multi-targets testing in one motif and relatively accurate for certain impurity samples as counted directly by atomic force microscopy rather than fluorescence signal detection, it may be widely used in quantification of miRNAs.	[Zhu, Jie; Feng, Xiaolu; Lou, Jingyu; Li, Weidong; Li, Sheng; Zhu, Hongxin; Yang, Lun; Zhang, Aiping; He, Lin; Li, Can] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	He, L (corresponding author), Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China.	helin@bio-x.cn; lican@sjtu.edu.cn	Zhu, Hongxin/HCI-9872-2022	Li, Weidong/0000-0001-5384-4838	973 Program [2013CB967400, 2012CB93600, 2010CB529600]; National Key Technology RD Program [2012BAI01B09]; National Nature Science Foundation of China [81121001]	973 Program(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was support by the 973 Program (2013CB967400, 2012CB93600, and 2010CB529600), the National Key Technology R&D Program (2012BAI01B09) and the National Nature Science Foundation of China (81121001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ES, 2008, ACS NANO, V2, P1213, DOI 10.1021/nn800215j; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beuvink I, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1118; Bui H, 2010, NANO LETT, V10, P3367, DOI 10.1021/nl101079u; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Jiang Q, 2012, J AM CHEM SOC; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Ke YG, 2008, SCIENCE, V319, P180, DOI 10.1126/science.1150082; Ke YG, 2009, NANO LETT, V9, P2445, DOI 10.1021/nl901165f; Ko SH, 2012, ADV FUNCTIONAL MAT; Kuzyk A, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/23/235305; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Niemeyer CM, 2000, ANGEW CHEM INT EDIT, V39, P3055, DOI 10.1002/1521-3773(20000901)39:17<3055::AID-ANIE3055>3.0.CO;2-R; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Qian L, 2006, CHINESE SCI BULL, V51, P2973, DOI 10.1007/s11434-006-2223-9; Rinker S, 2008, NAT NANOTECHNOL, V3, P418, DOI 10.1038/nnano.2008.164; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sacca B, 2010, ANGEW CHEM INT EDIT, V49, P9378, DOI 10.1002/anie.201005931; Sharma J, 2008, ANGEW CHEM INT EDIT, V47, P5157, DOI 10.1002/anie.200801485; Shen WQ, 2009, J AM CHEM SOC, V131, P6660, DOI 10.1021/ja901407j; Shen XB, 2012, J AM CHEM SOC, V134, P146, DOI 10.1021/ja209861x; Uchida Y, 2011, MIR133A INDUCES APOP; Voigt NV, 2010, NAT NANOTECHNOL, V5, P200, DOI [10.1038/nnano.2010.5, 10.1038/NNANO.2010.5]; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Zhang Z, 2010, SMALL, V6, P1854, DOI 10.1002/smll.201000908; Zhang Z, 2010, ADV MATER, V22, P2672, DOI 10.1002/adma.201000151; Zhou CS, 2012, J NANOTECHNOL, V2012, DOI 10.1155/2012/453953	37	8	9	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e69856	10.1371/journal.pone.0069856	http://dx.doi.org/10.1371/journal.pone.0069856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990889	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100014
J	Lin, QS; Jin, FL; Hu, ZD; Chen, HY; Yin, F; Li, ZY; Dong, XL; Zhang, DY; Ren, SX; Feng, X				Lin, Qingsheng; Jin, Fengliang; Hu, Zhendi; Chen, Huanyu; Yin, Fei; Li, Zhenyu; Dong, Xiaolin; Zhang, Deyong; Ren, Shunxiang; Feng, Xia			Transcriptome Analysis of Chlorantraniliprole Resistance Development in the Diamondback Moth Plutella xylostella	PLOS ONE			English	Article							RYANODINE RECEPTOR; HETEROLOGOUS EXPRESSION; LEPIDOPTERA PLUTELLIDAE; INSECTICIDE RESISTANCE; ANTHRANILIC DIAMIDES; MOLECULAR-CLONING; GENE-EXPRESSION; RNA-SEQ; IDENTIFICATION; MECHANISMS	Background: The diamondback moth Plutella xyllostella has developed a high level of resistance to the latest insecticide chlorantraniliprole. A better understanding of P. xylostella's resistance mechanism to chlorantraniliprole is needed to develop effective approaches for insecticide resistance management. Principal Findings: To provide a comprehensive insight into the resistance mechanisms of P. xylostella to chlorantraniliprole, transcriptome assembly and tag-based digital gene expression (DGE) system were performed using Illumina HiSeq (TM) 2000. The transcriptome analysis of the susceptible strain (SS) provided 45,231 unigenes (with the size ranging from 200 bp to 13,799 bp), which would be efficient for analyzing the differences in different chlorantraniliprole-resistant P. xylostella stains. DGE analysis indicated that a total of 1215 genes (189 up-regulated and 1026 down-regulated) were gradient differentially expressed among the susceptible strain (SS) and different chlorantraniliprole-resistant P. xylostella strains, including low-level resistance (GXA), moderate resistance (LZA) and high resistance strains (HZA). A detailed analysis of gradient differentially expressed genes elucidated the existence of a phase-dependent divergence of biological investment at the molecular level. The genes related to insecticide resistance, such as P450, GST, the ryanodine receptor, and connectin, had different expression profiles in the different chlorantraniliprole-resistant DGE libraries, suggesting that the genes related to insecticide resistance are involved in P. xylostella resistance development against chlorantraniliprole. To confirm the results from the DGE, the expressional profiles of 4 genes related to insecticide resistance were further validated by qRT-PCR analysis. Conclusions: The obtained transcriptome information provides large gene resources available for further studying the resistance development of P. xylostella to pesticides. The DGE data provide comprehensive insights into the gene expression profiles of the different chlorantraniliprole-resistant stains. These genes are specifically related to insecticide resistance, with different expressional profiles facilitating the study of the role of each gene in chlorantraniliprole resistance development.	[Lin, Qingsheng; Hu, Zhendi; Chen, Huanyu; Yin, Fei; Li, Zhenyu; Zhang, Deyong; Feng, Xia] Guangdong Acad Agr Sci, Insititute Plant Protect, Guangzhou, Guangdong, Peoples R China; [Jin, Fengliang; Dong, Xiaolin; Ren, Shunxiang] South China Agr Univ SCAU, Engn Res Ctr Biol Control, Minist Educ, Guangzhou, Guangdong, Peoples R China; [Lin, Qingsheng; Hu, Zhendi; Chen, Huanyu; Yin, Fei; Li, Zhenyu; Zhang, Deyong; Feng, Xia] Guangdong Prov Key Lab High Technol Plant Protect, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences; South China Agricultural University	Ren, SX (corresponding author), South China Agr Univ SCAU, Engn Res Ctr Biol Control, Minist Educ, Guangzhou, Guangdong, Peoples R China.	shxren@scau.edu.cn; fengx@gdppri.com			Special Fund for Agro-scientific Research in the Public Interest [201103021]; Presidential Foundation of Guangdong Academy of Agricultural Science, China [201206]	Special Fund for Agro-scientific Research in the Public Interest; Presidential Foundation of Guangdong Academy of Agricultural Science, China	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (201103021), and the Presidential Foundation of Guangdong Academy of Agricultural Science, China (201206).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Razek A.S., 2006, J APPL SCI RES, V2, P942; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bautista MAM, 2007, PESTIC BIOCHEM PHYS, V87, P85, DOI 10.1016/j.pestbp.2006.06.004; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Benjamini Y, 2001, ANN STAT, V29, P1165; Bin L, 2011, PLOS ONE, V6; Charleston DS, 2005, BIOL CONTROL, V33, P131, DOI 10.1016/j.biocontrol.2005.02.007; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Cordova D., 2007, PESTICIDE CHEM CROP, P121; Dinter A., 2008, IOBC/WPRS Bulletin, V35, P128; Edralin O D, 2011, 6 INT WORKSH MAN DIA, P63; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harcourt DG, 1956, 37TH REP QUEB SOC PR, P155; He WY, 2012, GENOMICS, V99, P169, DOI 10.1016/j.ygeno.2011.12.009; Hu Z D, 2012, GUANGDONG AGR SCI, V1, P79; Huang HS, 1998, INSECT BIOCHEM MOLEC, V28, P651, DOI 10.1016/S0965-1748(98)00049-6; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kfir R, 1998, ANN ENTOMOL SOC AM, V91, P164, DOI 10.1093/aesa/91.2.164; KRISHNAKUMAR N K, 1986, Progressive Horticulture, V18, P104; Lahm GP, 2007, BIOORG MED CHEM LETT, V17, P6274, DOI 10.1016/j.bmcl.2007.09.012; Lahm GP, 2009, BIOORGAN MED CHEM, V17, P4127, DOI 10.1016/j.bmc.2009.01.018; Lahm GP, 2005, BIOORG MED CHEM LETT, V15, P4898, DOI 10.1016/j.bmcl.2005.08.034; Lai TC, 2011, PESTIC BIOCHEM PHYS, V101, P198, DOI 10.1016/j.pestbp.2011.09.006; Li HS, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.45; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; McKenzie J., 1996, ECOLOGICAL EVOLUTION; Mohan M, 2003, CROP PROT, V22, P495, DOI 10.1016/S0261-2194(02)00201-6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; Pu X, 2010, PEST MANAG SCI, V66, P371, DOI 10.1002/ps.1885; Qian L, 2008, PESTIC BIOCHEM PHYS, V91, P175, DOI 10.1016/j.pestbp.2008.03.011; Shen BC, 2004, DNA SEQUENCE, V15, P228, DOI 10.1080/10425170410001716055; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Sial AA, 2011, PESTIC BIOCHEM PHYS, V99, P274, DOI 10.1016/j.pestbp.2011.01.006; Sonoda S, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3501; Troczka B, 2012, INSECT BIOCHEM MOLEC, V42, P873, DOI 10.1016/j.ibmb.2012.09.001; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang XL, 2012, J ECON ENTOMOL, V105, P1019, DOI 10.1603/EC12059; Wang XL, 2012, PESTIC BIOCHEM PHYS, V102, P204, DOI 10.1016/j.pestbp.2012.01.009; Watson GB, 2010, INSECT BIOCHEM MOLEC, V40, P376, DOI 10.1016/j.ibmb.2009.11.004; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zalucki MP, 2012, J ECON ENTOMOL, V105, P1115, DOI 10.1603/EC12107; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109	47	72	83	7	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72314	10.1371/journal.pone.0072314	http://dx.doi.org/10.1371/journal.pone.0072314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977278	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300078
J	Zhang, LN; Xu, L; Zhou, HY; Wu, LY; Li, YY; Pang, T; Xia, CM; Qiu, BY; Gu, M; Dong, TC; Li, JY; Shen, JK; Li, J				Zhang, Li-Na; Xu, Lei; Zhou, Hua-Yong; Wu, Ling-Yan; Li, Yuan-Yuan; Pang, Tao; Xia, Chun-Mei; Qiu, Bei-Ying; Gu, Min; Dong, Tian-Cheng; Li, Jing-Ya; Shen, Jing-Kang; Li, Jia			Novel Small-Molecule AMP-Activated Protein Kinase Allosteric Activator with Beneficial Effects in db/db Mice	PLOS ONE			English	Article							RESPIRATORY COMPLEX-I; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; MECHANISM; INSULIN; METFORMIN; A-769662; LIVER; AICAR; PHOSPHORYLATION; IDENTIFICATION	AMP-activated protein kinase (AMPK) is an energy sensor of metabolism that is an attractive therapeutic target for type 2 diabetes mellitus and metabolic syndrome. Using a homogeneous scintillation proximity assay (SPA), we identified a new small-molecule AMPK activator, ZLN024, which allosterically stimulated active AMPK heterotrimers and the inactive alpha 1 subunit truncations alpha 1 (1-394) and alpha 1 (1-335) but not alpha 1 (1-312). AMPK activation by ZLN024 requires the pre-phosphorylation of Thr-172 by at least one upstream kinase and protects AMPK Thr-172 against dephosphorylation by PP2C alpha. ZLN024 activated AMPK in L6 myotubes and stimulated glucose uptake and fatty acid oxidation without increasing the ADP/ATP ratio. ZLN024 also activated AMPK in primary hepatocytes, decreased fatty acid synthesis and glucose output. Treatment of db/db mice with 15 mg/kg/day ZLN024 improved glucose tolerance; liver tissue weight, triacylglycerol and the total cholesterol content were decreased. The hepatic transcriptional level of G6Pase, FAS and mtGPAT were reduced. The transcription of genes involved in fatty acid oxidation and the mitochondrial biogenesis of muscle tissue were elevated. The ACC phosphorylation was increased in muscle and liver. This study provides a novel allosteric AMPK activator for functional study in vitro and in vivo and demonstrates that AMPK allosteric activators could be a promising therapeutic approach for type 2 diabetes mellitus and metabolic syndrome.	[Zhang, Li-Na; Xu, Lei; Zhou, Hua-Yong; Wu, Ling-Yan; Li, Yuan-Yuan; Pang, Tao; Xia, Chun-Mei; Qiu, Bei-Ying; Gu, Min; Dong, Tian-Cheng; Li, Jing-Ya; Shen, Jing-Kang; Li, Jia] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Li, JY (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 200031, Peoples R China.	jyli@mail.shcnc.ac.cn; jkshen@mail.shcnc.ac.cn; jli@mail.shcnc.ac.cn	Wu, Ling/GZN-2235-2022; Li, Jia/F-9116-2011; Li, Yuanyuan/N-4447-2015; Li, Yuanyuan/AAC-5432-2019		National Natural Science Foundation of China [81125023, 81273566]; National Science and Technology Major Projects for Major New Drugs Innovation and Development [2012ZX09304011, 2012ZX09301-001-004]; National Program on Key Basic Research Project [2012CB524906, G1998051104]; Shanghai Commission of Science and Technology [11DZ2292200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects for Major New Drugs Innovation and Development; National Program on Key Basic Research Project(National Basic Research Program of China); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by the National Natural Science Foundation of China (81125023 and 81273566), the National Science and Technology Major Projects for Major New Drugs Innovation and Development (2012ZX09304011 and 2012ZX09301-001-004), National Program on Key Basic Research Project (2012CB524906 and G1998051104) and Shanghai Commission of Science and Technology (11DZ2292200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS AW, 1974, J BIOL CHEM, V249, P5241; Anderson SN, 2004, J BIOMOL SCREEN, V9, P112, DOI 10.1177/1087057103260592; Antonsson B, 1999, ANAL BIOCHEM, V267, P294, DOI 10.1006/abio.1998.2986; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Evans DB, 2002, J BIOCHEM BIOPH METH, V50, P151, DOI 10.1016/S0165-022X(01)00184-1; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Huang SL, 2012, DIABETOLOGIA, V55, P1469, DOI 10.1007/s00125-011-2366-3; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Iglesias MA, 2002, DIABETES, V51, P2886, DOI 10.2337/diabetes.51.10.2886; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; Marley AE, 1996, BIOCHEM J, V320, P801, DOI 10.1042/bj3200801; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pang T, 2008, J BIOL CHEM, V283, P16051, DOI 10.1074/jbc.M710114200; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Qiu BY, 2010, DIABETES, V59, P256, DOI 10.2337/db09-0223; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Treebak JT, 2009, AM J PHYSIOL-CELL PH, V297, pC1041, DOI 10.1152/ajpcell.00051.2009; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Van Aller GS, 2008, ANAL BIOCHEM, V383, P311, DOI 10.1016/j.ab.2008.08.037; WEEKES J, 1993, FEBS LETT, V334, P335, DOI 10.1016/0014-5793(93)80706-Z; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang LN, 2013, DIABETES, V62, P1297, DOI 10.2337/db12-0703; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	50	19	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72092	10.1371/journal.pone.0072092	http://dx.doi.org/10.1371/journal.pone.0072092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977216	gold, Green Published, Green Submitted			2022-12-25	WOS:000324527300062
J	Izgi, K; Altuntas, CZ; Bicer, F; Ozer, A; Sakalar, C; Li, XX; Tuohy, VK; Daneshgari, F				Izgi, Kenan; Altuntas, Cengiz Z.; Bicer, Fuat; Ozer, Ahmet; Sakalar, Cagri; Li, Xiaoxia; Tuohy, Vincent K.; Daneshgari, Firouz			Uroplakin Peptide-Specific Autoimmunity Initiates Interstitial Cystitis/Painful Bladder Syndrome in Mice	PLOS ONE			English	Article							LOWER URINARY-TRACT; POTENTIAL ANIMAL-MODEL; VISCERAL PAIN; SYNDROME/INTERSTITIAL CYSTITIS; CYCLOPHOSPHAMIDE CYSTITIS; NEUROGENIC CYSTITIS; INTERFERON-GAMMA; MURINE MODEL; INFLAMMATION; RAT	The pathophysiology of interstitial cystitis/painful bladder syndrome (IC/PBS) is enigmatic. Autoimmunity and impaired urothelium might lead the underlying pathology. A major shortcoming in IC/PBS research has been the lack of an appropriate animal model. In this study, we show that the bladder specific uroplakin 3A-derived immunogenic peptide UPK3A 65-84, which contains the binding motif for IA(d) MHC class II molecules expressed in BALB/c mice, is capable of inducing experimental autoimmune cystitis in female mice of that strain. A highly antigen-specific recall proliferative response of lymph node cells to UPK3A 65-84 was observed, characterized by selectively activated CD4+ T cells with a proinflammatory Th1-like phenotype, including enhanced production of interferon gamma and interleukin-2. T cell infiltration of the bladder and bladder-specific increased gene expression of inflammatory cytokines were observed. Either active immunization with UPK3A 65-84 or adoptive transfer of peptide-activated CD4+ T cells induced all of the predominant IC/PBS phenotypic characteristics, including increased micturition frequency, decreased urine output per micturition, and increased pelvic pain responses to stimulation with von Frey filaments. Our study demonstrates the creation of a more specific experimental autoimmune cystitis model that is the first inducible model for IC/PBS that manifests all of the major symptoms of this debilitating condition.	[Izgi, Kenan; Altuntas, Cengiz Z.; Bicer, Fuat; Ozer, Ahmet; Daneshgari, Firouz] Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA; [Izgi, Kenan; Bicer, Fuat] Cleveland State Univ, Dept Clin Chem, Cleveland, OH 44115 USA; [Ozer, Ahmet] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Sakalar, Cagri; Li, Xiaoxia; Tuohy, Vincent K.] Cleveland Clin, Dept Immunol, Lerner Res Inst, Cleveland, OH 44106 USA	Case Western Reserve University; University System of Ohio; Cleveland State University; Case Western Reserve University; Cleveland Clinic Foundation	Daneshgari, F (corresponding author), Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA.	fxd22@case.edu		Ozer, Ahmet/0000-0002-4780-583X	Department of Urology at Case Western Reserve University School of Medicine; University Hospitals Case Medical Center	Department of Urology at Case Western Reserve University School of Medicine; University Hospitals Case Medical Center	This study was supported by Departmental Funds of the Department of Urology at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboushwareb T, 2007, FASEB J, V21, pA1308; Abrams P, 2002, AM J OBSTET GYNECOL, V187, P116, DOI 10.1067/mob.2002.125704; Altuntas CZ, 2008, J NEUROIMMUNOL, V203, P58, DOI 10.1016/j.jneuroim.2008.06.038; Altuntas CZ, 2006, J IMMUNOL, V177, P1988, DOI 10.4049/jimmunol.177.3.1988; Altuntas CZ, 2012, EUR UROL, V61, P193, DOI 10.1016/j.eururo.2011.06.028; Benvenga S, 2006, THYROID, V16, P225, DOI 10.1089/thy.2006.16.225; Berry SH, 2011, J UROLOGY, V186, P540, DOI 10.1016/j.juro.2011.03.132; Birder LA, 2011, NEUROUROL URODYNAM, V30, P668, DOI 10.1002/nau.21109; Bjorling DE, 2011, NEUROUROL URODYNAM, V30, P673, DOI 10.1002/nau.21078; Bogart LM, 2007, J UROLOGY, V177, P450, DOI 10.1016/j.juro.2006.09.032; Buffington CAT, 2004, J UROLOGY, V172, P1242, DOI 10.1097/01.ju.0000137953.49304.6c; BULLOCK AD, 1992, J UROLOGY, V148, P1951, DOI 10.1016/S0022-5347(17)37091-X; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHRISTMAS TJ, 1994, BRIT J UROL, V73, P508, DOI 10.1111/j.1464-410X.1994.tb07635.x; CHRISTMAS TJ, 1992, CLIN EXP IMMUNOL, V87, P450; Clemens JQ, 2005, J UROLOGY, V173, P98, DOI 10.1097/01.ju.0000146114.53828.82; Doggweiler R, 1998, J UROLOGY, V160, P1551, DOI 10.1016/S0022-5347(01)62611-9; ELGEBALY SA, 1992, J UROLOGY, V147, P1382, DOI 10.1016/S0022-5347(17)37578-X; Jane-Wit D, 2002, J IMMUNOL, V169, P6507, DOI 10.4049/jimmunol.169.11.6507; Jasmin L, 1998, J NEUROSCI, V18, P10016; Jasmin L, 2000, J UROLOGY, V164, P852, DOI 10.1016/S0022-5347(05)67326-0; Jerde TJ, 2000, UROL RES, V28, P269, DOI 10.1007/s002400000114; KATO K, 1990, J UROLOGY, V144, P1272, DOI 10.1016/S0022-5347(17)39718-5; Keay S, 1997, J UROLOGY, V157, P1083, DOI 10.1016/S0022-5347(01)65146-2; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Laird JMA, 2001, PAIN, V92, P335, DOI 10.1016/S0304-3959(01)00275-5; LANTERIMINET M, 1995, EXP BRAIN RES, V105, P220, DOI 10.1007/BF00240958; Lee Gilho, 2011, Int Neurourol J, V15, P4, DOI 10.5213/inj.2011.15.1.4; Lin YH, 2008, BJU INT, V102, P1724, DOI 10.1111/j.1464-410X.2008.07891.x; Link CL, 2008, J UROLOGY, V180, P599, DOI 10.1016/j.juro.2008.04.009; Liu GM, 2006, AM J PHYSIOL-REG I, V291, pR837, DOI 10.1152/ajpregu.00917.2005; Liu WJ, 2008, J AUTOIMMUN, V30, P257, DOI 10.1016/j.jaut.2007.10.005; Liu WJ, 2007, J IMMUNOL, V178, P539, DOI 10.4049/jimmunol.178.1.539; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo Gomez Maria Fernanda, 2004, Arch Esp Urol, V57, P25; LuberNarod J, 1996, UROL RES, V24, P367, DOI 10.1007/BF00389795; MACDERMOTT JP, 1991, BRIT J UROL, V67, P44, DOI 10.1111/j.1464-410X.1991.tb15068.x; MCMAHON SB, 1987, PAIN, V28, P109, DOI 10.1016/0304-3959(87)91065-7; Moutzouris DA, 2009, CLIN J AM SOC NEPHRO, V4, P1844, DOI 10.2215/CJN.02000309; Mulder GB, 2004, CONTEMP TOP LAB ANIM, V43, P54; Ochs RL, 1997, CLIN LAB MED, V17, P571; Oottamasathien S, 2011, J UROLOGY, V186, P1684, DOI 10.1016/j.juro.2011.03.099; Phull H, 2007, BJU INT, V100, P664, DOI 10.1111/j.1464-410X.2007.07035.x; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rudick CN, 2008, AM J PHYSIOL-REG I, V294, pR1268, DOI 10.1152/ajpregu.00836.2007; Rudick CN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002096; Rudick Charles N, 2009, BMC Urol, V9, P16, DOI 10.1186/1471-2490-9-16; SAKATA T, 1989, Journal of Environmental Pathology Toxicology and Oncology, V9, P159; Sand PK, 2006, J REPROD MED, V51, P234; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SNAPPER CM, 1992, J EXP MED, V175, P1367, DOI 10.1084/jem.175.5.1367; Solares CA, 2004, J CLIN INVEST, V113, P1210, DOI 10.1172/JCI200418195; van de Merwe JP, 2007, NAT CLIN PRACT UROL, V4, P484, DOI 10.1038/ncpuro0874; Vera PL, 2010, NEUROUROL URODYNAM, V29, P1451, DOI 10.1002/nau.20878; Vera PL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003898; Westropp JL, 2002, J UROLOGY, V167, P694, DOI 10.1016/S0022-5347(01)69129-8	56	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72067	10.1371/journal.pone.0072067	http://dx.doi.org/10.1371/journal.pone.0072067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977210	gold, Green Published, Green Submitted			2022-12-25	WOS:000323570200056
J	Camenares, D; Dulebohn, DP; Svetlanov, A; Karzai, AW				Camenares, Devin; Dulebohn, Daniel P.; Svetlanov, Anton; Karzai, A. Wali			Active and Accurate trans-Translation Requires Distinct Determinants in the C-terminal Tail of SmpB Protein and the mRNA-like Domain of Transfer Messenger RNA (tmRNA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA-binding Protein; tmRNA; Transfer RNA (tRNA); Translation; Translation Control; SmpB; Ribosome	RIBOSOME-RESCUE; MEDIATED SURVEILLANCE; STALLED RIBOSOMES; BINDING; SYSTEM; DECAY; BACTERIA; DEGRADATION; INITIATION; MECHANISM	Unproductive ribosome stalling in eubacteria is resolved by the actions of SmpB protein and transfer messenger (tm) RNA. We examined the functional significance of conserved regions of SmpB and tmRNA to the trans-translation process. Our investigations reveal that the N-terminal 20 residues of SmpB, which are located near the ribosomal decoding center, are dispensable for all known SmpB activities. In contrast, a set of conserved residues that reside at the junction between the tmRNA-binding core and the C-terminal tail of SmpB play an important role in tmRNA accommodation. Our data suggest that the highly conserved glycine 132 acts as a flexible hinge that enables movement of the C-terminal tail, thus permitting proper positioning and establishment of the tmRNA open reading frame (ORF) as the surrogate template. To gain further insights into the function of the SmpB C-terminal tail, we examined the tagging activity of hybrid variants of tmRNA and the SmpB protein, in which the tmRNA ORF or the SmpB C-terminal tail was substituted with the equivalent but highly divergent sequences from Francisella tularensis. We observed that the hybrid tmRNA was active but resulted in less accurate selection of the resume codon. Cognate hybrid SmpB was necessary to restore activity. Furthermore, accurate tagging was observed when the identity of the resume codon was reverted from GGC to GCA. Taken together, these data suggest that the engagement of the tmRNA ORF and the selection of the correct translation resumption point are distinct activities that are influenced by independent tmRNA and SmpB determinants.	[Camenares, Devin; Dulebohn, Daniel P.; Svetlanov, Anton; Karzai, A. Wali] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Camenares, Devin; Svetlanov, Anton; Karzai, A. Wali] SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Karzai, AW (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Ctr Infect Dis, Stony Brook, NY 11794 USA.	wali.karzai@stonybrook.edu		Camenares, Devin/0000-0001-7047-1682	National Institutes of Health [R01 GM065319]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM065319.	Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Barends S, 2001, J MOL BIOL, V314, P9, DOI 10.1006/jmbi.2001.5114; Barends S, 2011, WIRES RNA, V2, P233, DOI 10.1002/wrna.48; Bessho Y, 2007, P NATL ACAD SCI USA, V104, P8293, DOI 10.1073/pnas.0700402104; Cheng K, 2010, J STRUCT BIOL, V169, P342, DOI 10.1016/j.jsb.2009.10.015; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Dulebohn D, 2007, BIOCHEMISTRY-US, V46, P4681, DOI 10.1021/bi6026055; Dulebohn DP, 2006, J BIOL CHEM, V281, P28536, DOI 10.1074/jbc.M605137200; Ge ZY, 2010, MOL MICROBIOL, V78, P1159, DOI 10.1111/j.1365-2958.2010.07396.x; Ge ZY, 2009, MOL MICROBIOL, V74, P1083, DOI 10.1111/j.1365-2958.2009.06923.x; Hayes CS, 2010, FEBS LETT, V584, P413, DOI 10.1016/j.febslet.2009.11.023; Janssen BD, 2012, ADV PROTEIN CHEM STR, V86, P151, DOI 10.1016/B978-0-12-386497-0.00005-0; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 2008, ANNU REV MICROBIOL, V62, P133, DOI 10.1146/annurev.micro.62.081307.162948; Konno T, 2007, RNA, V13, P1723, DOI 10.1261/rna.604907; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Mehta P, 2006, RNA, V12, P2187, DOI 10.1261/rna.247706; Metzinger L, 2008, RNA, V14, P1761, DOI 10.1261/rna.1185808; Miller MR, 2011, RNA, V17, P1727, DOI 10.1261/rna.2821711; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Neubauer C, 2012, SCIENCE, V335, P1366, DOI 10.1126/science.1217039; Nonin-Lecomte S, 2009, EMBO REP, V10, P160, DOI 10.1038/embor.2008.243; Okan Nihal A., 2006, PLoS Pathogens, V2, P50; Okan NA, 2010, INFECT IMMUN, V78, P1284, DOI 10.1128/IAI.00976-09; Ramrath DJF, 2012, NATURE, V485, P526, DOI 10.1038/nature11006; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Sundermeier T, 2008, METHOD ENZYMOL, V447, P329, DOI 10.1016/S0076-6879(08)02217-9; Sundermeier TR, 2007, J BIOL CHEM, V282, P34779, DOI 10.1074/jbc.M707256200; Sundermeier TR, 2005, P NATL ACAD SCI USA, V102, P2316, DOI 10.1073/pnas.0409694102; Svetlanov A, 2012, MOL MICROBIOL, V85, P122, DOI 10.1111/j.1365-2958.2012.08093.x; Watts T, 2009, J MOL BIOL, V391, P275, DOI 10.1016/j.jmb.2009.06.037; Williams KP, 1999, EMBO J, V18, P5423, DOI 10.1093/emboj/18.19.5423; Wills NM, 2008, EMBO J, V27, P2533, DOI 10.1038/emboj.2008.170; Withey J, 1999, J BACTERIOL, V181, P2148, DOI 10.1128/JB.181.7.2148-2157.1999; Withey JH, 2003, ANNU REV MICROBIOL, V57, P101, DOI 10.1146/annurev.micro.57.030502.090945; Withey JH, 2002, CURR OPIN MICROBIOL, V5, P154, DOI 10.1016/S1369-5274(02)00299-0; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zheng XB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-361	41	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30527	30542		10.1074/jbc.M113.503896	http://dx.doi.org/10.1074/jbc.M113.503896			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986442	Green Published, hybrid			2022-12-25	WOS:000329868100055
J	Hsieh, PH; Huang, KC; Shih, HN				Hsieh, Pang-Hsin; Huang, Kuo-Chin; Shih, Hsin-Nung			Prosthetic Joint Infection in Patients with Rheumatoid Arthritis: An Outcome Analysis Compared with Controls	PLOS ONE			English	Article							TOTAL KNEE ARTHROPLASTY; TOTAL HIP-ARTHROPLASTY; RISK-FACTORS; ORTHOPEDIC-SURGERY; COMPLICATIONS; METHOTREXATE; REPLACEMENT; DEBRIDEMENT; PREVALENCE; COMPONENTS	Background: Patients with rheumatoid arthritis (RA) have been shown to have an increased susceptibility to the development of prosthetic joint infection (PJI) after hip or knee replacement. However, little information is available on the demographic data, outcome of treatment and prognostic factors in RA patients when compared to those in non-RA patients. Methods/Principal Findings: We performed a retrospective cohort analysis of all cases of PJI that were treated at our institution between 2002 and 2008. Of 346 episodes of PJI during the study period, 46 (13.3%) occurred in patients with RA. Compared to the non-RA cohort, RA patients with PJI were female predominant (74% vs 27%, p<0.001), younger (median age, 51 vs 63 years, p<0.001) and developed infection earlier (median joint age, 72 vs 128 days, p<0.001). The 2-year survival rate free of treatment failure was lower in RA patients with PJI episodes either treated with debridement (22% vs 52%, p = 0.002) or two-stage exchange (78% vs 95%, p = 0.004). A longer duration of symptoms before debridement surgery (median, 11 vs 5 days, p = 0.015), and absence of antibiotics in bone cement for two-stage exchange (relative risk, 8.0; p = 0.02) were associated with treatment failure in patients with RA. Discussion: The outcome of PJI in RA patients was generally worse than that in non-RA patients. Risk of treatment failure increased in the setting of delayed debridement and two-stage exchange without the use of antibiotic-impregnated bone cement. These findings highlight the importance of vigilant monitoring and aggressive treatment for PJI in RA patients.	[Hsieh, Pang-Hsin; Shih, Hsin-Nung] Chang Gung Mem Hosp, Dept Orthopaed, Tao Yuan, Taiwan; [Huang, Kuo-Chin] Chiayi Chang Gung Mem Hosp, Dept Orthopaed, Chiayi, Taiwan; [Hsieh, Pang-Hsin; Huang, Kuo-Chin; Shih, Hsin-Nung] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Huang, KC (corresponding author), Chiayi Chang Gung Mem Hosp, Dept Orthopaed, Chiayi, Taiwan.	kc2672@adm.cgmh.org.tw	HUANG, Kuo-Chin/S-7371-2019	HUANG, Kuo-Chin/0000-0002-3225-1504				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Berbari EF, 1998, CLIN INFECT DIS, V27, P1247, DOI 10.1086/514991; Berbari EF, 2006, CLIN INFECT DIS, V42, P216, DOI 10.1086/498507; Bongartz T, 2008, ARTHRIT RHEUM-ARTHR, V59, P1713, DOI 10.1002/art.24060; BURGER RR, 1991, CLIN ORTHOP RELAT R, P105; Chiu FY, 2001, J BONE JOINT SURG BR, V83B, P691, DOI 10.1302/0301-620X.83B5.11737; Crockarell JR, 1998, J BONE JOINT SURG AM, V80A, P1306, DOI 10.2106/00004623-199809000-00009; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524; Fisman DN, 2001, CLIN INFECT DIS, V32, P419, DOI 10.1086/318502; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Grennan DM, 2001, ANN RHEUM DIS, V60, P214, DOI 10.1136/ard.60.3.214; Haleem AA, 2004, CLIN ORTHOP RELAT R, P35, DOI 10.1097/01.blo.0000147713.64235.73; Hsieh PH, 2004, J BONE JOINT SURG AM, V86A, P1989, DOI 10.2106/00004623-200409000-00018; Huo MH, 2007, J BONE JOINT SURG AM, V89A, P1874, DOI 10.2106/JBJS.G.00509; Jamsen E, 2009, J BONE JOINT SURG AM, V91A, P38, DOI 10.2106/JBJS.G.01686; Kapetanovic MC, 2008, ANN RHEUM DIS, V67, P1412, DOI 10.1136/ard.2007.086710; Marculescu CE, 2006, CLIN INFECT DIS, V42, P471, DOI 10.1086/499234; MIRRA JM, 1976, CLIN ORTHOP RELAT R, P221; Sanchez-Sotelo J, 2009, CLIN ORTHOP RELAT R, V467, P219, DOI 10.1007/s11999-008-0480-4; SANY J, 1993, J RHEUMATOL, V20, P1129; Tattevin P, 1999, CLIN INFECT DIS, V29, P292, DOI 10.1086/520202; Trebse R, 2005, J BONE JOINT SURG BR, V87B, P249, DOI 10.1302/0301-620X.87B2.15618	22	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71666	10.1371/journal.pone.0071666	http://dx.doi.org/10.1371/journal.pone.0071666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23990969	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800013
J	Burford, A; Little, SE; Jury, A; Popov, S; Laxton, R; Doey, L; Al-Sarraj, S; Jurgensmeier, JM; Jones, C				Burford, Anna; Little, Suzanne E.; Jury, Alexa; Popov, Sergey; Laxton, Ross; Doey, Lawrence; Al-Sarraj, Safa; Juergensmeier, Juliane M.; Jones, Chris			Distinct Phenotypic Differences Associated with Differential Amplification of Receptor Tyrosine Kinase Genes at 4q12 in Glioblastoma	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; INTEGRATED GENOMIC ANALYSIS; VEIN ENDOTHELIAL-CELLS; HIGH-GRADE GLIOMA; GROWTH-FACTOR; IDH2 MUTATIONS; KIT; EXPRESSION; MULTIFORME; INHIBITORS	Gene amplification at chromosome 4q12 is a common alteration in human high grade gliomas including glioblastoma, a CNS tumour with consistently poor prognosis. This locus harbours the known oncogenes encoding the receptor tyrosine kinases PDGFRA, KIT, and VEGFR2. These receptors are potential targets for novel therapeutic intervention in these diseases, with expression noted in tumour cells and/or associated vasculature. Despite this, a detailed assessment of their relative contributions to different high grade glioma histologies and the underlying heterogeneity within glioblastoma has been lacking. We studied 342 primary high grade gliomas for individual gene amplification using specific FISH probes, as well as receptor expression in the tumour and endothelial cells by immunohistochemistry, and correlated our findings with specific tumour cell morphological types and patterns of vasculature. We identified amplicons which encompassed PDGFRA only, PDGFRA/KIT, and PDGFRA/KIT/VEGFR2, with distinct phenotypic correlates. Within glioblastoma specimens, PDGFRA amplification alone was linked to oligodendroglial, small cell and sarcomatous tumour cell morphologies, and rare MGMT promoter methylation. A younger age at diagnosis and better clinical outcome in glioblastoma patients is only seen when PDGFRA and KIT are co-amplified. IDH1 mutation was only found when all three genes are amplified; this is a subgroup which also harbours extensive MGMT promoter methylation. Whilst PDGFRA amplification was tightly linked to tumour expression of the receptor, this was not the case for KIT or VEGFR2. Thus we have identified differential patterns of gene amplification and expression of RTKs at the 4q12 locus to be associated with specific phenotypes which may reflect their distinct underlying mechanisms.	[Burford, Anna; Little, Suzanne E.; Jury, Alexa; Popov, Sergey; Jones, Chris] Inst Canc Res, Div Mol Pathol, Sutton, Surrey, England; [Burford, Anna; Little, Suzanne E.; Jury, Alexa; Popov, Sergey; Jones, Chris] Inst Canc Res, Sutton, Surrey, England; [Laxton, Ross; Doey, Lawrence; Al-Sarraj, Safa] Kings Coll Hosp London, London, England; [Juergensmeier, Juliane M.] Alderley Pk, AstraZeneca, Macclesfield, Cheshire, England	University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; King's College Hospital NHS Foundation Trust; King's College Hospital; AstraZeneca	Jones, C (corresponding author), Inst Canc Res, Div Mol Pathol, Sutton, Surrey, England.	chris.jones@icr.ac.uk	Juergensmeier, Juliane/I-4117-2013; Laxton, Ross C/G-1205-2010; Jones, Chris/ABE-6059-2021	Laxton, Ross C/0000-0002-3164-1201; Jones, Chris/0000-0001-8118-2296	AstraZeneca; NHS; Cancer Research UK [13982] Funding Source: researchfish	AstraZeneca(AstraZeneca); NHS; Cancer Research UK(Cancer Research UK)	CJ receives research grant funding from AstraZeneca. AB, SEL, AJ, SP and CJ acknowledge NHS funding to the Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROUDY VC, 1994, BLOOD, V83, P2145; Chamberlain MC, 2011, CLIN MED INSIGHTS-ON, V5, P117, DOI 10.4137/CMO.S7232; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dai YJ, 2010, EXPERT OPIN THER PAT, V20, P885, DOI 10.1517/13543776.2010.493559; De Carli E, 2009, NEW ENGL J MED, V360, P2248, DOI 10.1056/NEJMc090593; Demetri GD, 2011, SEMIN ONCOL, V38, pS10, DOI 10.1053/j.seminoncol.2011.01.018; Dietrich J, 2009, EXPERT OPIN INV DRUG, V18, P1549, DOI 10.1517/13543780903183528; Fischer I, 2005, BRAIN PATHOL, V15, P297; Hamel W, 2000, ACTA NEUROCHIR, V142, P113, DOI 10.1007/s007010050015; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; HERMANSON M, 1992, CANCER RES, V52, P3213; Holdhoff M, 2010, J NEURO-ONCOL, V97, P241, DOI 10.1007/s11060-009-0008-0; Joensuu H, 2005, J PATHOL, V207, P224, DOI 10.1002/path.1823; Laxton RC, PRIMARY GLIOBL UNPUB; Linkous AG, 2011, ANTI-CANCER AGENT ME, V11, P712; Little SE, 2012, CANCER RES, V72, P1614, DOI 10.1158/0008-5472.CAN-11-4069; LoRusso PM, 2008, EXPERT OPIN INV DRUG, V17, P1013, DOI [10.1517/13543784.17.7.1013, 10.1517/13543784.17.7.1013 ]; Martin-Broto J, 2010, CLIN TRANSL ONCOL, V12, P670, DOI 10.1007/s12094-010-0576-7; Matsui J, 2004, J BIOL CHEM, V279, P18600, DOI 10.1074/jbc.M311643200; Nobusawa S, 2011, NEUROPATHOLOGY, V31, P583, DOI 10.1111/j.1440-1789.2011.01204.x; Norden AD, 2009, NAT REV NEUROL, V5, P610, DOI 10.1038/nrneurol.2009.159; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Razis E, 2009, CLIN CANCER RES, V15, P6258, DOI 10.1158/1078-0432.CCR-08-1867; Sihto H, 2007, J PATHOL, V211, P481, DOI 10.1002/path.2125; Sihto H, 2009, HISTOPATHOLOGY, V55, P544, DOI 10.1111/j.1365-2559.2009.03418.x; Sleijfer S, 2008, NAT CLIN PRACT ONCOL, V5, P102, DOI 10.1038/ncponc1037; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wen PY, 2006, CLIN CANCER RES, V12, P4899, DOI 10.1158/1078-0432.CCR-06-0773	33	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71777	10.1371/journal.pone.0071777	http://dx.doi.org/10.1371/journal.pone.0071777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990986	gold, Green Submitted, Green Published			2022-12-25	WOS:000324470100054
J	Kendal, D; Hauser, CE; Garrard, GE; Jellinek, S; Giljohann, KM; Moore, JL				Kendal, Dave; Hauser, Cindy E.; Garrard, Georgia E.; Jellinek, Sacha; Giljohann, Katherine M.; Moore, Joslin L.			Quantifying Plant Colour and Colour Difference as Perceived by Humans Using Digital Images	PLOS ONE			English	Article							COVER; VEGETATION; VISION; TRAITS; DETECTABILITY; PROTOCOLS; DATABASE; SEARCH; MODEL	Human perception of plant leaf and flower colour can influence species management. Colour and colour contrast may influence the detectability of invasive or rare species during surveys. Quantitative, repeatable measures of plant colour are required for comparison across studies and generalisation across species. We present a standard method for measuring plant leaf and flower colour traits using images taken with digital cameras. We demonstrate the method by quantifying the colour of and colour difference between the flowers of eleven grassland species near Falls Creek, Australia, as part of an invasive species detection experiment. The reliability of the method was tested by measuring the leaf colour of five residential garden shrub species in Ballarat, Australia using five different types of digital camera. Flowers and leaves had overlapping but distinct colour distributions. Calculated colour differences corresponded well with qualitative comparisons. Estimates of proportional cover of yellow flowers identified using colour measurements correlated well with estimates obtained by measuring and counting individual flowers. Digital SLR and mirrorless cameras were superior to phone cameras and point-and-shoot cameras for producing reliable measurements, particularly under variable lighting conditions. The analysis of digital images taken with digital cameras is a practicable method for quantifying plant flower and leaf colour in the field or lab. Quantitative, repeatable measurements allow for comparisons between species and generalisations across species and studies. This allows plant colour to be related to human perception and preferences and, ultimately, species management.	[Kendal, Dave; Moore, Joslin L.] Royal Bot Gardens, Australian Res Ctr Urban Ecol, Melbourne, Vic, Australia; [Hauser, Cindy E.; Jellinek, Sacha; Giljohann, Katherine M.] Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia; [Garrard, Georgia E.] RMIT Univ, Sch Global Urban & Social Studies, Melbourne, Vic, Australia	University of Melbourne; Royal Melbourne Institute of Technology (RMIT)	Kendal, D (corresponding author), Royal Bot Gardens, Australian Res Ctr Urban Ecol, Melbourne, Vic, Australia.	dkendal@unimelb.edu.au	Moore, Joslin L/C-5270-2009; Moore, Joslin/AAE-3819-2020; Hauser, Cindy/B-4000-2008	Moore, Joslin L/0000-0001-9809-5092; Moore, Joslin/0000-0001-9809-5092; Hauser, Cindy/0000-0001-5876-0342; Giljohann, Katherine/0000-0003-1622-5821; Jellinek, Sacha/0000-0002-6779-8948; Baracco, Mauro/0000-0002-4911-6827; kendal, dave/0000-0003-2816-1722	Australian Research Council Linkage Project [LP 100100441]	Australian Research Council Linkage Project(Australian Research Council)	This project was funded by Australian Research Council Linkage Project LP 100100441. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; BORNSTEIN MH, 1973, PSYCHOL BULL, V80, P257, DOI 10.1037/h0034837; Chades I, 2008, P NATL ACAD SCI USA, V105, P13936, DOI 10.1073/pnas.0805265105; CHEN P, 1991, J AGR ENG RES, V49, P85, DOI 10.1016/0021-8634(91)80030-I; CHITTKA L, 1992, J COMP PHYSIOL A, V171, P171, DOI 10.1007/BF00188925; Clegg MT, 2000, P NATL ACAD SCI USA, V97, P7016, DOI 10.1073/pnas.97.13.7016; Conklin HC, 1955, SOUTHWEST J ANTHROP, V11, P339, DOI 10.1086/soutjanth.11.4.3628909; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; Dyer AG, 2012, P ROY SOC B-BIOL SCI, V279, P3606, DOI 10.1098/rspb.2012.0827; El Gamal A, 2005, IEEE CIRCUITS DEVICE, V21, P6, DOI 10.1109/MCD.2005.1438751; Emry DJ, 2011, J APPL ECOL, V48, P1391, DOI 10.1111/j.1365-2664.2011.02050.x; Field SA, 2005, WILDLIFE RES, V32, P253, DOI 10.1071/WR05010; Fonseca CR, 2000, J ECOL, V88, P964, DOI 10.1046/j.1365-2745.2000.00506.x; Garrard GE, 2008, AUSTRAL ECOL, V33, P986, DOI 10.1111/j.1442-9993.2008.01869.x; Garrard GE, 2013, METHODS ECOL EVOL, V4, P45, DOI 10.1111/j.2041-210x.2012.00257.x; GIMP Development Team, 2004, GIMP GNU IM MAN PROG; Gobster PH, 2007, LANDSCAPE ECOL, V22, P959, DOI 10.1007/s10980-007-9110-x; Grose MJ, 2012, BIOL CONSERV, V153, P159, DOI 10.1016/j.biocon.2012.05.008; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; Hauser CE, 2009, ECOL LETT, V12, P683, DOI 10.1111/j.1461-0248.2009.01323.x; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kaufman AJ, 2004, ACTA HORTIC, P229, DOI 10.17660/ActaHortic.2004.639.29; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kendal D, 2012, LANDSCAPE URBAN PLAN, V105, P34, DOI 10.1016/j.landurbplan.2011.11.023; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Laliberte AS, 2007, J ARID ENVIRON, V69, P1, DOI 10.1016/j.jaridenv.2006.08.016; Lauziere Y. B., 1999, Proceedings Vision Interface '99, P280; Leiper IA, 2009, CAN J REMOTE SENS, V35, P276, DOI 10.5589/m09-016; Liu YK, 2012, J VEG SCI, V23, P406, DOI 10.1111/j.1654-1103.2011.01373.x; Luscier JD, 2006, FRONT ECOL ENVIRON, V4, P408, DOI 10.1890/1540-9295(2006)4[408:UDPAOI]2.0.CO;2; Macfarlane C, 2012, METHODS ECOL EVOL, V3, P405, DOI 10.1111/j.2041-210X.2011.00151.x; Mattfeldt SD, 2009, BIOL CONSERV, V142, P720, DOI 10.1016/j.biocon.2008.12.002; McCamy C. S., 1976, Journal of Applied Photographic Engineering, V2, P95; MCDONNELL MJ, 1993, HUMANS COMPONENTS EC; MCLAREN K, 1976, J SOC DYERS COLOUR, V92, P338; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; Pascale D., 2006, RGB COORDINATES MACB; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; R Development Core Team, 2010, LANG ENV STAT COMP; RawTherapee Development Team, 2012, RAWTHERAPEE; Rout TM, 2009, J APPL ECOL, V46, P110, DOI 10.1111/j.1365-2664.2008.01586.x; Rubner Y, 2000, INT J COMPUT VISION, V40, P99, DOI 10.1023/A:1026543900054; Schmidt V, 2004, OIKOS, V106, P551, DOI 10.1111/j.0030-1299.2004.12769.x; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stevens VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011123; Thierry G, 2009, P NATL ACAD SCI USA, V106, P4567, DOI 10.1073/pnas.0811155106; Tkalcic M, 2003, IEEE REGION 8 EUROCON 2003, VOL A, PROCEEDINGS, P304; Villafuerte R, 1998, ECOL LETT, V1, P151; Xiaoming Yao, 2010, 2010 IEEE International Conference on Intelligent Computing and Intelligent Systems (ICIS 2010), P460, DOI 10.1109/ICICISYS.2010.5658601	53	48	50	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72296	10.1371/journal.pone.0072296	http://dx.doi.org/10.1371/journal.pone.0072296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977275	gold, Green Submitted, Green Published			2022-12-25	WOS:000324527300077
J	Drews, C				Drews, Carl			Using Wind Setdown and Storm Surge on Lake Erie to Calibrate the Air-Sea Drag Coefficient	PLOS ONE			English	Article							SURFACE; MODEL; FLUX	The air-sea drag coefficient controls the transfer of momentum from wind to water. In modeling storm surge, this coefficient is a crucial parameter for estimating the surge height. This study uses two strong wind events on Lake Erie to calibrate the drag coefficient using the Coupled Ocean Atmosphere Wave Sediment Transport (COAWST) modeling system and the the Regional Ocean Modeling System (ROMS). Simulated waves are generated on the lake with Simulating WAves Nearshore (SWAN). Wind setdown provides the opportunity to eliminate wave setup as a contributing factor, since waves are minimal at the upwind shore. The study finds that model results significantly underestimate wind setdown and storm surge when a typical open-ocean formulation without waves is used for the drag coefficient. The contribution of waves to wind setdown and storm surge is 34.7%. Scattered lake ice also increases the effective drag coefficient by a factor of 1.1.	Natl Ctr Atmospher Res, NCAR Earth Syst Lab, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	Drews, C (corresponding author), Natl Ctr Atmospher Res, NCAR Earth Syst Lab, POB 3000, Boulder, CO 80307 USA.	drews@ucar.edu		Drews, Carl/0000-0002-0535-6538	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	The NCAR Earth System Laboratory (NESL) at the National Center for Atmospheric Research provided computational support. NCAR is sponsored by the National Science Foundation. Any opinions, findings and conclusions or recommendations expressed in the publication are those of the author and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argonne National Laboratory Mathematics and Computer Science Division, 2012, MOD COUPL TOOLK; Canadian Ice Service Archive, 2010, ARCH DAT; DERECKI JA, 1976, WATER RESOUR RES, V12, P1144, DOI 10.1029/WR012i006p01144; Drews C, 2013, USING WIND SETDOWN S, DOI [10.5065/D6513W5Z, DOI 10.5065/D6513W5Z]; Drews C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012481; Geyer WR, 2007, COMMUNITY SEDIMENT T, P1; Gill AE, 1982, ATMOSPHERE OCEAN DYN; Great Lakes Information Network, 2010, LAK ER FACTS FIG; HEAPS NS, 1969, PHILOS TR R SOC S-A, V265, P93, DOI 10.1098/rsta.1969.0041; HEAPS NS, 1973, GEOPHYS J ROY ASTR S, V35, P99, DOI 10.1111/j.1365-246X.1973.tb02417.x; HERDENDORF CE, 1990, ESTUARIES, V13, P493, DOI 10.2307/1351795; Kumar N, 2012, OCEAN MODEL, V47, P65, DOI 10.1016/j.ocemod.2012.01.003; LARGE WG, 1981, J PHYS OCEANOGR, V11, P324, DOI 10.1175/1520-0485(1981)011<0324:OOMFMI>2.0.CO;2; Matlock M, 2006, ENCY EARTH; Mellor GL, 2008, J PHYS OCEANOGR, V38, P2587, DOI 10.1175/2008JPO3971.1; National Geophysical Data Center, 2010, GEODAS GRID TRANSL D; National Oceanic and Atmospheric Administration, 2010, TID CURR; National Oceanographic and Atmospheric Administration, 2010, NOAA NAT OP MOD ARCH; Oey LY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025873; Powell MD, 2003, NATURE, V422, P279, DOI 10.1038/nature01481; Richardson WS, 1986, LAKE ERIE WAVE HEIGH, P1; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Skamarock C., 2008, NCARTN475STR, DOI [10.5065/D68S4MVH, DOI 10.5065/D68S4MVH]; SMITH SD, 1988, J GEOPHYS RES-OCEANS, V93, P15467, DOI 10.1029/JC093iC12p15467; STEWART RH, 2005, INTRO PHYS OCEANOGRA; Trebitz AS, 2006, J GREAT LAKES RES, V32, P102, DOI 10.3394/0380-1330(2006)32[102:CSATDW]2.0.CO;2; Tseng YH, 2010, TERR ATMOS OCEAN SCI, V21, P85, DOI 10.3319/TAO.2009.06.08.02(IWNOP); Uchiyama Y, 2010, OCEAN MODEL, V34, P16, DOI 10.1016/j.ocemod.2010.04.002; Wang SY, 2008, OCEAN MODEL, V25, P83, DOI 10.1016/j.ocemod.2008.06.009; Warner JC, 2004, ESTUAR COAST SHELF S, V60, P213, DOI 10.1016/j.ecss.2003.12.011; Warner JC, 2010, OCEAN MODEL, V35, P230, DOI 10.1016/j.ocemod.2010.07.010; Weaver RJ, 2004, EFF WAV FORC STORM S; Weisberg RH, 2006, ESTUAR COAST, V29, P899, DOI 10.1007/BF02798649; Woods Hole Science Center, 2013, COAWST COUPL OC ATM	34	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72510	10.1371/journal.pone.0072510	http://dx.doi.org/10.1371/journal.pone.0072510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977309	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700175
J	Jia, Q; Zhang, Q; Zhang, ZJ; Wang, YQ; Zhang, WG; Zhou, Y; Wan, Y; Cheng, T; Zhu, XF; Fang, XD; Yuan, WP; Jia, HB				Jia, Qiong; Zhang, Qian; Zhang, Zhaojun; Wang, Yaqin; Zhang, Wanguang; Zhou, Yang; Wan, Yang; Cheng, Tao; Zhu, Xiaofan; Fang, Xiangdong; Yuan, Weiping; Jia, Haibo			Transcriptome Analysis of the Zebrafish Model of Diamond-Blackfan Anemia from RPS19 Deficiency via p53-Dependent and -Independent Pathways	PLOS ONE			English	Article							HEMATOPOIETIC-CELL MIGRATION; RIBOSOMAL-PROTEIN S19; DEVELOPMENTAL ABNORMALITIES; EMBRYONIC-DEVELOPMENT; ERYTHROPOIESIS; EXPRESSION; LEADS	Diamond-Blackfan anemia (DBA) is a rare inherited bone marrow failure syndrome that is characterized by pure red-cell aplasia and associated physical deformities. It has been proven that defects of ribosomal proteins can lead to this disease and that RPS19 is the most frequently mutated gene in DBA patients. Previous studies suggest that p53-dependent genes and pathways play important roles in RPS19-deficient embryos. However, whether there are other vital factors linked to DBA has not been fully clarified. In this study, we compared the whole genome RNA-Seq data of zebrafish embryos injected with RPS19 morpholino (RPS19 MO), RPS19 and p53 morpholino simultaneously (RPS19+p53 MO) and control morpholino (control). We found that genes enriched in the functions of hematological systems, nervous system development and skeletal and muscular disorders had significant differential expression in RPS19 MO embryos compared with controls. Co-inhibition of p53 partially alleviates the abnormalities for RPS19-deficient embryos. However, the hematopoietic genes, which were down-regulated significantly in RPS19 MO embryos, were not completely recovered by the co-inhibition of p53. Furthermore, we identified the genome-wide p53-dependent and -independent genes and pathways. These results indicate that not only p53 family members but also other factors have important impacts on RPS19-deficient embryos. The detection of potential pathogenic genes and pathways provides us a new paradigm for future research on DBA, which is a systematic and complex hereditary disease.	[Jia, Qiong; Wan, Yang; Jia, Haibo] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol,Ctr Human Genome Res, Wuhan 430074, Hubei, Peoples R China; [Zhang, Qian; Zhang, Zhaojun; Fang, Xiangdong] Chinese Acad Sci, CAS Key Lab Genome Sci, Beijing Inst Genom, Beijing, Peoples R China; [Wang, Yaqin; Wan, Yang; Cheng, Tao; Zhu, Xiaofan; Yuan, Weiping] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Wang, Yaqin; Wan, Yang; Cheng, Tao; Zhu, Xiaofan; Yuan, Weiping] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Wang, Yaqin; Wan, Yang; Cheng, Tao; Zhu, Xiaofan; Yuan, Weiping] Peking Union Med Coll, Tianjin, Peoples R China; [Zhang, Wanguang] Huazhong Univ Sci & Technol, Tongji Med Coll, Hepat Surg Ctr, Tongji Hosp, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Huazhong University of Science & Technology	Jia, Q (corresponding author), Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol,Ctr Human Genome Res, Wuhan 430074, Hubei, Peoples R China.	wpyuan@ihcams.ac.cn; haibo.jia@mail.hust.edu.cn	duan, chris/J-2484-2015; jia, qiong/HGD-3633-2022		Ministry of Science and Technology [2012CB966600, 2011AA020118, 2011CB964800]; NSFC [81090410, 81130074, 31171387, 31000640, 81170465]; National Key Scientific Instrument and Equipment Development Projects of China [23/35, 2011YQ03013404]; "Strategic Priority Research Program'' of the Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research [XDA01040405]; Hubei National Natural Science Foundation [2010CDB02402]; State Key Laboratory of Experimental Hematology Pilot Project [ZK12-05]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NSFC(National Natural Science Foundation of China (NSFC)); National Key Scientific Instrument and Equipment Development Projects of China; "Strategic Priority Research Program'' of the Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research; Hubei National Natural Science Foundation; State Key Laboratory of Experimental Hematology Pilot Project	This work was supported by the following funds from the Ministry of Science and Technology (2012CB966600, 2011AA020118, 2011CB964800); NSFC (81090410, 81130074, 31171387, 31000640, 81170465); the National Key Scientific Instrument 23/35 and Equipment Development Projects of China (2011YQ03013404); the "Strategic Priority Research Program'' of the Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research (XDA01040405); Hubei National Natural Science Foundation Grant 2010CDB02402 and State Key Laboratory of Experimental Hematology Pilot Project Grant ZK12-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns CJ, 2008, DEV DYNAM, V237, P1614, DOI 10.1002/dvdy.21565; Chakraborty A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004152; Danilova N, 2011, BRIT J HAEMATOL, V152, P217, DOI 10.1111/j.1365-2141.2010.08396.x; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Dianzani I, 2008, HAEMATOL-HEMATOL J, V93, P1601, DOI 10.3324/haematol.2008.000513; Duan J, 2011, INT J BIOCHEM CELL B, V43, P1218, DOI 10.1016/j.biocel.2011.04.015; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Gazda HT, 2006, BRIT J HAEMATOL, V135, P149, DOI 10.1111/j.1365-2141.2006.06268.x; Gomez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031658; Hegde A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001479; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Luis TC, 2010, EXP HEMATOL, V38, pS95; Mendt M, 2012, STEM CELLS DEV, V21, P2142, DOI 10.1089/scd.2011.0565; Poulain M, 2011, DEVELOPMENT, V138, P3557, DOI 10.1242/dev.055921; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Taylor AM, 2012, EXP HEMATOL, V40, P228, DOI [10.1016/j.exphem.2011.11.007, 10.1016/j.exphem.2011.11.007.]; Torihara H, 2011, BRIT J HAEMATOL, V152, P648, DOI 10.1111/j.1365-2141.2010.08535.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Uechi T, 2008, HUM MOL GENET, V17, P3204, DOI 10.1093/hmg/ddn216; Westerfield M, 1999, TRENDS GENET, V15, P248, DOI 10.1016/S0168-9525(99)01741-2; Zhang Y, 2013, DEV CELL, V24, P411, DOI 10.1016/j.devcel.2013.01.018	25	19	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71782	10.1371/journal.pone.0071782	http://dx.doi.org/10.1371/journal.pone.0071782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990987	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700098
J	Miralles, L; Lens, S; Rodriguez-Folgar, A; Carrillo, M; Martin, V; Mikkelsen, B; Garcia-Vazquez, E				Miralles, Laura; Lens, Santiago; Rodriguez-Folgar, Antonio; Carrillo, Manuel; Martin, Vidal; Mikkelsen, Bjarni; Garcia-Vazquez, Eva			Interspecific Introgression in Cetaceans: DNA Markers Reveal Post-F1 Status of a Pilot Whale	PLOS ONE			English	Article							BALAENOPTERA-MUSCULUS; POPULATION-STRUCTURE; B-PHYSALUS; BLUE WHALE; FIN WHALE; IDENTIFICATION; HYBRIDIZATION; SOFTWARE; HYBRIDS	Visual species identification of cetacean strandings is difficult, especially when dead specimens are degraded and/or species are morphologically similar. The two recognised pilot whale species (Globicephala melas and Globicephala macrorhynchus) are sympatric in the North Atlantic Ocean. These species are very similar in external appearance and their morphometric characteristics partially overlap; thus visual identification is not always reliable. Genetic species identification ensures correct identification of specimens. Here we have employed one mitochondrial (D-Loop region) and eight nuclear loci (microsatellites) as genetic markers to identify six stranded pilot whales found in Galicia (Northwest Spain), one of them of ambiguous phenotype. DNA analyses yielded positive amplification of all loci and enabled species identification. Nuclear microsatellite DNA genotypes revealed mixed ancestry for one individual, identified as a post-F1 interspecific hybrid employing two different Bayesian methods. From the mitochondrial sequence the maternal species was Globicephala melas. This is the first hybrid documented between Globicephala melas and G. macrorhynchus, and the first post-F1 hybrid genetically identified between cetaceans, revealing interspecific genetic introgression in marine mammals. We propose to add nuclear loci to genetic databases for cetacean species identification in order to detect hybrid individuals.	[Miralles, Laura; Garcia-Vazquez, Eva] Univ Oviedo, Dept Funct Biol, Oviedo, Asturias, Spain; [Lens, Santiago] Inst Espanol Oceanog, Vigo, Galicia, Spain; [Rodriguez-Folgar, Antonio] GREM MAR Dolphin Rescue & Res Grp Marine Mammals, Campelo Parroquia De San, Galicia, Spain; [Carrillo, Manuel] Canarias Conservac Cetacean Res Soc, San Cristobal la Laguna, Canary Islands, Spain; [Martin, Vidal] SECAC, Yaiza, Canary Islands, Spain; [Mikkelsen, Bjarni] Faroese Museum Nat Hist, Torshavn, Faroe Islands, Denmark	University of Oviedo; Spanish Institute of Oceanography	Miralles, L (corresponding author), Univ Oviedo, Dept Funct Biol, Oviedo, Asturias, Spain.	lml.miralles@gmail.com	Garcia-Vazquez, Eva/Y-7293-2019; Martin, Vidal/GLR-0396-2022	Garcia-Vazquez, Eva/0000-0002-8429-838X; Miralles, Laura/0000-0002-7146-9776	Asturias Regional Government [BP 10-004]	Asturias Regional Government(Principality of Asturias)	Laura Miralles holds a PCTI Grant from the Asturias Regional Government, referenced BP 10-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016670; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson EC, 2002, GENETICS, V160, P1217; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Berube M, 1998, MAR MAMMAL SCI, V14, P82, DOI 10.1111/j.1748-7692.1998.tb00692.x; Bloch Dorete, 1993, V14, P117; Dalebout ML, 1998, MOL ECOL, V7, P687, DOI 10.1046/j.1365-294x.1998.00380.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Estoup A, 1996, MOL MAR BIOL BIOTECH, V5, P295; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J., 2005, PHYLIP V 3 6; Fullard KJ, 2000, MOL ECOL, V9, P949, DOI 10.1046/j.1365-294x.2000.00957.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; ICES, 2010, WORK GROUP MAR MAMM; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; NORES C, 1988, MAMMALIA, V52, P51, DOI 10.1515/mamm.1988.52.1.51; Olson P., 2002, ENCY MARINE MAMMALS, V2 nd, P898; Oremus M, 2009, BIOL J LINN SOC, V98, P729, DOI 10.1111/j.1095-8312.2009.01325.x; Palumbi SR, 1998, J HERED, V89, P459; Pierce GJ, 2010, J MAR BIOL ASSOC UK, V90, P1547, DOI 10.1017/S0025315410000664; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ross HA, 2003, J HERED, V94, P111, DOI 10.1093/jhered/esg027; Sanz N, 2009, CONSERV GENET, V10, P225, DOI 10.1007/s10592-008-9550-0; SPILLIAERT R, 1991, J HERED, V82, P269, DOI 10.1093/oxfordjournals.jhered.a111085; SYLVESTRE J-P, 1985, Aquatic Mammals, V11, P101; Van Bree P. J. H., 1971, Beaufortia, V19, P79; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Willis PM, 2004, CAN J ZOOL, V82, P828, DOI 10.1139/Z04-059	32	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e69511	10.1371/journal.pone.0069511	http://dx.doi.org/10.1371/journal.pone.0069511			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990883	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700004
J	Yamin, AE; Boulanger, VM; Falb, KL; Shuma, J; Leaning, J				Yamin, Alicia Ely; Boulanger, Vanessa M.; Falb, Kathryn L.; Shuma, Jane; Leaning, Jennifer			Costs of Inaction on Maternal Mortality: Qualitative Evidence of the Impacts of Maternal Deaths on Living Children in Tanzania	PLOS ONE			English	Article							RISK-FACTORS; ORPHANED ADOLESCENTS; INFANT-MORTALITY; PARENTS DEATH; SEXUAL RISK; SURVIVAL; PREVALENCE	Background: Little is known about the interconnectedness of maternal deaths and impacts on children, beyond infants, or the mechanisms through which this interconnectedness is established. A study was conducted in rural Tanzania to provide qualitative insight regarding how maternal mortality affects index as well as other living children and to identify shared structural and social factors that foster high levels of maternal mortality and child vulnerabilities. Methods and Findings: Adult family members of women who died due to maternal causes (N = 45) and key stakeholders (N = 35) participated in in-depth interviews. Twelve focus group discussions were also conducted (N = 83) among community leaders in three rural regions of Tanzania. Findings highlight the widespread impact of a woman's death on her children's health, education, and economic status, and, by inference, the roles that women play within their families in rural Tanzanian communities. Conclusions: The full costs of failing to address preventable maternal mortality include intergenerational impacts on the nutritional status, health, and education of children, as well as the economic capacity of families. When setting priorities in a resource-poor, high maternal mortality country, such as Tanzania, the far-reaching effects that reducing maternal deaths can have on families and communities, as well as women's own lives, should be considered.	[Yamin, Alicia Ely; Leaning, Jennifer] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Yamin, Alicia Ely; Boulanger, Vanessa M.; Falb, Kathryn L.; Shuma, Jane] Harvard Univ, Program Hlth Rights Women & Children, Francois Xavier Bagnoud Ctr Hlth & Human Rights, Boston, MA 02115 USA; [Falb, Kathryn L.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Shuma, Jane] Harvard Univ, Francois Xavier Bagnoud Ctr Hlth & Human Rights, Program Hlth Rights Women & Children, Dar Es Salaam, Tanzania; [Leaning, Jennifer] Harvard Univ, Francois Xavier Bagnoud Ctr Hlth & Human Rights, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Yale University; Harvard University; Harvard University	Yamin, AE (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	ayamin@hsph.harvard.edu			John and Katie Hansen Family Foundation	John and Katie Hansen Family Foundation	This project has been conducted with support from The John and Katie Hansen Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson FWJ, 2007, MATERN CHILD HLTH J, V11, P395, DOI 10.1007/s10995-006-0173-0; Bhutta ZA, 2012, INT J GYNECOL OBSTET, V119, pS13, DOI 10.1016/j.ijgo.2012.04.001; Bicego G, 2003, SOC SCI MED, V56, P1235, DOI 10.1016/S0277-9536(02)00125-9; Bryant John H, 2009, Health Hum Rights, V11, P65; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Correll L, 2006, TANZ NAT PLAN ACT MO; Espo M, 2002, ACTA PAEDIATR, V91, P1364, DOI 10.1111/j.1651-2227.2002.tb02835.x; Evans R., 2010, EXPERIENCES PRIORITI EXPERIENCES PRIORITI; Galler JR, 2001, AMBULATORY CHILD HLT, V7, P85, DOI DOI 10.1046/J.1467-0658.2001.00109.X; Ibhawoh B., 2003, AFR J POLIT SCI, P59; Katz J, 2003, B WORLD HEALTH ORGAN, V81, P717; Kruk M E, 2008, TROP MED INT HEALTH, V13, P1; Larsen U, 2003, SOC SCI MED, V57, P1099, DOI 10.1016/S0277-9536(02)00488-4; Masmas TN, 2004, ACTA PAEDIATR, V93, P99, DOI 10.1080/08035250310007970; Ministry of Health, 2003, NAT HLTH POL; Ministry of Health and Social Welfare, 2013, NAT COST PLAN ACT MO; Mishra V, 2008, ORPHANS VULNERABLE C; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; Pembe Andrea B, 2008, Afr J Reprod Health, V12, P120; Presern C, 2013, INTERACTIVE EXPERT P; Rivers J, 2008, FOOD NUTR BULL, V29, P32, DOI 10.1177/156482650802900104; Robertson L, 2013, LANCET; Robertson L, 2010, AIDS CARE, V22, P927, DOI 10.1080/09540121003758622; Ronsmans C, 2010, LANCET, V375, P2024, DOI 10.1016/S0140-6736(10)60704-0; Shimamura Y, 2011, DYNAMICS ED ATTAINME; Ssewamala FM, 2010, AM J PUBLIC HEALTH, V100, P483, DOI 10.2105/AJPH.2008.158840; Stover J, 2010, MATERN CHILD HLTH J, V14, P687, DOI 10.1007/s10995-009-0505-y; Tanzania National Bureau of Statistics and ICF Macro, 2011, 2010 TANZ DEM HLTH S; Taylor L, 1996, Health Transit Rev, V6, P49; UNESCO, 2009, IMPL HIV AIDS WOM UN; Wakoli A B, 2012, East Afr J Public Health, V9, P132; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Weiner R, 2003, B WORLD HEALTH ORGAN, V81, P561; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Yamin AE, 2010, SUR, V7, P95; Yusuf HR, 2010, LANCET, V375, P1944, DOI 10.1016/S0140-6736(10)60899-9; Zeck W, 2006, J PERINAT MED, V34, P459, DOI 10.1515/JPM.2006.090; Zubrick SR, 2011, PSYCHOL MED, V41, P1971, DOI 10.1017/S0033291710002485	38	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71674	10.1371/journal.pone.0071674	http://dx.doi.org/10.1371/journal.pone.0071674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	205ER	23990971	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700082
J	Sanchez-Lite, A; Garcia, M; Domingo, R; Sebastian, MA				Sanchez-Lite, Alberto; Garcia, Manuel; Domingo, Rosario; Angel Sebastian, Miguel			Novel Ergonomic Postural Assessment Method (NERPA) Using Product-Process Computer Aided Engineering for Ergonomic Workplace Design	PLOS ONE			English	Article							MUSCULOSKELETAL SYMPTOMS; RISK-FACTORS; WORK; DISORDERS; QUALITY; INTERVENTION; SIMULATION; POSITION; TOOLS; WRIST	Background: Musculoskeletal disorders (MSDs) that result from poor ergonomic design are one of the occupational disorders of greatest concern in the industrial sector. A key advantage in the primary design phase is to focus on a method of assessment that detects and evaluates the potential risks experienced by the operative when faced with these types of physical injuries. The method of assessment will improve the process design identifying potential ergonomic improvements from various design alternatives or activities undertaken as part of the cycle of continuous improvement throughout the differing phases of the product life cycle. Methodology/Principal Findings: This paper presents a novel postural assessment method (NERPA) fit for product-process design, which was developed with the help of a digital human model together with a 3D CAD tool, which is widely used in the aeronautic and automotive industries. The power of 3D visualization and the possibility of studying the actual assembly sequence in a virtual environment can allow the functional performance of the parts to be addressed. Such tools can also provide us with an ergonomic workstation design, together with a competitive advantage in the assembly process. Conclusions: The method developed was used in the design of six production lines, studying 240 manual assembly operations and improving 21 of them. This study demonstrated the proposed method's usefulness and found statistically significant differences in the evaluations of the proposed method and the widely used Rapid Upper Limb Assessment (RULA) method.	[Sanchez-Lite, Alberto] Univ Valladolid, Dept Ciencias Mat & Ingn Met, Valladolid, Spain; [Garcia, Manuel; Domingo, Rosario; Angel Sebastian, Miguel] Univ Nacl Educ Distancia, Dept Mfg Engn, E-28040 Madrid, Spain	Universidad de Valladolid; Universidad Nacional de Educacion a Distancia (UNED)	Garcia, M (corresponding author), Univ Nacl Educ Distancia, Dept Mfg Engn, E-28040 Madrid, Spain.	mggarcia@ind.uned.es	Domingo, Rosario/B-8776-2016; Sebastián, Miguel A/A-6635-2009	Domingo, Rosario/0000-0002-3018-6809; Sebastian, Miguel A./0000-0003-3463-3255				Batish A, 2004, P 34 INT C COMP; Brodie D., 1997, P 29 ANN C HUM FACT, P45; Burgess-Limerick R, 2003, ISSUES ASS FORCE WEI; Calvo R, 2007, INT J FLEX MANUF SYS, V19, P247, DOI 10.1007/s10696-008-9037-9; Chaffin DB, 2007, HUM FACTOR ERGON MAN, V17, P475, DOI 10.1002/hfm.20087; Chang SW, 2007, HUM FACTORS ERGONOM, V17, P445, DOI 10.1002/hfm.20085; Chiasson ME, 2012, INT J IND ERGONOM, V42, P478, DOI 10.1016/j.ergon.2012.07.003; Choobineh A, 2004, APPL ERGON, V35, P493, DOI 10.1016/j.apergo.2004.01.008; Choobineh Alireza, 2007, Indian J Occup Environ Med, V11, P32, DOI 10.4103/0019-5278.32462; Dempsey PG, 2005, APPL ERGON, V36, P489, DOI 10.1016/j.apergo.2005.01.007; Drinkaus Phillip, 2003, Work, V21, P165; EKLUND JAE, 1995, APPL ERGON, V26, P15, DOI 10.1016/0003-6870(95)95747-N; Escobar C, 2006, THESIS AUBURN U MICH; GlaxoSmithKline, 2007, GSTAT 2 01 STAT AN S; Gomez MSD, 2007, 311 TP; Gonzalez BA, 2003, INT J IND ERGONOM, V31, P33, DOI 10.1016/S0169-8141(02)00116-6; International Organization for Standardization, 2006, 112262000COR12006 IS; International Organization for Standardization - ISO, 2000, 112262000 ISO SO; Ramirez FJ, 2013, J INTELL MANUF, V24, P457, DOI 10.1007/s10845-011-0575-8; JuulKristensen B, 1997, INT J IND ERGONOM, V19, P397, DOI 10.1016/S0169-8141(96)00013-3; Kelly G, 2009, WORK, V32, P321, DOI 10.3233/WOR-2009-0830; Kilroy N, 2000, BRIT J BIOMED SCI, V57, P199; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Kurillo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045341; Lin L, 2001, HUM FACTOR ERGON MAN, V11, P377, DOI 10.1002/hfm.1020; Maldonado AA, 2005, ERGONOMIC DIAGNOSIS; Massaccesi M, 2003, APPL ERGON, V34, P303, DOI 10.1016/S0003-6870(03)00052-8; MCATAMNEY L, 1993, APPL ERGON, V24, P91, DOI 10.1016/0003-6870(93)90080-S; McPhee B. J., 1987, P INT S WORK RELATED, P244; Ministry of Employment and Social Security, 2011, OBS SOC SEC PROF CON; Ministry of Employment and Social Security, 2011, YB SOC AFF LAB STAT; Oates S., 1998, Computers in the Schools, V14, P55, DOI 10.1300/J025v14n03_06; Occhipinti E, 1998, ERGONOMICS, V41, P1290, DOI 10.1080/001401398186315; Pascual SA, 2008, INT J OCCUP SAF ERGO, V14, P237, DOI 10.1080/10803548.2008.11076755; Pourmahabadian M., 2006, Pakistan Journal of Medical Sciences, V22, P379; Rouviere H, 2002, ANATOMISE HUMAINE DE, V3; Salvendy G, 2012, HUM FACTORS ERGON, pXIII; Sanchez-Lite A, 2012, KEY ENG MATER, V502, P121, DOI 10.4028/www.scientific.net/KEM.502.121; Shuval K, 2005, INT J IND ERGONOM, V35, P569, DOI 10.1016/j.ergon.2005.01.004; Spanish Association for Standardization and Rationalization-AENOR, 2007, 100552007 UNEEN; Spanish Association for Standardization and Rationalization-AENOR, 2009, 100542005A12009 AENO; WEISS ND, 1995, J BONE JOINT SURG AM, V77A, P1695, DOI 10.2106/00004623-199511000-00008; Werner R, 1997, CLIN BIOMECH, V12, P44, DOI 10.1016/S0268-0033(96)00044-7; Yeow PHP, 2006, INT J IND ERGONOM, V36, P367, DOI 10.1016/j.ergon.2005.12.008	45	28	28	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72703	10.1371/journal.pone.0072703	http://dx.doi.org/10.1371/journal.pone.0072703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	207BA	23977340	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200079
J	Tamari, F; Chen, FW; Li, CL; Chaudhari, J; Ioannou, YA				Tamari, Farshad; Chen, Fannie W.; Li, Chunlei; Chaudhari, Jagrutiben; Ioannou, Yiannis A.			PKC Activation in Niemann Pick C1 Cells Restores Subcellular Cholesterol Transport	PLOS ONE			English	Article							PROTEIN-KINASE-C; VIMENTIN INTERMEDIATE-FILAMENTS; PHORBOL ESTERS; LATE ENDOSOMES; PHOSPHORYLATION; EPSILON; EXPRESSION; ACID; ESTERIFICATION; CYTOSKELETON	Activation of protein kinase C (PKC) has previously been shown to ameliorate the cholesterol transport defect in Niemann Pick Type C1 (NPC1) cells, presumably by increasing the soluble levels of one of its substrates, vimentin. This activity would then restore the vimentin cycle in these cells and allow vimentin-dependent retrograde transport to proceed. Here, we further investigate the effects of PKC activation in NPC1 cells by evaluating different isoforms for their ability to solubilize vimentin and correct the NPC1 cholesterol storage phenotype. We also examine the effects of PKC activators, including free fatty acids and the PKC-specific activator diazoxide, on the NPC1 disease phenotype. Our results indicate that PKC isoforms alpha, beta II, and epsilon have the greatest effects on vimentin solubilization. Furthermore, expression or activation of PKC epsilon in NPC1 cells dramatically reduces the amount of stored cholesterol and restores cholesterol transport out of endocytic vesicles. These results provide further support for the contribution of PKCs in NPC1 disease pathogenesis and suggest that PKCs may be targeted in future efforts to develop therapeutics for NPC1 disease.	[Tamari, Farshad; Chen, Fannie W.; Li, Chunlei; Chaudhari, Jagrutiben; Ioannou, Yiannis A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Tamari, Farshad] Kingsborough Community Coll, Dept Biol Sci, Brooklyn, NY USA	Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System	Ioannou, YA (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA.	Yiannis.Ioannou@mssm.edu			National institutes of Health [R01DK082712]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082712] Funding Source: NIH RePORTER	National institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a grant from the National institutes of Health R01DK082712 to YAI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZZI A, 1992, EUR J BIOCHEM, V208, P547, DOI 10.1111/j.1432-1033.1992.tb17219.x; BERTRAND F, 1994, AM J PHYSIOL, V266, pC611, DOI 10.1152/ajpcell.1994.266.3.C611; BOLARD J, 1986, BIOCHIM BIOPHYS ACTA, V864, P257, DOI 10.1016/0304-4157(86)90002-X; Chen FW, 2005, BIOCHEM J, V390, P549, DOI 10.1042/BJ20050236; CloudHeflin BA, 1996, EUR J BIOCHEM, V239, P796, DOI 10.1111/j.1432-1033.1996.0796u.x; DISATNIK MH, 1994, EXP CELL RES, V210, P287, DOI 10.1006/excr.1994.1041; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Garver WS, 1999, BBA-MOL BASIS DIS, V1453, P193, DOI 10.1016/S0925-4439(98)00101-X; GOLDIN E, 1992, BIOCHIM BIOPHYS ACTA, V1127, P303, DOI 10.1016/0005-2760(92)90236-O; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; IOANNOU YA, 2004, LYSOSOMAL DISORDERS, P206; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Kanno T, 2006, J LIPID RES, V47, P1146, DOI 10.1194/jlr.M500329-JLR200; KHAN WA, 1993, J BIOL CHEM, V268, P5063; Kim MY, 2006, BRIT J PHARMACOL, V149, P1059, DOI 10.1038/sj.bjp.0706922; Klymkowsky MW, 1995, CURR TOP DEV BIOL, V31, P455; Leventhal AR, 2004, J BIOL CHEM, V279, P8084, DOI 10.1074/jbc.M310672200; MANGOURA D, 1995, DEV BRAIN RES, V87, P1, DOI 10.1016/0165-3806(95)00046-G; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Millard EE, 2000, J BIOL CHEM, V275, P38445, DOI 10.1074/jbc.M003180200; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; PENTCHEV PG, 1984, J BIOL CHEM, V259, P5784; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Puri V, 1999, NAT CELL BIOL, V1, P386, DOI 10.1038/14084; RodriguezLafrasse C, 1997, BIOCHEM J, V325, P787, DOI 10.1042/bj3250787; SARRIA AJ, 1992, J BIOL CHEM, V267, P19455; Shen WJ, 2012, ENDOCRINOLOGY, V153, P3249, DOI 10.1210/en.2012-1048; SPUDICH A, 1992, CELL MOTIL CYTOSKEL, V22, P250, DOI 10.1002/cm.970220405; Styers ML, 2005, TRAFFIC, V6, P359, DOI 10.1111/j.1600-0854.2005.00286.x; Szalay J, 2001, J HISTOCHEM CYTOCHEM, V49, P49, DOI 10.1177/002215540104900106; Tanaka A, 2003, BIOORG MED CHEM LETT, V13, P1037, DOI 10.1016/S0960-894X(03)00089-1; Toda M, 2012, J BIOL CHEM, V287, P24516, DOI 10.1074/jbc.M111.319624; Walter M, 2003, J LIPID RES, V44, P243, DOI 10.1194/jlr.M200230-JLR200; Walter M, 2009, BIOL CELL, V101, P141, DOI 10.1042/BC20070171	37	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e74169	10.1371/journal.pone.0074169	http://dx.doi.org/10.1371/journal.pone.0074169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977398	Green Published, gold			2022-12-25	WOS:000323378000123
J	Walter-Nuno, AB; Oliveira, MP; Oliveira, MF; Goncalves, RL; Ramos, IB; Koerich, LB; Oliveira, PL; Paiva-Silva, GO				Walter-Nuno, Ana Beatriz; Oliveira, Matheus P.; Oliveira, Marcus F.; Goncalves, Renata L.; Ramos, Isabela B.; Koerich, Leonardo B.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.			Silencing of Maternal Heme-binding Protein Causes Embryonic Mitochondrial Dysfunction and Impairs Embryogenesis in the Blood Sucking Insect Rhodnius prolixus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-REGULATED FUSION; BOOPHILUS-MICROPLUS; BLOODSUCKING INSECT; LIPID-PEROXIDATION; YOLK GRANULES; CATTLE TICK; DEGRADATION; BIOSYNTHESIS; EGG; TRAFFICKING	The heme molecule is the prosthetic group of many hemeproteins involved in essential physiological processes, such as electron transfer, transport of gases, signal transduction, and gene expression modulation. However, heme is a pro-oxidant molecule capable of propagating reactions leading to the generation of reactive oxygen species. The blood-feeding insect Rhodnius prolixus releases enormous amounts of heme during host blood digestion in the midgut lumen when it is exposed to a physiological oxidative challenge. Additionally, this organism produces a hemolymphatic heme-binding protein (RHBP) that transports heme to pericardial cells for detoxification and to growing oocytes for yolk granules and as a source of heme for embryo development. Here, we show that silencing of RHBP expression in female fat bodies reduced total RHBP circulating in the hemolymph, promoting oxidative damage to hemolymphatic proteins. Moreover, RHBP knockdown did not cause reduction in oviposition but led to the production of heme-depleted eggs (white eggs). A lack of RHBP did not alter oocyte fecundation. However, produced white eggs were nonviable. Embryo development cellularization and vitellin yolk protein degradation, processes that normally occur in early stages of embryogenesis, were compromised in white eggs. Total cytochrome c content, cytochrome c oxidase activity, citrate synthase activity, and oxygen consumption, parameters that indicate mitochondrial function, were significantly reduced in white eggs compared with normal dark red eggs. Our results showed that reduction of heme transport from females to growing oocytes by RHBP leads to embryonic mitochondrial dysfunction and impaired embryogenesis.	[Walter-Nuno, Ana Beatriz; Oliveira, Matheus P.; Oliveira, Marcus F.; Goncalves, Renata L.; Ramos, Isabela B.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.] Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil; [Koerich, Leonardo B.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, BR-21941590 Rio De Janeiro, Brazil; [Oliveira, Matheus P.; Oliveira, Marcus F.; Goncalves, Renata L.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Lab Inflamacao & Metab, BR-21941590 Rio De Janeiro, Brazil; [Walter-Nuno, Ana Beatriz; Koerich, Leonardo B.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.] Inst Nacl Ciencia & Tecnol Entomol Mol, BR-21941590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Paiva-Silva, GO (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med, CCS,Ilha Fundao, Sala 5,Bloco D Subsolo, BR-21941590 Rio De Janeiro, Brazil.	gosilva@bioqmed.ufrj.br	Oliveira, Marcus/G-3158-2011; Ramos, Isabela B/N-7091-2017; Koerich, Leonardo/J-7004-2014; L. Oliveira, Pedro/A-9438-2010	Oliveira, Marcus/0000-0002-9890-8425; Ramos, Isabela B/0000-0003-0874-7902; Koerich, Leonardo/0000-0002-5668-3934; Pinto De Oliveira, Matheus/0000-0002-2124-8799; L. Oliveira, Pedro/0000-0003-0307-354X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior; Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro; Howard Hughes Medical Institute	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior; Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior, Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro, and the Howard Hughes Medical Institute.	AFT RL, 1983, J BIOL CHEM, V258, P2069; AFT RL, 1984, J BIOL CHEM, V259, P301; Braz GRC, 2002, INSECT BIOCHEM MOLEC, V32, P361, DOI 10.1016/S0965-1748(01)00163-1; Braz GRC, 2001, INSECT BIOCHEM MOLEC, V31, P359, DOI 10.1016/S0965-1748(00)00129-6; Braz GRC, 1999, CURR BIOL, V9, P703, DOI 10.1016/S0960-9822(99)80312-1; CANTATORE P, 1974, CELL DIFFER DEV, V3, P45, DOI 10.1016/0045-6039(74)90039-6; Chen CY, 2012, J BIOL CHEM, V287, P9601, DOI 10.1074/jbc.M111.307694; Chen CY, 2011, CELL, V145, P720, DOI 10.1016/j.cell.2011.04.025; DANSAPETRETSKI M, 1995, J BIOL CHEM, V270, P10893, DOI 10.1074/jbc.270.18.10893; Duchen MR, 2008, CELL CALCIUM, V44, P1, DOI 10.1016/j.ceca.2008.02.001; Dumollard R, 2004, DEVELOPMENT, V131, P3057, DOI 10.1242/dev.01181; Dumollard R, 2006, SEMIN CELL DEV BIOL, V17, P314, DOI 10.1016/j.semcdb.2006.02.009; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; FRIEND WG, 1965, CAN J ZOOLOG, V43, P891, DOI 10.1139/z65-092; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; HANSEN CA, 1983, AM J PHYSIOL, V244, pR356, DOI 10.1152/ajpregu.1983.244.3.R356; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; KELLY GM, 1989, J MORPHOL, V199, P175, DOI 10.1002/jmor.1051990205; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Machado EA, 1998, ARCH INSECT BIOCHEM, V39, P133, DOI 10.1002/(SICI)1520-6327(1998)39:4&lt;133::AID-ARCH1&gt;3.0.CO;2-D; Maya-Monteiro CM, 2000, J BIOL CHEM, V275, P36584, DOI 10.1074/jbc.M007344200; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Miao YL, 2012, MOL REPROD DEV, V79, P742, DOI 10.1002/mrd.22078; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; OLIVEIRA PL, 1995, J BIOL CHEM, V270, P10897, DOI 10.1074/jbc.270.18.10897; OLIVEIRA PL, 1989, INSECT BIOCHEM, V19, P489; ORJIH AU, 1981, SCIENCE, V214, P667, DOI 10.1126/science.7027441; Paiva-Silva GO, 2006, P NATL ACAD SCI USA, V103, P8030, DOI 10.1073/pnas.0602224103; Paiva-Silva GO, 2002, INSECT BIOCHEM MOLEC, V32, P1533, DOI 10.1016/S0965-1748(02)00074-7; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Rafie-Kolpin M, 2000, J BIOL CHEM, V275, P5171, DOI 10.1074/jbc.275.7.5171; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Ramos IB, 2007, J EXP BIOL, V210, P138, DOI 10.1242/jeb.02652; Ramos IB, 2006, MOL REPROD DEV, V73, P1247, DOI 10.1002/mrd.20560; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; Severance S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001044; TAPPEL AL, 1955, J BIOL CHEM, V217, P721; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P8742, DOI 10.1073/pnas.90.18.8742; VINCENT SH, 1989, SEMIN HEMATOL, V26, P105; WHITE DC, 1963, J BACTERIOL, V85, P842, DOI 10.1128/JB.85.4.842-850.1963; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	53	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29323	29332		10.1074/jbc.M113.504985	http://dx.doi.org/10.1074/jbc.M113.504985			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23986441	Green Published, hybrid			2022-12-25	WOS:000330615300012
J	Orebaugh, CD; Fye, JM; Harvey, S; Hollis, T; Wilkinson, JC; Perrino, FW				Orebaugh, Clinton D.; Fye, Jason M.; Harvey, Scott; Hollis, Thomas; Wilkinson, John C.; Perrino, Fred W.			The TREX1 C-terminal Region Controls Cellular Localization through Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmune Diseases; DNA; DNA Enzymes; Nucleic Acid; Ubiquitination	AICARDI-GOUTIERES-SYNDROME; FAMILIAL CHILBLAIN LUPUS; DNA EXONUCLEASE TREX1; DOMINANT MUTATIONS; GENE; PROTEIN; DEGRADATION; IDENTIFICATION; ERYTHEMATOSUS; ENCEPHALITIS	TREX1 is an autonomous 3-exonuclease that degrades DNA to prevent inappropriate immune activation. The TREX1 protein is composed of 314 amino acids; the N-terminal 242 amino acids contain the catalytic domain, and the C-terminal region (CTR) localizes TREX1 to the cytosolic compartment. In this study, we show that TREX1 modification by ubiquitination is controlled by a highly conserved sequence in the CTR to affect cellular localization. Transfection of TREX1 deletion constructs into human cells demonstrated that this sequence is required for ubiquitination at multiple lysine residues through a non-canonical ubiquitin linkage. A proteomic approach identified ubiquilin 1 as a TREX1 CTR-interacting protein, and this interaction was verified in vitro and in vivo. Cotransfection studies indicated that ubiquilin 1 localizes TREX1 to cytosolic punctate structures dependent upon the TREX1 CTR and lysines within the TREX1 catalytic core. Several TREX1 mutants linked to the autoimmune diseases Aicardi-Goutieres syndrome and systemic lupus erythematosus that exhibit full catalytic function were tested for altered ubiquitin modification and cellular localization. Our data show that these catalytically competent disease-causing TREX1 mutants exhibit differential levels of ubiquitination relative to WT TREX1, suggesting a novel mechanism of dysfunction. Furthermore, these differentially ubiquitinated disease-causing mutants also exhibit altered ubiquilin 1 co-localization. Thus, TREX1 post-translational modification indicates an additional mechanism by which mutations disrupt TREX1 biology, leading to human autoimmune disease.	[Orebaugh, Clinton D.; Fye, Jason M.; Harvey, Scott; Hollis, Thomas; Wilkinson, John C.; Perrino, Fred W.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University	Perrino, FW (corresponding author), Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wakehealth.edu			National Institutes of Health [GM069962]; Alliance for Lupus Research [179222]; American Heart Association [10GRNT3650033]; American Cancer Society Research Scholar Award [RSG-09-166-01-CCG]; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; American Heart Association(American Heart Association); American Cancer Society Research Scholar Award(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069962 (to F. W. P.). This work was also supported by Alliance for Lupus Research Grant 179222 (to F. W. P.), American Heart Association Grant 10GRNT3650033 (to T. H.), and American Cancer Society Research Scholar Award RSG-09-166-01-CCG (to J. C. W.).	Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Beverly LJ, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1119167109; Biswas N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021153; BLACK DN, 1988, ANN NEUROL, V24, P483, DOI 10.1002/ana.410240402; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Crow YJ, 2003, J MED GENET, V40, P183, DOI 10.1136/jmg.40.3.183; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; de Vries B, 2010, ANN RHEUM DIS, V69, P1886, DOI 10.1136/ard.2009.114157; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Funakoshi M, 1999, EMBO J, V18, P5009, DOI 10.1093/emboj/18.18.5009; Fye JM, 2011, J BIOL CHEM, V286, P32373, DOI 10.1074/jbc.M111.276287; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao L, 2003, J VIROL, V77, P4149, DOI 10.1128/JVI.77.7.4149-4159.2003; Gruver AM, 2011, J NEURO-OPHTHALMOL, V31, P20, DOI 10.1097/WNO.0b013e3181f45dba; Gunther C, 2009, DERMATOLOGY, V219, P162, DOI 10.1159/000222430; Hasan M, 2013, NAT IMMUNOL, V14, P61, DOI 10.1038/ni.2475; Hedrich CM, 2008, CLIN RHEUMATOL, V27, P949, DOI 10.1007/s10067-008-0942-9; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Kavanagh D, 2008, CELL CYCLE, V7, P1718, DOI 10.4161/cc.7.12.6162; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Lee-Kirsch MA, 2006, AM J HUM GENET, V79, P731, DOI 10.1086/507848; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lewis EM, 2011, BIOCHEMISTRY-US, V50, P11084, DOI 10.1021/bi201483g; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Migliorini A, 2012, NAT REV NEPHROL, V8, P183, DOI 10.1038/nrneph.2011.197; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakayasu ES, 2013, J AM SOC MASS SPECTR, V24, P1214, DOI 10.1007/s13361-013-0619-8; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Orebaugh CD, 2011, J BIOL CHEM, V286, P40246, DOI 10.1074/jbc.M111.297903; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Poole BD, 2009, AUTOIMMUN REV, V8, P337, DOI 10.1016/j.autrev.2008.12.008; Prendiville JS, 2009, J AM ACAD DERMATOL, V61, P727, DOI 10.1016/j.jaad.2009.05.002; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773; Rekvig OP, 2006, ADV EXP MED BIOL, V577, P117; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Stam AH, 2009, CEPHALALGIA, V29, P1006, DOI 10.1111/j.1468-2982.2009.01940.x; Stephenson JBP, 2008, EUR J PAEDIATR NEURO, V12, P355, DOI 10.1016/j.ejpn.2007.11.010; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wilkinson JC, 2008, MOL CELL BIOL, V28, P237, DOI 10.1128/MCB.01065-07; Wu AL, 1999, MOL CELL, V4, P619, DOI 10.1016/S1097-2765(00)80212-9; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yan N, 2011, CURR OPIN IMMUNOL, V23, P21, DOI 10.1016/j.coi.2010.11.004; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029	68	22	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28881	28892		10.1074/jbc.M113.503391	http://dx.doi.org/10.1074/jbc.M113.503391			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23979357	Green Published, hybrid			2022-12-25	WOS:000330298800040
J	Sharma, A; Berga-Bolanos, R; Sultana, DA; Sen, JM				Sharma, Archna; Berga-Bolanos, Rosa; Sultana, Dil Afroz; Sen, Jyoti Misra			IL-4 and IL-4 Receptor Expression Is Dispensable for the Development and Function of Natural Killer T Cells	PLOS ONE			English	Article							NKT CELLS; IMMUNE-SYSTEM; TRANSCRIPTION; LINEAGE; DIFFERENTIATION; PROGRAM; INTERLEUKIN-4; ACTIVATION; ANTI-CD3; SUBSETS	CD4 T cells acquire functional properties including cytokine production upon antigenic stimulation through the T cell receptor (TCR) and differentiate into T helper (Th) cells. Th1 cells produce interferon (IFN)-gamma and Th2 cells produce interleukin (IL)-4. Th1 and 2 cells utilize IFN-gamma and IL-4 for further maturation and maintenance, respectively. Promyelocytic leukemia zinc finger (PLZF)-expressing invariant natural killer T (iNKT) cells develop in the thymus and acquire functional ability to produce IL-4 and IFN-gamma in the thymus in the absence of antigenic stimulation. In response to antigenic stimulation, iNKT cells rapidly produce IFN-gamma and IL-4. However, it is still unknown as to whether iNKT cells require these cytokines for maturation or survival in vivo. In this study, using IL-4- and IL-4 receptor-(IL-4R) deficient mice, we demonstrate that IL-4 as well as IL-4R expression is dispensable for the development, function and maintenance of iNKT cells.	[Sharma, Archna; Berga-Bolanos, Rosa; Sultana, Dil Afroz; Sen, Jyoti Misra] NIA, Immune Cells & Inflammat Sect, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sen, JM (corresponding author), NIA, Immune Cells & Inflammat Sect, NIH, Baltimore, MD 21224 USA.	Jyoti-Sen@nih.gov	Sharma, Archna/R-9377-2016	Sharma, Archna/0000-0003-4745-0220	National Institute on Aging at the National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000772, ZIAAG000774, ZIAAG000771] Funding Source: NIH RePORTER	National Institute on Aging at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institute on Aging at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Boesteanu A, 1997, J EXP MED, V186, P331, DOI 10.1084/jem.186.2.331; Chen HJ, 1997, J IMMUNOL, V159, P2240; Corthay A, 2006, SCAND J IMMUNOL, V64, P93, DOI 10.1111/j.1365-3083.2006.01782.x; Dickgreber N, 2012, J LEUKOCYTE BIOL, V92, P999, DOI 10.1189/jlb.0512242; Gapin L, 2008, NAT IMMUNOL, V9, P1009, DOI 10.1038/ni0908-1009; Glimcher LH, 2000, GENE DEV, V14, P1693; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hu TS, 2011, IMMUNOLOGY, V134, P1, DOI 10.1111/j.1365-2567.2011.03463.x; Hu TS, 2010, NAT IMMUNOL, V11, P435, DOI 10.1038/ni.1865; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2005, CURR OPIN IMMUNOL, V17, P122, DOI 10.1016/j.coi.2005.01.002; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Noben-Trauth N, 2002, EUR J IMMUNOL, V32, P1428, DOI 10.1002/1521-4141(200205)32:5<1428::AID-IMMU1428>3.0.CO;2-0; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Raberger J, 2008, P NATL ACAD SCI USA, V105, P17919, DOI 10.1073/pnas.0805733105; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Thomas SY, 2011, J EXP MED, V208, P1179, DOI 10.1084/jem.20102630; Wang ZY, 2006, J IMMUNOL, V176, P880, DOI 10.4049/jimmunol.176.2.880; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	29	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71872	10.1371/journal.pone.0071872	http://dx.doi.org/10.1371/journal.pone.0071872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23990998	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800022
J	Zhang, X; Mu, X; Huang, O; Xie, ZQ; Jiang, M; Geng, MY; Shen, KW				Zhang, Xi; Mu, Xin; Huang, Ou; Xie, Zuoquan; Jiang, Min; Geng, Meiyu; Shen, Kunwei			Luminal Breast Cancer Cell Lines Overexpressing ZNF703 Are Resistant to Tamoxifen through Activation of Akt/mTOR Signaling	PLOS ONE			English	Article							ESTROGEN-RECEPTOR STATUS; GROWTH-FACTOR; ENDOCRINE RESISTANCE; THERAPEUTIC TARGET; NEOADJUVANT TAMOXIFEN; PROGESTERONE-RECEPTOR; POSTMENOPAUSAL WOMEN; NEGATIVE PHENOTYPE; CROSS-TALK; PATHWAY	Background: Selective estrogen receptor modulators, such as tamoxifen, play a pivotal role in the treatment of luminal-type breast cancer. However, in clinical applications, nearly half of breast cancer patients are insensitive to tamoxifen, a small number of whom have early recurrence or disease progression when receiving tamoxifen. The underlying mechanism of this resistance has not been determined. ZNF703 is a novel oncogene in the 15% of breast cancers that harbor 8p12 amplifications. Therefore, the goal of our study was to explore the role of ZNF703 in tamoxifen resistance. Methodology/Principal Findings: We used immunohistochemistry techniques to examine ZNF703 expression in stage I-III primary breast cancer specimens and found a positive expression rate of 91.3%. All patients were divided into either high or low ZNF703 expression groups. We found that high ZNF703 expression mainly occurred in ER+ and PR+ breast cancers. Furthermore, 4-hydroxytamoxifen had different modes of action in breast cancer cell lines with high or low ZNF703 expression. ZNF703 overexpression in MCF-7 breast cancer cells activated the Akt/mTOR signaling pathway, downregulated ER alpha, and reduced the antitumor effect of tamoxifen. Low-dose tamoxifen did not suppress, but rather, stimulated the growth of cells overexpressing ZNF703. ZNF703 knockdown in MDA-MB-134 and HCC1500 luminal B-type breast cancer cell lines by siRNA significantly decreased survival rates when cells were treated with tamoxifen. Furthermore, targeting ZNF703 with a mTOR inhibitor increased the inhibitory effects of tamoxifen in ZNF703-overexpressing cells. Conclusion/Significance: Our study suggests that ZNF703 expression levels may predict tamoxifen sensitivity. Tamoxifen should be administered with caution to those patients bearing tumors with ZNF703 overexpression. However, large clinical trials and prospective clinical studies are needed to verify these results.	[Zhang, Xi; Huang, Ou; Jiang, Min; Shen, Kunwei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Comprehens Breast Hlth Ctr, Shanghai 200030, Peoples R China; [Mu, Xin] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Urol, Shanghai 200030, Peoples R China; [Xie, Zuoquan; Geng, Meiyu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 200031, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Geng, MY (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 200031, Peoples R China.	mygeng@mail.shcnc.ac.cn; kwshen@medmail.com.cn	zhang, xi/AAD-7224-2021	Zhang, Xi/0000-0002-8865-0045	National Science and Technology Major Project of the Ministry of Science and Technology of China [2012ZX09301001-007]; National Natural Science Foundation of China [81202087, 81202088]	National Science and Technology Major Project of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Science and Technology Major Project of the Ministry of Science and Technology of China (No. 2012ZX09301001-007 to MYG) and National Natural Science Foundation of China (No. 81202087, 81202088 to KWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Arpino G, 2004, CLIN CANCER RES, V10, P5670, DOI 10.1158/1078-0432.CCR-04-0110; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Bayliss J, 2007, CLIN CANCER RES, V13, P7029, DOI 10.1158/1078-0432.CCR-07-0587; Bazarov AV, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2873; Beaver JA, 2012, FUTURE ONCOL, V8, P651, DOI [10.2217/fon.12.49, 10.2217/FON.12.49]; Ben T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2904; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Bostner J, 2013, BREAST CANCER RES TR, V137, P397, DOI 10.1007/s10549-012-2376-y; Boulay A, 2005, CLIN CANCER RES, V11, P5319, DOI 10.1158/1078-0432.CCR-04-2402; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; Carroll JS, 2003, CANCER RES, V63, P4322; Cavazzoni A, 2012, CANCER LETT, V323, P77, DOI 10.1016/j.canlet.2012.03.034; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chia S, 2005, LANCET, V365, P1665, DOI 10.1016/S0140-6736(05)66524-5; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Cui XJ, 2005, J CLIN ONCOL, V23, P7721, DOI 10.1200/JCO.2005.09.004; Cui XJ, 2003, MOL ENDOCRINOL, V17, P575, DOI 10.1210/me.2002-0318; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dawson SJ, 2013, EMBO J, V32, P617, DOI 10.1038/emboj.2013.19; Denkert C, 2012, VIRCHOWS ARCH, V460, P251, DOI 10.1007/s00428-012-1204-4; Dixon JM, 2003, J STEROID BIOCHEM, V86, P295, DOI 10.1016/S0960-0760(03)00370-4; Dubsky P, 2013, ANN ONCOL, V24, P640, DOI 10.1093/annonc/mds334; Early Breast Cancer Trialists' Collaborative G., 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Eriksson N, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-53; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Giamas G, 2011, NAT MED, V17, P715, DOI 10.1038/nm.2351; Guo SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052380; Guo SQ, 2004, MOL CELL BIOL, V24, P8681, DOI 10.1128/MCB.24.19.8681-8690.2004; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Holland DG, 2011, EMBO MOL MED, V3, P167, DOI 10.1002/emmm.201100122; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Jeong H, 2012, HISTOPATHOLOGY, V60, pE87, DOI 10.1111/j.1365-2559.2012.04195.x; Jin K, 2012, P NATL ACAD SCI USA, V109, P2736, DOI 10.1073/pnas.1018859108; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kennecke H, 2008, CANCER-AM CANCER SOC, V112, P1437, DOI 10.1002/cncr.23320; Kirkegaard T, 2005, J PATHOL, V207, P139, DOI 10.1002/path.1829; Lange CA, 2011, ENDOCR-RELAT CANCER, V18, pC19, DOI 10.1530/ERC-11-0112; Levin ER, 2008, BREAST CANCER RES TR, V108, P351, DOI 10.1007/s10549-007-9618-4; Lopez-Tarruella S, 2007, CLIN CANCER RES, V13, P6921, DOI 10.1158/1078-0432.CCR-07-1399; Mauriac L, 2002, ANN ONCOL, V13, P293, DOI 10.1093/annonc/mdf037; Muller BM, 2012, J CLIN PATHOL, V65, P660, DOI 10.1136/jclinpath-2012-200716; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Noguchi S, 2013, BREAST CANC; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Pan X, 2011, NAT MED, V17, P708, DOI 10.1038/nm.2369; Ramaswamy B, 2012, CANCER RES, V72, P5048, DOI 10.1158/0008-5472.CAN-12-1248; Santen RJ, 2009, STEROIDS, V74, P586, DOI 10.1016/j.steroids.2008.11.020; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Schiff R, 2003, CLIN CANCER RES, V9, p447S; Shoman N, 2005, MODERN PATHOL, V18, P250, DOI 10.1038/modpathol.3800296; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Sircoulomb F, 2011, EMBO MOL MED, V3, P153, DOI 10.1002/emmm.201100121; Slorach EM, 2011, GENE DEV, V25, P471, DOI 10.1101/gad.1998111; Smith IE, 2005, J CLIN ONCOL, V23, P5108, DOI 10.1200/JCO.2005.04.005; Spellman P, 2011, NAT MED, V17, P422, DOI 10.1038/nm0411-422; Stebbing J, 2012, BREAST CANCER RES TR, V132, P537, DOI 10.1007/s10549-011-1622-z; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Vyhlidal C, 2000, J MOL ENDOCRINOL, V24, P329, DOI 10.1677/jme.0.0240329; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018	65	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72053	10.1371/journal.pone.0072053	http://dx.doi.org/10.1371/journal.pone.0072053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991038	Green Published, gold, Green Submitted			2022-12-25	WOS:000324228800040
J	Al-Husari, M; Webb, SD				Al-Husari, Maymona; Webb, Steven D.			Theoretical Predictions of Lactate and Hydrogen Ion Distributions in Tumours	PLOS ONE			English	Article							HUMAN-MELANOMA CELLS; INTRACELLULAR PH; EXTRACELLULAR PH; MATHEMATICAL-MODEL; BLOOD-FLOW; AMINO-ACID; CANCER; GROWTH; MICROENVIRONMENT; GLYCOLYSIS	High levels of lactate and H+-ions play an important role in the invasive and metastatic cascade of some tumours. We develop a mathematical model of cellular pH regulation focusing on the activity of the Na+/H+ exchanger (NHE) and the lactate/H+ symporter (MCT) to investigate the spatial correlations of extracellular lactate and H+-ions. We highlight a crucial role for blood vessel perfusion rates in determining the spatial correlation between these two cations. We also predict critical roles for blood lactate, the activity of the MCTs and NHEs on the direction of the cellular pH gradient in the tumour. We also incorporate experimentally determined heterogeneous distributions of the NHE and MCT transporters. We show that this can give rise to a higher intracellular pH and a lower intracellular lactate but does not affect the direction of the reversed cellular pH gradient or redistribution of protons away from the glycolytic source. On the other hand, including intercellular gap junction communication in our model can give rise to a reversed cellular pH gradient and can influence the levels of pH.	[Al-Husari, Maymona] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Webb, Steven D.] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, MRC Ctr Drug Safety Sci, Liverpool L69 3BX, Merseyside, England	University of Strathclyde; University of Liverpool	Webb, SD (corresponding author), Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, MRC Ctr Drug Safety Sci, Liverpool L69 3BX, Merseyside, England.	steven.webb@liverpool.ac.uk			EPSRC [EP/I010378/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I010378/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Al-Husari M, 2013, J THEOR BIOL, V322, P58, DOI 10.1016/j.jtbi.2013.01.007; ARONSON PS, 1985, ANNU REV PHYSIOL, V47, P545, DOI 10.1146/annurev.ph.47.030185.002553; Aubert A, 2005, P NATL ACAD SCI USA, V102, P16448, DOI 10.1073/pnas.0505427102; Berg J. M., 2003, BIOCHEMISTRY; Bertuzzi A, 2010, J THEOR BIOL, V262, P142, DOI 10.1016/j.jtbi.2009.09.024; Boldt J, 2001, ACTA ANAESTH SCAND, V45, P194, DOI 10.1034/j.1399-6576.2001.450210.x; BORON WF, 1985, J GEN PHYSIOL, V85, P325, DOI 10.1085/jgp.85.3.325; BORON WF, 1986, ANNU REV PHYSIOL, V48, P377; BOYER MJ, 1992, CANCER RES, V52, P4441; Brooks G. A., 1986, FED P, V45; Bunimovich-Mendrazitsky S, 2008, B MATH BIOL, V70, P2055, DOI 10.1007/s11538-008-9344-z; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; CASCIARI JJ, 1992, J CELL PHYSIOL, V151, P386, DOI 10.1002/jcp.1041510220; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Crone C, 1984, HDB PHYSL CRITICAL C, VIV, p[414, 434]; Dakubo GD, 2010, MITOCHONDRIAL GENETICS AND CANCER, P1, DOI 10.1007/978-3-642-11416-8; Fitzgerald RC, 1997, J CELL SCI, V110, P663; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 1996, CANCER RES, V56, P5745; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Gerisch A, 2008, J THEOR BIOL, V250, P684, DOI 10.1016/j.jtbi.2007.10.026; GILLIES R J, 1992, Cellular Physiology and Biochemistry, V2, P159, DOI 10.1159/000154638; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Grillon E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017416; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Henning T, 2004, ANTI-CANCER DRUG, V15, P7, DOI 10.1097/00001813-200401000-00002; HOCHACHKA PW, 1983, SCIENCE, V219, P1391, DOI 10.1126/science.6298937; Humez S, 2004, AM J PHYSIOL-CELL PH, V287, pC1733, DOI 10.1152/ajpcell.00578.2003; KAMINSKAS E, 1978, BIOCHEM J, V174, P453, DOI 10.1042/bj1740453; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; Lawrence E, 1989, GUIDE MODERN BIOL GE; Lide DR., 1994, HDB CHEM PHYS; Lodish H., 2008, MOL CELL BIOL, V6th ed.; MACKENZIE C, 1961, J BIOPHYS BIOCHEM CY, V9, P141, DOI 10.1083/jcb.9.1.141; Martin C, 2011, AM J PHYSIOL-CELL PH, V300, pC490, DOI 10.1152/ajpcell.00280.2010; Martin NK, 2010, J THEOR BIOL, V267, P454, DOI 10.1016/j.jtbi.2010.07.041; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; MCDERMOTT JC, 1993, MOL CELL BIOCHEM, V122, P113, DOI 10.1007/BF01076095; McDonald DM, 2002, CANCER RES, V62, P5381; Neville AA, 2003, THESIS U NOTTINGHAM; Nichol A, 2011, CRITICAL CARE, V15; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; Parkins CS, 1997, BRIT J CANCER, V75, P319, DOI 10.1038/bjc.1997.53; Porth CM, 1995, PATHOPHYSIOLOGY CONC; POUYSSEGUR J, 1985, FEBS LETT, V190, P115, DOI 10.1016/0014-5793(85)80439-7; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Provent P, 2007, CANCER RES, V67, P7638, DOI 10.1158/0008-5472.CAN-06-3459; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Quennet V, 2006, RADIOTHER ONCOL, V81, P130, DOI 10.1016/j.radonc.2006.08.012; Raghunand N, 2003, BRIT J RADIOL, V76, pS11, DOI 10.1259/bjr/12913493; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Romero MF, 2004, ADV PHYSIOL EDUC, V28, P135, DOI 10.1152/advan.00048.2004; SAUER LA, 1982, CANCER RES, V42, P4090; Schumer W., 1978, LACTATE ACUTE CONDIT, P1; SCHWICKERT G, 1995, CANCER RES, V55, P4757; Smallbone K, 2005, J THEOR BIOL, V235, P476, DOI 10.1016/j.jtbi.2005.02.001; Stock C, 2005, J PHYSIOL-LONDON, V567, P225, DOI 10.1113/jphysiol.2005.088344; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; TANNOCK IF, 1989, CANCER RES, V49, P4373; VAUPEL P, 1989, CANCER RES, V49, P6449; Vinnakota KC, 2011, BIOPHYS J, V100, P369, DOI 10.1016/j.bpj.2010.11.079; Wachsberger PR, 1997, INT J HYPERTHER, V13, P251, DOI 10.3109/02656739709023533; Walenta S, 2000, CANCER RES, V60, P916; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Webb SD, 1999, J THEOR BIOL, V196, P237, DOI 10.1006/jtbi.1998.0836; Webb SD, 1999, CLIN EXP METASTAS, V17, P397, DOI 10.1023/A:1006667303583; Zhang X, 2001, ANAL CHEM, V73, P3528, DOI 10.1021/ac0101104	71	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72020	10.1371/journal.pone.0072020	http://dx.doi.org/10.1371/journal.pone.0072020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991029	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100072
J	Foster, KA; Foster, G				Foster, Kristi A.; Foster, Greg			Demography and Population Dynamics of Massive Coral Communities in Adjacent High Latitude Regions (United Arab Emirates)	PLOS ONE			English	Article							LIFE-HISTORIES; CLIMATE-CHANGE; GULF DUBAI; REEF; MORTALITY; RECOVERY; MODEL; AGE; DISTURBANCE; INTENSITY	Individual massive coral colonies, primarily faviids and poritids, from three distinct assemblages within the southeastern Arabian Gulf and northwestern Gulf of Oman (United Arab Emirates) were studied from 2006-2009. Annual photographic censuses of approximately 2000 colonies were used to describe the demographics (size class frequencies, abundance, area cover) and population dynamics under "normal" environmental conditions. Size class transitions included growth, which occurred in 10-20% of the colonies, followed in decending order by partial mortality (3-16%), colony fission (<5%) and ramet fusion (<3%). Recruitment and whole colony mortality rates were low (<0.7 colonies/m(2)) with minimal interannual variation. Transition matrices indicated that the Arabian Gulf assemblages have declining growth rates (lambda<1) whereas the massive coral population is stable (lambda = 1) in the Gulf of Oman. Projection models indicated that (i) the Arabian Gulf population and area cover declines would be exacerbated under 10-year and 16-year disturbance scenarios as the vital rates do not allow for recovery to pre-disturbance levels during these timeframes, and (ii) the Gulf of Oman assemblage could return to its pre-disturbance area cover but its overall population size would not fully recover under the same scenarios.	[Foster, Kristi A.; Foster, Greg] Nova SE Univ, Oceanog Ctr, Dania, FL USA	Nova Southeastern University	Foster, KA (corresponding author), Nova SE Univ, Oceanog Ctr, Dania, FL USA.	kfoster@nova.edu			National Coral Reef Institute (NCRI) at Nova Southeastern University's Oceanographic Center; Dolphin Energy Ltd.; World Wide Fund for Nature - Emirates Wildlife Society (WWF-EWS)	National Coral Reef Institute (NCRI) at Nova Southeastern University's Oceanographic Center; Dolphin Energy Ltd.; World Wide Fund for Nature - Emirates Wildlife Society (WWF-EWS)	National Coral Reef Institute (NCRI) at Nova Southeastern University's Oceanographic Center provided funding to the authors for the duration of this study. Additionally, funding for this study was provided by Dolphin Energy Ltd., in association with the World Wide Fund for Nature - Emirates Wildlife Society (WWF-EWS), in 2006-2007 as part of a project called "Coral Reef Investgations in Abu Dhabi and Eastern Qatar", for which NCRI was the technical advisor. Field support including the use of boats, staff, research stations and other equipment was provided by NCRI, the Environmental Agency - Abu Dhabi (EAD), Dibba Marine Centre of the Ministry of Environment and Water, Dibba-Fujairah Municipality, Fujairah Municipality, and Fujairah Marina Club. The funders were involved in the study design as follows: 1) The "Coral Investigations" project began in 2005, a year prior to this study. NCRI and EAD had selected several of the Arabian Gulf monitoring station locations in 2005. The authors selected additional Arabian Gulf sites in 2006 and 2007 and all Gulf of Oman sites in 2006 with the approval of NCRI and the respective team members and agencies in Abu Dhabi, Dibba and Fujairah. 2) The configuration of the three belt transects which radiated from a central point and from which all photo mosaics were created was previously used by Dr. Bernhard Riegl of NCRI. This pattern was replicated throughout this study. All monitoring stations were physically installed by the authors and local team members. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. URLs for funders: http://www.nova.edu/ocean/ncri/index.html; http://www.dolphinenergy.com/; http://uae.panda.org/ews_wwf/who_we_are/.	Al-Hashmi A., 2012, INT J ENV SUSTAIN, V1, P12; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burt J, 2008, MAR BIOL, V154, P27, DOI 10.1007/s00227-007-0892-9; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Claereboudt MR, 2006, REEF CORALS CORAL RE; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Coles S.L., 2003, ATOLL RES B, V507, P497; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Foster KA, 2013, OPEN J MARI IN PRESS; Foster Kristi, 2012, P51; Foster KA, 2011, MAR BIOL, V158, P955, DOI 10.1007/s00227-010-1622-2; GOTELLI NJ, 1991, ECOLOGY, V72, P457, DOI 10.2307/2937187; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hood G.M., 2010, POPTOOLS VERSION 3 2; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; HUGHES TP, 1980, SCIENCE, V209, P713, DOI 10.1126/science.209.4457.713; KINZIE RA, 1973, B MAR SCI, V23, P93; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Linares C, 2007, ECOLOGY, V88, P918, DOI 10.1890/05-1931; Lirman D, 2003, ECOL MODEL, V161, P169, DOI 10.1016/S0304-3800(02)00346-0; MARQUIS E, 2009, HARMFUL ALGAL BLOOM; MCFADDEN CS, 1991, ECOLOGY, V72, P1849, DOI 10.2307/1940983; Mercado-Molina AE, 2011, J EXP MAR BIOL ECOL, V407, P355, DOI 10.1016/j.jembe.2011.07.018; Ninio R, 2000, MAR ECOL PROG SER, V194, P65, DOI 10.3354/meps194065; Owen-Smith N., 2007, INTRO MODELING WILDL; Perry CT, 2003, CORAL REEFS, V22, P427, DOI 10.1007/s00338-003-0330-5; Rezai Hamid, 2004, P155; Richlen ML, 2010, HARMFUL ALGAE, V9, P163, DOI 10.1016/j.hal.2009.08.013; Riegl B, 2003, CORAL REEFS, V22, P433, DOI 10.1007/s00338-003-0335-0; Riegl B, 2002, MAR BIOL, V140, P29, DOI 10.1007/s002270100676; Riegl B, 1999, CORAL REEFS, V18, P63, DOI 10.1007/s003380050156; Riegl B, 2013, ECOL EVOL, V3, P1050, DOI 10.1002/ece3.519; Riegl BM, 2009, ECOL MODEL, V220, P192, DOI 10.1016/j.ecolmodel.2008.09.022; RYLAARSDAM KW, 1983, MAR ECOL PROG SER, V13, P249, DOI 10.3354/meps013249; SAMMARCO PW, 1980, J EXP MAR BIOL ECOL, V45, P245, DOI 10.1016/0022-0981(80)90061-1; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; SHINN EA, 1976, ENVIRON GEOL, V1, P241, DOI 10.1007/BF02407510; Shriadah M.M.A., 2001, ACTA ADRIAT, V42, P93; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; Westerberg L, 2007, FRONTIERS ECOLOGY RE, P141	44	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71049	10.1371/journal.pone.0071049	http://dx.doi.org/10.1371/journal.pone.0071049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990923	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100036
J	Jones, P; Guillaud, L; Desbois, C; Benoist, JF; Combrisson, H; Dauger, S; Peters, MJ				Jones, Peter; Guillaud, Laurent; Desbois, Christophe; Benoist, Jean-Francois; Combrisson, Helene; Dauger, Stephane; Peters, Mark J.			Pathology Influences Blood Pressure Change following Vagal Stimulation in an Animal Intubation Model	PLOS ONE			English	Article							ENDOTRACHEAL INTUBATION; HEMORRHAGIC-SHOCK; CLINICAL-PRACTICE; BRADYCARDIA; PROPOFOL; CHILDREN; PLASMA	Purpose: The haemodynamic response to critical care intubation is influenced by the use of sedation and relaxant drugs and the activation of the vagal reflex. It has been hypothesized that different disease states may have a contrasting effect on the cardiovascular response to vagal stimulation. Our objective was to determine whether the blood pressure response to vagal stimulation was modified by endotoxaemia or hypovolaemia. Methods: New Zealand White rabbits were anaesthetised with urethane before tracheotomy. The exposed left Vagus nerve of randomised groups of control (n = 11), endotoxin (n = 11, 1 mg/kg), hypovolaemia 40% (n = 8) and hypovolaemia 20% (n = 8) rabbits were subjected to 10 Hz pulsed electrical stimulations of 25 s duration every 15 min. Haemodynamic parameters were recorded from a catheter in the right carotid artery connected to an iWorx monitor. Serum catecholamines were measured every 30 min using reverse-phase ion-pairing liquid chromatography. The change in blood pressure after vagal stimulation was compared to controls for one hour after the first death in the experimental groups. Results: 29% of the rabbits died in the hypovolaemia 40% group and 27% in the endotoxin group. One rabbit died in the hypovolaemia 40% group before vagal stimulation and was excluded. Following electrical stimulation of the Vagus nerve there was a fall in blood pressure in control rabbits. Blood pressure was conserved in the hypovolaemic rabbits compared to controls (p<0.01). For the endotoxaemic rabbits, there was a non-significant trend for the mean blood pressure to decrease more than the controls. Serum catecholamines were significantly raised in both the hypovolaemic and endotoxaemic rabbits. Conclusions: Pathology may contribute to modifications in blood pressure when vagal activation occurs. Patients who are either already vasoconstricted, or not vasoplegic, may be less at risk from intubation-related vagally mediated reductions in blood pressure than those with vasodilatory pathologies.	[Jones, Peter; Peters, Mark J.] UCL, Inst Child Hlth, Portex Unit, Crit Care Grp, London WC1E 6BT, England; [Jones, Peter; Benoist, Jean-Francois; Dauger, Stephane] Hop Robert Debre, Assistance Publ Hop Paris, F-75019 Paris, France; [Guillaud, Laurent; Desbois, Christophe; Combrisson, Helene] Ecole Natl Vet Alfort, Maisons Alfort, France; [Dauger, Stephane] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Ecole Nationale Veterinaire d'Alfort (ENVA); UDICE-French Research Universities; Universite Paris Cite	Jones, P (corresponding author), UCL, Inst Child Hlth, Portex Unit, Crit Care Grp, London WC1E 6BT, England.	sejjprj@live.ucl.ac.uk	Peters, Mark/AAD-7518-2019; Dauger, Stéphane/AAX-9669-2021	Peters, Mark/0000-0003-3653-4808; 	University College London Graduate Student fund	University College London Graduate Student fund	Funding was received from the University College London Graduate Student fund to pay for the experimental animals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRIOT P, 1987, INTENS CARE MED, V13, P203; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Candito M, 2002, ANN BIOL CLIN-PARIS, V60, P15; Carroll CL, 2010, PEDIATR CRIT CARE ME, V11, P343, DOI 10.1097/PCC.0b013e3181c51426; CARRUBA MO, 1987, EUR J PHARMACOL, V134, P15, DOI 10.1016/0014-2999(87)90126-9; Chow LTC, 2001, ANAT RECORD, V264, P169, DOI 10.1002/ar.1158; Council NR, 1996, GUIDE SOINS UTILISAT, P31; Fastle RK, 2004, PEDIATR EMERG CARE, V20, P651, DOI 10.1097/01.pec.0000142947.35394.81; FELTES TF, 1994, CRIT CARE MED, V22, P1647, DOI 10.1097/00003246-199422100-00022; Fox JG, 2002, LAB ANIMAL MED, P335; HEWITT CD, 1989, CLIN CHEM, V35, P1777; Jaber S, 2006, CRIT CARE MED, V34, P2355, DOI 10.1097/01.CCM.0000233879.58720.87; Jardin F, 1999, CHEST, V116, P1354, DOI 10.1378/chest.116.5.1354; Jones P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057478; Jones P, 2012, ARCH DIS CHILD, V97, P139, DOI 10.1136/adc.2010.210518; LABORIT H C B, 1981, Agressologie, V22, P63; LAKE CR, 1976, LIFE SCI, V18, P1315, DOI 10.1016/0024-3205(76)90210-1; LEIGH MD, 1957, ANESTHESIOLOGY, V18, P698, DOI 10.1097/00000542-195709000-00004; LITTLE RA, 1970, J PHYSIOL-LONDON, V208, P485, DOI 10.1113/jphysiol.1970.sp009133; Lobo SM, 2009, MED SCI MONITOR, V15, pBR37; MARSHALL TA, 1984, CRIT CARE MED, V12, P501, DOI 10.1097/00003246-198406000-00006; Oei J, 2002, J PAEDIATR CHILD H, V38, P146, DOI 10.1046/j.1440-1754.2002.00726.x; Rang D, 1991, PHARMACOLOGY, P184; Remick DG, 2005, SHOCK, V24, P7, DOI 10.1097/01.shk.0000191384.34066.85; Riou B, 2004, HEMODYNAMIQUE COURS, P3; Robinson BJ, 1997, ANESTHESIOLOGY, V86, P64, DOI 10.1097/00000542-199701000-00010; RONNING G, 1995, EUR J SURG, V161, P387; SCHADT JC, 1991, AM J PHYSIOL, V260, pH305; Steur RJ, 2004, PEDIATR ANESTH, V14, P462, DOI 10.1111/j.1460-9592.2004.01238.x; Tirel O, 2005, ANAESTHESIA, V60, P982, DOI 10.1111/j.1365-2044.2005.04298.x; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; VANLAMBALGEN AA, 1984, CARDIOVASC RES, V18, P195, DOI 10.1093/cvr/18.4.195; WATSON JD, 1988, RES EXP MED, V188, P319, DOI 10.1007/BF01851200; Zhang YH, 2009, CIRC-HEART FAIL, V2, P692, DOI 10.1161/CIRCHEARTFAILURE.109.873968	34	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e69957	10.1371/journal.pone.0069957	http://dx.doi.org/10.1371/journal.pone.0069957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990892	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100017
J	Sastre, E; Caracuel, L; Xavier, FE; Balfagon, G; Blanco-Rivero, J				Sastre, Esther; Caracuel, Laura; Xavier, Fabiano E.; Balfagon, Gloria; Blanco-Rivero, Javier			Opposite Effect of Mast Cell Stabilizers Ketotifen and Tranilast on the Vasoconstrictor Response to Electrical Field Stimulation in Rat Mesenteric Artery	PLOS ONE			English	Article							NITRIC-OXIDE RELEASE; INHIBITS CONTRACTION; ANTIALLERGIC DRUG; INCREASES; ENDOTHELIUM; INVOLVEMENT; SUPEROXIDE; EXPRESSION; GENERATION; NERVES	Objectives: We analyzed whether mast cell stabilization by either ketotifen or tranilast could alter either sympathetic or nitrergic innervation function in rat mesenteric arteries. Methods: Electrical field stimulation (EFS)-induced contraction was analyzed in mesenteric segments from 6-month-old Wistar rats in three experimental groups: control, 3-hour ketotifen incubated (0.1 alpha mol/L), and 3-hour tranilast incubated (0.1 mmol/L). To assess the possible participation of nitrergic or sympathetic innervation, EFS contraction was analyzed in the presence of non-selective nitric oxide synthase (NOS) inhibitor L-NAME (0.1 mmol/L), alpha-adrenergic receptor antagonist phentolamine (0.1 mu mol/L), or the neurotoxin 6-hydroxydopamine (6-OHDA, 1.46 mmol/L). Nitric oxide (NO) and superoxide anion (O-2(-)) levels were measured, as were vasomotor responses to noradrenaline (NA) and to NO donor DEA-NO, in the presence and absence of 0.1 mmol/L tempol. Phosphorylated neuronal NOS (P-nNOS) expression was also analyzed. Results: EFS-induced contraction was increased by ketotifen and decreased by tranilast. L-NAME increased the vasoconstrictor response to EFS only in control segments. The vasodilator response to DEA-NO was higher in ketotifen- and tranilast-incubated segments, while tempol increased vasodilator response to DEA-NO only in control segments. Both NO and O-2(-) release, and P-nNOS expression were diminished by ketotifen and by tranilast treatment. The decrease in EFS-induced contraction produced by phentolamine was lower in tranilast-incubated segments. NA vasomotor response was decreased only by tranilast. The remnant vasoconstriction observed in control and ketotifen-incubated segments was abolished by 6-OHDA. Conclusion: While both ketotifen and tranilast diminish nitrergic innervation function, only tranilast diminishes sympathetic innnervation function, thus they alter the vasoconstrictor response to EFS in opposing manners.	[Sastre, Esther; Caracuel, Laura; Balfagon, Gloria; Blanco-Rivero, Javier] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [Sastre, Esther; Caracuel, Laura; Balfagon, Gloria; Blanco-Rivero, Javier] Inst Invest Paz IdIPaz, Madrid, Spain; [Xavier, Fabiano E.] Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Fisiol & Farmacol, Recife, PE, Brazil	Autonomous University of Madrid; Universidade Federal de Pernambuco	Blanco-Rivero, J (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.	javier.blanco@uam.es	Blanco-Rivero, Javier/J-6118-2014; Xavier, Fabiano Elias/G-1253-2012; Rivero, Javier Blanco/ABE-8749-2020; Xavier, Fabiano/G-1253-2012	Blanco-Rivero, Javier/0000-0001-7232-2314; Xavier, Fabiano Elias/0000-0003-2028-2562; Rivero, Javier Blanco/0000-0001-7232-2314; Xavier, Fabiano/0000-0002-1387-8491; Balfagon Calvo, Gloria/0000-0001-9477-7950	Ministerio de Ciencia e Innovacion [SAF2009-10374]; Ministerio de Economia y Competitividad [SAF2012-38530]; Fundacion Mapfre; FPI-UAM fellowship; Alianza 4 Universidades Program	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad(Spanish Government); Fundacion Mapfre; FPI-UAM fellowship; Alianza 4 Universidades Program	This work was supported by grants from Ministerio de Ciencia e Innovacion (SAF2009-10374), Ministerio de Economia y Competitividad (SAF2012-38530) and Fundacion Mapfre. E. Sastre received a FPI-UAM fellowship. L. Caracuel received a fellowship from Alianza 4 Universidades Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer O, 2000, NEWS PHYSIOL SCI, V15, P213, DOI 10.1152/physiologyonline.2000.15.5.213; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bischoff SC, 2006, ADV EXP MED BIOL, V579, P177; Bischoff SC, 2009, SEMIN IMMUNOPATHOL, V31, P185, DOI 10.1007/s00281-009-0165-4; Blanco-Rivero J, 2013, J HYPERTENS, V31, P916, DOI 10.1097/HJH.0b013e32835f749c; Blanco-Rivero J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053802; Blanco-Rivero J, 2011, CLIN SCI, V121, P331, DOI 10.1042/CS20110072; Blanco-Rivero J, 2011, BRIT J PHARMACOL, V162, P271, DOI 10.1111/j.1476-5381.2010.01030.x; Boeckxstaens GE, 1997, COMP BIOCHEM PHYS A, V118, P925, DOI 10.1016/S0300-9629(97)00022-4; Bugajski AJ, 1995, J PHYSIOL PHARMACOL, V46, P513; Cahill PA, 2001, PHARMACOL THERAPEUT, V89, P273, DOI 10.1016/S0163-7258(01)00128-0; De Giorgio R, 2008, GUT, V57, P5, DOI 10.1136/gut.2007.131870; FUKUISHI N, 1995, JPN J PHARMACOL, V68, P449, DOI 10.1254/jjp.68.449; GOLDHILL JM, 1995, J PHARMACOL EXP THER, V274, P72; Heyman SN, 1997, BRIT J PHARMACOL, V120, P1545, DOI 10.1038/sj.bjp.0701063; Ihara T, 1997, EUR J PHARMACOL, V329, P43, DOI 10.1016/S0014-2999(97)10087-5; Ishibashi S, 1997, ATHEROSCLEROSIS, V130, P113, DOI 10.1016/S0021-9150(96)06053-4; Jain NK, 2001, EUR J PHARMACOL, V423, P85, DOI 10.1016/S0014-2999(01)01083-4; Jin D, 1998, EUR J PHARMACOL, V361, P199, DOI 10.1016/S0014-2999(98)00740-7; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Konneh M, 1998, IDrugs, V1, P141; Lambiase A, 2009, CURR OPIN ALLERGY CL, V9, P454, DOI 10.1097/ACI.0b013e3283303ebb; LI YJ, 1992, EUR J PHARMACOL, V210, P23, DOI 10.1016/0014-2999(92)90647-M; Loesch A, 2002, HISTOL HISTOPATHOL, V17, P591, DOI 10.14670/HH-17.591; Marin J, 1998, BRIT J PHARMACOL, V124, P473, DOI 10.1038/sj.bjp.0701856; MIYACHI Y, 1987, J PHARMACOBIO-DYNAM, V10, P255, DOI 10.1248/bpb1978.10.255; Miyazawa K, 1996, ATHEROSCLEROSIS, V121, P167, DOI 10.1016/0021-9150(95)05709-9; Morrey C, 2010, J PHARMACOL EXP THER, V335, P76, DOI 10.1124/jpet.110.172262; NAGAI H, 1991, J PHARMACOBIO-DYNAM, V14, P309, DOI 10.1248/bpb1978.14.309; NIELSEN KC, 1971, BRAIN RES, V27, P33, DOI 10.1016/0006-8993(71)90370-2; Pae HO, 2008, BIOCHEM BIOPH RES CO, V371, P361, DOI 10.1016/j.bbrc.2008.04.054; Sastre E, 2012, CLIN SCI, V122, P337, DOI 10.1042/CS20110303; Sastre E, 2010, REV NEUROLOGIA, V50, P727, DOI 10.33588/rn.5012.2010334; Schwarzer G, 2004, COCHRANE DB SYST REV; Takala J, 1996, BRIT J ANAESTH, V77, P50, DOI 10.1093/bja/77.1.50; Van Nassauw L, 2007, AUTON NEUROSCI-BASIC, V133, P91, DOI 10.1016/j.autneu.2006.10.003; Vural KM, 1999, EUR J CARDIO-THORAC, V16, P150, DOI 10.1016/S1010-7940(99)00128-1; Xavier FE, 2011, EUR J PHARMACOL, V654, P280, DOI 10.1016/j.ejphar.2011.01.007; Xavier FE, 2004, J HYPERTENS, V22, P949, DOI 10.1097/00004872-200405000-00017; Zaza Stephane, 2005, Nephrol Ther, V1, P174, DOI 10.1016/j.nephro.2005.03.002	40	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e73232	10.1371/journal.pone.0073232	http://dx.doi.org/10.1371/journal.pone.0073232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977380	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300106
J	Torta, DME; Legrain, V; Algoet, M; Olivier, E; Duque, J; Mouraux, A				Torta, Diana M. E.; Legrain, Valery; Algoet, Maxime; Olivier, Etienne; Duque, Julie; Mouraux, Andre			Theta Burst Stimulation Applied over Primary Motor and Somatosensory Cortices Produces Analgesia Unrelated to the Changes in Nociceptive Event-Related Potentials	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; LASER-EVOKED POTENTIALS; CHRONIC NEUROPATHIC PAIN; A-DELTA-FIBER; EEG RESPONSES; CEREBRAL POTENTIALS; BASIC PRINCIPLES; CORTEX; PERCEPTION; HUMANS	Continuous theta burst stimulation (cTBS) applied over the primary motor cortex (M1) can alleviate pain although the neural basis of this effect remains largely unknown. Besides, the primary somatosensory cortex (S1) is thought to play a pivotal role in the sensori-discriminative aspects of pain perception but the analgesic effect of cTBS applied over S1 remains controversial. To investigate cTBS-induced analgesia we characterized, in two separate experiments, the effect of cTBS applied either over M1 or S1 on the event-related brain potentials (ERPs) and perception elicited by nociceptive (CO2 laser stimulation) and non-nociceptive (transcutaneous electrical stimulation) somatosensory stimuli. All stimuli were delivered to the ipsilateral and contralateral hand. We found that both cTBS applied over M1 and cTBS applied over S1 significantly reduced the percept elicited by nociceptive stimuli delivered to the contralateral hand as compared to similar stimulation of the ipsilateral hand. In contrast, cTBS did not modulate the perception of non-nociceptive stimuli. Surprisingly, this side-dependent analgesic effect of cTBS was not reflected in the amplitude modulation of nociceptive ERPs. Indeed, both nociceptive (N160, N240 and P360 waves) and late-latency non-nociceptive (N140 and P200 waves) ERPs elicited by stimulation of the contralateral and ipsilateral hands were similarly reduced after cTBS, suggesting an unspecific effect, possibly due to habituation or reduced alertness. In conclusion, cTBS applied over M1 and S1 reduces similarly the perception of nociceptive inputs originating from the contralateral hand, but this analgesic effect is not reflected in the magnitude of nociceptive ERPs.	[Torta, Diana M. E.; Legrain, Valery; Algoet, Maxime; Olivier, Etienne; Duque, Julie; Mouraux, Andre] Catholic Univ Louvain, Inst Neurosci IoNS, B-1200 Brussels, Belgium; [Torta, Diana M. E.] Univ Turin, Dept Psychol, Turin, Italy; [Legrain, Valery] Univ Ghent, Dept Expt & Clin Hlth Psychol, B-9000 Ghent, Belgium	Universite Catholique Louvain; University of Turin; Ghent University	Mouraux, A (corresponding author), Catholic Univ Louvain, Inst Neurosci IoNS, B-1200 Brussels, Belgium.	andre.mouraux@uclouvain.be	; Mouraux, Andre/F-3724-2012	Duque, Julie/0000-0001-9575-7097; Torta, Diana/0000-0002-3499-3982; Algoet, Maxime/0000-0002-1238-2048; Mouraux, Andre/0000-0003-1056-5980	IBRO In Europe Short Stay Fellowship; Research Foundation Flanders (FWO, Belgium); 'Mandat d'Impulsion Scientifique (MIS)' from the Belgian FNRS	IBRO In Europe Short Stay Fellowship; Research Foundation Flanders (FWO, Belgium)(FWO); 'Mandat d'Impulsion Scientifique (MIS)' from the Belgian FNRS	DT was supported by an IBRO In Europe Short Stay Fellowship; VL by the Research Foundation Flanders (FWO, Belgium); AM received support from a 'Mandat d'Impulsion Scientifique (MIS)' from the Belgian FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2010, RESTOR NEUROL NEUROS, V28, P477, DOI 10.3233/RNN-2010-0555; Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; BEYDOUN A, 1993, ELECTROEN CLIN NEURO, V88, P173, DOI 10.1016/0168-5597(93)90002-7; BROMM B, 1984, HUM NEUROBIOL, V3, P33; CARMON A, 1976, EXP BRAIN RES, V25, P103; Csifcsak G, 2009, NEUROREPORT, V20, P1051, DOI 10.1097/WNR.0b013e32832e0c74; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; Duque J, 2012, J NEUROSCI, V32, P806, DOI 10.1523/JNEUROSCI.4299-12.2012; Frot M, 1999, CLIN NEUROPHYSIOL, V110, P133, DOI 10.1016/S0168-5597(98)00054-9; Frot M, 2012, CORTICAL REPRESENTAT; Garcia-Larrea L, 2003, NEUROPHYSIOL CLIN, V33, P279, DOI 10.1016/j.neucli.2003.10.008; HARI R, 1984, ELECTROEN CLIN NEURO, V57, P254, DOI 10.1016/0013-4694(84)90126-3; Hu L, 2010, NEUROIMAGE, V50, P99, DOI 10.1016/j.neuroimage.2009.12.010; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Iannetti GD, 2008, J NEUROPHYSIOL, V100, P815, DOI 10.1152/jn.00097.2008; Ishikawa S, 2007, CLIN NEUROPHYSIOL, V118, P1033, DOI 10.1016/j.clinph.2007.02.003; Jacobs MF, 2012, NEUROREPORT, V23, P927, DOI 10.1097/WNR.0b013e328358b0f3; KAAS JH, 1983, PHYSIOL REV, V63, P206, DOI 10.1152/physrev.1983.63.1.206; Kanda M, 2000, BRAIN RES, V853, P282, DOI 10.1016/S0006-8993(99)02274-X; Katayama T, 2010, CLIN NEUROPHYSIOL, V121, P2097, DOI 10.1016/j.clinph.2010.05.014; Klein PA, 2012, J NEUROSCI; Lefaucheur JP, 2006, NEUROLOGY, V67, P1568, DOI 10.1212/01.wnl.0000242731.10074.3c; Lefaucheur JP, 2006, NEUROPHYSIOL CLIN, V36, P117, DOI 10.1016/j.neucli.2006.08.002; Lefaucheur JP, 2012, EUR J PAIN, V16, P1403, DOI 10.1002/j.1532-2149.2012.00150.x; Legrain V, 2012, NEUROPHYSIOL CLIN, V42, P325, DOI 10.1016/j.neucli.2012.06.003; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Mauguiere F., 1999, ELECTROENCEPHALOGRAP; MELZACK R, 1968, P423; Mountcastle VB, 2005, SENSORY HAND NEURAL, pxiv; Mouraux A, 2008, MAGN RESON IMAGING, V26, P1041, DOI 10.1016/j.mri.2008.01.011; Mouraux A, 2003, CLIN NEUROPHYSIOL, V114, P710, DOI 10.1016/S1388-2457(03)00027-0; Mylius V, 2012, PAIN, V153, P1350, DOI 10.1016/j.pain.2012.04.009; Noirhomme Q, 2004, IEEE T BIO-MED ENG, V51, P1994, DOI 10.1109/TBME.2004.834266; Ohara S, 2004, CLIN NEUROPHYSIOL, V115, P1641, DOI 10.1016/j.clinph.2004.02.023; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Poreisz C, 2008, EXP BRAIN RES, V185, P611, DOI 10.1007/s00221-007-1188-5; Poreisz C, 2008, NEUROREPORT, V19, P193, DOI 10.1097/WNR.0b013e3282f45498; Premji A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-91; Ren K., 2009, SCI PAIN, P723; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Tamura Y, 2004, NEUROLOGY, V62, P2176, DOI 10.1212/01.WNL.0000130081.96533.85; Tamura Y, 2004, PAIN, V107, P107, DOI 10.1016/j.pain.2003.10.011; Torta DM, 2012, EXP BRAIN RES, V218, P361, DOI 10.1007/s00221-012-3019-6; TREEDE RD, 1988, ELECTROEN CLIN NEURO, V70, P429, DOI 10.1016/0013-4694(88)90020-X; Tsubokawa T, 1991, Acta Neurochir Suppl (Wien), V52, P137; Valentini E, 2012, NEUROIMAGE, V59, P1571, DOI 10.1016/j.neuroimage.2011.08.069; Valentini E, 2011, J COGNITIVE NEUROSCI, V23, P2822, DOI 10.1162/jocn.2011.21609; Valeriani M, 2004, CLIN NEUROPHYSIOL, V115, P211, DOI 10.1016/S1388-2457(03)00287-6; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8	50	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e73263	10.1371/journal.pone.0073263	http://dx.doi.org/10.1371/journal.pone.0073263			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977382	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300107
J	Bello, M; Correa-Basurto, J				Bello, Martiniano; Correa-Basurto, Jose			Molecular Dynamics Simulations to Provide Insights into Epitopes Coupled to the Soluble and Membrane-Bound MHC-II Complexes	PLOS ONE			English	Article							PEPTIDE BINDING; INVARIANT CHAIN; PROTEIN HLA-DR1; CONFORMATIONAL ISOMERS; ANTIGENIC PEPTIDE; STRUCTURAL BASIS; PREDICTION; SOLVATION; HYDRATION; BILAYER	Epitope recognition by major histocompatibility complex II (MHC-II) is essential for the activation of immunological responses to infectious diseases. Several studies have demonstrated that this molecular event takes place in the MHC-II peptide-binding groove constituted by the alpha and beta light chains of the heterodimer. This MHC-II peptide-binding groove has several pockets (P1-P11) involved in peptide recognition and complex stabilization that have been probed through crystallographic experiments and in silico calculations. However, most of these theoretical calculations have been performed without taking into consideration the heavy chains, which could generate misleading information about conformational mobility both in water and in the membrane environment. Therefore, in absence of structural information about the difference in the conformational changes between the peptide-free and peptide-bound states (pMHC-II) when the system is soluble in an aqueous environment or non-covalently bound to a cell membrane, as the physiological environment for MHC-II is. In this study, we explored the mechanistic basis of these MHC-II components using molecular dynamics (MD) simulations in which MHC-II was previously co-crystallized with a small epitope (P-7) or coupled by docking procedures to a large (P-22) epitope. These MD simulations were performed at 310 K over 100 ns for the water-soluble (MHC-IIw, MHC-II-P-7w, and MHC-II-P-22w) and 150 ns for the membrane-bound species (MHC-IIm, MHC-II-P-7m, and MHC-II-P-22m). Our results reveal that despite the different epitope sizes and MD simulation environments, both peptides are stabilized primarily by residues lining P1, P4, and P6-7, and similar noncovalent intermolecular energies were observed for the soluble and membrane-bound complexes. However, there were remarkably differences in the conformational mobility and intramolecular energies upon complex formation, causing some differences with respect to how the two peptides are stabilized in the peptide-binding groove.	[Bello, Martiniano; Correa-Basurto, Jose] Inst Politecn Nacl, Escuela Super Med, Lab Modelado Mol & Bioinformat, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico	Bello, M (corresponding author), Inst Politecn Nacl, Escuela Super Med, Lab Modelado Mol & Bioinformat, Plan San Luis & Diaz Miron S-N, Mexico City, DF, Mexico.	bellomartini@gmail.com	Bello, Martiniano/AAH-4134-2019	RODRIGUEZ-CORTES, OCTAVIO/0000-0002-7380-5665; Bello Ramirez, Martiniano/0000-0002-9686-0755	Instituto de ciencia y tecnologia del DF [PIRIVE09-9]; Consejo Nacional de Ciencia y Tecnologia (CONACYT); programa integral de fortalecimiento institucional-secretaria de investifgacion y posgrado-Comision de Operacion y Fomento de Actividades Academicas/Instituto Politecnico Nacional; CONACYT	Instituto de ciencia y tecnologia del DF; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); programa integral de fortalecimiento institucional-secretaria de investifgacion y posgrado-Comision de Operacion y Fomento de Actividades Academicas/Instituto Politecnico Nacional; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors thank Instituto de ciencia y tecnologia del DF (PIRIVE09-9), Consejo Nacional de Ciencia y Tecnologia (CONACYT), and programa integral de fortalecimiento institucional-secretaria de investifgacion y posgrado-Comision de Operacion y Fomento de Actividades Academicas/Instituto Politecnico Nacional for financial support. MB thanks CONACYT for scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Belmares MP, 2003, BIOCHEMISTRY-US, V42, P838, DOI 10.1021/bi020466p; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bordner AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014383; BUUS S, 1987, SCIENCE, V235, P1353, DOI 10.1126/science.2435001; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ferrante A, 2007, J IMMUNOL, V178, P7181, DOI 10.4049/jimmunol.178.11.7181; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Godkin AJ, 2001, J IMMUNOL, V166, P6720, DOI 10.4049/jimmunol.166.11.6720; Hansen TH, 2005, IMMUNOL REV, V207, P100, DOI 10.1111/j.0105-2896.2005.00315.x; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Janeway CA, 1997, IMMUNOBIOLOGY, P41; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; Kasson PM, 2000, BIOCHEMISTRY-US, V39, P1048, DOI 10.1021/bi9921337; Knapp B, 2009, MOL IMMUNOL, V46, P1839, DOI 10.1016/j.molimm.2009.01.009; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; LAMB CA, 1992, J IMMUNOL, V148, P3478; Latek RR, 2000, IMMUNITY, V12, P699, DOI 10.1016/S1074-7613(00)80220-4; Lazavecchia AA, 1992, NATURE, V357, P249; Lichtman AH, 2009, ABBAS BASIC IMMUNOLO; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Lovitch SB, 2005, IMMUNOL REV, V207, P293, DOI 10.1111/j.0105-2896.2005.00298.x; Majera D, 2012, FEBS LETT, V586, P1318, DOI 10.1016/j.febslet.2012.03.038; Marrink SJ, 1998, BIOPHYS J, V74, P931, DOI 10.1016/S0006-3495(98)74016-0; Meng WS, 1997, INT IMMUNOL, V9, P1339, DOI 10.1093/intimm/9.9.1339; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Omasits U, 2008, MOL SIMULAT, V34, P781, DOI 10.1080/08927020802256298; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Painter CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002403; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; Loyola PKR, 2013, IMMUNOL RES, V56, P44, DOI 10.1007/s12026-013-8385-z; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; ROGNAN D, 1994, BIOCHEMISTRY-US, V33, P11476, DOI 10.1021/bi00204a009; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; Schmitt L, 1999, J MOL BIOL, V286, P207, DOI 10.1006/jmbi.1998.2463; SETTE A, 1994, ANNU REV IMMUNOL, V12, P413, DOI 10.1146/annurev.immunol.12.1.413; Simon A, 2002, MOL IMMUNOL, V38, P681, DOI 10.1016/S0161-5890(01)00103-1; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Stumptner-Cuvelette P, 2002, BBA-MOL CELL RES, V1542, P1, DOI 10.1016/S0167-4889(01)00166-5; Suri A, 2006, CURR OPIN IMMUNOL, V18, P70, DOI 10.1016/j.coi.2005.11.002; Tieleman DP, 1998, BIOCHEMISTRY-US, V37, P17554, DOI 10.1021/bi981802y; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wan S, 2008, MOL IMMUNOL, V45, P1221, DOI 10.1016/j.molimm.2007.09.022; Wan SZ, 2004, J COMPUT CHEM, V25, P1803, DOI 10.1002/jcc.20100; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Zacharias M, 2004, BIOPHYS J, V87, P2203, DOI 10.1529/biophysj.104.044743; Zarutskie JA, 1999, BIOCHEMISTRY-US, V38, P5878, DOI 10.1021/bi983048m; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	64	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72575	10.1371/journal.pone.0072575	http://dx.doi.org/10.1371/journal.pone.0072575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977319	gold, Green Submitted, Green Published			2022-12-25	WOS:000323425700177
J	Costa, B; Bendinelli, S; Gabelloni, P; Da Pozzo, E; Daniele, S; Scatena, F; Vanacore, R; Campiglia, P; Bertamino, A; Gomez-Monterrey, I; Sorriento, D; Del Giudice, C; Iaccarino, G; Novellino, E; Martini, C				Costa, Barbara; Bendinelli, Sara; Gabelloni, Pamela; Da Pozzo, Eleonora; Daniele, Simona; Scatena, Fabrizio; Vanacore, Renato; Campiglia, Pietro; Bertamino, Alessia; Gomez-Monterrey, Isabel; Sorriento, Daniela; Del Giudice, Carmine; Iaccarino, Guido; Novellino, Ettore; Martini, Claudia			Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; C6 GLIOMA-CELLS; P53-MDM2 INTERACTION; INDUCED APOPTOSIS; SOLID TUMORS; D-PEPTIDE; IN-VIVO; CANCER; THERAPY; CHEMOTHERAPY	Cancer development and chemo-resistance are often due to impaired functioning of the p53 tumor suppressor through genetic mutation or sequestration by other proteins. In glioblastoma multiforme (GBM), p53 availability is frequently reduced because it binds to the Murine Double Minute-2 (MDM2) oncoprotein, which accumulates at high concentrations in tumor cells. The use of MDM2 inhibitors that interfere with the binding of p53 and MDM2 has become a valid approach to inhibit cell growth in a number of cancers; however little is known about the efficacy of these inhibitors in GBM. We report that a new small-molecule inhibitor of MDM2 with a spirooxoindolepyrrolidine core structure, named ISA27, effectively reactivated p53 function and inhibited human GBM cell growth in vitro by inducing cell cycle arrest and apoptosis. In immunoincompetent BALB/c nude mice bearing a human GBM xenograft, the administration of ISA27 in vivo activated p53, inhibited cell proliferation and induced apoptosis in tumor tissue. Significantly, ISA27 was non-toxic in an in vitro normal human cell model and an in vivo mouse model. ISA27 administration in combination with temozolomide (TMZ) produced a synergistic inhibitory effect on GBM cell viability in vitro, suggesting the possibility of lowering the dose of TMZ used in the treatment of GBM. In conclusion, our data show that ISA27 releases the powerful antitumor capacities of p53 in GBM cells. The use of this MDM2 inhibitor could become a novel therapy for the treatment of GBM patients.	[Costa, Barbara; Bendinelli, Sara; Gabelloni, Pamela; Da Pozzo, Eleonora; Daniele, Simona; Martini, Claudia] Univ Pisa, Dept Pharm, Pisa, Italy; [Scatena, Fabrizio; Vanacore, Renato] Cisanello Hosp, UO Immunohaematol 2, Pisa, Italy; [Campiglia, Pietro] Univ Salerno, Dept Pharmaceut Sci, Div Biomed, I-84100 Salerno, Italy; [Bertamino, Alessia; Gomez-Monterrey, Isabel; Novellino, Ettore] Univ Naples Federico II, Dept Pharmaceut & Toxicol Chem, Naples, Italy; [Sorriento, Daniela; Del Giudice, Carmine] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Iaccarino, Guido] Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy; [Iaccarino, Guido] IRCCS Multimed, Milan, Italy	University of Pisa; University of Salerno; University of Naples Federico II; University of Naples Federico II; University of Salerno; IRCCS Multimedica	Costa, B (corresponding author), Univ Pisa, Dept Pharm, Pisa, Italy.	bcosta@farm.unipi.it; cmartini@farm.unipi.it	Iaccarino, Guido/D-4540-2009; Da Pozzo, Eleonora/AAW-8186-2020; Daniele, Simona/AAB-8888-2019; Da Pozzo, Eleonora/M-2215-2015; Del Giudice, Carmine/AFO-6296-2022; Campiglia, Pietro/J-5625-2018; IACCARINO, Guido/A-7702-2010; Martini, Claudia/AAC-4089-2019	Iaccarino, Guido/0000-0002-8997-835X; Da Pozzo, Eleonora/0000-0003-4762-8949; Daniele, Simona/0000-0001-7391-3087; Da Pozzo, Eleonora/0000-0003-4762-8949; Del Giudice, Carmine/0000-0002-7543-0609; IACCARINO, Guido/0000-0002-8997-835X; Martini, Claudia/0000-0001-9379-3027; Campiglia, Pietro/0000-0002-1069-2181; Novellino, Ettore/0000-0002-2181-2142; COSTA, BARBARA/0000-0002-7598-1275	Italian Ministry of University and Scientific Research [prot. 20098SJX4F]	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR))	Funding for this study was provided by the Italian Ministry of University and Scientific Research (PRIN2009-prot. 20098SJX4F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azmi AS, 2010, EUR J CANCER, V46, P1122, DOI 10.1016/j.ejca.2010.01.015; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chappell WH, 2012, CELL CYCLE, V11, P4579, DOI 10.4161/cc.22852; Chelli B, 2004, BIOCHEM PHARMACOL, V68, P125, DOI 10.1016/j.bcp.2004.03.008; Chelli B, 2005, CHEMBIOCHEM, V6, P1082, DOI 10.1002/cbic.200400350; CONRAD CA, 1995, NEUROL CLIN, V13, P795, DOI 10.1016/S0733-8619(18)30018-5; Desjardins A, 2005, FRONT BIOSCI-LANDMRK, V10, P2645, DOI 10.2741/1727; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Ghassemifar S, 2012, NEUROSCI LETT, V513, P106, DOI 10.1016/j.neulet.2012.02.022; Gomez-Monterrey I, 2010, J MED CHEM, V53, P8319, DOI 10.1021/jm100838z; Halatsch ME, 2006, ANTICANCER RES, V26, P4191; HE J, 1994, GENE CHROMOSOME CANC, V11, P91, DOI 10.1002/gcc.2870110205; Henze J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037776; Hess KR, 2004, CANCER, V101, P2293, DOI 10.1002/cncr.20621; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; KONDO S, 1995, ONCOGENE, V10, P2001; Lee SK, 2010, BIOCHEM BIOPH RES CO, V391, P1592, DOI 10.1016/j.bbrc.2009.12.077; Levin VA, 2001, CANC PRINCIPLES PRAC, P2100; Li C, 2012, J DRUG TARGET, V20, P264, DOI 10.3109/1061186X.2011.645162; Liu JB, 2012, EUR J CANCER, V48, P2328, DOI 10.1016/j.ejca.2012.03.001; Liu M, 2010, P NATL ACAD SCI USA, V107, P14321, DOI 10.1073/pnas.1008930107; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Nagasawa DT, 2012, NEUROSURG CLIN N AM, V23, P307, DOI 10.1016/j.nec.2012.01.007; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Ruan SB, 1999, CLIN CANCER RES, V5, P197; Santulli G, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001081; Secchiero P, 2006, BLOOD, V107, P4122, DOI 10.1182/blood-2005-11-4465; Shangary S, 2008, MOL CANCER THER, V7, P1533, DOI 10.1158/1535-7163.MCT-08-0140; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Sonnemann J, 2011, EUR J CANCER, V47, P1432, DOI 10.1016/j.ejca.2011.01.015; Sorriento D, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-97; Sosin AM, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-57; Stuhmer T, 2005, BLOOD, V106, P3609, DOI 10.1182/blood-2005-04-1489; Tabernero J, 2011, CLIN CANCER RES, V17, P6313, DOI 10.1158/1078-0432.CCR-11-1101; Tallarida RJ, 1999, J PHARMACOL EXP THER, V289, P8; Tallarida RJ, 2002, PAIN, V98, P163, DOI 10.1016/S0304-3959(02)00041-6; TALLARIDA RJ, 1992, PAIN, V49, P93, DOI 10.1016/0304-3959(92)90193-F; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Vandesompele J, 2002, ANAL BIOCHEM, V303, P95, DOI 10.1006/abio.2001.5564; Vaseva AV, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.39; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Villalonga-Planells R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018588; Vu BT, 2011, CURR TOP MICROBIOL, V348, P151, DOI 10.1007/82_2010_110; Wang B, 2012, ACTA BIOCH BIOPH SIN, V44, P685, DOI 10.1093/abbs/gms053; Wang CC, 2006, CANCER RES, V66, P6756, DOI 10.1158/0008-5472.CAN-06-0185; Zhao Po, 1998, Journal of Environmental Pathology Toxicology and Oncology, V17, P125	52	45	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72281	10.1371/journal.pone.0072281	http://dx.doi.org/10.1371/journal.pone.0072281			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977270	Green Published, gold			2022-12-25	WOS:000323425700160
J	Kubota, D; Yoshida, A; Tsuda, H; Suehara, Y; Okubo, T; Saito, T; Orita, H; Sato, K; Taguchi, T; Yao, T; Kaneko, K; Katai, H; Kawai, A; Kondo, T				Kubota, Daisuke; Yoshida, Akihiko; Tsuda, Hitoshi; Suehara, Yoshiyuki; Okubo, Taketo; Saito, Tsuyoshi; Orita, Hajime; Sato, Koichi; Taguchi, Takahiro; Yao, Takashi; Kaneko, Kazuo; Katai, Hitoshi; Kawai, Akira; Kondo, Tadashi			Gene Expression Network Analysis of ETV1 Reveals KCTD10 as a Novel Prognostic Biomarker in Gastrointestinal Stromal Tumor	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; PFETIN; INTERACTS; IMATINIB; INHIBIT; KINASE; KIT	Background: Prognostic biomarkers are required for risk stratification therapy in the patients with gastrointestinal stromal tumor (GIST). In this study, we aimed to identify prognostic biomarkers in GIST. We assessed the prognostic value of E twenty-six variant 1 (ETV1), a recently identified transcription factor unique to GIST. We also examined the clinical utility and functions of its downstream gene, potassium channel tetramerization domain containing protein 10 (KCTD10). Methods: The levels of ETV1 and KCTD10 were evaluated immunohistochemically in 112 patients with GIST treated at two hospitals. The functional properties of KCTD10 were examined by gene silencing assay in cultured GIST cells. Results: Immunohistochemistry revealed that ETV1 expression in GIST had no prognostic significance. In contrast, the disease-free survival rate was 88.5% in patients with KCTD10-positive tumors and 55.8% in those with KCTD10-negative tumors (p <0.0001). KCTD10 was an independent prognostic factor (p <0.05). In the low-risk classification group, KCTD10 was significantly associated with favorable prognosis (p = 0.0008). Gene silencing of KCTD10 increased cell proliferation and invasion, suggesting that KCTD10 has a tumor-suppressive function. Conclusions: The GIST-specific transcription factor ETV1 may have no prognostic potential, whereas its downstream gene KCTD10 is associated with a favorable prognosis. Our study indicated the novel prognostic utility of KCTD10 in GIST, and suggested its tumor-suppressive effects on GIST cells. Further validation studies of KCTD10 for clinical applications, and functional verification of KCTD10 for better understanding of molecular basis of malignant phenotypes are worth challenging in GIST.	[Kubota, Daisuke; Kondo, Tadashi] Natl Canc Ctr, Div Pharmacoprote, Tokyo, Japan; [Kubota, Daisuke; Suehara, Yoshiyuki; Okubo, Taketo; Kaneko, Kazuo] Juntendo Univ, Sch Med, Dept Orthoped Surg, Tokyo 113, Japan; [Yoshida, Akihiko; Tsuda, Hitoshi] Natl Canc Ctr, Pathol & Clin Lab Div, Tokyo, Japan; [Saito, Tsuyoshi; Yao, Takashi] Juntendo Univ, Sch Med, Dept Human Pathol, Shizuoka, Tokyo, Japan; [Orita, Hajime; Sato, Koichi] Juntendo Univ, Shizuoka Hosp, Dept Surg, Tokyo, Japan; [Taguchi, Takahiro] Kochi Univ, Grad Sch Kuroshio Sci, Dept Human Hlth & Med Sci, Kochi 780, Japan; [Katai, Hitoshi] Natl Canc Ctr, Dept Surg Oncol Div, Tokyo, Japan; [Kawai, Akira] Natl Canc Ctr, Div Musculoskeletal Oncol, Tokyo, Japan	National Cancer Center - Japan; Juntendo University; National Cancer Center - Japan; Juntendo University; Juntendo University; Kochi University; National Cancer Center - Japan; National Cancer Center - Japan	Kondo, T (corresponding author), Natl Canc Ctr, Div Pharmacoprote, Tokyo, Japan.	takondo@ncc.go.jp			National Cancer Center Research and Development Fund [23-A-10]	National Cancer Center Research and Development Fund(National Cancer Center - Japan)	This work was supported by a grant from the National Cancer Center Research and Development Fund (23-A-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaimy A, 2007, AM J SURG PATHOL, V31, P113, DOI 10.1097/01.pas.0000213307.05811.f0; Birner P, 2012, CLIN CANCER RES, V18, P1879, DOI 10.1158/1078-0432.CCR-11-2364; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; COX DR, 1972, J R STAT SOC B, V34, P187; Dagher R, 2002, CLIN CANCER RES, V8, P3034; FISHER RA, 1945, NATURE, V156, P388, DOI 10.1038/156388a0; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Hamilton SR, 2000, WHO CLASSIFICATION T; Hasegawa T, 2013, HUM PATHOL; Hu X, 2012, MOL BIOL REP, V39, P9911, DOI 10.1007/s11033-012-1858-7; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Joensuu H, 2012, JAMA-J AM MED ASSOC, V307, P1265, DOI 10.1001/jama.2012.347; Joensuu H, 2012, LANCET ONCOL, V13, P265, DOI 10.1016/S1470-2045(11)70299-6; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kawanowa K, 2006, HUM PATHOL, V37, P1527, DOI 10.1016/j.humpath.2006.07.002; Kikuta K, 2010, JPN J CLIN ONCOL, V40, P60, DOI 10.1093/jjco/hyp125; Kubota D, 2012, JPN J CLIN ONCOL, V42, P730, DOI 10.1093/jjco/hys092; Kubota D, 2011, JPN J CLIN ONCOL, V41, P1194, DOI 10.1093/jjco/hyr121; Lamba G, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-14; Lamba G, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-21; Miettinen M, 2002, HUM PATHOL, V33, P478, DOI 10.1053/hupa.2002.124123; Rubin BP, 2007, LANCET, V369, P1731, DOI 10.1016/S0140-6736(07)60780-6; Suehara Y, 2008, CLIN CANCER RES, V14, P1707, DOI 10.1158/1078-0432.CCR-07-1478; Taguchi T, 2002, LAB INVEST, V82, P663, DOI 10.1038/labinvest.3780461; Wang YB, 2009, J CELL BIOCHEM, V106, P409, DOI 10.1002/jcb.22026; Zhou JL, 2005, BBA-GENE STRUCT EXPR, V1729, P200, DOI 10.1016/j.bbaexp.2005.05.005	26	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e73896	10.1371/journal.pone.0073896	http://dx.doi.org/10.1371/journal.pone.0073896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977394	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700199
J	Liu, XJ; Li, F; Li, DQ; Ma, EB; Zhang, WQ; Zhu, KY; Zhang, JZ				Liu, Xiaojian; Li, Feng; Li, Daqi; Ma, Enbo; Zhang, Wenqing; Zhu, Kun Yan; Zhang, Jianzhen			Molecular and Functional Analysis of UDP-N-Acetylglucosamine Pyrophosphorylases from the Migratory Locust, Locusta migratoria	PLOS ONE			English	Article							CHITIN-SYNTHASE GENES; URIDINE DIPHOSPHOACETYLGLUCOSAMINE PYROPHOSPHORYLASE; TRIBOLIUM-CASTANEUM; PERITROPHIC MATRIX; EXPRESSION; PURIFICATION; DROSOPHILA; CUTICLE; MORPHOGENESIS; BIOSYNTHESIS	UDP-N-acetylglucosamine pyrophosphorylases (UAP) function in the formation of extracellular matrix by producing N-acetylglucosamine (GlcNAc) residues needed for chitin biosynthesis and protein glycosylation. Herein, we report two UAP cDNA's derived from two different genes (LmUAP1 and LmUAP2) in the migratory locust Locusta migratoria. Both the cDNA and their deduced amino acid sequences showed about 70% identities between the two genes. Phylogenetic analysis suggests that LmUAP1 and LmUAP2 derive from a relatively recent gene duplication event. Both LmUAP1 and LmUAP2 were widely expressed in all the major tissues besides chitin-containing tissues. However, the two genes exhibited different developmental expression patterns. High expression of LmUAP1 was detected during early embryogenesis, then decreased greatly, and slowly increased before egg hatch. During nymphal development, the highest expression of LmUAP1 appeared just after molting but declined in each inter-molting period and then increased before molting to the next stage, whereas LmUAP2 was more consistently expressed throughout all these stages. When the early second-and fifth-instar nymphs (1day-old) were injected with LmUAP1 double-stranded RNA (dsRNA), 100% mortality was observed 2 days after the injection. When the middle second-and fifth-instar nymphs (3-to 4-day-old) were injected with LmUAP1 dsRNA, 100% mortality was observed during their next molting process. In contrast, when the insects at the same stages were injected with LmUAP2 dsRNA, these insects were able to develop normally and molt to the next stage successfully. It is presumed that the lethality caused by RNAi of LmUAP1 is due to reduced chitin biosynthesis of the integument and midgut, whereas LmUAP2 is not essential for locust development at least in nymph stage. This study is expected to help better understand different functions of UAP1 and UAP2 in the locust and other insect species.	[Liu, Xiaojian; Li, Feng; Li, Daqi; Ma, Enbo; Zhang, Jianzhen] Shanxi Univ, Res Inst Appl Biol, Taiyuan, Shanxi, Peoples R China; [Zhang, Wenqing] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Kun Yan] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	Shanxi University; Sun Yat Sen University; Kansas State University	Zhu, KY (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	kzhu@ksu.edu; zjz@sxu.edu.cn	zhang, wenqing/GYA-0786-2022	Zhu, Kun Yan/0000-0001-9372-8030	National Basic Research Program of China [2012CB114102]; National Natural Science Foundation of China [31272380]; International Cooperation and Exchange Program [30810103907]; Science and Technology Research Project of Shanxi Province [20110311010]; Program for Top Young Academic Leaders of Higher Learning Institutions of Shanxi (TYAL)	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation and Exchange Program; Science and Technology Research Project of Shanxi Province; Program for Top Young Academic Leaders of Higher Learning Institutions of Shanxi (TYAL)	This work was supported by the National Basic Research Program of China (2012CB114102), the National Natural Science Foundation of China (Grant No. 31272380), the International Cooperation and Exchange Program (30810103907), the Science and Technology Research Project of Shanxi Province (20110311010), and the Program for Top Young Academic Leaders of Higher Learning Institutions of Shanxi (TYAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; Arakane Y, 2004, INSECT BIOCHEM MOLEC, V34, P291, DOI 10.1016/j.ibmb.2003.11.004; Arakane Y, 2011, INSECT BIOCHEM MOLEC, V41, P42, DOI 10.1016/j.ibmb.2010.09.011; Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031; CANDY DJ, 1962, J EXP BIOL, V39, P129; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010133; Cohen E, 2001, PEST MANAG SCI, V57, P946, DOI 10.1002/ps.363; DIEKMAN AB, 1994, BIOL REPROD, V50, P1087, DOI 10.1095/biolreprod50.5.1087; Eisenhaber B, 2003, BIOESSAYS, V25, P367, DOI 10.1002/bies.10254; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; HIRN M, 1979, J INSECT PHYSIOL, V25, P255, DOI 10.1016/0022-1910(79)90052-0; Hogenkamp DG, 2008, INSECT BIOCHEM MOLEC, V38, P478, DOI 10.1016/j.ibmb.2007.08.002; Hogenkamp DG, 2005, INSECT BIOCHEM MOLEC, V35, P529, DOI 10.1016/j.ibmb.2005.01.016; JAWORSKI E, 1963, NATURE, V198, P790, DOI 10.1038/198790a0; KAWAI H, 1976, J FERMENT TECHNOL, V54, P463; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Liu XJ, 2012, INSECT BIOCHEM MOLEC, V42, P902, DOI 10.1016/j.ibmb.2012.09.002; MARSCHALL HU, 1992, J CLIN INVEST, V89, P1981, DOI 10.1172/JCI115806; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mio T, 1998, J BIOL CHEM, V273, P14392, DOI 10.1074/jbc.273.23.14392; Moussian B, 2008, COMP BIOCHEM PHYS B, V149, P215, DOI 10.1016/j.cbpb.2007.10.009; PATTABIRAMAN T, 1961, BIOCHIM BIOPHYS ACTA, V50, P129, DOI 10.1016/0006-3002(61)91068-X; Peneff C, 2001, EMBO J, V20, P6191, DOI 10.1093/emboj/20.22.6191; Qu MB, 2011, INSECT BIOCHEM MOLEC, V41, P923, DOI 10.1016/j.ibmb.2011.09.001; Rezende GL, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-82; Schimmelpfeng K, 2006, MECH DEVELOP, V123, P487, DOI 10.1016/j.mod.2006.03.004; STROMINGER JL, 1959, J BIOL CHEM, V234, P1822; Szumilo T, 1996, J BIOL CHEM, V271, P13147, DOI 10.1074/jbc.271.22.13147; Tonning A, 2006, DEVELOPMENT, V133, P331, DOI 10.1242/dev.02206; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2010, INSECT BIOCHEM MOLEC, V42, P637; Xia JY., 2002, PLANT PROTECT TECH E, V22, P7; Zhang JZ, 2010, INSECT BIOCHEM MOLEC, V40, P824, DOI 10.1016/j.ibmb.2010.08.001	36	45	60	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71970	10.1371/journal.pone.0071970	http://dx.doi.org/10.1371/journal.pone.0071970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977188	Green Published, gold			2022-12-25	WOS:000323425700118
J	Mauris, J; Mantelli, F; Woodward, AM; Cao, ZY; Bertozzi, CR; Panjwani, N; Godula, K; Argueso, P				Mauris, Jerome; Mantelli, Flavio; Woodward, Ashley M.; Cao, Ziyhi; Bertozzi, Carolyn R.; Panjwani, Noorjahan; Godula, Kamil; Argueeso, Pablo			Modulation of Ocular Surface Glycocalyx Barrier Function by a Galectin-3 N-terminal Deletion Mutant and Membrane-Anchored Synthetic Glycopolymers	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; O-GLYCANS; TETHERED MUCINS; CROSS-LINKING; IN-VITRO; BINDING; EXPRESSION; CANCER; ASSOCIATION; RECEPTORS	Background: Interaction of transmembrane mucins with the multivalent carbohydrate-binding protein galectin-3 is critical to maintaining the integrity of the ocular surface epithelial glycocalyx. This study aimed to determine whether disruption of galectin-3 multimerization and insertion of synthetic glycopolymers in the plasma membrane could be used to modulate glycocalyx barrier function in corneal epithelial cells. Methodology/Principal Findings: Abrogation of galectin-3 biosynthesis in multilayered cultures of human corneal epithelial cells using siRNA, and in galectin-3 null mice, resulted in significant loss of corneal barrier function, as indicated by increased permeability to the rose bengal diagnostic dye. Addition of beta-lactose, a competitive carbohydrate inhibitor of galectin-3 binding activity, to the cell culture system, transiently disrupted barrier function. In these experiments, treatment with a dominant negative inhibitor of galectin-3 polymerization lacking the N-terminal domain, but not full-length galectin-3, prevented the recovery of barrier function to basal levels. As determined by fluorescence microscopy, both cellobiose- and lactose-containing glycopolymers incorporated into apical membranes of corneal epithelial cells, independently of the chain length distribution of the densely glycosylated, polymeric backbones. Membrane incorporation of cellobiose glycopolymers impaired barrier function in corneal epithelial cells, contrary to their lactose-containing counterparts, which bound to galectin-3 in pull-down assays. Conclusions/Significance: These results indicate that galectin-3 multimerization and surface recognition of lactosyl residues is required to maintain glycocalyx barrier function at the ocular surface. Transient modification of galectin-3 binding could be therapeutically used to enhance the efficiency of topical drug delivery.	[Mauris, Jerome; Mantelli, Flavio; Woodward, Ashley M.; Argueeso, Pablo] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02115 USA; [Mauris, Jerome; Mantelli, Flavio; Woodward, Ashley M.; Argueeso, Pablo] Harvard Univ, Sch Med, Dept Ophthalmol, Massachusetts Eye & Ear, Boston, MA USA; [Cao, Ziyhi; Panjwani, Noorjahan] Tufts Univ, Sch Med, Dept Ophthalmol, Ctr Vis Res, Boston, MA 02111 USA; [Bertozzi, Carolyn R.; Godula, Kamil] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.; Godula, Kamil] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Tufts University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Argueso, P (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02115 USA.	pablo_argueso@meei.harvard.edu		Argueso, Pablo/0000-0001-7321-9503	National Institutes of Health/National Eye Institute [R01 EY014847]; National Institutes of Health/American Recovery and Reinvestment Act [GM59907]; National Institutes of Health/Pathway to Independence Award [5 K99 EB013446-02]; NATIONAL EYE INSTITUTE [R01EY007088, R01EY014847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K99EB013446, R00EB013446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059907] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health/American Recovery and Reinvestment Act; National Institutes of Health/Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by: National Institutes of Health/National Eye Institute R01 EY014847 to PA; National Institutes of Health/American Recovery and Reinvestment Act GM59907 to CRB; National Institutes of Health/Pathway to Independence Award 5 K99 EB013446-02 to KG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Argueso P, 2013, JPN J OPHTHALMOL, V57, P150, DOI 10.1007/s10384-012-0228-2; Argueso P, 2006, INVEST OPHTH VIS SCI, V47, P113, DOI 10.1167/iovs.05-0735; Arguso P, 2012, METHODS MOL BIOL, V842, P313, DOI 10.1007/978-1-61779-513-8_19; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Belardi B, 2012, J AM CHEM SOC, V134, P9549, DOI 10.1021/ja301694s; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; Cao ZY, 2002, J BIOL CHEM, V277, P42299, DOI 10.1074/jbc.M200981200; Clark MC, 2012, BLOOD, V120, P4635, DOI 10.1182/blood-2012-06-438234; De Paiva CS, 2009, MUCOSAL IMMUNOL, V2, P243, DOI 10.1038/mi.2009.5; Earl LA, 2010, J BIOL CHEM, V285, P2242, DOI 10.1074/jbc.M109.066191; Escher P SD, 2011, CURRENT PROTOCOLS MO; Frey A, 1996, J EXP MED, V184, P1045, DOI 10.1084/jem.184.3.1045; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Godula K, 2012, J AM CHEM SOC, V134, P15732, DOI 10.1021/ja302193u; Godula K, 2009, J AM CHEM SOC, V131, P10263, DOI 10.1021/ja903114g; Guzman-Aranguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036628; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hsu DK, 2006, METHOD ENZYMOL, V417, P256, DOI 10.1016/S0076-6879(06)17018-4; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; Ideo H, 2002, GLYCOBIOLOGY, V12, P199, DOI 10.1093/glycob/12.3.199; Kompella UB, 2010, THER DELIV, V1, P435, DOI 10.4155/TDE.10.40; MADARA JL, 1990, AM J PATHOL, V137, P1273; Mantelli F, 2008, CURR OPIN ALLERGY CL, V8, P477, DOI 10.1097/ACI.0b013e32830e6b04; Mantelli F, 2009, INVEST OPHTH VIS SCI, V50, P2666, DOI 10.1167/iovs.08-2734; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Ochieng J, 1998, BBA-GEN SUBJECTS, V1379, P97, DOI 10.1016/S0304-4165(97)00086-X; OCHIENG J, 1994, BIOCHEMISTRY-US, V33, P14109, DOI 10.1021/bi00251a020; Oomizu S, 2012, CLIN IMMUNOL, V143, P51, DOI 10.1016/j.clim.2012.01.004; Peterson BR, 2005, ORG BIOMOL CHEM, V3, P3607, DOI 10.1039/b509866a; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Rabuka D, 2008, J AM CHEM SOC, V130, P5947, DOI 10.1021/ja710644g; Rabuka D, 2007, J AM CHEM SOC, V129, P5462, DOI 10.1021/ja067819i; Ricciuto J, 2008, INFECT IMMUN, V76, P5215, DOI 10.1128/IAI.00708-08; Rodriguez EC, 1998, J ORG CHEM, V63, P7134, DOI 10.1021/jo981351n; Sobrin L, 2000, INVEST OPHTH VIS SCI, V41, P1703; Stonebraker JR, 2004, J VIROL, V78, P13755, DOI 10.1128/JVI.78.24.13755-13768.2004; Sumiyoshi M, 2008, INVEST OPHTH VIS SCI, V49, P197, DOI 10.1167/iovs.07-1038; Urtti A, 2006, ADV DRUG DELIVER REV, V58, P1131, DOI 10.1016/j.addr.2006.07.027; Woodward A, 2013, J VIROL; Woodward AM, 2012, BIOCHEM BIOPH RES CO, V424, P12, DOI 10.1016/j.bbrc.2012.05.160; Yang RY, 1998, BIOCHEMISTRY-US, V37, P4086, DOI 10.1021/bi971409c; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200	49	36	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72304	10.1371/journal.pone.0072304	http://dx.doi.org/10.1371/journal.pone.0072304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977277	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700163
J	Trivers, R; Palestis, BG; Manning, JT				Trivers, Robert; Palestis, Brian G.; Manning, John T.			The Symmetry of Children's Knees Is Linked to Their Adult Sprinting Speed and Their Willingness to Sprint in a Long-Term Jamaican Study	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; PERFORMANCE	Jamaican athletes are prominent in sprint running but the reasons for their success are not clear. Here we consider the possibility that symmetry, particularly symmetry of the legs, in Jamaican children is linked to high sprinting speed in adults. Our study population was a cohort of 288 rural children, mean age 8.2 (+/- 1 SD = 1.7) years in 1996. Symmetry was measured in 1996 and 2006 from the fluctuating asymmetry (FA) of three lower- body traits and we constructed a lower body composite FA trait (Comp lb-FA). In 2010 we measured sprinting speed (for 90 m and 180 m races) in participants recruited from our original cohort. There were 163 untrained adults in our sample. We found: (i) high Comp lb and knee symmetry in 1996 and 2006 were linked to fast sprinting times in our 2010 runners and (ii) our sample of sprinters appears to have self-selected for greater symmetry. We conclude that high knee symmetry in childhood is linked to an ability to sprint fast in adult Jamaicans as well as a readiness to sprint.	[Trivers, Robert] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA; [Palestis, Brian G.] Wagner Coll, Dept Biol Sci, Staten Isl, NY 10301 USA; [Manning, John T.] Swansea Univ, Appl Sports Technol Exercise & Med Res Ctr, Swansea, W Glam, Wales	Rutgers State University New Brunswick; Swansea University	Trivers, R (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA.	trivers@rci.rutgers.edu			COUG Foundation; Ann and Gordon Getty Foundation; Biosocial Research Foundation	COUG Foundation; Ann and Gordon Getty Foundation; Biosocial Research Foundation	Financial support was provided by The COUG Foundation, The Ann and Gordon Getty Foundation, and The Biosocial Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Eisa E, 2004, EVOL HUM BEHAV, V25, P31, DOI 10.1016/S1090-5138(03)00081-3; AMA PFM, 1986, J APPL PHYSIOL, V61, P1758, DOI 10.1152/jappl.1986.61.5.1758; Babel K, 2005, INT J SPORTS MED, V26, P798, DOI 10.1055/s-2004-830562; Deason M, 2012, SCAND J MED SCI SPOR, V22, P217, DOI 10.1111/j.1600-0838.2010.01289.x; Deason ML, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-24; Entine J., 2000, TABOO WHY BLACK ATHL; Holden C, 2004, SCIENCE, V305, P637, DOI 10.1126/science.305.5684.637; Hope D, 2013, EARLY HUM DEV, V89, P531, DOI 10.1016/j.earlhumdev.2013.01.003; Longman D, 2011, INT J SPORTS MED, V32, P606, DOI 10.1055/s-0031-1275301; MANNING JT, 1994, NATURE, V370, P185, DOI 10.1038/370185a0; Manning JT, 1998, INT J SPORTS MED, V19, P205, DOI 10.1055/s-2007-971905; Manning JT, 1998, HUM NATURE-INT BIOS, V9, P53, DOI 10.1007/s12110-998-1011-4; MARKOW TA, 1992, PSYCHOL MED, V22, P295, DOI 10.1017/S0033291700030233; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Scott RA, 2010, MED SCI SPORT EXER, V42, P107, DOI 10.1249/MSS.0b013e3181ae2bc0; Simms TM, 2010, AM J PHYS ANTHROPOL, V142, P49, DOI 10.1002/ajpa.21194; Trivers R, 1999, HUM BIOL, V71, P417; VANVALEN L, 1962, EVOLUTION, V16, P125; Vollestad LA, 1999, HEREDITY, V83, P206, DOI 10.1046/j.1365-2540.1999.00555.x; Wilson JM, 1996, J HUM EVOL, V30, P529, DOI 10.1006/jhev.1996.0041	20	11	11	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72244	10.1371/journal.pone.0072244	http://dx.doi.org/10.1371/journal.pone.0072244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977263	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700156
J	Vardi-Oknin, D; Golan, M; Mabjeesh, NJ				Vardi-Oknin, Dikla; Golan, Maya; Mabjeesh, Nicola J.			Forchlorfenuron Disrupts SEPT9_i1 Filaments and Inhibits HIF-1	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MAMMALIAN SEPTIN; MICROTUBULE ORGANIZATION; TRANSCRIPTIONAL ACTIVITY; MSF-A; EXPRESSION; GENE; CYTOSKELETON; HIF-2-ALPHA; HIF-1-ALPHA	Forchlorfenuron (FCF) is a synthetic plant cytokinin that has been shown to alter yeast and mammalian septin organization. Septins are a highly conserved family of GTP-binding cytoskeletal proteins. Mammalian septins are involved in diverse cellular processes including tumorigenesis. We have been studying the interaction between septin 9 isoform 1 (SEPT9_i1) and hypoxia inducible factor-1 alpha (HIF-1 alpha), the oxygen regulated subunit of HIF-1. HIF-1 is a key transcription factor in the hypoxic responses pathway, and its activation has been observed in carcinogenesis and numerous cancers. SEPT9_i1/HIF-1 alpha interaction plays an important role in upregulation of HIF-1 transcriptional activity by preventing HIF-1 alpha's ubiquitination and degradation leading to increased tumor growth and angiogenesis. We tested the hypothesis whether FCF affects SEPT9_i1 filamentous structures and consequently HIF-1 pathway in cancer cells. We showed that FCF suppresses tumorigenic properties, including proliferation, migration and transformation, in prostate cancer cells. FCF did not alter SEPT9_i1 steady state protein expression levels but it affected its filamentous structures and subcellular localization. FCF induced degradation of HIF-1 alpha protein in a dose- and time-dependent manner. This inhibition was also shown in other common cancer types tested. Rapid degradation of HIF-1 alpha protein levels was accompanied by respective inhibition in HIF-1 alpha transcriptional activity. Moreover, HIF-1 alpha protein half-life was markedly decreased in the presence of FCF compared with that in the absence of FCF. The FCF-induced degradation of HIF-1 alpha was mediated in a significant part via the proteasome. To the best of our knowledge, this is the first demonstration of specific manipulation of septin filaments by pharmacological means having downstream inhibitory effects on the HIF-1 pathway.	[Vardi-Oknin, Dikla; Golan, Maya; Mabjeesh, Nicola J.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Prostate Canc Res Lab,Dept Urol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Mabjeesh, NJ (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Prostate Canc Res Lab,Dept Urol, IL-69978 Tel Aviv, Israel.	nicolam@tlvmc.gov.il			Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Cancer Association	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Cancer Association	This work was supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) and the Israel Cancer Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2006, CANCER RES, V66, P856, DOI 10.1158/0008-5472.CAN-05-2738; Amir S, 2009, J BIOL CHEM, V284, P11142, DOI 10.1074/jbc.M808348200; Bennett KL, 2008, CANCER RES, V68, P4494, DOI 10.1158/0008-5472.CAN-07-6509; Bowen JR, 2011, J CELL BIOL, V194, P187, DOI 10.1083/jcb.201102076; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Capurso G, 2005, NEUROENDOCRINOLOGY, V81, P311, DOI 10.1159/000088449; Connolly D, 2011, BIOL CHEM, V392, P725, DOI 10.1515/BC.2011.073; Demay BS, 2010, CYTOSKELETON, V67, P383, DOI 10.1002/cm.20452; Escuin D, 2005, CANCER RES, V65, P9021, DOI 10.1158/0008-5472.CAN-04-4095; Fuchtbauer A, 2011, BIOL CHEM, V392, P769, DOI 10.1515/BC.2011.088; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwase M, 2004, GENES GENET SYST, V79, P199, DOI 10.1266/ggs.79.199; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2003, EUR J BIOCHEM, V270, P781, DOI 10.1046/j.1432-1033.2003.03445.x; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Manisterski M, 2010, CELL CYCLE, V9, P3723, DOI 10.4161/cc.9.18.12931; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Montagna C, 2003, CANCER RES, V63, P2179; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; Ricci A, 2009, PLANT BIOLOGY, V11, P262, DOI 10.1111/j.1438-8677.2008.00165.x; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Sandrock K, 2011, BIOL CHEM, V392, P751, DOI 10.1515/BC.2011.081; Schmidt K, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-43; Scott M, 2006, INT J CANCER, V118, P1325, DOI 10.1002/ijc.21486; Sellin ME, 2012, MOL BIOL CELL, V23, P4242, DOI 10.1091/mbc.E12-06-0486; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Spiliotis ET, 2010, CYTOSKELETON, V67, P339, DOI 10.1002/cm.20448; Stanbery L, 2010, TRANSL ONCOL, V3, P239, DOI 10.1593/tlo.10109; Thomas SL, 2008, CELL CYCLE, V7, P2409, DOI 10.4161/cc.6410; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zhong H, 1998, CANCER RES, V58, P5280	39	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e73179	10.1371/journal.pone.0073179	http://dx.doi.org/10.1371/journal.pone.0073179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977378	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700193
J	Wuethrich, PY; Thalmann, GN; Studer, UE; Burkhard, FC				Wuethrich, Patrick Y.; Thalmann, George N.; Studer, Urs E.; Burkhard, Fiona C.			Epidural Analgesia during Open Radical Prostatectomy Does Not Improve Long-Term Cancer-Related Outcome: A Retrospective Study in Patients with Advanced Prostate Cancer	PLOS ONE			English	Article							KILLER-CELL CYTOTOXICITY; ANESTHETIC TECHNIQUE; HIGH-RISK; SURVIVAL; RECURRENCE; SURGERY; ANTIGEN; LYMPHADENECTOMY; METASTASIS; INDUCTION	Background: A beneficial effect of regional anesthesia on cancer related outcome in various solid tumors has been proposed. The data on prostate cancer is conflicting and reports on long-term cancer specific survival are lacking. Methods: In a retrospective, single-center study, outcomes of 148 consecutive patients with locally advanced prostate cancer pT3/4 who underwent retropubic radical prostatectomy (RRP) with general anesthesia combined with intra-and postoperative epidural analgesia (n=67) or with postoperative ketorolac-morphine analgesia (n=81) were reviewed. The median observation time was 14.00 years (range 10.87-17.75 yrs). Biochemical recurrence (BCR)-free, local and distant recurrence-free, cancer-specific, and overall survival were estimated using the Kaplan-Meier technique. Multivariate Cox proportional-hazards regression models were used to analyze clinicopathologic variables associated with disease progression and death. Results: The survival estimates for BCR-free, local and distant recurrence-free, cancer-specific survival and overall survival did not differ between the two groups (P=0.64, P=0.75, P=0.18, P=0.32 and P=0.07). For both groups, higher preoperative PSA (hazard ratio (HR) 1.02, 95% confidence interval (CI) 1.01-1.02, P<0.0001), increased specimen Gleason score (HR 1.24, 95% CI 1.06-1.46, P=0.007) and positive nodal status (HR 1.66, 95% CI 1.03-2.67, P=0.04) were associated with higher risk of BCR. Increased specimen Gleason score predicted death from prostate cancer (HR 2.46, 95% CI 1.65-3.68, P<0.0001). Conclusions: General anaesthesia combined with epidural analgesia did not reduce the risk of cancer progression or improve survival after RRP for prostate cancer in this group of patients at high risk for disease progression with a median observation time of 14.00 yrs.	[Wuethrich, Patrick Y.] Univ Hosp Bern, Univ Dept Anaesthesiol & Pain Therapy, CH-3010 Bern, Switzerland; [Thalmann, George N.; Studer, Urs E.; Burkhard, Fiona C.] Univ Hosp Bern, Dept Urol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Wuethrich, PY (corresponding author), Univ Hosp Bern, Univ Dept Anaesthesiol & Pain Therapy, CH-3010 Bern, Switzerland.	Patrick.wuethrich@insel.ch	Burkhard, Fiona/AAE-4524-2020	Burkhard, Fiona/0000-0002-8271-014X				Basler Joseph W., 2004, Journal of Urology, V171, pS59, DOI 10.1097/01.ju.0000107839.06670.27; Beilin B, 1996, ANESTH ANALG, V82, P492, DOI 10.1097/00000539-199603000-00011; Ben-Eliyahu S, 1999, ANESTHESIOLOGY, V91, P732, DOI 10.1097/00000542-199909000-00026; Benish M, 2008, ANN SURG ONCOL, V15, P2042, DOI 10.1245/s10434-008-9890-5; Biki B, 2008, ANESTHESIOLOGY, V109, P180, DOI 10.1097/ALN.0b013e31817f5b73; Brand JM, 1997, CLIN IMMUNOL IMMUNOP, V83, P190, DOI 10.1006/clin.1997.4351; Burkhard FC, 2005, NAT CLIN PRACT UROL, V2, P336, DOI 10.1038/ncpuro0245; Burkhard FC, 2008, WORLD J UROL, V26, P231, DOI 10.1007/s00345-008-0251-6; Burkhard FC, 2006, NAT CLIN PRACT UROL, V3, P454, DOI 10.1038/ncpuro0558; Christopherson R, 2008, ANESTH ANALG, V107, P325, DOI 10.1213/ane.0b013e3181770f55; DEVLIN EG, 1994, BRIT J ANAESTH, V73, P315, DOI 10.1093/bja/73.3.315; Exadaktylos AK, 2006, ANESTHESIOLOGY, V105, P660, DOI 10.1097/00000542-200610000-00008; Farooqui M, 2007, BRIT J CANCER, V97, P1523, DOI 10.1038/sj.bjc.6604057; Forget P, 2011, EUR J ANAESTH, V28, P830, DOI 10.1097/EJA.0b013e32834b7d9a; Forget P, 2010, EUR J ANAESTH, V27, P233, DOI 10.1097/EJA.0b013e32832d540e; Gupta S, 2000, PROSTATE, V42, P73, DOI 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G; Isbarn H, 2010, BJU INT, V106, P37, DOI 10.1111/j.1464-410X.2009.09134.x; James ND, 2012, LANCET ONCOL, V13, P549, DOI 10.1016/S1470-2045(12)70088-8; Jhaveri FM, 1999, UROLOGY, V54, P884, DOI 10.1016/S0090-4295(99)00252-6; Loeb S, 2007, UROLOGY, V69, P1170, DOI 10.1016/j.urology.2007.02.054; Lucia M. Scott, 2004, Journal of Urology, V171, pS30, DOI 10.1097/01.ju.0000108142.53241.47; MARKOVIC SN, 1993, ANESTHESIOLOGY, V78, P700, DOI 10.1097/00000542-199304000-00013; MARKOVIC SN, 1993, CELL IMMUNOL, V151, P474, DOI 10.1006/cimm.1993.1256; Myles PS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1491; SHAPIRO J, 1981, J CLIN INVEST, V68, P678, DOI 10.1172/JCI110303; Tsui BCH, 2010, CAN J ANAESTH, V57, P107, DOI 10.1007/s12630-009-9214-7; Ward JF, 2005, NAT CLIN PRACT UROL, V2, P174, DOI 10.1038/ncpuro0145; Ward JF, 2005, BJU INT, V95, P751, DOI 10.1111/j.1464-410X.2005.05394.x; Wuethrich PY, 2010, ANESTHESIOLOGY, V113, P570, DOI 10.1097/ALN.0b013e3181e4f6ec	29	43	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72873	10.1371/journal.pone.0072873	http://dx.doi.org/10.1371/journal.pone.0072873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977366	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700190
J	Nalls, AV; McNulty, E; Powers, J; Seelig, DM; Hoover, C; Haley, NJ; Hayes-Klug, J; Anderson, K; Stewart, P; Goldmann, W; Hoover, EA; Mathiason, CK				Nalls, Amy V.; McNulty, Erin; Powers, Jenny; Seelig, Davis M.; Hoover, Clare; Haley, Nicholas J.; Hayes-Klug, Jeanette; Anderson, Kelly; Stewart, Paula; Goldmann, Wilfred; Hoover, Edward A.; Mathiason, Candace K.			Mother to Offspring Transmission of Chronic Wasting Disease in Reeves' Muntjac Deer	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; WHITE-TAILED DEER; RESISTANT PRION PROTEIN; SCRAPIE-INFECTED SHEEP; BLOOD-TRANSFUSION; PRPSC ACCUMULATION; NATURAL SCRAPIE; MULE DEER; SYNEPITHELIOCHORIAL PLACENTA	The horizontal transmission of prion diseases has been well characterized in bovine spongiform encephalopathy (BSE), chronic wasting disease (CWD) of deer and elk and scrapie of sheep, and has been regarded as the primary mode of transmission. Few studies have monitored the possibility of vertical transmission occurring within an infected mother during pregnancy. To study the potential for and pathway of vertical transmission of CWD in the native cervid species, we used a small cervid model-the polyestrous breeding, indoor maintainable, Reeves' muntjac deer-and determined that the susceptibility and pathogenesis of CWD in these deer reproduce that in native mule and white-tailed deer. Moreover, we demonstrate here that CWD prions are transmitted from doe to fawn. Maternal CWD infection also appears to result in lower percentage of live birth offspring. In addition, evolving evidence from protein misfolding cyclic amplification (PMCA) assays on fetal tissues suggest that covert prion infection occurs in utero. Overall, our findings demonstrate that transmission of prions from mother to offspring can occur, and may be underestimated for all prion diseases.	[Nalls, Amy V.; McNulty, Erin; Hoover, Clare; Haley, Nicholas J.; Hayes-Klug, Jeanette; Anderson, Kelly; Hoover, Edward A.; Mathiason, Candace K.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Powers, Jenny] Natl Pk Serv, Biol Resource Management Div, Ft Collins, CO USA; [Seelig, Davis M.] Univ Minnesota, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Stewart, Paula; Goldmann, Wilfred] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Stewart, Paula; Goldmann, Wilfred] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland	Colorado State University; United States Department of the Interior; University of Minnesota System; University of Minnesota Twin Cities; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Mathiason, CK (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Candace.Mathiason@colostate.edu	Mathiason, Candace K/E-7843-2017; Mathiason, Candace/H-9769-2017	Mathiason, Candace K/0000-0002-5920-4556; Mathiason, Candace/0000-0002-5920-4556	NIH [N01-AI-25491, R01-AI-093634]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025491, R01AI093634] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251967, BBS/E/D/20251968] Funding Source: researchfish; BBSRC [BBS/E/D/20251968, BBS/E/D/20251967] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by NIH grants N01-AI-25491 and R01-AI-093634. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson J, 2006, J GEN VIROL, V87, P1035, DOI 10.1099/vir.0.81418-0; Andreoletti O, 2002, J GEN VIROL, V83, P2607, DOI 10.1099/0022-1317-83-10-2607; Bencsik A, 2009, PLOS ONE, V4, P7; Blanchong JA, 2012, J WILDLIFE DIS, V48, P361, DOI 10.7589/0090-3558-48.2.361; Braun U, 2009, SCHWEIZ ARCH TIERH, V151, P433, DOI 10.1024/0036-7281.151.9.433; BROTHERSTON JG, 1968, J COMP PATHOL, V78, P9, DOI 10.1016/0021-9975(68)90107-2; Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; Brugere-Picoux J, 1996, B ACAD NATL MED, V180, P300; BrugerePicoux J, 1996, B ACAD NAT MED PARIS, V180, P291; Caplazi P, 2004, J VET DIAGN INVEST, V16, P489, DOI 10.1177/104063870401600601; Garza MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027525; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2005, J VIROL, V79, P8665, DOI 10.1128/JVI.79.13.8665-8668.2005; CHAPMAN NG, 1993, DEV AN VET, V26, P199; Cho CKJ, 2007, MOL CELL PROTEOMICS, V6, P1406, DOI 10.1074/mcp.M700090-MCP200; Clarke P, 2005, J R SOC INTERFACE, V2, P19, DOI 10.1098/rsif.2004.0017; Clewley JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1442; Comoy EE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003017; Denkers ND, 2013, J VIROL, V87, P1890, DOI 10.1128/JVI.02852-12; Dickinson AG, 1974, J COMP PATHOLOGY, V84; EKLUND CM, 1973, MEDICINE, V52, P357, DOI 10.1097/00005792-197307000-00014; Espinosa JC, 2007, J GEN VIROL, V88, P1379, DOI 10.1099/vir.0.82647-0; Goldfarb LG, 2004, CURR MOL MED, V4, P375, DOI 10.2174/1566524043360627; Grassi R, 2005, AM J ROENTGENOL, V185, P1322, DOI 10.2214/AJR.04.1114; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; HARDING R, 1984, Q J EXP PHYSIOL CMS, V69, P487, DOI 10.1113/expphysiol.1984.sp002835; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; HOURRIGAN JL, 1990, J AM VET MED ASSOC, V196, P1678; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Hunter N, 2012, J VIROL, V86, P11856, DOI 10.1128/JVI.01573-12; Ironside JW, 2000, HISTOPATHOLOGY, V37, P1, DOI 10.1046/j.1365-2559.2000.00946.x; Jennelle CS, 2009, J TOXICOL ENV HEAL A, V72, P1018, DOI 10.1080/15287390903084249; Kariv-Inbal Z, 2006, NEURODEGENER DIS, V3, P123, DOI 10.1159/000094770; Konold T, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-14; Lacroux C, 2007, J GEN VIROL, V88, P1056, DOI 10.1099/vir.0.82218-0; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Ligios C, 2005, NAT MED, V11, P1137, DOI 10.1038/nm1105-1137; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2013, J VIROL, V87, P1947, DOI 10.1128/JVI.02592-12; Mathiason CK, 2010, J VIROL, V84, P5097, DOI 10.1128/JVI.02169-09; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; McCutcheon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023169; McIntyre K Marie, 2006, BMC Vet Res, V2, P20, DOI 10.1186/1746-6148-2-20; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Miller MW, 1998, J WILDLIFE DIS, V34, P532, DOI 10.7589/0090-3558-34.3.532; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Murray K, 2011, J NEUROL NEUROSUR PS, V82, P729, DOI 10.1136/jnnp.2009.172148; MYAGKAYA G, 1981, CELL TISSUE RES, V214, P501, DOI 10.1007/BF00233491; ONODERA T, 1993, MICROBIOL IMMUNOL, V37, P311, DOI 10.1111/j.1348-0421.1993.tb03215.x; PATTISON IH, 1965, VET REC, V77, P1388, DOI 10.1136/vr.77.47.1388; Peden AH, 2005, FOLIA NEUROPATHOL, V43, P271; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Race R, 1998, J INFECT DIS, V178, P949, DOI 10.1086/515669; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; Ross MG, 1998, AM J PHYSIOL-REG I, V274, pR879, DOI 10.1152/ajpregu.1998.274.4.R879; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Safar JG, 2008, J INFECT DIS, V198, P81, DOI 10.1086/588193; Saunders SE, 2008, PRION, V2, P162, DOI 10.4161/pri.2.4.7951; Siso S, 2006, BLOOD, V108, P745, DOI 10.1182/blood-2005-12-5156; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; TAMAI Y, 1992, NEW ENGL J MED, V327, P649; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; Team E, 2007, EUROSURVEILLANCE, V12; Terry LA, 2009, J VIROL, V83, P12552, DOI 10.1128/JVI.00311-09; Touzeau S, 2006, ARCH VIROL, V151, P735, DOI 10.1007/s00705-005-0666-y; Tuo WB, 2002, P NATL ACAD SCI USA, V99, P6310, DOI 10.1073/pnas.072071199; Tuo WB, 2001, J BIOL CHEM, V276, P18229, DOI 10.1074/jbc.M008887200; Williams E.S., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P551; Williams ES, 2002, J WILDLIFE MANAGE, V66, P551, DOI 10.2307/3803123; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wooding FBP, 1997, MICROSC RES TECHNIQ, V38, P88; WOODING FBP, 1992, PLACENTA, V13, P101, DOI 10.1016/0143-4004(92)90025-O; WOODING FBP, 1982, J REPROD FERTIL, P31; WOODING FBP, 1994, MARSHALLS PHYSL REPR, V3, P230; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	79	52	56	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71844	10.1371/journal.pone.0071844	http://dx.doi.org/10.1371/journal.pone.0071844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977159	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500107
J	Risner, LE; Kuntimaddi, A; Lokken, AA; Achille, NJ; Birch, NW; Schoenfelt, K; Bushweller, JH; Zeleznik-Le, NJ				Risner, Laurie E.; Kuntimaddi, Aravinda; Lokken, Alyson A.; Achille, Nicholas J.; Birch, Noah W.; Schoenfelt, Kelly; Bushweller, John H.; Zeleznik-Le, Nancy J.			Functional Specificity of CpG DNA-binding CXXC Domains in Mixed Lineage Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN MBD1; TRANSCRIPTIONAL REPRESSION; METHYLATION; GENE; COMPLEX; TRANSFORMATION; EXPRESSION; TRITHORAX; METHYLTRANSFERASE; TRANSLOCATIONS	The MLL CXXC domain binds nonmethylated CpG-containing DNA and is essential for the oncogenic properties of MLL fusion proteins. To determine potential functional promiscuity of similar DNA binding domains, we replaced the MLL CXXC domain in the context of the leukemogenic MLL-AF9 fusion with CXXC domains from DNMT1, CGBP (CFP1), and MBD1, or with a methyl-CpG-binding domain (MBD) from MBD1. MLL(DNMT1CXXC)-AF9 shows robust in vitro colony forming activity and in vivo leukemogenesis, similar to MLL-AF9. However, colony forming ability and leukemogenicity are abrogated in MLL-AF9 containing either the CGBP or MBD1 CXXC domains or the MBD1 MBD domain. Direct comparison of in vitro DNA binding affinity of the isolated CXXC or MBD domains demonstrated that MLL, DNMT1, and CGBP CXXC domains could each bind to unmethylated DNA but with differing affinity. In contrast, the isolated MBD1 CXXC and MBD1 MBD domains were unable to bind to the same DNA. However, all substituted domains still allowed targeting of the MLL fusions to the functionally important Hoxa9 locus in primary bone marrow progenitor cells. In addition to DNA binding activity, it was critical that specific CpG residues in the Hoxa9 locus were protected from methylation for leukemia development. This ultimately prevented histone 3 lysine 9 trimethylation (H3K9me3) of the locus and enabled Hoxa9 expression. These were properties shared by MLL and DNMT1 CXXC domains but not by CGBP CXXC or the other swapped fusions tested. We demonstrate that similar CXXC domains can be mechanistically distinguished by specificity of CpG nucleotides preferentially protected from DNA methylation.	[Risner, Laurie E.; Lokken, Alyson A.] Loyola Univ, Med Ctr, Program Mol Biol, Maywood, IL 60153 USA; [Kuntimaddi, Aravinda; Bushweller, John H.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Achille, Nicholas J.; Zeleznik-Le, Nancy J.] Loyola Univ, Med Ctr, Inst Oncol, Maywood, IL 60153 USA; [Birch, Noah W.] Loyola Univ, Med Ctr, Mol & Cellular Biochem Program, Maywood, IL 60153 USA; [Schoenfelt, Kelly] Loyola Univ, Med Ctr, Dept Physiol, Maywood, IL 60153 USA; [Zeleznik-Le, Nancy J.] Loyola Univ, Med Ctr, Dept Med, Maywood, IL 60153 USA	Loyola University Chicago; University of Virginia; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Zeleznik-Le, NJ (corresponding author), Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, 2160 S 1st Ave,Bldg 112,Rm 337, Maywood, IL 60153 USA.	nzelezn@lumc.edu		Bushweller, John/0000-0002-5386-1758	National Institutes of Health [CA105049, HL087188]; Dr. Ralph and Marian Falk Medical Research Trust; Arthur J. Schmitt Foundation; Leukemia and Lymphoma Society SCOR Grant [7006-05]; National Institutes of Health, NHLBI [1F30HL103208-01]; Stritch School of Medicine M.D./Ph.D. program; National Institutes of Health Experimental Immunology Training Grant [T32 AI007508-11A1]; NATIONAL CANCER INSTITUTE [R01CA155328, P01CA105049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087188, F30HL103208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Ralph and Marian Falk Medical Research Trust; Arthur J. Schmitt Foundation; Leukemia and Lymphoma Society SCOR Grant(Leukemia and Lymphoma Society); National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Stritch School of Medicine M.D./Ph.D. program; National Institutes of Health Experimental Immunology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA105049 and HL087188 (to N. J. Z.-L.); the Dr. Ralph and Marian Falk Medical Research Trust (to N. J. Z.-L.); the Arthur J. Schmitt Foundation (to L. E. R.); National Institutes of Health Experimental Immunology Training Grant T32 AI007508-11A1 (to L. E. R.); Leukemia and Lymphoma Society SCOR Grant 7006-05 (to J. H. B.); National Institutes of Health, NHLBI 1F30HL103208-01 (to N. W. B.); and the Stritch School of Medicine M.D./Ph.D. program (to N.W.B.).	Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2004, MOL CELL BIOL, V24, P10470, DOI 10.1128/MCB.24.23.10470-10478.2004; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; BERNARD OA, 1995, GENE CHROMOSOME CANC, V13, P75, DOI 10.1002/gcc.2870130202; Birke M, 2002, NUCLEIC ACIDS RES, V30, P958, DOI 10.1093/nar/30.4.958; CHEN CS, 1993, BLOOD, V82, P1080; Cierpicki T, 2010, NAT STRUCT MOL BIOL, V17, P62, DOI 10.1038/nsmb.1714; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; Erfurth FE, 2008, P NATL ACAD SCI USA, V105, P7517, DOI 10.1073/pnas.0800090105; Fujita N, 2003, J BIOL CHEM, V278, P24132, DOI 10.1074/jbc.M302283200; Fujita N, 1999, MOL CELL BIOL, V19, P6415; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Iida T, 2002, GENES CELLS, V7, P997, DOI 10.1046/j.1365-2443.2002.00584.x; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; MA Q, 1993, P NATL ACAD SCI USA, V90, P6350, DOI 10.1073/pnas.90.13.6350; Mann G, 2010, BLOOD, V116, P2644, DOI 10.1182/blood-2010-03-273532; Milne TA, 2010, MOL CELL, V38, P853, DOI 10.1016/j.molcel.2010.05.011; Muntean AG, 2010, CANCER CELL, V17, P609, DOI 10.1016/j.ccr.2010.04.012; Ng HH, 2000, MOL CELL BIOL, V20, P1394, DOI 10.1128/MCB.20.4.1394-1406.2000; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Reese BE, 2003, MOL CELL BIOL, V23, P3226, DOI 10.1128/MCB.23.9.3226-3236.2003; ROWLEY JD, 1993, SEMIN CANCER BIOL, V4, P377; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Wade PA, 2001, BIOESSAYS, V23, P1131, DOI 10.1002/bies.10008; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; ZELEZNIKLE NJ, 1994, P NATL ACAD SCI USA, V91, P10610, DOI 10.1073/pnas.91.22.10610	35	21	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29901	29910		10.1074/jbc.M113.474858	http://dx.doi.org/10.1074/jbc.M113.474858			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23990460	Green Published, hybrid			2022-12-25	WOS:000330615300063
J	Laing, C; Jung, S; Kim, N; Elmetwaly, S; Zahran, M; Schlick, T				Laing, Christian; Jung, Segun; Kim, Namhee; Elmetwaly, Shereef; Zahran, Mai; Schlick, Tamar			Predicting Helical Topologies in RNA Junctions as Tree Graphs	PLOS ONE			English	Article							CANDIDATE STRUCTURED RNAS; IN-VITRO SELECTION; SECONDARY STRUCTURES; DESIGN; MOTIFS; DATABASE; POOLS; IDENTIFICATION; ALGORITHMS; MOLECULES	RNA molecules are important cellular components involved in many fundamental biological processes. Understanding the mechanisms behind their functions requires knowledge of their tertiary structures. Though computational RNA folding approaches exist, they often require manual manipulation and expert intuition; predicting global long-range tertiary contacts remains challenging. Here we develop a computational approach and associated program module (RNAJAG) to predict helical arrangements/topologies in RNA junctions. Our method has two components: junction topology prediction and graph modeling. First, junction topologies are determined by a data mining approach from a given secondary structure of the target RNAs; second, the predicted topology is used to construct a tree graph consistent with geometric preferences analyzed from solved RNAs. The predicted graphs, which model the helical arrangements of RNA junctions for a large set of 200 junctions using a cross validation procedure, yield fairly good representations compared to the helical configurations in native RNAs, and can be further used to develop all-atom models as we show for two examples. Because junctions are among the most complex structural elements in RNA, this work advances folding structure prediction methods of large RNAs. The RNAJAG module is available to academic users upon request.	[Laing, Christian] Wilkes Univ, Dept Biol, Wilkes Barre, PA 18766 USA; [Laing, Christian] Wilkes Univ, Dept Math & Comp Sci, Wilkes Barre, PA 18766 USA; [Jung, Segun; Kim, Namhee; Elmetwaly, Shereef; Zahran, Mai; Schlick, Tamar] NYU, Dept Chem, New York, NY 10003 USA; [Schlick, Tamar] NYU, Courant Inst Math Sci, New York, NY USA	Wilkes University; Wilkes University; New York University; New York University	Schlick, T (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	schlick@nyu.edu	Elmetwaly, Shereef/H-5678-2019; Elmetwaly, Shereef/D-8097-2016	Elmetwaly, Shereef/0000-0002-0615-7071; Elmetwaly, Shereef/0000-0002-0615-7071; Schlick, Tamar/0000-0002-2392-2062	National Science Foundation [CCF-0727001]; National Institutes of Health [GM081410, GM100469]; MacCracken Fellowship; Research Corporation (Cottrell College Science Award); National Science Foundation, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081410, R01GM100469] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MacCracken Fellowship; Research Corporation (Cottrell College Science Award)(Research Corporation for Science Advancement); National Science Foundation, National Institutes of Health(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation [EMT award CCF-0727001 to T. S.]; and National Institutes of Health [grants GM081410 and GM100469 to T. S.]; and a MacCracken Fellowship to S.J; and the Research Corporation (Cottrell College Science Award) to C. L. Funding for open access charge: National Science Foundation, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andronescu M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-340; Benedetti G, 1996, BIOPHYS CHEM, V59, P179, DOI 10.1016/0301-4622(95)00119-0; Cruz JA, 2012, RNA, V18, P610, DOI 10.1261/rna.031054.111; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Frellsen J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000406; Gan HH, 2004, BIOINFORMATICS, V20, P1285, DOI 10.1093/bioinformatics/bth084; Gan HH, 2003, NUCLEIC ACIDS RES, V31, P2926, DOI 10.1093/nar/gkg365; Gendron P, 2001, J MOL BIOL, V308, P919, DOI 10.1006/jmbi.2001.4626; Gopal A, 2012, RNA, V18, P284, DOI 10.1261/rna.027557.111; Gorodkin J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002100; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hajdin CE, 2010, RNA, V16, P1340, DOI 10.1261/rna.1837410; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; HOLBROOK SR, 1978, J MOL BIOL, V123, P631, DOI 10.1016/0022-2836(78)90210-3; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Izzo JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-219; Jonikas MA, 2009, RNA, V15, P189, DOI 10.1261/rna.1270809; Jossinet F, 2010, BIOINFORMATICS, V26, P2057, DOI 10.1093/bioinformatics/btq321; Kim N, 2004, J MOL BIOL, V341, P1129, DOI 10.1016/j.jmb.2004.06.054; Kim N, 2013, BIOPHYSICS RNA FOLDI; Kim N, 2013, WSEAS T MATH; Kim N, 2007, BIOINFORMATICS, V23, P2959, DOI 10.1093/bioinformatics/btm439; Kim N, 2007, RNA, V13, P478, DOI 10.1261/rna.374907; Kim N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq282; Koessler DR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S21; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Laederach A, 2007, RNA, V13, P643, DOI 10.1261/rna.381407; Laing C, 2012, NUCLEIC ACIDS RES, V40, P487, DOI 10.1093/nar/gkr629; Laing C, 2011, CURR OPIN STRUC BIOL, V21, P306, DOI 10.1016/j.sbi.2011.03.015; Laing C, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/28/283101; Laing C, 2009, J MOL BIOL, V393, P67, DOI 10.1016/j.jmb.2009.07.089; Laing C, 2009, J MOL BIOL, V390, P547, DOI 10.1016/j.jmb.2009.04.084; LE SY, 1989, COMPUT BIOMED RES, V22, P461, DOI 10.1016/0010-4809(89)90039-6; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; Martinez HM, 2008, J BIOMOL STRUCT DYN, V25, P669, DOI 10.1080/07391102.2008.10531240; Masquida B, 2010, NEW BIOTECHNOL, V27, P170, DOI 10.1016/j.nbt.2010.02.022; Meyer MM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-268; Nanias M, 2003, P NATL ACAD SCI USA, V100, P1706, DOI 10.1073/pnas.252760199; NUSSINOV R, 1980, P NATL ACAD SCI-BIOL, V77, P6309, DOI 10.1073/pnas.77.11.6309; NUSSINOV R, 1978, SIAM J APPL MATH, V35, P68, DOI 10.1137/0135006; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Parisien M, 2009, RNA, V15, P1875, DOI 10.1261/rna.1700409; Rother K, 2011, J MOL MODEL, V17, P2325, DOI 10.1007/s00894-010-0951-x; Sarver M, 2008, J MATH BIOL, V56, P215, DOI 10.1007/s00285-007-0110-x; SCHLICK T, 1988, J COMPUT CHEM, V9, P861, DOI 10.1002/jcc.540090809; Schlick T, 2011, Q REV BIOPHYS, V44, P191, DOI 10.1017/S0033583510000284; SHAPIRO BA, 1990, COMPUT APPL BIOSCI, V6, P309; Sharma S, 2008, BIOINFORMATICS, V24, P1951, DOI 10.1093/bioinformatics/btn328; Sim AYL, 2012, P NATL ACAD SCI USA, V109, P2890, DOI 10.1073/pnas.1119918109; Waterman M.S., 1978, ADV MATH SUPPLEMENTA, V1, P167; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Xin YR, 2008, RNA, V14, P2465, DOI 10.1261/rna.1249208; Yang HW, 2003, NUCLEIC ACIDS RES, V31, P3450, DOI 10.1093/nar/gkg529; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	57	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71947	10.1371/journal.pone.0071947	http://dx.doi.org/10.1371/journal.pone.0071947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991010	gold, Green Submitted, Green Published			2022-12-25	WOS:000324228800027
J	Kaneko, K; Ikeda, T; Nagai, M; Hori, S; Umatani, C; Tadano, H; Ugajin, A; Nakaoka, T; Paul, RK; Fujiyuki, T; Shirai, K; Kunieda, T; Takeuchi, H; Kubo, T				Kaneko, Kumi; Ikeda, Tsubomi; Nagai, Mirai; Hori, Sayaka; Umatani, Chie; Tadano, Hiroto; Ugajin, Atsushi; Nakaoka, Takayoshi; Paul, Rajib Kumar; Fujiyuki, Tomoko; Shirai, Kenichi; Kunieda, Takekazu; Takeuchi, Hideaki; Kubo, Takeo			Novel Middle-Type Kenyon Cells in the Honeybee Brain Revealed by Area-Preferential Gene Expression Analysis	PLOS ONE			English	Article							SHORT-TERM-MEMORY; MUSHROOM BODIES; APIS-MELLIFERA; TRANSCRIPTION FACTOR; BODY; IDENTIFICATION; LOCALIZATION; ORGANIZATION; DROSOPHILA; PROTEINS	The mushroom bodies (a higher center) of the honeybee (Apis mellifera L) brain were considered to comprise three types of intrinsic neurons, including large- and small-type Kenyon cells that have distinct gene expression profiles. Although previous neural activity mapping using the immediate early gene kakusei suggested that small-type Kenyon cells are mainly active in forager brains, the precise Kenyon cell types that are active in the forager brain remain to be elucidated. We searched for novel gene(s) that are expressed in an area-preferential manner in the honeybee brain. By identifying and analyzing expression of a gene that we termed mKast (middle-type Kenyon cell-preferential arrestin-related protein), we discovered novel 'middle-type Kenyon cells' that are sandwiched between large- and small-type Kenyon cells and have a gene expression profile almost complementary to those of large- and small-type Kenyon cells. Expression analysis of kakusei revealed that both small-type Kenyon cells and some middle-type Kenyon cells are active in the forager brains, suggesting their possible involvement in information processing during the foraging flight. mKast expression began after the differentiation of small- and large-type Kenyon cells during metamorphosis, suggesting that middle-type Kenyon cells differentiate by modifying some characteristics of large- and/or small-type Kenyon cells. Interestingly, CaMKII and mKast, marker genes for large- and middle-type Kenyon cells, respectively, were preferentially expressed in a distinct set of optic lobe (a visual center) neurons. Our findings suggested that it is not simply the Kenyon cell-preferential gene expression profiles, rather, a 'clustering' of neurons with similar gene expression profiles as particular Kenyon cell types that characterize the honeybee mushroom body structure.	[Kaneko, Kumi; Ikeda, Tsubomi; Nagai, Mirai; Hori, Sayaka; Umatani, Chie; Tadano, Hiroto; Ugajin, Atsushi; Nakaoka, Takayoshi; Paul, Rajib Kumar; Fujiyuki, Tomoko; Shirai, Kenichi; Kunieda, Takekazu; Takeuchi, Hideaki; Kubo, Takeo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo	Kubo, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	stkubo@biol.s.u-tokyo.ac.jp	Fujiyuki, Tomoko Kaito/GYD-6398-2022; Takeuchi, Hideaki/W-6739-2018; KUBO, TAKEO/G-4951-2014; TAKEUCHI, HIDEAKI/G-4969-2014; Kunieda, Takekazu/G-4946-2014	Fujiyuki, Tomoko Kaito/0000-0001-5533-4129; Takeuchi, Hideaki/0000-0001-6610-3895; Ugajin, Atsushi/0000-0003-1834-3565; Kunieda, Takekazu/0000-0002-6256-1335; Umatani, Chie/0000-0003-3612-4374; Kubo, Takeo/0000-0002-5914-5269	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Grant-in-Aid for Scientific Research (B) and Grant-in Aid for Scientific Research on Innovative Areas "Systems Molecular Ethology" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; Farris SM, 2011, P ROY SOC B-BIOL SCI, V278, P940, DOI 10.1098/rspb.2010.2161; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Ganeshina O, 2000, J COMP NEUROL, V417, P349, DOI 10.1002/(SICI)1096-9861(20000214)417:3&lt;349::AID-CNE8&gt;3.0.CO;2-E; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Hammer M, 1998, LEARN MEMORY, V5, P146; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Han SO, 2013, EMBO REP, V14, P164, DOI 10.1038/embor.2012.187; Hayashi Y, 2009, NAT NEUROSCI, V12, P981, DOI 10.1038/nn.2347; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Kage E, 2005, CURR BIOL, V15, P1554, DOI 10.1016/j.cub.2005.07.057; Kamikouchi A, 1998, BIOCHEM BIOPH RES CO, V242, P181, DOI 10.1006/bbrc.1997.7870; Kamikouchi A, 2000, J COMP NEUROL, V417, P501, DOI 10.1002/(SICI)1096-9861(20000221)417:4&lt;501::AID-CNE8&gt;3.0.CO;2-4; Kaneko K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009213; Kiya T, 2008, INSECT MOL BIOL, V17, P531, DOI 10.1111/j.1365-2583.2008.00821.x; Kiya T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019301; Kobayashi M, 2006, P NATL ACAD SCI USA, V103, P14417, DOI 10.1073/pnas.0606571103; Kubo T, 1996, J BIOCHEM-TOKYO, V119, P291, DOI 10.1093/oxfordjournals.jbchem.a021237; Kunieda T, 2004, BIOCHEM BIOPH RES CO, V318, P25, DOI 10.1016/j.bbrc.2004.03.178; Locatelli F, 2005, J NEUROSCI, V25, P11614, DOI 10.1523/JNEUROSCI.3180-05.2005; Menzel R, 2006, CELL, V124, P237, DOI 10.1016/j.cell.2006.01.011; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Mobbs P.G., 1985, P299; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Paul RK, 2006, ZOOL SCI, V23, P1085, DOI 10.2108/zsj.23.1085; Paul RK, 2005, INSECT MOL BIOL, V14, P9, DOI 10.1111/j.1365-2583.2004.00524.x; Rybak J, 1998, LEARN MEMORY, V5, P133; Rybak J, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00030; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawata M, 2002, RNA, V8, P772, DOI 10.1017/S1355838202028790; Seeley T., 1995, WISDOM HIVE SOCIAL P; Sen Sarma M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-202; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Takeuchi H, 2004, CELL TISSUE RES, V316, P281, DOI 10.1007/s00441-004-0865-y; Takeuchi H, 2002, FEBS LETT, V513, P230, DOI 10.1016/S0014-5793(02)02319-0; Takeuchi H, 2001, INSECT MOL BIOL, V10, P487, DOI 10.1046/j.0962-1075.2001.00288.x; Takeuchi H, 2007, ZOOL SCI, V24, P596, DOI 10.2108/zsj.24.596; Ugajin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032902; Uno Y, 2013, INSECT MOL BIOL, V22, P52, DOI 10.1111/imb.12002; Uno Y, 2007, FEBS LETT, V581, P97, DOI 10.1016/j.febslet.2006.12.004; VONFRISCH K, 1967, SCIENCE, V158, P1072; Waddell S, 2001, TRENDS GENET, V17, P719, DOI 10.1016/S0168-9525(01)02526-4; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Winston M. L, 1986, BIOL HONEYBEE; WITHERS GS, 1995, J NEUROBIOL, V26, P130, DOI 10.1002/neu.480260111; Yamazaki Y, 2006, FEBS LETT, V580, P2667, DOI 10.1016/j.febslet.2006.04.016; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	52	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71732	10.1371/journal.pone.0071732	http://dx.doi.org/10.1371/journal.pone.0071732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990981	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100052
J	Lowery-North, DW; Hertzberg, VS; Elon, L; Cotsonis, G; Hilton, SA; Vaughns, CF; Hill, E; Shrestha, A; Jo, A; Adams, N				Lowery-North, Douglas W.; Hertzberg, Vicki Stover; Elon, Lisa; Cotsonis, George; Hilton, Sarah A.; Vaughns, Christopher F., II; Hill, Eric; Shrestha, Alok; Jo, Alexandria; Adams, Nathan			Measuring Social Contacts in the Emergency Department	PLOS ONE			English	Article							TRANSMISSION; NETWORK; RISK	Background: Infectious individuals in an emergency department (ED) bring substantial risks of cross infection. Data about the complex social and spatial structure of interpersonal contacts in the ED will aid construction of biologically plausible transmission risk models that can guide cross infection control. Methods and Findings: We sought to determine the number and duration of contacts among patients and staff in a large, busy ED. This prospective study was conducted between 1 July 2009 and 30 June 2010. Two 12-hour shifts per week were randomly selected for study. The study was conducted in the ED of an urban hospital. There were 81 shifts in the planned random sample of 104 (78%) with usable contact data, during which there were 9183 patient encounters. Of these, 6062 (66%) were approached to participate, of which 4732 (78%) agreed. Over the course of the year, 88 staff members participated (84%). A radiofrequency identification (RFID) system was installed and the ED divided into 89 distinct zones structured so copresence of two individuals in any zone implied a very high probability of contact <1 meter apart in space. During study observation periods, patients and staff were given RFID tags to wear. Contact events were recorded. These were further broken down with respect to the nature of the contacts, i.e., patient with patient, patient with staff, and staff with staff. 293,171 contact events were recorded, with a median of 22 contact events and 9 contacts with distinct individuals per participant per shift. Staff-staff interactions were more numerous and longer than patient-patient or patient-staff interactions. Conclusions: We used RFID to quantify contacts between patients and staff in a busy ED. These results are useful for studies of the spread of infections. By understanding contact patterns most important in potential transmission, more effective prevention strategies may be implemented.	[Lowery-North, Douglas W.; Hilton, Sarah A.; Vaughns, Christopher F., II; Shrestha, Alok; Jo, Alexandria] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; [Hertzberg, Vicki Stover; Elon, Lisa; Cotsonis, George; Hill, Eric; Adams, Nathan] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA	Emory University; Emory University	Lowery-North, DW (corresponding author), Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA.	DLOWERY@emory.edu			National Institute of Allergy and Infectious Diseases (NIAID) Center of Excellence in Influenza Research and Surveillance at Emory University [HHSN266200700006C]	National Institute of Allergy and Infectious Diseases (NIAID) Center of Excellence in Influenza Research and Surveillance at Emory University	This study was funded by the National Institute of Allergy and Infectious Diseases (NIAID) Center of Excellence in Influenza Research and Surveillance at Emory University (contract HHSN266200700006C, Richard Compans and Walter Orenstein, PIs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; FARIZO KM, 1991, PEDIATRICS, V87, P74; Farquharson Carolyn, 2003, J Emerg Nurs, V29, P222, DOI 10.1067/men.2003.109; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Ghendon Y., 1992, World Health Statistics Quarterly, V45, P306; Gundlapalli A, 2009, SOCIAL NETWORK ANAL, P213; Hornbeck T, 2012, J INFECT DIS, V206, P1549, DOI 10.1093/infdis/jis542; Isella L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017144; Isella L, 2011, J THEOR BIOL, V271, P166, DOI 10.1016/j.jtbi.2010.11.033; Jones RM, 2011, RISK ANAL, V31, P1226, DOI 10.1111/j.1539-6924.2011.01598.x; Kamps B, 2003, SARS REFERENCE, P170; Marascuilo LA, 1977, NONPARAMETRIC DISTRI; MIRANDA AC, 1994, INT J EPIDEMIOL, V23, P843, DOI 10.1093/ije/23.4.843; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Onnela JP, 2007, NEW J PHYS, V9, P27; Polgreen PM, 2010, INFECT CONT HOSP EP, V31, P893, DOI 10.1086/655466; Quach C, 2012, CAN MED ASSOC J, V184, pE232, DOI 10.1503/cmaj.110372; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Schuur JD, 2012, NEW ENGL J MED, V367, P391, DOI 10.1056/NEJMp1204431; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; US GAO, 2009, HOSP EM DEP CROWD CO; Varia M, 2003, CAN MED ASSOC J, V169, P285	26	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e70854	10.1371/journal.pone.0070854	http://dx.doi.org/10.1371/journal.pone.0070854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990915	gold, Green Submitted, Green Published			2022-12-25	WOS:000324470100033
J	Melzer, N; Wittenburg, D; Repsilber, D				Melzer, Nina; Wittenburg, Doerte; Repsilber, Dirk			Integrating Milk Metabolite Profile Information for the Prediction of Traditional Milk Traits Based on SNP Information for Holstein Cows	PLOS ONE			English	Article							NUCLEOTIDE; GENE; ASSOCIATION; SELECTION; SUBSETS; ABILITY; VALUES; YIELD; RISK; SET	In this study the benefit of metabolome level analysis for the prediction of genetic value of three traditional milk traits was investigated. Our proposed approach consists of three steps: First, milk metabolite profiles are used to predict three traditional milk traits of 1,305 Holstein cows. Two regression methods, both enabling variable selection, are applied to identify important milk metabolites in this step. Second, the prediction of these important milk metabolite from single nucleotide polymorphisms (SNPs) enables the detection of SNPs with significant genetic effects. Finally, these SNPs are used to predict milk traits. The observed precision of predicted genetic values was compared to the results observed for the classical genotype-phenotype prediction using all SNPs or a reduced SNP subset (reduced classical approach). To enable a comparison between SNP subsets, a special invariable evaluation design was implemented. SNPs close to or within known quantitative trait loci (QTL) were determined. This enabled us to determine if detected important SNP subsets were enriched in these regions. The results show that our approach can lead to genetic value prediction, but requires less than 1% of the total amount of (40,317) SNPs., significantly more important SNPs in known QTL regions were detected using our approach compared to the reduced classical approach. Concluding, our approach allows a deeper insight into the associations between the different levels of the genotype-phenotype map (genotype-metabolome, metabolome-phenotype, genotype-phenotype).	[Melzer, Nina; Wittenburg, Doerte; Repsilber, Dirk] Leibniz Inst Farm Anim Biol, Inst Genet & Biometry, Dummerstorf, Mecklenburg Wes, Germany	Forschungsinstitut fur Nutztierbiologie (FBN)	Repsilber, D (corresponding author), Leibniz Inst Farm Anim Biol, Inst Genet & Biometry, Dummerstorf, Mecklenburg Wes, Germany.	repsilber@fbn-dummerstorf.de		Wittenburg, Dorte/0000-0002-3639-2574	Federal ministry of Education and Research, Germany, FUGATO plus [0315137]	Federal ministry of Education and Research, Germany, FUGATO plus	Federal ministry of Education and Research, Germany, FUGATO plus, grant number 0315137. (BMBF, http://www.bmbf.de/en/index.php) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; BOLANDER FF, 1979, BIOCHEM BIOPH RES CO, V90, P1131, DOI 10.1016/0006-291X(79)91153-7; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cabrita ARJ, 2003, J DAIRY SCI, V86, P4020, DOI 10.3168/jds.S0022-0302(03)74013-2; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Cole JB, 2009, J DAIRY SCI, V92, P2931, DOI 10.3168/jds.2008-1762; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; Dejean S, 2011, MIXOMICS OMICS DATA; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Farr V. C., 2002, Proceedings of the New Zealand Society of Animal Production, V62, P22; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Geishauser T, 2000, J DAIRY SCI, V83, P296, DOI 10.3168/jds.S0022-0302(00)74877-6; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Habier D, 2009, GENETICS, V182, P343, DOI 10.1534/genetics.108.100289; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Ishwaran H, 2005, ANN STAT, V33, P730, DOI 10.1214/009053604000001147; Klein MS, 2012, J PROTEOME RES, V11, P1373, DOI 10.1021/pr201017n; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Loser C, 2000, BRIT J NUTR, V84, pS55; Melzer N, 2013, J DAIRY SCI, V96, P1521, DOI 10.3168/jds.2012-5743; Melzer N, 2010, PROCEEDINGS OF THE 9; Melzer N, 2013, ARCH TIERZUCHT, V56, P380, DOI 10.7482/0003-9438-56-037; Meuwissen THE, 2001, GENETICS, V157, P1819; Moser G, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-37; Mrode RA, 2005, LINEAR MODELS FOR THE PREDICTION OF ANIMAL BREEDING VALUES, 2ND EDITION, P1, DOI [10.1079/9781780643915.0000, 10.1079/9780851990002.0000]; PINHEIRO J., 2009, NLME LINEAR NONLINEA; R Development Core Team, 2010, R LANG ENV STAT COMP; Saebo S, 2008, CHEMOMETR INTELL LAB, V91, P121, DOI 10.1016/j.chemolab.2007.10.006; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; SANGUANSERMSRI J, 1974, AM J CLIN NUTR, V27, P859, DOI 10.1093/ajcn/27.8.859; Topel A, 2004, CHEM PHYS MILCH; Toro MA, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-33; Vazquez AI, 2010, J DAIRY SCI, V93, P5942, DOI 10.3168/jds.2010-3335; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Weigel KA, 2009, J DAIRY SCI, V92, P5248, DOI 10.3168/jds.2009-2092; Weller JI, 2011, J DAIRY SCI, V94, P1082, DOI 10.3168/jds.2010-3793; Wittenburg D, 2013, J DAIRY SCI, V96, P2557, DOI 10.3168/jds.2012-5635; Wittenburg D, 2011, 62 ANN M EAAP 62 ANN, P116; Wold H, 1975, SOFT MODELLING LATEN, P117	44	11	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e70256	10.1371/journal.pone.0070256	http://dx.doi.org/10.1371/journal.pone.0070256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990900	Green Submitted, gold, Green Published			2022-12-25	WOS:000324470100021
J	Nordbeck, P; Bonhof, L; Hiller, KH; Voll, S; Arias-Loza, P; Seidlmayer, L; Williams, T; Ye, YX; Gensler, D; Pelzer, T; Ertl, G; Jakob, PM; Bauer, WR; Ritter, O				Nordbeck, Peter; Boenhof, Leoni; Hiller, Karl-Heinz; Voll, Sabine; Arias-Loza, Paula; Seidlmayer, Lea; Williams, Tatjana; Ye, Yu-Xiang; Gensler, Daniel; Pelzer, Theo; Ertl, Georg; Jakob, Peter M.; Bauer, Wolfgang R.; Ritter, Oliver			Impact of Thoracic Surgery on Cardiac Morphology and Function in Small Animal Models of Heart Disease: A Cardiac MRI Study in Rats	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; EXPRESSION; MICE; SIZE	Background: Surgical procedures in small animal models of heart disease might evoke alterations in cardiac morphology and function. The aim of this study was to reveal and quantify such potential artificial early or long term effects in vivo, which might account for a significant bias in basic cardiovascular research, and, therefore, could potentially question the meaning of respective studies. Methods: Female Wistar rats (n = 6 per group) were matched for weight and assorted for sham left coronary artery ligation or control. Cardiac morphology and function was then investigated in vivo by cine magnetic resonance imaging at 7 Tesla 1 and 8 weeks after the surgical procedure. The time course of metabolic and inflammatory blood parameters was determined in addition. Results: Compared to healthy controls, rats after sham surgery showed a lower body weight both 1 week (267.5 +/- 10.6 vs. 317.0 +/- 11.3 g, n < 0.05) and 8 weeks (317.0 +/- 21.1 vs. 358.7 +/- 22.4 g, n < 0.05) after the intervention. Left and right ventricular morphology and function were not different in absolute measures in both groups 1 week after surgery. However, there was a confined difference in several cardiac parameters normalized to the body weight (bw), such as myocardial mass (2.19 +/- 0.30/0.83 +/- 0.13 vs. 1.85 +/- 0.22/0.70 +/- 0.07 mg left/right per g bw, p < 0.05), or enddiastolic ventricular volume (1.31 +/- 0.36/1.21 +/- 0.31 vs. 1.14 +/- 0.20/1.07 +/- 0.17 mu l left/right per g bw, p < 0.05). Vice versa, after 8 weeks, cardiac masses, volumes, and output showed a trend for lower values in sham operated rats compared to controls in absolute measures (782.2 +/- 57.2/260.2 +/- 33.2 vs. 805.9 +/- 84.8/310.4 +/- 48.5 mg, p < 0.05 for left/right ventricular mass), but not normalized to body weight. Matching these findings, blood testing revealed only minor inflammatory but prolonged metabolic changes after surgery not related to cardiac disease. Conclusion: Cardio-thoracic surgical procedures in experimental myocardial infarction cause distinct alterations upon the global integrity of the organism, which in the long term also induce circumscribed repercussions on cardiac morphology and function. This impact has to be considered when analyzing data from respective animal studies and transferring these findings to conditions in patients.	[Nordbeck, Peter; Boenhof, Leoni; Arias-Loza, Paula; Seidlmayer, Lea; Williams, Tatjana; Pelzer, Theo; Ertl, Georg; Bauer, Wolfgang R.; Ritter, Oliver] Univ Hosp Wurzburg, Dept Internal Med Cardiol 1, Wurzburg, Germany; [Nordbeck, Peter; Ertl, Georg; Bauer, Wolfgang R.; Ritter, Oliver] Univ Wurzburg, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Germany; [Hiller, Karl-Heinz; Gensler, Daniel; Jakob, Peter M.] Res Ctr Magnet Resonance Bavaria, Wurzburg, Germany; [Voll, Sabine; Ye, Yu-Xiang; Gensler, Daniel; Jakob, Peter M.] Univ Wurzburg, Dept Expt Phys 5, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Nordbeck, P (corresponding author), Univ Hosp Wurzburg, Dept Internal Med Cardiol 1, Wurzburg, Germany.	nordbeck_p@medizin.uni-wuerzburg.de	Nordbeck, Peter/D-4771-2018	Nordbeck, Peter/0000-0002-2560-4068; Arias-Loza, Anahi-Paula/0000-0003-4048-4719; Jakob, Peter/0000-0002-3481-5545	Deutsche Forschungsgemeinschaft [SFB 688, B5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 688, Project B5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coolen BF, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-56; FISHBEIN MC, 1978, AM J PATHOL, V90, P57; Lee WW, 2012, J AM COLL CARDIOL, V59, P153, DOI 10.1016/j.jacc.2011.08.066; Lichtenauer M, 2011, BASIC RES CARDIOL, V106, P645, DOI 10.1007/s00395-011-0173-0; Mueller P, 2008, CARDIOVASC RES, V77, P151, DOI 10.1093/cvr/cvm037; Nahrendorf M, 2006, CIRCULATION, V113, P1196, DOI 10.1161/CIRCULATIONAHA.105.602094; Nahrendorf M, 2005, CARDIOVASC RES, V65, P419, DOI 10.1016/j.cardiores.2004.10.006; Nahrendorf M, 2001, J MAGN RESON IMAGING, V14, P547, DOI 10.1002/jmri.1218; Oerlemans MIFJ, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0270-8; Oostendorp M, 2010, CIRCULATION, V121, P775, DOI 10.1161/CIRCULATIONAHA.109.889451; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Riegler J, 2010, J MAGN RESON IMAGING, V32, P869, DOI 10.1002/jmri.22305; Sherif HM, 2012, J NUCL MED, V53, P318, DOI 10.2967/jnumed.111.091652; Sosnovik DE, 2009, CIRC-CARDIOVASC IMAG, V2, P460, DOI 10.1161/CIRCIMAGING.109.859678; Stuckey DJ, 2008, MAGN RESON MED, V60, P582, DOI 10.1002/mrm.21677; Stuckey DJ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-38; Voss F, 2008, HEART RHYTHM, V5, P308, DOI 10.1016/j.hrthm.2007.10.026; Vujovic P, 2011, PHYSIOL RES, V60, pS165, DOI 10.33549/physiolres.932174	18	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e68275	10.1371/journal.pone.0068275	http://dx.doi.org/10.1371/journal.pone.0068275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990872	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100004
J	Siegle, MR; Taylor, EB; Miller, KM; Withler, RE; Yamanaka, KL				Siegle, Matthew R.; Taylor, Eric B.; Miller, Kristi M.; Withler, Ruth E.; Yamanaka, K. Lynne			Subtle Population Genetic Structure in Yelloweye Rockfish (Sebastes ruberrimus) Is Consistent with a Major Oceanographic Division in British Columbia, Canada	PLOS ONE			English	Article							LIMITED LARVAL DISPERSAL; MARINE RESERVES; F-STATISTICS; SEA STAR; FLOW; CONNECTIVITY; RECRUITMENT; RETENTION; DISTANCE; FISH	The boundaries between oceanographic domains often function as dispersal barriers for many temperate marine species with a dispersive pelagic larval phase. Yelloweye rockfish (Sebastes ruberrimus, YR) are widely distributed across the northeastern Pacific Ocean, inhabiting coastal rocky reefs from the Aleutian Islands in Alaska through southern California. This species exhibits an extended pelagic larval duration and has the capacity for long distance larval transport. We assayed 2,862 YR individuals from 13 general areas in the northeast Pacific Ocean for allelic variation at nine microsatellite loci. Bayesian model-based clustering analyses grouped individuals from the Strait of Georgia (SG) into a distinct genetic cluster, while individuals from outer coastal water locations (OCLs) were partitioned equally across two genetic clusters, including the cluster associated with the SG fish. Pairwise F-ST values were consistently an order of magnitude higher for comparisons between the SG and OCLs than they were for all OCL-OCL comparisons (similar to 0.016 vs. similar to 0.001). This same pattern was observed across two time points when individuals were binned into an "old" and "young" group according to birth year (old: similar to 0.020 vs. 0.0003; young: similar to 0.020 vs. similar to 0.004). Additionally, mean allelic richness was markedly lower within the SG compared to the OCLs (8.00 vs. 10.54-11.77). These results indicate that the Strait of Georgia "deep-basin" estuary oceanographic domain acts as a dispersal barrier from the outer coastal waters via the Juan de Fuca Strait. Alternatively, selection against maladapted dispersers across this oceanographic transition may underlie the observed genetic differentiation between the Georgia basin and the outer coastal waters, and further work is needed to confirm the SG-OCL divide acts as a barrier to larval dispersal.	[Siegle, Matthew R.; Taylor, Eric B.] Univ British Columbia, Dept Zool, Biodivers Res Ctr, Vancouver, BC, Canada; [Siegle, Matthew R.; Taylor, Eric B.] Univ British Columbia, Beaty Biodivers Museum, Vancouver, BC, Canada; [Miller, Kristi M.; Withler, Ruth E.; Yamanaka, K. Lynne] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9R 5K6, Canada	University of British Columbia; University of British Columbia; Fisheries & Oceans Canada	Siegle, MR (corresponding author), Univ British Columbia, Dept Zool, Biodivers Res Ctr, Vancouver, BC, Canada.	siegle@zoology.ubc.ca			Fisheries and Oceans Canada's Groundfish Surveys Program; Fisheries and Oceans Canada Genomics Research and Development Initiative	Fisheries and Oceans Canada's Groundfish Surveys Program; Fisheries and Oceans Canada Genomics Research and Development Initiative	Sampling was funded and conducted by Fisheries and Oceans Canada's Groundfish Surveys Program. The laboratory work and preliminary genetic analyses were funded and conducted by the Fisheries and Oceans Canada Genomics Research and Development Initiative. The authors state no conflict of interest between the sources of funding and the experimental design and analysis in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1981, CAN J FISH AQUAT SCI, V38, P1507, DOI 10.1139/f81-203; Andutta FP, 2012, ESTUAR COAST SHELF S, V101, P54, DOI 10.1016/j.ecss.2012.02.013; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bode M, 2006, MAR ECOL PROG SER, V308, P17, DOI 10.3354/meps308017; Botsford LW, 2001, ECOL LETT, V4, P144; Brewin PE, 2009, MAR ECOL PROG SER, V383, P225, DOI 10.3354/meps07987; Buonaccorsi VP, 2005, CONSERV GENET, V6, P697, DOI 10.1007/s10592-005-9029-1; Buonaccorsi VP, 2004, MAR BIOL, V145, P779, DOI 10.1007/s00227-004-1362-2; Buonaccorsi VP, 2002, CAN J FISH AQUAT SCI, V59, P1374, DOI 10.1139/F02-101; Burford MO, 2009, J EVOLUTION BIOL, V22, P1471, DOI 10.1111/j.1420-9101.2009.01760.x; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; CARVALHO GR, 1994, REV FISH BIOL FISHER, V4, P326, DOI 10.1007/BF00042908; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Cope JM, 2004, CAN J FISH AQUAT SCI, V61, P332, DOI 10.1139/F04-008; COSEWIC, 2008, COSWEIC ASS STAT REP; COWEN RK, 1994, B MAR SCI, V54, P228; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Crawford WR, 2002, J OCEANOGR, V58, P703, DOI 10.1023/A:1022898424333; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; DOWER J, 1992, DEEP-SEA RES, V39, P1139, DOI 10.1016/0198-0149(92)90061-W; Dower JF, 2001, FISH OCEANOGR, V10, P268, DOI 10.1046/j.1365-2419.2001.00162.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Feng M, 2010, MAR FRESHWATER RES, V61, P1259, DOI 10.1071/MF09275; FREELAND H, 1994, DEEP-SEA RES PT I, V41, P1715, DOI 10.1016/0967-0637(94)90069-8; Freeland H. J., 1984, ATMOS OCEAN, V22, P151, DOI [10.1080/07055900.1984.9649191, DOI 10.1080/07055900.1984.9649191]; GAINES S, 1985, P NATL ACAD SCI USA, V82, P3707, DOI 10.1073/pnas.82.11.3707; GOUDET J., 2001, FSTAT VERSION 2 9 3; Gunderson Donald R., 2006, P69, DOI 10.1016/B978-012088781-1/50006-6; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hastings A, 2003, ECOL APPL, V13, pS65; HAYWARD TL, 1990, J MAR RES, V48, P825, DOI 10.1357/002224090784988683; Hellberg ME, 2002, B MAR SCI, V70, P273; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hyde JR, 2009, CAN J FISH AQUAT SCI, V66, P1569, DOI 10.1139/F09-104; IHSSEN PE, 1981, CAN J FISH AQUAT SCI, V38, P1838, DOI 10.1139/f81-230; Johansson ML, 2008, MOL ECOL, V17, P3051, DOI 10.1111/j.1365-294X.2008.03814.x; Largier JL, 2003, ECOL APPL, V13, pS71; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; LOBEL PS, 1986, DEEP-SEA RES, V33, P483, DOI 10.1016/0198-0149(86)90127-5; Love M. S., 2002, ROCKFISHES NE PACIFI; Marshall DJ, 2010, ECOL LETT, V13, P128, DOI 10.1111/j.1461-0248.2009.01408.x; McManus MA, 2012, J EXP BIOL, V215, P1008, DOI 10.1242/jeb.059014; Morgan SG, 2009, ECOLOGY, V90, P3489, DOI 10.1890/08-1550.1; Mullineaux LS, 1997, DEEP-SEA RES PT I, V44, P745, DOI 10.1016/S0967-0637(96)00130-6; Palumbi SR, 2003, ECOL APPL, V13, pS146; Parker SJ, 2000, FISHERIES, V25, P22, DOI 10.1577/1548-8446(2000)025<0022:MOPR>2.0.CO;2; Pelc RA, 2009, J BIOGEOGR, V36, P1881, DOI 10.1111/j.1365-2699.2009.02138.x; Perrin C, 2004, MOL ECOL, V13, P2183, DOI 10.1111/j.1365-294X.2004.02241.x; Pinsky ML, 2010, EVOLUTION, V64, P2688, DOI 10.1111/j.1558-5646.2010.01003.x; Pritchard JK, 2000, GENETICS, V155, P945; Purcell JFH, 2006, P ROY SOC B-BIOL SCI, V273, P1483, DOI 10.1098/rspb.2006.3470; R Core Team, 2012, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rocha-Olivares A, 1999, CAN J FISH AQUAT SCI, V56, P803, DOI 10.1139/cjfas-56-5-803; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; Rousset F, 1997, GENETICS, V145, P1219; Sabates A, 2013, J MARINE SYST, V111, P108, DOI 10.1016/j.jmarsys.2012.10.002; SCHELTEMA RS, 1986, B MAR SCI, V39, P290; Seeb LW, 1998, J HERED, V89, P393, DOI 10.1093/jhered/89.5.393; Shanks AL, 2003, ECOL APPL, V13, pS159; Shanks AL, 2009, BIOL BULL-US, V216, P373; Siegle MR, 2011, THESIS U BRIT COLUMB; Skold M, 2003, MAR ECOL PROG SER, V250, P163, DOI 10.3354/meps250163; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; WALDICHUK M, 1957, J FISH RES BOARD CAN, V14, P321, DOI 10.1139/f57-013; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; White C, 2011, ECOL APPL, V21, P350, DOI 10.1890/09-1188.1; Withler RE, 2001, MAR BIOL, V139, P1; Wolanski E., 1994, PHYS OCEANOGRAPHIC P; Yamanaka K, 2000, 172 CAN STOCK ASS SE; Yamanaka KL, 2010, MAR COAST FISH, V2, P28, DOI 10.1577/C08-036.1; Yamanaka KL, 2006, 76 CAN SCI ADV SECR; Yelland D, 2005, DEEP-SEA RES PT II, V52, P875, DOI 10.1016/j.dsr2.2005.02.010; 2010, FED REG, V75, P22276; [No title captured]	85	14	15	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71083	10.1371/journal.pone.0071083	http://dx.doi.org/10.1371/journal.pone.0071083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990926	Green Submitted, gold, Green Published			2022-12-25	WOS:000324470100038
J	Wang, XR; Yano, E; Lin, SH; Yu, ITS; Lan, YJ; Tse, LA; Qiu, H; Christiani, DC				Wang, Xiaorong; Yano, Eiji; Lin, Sihao; Yu, Ignatius T. S.; Lan, Yajia; Tse, Lap Ah; Qiu, Hong; Christiani, David C.			Cancer Mortality in Chinese Chrysotile Asbestos Miners: Exposure-Response Relationships	PLOS ONE			English	Article							LUNG-CANCER; TEXTILE WORKERS; OCCUPATIONAL-EXPOSURE; DUST EXPOSURE; COHORT; RISK; MILLERS	Objective: This study was conducted to assess the relationship of mortality from lung cancer and other selected causes to asbestos exposure levels. Methods: A cohort of 1539 male workers from a chrysotile mine in China was followed for 26 years. Data on vital status, occupation and smoking were collected from the mine records and individual contacts. Causes and dates of death were further verified from the local death registry. Individual cumulative fibre exposures (f-yr/ml) were estimated based on converted dust measurements and working years at specific workshops. Standardized mortality ratios (SMRs) for lung cancer, gastrointestinal (GI) cancer, all cancers and nonmalignant respiratory diseases (NMRD) stratified by employment years, estimated cumulative fibre exposures, and smoking, were calculated. Poisson models were fitted to determine exposure-response relationships between estimated fibre exposures and cause-specific mortality, adjusting for age and smoking. Results: SMRs for lung cancer increased with employment years at entry to the study, by 3.5-fold in >= 10 years and 5.3-fold in >= 20 years compared with <10 years. A similar trend was seen for NMRD. Smokers had greater mortality from all causes than nonsmokers, but the latter also had slightly increased SMR for lung cancer. No excess lung cancer mortality was observed in cumulative exposures of <20 f-yrs/ml. However, significantly increased mortality was observed in smokers at the levels of >= 20 f-yrs/ml and above, and in nonsmokers at >= 100 f-yrs/ml and above. A similarly clear gradient was also displayed for NMRD. The exposure-response relationships with lung cancer and NMRD persisted in multivariate analysis. Moreover, a clear gradient was shown in GI cancer mortality when age and smoking were adjusted for. Conclusion: There were clear exposure-response relationships in this cohort, which imply a causal link between chrysotile asbestos exposure and lung cancer and nonmalignant respiratory diseases, and possibly to gastrointestinal cancer, at least for smokers.	[Wang, Xiaorong; Lin, Sihao; Yu, Ignatius T. S.; Tse, Lap Ah; Qiu, Hong] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Occupat & Environm Hlth, Hong Kong, Hong Kong, Peoples R China; [Yano, Eiji] Teikyo Univ, Sch Med, Sch Publ Hlth, Tokyo 173, Japan; [Lan, Yajia] Sichuan Univ, Huaxi Sch Publ Hlth, Chengdu 610064, Peoples R China; [Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Chinese University of Hong Kong; Teikyo University; Sichuan University; Harvard University; Harvard T.H. Chan School of Public Health	Wang, XR (corresponding author), Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Occupat & Environm Hlth, Hong Kong, Hong Kong, Peoples R China.	xrwang@cuhk.edu.hk; eyano@med.teikyo-u.ac.jp	Qiu, Hong/K-2047-2013; Yu, Ignatius Tak Sun/A-9936-2008	Tse, Lap Ah/0000-0003-0355-6218	Pneumoconiosis Compensation Fund Board, Hong Kong SAR, China	Pneumoconiosis Compensation Fund Board, Hong Kong SAR, China	This work was supported by the Pneumoconiosis Compensation Fund Board, Hong Kong SAR, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, SCAND J WORK ENV HLT, V23, P311; [Anonymous], 1956, ANN REP CHIEF INSP F, P206; Berman DW, 2008, CRIT REV TOXICOL, V38, P49, DOI 10.1080/10408440802273156; Chen Z. L., 2007, J SAFETY SCI TECHNOL, V3, P36; Clin B, 2011, OCCUP ENVIRON MED, V68, P832, DOI 10.1136/oem.2010.059790; Courtice MN, 2012, INT J OCCUP ENV HEAL, V18, P247, DOI 10.1179/1077352512Z.00000000021; Cullen MR, 1998, LANCET, V351, P1377, DOI 10.1016/S0140-6736(05)79440-X; de la Provote S, 2002, EUR J CANCER PREV, V11, P523, DOI 10.1097/00008469-200212000-00003; Dement JM, 2009, OCCUP ENVIRON MED, V66, P574, DOI 10.1136/oem.2008.040410; Deng Q, 2012, OCCUP ENVIRON MED, V69, P81, DOI 10.1136/oem.2011.064899; Doll R., 1985, EFFECTS HLTH EXPOSUR; Doll R, 1955, BRIT J IND MED, V12, P81; Fei HH, 1989, IND HYG OCCUP DIS, V15, P339; FRUMKIN H, 1988, AM J IND MED, V14, P79, DOI 10.1002/ajim.4700140110; Gamble J, 2008, REGUL TOXICOL PHARM, V52, pS124, DOI 10.1016/j.yrtph.2007.10.009; Hein MJ, 2007, OCCUP ENVIRON MED, V64, P616, DOI 10.1136/oem.2006.031005; HUANG J Q, 1990, Biomedical and Environmental Sciences, V3, P90; Hughes JM, 1991, MINERAL FIBERS HLTH, P135; LIDDELL D, 1994, ANN OCCUP HYG, V38, P519, DOI 10.1093/annhyg/38.4.519; Liddell FDK, 2002, ANN OCCUP HYG, V46, P5, DOI 10.1093/annhyg/mef008; Liddell FDK, 1998, ANN OCCUP HYG, V42, P7, DOI 10.1016/S0003-4878(97)00053-7; Loomis D, 2009, OCCUP ENVIRON MED, V66, P535, DOI 10.1136/oem.2008.044362; MCDONALD AD, 1984, BRIT J IND MED, V41, P151; MCDONALD JC, 1993, BRIT J IND MED, V50, P1073; MCDONALD JC, 1980, BRIT J IND MED, V37, P11; MORGAN RW, 1992, AM J IND MED, V22, P437, DOI 10.1002/ajim.4700220317; National Office for Cancer Prevention and Control, 2010, 3 NAT OFF CANC PREV; Pezerat H, 2009, INT J OCCUP ENV HEAL, V15, P102; Pira E, 2005, BRIT J CANCER, V92, P580, DOI 10.1038/sj.bjc.6602240; Ru L, 1994, CHIN J IND HLTH OCCU, V12, P344; SCHNEIDERMAN M A, 1974, Environmental Health Perspectives, V9, P307, DOI 10.2307/3428304; Selikoff I. J., 1964, JAMA-J AM MED ASSOC, V188, P142; Smith, 1935, AM J CANCER, V24, P56, DOI [DOI 10.1158/AJC.1935.56, 10.1158/ajc.1935.56]; Stayner L, 1997, OCCUP ENVIRON MED, V54, P646, DOI 10.1136/oem.54.9.646; Stayner LT, 1996, AM J PUBLIC HEALTH, V86, P179, DOI 10.2105/AJPH.86.2.179; Tomb T, 1988, ADV AIR SAMPLING; Wang XR, 2012, LUNG CANCER, V75, P151, DOI 10.1016/j.lungcan.2011.06.013; Wang XR, 2012, INT ARCH OCC ENV HEA, V85, P405, DOI 10.1007/s00420-011-0685-9; Wang XR, 2012, THORAX, V67, P106, DOI 10.1136/thoraxjnl-2011-200169; Yano E, 2001, AM J EPIDEMIOL, V154, P538, DOI 10.1093/aje/154.6.538; ZHU HL, 1993, BRIT J IND MED, V50, P1039	41	27	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71899	10.1371/journal.pone.0071899	http://dx.doi.org/10.1371/journal.pone.0071899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991003	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100062
J	Choi, HR; Kim, WK; Kim, EY; Han, BS; Min, JK; Chi, SW; Park, SG; Bae, KH; Lee, SC				Choi, Hye-Ryung; Kim, Won Kon; Kim, Eun Young; Han, Baek Soo; Min, Jeong-Ki; Chi, Seung-Wook; Park, Sung Goo; Bae, Kwang-Hee; Lee, Sang Chul			Dual-Specificity Phosphatase 10 Controls Brown Adipocyte Differentiation by Modulating the Phosphorylation of P38 Mitogen-Activated Protein Kinase	PLOS ONE			English	Article							PROMOTES ADIPOGENIC DIFFERENTIATION; TYROSINE-PHOSPHATASE; ADIPOSE-TISSUE; ROLES; CELLS; TARGET; MAPK	Background: Brown adipocytes play an important role in regulating the balance of energy, and as such, there is a strong correlation between obesity and the amount of brown adipose tissue. Although the molecular mechanism underlying white adipocyte differentiation has been well characterized, brown adipocyte differentiation has not been studied extensively. Here, we investigate the potential role of dual-specificity phosphatase 10 (DUSP10) in brown adipocyte differentiation using primary brown preadipocytes. Methods and Results: The expression of DUSP10 increased continuously after the brown adipocyte differentiation of mouse primary brown preadipocytes, whereas the phosphorylation of p38 was significantly upregulated at an early stage of differentiation followed by steep downregulation. The overexpression of DUSP10 induced a decrease in the level of p38 phosphorylation, resulting in lower lipid accumulation than that in cells overexpressing the inactive mutant DUSP10. The expression levels of several brown adipocyte markers such as PGC-1 alpha, UCP1, and PRDM16 were also significantly reduced upon the ectopic expression of DUSP10. Furthermore, decreased mitochondrial DNA content was detected in cells expressing DUSP10. The results obtained upon treatment with the p38 inhibitor, SB203580, clearly indicated that the phosphorylation of p38 at an early stage is important in brown adipocyte differentiation. The effect of the p38 inhibitor was partially recovered by DUSP10 knockdown using RNAi. Conclusions: These results suggest that p38 phosphorylation is controlled by DUSP10 expression. Furthermore, p38 phosphorylation at an early stage is critical in brown adipocyte differentiation. Thus, the regulation of DUSP10 activity affects the efficiency of brown adipogenesis. Consequently, DUSP10 can be used as a novel target protein for the regulation of obesity.	[Choi, Hye-Ryung; Kim, Won Kon; Kim, Eun Young; Han, Baek Soo; Min, Jeong-Ki; Bae, Kwang-Hee; Lee, Sang Chul] KRIBB, Res Ctr Integrated Cellul, Taejon, South Korea; [Han, Baek Soo; Min, Jeong-Ki; Bae, Kwang-Hee; Lee, Sang Chul] Univ Sci & Technol, Dept Funct Genom, Taejon, South Korea; [Chi, Seung-Wook; Park, Sung Goo] KRIBB, Biomed Prote Res Ctr, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Bae, KH (corresponding author), KRIBB, Res Ctr Integrated Cellul, Taejon, South Korea.	khbae@kribb.re.kr; lesach@kribb.re.kr		Bae, Kwang-Hee/0000-0002-5868-2556; Min, Jeong-Ki/0000-0003-4924-8739	Korea Research Institute of Bioscience and Biotechnology (KRIBB); Research Program of the Korea National Research Foundation [2012M3A9C7050101, 2006-2004112, 2011-0020507, 2011-0030028]	Korea Research Institute of Bioscience and Biotechnology (KRIBB); Research Program of the Korea National Research Foundation	This work was supported by grants from the Korea Research Institute of Bioscience and Biotechnology (KRIBB) and the Research Program (grants 2012M3A9C7050101, 2006-2004112, 2011-0020507, and 2011-0030028) of the Korea National Research Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Bae KH, 2012, BMB REP, V45, P700, DOI 10.5483/BMBRep.2012.45.12.235; Bermudez O, 2010, AM J PHYSIOL-CELL PH, V299, pC189, DOI 10.1152/ajpcell.00347.2009; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Choi H-R, 2013, BMB REP IN PRESS; Choi HR, 2012, J MICROBIOL BIOTECHN, V22, P1029, DOI 10.4014/jmb.1112.12059; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Engelman JA, 1999, J BIOL CHEM, V274, P35630, DOI 10.1074/jbc.274.50.35630; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Fruhbeck G, 2009, TRENDS PHARMACOL SCI, V30, P387, DOI 10.1016/j.tips.2009.05.003; Glondu-Lassis M, 2009, INT J BIOCHEM CELL B, V41, P2173, DOI 10.1016/j.biocel.2009.04.004; Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.E02-06-0356; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Jang M, 2009, ONCOGENE, V28, P1529, DOI 10.1038/onc.2009.11; Jung H, 2009, BIOCHEM BIOPH RES CO, V383, P252, DOI 10.1016/j.bbrc.2009.04.001; Kim EY, 2012, J LIPID RES, V53, P1864, DOI 10.1194/jlr.M026567; Kim WK, 2008, BMB REP, V41, P597, DOI 10.5483/BMBRep.2008.41.8.597; Kim WK, 2012, INT J BIOCHEM CELL B, V44, P327, DOI 10.1016/j.biocel.2011.11.004; Kim WK, 2011, MOL BIOL CELL, V22, P4883, DOI 10.1091/mbc.E11-03-0175; Kim WK, 2009, J CELL SCI, V122, P4160, DOI 10.1242/jcs.053009; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Mustelin T, 2002, FRONT BIOSCI-LANDMRK, V7, pD918, DOI 10.2741/musteli1; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Obata T, 2000, CRIT CARE MED, V28, pN67, DOI 10.1097/00003246-200004001-00008; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Tonoue T, 1999, J BIOL CHEM, V274; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Uehara T, 2007, INT J MOL MED, V19, P895; Vila-Bedmar R, 2010, ENDOCRINOLOGY, V151, P980, DOI 10.1210/en.2009-0810; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	39	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72340	10.1371/journal.pone.0072340	http://dx.doi.org/10.1371/journal.pone.0072340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977283	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300080
J	Gibb, H; Johansson, T; Stenbacka, F; Hjalten, J				Gibb, Heloise; Johansson, Therese; Stenbacka, Fredrik; Hjalten, Joakim			Functional Roles Affect Diversity-Succession Relationships for Boreal Beetles	PLOS ONE			English	Article							WOOD-DECAYING FUNGI; OLD-GROWTH FORESTS; SAPROXYLIC BEETLES; DEAD WOOD; SPECIES ABUNDANCE; COMMUNITY STRUCTURE; RELATIVE ABUNDANCE; ECOLOGICAL TRAPS; IPS-TYPOGRAPHUS; HABITAT	Species diversity commonly increases with succession and this relationship is an important justification for conserving large areas of old-growth habitats. However, species with different ecological roles respond differently to succession. We examined the relationship between a range of diversity measures and time since disturbance for boreal forest beetles collected over a 285 year forest chronosequence. We compared responses of "functional" groups related to threat status, dependence on dead wood habitats, diet and the type of trap in which they were collected (indicative of the breadth of ecologies of species). We examined fits of commonly used rank-abundance models for each age class and traditional and derived diversity indices. Rank abundance distributions were closest to the Zipf-Mandelbrot distribution, suggesting little role for competition in structuring most assemblages. Diversity measures for most functional groups increased with succession, but differences in slopes were common. Evenness declined with succession; more so for red-listed species than common species. Saproxylic species increased in diversity with succession while non-saproxylic species did not. Slopes for fungivores were steeper than other diet groups, while detritivores were not strongly affected by succession. Species trapped using emergence traps (log specialists) responded more weakly to succession than those trapped using flight intercept traps (representing a broader set of ecologies). Species associated with microhabitats that accumulate with succession (fungi and dead wood) thus showed the strongest diversity responses to succession. These clear differences between functional group responses to forest succession should be considered in planning landscapes for optimum conservation value, particularly functional resilience.	[Gibb, Heloise] La Trobe Univ, Dept Zool, Melbourne, Vic, Australia; [Johansson, Therese; Stenbacka, Fredrik; Hjalten, Joakim] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden	La Trobe University; Swedish University of Agricultural Sciences	Gibb, H (corresponding author), La Trobe Univ, Dept Zool, Melbourne, Vic, Australia.	h.gibb@latrobe.edu.au	Gibb, Heloise/B-8338-2013	Johansson, Therese/0000-0002-5864-2669; Gibb, Heloise/0000-0001-7194-0620; Hjalten, Joakim/0000-0002-8279-6633	FORMAS (Swedish Research Council); Kempe Foundation; Future Forests; Foundation for Strategic Environmental Research, MISTRA; Swedish University of Agricultural Sciences (SLU); Umea University; Forestry Research Institute of Sweden (Skogforsk); VINNOVA; Australian Academy of Science	FORMAS (Swedish Research Council)(Swedish Research Council Formas); Kempe Foundation; Future Forests; Foundation for Strategic Environmental Research, MISTRA; Swedish University of Agricultural Sciences (SLU); Umea University; Forestry Research Institute of Sweden (Skogforsk); VINNOVA(Vinnova); Australian Academy of Science	The study was financed by FORMAS (Swedish Research Council), the Kempe Foundation, Future Forests (supported by the Foundation for Strategic Environmental Research, MISTRA), the Swedish University of Agricultural Sciences (SLU), Umea University, and the Forestry Research Institute of Sweden (Skogforsk) (grants to JH) and VINNOVA (grant to TJ). HG is grateful for funding from the Australian Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alinvi O, 2007, J INSECT CONSERV, V11, P99, DOI 10.1007/s10841-006-9012-2; Andersson R, 2004, BIOL CONSERV, V118, P443, DOI 10.1016/j.biocon.2003.09.020; [Anonymous], 2010, R LANG ENV STAT COMP; Axelsson AL, 2001, FOREST ECOL MANAG, V147, P109, DOI 10.1016/S0378-1127(00)00470-9; Bach P, 1998, J CONS INT EXPLO MER, V44, P235; BADER P, 1995, BIOL CONSERV, V72, P355, DOI 10.1016/0006-3207(94)00029-P; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; Begon M, 2006, ECOLOGY INDIVIDUALS; Boswell M. T., 1971, STAT ECOLOGY, V1, P99; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Davies RG, 1999, J APPL ECOL, V36, P946, DOI 10.1046/j.1365-2664.1999.00450.x; DAY KR, 1988, AGR ECOSYST ENVIRON, V24, P407, DOI 10.1016/0167-8809(88)90120-X; DEAN RL, 1987, J EXP MAR BIOL ECOL, V109, P249, DOI 10.1016/0022-0981(87)90057-8; DENSLOW JS, 1980, OECOLOGIA, V46, P18, DOI 10.1007/BF00346960; Draper N.R., 1998, APPL REGRESSION ANAL, P79; DWERNYCHUK LW, 1972, CAN J ZOOLOG, V50, P559, DOI 10.1139/z72-076; Ebeling F, 1978, NORDSVENSKA SKOGSTYP; Edman M, 2004, ECOL APPL, V14, P893, DOI 10.1890/03-5103; Edman M, 2004, ECOGRAPHY, V27, P103, DOI 10.1111/j.0906-7590.2004.03671.x; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Fairchild GW, 2000, FRESHWATER BIOL, V44, P523, DOI 10.1046/j.1365-2427.2000.00601.x; Fenton NJ, 2008, BIOL CONSERV, V141, P1389, DOI 10.1016/j.biocon.2008.03.019; Fridman J, 2000, FOREST ECOL MANAG, V131, P23, DOI 10.1016/S0378-1127(99)00208-X; Gardenfors U, 2010, RODLISTADE ARTER SVE; Gibb H, 2006, BIOL CONSERV, V129, P437, DOI 10.1016/j.biocon.2005.11.010; Gibb H, 2006, ECOGRAPHY, V29, P191, DOI 10.1111/j.2006.0906-7590.04372.x; Gibb H, 2005, SCAND J FOREST RES, V20, P213, DOI 10.1080/02827580510008392; Gibb H, 2011, ECOLOGY, V92, P1871, DOI 10.1890/10-2363.1; Gibb H, 2007, J INSECT CONSERV, V11, P169, DOI 10.1007/s10841-006-9033-x; Gray AJ, 1987, COLONIZATION SUCCESS, P273; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; HAILA Y, 1994, ANN ZOOL FENN, V31, P187; Hanski I, 2000, ANN ZOOL FENN, V37, P271; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; Hart SA, 2008, ECOL MONOGR, V78, P123, DOI 10.1890/06-2140.1; Hedin J, 2008, SCAND J FOREST RES, V23, P348, DOI 10.1080/02827580802269991; Hjalten J, 2007, BASIC APPL ECOL, V8, P364, DOI 10.1016/j.baae.2006.08.003; HUGHES RG, 1986, AM NAT, V128, P879, DOI 10.1086/284611; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jeffries JM, 2006, ECOL APPL, V16, P901, DOI 10.1890/1051-0761(2006)016[0901:FAIOIH]2.0.CO;2; Johansson T, 2006, CAN J FOREST RES, V36, P174, DOI 10.1139/X05-235; Johansson T, 2007, FOREST ECOL MANAG, V242, P496, DOI 10.1016/j.foreco.2007.01.062; Jonsell Mats, 2001, Ecological Bulletins, V49, P173; Junninen K, 2011, BIOL CONSERV, V144, P11, DOI 10.1016/j.biocon.2010.07.010; Karlsson B, 2005, J ANIM ECOL, V74, P99, DOI 10.1111/j.1365-2656.2004.00902.x; Komonen A, 2001, ECOL ENTOMOL, V26, P63, DOI 10.1046/j.1365-2311.2001.00295.x; Komonen A, 2001, ENTOMOL FENNICA, V12, P3, DOI 10.33338/ef.84088; Komonen Atte, 2008, Endangered Species Research, V6, P149, DOI 10.3354/esr00074; Kouki J, 2001, SCAND J FOREST RES, P27, DOI 10.1080/028275801300090564; Lawrence J.F., 1995, P779; Lindenmayer DB, 2006, CONSERV BIOL, V20, P949, DOI 10.1111/j.1523-1739.2006.00497.x; Linder P, 1998, BIOL CONSERV, V85, P9, DOI 10.1016/S0006-3207(97)00168-7; MACARTHUR R, 1960, AM NAT, V94, P25, DOI 10.1086/282106; Magurran A E, 1988, ECOLOGICAL DIVERSITY; McGill BJ, 2003, ECOL LETT, V6, P766, DOI 10.1046/j.1461-0248.2003.00491.x; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Mouillot D, 2000, ENVIRON MONIT ASSESS, V63, P279, DOI 10.1023/A:1006297211561; Niemela J, 1996, ECOGRAPHY, V19, P352, DOI 10.1111/j.1600-0587.1996.tb01264.x; Niemela T, 1995, ANN BOT FENN, V32, P141; Odegaard F, 2000, CONSERV BIOL, V14, P1182, DOI 10.1046/j.1523-1739.2000.99393.x; Okland B, 1996, EUR J ENTOMOL, V93, P195; Ostlund L, 1997, CAN J FOREST RES, V27, P1198, DOI 10.1139/x97-070; Paquin P, 2008, BIOL CONSERV, V141, P261, DOI 10.1016/j.biocon.2007.10.001; Pawson SM, 2011, BIOL CONSERV, V144, P2842, DOI 10.1016/j.biocon.2011.08.001; Penttila R, 2004, BIOL CONSERV, V117, P271, DOI 10.1016/j.biocon.2003.12.007; Pettersson Roger B., 2007, Entomologisk Tidskrift, V128, P101; PIELOU E C, 1969, P286; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Ranius T, 2004, CAN J FOREST RES, V34, P1025, DOI [10.1139/x03-271, 10.1139/X03-271]; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; SAS-Institute, 2007, JMP 7; Sauvard D, 2004, BARK AND WOOD BORING INSECTS IN LIVING TREES IN EUROPE, A SYNTHESIS, P63; Schiegg K, 2001, FOREST ECOL MANAG, V149, P295, DOI 10.1016/S0378-1127(00)00563-6; Schimmel J, 1997, CAN J FOREST RES, V27, P1207, DOI 10.1139/x97-072; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; Silfverberg Hans, 2004, Sahlbergia, V9, P1; Southwood T. R. E., 1978, Ecological Methods.; Speight M.C.D., 1989, Council of Europe Nature and Environment Series, P1; Stenbacka F, 2010, ECOL APPL, V20, P2310, DOI 10.1890/09-0815.1; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; TOKESHI M, 1993, ADV ECOL RES, V24, P111, DOI 10.1016/S0065-2504(08)60042-2; UGLAND KI, 1983, ECOLOGY, V64, P603, DOI 10.2307/1939979; WATKINS AJ, 1994, OIKOS, V70, P91, DOI 10.2307/3545703; Wermelinger B, 2004, FOREST ECOL MANAG, V202, P67, DOI 10.1016/j.foreco.2004.07.018; Wermelinger B, 1999, ECOL ENTOMOL, V24, P103, DOI 10.1046/j.1365-2311.1999.00175.x; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Wilson EO, 1967, THEORY ISLAND BIOGEO; Wilson JB, 1996, J ECOL, V84, P527, DOI 10.2307/2261475; Wilson JB, 1991, J VEG SCI, V9, P213; Zaitsev AS, 2002, SOIL BIOL BIOCHEM, V34, P1919, DOI 10.1016/S0038-0717(02)00208-0	93	11	11	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72764	10.1371/journal.pone.0072764	http://dx.doi.org/10.1371/journal.pone.0072764			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977350	Green Submitted, Green Published, gold			2022-12-25	WOS:000324527300095
J	Klatt, BK; Burmeister, C; Westphal, C; Tscharntke, T; von Fragstein, M				Klatt, Bjoern K.; Burmeister, Carina; Westphal, Catrin; Tscharntke, Teja; von Fragstein, Maximillian			Flower Volatiles, Crop Varieties and Bee Responses	PLOS ONE			English	Article							COMBINED GAS-CHROMATOGRAPHY; COLONY COLLAPSE DISORDER; FLORAL SCENT; BRASSICA-NAPUS; FRUIT-SET; MASS-SPECTROMETRY; NATURAL-SELECTION; APIS-MELLIFERA; OLFACTORY CUES; LAND-USE	Pollination contributes to an estimated one third of global food production, through both the improvement of the yield and the quality of crops. Volatile compounds emitted by crop flowers mediate plant-pollinator interactions, but differences between crop varieties are still little explored. We investigated whether the visitation of crop flowers is determined by variety-specific flower volatiles using strawberry varieties (Fragaria x ananassa Duchesne) and how this affects the pollination services of the wild bee Osmia bicornis L. Flower volatile compounds of three strawberry varieties were measured via headspace collection. Gas chromatography showed that the three strawberry varieties produced the same volatile compounds but with quantitative differences of the total amount of volatiles and between distinct compounds. Electroantennographic recordings showed that inexperienced females of Osmia bicornis had higher antennal responses to all volatile compounds than to controls of air and paraffin oil, however responses differed between compounds. The variety Sonata was found to emit a total higher level of volatiles and also higher levels of most of the compounds that evoked antennal responses compared with the other varieties Honeoye and Darselect. Sonata also received more flower visits from Osmia bicornis females under field conditions, compared with Honeoye. Our results suggest that differences in the emission of flower volatile compounds among strawberry varieties mediate their attractiveness to females of Osmia bicornis. Since quality and quantity of marketable fruits depend on optimal pollination, a better understanding of the role of flower volatiles in crop production is required and should be considered more closely in crop-variety breeding.	[Klatt, Bjoern K.; Burmeister, Carina; Westphal, Catrin; Tscharntke, Teja] Univ Gottingen, D-37073 Gottingen, Germany; [Klatt, Bjoern K.] Lund Univ, Ctr Environm & Climate Res, Lund, Sweden; [von Fragstein, Maximillian] Univ Gottingen, Buesgen Inst, D-37073 Gottingen, Germany	University of Gottingen; Lund University; University of Gottingen	Klatt, BK (corresponding author), Univ Gottingen, D-37073 Gottingen, Germany.	klattbk@googlemail.com	Tscharntke, Teja/N-5123-2014; Westphal, Catrin/F-9560-2015	Westphal, Catrin/0000-0002-2615-1339; Klatt, Bjorn/0000-0001-8241-6445	German Research Foundation (DFG) [TS 45/29-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG)(http://www.dfg.de/en/index.jsp), funding number: TS 45/29-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABROL DP, 1992, J BIOSCIENCE, V17, P41, DOI 10.1007/BF02716772; Adler LS, 2012, NEW PHYTOL, V195, P510, DOI 10.1111/j.1469-8137.2012.04229.x; Anderson D, 2008, SCIENCE, V319, P724, DOI 10.1126/science.319.5864.724c; Ashman TL, 2005, ECOLOGY, V86, P2099, DOI 10.1890/04-1161; BEKER R, 1989, OECOLOGIA, V79, P446, DOI 10.1007/BF00378659; Blight MM, 1997, J CHEM ECOL, V23, P1715, DOI 10.1023/B:JOEC.0000006446.21160.c1; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Carlsson MA, 2006, BIOLOGY OF FLORAL SCENT, P243; CHAGNON M, 1993, J ECON ENTOMOL, V86, P416, DOI 10.1093/jee/86.2.416; CHEONG MW, 2011, J ESSENT OIL RES, V23, P34; Chess SKR, 2008, AM J BOT, V95, P1652, DOI 10.3732/ajb.0800118; Connor L. J., 1975, Proceedings of the III International Symposium on Pollination, 1974., P149; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dobson HEM, 2006, BIOLOGY OF FLORAL SCENT, P147; Dotterl S, 2010, CAN J ZOOL, V88, P668, DOI 10.1139/Z10-031; Dotterl S, 2005, PHYTOCHEMISTRY, V66, P203, DOI 10.1016/j.phytochem.2004.12.002; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Glaettli M, 2008, NEW PHYTOL, V179, P1193, DOI 10.1111/j.1469-8137.2008.02532.x; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Granero AM, 2005, NATURWISSENSCHAFTEN, V92, P371, DOI 10.1007/s00114-005-0002-0; Greenleaf SS, 2006, BIOL CONSERV, V133, P81, DOI 10.1016/j.biocon.2006.05.025; HAMILTONKEMP TR, 1990, PHYTOCHEMISTRY, V29, P2847, DOI 10.1016/0031-9422(90)87089-D; HENNING JA, 1992, J ECON ENTOMOL, V85, P226, DOI 10.1093/jee/85.1.226; Holzschuh A, 2012, BIOL CONSERV, V153, P101, DOI 10.1016/j.biocon.2012.04.032; Howell AD, 2007, ANIM BEHAV, V74, P199, DOI 10.1016/j.anbehav.2006.11.012; Hsu J., 1996, MULTIPLE COMP THEORY; Jauker F, 2012, AGR FOREST ENTOMOL, V14, P81, DOI 10.1111/j.1461-9563.2011.00541.x; Jurgens A, 2003, BIOCHEM SYST ECOL, V31, P345, DOI 10.1016/S0305-1978(02)00173-4; Karron JD, 2012, ANN BOT-LONDON, V109, P563, DOI 10.1093/aob/mcr193; Kessler A, 2009, FUNCT ECOL, V23, P901, DOI 10.1111/j.1365-2435.2009.01639.x; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2003, AM J BOT, V90, P153, DOI 10.3732/ajb.90.1.153; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; KNUDSEN JT, 1993, PHYTOCHEMISTRY, V33, P253, DOI 10.1016/0031-9422(93)85502-I; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; LeMetayer M, 1997, CHEM SENSES, V22, P391, DOI 10.1093/chemse/22.4.391; Majetic CJ, 2009, FUNCT ECOL, V23, P480, DOI 10.1111/j.1365-2435.2008.01517.x; Mayer C., 2011, Journal of Pollination Ecology, V3, P8; McLafferty F. W., 2009, REGISTRY MASS SPECTR; Parachnowitsch AL, 2010, NEW PHYTOL, V188, P393, DOI 10.1111/j.1469-8137.2010.03410.x; PHAMDELEGUE MH, 1989, J CHEM ECOL, V15, P329, DOI 10.1007/BF02027794; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Reinhard J, 2009, CONTEMP TOP ENTOMOL, P165; ROBERTSON GW, 1993, PHYTOCHEM ANALYSIS, V4, P152, DOI 10.1002/pca.2800040404; Rodriguez-Saona C, 2011, ANN BOT-LONDON, V107, P1377, DOI 10.1093/aob/mcr077; Sachse S, 2003, EUR J NEUROSCI, V18, P2119, DOI 10.1046/j.1460-9568.2003.02931.x; SKREBTSOVA N. D., 1957, PCHELOVODSTVO, V34, P34; Soler C, 2011, PHYTOCHEMISTRY, V72, P74, DOI 10.1016/j.phytochem.2010.10.012; Theis N, 2006, J CHEM ECOL, V32, P917, DOI 10.1007/s10886-006-9051-x; Tholl D, 2006, PLANT J, V45, P540, DOI 10.1111/j.1365-313X.2005.02612.x; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Weissbecker B, 2004, J CHROMATOGR A, V1056, P209, DOI 10.1016/j.chroma.2004.06.120; Winfree R, 2008, J APPL ECOL, V45, P793, DOI 10.1111/j.1365-2664.2007.01418.x; Wright GA, 2002, J CHEM ECOL, V28, P721, DOI 10.1023/A:1015232608858; Wright GA, 2009, FUNCT ECOL, V23, P841, DOI 10.1111/j.1365-2435.2009.01627.x; Zebrowska J, 1998, PLANT BREEDING, V117, P255, DOI 10.1111/j.1439-0523.1998.tb01935.x	61	42	43	6	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72724	10.1371/journal.pone.0072724	http://dx.doi.org/10.1371/journal.pone.0072724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977347	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300094
J	Luers, L; Bannach, O; Stohr, J; Wordehoff, MM; Wolff, M; Nagel-Steger, L; Riesner, D; Willbold, D; Birkmann, E				Luers, Lars; Bannach, Oliver; Stoehr, Jan; Woerdehoff, Michael Marius; Wolff, Martin; Nagel-Steger, Luitgard; Riesner, Detlev; Willbold, Dieter; Birkmann, Eva			Seeded Fibrillation as Molecular Basis of the Species Barrier in Human Prion Diseases	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; SCRAPIE; TRANSMISSION; VARIANT; BSE; EPIDEMIOLOGY; CONVERSION; PROTEIN	Prion diseases are transmissible spongiform encephalopathies in humans and animals, including scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle, chronic wasting disease (CWD) in deer, and Creutzfeldt-Jakob disease (CJD) in humans. The hallmark of prion diseases is the conversion of the host-encoded prion protein (PrPC) to its pathological isoform PrPSc, which is accompanied by PrP fibrillation. Transmission is not restricted within one species, but can also occur between species. In some cases a species barrier can be observed that results in limited or unsuccessful transmission. The mechanism behind interspecies transmissibility or species barriers is not completely understood. To analyse this process at a molecular level, we previously established an in vitro fibrillation assay, in which recombinant PrP (recPrP) as substrate can be specifically seeded by PrPSc as seed. Seeding with purified components, with no additional cellular components, is a direct consequence of the "prion-protein-only" hypothesis. We therefore hypothesise, that the species barrier is based on the interaction of PrPC and PrPSc. Whereas in our earlier studies, the interspecies transmission in animal systems was analysed, the focus of this study lies on the transmission from animals to humans. We therefore combined seeds from species cattle, sheep and deer (BSE, scrapie, CWD) with human recPrP. Homologous seeding served as a control. Our results are consistent with epidemiology, other in vitro aggregation studies, and bioassays investigating the transmission between humans, cattle, sheep, and deer. In contrast to CJD and BSE seeds, which show a seeding activity we can demonstrate a species barrier for seeds from scrapie and CWD in vitro. We could show that the seeding activity and therewith the molecular interaction of PrP as substrate and PrPSc as seed is sufficient to explain the phenomenon of species barriers. Therefore our data supports the hypothesis that CWD is not transmissible to humans.	[Luers, Lars; Bannach, Oliver; Woerdehoff, Michael Marius; Wolff, Martin; Nagel-Steger, Luitgard; Riesner, Detlev; Willbold, Dieter; Birkmann, Eva] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Wolff, Martin; Nagel-Steger, Luitgard; Willbold, Dieter; Birkmann, Eva] Res Ctr Juelich, Inst Complex Syst ICS 6, Julich, Germany; [Stoehr, Jan] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; University of California System; University of California San Francisco	Birkmann, E (corresponding author), Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany.	birkmann@uni-duesseldorf.de	Willbold, Dieter/A-6280-2013; Bannach, Oliver/A-4794-2015; Wördehoff, Michael MW/N-7271-2016; Nagel-Steger, Luitgard/H-6415-2013	Willbold, Dieter/0000-0002-0065-7366; Bannach, Oliver/0000-0002-7438-3791; Wördehoff, Michael MW/0000-0002-1591-0168; Nagel-Steger, Luitgard/0000-0001-5232-2149; Stoehr, Jan/0000-0003-2610-7458	Research Training Group 1033 of the German Research Foundation (DFG) [GRK1033]	Research Training Group 1033 of the German Research Foundation (DFG)(German Research Foundation (DFG))	This study has been funded by the Research Training Group 1033 (GRK1033) of the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002782; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Barria MA, 2011, J BIOL CHEM, V286, P7490, DOI 10.1074/jbc.M110.198465; Belay ED, 2004, EMERG INFECT DIS, V10, P977, DOI 10.3201/eid1006.031082; Beringue V, 2012, SCIENCE, V335, P472, DOI 10.1126/science.1215659; Birkmann E, 2006, BIOL CHEM, V387, P95, DOI 10.1515/BC.2006.013; Birkmann E, 2008, PRION, V2, P67, DOI 10.4161/pri.2.2.7060; Brookes E, 2010, P 2010 TER C; Brookes E, 2007, GECCO ACM P; Brown P, 2012, EMERG INFECT DIS, V18, P901, DOI 10.3201/eid1806.120116; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Caramelli M, 2006, CNS DRUGS, V20, P15, DOI 10.2165/00023210-200620010-00002; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; CUILLE J., 1938, Compte Rendu de l'Academie des Sciences, V206, P78; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Demeler B, 2008, COLLOID POLYM SCI, V286, P129, DOI 10.1007/s00396-007-1699-4; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, P45; Eigen M, 1996, BIOPHYS CHEM, V63, pA1, DOI 10.1016/S0301-4622(96)02250-8; Eigen M, 2001, BSE PRION PROBLEM SP, P40; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Hunter N, 1998, MOL BIOTECHNOL, V9, P225, DOI 10.1007/BF02915795; Ironside JW, 2010, HAEMOPHILIA, V16, P175, DOI 10.1111/j.1365-2516.2010.02317.x; Johnson RT, 2005, LANCET NEUROL, V4, P635, DOI 10.1016/S1474-4422(05)70192-7; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Leffers KW, 2005, BIOL CHEM, V386, P569, DOI 10.1515/BC.2005.067; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li L, 2007, BIOCHEM BIOPH RES CO, V364, P796, DOI 10.1016/j.bbrc.2007.10.087; Marsh RF, 2005, J VIROL, V79, P13794, DOI 10.1128/JVI.79.21.13794-13796.2005; MaWhinney S, 2006, EMERG INFECT DIS, V12, P1527, DOI 10.3201/eid1210.060019; Miller MW, 2005, J WILDLIFE DIS, V41, P275, DOI 10.7589/0090-3558-41.2.275; Orru CD, 2009, PROTEIN ENG DES SEL, V22, P515, DOI 10.1093/protein/gzp031; Panza G, 2008, BIOCHEM BIOPH RES CO, V373, P493, DOI 10.1016/j.bbrc.2008.06.059; Panza G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014283; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Post K, 2000, ARCH VIROL, P265; PRUSINER SB, 2007, FIELDS VIROLOGY, P3059; Raymond GJ, 2000, EMBO J, V19, P4425, DOI 10.1093/emboj/19.17.4425; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; Riesner D, 2007, PRIONS IN HUMANS AND ANIMALS, P104; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sandberg MK, 2010, J GEN VIROL, V91, P2651, DOI 10.1099/vir.0.024380-0; Schatzl HM, 2007, PRIONS IN HUMANS AND ANIMALS, P119; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; Vascellari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048969; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Will RG, 1998, ANN NEUROL, V43, P763, DOI 10.1002/ana.410430611; Wilson R, 2012, J GEN VIROL, V93, P1624, DOI 10.1099/vir.0.042507-0	59	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72623	10.1371/journal.pone.0072623	http://dx.doi.org/10.1371/journal.pone.0072623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977331	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300092
J	Cawley, K; Logue, SE; Gorman, AM; Zeng, QP; Patterson, J; Gupta, S; Samali, A				Cawley, Karen; Logue, Susan E.; Gorman, Adrienne M.; Zeng, Qingping; Patterson, John; Gupta, Sanjeev; Samali, Afshin			Disruption of microRNA Biogenesis Confers Resistance to ER Stress-Induced Cell Death Upstream of the Mitochondrion	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; INDUCED APOPTOSIS; DOWN-REGULATION; BREAST-CANCER; BCL-2 FAMILY; DICER EXPRESSION; POOR-PROGNOSIS; ETOPOSIDE; DROSHA	Global downregulation of microRNAs (miRNAs) is a common feature of human tumors and has been shown to enhance cancer progression. Several components of the miRNA biogenesis machinery (XPO5, DICER and TRBP) have been shown to act as haploinsufficient tumor suppressors. How the deregulation of miRNA biogenesis promotes tumor development is not clearly understood. Here we show that loss of miRNA biogenesis increased resistance to endoplasmic reticulum (ER) stress-induced cell death. We observed that HCT116 cells with a DICER hypomorphic mutation (Exn5/Exn5) or where DICER or DROSHA were knocked down were resistant to ER stress-induced cell death. Extensive analysis revealed little difference in the unfolded protein response (UPR) of WT compared to Exn5/Exn5 HCT116 cells upon ER stress treatment. However, analysis of the intrinsic apoptotic pathway showed that resistance occurred upstream of the mitochondria. In particular, BAX activation and dissipation of mitochondrial membrane potential was attenuated, and there was altered expression of BCL-2 family proteins. These observations demonstrate a key role for miRNAs as critical modulators of the ER stress response. In our model, downregulation of miRNA biogenesis delays ER stress-induced apoptosis. This suggests that disrupted miRNA biogenesis may contribute to cancer progression by inhibiting ER stress-induced cell death.	[Cawley, Karen; Logue, Susan E.; Gorman, Adrienne M.; Gupta, Sanjeev; Samali, Afshin] Natl Univ Ireland, Apoptosis Res Ctr, Galway, Ireland; [Cawley, Karen; Logue, Susan E.; Gorman, Adrienne M.; Samali, Afshin] Natl Univ Ireland, Sch Nat Sci, Galway, Ireland; [Zeng, Qingping; Patterson, John] MannKind Corp, Valencia, CA USA; [Gupta, Sanjeev] Natl Univ Ireland, Sch Med, Inst Clin Sci, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Samali, A (corresponding author), Natl Univ Ireland, Apoptosis Res Ctr, Galway, Ireland.	afshin.samali@nuigalway.ie	Samali, Afshin/A-9571-2008; Logue, Susan/K-7748-2019; Gupta, Sanjeev/AAG-9749-2020; Gorman, Adrienne/B-6525-2008; gupta, sanjeev/B-2824-2008	Samali, Afshin/0000-0002-8610-8375; Logue, Susan/0000-0001-7938-3558; Gupta, Sanjeev/0000-0002-4691-6853; Gorman, Adrienne/0000-0002-6068-0058; gupta, sanjeev/0000-0002-4691-6853	Breast Cancer campaign, UK [2008NovPhD21]; Science foundation Ireland [09/RFP/BIC2371, 09/RFP/BMT2153]; Thomas Crawford Hayes fund, School of Natural Sciences, NUI Galway, Ireland	Breast Cancer campaign, UK; Science foundation Ireland(Science Foundation IrelandEuropean Commission); Thomas Crawford Hayes fund, School of Natural Sciences, NUI Galway, Ireland	This work was supported by the following research grants: Breast Cancer campaign, UK (Grant number 2008NovPhD21), URL: www.breastcancercampaign.org; Science foundation Ireland (Grant number 09/RFP/BIC2371or 09/RFP/BMT2153) URL: www.sfi.ie; and the Thomas Crawford Hayes fund, School of Natural Sciences, NUI Galway, Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 2007, MOL THER, V15, P938, DOI 10.1038/sj.mt.6300118; Adachi R, 2011, BIOCHEM BIOPH RES CO, V411, P804, DOI 10.1016/j.bbrc.2011.07.033; Asada S, 2008, AM J PHYSIOL-HEART C, V295, pH2512, DOI 10.1152/ajpheart.00233.2008; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blandino G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1859; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Cawley K, 2012, CANC REPORTS, V2, P1; Cekaite L, 2012, NEOPLASIA, V14, P868, DOI 10.1593/neo.121094; Chae HJ, 2000, PHARMACOL RES, V42, P373, DOI 10.1006/phrs.2000.0700; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Day TW, 2009, MOL PHARMACOL, V76, P632, DOI 10.1124/mol.109.054999; Dedes KJ, 2011, EUR J CANCER, V47, P138, DOI 10.1016/j.ejca.2010.08.007; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; Faggad A, 2012, HISTOPATHOLOGY; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fukumi S, 2000, MOL CELL BIOCHEM, V206, P43, DOI 10.1023/A:1007056727876; Gefen N, 2010, LEUKEMIA, V24, P89, DOI 10.1038/leu.2009.208; Ghosh AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039586; Gogada R, 2012, J BIOL CHEM; Gupta S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.74; Jager R, 2012, BIOL CELL; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Karpinich NO, 2006, J CELL PHYSIOL, V208, P55, DOI 10.1002/jcp.20638; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kim M, 2005, BIOCHEM BIOPH RES CO, V338, P1834, DOI 10.1016/j.bbrc.2005.10.155; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lin CF, 2005, J BIOL CHEM, V280, P23758, DOI 10.1074/jbc.M412292200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logue SE, 2009, NAT PROTOC, V4, P1383, DOI 10.1038/nprot.2009.143; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Martinsson P, 2001, ANTI-CANCER DRUG, V12, P699, DOI 10.1097/00001813-200109000-00009; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Nakagawa A, 2010, SCIENCE, V328, P327, DOI 10.1126/science.1182374; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Samali A, 2001, CELL STRESS CHAPERON, V6, P49, DOI 10.1379/1466-1268(2001)006<0049:HPMOTC>2.0.CO;2; Sand M, 2010, CANCER INVEST, V28, P649, DOI 10.3109/07357901003630918; Schwer B, 2001, NAT STRUCT BIOL, V8, P113, DOI 10.1038/84091; Soifer HS, 2008, NUCLEIC ACIDS RES, V36, P6511, DOI 10.1093/nar/gkn687; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Torres A, 2011, TUMOR BIOL, V32, P769, DOI 10.1007/s13277-011-0179-0; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Weston RT, 2010, ADV EXP MED BIOL, V687, P65; Wiesen JL, 2009, MOL IMMUNOL, V46, P1222, DOI 10.1016/j.molimm.2008.11.012; Wu DY, 2012, MOL MED REP, V5, P695, DOI 10.3892/mmr.2011.711; Yoo SH, 2012, INT J ONCOL; Zhang XD, 2004, MOL CANCER THER, V3, P187; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103; Zhu DX, 2012, CANCER SCI, V103, P875, DOI 10.1111/j.1349-7006.2012.02234.x; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	59	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e73870	10.1371/journal.pone.0073870	http://dx.doi.org/10.1371/journal.pone.0073870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977393	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700198
J	Cheah, W; McMinn, A; Griffiths, FB; Westwood, KJ; Wright, SW; Clementson, LA				Cheah, Wee; McMinn, Andrew; Griffiths, F. Brian; Westwood, Karen J.; Wright, Simon W.; Clementson, Lesley A.			Response of Phytoplankton Photophysiology to Varying Environmental Conditions in the Sub-Antarctic and Polar Frontal Zone	PLOS ONE			English	Article							SOUTHERN-OCEAN; IRON-LIMITATION; CHLOROPHYLL FLUORESCENCE; MARINE-PHYTOPLANKTON; EXCESSIVE IRRADIANCE; COMMUNITY STRUCTURE; SEASONAL EVOLUTION; ELECTRON TURNOVER; LIGHT; PHOTOSYNTHESIS	Climate-driven changes are expected to alter the hydrography of the Sub-Antarctic Zone (SAZ) and Polar Frontal Zone (PFZ) south of Australia, in which distinct regional environments are believed to be responsible for the differences in phytoplankton biomass in these regions. Here, we report how the dynamic influences of light, iron and temperature, which are responsible for the photophysiological differences between phytoplankton in the SAZ and PFZ, contribute to the biomass differences in these regions. High effective photochemical efficiency of photosystem II (F-q'/F-m' > 0.4), maximum photosynthesis rate (P-max(B)), light-saturation intensity (E-k), maximum rate of photosynthetic electron transport (1/tau(PSII)), and low photoprotective pigment concentrations observed in the SAZ correspond to high chlorophyll a and iron concentrations. In contrast, phytoplankton in the PFZ exhibits low F-q'/F-m' (similar to 0.2) and high concentrations of photoprotective pigments under low light environment. Strong negative relationships between iron, temperature, and photoprotective pigments demonstrate that cells were producing more photoprotective pigments under low temperature and iron conditions, and are responsible for the low biomass and low productivity measured in the PFZ. As warming and enhanced iron input is expected in this region, this could probably increase phytoplankton photosynthesis in this region. However, complex interactions between the biogeochemical processes (e.g. stratification caused by warming could prevent mixing of nutrients), which control phytoplankton biomass and productivity, remain uncertain.	[Cheah, Wee; McMinn, Andrew] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Cheah, Wee; McMinn, Andrew; Griffiths, F. Brian; Westwood, Karen J.; Wright, Simon W.; Clementson, Lesley A.] Univ Tasmania, Antarctic Climate & Ecosyst CRC, Hobart, Tas, Australia; [Griffiths, F. Brian] CSIRO, Div Marine & Atmospher Res, Hobart, Tas, Australia; [Westwood, Karen J.; Wright, Simon W.; Clementson, Lesley A.] Australian Antarctic Div, Kingston, Tas, Australia	University of Tasmania; University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian Antarctic Division	Cheah, W (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	wee.cheah@utas.edu.au	Clementson, Lesley A/M-6905-2013; McMinn, Andrew/A-9910-2008; Cheah, Wee/C-8282-2012	McMinn, Andrew/0000-0002-2133-3854; Cheah, Wee/0000-0002-1824-0577; Westwood, Karen/0000-0003-1060-7140; Clementson, Lesley/0000-0003-4415-993X	Australian Government via Australian Antarctic Science Grants (AAS) [2720]; ACE CRC PhD scholarship	Australian Government via Australian Antarctic Science Grants (AAS)(Australian Government); ACE CRC PhD scholarship	Funding was provided by Australian Government via Australian Antarctic Science Grants (AAS) Project #2720. WC was supported by an ACE CRC PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderkamp AC, 2013, MAR ECOL PROG SER, V475, P15, DOI 10.3354/meps10097; Alderkamp AC, 2012, J PHYCOL, V48, P45, DOI 10.1111/j.1529-8817.2011.01098.x; Alderkamp AC, 2011, DEEP-SEA RES PT I, V58, P943, DOI 10.1016/j.dsr.2011.07.001; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Behrenfeld MJ, 1998, PHOTOSYNTH RES, V58, P259, DOI 10.1023/A:1006138630573; Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Bowie AR, 2011, DEEP-SEA RES PT II, V58, P2059, DOI 10.1016/j.dsr2.2011.05.033; Bowie AR, 2011, DEEP-SEA RES PT II, V58, P2051, DOI 10.1016/j.dsr2.2011.05.034; Bowie AR, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003500; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Boyd PW, 2010, LIMNOL OCEANOGR, V55, P1353, DOI 10.4319/lo.2010.55.3.1353; Boyd PW, 2001, J GEOPHYS RES-OCEANS, V106, P31573, DOI 10.1029/2000JC000348; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Boyd PW, 2001, DEEP-SEA RES PT II, V48, P2529, DOI 10.1016/S0967-0645(01)00007-8; Brunet C, 2010, J PLANKTON RES, V32, P1609, DOI 10.1093/plankt/fbq104; Cheah W, 2011, DEEP-SEA RES PT II, V58, P2179, DOI 10.1016/j.dsr2.2011.05.023; Clementson LA, 2001, J GEOPHYS RES-OCEANS, V106, P31611, DOI 10.1029/2000JC000359; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; de Salas MF, 2011, DEEP-SEA RES PT II, V58, P2135, DOI 10.1016/j.dsr2.2011.05.032; Demmig-Adams B, 2006, NEW PHYTOL, V172, P11, DOI 10.1111/j.1469-8137.2006.01835.x; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; FALKOWSKI PG, 1985, LIMNOL OCEANOGR, V30, P311, DOI 10.4319/lo.1985.30.2.0311; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Herraiz-Borreguero L, 2011, DEEP-SEA RES PT II, V58, P2071, DOI 10.1016/j.dsr2.2011.05.022; Higgins H.W., 2011, PHYTOPLANKTON PIGMEN, P257, DOI [10.1017/CBO9780511732263, DOI 10.1017/CBO9780511732263, DOI 10.1017/CBO9780511732263.010]; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Jakob T, 2001, J PLANT PHYSIOL, V158, P383, DOI 10.1078/0176-1617-00288; Koblizek M, 2001, PHOTOSYNTH RES, V68, P141, DOI 10.1023/A:1011830015167; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Korb RE, 2008, MAR ECOL PROG SER, V368, P75, DOI 10.3354/meps07525; Kosakowska A, 2004, BIOMETALS, V17, P45, DOI 10.1023/A:1024452802005; Lannuzel D, 2011, DEEP-SEA RES PT II, V58, P2094, DOI 10.1016/j.dsr2.2011.05.027; Lavaud J, 2006, PLANT CELL PHYSIOL, V47, P1010, DOI 10.1093/pcp/pcj058; LEWIS MR, 1983, MAR ECOL PROG SER, V13, P99, DOI 10.3354/meps013099; LI WKW, 1994, LIMNOL OCEANOGR, V39, P169, DOI 10.4319/lo.1994.39.1.0169; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Mongin M, 2011, DEEP-SEA RES PT II, V58, P2082, DOI 10.1016/j.dsr2.2011.06.002; Moore CM, 2006, LIMNOL OCEANOGR, V51, P936, DOI 10.4319/lo.2006.51.2.0936; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Petrou K, 2011, DEEP-SEA RES PT II, V58, P2200, DOI 10.1016/j.dsr2.2011.05.020; PLATT T, 1980, J MAR RES, V38, P687; Pollard RT, 2009, NATURE, V457, P577, DOI 10.1038/nature07716; Raateoja M, 2009, MAR ECOL PROG SER, V376, P85, DOI 10.3354/meps07759; RAVEN JA, 1988, NEW PHYTOL, V110, P441, DOI 10.1111/j.1469-8137.1988.tb00282.x; Reay DS, 2001, MAR ECOL PROG SER, V219, P51, DOI 10.3354/meps219051; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Rintoul SR, 2001, J GEOPHYS RES-OCEANS, V106, P31447, DOI 10.1029/2000JC000329; Rose JM, 2009, BIOGEOSCIENCES, V6, P3131, DOI 10.5194/bg-6-3131-2009; Sosik HM, 2002, DEEP-SEA RES PT I, V49, P1195, DOI 10.1016/S0967-0637(02)00015-8; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Suggett DJ, 2006, DEEP-SEA RES PT II, V53, P1573, DOI 10.1016/j.dsr2.2006.05.014; Suggett DJ, 2009, MAR ECOL PROG SER, V376, P1, DOI 10.3354/meps07830; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; TILZER MM, 1986, POLAR BIOL, V5, P105, DOI 10.1007/BF00443382; Trull T, 2001, DEEP-SEA RES PT II, V48, P2439, DOI 10.1016/S0967-0645(01)00003-0; van de Poll WH, 2007, LIMNOL OCEANOGR, V52, P1430, DOI 10.4319/lo.2007.52.4.1430; van de Poll WHV, 2009, J PHOTOCH PHOTOBIO B, V94, P32, DOI 10.1016/j.jphotobiol.2008.09.003; van de Poll WH, 2009, PHOTOCH PHOTOBIO SCI, V8, P1295, DOI 10.1039/b904501e; Venables H, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005361; Westwood KJ, 2011, DEEP-SEA RES PT II, V58, P2162, DOI 10.1016/j.dsr2.2011.05.017; Wright SW, 2010, DEEP-SEA RES PT II, V57, P758, DOI 10.1016/j.dsr2.2009.06.015; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029	63	16	16	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72165	10.1371/journal.pone.0072165	http://dx.doi.org/10.1371/journal.pone.0072165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977242	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000323425700145
J	Maidenbaum, S; Levy-Tzedek, S; Chebat, DR; Amedi, A				Maidenbaum, Shachar; Levy-Tzedek, Shelly; Chebat, Daniel-Robert; Amedi, Amir			Increasing Accessibility to the Blind of Virtual Environments, Using a Virtual Mobility Aid Based On the "EyeCane": Feasibility Study	PLOS ONE			English	Article							SUBSTITUTION; PEOPLE	Virtual worlds and environments are becoming an increasingly central part of our lives, yet they are still far from accessible to the blind. This is especially unfortunate as such environments hold great potential for them for uses such as social interaction, online education and especially for use with familiarizing the visually impaired user with a real environment virtually from the comfort and safety of his own home before visiting it in the real world. We have implemented a simple algorithm to improve this situation using single-point depth information, enabling the blind to use a virtual cane, modeled on the "EyeCane" electronic travel aid, within any virtual environment with minimal preprocessing. Use of the Virtual-EyeCane, enables this experience to potentially be later used in real world environments with identical stimuli to those from the virtual environment. We show the fast-learned practical use of this algorithm for navigation in simple environments.	[Maidenbaum, Shachar; Levy-Tzedek, Shelly; Chebat, Daniel-Robert; Amedi, Amir] Hebrew Univ Jerusalem, Fac Med, Dept Med Neurobiol, Inst Med Res Israel Canada, Jerusalem, Israel; [Levy-Tzedek, Shelly; Chebat, Daniel-Robert; Amedi, Amir] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Res, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Maidenbaum, S (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Med Neurobiol, Inst Med Res Israel Canada, Jerusalem, Israel.	shachar.maidenbaum@mail.huji.ac.il; amira@ekmd.huji.ac.il	Maidenbaum, Shachar/K-4277-2019; Chebat, Daniel-Robert/L-1840-2019; Chebat, Daniel-Robert/AAG-5664-2019; Levy-Tzedek, Shelly/E-8612-2017	Maidenbaum, Shachar/0000-0002-2078-3896; Chebat, Daniel-Robert/0000-0003-1252-9393; Amedi, Amir/0000-0001-5042-2533	European Research Council [310809]; Charitable Gatsby Foundation; James S. McDonnell Foundation [220020284]; Israel Science Foundation [ISF 1684/08]; Edmond and Lily Safra Center for Brain Sciences (ELSC) Vision center; Azrieli Foundation	European Research Council(European Research Council (ERC)European Commission); Charitable Gatsby Foundation; James S. McDonnell Foundation; Israel Science Foundation(Israel Science Foundation); Edmond and Lily Safra Center for Brain Sciences (ELSC) Vision center; Azrieli Foundation	This work was supported by a European Research Council grant to AA (grant number 310809); The Charitable Gatsby Foundation; The James S. McDonnell Foundation scholar award (to AA; grant number 220020284); The Israel Science Foundation (grant number ISF 1684/08); The Edmond and Lily Safra Center for Brain Sciences (ELSC) Vision center (to AA, SL, DRC); and The Azrieli Foundation (DRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACH P, 1969, NATURE, V221, P963, DOI 10.1038/221963a0; Chebat DR, 2011, NEUROREPORT, V22, P342, DOI 10.1097/WNR.0b013e3283462def; DODDS AG, 1982, J VISUAL IMPAIR BLIN, V76, P5; Feintuch U, 2006, 2006 INTERNATIONAL WORKSHOP ON VIRTUAL REHABILITATION, P78, DOI 10.1109/IWVR.2006.1707531; Folmer E, 2000, P 11 INT ACM SIGACCE, P59; Kupers R, 2010, P NATL ACAD SCI USA, V107, P12716, DOI 10.1073/pnas.1006199107; Lahav O, 2008, INT J HUM-COMPUT ST, V66, P23, DOI 10.1016/j.ijhcs.2007.08.001; Lahav O., 2012, P INT C DIS VIRT REA, P393; Lahav O., 2011, IEEE VIRTUAL REHABIL, P1; Lahav O, 2009, CYBERPSYCHOL BEHAV, V12, P88; Levy-Tzedek S, 2012, RESTOR NEUROL NEUROS, V30, P313, DOI 10.3233/RNN-2012-110219; Levy-Tzedek S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00949; Lumbreras M., 1999, CHI 1999 P SIGCHI C, P318; Maidenbaum S., 2012, P 9 INT C DIS VIRT R, P471; Maidenbaum S, 2012, SIGHT DEPTHS USING D, P35; Manduchi R., 2010, WATCH YOUR HEAD MIND; MEIJER PBL, 1992, IEEE T BIO-MED ENG, V39, P112, DOI 10.1109/10.121642; Reardon S, 2011, SCIENCE, V333, P1816, DOI 10.1126/science.333.6051.1816; Sanchez J, 2011, ASSETS 11: PROCEEDINGS OF THE 13TH INTERNATIONAL ACM SIGACCESS CONFERENCE ON COMPUTERS AND ACCESSIBILITY, P227; Sanchez J, 2010, ASSETS 2010: PROCEEDINGS OF THE 12TH INTERNATIONAL ACM SIGACCESS CONFERENCE ON COMPUTERS AND ACCESSIBILITY, P237; Spence J, 2008, J VIRTUAL WORLDS RES, V1, P6; Wasko M, 2011, MIS QUART, V35, P645; White G. R., 2008, P 3 INT C DIG INT ME, P134, DOI DOI 10.1145/1413634.1413663; Zero K, 2011, VIRTUAL WORLDS 2010	24	42	43	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72555	10.1371/journal.pone.0072555	http://dx.doi.org/10.1371/journal.pone.0072555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977316	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700176
J	Houtveen, JH; Sorbi, MJ				Houtveen, Jan H.; Sorbi, Marjolijn J.			Prodromal Functioning of Migraine Patients Relative to Their Interictal State - An Ecological Momentary Assessment Study	PLOS ONE			English	Article							PREMONITORY SYMPTOMS; PREVALENCE; TRIGGERS; ATTACK; QUESTIONNAIRE; TRAINERS; HEADACHE; STRESS; DIARY	Smartphones were used in an online Ecological Momentary Assessment (EMA) design to test prodromal functioning relative to the interictal state in migraine patients. Eighty-seven participants completed an electronic diary 4 times daily during 3-6 weeks to monitor their migraine attacks. Twice daily the diary additionally included 16 multi-answer questions covering physical symptoms (30 items), cognitive-affective functioning (25 items) and external factors (25 items). Eight clustered prodromal features were identified in the current study: sensory sensitivity, pain/stiffness, fatigue, cognitive functioning, positive affect, negative affect, effort spent and stressors encountered. Per feature, individual change scores with interictal control days - excluding 24-hour post-attack recovery - were computed for six 12-hour pre-attack time windows covering three prodromal days. Linear mixed model (fixed-effect) analysis established significant increases in sensory sensitivity, pain/stiffness and fatigue, and a tendency for increased negative affect, in the 12 hours prior to the attack. Positive affect and cognitive functioning were impaired both in the 25-36 hour and - more strongly - in the 12-hour time window before the attack. No effects were found for effort spent and stressors encountered. Exploratory (random effect) analysis revealed significant individual differences in the change scores in sensory sensitivity, pain/stiffness, fatigue and negative affect. It is concluded that the prodromal change in migraine - relative to interictal functioning - predominantly exists within the last 12 hours before attack onset. Individual diversity is large, however. Future research should zoom in to identify prodrome development within the 12 pre-attack hours as well as to isolate individual patterns.	[Houtveen, Jan H.; Sorbi, Marjolijn J.] Univ Utrecht, Fac Social & Behav Sci, Dept Clin & Hlth Psychol, NL-3508 TC Utrecht, Netherlands	Utrecht University	Houtveen, JH (corresponding author), Univ Utrecht, Fac Social & Behav Sci, Dept Clin & Hlth Psychol, NL-3508 TC Utrecht, Netherlands.	j.h.houtveen@uu.nl			Health Insurers Innovation Foundation, the Netherlands (Innovatiefonds Zorgverzekeraars) [1871]; Organization for Health Research and Development, the Netherlands (ZonMw) [11000.0009]; Utrecht University	Health Insurers Innovation Foundation, the Netherlands (Innovatiefonds Zorgverzekeraars); Organization for Health Research and Development, the Netherlands (ZonMw); Utrecht University	The project was supported by the Health Insurers Innovation Foundation, the Netherlands (Innovatiefonds Zorgverzekeraars; grant # 1871), the Organization for Health Research and Development, the Netherlands (ZonMw, grant # 11000.0009), and financial support from Utrecht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andress-Rothrock D, 2010, HEADACHE, V50, P1366, DOI 10.1111/j.1526-4610.2010.01753.x; Arjona A, 2007, HEADACHE, V47, P100, DOI 10.1111/j.1526-4610.2007.00656.x; Bolger N, 2003, ANNU REV PSYCHOL, V54, P579, DOI 10.1146/annurev.psych.54.101601.145030; Buzzi MG, 2005, FUNCT NEUROL, V20, P179; Cutrer FM, 2010, SEMIN NEUROL, V30, P120, DOI 10.1055/s-0030-1249222; Cuvellier JC, 2010, CEPHALALGIA, V30, P639; Cuvellier JC, 2009, CEPHALALGIA, V29, P1197, DOI 10.1111/j.1468-2982.2009.01854.x; Giffin NJ, 2003, NEUROLOGY, V60, P935, DOI 10.1212/01.WNL.0000052998.58526.A9; Hashizume M, 2008, BIOPSYCHOSOC MED, V2, DOI 10.1186/1751-0759-2-14; Hauge AW, 2010, CEPHALALGIA, V30, P346, DOI 10.1111/j.1468-2982.2009.01930.x; Hauge AW, 2011, CEPHALALGIA, V31, P416, DOI 10.1177/0333102410382795; Kelman L, 2007, CEPHALALGIA, V27, P394, DOI 10.1111/j.1468-2982.2007.01303.x; Kleiboer A, 2009, TELEMED J E-HEALTH, V15, P682, DOI 10.1089/tmj.2009.0014; Lieba-Samal D, 2011, EUR J PAIN, V15, P852, DOI 10.1016/j.ejpain.2011.02.003; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Merelle SYM, 2008, CEPHALALGIA, V28, P127, DOI 10.1111/j.1468-2982.2007.01472.x; Merelle SY, 2008, HEADACHE, V48, P1311, DOI 10.1111/j.1526-4610.2007.01043.x; Neut D, 2012, J HEADACHE PAIN, V13, P61, DOI 10.1007/s10194-011-0397-2; Rossi P, 2005, FUNCT NEUROL, V20, P185; Sandrini G, 2005, FUNCT NEUROL, V20, P177; Schoonman GG, 2007, PSYCHONEUROENDOCRINO, V32, P532, DOI 10.1016/j.psyneuen.2007.03.006; Schoonman GG, 2006, CEPHALALGIA, V26, P1209, DOI 10.1111/j.1468-2982.2006.01195.x; Shepherd AJ., 2010, J LIGHT VISUAL ENV, V34, P94; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sorbi MJ, 2010, J TELEMED TELECARE, V16, P20, DOI 10.1258/jtt.2009.001007; Sorbi MJ, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.5.e38; Sprenger T, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-71; Wober Christian, 2010, Handb Clin Neurol, V97, P161, DOI 10.1016/S0072-9752(10)97012-7; Wober C, 2007, CEPHALALGIA, V27, P304, DOI 10.1111/j.1468-2982.2007.01279.x	30	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72827	10.1371/journal.pone.0072827	http://dx.doi.org/10.1371/journal.pone.0072827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977358	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200085
J	Randau, TM; Schildberg, FA; Alini, M; Wimmer, MD; Haddouti, E; Gravius, S; Ito, K; Stoddart, MJ				Randau, Thomas M.; Schildberg, Frank A.; Alini, Mauro; Wimmer, Matthias D.; Haddouti, El-Mustapha; Gravius, Sascha; Ito, Keita; Stoddart, Martin J.			The Effect of Dexamethasone and Triiodothyronine on Terminal Differentiation of Primary Bovine Chondrocytes and Chondrogenically Differentiated Mesenchymal Stem Cells	PLOS ONE			English	Article							GROWTH-PLATE CHONDROCYTES; ENDOCHONDRAL BONE-FORMATION; SERUM-FREE CULTURE; ARTICULAR CHONDROCYTES; THYROID-HORMONE; IN-VITRO; HYPERTROPHIC DIFFERENTIATION; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; OSTEOGENIC DIFFERENTIATION	The newly evolved field of regenerative medicine is offering solutions in the treatment of bone or cartilage loss and deficiency. Mesenchymal stem cells, as well as articular chondrocytes, are potential cells for the generation of bone or cartilage. The natural mechanism of bone formation is that of endochondral ossification, regulated, among other factors, through the hormones dexamethasone and triiodothyronine. We investigated the effects of these hormones on articular chondrocytes and chondrogenically differentiated mesenchymal stem cells, hypothesizing that these hormones would induce terminal differentiation, with chondrocytes and differentiated stem cells being similar in their response. Using a 3D-alginate cell culture model, bovine chondrocytes and chondrogenically differentiated stem cells were cultured in presence of triiodothyronine or dexamethasone, and cell proliferation and extracellular matrix production were investigated. Collagen mRNA expression was measured by real-time PCR. Col X mRNA and alkaline phosphatase were monitored as markers of terminal differentiation, a prerequisite of endochondral ossification. The alginate culture system worked well, both for the culture of chondrocytes and for the chondrogenic differentiation of mesenchymal stem cells. Dexamethasone led to an increase in glycosaminoglycan production. Triiodothyronine increased the total collagen production only in chondrocytes, where it also induced signs of terminal differentiation, increasing both collagen X mRNA and alkaline phosphatase activity. Dexamethasone induced terminal differentiation in the differentiated stem cells. The immature articular chondrocytes used in this study seem to be able to undergo terminal differentiation, pointing to their possible role in the onset of degenerative osteoarthritis, as well as their potential for a cell source in bone tissue engineering. When chondrocyte-like cells, after their differentiation, can indeed be moved on towards terminal differentiation, they can be used to generate a model of endochondral ossification, but this limitation must be kept in mind when using them in cartilage tissue engineering application.	[Randau, Thomas M.; Wimmer, Matthias D.; Haddouti, El-Mustapha; Gravius, Sascha] Univ Clin Bonn, Dept Orthoped & Trauma Surg, Bonn, Germany; [Schildberg, Frank A.] Univ Bonn, Inst Mol Med & Expt Immunol, Bonn, Germany; [Randau, Thomas M.; Alini, Mauro; Ito, Keita; Stoddart, Martin J.] AO Fdn, AO Res Inst, Davos, Switzerland; [Ito, Keita] Eindhoven Univ Technol, Inst Mat Technol, NL-5600 MB Eindhoven, Netherlands	University of Bonn; University of Bonn; Eindhoven University of Technology	Randau, TM (corresponding author), Univ Clin Bonn, Dept Orthoped & Trauma Surg, Bonn, Germany.	thomas.randau@ukb.uni-bonn.de	Randau, Thomas/AAY-8690-2021; Ito, Keita/A-8592-2017; Stoddart, Martin J/E-3240-2013; Randau, Thomas Martin/AEP-9749-2022; Alini, Mauro/AAG-7961-2020	Ito, Keita/0000-0002-7372-4072; Stoddart, Martin J/0000-0002-9538-1517; Randau, Thomas Martin/0000-0002-5224-9639; 	AO Foundation	AO Foundation	The study was funded through the AO Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SL, 2007, J CELL PHYSIOL, V213, P635, DOI 10.1002/jcp.21262; Alini M, 1996, J BONE MINER RES, V11, P105; ALINI M, 1992, CALCIFIED TISSUE INT, V50, P327, DOI 10.1007/BF00301630; Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1; BARON J, 1992, AM J PHYSIOL, V263, pE489; Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Bian L, 2008, J BIOMECH, V41, P1153, DOI 10.1016/j.jbiomech.2008.01.026; Boeloni JN, 2009, HORM RES, V72, P88, DOI 10.1159/000232161; Boos N, 1999, J ORTHOPAED RES, V17, P495, DOI 10.1002/jor.1100170406; Bosnakovski D, 2005, CELL TISSUE RES, V319, P243, DOI 10.1007/s00441-004-1012-5; Bosnakovski D, 2004, EXP HEMATOL, V32, P502, DOI 10.1016/j.exphem.2004.02.009; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Busschers E, 2010, AM J VET RES, V71, P176, DOI 10.2460/ajvr.71.2.176; Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023; Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016; Carson FL, 1990, HISTOTECHNOLOGY SELF; Cheung JOP, 2003, J PATHOL, V201, P496, DOI 10.1002/path.1462; Chrysis D, 2005, ENDOCRINOLOGY, V146, P1391, DOI 10.1210/en.2004-1152; Chrysis D, 2003, J ENDOCRINOL, V176, P331, DOI 10.1677/joe.0.1760331; D'Lima DD, 2001, J BONE JOINT SURG AM, V83A, P25, DOI 10.2106/00004623-200100021-00006; Derfoul A, 2006, STEM CELLS, V24, P1487, DOI 10.1634/stemcells.2005-0415; Dhinsa BS, 2012, CURR STEM CELL RES T, V7, P143; Eyigor S, 2006, CLIN EXP RHEUMATOL, V24, P724; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; Garate A, 2012, THER DELIV, V3, P761, DOI 10.4155/TDE.12.53; Grad S, 2003, J BIOMED MATER RES A, V66A, P571, DOI 10.1002/jbm.a.10007; Gruters A, 2007, HORM RES, V68, P107, DOI 10.1159/000110591; HAUSELMANN HJ, 1994, J CELL SCI, V107, P17; HAUSELMANN HJ, 1992, MATRIX, V12, P116; Heino TJ, 2008, BONE, V42, P702, DOI 10.1016/j.bone.2008.01.001; HERING TM, 1994, ARCH BIOCHEM BIOPHYS, V314, P90, DOI 10.1006/abbi.1994.1415; Hochberg Z, 2002, HORM RES, V58, P33, DOI 10.1159/000064764; Hossain MA, 2008, VET COMP ORTHOPAED, V21, P337, DOI 10.3415/VCOT-07-06-0060; Ichinose S, 2005, CLIN EXP PHARMACOL P, V32, P561, DOI 10.1111/j.1440-1681.2005.04231.x; Ishikawa Y, 1998, J BONE MINER RES, V13, P1398, DOI 10.1359/jbmr.1998.13.9.1398; Jiang J, 2008, OSTEOARTHR CARTILAGE, V16, P70, DOI 10.1016/j.joca.2007.05.014; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; JONES DG, 1990, J ORTHOPAED RES, V8, P227, DOI 10.1002/jor.1100080211; Katayama R, 2004, RHEUMATOLOGY, V43, P980, DOI 10.1093/rheumatology/keh240; Kawaguchi H, 2008, MOL CELLS, V25, P1; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kuo TK, 2009, CELL TRANSPLANT, V18, P1013, DOI 10.3727/096368909X471206; Lidgren L, 2003, J RHEUMATOL, V30, P4; Lim HC, 2012, CLIN ORTHOP RELAT R, V470, P2261, DOI 10.1007/s11999-012-2304-9; Liu G, 2007, J BIOL CHEM, V282, P20407, DOI 10.1074/jbc.M608383200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malinin TI, 1997, TRANSPLANT P, V29, P2037, DOI 10.1016/S0041-1345(97)00220-0; Masuda K, 2003, J ORTHOP RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2; Mehlhorn AT, 2006, TISSUE ENG, V12, P1393, DOI 10.1089/ten.2006.12.1393; Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997; Miyazaki Y, 2000, OSTEOARTHR CARTILAGE, V8, P378, DOI 10.1053/joca.1999.0313; Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370; Na K, 2007, BIOTECHNOL LETT, V29, P1453, DOI 10.1007/s10529-007-9420-8; Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038; Pneumaticos SG, 2010, J CELL MOL MED, V14, P2561, DOI 10.1111/j.1582-4934.2010.01062.x; Pourmand EP, 2007, J CELL BIOCHEM, V100, P43, DOI 10.1002/jcb.20977; QUARTO R, 1992, J CELL BIOL, V119, P989, DOI 10.1083/jcb.119.4.989; Quinn TM, 2005, OSTEOARTHR CARTILAGE, V13, P672, DOI 10.1016/j.joca.2005.04.011; Randle WL, 2007, TISSUE ENG, V13, P2957, DOI 10.1089/ten.2007.0072; Richardson DW, 2003, INFLAMM RES, V52, P39, DOI 10.1007/s000110300012; Robson H, 2000, ENDOCRINOLOGY, V141, P3887, DOI 10.1210/en.141.10.3887; Rosenthal AK, 1999, J RHEUMATOL, V26, P395; Rosenthal AK, 2003, OSTEOARTHR CARTILAGE, V11, P463, DOI 10.1016/S1063-4584(03)00074-8; Rutges JPHJ, 2010, OSTEOARTHR CARTILAGE, V18, P1487, DOI 10.1016/j.joca.2010.08.006; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Siebler T, 2001, HORM RES, V56, P7, DOI 10.1159/000048127; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Stoddart MJ, 2006, J CELL MOL MED, V10, P480, DOI 10.1111/j.1582-4934.2006.tb00413.x; Studer D, 2012, EUR CELLS MATER, V24, P118, DOI 10.22203/eCM.v024a09; Sun Hengyun, 2011, Front Med, V5, P61, DOI 10.1007/s11684-011-0122-1; Weisser A, 2002, EXP CELL RES, V279, P1, DOI 10.1006/excr.2002.5580; Yates KE, 2005, PHENOTYPIC ANAL BOVI, P45; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Yudt MR, 2002, MOL ENDOCRINOL, V16, P1719, DOI 10.1210/me.2002-0106; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zomorodian E, 2012, STEM CELLS INT, V2012, P1, DOI DOI 10.1155/2012/980353	78	24	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72973	10.1371/journal.pone.0072973	http://dx.doi.org/10.1371/journal.pone.0072973			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977373	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200093
J	Yssouf, A; Socolovschi, C; Flaudrops, C; Ndiath, MO; Sougoufara, S; Dehecq, JS; Lacour, G; Berenger, JM; Sokhna, CS; Raoult, D; Parola, P				Yssouf, Amina; Socolovschi, Cristina; Flaudrops, Christophe; Ndiath, Mamadou Ousmane; Sougoufara, Seynabou; Dehecq, Jean-Sebastien; Lacour, Guillaume; Berenger, Jean-Michel; Sokhna, Cheikh Sadibou; Raoult, Didier; Parola, Philippe			Matrix-Assisted Laser Desorption Ionization - Time of Flight Mass Spectrometry: An Emerging Tool for the Rapid Identification of Mosquito Vectors	PLOS ONE			English	Article							ANOPHELES-GAMBIAE COMPLEX; CULICOIDES BITING MIDGES; MOLECULAR-FORMS; DIFFERENTIATION; DISCRIMINATION; CLASSIFICATION; TRANSMISSION; SUBGENERA; BACTERIA	Background: The identification of mosquito vectors is typically based on morphological characteristics using morphological keys of determination, which requires entomological expertise and training. The use of protein profiling by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS), which is increasingly being used for the routine identification of bacteria, has recently emerged for arthropod identification. Methods: To investigate the usefulness of MALDI-TOF-MS as a mosquito identification tool, we tested protein extracts made from mosquito legs to create a database of reference spectra. The database included a total of 129 laboratory-reared and field-caught mosquito specimens consisting of 20 species, including 4 Aedes spp., 9 Anopheles spp., 4 Culex spp., Lutzia tigripes, Orthopodomyia reunionensis and Mansonia uniformis. For the validation study, blind tests were performed with 76 specimens consisting of 1 to 4 individuals per species. A cluster analysis was carried out using the MALDI-Biotyper and some spectra from all mosquito species tested. Results: Biomarker mass sets containing 22 and 43 masses have been detected from 100 specimens of the Anopheles, Aedes and Culex species. By carrying out 3 blind tests, we achieved the identification of mosquito vectors at the species level, including the differentiation of An. gambiae complex, which is possible using MALDI-TOF-MS with 1.8 as the cut-off identification score. A cluster analysis performed with all available mosquito species showed that MALDI-Biotyper can distinguish between specimens at the subspecies level, as demonstrated for An gambiae M and S, but this method cannot yet be considered a reliable tool for the phylogenetic study of mosquito species. Conclusions: We confirmed that even without any specific expertise, MALDI-TOF-MS profiling of mosquito leg protein extracts can be used for the rapid identification of mosquito vectors. Therefore, MALDI-TOF-MS is an alternative, efficient and inexpensive tool that can accurately identify mosquitoes collected in the field during entomological surveys.	[Yssouf, Amina; Socolovschi, Cristina; Ndiath, Mamadou Ousmane; Sougoufara, Seynabou; Berenger, Jean-Michel; Sokhna, Cheikh Sadibou; Raoult, Didier; Parola, Philippe] Aix Marseille Univ, URMITE, UM63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France; [Flaudrops, Christophe] CHU Timone, APHM, Marseille, France; [Lacour, Guillaume] Entente Interdept Demousticat Mediterranee, Montpellier, France; [Dehecq, Jean-Sebastien] Agence Reg Sante ARS Ocean Indien, St Denis, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Parola, P (corresponding author), Aix Marseille Univ, URMITE, UM63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France.	philippe.parola@univ-amu.fr	Lacour, Guillaume/AAQ-5935-2021; RAOULT, Didier/A-8434-2008; Parola, Philippe/AAY-4346-2021; Berenger, Jean-Michel/W-3619-2019	Lacour, Guillaume/0000-0002-9588-6064; RAOULT, Didier/0000-0002-0633-5974; Parola, Philippe/0000-0002-1061-1927; 				[Anonymous], 1998, ANOPHELES REGION AFR; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Boissiere A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054820; Campbell PM, 2005, SYST ENTOMOL, V30, P186, DOI 10.1111/j.1365-3113.2004.00279.x; Cassagne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028425; Cienfuegos AV, 2011, ACTA TROP, V118, P128, DOI 10.1016/j.actatropica.2011.02.004; Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12; Cuisance D, 2004, COMP IMMUNOL MICROB, V27, P377, DOI 10.1016/j.cimid.2004.03.007; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Dridi B, 2012, APMIS, V120, P85, DOI 10.1111/j.1600-0463.2011.02833.x; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Feltens R, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-95; Fournier PE, 2009, J MED MICROBIOL, V58, P1154, DOI 10.1099/jmm.0.009647-0; Freiwald A, 2009, NAT PROTOC, V4, P732, DOI 10.1038/nprot.2009.37; Gillies M. T., 1968, PUBL S AFR I MED RES, V54, P343; Higa Y, 2010, JPN J INFECT DIS, V63, P312; Karger A, 2012, TICKS TICK-BORNE DIS, V3, P78, DOI 10.1016/j.ttbdis.2011.11.002; Kaufmann C, 2011, MED VET ENTOMOL, V25, P32, DOI 10.1111/j.1365-2915.2010.00927.x; Kaufmann C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-246; Kaufmann C, 2012, PARASITOLOGY, V139, P248, DOI 10.1017/S0031182011001764; Kent RJ, 2010, AM J TROP MED HYG, V83, P285, DOI 10.4269/ajtmh.2010.10-0077; Klempner MS, 2007, NEW ENGL J MED, V356, P2567, DOI 10.1056/NEJMp078081; Krzywinski J, 2003, ANNU REV ENTOMOL, V48, P111, DOI 10.1146/annurev.ento.48.091801.112647; La Scola B, 2010, INTERVIROLOGY, V53, P344, DOI 10.1159/000312919; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Mellmann A, 2008, J CLIN MICROBIOL, V46, P1946, DOI 10.1128/JCM.00157-08; Modika RP, 2005, ENTOMOLOGIA EXPT APP, V117, P243; Muller P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057486; Pages F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-178; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Seng P, 2010, FUTURE MICROBIOL, V5, P1733, DOI 10.2217/FMB.10.127; Simon F, 2008, MED CLIN N AM, V92, P1323, DOI 10.1016/j.mcna.2008.07.008; Suarez E, 2011, ANAL CHIM ACTA, V706, P157, DOI 10.1016/j.aca.2011.08.033; Tran TNN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017319; WHO, 2003, MAL ENT VECT CONTR; Wilson ME, 2007, CLIN INFECT DIS, V44, P1560, DOI 10.1086/518173; Yssouf A, 2013, J CLIN MICROBIOL, V51, P522, DOI 10.1128/JCM.02665-12; Zapata MA, 2007, AM J TROP MED HYG, V77, P67, DOI 10.4269/ajtmh.2007.77.67	40	81	84	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72380	10.1371/journal.pone.0072380	http://dx.doi.org/10.1371/journal.pone.0072380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977292	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000323378000096
J	Peng, WT; Lin, ZJ; Li, WR; Lu, J; Shen, YQ; Wang, CG				Peng, Wentao; Lin, Zhijie; Li, Weirong; Lu, Jing; Shen, Yuequan; Wang, Chunguang			Structural Insights into the Unusually Strong ATPase Activity of the AAA Domain of the Caenorhabditis elegans Fidgetin-like 1 (FIGL-1) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPASTIC PARAPLEGIA; CRYSTAL-STRUCTURE; HOMOLOG FIGL-1; ULTRACENTRIFUGATION; IDENTIFICATION; MECHANISM; MACHINE; MOTIONS; REVEAL	The FIGL-1 (fidgetin like-1) protein is a homolog of fidgetin, a protein whose mutation leads to multiple developmental defects. The FIGL-1 protein contains an AAA (ATPase associated with various activities) domain and belongs to the AAA superfamily. However, the biological functions and developmental implications of this protein remain unknown. Here, we show that the AAA domain of the Caenorhabditis elegans FIGL-1 protein (CeFIGL-1-AAA), in clear contrast to homologous AAA domains, has an unusually high ATPase activity and forms a hexamer in solution. By determining the crystal structure of CeFIGL-1-AAA, we found that the loop linking helices alpha 9 and alpha 10 folds into the short helix alpha 9a, which has an acidic surface and interacts with a positively charged surface of the neighboring subunit. Disruption of this charge interaction by mutagenesis diminishes both the ATPase activity and oligomerization capacity of the protein. Interestingly, the acidic residues in helix alpha 9a of CeFIGL-1-AAA are not conserved in other homologous AAA domains that have relatively low ATPase activities. These results demonstrate that the sequence of CeFIGL-1-AAA has adapted to establish an intersubunit charge interaction, which contributes to its strong oligomerization and ATPase activity. These unique properties of CeFIGL-1-AAA distinguish it from other homologous proteins, suggesting that CeFIGL-1 may have a distinct biological function.	[Peng, Wentao; Li, Weirong; Wang, Chunguang] Tongji Univ, Inst Prot Res, Shanghai 200092, Peoples R China; [Lin, Zhijie; Lu, Jing; Shen, Yuequan] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Lin, Zhijie; Lu, Jing; Shen, Yuequan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Tongji University; Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	yshen@nankai.edu.cn; chunguangwang@tongji.edu.cn	Lin, Zhijie/Y-4836-2019		Natural Science Foundation of China [31070690, 31170684]; Chinese Ministry of Science and Technology [2012CB917200, 2013CB910400]; Fundamental Research Funds for the Central Universities [2000219064]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Grants 31070690 and 31170684 from the Natural Science Foundation of China, Grants 2012CB917200 and 2013CB910400 from the Chinese Ministry of Science and Technology, and Grant 2000219064 from the Fundamental Research Funds for the Central Universities (to Tongji University).	Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Cox GA, 2000, NAT GENET, V26, P198, DOI 10.1038/79923; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Glynn SE, 2012, NAT STRUCT MOL BIOL, V19, P616, DOI 10.1038/nsmb.2288; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Grueneberg H., 1943, J GENET, V45, P22; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; KONYUKHOV BV, 1976, DEV BIOL, V54, P13, DOI 10.1016/0012-1606(76)90282-7; L'Hote D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027582; Luke-Glaser S, 2007, J CELL SCI, V120, P3179, DOI 10.1242/jcs.015883; Mackay RG, 2008, BIOCHEMISTRY-US, V47, P1918, DOI 10.1021/bi701714s; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; Mukherjee S, 2012, CELL CYCLE, V11, P2359, DOI 10.4161/cc.20849; Niwa H, 2002, STRUCTURE, V10, P1415, DOI 10.1016/S0969-2126(02)00855-9; Onitake A, 2012, J STRUCT BIOL, V179, P143, DOI 10.1016/j.jsb.2012.04.022; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng W., 2011, J SHANGHAI NORM U NA, V40, P533; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sharp DJ, 2012, J CELL SCI, V125, P2561, DOI 10.1242/jcs.101139; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; TAYLOR J, 2012, ANTIOCH REV, V70, P179; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Truslove G. M., 1956, Journal of Genetics, V54, P64, DOI 10.1007/BF02981704; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Vajjhala PR, 2008, FEBS J, V275, P1427, DOI 10.1111/j.1742-4658.2008.06300.x; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang WY, 2012, J BIOL CHEM, V287, P15143, DOI 10.1074/jbc.M111.317859; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Yakushiji Y, 2004, FEBS LETT, V578, P191, DOI 10.1016/j.febslet.2004.11.009; Yakushiji Y, 2006, J STRUCT BIOL, V156, P93, DOI 10.1016/j.jsb.2006.03.001; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	38	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29305	29312		10.1074/jbc.M113.502559	http://dx.doi.org/10.1074/jbc.M113.502559			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23979136	Green Published, hybrid			2022-12-25	WOS:000330615300010
J	Catherine, A; Mouillot, D; Maloufi, S; Troussellier, M; Bernard, C				Catherine, Arnaud; Mouillot, David; Maloufi, Selma; Troussellier, Marc; Bernard, Cecile			Projecting the Impact of Regional Land-Use Change and Water Management Policies on Lake Water Quality: An Application to Periurban Lakes and Reservoirs	PLOS ONE			English	Article							LONG-TERM; MULTIPLE STRESSORS; NUTRIENT EXPORTS; CLIMATE-CHANGE; FRESH-WATER; PHOSPHORUS; EUTROPHICATION; PHYTOPLANKTON; CATCHMENT; NITROGEN	As the human population grows, the demand for living space and supplies of resources also increases, which may induce rapid change in land-use/land-cover (LULC) and associated pressures exerted on aquatic habitats. We propose a new approach to forecast the impact of regional land cover change and water management policies (i.e., targets in nutrient loads reduction) on lake and reservoir water eutrophication status using a model that requires minimal parameterisation compared with alternative methods. This approach was applied to a set of 48 periurban lakes located in the Ile de France region (IDF, France) to simulate catchment-scale management scenarios. Model outputs were subsequently compared to governmental agencies' 2030 forecasts. Our model indicated that the efforts made to reduce pressure in the catchment of seepage lakes might be expected to be proportional to the gain that might be obtained, whereas drainage lakes will display little improvement until a critical level of pressure reduction is reached. The model also indicated that remediation measures, as currently planned by governmental agencies, might only have a marginal impact on improving the eutrophication status of lakes and reservoirs within the IDF region. Despite the commitment to appropriately managing the water resources in many countries, prospective tools to evaluate the potential impacts of global change on freshwater ecosystems integrity at medium to large spatial scales are lacking. This study proposes a new approach to investigate the impact of region-scale human-driven changes on lake and reservoir ecological status and could be implemented elsewhere with limited parameterisation. Issues are discussed that relate to model uncertainty and to its relevance as a tool applied to decision-making.	[Catherine, Arnaud; Maloufi, Selma; Bernard, Cecile] Museum Natl Hist Nat, Lab Mol Commun & Adaptat Microorganismes, F-75231 Paris, Ile De France, France; [Mouillot, David; Troussellier, Marc] Univ Montpellier 2, Lab Ecol Syst Marins Cotiers, Montpellier, Herault, France	Museum National d'Histoire Naturelle (MNHN); Universite de Montpellier	Catherine, A (corresponding author), Museum Natl Hist Nat, Lab Mol Commun & Adaptat Microorganismes, F-75231 Paris, Ile De France, France.	arnocat@mnhn.fr	Catherine, Arnaud/A-1305-2009; Bernard, Cecile/AAE-4242-2022	Catherine, Arnaud/0000-0002-2202-4850; Bernard, Cecile/0000-0001-7032-3989	French National Research Agency (ANR) through the "Cyanobacteries et cyanotoxines en milieu peri-urbain (Ile-de-France): distribution spatiale et toxicite" (CYANOTOX) project; "Lacs periurbains, societe et environnement" (PULSE) project; Monaco Foundation	French National Research Agency (ANR) through the "Cyanobacteries et cyanotoxines en milieu peri-urbain (Ile-de-France): distribution spatiale et toxicite" (CYANOTOX) project(French National Research Agency (ANR)); "Lacs periurbains, societe et environnement" (PULSE) project; Monaco Foundation	The authors acknowledge funding from the French National Research Agency (ANR; www.agence-nationale-recherche.fr) through the "Cyanobacteries et cyanotoxines en milieu peri-urbain (Ile-de-France): distribution spatiale et toxicite" (CYANOTOX) project and the "Lacs periurbains, societe et environnement" (PULSE) project. This work was also funded by a fellowship awarded to AC by the Prince Albert II of Monaco Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell JM, 2011, MAR FRESHWATER RES, V62, P162, DOI 10.1071/MF10180; AESN, 2004, ET LIEUX BASS SEIN C; Aspinall R, 2000, J ENVIRON MANAGE, V59, P299, DOI 10.1006/jema.2000.0372; BEAULAC MN, 1982, WATER RESOUR BULL, V18, P1013; Bergstrom AK, 2006, GLOBAL CHANGE BIOL, V12, P635, DOI 10.1111/j.1365-2486.2006.01129.x; BILLEN G, 1994, HYDROBIOLOGIA, V289, P119, DOI 10.1007/BF00007414; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bremigan MT, 2008, LIMNOL OCEANOGR, V53, P1420, DOI 10.4319/lo.2008.53.4.1420; Brookes JD, 2011, SCIENCE, V334, P46, DOI 10.1126/science.1207349; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; Catherine A, 2012, WATER RES, V46, P1771, DOI 10.1016/j.watres.2011.12.056; Catherine A, 2010, FRESHWATER BIOL, V55, P2425, DOI 10.1111/j.1365-2427.2010.02452.x; Catherine A, 2008, WATER RES, V42, P4989, DOI 10.1016/j.watres.2008.09.028; Catherine A, 2008, FEMS MICROBIOL ECOL, V65, P61, DOI 10.1111/j.1574-6941.2008.00494.x; CLESCERI NL, 1986, WATER RESOUR BULL, V22, P983; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; de Lange WJ, 2010, ENVIRON MODELL SOFTW, V25, P43, DOI 10.1016/j.envsoft.2009.06.011; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Dokulil MT, 2011, EUTROPHICATION: CAUSES, CONSEQUENCES AND CONTROL, P1, DOI 10.1007/978-90-481-9625-8_1; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Duethmann D, 2009, INT J RIVER BASIN MA, V7, P197, DOI 10.1080/15715124.2009.9635383; Edmondson W. T., 1961, Verhandlungen Internationalen Vereinigung Limnologie, V14, P167; EEA, 2012, CSI 020 NUTR FRESHW; Elliott JA, 2008, FRESHWATER BIOL, V53, P32, DOI 10.1111/j.1365-2427.2007.01865.x; Elliott JA, 2010, GLOBAL CHANGE BIOL, V16, P864, DOI 10.1111/j.1365-2486.2009.01998.x; European Environmental Bureau, 2010, 10 YEARS WAT FRAM DI; Ferguson CA, 2008, J APPL ECOL, V45, P193, DOI 10.1111/j.1365-2664.2007.01428.x; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Fraterrigo JM, 2008, ECOSYSTEMS, V11, P1021, DOI 10.1007/s10021-008-9176-6; FRINK CR, 1991, J ENVIRON QUAL, V20, P717, DOI 10.2134/jeq1991.00472425002000040002x; Giguet-Covex C, 2010, J PALEOLIMNOL, V43, P171, DOI 10.1007/s10933-009-9324-9; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hakanson L, 2008, WATER AIR SOIL POLL, V187, P119, DOI 10.1007/s11270-007-9502-1; Heathwaite AL, 2010, FRESHWATER BIOL, V55, P241, DOI 10.1111/j.1365-2427.2009.02368.x; Huisman J, 1999, AM NAT, V154, P46, DOI 10.1086/303220; Jakeman AJ, 2003, ENVIRON MODELL SOFTW, V18, P491, DOI 10.1016/S1364-8152(03)00024-0; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1616, DOI 10.1111/j.1365-2427.2005.01413.x; Jeppesen E., 1991, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V48, P127; Johnes PJ, 2007, SOIL USE MANAGE, V23, P176, DOI 10.1111/j.1475-2743.2007.00120.x; Jones JR, 2004, CAN J FISH AQUAT SCI, V61, P1503, DOI [10.1139/f04-088, 10.1139/F04-088]; Jordan TE, 1997, J AM WATER RESOUR AS, V33, P631, DOI 10.1111/j.1752-1688.1997.tb03538.x; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Keatley BE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015913; Knoll LB, 2003, LIMNOL OCEANOGR, V48, P608, DOI 10.4319/lo.2003.48.2.0608; Kortelainen P, 2006, AQUAT SCI, V68, P453, DOI 10.1007/s00027-006-0833-6; Maberly SC, 2012, FRESHWATER BIOL, V57, P233, DOI 10.1111/j.1365-2427.2011.02718.x; Maltby E., 2011, FRESHWATERS OPENWATE, P295; NAWQA, 2002, NUTR NAT SYNTH PROJ; Nemery J, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000331; Norton L, 2012, ENVIRON MODELL SOFTW, V36, P64, DOI 10.1016/j.envsoft.2011.07.011; OECD, 1982, EUTR WAT MON ASS CON; Olden JD, 2006, CAN J FISH AQUAT SCI, V63, P1812, DOI 10.1139/F06-082; Ormerod SJ, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02395.x; Ozkundakci D, 2010, ECOL ENG, V36, P396, DOI 10.1016/j.ecoleng.2009.11.006; Panagos P, 2011, INT J DIGIT EARTH, V4, P434, DOI 10.1080/17538947.2011.596580; Phillips G, 2008, AQUAT ECOL, V42, P213, DOI 10.1007/s10452-008-9180-0; PHILLIPS G, 1994, HYDROBIOLOGIA, V275, P445, DOI 10.1007/BF00026733; Pieterse NM, 2003, J HYDROL, V271, P213, DOI 10.1016/S0022-1694(02)00350-5; R Core Team, 2021, R LANG ENV STAT COMP; Refsgaard JC, 2007, ENVIRON MODELL SOFTW, V22, P1543, DOI 10.1016/j.envsoft.2007.02.004; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Russell MA, 1998, HYDROL PROCESS, V12, P1461, DOI 10.1002/(SICI)1099-1085(199807)12:9&lt;1461::AID-HYP650&gt;3.0.CO;2-6; Russell MA, 2001, J HYDROL, V252, P1, DOI 10.1016/S0022-1694(01)00388-2; Sas H, 1989, LAKE RESTORATION RED, P497; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M., 2005, ECOLOGY SHALLOW LAKE; Schindler DW, 2008, CAN J FISH AQUAT SCI, V65, P2211, DOI 10.1139/F08-117; SDRIF, 2008, SCHEM DIR REG IL DE; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Tetzlaff B, 2009, ENVIRON GEOL, V57, P183, DOI 10.1007/s00254-008-1293-1; Trolle D, 2008, LIMNOLOGICA, V38, P220, DOI 10.1016/j.limno.2008.05.009; UNEP, 1994, POLL LAK RES, V10; United Nations, 2012, WORLD URB PROSP 2011; Viessman W, 1993, WATER SUPPLY POLLUTI; VOLLENWEIDER R A, 1976, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V33, P53; Walling DE, 2003, GLOBAL PLANET CHANGE, V39, P111, DOI 10.1016/S0921-8181(03)00020-1; Wasson JG, 2002, TEMANORD, V566, P37; Wellen C, 2014, HYDROL PROCESS, V28, P1260, DOI 10.1002/hyp.9614; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER; Whitehead PG, 2009, HYDROLOG SCI J, V54, P101, DOI 10.1623/hysj.54.1.101; Wu JL, 2007, J PALEOLIMNOL, V38, P13, DOI 10.1007/s10933-006-9058-x; Young WJ, 1996, J ENVIRON MANAGE, V47, P165, DOI 10.1006/jema.1996.0043	86	14	15	2	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72227	10.1371/journal.pone.0072227	http://dx.doi.org/10.1371/journal.pone.0072227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991066	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800052
J	Colella, P; Sommella, A; Marrocco, E; Di Vicino, U; Polishchuk, E; Garrido, MG; Seeliger, MW; Polishchuk, R; Auricchio, A				Colella, Pasqualina; Sommella, Andrea; Marrocco, Elena; Di Vicino, Umberto; Polishchuk, Elena; Garrido, Marina Garcia; Seeliger, Mathias W.; Polishchuk, Roman; Auricchio, Alberto			Myosin7a Deficiency Results in Reduced Retinal Activity Which Is Improved by Gene Therapy	PLOS ONE			English	Article							ADENOASSOCIATED VIRAL VECTORS; ROD DARK-ADAPTATION; USHER-SYNDROME 1B; RETINITIS-PIGMENTOSA; PACKAGING CAPACITY; LENTIVIRAL VECTOR; VIRUS SEROTYPES; MOUSE MODEL; VIIA; EXPRESSION	Mutations in MYO7A cause autosomal recessive Usher syndrome type IB (USH1B), one of the most frequent conditions that combine severe congenital hearing impairment and retinitis pigmentosa. A promising therapeutic strategy for retinitis pigmentosa is gene therapy, however its pre-clinical development is limited by the mild retinal phenotype of the shaker1 (sh1(-/-)) murine model of USH1B which lacks both retinal functional abnormalities and degeneration. Here we report a significant, early-onset delay of sh1(-/-) photoreceptor ability to recover from light desensitization as well as a progressive reduction of both b-wave electroretinogram amplitude and light sensitivity, in the absence of significant loss of photoreceptors up to 12 months of age. We additionally show that subretinal delivery to the sh1(-/-) retina of AAV vectors encoding the large MYO7A protein results in significant improvement of sh1(-/-) photoreceptor and retinal pigment epithelium ultrastructural anomalies which is associated with improvement of recovery from light desensitization. These findings provide new tools to evaluate the efficacy of experimental therapies for USH1B. In addition, although AAV vectors expressing large genes might have limited clinical applications due to their genome heterogeneity, our data show that AAV-mediated MYO7A gene transfer to the sh1(-/-) retina is effective.	[Colella, Pasqualina; Sommella, Andrea; Marrocco, Elena; Di Vicino, Umberto; Polishchuk, Elena; Polishchuk, Roman; Auricchio, Alberto] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Garrido, Marina Garcia; Seeliger, Mathias W.] Ctr Ophthalmol, Inst Ophthalm Res, Div Ocular Neurodegenerat, Tubingen, Germany; [Auricchio, Alberto] Univ Naples Federico II, Dept Med Translat Sci, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Naples Federico II	Auricchio, A (corresponding author), Telethon Inst Genet & Med TIGEM, Naples, Italy.	auricchio@tigem.it	COLELLA, PASQUALINA/I-5478-2017; AURICCHIO, Alberto/AHE-7979-2022	COLELLA, PASQUALINA/0000-0002-4268-2391; AURICCHIO, Alberto/0000-0002-0832-2472; Polishchuk, Roman/0000-0002-7698-1955	Italian Telethon Foundation; European Union (EU) (grant FP7 "Treatrush"); European Union (EU) (ERC Starting Grant Award "RetGeneTx"); National Institutes of Health (NIH) [R24 RY019861-01A]; Italian Ministry of University and Scientific Research (grant PRIN) [2008SR7557_03]; NATIONAL EYE INSTITUTE [R24EY019861] Funding Source: NIH RePORTER	Italian Telethon Foundation(Fondazione Telethon); European Union (EU) (grant FP7 "Treatrush"); European Union (EU) (ERC Starting Grant Award "RetGeneTx"); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of University and Scientific Research (grant PRIN)(Ministry of Education, Universities and Research (MIUR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Italian Telethon Foundation (grant TAAMT1TELD); the European Union (EU) (grant FP7 "Treatrush" and the ERC Starting Grant Award "RetGeneTx"); the National Institutes of Health (NIH) (grant R24 RY019861-01A); and the Italian Ministry of University and Scientific Research (grant PRIN no. 2008SR7557_03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KR, 1984, BRIT J OPHTHALMOL, V68, P561, DOI 10.1136/bjo.68.8.561; Allocca M, 2008, J CLIN INVEST, V118, P1955, DOI 10.1172/JCI34316; Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; Auricchio A, 2001, HUM GENE THER, V12, P71, DOI 10.1089/104303401450988; Bainbridge JWB, 2001, GENE THER, V8, P1665, DOI 10.1038/sj.gt.3301574; Cideciyan AV, 2010, PROG RETIN EYE RES, V29, P398, DOI 10.1016/j.preteyeres.2010.04.002; Dong BA, 2010, MOL THER, V18, P87, DOI 10.1038/mt.2009.258; Dong XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013479; Drittanti L, 2000, GENE THER, V7, P924, DOI 10.1038/sj.gt.3301191; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Fischer MD, 2012, ADV EXP MED BIOL, V723, P489, DOI 10.1007/978-1-4614-0631-0_61; Gargiulo A, 2009, MOL THER, V17, P1347, DOI 10.1038/mt.2009.112; Ghosh A, 2008, MOL THER, V16, P124, DOI 10.1038/sj.mt.6300322; Gibbs D, 2004, J CELL SCI, V117, P6473, DOI 10.1242/jcs.01580; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; Gibbs D, 2010, INVEST OPHTH VIS SCI, V51, P1130, DOI 10.1167/iovs.09-4032; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Grieger JC, 2005, J VIROL, V79, P9933, DOI 10.1128/JVI.79.15.9933-9944.2005; Grose WE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039233; Gruter O, 2005, GENE THER, V12, P942, DOI 10.1038/sj.gt.3302485; Hashimoto T, 2007, GENE THER, V14, P584, DOI 10.1038/sj.gt.3302897; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; HOLLAND MG, 1972, AM J OPHTHALMOL, V74, P940, DOI 10.1016/0002-9394(72)91215-9; Jacobson SG, 2011, INVEST OPHTH VIS SCI, V52, P7924, DOI 10.1167/iovs.11-8313; Kalaitzis AA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-180; Kapranov P, 2012, HUM GENE THER, V23, P46, DOI 10.1089/hum.2011.160; KEMP CM, 1992, AM J OPHTHALMOL, V113, P165, DOI 10.1016/S0002-9394(14)71529-6; Lai Y, 2010, MOL THER, V18, P75, DOI 10.1038/mt.2009.256; LIANG FQ, 2000, METHODS MOL MED, V47, P125, DOI DOI 10.1385/1-59259-085-3:125; Libby RT, 2001, INVEST OPHTH VIS SCI, V42, P770; Lillo C, 2003, ADV EXP MED BIOL, V533, P143; Liu X, 2001, EXP EYE RES, V72, P351, DOI 10.1006/exer.2000.0963; Liu XR, 1999, J NEUROSCI, V19, P6267; Liu XR, 1997, CELL MOTIL CYTOSKEL, V37, P240, DOI 10.1002/(SICI)1097-0169(1997)37:3<240::AID-CM6>3.3.CO;2-2; Liu XR, 1998, NAT GENET, V19, P117, DOI 10.1038/470; Lopes VS, 2011, HUM MOL GENET, V20, P2560, DOI 10.1093/hmg/ddr155; Lopes VS, 2013, GENE THER; Lu H, 2008, HUM GENE THER, V19, P648, DOI 10.1089/hum.2007.0182; Mburu Philomena, 1997, Genes and Function, V1, P191; McIntosh J, 2013, BLOOD, V121, P3335, DOI 10.1182/blood-2012-10-462200; Millan JM, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/417217; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; Monahan PE, 2010, MOL THER, V18, P1907, DOI 10.1038/mt.2010.170; MOORE AT, 1992, BRIT J OPHTHALMOL, V76, P465, DOI 10.1136/bjo.76.8.465; Mueller C., 2012, CURR PROTOC MICROBIO; Mussolino C, 2011, GENE THER, V18, P637, DOI 10.1038/gt.2011.3; Naash MI, 1996, J NEUROSCI, V16, P7853; Pang JJ, 2006, MOL VIS, V12, P756; Peng YW, 2011, INVEST OPHTH VIS SCI, V52, P6421, DOI 10.1167/iovs.10-6557; Reich SJ, 2003, HUM GENE THER, V14, P37, DOI 10.1089/10430340360464697; Sahly I, 2012, J CELL BIOL, V199, P381, DOI 10.1083/jcb.201202012; Sambrook J, 2001, MOL CLONING LAB MANU; Saw D, 1997, EXP ANIM TOKYO, V46, P1; Self T, 1998, DEVELOPMENT, V125, P557; Smits BMG, 2005, GENETICS, V170, P1887, DOI 10.1534/genetics.105.044222; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; SONDHEIMER S, 1979, BRIT J OPHTHALMOL, V63, P547, DOI 10.1136/bjo.63.8.547; Surace EM, 2005, MOL THER, V12, P652, DOI 10.1016/j.ymthe.2005.06.001; Tsilou ET, 2002, ACTA OPHTHALMOL SCAN, V80, P196, DOI 10.1034/j.1600-0420.2002.800215.x; Venables V.N., 2002, MODERN APPL STAT S; Wang Y, 2012, HUM GENE THER METHOD, V23, P225, DOI 10.1089/hgtb.2012.090; Wu JQ, 2007, HUM GENE THER, V18, P171, DOI 10.1089/hum.2006.088; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255	63	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72027	10.1371/journal.pone.0072027	http://dx.doi.org/10.1371/journal.pone.0072027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991031	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800037
J	Kjos, SA; Irving, SA; Meece, JK; Belongia, EA				Kjos, Sonia A.; Irving, Stephanie A.; Meece, Jennifer K.; Belongia, Edward A.			Elementary School-Based Influenza Vaccination: Evaluating Impact on Respiratory Illness Absenteeism and Laboratory-Confirmed Influenza	PLOS ONE			English	Article							CHILDREN; IMMUNIZATION; VACCINES; BURDEN	Background: Studies of influenza vaccine effectiveness in schools have assessed all-cause absenteeism rather than laboratory-confirmed influenza. We conducted an observational pilot study to identify absences due to respiratory illness and laboratory-confirmed influenza in schools with and without school-based vaccination. Methods: A local public health agency initiated school-based influenza vaccination in two Wisconsin elementary schools during October 2010 (exposed schools); two nearby schools served as a comparison group (non-exposed schools). Absences due to fever or cough illness were monitored for 12 weeks. During the 4 weeks of peak influenza activity, parents of absent children with fever/cough illness were contacted and offered influenza testing. Results: Parental consent for sharing absenteeism data was obtained for 937 (57%) of 1,640 students. Fifty-two percent and 28%, respectively, of all students in exposed and non-exposed schools were vaccinated. Absences due to fever or cough illness were significantly lower in the exposed schools during seven of 12 surveillance weeks. Twenty-seven percent of students at exposed schools and 39% at unexposed schools had one or more days of absence due to fever/cough illness (p < 0.0001). There was no significant difference in the proportion of students absent for other reasons (p = 0.23). During the 4 week period of influenza testing, respiratory samples were obtained for 68 (42%) of 163 episodes of absence due to fever or cough illness. Influenza was detected in 6 students; 3 attended exposed schools. Conclusions: Detection of laboratory-confirmed influenza in schools was challenging due to multiple consent requirements, difficulty obtaining samples from absent children, and a mild influenza season. School-based influenza vaccination was associated with reduced absenteeism due to fever or cough illness, but not absenteeism for other reasons. Although nonspecific, absence due to fever or cough illness may be a useful surrogate endpoint in school-based studies if identification of laboratory confirmed influenza is not feasible.	[Kjos, Sonia A.; Irving, Stephanie A.; Meece, Jennifer K.; Belongia, Edward A.] Marshfield Clin Res Fdn, Marshfield, WI USA		Belongia, EA (corresponding author), Marshfield Clin Res Fdn, Marshfield, WI USA.	belongia.edward@marshfieldclinic.org		Irving, Stephanie/0000-0001-7437-6797; Belongia, Edward/0000-0001-7478-0415	Centers for Disease Control and Prevention [5U18IP000183-03]; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [U18IP000183] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for this research was provided by a cooperative agreement with the Centers for Disease Control and Prevention (5U18IP000183-03). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belderbos ME, 2011, PEDIATRICS, V127, pE1513, DOI 10.1542/peds.2010-3054; Cawley J, 2010, J SCHOOL HEALTH, V80, P167, DOI 10.1111/j.1746-1561.2009.00482.x; Davis MM, 2008, PEDIATRICS, V122, pE260, DOI 10.1542/peds.2007-2963; Graitcer SB, 2012, VACCINE, V30, P4835, DOI 10.1016/j.vaccine.2012.05.008; Heikkinen T, 2004, J INFECT DIS, V190, P1369, DOI 10.1086/424527; Irving SA, 2009, VACCINE, V27, P6546, DOI 10.1016/j.vaccine.2009.08.050; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Treanor JJ, 2012, CLIN INFECT DIS, V55, P951, DOI 10.1093/cid/cis574; Uzicanin A, 2012, J INFECT DIS, V206, P1059, DOI 10.1093/infdis/jis441; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044	13	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72243	10.1371/journal.pone.0072243	http://dx.doi.org/10.1371/journal.pone.0072243			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991071	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800053
J	Linossi, EM; Chandrashekaran, IR; Kolesnik, TB; Murphy, JM; Webb, AI; Willson, TA; Kedzierski, L; Bullock, AN; Babon, JJ; Norton, RS; Nicola, NA; Nicholson, SE				Linossi, Edmond M.; Chandrashekaran, Indu R.; Kolesnik, Tatiana B.; Murphy, James M.; Webb, Andrew I.; Willson, Tracy A.; Kedzierski, Lukasz; Bullock, Alex N.; Babon, Jeffrey J.; Norton, Raymond S.; Nicola, Nicos A.; Nicholson, Sandra E.			Suppressor of Cytokine Signaling (SOCS) 5 Utilises Distinct Domains for Regulation of JAK1 and Interaction with the Adaptor Protein Shc-1	PLOS ONE			English	Article							STIMULATING FACTOR-RECEPTOR; INDUCIBLE SH2 PROTEIN; JANUS TYROSINE KINASE; UNSTRUCTURED INSERTION; NEGATIVE REGULATOR; GROWTH; ACTIVATION; INHIBITION; BINDING; EXPRESSION	Suppressor of Cytokine Signaling (SOCS)5 is thought to act as a tumour suppressor through negative regulation of JAK/STAT and epidermal growth factor (EGF) signaling. However, the mechanism/s by which SOCS5 acts on these two distinct pathways is unclear. We show for the first time that SOCS5 can interact directly with JAK via a unique, conserved region in its N-terminus, which we have termed the JAK interaction region (JIR). Co-expression of SOCS5 was able to specifically reduce JAK1 and JAK2 (but not JAK3 or TYK2) autophosphorylation and this function required both the conserved JIR and additional sequences within the long SOCS5 N-terminal region. We further demonstrate that SOCS5 can directly inhibit JAK1 kinase activity, although its mechanism of action appears distinct from that of SOCS1 and SOCS3. In addition, we identify phosphoTyr317 in Shc-1 as a high-affinity substrate for the SOCS5-SH2 domain and suggest that SOCS5 may negatively regulate EGF and growth factor-driven Shc-1 signaling by binding to this site. These findings suggest that different domains in SOCS5 contribute to two distinct mechanisms for regulation of cytokine and growth factor signaling.	[Linossi, Edmond M.; Kolesnik, Tatiana B.; Murphy, James M.; Webb, Andrew I.; Willson, Tracy A.; Kedzierski, Lukasz; Babon, Jeffrey J.; Nicola, Nicos A.; Nicholson, Sandra E.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Linossi, Edmond M.; Kolesnik, Tatiana B.; Murphy, James M.; Webb, Andrew I.; Willson, Tracy A.; Kedzierski, Lukasz; Babon, Jeffrey J.; Nicola, Nicos A.; Nicholson, Sandra E.] Univ Melbourne, Parkville, Vic 3052, Australia; [Chandrashekaran, Indu R.; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Bullock, Alex N.] Univ Oxford, Struct Genom Consortium, Oxford, England	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Monash University; University of Oxford	Nicholson, SE (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	snicholson@wehi.edu.au	babon, jeffrey j/B-9170-2013; Murphy, James/B-4863-2017; Nicola, Nicos/D-2989-2011	babon, jeffrey j/0000-0002-5408-6239; Murphy, James/0000-0003-0195-3949; Chandrashekaran, Indu/0000-0002-7080-427X; Norton, Raymond/0000-0001-8893-0584; , Sandra/0000-0002-1314-2134; Kedzierski, Lukasz/0000-0003-0203-1057; Nicola, Nicos/0000-0003-1054-7889	National Health and Medical Research Council (NHMRC), Australia [461219, 487922, 1023559]; NHMRC IRIISS grant [361646]; Victorian State Government Operational Infrastructure Scheme grant; NHMRC fellowships; ARC Future Fellowships [FT110100169, FT100100100]; Australian Postgraduate Award; Structural Genomics Consortium [1097737]; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Lilly Canada; Novartis Research Foundation; Pfizer; Takeda; AbbVie; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Wellcome Trust [092809/Z/10/Z]; National Institutes of Health [RO1 CA22556-26]; NATIONAL CANCER INSTITUTE [R37CA022556, R01CA022556] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC IRIISS grant(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Scheme grant; NHMRC fellowships(National Health and Medical Research Council (NHMRC) of Australia); ARC Future Fellowships(Australian Research Council); Australian Postgraduate Award(Australian Government); Structural Genomics Consortium(University of Toronto); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Lilly Canada(Eli Lilly); Novartis Research Foundation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); AbbVie(AbbVie); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Economic Development and Innovation; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Health and Medical Research Council (NHMRC), Australia (Program grants #461219 and #487922, Project grant #1023559), as well as an NHMRC IRIISS grant 361646 and a Victorian State Government Operational Infrastructure Scheme grant. SEN, RSN and NAN are supported by NHMRC fellowships, JJB and JMM by ARC Future Fellowships (FT110100169 and FT100100100) and EML by an Australian Postgraduate Award. ANB was supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Lilly Canada, the Novartis Research Foundation, Pfizer, Takeda, AbbVie, the Canada Foundation for Innovation, the Ontario Ministry of Economic Development and Innovation, and the Wellcome Trust [092809/Z/10/Z]. This work was also supported in part by the National Institutes of Health (RO1 CA22556-26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babon Jeffrey J, 2013, Methods Mol Biol, V967, P39, DOI 10.1007/978-1-62703-242-1_3; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Babon JJ, 2006, MOL CELL, V22, P205, DOI 10.1016/j.molcel.2006.03.024; Babon JJ, 2005, FEBS J, V272, P6120, DOI 10.1111/j.1742-4658.2005.05010.x; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Bolanos-Garcia VM, 2005, MOL CELL BIOCHEM, V276, P149, DOI 10.1007/s11010-005-3696-6; Brender C, 2004, MOL CELL BIOL, V24, P6094, DOI 10.1128/MCB.24.13.6094-6103.2004; Bullock AN, 2007, STRUCTURE, V15, P1493, DOI 10.1016/j.str.2007.09.016; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Callus BA, 2002, ONCOGENE, V21, P4812, DOI 10.1038/sj.onc.1205618; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Choi YB, 2010, J BIOL CHEM, V285, P7271, DOI 10.1074/jbc.M109.073726; Croker BA, 2008, SEMIN CELL DEV BIOL; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Feng ZP, 2012, PROTEINS, V80, P946, DOI 10.1002/prot.23252; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Gan HK, 2012, CANCER RES, V72, P2924, DOI 10.1158/0008-5472.CAN-11-3898; Greenhalgh CJ, 2002, MOL ENDOCRINOL, V16, P1394, DOI 10.1210/me.16.6.1394; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kario E, 2005, J BIOL CHEM, V280, P7038, DOI 10.1074/jbc.M408575200; Kershaw NJ, 2013, NAT STRUCT MOL BIOL, V20, P469, DOI 10.1038/nsmb.2519; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li Z, 2007, EXP HEMATOL, V35, P1624, DOI 10.1016/j.exphem.2007.07.003; Lu BF, 1997, J IMMUNOL, V159, P1255; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Lucet IS, 2013, JAK STAT SIGNALLING, P273; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mullighan CG, 2012, HEMATOL-AM SOC HEMAT, P389, DOI 10.1182/asheducation-2012.1.389; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Nicholson SE, 2005, P NATL ACAD SCI USA, V102, P2328, DOI 10.1073/pnas.0409675102; NICHOLSON SE, 1995, BLOOD, V86, P3698, DOI 10.1182/blood.V86.10.3698.bloodjournal86103698; NICHOLSON SE, 1994, P NATL ACAD SCI USA, V91, P2985, DOI 10.1073/pnas.91.8.2985; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Ogura K, 1999, J MOL BIOL, V289, P439, DOI 10.1006/jmbi.1999.2792; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019; Qing Y, 2005, J BIOL CHEM, V280, P1849, DOI 10.1074/jbc.M409863200; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Ram PK, 2000, J BIOL CHEM, V275, P39487, DOI 10.1074/jbc.M004755200; Ramshaw HS, 2007, BLOOD, V110, P3582, DOI 10.1182/blood-2007-01-070391; Rawlings JS, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-38; Rohrschneider LR, 1997, MOL REPROD DEV, V46, P96; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; SALCINI AE, 1994, ONCOGENE, V9, P2827; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Seki Y, 2002, P NATL ACAD SCI USA, V99, P13003, DOI 10.1073/pnas.202477099; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang L, 2002, NAT IMMUNOL, V3, P749, DOI 10.1038/ni820; Zhuang G, 2012, EMBO J	64	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e70536	10.1371/journal.pone.0070536	http://dx.doi.org/10.1371/journal.pone.0070536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990909	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100029
J	Ng, V; Sargeant, JM				Ng, Victoria; Sargeant, Jan M.			A Quantitative Approach to the Prioritization of Zoonotic Diseases in North America: A Health Professionals' Perspective	PLOS ONE			English	Article							CONJOINT-ANALYSIS; UNITED-STATES; SURVEILLANCE	Background: Currently, zoonoses account for 58% to 61% of all communicable diseases causing illness in humans globally and up to 75% of emerging human pathogens. Although the impact of zoonoses on animal health and public health in North America is significant, there has been no published research involving health professionals on the prioritization of zoonoses in this region. Methodology/Principal Findings: We used conjoint analysis (CA), a well-established quantitative method in market research, to identify the relative importance of 21 key characteristics of zoonotic diseases for their prioritization in Canada and the US. Relative importance weights from the CA were used to develop a point-scoring system to derive a recommended list of zoonoses for prioritization in Canada and the US. Study participants with a background in epidemiology, public health, medical sciences, veterinary sciences and infectious disease research were recruited to complete the online survey (707 from Canada and 764 from the US). Hierarchical Bayes models were fitted to the survey data to derive CA-weighted scores for disease criteria. Scores were applied to 62 zoonotic diseases to rank diseases in order of priority. Conclusions/Significance: We present the first zoonoses prioritization exercise involving health professionals in North America. Our previous study indicated individuals with no prior knowledge in infectious diseases were capable of producing meaningful results with acceptable model fits (79.4%). This study suggests health professionals with some knowledge in infectious diseases were capable of producing meaningful results with better-fitted models than the general public (83.7% and 84.2%). Despite more similarities in demographics and model fit between the combined public and combined professional groups, there was more uniformity across priority lists between the Canadian public and Canadian professionals and between the US public and US professionals. Our study suggests that CA can be used as a potential tool for the prioritization of zoonoses.	[Ng, Victoria; Sargeant, Jan M.] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Ctr Publ Hlth & Zoonoses, Guelph, ON N1G 2W1, Canada	University of Guelph	Ng, V (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Populat Med, Ctr Publ Hlth & Zoonoses, Guelph, ON N1G 2W1, Canada.	vng03@uoguelph.ca		Ng, Victoria/0000-0002-7619-541X	Canadian Institute of Health Research (CIHR) Institute of Population and Public Health/Public Health Agency of Canada	Canadian Institute of Health Research (CIHR) Institute of Population and Public Health/Public Health Agency of Canada	Funding was provided from a Canadian Institute of Health Research (CIHR) Institute of Population and Public Health/Public Health Agency of Canada Applied Public Health Research Chair awarded to JMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha P.N., 2003, ZOONOSES COMMUNICABL; [Anonymous], 2002, EMERG INFECT DIS; [Anonymous], COMMUN DIS REP CDR S; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Balabanova Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025691; Borgundvaag B, 2004, CAN MED ASSOC J, V171, P1342, DOI 10.1503/cmaj.1031580; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Cardoen S, 2009, FOODBORNE PATHOG DIS, V6, P1083, DOI 10.1089/fpd.2009.0291; Centers for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V18, P1554; Chrzan K, 2010, INT J MARKET RES, V52, P827, DOI 10.2501/S1470785310201673; Dantas-Torres F, 2007, LANCET INFECT DIS, V7, P724, DOI 10.1016/S1473-3099(07)70261-X; Doherty J A, 2000, Can J Infect Dis, V11, P21; Doherty J A, 2006, Can Commun Dis Rep, V32, P211; GREEN PE, 1978, J CONSUM RES, V5, P103, DOI 10.1086/208721; Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965; Heymann DL, 2008, CONTROL COMMUNICABLE; Horby P, 2001, Commun Dis Public Health, V4, P8; Howden KJ, 2010, CAN VET J, V51, P837; Howell J., 2009, CBC HB BEGINNERS; Institut de Veille Sanitaire, 2010, DEF PRIOR DOM ZOON N; Institut de Veille Sanitaire, 2002, DEF PRIOR DOM ZOON A; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kermode-Scott B, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2746; Krause G, 2009, EUROSURVEILLANCE, V14, P5; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mele NL, 2008, NURS RES, V57, P220, DOI 10.1097/01.NNR.0000319499.52122.d2; Ng V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048519; Ng V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029752; Orme BK, 2012, MODEL FIT VALUES; Orme BK., 2019, GETTING STARTED CONJ, V4th; Patterson M., 2004, 10 SAWT SOFTW C P SA, V1, P173; Research Now, 2010, SSI WEB V7; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Sampietro-Colom L, 2008, MED DECIS MAKING, V28, P554, DOI 10.1177/0272989X08315235; Sawtooth Software, 2012, CBC HB V5 2 8; Sawtooth Software, 2010, SSI WEB V7; Sawtooth Software, 2008, CBC V6 0 TECHN PAP C; Sawtooth Software, 2010, SMRT V4 22 0 V7 SEQU; Statistics Canada, 2006, POP 15 YEARS HIGH CE; Statistics Canada, 2011, AG SEX HIGHL TABL 20; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; U.S. Census Bureau, 2010, ED ATT US 2010 DET T; United States Census Bureau, 2010, US CENS BUR WEBS 201; Vannier E, 2008, INFECT DIS CLIN N AM, V22, P469, DOI 10.1016/j.idc.2008.03.010; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; World Health Organization, 2003, COMMUNICABLE DIS R S; World Health Organization, 2012, NEG ZOON DIS	48	34	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72172	10.1371/journal.pone.0072172	http://dx.doi.org/10.1371/journal.pone.0072172			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991057	gold, Green Published			2022-12-25	WOS:000324470100083
J	Luerbke, A; Hagemeier, K; Cui, QL; Metz, I; Brueck, W; Antel, J; Kuhlmann, T				Luerbke, Alexander; Hagemeier, Karin; Cui, Qiao-Ling; Metz, Imke; Brueck, Wolfgang; Antel, Jack; Kuhlmann, Tanja			Limited TCF7L2 Expression in MS Lesions	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS LESIONS; CENTRAL-NERVOUS-SYSTEM; AXONAL DAMAGE; PROGENITOR CELLS; SPINAL-CORD; REMYELINATION; CNS; OLIGODENDROCYTES; DIFFERENTIATION; DEMYELINATION	Multiple sclerosis is the most frequent demyelinating disease in the human CNS characterized by inflammation, demyelination, relative axonal loss and gliosis. Remyelination occurs, but is frequently absent or restricted to a small remyelinated rim at the lesion border. Impaired differentiation of oligodendroglial precursor cells is one factor contributing to limited remyelination, especially in chronic MS. TCF7L2 is an oligodendroglial transcription factor regulating myelin gene expression during developmental myelination as well as remyelination. TCF7L2 binds to co-effectors such as beta-catenin or histone deacetylases and thereby activates or inhibits the transcription of downstream genes involved in oligodendroglial differentiation. To determine whether TCF7L2 can be used as a marker for differentiating or myelinating oligodendrocytes, we analyzed the expression patterns of TCF7L2 during myelination and remyelination in human and murine CNS tissue samples. Here, we demonstrate that marked expression of TCF7L2 in oligodendrocytes is restricted to a well defined time period during developmental myelination in human and mouse CNS tissue samples. In demyelinating diseases, such as multiple sclerosis, TCF7L2 is reexpressed in oligodendrocytes in a subset of MS patients, but is also present in tissue samples from patients with non-demyelinating, inflammatory diseases. Furthermore, TCF7L2 expression was also detected in astrocytes. HDAC2, a potential binding partner of TCF7L2 that promotes oligodendroglial differentiation and myelination, is expressed in the majority of oligodendrocytes in controls and MS tissue samples. In summary, our data demonstrate that the expression of TCF7L2 in oligodendrocytes is limited to a certain differentiation stage; however the expression of TCF7L2 is neither restricted to the oligodendroglial lineage nor to (re-)myelinating conditions.	[Luerbke, Alexander; Hagemeier, Karin; Kuhlmann, Tanja] Univ Hosp Munster, Inst Neuropathol, Munster, Germany; [Cui, Qiao-Ling; Antel, Jack] McGill Univ, Montreal Neurol Inst, Neuroimmunol Unit, Montreal, PQ, Canada; [Metz, Imke; Brueck, Wolfgang] Univ Med Ctr, Dept Neuropathol, Gottingen, Germany	University of Munster; McGill University; University of Gottingen	Kuhlmann, T (corresponding author), Univ Hosp Munster, Inst Neuropathol, Munster, Germany.	tanja.kuhlmann@ukmuenster.de		antel, jack/0000-0002-5148-0636	German Research Foundation [KU 1477/5-1]; Interdisciplinary Clinical Research Center (IZKF) in Munster, Germany [KuT3/006/11];  [SFB-TR 128]	German Research Foundation(German Research Foundation (DFG)); Interdisciplinary Clinical Research Center (IZKF) in Munster, Germany; 	This study was supported by the German Research Foundation (Grant KU 1477/5-1), the SFB-TR 128 and the Interdisciplinary Clinical Research Center (IZKF; KuT3/006/11) in Munster, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IV, 1991, MCALPINES MULTIPLE S, P341; Azim K, 2011, GLIA, V59, P540, DOI 10.1002/glia.21122; BRUCK W, 1995, ANN NEUROL, V38, P788, DOI 10.1002/ana.410380514; Carroll-Anzinger D, 2007, J VIROL, V81, P5864, DOI 10.1128/JVI.02234-06; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; De Stefano N, 1998, BRAIN, V121, P1469, DOI 10.1093/brain/121.8.1469; Duncan ID, 2009, P NATL ACAD SCI USA, V106, P6832, DOI 10.1073/pnas.0812500106; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Feigenson K, 2009, MOL CELL NEUROSCI, V42, P255, DOI 10.1016/j.mcn.2009.07.010; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Hesse A, 2010, NEUROBIOL DIS, V37, P362, DOI 10.1016/j.nbd.2009.10.016; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Kim S, 2008, DEV DYNAM, V237, P3324, DOI 10.1002/dvdy.21739; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Kuhlmann T, 2007, J NEUROPATH EXP NEUR, V66, P238, DOI 10.1097/01.jnen.0000248559.83573.71; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lassmann H, 1998, MCALPINES MULTIPLE S, P323; Lock CB, 2003, TRENDS MOL MED, V9, P535, DOI 10.1016/j.molmed.2003.10.008; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Miron VE, 2008, ANN NEUROL, V63, P61, DOI 10.1002/ana.21227; Neumann H, 2003, CURR OPIN NEUROL, V16, P267, DOI 10.1097/00019052-200306000-00004; Patani R, 2007, NEUROPATH APPL NEURO, V33, P277, DOI 10.1111/j.1365-2990.2007.00805.x; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; PRINEAS JW, 1985, DEMYELINATING DIS, P213; Ruffini F, 2004, AM J PATHOL, V165, P2167, DOI 10.1016/S0002-9440(10)63266-X; Schirmer L, 2011, BRAIN PATHOL, V21, P428, DOI 10.1111/j.1750-3639.2010.00466.x; Tallantyre EC, 2010, MULT SCLER J, V16, P406, DOI 10.1177/1352458510364992; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Wolswijk G, 1998, PROG BRAIN RES, V117, P233; Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333	40	20	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72822	10.1371/journal.pone.0072822	http://dx.doi.org/10.1371/journal.pone.0072822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977356	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300099
J	Balestri, E; Lardicci, C				Balestri, Elena; Lardicci, Claudio			The Impact of Physical Disturbance and Increased Sand Burial on Clonal Growth and Spatial Colonization of Sporobolus virginicus in a Coastal Dune System	PLOS ONE			English	Article							ADAPTIVE ARCHITECTURE; PSAMMOCHLOA-VILLOSA; RHIZOME FRAGMENTS; SEA-LEVEL; INTEGRATION; HETEROGENEITY; ECOSYSTEMS; PLASTICITY; SALINITY; SURVIVAL	Dune plants are subjected to disturbance and environmental stresses, but little is known about the possible combined effects of such factors on growth and spatial colonization. We investigated how clones of Sporobolus virginicus, a widespread dune species, responded to the independent and interactive effects of breakage of rhizomes, breakage position and burial regime. Horizontal rhizomes were severed at three different internode positions relative to the apex to span the range of damage by disturbance naturally observed or left intact, and apical portions exposed to two burial scenarios (ambient vs. increased frequency) for three months in the field. The performance of both parts of severed rhizomes, the apical portion and the remaining basal portion connected to clone containing four consecutive ramets, was compared with that of equivalent parts in intact rhizomes. Apical portions severed proximal to the third internode did not survive and their removal did not enhance branching on their respective basal portions. Severing the sixth or twelfth internode did not affect survival and rhizome extension of apical portions, but suppressed ramet production and reduced total biomass and specific shoot length. Their removal enhanced branching and ramet production on basal portions and changed the original rhizome growth trajectory. However, the gain in number of ramets in basal portions never compensated for the reduction in ramet number in apical portions. Recurrent burial increased biomass allocation to root tissues. Burial also stimulated rhizome extension only in intact rhizomes, indicating that disturbance interacts with, and counteracts, the positive burial effect. These results suggest that disturbance and recurrent burial in combination reduces the regeneration success and spread capacity of S. virginucus. Since global change leads to increasingly severe or frequent storms, the impact of disturbance and burial on clones could be greater in future and possibly prevent colonization of mobile dunes by the species.	[Balestri, Elena; Lardicci, Claudio] Univ Pisa, Dept Biol, Pisa, Italy	University of Pisa	Balestri, E (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	ebalestri@biologia.unipi.it	Balestri, Elena/AAV-5021-2021; lardicci, claudio/K-8698-2018	Balestri, Elena/0000-0002-4497-0418; LARDICCI, CLAUDIO/0000-0001-5356-7914	Solvay Chimica Italia of Rosignano Solvay; Department of Biology (Pisa University, Italy)	Solvay Chimica Italia of Rosignano Solvay(Solvay SA); Department of Biology (Pisa University, Italy)	Solvay Chimica Italia of Rosignano Solvay and Department of Biology (Pisa University, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegro Antun L., 2003, Natura Croatica, V12, P1; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 1992, PLANT PHYSIOL; Bach CE, 2000, AUST J BOT, V48, P159, DOI 10.1071/BT98030; Balestri E, 2010, MAR ECOL PROG SER, V417, P63, DOI 10.3354/meps08783; Balestri E, 2012, ESTUAR COAST SHELF S, V99, P74, DOI 10.1016/j.ecss.2011.12.017; BELL AD, 1980, BOT J LINN SOC, V80, P125, DOI 10.1111/j.1095-8339.1980.tb01662.x; Bell HL, 2003, AM J BOT, V90, P1416, DOI 10.3732/ajb.90.10.1416; Birch CPD, 1999, PLANT ECOL, V141, P21, DOI 10.1023/A:1009810731100; BREEN CM, 1977, HYDROBIOLOGIA, V54, P135, DOI 10.1007/BF00034987; Brown AC, 2002, ENVIRON CONSERV, V29, P62, DOI 10.1017/S037689290200005X; Brown JF, 1997, J ECOL, V85, P151, DOI 10.2307/2960647; Chen JS, 2010, ACTA OECOL, V36, P23, DOI 10.1016/j.actao.2009.09.006; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Cordazzo CV, 1999, J COASTAL RES, V15, P520; de Kroon H., 1990, CLONAL GROWTH PLANTS, P113; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; DISRAELI DJ, 1984, J ECOL, V72, P145, DOI 10.2307/2260010; Dong BC, 2012, BIOL INVASIONS, V14, P1101, DOI 10.1007/s10530-011-0141-5; Dong BC, 2010, EVOL ECOL, V24, P1447, DOI 10.1007/s10682-010-9390-5; Dong B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021012; Dong M, 1999, PLANT ECOL, V141, P53, DOI 10.1023/A:1009875000149; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Feagin RA, 2005, FRONT ECOL ENVIRON, V3, P359, DOI 10.2307/3868584; Frosini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047561; Gilbert M, 2008, OECOLOGIA, V156, P169, DOI 10.1007/s00442-008-0968-3; Gilbert ME, 2010, AUSTRAL ECOL, V35, P53, DOI 10.1111/j.1442-9993.2009.02011.x; Gornish ES, 2010, GLOBAL CHANGE BIOL, V16, P2668, DOI 10.1111/j.1365-2486.2009.02144.x; Gratani L, 2007, FITOSOCIOLOGIA, V44, P11; Greaver TL, 2010, GLOBAL CHANGE BIOL, V16, P1860, DOI 10.1111/j.1365-2486.2010.02168.x; Grime J.P., 2002, PLANT STRATEGIES VEG; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HARRIS D, 1986, J ECOL, V74, P1057, DOI 10.2307/2260233; KELLY CK, 1995, EVOL ECOL, V9, P575, DOI 10.1007/BF01237656; Kooijman AM, 1998, J ECOL, V86, P511, DOI 10.1046/j.1365-2745.1998.00273.x; Leckebusch GC, 2004, GLOBAL PLANET CHANGE, V44, P181, DOI 10.1016/j.gloplacha.2004.06.011; Leithead HL, 1971, USDA HDB, V389; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; MAUN MA, 1984, J ECOL, V72, P565, DOI 10.2307/2260067; Maun MA, 2009, BIOL COASTAL SAND DU; McPhee CS, 1997, ECOSCIENCE, V4, P490, DOI 10.1080/11956860.1997.11682428; Oborny B, 2001, EVOL ECOL, V15, P319, DOI 10.1023/A:1016084815108; Picket S. T. A, 1985, ECOLOGY NATURAL DIST; Pitelka L.F., 1985, POPULATION BIOL EVOL, P399; Provoost S, 2011, J COAST CONSERV, V15, P207, DOI 10.1007/s11852-009-0068-5; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sandrini-Neto L., 2011, GAD R PACKAGE ANOVA; Scartazza A, 2007, CLIMA E CAMBIAMENTI, P245; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Stuefer JF, 1996, FUNCT ECOL, V10, P328, DOI 10.2307/2390280; Thomas RG, 2004, EVOL ECOL, V18, P409, DOI 10.1007/s10682-004-5137-5; Underwood A.J, 1997, EXPT ECOLOGY THEIR L; Wilson JB, 1999, ECOL LETT, V2, P233; Yu FH, 2010, J ARID ENVIRON, V74, P632, DOI 10.1016/j.jaridenv.2009.12.008; Yu FH, 2004, NEW PHYTOL, V162, P697, DOI 10.1111/j.1469-8137.2004.01073.x; Yu FH, 2001, EVOL ECOL, V15, P303, DOI 10.1023/A:1016032831038	56	16	17	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72598	10.1371/journal.pone.0072598	http://dx.doi.org/10.1371/journal.pone.0072598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977326	gold, Green Submitted, Green Published			2022-12-25	WOS:000323425700180
J	Chen, Q; Kang, HY; Fan, X; Wang, Y; Sha, LN; Zhang, HQ; Zhong, MY; Xu, LL; Zeng, J; Yang, RW; Zhang, L; Ding, CB; Zhou, YH				Chen, Qian; Kang, Hou-Yang; Fan, Xing; Wang, Yi; Sha, Li-Na; Zhang, Hai-Qin; Zhong, Mei-Yu; Xu, Li-Li; Zeng, Jian; Yang, Rui-Wu; Zhang, Li; Ding, Chun-Bang; Zhou, Yong-Hong			Evolutionary History of Triticum petropavlovskyi Udacz. et Migusch Inferred from the Sequences of the 3-Phosphoglycerate Kinase Gene	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; PHYLOGENETIC ANALYSIS; MOLECULAR PHYLOGENY; COMMON WHEAT; LONG GLUME; B-GENOME; DIVERSITY; ORIGIN; DIVERGENCE; AESTIVUM	Single- and low-copy genes are less likely to be subject to concerted evolution. Thus, they are appropriate tools to study the origin and evolution of polyploidy plant taxa. The plastid 3-phosphoglycerate kinase gene (Pgk-1) sequences from 44 accessions of Triticum and Aegilops, representing diploid, tetraploid, and hexaploid wheats, were used to estimate the origin of Triticum petropavlovskyi. Our phylogenetic analysis was carried out on exon+intron, exon and intron sequences, using maximum likelihood, Bayesian inference and haplotype networking. We found the D genome sequences of Pgk-1 genes from T. petropavlovskyi are similar to the D genome orthologs in T. aestivum, while their relationship with Ae. tauschii is more distant. The A genome sequences of T. petropavlovskyi group with those of T. polonicum, but its Pgk-1 B genome sequences to some extent diverge from those of other species of Triticum. Our data do not support for the origin of T. petropavlovskyi either as an independent allopolyploidization event between Ae. tauschii and T. polonicum, or as a monomendelian mutation in T. aestivum. We suggest that T. petropavlovskyi originated via spontaneous introgression from T. polonicum into T. aestivum. The dating of this introgression indicates an age of 0.78 million years; a further mutation event concerning the B genome occurred 0.69 million years ago.	[Chen, Qian; Kang, Hou-Yang; Fan, Xing; Wang, Yi; Sha, Li-Na; Zhang, Hai-Qin; Zhong, Mei-Yu; Xu, Li-Li; Zhou, Yong-Hong] Sichuan Agr Univ, Triticeae Res Inst, Yaan City, Sichuan, Peoples R China; [Chen, Qian; Zhou, Yong-Hong] Sichuan Agr Univ, Minist Educ, Key Lab Crop Genet Resources & Improvement, Yaan City, Sichuan, Peoples R China; [Zeng, Jian] Sichuan Agr Univ, Coll Resources & Environm, Yaan City, Sichuan, Peoples R China; [Yang, Rui-Wu; Zhang, Li; Ding, Chun-Bang] Sichuan Agr Univ, Coll Biol & Sci, Yaan City, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Zhou, YH (corresponding author), Sichuan Agr Univ, Triticeae Res Inst, Yaan City, Sichuan, Peoples R China.	zhouyh@sicau.edu.cn	Haiqin, Zhang/ABC-4056-2020; xu, li/GNH-3667-2022		National Natural Science Foundation of China [31101151]; National Transgenic Major Project [2011zx08009001]; National High-tech R&D Program of China (863 Program) [2011AA100103-02]; Special Fund for Agro-Scientific Research in the Public Interest of China [201003021]; Science and Technology Bureau and Education Bureau of Sichuan Province, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Major Project; National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); Special Fund for Agro-Scientific Research in the Public Interest of China; Science and Technology Bureau and Education Bureau of Sichuan Province, China	This work was financially supported by the National Natural Science Foundation of China (31101151), the National Transgenic Major Project (2011zx08009001), the National High-tech R&D Program of China (863 Program) (2011AA100103-02), the Special Fund for Agro-Scientific Research in the Public Interest of China (201003021), and the Science and Technology Bureau and Education Bureau of Sichuan Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akond ASMGM, 2008, GENET RESOUR CROP EV, V55, P133, DOI 10.1007/s10722-007-9221-x; Akond ASMG, 2005, GENET RESOUR CROP EV, V52, P619, DOI 10.1007/s10722-005-6843-8; Allaby RG, 2001, GENETICS, V157, P1331; Arbuzova VS, 1996, EUPHYTICA, V89, P11, DOI 10.1007/BF00015713; Bordbar F, 2011, PLANT SYST EVOL, V291, P117, DOI 10.1007/s00606-010-0375-1; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Chen P. D., 1988, Proceedings of the seventh international wheat genetics symposium, held at Cambridge, UK, 13-19 July 1988., P75; Chen Q., 1985, Acta Agronomica Sinica, V11, P23; Chen Q., 1999, GUIZHOU AGR SCI, V27, P20; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DOROFEEV VF, 1979, FLORA CULTIVATED PLA, P1; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Doyle JJ, 1999, SYST ASSOC SPEC VOL, V57, P229; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Efremova TT, 2000, RUSS J GENET+, V36, P1142; Fan X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031122; Fan X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-247; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gaut BS, 1998, EVOL BIOL, V30, P93; Golovnina KA, 2007, PLANT SYST EVOL, V264, P195, DOI 10.1007/s00606-006-0478-x; Goncharov N. P., 2005, Czech Journal of Genetics and Plant Breeding, V41, P52; Gornicki P, 1997, P NATL ACAD SCI USA, V94, P14179, DOI 10.1073/pnas.94.25.14179; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Huang SX, 2002, PLANT MOL BIOL, V48, P805, DOI 10.1023/A:1014868320552; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JAKUBGINER M. M., 1959, Botanicheskii Zhurnal, V44, P1425; Kang HY, 2010, MOL BREEDING, V25, P381, DOI 10.1007/s11032-009-9337-0; Kang HouYang, 2008, International Journal of Agricultural Research, V3, P252; Kilian B, 2007, MOL BIOL EVOL, V24, P217, DOI 10.1093/molbev/msl151; Kim HS, 2000, EUPHYTICA, V115, P197, DOI 10.1023/A:1004022601879; [刘光欣 Liu Guangxin], 2002, [四川农业大学学报, Journal of Sichuan Agricultural University], V20, P189; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RILEY R, 1967, HEREDITY, V22, P233, DOI 10.1038/hdy.1967.29; Sang T, 2002, CRIT REV BIOCHEM MOL, V37, P121, DOI 10.1080/10409230290771474; Shao Q. Q., 1980, ACTA GENET SIN, V7, P150, DOI DOI 10.1098/RSPB.2009.1015; Smith JF, 2006, PLANT SYST EVOL, V261, P245, DOI 10.1007/s00606-006-0445-6; Sun GL, 2008, MOL PHYLOGENET EVOL, V46, P897, DOI 10.1016/j.ympev.2007.12.024; Sun G, 2009, BREEDING SCI, V59, P487, DOI 10.1270/jsbbs.59.487; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; Udachin R.A., 1970, VESTNIK SELSKOKHOZYA, V9, P20; Wang Haiyan, 2007, Journal of Genetics and Genomics, V34, P623, DOI 10.1016/S1673-8527(07)60071-X; Wang HJ, 2002, EUPHYTICA, V123, P287, DOI 10.1023/A:1014909331902; Ward RW, 1998, THEOR APPL GENET, V96, P312, DOI 10.1007/s001220050742; Watanabe N, 2002, EUPHYTICA, V128, P129, DOI 10.1023/A:1020633904782; Watanabe N, 2002, J GENET BREED, V57, P221; Wei YM, 2002, GENET RESOUR CROP EV, V49, P327, DOI 10.1023/A:1015544403431; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Yan C, 2011, BIOCHEM SYST ECOL, V39, P309, DOI 10.1016/j.bse.2011.08.009; Yan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026853; Yang RuiWu, 2001, Journal of Sichuan Agricultural University, V19, P112; Yang RW, 2000, J TRITICEAE CROPS, V20, P1; Yang W. Y., 1992, Wheat Information Service, P14; Yao J. X., 1983, Hereditas, China, V5, P17; Yen C., 1988, Proceedings of the seventh international wheat genetics symposium, held at Cambridge, UK, 13-19 July 1988., P175; Yen C., 1983, P 6 INT WHEAT GEN S, P55	60	7	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71139	10.1371/journal.pone.0071139	http://dx.doi.org/10.1371/journal.pone.0071139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990932	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700020
J	Habeck, CW; Lindroth, RL				Habeck, Christopher W.; Lindroth, Richard L.			Influence of Global Atmospheric Change on the Feeding Behavior and Growth Performance of a Mammalian Herbivore, Microtus ochrogaster	PLOS ONE			English	Article							WEANLING MEADOW VOLE; ELEVATED CO2; CARBON-DIOXIDE; PRAIRIE VOLE; NUTRITIVE QUALITY; FORAGE QUALITY; FOOD QUALITY; SHORTGRASS STEPPE; NITROGEN DYNAMICS; BODY-COMPOSITION	Global atmospheric change is influencing the quality of plants as a resource for herbivores. We investigated the impacts of elevated carbon dioxide (CO2) and ozone (O-3) on the phytochemistry of two forbs, Solidago canadensis and Taraxacum officinale, and the subsequent feeding behavior and growth performance of weanling prairie voles (Microtus ochrogaster) feeding on those plants. Plants for the chemical analyses and feeding trials were harvested from the understory of control (ambient air), elevated CO2 (560 mu l CO2 I-1), and elevated O-3 (ambient x 1.5) rings at the Aspen FACE (Free Air CO2 Enrichment) site near Rhinelander, Wisconsin. We assigned individual voles to receive plants from only one FACE ring and recorded plant consumption and weanling body mass for seven days. Elevated CO2 and O-3 altered the foliar chemistry of both forbs, but only female weanling voles on the O-3 diet showed negative responses to these changes. Elevated CO2 increased the fiber fractions of both plant species, whereas O-3 fumigation elicited strong responses among many phytochemical components, most notably increasing the carbon-to-nitrogen ratio by 40% and decreasing N by 26%. Consumption did not differ between plant species or among fumigation treatments. Male voles were unaffected by the fumigation treatments, whereas female voles grew 36% less than controls when fed O-3-grown plants. These results demonstrate that global atmospheric change has the potential to affect the performance of a mammalian herbivore through changes in plant chemistry.	[Habeck, Christopher W.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Habeck, Christopher W.] Kutztown State Univ, Dept Biol, Kutztown, PA 19530 USA; [Lindroth, Richard L.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Pennsylvania State System of Higher Education (PASSHE); Kutztown University - Pennsylvania; University of Wisconsin System; University of Wisconsin Madison	Habeck, CW (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	habeck@kutztown.edu	Habeck, Christopher W/K-2265-2013; Lindroth, Richard L/A-8538-2009	Lindroth, Richard L/0000-0003-4587-7255	U.S. Environmental Protection Agency Science to Achieve Results Fellowship Program; Department of Zoology at the University of Wisconsin-Madison; U.S. Department of Energy (Office of Science, BER) [DE-FG02-06ER64232]	U.S. Environmental Protection Agency Science to Achieve Results Fellowship Program; Department of Zoology at the University of Wisconsin-Madison; U.S. Department of Energy (Office of Science, BER)(United States Department of Energy (DOE))	This research was funded by the U.S. Environmental Protection Agency Science to Achieve Results Fellowship Program (C.W.H.), the Department of Zoology at the University of Wisconsin-Madison (C.W.H.), and U.S. Department of Energy (Office of Science, BER) grant DE-FG02-06ER64232 (R.L.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnan N, 2006, MATEMATIKA, V22, P109; AKIN DE, 1995, ANIM FEED SCI TECH, V53, P29, DOI 10.1016/0377-8401(94)00736-S; Batzli G.O., 1985, Special Publication American Society of Mammalogists, P779; BATZLI GO, 1986, ECOLOGY, V67, P406, DOI 10.2307/1938583; BAZZAZ FA, 1991, ECOLOGY, V72, P12, DOI 10.2307/1938896; BEACHAM TD, 1979, CAN J ZOOL, V57, P2375, DOI 10.1139/z79-309; Bender J, 2006, ENVIRON POLLUT, V142, P109, DOI 10.1016/j.envpol.2005.09.012; BERGERON JM, 1993, CAN J ZOOL, V71, P1823, DOI 10.1139/z93-260; Bidart-Bouzat MG, 2008, J INTEGR PLANT BIOL, V50, P1339, DOI 10.1111/j.1744-7909.2008.00751.x; BOLSINGER M, 1992, ENVIRON POLLUT, V77, P31, DOI 10.1016/0269-7491(92)90155-4; Carleton MD, 1985, BIOL NEW WORLD MICRO, P779; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Carter EB, 1999, J SCI FOOD AGR, V79, P1431, DOI 10.1002/(SICI)1097-0010(199908)79:11&lt;1431::AID-JSFA384&gt;3.0.CO;2-4; CASTLE KT, 1995, J COMP PHYSIOL B, V164, P609, DOI 10.1007/BF00389801; Clark JE, 2005, OECOLOGIA, V144, P447, DOI 10.1007/s00442-005-0004-9; DeGabriel JL, 2008, OECOLOGIA, V156, P107, DOI 10.1007/s00442-008-0960-y; DERTING TL, 1993, J MAMMAL, V74, P59, DOI 10.2307/1381905; DESY EA, 1983, J ANIM ECOL, V52, P127, DOI 10.2307/4592; Ditchkoff SS, 1998, AM MIDL NAT, V140, P387, DOI 10.1674/0003-0031(1998)140[0387:NROTAP]2.0.CO;2; Filion M, 2000, GLOB CHANGE BIOL, V6, P843, DOI 10.1046/j.1365-2486.2000.00353.x; Frei M, 2010, ANIM FEED SCI TECH, V155, P74, DOI 10.1016/j.anifeedsci.2009.09.013; Fritschi FB, 1999, GLOB CHANGE BIOL, V5, P743, DOI 10.1046/j.1365-2486.1999.00260.x; GAINES MS, 1984, AM MIDL NAT, V111, P223, DOI 10.2307/2425317; Gonzalez-Fernandez I, 2008, ATMOS ENVIRON, V42, P8755, DOI 10.1016/j.atmosenv.2008.08.030; GROSS JE, 1985, J MAMMAL, V66, P661, DOI 10.2307/1380792; Habeck CW, 2008, ECOL LETT, V11, P898, DOI 10.1111/j.1461-0248.2008.01198.x; HAMMOND KA, 1991, PHYSIOL ZOOL, V64, P541, DOI 10.1086/physzool.64.2.30158190; Howe HF, 2006, ECOLOGY, V87, P3007, DOI 10.1890/0012-9658(2006)87[3007:MADEOM]2.0.CO;2; HOWELL RK, 1977, J DAIRY SCI, V60, P924, DOI 10.3168/jds.S0022-0302(77)83964-7; KANGASJARVI J, 1994, PLANT CELL ENVIRON, V17, P783, DOI 10.1111/j.1365-3040.1994.tb00173.x; Karasov W. H., 2007, PHYSL ECOLOGY; KEYS JE, 1970, J DAIRY SCI, V53, P1502, DOI 10.3168/jds.S0022-0302(70)86422-0; KOTEJA P, 1993, OIKOS, V66, P505, DOI 10.2307/3544946; Kuokkanen K, 2004, GLOBAL CHANGE BIOL, V10, P1504, DOI 10.1111/j.1365-2486.2004.00820.x; Lewis JS, 2006, RANGELAND ECOL MANAG, V59, P267, DOI 10.2111/05-025R2.1; Lilley JM, 2001, NEW PHYTOL, V150, P385, DOI 10.1046/j.1469-8137.2001.00101.x; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Lindroth RL, 2012, ECOL REV, P120; Lindroth RL, 2010, J CHEM ECOL, V36, P2, DOI 10.1007/s10886-009-9731-4; LINDROTH RL, 1984, J MAMMAL, V65, P139, DOI 10.2307/1381215; Lindroth RL, 2002, BIOCHEM SYST ECOL, V30, P297, DOI 10.1016/S0305-1978(01)00088-6; MARQUIS RJ, 1989, J MAMMAL, V70, P503, DOI 10.2307/1381422; Mattson WJ, 2004, GLOBAL CHANGE BIOL, V10, P1402, DOI 10.1111/j.1365-2486.2004.00808.x; Milchunas DG, 2005, AGR ECOSYST ENVIRON, V111, P166, DOI 10.1016/j.agee.2005.06.014; Morgan JA, 2004, ECOL APPL, V14, P208, DOI 10.1890/02-5213; Muntifering RB, 2006, FUNCT ECOL, V20, P269, DOI 10.1111/j.1365-2435.2006.01093.x; Naya DE, 2007, EVOL ECOL RES, V9, P1363; Owensby Clenton E., 1996, P363, DOI 10.1016/B978-012420870-4/50056-6; Owl MY, 1998, FUNCT ECOL, V12, P4, DOI 10.1046/j.1365-2435.1998.00151.x; Pearson OP, 1985, BIOL NEW WORLD MICRO, P779; Powell MC, 2003, ENVIRON POLLUT, V122, P313, DOI 10.1016/S0269-7491(02)00331-7; Quinn GP, 2003, EXPT DESIGN DATA ANA; RUSSO SL, 1981, J ANIM SCI, V52, P1205, DOI 10.2527/jas1981.5251205x; Sakaguchi Ei, 2003, Animal Science Journal, V74, P327, DOI 10.1046/j.1344-3941.2003.00124.x; Schadler M, 2007, GLOBAL CHANGE BIOL, V13, P1005, DOI 10.1111/j.1365-2486.2007.01319.x; SHENK JS, 1975, AGRON J, V67, P569, DOI 10.2134/agronj1975.00021962006700040030x; Sirotnak JM, 2000, ECOLOGY, V81, P78, DOI 10.1890/0012-9658(2000)081[0078:DAIEOH]2.0.CO;2; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Szantoi Z, 2007, ENVIRON POLLUT, V150, P200, DOI 10.1016/j.envpol.2007.01.020; Szantoi Z, 2009, ENVIRON POLLUT, V157, P840, DOI 10.1016/j.envpol.2008.11.014; Trier TM, 1996, PHYSIOL ZOOL, V69, P1456, DOI 10.1086/physzool.69.6.30164269; Valkama E, 2007, GLOBAL CHANGE BIOL, V13, P184, DOI 10.1111/j.1365-2486.2006.01284.x; Voltura MB, 1998, PHYSIOL ZOOL, V71, P321, DOI 10.1086/515929; Voltura MB, 1997, CAN J ZOOL, V75, P1714, DOI 10.1139/z97-798; Wiggins NL, 2006, OECOLOGIA, V147, P272, DOI 10.1007/s00442-005-0268-0; Wittig VE, 2009, GLOBAL CHANGE BIOL, V15, P396, DOI 10.1111/j.1365-2486.2008.01774.x; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; Wold S., 1995, CHEMOMETRIC METHODS, P195; Zvereva EL, 2006, GLOBAL CHANGE BIOL, V12, P27, DOI 10.1111/j.1365-2486.2005.01086.x	69	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72717	10.1371/journal.pone.0072717	http://dx.doi.org/10.1371/journal.pone.0072717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977345	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700187
J	Rouabhia, M; Park, H; Meng, SY; Derbali, H; Zhang, Z				Rouabhia, Mahmoud; Park, Hyunjin; Meng, Shiyun; Derbali, Habib; Zhang, Ze			Electrical Stimulation Promotes Wound Healing by Enhancing Dermal Fibroblast Activity and Promoting Myofibroblast Transdifferentiation	PLOS ONE			English	Article							DIRECTIONAL MIGRATION; GROWTH-FACTORS; HUMAN KERATINOCYTES; CELL-MIGRATION; CYCLIC-AMP; FIELDS; REPAIR; DIFFERENTIATION; PROLIFERATION; EXPRESSION	Electrical stimulation (ES) has long been used as an alternative clinical treatment and an effective approach to modulate cellular behaviours. In this work we investigated the effects of ES on human skin fibroblast activity, myofibroblast transdifferentiation and the consequence on wound healing. Normal human fibroblasts were seeded on heparin-bioactivated PPy/PLLA conductive membranes, cultured for 24 h, and then exposed to ES of 50 or 200 mV/mm for 2, 4, or 6 h. Following ES, the cells were either subjected to various analyses or re-seeded to investigate their healing capacity. Our findings show that ES had no cytotoxic effect on the fibroblasts, as demonstrated by the similar LDH activity levels in the ES-exposed and non-exposed cultures, and by the comparable cell viability under both conditions. Furthermore, the number of viable fibroblasts was higher following exposure to 6 h of ES than in the non-exposed culture. This enhanced cell growth was likely due to the ES up-regulated secretion of FGF-1 and FGF-2. In an in vitro scratch-wound assay where cell monolayer was used as a healing model, the electrically stimulated dermal fibroblasts migrated faster following exposure to ES and recorded a high contractile behaviour toward the collagen gel matrix. This enhanced contraction was supported by the high level of alpha-smooth muscle actin expressed by the fibroblasts following exposure to ES, indicating the characteristics of myofibroblasts. Remarkably, the modulation of fibroblast growth continued long after ES. In conclusion, this work demonstrates for the first time that exposure to ES promoted skin fibroblast growth and migration, increased growth factor secretion, and promoted fibroblast to myofibroblast transdifferentiation, thus promoting wound healing.	[Rouabhia, Mahmoud; Park, Hyunjin; Derbali, Habib] Univ Laval, Fac Dent, Res Grp Oral Ecol, Quebec City, PQ, Canada; [Park, Hyunjin; Derbali, Habib; Zhang, Ze] Univ Laval, Fac Med, Dept Surg, St Francois dAssise Hosp Res Ctr,CHU, Quebec City, PQ G1K 7P4, Canada; [Meng, Shiyun] Chongqing Technol & Business Univ, Coll Environm & Biotechnol, Chongqing, Peoples R China	Laval University; Laval University; Chongqing Technology & Business University	Zhang, Z (corresponding author), Univ Laval, Fac Med, Dept Surg, St Francois dAssise Hosp Res Ctr,CHU, Quebec City, PQ G1K 7P4, Canada.	Ze.Zhang@chg.ulaval.ca		Rouabhia, Mahmoud/0000-0003-2205-8281; meng, shiyun/0000-0003-4523-7602	Canadian Institutes of Health Research [106555]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by The Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The grant number is 106555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DS, 2007, DEVELOPMENT, V134, P1323, DOI 10.1242/dev.02812; Akers T K, 1984, Biomed Sci Instrum, V20, P99; Alvarez Oscar M, 2003, J Foot Ankle Surg, V42, P30; BARKER AT, 1982, AM J PHYSIOL, V242, pR358, DOI 10.1152/ajpregu.1982.242.3.R358; BOURGUIGNON GJ, 1987, FASEB J, V1, P398, DOI 10.1096/fasebj.1.5.3678699; Castella LF, 2010, EXP CELL RES, V316, P2390, DOI 10.1016/j.yexcr.2010.04.033; Chao PHG, 2007, CONNECT TISSUE RES, V48, P188, DOI 10.1080/03008200701424451; CHIANG MC, 1992, EXP EYE RES, V54, P999, DOI 10.1016/0014-4835(92)90164-N; Cinar K, 2009, LASER MED SCI, V24, P735, DOI 10.1007/s10103-008-0631-6; Cochran DL, 1999, PERIODONTOL 2000, V19, P40, DOI 10.1111/j.1600-0757.1999.tb00146.x; COOMBER BL, 1990, ARTERIOSCLEROSIS, V10, P215, DOI 10.1161/01.ATV.10.2.215; Cuzick J, 1998, LANCET, V352, P359, DOI 10.1016/S0140-6736(97)10002-2; Dabiri G, 2008, J INVEST DERMATOL, V128, P2518, DOI 10.1038/jid.2008.90; Davidson D, 2005, J BIOL CHEM, V280, P20509, DOI 10.1074/jbc.M410148200; DiPietro LA, 2013, CURR OPIN RHEUMATOL, V25, P87, DOI 10.1097/BOR.0b013e32835b13b6; Dubey AK, 2011, J BIOMED MATER RES B, V98B, P18, DOI 10.1002/jbm.b.31827; Dusterhoft S, 1999, DIFFERENTIATION, V65, P203, DOI 10.1046/j.1432-0436.1999.6540203.x; Eldardiri M, 2012, TISSUE ENG PT A, V18, P587, DOI [10.1089/ten.TEA.2011.0258, 10.1089/ten.tea.2011.0258]; ELUL R, 1975, NATURE, V258, P616, DOI 10.1038/258616a0; Fang KS, 1998, J INVEST DERMATOL, V111, P751, DOI 10.1046/j.1523-1747.1998.00366.x; FEEDAR JA, 1991, PHYS THER, V71, P639, DOI 10.1093/ptj/71.9.639; Finkelstein E, 2004, J CELL SCI, V117, P1533, DOI 10.1242/jcs.00986; FOULDS IS, 1983, BRIT J DERMATOL, V109, P515, DOI 10.1111/j.1365-2133.1983.tb07673.x; Galzie Z, 1997, BIOCHEM CELL BIOL, V75, P669, DOI 10.1139/bcb-75-6-669; Gleitz J, 1996, J NEUROSCI METH, V67, P97; Gordon T, 2010, EXP NEUROL, V223, P192, DOI 10.1016/j.expneurol.2009.09.020; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Guo AH, 2010, J INVEST DERMATOL, V130, P2320, DOI 10.1038/jid.2010.96; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Jaffe L F, 1984, Clin Dermatol, V2, P34, DOI 10.1016/0738-081X(84)90025-7; JAFFE LF, 1977, ANNU REV BIOPHYS BIO, V6, P445, DOI 10.1146/annurev.bb.06.060177.002305; Joseph E, 2000, WOUNDS, V12, P60; Kakudo N, 2012, HUM CELL, V25, P87, DOI 10.1007/s13577-012-0049-0; Kis K, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001967; Klingberg F, 2013, J PATHOL, V229, P298, DOI 10.1002/path.4104; McCaig CD, 2002, TRENDS NEUROSCI, V25, P354, DOI 10.1016/S0166-2236(02)02174-4; MCGINNIS ME, 1986, DEV BIOL, V116, P184, DOI 10.1016/0012-1606(86)90055-2; Meng SY, 2008, J BIOMED MATER RES A, V87A, P332, DOI 10.1002/jbm.a.31735; Moretti B, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-54; Mukerjee E V, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P4326; Nishimura KY, 1996, J CELL SCI, V109, P199; NUCCITELLI R, 1983, EXP CELL RES, V147, P195, DOI 10.1016/0014-4827(83)90284-7; Nuccitelli R, 2008, WOUND REPAIR REGEN, V16, P432, DOI 10.1111/j.1524-475X.2008.00389.x; ORACINI KF, 2010, J BRACHIAL PLEX PERI, V5, P16, DOI DOI 10.1186/1749-7221-5-16; Peplow PV, 2012, PHOTOMED LASER SURG, V30, P617, DOI 10.1089/pho.2012.3312; Pu J, 2007, J CELL SCI, V120, P3395, DOI 10.1242/jcs.002774; Pullar CE, 2005, J CELL SCI, V118, P2023, DOI 10.1242/jcs.02330; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Quattrini C, 2004, Int J Low Extrem Wounds, V3, P16, DOI 10.1177/1534734603262483; Reid B, 2005, FASEB J, V19, P379, DOI 10.1096/fj.04-2325com; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; ROSS R, 1970, Journal of Cell Biology, V44, P645, DOI 10.1083/jcb.44.3.645; Rowlands AS, 2008, BIOMATERIALS, V29, P4510, DOI 10.1016/j.biomaterials.2008.07.052; Schimmelpfeng J, 1995, BIOELECTROMAGNETICS, V16, P381, DOI 10.1002/bem.2250160606; Semlali A, 2010, ALLERGY, V65, P1438, DOI 10.1111/j.1398-9995.2010.02376.x; Semlali A, 2011, J TOXICOL ENV HEAL A, V74, P848, DOI 10.1080/15287394.2011.570230; Sillman AL, 2003, EXP DERMATOL, V12, P396, DOI 10.1034/j.1600-0625.2002.120406.x; Song B, 2004, J CELL SCI, V117, P4681, DOI 10.1242/jcs.01341; Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299; Sta Iglesia Drina D., 1998, Wound Repair and Regeneration, V6, P531; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Zahm JM, 1997, CELL MOTIL CYTOSKEL, V37, P33, DOI 10.1002/(SICI)1097-0169(1997)37:1<33::AID-CM4>3.0.CO;2-I; Zhao M, 2004, J CELL SCI, V117, P397, DOI 10.1242/jcs.00868; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009; ZIPSE DW, 1993, IEEE T IND APPL, V29, P447, DOI 10.1109/28.216556	68	92	96	4	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71660	10.1371/journal.pone.0071660	http://dx.doi.org/10.1371/journal.pone.0071660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990967	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700081
J	Williams, PA; Howell, GR; Barbay, JM; Braine, CE; Sousa, GL; John, SWM; Morgan, JE				Williams, Pete A.; Howell, Gareth R.; Barbay, Jessica M.; Braine, Catherine E.; Sousa, Gregory L.; John, Simon W. M.; Morgan, James E.			Retinal Ganglion Cell Dendritic Atrophy in DBA/2J Glaucoma	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE ELEVATION; MOUSE MODEL; RAT MODEL; DEGENERATION; DAMAGE; OPA1; APOPTOSIS; RESPONSES; NEURODEGENERATION; MITOCHONDRIA	Glaucoma is a complex disease affecting an estimated 70 million people worldwide, characterised by the progressive degeneration of retinal ganglion cells and accompanying visual field loss. The common site of damage to retinal ganglion cells is thought to be at the optic nerve head, however evidence from other optic neuropathies and neurodegenerative disorders suggests that dendritic structures undergo a prolonged period of atrophy that may accompany or even precede soma loss and neuronal cell death. Using the DBA/2J mouse model of glaucoma this investigation aims to elucidate the impact of increasing intraocular pressure on retinal ganglion cell dendrites using DBA/2J mice that express YFP throughout the retinal ganglion cells driven by Thy1 (DBA/2J. Thy1(YFP)) and DiOlistically labelled retinal ganglion cells in DBA/2J mice. Here we show retinal ganglion cell dendritic degeneration in DiOlistically labelled DBA/2J retinal ganglion cells but not in the DBA/2J. Thy1(YFP) retinal ganglion cells suggesting that a potential downregulation of Thy1 allows only 'healthy' retinal ganglion cells to express YFP. These data may highlight alternative pathways to retinal ganglion cell loss in DBA/2J glaucoma.	[Williams, Pete A.; Morgan, James E.] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales; [Williams, Pete A.; Howell, Gareth R.; Barbay, Jessica M.; Braine, Catherine E.; Sousa, Gregory L.; John, Simon W. M.] Jackson Lab, Bar Harbor, ME 04609 USA; [John, Simon W. M.] Howard Hughes Med Inst, Bar Habor, ME USA; [John, Simon W. M.] Tufts Univ Med, Dept Ophthalmol, Boston, MA USA; [Morgan, James E.] Univ Wales Hosp, Cardiff Eye Unit, Cardiff CF4 4XW, S Glam, Wales	Cardiff University; Jackson Laboratory; Howard Hughes Medical Institute; Tufts University; Cardiff University	Morgan, JE (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales.	morganje3@cf.ac.uk	Williams, Pete/G-1861-2012; Morgan, James/GRO-2905-2022	Williams, Pete/0000-0001-6194-8397; Morgan, James/0000-0002-8920-1065; Sousa, Gregory/0000-0001-5254-8834	Barbara and Joseph Cohen Foundation, Pew Charitable Trust [EY021525, EY11721]; NATIONAL EYE INSTITUTE [R29EY011721, R01EY021525, R01EY011721] Funding Source: NIH RePORTER	Barbara and Joseph Cohen Foundation, Pew Charitable Trust; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by EY021525 (GRH); and EY11721, Barbara and Joseph Cohen Foundation, Pew Charitable Trust (SWMJ). Simon John is an HHMI Investigator; University Hospital of Wales, Cardiff UK (JEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2005, P NATL ACAD SCI USA, V102, P4566, DOI 10.1073/pnas.0407357102; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Anderson MG, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-20; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Dratviman-Storobinsky O, 2008, MOL VIS, V14, P2171; Feng L, 2013, INVEST OPHTH VIS SCI, V54, P1106, DOI 10.1167/iovs.12-10791; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Guo Y, 2010, INVEST OPHTH VIS SCI, V51, P3003, DOI 10.1167/iovs.09-4663; Gutierrez H, 2007, J NEUROSCI METH, V163, P24, DOI 10.1016/j.jneumeth.2007.02.002; Harwerth RS, 1999, INVEST OPHTH VIS SCI, V40, P2242; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Howell GR, 2013, EXP NEUROL, V246, P54, DOI 10.1016/j.expneurol.2012.01.014; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Howell GR, 2007, BMC GENET ENGLAND, P45; Huang W, 2006, CURR EYE RES, V31, P265, DOI 10.1080/02713680500545671; Inman DM, 2006, INVEST OPHTH VIS SCI, V47, P986, DOI 10.1167/iovs.05-0925; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; John, 1998, INVEST OPHTH VIS SCI, V39, P1641; Ju WK, 2008, INVEST OPHTH VIS SCI, V49, P4903, DOI 10.1167/iovs.07-1661; Ju WK, 2009, INVEST OPHTH VIS SCI, V50, P707, DOI 10.1167/iovs.08-2499; Kim BG, 2007, J NEUROSCI METH, V162, P237, DOI 10.1016/j.jneumeth.2007.01.016; King WM, 2006, VISUAL NEUROSCI, V23, P137, DOI 10.1017/S0952523806231122; Kong GYX, 2009, J GLAUCOMA, V18, P93, DOI 10.1097/IJG.0b013e318181284f; Leung CKS, 2009, BRIT J OPHTHALMOL, V93, P964, DOI 10.1136/bjo.2008.150482; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Martin KRG, 2006, EXP EYE RES, V83, P255, DOI 10.1016/j.exer.2005.11.025; Morgan JE, 2012, CLIN EXP OPHTHALMOL, V40, P364, DOI 10.1111/j.1442-9071.2012.02789.x; Morgan JE, 2006, ADV EXP MED BIOL, V572, P397; Morrison JC, 2005, PROG RETIN EYE RES, V24, P217, DOI 10.1016/j.preteyeres.2004.08.003; Munemasa Y, 2010, J NEUROCHEM, V115, P1508, DOI 10.1111/j.1471-4159.2010.07057.x; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Nickells RW, 2012, ANNU REV NEUROSCI, V35, P153, DOI 10.1146/annurev.neuro.051508.135728; Nickells RW, 1999, SURV OPHTHALMOL, V43, pS151, DOI 10.1016/S0039-6257(99)00029-6; Okisaka S, 1997, JPN J OPHTHALMOL, V41, P84, DOI 10.1016/S0021-5155(97)00013-0; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Schlamp CL, 2001, MOL VIS, V7, P192; SHOLL DA, 1953, J ANAT, V87, P387; Shou TD, 2003, INVEST OPHTH VIS SCI, V44, P3005, DOI 10.1167/iovs.02-0620; Smith RS, 2002, SYSTEMIC EVALUATION; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Vrabec JP, 2007, EYE, V21, pS11, DOI 10.1038/sj.eye.6702880; Wang L, 2003, INVEST OPHTH VIS SCI, V44, P2, DOI 10.1167/iovs.02-0333; Weber AJ, 2005, INVEST OPHTH VIS SCI, V46, P3197, DOI 10.1167/iovs.04-0834; Weber AJ, 1998, INVEST OPHTH VIS SCI, V39, P2304; Weber AJ, 2008, INVEST OPHTH VIS SCI, V49, P2456, DOI 10.1167/iovs.07-1325; Williams PA, 2012, BRAIN, V135, P493, DOI 10.1093/brain/awr330; Williams PA, 2010, BRAIN, V133, P2942, DOI 10.1093/brain/awq218; Zhou XH, 2005, J BIOL CHEM, V280, P31240, DOI 10.1074/jbc.M502641200	58	60	60	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72282	10.1371/journal.pone.0072282	http://dx.doi.org/10.1371/journal.pone.0072282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977271	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700161
J	Anderson, MT; Seifert, HS				Anderson, Mark T.; Seifert, H. Steven			Phase Variation Leads to the Misidentification of a Neisseria Gonorrhoeae Virulence Gene	PLOS ONE			English	Article							PILIN ANTIGENIC VARIATION; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; HUMAN-NEUTROPHILS; PROTEIN-II; INFLUENZAE LIPOPOLYSACCHARIDE; GONOCOCCUS INFECTION; ADHESION MOLECULES; OPACITY PROTEINS; EPITHELIAL-CELLS; STRAIN MS11	Neisseria gonorrhoeae is the causative agent of gonorrhea and an obligate pathogen of humans. The Opa proteins of these bacteria are known to mediate attachment and internalization by host cells, including neutrophils. The Opa protein repertoire of a typical N. gonorrhoeae isolate is encoded on similar to 11 genes distributed throughout the chromosome and is subject to stochastic changes in expression through phase variation. Together, these characteristics make Opa proteins a critical yet unpredictable aspect of any experimental investigation into the interaction of N. gonorrhoeae with host cells. The goal of this study was to identify novel virulence factors of N. gonorrhoeae by assessing the contribution of a set of uncharacterized hydrogen peroxide-induced genes to bacterial survival against neutrophil-mediated killing. To this end, a strain harboring an engineered mutation in the NGO0322 gene was identified that exhibited increased sensitivity to neutrophil-mediated killing, enhanced internalization by neutrophils, and the ability to induce high levels of neutrophil-generated reactive oxygen species. Each of these phenotypes reverted to near wild-type levels following genetic complementation of the NGO0322 mutation. However, after immunoblot analysis of Opa proteins expressed by the isogenic parent, mutant, and genetically complemented strains, it was determined that phase variation had resulted in a disparity between the Opa profiles of these strains. To determine whether Opa phase variation, rather than NGO0322 mutation, was the cause of the observed neutrophil-related phenotypes, NGO0322 function was investigated in N. gonorrhoeae strains lacking all Opa proteins or constitutively expressing the OpaD variant. In both cases, mutation of NGO0322 did not alter survival of gonococci in the presence of neutrophils. These results demonstrate the importance of controlling for the frequent and random variation in Opa protein production by N. gonorrhoeae when investigating host cell interactions.	[Anderson, Mark T.; Seifert, H. Steven] Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Seifert, HS (corresponding author), Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA.	h-seifert@northwestern.edu	Anderson, Mark/AAZ-2342-2021	Anderson, Mark/0000-0001-5097-3597	National Institutes of Health (NIH) [R01 AI044239, R37 AI033493]; NIH NSRA [AI080083]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044239, R01AI033493, R37AI033493] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NSRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants R01 AI044239 and R37 AI033493. MTA was partially suppoted by NIH NSRA AI080083. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1988, J EXP MED, V168, P507, DOI 10.1084/jem.168.2.507; Backstrom A, 2004, P NATL ACAD SCI USA, V101, P16923, DOI 10.1073/pnas.0404817101; Ball LM, 2013, J BACTERIOL, V195, P2982, DOI 10.1128/JB.00171-13; BARRITT DS, 1987, INFECT IMMUN, V55, P2026, DOI 10.1128/IAI.55.9.2026-2031.1987; BHAT KS, 1991, MOL MICROBIOL, V5, P1889, DOI 10.1111/j.1365-2958.1991.tb00813.x; BLACK WJ, 1984, INFECT IMMUN, V45, P453, DOI 10.1128/IAI.45.2.453-457.1984; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; CONNELL TD, 1990, MOL MICROBIOL, V4, P439, DOI 10.1111/j.1365-2958.1990.tb00610.x; Criss AK, 2008, CELL MICROBIOL, V10, P2257, DOI 10.1111/j.1462-5822.2008.01205.x; Criss AK, 2006, CELL MICROBIOL, V8, P1430, DOI 10.1111/j.1462-5822.2006.00722.x; Criss AK, 2009, CELL MICROBIOL, V11, P1074, DOI 10.1111/j.1462-5822.2009.01308.x; DEMPSEY JAF, 1991, J BACTERIOL, V173, P5476, DOI 10.1128/jb.173.17.5476-5486.1991; FISCHER SH, 1988, INFECT IMMUN, V56, P1574, DOI 10.1128/IAI.56.6.1574-1579.1988; FRANGIPANE JV, 1992, INFECT IMMUN, V60, P1793, DOI 10.1128/IAI.60.5.1793-1799.1992; GOTSCHLICH EC, 1994, J EXP MED, V180, P2181, DOI 10.1084/jem.180.6.2181; HIGH NJ, 1993, MOL MICROBIOL, V9, P1275, DOI 10.1111/j.1365-2958.1993.tb01257.x; HOOK EW, 1985, ANN INTERN MED, V102, P229, DOI 10.7326/0003-4819-102-2-229; Howell-Adams B, 2000, MOL MICROBIOL, V37, P1146, DOI 10.1046/j.1365-2958.2000.02067.x; HowellAdams B, 1996, MOL MICROBIOL, V22, P509, DOI 10.1046/j.1365-2958.1996.00128.x; JAMES JF, 1978, INFECT IMMUN, V19, P332, DOI 10.1128/IAI.19.1.332-340.1978; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; Jordan PW, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-21; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kline KA, 2005, J BACTERIOL, V187, P5347, DOI 10.1128/JB.187.15.5347-5355.2005; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LeVan A, 2012, J BACTERIOL, V194, P6468, DOI 10.1128/JB.00969-12; MAYER LW, 1982, INFECT IMMUN, V37, P481, DOI 10.1128/IAI.37.2.481-485.1982; Mehr IJ, 2000, GENETICS, V154, P523; REST RF, 1982, INFECT IMMUN, V36, P737, DOI 10.1128/IAI.36.2.737-744.1982; Sadarangani M, 2011, FEMS MICROBIOL REV, V35, P498, DOI 10.1111/j.1574-6976.2010.00260.x; Sarantis H, 2012, INFECT IMMUN, V80, P345, DOI 10.1128/IAI.05702-11; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seib KL, 2005, INFECT IMMUN, V73, P5269, DOI 10.1128/IAI.73.8.5269-5272.2005; SEIFERT HS, 1994, J CLIN INVEST, V93, P2744, DOI 10.1172/JCI117290; Simms AN, 2006, INFECT IMMUN, V74, P2965, DOI 10.1128/IAI.74.5.2965-2974.2006; Simons MP, 2005, INFECT IMMUN, V73, P1971, DOI 10.1128/IAI.73.4.1971-1977.2005; Skaar EP, 2002, P NATL ACAD SCI USA, V99, P10108, DOI 10.1073/pnas.152334799; Solnick JV, 2004, P NATL ACAD SCI USA, V101, P2106, DOI 10.1073/pnas.0308573100; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; Stohl EA, 2005, MOL MICROBIOL, V58, P520, DOI 10.1111/j.1365-2958.2005.04839.x; SUGASAWARA RJ, 1983, INFECT IMMUN, V42, P980, DOI 10.1128/IAI.42.3.980-985.1983; SWANSON J, 1975, INFECT IMMUN, V11, P1352, DOI 10.1128/IAI.11.6.1352-1361.1975; SWANSON J, 1988, J EXP MED, V168, P2121, DOI 10.1084/jem.168.6.2121; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANHAM SM, 1993, CELL, V73, P1187, DOI 10.1016/0092-8674(93)90647-9; WEISER JN, 1989, CELL, V59, P657, DOI 10.1016/0092-8674(89)90011-1; WILLEMS R, 1990, EMBO J, V9, P2803, DOI 10.1002/j.1460-2075.1990.tb07468.x; Wisniewski-Dye F, 2008, ANTON LEEUW INT J G, V94, P493, DOI 10.1007/s10482-008-9267-6; Yang QL, 1996, J EXP MED, V183, P323, DOI 10.1084/jem.183.1.323	51	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72183	10.1371/journal.pone.0072183	http://dx.doi.org/10.1371/journal.pone.0072183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977246	Green Submitted, gold, Green Published			2022-12-25	WOS:000323570200061
J	Guo, J; Hirsch, S; Fehlner, A; Papazoglou, S; Scheel, M; Braun, J; Sack, I				Guo, Jing; Hirsch, Sebastian; Fehlner, Andreas; Papazoglou, Sebastian; Scheel, Michael; Braun, Juergen; Sack, Ingolf			Towards an Elastographic Atlas of Brain Anatomy	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; FRACTAL NETWORK DIMENSION; MR ELASTOGRAPHY; VISCOELASTIC PROPERTIES; IN-VIVO; INVERSION; ELASTICITY; STIFFNESS; RHEOMETRY	Cerebral viscoelastic constants can be measured in a noninvasive, image-based way by magnetic resonance elastography (MRE) for the detection of neurological disorders. However, MRE brain maps of viscoelastic constants are still limited by low spatial resolution. Here we introduce three-dimensional multifrequency MRE of the brain combined with a novel reconstruction algorithm based on a model-free multifrequency inversion for calculating spatially resolved viscoelastic parameter maps of the human brain corresponding to the dynamic range of shear oscillations between 30 and 60 Hz. Maps of two viscoelastic parameters, the magnitude and the phase angle of the complex shear modulus, vertical bar G*vertical bar and phi, were obtained and normalized to group templates of 23 healthy volunteers in the age range of 22 to 72 years. This atlas of the anatomy of brain mechanics reveals a significant contrast in the stiffness parameter vertical bar G*vertical bar between different anatomical regions such as white matter (WM; 1.252 +/- 0.260 kPa), the corpus callosum genu (CCG; 1.104 +/- 0.280 kPa), the thalamus (TH; 1.058 +/- 0.208 kPa) and the head of the caudate nucleus (HCN; 0.649 +/- 0.101 kPa). phi, which is sensitive to the lossy behavior of the tissue, was in the order of CCG (1.011 +/- 0.172), TH (1.037 +/- 0.173), CN (0.906 +/- 0.257) and WM (0.854 +/- 0.169). The proposed method provides the first normalized maps of brain viscoelasticity with anatomical details in subcortical regions and provides useful background data for clinical applications of cerebral MRE.	[Guo, Jing; Hirsch, Sebastian; Fehlner, Andreas; Papazoglou, Sebastian; Scheel, Michael; Sack, Ingolf] Charite, Dept Radiol, D-13353 Berlin, Germany; [Braun, Juergen] Charite, Inst Med Informat, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sack, I (corresponding author), Charite, Dept Radiol, Campus Charite Mitte, D-13353 Berlin, Germany.	ingolf.sack@charite.de	Fehlner, Andreas/L-8527-2016; Scheel, Michael/M-2350-2019	Fehlner, Andreas/0000-0003-0448-7138; Braun, Jurgen/0000-0001-5183-7546; Scheel, Michael/0000-0002-3505-2914; Guo, Jing/0000-0002-1170-8157	German Research Foundation [Sa901/10]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation Sa901/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Clayton EH, 2012, J R SOC INTERFACE; Doyley MM, 2012, PHYS MED BIOL, V57, pR35, DOI 10.1088/0031-9155/57/3/R35; Ghiglia D.C., 1998, 2 DIMENSIONAL PHASE, V1st; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Guo J, 2012, PHYS MED BIOL, V57, P4041, DOI 10.1088/0031-9155/57/12/4041; Hirsch S, 2012, MAGN RESON MED, DOI [10.1002/mrm.24499, DOI 10.1002/MRM.24499.[]; Hirsch S, 2012, MAGN RESON MED, DOI [10.1002/mrm.24294, DOI 10.1002/MRM.24294.[]; Hirsch S, 2014, MAGN RESON MED, V71, P267, DOI 10.1002/mrm.24674; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson C.L., 2012, MAGN RESON MED; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; McGarry MDJ, 2012, MED PHYS, V39, P6388, DOI 10.1118/1.4754649; McRobbie DW., 2006, MRI PICTURE PROTON; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; Murphy MC, 2012, J NEUROSURG; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Papazoglou S, 2008, PHYS MED BIOL, V53, P3147, DOI 10.1088/0031-9155/53/12/005; Papazoglou S, 2006, MAGN RESON MED, V56, P489, DOI 10.1002/mrm.20993; Papazoglou S, 2012, PHYS MED BIOL, V57, P2329, DOI 10.1088/0031-9155/57/8/2329; Papazoglou S, 2009, PHYS MED BIOL, V54, P2229, DOI 10.1088/0031-9155/54/7/025; Perrinez PR, 2009, IEEE T BIO-MED ENG, V56, P598, DOI 10.1109/TBME.2008.2009928; Posnansky O, 2012, PHYS MED BIOL, V57, P4023, DOI 10.1088/0031-9155/57/12/4023; Riek K, 2012, NEUROIMAGE-CLIN, V1, P81, DOI 10.1016/j.nicl.2012.09.003; Romano A, 2012, MAGN RESON MED, V68, P1410, DOI 10.1002/mrm.24141; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Sack I, 2013, SOFT MATTER, V9, P5672, DOI 10.1039/c3sm50552a; Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; Streitberger KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029888; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Uffmann K, 2002, CONCEPT MAGNETIC RES, V15, P239, DOI 10.1002/cmr.10045; Urayama K, 2009, POLYMER, V50, P347, DOI 10.1016/j.polymer.2008.10.027; Vappou J, 2007, MAGN RESON MATER PHY, V20, P273, DOI 10.1007/s10334-007-0098-7; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018; Zhang J, 2011, J BIOMECH, V44, P1909, DOI 10.1016/j.jbiomech.2011.04.034	40	80	81	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71807	10.1371/journal.pone.0071807	http://dx.doi.org/10.1371/journal.pone.0071807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977148	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500106
J	Estey, MP; Di Ciano-Oliveira, C; Froese, CD; Fung, KYY; Steels, JD; Litchfield, DW; Trimble, WS				Estey, Mathew P.; Di Ciano-Oliveira, Caterina; Froese, Carol D.; Fung, Karen Y. Y.; Steels, Jonathan D.; Litchfield, David W.; Trimble, William S.			Mitotic Regulation of SEPT9 Protein by Cyclin-dependent Kinase 1 (Cdk1) and Pin1 Protein Is Important for the Completion of Cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CDK (Cyclin-dependent Kinase); Cytokinesis; Cytoskeleton; GTPase; Phosphorylation; Pin1; Proline Isomerase; Septin	PROLYL ISOMERASE PIN1; SACCHAROMYCES-CEREVISIAE; MAMMALIAN SEPTINS; BREAST-CANCER; CELL-CYCLE; PHOSPHORYLATION; GENE; EXPRESSION; TUMORIGENESIS; LOCALIZATION	Background: Evidence is lacking to explain how septin function is controlled during the cell cycle. Results: Phosphorylation of SEPT9 by Cdk1 creates a binding site for Pin1 that is required for cytokinesis. Conclusion: Septin interaction with Pin1 is controlled by Cdk1 and is necessary for timely cytokinesis. Significance: Improper cell division results in cancer, in which both SEPT9 and Pin1 have been implicated. Precise cell division is essential for multicellular development, and defects in this process have been linked to cancer. Septins are a family of proteins that are required for mammalian cell division, but their function and mode of regulation during this process are poorly understood. Here, we demonstrate that cyclin-dependent kinase 1 (Cdk1) phosphorylates septin 9 (SEPT9) upon mitotic entry, and this phosphorylation controls association with the proline isomerase, Pin1. Both SEPT9 and Pin1 are critical for mediating the final separation of daughter cells. Expression of mutant SEPT9 that is defective in Pin1 binding was unable to rescue cytokinesis defects caused by SEPT9 depletion but rather induced dominant-negative defects in cytokinesis. However, unlike SEPT9 depletion, Pin1 was not required for the accumulation of the exocyst complex at the midbody. These results suggest that SEPT9 plays multiple roles in abscission, one of which is regulated by the action of Cdk1 and Pin1.	[Estey, Mathew P.; Fung, Karen Y. Y.; Steels, Jonathan D.; Trimble, William S.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Estey, Mathew P.; Di Ciano-Oliveira, Caterina; Froese, Carol D.; Fung, Karen Y. Y.; Steels, Jonathan D.; Trimble, William S.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Litchfield, David W.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Western University (University of Western Ontario)	Trimble, WS (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	wtrimble@sickkids.ca	Litchfield, David/E-4636-2015	Litchfield, David/0000-0002-2425-6620	Canadian Cancer Society; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Research and Innovation	Canadian Cancer Society(Canadian Cancer Society (CCS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was supported in part by the Canadian Cancer Society.; Recipient of an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada.; Supported by a postdoctoral fellowship from the Ontario Ministry of Research and Innovation.	Amin ND, 2008, J NEUROSCI, V28, P3631, DOI 10.1523/JNEUROSCI.0453-08.2008; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Estey MP, 2010, J CELL BIOL, V191, P741, DOI 10.1083/jcb.201006031; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; HANES SD, 1989, YEAST, V5, P55, DOI 10.1002/yea.320050108; Kim MS, 2011, J CELL BIOL, V195, P815, DOI 10.1083/jcb.201106131; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Lu KP, 1996, NATURE, V380, P544; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; McIlhatton MA, 2001, ONCOGENE, V20, P5930, DOI 10.1038/sj.onc.1204752; McMurray MA, 2009, CELL CYCLE, V8, P195, DOI 10.4161/cc.8.2.7381; Messenger MM, 2002, J BIOL CHEM, V277, P23054, DOI 10.1074/jbc.M200111200; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Scott M, 2006, INT J CANCER, V118, P1325, DOI 10.1002/ijc.21486; Sellin ME, 2011, MOL BIOL CELL, V22, P3152, DOI 10.1091/mbc.E11-03-0253; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Tang CSL, 2002, CELL CYCLE, V1, P42, DOI 10.4161/cc.1.1.99; Taniguchi M, 2007, J BIOL CHEM, V282, P7869, DOI 10.1074/jbc.M609457200; van der Horst A, 2009, CANCER RES, V69, P6651, DOI 10.1158/0008-5472.CAN-09-0825; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu YX, 2007, MOL CELL, V26, P287, DOI 10.1016/j.molcel.2007.03.020; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zhu JX, 2007, BIOCHEM BIOPH RES CO, V359, P529, DOI 10.1016/j.bbrc.2007.05.124	43	39	39	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30075	30086		10.1074/jbc.M113.474932	http://dx.doi.org/10.1074/jbc.M113.474932			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23990466	Green Published, hybrid			2022-12-25	WOS:000329868100008
J	Liu, J; Gao, LW; Zhang, H; Wang, DW; Wang, M; Zhu, JQ; Pang, C; Wang, CL				Liu, Jun; Gao, Liuwei; Zhang, Hua; Wang, Daowei; Wang, Meng; Zhu, Jianquan; Pang, Cong; Wang, Changli			Succinate Dehydrogenase 5 (SDH5) Regulates Glycogen Synthase Kinase 3 beta-beta-Catenin-mediated Lung Cancer Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL TRANSITION; CLINICAL-TRIALS; PARAGANGLIOMA; GENE; PHOSPHORYLATION; MUTATIONS; THERAPIES; CARCINOMA; PATHWAY; HEART	We demonstrate that loss of succinate dehydrogenase 5 (SDH5) expression initiates epithelial-mesenchymal transition (EMT), which is visualized by the repression of E-cadherin and up-regulation of vimentin in lung cancer cell lines and clinical lung cancer specimens. In SDH5 knock-out mice, lung epithelial cells exhibited elevated mesenchymal markers, which is characteristic of EMT. Using a human lung xenograft-mouse model, we observed that knocking down endogenous SDH5 in human carcinoma cells leads to the development of multiple lymph node metastases. Moreover, our data indicate that SDH5 functions as a critical protein in regulating EMT by modulating the glycogen synthase kinase (GSK)-3 beta-beta-catenin signaling pathway. These results reveal a critical role for SDH5 in EMT and suggest that SDH5 may be a prognostic biomarker and potential therapeutic target for lung cancer metastasis.	[Liu, Jun; Gao, Liuwei; Zhang, Hua; Wang, Daowei; Wang, Meng; Zhu, Jianquan; Pang, Cong; Wang, Changli] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr, Dept Lung Canc, Tianjin 300060, Peoples R China	Tianjin Medical University	Wang, CL (corresponding author), Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.	changliwangtj@163.com			National Natural Science Foundation of China [81101776]; China Postdoctoral Science Foundation [2013T60256]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China Grant 81101776 and China Postdoctoral Science Foundation Grant 2013T60256.	Bokobza SM, 2011, MOL CELL BIOCHEM, V349, P33, DOI 10.1007/s11010-010-0657-5; Brabant G, 2005, FASEB J, V19, P1048, DOI 10.1096/fj.04-2846fje; Cao YJ, 2011, CANCER RES, V71, P1235, DOI 10.1158/0008-5472.CAN-10-2217; Chen HZ, 2012, GUT, V61, P714, DOI 10.1136/gutjnl-2011-300783; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Couzin-Frankel J, 2012, SCIENCE, V335, P282, DOI 10.1126/science.335.6066.282; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Jakobsen JN, 2013, LUNG CANCER, V79, P1, DOI 10.1016/j.lungcan.2012.10.008; Janku F, 2012, CLIN CANCER RES, V18, P6356, DOI 10.1158/1078-0432.CCR-12-0178; Kaag D, 2013, LUNG CANCER, V79, P54, DOI 10.1016/j.lungcan.2012.10.009; Kaelin WG, 2009, CANCER CELL, V16, P180, DOI 10.1016/j.ccr.2009.08.013; Kitazawa M, 2011, J IMMUNOL, V187, P6539, DOI 10.4049/jimmunol.1100620; Kunst HPM, 2011, CLIN CANCER RES, V17, P247, DOI 10.1158/1078-0432.CCR-10-0420; Li CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027053; Liu J., 2013, J CLIN ONCOL CANC RE, V40, P1789; Matsuda T, 2008, P NATL ACAD SCI USA, V105, P20900, DOI 10.1073/pnas.0808315106; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Ramachandran R, 2011, P NATL ACAD SCI USA, V108, P15858, DOI 10.1073/pnas.1107220108; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Shinagare AB, 2012, LUNG CANCER, V78, P161, DOI 10.1016/j.lungcan.2012.08.007; Starker LF, 2010, ENDOCRINE, V38, P397, DOI 10.1007/s12020-010-9399-0; Toth MJ, 2011, J APPL PHYSIOL, V110, P892, DOI 10.1152/japplphysiol.00545.2010; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Yang WJ, 2009, HEPATOLOGY, V49, P1515, DOI 10.1002/hep.22833; Zhang Y., 2011, J BIOL CHEM, V286, P16218; Zhang YH, 2012, J BIOL CHEM, V287, P17746, DOI 10.1074/jbc.M112.358143; Zhang Y, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-58	28	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29965	29973		10.1074/jbc.M113.450106	http://dx.doi.org/10.1074/jbc.M113.450106			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23983127	hybrid, Green Published			2022-12-25	WOS:000330615300069
J	Lopez-Rodriguez, E; Cruz, A; Richter, RP; Taeusch, HW; Perez-Gil, J				Lopez-Rodriguez, Elena; Cruz, Antonio; Richter, Ralf P.; Taeusch, H. William; Perez-Gil, Jesus			Transient Exposure of Pulmonary Surfactant to Hyaluronan Promotes Structural and Compositional Transformations into a Highly Active State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS SP-B; COMPETITIVE ADSORPTION; HYDROPHILIC POLYMERS; GRAFTED HYALURONAN; MOLECULAR-WEIGHT; CHOLESTEROL; SERUM; FILMS; INACTIVATION; MEMBRANES	Pulmonary surfactant is a lipid-protein complex that lowers surface tension at the respiratory air-liquid interface, stabilizing the lungs against physical forces tending to collapse alveoli. Dysfunction of surfactant is associated with respiratory pathologies such as acute respiratory distress syndrome or meconium aspiration syndrome where naturally occurring surfactant-inhibitory agents such as serum, meconium, or cholesterol reach the lung. We analyzed the effect of hyaluronan(HA) on the structure and surface behavior of pulmonary surfactant to understand the mechanism for HA-promoted surfactant protection in the presence of inhibitory agents. In particular, we found that HA affects structural properties such as the aggregation state of surfactant membranes and the size, distribution, and order/packing of phase-segregated lipid domains. These effects do not require a direct interaction between surfactant complexes and HA and are accompanied by a compositional reorganization of large surfactant complexes that become enriched with saturated phospholipid species. HA-exposed surfactant reaches very high efficiency in terms of rapid and spontaneous adsorption of surfactant phospholipids at the air-liquid interface and shows significantly improved resistance to inactivation by serum or cholesterol. We propose that physical effects pertaining to the formation of a meshwork of interpenetrating HA polymer chains are responsible for the changes in surfactant structure and composition that enhance surfactant function and, thus, resistance to inactivation. The higher resistance of HA-exposed surfactant to inactivation persists even after removal of the polymer, suggesting that transient exposure of surfactant to polymers like HA could be a promising strategy for the production of more efficient therapeutic surfactant preparations.	[Lopez-Rodriguez, Elena; Cruz, Antonio; Perez-Gil, Jesus] Univ Complutense, Fac Biol, Dept Biochem & Mol Biol, E-28040 Madrid, Spain; [Richter, Ralf P.] CIC BiomaGUNE, Biosurfaces Unit, San Sebastian 20009, Spain; [Richter, Ralf P.] Univ Grenoble 1, Dept Mol Chem, Lab I2BM, F-38041 Grenoble 9, France; [Richter, Ralf P.] Univ Basque Country, Dept Biochem & Mol Biol, Leioa 48940, Spain; [Richter, Ralf P.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany; [Taeusch, H. William] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94110 USA	Complutense University of Madrid; CIC biomaGUNE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Basque Country; Max Planck Society; University of California System; University of California San Francisco	Perez-Gil, J (corresponding author), Univ Complutense, Fac Biol, Dept Biochem & Mol Biol, C JoseAntonio Novais 2, E-28040 Madrid, Spain.	jperezgil@bio.ucm.es	Richter, Ralf Peter/B-3343-2013; Cruz, Antonio/H-2881-2015; Perez-Gil, Jesus/H-3102-2019; Lopez-Rodriguez, Elena/ABC-4033-2020; biomaGUNE, CIC/J-9136-2014	Richter, Ralf Peter/0000-0003-3071-2837; Cruz, Antonio/0000-0002-0465-4111; Perez-Gil, Jesus/0000-0003-3587-7147; Lopez-Rodriguez, Elena/0000-0002-1549-8150; biomaGUNE, CIC/0000-0001-7690-0660	National Institutes of Health [HLBI RO1 HL 66410]; Spanish Ministry of Economy and Competitivity [BIO2012-30733, MAT2011-24306, CSD2007-00010]; Regional Government of Madrid [S2009MAT-1507]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Economy and Competitivity(Spanish Government); Regional Government of Madrid; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HLBI RO1 HL 66410. This work was also supported by Spanish Ministry of Economy and Competitivity Grants BIO2012-30733, MAT2011-24306, and CSD2007-00010 and by Regional Government of Madrid Grant S2009MAT-1507.	Almond A, 2000, J PHYS CHEM B, V104, P5634, DOI 10.1021/jp000402t; Attili S, 2012, BIOMACROMOLECULES, V13, P1466, DOI 10.1021/bm3001759; Attili S, 2012, LANGMUIR, V28, P3206, DOI 10.1021/la204602n; de la Serna JB, 2009, BIOPHYS J, V97, P1381, DOI 10.1016/j.bpj.2009.06.040; Blanco O, 2007, EUR J PHARMACOL, V568, P1, DOI 10.1016/j.ejphar.2007.04.035; Bray BA, 2001, J THEOR BIOL, V210, P121, DOI 10.1006/jtbi.2001.2305; Campbell H, 2002, AM J RESP CRIT CARE, V165, P475, DOI 10.1164/ajrccm.165.4.2106109; CASTRESANA J, 1992, BIOCHEM J, V282, P467, DOI 10.1042/bj2820467; Chavarha M, 2010, BIOPHYS J, V98, P1549, DOI 10.1016/j.bpj.2009.12.4302; COMPER WD, 1978, PHYSIOL REV, V58, P255, DOI 10.1152/physrev.1978.58.1.255; Cowman MK, 2005, CARBOHYD RES, V340, P791, DOI 10.1016/j.carres.2005.01.022; de la Serna JB, 2004, J BIOL CHEM, V279, P40715, DOI 10.1074/jbc.M404648200; DE SMEDT SC, 1993, BIORHEOLOGY, V30, P31; Dehority W, 2005, PEDIATR RES, V58, P913, DOI 10.1203/01.PDR.0000182581.39561.01; El Shahed A. I., 2007, COCHRANE DB SYST REV, V3; Fam H, 2007, BIORHEOLOGY, V44, P59; Fam H, 2009, BIORHEOLOGY, V46, P31, DOI 10.3233/BIR-2009-0521; Gaver D. P., 2005, LUNG SURFACTANT DYSF, P192; Gomez-Gil L, 2009, BIOPHYS J, V97, P2736, DOI 10.1016/j.bpj.2009.08.045; HEATLEY F, 1988, BIOCHEM J, V254, P489, DOI 10.1042/bj2540489; Hunger J, 2012, BIOPHYS J, V103, pL10, DOI 10.1016/j.bpj.2012.05.028; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; JOANNY JF, 1979, J POLYM SCI POL PHYS, V17, P1073, DOI 10.1002/pol.1979.180170615; Keating E, 2012, BBA-BIOMEMBRANES, V1818, P1225, DOI 10.1016/j.bbamem.2011.12.007; Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32; Leckband D, 2001, Q REV BIOPHYS, V34, P105, DOI 10.1017/S0033583501003687; Lopez-Rodriguez E, 2012, BIOPHYS J, V103, P1451, DOI 10.1016/j.bpj.2012.08.024; Lopez-Rodriguez E, 2011, BIOPHYS J, V100, P646, DOI 10.1016/j.bpj.2010.12.3715; Lu KW, 2009, BBA-BIOMEMBRANES, V1788, P632, DOI 10.1016/j.bbamem.2009.01.005; Lu KW, 2005, PEDIATR RES, V57, P237, DOI 10.1203/01.PDR.0000150726.75308.22; Matar OK, 2002, J FLUID MECH, V466, P85, DOI 10.1017/S0022112002001106; NETTELBLADT O, 1989, AM J PHYSIOL, V257, pL379, DOI 10.1152/ajplung.1989.257.6.L379; Parra E, 2013, BIOPHYS J, V104, P146, DOI 10.1016/j.bpj.2012.11.014; Parra E, 2011, BIOCHEM J, V438, P555, DOI 10.1042/BJ20110681; Perez-Gil J, 1998, BBA-MOL BASIS DIS, V1408, P203, DOI 10.1016/S0925-4439(98)00068-4; Perkins WR, 1996, SCIENCE, V273, P330, DOI 10.1126/science.273.5273.330; Possmayer F, 2010, RESP PHYSIOL NEUROBI, V173, pS55, DOI 10.1016/j.resp.2010.02.014; Pott T, 2008, CHEM PHYS LIPIDS, V154, P115, DOI 10.1016/j.chemphyslip.2008.03.008; Reviakine I, 2011, ANAL CHEM, V83, P8838, DOI 10.1021/ac201778h; Richter RP, 2007, J AM CHEM SOC, V129, P5306, DOI 10.1021/ja068768s; Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Rubinstein M, 2008, POLYM PHYS; SAHU SC, 1980, INFLAMMATION, V4, P107, DOI 10.1007/BF00914107; SCHOEL WM, 1994, BBA-GEN SUBJECTS, V1200, P281, DOI 10.1016/0304-4165(94)90169-4; Schurch S, 1998, BBA-MOL BASIS DIS, V1408, P180, DOI 10.1016/S0925-4439(98)00067-2; Shieh IC, 2012, BIOPHYS J, V102, P777, DOI 10.1016/j.bpj.2012.01.014; Spragg RG, 2011, AM J RESP CRIT CARE, V183, P1055, DOI 10.1164/rccm.201009-1424OC; Stenger PC, 2009, BBA-BIOMEMBRANES, V1788, P1033, DOI 10.1016/j.bbamem.2009.01.006; Strobl G., 2007, PHYS POLYM CONCEPTS; Taeusch HW, 2008, COLLOID SURFACE B, V62, P243, DOI 10.1016/j.colsurfb.2007.10.009; Taeusch HW, 2005, BIOPHYS J, V89, P1769, DOI 10.1529/biophysj.105.062620; Turino GM, 2003, AM J RESP CRIT CARE, V167, P1169, DOI 10.1164/rccm.200205-449PP; Wolny PM, 2010, J BIOL CHEM, V285, P30170, DOI 10.1074/jbc.M110.137562; Wolny PM, 2010, LANGMUIR, V26, P1029, DOI 10.1021/la902226b; Zasadzinski JA, 2005, BIOPHYS J, V89, P1621, DOI 10.1529/biophysj.105.062646; Zasadzinski JA, 2010, BBA-BIOMEMBRANES, V1798, P801, DOI 10.1016/j.bbamem.2009.12.010	57	16	17	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29872	29881		10.1074/jbc.M113.493957	http://dx.doi.org/10.1074/jbc.M113.493957			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23983120	hybrid, Green Published			2022-12-25	WOS:000330615300060
J	Cheng, F; Torzewski, M; Degreif, A; Rossmann, H; Canisius, A; Lackner, KJ				Cheng, Fei; Torzewski, Michael; Degreif, Adriana; Rossmann, Heidi; Canisius, Antje; Lackner, Karl J.			Impact of Glutathione Peroxidase-1 Deficiency on Macrophage Foam Cell Formation and Proliferation: Implications for Atherogenesis	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; REACTIVE OXYGEN; GLUTATHIONE-PEROXIDASE-1 ACTIVITY; ATHEROSCLEROTIC LESIONS; COMPLEMENT ACTIVATION; ANTIOXIDANT ENZYMES; INDUCED APOPTOSIS; OXIDIZED LDL	Clinical and experimental evidence suggests a protective role for the antioxidant enzyme glutathione peroxidase-1 (GPx-1) in the atherogenic process. GPx-1 deficiency accelerates atherosclerosis and increases lesion cellularity in ApoE(-/-) mice. However, the distribution of GPx-1 within the atherosclerotic lesion as well as the mechanisms leading to increased macrophage numbers in lesions is still unknown. Accordingly, the aims of the present study were (1) to analyze which cells express GPx-1 within atherosclerotic lesions and (2) to determine whether a lack of GPx-1 affects macrophage foam cell formation and cellular proliferation. Both in situ-hybridization and immunohistochemistry of lesions of the aortic sinus of ApoE(-/-) mice after 12 weeks on a Western type diet revealed that both macrophages and -even though to a less extent smooth muscle cells contribute to GPx-1 expression within atherosclerotic lesions. In isolated mouse peritoneal macrophages differentiated for 3 days with macrophage-colony-stimulating factor (MCSF), GPx-1 deficiency increased oxidized low density-lipoprotein (oxLDL) induced foam cell formation and led to increased proliferative activity of peritoneal macrophages. The MCSF- and oxLDL-induced proliferation of peritoneal macrophages from GPx-1(-/-) ApoE(-/-) mice was mediated by the p44/42 MAPK (p44/42 mitogen-activated protein kinase), namely ERK1/2 (extracellular-signal regulated kinase 1/2), signaling pathway as demonstrated by ERK1/2 signaling pathways inhibitors, Western blots on cell lysates with primary antibodies against total and phosphorylated ERK1/2, MEK1/2 (mitogen-activated protein kinase kinase 1/2), p90RSK (p90 ribosomal s6 kinase), p38 MAPK and SAPK/JNK (stress-activated protein kinase/c-Jun N-terminal kinase), and immunohistochemistry of mice atherosclerotic lesions with antibodies against phosphorylated ERK1/2, MEK1/2 and p90RSK. Representative effects of GPx-1 deficiency on both macrophage proliferation and MAPK phosphorylation could be abolished by the GPx mimic ebselen. The present study demonstrates that GPx-1 deficiency has a significant impact on macrophage foam cell formation and proliferation via the p44/42 MAPK (ERK1/2) pathway encouraging further studies on new therapeutic strategies against atherosclerosis.	[Cheng, Fei; Degreif, Adriana; Rossmann, Heidi; Canisius, Antje; Lackner, Karl J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Clin Chem & Lab Med, D-55122 Mainz, Germany; [Torzewski, Michael] Robert Bosch Krankenhaus, Dept Lab Med, Stuttgart, Germany	Johannes Gutenberg University of Mainz; Bosch; Robert Bosch Krankenhaus	Torzewski, M (corresponding author), Robert Bosch Krankenhaus, Dept Lab Med, Stuttgart, Germany.	michael.torzewski@rbk.de	Rossmann, Heidi/ABE-5694-2020	Rossmann, Heidi/0000-0002-7532-8540	Mainzer Forschungsfoderungsprogramm (MAIFOR); Deutsche Forschungsgemeinschaft [DFG LA 499/3-1, 499/3-2]	Mainzer Forschungsfoderungsprogramm (MAIFOR); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Mainzer Forschungsfoderungsprogramm (MAIFOR 2004 to MT), and the Deutsche Forschungsgemeinschaft (DFG LA 499/3-1 and 499/3-2 to KJL and MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Bhakdi S, 2004, CIRCULATION, V109, P1870, DOI 10.1161/01.CIR.0000124228.08972.26; Blanc A, 2003, INT J MOL MED, V11, P229; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Buder-Hoffmann S, 2001, AM J RESP CELL MOL, V24, P405, DOI 10.1165/ajrcmb.24.4.4290; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cheng WH, 2003, BIOCHEM J, V370, P927, DOI 10.1042/BJ20021870; Chew P, 2009, ARTERIOSCL THROM VAS, V29, P823, DOI 10.1161/ATVBAHA.109.186619; Conde de la Rosa L, 2006, J HEPATOL, V44, P918, DOI 10.1016/j.jhep.2005.07.034; Dayal S, 2002, ARTERIOSCL THROM VAS, V22, P1996, DOI 10.1161/01.ATV.0000041629.92741.DC; de Haan JB, 2003, REDOX REP, V8, P69, DOI 10.1179/135100003125001378; Emerling BM, 2005, MOL CELL BIOL, V25, P4853, DOI 10.1128/MCB.25.12.4853-4862.2005; Flohe L, 1988, Basic Life Sci, V49, P663; Forgione MA, 2002, CIRCULATION, V106, P1154, DOI 10.1161/01.CIR.0000026820.87824.6A; Fu YX, 2001, J BIOL CHEM, V276, P43004, DOI 10.1074/jbc.M106946200; Fu YX, 2001, BIOCHEM J, V359, P687, DOI 10.1042/0264-6021:3590687; Guo ZM, 2001, ARTERIOSCL THROM VAS, V21, P1131, DOI 10.1161/hq0701.092092; Hamilton JA, 1999, ARTERIOSCL THROM VAS, V19, P98, DOI 10.1161/01.ATV.19.1.98; Hu YH, 2000, ARTERIOSCL THROM VAS, V20, P18, DOI 10.1161/01.ATV.20.1.18; Jimenez LA, 1997, AM J PHYSIOL-LUNG C, V273, pL1029, DOI 10.1152/ajplung.1997.273.5.L1029; Kim BY, 2001, FREE RADICAL BIO MED, V30, P686, DOI 10.1016/S0891-5849(00)00514-1; Lapenna D, 1998, CIRCULATION, V97, P1930, DOI 10.1161/01.CIR.97.19.1930; Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Martens JS, 1998, J BIOL CHEM, V273, P4915, DOI 10.1074/jbc.273.9.4915; Matsumura T, 1997, ARTERIOSCL THROM VAS, V17, P3013, DOI 10.1161/01.ATV.17.11.3013; MIROCHNITCHENKO O, 1995, P NATL ACAD SCI USA, V92, P8120, DOI 10.1073/pnas.92.18.8120; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nasr MA, 2004, FREE RADICAL BIO MED, V37, P187, DOI 10.1016/j.freeradbiomed.2004.04.038; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; SAKAI M, 1994, J BIOL CHEM, V269, P31430; Senokuchi T, 2004, ATHEROSCLEROSIS, V176, P233, DOI 10.1016/j.atherosclerosis.2004.05.019; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; 't Hoen PAC, 2003, CIRC RES, V93, P262, DOI 10.1161/01.RES.0000082978.92494.B1; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Takapoo M, 2011, VASC PHARMACOL, V55, P143, DOI 10.1016/j.vph.2011.07.002; Torzewski M, 2007, ARTERIOSCL THROM VAS, V27, P850, DOI 10.1161/01.ATV.0000258809.47285.07; Wagner AH, 2009, ARTERIOSCL THROM VAS, V29, P1894, DOI 10.1161/ATVBAHA.109.194738; Wang HZ, 2006, REPRODUCTION, V132, P485, DOI 10.1530/rep.1.01213; Wieland E, 1999, EUR J CLIN INVEST, V29, P835; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	44	33	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72063	10.1371/journal.pone.0072063	http://dx.doi.org/10.1371/journal.pone.0072063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991041	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470700028
J	Wu, HJ; Sun, H; Liang, XH; Lima, WF; Crooke, ST				Wu, Hongjiang; Sun, Hong; Liang, Xuehai; Lima, Walt F.; Crooke, Stanley T.			Human RNase H1 Is Associated with Protein P32 and Is Involved in Mitochondrial Pre-rRNA Processing	PLOS ONE			English	Article							RIBONUCLEASE-H; SACCHAROMYCES-CEREVISIAE; JUNCTION RIBONUCLEASE; MOLECULAR-CLONING; RNA/DNA HYBRID; BINDING; SUBSTRATE; EXPRESSION; TRANSCRIPTION; INTERACTS	Mammalian RNase H1 has been implicated in mitochondrial DNA replication and RNA processing and is required for embryonic development. We identified the mitochondrial protein P32 that binds specifically to human RNase H1, but not human RNase H2. P32 binds human RNase H1 via the hybrid-binding domain of the enzyme at an approximately 1: 1 ratio. P32 enhanced the cleavage activity of RNase H1 by reducing the affinity of the enzyme for the heteroduplex substrate and enhancing turnover, but had no effect on the cleavage pattern. RNase H1 and P32 were partially co-localized in mitochondria and reduction of P32 or RNase H1 levels resulted in accumulation of mitochondrial pre ribosomal RNA [12S/16S] in HeLa cells. P32 also co-immunoprecipitated with MRPP1, a mitochondrial RNase P protein required for mitochondrial pre-rRNA processing. The P32-RNase H1 complex was shown to physically interact with mitochondrial DNA and pre-rRNA. These results expand the potential roles for RNase H1 to include assuring proper transcription and processing of guanosine-cytosine rich pre-ribosomal RNA in mitochondria. Further, the results identify P32 as a member of the 'RNase H1 degradosome' and the key P32 enhances the enzymatic efficiency of human RNase H1.	[Wu, Hongjiang; Sun, Hong; Liang, Xuehai; Lima, Walt F.; Crooke, Stanley T.] Isis Pharmaceut Inc, Dept Core Antisense Res, Carlsbad, CA USA	Isis Pharmaceuticals Inc	Crooke, ST (corresponding author), Isis Pharmaceut Inc, Dept Core Antisense Res, Carlsbad, CA USA.	scrooke@isisph.com			Isis Pharmaceuticals	Isis Pharmaceuticals	This work was supported by Isis Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 1991, CURRENT PROTOCOLS MO; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; BUSEN W, 1980, J BIOL CHEM, V255, P9434; Cerritelli SM, 1998, GENOMICS, V53, P300, DOI 10.1006/geno.1998.5497; CERRITELLI SM, 1995, RNA, V1, P246; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chattopadhyay C, 2004, NUCLEIC ACIDS RES, V32, P3632, DOI 10.1093/nar/gkh692; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; Crooke S.T, 2008, ANTISENSE DRUG TECHN, V2nd, P47; Crouch R. J., 1982, NUCLEASES, P211; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Dedio J, 1998, J IMMUNOL, V160, P3534; EDER PS, 1993, BIOCHIMIE, V75, P123, DOI 10.1016/0300-9084(93)90033-O; EDER PS, 1991, J BIOL CHEM, V266, P6472; Evans SP, 1999, J MOL BIOL, V291, P661, DOI 10.1006/jmbi.1999.2971; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; Fogal V, 2008, CANCER RES, V68, P7210, DOI 10.1158/0008-5472.CAN-07-6752; Frank P, 1998, P NATL ACAD SCI USA, V95, P12872, DOI 10.1073/pnas.95.22.12872; Gaidamakov SA, 2005, NUCLEIC ACIDS RES, V33, P2166, DOI 10.1093/nar/gki510; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Huang LJ, 2008, INVEST OPHTH VIS SCI, V49, P5243, DOI 10.1167/iovs.07-1625; ITAYA M, 1991, NUCLEIC ACIDS RES, V19, P4443, DOI 10.1093/nar/19.16.4443; ITAYA M, 1991, MOL GEN GENET, V227, P438, DOI 10.1007/BF00273935; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; KANAYA S, 1992, J BIOL CHEM, V267, P10184; KANAYA S, 1991, J BIOL CHEM, V266, P11621; KATAYANAGI K, 1990, NATURE, V347, P306, DOI 10.1038/347306a0; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Liang XH, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1121; Lima WF, 2009, J BIOL CHEM, V284, P2535, DOI 10.1074/jbc.M803748200; Lima WF, 2004, J BIOL CHEM, V279, P36317, DOI 10.1074/jbc.M405035200; Lima WF, 2003, J BIOL CHEM, V278, P49860, DOI 10.1074/jbc.M306543200; Lima WF, 2003, J BIOL CHEM, V278, P14906, DOI 10.1074/jbc.M211279200; Matthews DA, 1998, J GEN VIROL, V79, P1677, DOI 10.1099/0022-1317-79-7-1677; Murante RS, 1998, P NATL ACAD SCI USA, V95, P2244, DOI 10.1073/pnas.95.5.2244; NAKAMURA H, 1991, P NATL ACAD SCI USA, V88, P11535, DOI 10.1073/pnas.88.24.11535; Nowotny M, 2008, EMBO J, V27, P1172, DOI 10.1038/emboj.2008.44; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Ohtani N, 1999, BIOCHEMISTRY-US, V38, P605, DOI 10.1021/bi982207z; Ohtani N, 2008, FEBS J, V275, P5444, DOI 10.1111/j.1742-4658.2008.06673.x; Peerschke EIB, 2007, IMMUNOBIOLOGY, V212, P333, DOI 10.1016/j.imbio.2006.11.011; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; RONG YW, 1990, BIOCHEMISTRY-US, V29, P383, DOI 10.1021/bi00454a012; Rozanov DV, 2002, FEBS LETT, V527, P51, DOI 10.1016/S0014-5793(02)03153-8; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; STEIN H, 1969, SCIENCE, V166, P393, DOI 10.1126/science.166.3903.393; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Storz P, 2000, J BIOL CHEM, V275, P24601, DOI 10.1074/jbc.M002964200; Tadokoro T, 2009, FEBS J, V276, P1482, DOI 10.1111/j.1742-4658.2009.06907.x; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; Wu HJ, 1999, J BIOL CHEM, V274, P28270, DOI 10.1074/jbc.274.40.28270; Wu HJ, 2004, J BIOL CHEM, V279, P17181, DOI 10.1074/jbc.M311683200; Wu HJ, 2001, J BIOL CHEM, V276, P23547, DOI 10.1074/jbc.M009676200; Wu HJ, 1998, ANTISENSE NUCLEIC A, V8, P53, DOI 10.1089/oli.1.1998.8.53; Yagi M, 2012, NUCLEIC ACIDS RES, V40, P9717, DOI 10.1093/nar/gks774; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648; Yoshikawa H, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006148	63	44	45	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e71006	10.1371/journal.pone.0071006	http://dx.doi.org/10.1371/journal.pone.0071006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23990920	Green Submitted, gold, Green Published			2022-12-25	WOS:000324470700007
J	Brooks, BR; Crumpacker, D; Fellus, J; Kantor, D; Kaye, RE				Brooks, Benjamin Rix; Crumpacker, David; Fellus, Jonathan; Kantor, Daniel; Kaye, Randall E.			PRISM: A Novel Research Tool to Assess the Prevalence of Pseudobulbar Affect Symptoms across Neurological Conditions	PLOS ONE			English	Article							EMOTIONAL EXPRESSION DISORDER; PATHOLOGICAL LAUGHTER; POSTSTROKE DEPRESSION; INCONTINENCE; EPIDEMIOLOGY; SCLEROSIS; DISEASE; STROKE; ALS; PATHOPHYSIOLOGY	Background: Pseudobulbar affect (PBA) is a neurological condition characterized by involuntary, sudden, and frequent episodes of laughing and/or crying, which can be socially disabling. Although PBA occurs secondary to many neurological conditions, with an estimated United States (US) prevalence of up to 2 million persons, it is thought to be under-recognized and undertreated. The PBA Registry Series (PRISM) was established to provide additional PBA symptom prevalence data in a large, representative US sample of patients with neurological conditions known to be associated with PBA. Methods: Participating clinicians were asked to enroll >= 20 consenting patients with any of 6 conditions: Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), Parkinson's disease (PD), stroke, or traumatic brain injury (TBI). Patients (or their caregivers) completed the Center for Neurologic Study-Lability Scale (CNS-LS) and an 11-point scale measuring impact of the neurological condition on the patient's quality of life (QOL). Presence of PBA symptoms was defined as a CNS-LS score >= 13. Demographic data and current use of antidepressant or antipsychotic medications were also recorded. Results: PRISM enrolled 5290 patients. More than one third of patients (n = 1944; 36.7%) had a CNS-LS score >= 13, suggesting PBA symptoms. The mean (SD) score measuring impact of neurological condition on QOL was significantly higher (worse) in patients with CNS-LS >= 13 vs,13 (6.7 [2.5] vs. 4.7 [3.1], respectively; P<0.0001 two-sample t-test). A greater percentage of patients with CNS-LS >= 13 versus <13 were using antidepressant/antipsychotic medications (53.0% vs 35.4%, respectively; P<0.0001, chi-square test). Conclusions: Data from PRISM, the largest clinic-based study to assess PBA symptom prevalence, showed that PBA symptoms were common among patients with diverse neurological conditions. Higher CNS-LS scores were associated with impaired QOL and greater use of antipsychotic/antidepressant medications. These data underscore a need for greater awareness, recognition, and diagnosis of PBA.	[Brooks, Benjamin Rix] Univ N Carolina, Sch Med, Carolinas Med Ctr, Charlotte, NC 28223 USA; [Crumpacker, David] Baylor Univ, Med Ctr, Dallas, TX USA; [Fellus, Jonathan] Int Brain Res Fdn, Flanders, NJ USA; [Kantor, Daniel] Neurologique, Ponte Vedra Beach, FL USA; [Kaye, Randall E.] Avanir Pharmaceut Inc, Aliso Viejo, CA USA	Carolinas Medical Center; University of North Carolina; University of North Carolina Charlotte; Baylor University; Baylor University Medical Center	Kaye, RE (corresponding author), Avanir Pharmaceut Inc, Aliso Viejo, CA USA.	RKaye@avanir.com			Avanir Pharmaceuticals, Inc.	Avanir Pharmaceuticals, Inc.	Funding for the PRISM study and editorial support for manuscript preparation were provided by Avanir Pharmaceuticals, Inc. RK is an employee of Avanir and participated in study design, data analysis and contributed as an author. The data were gathered by the individual investigators and were analyzed by MMS Holdings. The decision to publish was that of the authors.	Arciniegas D B, 2000, Semin Clin Neuropsychiatry, V5, P290, DOI 10.1053/scnp.2000.9554; Calvert T, 1998, J NEUROL NEUROSUR PS, V65, P928, DOI 10.1136/jnnp.65.6.928; CAROSCIO JT, 1987, NEUROL CLIN, V5, P1; Chio A, 2009, NEUROLOGY, V72, P725, DOI 10.1212/01.wnl.0000343008.26874.d1; Choi-Kwon S, 2012, NEUROLOGY, V78, P1130, DOI 10.1212/WNL.0b013e31824f8090; Colamonico J, 2012, ADV THER, V29, P775, DOI 10.1007/s12325-012-0043-7; Cottrell SS, 1926, J NEUROL PSYCHOPATHO, V7, P1; Cummings JL, 2007, CNS SPECTRUMS, V12, P11; Cummings JL, 2006, CNS SPECTRUMS, V11, P1; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Davison C, 1939, ARCH NEURO PSYCHIATR, V42, P595, DOI 10.1001/archneurpsyc.1939.02270220011001; Di Poggio MB, 2013, AMYOTROPH LAT SCL FR, V14, P52, DOI 10.3109/17482968.2012.729062; Feinstein A, 1997, ARCH NEUROL-CHICAGO, V54, P1116, DOI 10.1001/archneur.1997.00550210050012; GALLAGHER JP, 1989, ACTA NEUROL SCAND, V80, P114, DOI 10.1111/j.1600-0404.1989.tb03851.x; HASTRUP JL, 1986, GERONTOLOGIST, V26, P91, DOI 10.1093/geront/26.1.91; HOUSE A, 1989, BMJ-BRIT MED J, V298, P991, DOI 10.1136/bmj.298.6679.991; Hurwitz BJ, 2009, NEUROLOGY S1, pS3; Kim JS, 2000, NEUROLOGY, V54, P1805, DOI 10.1212/WNL.54.9.1805; Kim JS, 2002, NEUROLOGY, V58, P1106, DOI 10.1212/WNL.58.7.1106; Langworthy OR, 1941, AM J PSYCHIAT, V98, P243, DOI 10.1176/ajp.98.2.243; Lopez OL, 1996, NEUROPSY NEUROPSY BE, V9, P154; McElvaney NG, 1997, CHEST, V111, P394, DOI 10.1378/chest.111.2.394; Miller A, 2011, EXPERT REV NEUROTHER, V11, P1077, DOI [10.1586/ern.11.68, 10.1586/ERN.11.68]; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; MORRIS PLP, 1993, AUST NZ J PSYCHIAT, V27, P601, DOI 10.3109/00048679309075822; MULLER R, 1952, ACTA PSYCH NEUROL, V27, P137; Newsom-Davis IC, 1999, J NEUROL SCI, V169, P22, DOI 10.1016/S0022-510X(99)00211-7; Nieuwenhuis-Mark RE, 2008, COGN BEHAV NEUROL, V21, P111, DOI 10.1097/WNN.0b013e31816be8f8; Oppenheim H., 1911, TXB NERVOUS DIS PHYS; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; Parvizi J, 2007, MOVEMENT DISORD, V22, P798, DOI 10.1002/mds.21348; Parvizi J, 2009, J NEUROPSYCH CLIN N, V21, P75, DOI 10.1176/appi.neuropsych.21.1.75; Petracca GM, 2009, J NEUROPSYCH CLIN N, V21, P406, DOI 10.1176/appi.neuropsych.21.4.406; Phuong L, 2009, PARKINSONISM RELAT D, V15, P511, DOI 10.1016/j.parkreldis.2009.01.001; Pioro EP, 2011, DRUGS, V71, P1193, DOI 10.2165/11591450-000000000-00000; PRATT RTC, 1951, J NEUROL NEUROSUR PS, V14, P326, DOI 10.1136/jnnp.14.4.326; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; Rottenberg J, 2002, J ABNORM PSYCHOL, V111, P302, DOI 10.1037//0021-843X.111.2.302; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; Siddiqui MS, 2009, WORLD J BIOL PSYCHIA, V10, P234, DOI 10.1080/15622970701639445; Siegert RJ, 2005, J NEUROL NEUROSUR PS, V76, P469, DOI 10.1136/jnnp.2004.054635; Smi CK, 2006, STROKE, V37, P156, DOI 10.1161/01.STR.0000190892.93663.e2; Smith RA, 2004, MULT SCLER, V10, P1; Smith RA, 2006, EXPERT OPIN PHARMACO, V7, P2581, DOI 10.1517/14656566.7.18.2581; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; Strowd RE, 2010, J NEUROL, V257, P1382, DOI 10.1007/s00415-010-5550-3; Tang WK, 2009, J NEUROL NEUROSUR PS, V80, P1082, DOI 10.1136/jnnp.2009.175372; Tang WK, 2009, J INT NEUROPSYCH SOC, V15, P62, DOI 10.1017/S1355617708090061; Tang WK, 2004, J NEUROL, V251, P865, DOI 10.1007/s00415-004-0450-z; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Vinceti M, 2012, Ann Ig, V24, P407; Vingerhoets AJJM, 2007, ACTA PSYCHIAT SCAND, V115, P340, DOI 10.1111/j.1600-0447.2006.00948.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wicks P, 2007, EUR J NEUROL, V14, P993, DOI 10.1111/j.1468-1331.2007.01843.x; Wilson SAK, 1924, J NEUROL PSYCHOPATHO, V4, P299; Work SS, 2011, ADV THER, V28, P586, DOI 10.1007/s12325-011-0031-3; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160; Ziegler LH, 1930, ARCH NEURO PSYCHIATR, V24, P930, DOI 10.1001/archneurpsyc.1930.02220170050006	60	48	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72232	10.1371/journal.pone.0072232	http://dx.doi.org/10.1371/journal.pone.0072232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991068	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470100088
J	Huang, W; Dai, B; Wen, ZL; Millard, RW; Yu, XY; Luther, K; Xu, MF; Zhao, TC; Yang, HT; Qi, ZH; LaSance, K; Ashraf, M; Wang, YG				Huang, Wei; Dai, Bo; Wen, Zhili; Millard, Ronald W.; Yu, Xi-Yong; Luther, Kristin; Xu, Meifeng; Zhao, Ting C.; Yang, Huang-Tian; Qi, Zhihua; LaSance, Kathleen; Ashraf, Muhammad; Wang, Yigang			Molecular Strategy to Reduce In Vivo Collagen Barrier Promotes Entry of NCX1 Positive Inducible Pluripotent Stem Cells (iPSC(NCX1+)) into Ischemic (or Injured) Myocardium	PLOS ONE			English	Article							GENE-EXPRESSION; FIBROBLASTS; MICRORNAS; ANGIOGENESIS; ENGRAFTMENT; HEART	Objective: The purpose of this study was to assess the effect of collagen composition on engraftment of progenitor cells within infarcted myocardium. Background: We previously reported that intramyocardial penetration of stem/progenitor cells in epicardial patches was enhanced when collagen was reduced in hearts overexpressing adenylyl cyclase-6 (AC6). In this study we hypothesized an alternative strategy wherein overexpression of microRNA-29b (miR-29b), inhibiting mRNAs that encode cardiac fibroblast proteins involved in fibrosis, would similarly facilitate progenitor cell migration into infarcted rat myocardium. Methods: In vitro: A tri-cell patch (Tri-P) consisting of cardiac sodium-calcium exchanger-1 (NCX1) positive iPSC (iPSC(NCX1+)), endothelial cells (EC), and mouse embryonic fibroblasts (MEF) was created, co-cultured, and seeded on isolated peritoneum. The expression of fibrosis-related genes was analyzed in cardiac fibroblasts (CFb) by qPCR and Western blot. In vivo: Nude rat hearts were administered mimic miRNA-29b (miR-29b), miRNA-29b inhibitor (Anti-29b), or negative mimic (Ctrl) before creation of an ischemically induced regional myocardial infarction (MI). The Tri-P was placed over the infarcted region 7 days later. Angiomyogenesis was analyzed by micro-CT imaging and immunofluorescent staining. Echocardiography was performed weekly. Results: The number of green fluorescent protein positive (GFP(+)) cells, capillary density, and heart function were significantly increased in hearts overexpressing miR-29b as compared with Ctrl and Anti-29b groups. Conversely, down-regulation of miR-29b with anti-29b in vitro and in vivo induced interstitial fibrosis and cardiac remodeling. Conclusion: Overexpression of miR-29b significantly reduced scar formation after MI and facilitated iPSC(NCX1+) penetration from the cell patch into the infarcted area, resulting in restoration of heart function after MI.	[Huang, Wei; Dai, Bo; Wen, Zhili; Luther, Kristin; Xu, Meifeng; Ashraf, Muhammad; Wang, Yigang] Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; [Wen, Zhili] Nanchang Univ, Infect Dis Hosp, Nanchang, Jiangxi, Peoples R China; [Millard, Ronald W.] Univ Cincinnati, Med Ctr, Dept Pharmacol & Cell Biophys, Coll Med, Cincinnati, OH 45267 USA; [Yu, Xi-Yong] Guangdong Acad Med Sci, Guangdong Gen Hosp, Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [Zhao, Ting C.] Boston Univ, Sch Med, Roger William Med Ctr, Cardiovasc Labs,Dept Surg, Providence, RI USA; [Yang, Huang-Tian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Stem Cell Biol, Shanghai, Peoples R China; [Yang, Huang-Tian] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Qi, Zhihua; LaSance, Kathleen] Univ Cincinnati, Dept Radiol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; Nanchang University; University System of Ohio; University of Cincinnati; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Boston University; Roger Williams Medical Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; University System of Ohio; University of Cincinnati	Wang, YG (corresponding author), Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA.	yi-gang.wang@uc.edu	Ashraf, Muhammad/ABB-3463-2021; HUANG, WEI/A-4639-2013	Huang, Wei/0000-0003-3046-4220	National Institutes of Health [HL089824, HL110740]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110740, R01HL089824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health grants HL089824 and HL110740 (Y. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cataluccia D, 2008, ANN NY ACAD SCI, V1123, P20, DOI 10.1196/annals.1420.004; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Dai B, 2011, J AM COLL CARDIOL, V58, P2118, DOI 10.1016/j.jacc.2011.06.062; Diez J, 2009, NAT CLIN PRACT CARD, V6, P88, DOI 10.1038/ncpcardio1415; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Dufourcq P, 2008, STEM CELLS, V26, P2991, DOI 10.1634/stemcells.2008-0372; EGHBALI M, 1992, BASIC RES CARDIOL, V87, P183; Fleury S, 2003, CIRCULATION, V107, P2375, DOI 10.1161/01.CIR.0000065598.46411.EF; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; Huang W, 2010, J MOL CELL CARDIOL, V48, P702, DOI 10.1016/j.yjmcc.2009.10.032; Iyer RK, 2011, CURR OPIN BIOTECH, V22, P706, DOI 10.1016/j.copbio.2011.04.004; Kammili RK, 2010, STEM CELLS DEV, V19, P1437, DOI 10.1089/scd.2009.0308; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Kwon HM, 1998, J AM COLL CARDIOL, V32, P2072, DOI 10.1016/S0735-1097(98)00482-3; Liang JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046158; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; Maubach G, 2011, WORLD J GASTROENTERO, V17, P2748, DOI [10.3748/wjg.v17.i22., 10.3748/wjg.v17.i22.2748]; Muller JG, 2002, CIRC RES, V90, P158, DOI 10.1161/hh0202.103231; NAG AC, 1980, CYTOBIOS, V28, P41; Noseda M, 2009, DEV CELL, V16, P161, DOI 10.1016/j.devcel.2009.01.020; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Rivard A, 1998, MOL MED, V4, P429, DOI 10.1007/BF03401749; Sachse FB, 2008, ANN BIOMED ENG, V36, P41, DOI 10.1007/s10439-007-9405-8; Samuel CS, 2011, LAB INVEST, V91, P675, DOI 10.1038/labinvest.2010.198; Simpson D, 2007, STEM CELLS, V25, P2350, DOI 10.1634/stemcells.2007-0132; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Zagorchev Lyubomir, 2010, J Angiogenes Res, V2, P7, DOI 10.1186/2040-2384-2-7	33	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e70023	10.1371/journal.pone.0070023	http://dx.doi.org/10.1371/journal.pone.0070023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990893	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470100018
J	Hutchinson, KR; Lord, KC; West, TA; Stewart, JA				Hutchinson, Kirk R.; Lord, Kevin C.; West, T. Aaron; Stewart, James A.			Cardiac Fibroblast-Dependent Extracellular Matrix Accumulation Is Associated with Diastolic Stiffness in Type 2 Diabetes	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; HIGH-GLUCOSE; STELLATE CELLS; MYOCARDIAL-INFARCTION; COLLAGEN PRODUCTION; TISSUE INHIBITORS; GENE-EXPRESSION; HEART-FAILURE; IN-VITRO; FIBROSIS	Cardiovascular complications are a leading cause of death in patients with type 2 diabetes mellitus (T2DM). Diastolic dysfunction is one of the earliest manifestations of diabetes-induced changes in left ventricular (LV) function, and results from a reduced rate of relaxation and increased stiffness. The mechanisms responsible for increased stiffness are not completely understood. Chronic hyperglycemia, advanced glycation endproducts (AGEs), and increased levels of proinflammatory and profibrotic cytokines are molecular pathways known to be involved in regulating extracellular matrix (ECM) synthesis and accumulation resulting in increased LV diastolic stiffness. Experiments were conducted using a genetically-induced mouse model of T2DM generated by a point mutation in the leptin receptor resulting in nonfunctional leptin receptors (db/db murine model). This study correlated changes in LV ECM and stiffness with alterations in basal activation of signaling cascades and expression of profibrotic markers within primary cultures of cardiac fibroblasts from diabetic (db/db) mice with nondiabetic (db/wt) littermates as controls. Primary cultures of cardiac fibrobroblasts were maintained in 25 mM glucose (hyperglycemic-HG; diabetic db/db) media or 5 mM glucose (normoglycemic-NG, nondiabetic db/wt) media. The cells then underwent a 24-hour exposure to their opposite (NG; diabetic db/db) media or 5 mM glucose (HG, nondiabetic db/wt) media. Protein analysis demonstrated significantly increased expression of type I collagen, TIMP-2, TGF-beta, PAI-1 and RAGE in diabetic db/db cells as compared to nondiabetic db/wt, independent of glucose media concentration. This pattern of protein expression was associated with increased LV collagen accumulation, myocardial stiffness and LV diastolic dysfunction. Isolated diabetic db/db fibroblasts were phenotypically distinct from nondiabetic db/wt fibroblasts and exhibited a profibrotic phenotype in normoglycemic conditions.	[Hutchinson, Kirk R.] Univ Arizona, Dept Physiol, Tucson, AZ USA; [Lord, Kevin C.] Univ Incarnate Word, Feik Sch Pharm, San Antonio, TX USA; [West, T. Aaron] Nationwide Childrens Hosp, Ctr Cardiovasc & Pulm Res, Columbus, OH USA; [Stewart, James A.] Mississippi State Univ, Dept Biol Sci, Starkville, MS 39759 USA	University of Arizona; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Mississippi State University	Stewart, JA (corresponding author), Mississippi State Univ, Dept Biol Sci, Starkville, MS 39759 USA.	jstewart@biology.msstate.edu			American Heart Association [SDG5310006, BGIA4150122]	American Heart Association(American Heart Association)	This work was supported by grants from the American Heart Association SDG5310006 (JAS) and BGIA4150122 (JAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2002, AM J PHYSIOL-HEART C, V282, pH138, DOI 10.1152/ajpheart.2002.282.1.H138; Asbun J, 2005, AM J PHYSIOL-HEART C, V288, pH227, DOI 10.1152/ajpheart.00340.2004; Asif M, 2000, P NATL ACAD SCI USA, V97, P2809, DOI 10.1073/pnas.040558497; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Benazzoug Y, 1998, EXP GERONTOL, V33, P445, DOI 10.1016/S0531-5565(98)00015-1; Borbely A, 2009, CIRC RES, V104, P12, DOI 10.1161/CIRCRESAHA.108.191130; Borg TK, 2005, MICROSC MICROANAL, V11, P189, DOI 10.1017/S1431927605050439; Burgess ML, 2002, CARDIOVASC PATHOL, V11, P78, DOI 10.1016/S1054-8807(01)00104-1; BUTT RP, 1995, EUR J CELL BIOL, V68, P330; Choi SS, 2010, J BIOL CHEM, V285, P36551, DOI 10.1074/jbc.M110.168542; Cooper ME, 2004, AM J HYPERTENS, V17, p31S, DOI 10.1016/j.amjhyper.2004.08.021; Derosa G, 2007, DIABETES METAB, V33, P129, DOI 10.1016/j.diabet.2006.11.008; Eguchi M, 2012, J CELL MOL MED, V16, P2925, DOI 10.1111/j.1582-4934.2012.01613.x; Falcao-Pires I, 2011, CIRCULATION, V124, P1151, DOI 10.1161/CIRCULATIONAHA.111.025270; Flack EC, 2006, J MOL CELL CARDIOL, V40, P474, DOI 10.1016/j.yjmcc.2006.01.019; Fleming TH, 2011, GERONTOLOGY, V57, P435, DOI 10.1159/000322087; Fowlkes V, 2013, LIFE SCI, V92, P669, DOI 10.1016/j.lfs.2013.01.003; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Glasow A, 2001, J CLIN ENDOCR METAB, V86, P4472, DOI 10.1210/jc.86.9.4472; Higgins PJ, 1999, EXP CELL RES, V248, P634, DOI 10.1006/excr.1999.4466; Iwasaki Y, 2007, J DIABETES COMPLICAT, V21, P56, DOI 10.1016/j.jdiacomp.2006.02.001; Joshi SM, 2009, AM J SPORT MED, V37, P2401, DOI 10.1177/0363546509339915; Kellouche S, 2007, EXP CELL RES, V313, P486, DOI 10.1016/j.yexcr.2006.10.023; Khavandi K, 2009, BEST PRACT RES CL EN, V23, P347, DOI 10.1016/j.beem.2008.10.016; Klingberg F, 2013, J PATHOL, V229, P298, DOI 10.1002/path.4104; Lebeche D, 2008, NAT CLIN PRACT CARD, V5, P715, DOI 10.1038/ncpcardio1347; Li Q, 2007, ACTA CARDIOL, V62, P485, DOI 10.2143/AC.62.5.2023412; Lindsey ML, 2005, CARDIOVASC RES, V66, P410, DOI 10.1016/j.cardiores.2004.11.029; Loftis MJ, 2003, J CELL PHYSIOL, V196, P504, DOI 10.1002/jcp.10330; Lovelock JD, 2005, AM J PHYSIOL-HEART C, V288, pH461, DOI 10.1152/ajpheart.00402.2004; Ma H, 2009, J CELL MOL MED, V13, P1751, DOI 10.1111/j.1582-4934.2008.00547.x; Marganski WA, 2003, CARDIOVASC RES, V60, P547, DOI 10.1016/j.cardiores.2003.09.021; Ouzounian M, 2008, NAT CLIN PRACT CARD, V5, P375, DOI 10.1038/ncpcardio1245; Polhill TS, 2004, AM J PHYSIOL-RENAL, V287, pF268, DOI 10.1152/ajprenal.00084.2004; Qamar A, 2006, DIGEST DIS SCI, V51, P1697, DOI 10.1007/s10620-006-9244-8; Radke MH, 2007, P NATL ACAD SCI USA, V104, P3444, DOI 10.1073/pnas.0608543104; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Sakata Y, 2008, BASIC RES CARDIOL, V103, P60, DOI 10.1007/s00395-007-0689-5; Saxena NK, 2002, HEPATOLOGY, V35, P762, DOI 10.1053/jhep.2002.32029; Sigel AV, 1996, J MOL CELL CARDIOL, V28, P1921, DOI 10.1006/jmcc.1996.0185; Silzle T, 2004, INT J CANCER, V108, P173, DOI 10.1002/ijc.11542; Solini A, 2006, DIABETOLOGIA, V49, P2499, DOI 10.1007/s00125-006-0377-2; Squires CE, 2005, J MOL CELL CARDIOL, V39, P699, DOI 10.1016/j.yjmcc.2005.07.008; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Stewart JA, 2006, J MOL CELL CARDIOL, V41, P97, DOI 10.1016/j.yjmcc.2006.04.019; Stewart JA, 2010, CELL TISSUE RES, V340, P117, DOI 10.1007/s00441-010-0943-2; Thrailkill KM, 2010, ENDOCRINE, V37, P336, DOI 10.1007/s12020-010-9308-6; van Heerebeek L, 2008, CIRCULATION, V117, P43, DOI 10.1161/CIRCULATIONAHA.107.728550; VANHOEVEN KH, 1991, ACTA CARDIOL, V46, P329; Watson S, 1998, J CELL PHYSIOL, V177, P224, DOI 10.1002/(SICI)1097-4652(199811)177:2<224::AID-JCP4>3.0.CO;2-P; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; Wendt T, 2003, J AM SOC NEPHROL, V14, P1383, DOI 10.1097/01.ASN.0000065100.17349.CA; Wrobel K, 1997, CLIN CHEM, V43, P1563; Yamazaki KG, 2012, J CARDIOVASC TRANSL, V5, P805, DOI 10.1007/s12265-012-9405-4; Zhang Y, 2012, EUR J HEART FAIL, V14, P549, DOI 10.1093/eurjhf/hfs011	55	61	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72080	10.1371/journal.pone.0072080	http://dx.doi.org/10.1371/journal.pone.0072080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991045	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100076
J	Iida, T; Odate, T; Fukuchi, M				Iida, Takahiro; Odate, Tsuneo; Fukuchi, Mitsuo			Long-Term Trends of Nutrients and Apparent Oxygen Utilization South of the Polar Front in Southern Ocean Intermediate Water from 1965 to 2008	PLOS ONE			English	Article							ANTARCTIC CIRCUMPOLAR WAVE; SEA-ICE; ANNULAR MODE; TEMPERATURE; CIRCULATION; VARIABILITY; HEMISPHERE; BIOLOGY; SECTOR; IMPACT	The variation of nutrients over decadal timescales south of the polar front in the Southern Ocean is poorly known because of a lack of continuous observational data in this area. We examined data from long-term continuous hydrographic monitoring of 43 years (1965-2008) in the Indian sector of the Southern Ocean, via the resupply of Antarctic stations under the Japanese Antarctic Research Expedition and Australian Antarctic Research Expedition. We found significant increasing trends in phosphate and nitrate, and a decreasing trend in apparent oxygen utilization (AOU) in intermediate water (neutral density = 27.8-28.1 kgm(-3)) south of the polar front. The rates of phosphate and nitrate increase are 0.004 mu mol yr(-1) and 0.02 mu mol yr(-1), respectively. The rate of decline of AOU was 0.32 mu mol yr(-1). One reason for this phosphate and nitrate increase and AOU decline is reduced horizontal advection of North Atlantic Deep Water, which is characterized by low nutrients and high AOU. The relationship between climate change and nutrient variability remains obscure, emphasizing the importance of long-term monitoring.	[Iida, Takahiro; Odate, Tsuneo; Fukuchi, Mitsuo] Natl Inst Polar Res, Midori Cho, Tachikawa, Tokyo, Japan; [Iida, Takahiro; Odate, Tsuneo; Fukuchi, Mitsuo] Grad Univ Adv Studies, Sch Multidisciplinary Sci, Dept Polar Sci, Hayama, Kanagawa, Japan	Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Graduate University for Advanced Studies - Japan	Iida, T (corresponding author), Natl Inst Polar Res, Midori Cho, Tachikawa, Tokyo, Japan.	iida@nipr.ac.jp			Japan Science and Technology Agency (JST); SOUKENDAI (The Graduate University for Advanced Studies); NIPR [KP-4]	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); SOUKENDAI (The Graduate University for Advanced Studies); NIPR(National Institute of Polar Research (NIPR) - Japan)	This work was supported in part by Japan Science and Technology Agency (JST) strategic international research cooperative program "Establishing a benchmark to assess climate change impact in the eastern Antarctic Marine System" (http://www.jst.go.jp/inter/english/project/country/australia.html). The additional part was supported by SOUKENDAI (The Graduate University for Advanced Studies) grant for young scientists studying overseas (http://www.soken.ac.jp/staff/overseasDeploy.html; Japanese only). This research was also supported by the project fund NIPR KP-4. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON L, 1979, ANAL CHIM ACTA, V110, P123, DOI 10.1016/S0003-2670(01)83537-6; Aoki S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024246; Aoki S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022220; Aoki S, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000307; Barber DG, 2007, ELSEV OCEANOGR SERIE, V74, P1, DOI 10.1016/S0422-9894(06)74001-6; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bindoff NL, 2000, J PHYS OCEANOGR, V30, P1207, DOI 10.1175/1520-0485(2000)030<1207:DCAAIO>2.0.CO;2; Brocker WS, 1982, TRACES SEA; Bryden HL, 2003, SCIENCE, V300, P2086, DOI 10.1126/science.1083980; Conkright M., 2002, NOAA ATLAS NESDIS42; Croxall JP, 2002, SCIENCE, V297, P1510, DOI 10.1126/science.1071987; DUGDALE RC, 1995, DEEP-SEA RES PT I, V42, P697, DOI 10.1016/0967-0637(95)00015-X; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Hall A, 2002, J CLIMATE, V15, P3043, DOI 10.1175/1520-0442(2002)015<3043:SVITSH>2.0.CO;2; Hirawake T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021394; Hoppema M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001957; Jackett DR, 1997, J PHYS OCEANOGR, V27, P237, DOI 10.1175/1520-0485(1997)027<0237:ANDVFT>2.0.CO;2; Jacobs S, 2006, PHILOS T R SOC A, V364, P1657, DOI 10.1098/rsta.2006.1794; Johnston BM, 2011, TELLUS B, V63, P266, DOI 10.1111/j.1600-0889.2011.00526.x; Johnston BM, 2010, TELLUS A, V62, P719, DOI 10.1111/j.1600-0870.2010.00462.x; Kato A, 2002, POLAR BIOL, V25, P934, DOI 10.1007/s00300-002-0434-3; Le Quere C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014585; Lefebvre W, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002403; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Lovenduski NS, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022727; Maqueda MAM, 2004, REV GEOPHYS, V42, DOI 10.1029/2002RG000116; Matear RJ, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000086; Meredith MP, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026499; Mo KC, 2000, J CLIMATE, V13, P3599, DOI 10.1175/1520-0442(2000)013<3599:RBLFVI>2.0.CO;2; Nicol S, 2000, NATURE, V406, P504, DOI 10.1038/35020053; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; PARK YH, 1993, J GEOPHYS RES-OCEANS, V98, P12361, DOI 10.1029/93JC00938; Patterson SL, 1990, OCEAN BIOGEOCHEMICAL, P55; Rintoul SR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028550; Robertson R, 2002, DEEP-SEA RES PT II, V49, P4791, DOI 10.1016/S0967-0645(02)00159-5; Sarmiento J.L., 2006, OCEAN BIOGEOCHEMICAL, DOI [10.1017/S0016756807003755, DOI 10.1017/S0016756807003755]; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Smith WO, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004251; Sokolov S, 2002, J MARINE SYST, V37, P151, DOI 10.1016/S0924-7963(02)00200-2; Strickland J D H, 1972, B FISH RES BOARD CAN, V167, P311; Tamura T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032903; Trenberth KE, 1998, J GEOPHYS RES-OCEANS, V103, P14291, DOI 10.1029/97JC01444; Udagawa Y, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011807; White WB, 1996, NATURE, V380, P699, DOI 10.1038/380699a0; Wong APS, 2001, J CLIMATE, V14, P1613, DOI 10.1175/1520-0442(2001)014<1613:FAHCIT>2.0.CO;2; Yuan XJ, 2001, GEOPHYS RES LETT, V28, P3609, DOI 10.1029/2001GL012969	47	5	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71766	10.1371/journal.pone.0071766	http://dx.doi.org/10.1371/journal.pone.0071766			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990984	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100053
J	Park, NJ; Wang, XQ; Diaz, A; Goos-Root, DM; Bock, C; Vaught, JD; Sun, WM; Strom, CM				Park, Noh Jin; Wang, Xiuqiang; Diaz, Angelica; Goos-Root, Dana M.; Bock, Christopher; Vaught, Jonathan D.; Sun, Weimin; Strom, Charles M.			Measurement of Cetuximab and Panitumumab-Unbound Serum EGFR Extracellular Domain Using an Assay Based on Slow Off-Rate Modified Aptamer (SOMAmer) Reagents	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; COLORECTAL-CANCER; RESISTANCE; CHEMOTHERAPY; MECHANISMS; EXPRESSION; SELECTION; MUTATION; LIGANDS	Background: Response to cetuximab (Erbitux (R)) and panitumumab (Vectibix (R)) varies among individuals, and even those who show response ultimately gain drug resistance. One possible etiologic factor is differential interaction between the drug and target. We describe the development of an assay based on Slow Off-rate Modified Aptamer (SOMAmer (TM)) reagents that can distinguish drug-bound from unbound epidermal growth factor receptor (EGFR). Methods: This quantitative assay uses a SOMAmer reagent specific for EGFR extracellular domain (ECD) as a capturing reagent. Captured SOMAmer is quantitated using PCR. Linearity and accuracy (recovery) of the assay were assessed using normal sera and purified EGFR ECD. Results: This EGFR ECD assay showed linearity between 2.5 and 600 ng/mL. Average recovery was 101%. The assay detected EGFR but showed little cross-reactivity to other ErbB proteins: 0.4% for ErbB2, 6.9% for ErbB3, and 1.3% for ErbB4. Preincubation of normal serum with either cetuximab or panitumumab resulted in a dose-dependent decrease in EGFR ECD levels measured using the SOMAmer assay; preincubation did not affect measurement with an ELISA. Conclusions: This SOMAmer-based serum EGFR ECD assay accurately and specifically measures EGFR in serum. Detection of significant amounts of drug-unbound EGFR in patients undergoing cetuximab or panitumumab treatment could be an indicator of poor drug response. Further studies are needed to evaluate the utility of the assay as an indicator of drug efficacy or as a guide to dosing.	[Park, Noh Jin; Wang, Xiuqiang; Diaz, Angelica; Goos-Root, Dana M.; Sun, Weimin; Strom, Charles M.] Quest Diagnost Nichols Inst San Juan Capistrano, San Juan Capistrano, CA USA; [Bock, Christopher; Vaught, Jonathan D.] SomaLogic Inc, Boulder, CO USA	Nichols Institute	Strom, CM (corresponding author), Quest Diagnost Nichols Inst San Juan Capistrano, San Juan Capistrano, CA USA.	charles.m.strom@questdiagnostics.com			Quest Diagnostics; SomaLogic	Quest Diagnostics; SomaLogic	NJP, XKW, AD, DMG, WS, and CMS are employees of Quest Diagnostics and CB and JDV are employees from SomaLogic. These companies funded this study. All the lung cancer markers and methods are patented, and the lung cancer test is under the development in Quest Diagnostics. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Carney WP, 2007, EXPERT REV MOL DIAGN, V7, P309, DOI 10.1586/14737159.7.3.309; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Esposito CL, 2011, DISCOV MED, V11, P487; Ghaderi D, 2010, NAT BIOTECHNOL, V28, P863, DOI 10.1038/nbt.1651; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Gregorc V, 2004, CLIN CANCER RES, V10, P6006, DOI 10.1158/1078-0432.CCR-03-0770; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Kraemer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026332; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609; Pirker R, 2012, LANCET ONCOL, V13, P33, DOI 10.1016/S1470-2045(11)70318-7; Pirker R, 2009, LANCET, V373, P1525, DOI 10.1016/S0140-6736(09)60569-9; Planque S, 2003, FASEB J, V17, P136, DOI 10.1096/fj.01-0847com; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vaught JD, 2010, J AM CHEM SOC, V132, P4141, DOI 10.1021/ja908035g; Weeraratne Dohan, 2011, BMC Clin Pharmacol, V11, P17, DOI 10.1186/1472-6904-11-17; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; XU YH, 1984, P NATL ACAD SCI-BIOL, V81, P7308, DOI 10.1073/pnas.81.23.7308; ZABRECKY JR, 1991, J BIOL CHEM, V266, P1716	22	15	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71703	10.1371/journal.pone.0071703	http://dx.doi.org/10.1371/journal.pone.0071703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990977	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100051
J	Truong, HHM; Grasso, M; Chen, YH; Kellogg, TA; Robertson, T; Curotto, A; Steward, WT; McFarland, W				Truong, Hong-Ha M.; Grasso, Michael; Chen, Yea-Hung; Kellogg, Timothy A.; Robertson, Tyler; Curotto, Alberto; Steward, Wayne T.; McFarland, Willi			Balancing Theory and Practice in Respondent-Driven Sampling: A Case Study of Innovations Developed to Overcome Recruitment Challenges	PLOS ONE			English	Article							ONLINE; HIV	Introduction: Respondent-driven sampling (RDS) offers a recruitment strategy for hard-to-reach populations. However, RDS faces logistical and theoretical challenges that threaten efficiency and validity in settings worldwide. We present innovative adaptations to conventional RDS to overcome barriers encountered in recruiting a large, representative sample of men who have sex with men (MSM) who travel internationally. Methods: Novel methodological adaptations for the "International Travel Research to Inform Prevention" or "I-TRIP" study were offering participants a choice between electronic and paper coupons referrals for recruitment and modifying the secondary incentives structure from small cash amounts to raffle entries for periodic large cash prize raffle drawings. Staged referral limit increases from 3 to 10 referrals and progressive addition of 70 seeds were also implemented. Results: There were 501 participants enrolled in up to 13 waves of growth. Among participants with a choice of referral methods, 81% selected electronic referrals. Of participants who were recruited electronically, 90% chose to remain with electronic referrals when it was their turn to recruit. The mean number of enrolled referrals was 0.91 for electronic referrals compared to 0.56 for paper coupons. Median referral lag time, i.e., the time interval between when recruiters were given their referrals and when a referred individual enrolled in the study, was 20 days (IQR 10-40) for electronic referrals, 20 days (IQR 8-58) for paper coupons, 20 days (IQR 10-41) for raffle entries and 33 days (IQR 16-148) for small cash incentives. Conclusions: The recruitment of MSM who travel internationally required maximizing known flexible tools of RDS while at the same time necessitating innovations to increase recruitment efficiency. Electronic referrals emerged as a major advantage in recruiting this hard-to-reach population who are of high socio-economic status, geographically diffuse and highly mobile. These enhancements may improve the performance of RDS in target populations with similar characteristics.	[Truong, Hong-Ha M.; Curotto, Alberto; Steward, Wayne T.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Truong, Hong-Ha M.] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Grasso, Michael; Chen, Yea-Hung; Kellogg, Timothy A.; Robertson, Tyler; McFarland, Willi] Dept Publ Hlth, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Truong, HHM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Hong-Ha.Truong@ucsf.edu		Grasso, Michael/0000-0001-9529-6542; Chen, Yea-Hung/0000-0002-7949-0692	National Institute of Mental Health at the National Institutes of Health [R01 MH080657, R01 MH080657-03S1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080657] Funding Source: NIH RePORTER	National Institute of Mental Health at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health at the National Institutes of Health (R01 MH080657 and R01 MH080657-03S1; PI: HMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauermeister JA, 2012, J STUD ALCOHOL DRUGS, V73, P834, DOI 10.15288/jsad.2012.73.834; Carballo-Dieguez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027447; Damacena GN, 2011, JAIDS-J ACQ IMM DEF, V57, pS144, DOI 10.1097/QAI.0b013e31821e9bf6; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Li J, 2011, SEX TRANSM DIS, V38, P1161, DOI 10.1097/OLQ.0b013e3182315772; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; Pew Internet and American Life Project, WHOS ONL INT US DEM; Pew Internet and American Life Project, WHAT INT US DO ONL; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Volz E, 2008, J OFF STAT, V24, P79; Wejnert C, 2008, SOCIOL METHOD RES, V37, P105, DOI 10.1177/0049124108318333	13	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e70344	10.1371/journal.pone.0070344	http://dx.doi.org/10.1371/journal.pone.0070344			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218YW	23990901	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470100022
J	Gu, XL; Yao, YW; Wu, GN; Lv, TF; Luo, L; Song, Y				Gu, Xiaoling; Yao, Yanwen; Wu, Guannan; Lv, Tangfeng; Luo, Liang; Song, Yong			The Plasma Mitochondrial DNA Is an Independent Predictor for Post-Traumatic Systemic Inflammatory Response Syndrome	PLOS ONE			English	Article							ORGAN FAILURE; SEPTIC SHOCK; NUCLEAR; HYDROCORTISONE; SEVERITY	Background and Purpose: Mitochondrial DNA (mtDNA), a newly identified damage-associated molecular pattern, has been observed in trauma patients, however, little is known concerning the relationship between plasma mtDNA levels and concrete post-traumatic complications, particularly systemic inflammatory response syndrome (SIRS). The aim of this study is to determine whether plasma mtDNA levels are associated with injury severity and cloud predict post-traumatic SIRS in patients with acute traumatic injury. Patients and Methods: Eighty-six consecutive patients with acute traumatic injury were prospectively enrolled in this study. The plasma mtDNA concentration was measured by a real-time, quantitative PCR assay for the human ND2 gene. The study population's clinical and laboratory data were analyzed. Results: The median plasma mtDNA was higher in trauma patients than in healthy controls (865.196 (251.042-2565.40)pg/ml vs 64.2147 (43.9049-80.6371)pg/ml, P<0.001) and was independently correlated with the ISS score (r=0.287, P<0.001). The plasma mtDNA concentration was also significantly higher in patients who developed post-traumatic SIRS than in patients who did not (1774.03 (564.870-10901.3)pg/ml vs 500.496 (145.415-1285.60)pg/ml, P<0.001). Multiple logistic regression analysis revealed that the plasma mtDNA was an independent predictors for post-traumatic SIRS (OR, 1.183 (95% CI, 1.015-1.379), P=0.032). Further ROC analysis demonstrated that a high plasma mtDNA level predicted post-traumatic SIRS with a sensitivity of 67% and a specificity of 76%, with a cut-off value of 1.3185 mu g/ml being established, and the area under the ROC curves (AUC) was 0.725 (95% CI 0.613-0.837). Conclusions: Plasma mtDNA was an independent indictor with moderate discriminative power to predict the risk of post-traumatic SIRS.	[Gu, Xiaoling; Yao, Yanwen; Wu, Guannan; Lv, Tangfeng; Luo, Liang; Song, Yong] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp Med, Nanjing 210008, Jiangsu, Peoples R China; [Luo, Liang] Nanjing Med Univ, Intens Care Unit, Wu Xi Affiliated Hosp 2, Wu Xi, Peoples R China	Nanjing University; Nanjing Medical University	Song, Y (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp Med, Nanjing 210008, Jiangsu, Peoples R China.	yong_song6310@yahoo.com			National Natural Scientific Foundation of China Grants [81170064]	National Natural Scientific Foundation of China Grants	This present study was supported by the National Natural Scientific Foundation of China Grants (no. 81170064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabi YM, 2010, CAN MED ASSOC J, V182, P1971, DOI 10.1503/cmaj.090707; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Chou CC, 2008, DIGEST SURG, V25, P300, DOI 10.1159/000152846; Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kohler C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-105; Kung CT, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-130; Lam NYL, 2004, CLIN CHEM, V50, P213, DOI 10.1373/clinchem.2003.025783; Li CN, 2003, J CLIN LAB ANAL, V17, P103, DOI 10.1002/jcla.10081; Mehra N, 2007, CLIN CANCER RES, V13, P421, DOI 10.1158/1078-0432.CCR-06-1087; Moreno R, 2011, INTENS CARE MED, V37, P1765, DOI 10.1007/s00134-011-2334-x; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; POLLACK Y, 1984, NUCLEIC ACIDS RES, V12, P4811, DOI 10.1093/nar/12.12.4811; Sauaia A, 1998, J TRAUMA, V45, P291, DOI 10.1097/00005373-199808000-00014; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; Tsai NW, 2011, CLIN CHIM ACTA, V412, P476, DOI 10.1016/j.cca.2010.11.036; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	22	62	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72834	10.1371/journal.pone.0072834	http://dx.doi.org/10.1371/journal.pone.0072834			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977360	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300101
J	Heimpel, GE; Yang, Y; Hill, JD; Ragsdale, DW				Heimpel, George E.; Yang, Yi; Hill, Jason D.; Ragsdale, David W.			Environmental Consequences of Invasive Species: Greenhouse Gas Emissions of Insecticide Use and the Role of Biological Control in Reducing Emissions	PLOS ONE			English	Article							SOYBEAN APHID HEMIPTERA; NATURAL ENEMIES; MANAGEMENT; SUPPRESSION; LANDSCAPE; ABUNDANCE; SERVICES; GLYCINES; PESTICIDES; RESISTANCE	Greenhouse gas emissions associated with pesticide applications against invasive species constitute an environmental cost of species invasions that has remained largely unrecognized. Here we calculate greenhouse gas emissions associated with the invasion of an agricultural pest from Asia to North America. The soybean aphid, Aphis glycines, was first discovered in North America in 2000, and has led to a substantial increase in insecticide use in soybeans. We estimate that the manufacture, transport, and application of insecticides against soybean aphid results in approximately 10.6 kg of carbon dioxide (CO2) equivalent greenhouse gasses being emitted per hectare of soybeans treated. Given the acreage sprayed, this has led to annual emissions of between 6 and 40 million kg of CO2 equivalent greenhouse gasses in the United States since the invasion of soybean aphid, depending on pest population size. Emissions would be higher were it not for the development of a threshold aphid density below which farmers are advised not to spray. Without a threshold, farmers tend to spray preemptively and the threshold allows farmers to take advantage of naturally occurring biological control of the soybean aphid, which can be substantial. We find that adoption of the soybean aphid economic threshold can lead to emission reductions of approximately 300 million kg of CO2 equivalent greenhouse gases per year in the United States. Previous studies have documented that biological control agents such as lady beetles are capable of suppressing aphid densities below this threshold in over half of the soybean acreage in the U.S. Given the acreages involved this suggests that biological control results in annual emission reductions of over 200 million kg of CO2 equivalents. These analyses show how interactions between invasive species and organisms that suppress them can interact to affect greenhouse gas emissions.	[Heimpel, George E.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Yang, Yi] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Hill, Jason D.] Univ Minnesota, Dept Bioprod & Biosyst Engn, St Paul, MN 55108 USA; [Ragsdale, David W.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Santa Barbara; University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station	Heimpel, GE (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	heimp001@umn.edu	Hill, Jason/A-8919-2008	Hill, Jason/0000-0001-7609-6713	University of Minnesota Institute on the Environment; University of Minnesota Agricultural Experiment station	University of Minnesota Institute on the Environment; University of Minnesota Agricultural Experiment station	1. The University of Minnesota Institute on the Environment. They provided a fellowship for the corresponding author of $50,000. This will be used to cover publication charges; http://environment.umn.edu/research/residentfellows2011.html. 2. The University of Minnesota Agricultural Experiment station provides $6,000 per year to the laboratory of the corresponding author so long as the work is focused on biological control i Minnesota. This fund was used for photocopying associated with the project; http://www.maes.umn.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alluvione F, 2011, ENERGY, V36, P4468, DOI 10.1016/j.energy.2011.03.075; ANAGNOSTAKIS SL, 1987, MYCOLOGIA, V79, P23, DOI 10.2307/3807741; Asplen MK, 2011, ANN ENTOMOL SOC AM, V104, P935, DOI 10.1603/AN10172; Bartlett MD, 2011, SCI TOTAL ENVIRON, V409, P1357, DOI 10.1016/j.scitotenv.2010.12.041; Baur ME, 2000, ENVIRON ENTOMOL, V29, P312, DOI 10.1603/0046-225X(2000)029[0312:APIESP]2.0.CO;2; Brown SA, 2012, FLA ENTOMOL, V95, P1182, DOI 10.1653/024.095.0449; Costamagna AC, 2007, ECOL APPL, V17, P441, DOI 10.1890/06-0284; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Davis M. A., 2009, INVASION BIOL; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2006, ENVIRON ENTOMOL, V35, P1342, DOI 10.1603/0046-225X(2006)35[1342:SOPGOT]2.0.CO;2; Eisenhauer N, 2012, OIKOS, V121, P1121, DOI 10.1111/j.1600-0706.2011.19807.x; Elton C. S., 1958, ECOLOGY INVASIONS AN; Floyd EY, 2008, ENVIRON TOXICOL CHEM, V27, P1780, DOI 10.1897/07-448.1; Gardiner MM, 2010, BIOL CONTROL, V55, P11, DOI 10.1016/j.biocontrol.2010.06.008; Gardiner MM, 2009, ECOL APPL, V19, P143, DOI 10.1890/07-1265.1; Green M. R., 1987, Energy in World Agriculture, P166; GRISSO R. D., 2010, PREDICTING TRACTOR D; GURR GM, 2000, IOL CONTROL MEASURES, V429; Heimpel GE, 2004, ANN ENTOMOL SOC AM, V97, P249, DOI 10.1603/0013-8746(2004)097[0249:PFIBCO]2.0.CO;2; Heimpel GE, 2010, BIOL INVASIONS, V12, P2913, DOI 10.1007/s10530-010-9736-5; Heinz KM, 2005, BIOCONTROL PROTECTED; Helsel Z. R., 2006, ENCY PEST MANAGEMENT, V1, P1; Heuer E, 2000, Z PFLANZENK PFLANZEN, P735; Hill CB, 2012, EUPHYTICA, V186, P635, DOI 10.1007/s10681-012-0695-z; Hoddle MS, 2008, CONTROL PESTS WEEDS; Hodgson EW, 2012, J INTEGR PEST MANAG, V3, DOI 10.1603/IPM11019; HODGSON EW, 2012, J EXTENSION; Johnson KD, 2009, J ECON ENTOMOL, V102, P2101, DOI 10.1603/029.102.0613; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; Koch RL, 2012, ENVIRON ENTOMOL, V41, P750, DOI 10.1603/EN11168; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Landis DA, 2008, P NATL ACAD SCI USA, V105, P20552, DOI 10.1073/pnas.0804951106; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Lundgren JG, 2013, CROP PROT, V43, P104, DOI 10.1016/j.cropro.2012.08.005; Magalhaes LC, 2009, J ECON ENTOMOL, V102, P187, DOI 10.1603/029.102.0127; Maron JL, 2001, OIKOS, V95, P361, DOI 10.1034/j.1600-0706.2001.950301.x; MCCORNACK B, 2006, CROPS MANAGE, DOI DOI 10.1094/CM-2006-0915-1001-RS; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Myers JL, 2003, ECOLOGY CONTROL INTR; Noma T, 2010, ENVIRON ENTOMOL, V39, P31, DOI 10.1603/EN09073; Normile D, 2008, SCIENCE, V319, P1606, DOI 10.1126/science.319.5870.1606; OLSON K, 2008, FAMERS AWARENESS USE; PEDIGO L.P., 2006, ENTOMOLOGY PEST MANA; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pretty JN, 2002, PHILOS T R SOC A, V360, P1741, DOI 10.1098/rsta.2002.1029; Pretty J, 2008, PHILOS T R SOC B, V363, P447, DOI 10.1098/rstb.2007.2163; Ragsdale DW, 2007, J ECON ENTOMOL, V100, P1258, DOI 10.1603/0022-0493(2007)100[1258:ETFSAH]2.0.CO;2; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Rhainds M, 2010, AGR FOREST ENTOMOL, V12, P251, DOI 10.1111/j.1461-9563.2010.00471.x; Riedell WE, 2009, J PLANT NUTR, V32, P1674, DOI 10.1080/01904160903150925; Roy HE, 2012, DIVERS DISTRIB, V18, P717, DOI 10.1111/j.1472-4642.2012.00883.x; Schmidt NP, 2007, ENVIRON ENTOMOL, V36, P416, DOI 10.1603/0046-225X(2007)36[416:ALMABC]2.0.CO;2; Simberloff D, 2005, J AGR ENVIRON ETHIC, V18, P595, DOI 10.1007/s10806-005-2851-0; Smith AL, 2012, ENVIRON REV, V20, P1, DOI [10.1139/A11-020, 10.1139/a11-020]; Smith JF, 2009, J ECON ENTOMOL, V102, P229, DOI 10.1603/029.102.0132; Song F, 2009, J ECON ENTOMOL, V102, P2116, DOI 10.1603/029.102.0615; Thrasher JD, 2002, ARCH ENVIRON HEALTH, V57, P181, DOI 10.1080/00039890209602934; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Wang M, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/2/024001; WANG MQ, 1999, GREET TRANSPORTATION, P1; Ware G.W., 2004, PESTICIDE BOOK; Webber BL, 2012, GLOBAL ECOL BIOGEOGR, V21, P305, DOI 10.1111/j.1466-8238.2011.00684.x; Williamson M., 1996, BIOL INVASIONS; Woltz JM, 2013, BIOL CONTROL, V64, P330, DOI 10.1016/j.biocontrol.2012.11.012; Woltz JM, 2012, AGR ECOSYST ENVIRON, V152, P40, DOI 10.1016/j.agee.2012.02.008; Yu S., 2008, TOXICOLOGY BIOCH INS, DOI 10.1201/9781420059762	68	40	41	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72293	10.1371/journal.pone.0072293	http://dx.doi.org/10.1371/journal.pone.0072293			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977273	gold, Green Published, Green Submitted			2022-12-25	WOS:000324527300075
J	Hsu, HY; Kuo, LC; Kuo, YL; Chiu, HY; Jou, IM; Wu, PT; Su, FC				Hsu, Hsiu-Yun; Kuo, Li-Chieh; Kuo, Yao-Lung; Chiu, Haw-Yen; Jou, I-Ming; Wu, Po-Ting; Su, Fong-Chin			Feasibility of a Novel Functional Sensibility Test as an Assisted Examination for Determining Precision Pinch Performance in Patients with Carpal Tunnel Syndrome	PLOS ONE			English	Article							GRIP FORCE CONTROL; MEDIAN NERVE; HAND; CLASSIFICATION; COMPRESSION; VALIDATION; SENSATION; DEFICITS; OBJECT; SYSTEM	To understand the feasibility of a novel functional sensibility test for determining precision pinch performance in patients with carpal tunnel syndrome, this study investigates the validity, sensitivity and specificity of functional sensibility derived from a pinch-holding-up activity (PHUA) test. Participants include 70 clinically defined carpal tunnel syndrome (CTS) patients with 119 involved hands and 70 age- and gender-matched controls. To examine the discriminating ability of the functional sensibility test, the differences in the ability of pinch force adjustments to the inertial load of handling object between CTS and control subjects are analyzed. The results of functional sensibility are correlated with the severity of CTS to establish concurrent validity. The receiver operating characteristic (ROC) curve is constructed to demonstrate the accuracy of the proposed test. The functional sensibility score significantly discriminates the patients and control groups (respectively, 12.94 +/- 1.72 vs. 11.51 +/- 1.15N in peak pinch force (FPPeak), p<0.001; 2.92 +/- 0.41 vs. 2.52 +/- 0.24 in force ratio, p<0.001) and is moderately correlated (r = 0.42-0.54, p<0.001) with the results of traditional sensibility tests (touch-pressure threshold and two-point discrimination test). In addition, there is a statistical difference in the results of functional sensibility (p<0.001) among the subgroups of CTS severity based on electrophysiological study. The sensitivity and specificity are 0.79 and 0.76, respectively, for the functional sensibility test. The areas under the ROC curve are 0.85 and 0.80 for the force ratio and FPPeak, respectively. In conclusion, the functional sensibility test could be feasibly used as a clinical tool for determining both the sensibility and precision pinch performance of hands for the patients with CTS.	[Hsu, Hsiu-Yun; Su, Fong-Chin] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Hsu, Hsiu-Yun] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Phys Med & Rehabil, Tainan 70101, Taiwan; [Kuo, Li-Chieh] Natl Cheng Kung Univ, Dept Occupat Therapy, Tainan 70101, Taiwan; [Kuo, Yao-Lung; Chiu, Haw-Yen] Natl Cheng Kung Univ, Dept Surg, Sect Plast Surg, Tainan 70101, Taiwan; [Jou, I-Ming; Wu, Po-Ting] Natl Cheng Kung Univ, Dept Orthoped, Tainan 70101, Taiwan; [Su, Fong-Chin] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Su, FC (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan.	fcsu@mail.ncku.edu.tw	Kuo, Li-Chieh/ABC-3826-2021; Hsu, Hsiu-Yun/AGZ-2698-2022; SU, FONG-CHIN/C-8094-2011	Kuo, Li-Chieh/0000-0001-7728-0096; SU, FONG-CHIN/0000-0002-3870-4842; Kuo, Li-Chieh/0000-0002-5644-655X	National Science Council, Taiwan [99-2314-B-006-014-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council grant 99-2314-B-006-014-MY3, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, LANCET, V1, P854; Chiu HY, 2009, J ORTHOP RES, V27, P1116, DOI 10.1002/jor.20859; Cole KJ, 2003, EXP BRAIN RES, V148, P150, DOI 10.1007/s00221-002-1283-6; Dannenbaum RM, 2002, CLIN REHABIL, V16, P630, DOI 10.1191/0269215502cr532oa; DELLON AL, 1990, J HAND SURG-BRIT EUR, V15B, P14, DOI 10.1016/0266-7681(90)90042-3; Dellon AL, 2015, EVALUATION SENSIBILI, V4th; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; HEYWOOD JT, 1992, BRAIN, V115, P1081, DOI 10.1093/brain/115.4.1081; Hsu HY, 2009, J ORTHOP RES, V27, P1534, DOI 10.1002/jor.20903; Jablecki CK, 2002, NEUROLOGY, V58, P1589, DOI 10.1212/WNL.58.11.1589; JABLECKI CK, 1993, MUSCLE NERVE, V16, P1392; Jeng OJ, 1997, AM IND HYG ASSOC J, V58, P852, DOI 10.1202/0002-8894(1997)058<0852:PEOASA>2.0.CO;2; JENG OJ, 1994, ERGONOMICS, V37, P1055, DOI 10.1080/00140139408963718; JOHANSSON RS, 1987, EXP BRAIN RES, V66, P141; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; KATZ JN, 1991, AM J PUBLIC HEALTH, V81, P189, DOI 10.2105/AJPH.81.2.189; KENDALL D, 1960, BRIT MED J, V2, P1633, DOI 10.1136/bmj.2.5213.1633; Lowe BD, 1999, ERGONOMICS, V42, P550, DOI 10.1080/001401399185469; MOBERG E, 1958, J BONE JOINT SURG BR, V40, P454, DOI 10.1302/0301-620X.40B3.454; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Nishimura Akiyo, 2003, J Orthop Sci, V8, P625, DOI 10.1007/s00776-003-0684-0; Nowak DA, 2004, BRAIN, V127, P182, DOI 10.1093/brain/awh016; Nowak DA, 2003, NEUROSCI RES, V47, P65, DOI 10.1016/S0168-0102(03)00182-2; Nowak DA, 2002, EXP BRAIN RES, V145, P28, DOI 10.1007/s00221-002-1079-8; Padua L, 1997, ITAL J NEUROL SCI, V18, P145, DOI 10.1007/BF02048482; Rajesh KS, 1989, ELECTROMYOGRAPHERS H; Rempel D, 1998, AM J PUBLIC HEALTH, V88, P1447, DOI 10.2105/AJPH.88.10.1447; Sen D, 2002, HOSP MED, V63, P392, DOI 10.12968/hosp.2002.63.7.1981; Shieh SJ, 2011, J ORTHOP RES, V29, P1210, DOI 10.1002/jor.21365; SHIEH SJ, 1995, MICROSURG, V16, P578, DOI 10.1002/micr.1920160813; Soreide K, 2011, ANN SURG, V253, P27, DOI 10.1097/SLA.0b013e318204a892; Tamburin S, 2008, J NEUROL, V255, P1636, DOI 10.1007/s00415-008-0895-6; Thonnard JL, 1999, EXP BRAIN RES, V128, P61, DOI 10.1007/s002210050817; Tinazzi M, 1998, BRAIN, V121, P1785, DOI 10.1093/brain/121.9.1785; Voerman VF, 2000, ARCH PHYS MED REHAB, V81, P430, DOI 10.1053/mr.2000.3777; WESTLING G, 1984, EXP BRAIN RES, V53, P277; Williams PS, 2006, ARCH PHYS MED REHAB, V87, P1471, DOI 10.1016/j.apmr.2006.08.019; Witney AG, 2004, TRENDS NEUROSCI, V27, P637, DOI 10.1016/j.tins.2004.08.006	38	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72064	10.1371/journal.pone.0072064	http://dx.doi.org/10.1371/journal.pone.0072064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977209	Green Submitted, gold, Green Published			2022-12-25	WOS:000324527300060
J	Schrallhammer, M; Ferrantini, F; Vannini, C; Galati, S; Schweikert, M; Gortz, HD; Verni, F; Petroni, G				Schrallhammer, Martina; Ferrantini, Filippo; Vannini, Claudia; Galati, Stefano; Schweikert, Michael; Goertz, Hans-Dieter; Verni, Franco; Petroni, Giulio			'Candidatus Megaira polyxenophila' gen. nov., sp nov.: Considerations on Evolutionary History, Host Range and Shift of Early Divergent Rickettsiae	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; IN-SITU DETECTION; MARINE CILIATE; BACTERIAL ENDOSYMBIONTS; CILIOPHORA; PHYLOGENY; SYMBIONT; IDENTIFICATION; SEQUENCE; TICKS	"Neglected Rickettsiaceae" (i.e. those harboured by non-hematophagous eukaryotic hosts) display greater phylogenetic variability and more widespread dispersal than pathogenic ones; yet, the knowledge about their actual host range and host shift mechanism is scarce. The present work reports the characterization following the full-cycle rRNA approach (SSU rRNA sequence, specific in situ hybridization, and ultrastructure) of a novel rickettsial bacterium, herewith proposed as 'Candidatus Megaira polyxenophila' gen. nov., sp. nov. We found it in association with four different free-living ciliates (Diophrys oligothrix, Euplotes octocarinatus, Paramecium caudatum, and Spirostomum sp., all belonging to Alveolata, Ciliophora); furthermore it was recently observed as intracellular occurring in Carteria cerasiformis and Pleodorina japonica (Chlorophyceae, Chlorophyta). Phylogenetic analyses demonstrated the belonging of the candidate new genus to the family Rickettsiaceae (Alphaproteobacteria, Rickettsiales) as a sister group of the genus Rickettsia. In situ observations revealed the ability of the candidate new species to colonize either nuclear or cytoplasmic compartments, depending on the host organism. The presence of the same bacterial species within different, evolutionary distant, hosts indicates that 'Candidatus Megaira polyxenophila' recently underwent several distinct host shifts, thus suggesting the existence of horizontal transmission pathways. We consider these findings as indicative of an unexpected spread of rickettsial infections in aquatic communities, possibly by means of trophic interactions, and hence propose a new interpretation of the origin and phylogenetic diversification of rickettsial bacteria.	[Schrallhammer, Martina; Ferrantini, Filippo; Vannini, Claudia; Galati, Stefano; Verni, Franco; Petroni, Giulio] Univ Pisa, Dipartimento Biol, Pisa, Italy; [Schrallhammer, Martina; Schweikert, Michael; Goertz, Hans-Dieter] Univ Stuttgart, Inst Biol, D-70174 Stuttgart, Germany; [Schrallhammer, Martina] Tech Univ Dresden, Inst Hydrobiol, D-01062 Dresden, Germany	University of Pisa; University of Stuttgart; Technische Universitat Dresden	Schrallhammer, M (corresponding author), Univ Pisa, Dipartimento Biol, Pisa, Italy.	martina.schrallhammer@tu-dresden.de; gpetroni@biologia.unipi.it	Petroni, Giulio/B-6086-2008; Schrallhammer, Martina/AAZ-5894-2020	Petroni, Giulio/0000-0001-9572-9897; Schrallhammer, Martina/0000-0003-2061-2998; VANNINI, CLAUDIA/0000-0002-6195-695X	European Commission [247658]; Volkswagen foundation [84816]; Cooperlink action [CII11DH8DZ]; Italian Research Ministry [2008R9WRTB]; German Research Foundation; TU Dresden	European Commission(European CommissionEuropean Commission Joint Research Centre); Volkswagen foundation(Volkswagen); Cooperlink action; Italian Research Ministry(Ministry of Education, Universities and Research (MIUR)); German Research Foundation(German Research Foundation (DFG)); TU Dresden(European Commission)	This work was supported by the European Commission FP7-PEOPLE-2009-IRSES project CINAR-PATHOBACTER (247658), the Volkswagen foundation (project number: 84816), the Cooperlink action (protocol CII11DH8DZ), and the PRIN fellowship (protocol 2008R9WRTB) from the Italian Research Ministry. The authors acknowledge support by the German Research Foundation and the Open Access Publication Funds of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Anstead CA, 2013, TICKS TICK-BORNE DIS, V4, P202, DOI 10.1016/j.ttbdis.2012.11.013; Balraj P, 2009, ANN NY ACAD SCI, V1166, P94, DOI 10.1111/j.1749-6632.2009.04517.x; Boscaro V, 2013, MICROB ECOL, V65, P302, DOI 10.1007/s00248-012-0170-3; Boscaro V, 2013, MICROB ECOL, V65, P255, DOI 10.1007/s00248-012-0110-2; Brofft JE, 2002, ENVIRON MICROBIOL, V4, P764, DOI 10.1046/j.1462-2920.2002.00337.x; Caspi-Fluger A, 2012, P ROY SOC B-BIOL SCI, V279, P1791, DOI 10.1098/rspb.2011.2095; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; Chouari R, 2010, MICROB ECOL, V60, P272, DOI 10.1007/s00248-009-9632-7; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Davis MJ, 1998, CURR MICROBIOL, V36, P80, DOI 10.1007/s002849900283; DINI F, 1994, J EUKARYOT MICROBIOL, V41, P373, DOI 10.1111/j.1550-7408.1994.tb06092.x; Dykova I, 2003, FOLIA PARASIT, V50, P161, DOI 10.14411/fp.2003.030; Ferrantini F, 2009, J EUKARYOT MICROBIOL, V56, P119, DOI 10.1111/j.1550-7408.2008.00377.x; Fournier PE, 2009, ANN NY ACAD SCI, V1166, P1, DOI 10.1111/j.1749-6632.2009.04528.x; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; FREIBURG M, 1993, ARCH PROTISTENKD, V143, P311, DOI 10.1016/S0003-9365(11)80327-1; Fritsche TR, 1999, APPL ENVIRON MICROB, V65, P206; Galand PE, 2012, FEMS MICROBIOL ECOL, V79, P203, DOI 10.1111/j.1574-6941.2011.01209.x; Gihring TM, 2006, GEOMICROBIOL J, V23, P415, DOI 10.1080/01490450600875696; Gortz H D, 2001, Int Microbiol, V4, P143; Gottlieb Y, 2012, FRONT MICROBIOL SER, P191; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hine PM, 2002, DIS AQUAT ORGAN, V49, P207, DOI 10.3354/dao049207; Hollants J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2659; Huang J, 2012, MOL PHYLOGENET EVOL, V63, P598, DOI 10.1016/j.ympev.2012.02.007; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Izzard L, 2009, EMERG INFECT DIS, V15, P1654, DOI 10.3201/eid1510.090799; Kawafune K, 2013, PROTOPLASMA, V250, P949, DOI 10.1007/s00709-012-0469-4; Kawafune K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031749; Kikuchi Y, 2002, APPL ENVIRON MICROB, V68, P999, DOI 10.1128/AEM.68.2.999-1004.2002; Kim E, 2010, ISME J, V4, P1108, DOI 10.1038/ismej.2010.40; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Kuo RC, 2013, PROTIST, V164, P60, DOI 10.1016/j.protis.2012.08.004; Kusch J, 2002, PROTIST, V153, P47, DOI 10.1078/1434-4610-00082; Li T, 2011, J INVERTEBR PATHOL, V106, P418, DOI 10.1016/j.jip.2010.12.003; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Mediannikov O, 2012, COMP IMMUNOL MICROB, V35, P145, DOI 10.1016/j.cimid.2011.12.011; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Merhej V, 2011, BIOL REV, V86, P379, DOI 10.1111/j.1469-185X.2010.00151.x; Modeo L, 2006, P JPN ACAD B-PHYS, V82, P359, DOI 10.2183/pjab.82.359; Mollenbeck M, 1999, MOL ECOL, V8, P1971, DOI 10.1046/j.1365-294x.1999.00774.x; Montagna M, 2013, APPL ENVIRON MICROB, V79, P3241, DOI 10.1128/AEM.03971-12; Mott J, 2002, J CLIN MICROBIOL, V40, P690, DOI 10.1128/JCM.40.2.690-693.2002; Palomar AM, 2012, TICKS TICK-BORNE DIS, V3, P318, DOI 10.1016/j.ttbdis.2012.10.025; Peng Y., UNPUB; Penn K, 2006, APPL ENVIRON MICROB, V72, P1680, DOI 10.1128/AEM.72.2.1680-1683.2006; Percent SF, 2008, APPL ENVIRON MICROB, V74, P1856, DOI 10.1128/AEM.01719-07; Petroni G, 2002, MOL PHYLOGENET EVOL, V22, P118, DOI 10.1006/mpev.2001.1030; PINKERTON H., 1936, Parasitology, V28, P172, DOI 10.1017/S003118200002237X; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; SILVERMAN DJ, 1991, EUR J EPIDEMIOL, V7, P200, DOI 10.1007/BF00145667; Song H, 2012, J APPL MICROBIOL, V112, P79, DOI 10.1111/j.1365-2672.2011.05187.x; Song WB, 2009, EUR J PROTISTOL, V45, P38, DOI 10.1016/j.ejop.2008.06.002; SPRINGER N, 1993, P NATL ACAD SCI USA, V90, P9892, DOI 10.1073/pnas.90.21.9892; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Sun HY, 2009, APPL ENVIRON MICROB, V75, P7445, DOI 10.1128/AEM.00850-09; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Tsai KH, 2008, AM J TROP MED HYG, V79, P256, DOI 10.4269/ajtmh.2008.79.256; Van de Peer Y, 2000, J MOL EVOL, V51, P565, DOI 10.1007/s002390010120; Vannini C, 2005, MICROB ECOL, V49, P434, DOI 10.1007/s00248-004-0055-1; Vannini C, 2005, J EUKARYOT MICROBIOL, V52, P116, DOI 10.1111/j.1550-7408.2005.04-3319.x; Vannini C, 2004, INT J SYST EVOL MICR, V54, P1151, DOI 10.1099/ijs.0.02759-0; Vannini C, 2012, ENVIRON MICROBIOL, V14, P2553, DOI 10.1111/j.1462-2920.2012.02760.x; Vlahos N, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-66; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Werren JH, 2005, MICROBIAL EVOLUTION, P290; Zhao Z, UNPUB	73	48	49	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72581	10.1371/journal.pone.0072581	http://dx.doi.org/10.1371/journal.pone.0072581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977321	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300088
J	Ebrahimi, KH; Dienemann, C; Hoefgen, S; Than, ME; Hagedoorn, PL; Hagen, WR				Ebrahimi, Kourosh Honarmand; Dienemann, Christian; Hoefgen, Sandra; Than, Manuel E.; Hagedoorn, Peter-Leon; Hagen, Wilfred R.			The Amyloid Precursor Protein (APP) Does Not Have a Ferroxidase Site in Its E2 Domain	PLOS ONE			English	Article							PYROCOCCUS-FURIOSUS FERRITIN; CELLULAR IRON UPTAKE; MULTICOPPER OXIDASE; ALZHEIMERS-DISEASE; HYDROLYSIS CHEMISTRY; HUMAN CERULOPLASMIN; HUMAN HEPHAESTIN; HORSE SPLEEN; EXPRESSION; MECHANISM	The ubiquitous 24-meric iron-storage protein ferritin and multicopper oxidases such as ceruloplasmin or hephaestin catalyze oxidation of Fe(II) to Fe(III), using molecular oxygen as oxidant. The ferroxidase activity of these proteins is essential for cellular iron homeostasis. It has been reported that the amyloid precursor protein (APP) also has ferroxidase activity. The activity is assigned to a ferroxidase site in the E2 domain of APP. A synthetic 22-residue peptide that carries the putative ferroxidase site of E2 domain (FD1 peptide) has been claimed to encompass the same activity. We previously tested the ferroxidase activity of the synthetic FD1 peptide but we did not observe any activity above the background oxidation of Fe(II) by molecular oxygen. Here we used isothermal titration calorimetry to study Zn(II) and Fe(II) binding to the natural E2 domain of APP, and we employed the transferrin assay and oxygen consumption measurements to test the ferroxidase activity of the E2 domain. We found that this domain neither in the presence nor in the absence of the E1 domain binds Fe(II) and it is not able to catalyze the oxidation of Fe(II). Binding of Cu(II) to the E2 domain did not induce ferroxidase activity contrary to the presence of redox active Cu(II) centers in ceruloplasmin or hephaestin. Thus, we conclude that E2 or E1 domains of APP do not have ferroxidase activity and that the potential involvement of APP as a ferroxidase in the pathology of Alzheimer's disease must be re-evaluated.	[Ebrahimi, Kourosh Honarmand; Hagedoorn, Peter-Leon; Hagen, Wilfred R.] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands; [Dienemann, Christian; Hoefgen, Sandra; Than, Manuel E.] FLI, Leibniz Inst Age Res, Prot Crystallog Grp, Jena, Germany	Delft University of Technology; Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Hagen, WR (corresponding author), Delft Univ Technol, Dept Biotechnol, Delft, Netherlands.	w.r.hagen@tudelft.nl	Than, Manuel/F-7536-2015; Hagedoorn, Peter-Leon/C-8535-2014; Ebrahimi, Kourosh Honarmand/X-4579-2019; Hagen, Wilfred R./H-8918-2017	Than, Manuel/0000-0002-4707-9225; Hagedoorn, Peter-Leon/0000-0001-6342-2022; Ebrahimi, Kourosh Honarmand/0000-0001-6628-944X; Hagen, Wilfred R./0000-0002-1609-6671; Dienemann, Christian/0000-0002-2172-5110; Hoefgen, Sandra/0000-0002-6806-7063	Dutch National Research School Combination, Catalysis Controlled by Chemical Design (NRSC-Catalysis)	Dutch National Research School Combination, Catalysis Controlled by Chemical Design (NRSC-Catalysis)	This work was financially supported by a research grant from the Dutch National Research School Combination, Catalysis Controlled by Chemical Design (NRSC-Catalysis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Attieh ZK, 1999, J BIOL CHEM, V274, P1116, DOI 10.1074/jbc.274.2.1116; BAKKER GR, 1986, J BIOL CHEM, V261, P3182; Bou-Abdallah F, 2010, BBA-GEN SUBJECTS, V1800, P719, DOI 10.1016/j.bbagen.2010.03.021; Chen HJ, 2004, BLOOD, V103, P3933, DOI 10.1182/blood-2003-09-3139; Dahms SO, 2012, J MOL BIOL, V416, P438, DOI 10.1016/j.jmb.2011.12.057; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Ebrahimi KH, 2013, CHEMBIOCHEM, V14, P1123, DOI 10.1002/cbic.201300149; Ebrahimi KH, 2013, FEBS LETT, V587, P220, DOI 10.1016/j.febslet.2012.11.029; Ebrahimi KH, 2012, NAT CHEM BIOL, V8, P941, DOI [10.1038/NCHEMBIO.1071, 10.1038/nchembio.1071]; Ebrahimi KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040287; Ebrahimi KH, 2010, J BIOL INORG CHEM, V15, P1243, DOI 10.1007/s00775-010-0682-6; Ebrahimi KH, 2009, J BIOL INORG CHEM, V14, P1265, DOI 10.1007/s00775-009-0571-z; Griffiths TAM, 2005, BIOCHEMISTRY-US, V44, P14725, DOI 10.1021/bi051559k; Hagen WR, 2006, DALTON T, P4415, DOI 10.1039/b608163k; Hahn P, 2004, P NATL ACAD SCI USA, V101, P13850, DOI 10.1073/pnas.0405146101; Harrington JM, 2009, BIOMETALS, V22, P679, DOI 10.1007/s10534-009-9233-4; HARRIS DC, 1973, BIOCHIM BIOPHYS ACTA, V329, P156, DOI 10.1016/0304-4165(73)90019-6; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Herbik A, 2002, PLANT PHYSIOL, V130, P2039, DOI 10.1104/pp.013060; Hudson DM, 2010, AM J PHYSIOL-GASTR L, V298, pG425, DOI 10.1152/ajpgi.00453.2009; IULIANO L, 1992, ARCH BIOCHEM BIOPHYS, V293, P153, DOI 10.1016/0003-9861(92)90378-A; Keil C, 2004, ACTA CRYSTALLOGR D, V60, P1614, DOI 10.1107/S0907444904015343; KONIG G, 1992, J BIOL CHEM, V267, P10804; Le Brun NE, 2010, BBA-GEN SUBJECTS, V1800, P732, DOI 10.1016/j.bbagen.2010.04.002; LEVI S, 1988, J BIOL CHEM, V263, P18086; Lindley PF, 1997, J BIOL INORG CHEM, V2, P454, DOI 10.1007/s007750050156; LUNDIN A, 1972, J MAGN RESON, V8, P70, DOI 10.1016/0022-2364(72)90023-6; MACARA IG, 1972, BIOCHEM J, V126, P151, DOI 10.1042/bj1260151; Mialane P, 1999, INORG CHEM, V38, P1085, DOI 10.1021/ic971059i; Mukhopadhyay CK, 1998, SCIENCE, V279, P714, DOI 10.1126/science.279.5351.714; OSAKI S, 1969, J BIOL CHEM, V244, P5757; OSAKI S, 1966, J BIOL CHEM, V241, P2746; Petrak J, 2005, INT J BIOCHEM CELL B, V37, P1173, DOI 10.1016/j.biocel.2004.12.007; Pouvreau LAM, 2008, METHOD ENZYMOL, V436, P97, DOI 10.1016/S0076-6879(08)36006-6; Qian ZM, 2007, J CELL BIOCHEM, V102, P1225, DOI 10.1002/jcb.21352; Quintanar L, 2004, J AM CHEM SOC, V126, P6579, DOI 10.1021/ja049220t; Quintanar L, 2007, ACCOUNTS CHEM RES, V40, P445, DOI 10.1021/ar600051a; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SUN S, 1992, J BIOL CHEM, V267, P25160; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Yang XO, 2000, BIOCHEMISTRY-US, V39, P4915, DOI 10.1021/bi992631f; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4	48	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72177	10.1371/journal.pone.0072177	http://dx.doi.org/10.1371/journal.pone.0072177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977245	Green Submitted, gold, Green Published			2022-12-25	WOS:000323425700146
J	Kong, XM; Hong, J; Chen, Y; Chen, L; Zhao, ZG; Li, Q; Ge, JP; Chen, G; Guo, XH; Lu, JM; Weng, JP; Jia, WP; Ji, LN; Xiao, JZ; Shan, ZY; Liu, J; Tian, HM; Ji, QH; Zhu, DL; Zhou, ZG; Shan, GL; Yang, WY				Kong, Xiaomu; Hong, Jing; Chen, Ying; Chen, Li; Zhao, Zhigang; Li, Qiang; Ge, Jiapu; Chen, Gang; Guo, Xiaohui; Lu, Juming; Weng, Jianping; Jia, Weiping; Ji, Linong; Xiao, Jianzhong; Shan, Zhongyan; Liu, Jie; Tian, Haoming; Ji, Qiuhe; Zhu, Dalong; Zhou, Zhiguang; Shan, Guangliang; Yang, Wenying			Association of Genetic Variants with Isolated Fasting Hyperglycaemia and Isolated Postprandial Hyperglycaemia in a Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TYPE-2 DIABETES RISK; FTO GENE; SUSCEPTIBILITY LOCI; INSULIN SENSITIVITY; COMMON VARIANTS; CONFERS RISK; FAT MASS; CDKAL1; GLUCOSE	Background: Though multiple single nucleotide polymorphisms (SNPs) associated with type 2 diabetes have been identified, the genetic bases of isolated fasting hyperglycaemia (IFH) and isolated postprandial hyperglycaemia (IPH) were still unclear. In present study, we aimed to investigate the association of genome-wide association study-validated genetic variants and IFH or IPH in Han Chinese. Methods/Principal Findings: We genotyped 27 validated SNPs in 6,663 unrelated individuals comprising 341 IFH, 865 IPH, 1,203 combined fasting hyperglycaemia and postprandial hyperglycaemia, and 4,254 normal glycaemic subjects of Han ancestry. The distributions of genotype frequencies of FTO, CDKAL1 and GCKR were significant different between individuals with IFH and those with IPH (SNP(p(trend)): rs8050136(0.0024), rs9939609(0.0049), rs7756992(0.0122), rs780094(0.0037)). Risk allele of FTO specifically increased the risk of IFH (rs8050136: OR 1.403 [95% CI 1.125-1.750], p = 0.0027; rs9939609: 1.398 [1.120-1.744], p = 0.0030). G allele of CDKAL1 specifically increased the risk of IPH (1.217 [1.092-1.355], p = 0.0004). G allele of GCKR increased the risk of IFH (1.167 [0.999-1.362], p = 0.0513), but decreased the risk of IPH (0.891 [0.801-0.991], p = 0.0331). In addition, TCF7L2 and KCNQ1 increased the risk of both IFH and IPH. When combined, each additional risk allele associated with IFH increased the risk for IFH by 1.246-fold (p < 0.0001), while each additional risk allele associated with IPH increased the risk for IPH by 1.190-fold (p < 0.0001). Conclusion/Significance: Our results indicate that genotype distributions of variants from FTO, GCKR, CDKAL1 were different between IPH and IFH in Han Chinese. Variants of genes modulating insulin sensitivity (FTO, GCKR) contributed to the risk of IFH, while variants of genes related to beta cell function (CDKAL1) increase the risk of IPH.	[Kong, Xiaomu; Hong, Jing; Xiao, Jianzhong; Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol, Key Lab Diabet Prevent & Control, Beijing, Peoples R China; [Chen, Ying] Beijing Genet Inst, Dept Bioinformat, Shenzhen, Guangdong, Peoples R China; [Chen, Li] Shandong Univ, Dept Endocrinol, Qilu Hosp, Jinan, Shandong, Peoples R China; [Zhao, Zhigang] Henan Prov Peoples Hosp, Dept Endocrinol, Zhengzhou, Henan, Peoples R China; [Li, Qiang] Harbin Med Univ, Dept Endocrinol, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Ge, Jiapu] Xinjiang Uygur Autonomous Reg Hosp, Dept Endocrinol, Urumqi, Xinjiang, Peoples R China; [Chen, Gang] Fujian Prov Hosp, Dept Endocrinol, Fuzhou, Fujian, Peoples R China; [Guo, Xiaohui] Peking Univ, Dept Endocrinol, Hosp 1, Beijing 100871, Peoples R China; [Lu, Juming] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Weiping] Shanghai Jiao Tong Univ, Dept Endocrinol, Peoples Hosp 6, Shanghai 200030, Peoples R China; [Ji, Linong] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; [Shan, Zhongyan] China Med Univ, Dept Endocrinol, Hosp 1, Shenyang, Liaoning, Peoples R China; [Liu, Jie] Shanxi Prov Peoples Hosp, Dept Endocrinol, Taiyuan, Shanxi, Peoples R China; [Tian, Haoming] Sichuan Univ, Dept Endocrinol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Ji, Qiuhe] Fourth Mil Med Univ, Dept Endocrinol, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Zhu, Dalong] Nanjing Univ, Dept Endocrinol, Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Zhiguang] Xiangya Second Hosp, Dept Endocrinol, Changsha, Hunan, Peoples R China; [Shan, Guangliang] Peking Union Med Coll, Dept Epidemiol, Beijing 100021, Peoples R China	China-Japan Friendship Hospital; Shandong University; Zhengzhou University; Harbin Medical University; Fujian Provincial Hospital; Peking University; Chinese People's Liberation Army General Hospital; Sun Yat Sen University; Shanghai Jiao Tong University; Peking University; China Medical University; Shanxi People's Hospital; Sichuan University; Air Force Military Medical University; Nanjing University; Central South University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, WY (corresponding author), China Japan Friendship Hosp, Dept Endocrinol, Key Lab Diabet Prevent & Control, Beijing, Peoples R China.	ywying_1010@163.com	Jia, Weiping/B-7483-2012; Linong, Ji/AAB-6543-2020	Zhou, Zhiguang/0000-0002-0374-1838; Weng, Jianping/0000-0002-7889-1697; Kong, Xiaomu/0000-0002-5920-4759	Chinese Medical Association Foundation; Chinese Diabetes Society; National 973 Program [2011CB504001]; China Postdoctoral Science Foundation Grant [2012M520200]	Chinese Medical Association Foundation; Chinese Diabetes Society; National 973 Program(National Basic Research Program of China); China Postdoctoral Science Foundation Grant(China Postdoctoral Science Foundation)	This research project was supported by grants from Chinese Medical Association Foundation and Chinese Diabetes Society (http://www.cma.org.cn/ensite/), National 973 Program (2011CB504001)(http://www.973.gov.cn/), China Postdoctoral Science Foundation Grant (2012M520200)(http://res.chinapostdoctor.org.cn/Program/Main.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam John M F, 2008, Acta Med Indones, V40, P171; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Boini KM, 2009, AM J PHYSIOL-REG I, V296, pR1695, DOI 10.1152/ajpregu.90839.2008; Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371; Ceriello A, 2003, DIABETOLOGIA, V46, pM9, DOI 10.1007/s00125-002-0931-5; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Chang YC, 2010, J MOL MED, V88, P183, DOI 10.1007/s00109-009-0542-4; Cui B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022353; Farrelly D, 1999, P NATL ACAD SCI USA, V96, P14511, DOI 10.1073/pnas.96.25.14511; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Han XY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-81; Hu C, 2009, DIABETOLOGIA, V52, P1322, DOI 10.1007/s00125-009-1335-6; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011761; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; Le Bacquer O, 2012, DIABETOLOGIA, V55, P2677, DOI 10.1007/s00125-012-2660-8; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Lin Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-97; Liu Y, 2009, DIABETOLOGIA, V52, P1315, DOI 10.1007/s00125-009-1375-y; Liu Y, 2010, OBESITY, V18, P1619, DOI 10.1038/oby.2009.469; Meigs JB, 2003, DIABETES, V52, P1475, DOI 10.2337/diabetes.52.6.1475; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Qi Q, 2010, DIABETOLOGIA, V53, P2163, DOI 10.1007/s00125-010-1826-5; Qi Q, 2009, DIABETOLOGIA, V52, P834, DOI 10.1007/s00125-009-1290-2; Qiao Q, 2000, DIABETOLOGIA, V43, P1470, DOI 10.1007/s001250051557; Rosengren AH, 2012, DIABETES, V61, P1726, DOI 10.2337/db11-1516; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stancakova A, 2009, DIABETES, V58, P2129, DOI 10.2337/db09-0117; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Tung YCL, 2011, ANN NY ACAD SCI, V1220, P162, DOI 10.1111/j.1749-6632.2010.05903.x; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056; Wen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009153; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Xu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014022; Yamagata K, 2011, BIOCHEM BIOPH RES CO, V407, P620, DOI 10.1016/j.bbrc.2011.03.083; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yu W, 2012, DIABETOLOGIA, V55, P2655, DOI 10.1007/s00125-012-2636-8; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	50	9	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71399	10.1371/journal.pone.0071399	http://dx.doi.org/10.1371/journal.pone.0071399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990951	Green Submitted, gold, Green Published			2022-12-25	WOS:000323425700047
J	Munoz, F; Beeravolu, CR; Pelissier, R; Couteron, P				Munoz, Francois; Beeravolu, Champak R.; Pelissier, Raphael; Couteron, Pierre			Do Spatially-Implicit Estimates of Neutral Migration Comply with Seed Dispersal Data in Tropical Forests?	PLOS ONE			English	Article							THEORY REVEALS ISOLATION; SPECIES-ABUNDANCE; MULTIPLE SAMPLES; COMMUNITY MODELS; RAPID SPECIATION; BETA-DIVERSITY; CONSEQUENCES; PARAMETERS; PATTERNS; DISTRIBUTIONS	Neutral community models have shown that limited migration can have a pervasive influence on the taxonomic composition of local communities even when all individuals are assumed of equivalent ecological fitness. Notably, the spatially implicit neutral theory yields a single parameter / for the immigration-drift equilibrium in a local community. In the case of plants, seed dispersal is considered as a defining moment of the immigration process and has attracted empirical and theoretical work. In this paper, we consider a version of the immigration parameter / depending on dispersal limitation from the neighbourhood of a community. Seed dispersal distance is alternatively modelled using a distribution that decreases quickly in the tails (thin-tailed Gaussian kernel) and another that enhances the chance of dispersal events over very long distances (heavily fat-tailed Cauchy kernel). Our analysis highlights two contrasting situations, where / is either mainly sensitive to community size (related to ecological drift) under the heavily fat-tailed kernel or mainly sensitive to dispersal distance under the thin-tailed kernel. We review dispersal distances of rainforest trees from field studies and assess the consistency between published estimates of / based on spatially-implicit models and the predictions of the kernel-based model in tropical forest plots. Most estimates of / were derived from large plots (10-50 ha) and were too large to be accounted for by a Cauchy kernel. Conversely, a fraction of the estimates based on multiple smaller plots (1 ha) appeared too small to be consistent with reported ranges of dispersal distances in tropical forests. Very large estimates may reflect within-plot habitat heterogeneity or estimation problems, while the smallest estimates likely imply other factors inhibiting migration beyond dispersal limitation. Our study underscores the need for interpreting / as an integrative index of migration limitation which, besides the limited seed dispersal, possibly includes habitat filtering or fragmentation.	[Munoz, Francois] Univ Montpellier 2, UMR AMAP, Montpellier, France; [Beeravolu, Champak R.; Pelissier, Raphael; Couteron, Pierre] IRD, UMR AMAP, Montpellier, France; [Beeravolu, Champak R.] INRA, UMR CBGP, Montferrier Sur Lez, France; [Beeravolu, Champak R.] IFP, UMIFRE CNRS MAEE 21, Pondicherry, India	CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; Institut de Recherche pour le Developpement (IRD)	Munoz, F (corresponding author), Univ Montpellier 2, UMR AMAP, Montpellier, France.	francois.munoz@univ-montp2.fr	Pélissier, Raphaël/C-1224-2008; Munoz, Francois/C-4239-2015	Pélissier, Raphaël/0000-0003-4845-5090; Munoz, Francois/0000-0001-8776-4705; Beeravolu Reddy, Champak/0000-0002-0800-1994	French Ministere de l'Ecologie et du Developpement Durable (EcoTrop 05 OSDA); program BRIDGE (ANR Biodiv 06); BSTD (DSF) grant from the Institut de Recherche pour le Developpement (IRD)	French Ministere de l'Ecologie et du Developpement Durable (EcoTrop 05 OSDA); program BRIDGE (ANR Biodiv 06)(French National Research Agency (ANR)); BSTD (DSF) grant from the Institut de Recherche pour le Developpement (IRD)	This research was supported by grants from the French Ministere de l'Ecologie et du Developpement Durable (EcoTrop 05 OSDA) to C.B.R., P.C., R.P. and F.M., and partly by the program BRIDGE (ANR Biodiv 06) to P.C. and R.P. C.B.R.'s Ph.D. was funded by a BSTD (DSF) grant from the Institut de Recherche pour le Developpement (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeravolu CR, 2009, ECOL MODEL, V220, P2603, DOI 10.1016/j.ecolmodel.2009.06.041; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Chave J, 2006, NATURE, V441, pE1, DOI 10.1038/nature04826; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Chisholm RA, 2012, B MATH BIOL, V74, P1754, DOI 10.1007/s11538-012-9734-0; Chisholm RA, 2009, ECOL LETT, V12, P1385, DOI 10.1111/j.1461-0248.2009.01389.x; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.2307/176541; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Cousens R, 2008, DISPERSAL IN PLANTS: A POPULATION PERSPECTIVE, P1; Dalling JW, 2002, J ECOL, V90, P714, DOI 10.1046/j.1365-2745.2002.00706.x; Etienne RS, 2007, ECOL LETT, V10, P608, DOI 10.1111/j.1461-0248.2007.01052.x; Etienne RS, 2007, OIKOS, V116, P241, DOI [10.1111/j.2007.0030-1299.15438.x, 10.1111/j.0030-1299.2007.15438.x]; Etienne RS, 2012, SCIENCE, V336, DOI [10.1126/science.1222718, 10.1126/science.1222056]; Etienne RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014717; Etienne RS, 2009, J THEOR BIOL, V257, P510, DOI 10.1016/j.jtbi.2008.12.016; Etienne RS, 2006, SCIENCE, V311, p610B, DOI 10.1126/science.1121914; Etienne RS, 2005, ECOL LETT, V8, P253, DOI 10.1111/j.1461-0248.2004.00717.x; Etienne RS, 2004, ECOL LETT, V7, P170, DOI 10.1111/j.1461-0248.2004.00572.x; Etienne RS, 2004, AM NAT, V163, P69, DOI 10.1086/380582; Hirsch BT, 2012, METHODS ECOL EVOL, V3, P595, DOI 10.1111/j.2041-210X.2011.00183.x; Hubbell Stephen P., 2001, V32, pi; Jabot F, 2008, OIKOS, V117, P1308, DOI 10.1111/j.0030-1299.2008.16724.x; Jabot F, 2009, ECOL LETT, V12, P239, DOI 10.1111/j.1461-0248.2008.01280.x; Jones FA, 2005, AM NAT, V166, P543, DOI 10.1086/491661; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Latimer AM, 2005, SCIENCE, V309, P1722, DOI 10.1126/science.1115576; Leigh EG, 2007, J EVOLUTION BIOL, V20, P2075, DOI 10.1111/j.1420-9101.2007.01410.x; Lessard JP, 2012, TRENDS ECOL EVOL, V27, P600, DOI 10.1016/j.tree.2012.07.006; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; Lortie CJ, 2004, OIKOS, V107, P433, DOI 10.1111/j.0030-1299.2004.13250.x; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; Muller-Landau HC, 2005, BIORIC INTERACTIONS; Munoz F, 2008, AM NAT, V172, P116, DOI 10.1086/587842; Munoz F, 2007, ECOLOGY, V88, P2482, DOI 10.1890/07-0049.1; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Ollivier M, 2007, ANN FOREST SCI, V64, P781, DOI 10.1051/forest:2007058; Partel M, 2011, TRENDS ECOL EVOL, V26, P124, DOI 10.1016/j.tree.2010.12.004; PEART DR, 1985, ECOLOGY, V66, P1081, DOI 10.2307/1940567; Ricklefs RE, 2008, AM NAT, V172, P741, DOI 10.1086/593002; Rosindell J, 2013, OIKOS, V122, P1101, DOI 10.1111/j.1600-0706.2012.20751.x; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Turner I.M., 2001, CAM TROP B, DOI 10.1017/CBO9780511542206; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883	46	5	5	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72497	10.1371/journal.pone.0072497	http://dx.doi.org/10.1371/journal.pone.0072497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977307	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700174
J	Xu, P; Liu, L; Wang, JZ; Zhang, K; Hong, XH; Deng, QF; Xiang, JJ; Zhang, XM; He, MA; Wu, TC; Guo, H				Xu, Ping; Liu, Li; Wang, Jianzhong; Zhang, Kai; Hong, Xiaohua; Deng, Qifei; Xiang, Jingjun; Zhang, Xiaomin; He, Meian; Wu, Tangchun; Guo, Huan			Genetic Variation in BCL2 3 '-UTR Was Associated with Lung Cancer Risk and Prognosis in Male Chinese Population	PLOS ONE			English	Article							MODULATES MULTIDRUG-RESISTANCE; TARGETING BCL2; APOPTOSIS; POLYMORPHISMS; EXPRESSION; INHIBITION; VARIANTS; PROMOTER; DELIVERY; OUTCOMES	Objectives: Bcl-2 is a critical apoptosis inhibitor with established carcinogenic potential, and can confer cancer cell resistance to therapeutic treatments by activating anti-apoptotic cellular defense. We hypothesized that genetic variants of BCL2 gene may be associated with lung cancer susceptibility and prognosis. Methods: Three selected tagSNPs of BCL2 (rs2279115, rs1801018, and rs1564483) were genotyped in 1017 paired male Chinese lung cancer cases and controls by TaqMan assay. The associations of these variants with risk of lung cancer and overall survival of 242 male advanced non-small-cell lung cancer (NSCLC) patients were separately investigated. Results: Compared with the BCL2 3'UTR rs1564483GG genotype, the rs1564483GA, AA, and GA+AA genotypes were associated with significantly decreased susceptibilities of lung cancer in male Chinese (adjusted OR = 0.78, 0.73, and 0.76, P = 0.016, 0.038, and 0.007, respectively), while rs1564483A allele has a inverse dose-response relationship with lung cancer risk (P-trend = 0.010). These effects were more evident in the elders, smokers, and subjects without family history of cancer (P-trend = 0.017, 0.043 and 0.005, respectively). Furthermore, advanced NSCLC males carrying BCL2 rs1564483 GA+AA genotypes had significantly longer median survival time (Long-rank P = 0.036) and decreased death risk (adjusted HR = 0.69, P = 0.027) than patients with rs1564483GG genotype. These effects were more obvious in patients with smoking, stage IIIA, and in patients without surgery but underwent chemotherapy or radiotherapy (adjusted HR = 0.68, 0.49, 0.67, 0.69, 0.50, respectively, all P<0.05). Conclusion: The BCL2 3'UTR rs1564483A allele was associated with a decreased lung cancer risk and better survival for advanced NSCLC in male Chinese, which may offer a novel biomarker for identifying high-risk population and predicting clinical outcomes.	[Xu, Ping; Deng, Qifei; Zhang, Xiaomin; He, Meian; Wu, Tangchun; Guo, Huan] Huazhong Univ Sci & Technol, Dept Occupat & Environm Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Xu, Ping; Deng, Qifei; Zhang, Xiaomin; He, Meian; Wu, Tangchun; Guo, Huan] Huazhong Univ Sci & Technol, Key Lab Environm & Hlth, Sch Publ Hlth, Tongji Med Coll,Minist Educ, Wuhan 430074, Peoples R China; [Xu, Ping; Wang, Jianzhong; Xiang, Jingjun] Corp Staff Worker Hosp, Wuhan Iron & Steel Grp, Dept Oncol, Wuhan, Peoples R China; [Liu, Li; Zhang, Kai; Hong, Xiaohua] Huazhong Univ Sci & Technol, Union Hosp, Ctr Canc, Dept Oncol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; China Baowu Steel Group; Huazhong University of Science & Technology	Guo, H (corresponding author), Huazhong Univ Sci & Technol, Dept Occupat & Environm Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China.	ghuan5011@hust.edu.cn			National Natural Scientific Foundation of China [81272589]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-12-0209]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This study is supported by the National Natural Scientific Foundation of China grants (no. 81272589), and Program for New Century Excellent Talents in University of Ministry of Education of China (no. NCET-12-0209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azad N, 2010, ANN NY ACAD SCI, V1203, P1, DOI 10.1111/j.1749-6632.2010.05608.x; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Enjuanes A, 2008, CANCER RES, V68, P10178, DOI 10.1158/0008-5472.CAN-08-2221; Ferron PE, 1997, TUMORI, V83, P587, DOI 10.1177/030089169708300222; Gao Q, 2012, MOL MED REP, V5, P1409, DOI 10.3892/mmr.2012.840; Garbuzenko OB, 2010, P NATL ACAD SCI USA, V107, P10737, DOI 10.1073/pnas.1004604107; Godtfredsen NS, 2005, JAMA-J AM MED ASSOC, V294, P1505, DOI 10.1001/jama.294.12.1505; Gridelli C, 2003, ONCOGENE, V22, P6629, DOI 10.1038/sj.onc.1206957; Guo HD, 2010, INT J DIGIT EARTH, V3, P1, DOI 10.1080/17538941003650702; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Herbst RS, 2004, CLIN CANCER RES, V10, p4245S, DOI 10.1158/1078-0432.CCR-040018; Hirata H, 2009, J UROLOGY, V182, P721, DOI 10.1016/j.juro.2009.03.081; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kim DH, 2009, BLOOD, V113, P2517, DOI 10.1182/blood-2008-07-169110; Kim R, 2004, CANCER-AM CANCER SOC, V101, P2491, DOI 10.1002/cncr.20696; Knoefel LF, 2011, J THORAC ONCOL, V6, P183, DOI 10.1097/JTO.0b013e3181f8a20e; Lee JH, 2004, J BIOL CHEM, V279, P42758, DOI 10.1074/jbc.M407357200; Leibowitz Brian, 2010, Cancer Biol Ther, V9, P417, DOI 10.4161/cbt.9.6.11392; Lin J, 2012, CARCINOGENESIS, V33, P1699, DOI 10.1093/carcin/bgs192; Moon JH, 2010, LEUKEMIA RES, V34, P166, DOI 10.1016/j.leukres.2009.05.009; Nuckel H, 2007, BLOOD, V109, P290, DOI 10.1182/blood-2006-03-007567; Pakunlu RI, 2004, CANCER RES, V64, P6214, DOI 10.1158/0008-5472.CAN-04-0001; Park JY, 2006, HUM MOL GENET, V15, P1963, DOI 10.1093/hmg/ddl119; Park YH, 2009, CLIN CANCER RES, V15, P2107, DOI 10.1158/1078-0432.CCR-08-1588; Patel JD, 2005, J CLIN ONCOL, V23, P3212, DOI 10.1200/JCO.2005.11.486; PIETENPOL JA, 1994, CANCER RES, V54, P3714; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Sacconi A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.160; Shivapurkar N, 2003, J CELL BIOCHEM, V88, P885, DOI 10.1002/jcb.10440; Sobin, 2009, UICC TNM CLASSIFICAT; Stabile Laura P, 2003, J Gend Specif Med, V6, P37; Ter-Minassian M, 2008, CARCINOGENESIS, V29, P2147, DOI 10.1093/carcin/bgn205; Thomas L, 2005, CHEST, V128, P370, DOI 10.1378/chest.128.1.370; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhu W, 2012, CANCER CHEMOTH PHARM, V69, P723, DOI 10.1007/s00280-011-1752-3; Zhu W, 2010, INT J CANCER, V127, P2520, DOI 10.1002/ijc.25260	36	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72197	10.1371/journal.pone.0072197	http://dx.doi.org/10.1371/journal.pone.0072197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977251	gold, Green Published, Green Submitted			2022-12-25	WOS:000323570200064
J	Wei, W; Ning, LW; Ye, YN; Guo, FB				Wei, Wen; Ning, Lu-Wen; Ye, Yuan-Nong; Guo, Feng-Biao			Geptop: A Gene Essentiality Prediction Tool for Sequenced Bacterial Genomes Based on Orthology and Phylogeny	PLOS ONE			English	Article							IN-SILICO IDENTIFICATION; FLUX BALANCE ANALYSIS; TARGETS; DATABASE; DRUG; NETWORKS; PATHWAYS; LIBRARY; RATES; CORE	Integrative genomics predictors, which score highly in predicting bacterial essential genes, would be unfeasible in most species because the data sources are limited. We developed a universal approach and tool designated Geptop, based on orthology and phylogeny, to offer gene essentiality annotations. In a series of tests, our Geptop method yielded higher area under curve (AUC) scores in the receiver operating curves than the integrative approaches. In the ten-fold cross-validations among randomly upset samples, Geptop yielded an AUC of 0.918, and in the cross-organism predictions for 19 organisms Geptop yielded AUC scores between 0.569 and 0.959. A test applied to the very recently determined essential gene dataset from the Porphyromonas gingivalis, which belongs to a phylum different with all of the above 19 bacterial genomes, gave an AUC of 0.77. Therefore, Geptop can be applied to any bacterial species whose genome has been sequenced. Compared with the essential genes uniquely identified by the lethal screening, the essential genes predicted only by Gepop are associated with more protein-protein interactions, especially in the three bacteria with lower AUC scores (<0.7). This may further illustrate the reliability and feasibility of our method in some sense. The web server and standalone version of Geptop are available at http://cefg.uestc.edu.cn/geptop/free of charge. The tool has been run on 968 bacterial genomes and the results are accessible at the website.	[Guo, Feng-Biao] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Ctr Bioinformat, Chengdu 610054, Peoples R China; Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Guo, FB (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Ctr Bioinformat, Chengdu 610054, Peoples R China.	fbguo@uestc.edu.cn	Guo, Feng-Biao/C-2761-2015; Ye, Yuan-Nong/C-2321-2015	Guo, Feng-Biao/0000-0002-1129-5233; Ye, Yuan-Nong/0000-0002-2029-4558	program for New Century Excellent Talents in University [NCET-11-0059]; National Natural Science Foundation of China [31071109, 60801058]; China Postdoctoral Science Foundation [201104687]	program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the program for New Century Excellent Talents in University (NCET-11-0059, http://www.moe.gov.cn/), National Natural Science Foundation of China (grant 31071109 and 60801058, http://www.nsfc.gov.cn/), and the special fund of the China Postdoctoral Science Foundation (Grant 201104687, http://res.chinapostdoctor.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Rocha CG, 2012, TRENDS GENET; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barh Debmalya, 2009, In Silico Biology, V9, P225, DOI 10.3233/ISB-2009-0399; Bergmiller T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002803; Chen WH, 2012, MOL BIOL EVOL, V29, P1703, DOI 10.1093/molbev/mss014; Chen X, 2013, MOL BIOL EVOL; Chen Y, 2005, BIOINFORMATICS, V21, P575, DOI 10.1093/bioinformatics/bti058; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; del Rio G, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-102; Deng JY, 2011, NUCLEIC ACIDS RES, V39, P795, DOI 10.1093/nar/gkq784; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Duffield M, 2010, MOL BIOSYST, V6, P2482, DOI 10.1039/c0mb00001a; Dutta Anirban, 2006, In Silico Biology, V6, P43; Edwards JS, 2000, BMC BIOINFORMATICS, V1, DOI 10.1186/1471-2105-1-1; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Gao F, 2007, BIOINFORMATICS, V23, P1866, DOI 10.1093/bioinformatics/btm255; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Gong XD, 2008, MOL GENET GENOMICS, V279, P87, DOI 10.1007/s00438-007-0298-x; Holman AG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-243; Hwang YC, 2009, MOL BIOSYST, V5, P1672, DOI [10.1039/b900611g, 10.1039/B900611G]; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Juhas M, 2012, TRENDS BIOTECHNOL, V30, P601, DOI 10.1016/j.tibtech.2012.08.002; Juhas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040064; Juhas M, 2011, TRENDS CELL BIOL, V21, P562, DOI 10.1016/j.tcb.2011.07.005; Kato JI, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100174; Klein BA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-578; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lin Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00053; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Perumal D, 2011, J DRUG TARGET, V19, P1, DOI 10.3109/10611861003649753; Plaimas K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-56; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rocha EPC, 2004, MOL BIOL EVOL, V21, P108, DOI 10.1093/molbev/msh004; Rocha EPC, 2003, NUCLEIC ACIDS RES, V31, P6570, DOI 10.1093/nar/gkg859; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Saha S, 2006, GENET MOL RES, V5, P224; Sakharkar Kishore R, 2004, In Silico Biol, V4, P355; Seringhaus M, 2006, GENOME RES, V16, P1126, DOI 10.1101/gr.5144106; Sharma Vibhuti, 2008, In Silico Biology, V8, P331; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shatkay H, 2008, BIOINFORMATICS, V24, P2086, DOI 10.1093/bioinformatics/btn381; Shuler Michael L, 2012, Methods Mol Biol, V881, P573, DOI 10.1007/978-1-61779-827-6_20; Singh Nitesh Kumar, 2006, In Silico Biology, V6, P485; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Wolf YI, 2009, P NATL ACAD SCI USA, V106, P7273, DOI 10.1073/pnas.0901808106; Xu Z, 2009, NUCLEIC ACIDS RES, V37, pW174, DOI 10.1093/nar/gkp278; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	56	44	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72343	10.1371/journal.pone.0072343	http://dx.doi.org/10.1371/journal.pone.0072343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977285	gold, Green Submitted, Green Published			2022-12-25	WOS:000323378000092
J	Kola, B; Wittman, G; Bodnar, I; Amin, F; Lim, CT; Olah, M; Christ-Crain, M; Lolli, F; van Thuijl, H; Leontiou, CA; Fuzesi, T; Dalino, P; Isidori, AM; Harvey-White, J; Kunos, G; Nagy, GM; Grossman, AB; Fekete, C; Korbonits, M				Kola, Blerina; Wittman, Gabor; Bodnar, Ibolya; Amin, Faisal; Lim, Chung Thong; Olah, Mark; Christ-Crain, Mirjam; Lolli, Francesca; van Thuijl, Hinke; Leontiou, Chrysanthia A.; Fuezesi, Tamas; Dalino, Paolo; Isidori, Andrea M.; Harvey-White, Judith; Kunos, George; Nagy, Gyoergy M.; Grossman, Ashley B.; Fekete, Csaba; Korbonits, Marta			The CB1 receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release	FASEB JOURNAL			English	Article						cannabinoids; rimonabant; CB1 knockout	ACTIVATED PROTEIN-KINASE; MESSENGER-RNA EXPRESSION; FOOD-INTAKE; ENDOCANNABINOID SYSTEM; CARDIOMETABOLIC RISK; CARDIAC DYSFUNCTION; OXIDATIVE STRESS; ADIPOSE-TISSUE; RIMONABANT; OBESITY	This study aimed to investigate whether the growth hormone release and metabolic effects of ghrelin on AMPK activity of peripheral tissues are mediated by cannabinoid receptor type 1 (CB1) and the central nervous system. CB1-knockout (KO) and/or wild-type mice were injected peripherally or intracerebroventricularly with ghrelin and CB1 antagonist rimonabant to study tissue AMPK activity and gene expression (transcription factors SREBP1c, transmembrane protein FAS, enzyme PEPCK, and protein HSL). Growth hormone levels were studied both in vivo and in vitro. Peripherally administered ghrelin in liver, heart, and adipose tissue AMPK activity cannot be observed in CB1-KO or CB1 antagonist-treated mice. Intracerebroventricular ghrelin treatment can influence peripheral AMPK activity. This effect is abolished in CB1-KO mice and by intracerebroventricular rimonabant treatment, suggesting that central CB1 receptors also participate in the signaling pathway that mediates the effects of ghrelin on peripheral tissues. Interestingly, in vivo or in vitro growth hormone release is intact in response to ghrelin in CB1-KO animals. Our data suggest that the metabolic effects of ghrelin on AMPK in peripheral tissues are abolished by the lack of functional CB1 receptor via direct peripheral effect and partially through the central nervous system, thus supporting the existence of a possible ghrelin-cannabinoid-CB1-AMPK pathway.	[Kola, Blerina; Amin, Faisal; Lim, Chung Thong; Christ-Crain, Mirjam; Lolli, Francesca; van Thuijl, Hinke; Leontiou, Chrysanthia A.; Dalino, Paolo; Grossman, Ashley B.; Korbonits, Marta] Queen Mary Univ London, Barts & London Med Sch, Ctr Endocrinol, London, England; [Wittman, Gabor; Fuezesi, Tamas; Fekete, Csaba] Hungarian Acad Sci, Inst Expt Med, Dept Endocrine Neurobiol, Budapest, Hungary; [Wittman, Gabor; Fekete, Csaba] Tufts Med Ctr, Div Endocrinol Diabet Metab & Mol Med, Dept Med, Boston, MA USA; [Bodnar, Ibolya; Olah, Mark; Nagy, Gyoergy M.] Semmelweis Univ, Fac Med, Dept Human Morphol & Dev Biol, H-1085 Budapest, Hungary; [Dalino, Paolo] Osped Niguarda Ca Granda, Endocrinol Unit, Milan, Italy; [Isidori, Andrea M.] Univ Roma La Sapienza, Dept Med Pathophysiol, I-00185 Rome, Italy; [Harvey-White, Judith; Kunos, George] NIAAA, Lab Physiol Studies, NIH, Bethesda, MD USA; [Grossman, Ashley B.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England	University of London; Queen Mary University London; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Tufts Medical Center; Semmelweis University; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Sapienza University Rome; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Oxford	Korbonits, M (corresponding author), Barts & London Queen Marys Sch Med & Dent, Dept Endocrinol, Charterhouse Sq, London EC1M 6BQ, England.	m.korbonits@qmul.ac.uk	Isidori, Andrea/AAL-3249-2020; Isidori, Andrea M./F-3062-2010	Isidori, Andrea/0000-0002-9037-5417; Isidori, Andrea M./0000-0002-9037-5417; Christ-Crain, Mirjam/0000-0002-6336-0965; Korbonits, Marta/0000-0002-4101-9432; Fekete, Csaba/0000-0002-8206-562X	Wellcome Trust Project Grant; Seventh EU Research Framework Program [Health-F2-2010-259772]; Lendulet Award of the Hungarian Academy of Sciences; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000350] Funding Source: NIH RePORTER	Wellcome Trust Project Grant(Wellcome Trust); Seventh EU Research Framework Program; Lendulet Award of the Hungarian Academy of Sciences; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was supported by a Wellcome Trust Project Grant, the Seventh EU Research Framework Program (Health-F2-2010-259772), and a Lendulet Award of the Hungarian Academy of Sciences.	Al-Massadi O, 2010, J NEUROENDOCRINOL, V22, P1127, DOI 10.1111/j.1365-2826.2010.02065.x; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Andrews ZB, 2011, PEPTIDES, V32, P2248, DOI 10.1016/j.peptides.2011.05.014; Arnone M, 1997, PSYCHOPHARMACOLOGY, V132, P104, DOI 10.1007/s002130050326; Baran K, 2002, DIABETES, V51, P152, DOI 10.2337/diabetes.51.1.152; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; D'Eon TM, 2008, DIABETES, V57, P1262, DOI 10.2337/db07-1186; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Dieguez C, 2011, NEUROENDOCRINOLOGY, V94, P1, DOI 10.1159/000328122; Fekete C, 2004, ENDOCRINOLOGY, V145, P4816, DOI 10.1210/en.2004-0476; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Herling AW, 2008, ENDOCRINOLOGY, V149, P2557, DOI 10.1210/en.2007-1515; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kola B, 2005, J BIOL CHEM, V280, P25196, DOI 10.1074/jbc.C500175200; Kola B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001797; Kola B, 2006, TRENDS ENDOCRIN MET, V17, P205, DOI 10.1016/j.tem.2006.05.006; Kola B, 2009, J ENDOCRINOL, V202, P191, DOI 10.1677/JOE-09-0056; Korbonits M, 2004, FRONT NEUROENDOCRIN, V25, P27, DOI 10.1016/j.yfrne.2004.03.002; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Lindqvist A, 2007, REGUL PEPTIDES, V142, P24, DOI 10.1016/j.regpep.2007.01.007; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Morris DG, 2003, J CLIN ENDOCR METAB, V88, P6080, DOI 10.1210/jc.2002-022048; Mukhopadhyay P, 2010, CARDIOVASC RES, V85, P773, DOI 10.1093/cvr/cvp369; Niyuhire F, 2007, J PHARMACOL EXP THER, V322, P1067, DOI 10.1124/jpet.107.119594; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Perez-Tilve D, 2011, FASEB J, V25, P2814, DOI 10.1096/fj.11-183632; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Poirier B, 2005, DIABETES OBES METAB, V7, P65, DOI 10.1111/j.1463-1326.2004.00374.x; Rajesh M, 2012, DIABETES, V61, P716, DOI 10.2337/db11-0477; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sangiao-Alvarellos S, 2009, ENDOCRINOLOGY, V150, P4562, DOI 10.1210/en.2009-0482; Sato T, 2012, J BIOCHEM, V151, P119, DOI 10.1093/jb/mvr134; Shearman LP, 2008, EUR J PHARMACOL, V579, P215, DOI 10.1016/j.ejphar.2007.10.033; Slavic S, 2013, J MOL MED, V91, P811, DOI 10.1007/s00109-013-1034-0; Sugamura K, 2009, CIRCULATION, V119, P28, DOI 10.1161/CIRCULATIONAHA.108.811992; Tam J, 2012, CELL METAB, V16, P167, DOI 10.1016/j.cmet.2012.07.002; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Tiyerili V, 2010, BASIC RES CARDIOL, V105, P465, DOI 10.1007/s00395-010-0090-7; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tsubone T, 2005, REGUL PEPTIDES, V130, P97, DOI 10.1016/j.regpep.2005.04.004; Weekers F, 2000, ENDOCRINOLOGY, V141, P3993, DOI 10.1210/en.141.11.3993; Wortley KE, 2004, P NATL ACAD SCI USA, V101, P8227, DOI 10.1073/pnas.0402763101; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540	56	18	20	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					5112	5121		10.1096/fj.13-232918	http://dx.doi.org/10.1096/fj.13-232918			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23982145	Green Published			2022-12-25	WOS:000329999000043
J	Kakihana, T; Araki, K; Vavassori, S; Iemura, S; Cortini, M; Fagioli, C; Natsume, T; Sitia, R; Nagata, K				Kakihana, Taichi; Araki, Kazutaka; Vavassori, Stefano; Iemura, Shun-ichiro; Cortini, Margherita; Fagioli, Claudio; Natsume, Tohru; Sitia, Roberto; Nagata, Kazuhiro			Dynamic Regulation of Ero1 alpha and Peroxiredoxin 4 Localization in the Secretory Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; ENDOPLASMIC-RETICULUM; PDI; IV; RETENTION; ERP44	In the early secretory compartment (ESC), a network of chaperones and enzymes assists oxidative folding of nascent proteins. Ero1 flavoproteins oxidize protein disulfide isomerase (PDI), generating H2O2 as a byproduct. Peroxiredoxin 4 (Prx4) can utilize luminal H2O2 to oxidize PDI, thus favoring oxidative folding while limiting oxidative stress. Interestingly, neither ER oxidase contains known ER retention signal(s), raising the question of how cells prevent their secretion. Here we show that the two proteins share similar intracellular localization mechanisms. Their secretion is prevented by sequential interactions with PDI and ERp44, two resident proteins of the ESC-bearing KDEL-like motifs. PDI binds preferentially Ero1 alpha, whereas ERp44 equally retains Ero1 alpha and Prx4. The different binding properties of Ero1 alpha and Prx4 increase the robustness of ER redox homeostasis.	[Kakihana, Taichi] Kyoto Univ, Dept Mol & Cellular Biol, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068397, Japan; [Kakihana, Taichi; Nagata, Kazuhiro] Kyoto Sangyo Univ, Lab Mol & Cellular Biol, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Cortini, Margherita; Fagioli, Claudio; Sitia, Roberto] Univ Vita Salute, San Raffaele Sci Inst, Div Genet & Cell Biol, I-20132 Milan, Italy; [Araki, Kazutaka; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, Tokyo 1350064, Japan; [Iemura, Shun-ichiro] Fukushima Med Univ, Med Ind Translat Res Ctr, Fukushima 9601295, Japan	Kyoto University; Kyoto Sangyo University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; National Institute of Advanced Industrial Science & Technology (AIST); Fukushima Medical University	Sitia, R (corresponding author), Univ Vita Salute, San Raffaele Sci Inst, Div Genet & Cell Biol, Via Olgettina 58, I-20132 Milan, Italy.	sitia.roberto@hsr.it; nagata@cc.kyoto-su.ac.jp	Araki, Kazutaka/L-6296-2018; Sitia, Roberto/AAB-5005-2019; Cortini, Margherita/J-7325-2018; Fagioli, Claudio/AAN-4147-2020; Natsume, Tohru/M-7627-2018	Araki, Kazutaka/0000-0003-2901-2454; Sitia, Roberto/0000-0001-7086-4152; Fagioli, Claudio/0000-0001-9889-4695; Natsume, Tohru/0000-0002-1510-2582; Kakihana, Taichi/0000-0001-5037-9184; Cortini, Margherita/0000-0002-8151-8105	Human Frontier Science Program (HFSP); Telethon [GGP11077]; Associazione Italiana Ricerca Cancro (AIRC); Japan Society for the Promotion of Science (JSPS) [08J03849, 12J02049, 12J04142]	Human Frontier Science Program (HFSP)(Human Frontier Science Program); Telethon(Fondazione Telethon); Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Scientific Research (S) 24227009 and a grant from the Human Frontier Science Program (HFSP) (to K. N.), by grants from Telethon (GGP11077) and the Associazione Italiana Ricerca Cancro (AIRC; IG and 5 x 1000 program) (to R. S.), and by Japan Society for the Promotion of Science (JSPS) Fellowships 08J03849 and 12J02049) (to K. A.) and 12J04142 (to T. K.).	Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Anelli T, 2007, EMBO J, V26, P4177, DOI 10.1038/sj.emboj.7601844; Anelli T, 2012, ANTIOXID REDOX SIGN, V16, P1077, DOI 10.1089/ars.2011.4004; Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; Araki K, 2013, J CELL BIOL, V202, P861, DOI 10.1083/jcb.201303027; Araki K, 2012, ANTIOXID REDOX SIGN, V16, P790, DOI 10.1089/ars.2011.4418; Araki K, 2011, J BIOL CHEM, V286, P32705, DOI 10.1074/jbc.M111.227181; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Birk J, 2013, J CELL SCI, V126, P1604, DOI 10.1242/jcs.117218; Cortini M, 2010, DIABETES OBES METAB, V12, P39, DOI 10.1111/j.1463-1326.2010.01272.x; Fagioli C, 2001, J BIOL CHEM, V276, P40962, DOI 10.1074/jbc.M107456200; Fraldi A, 2008, HUM MOL GENET, V17, P2610, DOI 10.1093/hmg/ddn161; Gilady SY, 2010, CELL STRESS CHAPERON, V15, P619, DOI 10.1007/s12192-010-0174-1; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Kakihana T, 2012, ANTIOXID REDOX SIGN, V16, P763, DOI 10.1089/ars.2011.4238; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Okado-Matsumoto A, 2000, J BIOCHEM, V127, P493, DOI 10.1093/oxfordjournals.jbchem.a022632; Otsu M, 2006, ANTIOXID REDOX SIGN, V8, P274, DOI 10.1089/ars.2006.8.274; Ronzoni R, 2010, TRAFFIC, V11, P947, DOI 10.1111/j.1600-0854.2010.01071.x; Swiatkowska M, 2010, J BIOL CHEM, V285, P29874, DOI 10.1074/jbc.M109.092486; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Vavassori S, 2013, MOL CELL, V50, P783, DOI 10.1016/j.molcel.2013.04.016; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Zito E, 2013, ANTIOXID REDOX SIGN, V18, P1666, DOI 10.1089/ars.2012.4966; Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	35	47	47	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29586	29594		10.1074/jbc.M113.467845	http://dx.doi.org/10.1074/jbc.M113.467845			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23979138	hybrid, Green Published			2022-12-25	WOS:000330615300034
J	Koskinen, C; Persson, E; Baldock, P; Stenberg, A; Bostrom, I; Matozaki, T; Oldenborg, PA; Lundberg, P				Koskinen, Cecilia; Persson, Emelie; Baldock, Paul; Stenberg, Asa; Bostrom, Ingrid; Matozaki, Takashi; Oldenborg, Per-Arne; Lundberg, Pernilla			Lack of CD47 Impairs Bone Cell Differentiation and Results in an Osteopenic Phenotype in Vivo due to Impaired Signal Regulatory Protein alpha (SIRP alpha) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOCLAST FORMATION; RECEPTOR; EXPRESSION; SHPS-1; GENE	Here, we investigated whether the cell surface glycoprotein CD47 was required for normal formation of osteoblasts and osteoclasts and to maintain normal bone formation activity in vitro and in vivo. In parathyroid hormone or 1 alpha,25(OH)(2)-vitamin D3 (D3)-stimulated bone marrow cultures (BMC) from CD47(-/-) mice, we found a strongly reduced formation of multinuclear tartrate-resistant acid phosphatase (TRAP)(+) osteoclasts, associated with reduced expression of osteoclastogenic genes (nfatc1, Oscar, Trap/Acp, ctr, catK, and dc-stamp). The production of M-CSF andRANKL(receptor activator of nuclear factor kappa beta ligand) was reduced in CD47(-/-) BMC, as compared with CD47(+/+) BMC. The stromal cell phenotype in CD47(-/-) BMC involved a blunted expression of the osteoblast-associated genes osterix, Alp/Akp1, and alpha-1-collagen, and reduced mineral deposition, as compared with that in CD47(+/+) BMC. CD47 is a ligand for SIRP alpha (signal regulatory protein alpha), which showed strongly reduced tyrosine phosphorylation in CD47(-/-) bone marrow stromal cells. In addition, stromal cells lacking the signaling SIRP alpha cytoplasmic domain also had a defect in osteogenic differentiation, and both CD47(-/-) and non-signaling SIRP alpha mutant stromal cells showed a markedly reduced ability to support osteoclastogenesis in wild-type bone marrow macrophages, demonstrating that CD47-induced SIRP alpha signaling is critical for stromal cell support of osteoclast formation. In vivo, femoral bones of 18-or 28-week-old CD47(-/-) mice showed significantly reduced osteoclast and osteoblast numbers and exhibited an osteopenic bone phenotype. In conclusion, lack of CD47 strongly impairs SIRP alpha-dependent osteoblast differentiation, deteriorate bone formation, and cause reduced formation of osteoclasts.	[Koskinen, Cecilia; Persson, Emelie; Bostrom, Ingrid; Lundberg, Pernilla] Umea Univ, Dept Odontol, Sect Mol Periodontol, SE-90187 Umea, Sweden; [Baldock, Paul] St Vincents Hosp, Garvan Inst Med Res, Neurol Dis Div, Darlinghurst, NSW 2010, Australia; [Stenberg, Asa; Oldenborg, Per-Arne] Umea Univ, Sect Histol & Cell Biol, SE-90187 Umea, Sweden; [Matozaki, Takashi] Kobe Univ, Grad Sch Med, Div Mol & Cellular Signaling, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan	Umea University; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Umea University; Kobe University	Lundberg, P (corresponding author), Umea Univ, Dept Odontol, Sect Mol Periodontol, SE-90187 Umea, Sweden.	pernilla.lundberg@odont.umu.se	Baldock, Paul/B-3840-2012		Swedish Research Council; Faculty of Medicine of Umea University; Umea University; Swedish Dental Society; County Council of Vasterbotten	Swedish Research Council(Swedish Research CouncilEuropean Commission); Faculty of Medicine of Umea University; Umea University; Swedish Dental Society; County Council of Vasterbotten	This work was supported by Swedish Research Council 2010-4286 Grant (to P.-A.O.), the Faculty of Medicine of Umea University, a Young Researcher Award from Umea University (to P.-A.O.), the Swedish Dental Society, and the County Council of Vasterbotten.	Baldock PA, 2005, J BONE MINER RES, V20, P1851, DOI 10.1359/JBMR.050523; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Conaway HH, 2009, FASEB J, V23, P3526, DOI 10.1096/fj.09-132548; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Johansen ML, 2007, J BIOL CHEM, V282, P24219, DOI 10.1074/jbc.M701565200; Kukreja A, 2009, BLOOD, V114, P3413, DOI 10.1182/blood-2009-03-211920; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Lundberg P, 2007, BIOCHEM BIOPH RES CO, V352, P444, DOI 10.1016/j.bbrc.2006.11.057; Maile LA, 2011, J BONE MINER RES, V26, P2068, DOI 10.1002/jbmr.441; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nemeth K, 2011, J IMMUNOL, V186, P13, DOI 10.4049/jimmunol.1002483; Nishimura R, 2008, J BONE MINER METAB, V26, P203, DOI 10.1007/s00774-007-0824-2; Okazawa H, 2005, J IMMUNOL, V174, P2004, DOI 10.4049/jimmunol.174.4.2004; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Uluckan O, 2009, CANCER RES, V69, P3196, DOI 10.1158/0008-5472.CAN-08-3358; van Beek EM, 2009, FASEB J, V23, P4081, DOI 10.1096/fj.09-131557; Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	24	20	21	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29333	29344		10.1074/jbc.M113.494591	http://dx.doi.org/10.1074/jbc.M113.494591			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23990469	Green Published, hybrid			2022-12-25	WOS:000330615300013
J	Tse, AKW; Chow, KY; Cao, HH; Cheng, CY; Kwan, HY; Yu, H; Zhu, GY; Wu, YC; Fong, WF; Yu, ZL				Tse, Anfernee Kai-Wing; Chow, Ka-Yu; Cao, Hui-Hui; Cheng, Chi-Yan; Kwan, Hiu-Yee; Yu, Hua; Zhu, Guo-Yuan; Wu, Yiu-Cheong; Fong, Wang-Fun; Yu, Zhi-Ling			The Herbal Compound Cryptotanshinone Restores Sensitivity in Cancer Cells That Are Resistant to the Tumor Necrosis Factor-related Apoptosis-inducing Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED APOPTOSIS; KAPPA-B; MEDIATED APOPTOSIS; KILLER/DR5 GENE; TANSHINONE IIA; UP-REGULATION; ER-STRESS; RECEPTOR; EXPRESSION; MELANOMA	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis and kills cancer cells but not normal cells. However, TRAIL resistance due to low level of TRAIL receptor expression is widely found in cancer cells and hampers its development for cancer treatment. Thus, the agents that can sensitize the tumor cells to TRAIL-mediated apoptosis are urgently needed. We investigated whether tanshinones, the major bioactive compounds of Salvia miltiorrhiza (danshen), can up-regulate TRAIL receptor expression. Among the major tanshinones being tested, cryptotanshinone (CT) showed the best ability to induce TRAIL receptor 2 (DR5) expression. We further showed that CT was capable of promoting TRAIL-induced cell death and apoptosis in A375 melanoma cells. CT-induced DR5 induction was not cell type-specific, as DR5 induction was observed in other cancer cell types. DR5 knockdown abolished the enhancing effect of CT on TRAIL responses. Mechanistically, induction of the DR5 by CT was found to be p53-independent but dependent on the induction of CCAAT/enhancer-binding protein-homologous protein (CHOP). Knockdown of CHOP abolished CT-induced DR5 expression and the associated potentiation of TRAIL-mediated cell death. In addition, CT-induced ROS production preceded up-regulation of CHOP and DR5 and consequent sensitization of cells to TRAIL. Interestingly, CT also converted TRAIL-resistant lung A549 cancer cells into TRAIL-sensitive cells. Taken together, our results indicate that CT can potentiate TRAIL-induced apoptosis through up-regulation of DR5.	[Tse, Anfernee Kai-Wing; Chow, Ka-Yu; Cao, Hui-Hui; Cheng, Chi-Yan; Kwan, Hiu-Yee; Yu, Hua; Zhu, Guo-Yuan; Wu, Yiu-Cheong; Fong, Wang-Fun; Yu, Zhi-Ling] Hong Kong Baptist Univ, Sch Chinese Med, Ctr Canc & Inflammat Res, Kowloon Tong, Hong Kong, Peoples R China	Hong Kong Baptist University	Yu, ZL (corresponding author), Sch Chinese Med, Jockey Club Sch Chinese Med Bldg,7 Baptist Univ R, Kowloon Tong, Hong Kong, Peoples R China.	zlyu@hkbu.edu.hk	Yu, Hua/B-8854-2012; Zhu, Guo-Yuan/AAG-7914-2019	Yu, Hua/0000-0003-0737-9925; Zhu, Guo-Yuan/0000-0002-4355-894X; KWAN, Hiu Yee/0000-0002-6088-7323; Tse, Kai Wing/0000-0002-0046-9808; Yu, Zhiling/0000-0002-2979-9608; CHENG, Brian Chi-yan/0000-0002-2447-6893	Hong Kong Baptist University [HKBU 38-40-076, FRG1/11-12/053, FRG2/11-12/057, FRG1/13-14/002]; University Grants Committee of Hong Kong [HKBU 262512]	Hong Kong Baptist University; University Grants Committee of Hong Kong	This work was supported by Hong Kong Baptist University Grants HKBU 38-40-076, FRG1/11-12/053, FRG2/11-12/057, and FRG1/13-14/002 and the University Grants Committee of Hong Kong Grant HKBU 262512.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Aydin C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-584; Cheng CY, 2010, MOL MED REP, V3, P645, DOI 10.3892/mmr_00000310; Chiu TL, 2010, INT J MOL MED, V25, P231, DOI 10.3892/ijmm_00000335; Dimberg LY, 2013, ONCOGENE, V32, P1341, DOI 10.1038/onc.2012.164; Eigentler TK, 2003, LANCET ONCOL, V4, P748, DOI 10.1016/S1470-2045(03)01280-4; Griffith TS, 1998, J IMMUNOL, V161, P2833; Julia F, 2012, DERMATOL THER, V25, P452, DOI 10.1111/j.1529-8019.2012.01487.x; KASTRINAKIS WV, 1995, ONCOGENE, V11, P647; Kim JH, 2011, APOPTOSIS, V16, P696, DOI 10.1007/s10495-011-0605-1; Kim YH, 2008, FREE RADICAL BIO MED, V44, P1055, DOI 10.1016/j.freeradbiomed.2007.12.001; Lee WYW, 2009, CANCER LETT, V285, P46, DOI 10.1016/j.canlet.2009.04.040; Liu AH, 2006, J PHARM PHARM SCI, V9, P1; Mellier G, 2012, FREE RADICAL RES, V46, P996, DOI 10.3109/10715762.2012.690514; Meng RD, 2001, EXP CELL RES, V262, P154, DOI 10.1006/excr.2000.5073; Moon DO, 2011, BIOCHEM PHARMACOL, V82, P1641, DOI 10.1016/j.bcp.2011.08.019; Nguyen T, 2001, CLIN CANCER RES, V7, p966S; OConnor PM, 1997, CANCER RES, V57, P4285; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Park IJ, 2012, APOPTOSIS, V17, P248, DOI 10.1007/s10495-011-0680-3; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Russo M, 2010, BIOCHEM PHARMACOL, V80, P674, DOI 10.1016/j.bcp.2010.03.011; Seol JY, 2003, CANCER GENE THER, V10, P540, DOI 10.1038/sj.cgt.7700597; Sheikh MS, 1998, CANCER RES, V58, P1593; Siegelin MD, 2012, EXPERT OPIN THER TAR, V16, P801, DOI 10.1517/14728222.2012.703655; Su CC, 2012, EXP THER MED, V3, P555, DOI 10.3892/etm.2011.441; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; The State Pharmacopoeia Commission of China, 2005, CHIN PHARM, P528; Tse AKW, 2005, BIOCHEM PHARMACOL, V70, P1443, DOI 10.1016/j.bcp.2005.08.011; Tse AKW, 2010, MOL IMMUNOL, V47, P1728, DOI 10.1016/j.molimm.2010.03.004; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; YAGINUMA Y, 1992, CANCER RES, V52, P4196; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang Y, 2011, ONCOGENE, V30, P2207, DOI 10.1038/onc.2010.600; Ye YT, 2012, MOL CELL BIOCHEM, V363, P191, DOI 10.1007/s11010-011-1171-0; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200; Zhang Y, 2012, INT J MOL SCI, V13, P13621, DOI 10.3390/ijms131013621; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	38	37	41	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29923	29933		10.1074/jbc.M113.483909	http://dx.doi.org/10.1074/jbc.M113.483909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23986445	Green Published, hybrid			2022-12-25	WOS:000330615300065
J	Masuda, I; Sakaguchi, R; Liu, CP; Gamper, H; Hou, YM				Masuda, Isao; Sakaguchi, Reiko; Liu, Cuiping; Gamper, Howard; Hou, Ya-Ming			The Temperature Sensitivity of a Mutation in the Essential tRNA Modification Enzyme tRNA Methyltransferase D (TrmD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Protein Folding; RNA Methyltransferase; RNA Modification; Transfer RNA (tRNA); TrmD; m1G37-tRNA Modification; Methyl Transfer; Trefoil Knot Fold	TRANSFER RNA(M1G)METHYLTRANSFERASE; STRUCTURAL ALTERATIONS; GENE TRMD; TRANSLATION; DETERMINANTS; RECOGNITION; INSIGHTS	Conditional temperature-sensitive (ts) mutations are important reagents to study essential genes. Although it is commonly assumed that the ts phenotype of a specific mutation arises from thermal denaturation of the mutant enzyme, the possibility also exists that the mutation decreases the enzyme activity to a certain level at the permissive temperature and aggravates the negative effect further upon temperature upshifts. Resolving these possibilities is important for exploiting the ts mutation for studying the essential gene. The trmD gene is essential for growth in bacteria, encoding the enzyme for converting G37 to m(1)G37 on the 3 side of the tRNA anticodon. This conversion involves methyl transfer from S-adenosyl methionine and is critical to minimize tRNA frameshift errors on the ribosome. Using the ts-S88L mutation of Escherichia coli trmD as an example, we show that although the mutation confers thermal lability to the enzyme, the effect is relatively minor. In contrast, the mutation decreases the catalytic efficiency of the enzyme to 1% at the permissive temperature, and at the nonpermissive temperature, it renders further deterioration of activity to 0.1%. These changes are accompanied by losses of both the quantity and quality of tRNA methylation, leading to the potential of cellular pleiotropic effects. This work illustrates the principle that the ts phenotype of an essential gene mutation can be closely linked to the catalytic defect of the gene product and that such a mutation can provide a useful tool to study the mechanism of catalytic inactivation.	[Masuda, Isao; Sakaguchi, Reiko; Liu, Cuiping; Gamper, Howard; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Hou, YM (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St,BLSB 220, Philadelphia, PA 19107 USA.	ya-ming.hou@jefferson.edu	Masuda, Isao/X-8797-2019	Masuda, Isao/0000-0001-9385-4424; Hou, Ya-Ming/0000-0001-6546-2597	National Institutes of Health [GM081601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM108972, R01GM108972, R01GM081601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM081601 (to Y.M.H.).	Ahn HJ, 2003, EMBO J, V22, P2593, DOI 10.1093/emboj/cdg269; Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Bjork GR, 2003, J BACTERIOL, V185, P750, DOI 10.1128/JB.185.3.750-759.2003; BJORK GR, 1989, SCIENCE, V244, P986, DOI 10.1126/science.2471265; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; BYSTROM AS, 1982, MOL GEN GENET, V188, P447, DOI 10.1007/BF00330047; BYSTROM AS, 1982, MOL GEN GENET, V188, P440, DOI 10.1007/BF00330046; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Chen R, 2008, MOL BIOTECHNOL, V40, P224, DOI 10.1007/s12033-008-9078-z; Christian T, 2004, J MOL BIOL, V339, P707, DOI 10.1016/j.jmb.2004.04.025; Christian T, 2007, J MOL BIOL, V373, P623, DOI 10.1016/j.jmb.2007.08.010; Christian T, 2010, J MOL BIOL, V400, P204, DOI 10.1016/j.jmb.2010.05.003; CLARK DJ, 1988, EMBO J, V7, P69, DOI 10.1002/j.1460-2075.1988.tb02784.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Bie LGS, 2003, J BACTERIOL, V185, P3238, DOI 10.1128/JB.185.10.3238-3243.2003; Elkins PA, 2003, J MOL BIOL, V333, P931, DOI 10.1016/j.jmb.2003.09.011; Guisbert E, 2004, GENE DEV, V18, P2812, DOI 10.1101/gad.1219204; HAGERVALL TG, 1993, J MOL BIOL, V232, P756, DOI 10.1006/jmbi.1993.1429; Hou YM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj018; King NP, 2010, P NATL ACAD SCI USA, V107, P20732, DOI 10.1073/pnas.1007602107; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Li JN, 1999, RNA, V5, P395, DOI 10.1017/S1355838299980834; Nasvall SJ, 2009, J MOL BIOL, V385, P350, DOI 10.1016/j.jmb.2008.10.069; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; O'Dwyer K, 2004, J BACTERIOL, V186, P2346, DOI 10.1128/JB.186.8.2346-2354.2004; Patil A, 2012, CELL CYCLE, V11, P3656, DOI 10.4161/cc.21919; Qian Q, 1997, J MOL BIOL, V273, P978, DOI 10.1006/jmbi.1997.1363; Redlak M, 1997, BIOCHEMISTRY-US, V36, P8699, DOI 10.1021/bi9701538; Sakaguchi R, 2012, RNA, V18, P1687, DOI 10.1261/rna.032029.111; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; WIKSTROM PM, 1988, J BACTERIOL, V170, P3025, DOI 10.1128/jb.170.7.3025-3031.1988; Yi CQ, 2011, ACCOUNTS CHEM RES, V44, P1380, DOI 10.1021/ar200057m; Yokogawa T, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1182	38	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28987	28996		10.1074/jbc.M113.485797	http://dx.doi.org/10.1074/jbc.M113.485797			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23986443	Green Published, hybrid			2022-12-25	WOS:000330298800053
J	Araujo, A; Baum, B; Bentley, P				Araujo, Arturo; Baum, Buzz; Bentley, Peter			The Role of Chromosome Missegregation in Cancer Development: A Theoretical Approach Using Agent-Based Modelling	PLOS ONE			English	Article							NUCLEAR ARCHITECTURE; CONTACT INHIBITION; INSTABILITY; ANEUPLOIDY; PATHWAY; EVOLUTION; HALLMARKS	Many cancers are aneuploid. However, the precise role that chromosomal instability plays in the development of cancer and in the response of tumours to treatment is still hotly debated. Here, to explore this question from a theoretical standpoint we have developed an agent-based model of tissue homeostasis in which to test the likely effects of whole chromosome mis-segregation during cancer development. In stochastic simulations, chromosome mis-segregation events at cell division lead to the generation of a diverse population of aneuploid clones that over time exhibit hyperplastic growth. Significantly, the course of cancer evolution depends on genetic linkage, as the structure of chromosomes lost or gained through mis-segregation events and the level of genetic instability function in tandem to determine the trajectory of cancer evolution. As a result, simulated cancers differ in their level of genetic stability and in their growth rates. We used this system to investigate the consequences of these differences in tumour heterogeneity for anti-cancer therapies based on surgery and anti-mitotic drugs that selectively target proliferating cells. As expected, simulated treatments induce a transient delay in tumour growth, and reveal a significant difference in the efficacy of different therapy regimes in treating genetically stable and unstable tumours. These data support clinical observations in which a poor prognosis is correlated with a high level of chromosome mis-segregation. However, stochastic simulations run in parallel also exhibit a wide range of behaviours, and the response of individual simulations (equivalent to single tumours) to anti-cancer therapy prove extremely variable. The model therefore highlights the difficulties of predicting the outcome of a given anti-cancer treatment, even in cases in which it is possible to determine the genotype of the entire set of cells within the developing tumour.	[Araujo, Arturo] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London, England; [Baum, Buzz] UCL, MRC Lab Mol Cell Biol, London, England; [Bentley, Peter] UCL, Dept Comp Sci, London, England	University of London; University College London; MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London	Baum, B (corresponding author), UCL, MRC Lab Mol Cell Biol, London, England.	b.baum@ucl.ac.uk		Baum, Buzz/0000-0002-9201-6186; Bentley, Peter/0000-0001-6744-9302	CONACYT; UCL CoMPLEX; Cancer Research UK; Cancer Research UK [9786] Funding Source: researchfish; Medical Research Council [MC_CF12266] Funding Source: researchfish	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UCL CoMPLEX; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	AA was funded by CONACYT and UCL CoMPLEX. BB was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RG, 2006, ARTIF LIFE, V12, P617, DOI 10.1162/artl.2006.12.4.617; Basanta D, 2011, MATH BIOSCI, V229, P22, DOI 10.1016/j.mbs.2010.10.005; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goodsell D S, 1999, Oncologist, V4, P263; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; HUSTON M, 1988, BIOSCIENCE, V38, P682, DOI 10.2307/1310870; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Lecerf C, 2003, P RES INN VIS FUT RI, V2003, P93; Luu HH, 1999, AM J SURG, V178, P362, DOI 10.1016/S0002-9610(99)00198-1; Macal CM, 2007, PROCEEDINGS OF THE 2007 WINTER SIMULATION CONFERENCE, VOLS 1-5, P83; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Ottino JM, 2003, AICHE J, V49, P292, DOI 10.1002/aic.690490202; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Ricke RM, 2011, J CELL BIOL, V193, P1049, DOI 10.1083/jcb.201012035; Rubin H, 2011, BIOESSAYS, V33, P224, DOI 10.1002/bies.201000067; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Sotillo R, 2010, NATURE, V464, P436, DOI 10.1038/nature08803; Spencer SL, 2006, PLOS COMPUT BIOL, V2, P939, DOI 10.1371/journal.pcbi.0020108; Swanton C, 2009, BRIT J CANCER, V100, P1517, DOI 10.1038/sj.bjc.6605031; Swanton C, 2006, CELL CYCLE, V5, P818, DOI 10.4161/cc.5.8.2682; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Zangeneh L, PARALLEL PROBLEM SOL, VXI, P434; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011	36	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72206	10.1371/journal.pone.0072206	http://dx.doi.org/10.1371/journal.pone.0072206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991060	Green Published, gold, Green Submitted			2022-12-25	WOS:000324228800050
J	Yu, LS; Zhao, Y; Quan, C; Ji, W; Zhu, J; Huang, Y; Guan, RW; Sun, DL; Jin, Y; Meng, XN; Zhang, CY; Yu, Y; Bai, J; Sun, WJ; Fu, SB				Yu, Lisa; Zhao, Yan; Quan, Chao; Ji, Wei; Zhu, Jing; Huang, Yun; Guan, Rongwei; Sun, Donglin; Jin, Yan; Meng, Xiangning; Zhang, Chunyu; Yu, Yang; Bai, Jing; Sun, Wenjing; Fu, Songbin			Gemcitabine Eliminates Double Minute Chromosomes from Human Ovarian Cancer Cells	PLOS ONE			English	Article							HOMOGENEOUSLY STAINING REGIONS; EXTRACHROMOSOMAL DOUBLE MINUTES; TUMOR-CELLS; SELECTIVE ELIMINATION; GENE AMPLIFICATION; AMPLIFIED MYCN; DNA; HYDROXYUREA; RESISTANCE; CHROMATIN	Double minute chromosomes are cytogenetic manifestations of gene amplification frequently seen in cancer cells. Genes amplified on double minute chromosomes include oncogenes and multi-drug resistant genes. These genes encode proteins which contribute to cancer formation, cancer progression, and development of resistance to drugs used in cancer treatment. Elimination of double minute chromosomes, and therefore genes amplified on them, is an effective way to decrease the malignancy of cancer cells. We investigated the effectiveness of a cancer drug, gemcitabine, on the loss of double minute chromosomes from the ovarian cancer cell line UACC-1598. Gemcitabine is able to decrease the number of double minute chromosomes in cells at a 7500X lower concentration than the commonly used cancer drug hydroxyurea. Amplified genes present on the double minute chromosomes are decreased at the DNA level upon gemcitabine treatment. Gemcitabine, even at a low nanomolar concentration, is able to cause DNA damage. The selective incorporation of double minutes chromatin and gamma-H2AX signals into micronuclei provides a strong link between DNA damage and the loss of double minute chromosomes from gemcitabine treated cells. Cells treated with gemcitabine also showed decreased cell growth, colony formation, and invasion. Together, our results suggest that gemcitabine is effective in decreasing double minute chromosomes and this affects the biology of ovarian cancer cells.	[Yu, Lisa; Zhao, Yan; Quan, Chao; Ji, Wei; Zhu, Jing; Huang, Yun; Guan, Rongwei; Sun, Donglin; Jin, Yan; Meng, Xiangning; Zhang, Chunyu; Yu, Yang; Bai, Jing; Sun, Wenjing; Fu, Songbin] Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China; [Jin, Yan; Fu, Songbin] Harbin Med Univ, Heilongjiang Higher Educ Inst, Key Lab Med Genet, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Sun, WJ (corresponding author), Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China.	sunwj@ems.hrbmu.edu.cn; fusb@ems.hrbmu.edu.cn	Zhang, Chun-yu/HDP-5776-2022		International Science & Technology Cooperation Program of China [2013DFA31610]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1230]; National Natural Science Foundation of China [31000626, 31271347, 81201761]; New Century Support Program for the Excellent Scholar, Ministry of Education of China [NCET-10-0149, NCET-11-0954]	International Science & Technology Cooperation Program of China; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Support Program for the Excellent Scholar, Ministry of Education of China(Ministry of Education, China)	This work was supported by the International Science & Technology Cooperation Program of China (2013DFA31610 to S. F.), the Program for Changjiang Scholars and Innovative Research Team in University (IRT1230 to Y.J.), the National Natural Science Foundation of China (31000626 and 31271347 to W. S., 81201761 to L.Y.), and the New Century Support Program for the Excellent Scholar, Ministry of Education of China (NCET-10-0149 to W. S., NCET-11-0954 to Y.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuShahin F, 2007, WOMENS HEALTH, V3, P279, DOI 10.2217/17455057.3.3.279; Akita H, 2009, ONCOGENE, V28, P2903, DOI 10.1038/onc.2009.158; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Ambros IM, 1997, EUR J CANCER, V33, P2043, DOI 10.1016/S0959-8049(97)00204-9; ATKIN NB, 1983, ACTA CYTOL, V27, P450; BAHR G, 1983, J NATL CANCER I, V71, P657; BARKER PE, 1982, CANCER GENET CYTOGEN, V5, P81, DOI 10.1016/0165-4608(82)90043-7; Bepler G, 2006, J CLIN ONCOL, V24, P4731, DOI 10.1200/JCO.2006.06.1101; Bergman AM, 2005, CANCER RES, V65, P9510, DOI 10.1158/0008-5472.CAN-05-0989; Bonatti S, 1989, Prog Clin Biol Res, V318, P271; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Canute GW, 1998, NEUROSURGERY, V42, P609, DOI 10.1097/00006123-199803000-00031; CARMICHAEL J, 1995, J CLIN ONCOL, V13, P2731, DOI 10.1200/JCO.1995.13.11.2731; COWELL JK, 1982, ANNU REV GENET, V16, P21, DOI 10.1146/annurev.ge.16.120182.000321; Crino L, 1999, J CLIN ONCOL, V17, P3522, DOI 10.1200/JCO.1999.17.11.3522; DONEHOWER RC, 1992, SEMIN ONCOL, V19, P11; ECKHARDT SG, 1994, P NATL ACAD SCI USA, V91, P6674, DOI 10.1073/pnas.91.14.6674; Freeman-Edward J, 2000, CANCER GENET CYTOGEN, V116, P87; Guan XY, 2004, CANCER RES, V64, P4197, DOI 10.1158/0008-5472.CAN-03-3747; Guan XY, 2001, CANCER RES, V61, P3806; HAAF T, 1988, CANCER GENET CYTOGEN, V30, P73, DOI 10.1016/0165-4608(88)90094-5; HAMKALO BA, 1985, P NATL ACAD SCI USA, V82, P1126, DOI 10.1073/pnas.82.4.1126; KRAKOFF IH, 1968, CANCER RES, V28, P1559; Lorusso D, 2006, ANN ONCOL, V17, pV188, DOI 10.1093/annonc/mdj979; LUND B, 1993, CANCER TREAT REV, V19, P45, DOI 10.1016/0305-7372(93)90026-N; Massey AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013123; Matsuo K, 2010, EXPERT OPIN INV DRUG, V19, P1339, DOI 10.1517/13543784.2010.515585; MCGILL JR, 1993, CANCER GENET CYTOGEN, V71, P125, DOI 10.1016/0165-4608(93)90017-G; Nakahira S, 2007, INT J CANCER, V120, P1355, DOI 10.1002/ijc.22390; Narath R, 2007, GENE CHROMOSOME CANC, V46, P130, DOI 10.1002/gcc.20393; Niida H, 2010, CANCER SCI, V101, P2505, DOI 10.1111/j.1349-7006.2010.01719.x; OLINICI CD, 1971, BRIT J CANCER, V25, P350, DOI 10.1038/bjc.1971.45; Rao XT, 2008, MUTAT RES-FUND MOL M, V646, P41, DOI 10.1016/j.mrfmmm.2008.09.004; RATTNER JB, 1984, CYTOGENET CELL GENET, V38, P176, DOI 10.1159/000132056; Raymond E, 2001, CLIN CANCER RES, V7, P1171; Reynolds C, 2009, J CLIN ONCOL, V27, P5808, DOI 10.1200/JCO.2009.21.9766; Schoenlein PV, 2003, INT J RADIAT ONCOL, V55, P1051, DOI 10.1016/S0360-3016(02)04473-5; SHIMIZU N, 1994, CANCER RES, V54, P3561; Shimizu N, 1998, J CELL BIOL, V140, P1307, DOI 10.1083/jcb.140.6.1307; Shimizu N, 2000, MUTAT RES-FUND MOL M, V448, P81, DOI 10.1016/S0027-5107(00)00003-8; Shimizu N, 2009, CYTOGENET GENOME RES, V124, P312, DOI 10.1159/000218135; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Shimizu N, 2011, MUTAGENESIS, V26, P119, DOI 10.1093/mutage/geq053; SNAPKA RM, 1983, P NATL ACAD SCI-BIOL, V80, P7533, DOI 10.1073/pnas.80.24.7533; Suprasert P, 2012, ASIAN PAC J CANCER P, V13, P517, DOI 10.7314/APJCP.2012.13.2.517; TANAKA K, 1989, CANCER GENET CYTOGEN, V43, P1, DOI 10.1016/0165-4608(89)90122-2; Tanaka T, 2000, J CELL SCI, V113, P697; Toschi L, 2005, Future Oncol, V1, P7, DOI 10.1517/14796694.1.1.7; VANDEVANTER DR, 1990, J NATL CANCER I, V82, P1815, DOI 10.1093/jnci/82.23.1815; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; VONHOFF DD, 1991, CANCER RES, V51, P6273; VONHOFF DD, 1992, P NATL ACAD SCI USA, V89, P8165, DOI 10.1073/pnas.89.17.8165; WOODS LK, 1979, CANCER RES, V39, P4449; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018618; YARBRO JW, 1965, P NATL ACAD SCI USA, V53, P1033, DOI 10.1073/pnas.53.5.1033; YOUNG CW, 1964, SCIENCE, V146, P1172, DOI 10.1126/science.146.3648.1172	57	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e71988	10.1371/journal.pone.0071988	http://dx.doi.org/10.1371/journal.pone.0071988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991020	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470700023
J	Bamias, G; Dahman, MI; Arseneau, KO; Guanzon, M; Gruska, D; Pizarro, TT; Cominelli, F				Bamias, Giorgos; Dahman, Mohamed I.; Arseneau, Kristen O.; Guanzon, Mitchell; Gruska, Dennis; Pizarro, Theresa T.; Cominelli, Fabio			Intestinal-Specific TNF alpha Overexpression Induces Crohn's-Like Ileitis in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; CYTOKINE MESSENGER-RNA; EPITHELIAL-CELLS; MAINTENANCE THERAPY; ULCERATIVE-COLITIS; INNATE IMMUNITY; MURINE MODEL; APOPTOSIS; RECEPTOR	Background and Aim: Human and animal studies have clearly established tumor necrosis factor (TNF)alpha as an important mediator of Crohn's disease pathogenesis. However, whether systemic or only local TNF alpha overproduction is required for the development of chronic intestinal inflammation and Crohn's disease remains unclear. The aim of this study was to assess the contribution of intestinal epithelial-derived TNF alpha to the development of murine Crohn's-like ileitis. Methods: We adapted the well-established TNF Delta ARE/+ mouse model of Crohn's disease (which systemically overexpresses TNF alpha) to generate a homozygous mutant strain that overexpress TNF alpha only within the intestinal epithelium. Intestinal-specific TNFi Delta ARE/i Delta ARE mice were examined for histopathological signs of gut inflammation and extraintestinal manifestations of Crohn's disease. The mucosal immune phenotype was characterized, and the contribution of specific lymphocyte populations to the pathogenesis of TNFi Delta ARE/i Delta ARE ileitis was assessed. Results: TNFi Delta ARE/i Delta ARE mice had increased mucosal and systemic TNF alpha levels compared to wild-type controls (P<0.001), as well as severe chronic ileitis with increased neutrophil infiltration and villous distortion, but no extraintestinal manifestations (P<0.001 vs. wild- type controls). The gut mucosal lymphocytic compartment was also expanded in TNFi Delta ARE/i Delta ARE mice (P<0.05), consisting of activated CD69(+) and CD4(+)CD62L(-) lymphocytes (P<0.05). FasL expression was significantly elevated in the mesenteric lymph nodes of TNFi Delta ARE/i Delta ARE mice (P<0.05). Adoptive transfer of mucosal TNFi Delta ARE/i Delta ARE lymphocytes resulted in ileitis in immunologically naive severe combined immunodeficiency recipients (P<0.05 vs. wild-type controls), indicating an effector phenotype that was associated with increased production of both Th1 (IFN gamma) and Th2 (IL-5, IL-13) cytokines. Conclusion: Intestinal epithelial-derived TNF alpha is sufficient for the induction of Crohn's-like ileitis, but not for the occurrence of extraintestinal manifestations, in TNFi Delta ARE/i Delta ARE mice. These effects were associated with generation of effector lymphocytes within the intestinal mucosa and dysregulated apoptosis. Thus, targeted intestinal blockade of TNF alpha may provide an effective means to neutralize gut-derived TNF alpha with reduced side effects.	[Bamias, Giorgos] Ethnikon & Kapodistriakon Univ Athens, Laikon Hosp, Dept Gastroenterol 1, Athens, Greece; [Dahman, Mohamed I.] Mercy Hlth Syst, Dept Surg, Fairfield, OH USA; [Arseneau, Kristen O.; Guanzon, Mitchell; Gruska, Dennis; Pizarro, Theresa T.; Cominelli, Fabio] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Arseneau, Kristen O.; Guanzon, Mitchell; Gruska, Dennis; Pizarro, Theresa T.; Cominelli, Fabio] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Arseneau, Kristen O.; Guanzon, Mitchell; Gruska, Dennis; Pizarro, Theresa T.; Cominelli, Fabio] Case Western Reserve Univ, Digest Hlth Res Ctr, Cleveland, OH 44106 USA	Laiko General Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Cominelli, F (corresponding author), Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA.	fabio.cominelli@uhhospitals.org			NIH [DK042191, DK091222, DK055812]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK042191, R01DK042191, R29DK042191, R37DK042191, R01DK055812, P01DK091222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK042191 (F.C., T.T.P.), DK091222 (F.C.) and DK055812 (F.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamias G, 2005, ANN INTERN MED, V143, P895, DOI 10.7326/0003-4819-143-12-200512200-00007; Bamias G, 2005, GASTROENTEROLOGY, V128, P654, DOI 10.1053/j.gastro.2004.11.053; Chen CY, 1995, TRENDS BIOCHEM SCI, V11, P465, DOI DOI 10.1016/S0968-0004(00)89102-1.PUBMED:8578590; Colombel JF, 2009, GUT, V58, P940, DOI 10.1136/gut.2008.159251; Dotan I, 2007, AM J PHYSIOL-GASTR L, V292, pG1630, DOI 10.1152/ajpgi.00294.2006; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kosiewicz MM, 2001, J CLIN INVEST, V107, P695, DOI 10.1172/JCI10956; KRUYS V, 1989, SCIENCE, V245, P852, DOI 10.1126/science.2672333; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Marini M, 2003, P NATL ACAD SCI USA, V100, P8366, DOI 10.1073/pnas.1432897100; Matsuda R, 2009, INFLAMM BOWEL DIS, V15, P328, DOI 10.1002/ibd.20759; Mizoguchi E, 2008, GASTROENTEROLOGY, V134, P470, DOI 10.1053/j.gastro.2007.11.055; Naito Y, 2003, J GASTROEN HEPATOL, V18, P560, DOI 10.1046/j.1440-1746.2003.03034.x; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Neurath MF, 1997, EUR J IMMUNOL, V27, P1743, DOI 10.1002/eji.1830270722; Olson TS, 2006, J EXP MED, V203, P541, DOI 10.1084/jem.20050407; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Raddatz D, 2005, EUR J GASTROEN HEPAT, V17, P547, DOI 10.1097/00042737-200505000-00012; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; Rivera-Nieves J, 2003, GASTROENTEROLOGY, V124, P972, DOI 10.1053/gast.2003.50148; Roulis M, 2011, P NATL ACAD SCI USA, V108, P5396, DOI 10.1073/pnas.1007811108; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; Sandborn WJ, 2007, GUT, V56, P1232, DOI 10.1136/gut.2006.106781; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Spencer DM, 2002, GASTROENTEROLOGY, V122, P94, DOI 10.1053/gast.2002.30308; TAN XD, 1993, AM J PATHOL, V142, P1858; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632	33	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72594	10.1371/journal.pone.0072594	http://dx.doi.org/10.1371/journal.pone.0072594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977323	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300090
J	Xie, YQ; Li, MH; Wang, XG; Zhang, X; Peng, TQ; Yang, YZ; Zou, YZ; Ge, JB; Chen, HZ; Chen, RZ				Xie, Yuquan; Li, Minghui; Wang, Xinggang; Zhang, Xian; Peng, Tianqing; Yang, Yingzhen; Zou, Yunzeng; Ge, Junbo; Chen, Haozhu; Chen, Ruizhen			In Vivo Delivery of Adenoviral Vector Containing Interleukin-17 Receptor A Reduces Cardiac Remodeling and Improves Myocardial Function in Viral Myocarditis Leading to Dilated Cardiomyopathy	PLOS ONE			English	Article							COXSACKIEVIRUS B3-INDUCED MYOCARDITIS; AUTOIMMUNE MYOCARDITIS; EXTRACELLULAR-MATRIX; HEART-FAILURE; EXPRESSION; CELLS; MICE; PROLIFERATION; INFLAMMATION; MOUSE	Th17 cells have been implicated in the pathogenesis of myocarditis. Interleukin (IL)-17A produced by Th17 cells is dispensable for viral myocarditis but essential for the progression to dilated cardiomyopathy (DCM). This study investigated whether the adenoviral transfer of the IL-17 receptor A reduces myocardial remodeling and dysfunction in viral myocarditis leading to DCM. In a mouse model of Coxsackievirus B3 (CVB3)-induced chronic myocarditis, the delivery of the adenovirus-containing IL-17 receptor A (Ad-IL17RA:Fc) reduced IL-17A production and decreased the number of Th17 cells in the spleen and heart, leading to the down-regulation of systemic TNF-alpha and IL-6 production. Cardiac function improved significantly in the Ad-IL17R:Fc- compared with the Ad-null-treated mice 3 months after the first CVB3 infection. Ad-IL17R: Fc reduced the left ventricle dilation and decreased the mortality in viral myocarditis, leading to DCM (56% in the Ad-IL17R: Fc versus 76% in the Ad-null group). The protective effects of Ad-IL17R-Fc on remodeling correlated with the attenuation of myocardial collagen deposition and the reduction of fibroblasts in CVB3-infected hearts, which was accompanied by the down-regulation of A distintegrin and metalloprotease with thrombospondin type 1 motifs (ADAMTS-1), Matrix metalloproteinase-2(MMP-2), and collagen subtypes I and III in the heart. Moreover, in cultured cardiac fibroblasts, IL-17A induced the expression of ADAMTS-1, MMP-2, and collagen subtypes I and III and increased the proliferation of fibroblasts. We determined that the delivery of IL-17-RA:Fc reduces cardiac remodeling, improves function, and decreases mortality in viral myocarditis leading to DCM, possibly by suppressing fibrosis. Therefore, the adenoviral transfer of the IL-17 receptor A may represent an alternative therapy for chronic viral myocarditis and its progression to DCM.	[Xie, Yuquan; Li, Minghui; Wang, Xinggang; Zhang, Xian; Yang, Yingzhen; Zou, Yunzeng; Ge, Junbo; Chen, Haozhu; Chen, Ruizhen] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Minist Publ Hlth,Key Lab Viral Heart Dis, Shanghai 200433, Peoples R China; [Xie, Yuquan] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Peng, Tianqing] Univ Western Ontario, Lawson Hlth Res Inst, London, ON, Canada	Fudan University; Shanghai Jiao Tong University; Western University (University of Western Ontario)	Chen, RZ (corresponding author), Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Minist Publ Hlth,Key Lab Viral Heart Dis, Shanghai 200433, Peoples R China.	chenruizhenzs@gmail.com	Peng, Tianqing/G-3340-2011		National Natural Science Foundation of China [31070786]; PhD Program Scholarship Fund of Fudan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PhD Program Scholarship Fund of Fudan University	This work was supported by grants from National Natural Science Foundation of China (No. 31070786) and PhD Program Scholarship Fund of Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P854; Baldeviano GC, 2010, CIRC RES, V106, P1646, DOI 10.1161/CIRCRESAHA.109.213157; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Chen P, 2011, EUR J PHARMACOL, V658, P168, DOI 10.1016/j.ejphar.2011.02.040; Cihakova D, 2008, ADV IMMUNOL, V99, P95, DOI 10.1016/S0065-2776(08)00604-4; Ellis Christopher R, 2007, Cardiol Rev, V15, P170, DOI 10.1097/CRD.0b013e31806450c4; Eriksson U, 2003, CIRCULATION, V107, P320, DOI 10.1161/01.CIR.0000043802.38699.66; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Feng WW, 2009, EXP MOL PATHOL, V87, P212, DOI 10.1016/j.yexmp.2009.06.001; Fouser LA, 2008, IMMUNOL REV, V226, P87, DOI 10.1111/j.1600-065X.2008.00712.x; Glenn DJ, 2009, CARDIOVASC RES, V84, P209, DOI 10.1093/cvr/cvp208; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; HENKE A, 1995, J VIROL, V69, P6720, DOI 10.1128/JVI.69.11.6720-6728.1995; Huber SA, 2002, J VIROL, V76, P10785, DOI 10.1128/JVI.76.21.10785-10790.2002; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Kuno K, 2000, FEBS LETT, V478, P241, DOI 10.1016/S0014-5793(00)01854-8; Li YY, 2002, AM J PHYSIOL-HEART C, V282, pH983, DOI 10.1152/ajpheart.00233.2001; Luque A, 2003, J BIOL CHEM, V278, P23656, DOI 10.1074/jbc.M212964200; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Sonderegger I, 2006, EUR J IMMUNOL, V36, P2849, DOI 10.1002/eji.200636484; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Valaperti A, 2008, J IMMUNOL, V180, P2686, DOI 10.4049/jimmunol.180.4.2686; Xie Y, 2011, VIROLOGY; Yan S, 2012, IMMUNOL CELL BIOL, V90, P421, DOI 10.1038/icb.2011.59; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91; Zhang ZC, 2004, CHINESE MED J-PEKING, V117, P1228	27	19	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72158	10.1371/journal.pone.0072158	http://dx.doi.org/10.1371/journal.pone.0072158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977238	Green Submitted, gold, Green Published			2022-12-25	WOS:000324527300068
J	Boulland, JL; Lambert, FM; Zuchner, M; Strom, S; Glover, JC				Boulland, Jean-Luc; Lambert, Francois M.; Zuchner, Mark; Strom, Susanne; Glover, Joel C.			A Neonatal Mouse Spinal Cord Injury Model for Assessing Post-Injury Adaptive Plasticity and Human Stem Cell Integration	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MEDIATED SYNAPTIC INPUTS; FUNCTIONAL CONNECTIVITY; IN-VITRO; RAT; NEURONS; MOTONEURONS; TRANSECTION; EXPRESSION; RECOVERY	Despite limited regeneration capacity, partial injuries to the adult mammalian spinal cord can elicit variable degrees of functional recovery, mediated at least in part by reorganization of neuronal circuitry. Underlying mechanisms are believed to include synaptic plasticity and collateral sprouting of spared axons. Because plasticity is higher in young animals, we developed a spinal cord compression (SCC) injury model in the neonatal mouse to gain insight into the potential for reorganization during early life. The model provides a platform for high-throughput assessment of functional synaptic connectivity that is also suitable for testing the functional integration of human stem and progenitor cell-derived neurons being considered for clinical cell replacement strategies. SCC was generated at T9-T11 and functional recovery was assessed using an integrated approach including video kinematics, histology, tract tracing, electrophysiology, and high-throughput optical recording of descending inputs to identified spinal neurons. Dramatic degeneration of axons and synaptic contacts was evident within 24 hours of SCC, and loss of neurons in the injured segment was evident for at least a month thereafter. Initial hindlimb paralysis was paralleled by a loss of descending inputs to lumbar motoneurons. Within 4 days of SCC and progressively thereafter, hindlimb motility began to be restored and descending inputs reappeared, but with examples of atypical synaptic connections indicating a reorganization of circuitry. One to two weeks after SCC, hindlimb motility approached sham control levels, and weight-bearing locomotion was virtually indistinguishable in SCC and sham control mice. Genetically labeled human fetal neural progenitor cells injected into the injured spinal cord survived for at least a month, integrated into the host tissue and began to differentiate morphologically. This integrative neonatal mouse model provides opportunities to explore early adaptive plasticity mechanisms underlying functional recovery as well as the capacity for human stem cell-derived neurons to integrate functionally into spinal circuits.	[Boulland, Jean-Luc; Lambert, Francois M.; Zuchner, Mark; Strom, Susanne; Glover, Joel C.] Univ Oslo, Inst Basic Med Sci, Dept Physiol, Lab Neural Dev & Opt Recording NDEVOR,Fac Med, Oslo, Norway; [Boulland, Jean-Luc; Strom, Susanne; Glover, Joel C.] Oslo Univ Hosp, Dept Immunol & Transfus Med, Norwegian Ctr Stem Cell Res, Oslo, Norway; [Zuchner, Mark] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Glover, JC (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Physiol, Lab Neural Dev & Opt Recording NDEVOR,Fac Med, Oslo, Norway.	joel.glover@medisin.uio.no	Lambert, François/AAG-1626-2021; Boulland, Jean-Luc/J-2946-2019	Boulland, jean-Luc/0000-0002-7272-357X	Norwegian Research Council through the Norwegian Center for Stem Cell Research; University of Oslo; ExtraStiftelsen Helse og Rehabilitering	Norwegian Research Council through the Norwegian Center for Stem Cell Research; University of Oslo; ExtraStiftelsen Helse og Rehabilitering	This work was funded by grants from the Norwegian Research Council through the Norwegian Center for Stem Cell Research (JCG), the University of Oslo (JCG, JLB), and ExtraStiftelsen Helse og Rehabilitering (JCG, JLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Boulenguez P, 2009, CURR OPIN NEUROBIOL, V19, P587, DOI 10.1016/j.conb.2009.10.005; Boulland JL, 2012, CELL TRANSPLANT, V21, P1743, DOI 10.3727/096368911X627598; Boulland JL, 2004, J COMP NEUROL, V480, P264, DOI 10.1002/cne.20354; Boulland JL, 2002, EUR J NEUROSCI, V15, P1615, DOI 10.1046/j.1460-9568.2002.01995.x; Broccard Frederic D, 2009, BMC Res Notes, V2, P13, DOI 10.1186/1756-0500-2-13; Brockmeyer D, 1998, PEDIAT SPINAL CORD S; Brumley MR, 2012, BEHAV BRAIN RES, V229, P257, DOI 10.1016/j.bbr.2012.01.006; Cai LL, 2006, PHILOS T R SOC B, V361, P1635, DOI 10.1098/rstb.2006.1884; Cheng JG, 2011, EXP BRAIN RES, V214, P151, DOI 10.1007/s00221-011-2816-7; Clarac F, 2004, J COMP PHYSIOL A, V190, P343, DOI 10.1007/s00359-004-0499-2; Cordelieres FP, 2006, AM SOC CELL BIOL 46; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Dalous J, 2012, PEDIATR RES, V71, P482, DOI 10.1038/pr.2011.67; DOLAN EJ, 1979, J NEUROSURG, V51, P229, DOI 10.3171/jns.1979.51.2.0229; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308; Emery DL, 2003, J NEUROTRAUM, V20, P1271, DOI 10.1089/089771503322686085; Fenrich KK, 2011, J COMP NEUROL, V519, P3240, DOI 10.1002/cne.22686; Fenrich KK, 2009, J NEUROSCI, V29, P12145, DOI 10.1523/JNEUROSCI.0897-09.2009; Ferguson AR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00399; Filli L, 2012, ANN NEUROL, V72, P491, DOI 10.1002/ana.23630; Flynn JR, 2013, J NEUROTRAUM, V30, P891, DOI 10.1089/neu.2012.2714; Flynn JR, 2011, J NEUROSCI METH, V200, P113, DOI 10.1016/j.jneumeth.2011.06.017; Flynn JR, 2011, NEUROPHARMACOLOGY, V60, P809, DOI 10.1016/j.neuropharm.2011.01.016; FORAN DR, 1992, J NEUROSCI, V12, P4890; Fujimoto Y, 2012, STEM CELLS, V30, P1163, DOI 10.1002/stem.1083; Fukushima K, 1979, Prog Brain Res, V50, P121; Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x; GLOVER JC, 1986, J NEUROSCI METH, V18, P243, DOI 10.1016/0165-0270(86)90011-7; Glover JC., 1995, NEUROSCI PROTOCOLS, V95, P1; Glover JC, 2011, MOTOR FUNCTIONS SPIN; Glover JC, 2008, DEV NEUROBIOL, V68, P804, DOI 10.1002/dneu.20629; Gordon IT, 2008, J NEUROPHYSIOL, V100, P117, DOI 10.1152/jn.00829.2007; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hsu JYC, 2006, BRAIN RES, V1084, P16, DOI 10.1016/j.brainres.2006.02.036; Ichiyama RM, 2011, J NEUROSCI, V31, P26, DOI 10.1523/JNEUROSCI.6433-09.2011; Jefferson SC, 2011, J NEUROSCI, V31, P5710, DOI 10.1523/JNEUROSCI.4459-10.2011; Juvin L, 2005, EUR J NEUROSCI, V21, P808, DOI 10.1111/j.1460-9568.2005.03910.x; Kasumacic N, 2012, J PHYSIOL-LONDON, V590, P5809, DOI 10.1113/jphysiol.2012.234609; Kasumacic N, 2010, J PHYSIOL-LONDON, V588, P4905, DOI 10.1113/jphysiol.2010.195644; Kriss VM, 1996, CLIN PEDIATR, V35, P119, DOI 10.1177/000992289603500302; Lukovic D, 2012, STEM CELLS, V30, P1787, DOI 10.1002/stem.1159; Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890; NAGARA H, 1981, NEUROPATH APPL NEURO, V7, P135, DOI 10.1111/j.1365-2990.1981.tb00083.x; Nissen UV, 2005, J COMP NEUROL, V483, P30, DOI 10.1002/cne.20435; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Perreault MC, 2013, ANN NY ACAD SCI, V1279, P80, DOI 10.1111/nyas.12054; Peterson B.W, 1984, RETICULOSPINAL SYSTE; Petruska JC, 2007, J NEUROSCI, V27, P4460, DOI 10.1523/JNEUROSCI.2302-06.2007; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Rasband W., 2006, IMAGEJ; Rivlin A S, 1978, Surg Neurol, V10, P38; RIVLIN AS, 1978, J NEUROSURG, V49, P844, DOI 10.3171/jns.1978.49.6.0844; Roy RR, 2012, ARCH PHYS MED REHAB, V93, P1487, DOI 10.1016/j.apmr.2012.04.034; Sadlaoud K, 2010, J NEUROSCI, V30, P3358, DOI 10.1523/JNEUROSCI.6310-09.2010; Sandner B, 2012, CELL TISSUE RES, V349, P349, DOI 10.1007/s00441-012-1363-2; Sivertsen M, 2011, SOC NEUR ABTR, V41; Skaper Stephen D, 2012, Methods Mol Biol, V846, P13, DOI 10.1007/978-1-61779-536-7_2; STELZNER DJ, 1975, EXP NEUROL, V46, P156, DOI 10.1016/0014-4886(75)90039-4; Szokol K, 2008, J PHYSIOL-LONDON, V586, P5259, DOI 10.1113/jphysiol.2008.158105; Szokol K, 2011, J NEUROSCI, V31, P4731, DOI 10.1523/JNEUROSCI.5486-10.2011; Szokol K, 2009, J NEUROSCI METH, V180, P1, DOI 10.1016/j.jneumeth.2009.01.018; Talpalar AE, 2011, NEURON, V71, P1071, DOI 10.1016/j.neuron.2011.07.011; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tillakaratne NJK, 2010, NEUROSCIENCE, V166, P23, DOI 10.1016/j.neuroscience.2009.12.010; Woodruff RH, 1998, J NEUROCYTOL, V27, P683, DOI 10.1023/A:1006972316697; Young W, 2002, PROG BRAIN RES, V137, P231; Z'Graggen WJ, 2000, J NEUROSCI, V20, P6561, DOI 10.1523/JNEUROSCI.20-17-06561.2000	73	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71701	10.1371/journal.pone.0071701	http://dx.doi.org/10.1371/journal.pone.0071701			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990976	Green Published, gold			2022-12-25	WOS:000323425700087
J	Figueroa, M; Oliveira, N; Lejeune, A; Kaufmann, KW; Dorr, BM; Matagne, A; Martial, JA; Meiler, J; Van de Weerdt, C				Figueroa, Maximiliano; Oliveira, Nicolas; Lejeune, Annabelle; Kaufmann, Kristian W.; Dorr, Brent M.; Matagne, Andre; Martial, Joseph A.; Meiler, Jens; Van de Weerdt, Cecile			Octarellin VI: Using Rosetta to Design a Putative Artificial (beta/alpha)(8) Protein	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE; SECONDARY STRUCTURE ANALYSES; COMPUTER-BASED DESIGN; BARREL PROTEINS; COMPUTATIONAL DESIGN; STRUCTURE PREDICTION; SULFOLOBUS-SOLFATARICUS; (BETA-ALPHA)(8) BARREL; TRYPTOPHAN SYNTHASE	The computational protein design protocol Rosetta has been applied successfully to a wide variety of protein engineering problems. Here the aim was to test its ability to design de novo a protein adopting the TIM-barrel fold, whose formation requires about twice as many residues as in the largest proteins successfully designed de novo to date. The designed protein, Octarellin VI, contains 216 residues. Its amino acid composition is similar to that of natural TIM-barrel proteins. When produced and purified, it showed a far-UV circular dichroism spectrum characteristic of folded proteins, with alpha-helical and beta-sheet secondary structure. Its stable tertiary structure was confirmed by both tryptophan fluorescence and circular dichroism in the near UV. It proved heat stable up to 70 degrees C. Dynamic light scattering experiments revealed a unique population of particles averaging 4 nm in diameter, in good agreement with our model. Although these data suggest the successful creation of an artificial alpha/beta protein of more than 200 amino acids, Octarellin VI shows an apparent noncooperative chemical unfolding and low solubility.	[Figueroa, Maximiliano; Oliveira, Nicolas; Lejeune, Annabelle; Martial, Joseph A.; Van de Weerdt, Cecile] Univ Liege, GIGA Res, Mol Biol & Genet Engn Unit, Liege, Belgium; [Kaufmann, Kristian W.; Dorr, Brent M.; Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Dept Chem, Nashville, TN 37235 USA; [Kaufmann, Kristian W.; Dorr, Brent M.; Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Dept Pharmacol, Nashville, TN 37235 USA; [Matagne, Andre] Univ Liege, Ctr Prot Engn, Lab Enzymol & Repliement Prot, Liege, Belgium	University of Liege; Vanderbilt University; Vanderbilt University; University of Liege	Van de Weerdt, C (corresponding author), Univ Liege, GIGA Res, Mol Biol & Genet Engn Unit, Liege, Belgium.	c.vandeweerdt@ulg.ac.be		Matagne, Andre/0000-0001-6417-6791; Meiler, Jens/0000-0001-8945-193X	Wallonie-Bruxelles International; Belgian Science Policy Office; "Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture'' (FRIA) of the French Community of Belgium; Fonds de la Recherche Fondamentale et Collective [2.4530.09]; Belgian Interuniversity Attraction Poles program; Protein Design Project of the Defense Advanced Research Projects Agency (DARPA) [04 12]; European Space Agency [C90035, AO004]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	Wallonie-Bruxelles International; Belgian Science Policy Office(Belgian Federal Science Policy Office); "Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture'' (FRIA) of the French Community of Belgium(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Fondamentale et Collective(Fonds de la Recherche Scientifique - FNRS); Belgian Interuniversity Attraction Poles program(Belgian Federal Science Policy Office); Protein Design Project of the Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); European Space Agency(European Space AgencyEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.F. is the recipient of postdoctoral fellowships from "Wallonie-Bruxelles International'' and the "Belgian Science Policy Office''. N.O. is the recipient of a fellowship from the "Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture'' (FRIA) of the French Community of Belgium. A.M. is supported in part by a grant from the Fonds de la Recherche Fondamentale et Collective (contract number 2.4530.09) and by the Belgian Interuniversity Attraction Poles program initiated by the Belgian Federal Office for Scientific, Technical, and Cultural Affairs (PAI no P6/19). J.M. and K.K. are supported by the Protein Design Project of the Defense Advanced Research Projects Agency (DARPA grant 04 12). The authors are grateful to the European Space Agency for funding in the context of the Prodex projects C90035 and AO004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma S, 2005, J MOL BIOL, V353, P1161, DOI 10.1016/j.jmb.2005.08.070; Akanuma S, 2005, PROTEINS, V58, P538, DOI 10.1002/prot.20349; Ambroggio XI, 2006, CURR OPIN STRUC BIOL, V16, P525, DOI 10.1016/j.sbi.2006.05.014; Ambroggio XI, 2006, J AM CHEM SOC, V128, P1154, DOI 10.1021/ja054718w; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BEAUREGARD M, 1991, PROTEIN ENG, V4, P745, DOI 10.1093/protein/4.7.745; Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734; Bilsel O, 1999, BIOCHEMISTRY-US, V38, P4177, DOI 10.1021/bi9829433; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Butterfoss GL, 2006, ANNU REV BIOPH BIOM, V35, P49, DOI 10.1146/annurev.biophys.35.040405.102046; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DeLuca S, 2011, BIOCHEMISTRY-US, V50, P8521, DOI 10.1021/bi200664b; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; EDER J, 1992, BIOCHEMISTRY-US, V31, P3617, DOI 10.1021/bi00129a010; Forge V, 2000, J MOL BIOL, V296, P1039, DOI 10.1006/jmbi.1999.3515; Forsyth WR, 2007, J MOL BIOL, V372, P236, DOI 10.1016/j.jmb.2007.06.018; Forsyth WR, 2002, J MOL BIOL, V320, P1119, DOI 10.1016/S0022-2836(02)00557-0; Fu HL, 2009, PROTEINS, V77, P491, DOI 10.1002/prot.22509; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; GORAJ K, 1990, PROTEIN ENG, V3, P259, DOI 10.1093/protein/3.4.259; Gromiha MM, 2004, PROTEINS, V55, P316, DOI 10.1002/prot.20052; Gu ZY, 2007, J MOL BIOL, V368, P582, DOI 10.1016/j.jmb.2007.02.027; Hocker B, 2001, NAT STRUCT BIOL, V8, P32; HOUBRECHTS A, 1995, PROTEIN ENG, V8, P249, DOI 10.1093/protein/8.3.249; Idicula-Thomas S, 2005, PROTEIN SCI, V14, P582, DOI 10.1110/ps.041009005; Idicula-Thomas Susan, 2007, In Silico Biology, V7, P225; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kuhlman B, 2002, J MOL BIOL, V315, P471, DOI 10.1006/jmbi.2001.5229; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUGER K, 1989, SCIENCE, V243, P206, DOI 10.1126/science.2643160; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; Meiler J, 2001, J MOL MODEL, V7, P360, DOI 10.1007/s008940100038; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; MELO F, 1997, P INT C INTELL SYST, V5, P187; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Offredi F, 2003, J MOL BIOL, V325, P163, DOI 10.1016/S0022-2836(02)01206-8; Pace C N, 1986, Methods Enzymol, V131, P266; Parmeggiani F, 2008, J MOL BIOL, V376, P1282, DOI 10.1016/j.jmb.2007.12.014; Poole AM, 2006, CURR OPIN STRUC BIOL, V16, P508, DOI 10.1016/j.sbi.2006.06.013; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SCHEERLINCK JPY, 1992, PROTEINS, V12, P299, DOI 10.1002/prot.340120402; Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Silverman JA, 2002, J MOL BIOL, V324, P1031, DOI 10.1016/S0022-2836(02)01100-2; Skolnick J, 2006, CURR OPIN STRUC BIOL, V16, P166, DOI 10.1016/j.sbi.2006.02.004; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; TANAKA T, 1994, PROTEIN ENG, V7, P969, DOI 10.1093/protein/7.8.969; TANAKA T, 1994, BIOPHYS CHEM, V50, P47, DOI 10.1016/0301-4622(94)85019-4; TANAKA T, 1994, PROTEIN SCI, V3, P419; URFER R, 1992, PROTEIN SCI, V1, P31; Urvoas A, 2010, J MOL BIOL, V404, P307, DOI 10.1016/j.jmb.2010.09.048; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANDENBURG B, 1994, EUR J BIOCHEM, V220, P981; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vincentelli R, 2004, PROTEIN SCI, V13, P2782, DOI 10.1110/ps.04806004; Voigt CA, 2000, J MOL BIOL, V299, P789, DOI 10.1006/jmbi.2000.3758; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Yang XY, 2007, PROTEIN SCI, V16, P1398, DOI 10.1110/ps.062704507; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	79	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71858	10.1371/journal.pone.0071858	http://dx.doi.org/10.1371/journal.pone.0071858			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977165	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700108
J	Parlato, S; Bruni, R; Fragapane, P; Salerno, D; Marcantonio, C; Borghi, P; Tataseo, P; Ciccaglione, AR; Presutti, C; Romagnoli, G; Bozzoni, I; Belardelli, F; Gabriele, L				Parlato, Stefania; Bruni, Roberto; Fragapane, Paola; Salerno, Debora; Marcantonio, Cinzia; Borghi, Paola; Tataseo, Paola; Ciccaglione, Anna Rita; Presutti, Carlo; Romagnoli, Giulia; Bozzoni, Irene; Belardelli, Filippo; Gabriele, Lucia			IFN-alpha Regulates Blimp-1 Expression via miR-23a and miR-125b in Both Monocytes-Derived DC and pDC	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; INTERFERON-ALPHA; GENE; MICRORNAS; DIFFERENTIATION; ROLES; IDENTIFICATION; GENERATION; REPRESSOR; PROMOTES	Type I interferon (IFN-I) have emerged as crucial mediators of cellular signals controlling DC differentiation and function. Human DC differentiated from monocytes in the presence of IFN-alpha (IFN-alpha DC) show a partially mature phenotype and a special capability of stimulating CD4+ T cell and cross-priming CD8+ T cells. Likewise, plasmacytoid DC (pDC) are blood DC highly specialized in the production of IFN-alpha in response to viruses and other danger signals, whose functional features may be shaped by IFN-I. Here, we investigated the molecular mechanisms stimulated by IFN-alpha in driving human monocyte-derived DC differentiation and performed parallel studies on peripheral unstimulated and IFN-alpha-treated pDC. A specific miRNA signature was induced in IFN-alpha DC and selected miRNAs, among which miR-23a and miR-125b, proved to be negatively associated with up-modulation of Blimp-1 occurring during IFN-alpha-driven DC differentiation. Of note, monocyte-derived IFN-alpha DC and in vitro IFN-alpha-treated pDC shared a restricted pattern of miRNAs regulating Blimp-1 expression as well as some similar phenotypic, molecular and functional hallmarks, supporting the existence of a potential relationship between these DC populations. On the whole, these data uncover a new role of Blimp-1 in human DC differentiation driven by IFN-alpha and identify Blimp-1 as an IFN-alpha-mediated key regulator potentially accounting for shared functional features between IFN-alpha DC and pDC.	[Parlato, Stefania; Salerno, Debora; Borghi, Paola; Romagnoli, Giulia; Belardelli, Filippo; Gabriele, Lucia] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Bruni, Roberto; Marcantonio, Cinzia; Ciccaglione, Anna Rita] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Fragapane, Paola] CNR, Inst Mol Biol & Pathol, Rome, Italy; [Tataseo, Paola] ASL, Transfus Med & Mol Biol Lab, Avezzano Sulmona, Sulmona, Italy; [Presutti, Carlo; Bozzoni, Irene] Univ Roma La Sapienza, Dept Genet & Mol Biol, Rome, Italy	Istituto Superiore di Sanita (ISS); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Gabriele, L (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	lucia.gabriele@iss.it	CICCAGLIONE, ANNA RITA/M-2956-2015; Bruni, Roberto/ABA-8555-2021; MARCANTONIO, CINZIA/M-2963-2015; Gabriele, Lucia/J-8335-2016; Salerno, Debora/AAM-9940-2021; PARLATO, STEFANIA/J-2777-2018; Fragapane, Paola/ABD-1892-2020; BRUNI, ROBERTO/M-2957-2015	CICCAGLIONE, ANNA RITA/0000-0002-3791-3781; Bruni, Roberto/0000-0002-3035-5510; MARCANTONIO, CINZIA/0000-0002-7392-9780; Gabriele, Lucia/0000-0002-1483-866X; PARLATO, STEFANIA/0000-0001-6727-0900; Fragapane, Paola/0000-0003-4261-8020; BRUNI, ROBERTO/0000-0002-3035-5510; romagnoli, giulia/0000-0002-0621-2579; PRESUTTI, Carlo/0000-0003-3837-2275; SALERNO, DEBORA/0000-0003-0504-1904; Belardelli, Filippo/0000-0002-3082-3169; bozzoni, irene/0000-0002-3485-8537	European Community [200732 HOMITB, LSHG-CT-2006-037900]; ACC Italian National Program 2 [ACC2/WP5.4]; Italian Association for Research against Cancer (AIRC); FIRB; SEED	European Community; ACC Italian National Program 2; Italian Association for Research against Cancer (AIRC); FIRB; SEED	This work was supported by European Community Grant 200732 HOMITB, ACC 2006 Italian National Program 2 (ACC2/WP5.4), and the Italian Association for Research against Cancer (AIRC), grants to LG and FB; by European Community Grant SIROCCO (LSHG-CT-2006-037900), FIRB and "SEED" IIT to IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinikula J, 2011, SCAND J IMMUNOL, V73, P512, DOI 10.1111/j.1365-3083.2011.02556.x; Bai Y, 2012, J IMMUNOL, V188, P5293, DOI 10.4049/jimmunol.1102371; Chan YH, 2009, J IMMUNOL, V183, P7039, DOI 10.4049/jimmunol.0901543; Chaudhuri AA, 2012, P NATL ACAD SCI USA, V109, P4233, DOI 10.1073/pnas.1200677109; Chen T, 2011, FEBS LETT, V585, P567, DOI 10.1016/j.febslet.2011.01.010; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; David M, 2010, J INTERF CYTOK RES, V30, P825, DOI 10.1089/jir.2010.0080; Denti MA, 2004, MOL THER, V10, P191, DOI 10.1016/j.ymthe.2004.04.008; Doody GM, 2007, J IMMUNOL, V179, P7614, DOI 10.4049/jimmunol.179.11.7614; Dunand-Sauthier I, 2011, BLOOD, V117, P4490, DOI 10.1182/blood-2010-09-308064; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; El Gazzar M, 2012, IMMUNOL CELL BIOL, V90, P587, DOI 10.1038/icb.2011.74; Enomoto Y, 2011, LEUKEMIA, V25, P1849, DOI 10.1038/leu.2011.166; Farkas A, 2011, BRIT J DERMATOL, V165, P247, DOI 10.1111/j.1365-2133.2011.10301.x; Farkas A, 2012, INT IMMUNOPHARMACOL, V13, P215, DOI 10.1016/j.intimp.2012.04.003; Gabriele L, 2004, BLOOD, V103, P980, DOI 10.1182/blood-2003-03-0981; Gabriele L, 2007, CYTOKINE GROWTH F R, V18, P503, DOI 10.1016/j.cytogfr.2007.06.008; Gururajan M, 2010, INT IMMUNOL, V22, P583, DOI 10.1093/intimm/dxq042; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Hon LS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r166; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; Kim SJ, 2013, J CLIN INVEST, V123, P823, DOI 10.1172/JCI64712; Kim SJ, 2011, J EXP MED, V208, P2193, DOI 10.1084/jem.20110658; Kong KY, 2010, EXP HEMATOL, V38, P629, DOI 10.1016/j.exphem.2010.04.004; Kuipers H, 2010, MOL IMMUNOL, V48, P333, DOI 10.1016/j.molimm.2010.07.007; Lapenta C, 2006, EUR J IMMUNOL, V36, P2046, DOI 10.1002/eji.200535579; Li HS, 2011, BLOOD, V118, P3879, DOI 10.1182/blood-2011-04-349761; Liou LY, 2008, EUR J IMMUNOL, V38, P3388, DOI 10.1002/eji.200838282; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Marafioti T, 2008, BLOOD, V111, P3778, DOI 10.1182/blood-2007-10-117531; Morgan MAJ, 2012, MOL CELL BIOL, V32, P3403, DOI 10.1128/MCB.00174-12; Parlato S, 2010, BLOOD, V115, P1554, DOI 10.1182/blood-2009-07-234468; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Reizis B, 2010, CURR OPIN IMMUNOL, V22, P206, DOI 10.1016/j.coi.2010.01.005; Rinaldi A, 2010, BEHAV BRAIN RES, V208, P265, DOI 10.1016/j.bbr.2009.11.012; Rizza P, 2010, AUTOIMMUNITY, V43, P204, DOI 10.3109/08916930903510880; Santini Stefano Maria, 2009, Handb Exp Pharmacol, P295, DOI 10.1007/978-3-540-71029-5_14; Savitsky D, 2007, ADV EXP MED BIOL, V596, P9; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schmidt D, 2008, EXP CELL RES, V314, P3614, DOI 10.1016/j.yexcr.2008.09.008; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Smith MA, 2011, J BIOL CHEM, V286, P7893, DOI 10.1074/jbc.M110.165431; Smith MA, 2010, J IMMUNOL, V185, P6058, DOI 10.4049/jimmunol.1001682; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Tel J, 2011, J INVEST DERMATOL, V131, P900, DOI 10.1038/jid.2010.410; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137; VERMI W, 2011, J LEUKOC BIOL; Vermi W, 2011, J INVEST DERMATOL, V131, P426, DOI 10.1038/jid.2010.256; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Xin A, 2011, ADV EXP MED BIOL, V780, P85, DOI 10.1007/978-1-4419-5632-3_8; Zhan YF, 2012, PROTEIN CELL, V3, P497, DOI 10.1007/s13238-012-0042-0; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156	56	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72833	10.1371/journal.pone.0072833	http://dx.doi.org/10.1371/journal.pone.0072833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977359	Green Submitted, Green Published, gold			2022-12-25	WOS:000323570200086
J	Smidler, AL; Terenzi, O; Soichot, J; Levashina, EA; Marois, E				Smidler, Andrea L.; Terenzi, Olivier; Soichot, Julien; Levashina, Elena A.; Marois, Eric			Targeted Mutagenesis in the Malaria Mosquito Using TALE Nucleases	PLOS ONE			English	Article							COMPLEMENT-LIKE PROTEIN; ZINC-FINGER NUCLEASES; ANOPHELES-GAMBIAE; PLASMODIUM-FALCIPARUM; EFFICIENT; VECTOR; GENOME; KNOCKOUT; EFFECTORS; SYSTEM	Anopheles gambiae, the main mosquito vector of human malaria, is a challenging organism to manipulate genetically. As a consequence, reverse genetics studies in this disease vector have been largely limited to RNA interference experiments. Here, we report the targeted disruption of the immunity gene TEP1 using transgenic expression of Transcription-Activator Like Effector Nucleases (TALENs), and the isolation of several TEP1 mutant A. gambiae lines. These mutations inhibited protein production and rendered TEP1 mutants hypersusceptible to Plasmodium berghei. The TALEN technology opens up new avenues for genetic analysis in this disease vector and may offer novel biotechnology-based approaches for malaria control.	[Smidler, Andrea L.; Terenzi, Olivier; Soichot, Julien; Levashina, Elena A.; Marois, Eric] INSERM, U963, Strasbourg, France; [Smidler, Andrea L.; Terenzi, Olivier; Soichot, Julien; Levashina, Elena A.; Marois, Eric] CNRS, UPR9022, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Marois, E (corresponding author), INSERM, U963, Strasbourg, France.	e.marois@unistra.fr	Marois, Eric/H-9246-2016; Marois, Eric/AAZ-5549-2021	Marois, Eric/0000-0003-4147-3747; Marois, Eric/0000-0003-4147-3747; Levashina, Elena/0000-0003-4605-906X; Smidler, Andrea/0000-0002-3281-1161	Agence Nationale de la Recherche (ANR); European Commission [228421]; EVIMalar [242095]; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS)	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); EVIMalar; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This study was funded by an Agence Nationale de la Recherche (ANR) young researcher grant to E.M. (project GEMM), by the European Commission FP7 projects INFRAVEC (grant agreement no. 228421) and EVIMalar (grant agreement no. 242095), by the Institut National de la Sante et de la Recherche Medicale (INSERM) and by the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MAL REP; [Anonymous], 2011, NAT BIOTECHNOL, V29, P681, DOI [10.1038/nbt.1935, DOI 10.1038/NBT.1935.PUBMED:21822235]; Aryan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060082; Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bhattacharyya MK, 2001, INT J PARASITOL, V31, P1129, DOI 10.1016/S0020-7519(01)00222-3; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2004, MOL IMMUNOL, V40, P903, DOI 10.1016/j.molimm.2003.10.010; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Catteruccia F, 2007, PEST MANAG IN PRESS; Catteruccia F, 2009, METHODS MOL BIOL, V555, P63, DOI 10.1007/978-1-60327-295-7_5; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen S, 2013, NUCL ACIDS RES; Degennaro M, 2013, NATURE; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Ghosh AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000265; Gupta A, 2011, NUCLEIC ACIDS RES, V39, P381, DOI 10.1093/nar/gkq787; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Le BV, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002958; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Marois E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-302; Meredith JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014587; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nsango SE, 2012, INT J PARASITOL, V42, P589, DOI 10.1016/j.ijpara.2012.03.008; Papathanos PA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-65; Paton D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067364; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Sambrook J., 2002, MOL CLONING LAB MANU; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Thailayil J, 2011, P NATL ACAD SCI USA, V108, P13677, DOI 10.1073/pnas.1104738108; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; WATANABE TH, 2012, NAT COMMUN, V399, DOI DOI 10.1038/NC0MMS2020.PUBMED:22910363	45	58	60	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e74511	10.1371/journal.pone.0074511	http://dx.doi.org/10.1371/journal.pone.0074511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977401	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000125
J	Michau, A; Guillemain, G; Grosfeld, A; Vuillaumier-Barrot, S; Grand, T; Keck, M; L'Hoste, S; Chateau, D; Serradas, P; Teulon, J; De Lonlay, P; Scharfmann, R; Brot-Laroche, E; Leturque, A; Le Gall, M				Michau, Aurelien; Guillemain, Ghislaine; Grosfeld, Alexandra; Vuillaumier-Barrot, Sandrine; Grand, Teddy; Keck, Mathilde; L'Hoste, Sebastien; Chateau, Danielle; Serradas, Patricia; Teulon, Jacques; De Lonlay, Pascale; Scharfmann, Raphael; Brot-Laroche, Edith; Leturque, Armelle; Le Gall, Maude			Mutations in SLC2A2 Gene Reveal hGLUT2 Function in Pancreatic beta Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; GLUCOSE TRANSPORTERS; INSULIN-SECRETION; GLUT2 MUTATIONS; EXPRESSION; GLUCOKINASE; IDENTIFICATION; POLYMORPHISMS; ERYTHROCYTE; MECHANISM	The structure-function relationships of sugar transporter-receptor hGLUT2 coded by SLC2A2 and their impact on insulin secretion and beta cell differentiation were investigated through the detailed characterization of a panel of mutations along the protein. We studied naturally occurring SLC2A2 variants or mutants: two single-nucleotide polymorphisms and four proposed inactivating mutations associated to Fanconi-Bickel syndrome. We also engineered mutations based on sequence alignment and conserved amino acids in selected domains. The single-nucleotide polymorphisms P68L and T110I did not impact on sugar transport as assayed in Xenopus oocytes. All the Fanconi-Bickel syndrome-associated mutations invalidated glucose transport by hGLUT2 either through absence of protein at the plasma membrane (G20D and S242R) or through loss of transport capacity despite membrane targeting (P417L and W444R), pointing out crucial amino acids for hGLUT2 transport function. In contrast, engineered mutants were located at the plasma membrane and able to transport sugar, albeit with modified kinetic parameters. Notably, these mutations resulted in gain of function. G20S and L368P mutations increased insulin secretion in the absence of glucose. In addition, these mutants increased insulin-positive cell differentiation when expressed in cultured rat embryonic pancreas. F295Y mutation induced beta cell differentiation even in the absence of glucose, suggesting that mutated GLUT2, as a sugar receptor, triggers a signaling pathway independently of glucose transport and metabolism. Our results describe the first gain of function mutations for hGLUT2, revealing the importance of its receptor versus transporter function in pancreatic beta cell development and insulin secretion.	[Michau, Aurelien; Grosfeld, Alexandra; Grand, Teddy; Keck, Mathilde; L'Hoste, Sebastien; Chateau, Danielle; Serradas, Patricia; Teulon, Jacques; Brot-Laroche, Edith; Leturque, Armelle; Le Gall, Maude] Univ Paris 06, INSERM, UMRS872, Cordeliers Res Ctr, F-75006 Paris, France; [Guillemain, Ghislaine; Scharfmann, Raphael] Univ Paris 05, INSERM U845, Res Ctr Growth & Signalling, Sorbonne Paris Cite,Fac Med,Hop Necker, F-75006 Paris, France; [Vuillaumier-Barrot, Sandrine] Hop Xavier Bichat Claude Bernard, Unite Fonct Genet, CHU Paris Nord Val de Seine, F-75018 Paris, France; [De Lonlay, Pascale] Hop Necker Enfants Malad, Reference Ctr Metab Dis, F-75006 Paris, France; [Brot-Laroche, Edith; Leturque, Armelle] Inst CardioMetab & Nutr ICAN, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Le Gall, M (corresponding author), Univ Paris 07, INSERM U773, Fac Med, Site Bichat,16 Rue Henri Huchard, F-75890 Paris 18, France.	maude.le-gall@inserm.fr	Grosfeld, Alexandra/AAH-3510-2020; Guillemain, Ghislaine/P-7740-2017; Keck, Mathilde/Q-4574-2017; Leturque, Armelle/Q-9437-2017; Serradas, Patricia/R-2185-2017; scharfmann, raphael/L-3296-2017; Grosfeld, Alexandra/R-1404-2017; Le Gall, Maude/W-2593-2019; Le Gall, Maude/C-3917-2017	Keck, Mathilde/0000-0003-4717-3446; Leturque, Armelle/0000-0001-6570-6387; Serradas, Patricia/0000-0002-6652-9746; Grosfeld, Alexandra/0000-0002-9508-036X; Le Gall, Maude/0000-0002-5372-4585; Le Gall, Maude/0000-0002-5372-4585; Scharfmann, Raphael/0000-0001-7619-337X; Guillemain, Ghislaine/0000-0002-8256-9545	Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Pierre & Marie Curie Paris 6 (UMPC); Universite Rene Descartes Paris 5; Centre National de la Recherche Scientifique (CNRS); European Union; UPMC Paris 6	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre & Marie Curie Paris 6 (UMPC); Universite Rene Descartes Paris 5; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); European Union(European Commission); UPMC Paris 6	The work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Universite Pierre & Marie Curie Paris 6 (UMPC) and Universite Rene Descartes Paris 5, Centre National de la Recherche Scientifique (CNRS), and the 6th European Union Framework Program (Beta-Cell Therapy Integrated Project) (to R. S.).; Recipient of a doctoral fellowship from UPMC Paris 6.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; ANTOINE B, 1992, EXP CELL RES, V200, P175, DOI 10.1016/S0014-4827(05)80086-2; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Burgdorf KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015813; Carruthers A, 2009, AM J PHYSIOL-ENDOC M, V297, pE836, DOI 10.1152/ajpendo.00496.2009; Cassany A, 2004, TRAFFIC, V5, P10, DOI 10.1046/j.1398-9219.2003.0143.x; Clark SA, 1997, DIABETES, V46, P958, DOI 10.2337/diabetes.46.6.958; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Eny KM, 2008, PHYSIOL GENOMICS, V33, P355, DOI 10.1152/physiolgenomics.00148.2007; Ganesh R, 2009, CLIN PEDIATR, V48, P271, DOI 10.1177/0009922808324950; Ge Q, 2011, J BIOL CHEM, V286, P28119, DOI 10.1074/jbc.M111.237016; Giurgea I, 2006, HORM RES, V66, P289, DOI 10.1159/000095938; GOULD GW, 1991, BIOCHEMISTRY-US, V30, P5139, DOI 10.1021/bi00235a004; Grand T, 2011, HUM MUTAT, V32, P476, DOI 10.1002/humu.21467; Grunert SC, 2012, MOL GENET METAB, V105, P433, DOI 10.1016/j.ymgme.2011.11.200; Guillemain G, 2004, BIOCHEM J, V378, P219, DOI 10.1042/BJ20031549; Guillemain G, 2000, J CELL SCI, V113, P841; Guillemain G, 2002, BIOCHEM J, V364, P201, DOI 10.1042/bj3640201; Guillemain G, 2007, J BIOL CHEM, V282, P15228, DOI 10.1074/jbc.M610986200; Hou JCQ, 2009, VITAM HORM, V80, P473, DOI 10.1016/S0083-6729(08)00616-X; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; Igl W, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000798; JANSSEN RC, 1994, DIABETES, V43, P558, DOI 10.2337/diabetes.43.4.558; Laukkanen O, 2005, DIABETES, V54, P2256, DOI 10.2337/diabetes.54.7.2256; Le Gall M, 2007, J CELL PHYSIOL, V213, P834, DOI 10.1002/jcp.21245; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Levy S, 2011, SCIENCE, V334, P1408, DOI 10.1126/science.1207154; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Moller AM, 2001, J CLIN ENDOCR METAB, V86, P2181, DOI 10.1210/jc.86.5.2181; MUECKLER M, 1994, J BIOL CHEM, V269, P17765; PANG K, 1994, P NATL ACAD SCI USA, V91, P9559, DOI 10.1073/pnas.91.20.9559; Pena L, 2011, AM J MED GENET A, V155A, P415, DOI 10.1002/ajmg.a.33822; Richardson CC, 2007, DIABETOLOGIA, V50, P1000, DOI 10.1007/s00125-007-0644-x; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Sansbury FH, 2012, DIABETOLOGIA, V55, P2381, DOI 10.1007/s00125-012-2595-0; Santer R., 2002, Current Molecular Medicine (Hilversum), V2, P213, DOI 10.2174/1566524024605743; Schuit F, 2002, DIABETES, V51, pS326, DOI 10.2337/diabetes.51.2007.S326; Soggia A, 2012, DIABETOLOGIA, V55, P2713, DOI 10.1007/s00125-012-2623-0; Stolarczyk E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001288; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Taha D, 2008, J PEDIATR ENDOCR MET, V21, P581; THORENS B, 1990, DIABETES CARE, V13, P209, DOI 10.2337/diacare.13.3.209; Tsatsos NG, 2008, BIOCHEM J, V411, P261, DOI 10.1042/BJ20071156; Willer CJ, 2007, DIABETES, V56, P256, DOI 10.2337/db06-0461; Yang H, 2011, ANN NEUROL, V70, P996, DOI 10.1002/ana.22640	47	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31080	31092		10.1074/jbc.M113.469189	http://dx.doi.org/10.1074/jbc.M113.469189			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	23986439	Green Published, hybrid			2022-12-25	WOS:000330778900027
J	Ishizaki, Y; Hayashi, C; Inoue, K; Igarashi, M; Takahashi, Y; Pujari, V; Crick, DC; Brennan, PJ; Nomoto, A				Ishizaki, Yoshimasa; Hayashi, Chigusa; Inoue, Kunio; Igarashi, Masayuki; Takahashi, Yoshiaki; Pujari, Venugopal; Crick, Dean C.; Brennan, Patrick J.; Nomoto, Akio			Inhibition of the First Step in Synthesis of the Mycobacterial Cell Wall Core, Catalyzed by the GlcNAc-1-phosphate Transferase WecA, by the Novel Caprazamycin Derivative CPZEN-45	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics Action; Bacillus; Cell Wall; Teichoic Acid; Tuberculosis; CPZEN-45; TagO; WecA; Caprazamycin B; Mycolylarabinogalactan	TEICHOIC-ACID; BACILLUS-SUBTILIS; NUCLEOSIDE ANTIBIOTICS; BIOSYNTHESIS; MUTANTS; TRANSFORMATION; SMEGMATIS; GROWTH; GENES; LEAD	Because tuberculosis is one of the most prevalent and serious infections, countermeasures against it are urgently required. We isolated the antitubercular agents caprazamycins from the culture of an actinomycete strain and created CPZEN-45 as the most promising derivative of the caprazamycins. Herein, we describe the mode of action of CPZEN-45 first against Bacillus subtilis. Unlike the caprazamycins, CPZEN-45 strongly inhibited incorporation of radiolabeled glycerol into growing cultures and showed antibacterial activity against caprazamycin-resistant strains, including a strain overexpressing translocase-I (MraY, involved in the biosynthesis of peptidoglycan), the target of the caprazamycins. By contrast, CPZEN-45 was not effective against a strain overexpressing undecaprenyl-phosphate-GlcNAc-1-phosphate transferase (TagO, involved in the biosynthesis of teichoic acid), and a mutation was found in the tagO gene of the spontaneous CPZEN-45-resistant strain. This suggested that the primary target of CPZEN-45 in B. subtilis is TagO, which is a different target from that of the parent caprazamycins. This suggestion was confirmed by evaluation of the activities of these enzymes. Finally, we showed that CPZEN-45 was effective against WecA (Rv1302, also called Rfe) of Mycobacterium tuberculosis, the ortholog of TagO and involved in the biosynthesis of the mycolylarabinogalactan of the cell wall of M. tuberculosis. The outlook for WecA as a promising target for the development of antituberculous drugs as a countermeasure of drug resistant tuberculosis is discussed.	[Ishizaki, Yoshimasa; Hayashi, Chigusa; Inoue, Kunio; Igarashi, Masayuki; Nomoto, Akio] Inst Microbial Chem BIKAKEN, Shinagawa Ku, Tokyo, Japan; [Takahashi, Yoshiaki] Inst Microbial Chem BIKAKEN, Nakahara Ku, Kawasaki, Kanagawa, Japan; [Pujari, Venugopal; Crick, Dean C.; Brennan, Patrick J.] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Ishizaki, Y (corresponding author), Inst Microbial Chem BIKAKEN, Shinagawa Ku, 3-14-23 Kamiosaki, Tokyo, Japan.	ishizakiy@bikaken.or.jp	Crick, Dean/H-8251-2017; Brennan, Patrick J/G-6896-2017; Igarashi, Masayuki/AAG-1628-2020	Crick, Dean/0000-0001-9281-7058; 	National Institutes of Health from NIAID [AI049151, AI018357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI049151, R01AI018357, R01AI049151, R22AI018357, R37AI018357] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI049151 and AI018357 from NIAID.	Al-Dabbagh B, 2008, J BACTERIOL, V190, P7141, DOI 10.1128/JB.00676-08; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Bhavsar AP, 2006, MOL MICROBIOL, V60, P1077, DOI 10.1111/j.1365-2958.2006.05169.x; Brotz-Oesterhelt H, 2008, CURR OPIN PHARMACOL, V8, P564, DOI 10.1016/j.coph.2008.06.008; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; Denapaite D, 2012, MICROB DRUG RESIST, V18, P344, DOI 10.1089/mdr.2012.0026; Engohang-Ndong J, 2012, EXPERT OPIN INV DRUG, V21, P1789, DOI 10.1517/13543784.2012.724397; Galamba A, 2001, MICROBIOL-SGM, V147, P3281, DOI 10.1099/00221287-147-12-3281; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hashimoto-Gotoh T, 2000, GENE, V241, P185, DOI 10.1016/S0378-1119(99)00434-5; Hashizume H, 2011, ANTIMICROB AGENTS CH, V55, P3821, DOI 10.1128/AAC.00443-11; Igarahi M, 2003, J ANTIBIOT, V56, P580, DOI 10.7164/antibiotics.56.580; Igarashi M, 2005, J ANTIBIOT, V58, P327, DOI 10.1038/ja.2005.41; ISONO F, 1991, ANTIMICROB AGENTS CH, V35, P234, DOI 10.1128/AAC.35.2.234; ISONO K, 1985, J ANTIBIOT, V38, P1617, DOI 10.7164/antibiotics.38.1617; Jin Y, 2010, FEMS MICROBIOL LETT, V310, P54, DOI 10.1111/j.1574-6968.2010.02045.x; KARAMATA D, 1970, MOL GEN GENET, V108, P277, DOI 10.1007/BF00283358; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lechartier B, 2012, ANTIMICROB AGENTS CH, V56, P5790, DOI 10.1128/AAC.01476-12; McDonald LA, 2002, J AM CHEM SOC, V124, P10260, DOI 10.1021/ja017748h; Mikusova K, 1996, J BIOL CHEM, V271, P7820, DOI 10.1074/jbc.271.13.7820; Muramatsu Y, 2003, J ANTIBIOT, V56, P253, DOI 10.7164/antibiotics.56.253; Phillips L, 2013, NATURE, V493, P14, DOI 10.1038/493014a; Plinke C, 2010, J ANTIMICROB CHEMOTH, V65, P1359, DOI 10.1093/jac/dkq120; Pooley HM, 2000, MICROBIOL-SGM, V146, P797, DOI 10.1099/00221287-146-4-797; Price NP, 2005, GLYCOBIOLOGY, V15, p29R, DOI 10.1093/glycob/cwi065; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sawa R, 2012, CHEM-EUR J, V18, P15772, DOI 10.1002/chem.201202645; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Soldo B, 2002, MICROBIOL-SGM, V148, P2079, DOI 10.1099/00221287-148-7-2079; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Takahashi Y, 2013, J ANTIBIOT, V66, P171, DOI 10.1038/ja.2013.9; TAKAYAMA K, 1975, J LIPID RES, V16, P308; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301	39	101	109	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30309	30319		10.1074/jbc.M113.492173	http://dx.doi.org/10.1074/jbc.M113.492173			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986448	Green Published, hybrid			2022-12-25	WOS:000329868100028
J	Cabrera, M; Ungermann, C				Cabrera, Margarita; Ungermann, Christian			Guanine Nucleotide Exchange Factors (GEFs) Have a Critical but Not Exclusive Role in Organelle Localization of Rab GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Guanine Nucleotide Exchange Factor (GEF); Membrane Fusion; Rab; Rab Proteins; Subcellular Organelles; GAP; GDF	GDP-DISSOCIATION INHIBITOR; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; DISPLACEMENT FACTOR; ESCORT PROTEIN; COMPLEX; FUSION; YEAST; IDENTIFICATION; PRENYLATION	Membrane fusion at eukaryotic organelles is initiated by Rab GTPases and tethering factors. Rabs in their GDP-bound form are kept soluble in the cytoplasm by the GDP dissociation inhibitor (GDI) chaperone. Guanine nucleotide exchange factors (GEFs) are found at organelles and are critical for Rab function. Here, we surveyed the overall role of GEFs in Rab localization. We show that GEFs, but none of the proposed GDI displacement factors, are essential for the correct membrane localization of yeast Rabs. In the absence of the GEF, Rabs lost their primary localization to the target organelle. Several Rabs, such as vacuolar Ypt7, were found at the endoplasmic reticulum and thus were still membrane-bound. Surprisingly, a Ypt7 mutant that undergoes facilitated nucleotide exchange localized to vacuoles independently of its GEF Mon1-Ccz1 and rescued vacuole morphology. In contrast, wild-type Ypt7 required its GEF for localization and to counteract the extraction by GDI. Our data agree with the emerging model that GEFs are critical for Rab localization but raise the possibility that additional factors can contribute to this process.	[Cabrera, Margarita; Ungermann, Christian] Univ Osnabruck, Biochem Sect, Dept Biol Chem, D-49076 Osnabruck, Germany	University Osnabruck	Cabrera, M (corresponding author), Dept Biol Chem, Biochem Sect, Barbarastr 13, D-49076 Osnabruck, Germany.	margarita.cabrera@biologie.uni-osnabrueck.de	Cabrera, Margarita/F-3306-2016; Cabrera, Margarita/Y-1225-2019	Cabrera, Margarita/0000-0002-2978-8255; Cabrera, Margarita/0000-0002-2978-8255	Hans-Muhlenhoff Foundation;  [Sonderforschungsbereich (SFB) 944 (Project P11)]	Hans-Muhlenhoff Foundation; 	This work was supported by Sonderforschungsbereich (SFB) 944 (Project P11) and by the Hans-Muhlenhoff Foundation (to C. U.).	Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Barrowman J, 2003, J BIOL CHEM, V278, P19878, DOI 10.1074/jbc.M302406200; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Brett CL, 2008, J CELL BIOL, V182, P1141, DOI 10.1083/jcb.200801001; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Brocker C, 2010, CURR BIOL, V20, pR943, DOI 10.1016/j.cub.2010.09.015; Cabrera M, 2013, J BIOL CHEM, V288, P5166, DOI 10.1074/jbc.M112.431536; Cabrera M, 2009, MOL BIOL CELL, V20, P1937, DOI 10.1091/mbc.E08-09-0943; Calero M, 2003, MOL BIOL CELL, V14, P1852, DOI 10.1091/mbc.E02-11-0707; Calero M, 2002, FEBS LETT, V515, P89, DOI 10.1016/S0014-5793(02)02442-0; Chen CZ, 2004, GENETICS, V168, P1827, DOI 10.1534/genetics.104.032888; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465; Geng JM, 2005, EUKARYOT CELL, V4, P1166, DOI 10.1128/EC.4.7.1166-1174.2005; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; Heidtman M, 2003, J CELL BIOL, V163, P57, DOI 10.1083/jcb.200306118; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Itzen A, 2011, SEMIN CELL DEV BIOL, V22, P48, DOI 10.1016/j.semcdb.2010.10.003; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; Kucharczyk R, 2001, J CELL SCI, V114, P3137; Lachmann Jens, 2011, Small GTPases, V2, P182; Lachmann J, 2012, MOL BIOL CELL, V23, P2516, DOI 10.1091/mbc.E11-12-1030; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Morozova N, 2006, NAT CELL BIOL, V8, P1263, DOI 10.1038/ncb1489; Nickerson DP, 2012, TRAFFIC, V13, P1411, DOI 10.1111/j.1600-0854.2012.01390.x; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Paulsel AL, 2013, J BIOL CHEM, V288, P18162, DOI 10.1074/jbc.M113.457069; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Puig O, 1998, YEAST, V14, P1139; Pusapati GV, 2012, J BIOL CHEM, V287, P42129, DOI 10.1074/jbc.M112.414565; Rak A, 2004, CELL, V117, P749, DOI 10.1016/j.cell.2004.05.017; Rak A, 2003, SCIENCE, V302, P646, DOI 10.1126/science.1087761; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Shen F, 1996, J BIOL CHEM, V271, P3692; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; SMELAND TE, 1994, P NATL ACAD SCI USA, V91, P10712, DOI 10.1073/pnas.91.22.10712; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; STENMARK H, 1994, EMBO J, V13, P575, DOI 10.1002/j.1460-2075.1994.tb06295.x; Suh HY, 2010, EMBO J, V29, P496, DOI 10.1038/emboj.2009.347; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Yang XP, 1998, EMBO J, V17, P4954, DOI 10.1093/emboj/17.17.4954; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zhu YQ, 2010, P NATL ACAD SCI USA, V107, P4699, DOI 10.1073/pnas.0914231107	53	47	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28704	28712		10.1074/jbc.M113.488213	http://dx.doi.org/10.1074/jbc.M113.488213			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23979137	Green Published, hybrid			2022-12-25	WOS:000330298800024
J	Chen, JKC; Chuang, AYC; Sprinzl, GM; Tung, TH; Li, LPH				Chen, Joshua Kuang-Chao; Chuang, Ann Yi-Chiun; Sprinzl, Georg Mathias; Tung, Tao-Hsin; Li, Lieber Po-Hung			Impedance and Electrically Evoked Compound Action Potential (ECAP) Drop within 24 Hours after Cochlear Implantation	PLOS ONE			English	Article							ELECTRODE IMPEDANCE; STIMULATION LEVELS; HEARING-LOSS; GUINEA-PIG; CONSERVATION; PLASTICITY; NUCLEUS	Previous animal study revealed that post-implantation electrical detection levels significantly declined within days. The impact of cochlear implant (CI) insertion on human auditory pathway in terms of impedance and electrically evoked compound action potential (ECAP) variation within hours after surgery remains unclear, since at this time frequency mapping can only commence weeks after implantation due to factors associated with wound conditions. The study presented our experiences with regards to initial switch-on within 24 hours, and thus the findings about the milieus inside cochlea within the first few hours after cochlear implantation in terms of impedance/ECAP fluctuations. The charts of fifty-four subjects with profound hearing impairment were studied. A minimal invasive approach was used for cochlear implantation, characterized by a small skin incision (approximate to 2.5 cm) and soft techniques for cochleostomy. Impedance/ECAP was measured intro-operatively and within 24 hours post-operatively. Initial mapping within 24 hours post-operatively was performed in all patients without major complications. Impedance/ECAP became significantly lower measured within 24 hours post-operatively as compared with intra-operatively (p<0.001). There were no differences between pre-operative and post-operative threshold for air-conduction hearing. A significant drop of impedance/ECAP in one day after cochlear implantation was revealed for the first time in human beings. Mechanisms could be related to the restoration of neuronal sensitivity to the electrical stimulation, and/or the interaction between the matrix enveloping the electrodes and the electrical stimulation of the initial switch-on. Less wound pain/swelling and soft techniques both contributed to the success of immediate initial mapping, which implied a stable micro-environment inside the cochlea despite electrodes insertion. Our research invites further studies to correlate initial impedance/ECAP changes with long-term hearing/speech performance.	[Chen, Joshua Kuang-Chao; Li, Lieber Po-Hung] Cheng Hsin Gen Hosp, Dept Otolaryngol, Taipei, Taiwan; [Tung, Tao-Hsin] Cheng Hsin Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chen, Joshua Kuang-Chao; Li, Lieber Po-Hung] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Chuang, Ann Yi-Chiun] Mackay Mem Hosp, Taipei, Taiwan; [Sprinzl, Georg Mathias] Med Univ Innsbruck, Dept Otorhinolaryngol, A-6020 Innsbruck, Austria; [Li, Lieber Po-Hung] Taipei Vet Gen Hosp, Dept Med Res & Educ, Integrated Brain Res Lab, Taipei, Taiwan	Cheng Hsin General Hospital; Cheng Hsin General Hospital; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Medical University of Innsbruck; Taipei Veterans General Hospital	Li, LPH (corresponding author), Cheng Hsin Gen Hosp, Dept Otolaryngol, Taipei, Taiwan.	lieber.li@msa.hinet.net	Li, Lieber/AFL-7454-2022; Li, Lieber/AAG-7397-2022		Cheng Hsin General Hospital of Taiwan [9522, 9739, 9840, 9941, 10032]	Cheng Hsin General Hospital of Taiwan	Conceived and designed the experiments: LPHL JKCC. Performed the experiments: LPHL JKCC. Analyzed the data: AYCC THT. Contributed reagents/materials/analysis tools: THT. Wrote the paper: LPHL GMS JKCC. This work was supported by Cheng Hsin General Hospital (9522, 9739, 9840, 9941, and 10032) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Vinamra, 2012, Cochlear Implants Int, V13, P113, DOI 10.1179/1754762811Y.0000000015; Balkany TJ, 2006, OTOL NEUROTOL, V27, P1083, DOI 10.1097/01.mao.0000244355.34577.85; Brown CJ, 2010, J AM ACAD AUDIOL, V21, P5, DOI 10.3766/jaaa.21.1.2; Clark G M, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P40; deSauvage RC, 1997, HEARING RES, V110, P119, DOI 10.1016/S0378-5955(97)00066-X; Di Nardo W, 2007, EUR ARCH OTO-RHINO-L, V264, P855, DOI 10.1007/s00405-007-0270-8; Dodson HC, 1997, J NEUROCYTOL, V26, P541, DOI 10.1023/A:1015434524040; DUCKERT LG, 1983, LARYNGOSCOPE, V93, P841; Durham D, 2000, HEARING RES, V147, P145, DOI 10.1016/S0378-5955(00)00128-3; Friedland David R, 2009, Trends Amplif, V13, P124, DOI 10.1177/1084713809336422; Henkin Y, 2006, ACTA OTO-LARYNGOL, V126, P581, DOI 10.1080/00016480500443391; Henkin Y, 2003, INT J PEDIATR OTORHI, V67, P873, DOI 10.1016/S0165-5876(03)00131-9; Illing RB, 2006, HEARING RES, V216, P189, DOI 10.1016/j.heares.2005.12.014; JUIZ JM, 1988, ACTA OTO-LARYNGOL, V106, P29, DOI 10.3109/00016488809107367; Kawano A, 1998, ACTA OTO-LARYNGOL, V118, P313; Kiefer J, 2004, ACTA OTO-LARYNGOL, V124, P272, DOI 10.1080/00016480310000755a; Leake-Jones P A, 1980, Scan Electron Microsc, P427; Li LPH, 2006, EUR J NEUROSCI, V24, P937, DOI 10.1111/j.1460-9568.2006.04961.x; Li LPH, 2013, NEUROIMAGE, V64, P356, DOI 10.1016/j.neuroimage.2012.09.002; Li LPH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035055; Li LPH, 2003, ANN NEUROL, V53, P810, DOI 10.1002/ana.10599; Nadol JB, 2008, OTOL NEUROTOL, V29, P1076, DOI 10.1097/MAO.0b013e31818c33cf; Newbold C, 2004, J NEURAL ENG, V1, P218, DOI 10.1088/1741-2560/1/4/005; PFINGST BE, 1981, ACTA OTO-LARYNGOL, V92, P1, DOI 10.3109/00016488109133232; Roland JT, 2005, LARYNGOSCOPE, V115, P1325, DOI 10.1097/01.mlg.0000167993.05007.35; Somdas MA, 2007, AUDIOL NEURO-OTOL, V12, P277, DOI 10.1159/000103208; Su GL, 2008, HEARING RES, V241, P64, DOI 10.1016/j.heares.2008.04.011	27	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71929	10.1371/journal.pone.0071929	http://dx.doi.org/10.1371/journal.pone.0071929			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991008	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800025
J	Li, SM; Yu, Q; Wang, GX; Lin, JD				Li, Siming; Yu, Qi; Wang, Guo-Xiao; Lin, Jiandie D.			The Biological Clock is Regulated by Adrenergic Signaling in Brown Fat but is Dispensable for Cold-Induced Thermogenesis	PLOS ONE			English	Article							PERIPHERAL CIRCADIAN CLOCKS; ADIPOSE-TISSUE; TRANSCRIPTIONAL CONTROL; GENE-EXPRESSION; COMPONENT; MUSCLE; MICE; BMAL1; MOUSE; IDENTIFICATION	The biological clock plays an important role in integrating nutrient and energy metabolism with other cellular processes. Previous studies have demonstrated that core clock genes are rhythmically expressed in peripheral tissues, including the liver, skeletal muscle, pancreatic islets, and white and brown adipose tissues. These peripheral clocks are entrained by physiological cues, thereby aligning the circadian pacemaker to tissue functions. The mechanisms that regulate brown adipose tissue clock in response to physiological signals remain poorly understood. Here we found that the expression of core clock genes is highly responsive to cold exposure in brown fat, but not in white fat. This cold-inducible regulation of the clock network is mediated by adrenergic receptor activation and the transcriptional coactivator PGC-1 alpha. Brown adipocytes in mice lacking a functional clock contain large lipid droplets accompanied by dysregulation of genes involved in lipid metabolism and adaptive thermogenesis. Paradoxically, the "clockless" mice were competent in maintaining core body temperature during cold exposure. These studies elucidated the presence of adrenergic receptor/clock crosstalk that appears to be required for normal thermogenic gene expression in brown fat.	[Lin, Jiandie D.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lin, JD (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	jdlin@umich.edu			National Institutes of Health [DK077086, HL097738]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK077086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (DK077086 and HL097738 to JDL). SL and GXW were supported by Scientist Development Grant and Predoctoral Fellowship from the American Heart Association, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2005, ENDOCRINOLOGY, V146, P5631, DOI 10.1210/en.2005-0771; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; COUSIN B, 1992, J CELL SCI, V103, P931; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Damiola F., 2000, GENE DEV, V14, DOI DOI 10.1101/gad.183500; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gimble JM, 2011, CURR OPIN CLIN NUTR, V14, P554, DOI 10.1097/MCO.0b013e32834ad94b; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guo BY, 2012, FASEB J, V26, P3453, DOI 10.1096/fj.12-205781; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Pan DN, 2009, CELL, V137, P73, DOI 10.1016/j.cell.2009.01.051; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	53	25	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e70109	10.1371/journal.pone.0070109	http://dx.doi.org/10.1371/journal.pone.0070109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23990898	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800007
J	Nittby, H; Ericsson, P; Fornvik, K; Stromblad, S; Jansson, L; Xue, ZT; Skagerberg, G; Widegren, B; Sjogren, HO; Salford, LG				Nittby, Henrietta; Ericsson, Peter; Fornvik, Karolina; Stromblad, Susanne; Jansson, Linda; Xue, Zhongtian; Skagerberg, Gunnar; Widegren, Bengt; Sjogren, Hans-Olov; Salford, Leif G.			Zebularine Induces Long-Term Survival of Pancreatic Islet Allotransplants in Streptozotocin Treated Diabetic Rats	PLOS ONE			English	Article							CARDIAC ALLOGRAFT SURVIVAL; INDOLEAMINE 2,3-DIOXYGENASE; DENDRITIC CELLS; GENE-EXPRESSION; INHIBITION	Background: Coping with the immune rejection of allotransplants or autologous cells in patients with an active sensitization towards their autoantigens and autoimmunity presently necessitates life-long immune suppressive therapy acting on the immune system as a whole, which makes the patients vulnerable to infections and increases their risk of developing cancer. New technologies to induce antigen selective long-lasting immunosuppression or immune tolerance are therefore much needed. Methodology/Principal Findings: The DNA demethylating agent Zebularine, previously demonstrated to induce expression of the genes for the immunosuppressive enzymes indolamine-2,3-deoxygenase-1 (IDO1) and kynureninase of the kynurenine pathway, is tested for capacity to suppress rejection of allotransplants. Allogeneic pancreatic islets from Lewis rats were transplanted under the kidney capsule of Fischer rats previously made diabetic by a streptozotocin injection (40 mg/kg). One group was treated with Zebularine (225 mg/kg) daily for 14 days from day 6 or 8 after transplantation, and a control group received no further treatment. Survival of the transplants was monitored by blood sugar measurements. Rats, normoglycemic for 90 days after allografting, were subjected to transplant removal by nephrectomy to confirm whether normoglycemia was indeed due to a surviving insulin producing transplant, or alternatively was a result of recovery of pancreatic insulin production in some toxin-treated rats. Of 9 Zebularine treated rats, 4 were still normoglycemic after 90 days and became hyperglycemic after nephrectomy. The mean length of normoglycemia in the Zebularine group was 67 +/- 8 days as compared to 14 +/- 3 days in 9 controls. Seven rats (2 controls and 5 Zebularine treated) were normoglycemic at 90 days due to pancreatic recovery as demonstrated by failure of nephrectomy to induce hyperglycemia. Conclusions/Significance: Zebularine treatment in vivo induces a long-lasting suppression of the immune destruction of allogeneic pancreatic islets resulting in protection of allograft function for more than 10 weeks after end of treatment.	[Nittby, Henrietta; Ericsson, Peter; Fornvik, Karolina; Stromblad, Susanne; Jansson, Linda; Xue, Zhongtian; Skagerberg, Gunnar; Widegren, Bengt; Sjogren, Hans-Olov; Salford, Leif G.] Lund Univ, Inst Clin Sci, Dept Neurosurg, Rausing Lab, Lund, Sweden	Lund University	Nittby, H (corresponding author), Lund Univ, Inst Clin Sci, Dept Neurosurg, Rausing Lab, Lund, Sweden.	Henrietta.Nittby@med.lu.se		Fornvik, Karolina/0000-0003-1247-2569; Nittby Redebrandt, Henrietta/0000-0003-0140-8107	Hans and Marit Rausing Charitable Trust; Lund University Hospital Funds; Janne Troedsson Research Fund	Hans and Marit Rausing Charitable Trust; Lund University Hospital Funds; Janne Troedsson Research Fund	The authors are grateful to the Hans and Marit Rausing Charitable Trust, the Lund University Hospital Funds and the Janne Troedsson Research Fund for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belladonna ML, 2006, J IMMUNOL, V177, P130, DOI 10.4049/jimmunol.177.1.130; Bianco NR, 2009, ARTHRITIS RHEUM-US, V60, P380, DOI 10.1002/art.24229; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Delle H, 2010, AM J TRANSPLANT, V10, P1918, DOI 10.1111/j.1600-6143.2010.03190.x; FERRAND N, 1995, AM J PHYSIOL-CELL PH, V269, pC1250, DOI 10.1152/ajpcell.1995.269.5.C1250; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Funeshima-Fuji N, 2009, J HEART LUNG TRANSPL, V28, P176, DOI 10.1016/j.healun.2008.11.914; Hautz T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/757310; He Z, 2006, XENOTRANSPLANTATION, V13, P195, DOI 10.1111/j.1399-3089.2006.00274.x; Hemmings SJ, 1994, MOL CELL BIOCHEM, V39, P131; Hertenstein A, 2011, BIOCHEM PHARMACOL, V82, P632, DOI 10.1016/j.bcp.2011.06.013; Li JP, 2007, AM J PHYSIOL-HEART C, V293, pH3415, DOI 10.1152/ajpheart.00532.2007; Liu H, 2007, CANCER LETT, V257, P107, DOI 10.1016/j.canlet.2007.07.013; Mudigonda T, 2013, INCIDENCE RISK FACTO; Orabona C, 2011, METHODS MOL BIOL, V677, P269, DOI 10.1007/978-1-60761-869-0_19; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; RAKIETEN N, 1976, P SOC EXP BIOL MED, V151, P356; SLOAN GM, 1981, J SURG RES, V30, P463, DOI 10.1016/0022-4804(81)90091-3; TAKEMOTO S, 1992, NEW ENGL J MED, V327, P834, DOI 10.1056/NEJM199209173271202; Tuduri E, 2011, DIABETES OBES METAB, V13, P53, DOI 10.1111/j.1463-1326.2011.01446.x; Xue ZT, 2012, MOL IMMUNOL, V51, P101, DOI 10.1016/j.molimm.2012.01.006; YOSHINO G, 1992, HORM METAB RES, V24, P306, DOI 10.1055/s-2007-1003319	22	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71981	10.1371/journal.pone.0071981	http://dx.doi.org/10.1371/journal.pone.0071981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991016	gold, Green Submitted, Green Published			2022-12-25	WOS:000324228800031
J	Leleu, H; Minvielle, E				Leleu, Henri; Minvielle, Etienne			Relationship between Longitudinal Continuity of Primary Care and Likelihood of Death: Analysis of National Insurance Data	PLOS ONE			English	Article							HEALTH-CARE; PHYSICIAN; QUESTIONNAIRE; ASSOCIATION; OUTCOMES	Background: Continuity of care (COC) is a widely accepted core principle of primary care and has been associated with patient satisfaction, healthcare utilization and mortality in many, albeit small, studies. Objective: To assess the relationship between longitudinal continuity with a primary care physician (PCP) and likelihood of death in the French general population. Design: Observational study based on reimbursement claims from the French national health insurance (NHI) database for salaried workers (2007-2010). Setting: Primary care. Patients: We extracted data on the number and pattern of visits made to a PCP and excluded all patients who did not visit a PCP at least twice within 6 months. We recorded age, gender, comorbidities, social status, and deaths. Main outcome measures: The primary endpoint was death by all causes. We measured longitudinal continuity of care (COC) with a PCP twice a year between 2007 and 2010, using the COC index developed by Bice and Boxerman. We introduced the COC index as time-dependent variables in a survival analysis after adjustment for age, gender and stratifying on comorbidities and social status. Results: A total of 325 742 patients were included in the analysis. The average COC index ranged from 0.74 (SD: 0.35) to 0.76 (0.35) (where 1.0 is perfect continuity). Likelihood of death was lower in patients with higher continuity (hazard ratio for an increase in 0.1 of continuity, adjusted for age, sex, and stratified on comorbidities and social status: 0.96 [0.95-0.96]). Conclusion: Higher longitudinal continuity was associated with a reduced likelihood of death.	[Leleu, Henri] Publ Hlth Expertise, Hlth Econ & Outcome Res, Loos, France; [Leleu, Henri; Minvielle, Etienne] Ecole Hautes Etud Sante Publ Gustave Roussy, Res Unit, Management Healthcare Org, Villejuif, France	UNICANCER; Gustave Roussy	Leleu, H (corresponding author), Publ Hlth Expertise, Hlth Econ & Outcome Res, Loos, France.	henri.leleu@ph-expertise.com		Leleu, Henri/0000-0003-4930-6767				Alazri Mohammed, 2007, Sultan Qaboos Univ Med J, V7, P197; Aller MB, 2012, J CLIN EPIDEMIOL, V65, P578, DOI 10.1016/j.jclinepi.2011.11.009; [Anonymous], 2002, HEALTH CARE; BECKER MH, 1974, AM J PUBLIC HEALTH, V64, P1062, DOI 10.2105/AJPH.64.11.1062; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; Cabana MD, 2004, J FAM PRACTICE, V53, P974; EJLERTSSON G, 1984, MED CARE, V22, P231, DOI 10.1097/00005650-198403000-00006; ERIKSSON EA, 1983, MED CARE, V21, P858, DOI 10.1097/00005650-198309000-00003; ERIKSSON EA, 1990, MED CARE, V28, P180, DOI 10.1097/00005650-199002000-00009; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Guthrie B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a867; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jee SH, 2006, MED CARE RES REV, V63, P158, DOI 10.1177/1077558705285294; Ridd MJ, 2011, ANN FAM MED, V9, P538, DOI 10.1370/afm.1322; ROGERS J, 1980, AM J PUBLIC HEALTH, V70, P122, DOI 10.2105/AJPH.70.2.122; Salisbury C, 2009, BRIT J GEN PRACT, V59, P276, DOI 10.3399/bjgp09X420257; Saultz John W, 2003, Ann Fam Med, V1, P134, DOI 10.1370/afm.23; Saultz JW, 2004, ANN FAM MED, V2, P445, DOI 10.1370/afm.91; SMEDBY O, 1986, MED CARE, V24, P511; Starfield B., 1992, PRIMARY CARE CONCEPT; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Therneau TM, 2000, MODELING SURVIVAL DA; Tuppin P, 2010, REV EPIDEMIOL SANTE, V58, P286, DOI 10.1016/j.respe.2010.04.005; Uijen AA, 2012, J CLIN EPIDEMIOL, V65, P577, DOI 10.1016/j.jclinepi.2011.10.015; Uijen AA, 2011, J CLIN EPIDEMIOL, V64, P1391, DOI 10.1016/j.jclinepi.2011.03.006; van Walraven C, 2010, J EVAL CLIN PRACT, V16, P947, DOI 10.1111/j.1365-2753.2009.01235.x; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413; Weiss LJ, 1996, AM J PUBLIC HEALTH, V86, P1742, DOI 10.2105/AJPH.86.12.1742; Wolinsky FD, 2010, J GERONTOL A-BIOL, V65, P421, DOI 10.1093/gerona/glp188	30	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e71669	10.1371/journal.pone.0071669	http://dx.doi.org/10.1371/journal.pone.0071669			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218ZA	23990970	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470700019
J	Dexter, N; Hudson, M; James, S; MacGregor, C; Lindenmayer, DB				Dexter, Nick; Hudson, Matt; James, Stuart; MacGregor, Christopher; Lindenmayer, David B.			Unintended Consequences of Invasive Predator Control in an Australian Forest: Overabundant Wallabies and Vegetation Change	PLOS ONE			English	Article							WHITE-TAILED DEER; NEW-SOUTH-WALES; SWAMP WALLABY; FOX-CONTROL; GRAZING RESPONSE; BROWSING DAMAGE; DIET SELECTION; HERBIVORY; IMPACT; RECRUITMENT	Over-abundance of native herbivores is a problem in many forests worldwide. The abundance of native macropod wallabies is extremely high at Booderee National Park (BNP) in south-eastern Australia. This has occurred because of the reduction of exotic predators through an intensive baiting program, coupled with the absence of other predators. The high density of wallabies at BNP may be inhibiting the recruitment of many plant species following fire-induced recruitment events. We experimentally examined the post-fire response of a range of plant species to browsing by wallabies in a forest heavily infested with the invasive species, bitou bush Chrysanthemoides monilifera. We recorded the abundance and size of a range of plant species in 18 unfenced (browsed) and 16 fenced (unbrowsed) plots. We found the abundance and size of bitou bush was suppressed in browsed plots compared to unbrowsed plots. Regenerating seedlings of the canopy or middle storey tree species Eucalyptus pilularis, Acacia implexa, Allocasuarina littoralis, Breynia oblongifolia and Banksia integrifolia were either smaller or fewer in number in grazed plots than treatment plots as were the vines Kennedia rubicunda, Glycine tabacina and Glycine clandestina. In contrast, the understorey fern, Pteridium esculentum increased in abundance in the browsed plots relative to unbrowsed plots probably because of reduced competition with more palatable angiosperms. Twelve months after plots were installed the community structure of the browsed and unbrowsed plots was significantly different (P = 0.023, Global R = 0.091). The relative abundance of C. monilifera and P. esculentum contributed most to the differences. We discuss the possible development of a low diversity bracken fern parkland in Booderee National Park through a trophic cascade, similar to that caused by overabundant deer in the northern hemisphere. We also discuss its implications for broad scale fox control in southern Australian forests.	[Dexter, Nick; Hudson, Matt; James, Stuart] Booderee Natl Pk, Jervis Bay, Australia; [MacGregor, Christopher; Lindenmayer, David B.] Australian Natl Univ, Natl Environm Res Program, Fenner Sch Environm & Soc, Canberra, ACT, Australia	Australian National University	Dexter, N (corresponding author), Booderee Natl Pk, Jervis Bay, Australia.	nicholas.dexter@environment.gov.au	MacGregor, Christopher/AFQ-6785-2022; Lindenmayer, David B/P-7183-2017	MacGregor, Christopher/0000-0002-7908-204X; Lindenmayer, David B/0000-0002-4766-4088	Parks Australia; Australian Research Council	Parks Australia; Australian Research Council(Australian Research Council)	Funding was provided by Parks Australia, and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allombert S, 2005, CONSERV BIOL, V19, P1917, DOI 10.1111/j.1523-1739.2005.00280.x; ATTIWILL PM, 1994, FOREST ECOL MANAG, V63, P301, DOI 10.1016/0378-1127(94)90115-5; Balfour D., 2007, REV OPTIONS MANAGING, P80; Banks PB, 2000, AUSTRAL ECOL, V25, P283, DOI 10.1046/j.1442-9993.2000.01039.x; Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; Boland DJ, 2006, FOREST TREES AUSTR; Booderee National Park Management Plan, 2002, CONS DESCR BOOD NAT; Bradstock RA, 2012, FLAMMABLE AUSTRALIA: FIRE REGIMES, BIODIVERSITY AND ECOSYSTEMS IN A CHANGING WORLD, P1; Brathen KA, 2007, ECOSYSTEMS, V10, P773, DOI 10.1007/s10021-007-9058-3; Cho G., 1995, JERVIS BAY PLACE CUL, P3; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; COOKE BD, 1988, AUST J ECOL, V13, P11, DOI 10.1111/j.1442-9993.1988.tb01414.x; COOPERDRIVER G, 1977, BIOCHEM SYST ECOL, V5, P177, DOI 10.1016/0305-1978(77)90002-3; COULSON G, 1998, MANAGING MARSUPIAL A, P37; COWLING RM, 1987, J APPL ECOL, V24, P645, DOI 10.2307/2403899; DECALESTA DS, 1994, J WILDLIFE MANAGE, V58, P711, DOI 10.2307/3809685; Dexter N, 1998, WILDLIFE RES, V25, P147, DOI 10.1071/WR97020; Dexter N, 2012, ECOSYSTEMS, V15, P1363, DOI 10.1007/s10021-012-9590-7; Dexter N, 2011, AUSTRAL ECOL, V36, P745, DOI 10.1111/j.1442-9993.2010.02213.x; Dexter N, 2009, WILDLIFE RES, V36, P252, DOI 10.1071/WR08135; Di Stefano J, 2005, NEW FOREST, V29, P43, DOI 10.1007/s11056-004-6767-8; Di Stefano J, 2008, J MAMMAL, V89, P1540, DOI 10.1644/07-MAMM-A-193.1; Diaz S, 2001, J APPL ECOL, V38, P497, DOI 10.1046/j.1365-2664.2001.00635.x; Edmonds J.M., 1997, BLACK NIGHTSHADES SO, V15; Ens EJ, 2008, BIOL CONSERV, V141, P590, DOI 10.1016/j.biocon.2007.12.012; FALVEY JL, 1981, TROP GRASSLANDS, V15, P52; Fensham RJ, 1999, J VEG SCI, V10, P77, DOI 10.2307/3237163; FENWICK G R, 1988, Journal of the Science of Food and Agriculture, V46, P147; Florence R.G, 1996, ECOLOGY SILVICULTURE; FRELICH LE, 1985, BIOL CONSERV, V34, P99, DOI 10.1016/0006-3207(85)90103-X; Gill A. Malcolm, 2002, P351; GILL RMA, 1992, FORESTRY, V65, P363, DOI 10.1093/forestry/65.4.363-a; Hanley ME, 2001, OECOLOGIA, V126, P409, DOI 10.1007/s004420000538; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; HOLLIS CJ, 1986, AUST WILDLIFE RES, V13, P355, DOI 10.1071/WR9860355; Horsley SB, 2003, ECOL APPL, V13, P98, DOI 10.1890/1051-0761(2003)013[0098:WTDIOT]2.0.CO;2; HORSLEY SB, 1983, CAN J FOREST RES, V13, P61, DOI 10.1139/x83-009; Kinnear JE, 1998, WILDLIFE RES, V25, P81, DOI 10.1071/WR96072; Kinnear JE, 2002, BIOL CONSERV, V108, P335, DOI 10.1016/S0006-3207(02)00116-7; Kirby KJ, 2001, FORESTRY, V74, P219, DOI 10.1093/forestry/74.3.219; LANGE RT, 1983, AUST J ECOL, V8, P377, DOI 10.1111/j.1442-9993.1983.tb01334.x; LEIGH JH, 1979, AUST J ECOL, V4, P25, DOI 10.1111/j.1442-9993.1979.tb01196.x; Lindenmayer DB, 2008, WILDLIFE RES, V35, P395, DOI 10.1071/WR07156; McArthur C, 2000, FOREST ECOL MANAG, V139, P157, DOI 10.1016/S0378-1127(99)00342-4; MCCAW W L, 1988, Journal of the Royal Society of Western Australia, V71, P1; McCulloch C.E., 2005, ENCY BIOSTATISTICS, V4; Meek P. D., 1998, Proceedings of the Linnean Society of New South Wales, V120, P117; Meek Paul, 1995, Kowari, V5, P115; Niu KC, 2010, PLANT SOIL, V330, P215, DOI 10.1007/s11104-009-0194-8; Nomiya H, 2003, PLANT ECOL, V164, P263, DOI 10.1023/A:1021294021438; Orell P, 1996, W SHIELD REV CONS LA; PAINE RT, 1969, LIMNOL OCEANOGR, V14, P710, DOI 10.4319/lo.1969.14.5.0710; Parsons MH, 2007, RESTOR ECOL, V15, P250, DOI 10.1111/j.1526-100X.2007.00208.x; Parsons MH, 2006, FOREST ECOL MANAG, V229, P39, DOI 10.1016/j.foreco.2006.03.020; Parsons Michael H., 2007, BMC Ecology, V7, P13, DOI 10.1186/1472-6785-7-13; Prattis K. E., 2004, THESIS U WOLLONGONG; Rafferty C, 2005, PLANT ECOL, V177, P201, DOI 10.1007/s11258-005-2362-0; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; Roberts MW, 2006, WILDLIFE RES, V33, P481, DOI 10.1071/WR05009; ROBERTSHAW JD, 1986, AUST WILDLIFE RES, V13, P141, DOI 10.1071/WR9860141; Rooney TP, 2001, FORESTRY, V74, P201, DOI 10.1093/forestry/74.3.201; Saunders GR, 2010, MAMMAL REV, V40, P181, DOI 10.1111/j.1365-2907.2010.00159.x; Scurr G, 2008, AUSTRAL ECOL, V33, P941, DOI 10.1111/j.1442-9993.2008.01865.x; Semple WS, 2001, RANGELAND J, V23, P182, DOI 10.1071/RJ01005; Sprent JA, 2002, AUST J ZOOL, V50, P183, DOI 10.1071/ZO01043; SYMON DE, 1986, ANN MO BOT GARD, V73, P745, DOI 10.2307/2399203; Taws N., 1998, FIRE VEGETATION MANA; Thomas J, 2006, ECOLOGICAL MANAGEMEN, V7, P80; TOLHURST KG, 1992, FOREST ECOL MANAG, V54, P45, DOI 10.1016/0378-1127(92)90004-S; Vanak AT, 2012, ECOGRAPHY, V35, P315, DOI 10.1111/j.1600-0587.2011.07213.x; Vesk PA, 2004, J APPL ECOL, V41, P22, DOI 10.1111/j.1365-2664.2004.00857.x; Von Ende CN., 2001, DESIGN ANAL ECOLOGIC, P134; Vourc'h G, 2002, OIKOS, V98, P271, DOI 10.1034/j.1600-0706.2002.980209.x; Vranjic JA, 1996, 2 AUSTR NAT SEED BIO, P221; Waller DM, 1997, WILDLIFE SOC B, V25, P217; Wardle DA, 2004, FRONT ECOL ENVIRON, V2, P145, DOI 10.1890/1540-9295(2004)002[0145:HCILHM]2.0.CO;2; WILKINSON GR, 1995, FOREST ECOL MANAG, V74, P117, DOI 10.1016/0378-1127(94)03502-N; Winkler M. A., 2008, BITOU BUSH MANAGEMEN	78	47	51	0	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e69087	10.1371/journal.pone.0069087	http://dx.doi.org/10.1371/journal.pone.0069087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990879	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100008
J	Mitry, D; Peto, T; Hayat, S; Morgan, JE; Khaw, KT; Foster, PJ				Mitry, Danny; Peto, Tunde; Hayat, Shabina; Morgan, James E.; Khaw, Kay-Tee; Foster, Paul J.			Crowdsourcing as a Novel Technique for Retinal Fundus Photography Classification: Analysis of Images in the EPIC Norfolk Cohort on Behalf of the UKBiobank Eye and Vision Consortium	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; DIAGNOSIS; QUALITY	Aim: Crowdsourcing is the process of outsourcing numerous tasks to many untrained individuals. Our aim was to assess the performance and repeatability of crowdsourcing for the classification of retinal fundus photography. Methods: One hundred retinal fundus photograph images with pre-determined disease criteria were selected by experts from a large cohort study. After reading brief instructions and an example classification, we requested that knowledge workers (KWs) from a crowdsourcing platform classified each image as normal or abnormal with grades of severity. Each image was classified 20 times by different KWs. Four study designs were examined to assess the effect of varying incentive and KW experience in classification accuracy. All study designs were conducted twice to examine repeatability. Performance was assessed by comparing the sensitivity, specificity and area under the receiver operating characteristic curve (AUC). Results: Without restriction on eligible participants, two thousand classifications of 100 images were received in under 24 hours at minimal cost. In trial 1 all study designs had an AUC (95%CI) of 0.701(0.680-0.721) or greater for classification of normal/abnormal. In trial 1, the highest AUC (95%CI) for normal/abnormal classification was 0.757 (0.738-0.776) for KWs with moderate experience. Comparable results were observed in trial 2. In trial 1, between 64-86% of any abnormal image was correctly classified by over half of all KWs. In trial 2, this ranged between 74-97%. Sensitivity was >= 96% for normal versus severely abnormal detections across all trials. Sensitivity for normal versus mildly abnormal varied between 61-79% across trials. Conclusions: With minimal training, crowdsourcing represents an accurate, rapid and cost-effective method of retinal image analysis which demonstrates good repeatability. Larger studies with more comprehensive participant training are needed to explore the utility of this compelling technique in large scale medical image analysis.	[Mitry, Danny; Peto, Tunde; Foster, Paul J.] Moorfields Eye Hosp, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Mitry, Danny; Peto, Tunde; Foster, Paul J.] UCL, Inst Ophthalmol, London, England; [Hayat, Shabina] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge, England; [Morgan, James E.] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales; [Khaw, Kay-Tee] Univ Cambridge, Addenbrookes Hosp, Dept Clin Gerontol, Cambridge CB2 2QQ, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of Cambridge; Cardiff University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Mitry, D (corresponding author), Moorfields Eye Hosp, Natl Inst Hlth Res, Biomed Res Ctr, London, England.	mitryd@gmail.com	Morgan, James/GRO-2905-2022; Peto, Tunde/G-8812-2018; Khaw, Kay-Tee/AAZ-3209-2021; Foster, Paul/V-7288-2019	Morgan, James/0000-0002-8920-1065; Peto, Tunde/0000-0001-6265-0381; Foster, Paul/0000-0002-4755-177X	Special Trustees of Moorfields Eye Hospital; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; University College London Institute of Ophthalmology; Medical Research Council [G0401527]; Cancer Research United Kingdom [C864/A8257]; Research into Ageing [262]; Medical Research Council [G1000143, MC_qA137853, MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish	Special Trustees of Moorfields Eye Hospital; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; University College London Institute of Ophthalmology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research United Kingdom(Cancer Research UK); Research into Ageing; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Special Trustees of Moorfields Eye Hospital and National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology. EPIC-Norfolk infrastructure and core functions are supported by grants from the Medical Research Council (G0401527) and Cancer Research United Kingdom (C864/A8257). The clinic for the third health examination was funded by Research into Ageing (262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2010, OPHTHALMOLOGY, V117, P1147, DOI 10.1016/j.ophtha.2010.03.046; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Chiang MF, 2007, ARCH OPHTHALMOL-CHIC, V125, P1531, DOI 10.1001/archopht.125.11.1531; Eiben CB, 2012, NAT BIOTECHNOL, V30, P190, DOI 10.1038/nbt.2109; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Kankanahalli S, 2013, INVEST OPHTH VIS SCI, V54, P1789, DOI 10.1167/iovs.12-10928; Khawaja AP, 2013, BMJ OPEN, P3; Lessl M, 2011, NAT REV DRUG DISCOV, V10, P241, DOI 10.1038/nrd3412; LEUREDUPREE AE, 1981, INVEST OPHTH VIS SCI, V21, P1; Mavandadi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037245; Nguyen TB, 2012, RADIOLOGY, V262, P824, DOI 10.1148/radiol.11110938; Niemeijer M, 2007, INVEST OPHTH VIS SCI, V48, P2260, DOI 10.1167/iovs.06-0996; Raddick MJ, 2013, ARXIV13036886; Sanchez CI, 2011, INVEST OPHTH VIS SCI, V52, P4866, DOI 10.1167/iovs.10-6633; Sinclair SH, 2006, EXPERT REV MED DEVIC, V3, P301, DOI 10.1586/17434440.3.3.301; Turner AM, 2012, J MED INTERNET RES, V14, P218, DOI 10.2196/jmir.2063	16	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71154	10.1371/journal.pone.0071154	http://dx.doi.org/10.1371/journal.pone.0071154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990935	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100039
J	Le, VH; Nagesh, N; Lewis, EA				Le, Vu H.; Nagesh, Narayana; Lewis, Edwin A.			Bcl-2 Promoter Sequence G-Quadruplex Interactions with Three Planar and Non-Planar Cationic Porphyrins: TMPyP4, TMPyP3, and TMPyP2	PLOS ONE			English	Article							DRUG-RECOGNITION; BINDING; DNA; STABILIZATION; COMPLEXITY; PROTEIN; FAMILY; REGION; MODE	The interactions of three related cationic porphyrins, TMPyP4, TMPyP3 and TMPyP2, with a WT 39-mer Bcl-2 promoter sequence G-quadruplex were studied using Circular Dichroism, ESI mass spectrometry, Isothermal Titration Calorimetry, and Fluorescence spectroscopy. The planar cationic porphyrin TMPyP4 (5, 10, 15, 20-meso-tetra (N-methyl-4-pyridyl) porphine) is shown to bind to a WT Bcl-2 G-quadruplex via two different binding modes, an end binding mode and a weaker mode attributed to intercalation. The related non-planar ligands, TMPyP3 and TMPyP2, are shown to bind to the Bcl-2 G-quadruplex by a single mode. ESI mass spectrometry experiments confirmed that the saturation stoichiometry is 4:1 for the TMPyP4 complex and 2: 1 for the TMPyP2 and TMPyP3 complexes. ITC experiments determined that the equilibrium constant for formation of the (TMPyP4)(1)/DNA complex (K-1 = 3.7 x 10(6)) is approximately two orders of magnitude greater than the equilibrium constant for the formation of the (TMPyP2)(1)/DNA complex, (K-1 = 7.0 x 10(4)). Porphyrin fluorescence is consistent with intercalation in the case of the (TMPyP4)(3)/DNA and (TMPyP4)(4)/DNA complexes. The non-planar shape of the TMPyP2 and TMPyP3 molecules results in both a reduced affinity for the end binding interaction and the elimination of the intercalation binding mode.	[Le, Vu H.; Lewis, Edwin A.] Mississippi State Univ, Dept Chem, Mississippi State, MS 39762 USA; [Nagesh, Narayana] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Mississippi State University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Lewis, EA (corresponding author), Mississippi State Univ, Dept Chem, Mississippi State, MS 39762 USA.	ELewis@chemistry.msstate.edu	; Le, Vu/H-2666-2014	Nagesh, Narayana/0000-0002-8998-8013; Le, Vu/0000-0002-6027-6821				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Anantha NV, 1998, BIOCHEMISTRY-US, V37, P2709, DOI 10.1021/bi973009v; Baretton GB, 1996, CANCER, V77, P255, DOI 10.1002/(SICI)1097-0142(19960115)77:2<255::AID-CNCR6>3.0.CO;2-L; CARVLIN MJ, 1983, NUCLEIC ACIDS RES, V11, P6141, DOI 10.1093/nar/11.17.6141; Cashman DJ, 2008, J MOL MODEL, V14, P93, DOI 10.1007/s00894-007-0254-z; Cavallari M, 2009, J PHYS CHEM B, V113, P13152, DOI 10.1021/jp9039226; Chaires JB, 2001, METHOD ENZYMOL, V340, P3; Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Clark GR, 2003, J AM CHEM SOC, V125, P4066, DOI 10.1021/ja0297988; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; Dettler JM, 2011, BIOPHYS J, V100, P1517, DOI 10.1016/j.bpj.2011.01.068; Dettler JM, 2010, BIOPHYS J, V99, P561, DOI 10.1016/j.bpj.2010.04.042; Dexheimer TS, 2006, J AM CHEM SOC, V128, P5404, DOI 10.1021/ja0563861; Dixon IM, 2005, CHEMBIOCHEM, V6, P123, DOI 10.1002/cbic.200400113; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Freyer MW, 2007, BIOPHYS J, V92, P2007, DOI 10.1529/biophysj.106.097246; Freyer MW, 2006, ANAL BIOCHEM, V355, P259, DOI 10.1016/j.ab.2006.04.049; Gavathiotis E, 2003, J MOL BIOL, V334, P25, DOI 10.1016/j.jmb.2003.09.018; Haider SM, 2003, J MOL BIOL, V326, P117, DOI 10.1016/S0022-2836(02)01354-2; Han FXG, 1999, J AM CHEM SOC, V121, P3561, DOI 10.1021/ja984153m; Han HY, 2001, J AM CHEM SOC, V123, P8902, DOI 10.1021/ja002179j; Haq I, 1999, J AM CHEM SOC, V121, P1768, DOI 10.1021/ja981554t; Heckman C, 1997, J BIOL CHEM, V272, P19609, DOI 10.1074/jbc.272.31.19609; Hounsou C, 2007, CHEMMEDCHEM, V2, P655, DOI 10.1002/cmdc.200600286; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Hyun KM, 1997, BBA-GEN SUBJECTS, V1334, P312, DOI 10.1016/S0304-4165(96)00111-0; Izbicka E, 1999, CANCER RES, V59, P639; Keating LR, 2004, BIOCHEMISTRY-US, V43, P15891, DOI 10.1021/bi0483209; Kumar N, 2005, NUCLEIC ACIDS RES, V33, P6723, DOI 10.1093/nar/gki961; Le VH, 2013, ANAL BIOCHEM, V434, P233, DOI 10.1016/j.ab.2012.11.030; Miyoshi D, 2003, NUCLEIC ACIDS RES, V31, P1156, DOI 10.1093/nar/gkg211; Nagesh N, 2010, BIOPHYS J, V98, P2628, DOI 10.1016/j.bpj.2010.02.050; PASTERNACK RF, 1983, BIOCHEMISTRY-US, V22, P2406, DOI 10.1021/bi00279a016; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; Rezler EM, 2005, J AM CHEM SOC, V127, P9439, DOI 10.1021/ja0505088; SCHEIDT WR, 1974, J AM CHEM SOC, V96, P84, DOI 10.1021/ja00808a013; SUH D, 1995, BIOORGAN MED CHEM, V3, P723, DOI 10.1016/0968-0896(95)00053-J; Vialas C, 2000, BIOCHEMISTRY-US, V39, P9514, DOI 10.1021/bi000743x; Wei CY, 2006, BIOCHEMISTRY-US, V45, P6681, DOI 10.1021/bi052356z; Weisman-Shomer P, 2003, NUCLEIC ACIDS RES, V31, P3963, DOI 10.1093/nar/gkg453; Zhang ZJ, 2010, NUCLEIC ACIDS RES, V38, P1009, DOI 10.1093/nar/gkp1029	42	46	45	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72462	10.1371/journal.pone.0072462	http://dx.doi.org/10.1371/journal.pone.0072462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977303	gold, Green Published, Green Submitted			2022-12-25	WOS:000324527300086
J	Tombre, IM; Eythorsson, E; Madsen, J				Tombre, Ingunn M.; Eythorsson, Einar; Madsen, Jesper			Towards a Solution to the Goose-Agriculture Conflict in North Norway, 1988-2012: The Interplay between Policy, Stakeholder Influence and Goose Population Dynamics	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; GEESE BRANTA-LEUCOPSIS; PINK-FOOTED GEESE; ANSER-BRACHYRHYNCHUS; BARNACLE GEESE; SNOW GEESE; LAND-USE; HABITAT USE; CONSEQUENCES; CONSERVATION	This paper presents results from a multidisciplinary study of a negotiation process between farmers and wildlife authorities which led to an agricultural subsidy scheme to alleviate conflicts between agriculture and geese in Norway. The Svalbard-breeding population of pink-footed geese Anser brachyrhynchus has increased considerably over the last decades and conflicts with farmers have escalated, especially at stopover sites in spring when geese feed on newly sprouted pasture grass. In Vesteralen, an important stopover site for geese in North Norway, farmers deployed scaring of geese at varying intensity dependent on the level of conflict during 1988-2012. We assessed the efficiency of a subsidy scheme established in 2006, in terms of its conflict mitigation, reflected in a near discontinuation of scaring activities. The presence of pink-footed geese was analysed in relation to scaring intensity, the total goose population size and the increasing occurrence of another goose species, the barnacle goose Branta leucopsis. Scaring significantly affected the number of geese staging in Vesteralen, both in absolute and relative terms (controlling for total population size). The geese responded immediately to an increased, and reduced, level of scaring. Despite the establishment of the subsidy scheme, the number of pink-footed geese has recently declined which is probably caused by the increasing number of barnacle geese. For the farmers, the subsidy scheme provides funding that reduces the economic costs caused by the geese. Sustaining a low level of conflict will require close monitoring, dialogue and adaptation of the subsidy scheme to cater for changes in goose population dynamics.	[Tombre, Ingunn M.] Norwegian Inst Nat Res, Arctic Ecol Dept, Fram Ctr, Tromso, Norway; [Eythorsson, Einar] Norwegian Inst Cultural Heritage Res, Fram Ctr, Tromso, Norway; [Madsen, Jesper] Aarhus Univ, Dept Biosci, Arctic Res Ctr, Aarhus, Denmark	Norwegian Institute Nature Research; Aarhus University	Tombre, IM (corresponding author), Norwegian Inst Nat Res, Arctic Ecol Dept, Fram Ctr, Tromso, Norway.	ingunn.tombre@nina.no	Eythorsson, Einar/J-6012-2014; Madsen, Jesper/J-7853-2013	Madsen, Jesper/0000-0003-3246-0215	Research Council of Norway; Directorate for Nature Management; County of Nordland, Sortland Municipality; County of Nord-Trondelag, Sortland Municipality; Fram Centre	Research Council of Norway(Research Council of Norway); Directorate for Nature Management; County of Nordland, Sortland Municipality; County of Nord-Trondelag, Sortland Municipality; Fram Centre	The authors acknowledge the funding from the Research Council of Norway, the Directorate for Nature Management, the County Governor of Nordland, the County Governor of Nord-Trondelag, Sortland Municipality and the Fram Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham KF, 2005, GLOBAL CHANGE BIOL, V11, P841, DOI 10.1111/j.1365-2486.2005.00943.x; Barlindhaug S, 2007, ARCHAEOL PROSPECT, V14, P231, DOI 10.1002/arp.307; Bechet A, 2004, J APPL ECOL, V41, P689, DOI 10.1111/j.0021-8901.2004.00928.x; Bos D, 2003, ARDEA, V91, P153; Cope D, 2005, CONSERV BIOL SER, V9, P176; Cope DR, 2003, BIOL CONSERV, V110, P113, DOI 10.1016/S0006-3207(02)00182-9; County Governor of Nordland, 2007, FORV KORTN HVITK GRA; County Governor of Nordland & County Governor of Nord-Trondelag, 2005, SLUTTR PROSJ FORV GJ; Directorate for Nature Management, 1996, 19962 DN DIR NAT MAN; Drent R, 2003, OIKOS, V103, P274, DOI 10.1034/j.1600-0706.2003.12274.x; Eythorsson E, 1999, NORSK RESSURSFORVALT; Eythorsson E, 2004, 20042 NIBR, P2; EYTHORSSON Einar, 1998, FJORDRESSURSER REGUL; Fortin MJ, 1999, ENVIRON CONSERV, V26, P200, DOI 10.1017/S0376892999000284; Fox AD, 2005, GLOBAL CHANGE BIOL, V11, P881, DOI 10.1111/j.1365-2486.2005.00941.x; Fox Anthony D., 2010, Ornis Svecica, V20, P115; Fyhri A, 2009, LANDSCAPE URBAN PLAN, V91, P202, DOI 10.1016/j.landurbplan.2009.01.002; Ganter B, 2001, BIRD STUDY, V48, P90, DOI 10.1080/00063650109461206; Gauthier G, 2005, GLOBAL CHANGE BIOL, V11, P856, DOI 10.1111/j.1365-2486.2005.00944.x; Hall C, 2011, UPDATE STATUS GEESE; Jacobsen JKS, 2010, GJENGRONING TAP MANG, V3; Klaassen M, 2006, J APPL ECOL, V43, P92, DOI 10.1111/j.1365-2664.2005.01109.x; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Madsen J., 1982, Aquila, V89, P133; Madsen J, 2001, ARDEA, V89, P43; Madsen J, 1998, NORSK POLARINST SKRI, P303; Madsen J, 1999, WETLANDS INT PUBL, V48; Madsen J., 2012, 48 AWEA; Mitchell Carl, 2010, Ornis Svecica, V20, P128; Municipality of Sortland, 1997, FORV KORTN GRAG SORT; NEPAL SK, 1995, ENVIRON MANAGE, V19, P853, DOI 10.1007/BF02471937; Nyhus PJ, 2005, CONSERV BIOL SER, V9, P107; O'Connell-Rodwell CE, 2000, BIOL CONSERV, V93, P381, DOI 10.1016/S0006-3207(99)00108-1; Ormerod SJ, 2003, J APPL ECOL, V40, P939, DOI 10.1111/j.1365-2664.2003.00872.x; PATTERSON I J, 1991, Ardea, V79, P179; Patterson IJ, 2001, J APPL ECOL, V38, P637, DOI 10.1046/j.1365-2664.2001.00627.x; Percival SM, 1997, BIOL CONSERV, V82, P273, DOI 10.1016/S0006-3207(97)00041-4; Prop J, 1998, BIOL CONSERV, V86, P339, DOI 10.1016/S0006-3207(98)00029-9; *SAS I, 2008, SAS 9 2 FDN MICR WIN; Shimmings P, 2011, MONITORING STAGING B; Shimmings P, 2012, OVERVAKING RASTENDEN; Soreng SU, 2008, KORTNEBBGJESS RAST M, V1; Tombre I.M, 2010, 613 NINA; Tombre IM, 2005, AGR ECOSYST ENVIRON, V111, P311, DOI 10.1016/j.agee.2005.06.007; Tombre IM, 2005, AGR ECOSYST ENVIRON, V109, P284, DOI 10.1016/j.agee.2005.02.023; TOMBRE IM, 2005, 83 NINA; Tombre Ingunn M., 2010, Wildfowl, V60, P3; Tombre IM, 2008, J AVIAN BIOL, V39, P691, DOI 10.1111/j.1600-048X.2008.04440.x; Tommervik H, 2010, GJENGROING TAP MANGF, p3 ; van Eerden M. R., 1996, Gibier Faune Sauvage, V13, P681; Van Roomen M, 1992, IWRB SPECIAL PUBLICA, V21, P21; VICKERY JA, 1994, J APPL ECOL, V31, P371, DOI 10.2307/2404551; Vickery JA, 1992, CROP PROTEC, V11, P280; Whitfield J, 2006, NATURE, V439, P908, DOI 10.1038/439908a; Wilson JD, 2010, IBIS, V152, P176, DOI 10.1111/j.1474-919X.2009.00992.x; Wisz M, 2008, DIVERS DISTRIB, V14, P721, DOI 10.1111/j.1472-4642.2008.00476.x; [No title captured], DOI DOI 10.1111/J.1474-919X.1995.TB08459.X	58	35	36	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71912	10.1371/journal.pone.0071912	http://dx.doi.org/10.1371/journal.pone.0071912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977175	Green Submitted, gold, Green Published			2022-12-25	WOS:000324527300050
J	Fukushima, H; Goto, Y; Maeda, T; Kato, M; Umeda, S				Fukushima, Hirokata; Goto, Yurie; Maeda, Takaki; Kato, Motoichiro; Umeda, Satoshi			Neural Substrates for Judgment of Self-Agency in Ambiguous Situations	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; SENSORY CONSEQUENCES; OWN ACTIONS; AWARENESS; SCHIZOPHRENIA; EXPERIENCE; ATTRIBUTION; PRECUNEUS; CINGULATE; EMOTION	The sense of agency is the attribution of oneself as the cause of one's own actions and their effects. Accurate agency judgments are essential for adaptive behaviors in dynamic environments, especially in conditions of uncertainty. However, it is unclear how agency judgments are made in ambiguous situations where self-agency and non-self-agency are both possible. Agency attribution is thus thought to require higher-order neurocognitive processes that integrate several possibilities. Furthermore, neural activity specific to self-attribution, as compared with non-self-attribution, may reflect higher-order critical operations that contribute to constructions of self-consciousness. Based on these assumptions, the present study focused on agency judgments under ambiguous conditions and examined the neural correlates of this operation with functional magnetic resonance imaging. Participants performed a simple but demanding agency-judgment task, which required them to report on whether they attributed their own action as the cause of a visual stimulus change. The temporal discrepancy between the participant's action and the visual events was adaptively set to be maximally ambiguous for each individual on a trial-by-trial basis. Comparison with results for a control condition revealed that the judgment of agency was associated with activity in lateral temporo-parietal areas, medial frontal areas, the dorsolateral prefrontal area, and frontal operculum/insula regions. However, most of these areas did not differentiate between self-and non-self-attribution. Instead, self-attribution was associated with activity in posterior midline areas, including the precuneus and posterior cingulate cortex. These results suggest that deliberate self-attribution of an external event is principally associated with activity in posterior midline structures, which is imperative for self-consciousness.	[Fukushima, Hirokata] Kansai Univ, Fac Sociol, Osaka, Japan; [Fukushima, Hirokata; Goto, Yurie; Umeda, Satoshi] Keio Univ, Dept Psychol, Tokyo, Japan; [Maeda, Takaki; Kato, Motoichiro] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan	Kansai University; Keio University; Keio University	Fukushima, H (corresponding author), Kansai Univ, Fac Sociol, Osaka, Japan.	fukush@kansai-u.ac.jp			JSPS [08J06052, 23830107, 24119005, 24330210, 23120009, 24120518]; Health and Labour Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japanese Ministry of Health, Labour and Welfare; Global COE Program "Centre for Advanced Research on Logic and Sensibility" by the MEXT of Japan; Program for the Advancement of Next Generation Research Projects, Keio University	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labour Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japanese Ministry of Health, Labour and Welfare; Global COE Program "Centre for Advanced Research on Logic and Sensibility" by the MEXT of Japan; Program for the Advancement of Next Generation Research Projects, Keio University	This study was financially supported by Grants-in-Aid for Scientific Research (grant numbers 08J06052, 23830107, 24119005 to HF, and 24330210 to SU) and a Grant-in-Aid for Scientific Research on Innovative Areas: Prediction and Decision Making (23120009 to MK, and 24120518 to SU) from JSPS (http://www.jsps.go.jp/english/e-grants/index.html). This research was also funded by a Health and Labour Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japanese Ministry of Health, Labour and Welfare to MK. This research was also supported by the Global COE Program "Centre for Advanced Research on Logic and Sensibility" by the MEXT of Japan and Program for the Advancement of Next Generation Research Projects, Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; Bays PM, 2005, CURR BIOL, V15, P1125, DOI 10.1016/j.cub.2005.05.023; Blakemore SJ, 1998, J NEUROSCI, V18, P7511; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Budson AE, 2005, NEW ENGL J MED, V352, P692, DOI 10.1056/NEJMra041071; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; David N, 2008, CONSCIOUS COGN, V17, P523, DOI 10.1016/j.concog.2008.03.004; David N, 2007, NEUROIMAGE, V36, P1004, DOI 10.1016/j.neuroimage.2007.03.030; den Ouden HEM, 2005, NEUROIMAGE, V28, P787, DOI 10.1016/j.neuroimage.2005.05.001; Dijksterhuis A, 2008, J EXP SOC PSYCHOL, V44, P2, DOI 10.1016/j.jesp.2007.01.003; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Farrer C, 2008, CEREB CORTEX, V18, P254, DOI 10.1093/cercor/bhm050; Fink GR, 1996, J NEUROSCI, V16, P4275; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Franck N, 2001, AM J PSYCHIAT, V158, P454, DOI 10.1176/appi.ajp.158.3.454; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Frith C, 2005, CONSCIOUS COGN, V14, P752, DOI 10.1016/j.concog.2005.04.002; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Fukushima H, 2009, SOC NEUROSCI-UK, V4, P261, DOI 10.1080/17470910802625009; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Georgieff N, 1998, CONSCIOUS COGN, V7, P465, DOI 10.1006/ccog.1998.0367; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Holst E. von, 1954, British Journal of Animal Behaviour, V2, P89; Johnson SC, 2005, J COGNITIVE NEUROSCI, V17, P1897, DOI 10.1162/089892905775008607; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kuhn S, 2013, CORTEX, V49, P1935, DOI 10.1016/j.cortex.2012.09.002; Legrand D, 2009, PSYCHOL REV, V116, P252, DOI 10.1037/a0014172; Leube DT, 2003, NEUROIMAGE, V20, P2084, DOI 10.1016/j.neuroimage.2003.07.033; Leube DT, 2003, CONSCIOUS COGN, V12, P597, DOI 10.1016/S1053-8100(03)00079-5; Lou HC, 2005, PROG BRAIN RES, V150, P197, DOI 10.1016/S0079-6123(05)50014-1; Maeda T, 2013, PSYCHIAT RES, V209, P386, DOI 10.1016/j.psychres.2013.04.017; Maeda T, 2012, PSYCHIAT RES, V198, P1, DOI 10.1016/j.psychres.2011.10.021; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Metcalfe J, 2007, J EXP PSYCHOL GEN, V136, P184, DOI 10.1037/0096-3445.136.2.184; Miele DB, 2011, J COGNITIVE NEUROSCI, V23, P3620, DOI 10.1162/jocn_a_00052; Moore JW, 2012, CONSCIOUS COGN, V21, P59, DOI 10.1016/j.concog.2011.08.010; Nahab FB, 2011, CEREB CORTEX, V21, P48, DOI 10.1093/cercor/bhq059; Northoff G, 2008, TRENDS COGN SCI, V12, P259, DOI 10.1016/j.tics.2008.04.007; Northoff G, 2011, CONSCIOUS COGN, V20, P52, DOI 10.1016/j.concog.2010.09.011; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Repp BH, 2007, J EXP PSYCHOL HUMAN, V33, P469, DOI 10.1037/0096-1523.33.2.469; Ridderinkhof KR, 2007, COGN AFFECT BEHAV NE, V7, P261, DOI 10.3758/CABN.7.4.261; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Sato A, 2005, COGNITION, V94, P241, DOI 10.1016/j.cognition.2004.04.003; Schnell K, 2007, NEUROIMAGE, V34, P332, DOI 10.1016/j.neuroimage.2006.08.027; Seidel EM, 2010, SOC NEUROSCI-UK, V5, P335, DOI 10.1080/17470911003615997; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shane MS, 2008, NEUROIMAGE, V42, P450, DOI 10.1016/j.neuroimage.2007.12.067; Slachevsky A, 2001, J COGNITIVE NEUROSCI, V13, P332, DOI 10.1162/08989290151137386; Spengler S, 2009, NEUROIMAGE, V46, P290, DOI 10.1016/j.neuroimage.2009.01.047; Sperduti M, 2011, BRAIN STRUCT FUNCT, V216, P151, DOI 10.1007/s00429-010-0298-1; Stephens G. L., 2000, SELF CONSCIOUSNESS B; Synofzik M, 2010, NEUROPSYCHOLOGY OF THE SENSE OF AGENCY: FROM CONSCIOUSNESS TO ACTION, P145, DOI 10.1007/978-88-470-1587-6_8; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Synofzik M, 2006, J NEUROPHYSIOL, V96, P1592, DOI 10.1152/jn.00104.2006; Synofzik M, 2010, BRAIN, V133, P262, DOI 10.1093/brain/awp291; Takahashi H, 2008, CEREB CORTEX, V18, P898, DOI 10.1093/cercor/bhm120; Terasawa Y, 2013, HUM BRAIN MAPP, V34, P598, DOI 10.1002/hbm.21458; Tsakiris M, 2007, CONSCIOUS COGN, V16, P645, DOI 10.1016/j.concog.2007.05.012; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P2740, DOI 10.1016/j.neuropsychologia.2010.05.021; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; van Noordt SJR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00197; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Voss M, 2010, BRAIN, V133, P3104, DOI 10.1093/brain/awq152; Wegner DM, 2003, TRENDS COGN SCI, V7, P65, DOI 10.1016/S1364-6613(03)00002-0; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; Yomogida Y, 2010, NEUROIMAGE, V50, P198, DOI 10.1016/j.neuroimage.2009.12.054; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023	79	26	27	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72267	10.1371/journal.pone.0072267	http://dx.doi.org/10.1371/journal.pone.0072267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	205ER	23977268	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700158
J	Miller, JC; Volz, EM				Miller, Joel C.; Volz, Erik M.			Incorporating Disease and Population Structure into Models of SIR Disease in Contact Networks	PLOS ONE			English	Article							EPIDEMIC MODEL; TRANSMISSION; DYNAMICS; SPREAD; APPROXIMATIONS; LIMIT	We consider the recently introduced edge-based compartmental models (EBCM) for the spread of susceptible-infected-recovered (SIR) diseases in networks. These models differ from standard infectious disease models by focusing on the status of a random partner in the population, rather than a random individual. This change in focus leads to simple analytic models for the spread of SIR diseases in random networks with heterogeneous degree. In this paper we extend this approach to handle deviations of the disease or population from the simplistic assumptions of earlier work. We allow the population to have structure due to effects such as demographic features or multiple types of risk behavior. We allow the disease to have more complicated natural history. Although we introduce these modifications in the static network context, it is straightforward to incorporate them into dynamic network models. We also consider serosorting, which requires using dynamic network models. The basic methods we use to derive these generalizations are widely applicable, and so it is straightforward to introduce many other generalizations not considered here. Our goal is twofold: to provide a number of examples generalizing the EBCM method for various different population or disease structures and to provide insight into how to derive such a model under new sets of assumptions.	[Miller, Joel C.] Penn State Univ, Dept Math, University Pk, PA 16802 USA; [Miller, Joel C.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Volz, Erik M.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Michigan System; University of Michigan	Miller, JC (corresponding author), Penn State Univ, Dept Math, University Pk, PA 16802 USA.	joel.c.miller.research@gmail.com	Miller, Joel C./C-4229-2015	Miller, Joel C./0000-0003-4426-0405; Volz, Erik/0000-0001-6268-8937	RAPIDD program of the Science and Technology Directorate, Department of Homeland Security and the Fogarty International Center, National Institutes of Health; Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health from the National Institute Of General Medical Sciences [U54GM088558]; NIH [K01 AI091440]; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1, MR/K010174/1B] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI091440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	RAPIDD program of the Science and Technology Directorate, Department of Homeland Security and the Fogarty International Center, National Institutes of Health; Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health from the National Institute Of General Medical Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JCM was supported in part by 1) the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security and the Fogarty International Center, National Institutes of Health and 2) the Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health under Award Number U54GM088558 from the National Institute Of General Medical Sciences. EMV was supported by NIH K01 AI091440. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of General Medical Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann M, 1998, MATH BIOSCI, V150, P153, DOI 10.1016/S0025-5564(98)00012-1; ANDERSON R M, 1991; BALL F, 1985, ADV APPL PROBAB, V17, P1, DOI 10.2307/1427049; BALL F, 1995, J APPL PROBAB, V32, P579, DOI 10.2307/3215114; Ball F, 2002, MATH BIOSCI, V180, P73, DOI 10.1016/S0025-5564(02)00125-6; Ball F, 2008, MATH BIOSCI, V212, P69, DOI 10.1016/j.mbs.2008.01.001; Bauch CT, 2002, J MATH BIOL, V45, P375, DOI 10.1007/s002850200153; Decreusefond L, 2012, ANN APPL PROBAB, V22, P541, DOI 10.1214/11-AAP773; Diekmann O, 1998, J APPL PROBAB, V35, P448, DOI 10.1017/S0021900200015072; DIETZ K, 1988, J MATH BIOL, V26, P1, DOI 10.1007/BF00280169; Eames KTD, 2006, AM NAT, V168, P230, DOI 10.1086/505760; Eames KTD, 2002, P NATL ACAD SCI USA, V99, P13330, DOI 10.1073/pnas.202244299; Farewell VT, 1992, AIDS EPIDEMIOLOGY ME, P143; House Thomas, 2011, J R Soc Interface, V8, P67, DOI 10.1098/rsif.2010.0179; House T, 2009, B MATH BIOL, V71, P1693, DOI 10.1007/s11538-009-9420-z; Lindquist J, 2011, J MATH BIOL, V62, P143, DOI 10.1007/s00285-010-0331-2; Lloyd-Smith JO, 2004, P ROY SOC B-BIOL SCI, V271, P625, DOI 10.1098/rspb.2003.2632; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; Meyers LA, 2006, J THEOR BIOL, V240, P400, DOI 10.1016/j.jtbi.2005.10.004; Miller JC, 2013, EPIDEMIC SP IN PRESS; Miller JC, EPIDEMICS N IN PRESS; Miller JC., 2012, J MATH BIOL, P1; Miller JC, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.010101; Miller JC, 2012, J R SOC INTERFACE, V9, P890, DOI 10.1098/rsif.2011.0403; Miller JC, 2011, J MATH BIOL, V62, P349, DOI 10.1007/s00285-010-0337-9; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Parsons JT, 2005, AIDS, V19, pS13, DOI 10.1097/01.aids.0000167348.15750.9a; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Sharkey KJ, 2006, J MATH BIOL, V53, P61, DOI 10.1007/s00285-006-0377-3; van der Hofstad R., 2010, RANDOM GRAPHS COMPLE; Volz E, 2008, J MATH BIOL, V56, P293, DOI 10.1007/s00285-007-0116-4; Volz E, 2010, EPIDEMICS-NETH, V2, P155, DOI 10.1016/j.epidem.2010.06.003; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317	38	62	62	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e69162	10.1371/journal.pone.0069162	http://dx.doi.org/10.1371/journal.pone.0069162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990880	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700003
J	Hindi, SM; Shin, J; Ogura, Y; Li, H; Kumar, A				Hindi, Sajedah M.; Shin, Jonghyun; Ogura, Yuji; Li, Hong; Kumar, Ashok			Matrix Metalloproteinase-9 Inhibition Improves Proliferation and Engraftment of Myogenic Cells in Dystrophic Muscle of mdx Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; MATRIX METALLOPROTEINASES; STEM-CELLS; MYOFIBER REGENERATION; SIGNALING PATHWAY; MYOBLAST FUSION; SATELLITE CELLS; MOUSE; NOTCH	Duchenne muscular dystrophy (DMD) caused by loss of cytoskeletal protein dystrophin is a devastating disorder of skeletal muscle. Primary deficiency of dystrophin leads to several secondary pathological changes including fiber degeneration and regeneration, extracellular matrix breakdown, inflammation, and fibrosis. Matrix metalloproteinases (MMPs) are a group of extracellular proteases that are involved in tissue remodeling, inflammation, and development of interstitial fibrosis in many disease states. We have recently reported that the inhibition of MMP-9 improves myopathy and augments myofiber regeneration in mdx mice (a mouse model of DMD). However, the mechanisms by which MMP-9 regulates disease progression in mdx mice remain less understood. In this report, we demonstrate that the inhibition of MMP-9 augments the proliferation of satellite cells in dystrophic muscle. MMP-9 inhibition also causes significant reduction in percentage of M1 macrophages with concomitant increase in the proportion of promyogenic M2 macrophages in mdx mice. Moreover, inhibition of MMP-9 increases the expression of Notch ligands and receptors, and Notch target genes in skeletal muscle of mdx mice. Furthermore, our results show that while MMP-9 inhibition augments the expression of components of canonical Wnt signaling, it reduces the expression of genes whose products are involved in activation of non-canonical Wnt signaling in mdx mice. Finally, the inhibition of MMP-9 was found to dramatically improve the engraftment of transplanted myoblasts in skeletal muscle of mdx mice. Collectively, our study suggests that the inhibition of MMP-9 is a promising approach to stimulate myofiber regeneration and improving engraftment of muscle progenitor cells in dystrophic muscle.	[Hindi, Sajedah M.; Shin, Jonghyun; Ogura, Yuji; Li, Hong; Kumar, Ashok] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA	University of Louisville	Kumar, A (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	ashok.kumar@louisville.edu		Kumar, Ashok/0000-0001-8571-2848	Muscular Dystrophy Association, USA; National Institute of Health [R01AR059810, RO1AG029623]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	Muscular Dystrophy Association, USA(Muscular Dystrophy Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a research grant from Muscular Dystrophy Association, USA and National Institute of Health grants R01AR059810 and RO1AG029623 to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alameddine HS, 2012, NEUROBIOL DIS, V48, P508, DOI 10.1016/j.nbd.2012.07.023; Alexakis C, 2007, AM J PHYSIOL-CELL PH, V293, pC661, DOI 10.1152/ajpcell.00061.2007; Baeg GH, 2000, CURR OPIN CELL BIOL, V12, P575, DOI 10.1016/S0955-0674(00)00134-4; BETZ W, 1973, J PHYSIOL-LONDON, V230, P673, DOI 10.1113/jphysiol.1973.sp010211; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Bockhold KJ, 1998, MUSCLE NERVE, V21, P173, DOI 10.1002/(SICI)1097-4598(199802)21:2<173::AID-MUS4>3.0.CO;2-8; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Burkin DJ, 1999, CELL TISSUE RES, V296, P183, DOI 10.1007/s004410051279; Carmeli E, 2004, MUSCLE NERVE, V29, P191, DOI 10.1002/mus.10529; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Dahiya S, 2011, HUM MOL GENET, V20, P4345, DOI 10.1093/hmg/ddr362; Dahiya S, 2011, J IMMUNOL, V187, P2723, DOI 10.4049/jimmunol.1101342; Dalkilic I, 2003, CURR OPIN GENET DEV, V13, P231, DOI 10.1016/S0959-437X(03)00048-0; DANGAIN J, 1984, MUSCLE NERVE, V7, P700, DOI 10.1002/mus.880070903; Darabi R, 2008, STEM CELL REV, V4, P217, DOI 10.1007/s12015-008-9023-3; Delfin DA, 2012, NEUROMUSCULAR DISORD, V22, P1006, DOI 10.1016/j.nmd.2012.05.002; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; DIMARIO JX, 1991, DEV BIOL, V148, P314, DOI 10.1016/0012-1606(91)90340-9; DUANCE VC, 1980, NATURE, V284, P470, DOI 10.1038/284470a0; Dunaevsky A, 1998, DEV BIOL, V194, P61, DOI 10.1006/dbio.1997.8805; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Fukushima K, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-54; Guo LY, 2012, WORLD J GASTROENTERO, V18, P7262, DOI 10.3748/wjg.v18.i48.7262; Heslop L, 2000, J CELL SCI, V113, P2299; Hindi SM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003832; Hindi SM, 2012, MOL CELL BIOL, V32, P4833, DOI 10.1128/MCB.00717-12; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Irintchev A, 1997, NEUROMUSCULAR DISORD, V7, P117, DOI 10.1016/S0960-8966(96)00422-1; ITAGAKI Y, 1995, ACTA NEUROPATHOL, V89, P380; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kherif S, 1999, DEV BIOL, V205, P158, DOI 10.1006/dbio.1998.9107; Kim MH, 2011, HUM MOL GENET, V20, P1324, DOI 10.1093/hmg/ddr015; Kitamoto T, 2010, STEM CELLS, V28, P2205, DOI 10.1002/stem.547; Kofler Natalie M, 2011, Genes Cancer, V2, P1106, DOI 10.1177/1947601911423030; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kumar A, 2010, AM J PATHOL, V177, P248, DOI 10.2353/ajpath.2010.091176; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Li H, 2009, HUM MOL GENET, V18, P2584, DOI 10.1093/hmg/ddp191; Nadarajah VD, 2011, NEUROMUSCULAR DISORD, V21, P569, DOI 10.1016/j.nmd.2011.05.011; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parker MH, 2012, STEM CELLS, V30, P2212, DOI 10.1002/stem.1181; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Seale Patrick, 2000, Cell, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Srivastava AK, 2007, J BIOL CHEM, V282, P35113, DOI 10.1074/jbc.M705329200; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tran TH, 2012, J BIOL CHEM, V287, P32651, DOI 10.1074/jbc.M112.353243; Villalta SA, 2011, HUM MOL GENET, V20, P790, DOI 10.1093/hmg/ddq523; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; von Maltzahn J, 2012, P NATL ACAD SCI USA, V109, P20614, DOI 10.1073/pnas.1215765109; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; VRACKO R, 1972, J CELL BIOL, V55, P406, DOI 10.1083/jcb.55.2.406; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400	64	54	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72121	10.1371/journal.pone.0072121	http://dx.doi.org/10.1371/journal.pone.0072121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977226	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000080
J	Maussang, D; Mujic-Delic, A; Descamps, FJ; Stortelers, C; Vanlandschoot, P; Stigter-van Walsum, M; Vischer, HF; van Roy, M; Vosjan, M; Gonzalez-Pajuelo, M; van Dongen, GAMS; Merchiers, P; van Rompaey, P; Smit, MJ				Maussang, David; Mujic-Delic, Azra; Descamps, Francis J.; Stortelers, Catelijne; Vanlandschoot, Peter; Stigter-van Walsum, Marijke; Vischer, Henry F.; van Roy, Maarten; Vosjan, Maria; Gonzalez-Pajuelo, Maria; van Dongen, Guus A. M. S.; Merchiers, Pascal; van Rompaey, Philippe; Smit, Martine J.			Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-GROWTH; ANGIOGENESIS; EXPRESSION; MIGRATION; BREAST; SDF-1/CXCL12; INHIBITION; SURVIVAL; CXCL12; RDC1	The chemokine receptor CXCR7, belonging to the membrane-bound G protein-coupled receptor superfamily, is expressed in several tumor types. Inhibition of CXCR7 with either small molecules or small interference (si) RNA has shown promising therapeutic benefits in several tumor models. With the increased interest and effectiveness of biologicals inhibiting membrane-bound receptors we made use of the "Nanobody platform" to target CXCR7. Previously we showed that Nanobodies, i.e. immunoglobulin single variable domains derived from naturally occurring heavy chain-only camelids antibodies, represent new biological tools to efficiently tackle difficult drug targets such as G protein-coupled receptors. In this study we developed and characterized highly selective and potent Nanobodies against CXCR7. Interestingly, the CXCR7-targeting Nanobodies displayed antagonistic properties in contrast with previously reported CXCR7-targeting agents. Several high affinity CXCR7-specific Nanobodies potently inhibited CXCL12-induced beta-arrestin2 recruitment in vitro. A wide variety of tumor biopsies was profiled, showing for the first time high expression of CXCR7 in head and neck cancer. Using a patient-derived CXCR7-expressing head and neck cancer xenograft model in nude mice, tumor growth was inhibited by CXCR7-targeting Nanobody therapy. Mechanistically, CXCR7-targeting Nanobodies did not inhibit cell cycle progression but instead reduced secretion of the angiogenic chemokine CXCL1 from head and neck cancer cells in vitro, thus acting here as inverse agonists, and subsequent angiogenesis in vivo. Hence, with this novel class of CXCR7 inhibitors, we further substantiate the therapeutic relevance of targeting CXCR7 in head and neck cancer.	[Maussang, David; Mujic-Delic, Azra; Vischer, Henry F.; Smit, Martine J.] Vrije Univ Amsterdam, Div Med Chem, Amsterdam Inst Mol Med & Syst, Fac Sci, NL-1081 HV Amsterdam, Netherlands; [Descamps, Francis J.; Stortelers, Catelijne; Vanlandschoot, Peter; van Roy, Maarten; Gonzalez-Pajuelo, Maria; Merchiers, Pascal; van Rompaey, Philippe] Ablynx NV, B-9052 Ghent, Belgium; [Stigter-van Walsum, Marijke; Vosjan, Maria; van Dongen, Guus A. M. S.] Vrije Univ Amsterdam Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Smit, MJ (corresponding author), Vrije Univ Amsterdam, Div Med Chem, Amsterdam Inst Mol Med & Syst, De Boelelaan 1083, NL-1081 HV Amsterdam, Netherlands.	mj.smit@vu.nl	Vosjan, Maria/AAV-4987-2021	Smit, Martine/0000-0003-2713-0238				[Anonymous], 2012, Drug Discov Today Technol, V9, pe227, DOI 10.1016/j.ddtec.2012.05.003; Arenberg DA, 1997, J LEUKOCYTE BIOL, V62, P554, DOI 10.1002/jlb.62.5.554; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Behdani M, 2012, MOL IMMUNOL, V50, P35, DOI 10.1016/j.molimm.2011.11.013; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Canals M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034192; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Gahan JC, 2012, J UROLOGY, V187, P827, DOI 10.1016/j.juro.2011.10.150; Hao MG, 2012, BIOCHEM PHARMACOL, V84, P204, DOI 10.1016/j.bcp.2012.04.007; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Helman EE, 2010, CANCER BIOL THER, V10, P166, DOI 10.4161/cbt.10.2.12164; Huang L, 2008, MOL IMAGING BIOL, V10, P167, DOI 10.1007/s11307-008-0133-8; Jahnichen S, 2010, P NATL ACAD SCI USA, V107, P20565, DOI 10.1073/pnas.1012865107; Kollmar O, 2010, INT J CANCER, V126, P1302, DOI 10.1002/ijc.24956; Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006; Lane BR, 2002, J VIROL, V76, P11570, DOI 10.1128/JVI.76.22.11570-11583.2002; Lansford CGR, 2002, HUM CELL CULTURE, V2, P185; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059750; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Maussang D, 2006, P NATL ACAD SCI USA, V103, P13068, DOI 10.1073/pnas.0604433103; Maussang D, 2009, METHOD ENZYMOL, V460, P151, DOI 10.1016/S0076-6879(09)05207-0; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Omidfar K, 2004, TUMOR BIOL, V25, P296, DOI 10.1159/000081395; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Roovers RC, 2007, CANCER IMMUNOL IMMUN, V56, P303, DOI 10.1007/s00262-006-0180-4; Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Schrevel M, 2012, BRIT J CANCER, V106, P1520, DOI 10.1038/bjc.2012.110; Senkal CE, 2006, J PHARMACOL EXP THER, V317, P1188, DOI 10.1124/jpet.106.101949; Shimizu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020680; Shintani S, 2004, ONCOLOGY-BASEL, V66, P316, DOI 10.1159/000078333; Singh RK, 2011, CANCER RES, V71, P3268, DOI 10.1158/0008-5472.CAN-10-2769; Smith Victoria, 2008, Cancer Genomics & Proteomics, V5, P263; Tijink BM, 2008, MOL CANCER THER, V7, P2288, DOI 10.1158/1535-7163.MCT-07-2384; Vaneycken I, 2011, CURR OPIN BIOTECH, V22, P877, DOI 10.1016/j.copbio.2011.06.009; Vaneycken I, 2011, FASEB J, V25, P2433, DOI 10.1096/fj.10-180331; Vosjan MJWD, 2012, MOL CANCER THER, V11, P1017, DOI 10.1158/1535-7163.MCT-11-0891; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wijtmans M, 2012, EUR J MED CHEM, V51, P184, DOI 10.1016/j.ejmech.2012.02.041; Xia J, 2011, J MOL HISTOL, V42, P175, DOI 10.1007/s10735-011-9322-x; Xu HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027399; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Zabel BA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-73; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zheng K, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-31	50	109	129	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29562	29572		10.1074/jbc.M113.498436	http://dx.doi.org/10.1074/jbc.M113.498436			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23979133	Green Published, hybrid			2022-12-25	WOS:000330615300032
J	Chen, P; Li, L; Wang, JY; Li, HY; Li, Y; Lv, Y; Lu, C				Chen, Ping; Li, Li; Wang, Jiying; Li, Haiyin; Li, Yan; Lv, Yin; Lu, Cheng			BmPAH Catalyzes the Initial Melanin Biosynthetic Step in Bombyx mori	PLOS ONE			English	Article							PHENYLALANINE-HYDROXYLASE GENE; AMINO-ACID HYDROXYLASES; DOPA DECARBOXYLASE; PAPILIO-XUTHUS; MANDUCA-SEXTA; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; TYROSINE-HYDROXYLASE; SYNTHESIS ENZYMES; IMMUNE-RESPONSES	Pigmentation during insect development is a primal adaptive requirement. In the silkworm, melanin is the primary component of larval pigments. The rate limiting substrate in melanin synthesis is tyrosine, which is converted from phenylalanine by the rate-limiting enzyme phenylalanine hydroxylase (PAH). While the role of tyrosine, derived from phenylalanine, in the synthesis of fiber proteins has long been known, the role of PAH in melanin synthesis is still unknown in silkworm. To define the importance of PAH, we cloned the cDNA sequence of BmPAH and expressed its complete coding sequence using the Bac-to-Bac baculovirus expression system. Purified recombinant protein had high PAH activity, some tryptophan hydroxylase activity, but no tyrosine hydroxylase activity, which are typical properties of PAH in invertebrates. Because melanin synthesis is most robust during the embryonic stage and larval integument recoloring stage, we injected BmPAH dsRNA into silkworm eggs and observed that decreasing BmPAH mRNA reduced neonatal larval tyrosine and caused insect coloration to fail. In vitro cultures and injection of 4th instar larval integuments with PAH inhibitor revealed that PAH activity was essential for larval marking coloration. These data show that BmPAH is necessary for melanin synthesis and we propose that conversion of phenylalanine to tyrosine by PAH is the first step in the melanin biosynthetic pathway in the silkworm.	[Chen, Ping; Lu, Cheng] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Chen, Ping; Li, Li; Wang, Jiying; Li, Haiyin; Li, Yan; Lv, Yin; Lu, Cheng] Southwest Univ, Coll Biotechnol, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Lu, C (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	lucheng@swau.cq.cn			Natural Science Foundation Unode Program of Chongqing [CSTC 2013 jjB80004]; Doctor Founding Program of Southwest University, China [104310/20700911]	Natural Science Foundation Unode Program of Chongqing; Doctor Founding Program of Southwest University, China	This work was funded by the Natural Science Foundation Unode Program of Chongqing (grant no. CSTC 2013 jjB80004) (http://cstc.gov.cn/), the Doctor Founding Program of Southwest University, China (No. 104310/20700911; http://www.swu.edu.cn/). The sponsors had no role in study design, data collection and analysis, the decision to publish the data, or the preparation of the manuscript.	Alcaniz S, 1997, COMP BIOCHEM PHYS C, V116, P205, DOI 10.1016/S0742-8413(96)00148-X; Bilandzija H, 2012, EVOL DEV, V14, P196, DOI 10.1111/j.1525-142X.2012.00535.x; BODNARYK RP, 1974, J INSECT PHYSIOL, V20, P911, DOI 10.1016/0022-1910(74)90180-2; Calvo AC, 2008, FASEB J, V22, P3046, DOI 10.1096/fj.08-108522; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Flydal MI, 2010, AMINO ACIDS, V39, P1463, DOI 10.1007/s00726-010-0611-6; FUKUDA T, 1956, NATURE, V177, P429, DOI 10.1038/177429b0; Futahashi R, 2006, INSECT BIOCHEM MOLEC, V36, P63, DOI 10.1016/j.ibmb.2005.11.002; Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; Futahashi R, 2007, INSECT BIOCHEM MOLEC, V37, P855, DOI 10.1016/j.ibmb.2007.02.014; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Gorman MJ, 2007, INSECT BIOCHEM MOLEC, V37, P1327, DOI 10.1016/j.ibmb.2007.08.006; Gorman MJ, 2010, INSECT BIOCHEM MOLEC, V40, P267, DOI 10.1016/j.ibmb.2010.01.004; HILL HZ, 1992, BIOESSAYS, V14, P49, DOI 10.1002/bies.950140111; HIRUMA K, 1985, DEV BIOL, V110, P509, DOI 10.1016/0012-1606(85)90109-5; HIRUMA K, 1995, DEV BIOL, V169, P195, DOI 10.1006/dbio.1995.1137; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hou Y, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-45; HUFTON SE, 1995, BIOCHEM J, V311, P353, DOI 10.1042/bj3110353; Infanger LC, 2004, INSECT BIOCHEM MOLEC, V34, P1329, DOI 10.1016/j.ibmb.2004.09.004; Johnson JK, 2003, INSECT BIOCHEM MOLEC, V33, P345, DOI 10.1016/S0965-1748(02)00257-6; KILANI RA, 1995, AM J CLIN NUTR, V61, P1218, DOI 10.1093/ajcn/61.6.1218; Koch PB, 1998, DEVELOPMENT, V125, P2303; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; Li JS, 2006, SCI SERICULTURE CHIN, V32, P268; Liu C, 2010, P NATL ACAD SCI USA, V107, P12980, DOI 10.1073/pnas.1001725107; Loer CM, 1999, J NEUROGENET, V13, P157, DOI 10.3109/01677069909083472; LU PW, 1982, INSECT BIOCHEM, V12, P377, DOI 10.1016/0020-1790(82)90034-8; LUNAN KD, 1969, ARCH BIOCHEM BIOPHYS, V132, P450, DOI 10.1016/0003-9861(69)90388-9; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Paskewitz SM, 2008, COMP BIOCHEM PHYS B, V150, P403, DOI 10.1016/j.cbpb.2008.04.010; PATEL RP, 1971, BIOCHEM J, V124, P439, DOI 10.1042/bj1240439; PAWELEK JM, 1978, NATURE, V276, P627, DOI 10.1038/276627a0; Peri S, 2001, TRENDS BIOCHEM SCI, V26, P687, DOI 10.1016/S0968-0004(01)01954-5; Quan GX, 2002, INSECT MOL BIOL, V11, P217, DOI 10.1046/j.1365-2583.2002.00328.x; RuizVazquez P, 1996, BIOCHEM BIOPH RES CO, V225, P238, DOI 10.1006/bbrc.1996.1160; Ruuhola T, 2010, CHEMOECOLOGY, V20, P11, DOI 10.1007/s00049-009-0029-3; sa M., 2011, CHIN J CLIN LAB SCI, V29, P161; Schallreuter KU, 1999, BIOCHEM BIOPH RES CO, V262, P423, DOI 10.1006/bbrc.1999.1241; Schallreuter KU, 2005, MOL GENET METAB, V86, pS27, DOI 10.1016/j.ymgme.2005.07.023; SCHALLREUTER KU, 1994, SCIENCE, V263, P1444, DOI 10.1126/science.8128228; Scriver CR, 2007, HUM MUTAT, V28, P831, DOI 10.1002/humu.20526; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Tang HP, 2009, FLY, V3, P105, DOI 10.4161/fly.3.1.7747; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; Wang JY, 2012, SCI SERICULTURE CHIN, V38, P65; Wang YL, 1996, J S CHINA U TECHNOLO, V24, P117; Wiens M, 1998, DEV COMP IMMUNOL, V22, P469, DOI 10.1016/S0145-305X(98)00034-2; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Zhan SA, 2010, DEVELOPMENT, V137, P4083, DOI 10.1242/dev.053678; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001; 王勤, 2008, [中国科学. C辑, 生命科学, Science in China. Series C, Life Sciences], V38, P742	53	12	15	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71984	10.1371/journal.pone.0071984	http://dx.doi.org/10.1371/journal.pone.0071984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991017	Green Published, gold, Green Submitted			2022-12-25	WOS:000324228800032
J	Kato, A; Imai, K; Ochiai, K; Ogata, Y				Kato, Ayako; Imai, Kenichi; Ochiai, Kuniyasu; Ogata, Yorimasa			Higher Prevalence of Epstein-Barr Virus DNA in Deeper Periodontal Pockets of Chronic Periodontitis in Japanese Patients	PLOS ONE			English	Article							CHAIN-REACTION QUANTIFICATION; RNA GENE PRIMERS; PORPHYROMONAS-GINGIVALIS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BACTEROIDES-FORSYTHUS; HERPESVIRUSES; DISEASE; PATHOGENS; BACTERIAL; CYTOMEGALOVIRUS	Periodontitis, a complex chronic inflammatory disease caused by subgingival infection, is among the most prevalent microbial diseases in humans. Although traditional microbiological research on periodontitis has focused on putative bacteria such as Porphyromonas gingivalis, the herpes virus is proposed to be involved in the pathogenesis of periodontitis because bacterial etiology alone does not adequately explain various clinical aspects. In this study, we established for the first time, more Epstein-Barr virus (EBV) DNA is found deeper in periodontal pockets of chronic periodontitis in Japanese patients. Subgingival samples were collected from 85 patients with chronic periodontitis having two periodontal sites with probing depths (PD) of <= 3 mm (shallow) or >= 5 mm (deep) and were subjected to a nested polymerase chain reaction. EBV DNA was more frequently detected in patients with deeper PD sites (66%) than in those with shallow PD sites (48%) or healthy controls (45%). Coexistence of EBV DNA and P. gingivalis was significantly higher in patients with deeper PD sites (40%) than in those with shallow PD sites (14%) or healthy controls (13%). Although no difference in clinical index for periodontitis, the odds ratio of EBV DNA in patients with deeper PD sites was 2.36, which was 2.07-fold higher than that in those with shallow PD sites. Interestingly, the odds of acquiring chronic periodontitis (PD >= 5 mm) were higher in the presence of both EBV DNA and P. gingivalis compared with either EBV DNA or P. gingivalis only. In addition, we also observed that EBV-encoded small RNA (EBER) in positive cells of human gingival tissues. These results would suggest that EBV DNA may serve as a pathogenic factor leading to chronic periodontitis among Japanese patients.	[Kato, Ayako; Ogata, Yorimasa] Nihon Univ, Sch Dent Matsudo, Dept Periodontol, Chiba, Japan; [Imai, Kenichi; Ochiai, Kuniyasu] Nihon Univ, Sch Dent, Dent Res Ctr, Dept Microbiol,Div Immunol & Pathobiol, Tokyo 101, Japan; [Ogata, Yorimasa] Nihon Univ, Sch Dent Matsudo, Res Inst Oral Sci, Chiba, Japan	Nihon University; Nihon University; Nihon University	Imai, K (corresponding author), Nihon Univ, Sch Dent, Dent Res Ctr, Dept Microbiol,Div Immunol & Pathobiol, Tokyo 101, Japan.	imai.kenichi@nihon-u.ac.jp; ogata.yorimasa@nihon-u.ac.jp			Dental Research Center, Nihon University School of Dentistry, Nihon University President's Grant for Specified Multidisciplinary Research [25463229]; Supporting Project for Strategic Research in Private Universities by the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT); Strategic Research Base Development Program for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [S1001024]	Dental Research Center, Nihon University School of Dentistry, Nihon University President's Grant for Specified Multidisciplinary Research; Supporting Project for Strategic Research in Private Universities by the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT); Strategic Research Base Development Program for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT)	This work was supported in part by a Grant-in-Aid for Scientific Research (C; No. 25463229), Dental Research Center, Nihon University School of Dentistry, Nihon University President's Grant for Specified Multidisciplinary Research, a grant from the Supporting Project for Strategic Research in Private Universities by the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT), 2008-2012 and a grant of Strategic Research Base Development Program for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT), 2010-2014 (S1001024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusleme L, 2013, ISME J, P1; Ahmed A, 2012, AFR J MICROBIOL RES, V6, P2559, DOI 10.5897/AJMR12.115; Ascherio A, 2010, J NEUROIMMUNE PHARM, V5, P271, DOI 10.1007/s11481-010-9201-3; Chalabi M, 2010, MOL ORAL MICROBIOL, V25, P236, DOI 10.1111/j.2041-1014.2010.00571.x; Contreras A, 2000, J PERIODONTAL RES, V35, P3, DOI 10.1034/j.1600-0765.2000.035001003.x; Contreras A, 1999, ORAL MICROBIOL IMMUN, V14, P206, DOI 10.1034/j.1399-302X.1999.140402.x; Contreras A, 2000, ORAL MICROBIOL IMMUN, V15, P15, DOI 10.1034/j.1399-302x.2000.150103.x; GOODSON JM, 1982, J CLIN PERIODONTOL, V9, P472, DOI 10.1111/j.1600-051X.1982.tb02108.x; Ikuta K, 2000, MICROBES INFECT, V2, P115, DOI 10.1016/S1286-4579(00)00277-X; Imai K, 2012, J ORAL BIOSCI, V54, P164, DOI 10.1016/j.job.2012.07.001; Imai K, 2012, BIOCHIMIE, V94, P839, DOI 10.1016/j.biochi.2011.12.001; Klemenc P, 2005, J CLIN VIROL, V34, P147, DOI 10.1016/j.jcv.2005.03.001; Konstantinidis A, 2005, J PERIODONTAL RES, V40, P294, DOI 10.1111/j.1600-0765.2005.00796.x; Kubar A, 2005, J PERIODONTAL RES, V40, P97, DOI 10.1111/j.1600-0765.2005.00770.x; Lang NP, 1999, ANN PERIODONTOL, V4, P53, DOI DOI 10.1902/ANNALS.1999.4.1.53; Ledder RG, 2007, APPL ENVIRON MICROB, V73, P516, DOI 10.1128/AEM.01419-06; LIN JC, 1993, BLOOD, V81, P3372; Lindhe J, 1999, ANN PERIODONTOL, V4, P38, DOI DOI 10.1902/ANNALS.1999.4.1.38; LISTGARTEN MA, 1995, J PERIODONTOL, V66, P158, DOI 10.1902/jop.1995.66.2.158; Maeda E, 2009, JPN J RADIOL, V27, P4, DOI 10.1007/s11604-008-0291-2; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Riep B, 2009, J CLIN MICROBIOL, V47, P1705, DOI 10.1128/JCM.01387-08; Saygun I, 2005, J PERIODONTAL RES, V40, P187, DOI 10.1111/j.1600-0765.2005.00790.x; Saygun I, 2004, J PERIODONTAL RES, V39, P207, DOI 10.1111/j.1600-0765.2004.00728.x; SEYMOUR GJ, 1983, J PERIODONTAL RES, V18, P375, DOI 10.1111/j.1600-0765.1983.tb00373.x; Shotelersuk K, 2000, CLIN CANCER RES, V6, P1046; Slots J, 2006, J PERIODONTAL RES, V41, P235, DOI 10.1111/j.1600-0765.2006.00865.x; Slots J, 2007, CURR OPIN INFECT DIS, V20, P278, DOI 10.1097/QCO.0b013e3280964da0; Slots J, 2011, PERIODONTOL 2000, V55, P48, DOI 10.1111/j.1600-0757.2010.00361.x; Slots J, 2010, PERIODONTOL 2000, V53, P89, DOI 10.1111/j.1600-0757.2009.00325.x; Speck SH, 1997, TRENDS MICROBIOL, V5, P399, DOI 10.1016/S0966-842X(97)01129-3; Tao Q, 2006, FRONT BIOSCI-LANDMRK, V11, P2672, DOI 10.2741/2000; Ting M, 2000, J PERIODONTAL RES, V35, P17, DOI 10.1034/j.1600-0765.2000.035001017.x; Toussirot E, 2008, BEST PRACT RES CL RH, V22, P883, DOI 10.1016/j.berh.2008.09.007; Tran SD, 1999, J CLIN MICROBIOL, V37, P3504, DOI 10.1128/JCM.37.11.3504-3508.1999; Tran SD, 1996, J CLIN MICROBIOL, V34, P2674, DOI 10.1128/JCM.34.11.2674-2678.1996; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; van Winkelhoff AJ, 2002, J CLIN PERIODONTOL, V29, P1023, DOI 10.1034/j.1600-051X.2002.291107.x	38	50	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71990	10.1371/journal.pone.0071990	http://dx.doi.org/10.1371/journal.pone.0071990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991022	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800034
J	Soeno, Y; Fujita, K; Kudo, T; Asagiri, M; Kakuta, S; Taya, Y; Shimazu, Y; Sato, K; Tanaka-Fujita, R; Kubo, S; Iwakura, Y; Nakamura, Y; Mori, S; Aoba, T				Soeno, Yuuichi; Fujita, Kazuya; Kudo, Tomoo; Asagiri, Masataka; Kakuta, Shigeru; Taya, Yuji; Shimazu, Yoshihito; Sato, Kaori; Tanaka-Fujita, Ritsuko; Kubo, Sachiko; Iwakura, Yoichiro; Nakamura, Yoshikazu; Mori, Shigeo; Aoba, Takaaki			Generation of a Mouse Model with Down-Regulated U50 snoRNA (SNORD50) Expression and Its Organ-Specific Phenotypic Modulation	PLOS ONE			English	Article							METHYLATION GUIDE SNORNAS; SMALL NUCLEOLAR RNAS; HOST GENE; NONCODING RNAS; RIBOSE METHYLATION; PROLIFERATION; MEMBER; GAS5	Box C/D-type small nucleolar RNAs (snoRNAs) are functional RNAs responsible for mediating 2'-O-ribose methylation of ribosomal RNAs (rRNAs) within the nucleolus. In the past years, evidence for the involvement of human U50 snoRNA in tumorigenesis has been accumulating. We previously identified U50HG, a non-protein-coding gene that hosted a box C/D-type U50 snoRNA, in a chromosomal breakpoint in a human B-cell lymphoma. Mouse genome analysis revealed four mouse U50 (mU50) host-genes: three mU50HG-a gene variants that were clustered in the genome and an mU50HG-b gene that we supposed to be the U50HG ortholog. In this study, to investigate the physiological importance of mU50 snoRNA and its involvement in tumorigenesis, we eliminated mU50 snoRNA sequences from the mU50HG-b gene. The established mouse line (Delta mU50((HG-b))) showed a significant reduction of mU50 snoRNA expression without alteration of the host-gene length and exon-intron structure, and the corresponding target rRNA methylation in various organs was reduced. Lifelong phenotypic monitoring showed that the Delta mU50((HG-b)) mice looked almost normal without accelerated tumorigenicity; however, a notable difference was the propensity for anomalies in the lymphoid organs. Transcriptome analysis showed that dozens of genes, including heat shock proteins, were differentially expressed in Delta mU50((HG-b)) mouse lymphocytes. This unique model of a single snoRNA knockdown with intact host-gene expression revealed further new insights into the discrete transcriptional regulation of multiple mU50 host-genes and the complicated dynamics involved in organ-specific processing and maintenance of snoRNAs.	[Soeno, Yuuichi; Fujita, Kazuya; Taya, Yuji; Shimazu, Yoshihito; Sato, Kaori; Aoba, Takaaki] Nippon Dent Univ Tokyo, Sch Life Dent, Dept Pathol, Tokyo, Japan; [Kudo, Tomoo] Hyogo Coll Med, Dept Pathol, Kobe, Hyogo, Japan; [Asagiri, Masataka] Kyoto Univ, Grad Sch Med, Innovat Ctr Immunoregulat & Therapeut, Kyoto, Japan; [Kakuta, Shigeru] Univ Tokyo, Dept Biomed Sci, Grad Sch Agr & Life Sci, Tokyo, Japan; [Kakuta, Shigeru; Kubo, Sachiko; Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Tokyo, Japan; [Tanaka-Fujita, Ritsuko] Govt Japan, Cabinet Off, Risk Assessment Div, Food Safety Commiss Secretari, Tokyo, Japan; [Kubo, Sachiko; Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Div Expt Anim Immunol, Chiba, Japan; [Nakamura, Yoshikazu] Univ Tokyo, Inst Med Sci, Div RNA Med Sci, Tokyo, Japan; [Nakamura, Yoshikazu] Ribomic Inc, Tokyo, Japan; [Mori, Shigeo] Kotobiken Med Labs Inc, Tokyo, Japan	Nippon Dental University; Hyogo College of Medicine; University of Hyogo; Kyoto University; University of Tokyo; University of Tokyo; Tokyo University of Science; University of Tokyo	Soeno, Y (corresponding author), Nippon Dent Univ Tokyo, Sch Life Dent, Dept Pathol, Tokyo, Japan.	soeno-path@tky.ndu.ac.jp	Kakuta, Shigeru/L-2241-2018; Taya, Yuji/ABA-2220-2020; Iwakura, Yoichiro/E-5457-2011; Sato, Kaori/AAZ-8493-2020; Soeno, Yuuichi/W-1367-2019	Kakuta, Shigeru/0000-0002-5900-1425; Taya, Yuji/0000-0001-5663-0835; Iwakura, Yoichiro/0000-0002-9934-5775; Soeno, Yuuichi/0000-0001-8466-6376	Ministry of Education, Science and Culture of Japan [20791374]; Grants-in-Aid for Scientific Research [25462935, 25463154, 24592780, 23592716] Funding Source: KAKEN	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan #20791374 (http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Askarian-Amiri ME, 2011, RNA, V17, P878, DOI 10.1261/rna.2528811; Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Baxter-Roshek JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000174; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; BRIMACOMBE R, 1993, FASEB J, V7, P161, DOI 10.1096/fasebj.7.1.8422963; COHEN DI, 1985, NATURE, V314, P372, DOI 10.1038/314372a0; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Dong XY, 2009, J GENET GENOMICS, V36, P447, DOI 10.1016/S1673-8527(08)60134-4; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Esguerra J, 2008, RNA, V14, P649, DOI 10.1261/rna.845808; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Hirose T, 2001, P NATL ACAD SCI USA, V98, P12914, DOI 10.1073/pnas.231490998; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huttenhofer A, 2002, CURR OPIN CHEM BIOL, V6, P835, DOI 10.1016/S1367-5931(02)00397-6; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kiss-Laszlo Z, 1998, EMBO J, V17, P797, DOI 10.1093/emboj/17.3.797; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Makarova JA, 2005, GENE, V363, P51, DOI 10.1016/j.gene.2005.08.010; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Mourtada-Maarabouni M, 2010, MOL PHARMACOL, V78, P19, DOI 10.1124/mol.110.064055; Nakajima M, 2011, J BONE MINER METAB, V29, P300, DOI 10.1007/s00774-010-0230-z; Pelczar P, 1998, MOL CELL BIOL, V18, P4509, DOI 10.1128/MCB.18.8.4509; Richard P, 2006, MOL CELL BIOL, V26, P2540, DOI 10.1128/MCB.26.7.2540-2549.2006; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Schoemaker RJW, 2006, NUCLEIC ACIDS RES, V34, P2015, DOI 10.1093/nar/gkl154; Skryabin BV, 2007, PLOS GENET, V3, P2529, DOI 10.1371/journal.pgen.0030235; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Tanaka R, 2000, GENES CELLS, V5, P277, DOI 10.1046/j.1365-2443.2000.00325.x; Tanaka-Fujita R, 2007, RNA, V13, P811, DOI 10.1261/rna.209707; Tycowski KT, 1996, NATURE, V379, P464, DOI 10.1038/379464a0; Vitali P, 2005, J CELL BIOL, V169, P745, DOI 10.1083/jcb.200411129; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Williams GT, 2012, NAT REV CANCER, V12, P84, DOI 10.1038/nrc3195; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	45	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72105	10.1371/journal.pone.0072105	http://dx.doi.org/10.1371/journal.pone.0072105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991050	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800045
J	Toka, HR; Genovese, G; Mount, DB; Pollak, MR; Curhan, GC				Toka, Hakan R.; Genovese, Giulio; Mount, David B.; Pollak, Martin R.; Curhan, Gary C.			Frequency of Rare Allelic Variation in Candidate Genes among Individuals with Low and High Urinary Calcium Excretion	PLOS ONE			English	Article							BARTTERS-SYNDROME; KIDNEY-STONES; MITOCHONDRIAL ACONITASE; HYPOKALEMIC ALKALOSIS; CHLORIDE CHANNEL; DIETARY CALCIUM; RENAL-FAILURE; MUTATIONS; RISK; HYPERCALCIURIA	Our study investigated the association of rare allelic variants with extremes of 24-hour urinary calcium excretion because higher urinary calcium excretion is a dominant risk factor for calcium-based kidney stone formation. We resequenced 40 candidate genes potentially related to urinary calcium excretion in individuals from the Nurses' Health Studies I & II and the Health Professionals Follow-up Study. A total of 960 participants were selected based on availability of 24-hour urine collection data and level of urinary calcium excretion (low vs. high). We utilized DNA sample pooling, droplet-based target gene enrichment, multiplexing, and high-throughput sequencing. Approximately 64% of samples (n = 615) showed both successful target enrichment and sequencing data with >20-fold deep coverage. A total of 259 novel allelic variants were identified. None of the rare gene variants (allele frequencies <2%) were found with increased frequency in the low vs. high urinary calcium groups; most of these variants were only observed in single individuals. Unadjusted analysis of variants with allele frequencies >= 2% suggested an association of the Claudin14 SNP rs113831133 with lower urinary calcium excretion (6/520 versus 29/710 haplotypes, P value = 0.003). Our data, together with previous human and animal studies, suggest a possible role for Claudin14 in urinary calcium excretion. Genetic validation studies in larger sample sets will be necessary to confirm our findings for rs113831133. In the tested set of candidate genes, rare allelic variants do not appear to contribute significantly to differences in urinary calcium excretion between individuals.	[Toka, Hakan R.; Mount, David B.; Curhan, Gary C.] Brigham & Womens Hosp, Div Nephrol, Boston, MA 02115 USA; [Toka, Hakan R.; Genovese, Giulio; Pollak, Martin R.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Nephrol, Boston, MA 02215 USA; [Curhan, Gary C.] Channing Div Network Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Toka, HR (corresponding author), Brigham & Womens Hosp, Div Nephrol, 75 Francis St, Boston, MA 02115 USA.	htoka@bidmc.harvard.edu	Toka, Hakan/AAQ-2162-2021		National Institute for Health [DK070756]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK070756] Funding Source: NIH RePORTER	National Institute for Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Institute for Health, PO1 grant DK070756 (to D.B.M, M.R.P. and G.C.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper SL, 2002, J NEPHROL, V15, pS41; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Attanasio M, 2011, PEDIATR NEPHROL, V26, P337, DOI 10.1007/s00467-010-1562-6; Ba JM, 2003, AM J PHYSIOL-RENAL, V285, pF1233, DOI 10.1152/ajprenal.00249.2003; Bergeron MJ, 2013, MOL ASPECTS MED, V34, P299, DOI 10.1016/j.mam.2012.12.001; Borghi L, 1996, J UROLOGY, V155, P839, DOI 10.1016/S0022-5347(01)66321-3; Breiderhoff T, 2012, P NATL ACAD SCI USA, V109, P14241, DOI 10.1073/pnas.1203834109; Chau H, 2003, J BONE MINER RES, V18, P644, DOI 10.1359/jbmr.2003.18.4.644; Curhan GC, 2008, KIDNEY INT, V73, P489, DOI 10.1038/sj.ki.5002708; Curhan GC, 2004, ARCH INTERN MED, V164, P885, DOI 10.1001/archinte.164.8.885; Curhan GC, 1997, ANN INTERN MED, V126, P497, DOI 10.7326/0003-4819-126-7-199704010-00001; Curhan GC, 1997, J AM SOC NEPHROL, V8, P1568; CURHAN GC, 1993, NEW ENGL J MED, V328, P833, DOI 10.1056/NEJM199303253281203; Dawson PA, 2010, J CLIN INVEST, V120, P706, DOI 10.1172/JCI31474; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dimke H, 2013, AM J PHYSIOL-RENAL, V304, pF761, DOI 10.1152/ajprenal.00263.2012; Fahmi S, 2008, HUM MOL GENET, V17, P2101, DOI 10.1093/hmg/ddn108; Gong YF, 2012, EMBO J, V31, P1999, DOI 10.1038/emboj.2012.49; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Heneghan JF, 2010, AM J PHYSIOL-CELL PH, V298, pC1363, DOI 10.1152/ajpcell.00004.2010; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hou JH, 2013, ANNU REV PHYSIOL, V75, P479, DOI 10.1146/annurev-physiol-030212-183705; Hou JH, 2009, P NATL ACAD SCI USA, V106, P15350, DOI 10.1073/pnas.0907724106; Ichikawa S, 2006, J CLIN ENDOCR METAB, V91, P4022, DOI 10.1210/jc.2005-2840; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Loh NY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055412; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Mayan H, 2004, J CLIN ENDOCR METAB, V89, P4025, DOI 10.1210/jc.2004-0037; Melnick JZ, 1998, KIDNEY INT, V54, P160, DOI 10.1046/j.1523-1755.1998.00974.x; Moe OW, 2005, J AM SOC NEPHROL, V16, P729, DOI 10.1681/ASN.2004100888; Nota B, 2013, AM J HUM GENET, V92, P627, DOI 10.1016/j.ajhg.2013.03.009; Okamoto N, 2007, INT J UROL, V14, P344, DOI 10.1111/j.1442-2042.2007.01554.x; Palmada M, 2005, CELL PHYSIOL BIOCHEM, V15, P175, DOI 10.1159/000083650; PARKINSON DB, 1992, NAT GENET, V1, P149, DOI 10.1038/ng0592-149; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; Pearle MS, 2005, J UROLOGY, V173, P848, DOI 10.1097/01.ju.0000152082.14384.d7; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; Rendina D, 2006, J CLIN ENDOCR METAB, V91, P959, DOI 10.1210/jc.2005-1606; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Ruggiero M, 1999, MINER ELECTROL METAB, V25, P185, DOI 10.1159/000057443; Seidler U, 2009, EXP PHYSIOL, V94, P175, DOI 10.1113/expphysiol.2008.043018; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Suzuki Y, 2008, HUM MOL GENET, V17, P1613, DOI 10.1093/hmg/ddn048; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Thomee C, 2005, J CLIN ENDOCR METAB, V90, P2487, DOI 10.1210/jc.2004-2450; Thorleifsson G, 2009, NAT GENET, V41, P926, DOI 10.1038/ng.404; Toka HR, 2012, J AM SOC NEPHROL; Tosukhowong P, 2005, INT J UROL, V12, P140, DOI 10.1111/j.1442-2042.2005.01001.x; Uchida S, 2000, NEPHROL DIAL TRANSPL, V15, P14, DOI 10.1093/ndt/15.suppl_6.14; Wang ZH, 2005, AM J PHYSIOL-CELL PH, V288, pC957, DOI 10.1152/ajpcell.00505.2004; Worcester EM, 2010, NEW ENGL J MED, V363, P954, DOI 10.1056/NEJMcp1001011; WRONG OM, 1994, Q J MED, V87, P473; YOSHIDA O, 1990, UROL INT, V45, P104, DOI 10.1159/000281680; Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683; Zhang Z, 2012, ARCH MED RES, V43, P298, DOI 10.1016/j.arcmed.2012.05.001	66	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71885	10.1371/journal.pone.0071885	http://dx.doi.org/10.1371/journal.pone.0071885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991001	Green Published, gold, Green Submitted			2022-12-25	WOS:000324228800024
J	Lyman, NB; Jagadish, KSV; Nalley, LL; Dixon, BL; Siebenmorgen, T				Lyman, Nathaniel B.; Jagadish, Krishna S. V.; Nalley, L. Lanier; Dixon, Bruce L.; Siebenmorgen, Terry			Neglecting Rice Milling Yield and Quality Underestimates Economic Losses from High-Temperature Stress	PLOS ONE			English	Article							NIGHTTIME AIR TEMPERATURES; GRAIN-FILLING PERIOD; KERNEL DEVELOPMENT; CLIMATE-CHANGE; DRY-MATTER; WHEAT; SENESCENCE; CHALKINESS; DECLINE; IMPACT	Future increases in global surface temperature threaten those worldwide who depend on rice production for their livelihoods and food security. Past analyses of high-temperature stress on rice production have focused on paddy yitemperatures on milling quality outcomes, which ultimately determine edible (marketableeld and have failed to account for the detrimental impact of high ) rice yield and market value. Using genotype specific rice yield and milling quality data on six common rice varieties from Arkansas, USA, combined with on-site, half-hourly and daily temperature observations, we show a nonlinear effect of high-temperature stress exposure on yield and milling quality. A 1 degrees C increase in average growing season temperature reduces paddy yield by 6.2%, total milled rice yield by 7.1% to 8.0%, head rice yield by 9.0% to 13.8%, and total milling revenue by 8.1% to 11.0%, across genotypes. Our results indicate that failure to account for changes in milling quality leads to understatement of the impacts of high temperatures on rice production outcomes. These dramatic losses result from reduced paddy yield and increased percentages of chalky and broken kernels, which together decrease the quantity and market value of milled rice. Recently published estimates show paddy yield reductions of up to 10% across the major rice- producing regions of South and Southeast Asia due to rising temperatures. The results of our study suggest that the often-cited 10% figure underestimates the economic implications of climate change for rice producers, thus potentially threatening future food security for global rice producers and consumers.	[Lyman, Nathaniel B.; Nalley, L. Lanier; Dixon, Bruce L.] Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA; [Jagadish, Krishna S. V.] Int Rice Res Inst, Crop & Environm Sci Div, Manila, Philippines; [Siebenmorgen, Terry] Univ Arkansas, Dept Food Sci, Fayetteville, AR 72703 USA	University of Arkansas System; University of Arkansas Fayetteville; CGIAR; International Rice Research Institute (IRRI); University of Arkansas System; University of Arkansas Fayetteville	Jagadish, KSV (corresponding author), Int Rice Res Inst, Crop & Environm Sci Div, Manila, Philippines.	k.jagadish@irri.org	Nalley, Lawton/AAN-7643-2021					Adams RM, 1998, CLIMATE RES, V11, P19, DOI 10.3354/cr011019; Ambardekar AA, 2011, FIELD CROP RES, V122, P179, DOI 10.1016/j.fcr.2011.03.012; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Cooper NTW, 2008, CEREAL CHEM, V85, P276, DOI 10.1094/CCHEM-85-3-0276; Cooper NTW, 2006, CEREAL CHEM, V83, P447, DOI 10.1094/CC-83-0447; Counce PA, 2005, CEREAL CHEM, V82, P645, DOI 10.1094/CC-82-0645; Dawe D., 2011, RICE GLOBAL EC STRAT; FAO, 2002, WORLD AGR 2015 2030; Fitzgerald MA, 2009, FUNCT PLANT BIOL, V36, P1037, DOI 10.1071/FP09055; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; GRiSP, 2010, SUMM; HOWELL TA, 1995, J IRRIG DRAIN ENG, V121, P191, DOI 10.1061/(ASCE)0733-9437(1995)121:2(191); Ishimaru T, 2009, J CEREAL SCI, V50, P166, DOI 10.1016/j.jcs.2009.04.011; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Kim J, 2011, FIELD CROP RES, V122, P207, DOI 10.1016/j.fcr.2011.03.014; Kobata T, 2004, AGRON J, V96, P406, DOI 10.2134/agronj2004.0406; Lanning SB, 2011, FIELD CROP RES, V124, P132, DOI 10.1016/j.fcr.2011.06.012; Lobell DB, 2007, AGRON J, V99, P469, DOI 10.2134/agronj2006.0209; Lobell DB, 2012, NAT CLIM CHANGE, V2, P186, DOI [10.1038/nclimate1356, 10.1038/NCLIMATE1356]; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Matsui T, 1997, JPN J CROP SCI, V66, P449, DOI 10.1626/jcs.66.449; Mohammed AR, 2009, AGR FOREST METEOROL, V149, P999, DOI 10.1016/j.agrformet.2008.12.003; Morita S., 2004, Japanese Journal of Crop Science, V73, P77, DOI 10.1626/jcs.73.77; NASA POWER, 2012, NASA CLIM RES AGR DA; NOAA, 2012, NOAA SOL CALC; Okada M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034031; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; PETERS DB, 1971, AGRON J, V63, P809, DOI 10.2134/agronj1971.00021962006300050046x; Peterson TC, 2012, B AM METEOROL SOC, V93, P1041, DOI 10.1175/BAMS-D-12-00021.1; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Sheehy JE, 2006, FIELD CROP RES, V98, P151, DOI 10.1016/j.fcr.2006.01.001; Siebenmorgen TJ, 2007, APPL ENG AGRIC, V24, P359; TAKEOKA Y, 1991, SEX PLANT REPROD, V4, P39, DOI 10.1007/BF00194570; TASHIRO T, 1991, AUST J PLANT PHYSIOL, V18, P259, DOI 10.1071/PP9910259; Tsukaguchi T, 2008, PLANT PROD SCI, V11, P203, DOI 10.1626/pps.11.203; United Nations, 2011, WORLD POP PROSP 2010; USDA ERS, 2012, RIC YB TABL; Verbeek M., 2008, GUIDE MODERN ECONOME, V3rd ed.; Wassmann R, 2009, ADV AGRON, V101, P59, DOI 10.1016/S0065-2113(08)00802-X; Welch JR, 2010, P NATL ACAD SCI USA, V107, P14562, DOI 10.1073/pnas.1001222107; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Zinn KE, 2010, J EXP BOT, V61, P1959, DOI 10.1093/jxb/erq053	43	125	132	7	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72157	10.1371/journal.pone.0072157	http://dx.doi.org/10.1371/journal.pone.0072157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991056	gold, Green Submitted, Green Published			2022-12-25	WOS:000324470700030
J	Yu, KX; Sheng, ZZ; Huang, B; Ma, XL; Li, YF; Yuan, XY; Qin, ZM; Wang, D; Chakravarty, S; Li, F; Song, MX; Sun, HC				Yu, Kexiang; Sheng, Zhi-Zhang; Huang, Bing; Ma, Xiuli; Li, Yufeng; Yuan, Xiaoyuan; Qin, Zhuoming; Wang, Dan; Chakravarty, Suvobrata; Li, Feng; Song, Minxun; Sun, Huaichang			Structural, Antigenic, and Evolutionary Characterizations of the Envelope Protein of Newly Emerging Duck Tembusu Virus	PLOS ONE			English	Article							WEST-NILE-VIRUS; REVERSE-TRANSCRIPTION; RAPID DETECTION; FLAVIVIRUS; NEUTRALIZATION; ANTIBODIES; CHINA; ENCEPHALITIS	Since the first reported cases of ducks infected with a previously unknown flavivirus in eastern China in April 2010, the virus, provisionally designated Duck Tembusu Virus (DTMUV), has spread widely in domestic ducks in China and caused significant economic losses to poultry industry. In this study, we examined in detail structural, antigenic, and evolutionary properties of envelope (E) proteins of six DTMUV isolates spanning 2010-2012, each being isolated from individual farms with different geographical locations where disease outbreaks were documented. Structural analysis showed that E proteins of DTMUV and its closely related flavivirus (Japanese Encephalitis Virus) shared a conserved array of predicted functional domains and motifs. Among the six DTMUV strains, mutations were observed only at thirteen amino acid positions across three separate domains of the E protein. Interestingly, these genetic polymorphisms resulted in no detectable change in viral neutralization properties as demonstrated in a serum neutralization assay. Furthermore, phylogenetic analysis of the nucleotide sequences of the E proteins showed that viruses evolved into two distinct genotypes, termed as DTMUV. I and DTMUV. II, with II emerging as the dominant genotype. New findings described here shall give insights into the antigenicity and evolution of this new pathogen and provide guidance for further functional studies of the E protein for which no effective vaccine has yet been developed.	[Yu, Kexiang; Sun, Huaichang] Yangzhou Univ, Coll Vet Med, Yangzhou, Peoples R China; [Yu, Kexiang; Huang, Bing; Ma, Xiuli; Li, Yufeng; Yuan, Xiaoyuan; Qin, Zhuoming; Li, Feng; Song, Minxun] Shandong Acad Agr Sci, Inst Poultry Sci, Jinan, Peoples R China; [Sheng, Zhi-Zhang; Chakravarty, Suvobrata] S Dakota State Univ, Dept Chem & Biochem, Brookings, SD 57007 USA; [Wang, Dan] S Dakota State Univ, Dept Hlth & Nutr Sci, Brookings, SD 57007 USA; [Li, Feng] S Dakota State Univ, Dept Vet & Biomed Sci, Brookings, SD 57007 USA; [Li, Feng] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA	Yangzhou University; Shandong Academy of Agricultural Sciences; South Dakota State University; South Dakota State University; South Dakota State University; South Dakota State University	Li, F (corresponding author), Shandong Acad Agr Sci, Inst Poultry Sci, Jinan, Peoples R China.	feng.li@sdstate.edu; songsdpi@gmail.com; sunh@yzu.edu.cn	Li, yu/HHZ-5236-2022; Sheng, Zizhang/AFR-8049-2022	Sheng, Zizhang/0000-0002-3253-3309; Wang, Dan/0000-0002-7263-8420; Li, Feng/0000-0002-8904-2893	Shandong Provincial Natural Science Foundation [BS2009YY019]; Taishan Scholar Program to Institute of Poultry Science, Chinese National Science foundation [31172355/C1806]; Agro-scientific research in the public interest [201003012]; key agricultural program of application technology of Shandong province; SDSU AES Fund [3AH203]; SD 2010 Research Center (Biological Control and Analysis of Applied Photonics, BCAAP) Fund [3SJ163]; SDSU AES; South Dakota 2010 Research Center, BCAAP (Biological Control and Analysis of Applied Photonics) Fund [3SG163]	Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Taishan Scholar Program to Institute of Poultry Science, Chinese National Science foundation; Agro-scientific research in the public interest; key agricultural program of application technology of Shandong province; SDSU AES Fund; SD 2010 Research Center (Biological Control and Analysis of Applied Photonics, BCAAP) Fund; SDSU AES; South Dakota 2010 Research Center, BCAAP (Biological Control and Analysis of Applied Photonics) Fund	The study was partially supported by funds from Shandong Provincial Natural Science Foundation (BS2009YY019), Taishan Scholar Program to Institute of Poultry Science, Chinese National Science foundation (31172355/C1806), Agro-scientific research in the public interest (201003012): Rapid diagnosis and vaccine development in major infectious diseases of waterfowl, and the key agricultural program of application technology of Shandong province in 2012: Integrated preventing and controlling technique of Duck Tembusu virus. Works at South Dakota State University (SDSU) were supported in part by the SDSU AES Fund 3AH203 and SD 2010 Research Center (Biological Control and Analysis of Applied Photonics, BCAAP) Fund (3SJ163 to F. L.). Research in the S. C. laboratory was supported by the SDSU AES to S. C. and the South Dakota 2010 Research Center, BCAAP (Biological Control and Analysis of Applied Photonics) Fund (3SG163 to S. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10; Cao ZZ, 2011, EMERG INFECT DIS, V17, P1873, DOI 10.3201/eid1710.101890; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081; Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005; Kono Y, 2000, AM J TROP MED HYG, V63, P94, DOI 10.4269/ajtmh.2000.63.94; Liu M, 2012, J CLIN MICROBIOL, V50, P2807, DOI 10.1128/JCM.00655-12; Liu PP, 2012, J GEN VIROL, V93, P2158, DOI 10.1099/vir.0.043554-0; Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11; Ma X.P., 2013, J IMMUNOL TECH INFEC, V2, P1, DOI [DOI 10.4172/2325-9752.1000103, 10. 4172/2325-9752. 1000103]; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; PLATT GS, 1975, ANN TROP MED PARASIT, V69, P65, DOI 10.1080/00034983.1975.11686984; Sanchez MD, 2005, VIROLOGY, V336, P70, DOI 10.1016/j.virol.2005.02.020; Su JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018106; Tang Y, 2012, TRANSBOUND EMERG DIS, V59, P336, DOI 10.1111/j.1865-1682.2011.01275.x; Tang Y, 2012, TRANSBOUND EMERG DIS, V59, P208, DOI 10.1111/j.1865-1682.2011.01257.x; Wang YL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-553; YAMASHITA M, 1988, VIROLOGY, V163, P112, DOI 10.1016/0042-6822(88)90238-3	23	37	49	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e71319	10.1371/journal.pone.0071319	http://dx.doi.org/10.1371/journal.pone.0071319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23990944	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470700014
J	Droit-Volet, S; Zelanti, PS				Droit-Volet, Sylvie; Zelanti, Pierre S.			Development of Time Sensitivity and Information Processing Speed	PLOS ONE			English	Article							AGE-RELATED-CHANGES; WORKING-MEMORY; FLUID INTELLIGENCE; INTERNAL CLOCK; TEMPORAL GENERALIZATION; INDIVIDUAL-DIFFERENCES; DURATION; REPRODUCTION; PERCEPTION; CHILDHOOD	The aim of this study was to examine whether age-related changes in the speed of information processing are the best predictors of the increase in sensitivity to time throughout childhood. Children aged 5 and 8 years old, as well adults, were given two temporal bisection tasks, one with short (0.5/1-s) and the other with longer (4/8-s) anchor durations. In addition, the participants' scores on different neuropsychological tests assessing both information processing speed and other dimensions of cognitive control (short-term memory, working memory, selective attention) were calculated. The results showed that the best predictor of individual variances in sensitivity to time was information processing speed, although working memory also accounted for some of the individual differences in time sensitivity, albeit to a lesser extent. In sum, the faster the information processing speed of the participants, the higher their sensitivity to time was. These results are discussed in the light of the idea that the development of temporal capacities has its roots in the maturation of the dynamic functioning of the brain.	[Droit-Volet, Sylvie; Zelanti, Pierre S.] Univ Blaise Pascal, Lab Psychol Sociale & Cognit, Ctr Natl Rech Sci, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Droit-Volet, S (corresponding author), Univ Blaise Pascal, Lab Psychol Sociale & Cognit, Ctr Natl Rech Sci, Clermont Ferrand, France.	Sylvie.DROIT-VOLET@univ-bpclermont.fr			ANR (Agence Nationale de la Recherche), Emotion(s), Cognition, Comportement, France [EMCO-01-2011]	ANR (Agence Nationale de la Recherche), Emotion(s), Cognition, Comportement, France(French National Research Agency (ANR))	This study was supported by a grant from the ANR (Agence Nationale de la Recherche), Emotion(s), Cognition, Comportement (EMCO-01-2011), France. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 1996, PHILOS T ROY SOC B, V351, P1397, DOI 10.1098/rstb.1996.0123; Baddeley A. D., 1974, RECENT ADV LEARNING, P647; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Ball WS, 2012, CEREB CORTEX, V22, P1, DOI 10.1093/cercor/bhr018; Baudouin A, 2006, ACTA PSYCHOL, V121, P285, DOI 10.1016/j.actpsy.2005.07.004; Baudouin A, 2006, BRAIN COGNITION, V62, P17, DOI 10.1016/j.bandc.2006.03.003; Block RA, 2000, MEM COGNITION, V28, P1333, DOI 10.3758/BF03211834; Brannon EM, 2007, DEVELOPMENTAL SCI, V10, P770, DOI 10.1111/j.1467-7687.2007.00635.x; Brannon EM, 2004, COGNITIVE BRAIN RES, V21, P227, DOI 10.1016/j.cogbrainres.2004.04.007; Broadway JM, 2011, ACTA PSYCHOL, V137, P115, DOI 10.1016/j.actpsy.2011.03.008; Brown TT, 2012, NEUROPSYCHOL REV, V22, P313, DOI 10.1007/s11065-012-9214-1; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Burle B, 1999, BEHAV PROCESS, V45, P59, DOI 10.1016/S0376-6357(99)00009-1; Camos V, 2013, DEV MEMOIRE TRAVAIL; Case R, 1985, INTELLECTUAL DEV BIR; Chelonis JJ, 2004, NEUROTOXICOL TERATOL, V26, P461, DOI 10.1016/j.ntt.2004.01.004; Cohen MJ, 1997, NATURE; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; de Abreu PMJE, 2010, INTELLIGENCE, V38, P552, DOI 10.1016/j.intell.2010.07.003; Demetriou A, 2008, INTELLIGENCE, V36, P437, DOI 10.1016/j.intell.2007.10.002; Droit-Volet S, 2002, Q J EXP PSYCHOL-A, V55, P1193, DOI 10.1080/02724980244000161; Droit-Volet S, 2001, J EXP CHILD PSYCHOL, V80, P271, DOI 10.1006/jecp.2001.2629; Droit-Volet S, 2001, J EXP CHILD PSYCHOL, V80, P142, DOI 10.1006/jecp.2001.2631; Droit-Volet S, 2013, Q J EXP PSYCHOL, V66, P671, DOI 10.1080/17470218.2012.712148; Droit-Volet S, 2013, NEUROPSYCHOLOGIA, V51, P220, DOI 10.1016/j.neuropsychologia.2012.09.023; Droit-Volet S, 2011, LECT NOTES ARTIF INT, V6789, P151; Dutke S, 2005, PERCEPT PSYCHOPHYS, V67, P1404, DOI 10.3758/BF03193645; Eisermann M, 2013, NEUROPHYSIOL CLIN, V43, P35, DOI 10.1016/j.neucli.2012.09.091; Espinosa-Fernandez L, 2003, ACTA PSYCHOL, V112, P221, DOI 10.1016/S0001-6918(02)00093-8; Fink A, 2005, INTELLIGENCE, V33, P5, DOI 10.1016/j.intell.2004.09.001; FORTIN C, 1995, PERCEPT PSYCHOPHYS, V57, P203, DOI 10.3758/BF03206507; FORTIN C, 1993, PERCEPT PSYCHOPHYS, V53, P536, DOI 10.3758/BF03205202; FORTIN C, 2003, METH NE FRO NEUROSCI, P235; Fry AF, 1996, PSYCHOL SCI, V7, P237, DOI 10.1111/j.1467-9280.1996.tb00366.x; Haier RJ, 2005, NEUROIMAGE, V25, P320, DOI 10.1016/j.neuroimage.2004.11.019; Hancock PA, 2010, ACTA PSYCHOL, V133, P170, DOI 10.1016/j.actpsy.2009.11.005; Harrington DL, 2010, CEREB CORTEX, V20, P1274, DOI 10.1093/cercor/bhp194; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; KAIL R, 1994, ACTA PSYCHOL, V86, P199, DOI 10.1016/0001-6918(94)90003-5; KAIL R, 1991, PSYCHOL BULL, V109, P490, DOI 10.1037/0033-2909.109.3.490; Kail RV, 2001, ADV CHILD DEV BEHAV, P151; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Korkman M., 2007, NEPSY 2, V2nd; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Matell MS, 2000, BIOESSAYS, V22, P94, DOI 10.1002/(SICI)1521-1878(200001)22:1<94::AID-BIES14>3.0.CO;2-E; MATSUDA F, 1983, JPN PSYCHOL RES, V25, P119, DOI 10.4992/psycholres1954.25.119; McCormack T, 1999, DEV PSYCHOL, V35, P1143, DOI 10.1037/0012-1649.35.4.1143; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Neufang S, 2008, NEUROIMAGE, V43, P399, DOI 10.1016/j.neuroimage.2008.07.039; Noreika V, 2013, NEUROPSYCHOLOGIA, V51, P235, DOI 10.1016/j.neuropsychologia.2012.09.036; Perbal S, 2002, AGING NEUROPSYCHOL C, V9, P201, DOI 10.1076/anec.9.3.201.9609; PETERSEN I, 1971, NEUROPADIATRIE, V2, P247, DOI 10.1055/s-0028-1091786; Provasi J, 2011, J EXP PSYCHOL ANIM B, V37, P108, DOI 10.1037/a0019976; Rammsayer TH, 2002, J RES PERS, V36, P507, DOI 10.1016/S0092-6566(02)00006-5; Rammsayer TH, 2007, INTELLIGENCE, V35, P123, DOI 10.1016/j.intell.2006.04.007; Rattat AC, 2012, BEHAV RES METHODS, V44, P67, DOI 10.3758/s13428-011-0135-3; Rubia K, 2004, ACTA NEUROBIOL EXP, V64, P329; Smith AB, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00136; Survillo WW, 1961, NATURE, V19, P823; SURWILLO WW, 1963, ELECTROEN CLIN NEURO, V15, P1029, DOI 10.1016/0013-4694(63)90146-9; Szelag E, 2002, ACTA PSYCHOL, V110, P1, DOI 10.1016/S0001-6918(01)00067-1; TREISMAN M, 1990, PERCEPTION, V19, P705, DOI 10.1068/p190705; Troche SJ, 2009, INTELLIGENCE, V37, P479, DOI 10.1016/j.intell.2009.06.001; Ulbrich P, 2007, ACTA PSYCHOL, V125, P51, DOI 10.1016/j.actpsy.2006.06.004; vanMarle K., 2006, DEVELOPMENTAL SCI, V9, P41, DOI DOI 10.1111/J.1467-7687.2006.00508.X; Weschler D, 2009, INTELLIGENCE; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Zelanti PS, 2012, J EXP CHILD PSYCHOL, V112, P296, DOI 10.1016/j.jecp.2012.01.003; Zelanti PS, 2011, J EXP CHILD PSYCHOL, V109, P143, DOI 10.1016/j.jecp.2011.01.003	73	35	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71424	10.1371/journal.pone.0071424	http://dx.doi.org/10.1371/journal.pone.0071424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218YW	23990953	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100044
J	Gao, YY; Lin, XY; Shi, KR; Yan, ZG; Wang, ZH				Gao, Yuanyuan; Lin, Xueyan; Shi, Kerong; Yan, Zhengui; Wang, Zhonghua			Bovine Mammary Gene Expression Profiling during the Onset of Lactation	PLOS ONE			English	Article							MILK PROTEIN-SYNTHESIS; CASEIN MESSENGER-RNA; FATTY-ACID SYNTHESIS; DRY PERIOD LENGTH; TRANSCRIPTION FACTORS; AMINO-ACIDS; GLAND; GROWTH; CARBOXYLASE; PREGNANCY	Background: Lactogenesis includes two stages. Stage I begins a few weeks before parturition. Stage II is initiated around the time of parturition and extends for several days afterwards. Methodology/Principal Findings: To better understand the molecular events underlying these changes, genome-wide gene expression profiling was conducted using digital gene expression (DGE) on bovine mammary tissue at three time points (on approximately day 35 before parturition (-35 d), day 7 before parturition (-7 d) and day 3 after parturition (+3 d)). Approximately 6.2 million (M), 5.8 million (M) and 6.1 million (M) 21-nt cDNA tags were sequenced in the three cDNA libraries (-35 d, -7 d and +3 d), respectively. After aligning to the reference sequences, the three cDNA libraries included 8,662, 8,363 and 8,359 genes, respectively. With a fold change cutoff criteria of >= 2 or <=-2 and a false discovery rate (FDR) of <= 0.001, a total of 812 genes were significantly differentially expressed at -7 d compared with -35 d (stage I). Gene ontology analysis showed that those significantly differentially expressed genes were mainly associated with cell cycle, lipid metabolism, immune response and biological adhesion. A total of 1,189 genes were significantly differentially expressed at +3 d compared with -7 d (stage II), and these genes were mainly associated with the immune response and cell cycle. Moreover, there were 1,672 genes significantly differentially expressed at +3 d compared with -35 d. Gene ontology analysis showed that the main differentially expressed genes were those associated with metabolic processes. Conclusions: The results suggest that the mammary gland begins to lactate not only by a gain of function but also by a broad suppression of function to effectively push most of the cell's resources towards lactation.	[Gao, Yuanyuan; Lin, Xueyan; Shi, Kerong; Yan, Zhengui; Wang, Zhonghua] Shandong Agr Univ, Shandong Prov Key Lab Ruminant Nutrit Physiol, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, ZH (corresponding author), Shandong Agr Univ, Shandong Prov Key Lab Ruminant Nutrit Physiol, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China.	zhwang@sdau.edu.cn	Shi, Kerong/AAA-4004-2022		Fund of Modern Agro-industry Technology Research System of China [CARS-37]; Shandong Province Science Technology Development Plan [2012NC11103]; Natural Science Fund of China [31072050]; Cattle Breed Project of Shandong Province	Fund of Modern Agro-industry Technology Research System of China; Shandong Province Science Technology Development Plan; Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Cattle Breed Project of Shandong Province	This research was supported by the Fund of Modern Agro-industry Technology Research System of China (CARS-37), Shandong Province Science Technology Development Plan (2012NC11103), Natural Science Fund of China (31072050) and Cattle Breed Project of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RR, 1981, J DAIRY SCI, V64, P427, DOI 10.3168/jds.S0022-0302(81)82589-1; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barash I, 2006, J CELL PHYSIOL, V209, P305, DOI 10.1002/jcp.20771; Barry JM, 1970, REV LACTOGENESIS; Benjamini Y, 2001, ANN STAT, V29, P1165; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; COPPOCK CE, 1974, J DAIRY SCI, V57, P712, DOI 10.3168/jds.S0022-0302(74)84953-2; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Galbaugh T, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-34; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hieshima K, 2012, J IMMUNOL, V189, P1452; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hovey RC, 2002, J MAMMARY GLAND BIOL, V7, P17, DOI 10.1023/A:1015766322258; Jankiewicz M, 2006, MOL ENDOCRINOL, V20, P2369, DOI 10.1210/me.2006-0071; Jones FE, 1999, ONCOGENE, V18, P3481, DOI 10.1038/sj.onc.1202698; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lemay DG, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-56; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Lopez JM, 1996, P NATL ACAD SCI USA, V93, P1049, DOI 10.1073/pnas.93.3.1049; Madsen TG, 2008, J DAIRY SCI, V91, P1791, DOI 10.3168/jds.2007-0905; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Moshel Y, 2006, J CELL BIOCHEM, V98, P685, DOI 10.1002/jcb.20825; Oh SY, 2003, J BIOL CHEM, V278, P28410, DOI 10.1074/jbc.M300553200; Prizant RL, 2008, J CELL BIOCHEM, V105, P1038, DOI 10.1002/jcb.21904; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; ROSEN JM, 1975, BIOCHEMISTRY-US, V14, P2895, DOI 10.1021/bi00684a016; Rudolph MC, 2010, AM J PHYSIOL-ENDOC M, V299, pE918, DOI 10.1152/ajpendo.00376.2010; Schild L, 2001, ADV EXP MED BIOL, V502, P305; Schweizer M, 2002, BIOCHEM SOC T, V30, P1070, DOI 10.1042/BST0301070; SHAMAY A, 1988, ENDOCRINOLOGY, V123, P804, DOI 10.1210/endo-123-2-804; SHUSTER RC, 1976, EUR J BIOCHEM, V71, P193, DOI 10.1111/j.1432-1033.1976.tb11106.x; Sordillo LM, 2002, J MAMMARY GLAND BIOL, V7, P135, DOI 10.1023/A:1020347818725; Sordillo LM, 1997, J DAIRY SCI, V80, P1851, DOI 10.3168/jds.S0022-0302(97)76121-6; SORENSEN JT, 1991, J DAIRY SCI, V74, P1277, DOI 10.3168/jds.S0022-0302(91)78283-0; Sorensen MT, 2006, J DAIRY SCI, V89, P4632, DOI 10.3168/jds.S0022-0302(06)72513-9; Suchyta SP, 2003, PHYSIOL GENOMICS, V16, P8, DOI 10.1152/physiolgenomics.00028.2003; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Toerien CA, 2010, J NUTR, V140, P285, DOI 10.3945/jn.109.114033; Trajkovski I, 2008, J BIOMED INFORM, V41, P588, DOI 10.1016/j.jbi.2007.12.001; Travers MT, 2001, BIOCHEM J, V359, P273, DOI 10.1042/0264-6021:3590273; Tucker HA, 2000, J DAIRY SCI, V83, P874, DOI 10.3168/jds.S0022-0302(00)74951-4; WHEELER TT, 1995, EXP CELL RES, V217, P346, DOI 10.1006/excr.1995.1096; Yadav P, 2012, TROP ANIM HEALTH PRO, V44, P693, DOI 10.1007/s11250-011-9988-9; Yang J, 2000, J ANIM SCI, V78, P3126; Yang J, 2000, J ANIM SCI, V78, P3114	49	30	31	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e70393	10.1371/journal.pone.0070393	http://dx.doi.org/10.1371/journal.pone.0070393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990904	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100025
J	Goodman, A				Goodman, Anna			Walking, Cycling and Driving to Work in the English and Welsh 2011 Census: Trends, Socio-Economic Patterning and Relevance to Travel Behaviour in General	PLOS ONE			English	Article							CARBON-DIOXIDE EMISSIONS; PHYSICAL-ACTIVITY; EUROPEAN ADULTS; HEALTH; INEQUALITIES; TRANSPORT; UK; DETERMINANTS; ASSOCIATIONS; BENEFITS	Objectives: Increasing walking and cycling, and reducing motorised transport, are health and environmental priorities. This paper examines levels and trends in the use of different commute modes in England and Wales, both overall and with respect to small-area deprivation. It also investigates whether commute modal share can serve as a proxy for travel behaviour more generally. Methods: 23.7 million adult commuters reported their usual main mode of travelling to work in the 2011 census in England and Wales; similar data were available for 1971-2001. Indices of Multiple Deprivation were used to characterise socioeconomic patterning. The National Travel Survey (2002-2010) was used to examine correlations between commute modal share and modal share of total travel time. These correlations were calculated across 150 non-overlapping populations defined by region, year band and income. Results: Among commuters in 2011, 67.1% used private motorised transport as their usual main commute mode (-1.8 percentage-point change since 2001); 17.8% used public transport (+1.8% change); 10.9% walked (-0.1% change); and 3.1% cycled (+0.1% change). Walking and, to a marginal extent, cycling were more common among those from deprived areas, but these gradients had flattened over the previous decade to the point of having essentially disappeared for cycling. In the National Travel Survey, commute modal share and total modal share were reasonably highly correlated for private motorised transport (r = 0.94), public transport (r = 0.96), walking (r = 0.88 excluding London) and cycling (r = 0.77). Conclusions: England and Wales remain car-dependent, but the trends are slightly more encouraging. Unlike many health behaviours, it is more common for socio-economically disadvantaged groups to commute using physically active modes. This association is, however, weakening and may soon reverse for cycling. At a population level, commute modal share provides a reasonable proxy for broader travel patterns, enhancing the value of the census in characterising background trends and evaluating interventions.	London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Goodman, A (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1, England.	anna.goodman@LSHTM.ac.uk			National Institute of Health Research (NIHR); National Institute for Health Research [PDF-2010-03-15] Funding Source: researchfish	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	AG is funded by a National Institute of Health Research (NIHR) post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed in this article are those of the author and do not necessarily reflect those of the NIHR, the Department of Health or the NHS.	Adams J, 2006, J PUBLIC HEALTH, V28, P379, DOI 10.1093/pubmed/fdl061; American Public Health Association, 2012, PROM ACT TRANSP OPP; [Anonymous], 2007, CLIMATE CHANGE 2007; Beenackers MA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-116; Bhat CR, 2000, TRANSPORT RES A-POL, V34, P1, DOI 10.1016/S0965-8564(98)00037-8; Bibby P., 2004, DEV NEW CLASSIFICATI; Brand C, 2008, ENERG POLICY, V36, P224, DOI 10.1016/j.enpol.2007.08.016; Brand C, 2013, APPL ENERG, V104, P158, DOI 10.1016/j.apenergy.2012.11.001; Chief medical officers of England Scotland Wales and Northern Island, 2011, START ACT STAY ACT R; Craig R, 2012, HLTH SURVEY ENGLAND, V1; Crosby L, 2011, THESIS; Cumberlege J., 2010, FAIR SOC HEARLY LIVE; DCLG (Department for Communities and Local Government), 2011, ENGL IND DEPR 2010; Department for Transport, 2011, NAT TRAV SURV 2010 N; Department for Transport, 2013, ROAD TRAFF VEH MIL V; Department for Transport, 1996, NAT CYCL STRAT; Department for Transport, 2011, CMND7996; Department of Health and Department for Transport, 2010, ACT TRAV STRAT; Department of Transport, 2004, FUT TRANSP NETW 2030; Employment Development Institute, 2009, 2009 DIS STAT; Giskes K, 2010, OBES REV, V11, P413, DOI 10.1111/j.1467-789X.2009.00658.x; Goodman A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-52; Goodman A, 2012, SOC SCI MED, V74, P1929, DOI 10.1016/j.socscimed.2012.01.042; Goodman A, 2011, HEALTH PLACE, V17, P767, DOI 10.1016/j.healthplace.2011.02.002; Goodwin P., 2012, WORLD TRANSPORTATION, V17, P8; Gordon-Larsen P, 2009, ARCH INTERN MED, V169, P1216, DOI 10.1001/archinternmed.2009.163; Gower TL, 2013, 2011 CENSUS ANAL MET; Green J., 2010, CYCLING LONDON STUDY; Hamer M, 2008, PREV MED, V46, P9, DOI 10.1016/j.ypmed.2007.03.006; Healthy People 2020, 2010, FDN HLTH MEAS REP HE; Jarrett J, 2012, LANCET, V379, P2198, DOI 10.1016/S0140-6736(12)60766-1; Lindstrom M, 2008, PREV MED, V46, P22, DOI 10.1016/j.ypmed.2007.07.012; Markovich J., 2011, 1055 SCH GEOGR ENV T, P1055; Metz D, 2012, TRANSPORT POLICY, V21, P20, DOI 10.1016/j.tranpol.2012.01.007; Millard-Ball A, 2011, TRANSPORT REV, V31, P357, DOI 10.1080/01441647.2010.518291; Office for National Statistics, 2011, RESP RAT SUMM; Office for National Statistics, 2012, 2011 CENS LOC AUTH R; Ogilvie F, 2012, PREV MED, V55, P40, DOI 10.1016/j.ypmed.2012.05.002; Parkin J, 2008, TRANSPORTATION, V35, P93, DOI 10.1007/s11116-007-9137-5; Pucher J, 2012, URBAN IND ENVIRON, P1; Rabl A, 2012, TRANSPORT POLICY, V19, P121, DOI 10.1016/j.tranpol.2011.09.008; Rissel C, 2012, INT J ENV RES PUB HE, V9, P2454, DOI 10.3390/ijerph9072454; Rofique J, 2011, NATL TRAVEL SURVEY 2; SALOMON I, 1983, ENVIRON PLANN A, V15, P623, DOI 10.1068/a150623; Sloman L., 2009, ANAL SYNTHESIS EVIDE; Social Exclusion Unit, 2003, MAK CONN FIN REP TRA; Stamatakis E, 2008, BRIT J SPORT MED, V42, P901, DOI 10.1136/bjsm.2008.048082; Statistics for Wales, 2011, WELSH IND MULT DEPR; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Sustainable Development Commission, 2011, FAIRN CAR DEP SOC; Transport for London, 2010, TRAVEL LONDON REPORT; Transport for London, 2011, TRAV LOND SUPPL REP; Turrell G, 2013, HEALTH PLACE, V19, P89, DOI 10.1016/j.healthplace.2012.10.008; Welsh Government, 2012, WHIT PAP CONS ACT TR; WHO, 2002, PHYS ACT LIV EV TRAN; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; Woodcock J, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-4	57	77	78	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71790	10.1371/journal.pone.0071790	http://dx.doi.org/10.1371/journal.pone.0071790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218YW	23990990	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000324470100055
J	He, XN; Zhang, WK; Liao, L; Fu, X; Yu, Q; Jin, Y				He, Xiaoning; Zhang, Wenkai; Liao, Li; Fu, Xin; Yu, Qing; Jin, Yan			Identification and Characterization of MicroRNAs by High Through-Put Sequencing in Mesenchymal Stem Cells and Bone Tissue from Mice of Age-Related Osteoporosis	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; ADIPOSE-TISSUE; STROMAL CELLS; FEEDBACK LOOP; EXPRESSION; TARGETS; CANCER; SENESCENCE; MIRNA	The functional deficiencies of bone marrow-derived mesenchymal stem cells (MSCs) may contribute to the aging process and age-related diseases, such as osteoporosis. Although it has been reported that microRNAs (miRNAs) played an important role in mechanisms of gene regulation of aging, and their expression profiles in MSCs osteogenic differentiation were established in recent years, but it is still elusive for the dynamic patterns of miRNAs in aging process. Importantly, the miRNAs in aged bone tissue had not been yet reported so far. Here, we combined high through-put sequencing with computational techniques to detect miRNAs dynamics in MSCs and bone tissue of age-related osteoporosis. Among the detected miRNAs, 59 identified miRNAs in MSCs and 159 in bone showed significantly differential expressions. And more importantly, there existed 8 up-regulated and 30 down-regulated miRNAs in both MSCs and bone during the aging process, with the majority having a trend of down-regulation. Furthermore, after target prediction and KEGG pathway analysis, we found that their targeted genes were significantly enriched in pathways in cancer, which are complex genetic networks, comprise of a number of age-related pathways. These results strongly suggest that these analyzed miRNAs may be negatively involved in age-related osteoporosis, given that most of them showed a decreased expression, which could lay a good foundation for further functional analysis of these miRNAs in age-related osteoporosis.	[He, Xiaoning; Zhang, Wenkai; Liao, Li; Fu, Xin; Jin, Yan] Fourth Mil Med Univ, Res & Dev Ctr Tissue Engn, Xian 710032, Shaanxi, Peoples R China; [He, Xiaoning; Zhang, Wenkai; Liao, Li; Fu, Xin; Jin, Yan] Engn Technol Ctr Tissue Engn Xian, Xian, Shaanxi, Peoples R China; [He, Xiaoning; Liao, Li; Fu, Xin; Jin, Yan] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Histopathol, Xian 710032, Shaanxi, Peoples R China; [Zhang, Wenkai; Yu, Qing] Fourth Mil Med Univ, Sch Stomatol, Dept Endodont, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yu, Q (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Endodont, Xian 710032, Shaanxi, Peoples R China.	yuqing@fmmu.edu.cn; yanjinfmmu@gmail.com	Liao, Li/U-6866-2017; Jin, Yan/I-4204-2013	Liao, Li/0000-0003-0030-1009; 	National Major Scientific Research Program of China [2010CB944800, 2011CB964700]; Nature Science Foundation of China [81020108019, 31030033]	National Major Scientific Research Program of China; Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Major Scientific Research Program of China (2010CB944800 and 2011CB964700) and the Nature Science Foundation of China (81020108019, 31030033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2006, BONE, V39, P181, DOI 10.1016/j.bone.2005.12.082; [Anonymous], 2003, World Health Organ Tech Rep Ser, V921, P1; Chen LH, 2010, AGEING RES REV, V9, pS59, DOI 10.1016/j.arr.2010.08.002; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; DeCarolis NA, 2008, BIOESSAYS, V30, P102, DOI 10.1002/bies.20709; Dhahbi JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020509; Faraonio R, 2012, CELL DEATH DIFFER, V19, P713, DOI 10.1038/cdd.2011.143; Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gao J, 2011, J CELL BIOCHEM, V112, P1844, DOI 10.1002/jcb.23106; Gaur T, 2010, DEV BIOL, V340, P10, DOI 10.1016/j.ydbio.2010.01.008; Goff LA, 2008, EXP HEMATOL, V36, P1354, DOI 10.1016/j.exphem.2008.05.004; Guo L, 2011, EXP HEMATOL, V39, P608, DOI 10.1016/j.exphem.2011.01.011; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; Hamrick MW, 2010, BIOCHEM BIOPH RES CO, V400, P379, DOI 10.1016/j.bbrc.2010.08.079; Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014; Inukai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040028; Izzotti A, 2009, FASEB J, V23, P3243, DOI 10.1096/fj.09-135251; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kasper G, 2009, STEM CELLS, V27, P1288, DOI 10.1002/stem.49; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Lakshmipathy U, 2008, STEM CELLS, V26, P356, DOI 10.1634/stemcells.2007-0625; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Liu W, 2012, NEUROBIOL AGING, V33, P522, DOI 10.1016/j.neurobiolaging.2010.04.034; Lynam-Lennon N, 2012, J MOL MED BERL; Marion NW, 2006, METHOD ENZYMOL, V420, P339, DOI 10.1016/S0079-6879(06)20016-8; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Mizuno Y, 2009, FEBS LETT, V583, P2263, DOI 10.1016/j.febslet.2009.06.006; Mori MA, 2012, CELL METAB, V16, P336, DOI 10.1016/j.cmet.2012.07.017; Okamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043800; Pan CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039151; Park S, 2012, IMMUNOL INVEST; Pietschmann P, 2009, GERONTOLOGY, V55, P3, DOI 10.1159/000166209; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rokah OH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035501; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Roura S, 2006, EUR J HEART FAIL, V8, P555, DOI 10.1016/j.ejheart.2005.11.006; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; Taipaleenmaki H, 2012, EUR J ENDOCRINOL, V166, P359, DOI 10.1530/EJE-11-0646; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Ugalde AP, 2011, NUCLEUS-PHILA, V2, P549, DOI 10.4161/nucl.2.6.17986; Vasa-Nicotera M, 2011, ATHEROSCLEROSIS, V217, P326, DOI 10.1016/j.atherosclerosis.2011.03.034; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2010, TISSUE ENG PART B-RE, V16, P445, DOI [10.1089/ten.teb.2009.0825, 10.1089/ten.TEB.2009.0825]; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Wang Y, 2011, INT J RADIAT ONCOL, V81, P839, DOI 10.1016/j.ijrobp.2010.09.048; Wilson A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-229; Xiao JN, 2011, EMBO J, V30, P524, DOI 10.1038/emboj.2010.347; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Xu RS, 2013, INT J ONCOL, V42, P676, DOI 10.3892/ijo.2012.1746; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009	63	21	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71895	10.1371/journal.pone.0071895	http://dx.doi.org/10.1371/journal.pone.0071895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991002	gold, Green Submitted, Green Published			2022-12-25	WOS:000324470100061
J	Polesskaya, A; Degerny, C; Pinna, G; Maury, Y; Kratassiouk, G; Mouly, V; Morozova, N; Kropp, J; Frandsen, N; Harel-Bellan, A				Polesskaya, Anna; Degerny, Cindy; Pinna, Guillaume; Maury, Yves; Kratassiouk, Gueorgui; Mouly, Vincent; Morozova, Nadya; Kropp, Jeremie; Frandsen, Niels; Harel-Bellan, Annick			Genome-Wide Exploration of miRNA Function in Mammalian Muscle Cell Differentiation	PLOS ONE			English	Article							MESSENGER-RNA; MICRORNAS; TARGETS; SCREEN; GROWTH; LIN-28	MiRNAs impact on the control of cell fate by regulating gene expression at the post-transcriptional level. Here, using mammalian muscle differentiation as a model and a phenotypic loss-of-function screen, we explored the function of miRNAs at the genome-wide level. We found that the depletion of a high number of miRNAs (63) impacted on differentiation of human muscle precursors, underscoring the importance of this post-transcriptional mechanism of gene regulation. Interestingly, a comparison with miRNA expression profiles revealed that most of the hit miRNAs did not show any significant variations of expression during differentiation. These constitutively expressed miRNAs might be required for basic and/or essential cell function, or else might be regulated at the post-transcriptional level. MiRNA inhibition yielded a variety of phenotypes, reflecting the widespread miRNA involvement in differentiation. Using a functional screen (the STarS - Suppressor Target Screen - approach, i. e. concomitant knockdown of miRNAs and of candidate target proteins), we discovered miRNA protein targets that are previously uncharacterized controllers of muscle-cell terminal differentiation. Our results provide a strategy for functional annotation of the human miRnome.	[Polesskaya, Anna; Degerny, Cindy; Pinna, Guillaume; Kratassiouk, Gueorgui; Morozova, Nadya; Kropp, Jeremie; Harel-Bellan, Annick] Commissariat Energie Atom Saclay, CNRS, Dept Epigenet & Canc, FRE 3377, Gif Sur Yvette, France; [Polesskaya, Anna; Degerny, Cindy; Pinna, Guillaume; Kratassiouk, Gueorgui; Morozova, Nadya; Kropp, Jeremie; Harel-Bellan, Annick] Univ Paris 11, Gif Sur Yvette, France; [Maury, Yves; Frandsen, Niels] Assoc Francaise Myopathies, Inst Cellules Souches Traitement & Etude Malad Mo, Evry, France; [Mouly, Vincent] Univ Paris 06, Inst Myol, UM76, Paris, France; Exiqon AS, Vedbaek, Denmark	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Exiqon	Harel-Bellan, A (corresponding author), Commissariat Energie Atom Saclay, CNRS, Dept Epigenet & Canc, FRE 3377, Gif Sur Yvette, France.	annick.harel-bellan@cea.fr	Harel-Bellan, Annick/M-9795-2015	Harel-Bellan, Annick/0000-0002-2339-153X; PINNA, Guillaume/0000-0001-7841-7250; Mouly, Vincent/0000-0003-3809-4033; Kratassiouk, Gueorgui/0000-0003-1174-004X; Degerny, Cindy/0000-0002-9810-3627	European Commission Sixth Framework Programme (Integrated Project SIROCCO) [LSHG-CT-2006-037900]; ANR; ARC; AFM	European Commission Sixth Framework Programme (Integrated Project SIROCCO); ANR(French National Research Agency (ANR)); ARC(Australian Research Council); AFM(Association Francaise contre les Myopathies)	This work was supported by the European Commission Sixth Framework Programme (Integrated Project SIROCCO contract number LSHG-CT-2006-037900) and by grants from ANR, ARC and AFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen PY, 2005, BIOL CHEM, V386, P1205, DOI 10.1515/BC.2005.139; Crist CG, 2009, CELL CYCLE, V8, P3627, DOI 10.4161/cc.8.22.9960; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Davies B, 2004, MOL CELL BIOL, V24, P8642, DOI 10.1128/MCB.24.19.8642-8648.2004; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; Dey BR, 1998, GENE, V209, P175, DOI 10.1016/S0378-1119(98)00045-6; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Liu X, 2008, BRAIN PATHOL, V18, P113, DOI 10.1111/j.1750-3639.2007.00121.x; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Morita M, 2007, MOL CELL BIOL, V27, P4980, DOI 10.1128/MCB.02304-06; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Naguibneva I, 2006, BIOMED PHARMACOTHER, V60, P633, DOI 10.1016/j.biopha.2006.07.078; Nonne N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1100; Orom UA, 2007, METHODS, V43, P162, DOI 10.1016/j.ymeth.2007.04.007; Parreiras-e-Silva LT, 2010, J CELL PHYSIOL, V225, P500, DOI 10.1002/jcp.22229; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	29	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71927	10.1371/journal.pone.0071927	http://dx.doi.org/10.1371/journal.pone.0071927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991007	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100066
J	Iovino, P; Chiarioni, G; Bilancio, G; Cirillo, M; Mekjavic, IB; Pisot, R; Ciacci, C				Iovino, Paola; Chiarioni, Giuseppe; Bilancio, Giancarlo; Cirillo, Massimo; Mekjavic, Igor B.; Pisot, Rado; Ciacci, Carolina			New Onset of Constipation during Long-Term Physical Inactivity: A Proof-of-Concept Study on the Immobility-Induced Bowel Changes	PLOS ONE			English	Article							INTESTINAL TRANSIT; BED REST; SYMPTOMS; EXERCISE; IMPACT; TRIAL; COLON	Background: The pathophysiological mechanisms underlining constipation are incompletely understood, but prolonged bed rest is commonly considered a relevant determinant. Aims: Our primary aim was to study the effect of long-term physical inactivity on determining a new onset of constipation. Secondary aim were the evaluation of changes in stool frequency, bowel function and symptoms induced by this prolonged physical inactivity. Methods: Ten healthy men underwent a 7-day run-in followed by 35-day study of experimentally-controlled bed rest. The study was sponsored by the Italian Space Agency. The onset of constipation was evaluated according to Rome III criteria for functional constipation. Abdominal bloating, flatulence, pain and urgency were assessed by a 100mm Visual Analog Scales and bowel function by adjectival scales (Bristol Stool Form Scale, ease of passage of stool and sense of incomplete evacuation). Daily measurements of bowel movements was summarized on a weekly score. Pre and post bed rest Quality of Life (SF-36), general health (Goldberg's General Health) and depression mood (Zung scale) questionnaires were administered. Results: New onset of functional constipation fulfilling Rome III criteria was found in 60% (6/10) of participants (p=0.03). The score of flatulence significantly increased whilst the stool frequency significantly decreased during the week-by-week comparisons period (repeated-measures ANOVA, p=0.02 and p=0.001, respectively). Stool consistency and bowel symptoms were not influenced by prolonged physical inactivity. In addition, no significant changes were observed in general health, in mood state and in quality of life at the end of bed rest Conclusions: Our results provide evidence that prolonged physical inactivity is relevant etiology in functional constipation in healthy individuals. The common clinical suggestion of early mobilization in bedridden patients is supported as well.	[Iovino, Paola; Bilancio, Giancarlo; Cirillo, Massimo; Ciacci, Carolina] Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy; [Chiarioni, Giuseppe] Univ Verona, AOUI, Div Gastroenterol, I-37100 Verona, Italy; [Chiarioni, Giuseppe] Univ N Carolina, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Chiarioni, Giuseppe] Univ N Carolina, Ctr Funct Gastrointestinal & Motil Disorders, Chapel Hill, NC USA; [Mekjavic, Igor B.] Jozef Stefan Inst, Ljubljana, Slovenia; [Pisot, Rado] Univ Primorska, Ctr Sci Res, Koper, Slovenia	University of Salerno; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Primorska	Iovino, P (corresponding author), Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy.	piovino@unisa.it	IOVINO, PAOLA/G-6195-2011; Mekjavic, Igor/AAM-6962-2021; Chiarioni, Giuseppe/C-1876-2016; ciacci, carolina/A-2594-2012; Cirillo, Massimo/G-5480-2018	IOVINO, PAOLA/0000-0002-9568-0680; Mekjavic, Igor/0000-0001-5930-2159; Chiarioni, Giuseppe/0000-0002-9183-4750; ciacci, carolina/0000-0002-7426-1145; Cirillo, Massimo/0000-0002-6409-3504; Bilancio, Giancarlo/0000-0002-0845-1194				Amato G, 2008, AM J SURG, V196, P582, DOI 10.1016/j.amjsurg.2007.09.038; Apolone G, 1998, J CLIN EPIDEMIOL, V51, P1025, DOI 10.1016/S0895-4356(98)00094-8; BERARDI RS, 1983, DIS COLON RECTUM, V26, P283, DOI 10.1007/BF02562500; BINGHAM SA, 1989, GASTROENTEROLOGY, V97, P1389, DOI 10.1016/0016-5085(89)90381-8; Biolo G, 2008, AM J CLIN NUTR, V88, P950, DOI 10.1093/ajcn/88.4.950; Bliss MR, 2004, MED HYPOTHESES, V62, P471, DOI 10.1016/j.mehy.2004.01.002; Brown WJ, 2000, RES Q EXERCISE SPORT, V71, P206, DOI 10.1080/02701367.2000.10608901; Cappello C, 2013, INT J COLORECTAL DIS, V28, P349, DOI 10.1007/s00384-012-1552-1; Cardin F, 2010, ARCH GERONTOL GERIAT, V50, P277, DOI 10.1016/j.archger.2009.04.007; Charach G, 2001, GERONTOLOGY, V47, P72, DOI 10.1159/000052776; Dainese R, 2003, GUT, V52, P971, DOI 10.1136/gut.52.7.971; DONALD IP, 1985, GERONTOLOGY, V31, P112, DOI 10.1159/000212689; Feyen Bryan J, 2007, Curr Treat Options Gastroenterol, V10, P221, DOI 10.1007/s11938-007-0015-1; Guarino M, 2011, NEUROGASTROENT MOTIL, V23, P575, DOI 10.1111/j.1365-2982.2011.01705.x; Harari D, 2007, AGE AGEING, V36, P670, DOI 10.1093/ageing/afm089; Harder H, 2004, AM J PHYSIOL-GASTR L, V286, pG89, DOI 10.1152/ajpgi.00174.2003; Kim HJ, 2003, ALIMENT PHARM THER, V17, P895, DOI 10.1046/j.1365-2036.2003.01543.x; Kinnunen O, 1991, Aging (Milano), V3, P161; KLAUSER AG, 1990, DIGEST DIS SCI, V35, P1271, DOI 10.1007/BF01536418; Kozakova M, 2011, J HYPERTENS, V29, P137, DOI 10.1097/HJH.0b013e32833f5e01; Lembo A, 2003, NEW ENGL J MED, V349, P1360, DOI 10.1056/NEJMra020995; Leung FW, 2007, DIGEST DIS SCI, V52, P313, DOI 10.1007/s10620-006-9298-7; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; LIU F, 1993, INT J SPORTS MED, V14, P465, DOI 10.1055/s-2007-1021212; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Mazzucco S, 2010, J CLIN ENDOCR METAB, V95, P2508, DOI 10.1210/jc.2009-2561; McCallum IJD, 2009, BMJ-BRIT MED J, V338, P763, DOI [10.1136/bmj.b763, DOI 10.1136/BMJ.B763.PUBMED:19304766]; Meshkinpour H, 1998, DIGEST DIS SCI, V43, P2379, DOI 10.1023/A:1026609610466; Muller-Lissner S, 2002, BEST PRACT RES CL GA, V16, P115, DOI 10.1053/bega.2002.0269; Nassar AP, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.03.007; ODONNELL LJD, 1990, BMJ-BRIT MED J, V300, P439, DOI 10.1136/bmj.300.6722.439; Peters HPF, 2001, GUT, V48, P435, DOI 10.1136/gut.48.3.435; Pevalin DJ, 2000, SOC PSYCH PSYCH EPID, V35, P508, DOI 10.1007/s001270050272; Rittweger J, 2009, BONE, V44, P612, DOI 10.1016/j.bone.2009.01.001; Ross D G, 1995, Orthop Nurs, V14, P25, DOI 10.1097/00006416-199501000-00006; Saad RJ, 2010, AM J GASTROENTEROL, V105, P403, DOI 10.1038/ajg.2009.612; Shim L, 2010, AM J GASTROENTEROL, V105, P883, DOI 10.1038/ajg.2010.54; Simren M, 2002, EUR J GASTROEN HEPAT, V14, P1053, DOI 10.1097/00042737-200210000-00003; Su YJ, 2009, STROKE, V40, P1304, DOI 10.1161/STROKEAHA.108.534776; SULLIVAN SN, 1994, NEW ZEAL MED J, V107, P328; Tremolaterra F, 2013, TECH COLOPROCTOL, V17, P405, DOI 10.1007/s10151-012-0951-1; WARE J, 1994, PHYS MENTAL COMPONEN; ZUNG WWK, 1973, ARCH GEN PSYCHIAT, V29, P328	43	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72608	10.1371/journal.pone.0072608	http://dx.doi.org/10.1371/journal.pone.0072608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977327	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300091
J	Jie, WG; Liu, XR; Cai, BY				Jie, Weiguang; Liu, Xiaorui; Cai, Baiyan			Diversity of Rhizosphere Soil Arbuscular Mycorrhizal Fungi in Various Soybean Cultivars under Different Continuous Cropping Regimes	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; GLOMUS-INTRARADICES; FIELD; FERTILIZATION; AMPLIFICATION; ISOFLAVONES; JAPONICUM; ROTATION; CLONING; ROOTS	Recent studies have shown that continuous cropping in soybean causes substantial changes to the microbial community in rhizosphere soil. In this study, we investigated the effects of continuous cropping for various time periods on the diversity of rhizosphere soil arbuscular mycorrhizal (AM) fungi in various soybean cultivars at the branching stage. The soybean cultivars Heinong 37 (an intermediate cultivar), Heinong 44 (a high-fat cultivar) and Heinong 48 (a high-protein cultivar) were seeded in a field and continuously cropped for two or three years. We analyzed the diversity of rhizosphere soil AM fungi of these soybean plants at the branching stage using morphological and denaturing gradient gel electrophoresis (DGGE) techniques. The clustering analysis of unweighted pair-group method with arithmetic averages (UPGMA) was then used to investigate the AM fungal community shifts. The results showed that increasing the number of years of continuous cropping can improve the colonization rate of AM fungi in different soybean cultivars at the branching stage. The dominant AM fungi in the experimental fields were Funneliformis mosseae and Glomus spp. The number of years of continuous cropping and the soybean cultivar both had obvious effects on the diversity of AM fungi, which was consistent with the results of colonization rate analysis. This study establishes a basis for screening dominant AM fungi of soybean. In addition, the results of this study may be useful for the development of AM fungal inoculants.	[Jie, Weiguang; Liu, Xiaorui; Cai, Baiyan] Heilongjiang Univ, Coll Life Sci, Harbin, Peoples R China; [Jie, Weiguang; Cai, Baiyan] Heilongjiang East Univ, Dept Food & Environm Engn, Harbin, Peoples R China; [Jie, Weiguang; Cai, Baiyan] Key Lab Microbiol, Harbin, Heilongjiang Pr, Peoples R China	Heilongjiang University	Cai, BY (corresponding author), Heilongjiang Univ, Coll Life Sci, Harbin, Peoples R China.	caibaiyan@126.com			Natural Science Foundation of China [31170466]; Heilongjiang Provincial Education Department [12521394]; Heilongjiang University; Open Projects Foundation of Key Laboratory of Microbiology, Heilongjiang Province, Heilongjiang University [2012MOI-7]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial Education Department; Heilongjiang University; Open Projects Foundation of Key Laboratory of Microbiology, Heilongjiang Province, Heilongjiang University	This work was supported by a grant from Natural Science Foundation of China (31170466)(www.nsfc.gov.cn), Science and Technology Project from Heilongjiang Provincial Education Department (12521394)(http://61.167.33.11/), High-level Personnel Supported Program of Heilongjiang University (ecological restoration team Hdtd 2010-12), and Open Projects Foundation of Key Laboratory of Microbiology, Heilongjiang Province, Heilongjiang University (2012MOI-7)(www.hljlab.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah YEY, 2012, J BASIC APPL ZOOL, V1, P37; Asghari HR, 2012, PLOS ONE, V7, P151, DOI 10.1371/journal.pone.0029825; BAZIRAMAKENGA R, 1995, J CHEM ECOL, V21, P1271, DOI 10.1007/BF02027561; Bever JD, 2001, BIOSCIENCE, V51, P923, DOI 10.1641/0006-3568(2001)051[0923:AMFMDT]2.0.CO;2; [蔡柏岩 CAI Bai-Yan], 2009, [菌物学报, Mygosystema], V28, P512; Cornejo P, 2004, FEMS MICROBIOL LETT, V241, P265, DOI 10.1016/j.femsle.2004.10.030; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1111/j.1574-6941.2001.tb00841.x; Einhellig FA, 1995, ALLELOPATHY J, V1, P97; Eisenhauer N, 2009, SOIL BIOL BIOCHEM, V41, P561, DOI 10.1016/j.soilbio.2008.12.017; Feddermann N, 2010, FUNGAL ECOL, V3, P1, DOI 10.1016/j.funeco.2009.07.003; FitzGibbon F, 1998, PROCESS BIOCHEM, V33, P799, DOI 10.1016/S0032-9592(98)00050-8; Gesch RW, 2013, IND CROP PROD, V44, P718, DOI 10.1016/j.indcrop.2012.05.023; Golubski AJ, 2011, PEDOBIOLOGIA, V54, P209, DOI 10.1016/j.pedobi.2011.03.003; Guo ZY, 2011, SOIL BIOL BIOCHEM, V43, P2257, DOI 10.1016/j.soilbio.2011.07.022; Hart MM, 2012, SCI HORTIC-AMSTERDAM, V148, P206, DOI 10.1016/j.scienta.2012.09.018; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Hou J, 2011, RENEW SUST ENERG REV, V15, P5081, DOI 10.1016/j.rser.2011.07.048; Jin J, 2010, FIELD CROP RES, V115, P116, DOI 10.1016/j.fcr.2009.10.016; Ley RE, 2002, SOIL BIOL BIOCHEM, V34, P989, DOI 10.1016/S0038-0717(02)00032-9; Liang ZB, 2008, SOIL BIOL BIOCHEM, V40, P956, DOI 10.1016/j.soilbio.2007.11.016; Liu XB, 2012, FIELD CROP RES, V138, P52, DOI 10.1016/j.fcr.2012.09.012; [龙良鲲 Long Liangkun], 2005, [菌物学报, Mygosystema], V24, P564; Lv XC, 2012, FOOD CONTROL, V28, P426, DOI 10.1016/j.foodcont.2012.05.025; Ma WK, 2005, SOIL BIOL BIOCHEM, V37, P1589, DOI 10.1016/j.soilbio.2005.01.020; Meghvansi MK, 2008, EUR J SOIL BIOL, V44, P316, DOI 10.1016/j.ejsobi.2008.03.003; Meriles JM, 2009, SOIL TILL RES, V103, P271, DOI 10.1016/j.still.2008.10.008; Miransari M, 2011, BIOTECHNOL ADV, V29, P645, DOI 10.1016/j.biotechadv.2011.04.006; Mummey DL, 2009, SOIL BIOL BIOCHEM, V41, P1173, DOI 10.1016/j.soilbio.2009.02.027; Pedersen P, 2004, AGRON J, V96, P1005, DOI 10.2134/agronj2004.1005; Porras-Soriano A, 2009, J PLANT PHYSIOL, V166, P1350, DOI 10.1016/j.jplph.2009.02.010; Powell JR, 2009, APPL SOIL ECOL, V41, P128, DOI 10.1016/j.apsoil.2008.10.002; Schultz PA, 1999, MYCOLOGIA, V91, P676, DOI 10.2307/3761255; Schwarzott D, 2001, MYCORRHIZA, V10, P203, DOI 10.1007/PL00009996; Shao SQ, 2009, J FUNCT FOODS, V1, P119, DOI 10.1016/j.jff.2008.09.013; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Tan FX, 2011, SOIL BIOL BIOCHEM, V43, P2473, DOI 10.1016/j.soilbio.2011.08.014; Tanaka Y, 2012, FOOD MICROBIOL, V31, P100, DOI 10.1016/j.fm.2012.02.005; Tantry MA, 2013, FITOTERAPIA, V87, P49, DOI 10.1016/j.fitote.2013.03.021; Tian H, 2013, AGR ECOSYST ENVIRON, V164, P53, DOI 10.1016/j.agee.2012.09.007; Gil SV, 2011, EUR J SOIL BIOL, V47, P55, DOI 10.1016/j.ejsobi.2010.11.006; Vaz ABM, 2012, APPL SOIL ECOL, V61, P288, DOI 10.1016/j.apsoil.2011.10.017; Wang QS, 2012, J FOOD ENG, V111, P386, DOI 10.1016/j.jfoodeng.2012.02.005; [王树起 WANG Shu-qi], 2009, [大豆科学, Soybean Science], V28, P611; Whiteside MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047643; Whiteside MD, 2012, SOIL BIOL BIOCHEM, V55, P7, DOI 10.1016/j.soilbio.2012.06.001; Yu ZH, 2011, EUR J SOIL BIOL, V47, P357, DOI 10.1016/j.ejsobi.2011.09.001; Zhao Yanwen, 2006, Yingyong Shengtai Xuebao, V17, P2376	47	25	32	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72898	10.1371/journal.pone.0072898	http://dx.doi.org/10.1371/journal.pone.0072898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977368	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300102
J	Skoczynska, A; Wasko, I; Kuch, A; Kadlubowski, M; Golebiewska, A; Forys, M; Markowska, M; Ronkiewicz, P; Wasiak, K; Kozinska, A; Matynia, B; Hryniewicz, W				Skoczynska, Anna; Wasko, Izabela; Kuch, Alicja; Kadlubowski, Marcin; Golebiewska, Agnieszka; Forys, Malgorzata; Markowska, Marlena; Ronkiewicz, Patrycja; Wasiak, Katarzyna; Kozinska, Aleksandra; Matynia, Bozena; Hryniewicz, Waleria		Lab Based Surveillance Community A	A Decade of Invasive Meningococcal Disease Surveillance in Poland	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS C-2B-P1.2,5; CHANGING EPIDEMIOLOGY; SEROGROUP; SUSCEPTIBILITY; EMERGENCE; IDENTIFICATION; RESISTANCE; PENICILLIN; OUTBREAK; STRAINS	Background: Neisseria meningitidis is a leading etiologic agent of severe invasive disease. The objective of the study was to characterise invasive meningococcal disease (IMD) epidemiology in Poland during the last decade, based on laboratory confirmed cases. Methods: The study encompassed all invasive meningococci collected between 2002 and 2011 in the National Reference Centre for Bacterial Meningitis. The isolates were re-identified and characterised by susceptibility testing, MLST analysis, porA and fetA sequencing. A PCR technique was used for meningococcal identification directly from clinical materials. Results: In the period studied, 1936 cases of IMD were confirmed, including 75.6% identified by culture. Seven IMD outbreaks, affecting mostly adolescents, were reported; all were caused by serogroup C meningococci of ST-11. The highest incidence was observed among children under one year of age (15.71/100,000 in 2011). The general case fatality rate in the years 2010-2011 was 10.0%. Meningococci of serogroup B, C, Y and W-135 were responsible for 48.8%, 36.6%, 1.2% and 1.2% of cases, respectively. All isolates were susceptible to third generation cephalosporins, chloramphenicol, ciprofloxacin, and 84.2% were susceptible to penicillin. MLST analysis (2009-2011) revealed that among serogroup B isolates the most represented were clonal complexes (CC) ST-32CC, ST-18CC, ST-41/44CC, ST-213CC and ST-269CC, and among serogroup C: ST-103CC, ST-41/44CC and ST-11CC. Conclusions: The detection of IMD in Poland has changed over time, but observed increase in the incidence of the disease was mostly attributed to changes in the surveillance system including an expanded case definition and inclusion of data from non-culture diagnostics.	[Skoczynska, Anna; Wasko, Izabela; Kuch, Alicja; Kadlubowski, Marcin; Golebiewska, Agnieszka; Forys, Malgorzata; Markowska, Marlena; Ronkiewicz, Patrycja; Wasiak, Katarzyna; Kozinska, Aleksandra; Matynia, Bozena; Hryniewicz, Waleria; Lab Based Surveillance Community A] Natl Med Inst, Dept Epidemiol & Clin Microbiol, Natl Reference Ctr Bacterial Meningitis, Warsaw, Poland	National Medicines Institute Lekow (NIL)	Skoczynska, A (corresponding author), Natl Med Inst, Dept Epidemiol & Clin Microbiol, Natl Reference Ctr Bacterial Meningitis, Warsaw, Poland.	skoczek@cls.edu.pl	Kuch, Alicja/V-1047-2018; Markowska, Magdalena/AGT-8435-2022; Ronkiewicz, Patrycja/V-6965-2018	Kuch, Alicja/0000-0001-5416-1422; Markowska, Magdalena/0000-0002-5082-6690; Ronkiewicz, Patrycja/0000-0003-4427-5076; Wasko, Izabela/0000-0001-5494-3635; Kozinska, Aleksandra/0000-0001-6949-4860; Skoczynska, Anna/0000-0002-2247-830X	Ministry of Health within the framework of the Modul I of the National Programme of Antibiotic Protection (NPOA); Ministry of Science and Higher Education (Mikrobank 2 Programme); Glaxo SmithKline [114538]	Ministry of Health within the framework of the Modul I of the National Programme of Antibiotic Protection (NPOA); Ministry of Science and Higher Education (Mikrobank 2 Programme); Glaxo SmithKline(GlaxoSmithKline)	The study was partially supported by the Ministry of Health within the framework of the Modul I of the National Programme of Antibiotic Protection (NPOA), by the Ministry of Science and Higher Education (Mikrobank 2 Programme), and by an unrestricted grant from Glaxo SmithKline (114538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala B, 2002, EMERG INFECT DIS, V8, P1512, DOI 10.3201/eid0812.020081; Broker M, 2012, HUM VACC IMMUNOTHER, V8, P1907, DOI 10.4161/hv.21794; Canica M, 2004, EMERG INFECT DIS, V10, P526, DOI 10.3201/eid1003.030357; CAUGANT DA, 1986, P NATL ACAD SCI USA, V83, P4927, DOI 10.1073/pnas.83.13.4927; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; Diermayer M, 1999, JAMA-J AM MED ASSOC, V281, P1493, DOI 10.1001/jama.281.16.1493; EDWARDS MS, 1981, J PEDIATR-US, V99, P540, DOI 10.1016/S0022-3476(81)80250-8; EU-IBIS Network, 2006, INV NEISS MEN EUR 20; European Centre for Disease Prevention and Control, 2011, ANN EP REP REP 2009, P155; European Committee on Antimicrobial Susceptibility Testing, 2013, BREAKP TABL INT MICS; Grecki M., 2006, EUR COMMUN DIS B, V11, pE060706, DOI [10.2807/esw.11.27.02996-en, DOI 10.2807/ESW.11.27.02996-EN]; Gryniewicz O, 2007, EUROSURVEILLANCE, V12, P1970; Guiver M, 2000, FEMS IMMUNOL MED MIC, V28, P173, DOI 10.1111/j.1574-695X.2000.tb01473.x; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Harrison LH, 2006, J INFECT DIS, V193, P1266, DOI 10.1086/501371; Harrison LH, 2001, JAMA-J AM MED ASSOC, V286, P694, DOI 10.1001/jama.286.6.694; Healy CM, 2002, CLIN INFECT DIS, V34, P1323, DOI 10.1086/340050; Iser BPM, 2012, EPIDEMIOL INFECT, V140, P906, DOI 10.1017/S0950268811001610; Jelfs J, 2000, EPIDEMIOL INFECT, V125, P285, DOI 10.1017/S0950268899004471; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; Kaczmarski E B, 1998, Commun Dis Public Health, V1, P54; Kadlubowski M., 2007, EUROSURVEILLANCE, V12; Khatami A, 2010, EXPERT REV VACCINES, V9, P285, DOI 10.1586/ERV.10.3; Konior R, 2012, PEDIAT POLSKA, V87, P489; Kriz P, 2011, EXPERT REV VACCINES, V10, P1477, DOI [10.1586/ERV.11.117, 10.1586/erv.11.117]; Krizova P, 1995, Cent Eur J Public Health, V3, P189; Ladhani SN, 2012, EMERG INFECT DIS, V18, P63, DOI 10.3201/eid1801.110901; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; MCGUINNESS BT, 1991, LANCET, V337, P514, DOI 10.1016/0140-6736(91)91297-8; Neri A, 2012, J Prev Med Hyg, V53, P109; Papavasileiou K, 2011, MOL DIAGN THER, V15, P109, DOI 10.2165/11587690-000000000-00000; Pollard AJ, 2006, HDB MENINGOCOCCAL DI, P481; Posmyk Urszula, 2012, Pol Merkur Lekarski, V32, P287; Racloz VN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-175; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Rouaud P, 2006, Euro Surveill, V11, P178, DOI 10.2807/esm.11.07.00635-en; de Lemos APS, 2007, J CLIN MICROBIOL, V45, P1266, DOI 10.1128/JCM.02510-06; Skoczynska A, 2000, MICROB DRUG RESIST, V6, P147, DOI 10.1089/107662900419465; Skoczynska A, 2006, CLIN MICROBIOL INFEC, V12, P1027, DOI 10.1111/j.1469-0691.2006.01554.x; Skoczynska A, 2006, FEMS IMMUNOL MED MIC, V46, P230, DOI 10.1111/j.1574-695X.2005.00027.x; Skoczynska A, 2010, EUROSURVEILLANCE, V15; Skoczynska A, 2012, PEDIAT POLSKA, V87, P438; Skoczynska A, 2012, STANDARDY MED PEDIAT, V9, P389; Skoczynska A, 2011, VACCINE, V29, P2199, DOI 10.1016/j.vaccine.2010.09.100; Stefanelli P, 2004, ANTIMICROB AGENTS CH, V48, P3103, DOI 10.1128/AAC.48.8.3103-3106.2004; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Taha MK, 2007, ANTIMICROB AGENTS CH, V51, P2784, DOI 10.1128/AAC.00412-07; Taha MK, 2010, ANTIMICROB AGENTS CH, V54, P3651, DOI 10.1128/AAC.00315-10; The European Commission of the European Communities European Union website, 2000, OFFICIAL J EUR COM L, V28; The European Parliament the Council of the EU European Union website, 1998, OFFICIAL J EUR COM L, V268; Trotter CL, 2007, FEMS MICROBIOL REV, V31, P27, DOI 10.1111/j.1574-6976.2006.00060.x; Trotter CL, 2002, J MED MICROBIOL, V51, P855, DOI 10.1099/0022-1317-51-10-855; Tyrrell GJ, 2002, EMERG INFECT DIS, V8, P519; Vogel U, 2003, FRONT BIOSCI, V8, P14; WHALEN CM, 1995, JAMA-J AM MED ASSOC, V273, P390, DOI 10.1001/jama.273.5.390	58	28	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71943	10.1371/journal.pone.0071943	http://dx.doi.org/10.1371/journal.pone.0071943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977184	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300055
J	You, ZY; De Falco, M; Kamada, K; Pisani, FM; Masai, H				You, Zhiying; De Falco, Mariarosaria; Kamada, Katsuhiko; Pisani, Francesca M.; Masai, Hisao			The Mini-Chromosome Maintenance (Mcm) Complexes Interact with DNA Polymerase alpha-Primase and Stimulate Its Ability to Synthesize RNA Primers	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; HELICASE ACTIVITY; REPLICATIVE HELICASE; T-ANTIGEN; MOLECULAR ARCHITECTURE; ESCHERICHIA-COLI; GINS COMPLEX; ORIGIN DNA; MECHANISM; CDC45	The Mini-chromosome maintenance (Mcm) proteins are essential as central components for the DNA unwinding machinery during eukaryotic DNA replication. DNA primase activity is required at the DNA replication fork to synthesize short RNA primers for DNA chain elongation on the lagging strand. Although direct physical and functional interactions between helicase and primase have been known in many prokaryotic and viral systems, potential interactions between helicase and primase have not been explored in eukaryotes. Using purified Mcm and DNA primase complexes, a direct physical interaction is detected in pull-down assays between the Mcm2 similar to 7 complex and the hetero-dimeric DNA primase composed of the p48 and p58 subunits. The Mcm4/6/7 complex co-sediments with the primase and the DNA polymerase alpha-primase complex in glycerol gradient centrifugation and forms a Mcm4/6/7-primase-DNA ternary complex in gel-shift assays. Both the Mcm4/6/7 and Mcm2 similar to 7 complexes stimulate RNA primer synthesis by DNA primase in vitro. However, primase inhibits the Mcm4/6/7 helicase activity and this inhibition is abolished by the addition of competitor DNA. In contrast, the ATP hydrolysis activity of Mcm4/6/7 complex is not affected by primase. Mcm and primase proteins mutually stimulate their DNA-binding activities. Our findings indicate that a direct physical interaction between primase and Mcm proteins may facilitate priming reaction by the former protein, suggesting that efficient DNA synthesis through helicase-primase interactions may be conserved in eukaryotic chromosomes.	[You, Zhiying; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Tokyo 113, Japan; [De Falco, Mariarosaria; Pisani, Francesca M.] CNR, Ist Biochim Prot, I-80125 Naples, Italy; [Kamada, Katsuhiko] RIKEN, Discovery Res Inst, Chromosome Dynam Lab, Wako, Saitama, Japan	Tokyo Metropolitan Institute of Medical Science; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); RIKEN	You, ZY (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Tokyo 113, Japan.	takai-yk@igakuken.or.jp	Kamada, Katsuhiko/M-3666-2017; Pisani, Francesca M./AAX-4025-2020	Kamada, Katsuhiko/0000-0001-8523-3417; 	Japan Society for the Promotion of Science (JSPS); Mochida Memory Medicine Pharmacy Promotion Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Associazione Italiana per la Ricerca sul Cancro (AIRC) [9087]; Grants-in-Aid for Scientific Research [23657081] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mochida Memory Medicine Pharmacy Promotion Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Basic Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS), and a research grant from Mochida Memory Medicine Pharmacy Promotion Foundation (to ZY) and by Grants-in-Aid for Basic Scientific Research (A) and Grant-in-Aid for Scientific Research on Priority Area "Chromosome Cycle" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to HM). The financial support of Associazione Italiana per la Ricerca sul Cancro (AIRC; IG Grant #9087) to FMP is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI K, 1981, J BIOL CHEM, V256, P5260; ARAI K, 1979, P NATL ACAD SCI USA, V76, P4308, DOI 10.1073/pnas.76.9.4308; Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bauer RJ, 2013, J MOL BIOL; Bird LE, 2000, BIOCHEMISTRY-US, V39, P171, DOI 10.1021/bi9918801; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2007, J BIOL CHEM, V282, P33795, DOI 10.1074/jbc.M703824200; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; Corn JE, 2008, NAT STRUCT MOL BIOL, V15, P163, DOI 10.1038/nsmb.1373; Corn JE, 2006, NUCLEIC ACIDS RES, V34, P4082, DOI 10.1093/nar/gkl363; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; De Falco M, 2007, EMBO REP, V8, P99, DOI 10.1038/sj.embor.7400870; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; HINTON DM, 1987, J BIOL CHEM, V262, P10873; HOLMES AM, 1985, J BIOL CHEM, V260, P840; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Johnson DE, 2007, P NATL ACAD SCI USA, V104, P5312, DOI 10.1073/pnas.0701062104; Kanke M, 2012, EMBO J, V31, P2182, DOI 10.1038/emboj.2012.68; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kawaguchi A, 2007, EMBO J, V26, P4566, DOI 10.1038/sj.emboj.7601881; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Kukimoto I, 1999, EUR J BIOCHEM, V265, P936, DOI 10.1046/j.1432-1327.1999.00791.x; Lu YB, 1996, P NATL ACAD SCI USA, V93, P12902, DOI 10.1073/pnas.93.23.12902; Manosas M, 2009, NAT CHEM BIOL, V5, P904, DOI 10.1038/nchembio.236; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; McGeoch AT, 2005, CELL, V120, P167, DOI 10.1016/j.cell.2004.11.031; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Mitkova AV, 2003, J BIOL CHEM, V278, P52253, DOI 10.1074/jbc.M308956200; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Nunez-Ramirez R, 2011, NUCLEIC ACIDS RES, V39, P8187, DOI 10.1093/nar/gkr534; Pandey M, 2009, NATURE, V462, P940, DOI 10.1038/nature08611; Patel SS, 2011, CURR OPIN CHEM BIOL, V15, P595, DOI 10.1016/j.cbpa.2011.08.003; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; SAITOH A, 1995, NUCLEIC ACIDS RES, V23, P2014, DOI 10.1093/nar/23.11.2014; Sanchez-Berrondo J, 2012, NUCLEIC ACIDS RES, V40, P1366, DOI 10.1093/nar/gkr831; Sato M, 2000, J MOL BIOL, V300, P421, DOI 10.1006/jmbi.2000.3865; Schneider A, 1998, J BIOL CHEM, V273, P21608, DOI 10.1074/jbc.273.34.21608; SCHNEIDER C, 1994, MOL CELL BIOL, V14, P3176, DOI 10.1128/MCB.14.5.3176; SHRIMANKAR P, 1992, J BACTERIOL, V174, P7689, DOI 10.1128/JB.174.23.7689-7696.1992; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; THOMMES P, 1992, NUCLEIC ACIDS RES, V20, P1069, DOI 10.1093/nar/20.5.1069; Valentine AM, 2001, BIOCHEMISTRY-US, V40, P15074, DOI 10.1021/bi0108554; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; Weisshart K, 2000, J BIOL CHEM, V275, P17328, DOI 10.1074/jbc.M000717200; Yang JS, 2005, J BIOL CHEM, V280, P25416, DOI 10.1074/jbc.M501847200; Yoshimochi T, 2008, J BIOL CHEM, V283, P1601, DOI 10.1074/jbc.M707654200; You ZY, 2008, J BIOL CHEM, V283, P24469, DOI 10.1074/jbc.M803212200; You ZY, 2003, EMBO J, V22, P6148, DOI 10.1093/emboj/cdg576; You ZY, 1999, MOL CELL BIOL, V19, P8003; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	58	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72408	10.1371/journal.pone.0072408	http://dx.doi.org/10.1371/journal.pone.0072408			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977294	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300084
J	Lao, XZ; Liu, M; Chen, J; Zheng, H				Lao, Xingzhen; Liu, Meng; Chen, Jiao; Zheng, Heng			A Tumor-Penetrating Peptide Modification Enhances the Antitumor Activity of Thymosin Alpha 1	PLOS ONE			English	Article							CELL LUNG-CANCER; INTERFERON-ALPHA; METASTATIC MELANOMA; INTERLEUKIN-2; NANOPARTICLES; VASCULATURE; LYMPHOCYTES; DACARBAZINE; INTEGRINS; DELIVERY	A serious limitation of numerous antitumor drugs is the incapacity to penetrate solid tumors. However, addition of an RGD fragment to peptide drugs might solve this problem. In this study, we explored whether the introduction of a permeability-enhancing sequence, such as iRGD (CRGDK/RGPD/EC) fragments, would enhance the activity of thymosin alpha 1 (T alpha 1). The modified T alpha 1 (T alpha 1-iRGD) was successfully expressed and purified, and the in vitro assay showed that T alpha 1-iRGD presented a similar activity as T alpha 1 in promoting proliferation of mouse splenocytes. Meanwhile, cell adhesion analysis revealed that T alpha 1-iRGD exhibited more specific and greater binding with tumor cells compared with T alpha 1. Furthermore, the iRGD fragment evidently enhanced the basal ability of T alpha 1 to inhibit proliferation of cancer cells in vitro, particularly of mouse melanoma cell line B16F10 and human lung cancer cell line H460. Our findings indicated that the addition of an iRGD fragment increased the anti-proliferative activity of T alpha 1 against cancer cells by improving the ability of T alpha 1 to penetrate the tumor cells. This study highlighted the important roles of an iRGD sequence in the therapeutic strategy of T alpha 1-iRGD. Thus, T alpha 1-iRGD could be a novel drug candidate for cancer treatment.	[Lao, Xingzhen; Liu, Meng; Chen, Jiao; Zheng, Heng] China Pharmaceut Univ, Dept Life Sci & Technol, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Zheng, H (corresponding author), China Pharmaceut Univ, Dept Life Sci & Technol, Nanjing, Jiangsu, Peoples R China.	zhengh18@hotmail.com	chen, JJ/HGB-6029-2022; CHEN, JIAO/GZA-5784-2022		National High Technology Research and Development Program of China (863) [2012AA020304]; Fundamental Research Funds for the Central Universities of China [JKQ2011044]	National High Technology Research and Development Program of China (863)(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by a grant from the National High Technology Research and Development Program of China (863) (number 2012AA020304) and the Fundamental Research Funds for the Central Universities of China (number JKQ2011044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; CARMICHAEL J, 1987, CANCER RES, V47, P943; Chen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019111; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Danielli R, 2012, ANN NY ACAD SCI, V1270, P8, DOI 10.1111/j.1749-6632.2012.06757.x; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Eliceiri BP, 2001, CURR OPIN CELL BIOL, V13, P563, DOI 10.1016/S0955-0674(00)00252-0; Elizondo-Riojas MA, 2011, BIOCHEM BIOPH RES CO, V416, P356, DOI 10.1016/j.bbrc.2011.11.041; Garaci E, 1995, EUR J CANCER, V31A, P2403, DOI 10.1016/0959-8049(95)00477-7; Garaci E, 2007, ANN NY ACAD SCI, V1112, P225, DOI 10.1196/annals.1415.044; Garaci E, 2012, ANN NY ACAD SCI, V1269, P26, DOI 10.1111/j.1749-6632.2012.06697.x; GOLDSTEIN AL, 1977, P NATL ACAD SCI USA, V74, P725, DOI 10.1073/pnas.74.2.725; Goldstein AL, 2009, EXPERT OPIN BIOL TH, V9, P593, DOI [10.1517/14712590902911412 , 10.1517/14712590902911412]; LEICHTLING KD, 1990, INT J IMMUNOPHARMACO, V12, P19, DOI 10.1016/0192-0561(90)90064-T; LOPEZ M, 1994, ANN ONCOL, V5, P741, DOI 10.1093/oxfordjournals.annonc.a058979; Maio M, 2010, J CLIN ONCOL, V28, P1780, DOI 10.1200/JCO.2009.25.5208; Moody TW, 2007, ANN NY ACAD SCI, V1112, P297, DOI 10.1196/annals.1415.040; Moody TW, 2002, PEPTIDES, V23, P1011, DOI 10.1016/S0196-9781(02)00025-6; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Peng YW, 2008, CELL BIOL INT, V32, P1265, DOI 10.1016/j.cellbi.2008.07.011; Romani L, 2004, BLOOD, V103, P4232, DOI 10.1182/blood-2003-11-4036; Ruoslahti E, 2002, NAT REV CANCER, V2, P83, DOI 10.1038/nrc724; Salvati F, 1996, ANTICANCER RES, V16, P1001; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Sungarian A, 2009, J ONCOL, V2009, DOI 10.1155/2009/302084; Wang J, 2011, INT J NANOMED, V6, P605, DOI 10.2147/IJN.S16176; Wang PB, 2011, J CELL BIOL, V195, P499, DOI 10.1083/jcb.201104128; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yao WY, 2007, J GASTROEN HEPATOL, V22, P1866, DOI 10.1111/j.1440-1746.2006.04699.x; Zetter BR, 1997, NAT BIOTECHNOL, V15, P1243, DOI 10.1038/nbt1197-1243; Zitzmann S, 2002, CANCER RES, V62, P5139	32	21	24	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72242	10.1371/journal.pone.0072242	http://dx.doi.org/10.1371/journal.pone.0072242			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977262	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700155
J	Wenger, J; Klinglmayr, E; Frohlich, C; Eibl, C; Gimeno, A; Hessenberger, M; Puehringer, S; Daumke, O; Goettig, P				Wenger, Julia; Klinglmayr, Eva; Froehlich, Chris; Eibl, Clarissa; Gimeno, Ana; Hessenberger, Manuel; Puehringer, Sandra; Daumke, Oliver; Goettig, Peter			Functional Mapping of Human Dynamin-1-Like GTPase Domain Based on X-ray Structure Analyses	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; MITOCHONDRIAL DIVISION; NUCLEOTIDE-FREE; MIDDLE DOMAIN; PROTEIN DRP1; IN-VITRO; BINDING; MECHANISM; DYNAMINS; INSIGHTS	Human dynamin-1-like protein (DNM1L) is a GTP-driven molecular machine that segregates mitochondria and peroxisomes. To obtain insights into its catalytic mechanism, we determined crystal structures of a construct comprising the GTPase domain and the bundle signaling element (BSE) in the nucleotide-free and GTP-analogue-bound states. The GTPase domain of DNM1L is structurally related to that of dynamin and binds the nucleotide 59-Guanylyl-imidodiphosphate (GMP-PNP) via five highly conserved motifs, whereas the BSE folds into a pocket at the opposite side. Based on these structures, the GTPase center was systematically mapped by alanine mutagenesis and kinetic measurements. Thus, residues essential for the GTPase reaction were characterized, among them Lys38, Ser39 and Ser40 in the phosphate binding loop, Thr59 from switch I, Asp146 and Gly149 from switch II, Lys216 and Asp218 in the G4 element, as well as Asn246 in the G5 element. Also, mutated Glu81 and Glu82 in the unique 16-residue insertion of DNM1L influence the activity significantly. Mutations of Gln34, Ser35, and Asp190 in the predicted assembly interface interfered with dimerization of the GTPase domain induced by a transition state analogue and led to a loss of the lipid-stimulated GTPase activity. Our data point to related catalytic mechanisms of DNM1L and dynamin involving dimerization of their GTPase domains.	[Wenger, Julia; Klinglmayr, Eva; Eibl, Clarissa; Gimeno, Ana; Hessenberger, Manuel; Goettig, Peter] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Froehlich, Chris; Daumke, Oliver] Max Delbruck Ctr Mol Med, Berlin, Germany; [Puehringer, Sandra] Helmholtz Zentrum Berlin Mat & Energie, Berlin, Germany; [Puehringer, Sandra] Free Univ Berlin, Dept Biol & Chem, Berlin, Germany	Salzburg University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Free University of Berlin	Goettig, P (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	peter.goettig@sbg.ac.at	Goettig, Peter/R-7996-2017; Goettig, Peter/K-4508-2019; Klinglmayr, Eva/L-2967-2015	Goettig, Peter/0000-0002-2430-1970; Goettig, Peter/0000-0002-2430-1970; Eibl, Clarissa/0000-0001-8248-5133; Locke, Julia/0000-0002-0641-3389; Hessenberger, Manuel/0000-0003-3021-1100	Austrian Science Fund project [W_01213]; Erwin-Schrodinger Postdoc Fellowship [J3173-N17]; Austrian Science Fund (FWF) [J 3173] Funding Source: researchfish	Austrian Science Fund project(Austrian Science Fund (FWF)); Erwin-Schrodinger Postdoc Fellowship; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund project W_01213 and by the Erwin-Schrodinger Postdoc Fellowship J3173-N17 for Sandra Puehringer (both http://www.fwf.ac.at/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Binns DD, 1999, J PROTEIN CHEM, V18, P277, DOI 10.1023/A:1021083211267; BODE W, 1975, FEBS LETT, V56, P139, DOI 10.1016/0014-5793(75)80128-1; Bossy B, 2010, J ALZHEIMERS DIS, V20, pS513, DOI 10.3233/JAD-2010-100552; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dudev M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-106; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Faelber K, 2012, STRUCTURE, V20, P1621, DOI 10.1016/j.str.2012.08.028; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Fenner G, 1931, NATURWISSENSCHAFTEN, V19, P310; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18; Heymann JAW, 2009, J CELL SCI, V122, P3427, DOI 10.1242/jcs.051714; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Kageyama Y, 2011, CURR OPIN CELL BIOL, V23, P427, DOI 10.1016/j.ceb.2011.04.009; Klinglmayr E, 2012, ACTA CRYSTALLOGR F, V68, P1217, DOI 10.1107/S174430911203607X; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Nelsestuen GL, 1999, CURR OPIN STRUC BIOL, V9, P433, DOI 10.1016/S0959-440X(99)80060-8; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Otera Hidenori, 2011, Small GTPases, V2, P167; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song BD, 2004, J BIOL CHEM, V279, P40431, DOI 10.1074/jbc.M407007200; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Strack S, 2012, J BIOL CHEM, V287, P10990, DOI 10.1074/jbc.M112.342105; TUMA PL, 1993, J BIOL CHEM, V268, P17240; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; von der Malsburg A, 2011, J BIOL CHEM, V286, P37858, DOI 10.1074/jbc.M111.249037; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yan LM, 2011, J MOL CELL BIOL, V3, P378, DOI 10.1093/jmcb/mjr032; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	62	49	49	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71835	10.1371/journal.pone.0071835	http://dx.doi.org/10.1371/journal.pone.0071835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977156	Green Published, gold, Green Accepted			2022-12-25	WOS:000323425700105
J	Guernsey, MW; Ritscher, L; Miller, MA; Smith, DA; Schoneberg, T; Shapiro, MD				Guernsey, Michael W.; Ritscher, Lars; Miller, Matthew A.; Smith, Daniel A.; Schoeneberg, Torsten; Shapiro, Michael D.			A Val85Met Mutation in Melanocortin-1 Receptor Is Associated with Reductions in Eumelanic Pigmentation and Cell Surface Expression in Domestic Rock Pigeons (Columba livia)	PLOS ONE			English	Article							PLUMAGE POLYMORPHISM; MC1R GENE; PHENOTYPIC CONVERGENCE; COLOR DIFFERENCES; FEATHER COLOR; EVOLUTION; CHICKEN; LOCUS; MICE; WILD	Variation in the melanocortin-1 receptor (Mc1r) is associated with pigmentation diversity in wild and domesticated populations of vertebrates, including several species of birds. Among domestic bird species, pigmentation variation in the rock pigeon (Columba livia) is particularly diverse. To determine the potential contribution of Mc1r variants to pigment diversity in pigeons, we sequenced Mc1r in a wide range of pigeon breeds and identified several single nucleotide polymorphisms, including a variant that codes for an amino acid substitution (Val85Met). In contrast to the association between Val85Met and eumelanism in other avian species, this change was associated with pheomelanism in pigeons. In vitro cAMP accumulation and protein expression assays revealed that Val85Met leads to decreased receptor function and reduced cell surface expression of the mutant protein. The reduced in vitro function is consistent with the observed association with reduced eumelanic pigmentation. Comparative genetic and cellular studies provide important insights about the range of mechanisms underlying diversity among vertebrates, including different phenotypic associations with similar mutations in different species.	[Guernsey, Michael W.; Miller, Matthew A.; Shapiro, Michael D.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Ritscher, Lars; Schoeneberg, Torsten] Univ Leipzig, Fac Med, Inst Biochem, D-04109 Leipzig, Germany; [Smith, Daniel A.] Goshen Coll, Dept Chem, Goshen, IN USA	Utah System of Higher Education; University of Utah; Leipzig University	Shapiro, MD (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	mike.shapiro@utah.edu		Miller, Matthew/0000-0002-6776-9776	Burroughs Wellcome Fund; NSF [DEB-1149160]; DEB-1149160 to MDS; German Research Foundation [Sfb610]; Goshen College	Burroughs Wellcome Fund(Burroughs Wellcome Fund); NSF(National Science Foundation (NSF)); DEB-1149160 to MDS; German Research Foundation; Goshen College	This work was supported by a Burroughs Wellcome Fund (www.bwfund.org) Career Award in the Biomedical Sciences and NSF (www.nsf.gov) CAREER Award DEB-1149160 to MDS; German Research Foundation (www.dfg.de) grant Sfb610 to TS; Mininger Grants from Goshen College (www.goshen.edu) to DAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2009, COLD SH Q B, V74, P319, DOI 10.1101/sqb.2009.74.039; Baiao PC, 2007, J HERED, V98, P287, DOI 10.1093/jhered/esm030; Coster M, 2012, FASEB J, V26, P3273, DOI 10.1096/fj.12-203737; Cox CL, 2013, GENE, V513, P282, DOI 10.1016/j.gene.2012.10.065; Darwin C., 1859, ORIGIN SPECIES MEANS; Doncaster L, 1912, J GENET, V2, P89, DOI 10.1007/BF02984337; Driscoll CA, 2009, P NATL ACAD SCI USA, V106, P9971, DOI 10.1073/pnas.0901586106; DUNMORE R, 1968, AM MIDL NAT, V79, P1, DOI 10.2307/2423151; Gangoso L, 2011, J EVOLUTION BIOL, V24, P2055, DOI 10.1111/j.1420-9101.2011.02336.x; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; HAASE E, 1992, J HERED, V83, P64, DOI 10.1093/oxfordjournals.jhered.a111160; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Jacquin L, 2012, BEHAV ECOL, V23, P907, DOI 10.1093/beheco/ars055; Johnson JA, 2012, GYRFALCONS PTARMIGAN, P1; Johnson JA, 2012, J HERED, V103, P315, DOI 10.1093/jhered/ess023; Kerje S, 2003, ANIM GENET, V34, P241, DOI 10.1046/j.1365-2052.2003.00991.x; LEVI W. M., 1965, Encyclopaedia of pigeon breeds.; Ling MK, 2003, EUR J BIOCHEM, V270, P1441, DOI 10.1046/j.1432-1033.2003.03506.x; Lloyd-Jones O, 1915, J EXP ZOOL, V18, P453, DOI 10.1002/jez.1400180304; Majerus MEN, 2003, TRENDS GENET, V19, P585, DOI 10.1016/j.tig.2003.09.003; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; Mas JS, 2002, EUR J BIOCHEM, V269, P6133, DOI 10.1046/j.1432-1033.2002.03329.x; Mogil JS, 2005, J MED GENET, V42, P583, DOI 10.1136/jmg.2004.027698; Morgan TH, 1911, BIOL BULL-US, V21, P0215, DOI 10.2307/1536043; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Mundy NI, 2004, SCIENCE, V303, P1870, DOI 10.1126/science.1093834; MURTON RK, 1974, J APPL ECOL, V11, P841, DOI 10.2307/2401748; Nadeau NJ, 2006, ANIM GENET, V37, P287, DOI 10.1111/j.1365-2052.2006.01442.x; Pointer MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-249; Price TD, 2002, GENETICA, V116, P311, DOI 10.1023/A:1021248913179; Rosenblum EB, 2004, EVOLUTION, V58, P1794, DOI 10.1111/j.0014-3820.2004.tb00462.x; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; Sanchez-Laorden L, 2006, CELL MOL BIOL, V52, P39, DOI 10.1170/T706; Schoneberg T, 1998, HUM MUTAT, V12, P196, DOI 10.1002/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F; Sell A, 1994, REEDING INHERITANCE, P202; Shapiro MD, 2013, CURR BIOL, V23, pR302, DOI 10.1016/j.cub.2013.01.063; Shapiro MD, 2013, SCIENCE, V339, P1063, DOI 10.1126/science.1230422; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Steiner CC, 2009, MOL BIOL EVOL, V26, P35, DOI 10.1093/molbev/msn218; Stringham SA, 2012, CURR BIOL, V22, P302, DOI 10.1016/j.cub.2011.12.045; Takeuchi S, 1996, BBA-GENE STRUCT EXPR, V1308, P164, DOI 10.1016/0167-4781(96)00100-5; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0; Uy JAC, 2009, AM NAT, V174, P244, DOI 10.1086/600084; Vidal O, 2010, POULTRY SCI, V89, P1599, DOI 10.3382/ps.2010-00726; Wlasiuk G, 2007, J HERED, V98, P567, DOI 10.1093/jhered/esm059; Yu WH, 2013, ANIM GENET, V44, P214, DOI 10.1111/j.1365-2052.2012.02377.x	48	17	17	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e74475	10.1371/journal.pone.0074475	http://dx.doi.org/10.1371/journal.pone.0074475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977400	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000124
J	Li, SL; Du, LL; Zhang, L; Hu, Y; Xia, WC; Wu, J; Zhu, J; Chen, LL; Zhu, FQ; Li, CX; Yang, SJ				Li, Shali; Du, Leilei; Zhang, Lu; Hu, Yue; Xia, Wenchun; Wu, Jia; Zhu, Jing; Chen, Lingling; Zhu, Fengqi; Li, Chunxian; Yang, SiJun			Cathepsin B Contributes to Autophagy-related 7 (Atg7)-induced Nod-like Receptor 3 (NLRP3)-dependent Proinflammatory Response and Aggravates Lipotoxicity in Rat Insulinoma Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Cytokine; Glucose Metabolism; Inflammation; Insulin Resistance; Pancreatic Islets	ENDOPLASMIC-RETICULUM STRESS; NLRP3 INFLAMMASOME; PALMITIC ACID; PROTEIN-KINASE; ACTIVATION; APOPTOSIS; MATURATION; IL-1-BETA; PATHWAY; GLUCOSE	Background: Previous studies show that autophagy deficiency leads to inflammasome activation. Results: Excessive autophagy activation induces a proinflammatory response. Conclusion: Our findings provide new insights into the release mechanisms of proinflammatory cytokines regulated by autophagy. Significance: That autophagy may play a deleterious role in pathogenesis in T2D is a novel finding. Impairment of glucose-stimulated insulin secretion caused by the lipotoxicity of palmitate was found in -cells. Recent studies have indicated that defects in autophagy contribute to pathogenesis in type 2 diabetes. Here, we report that autophagy-related 7 (Atg7) induced excessive autophagic activation in INS-1(823/13) cells exposed to saturated fatty acids. Atg7-induced cathepsin B (CTSB) overexpression resulted in an unexpected significant increase in proinflammatory chemokine and cytokine production levels of IL-1, monocyte chemotactic protein-1, IL-6, and TNF-. Inhibition of receptor-interacting protein did not affect the inflammatory response, ruling out involvement of necrosis. CTSB siRNA suppressed the inflammatory response but did not affect apoptosis significantly, suggesting that CTSB was a molecular linker between autophagy and the proinflammatory response. Blocking caspase-3 suppressed apoptosis but did not affect the inflammatory response, suggesting that CTSB induced inflammatory effects independently of apoptosis. Silencing of Nod-like receptor 3 (NLRP3) completely abolished both IL-1 secretion and the down-regulation effects of Atg7-induced CTSB overexpression on glucose-stimulated insulin secretion impairment, thus identifying the NLRP3 inflammasome as an autophagy-responsive element in the pancreatic INS-1(823/13) cell line. Combined together, our results indicate that CTSB contributed to the Atg7-induced NLRP3-dependent proinflammatory response, resulting in aggravation of lipotoxicity, independently of apoptosis in the pancreatic INS-1(823/13) cell line.	[Li, Shali; Du, Leilei; Zhang, Lu; Hu, Yue; Xia, Wenchun; Wu, Jia; Zhu, Jing; Chen, Lingling; Zhu, Fengqi; Li, Chunxian; Yang, SiJun] Nanjing Normal Univ, Dept Cell Biol, Coll Life Sci, Nanjing 210046, Jiangsu, Peoples R China	Nanjing Normal University	Yang, SJ (corresponding author), Nanjing Normal Univ, Dept Cell Biol, Coll Life Sci, Nanjing 210046, Jiangsu, Peoples R China.	08275@njnu.edu.cn	Chen, Ling-Ling/AAY-3547-2021					Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Caglic D, 2011, BIOORGAN MED CHEM, V19, P1055, DOI 10.1016/j.bmc.2010.10.028; Cao LZ, 2004, DIABETES, V53, P3168, DOI 10.2337/diabetes.53.12.3168; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Deretic V, 2009, CURR OPIN IMMUNOL, V21, P53, DOI 10.1016/j.coi.2009.02.002; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Khan MJ, 2012, J BIOL CHEM, V287, P21110, DOI 10.1074/jbc.M111.319129; Kolattukudy PE, 2012, CIRC RES, V110, P174, DOI 10.1161/CIRCRESAHA.111.243212; Komatsu M, 2012, J BIOCHEM, V152, P5, DOI 10.1093/jb/mvs059; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liang HS, 2011, IN VIVO, V25, P711; Lightfoot YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020617; Martino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036188; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Meng QY, 2011, J BIOL CHEM, V286, P32324, DOI 10.1074/jbc.M111.254417; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Orlichenko L, 2012, J BIOL CHEM, V287, P24284, DOI 10.1074/jbc.M111.328815; Osborn O, 2008, CYTOKINE, V44, P141, DOI 10.1016/j.cyto.2008.07.004; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Shao SY, 2010, J CELL BIOCHEM, V111, P634, DOI 10.1002/jcb.22750; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Song MK, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/323784; Sun L, 2012, J NEUROSCI, V32, P11330, DOI 10.1523/JNEUROSCI.0677-12.2012; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	39	44	48	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30094	30104		10.1074/jbc.M113.494286	http://dx.doi.org/10.1074/jbc.M113.494286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986436	Green Published, hybrid			2022-12-25	WOS:000329868100010
J	Leitao, J; Ribeiro, R; Soares, AMVM; Lopes, I				Leitao, Joao; Ribeiro, Rui; Soares, Amadeu M. V. M.; Lopes, Isabel			Tolerance to Copper and to Salinity in Daphnia longispina: Implications within a Climate Change Scenario	PLOS ONE			English	Article							DRIVEN GENETIC EROSION; STRESSED POPULATIONS; CATION COTOLERANCE; FIELD POPULATIONS; CO-TOLERANCE; FRESH; RESISTANCE; MINE; TOXICITY; GROWTH	Considering IPPC climate change scenarios, it is pertinent to predict situations where coastal ecosystems already impacted with chemical contamination became exposed to an additional stressor under a future scenario of seawater intrusion. Accordingly, the present study aimed at evaluating if a negative association between tolerance to a metal and to saltwater exists among genotypes of a freshwater organism. For this, five clonal lineages of the cladoceran Daphnia longispina O.F. Muller, exhibiting a differential tolerance to lethal levels of copper, were selected. Each clonal lineage was exposed to lethal and sublethal concentrations of sodium chloride (assumed as a protective surrogate to evaluate the toxicity of increased salinity to freshwater organisms). Mortality, time to release the first brood and total number of neonates per female were monitored and the somatic growth rate and intrinsic rate of natural increase were computed for each clonal lineage. Data here obtained were compared with their lethal responses to copper and significant negative correlations were found. These results suggest that genetically eroded populations of D. longispina, due to copper or salinity, may be particularly susceptible to a later exposure to the other contaminant supporting the multiple stressors differential tolerance.	[Leitao, Joao; Soares, Amadeu M. V. M.; Lopes, Isabel] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Ribeiro, Rui] Univ Coimbra, Dept Life Sci, IMAR Inst Mar, Coimbra, Portugal; [Soares, Amadeu M. V. M.; Lopes, Isabel] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal	Universidade de Aveiro; Universidade de Coimbra; Universidade de Aveiro	Lopes, I (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.	ilopes@ua.pt	Soares, Amadeu/A-8304-2008; Ribeiro, Rui/C-7788-2012; Lopes, Isabel/C-2858-2009	Soares, Amadeu/0000-0003-0879-9470; Ribeiro, Rui/0000-0002-0883-1939; Lopes, Isabel/0000-0002-9325-0329	FEDER through COMPETE-programa Operacional Factores de Competitividade [FCOMP-01-0124-FEDER-014016, PTDC/AAC-CLI/111706/2009]; Fundação para a Ciência e a Tecnologia [PTDC/AAC-CLI/111706/2009] Funding Source: FCT	FEDER through COMPETE-programa Operacional Factores de Competitividade; Fundação para a Ciência e a Tecnologia	This work has been developed under the scope of the Portuguese Science Foundation (FCT, Portugal) through FSE and POPH funds (Programa Ciencia 2007), and FEDER through COMPETE-programa Operacional Factores de Competitividade (research project FCOMP-01-0124-FEDER-014016; PTDC/AAC-CLI/111706/2009). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agra AR, 2010, ENVIRON TOXICOL CHEM, V29, P939, DOI 10.1002/etc.97; Ahearn GA, 2004, J COMP PHYSIOL B, V174, P439, DOI 10.1007/s00360-004-0438-0; [Anonymous], 1998, 211 OECD, P1; ASTM (American Society for Testing and Materials), 2000, STAND GUID COND AC T; Baird DJ, 1989, P 1 EUR C EC LYNGB D, P144; Barata C, 2000, ENVIRON TOXICOL CHEM, V19, P2314, DOI 10.1002/etc.5620190922; Bianchini A, 2008, J EXP BIOL, V211, P539, DOI 10.1242/jeb.009175; Brouwer M, 2002, J INORG BIOCHEM, V88, P228, DOI 10.1016/S0162-0134(01)00381-6; De Schamphelaere KAC, 2002, ENVIRON SCI TECHNOL, V36, P48, DOI 10.1021/es000253s; Goncalves AMM, 2007, ANN LIMNOL-INT J LIM, V43, P13, DOI 10.1051/limn/2007022; Harmon SM, 2003, ARCH ENVIRON CON TOX, V45, P79, DOI 10.1007/s00244-002-0116-8; HODSON MJ, 1982, NEW PHYTOL, V90, P253, DOI 10.1111/j.1469-8137.1982.tb03257.x; Hoffmann A. A., 1994, EVOLUTIONARY GENETIC; Intergovernmental Panel on Climate Change IPCC, 2007, CLIM CHANG 2007 CLIM; Kefford BJ, 2005, ENVIRON POLLUT, V134, P377, DOI 10.1016/j.envpol.2004.09.018; Kefford BJ, 2004, WATER SA, V30, P499; Klerks PL, 2011, ECOTOXICOLOGY, V20, P513, DOI 10.1007/s10646-011-0640-2; Kobayashi H, 2004, PLANT PROD SCI, V7, P30, DOI 10.1626/pps.7.30; Langdon CJ, 1999, SOIL BIOL BIOCHEM, V31, P1963, DOI 10.1016/S0038-0717(99)00118-2; Langdon CJ, 2001, ENVIRON TOXICOL CHEM, V20, P2336, DOI [10.1002/etc.5620201028, 10.1897/1551-5028(2001)020&lt;2336:RTCTIP&gt;2.0.CO;2]; Lopes I, 2005, CHEMOSPHERE, V61, P1189, DOI 10.1016/j.chemosphere.2005.02.072; Lopes I, 2005, ENVIRON TOXICOL CHEM, V24, P1414, DOI 10.1897/04-132R.1; Lopes I, 2004, ENVIRON TOXICOL CHEM, V23, P1702, DOI 10.1897/03-231; Lopes I, 2004, ARCH ENVIRON CON TOX, V46, P43, DOI 10.1007/s00244-003-2143-5; Lopes I, 2009, ENVIRON TOXICOL CHEM, V28, P1912, DOI 10.1897/08-359.1; Martinez-Jeronimo F, 2007, ECOTOX ENVIRON SAFE, V67, P411, DOI 10.1016/j.ecoenv.2006.08.009; Martins N, 2007, ENVIRON TOXICOL CHEM, V26, P1904, DOI 10.1897/06-111R.1; MEYER JS, 1986, ECOLOGY, V67, P1156, DOI 10.2307/1938671; Mohammed A, 2007, ENVIRON MONIT ASSESS, V127, P307, DOI 10.1007/s10661-006-9281-y; Nielsen DL, 2008, MAR FRESHWATER RES, V59, P549, DOI 10.1071/MF07166; OECD, 2004, DAPHN SP AC IMM TEST, P202; Pereira R, 2004, HUM ECOL RISK ASSESS, V10, P543, DOI 10.1080/10807030490452197; Ribeiro R, 2013, ECOTOXICOLOGY, V22, P889, DOI 10.1007/s10646-013-1070-0; Ribeiro R, 2012, ENVIRON TOXICOL CHEM, V31, P977, DOI 10.1002/etc.1802; Sakuma M, 1998, APPL ENTOMOL ZOOL, V33, P339, DOI 10.1303/aez.33.339; SANTOS MAPF, 2007, J BRAZILIAN SOC ECOT, V2, P229, DOI DOI 10.5132/JBSE.2007.03.004; Saro L, 2012, ENVIRON TOXICOL CHEM, V31, P1; Schallenberg M, 2003, MAR ECOL PROG SER, V251, P181, DOI 10.3354/meps251181; SHAH SH, 1993, PLANT SCI, V89, P81, DOI 10.1016/0168-9452(93)90172-V; Shah SH, 2002, PLANT CELL TISS ORG, V71, P95, DOI 10.1023/A:1019912800672; Silva R.M., 2010, INTERDISCIPLINARY ST, P213; Soldo D, 2000, AQUAT TOXICOL, V47, P181, DOI 10.1016/S0166-445X(99)00020-X; Tilstone GH, 1997, PLANT SOIL, V191, P173, DOI 10.1023/A:1004234604143; Ungherese G, 2010, ENVIRON POLLUT, V158, P1638, DOI 10.1016/j.envpol.2009.12.007; van Straalen NM, 2002, HUM ECOL RISK ASSESS, V8, P983, DOI 10.1080/1080-700291905783; Venancio C, 2010, THESIS U AVEIRO AVEI; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; WU L, 1991, ECOTOX ENVIRON SAFE, V21, P47, DOI 10.1016/0147-6513(91)90007-C	48	15	15	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e68702	10.1371/journal.pone.0068702	http://dx.doi.org/10.1371/journal.pone.0068702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23990877	Green Published, gold, Green Submitted			2022-12-25	WOS:000324228800004
J	Li, JQ; Zhang, JH; Chen, HM; Chen, XD; Lan, J; Liu, C				Li, Jianqin; Zhang, Jianhui; Chen, Haimei; Chen, Xiangdong; Lan, Jin; Liu, Chang			Complete Mitochondrial Genome of the Medicinal Mushroom Ganoderma lucidum	PLOS ONE			English	Article							GENE; TRANSCRIPTOME; INTEGRATION; NUCLEOTIDE; EVOLUTION; CONTAINS; PLASMIDS; INTRONS; REPEATS; PROGRAM	Ganoderma lucidum is one of the well-known medicinal basidiomycetes worldwide. The mitochondrion, referred to as the second genome, is an organelle found in most eukaryotic cells and participates in critical cellular functions. Elucidating the structure and function of this genome is important to understand completely the genetic contents of G. lucidum. In this study, we assembled the mitochondrial genome of G. lucidum and analyzed the differential expressions of its encoded genes across three developmental stages. The mitochondrial genome is a typical circular DNA molecule of 60,630 bp with a GC content of 26.67%. Genome annotation identified genes that encode 15 conserved proteins, 27 tRNAs, small and large rRNAs, four homing endonucleases, and two hypothetical proteins. Except for genes encoding trnW and two hypothetical proteins, all genes were located on the positive strand. For the repeat structure analysis, eight forward, two inverted, and three tandem repeats were detected. A pair of fragments with a total length around 5.5 kb was found in both the nuclear and mitochondrial genomes, which suggests the possible transfer of DNA sequences between two genomes. RNA-Seq data for samples derived from three stages, namely, mycelia, primordia, and fruiting bodies, were mapped to the mitochondrial genome and qualified. The protein-coding genes were expressed higher in mycelia or primordial stages compared with those in the fruiting bodies. The rRNA abundances were significantly higher in all three stages. Two regions were transcribed but did not contain any identified protein or tRNA genes. Furthermore, three RNA-editing sites were detected. Genome synteny analysis showed that significant genome rearrangements occurred in the mitochondrial genomes. This study provides valuable information on the gene contents of the mitochondrial genome and their differential expressions at various developmental stages of G. lucidum. The results contribute to the understanding of the functions and evolution of fungal mitochondrial DNA.	[Li, Jianqin; Zhang, Jianhui; Chen, Haimei; Chen, Xiangdong; Lan, Jin; Liu, Chang] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS	Liu, C (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	cliu6688@yahoo.com	Zhang, Jianhui/ABD-5476-2020; Zhang, Jianhui/K-8793-2019; Liu, Chang/A-1148-2014	Zhang, Jianhui/0000-0002-6362-4027; Zhang, Jianhui/0000-0002-6362-4027; 	Chinese Academy of Medical Science [431118]; Basic Scientific Research Operation Grants for State-Level Public Welfare Scientific Research Initiatives [YZ-12-04]; Ministry of Human Resources [431207]; National Science Foundation [81202859, 81173660]; Program for Changjiang Scholars and Innovative Research Team in the University of Ministry of Education of China [IRT1150]	Chinese Academy of Medical Science; Basic Scientific Research Operation Grants for State-Level Public Welfare Scientific Research Initiatives; Ministry of Human Resources; National Science Foundation(National Science Foundation (NSF)); Program for Changjiang Scholars and Innovative Research Team in the University of Ministry of Education of China	This work was supported by a start fund from the Chinese Academy of Medical Science (Grant No. 431118) granted to C. Liu; the Basic Scientific Research Operation Grants for State-Level Public Welfare Scientific Research Initiatives (Grant No. YZ-12-04) granted to C. Liu; a research grant for returned Overseas Chinese Scholars, Ministry of Human Resources (Grant No. 431207) granted to C. Liu; a grant from the National Science Foundation (Grant No. 81202859) for HM. Chen; a grant from the National Science Foundation (Grant No. 81173660) for J. Lan; and the Program for Changjiang Scholars and Innovative Research Team in the University of Ministry of Education of China (Grant No. IRT1150). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Bullerwell CE, 2005, CURR OPIN MICROBIOL, V8, P362, DOI 10.1016/j.mib.2005.06.009; Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P1614, DOI 10.1093/nar/gkg264; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Cahan P, 2005, MOL GENET GENOMICS, V273, P462, DOI 10.1007/s00438-005-1133-x; Carullo M, 2008, J MOL EVOL, V66, P484, DOI 10.1007/s00239-008-9102-8; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Edgell DR, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-22; Ferandon C, 2008, FUNGAL GENET BIOL, V45, P292, DOI 10.1016/j.fgb.2007.10.012; Formighieri EF, 2008, MYCOL RES, V112, P1136, DOI 10.1016/j.mycres.2008.04.014; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Ghikas DV, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-174; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; GRIFFITHS AJF, 1995, MICROBIOL REV, V59, P673, DOI 10.1128/MMBR.59.4.673-685.1995; Haridas S, 2010, FEMS MICROBIOL LETT, V308, P29, DOI 10.1111/j.1574-6968.2010.01979.x; Henze K, 2003, NATURE, V426, P127, DOI 10.1038/426127a; Joardar V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-698; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Kim EK, 2000, CURR GENET, V38, P283, DOI 10.1007/s002940000157; Kouvelis VN, 2004, FUNGAL GENET BIOL, V41, P930, DOI 10.1016/j.fgb.2004.07.003; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Pegler D. N., 2002, Mycologist, V16, P100, DOI 10.1017/S0269915X0200304X; Revanna KV, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-190; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torriani SFF, 2011, MOL PHYLOGENET EVOL, V58, P192, DOI 10.1016/j.ympev.2010.12.002; van de Sande WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038654; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036663, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0040084, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0045036, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045380]; Wang Y, 2008, FEMS MICROBIOL LETT, V280, P34, DOI 10.1111/j.1574-6968.2007.01048.x; Xavier BB, 2012, FUNGAL BIOL-UK, V116, P802, DOI 10.1016/j.funbio.2012.04.013; Xia XH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-211; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762	38	13	17	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72038	10.1371/journal.pone.0072038	http://dx.doi.org/10.1371/journal.pone.0072038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991034	gold, Green Submitted, Green Published			2022-12-25	WOS:000324228800038
J	Wang, MY; Zhao, QS; Yang, JH; Jiang, BJ; Wang, FZ; Liu, KM; Fang, X				Wang, Mingyu; Zhao, Qiushuang; Yang, Jinghua; Jiang, Baojie; Wang, Fangzhong; Liu, Kuimei; Fang, Xu			A Mitogen-Activated Protein Kinase Tmk3 Participates in High Osmolarity Resistance, Cell Wall Integrity Maintenance and Cellulase Production Regulation in Trichoderma reesei	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MAP KINASE; OSMOTIC-STRESS; HYPHAL MORPHOGENESIS; HYPEROSMOTIC STRESS; SIGNAL-TRANSDUCTION; FILAMENTOUS FUNGUS; CHITIN SYNTHESIS; GENE-EXPRESSION; GROWTH	The mitogen-activated protein kinase (MAPK) pathways are important signal transduction pathways conserved in essentially all eukaryotes, but haven't been subjected to functional studies in the most important cellulase-producing filamentous fungus Trichoderma reesei. Previous reports suggested the presence of three MAPKs in T. reesei: Tmk1, Tmk2, and Tmk3. By exploring the phenotypic features of T. reesei Delta tmk3, we first showed elevated NaCl sensitivity and repressed transcription of genes involved in glycerol/trehalose biosynthesis under higher osmolarity, suggesting Tmk3 participates in high osmolarity resistance via derepression of genes involved in osmotic stabilizer biosynthesis. We also showed significant downregulation of genes encoding chitin synthases and a beta-1,3-glucan synthase, decreased chitin content, 'budded' hyphal appearance typical to cell wall defective strains, and increased sensitivity to calcofluor white/Congo red in the tmk3 deficient strain, suggesting Tmk3 is involved in cell wall integrity maintenance in T. reesei. We further observed the decrease of cellulase transcription and production in T. reesei Delta tmk3 during submerged cultivation, as well as the presence of MAPK phosphorylation sites on known transcription factors involved in cellulase regulation, suggesting Tmk3 is also involved in the regulation of cellulase production. Finally, the expression of cell wall integrity related genes, the expression of cellulase coding genes, cellulase production and biomass accumulation were compared between T. reesei Delta tmk3 grown in solid state media and submerged media, showing a strong restoration effect in solid state media from defects resulted from tmk3 deletion. These results showed novel physiological processes that fungal Hog1-type MAPKs are involved in, and present the first experimental investigation of MAPK signaling pathways in T. reesei. Our observations on the restoration effect during solid state cultivation suggest that T. reesei is evolved to favor solid state growth, bringing up the proposal that the submerged condition normally used during investigations on fungal physiology might be misleading.	[Wang, Mingyu; Zhao, Qiushuang; Jiang, Baojie; Wang, Fangzhong; Liu, Kuimei; Fang, Xu] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Wang, Mingyu; Fang, Xu] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China; [Yang, Jinghua] Boston Univ, Dept Surg, VA Boston Healthcare Syst, Boston, MA 02215 USA; [Yang, Jinghua] Shandong Univ, Sch Med, Canc Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Shandong University	Fang, X (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	fangxu@sdu.edu.cn	Fang, Xu/B-8313-2015	Fang, Xu/0000-0002-9196-5697; Wang, Mingyu/0000-0003-1215-9556	National High-Tech R&D Program of China (863 program) [2011AA022302]; National Natural Science Foundation of China [31200051]; Shandong Province Natural Science Foundation [ZR2012CQ022]; Independent Innovation Foundation of Shandong University [2011HW008]	National High-Tech R&D Program of China (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Independent Innovation Foundation of Shandong University	This work was supported by National High-Tech R&D Program of China (863 program, number 2011AA022302), National Natural Science Foundation of China (number 31200051), Shandong Province Natural Science Foundation (number ZR2012CQ022), and Independent Innovation Foundation of Shandong University (number 2011HW008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Agrawal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029302; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Aro N, 2003, APPL ENVIRON MICROB, V69, P56, DOI 10.1128/AEM.69.1.56-65.2003; Aro N, 2001, J BIOL CHEM, V276, P24309, DOI 10.1074/jbc.M003624200; Atoui A, 2008, APPL ENVIRON MICROB, V74, P3596, DOI 10.1128/AEM.02842-07; BULAWA CE, 1986, CELL, V46, P213, DOI 10.1016/0092-8674(86)90738-5; Bussink HJ, 1999, FEMS MICROBIOL LETT, V173, P117, DOI 10.1016/S0378-1097(99)00060-9; Cziferszky A, 2002, J BIOL CHEM, V277, P14688, DOI 10.1074/jbc.M200744200; Delgado-Jarana J, 2006, MICROBIOL-SGM, V152, P1687, DOI 10.1099/mic.0.28729-0; Dixon KP, 1999, PLANT CELL, V11, P2045, DOI 10.1105/tpc.11.10.2045; Guangtao Z, 2009, J BIOTECHNOL, V139, P146, DOI 10.1016/j.jbiotec.2008.10.007; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Ha YS, 2006, EUKARYOT CELL, V5, P1036, DOI 10.1128/EC.00030-06; Han KH, 2002, MOL MICROBIOL, V43, P1065, DOI 10.1046/j.1365-2958.2002.02774.x; Harris SD, 1999, GENETICS, V151, P1015; Hideno A, 2011, ENZYME MICROB TECH, V48, P162, DOI 10.1016/j.enzmictec.2010.10.005; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hounsa CG, 1998, MICROBIOL-UK, V144, P671, DOI 10.1099/00221287-144-3-671; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Jain R, 2011, MOL MICROBIOL, V82, P39, DOI 10.1111/j.1365-2958.2011.07778.x; Kim J, 2008, BIOCHEM BIOPH RES CO, V372, P266, DOI 10.1016/j.bbrc.2008.05.030; Kubicek CP, 2013, J BIOTECHNOL, V163, P133, DOI 10.1016/j.jbiotec.2012.05.020; Kumar A, 2010, BIOCHEM BIOPH RES CO, V398, P765, DOI 10.1016/j.bbrc.2010.07.020; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mendoza-Mendoza A, 2003, P NATL ACAD SCI USA, V100, P15965, DOI 10.1073/pnas.2136716100; Mey G, 2002, MOL MICROBIOL, V46, P305, DOI 10.1046/j.1365-2958.2002.03133.x; Mukherjee PK, 2003, EUKARYOT CELL, V2, P446, DOI 10.1128/EC.2.3.446-455.2003; Norbeck J, 1996, J BIOL CHEM, V271, P13875, DOI 10.1074/jbc.271.23.13875; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; Park SM, 2004, MOL MICROBIOL, V51, P1267, DOI 10.1111/j.1365-2958.2004.03919.x; REISSIG JL, 1955, J BIOL CHEM, V217, P959; Reithrier B, 2007, FUNGAL GENET BIOL, V44, P1123, DOI 10.1016/j.fgb.2007.04.001; RICHARDS WC, 1994, PHYSIOL MOL PLANT P, V44, P311, DOI 10.1016/S0885-5765(05)80045-1; Roncero C, 2002, CURR GENET, V41, P367, DOI 10.1007/s00294-002-0318-7; Rui O, 2007, MICROBIOL-SGM, V153, P2791, DOI 10.1099/mic.0.2007/006338-0; Schmoll M, 2009, EUKARYOT CELL, V8, P410, DOI 10.1128/EC.00256-08; Schmoll M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-430; Schuster A, 2012, APPL ENVIRON MICROB, V78, P2168, DOI 10.1128/AEM.06959-11; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Seibel C, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-58; Seibel C, 2012, EUKARYOT CELL, V11, P885, DOI 10.1128/EC.05321-11; STRAUSS J, 1995, FEBS LETT, V376, P103, DOI 10.1016/0014-5793(95)01255-5; Stricker AR, 2008, FUNGAL GENET BIOL, V45, P436, DOI 10.1016/j.fgb.2007.08.005; Stricker AR, 2008, APPL MICROBIOL BIOT, V78, P211, DOI 10.1007/s00253-007-1322-0; Sun WC, 2008, PROCESS BIOCHEM, V43, P1083, DOI 10.1016/j.procbio.2008.05.015; Tisch D, 2011, FUNGAL GENET BIOL, V48, P631, DOI 10.1016/j.fgb.2010.12.009; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Vitalini MW, 2007, P NATL ACAD SCI USA, V104, P18223, DOI 10.1073/pnas.0704900104; Waltermann C, 2010, BIOCHEM SOC T, V38, P1257, DOI 10.1042/BST0381257; Wendland J, 2001, GENETICS, V157, P601; WOOD TM, 1988, METHOD ENZYMOL, V160, P87; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Xu Q, 2009, CURR OPIN BIOTECH, V20, P364, DOI 10.1016/j.copbio.2009.05.006; Xue T, 2004, EUKARYOT CELL, V3, P557, DOI 10.1128/EC.3.2.557-560.2004; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Zhang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048786; Zhang Y, 2002, APPL ENVIRON MICROB, V68, P532, DOI 10.1128/AEM.68.2.532-538.2002	60	10	16	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72189	10.1371/journal.pone.0072189	http://dx.doi.org/10.1371/journal.pone.0072189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991059	Green Published, gold, Green Submitted			2022-12-25	WOS:000324228800049
J	Zanin, M; Menasalvas, E; Boccaletti, S; Sousa, P				Zanin, Massimiliano; Menasalvas, Ernestina; Boccaletti, Stefano; Sousa, Pedro			Feature Selection in the Reconstruction of Complex Network Representations of Spectral Data	PLOS ONE			English	Article							PROTEOMIC PATTERNS; MASS-SPECTROMETRY; SERUM	Complex networks have been extensively used in the last decade to characterize and analyze complex systems, and they have been recently proposed as a novel instrument for the analysis of spectra extracted from biological samples. Yet, the high number of measurements composing spectra, and the consequent high computational cost, make a direct network analysis unfeasible. We here present a comparative analysis of three customary feature selection algorithms, including the binning of spectral data and the use of information theory metrics. Such algorithms are compared by assessing the score obtained in a classification task, where healthy subjects and people suffering from different types of cancers should be discriminated. Results indicate that a feature selection strategy based on Mutual Information outperforms the more classical data binning, while allowing a reduction of the dimensionality of the data set in two orders of magnitude.	[Zanin, Massimiliano; Sousa, Pedro] Univ Nova Lisboa, Dept Engn Electrotecn, Fac Ciencias & Tecnol, P-1200 Lisbon, Portugal; [Zanin, Massimiliano] Innaxis Fdn & Res Inst, Madrid, Spain; [Menasalvas, Ernestina] Tech Univ Madrid, Ctr Biomed Technol, Madrid, Spain; [Boccaletti, Stefano] CNR, Inst Complex Syst, Florence, Italy	Universidade Nova de Lisboa; Universidad Politecnica de Madrid; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Zanin, M (corresponding author), Univ Nova Lisboa, Dept Engn Electrotecn, Fac Ciencias & Tecnol, P-1200 Lisbon, Portugal.	massimiliano.zanin@ctb.upm.es	Boccaletti, Stefano/U-7603-2019; Sousa, Pedro A. C./A-8849-2011	Boccaletti, Stefano/0000-0002-5758-7012; Sousa, Pedro A. C./0000-0003-3814-6331; menasalvas, ernestina/0000-0002-5615-6798; Zanin, Massimiliano/0000-0002-5839-0393				Adam BL, 2002, CANCER RES, V62, P3609; ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Andersson CO, 1958, ACTA CHEM SCAND, V12; Beckonert O, 2003, ANAL CHIM ACTA, V490, P3, DOI 10.1016/S0003-2670(03)00060-6; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Clark JW, 1988, EVOLUTION LEARNING C, P129; Costa LD, 2011, ADV PHYS, V60, P329, DOI 10.1080/00018732.2011.572452; COVEY TR, 1986, ANAL CHEM, V58, P2453, DOI 10.1021/ac00125a022; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Fleuret F, 2004, J MACH LEARN RES, V5, P1531; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Griffin JL, 2001, ANAL BIOCHEM, V293, P16, DOI 10.1006/abio.2001.5096; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hamel L.H., 2011, KNOWLEDGE DISCOVERY, V3; Havlin S, 2012, EUR PHYS J-SPEC TOP, V214, P273, DOI 10.1140/epjst/e2012-01695-x; Hoffmann E., 1996, MASS SPECTROMETRY; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Karmeshu J, 2003, ENTROPY MEASURES MAX; KIRA K, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P129; Langley P., 1996, ELEMENTS MACHINE LEA; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liu H, 2008, CH CRC DATA MIN KNOW, P3; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Moseley III MA, 1998, MASS SPECTROMETRY BI, V2, P162; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Petricoin EF, 2002, J NATL CANCER I, V94, P1576; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Powers D., 2011, ARXIV201016061, V2, P2229, DOI 10.9735/2229-3981; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Scott J., 2012, SOCIAL NETWORK ANAL; SPECHT DF, 1990, NEURAL NETWORKS, V3, P109, DOI 10.1016/0893-6080(90)90049-Q; Yang Y, 1997, ICML, P412, DOI DOI 10.1093/BI0INF0RMATICS/BTH267; Zanin M., 2012, SCI REPORTS, V2; Zanin M, 2013, METABOLITES, V3, P155, DOI 10.3390/metabo3010155; Zanin M, 2013, EUR PHYS J-SPEC TOP, V215, P5, DOI 10.1140/epjst/e2013-01711-9; ZWEIG MH, 1993, CLIN CHEM, V39, P561	39	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72045	10.1371/journal.pone.0072045	http://dx.doi.org/10.1371/journal.pone.0072045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991036	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000324228800039
J	Zhao, SQ; Zhu, C; Zhou, DC; Huang, D; Werner, J				Zhao, Shuqing; Zhu, Chao; Zhou, Decheng; Huang, Dian; Werner, Jeremy			Organic Carbon Storage in China's Urban Areas	PLOS ONE			English	Article							SOIL; SEQUESTRATION; URBANIZATION; STOCKS; TREES	China has been experiencing rapid urbanization in parallel with its economic boom over the past three decades. To date, the organic carbon storage in China's urban areas has not been quantified. Here, using data compiled from literature review and statistical yearbooks, we estimated that total carbon storage in China's urban areas was 577 +/- 60 Tg C (1 Tg = 10(12) g) in 2006. Soil was the largest contributor to total carbon storage (56%), followed by buildings (36%), and vegetation (7%), while carbon storage in humans was relatively small (1%). The carbon density in China's urban areas was 17.1 +/- 1.8 kg C m(-2), about two times the national average of all lands. The most sensitive variable in estimating urban carbon storage was urban area. Examining urban carbon storages over a wide range of spatial extents in China and in the United States, we found a strong linear relationship between total urban carbon storage and total urban area, with a specific urban carbon storage of 16 Tg C for every 1,000 km(2) urban area. This value might be useful for estimating urban carbon storage at regional to global scales. Our results also showed that the fraction of carbon storage in urban green spaces was still much lower in China relative to western countries, suggesting a great potential to mitigate climate change through urban greening and green spaces management in China.	[Zhao, Shuqing; Zhu, Chao; Zhou, Decheng; Huang, Dian] Peking Univ, Coll Urban & Environm Sci, Beijing 100871, Peoples R China; [Zhao, Shuqing; Zhu, Chao; Zhou, Decheng; Huang, Dian] Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China; [Werner, Jeremy] US Geol Survey, Earth Resources Observat & Sci EROS Ctr, Sioux Falls, SD USA	Peking University; Peking University; United States Department of the Interior; United States Geological Survey	Zhao, SQ (corresponding author), Peking Univ, Coll Urban & Environm Sci, Beijing 100871, Peoples R China.	sqzhao@urban.pku.edu.cn	Zhou, Decheng/H-5583-2019	Zhou, Decheng/0000-0003-0947-0853	National Basic Research Program of China on Global Change [2010CB50600]; National Natural Science Foundation of China [41071050, 31021001]	National Basic Research Program of China on Global Change(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China on Global Change (#2010CB50600) and the National Natural Science Foundation of China (#41071050 and #31021001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birdsey R, 1992, CARBON STORAGE ACCUM, DOI DOI 10.2737/WO-GTR-59; BRAMRYD T, 1983, ECOL BULL, P301; Bramryd T, 1980, URBAN ECOL, P3; Brejda JJ, 2000, SOIL SCI SOC AM J, V64, P974, DOI 10.2136/sssaj2000.643974x; Brown Lester, 2001, ECOECONOMY BUILDING, P121; Chan KW, 2007, EURASIAN GEOGR ECON, V48, P383, DOI 10.2747/1538-7216.48.4.383; Chan KW, 2010, CHINA REV, V10, P63; Churkina G, 2010, GLOBAL CHANGE BIOL, V16, P135, DOI 10.1111/j.1365-2486.2009.02002.x; CIESIN, 2004, GLOB RUR URB MAPP PR; Davies ZG, 2011, J APPL ECOL, V48, P1125, DOI 10.1111/j.1365-2664.2011.02021.x; Edmondson JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00963; Escobedo F, 2010, ENVIRON SCI POLICY, V13, P362, DOI 10.1016/j.envsci.2010.03.009; Fang J., 1996, CARBON POOLS TERREST, V1st, P109; Fang JY, 2007, SCI CHINA SER D, V50, P92, DOI 10.1007/s11430-007-2031-3; FANG JY, 1996, CHINESE TERRESTRIAL, P129; Folke C, 1997, AMBIO, V26, P167; Gregg JS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032887; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hu MX, 1993, J BEIJING FORESTRY U, V15, P123; Hutyra LR, 2011, GLOBAL CHANGE BIOL, V17, P783, DOI 10.1111/j.1365-2486.2010.02238.x; Jim CY, 2009, CITIES, V26, P187, DOI 10.1016/j.cities.2009.03.003; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kaye JP, 2005, GLOBAL CHANGE BIOL, V11, P575, DOI 10.1111/j.1365-2486.2005.00921.x; Leggett J., 2008, C RES SERV; Liu A., 2000, RESOURCES SCI, V22, P9; MOHURD, 2007, CHIN URB CONSTR STAT; Nowak DJ, 1996, LANDSCAPE URBAN PLAN, V36, P49, DOI 10.1016/S0169-2046(96)00324-6; Nowak DJ, 2002, ENVIRON POLLUT, V116, P381, DOI 10.1016/S0269-7491(01)00214-7; Nowak DJ, 2001, J FOREST, V99, P37; ODUM HT, 1971, ENV POWER SOC; Pataki DE, 2006, GLOBAL CHANGE BIOL, V12, P2092, DOI 10.1111/j.1365-2486.2006.01242.x; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Pouyat Richard V., 2009, Urban Ecosystems, V12, P45, DOI 10.1007/s11252-008-0059-6; R Core Team, 2012, R LANG ENV STAT COMP; Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003; State Statistical Bureau (SSB), 2007, CHIN POP EMPL STAT Y; State Statistical Bureau (SSB), 2007, CHIN STAT YB REG EC; State Statistical Bureau (SSB), 2007, CHIN STAT YB; State Statistical Bureau (SSB), 2007, CHIN CIT STAT YB; United Nations, 2012, WORLD URB PROSP 2011; Wen Jia-Shi, 2010, Chinese Journal of Plant Ecology, V34, P651, DOI 10.3773/j.issn.1005-264x.2010.06.004; Wu HB, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001844; Xu MQ, 2004, INT WOOD IND, P3; Yang YH, 2007, BIOGEOCHEMISTRY, V84, P131, DOI 10.1007/s10533-007-9109-z; Zhu Chao, 2012, Yingyong Shengtai Xuebao, V23, P1195	45	58	62	26	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71975	10.1371/journal.pone.0071975	http://dx.doi.org/10.1371/journal.pone.0071975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991014	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800030
J	Ozomaro, U; Cai, GQ; Kajiwara, Y; Yoon, S; Makarov, V; Delorme, R; Betancur, C; Ruhrmann, S; Falkai, P; Grabe, HJ; Maier, W; Wagner, M; Lennertz, L; Moessner, R; Murphy, DL; Buxbaum, JD; Zuchner, S; Grice, DE				Ozomaro, Uzoezi; Cai, Guiqing; Kajiwara, Yuji; Yoon, Seungtai; Makarov, Vladimir; Delorme, Richard; Betancur, Catalina; Ruhrmann, Stephan; Falkai, Peter; Grabe, Hans Joergen; Maier, Wolfgang; Wagner, Michael; Lennertz, Leonhard; Moessner, Rainald; Murphy, Dennis L.; Buxbaum, Joseph D.; Zuechner, Stephan; Grice, Dorothy E.			Characterization of SLITRK1 Variation in Obsessive-Compulsive Disorder	PLOS ONE			English	Article							LA-TOURETTE-SYNDROME; NEURITE OUTGROWTH; ITALIAN FAMILY; ASSOCIATION; GENE; VARIANTS; VAR321	Obsessive compulsive disorder (OCD) is a syndrome characterized by recurrent and intrusive thoughts and ritualistic behaviors or mental acts that a person feels compelled to perform. Twin studies, family studies, and segregation analyses provide compelling evidence that OCD has a strong genetic component. The SLITRK1 gene encodes a developmentally regulated stimulator of neurite outgrowth and previous studies have implicated rare variants in this gene in disorders in the OC spectrum, specifically Tourette syndrome (TS) and trichotillomania (TTM). The objective of the current study was to evaluate rare genetic variation in SLITRK1 in risk for OCD and to functionally characterize associated coding variants. We sequenced SLITRK1 coding exons in 381 individuals with OCD as well as in 356 control samples and identified three novel variants in seven individuals. We found that the combined mutation load in OCD relative to controls was significant (p = 0.036). We identified a missense N400I change in an individual with OCD, which was not found in more than 1000 control samples (P<0.05). In addition, we showed the the N400I variant failed to enhance neurite outgrowth in primary neuronal cultures, in contrast to wildtype SLITRK1, which enhanced neurite outgrowth in this assay. These important functional differences in the N400I variant, as compared to the wildtype SLITRK1 sequence, may contribute to OCD and OC spectrum symptoms. A synonymous L63L change identified in an individual with OCD and an additional missense change, T418S, was found in four individuals with OCD and in one individual without an OCD spectrum disorder. Examination of additional samples will help assess the role of rare SLITRK1 variation in OCD and in related psychiatric illness.	[Ozomaro, Uzoezi; Zuechner, Stephan] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Ozomaro, Uzoezi] Univ Miami, Miller Sch Med, Dept Neurosci, Miami, FL 33136 USA; [Cai, Guiqing; Kajiwara, Yuji; Yoon, Seungtai; Makarov, Vladimir; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, Seaver Autism Ctr Res & Treatment, New York, NY USA; [Cai, Guiqing; Kajiwara, Yuji; Yoon, Seungtai; Makarov, Vladimir; Buxbaum, Joseph D.; Grice, Dorothy E.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY USA; [Delorme, Richard] Hop Robert Debre, Child Psychiat Dept, F-75019 Paris, France; [Delorme, Richard] Inst Pasteur, Paris, France; [Betancur, Catalina] CNRS, INSERM, U952, UMR 7224, Paris, France; [Betancur, Catalina] Univ Paris 06, Paris, France; [Ruhrmann, Stephan] Univ Cologne, Dept Psychiat & Psychotherapy, D-50931 Cologne, Germany; [Falkai, Peter] Univ Homburg, Dept Psychiat & Psychotherapy, Homburg, Germany; [Grabe, Hans Joergen] Ernst Moritz Arndt Univ Greifswald, Dept Psychiat & Psychotherapy, Stralsund, Germany; [Maier, Wolfgang; Wagner, Michael; Lennertz, Leonhard; Moessner, Rainald] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany; [Murphy, Dennis L.] NIMH, Clin Sci Lab, Intramural Res Program, Bethesda, MD 20892 USA; [Grice, Dorothy E.] Icahn Sch Med Mt Sinai, Div Tics Obsess Compuls & Related Disorders, Dept Psychiat, New York, NY USA	University of Miami; University of Miami; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Cologne; Ernst Moritz Arndt Universitat Greifswald; University of Bonn; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Icahn School of Medicine at Mount Sinai	Grice, DE (corresponding author), Icahn Sch Med Mt Sinai, Div Tics Obsess Compuls & Related Disorders, Dept Psychiat, New York, NY USA.	Dorothy.grice@mssm.edu	Wagner, Michael/E-2325-2011; Buxbaum, Joseph D/G-6001-2010; Ruhrmann, Stephan/AAG-9470-2020; Falkai, Peter/E-3273-2017; Betancur, Catalina/K-3791-2017; Grice, Dorothy E/X-3372-2019	Wagner, Michael/0000-0003-2589-6440; Ruhrmann, Stephan/0000-0002-6022-2364; Falkai, Peter/0000-0003-2873-8667; Betancur, Catalina/0000-0002-3327-4804; Grice, Dorothy E/0000-0002-8833-2549; Delorme, Richard/0000-0002-5614-3663; Buxbaum, Joseph/0000-0001-8898-8313; kajiwara, yuji/0000-0002-9307-8215	National Institutes of Health under Ruth L. Kirschstein National Research Service Award [F31MH086275]; Lois Pope LIFE Fellowship; Beatrice and Samuel A. Seaver Foundation; New Jersey Center for Tourette Syndrome and Associated Disorders; National Tourette Syndrome Association; German Research Foundation DFG [Fa 731/6]; Fondamental Foundation, Creteil, France; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH086275, ZIAMH000336] Funding Source: NIH RePORTER	National Institutes of Health under Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lois Pope LIFE Fellowship; Beatrice and Samuel A. Seaver Foundation; New Jersey Center for Tourette Syndrome and Associated Disorders; National Tourette Syndrome Association; German Research Foundation DFG(German Research Foundation (DFG)); Fondamental Foundation, Creteil, France; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award (UO; F31MH086275), the Lois Pope LIFE Fellowship (UO), the Beatrice and Samuel A. Seaver Foundation (JDB), and the New Jersey Center for Tourette Syndrome and Associated Disorders and the National Tourette Syndrome Association (DEG), the German Research Foundation DFG (PF, MW, WM, HJG, grant Fa 731/6) and Fondamental Foundation, Creteil, France (R.D). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Chou IC, 2007, PEDIATR NEUROL, V37, P404, DOI 10.1016/j.pediatrneurol.2007.06.017; Deng H, 2006, ACTA NEUROL SCAND, V114, P400, DOI 10.1111/j.1600-0404.2006.00706.x; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Fabbrini G, 2007, MOVEMENT DISORD, V22, P2229, DOI 10.1002/mds.21697; Ferrao YA, 2009, PSYCHIAT RES, V170, P32, DOI 10.1016/j.psychres.2008.06.008; Gonzalez O., 2010, Morbidity and Mortality Weekly Report, V59, P1229; Grabe HJ, 2006, AM J PSYCHIAT, V163, P1986, DOI 10.1176/appi.ajp.163.11.1986; Kajiwara Y, 2009, BIOL PSYCHIAT, V66, P918, DOI 10.1016/j.biopsych.2009.05.033; Katayama K, 2010, MOL PSYCHIATR, V15, P177, DOI 10.1038/mp.2008.97; Keen-Kim D, 2006, HUM MOL GENET, V15, P3324, DOI 10.1093/hmg/ddl408; Leckman JE, 2010, DEPRESS ANXIETY, V27, P507, DOI 10.1002/da.20669; Miranda DM, 2009, AM J MED GENET B, V150B, P483, DOI 10.1002/ajmg.b.30840; O'Roak BJ, 2010, MOL PSYCHIATR, V15, P447, DOI 10.1038/mp.2009.105; Pasquini M, 2008, PSYCHIAT RES, V161, P109, DOI 10.1016/j.psychres.2008.02.012; Pauls DL, 2008, AM J MED GENET C, V148C, P133, DOI 10.1002/ajmg.c.30168; Pool M, 2008, J NEUROSCI METH, V168, P134, DOI 10.1016/j.jneumeth.2007.08.029; Scharf JM, 2008, NEUROLOGY, V70, P1495, DOI 10.1212/01.wnl.0000296833.25484.bb; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Talati A, 2008, MOL PSYCHIATR, V13, P122, DOI 10.1038/sj.mp.4002114; Verkerk AJMH, 2006, MOL PSYCHIATR, V11, P954, DOI 10.1038/sj.mp.4001877; Wendland JR, 2006, MOL PSYCHIATR, V11, P802, DOI 10.1038/sj.mp.4001848; Zimprich A, 2008, PSYCHIAT GENET, V18, P308, DOI 10.1097/YPG.0b013e3283060f6f; Zuchner S, 2006, MOL PSYCHIATR, V11, P888, DOI 10.1038/sj.mp.4001865	25	27	29	8	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e70376	10.1371/journal.pone.0070376	http://dx.doi.org/10.1371/journal.pone.0070376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990902	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470100023
J	Prazuck, T; Chaillon, A; Avettand-Fenoel, V; Caplan, AL; Sayang, C; Guigon, A; Niang, M; Barin, F; Rouzioux, C; Hocqueloux, L				Prazuck, Thierry; Chaillon, Antoine; Avettand-Fenoel, Veronique; Caplan, Anne-Laure; Sayang, Collins; Guigon, Aurelie; Niang, Mohamadou; Barin, Francis; Rouzioux, Christine; Hocqueloux, Laurent			HIV-DNA in the Genital Tract of Women on Long-Term Effective Therapy Is Associated to Residual Viremia and Previous AIDS-Defining Illnesses	PLOS ONE			English	Article							ANTIRETROVIRAL DRUG CONCENTRATIONS; IMMUNODEFICIENCY-VIRUS TYPE-1; CERVICOVAGINAL SECRETIONS; VIRAL LOAD; HETEROSEXUAL TRANSMISSION; SEXUAL TRANSMISSION; COITAL ACT; BLOOD; RNA; METAANALYSIS	Objectives: To assess the impact of long-term combined antiretroviral therapy (cART) on HIV-RNA and HIV-DNA levels in cervicovaginal secretions of HIV-1-infected women with sustained undetectable plasma RNA viral load (PVL); to explore factors predictive of residual viral shedding; and to evaluate the risk of heterosexual transmission. Methods: Women with undetectable PVL (<50 copies/mL) for >6 months were included in this cross-sectional study. HIV-RNA and HIV-DNA were measured in blood and cervicovaginal lavage fluid (CVL). Women were systematically tested for genital infections. The risk of transmission to male partners during unprotected intercourse was estimated. Results: Eighty-one women composed the study population: all had HIV-RNA <40 copies/mL in CVL. HIV-DNA was detectable in CVL of 29/78 patients (37%). There was a weak positive correlation between HIV-DNA levels in PBMCs and CVL (r = 0.20; p = 0.08). In multivariate analysis, two factors were associated with HIV-DNA detection in CVL: previous AIDS-defining illnesses (OR = 11; 95%CI = 2-61) and current residual viremia (20<PVL<50 cp/mL) (OR = 3.4; 95%CI = 1.1-10.9). Neither the classes of cART regimen nor the presence of genital bacterial or fungal colonization were associated with HIV-DNA detection in CVL. Twenty-eight percent of the women had unprotected intercourse with their regular HIV-seronegative male partner, for between 8 and 158 months. None of their male partners became infected, after a total of 14 000 exposures. Conclusion: In our experience, HIV-RNA was undetectable in the genital tract of women with sustained control of PVL on cART. HIV-DNA shedding persisted in about one third of cases, with no substantial evidence of residual infectiousness.	[Prazuck, Thierry; Caplan, Anne-Laure; Sayang, Collins; Niang, Mohamadou; Hocqueloux, Laurent] CHR Orleans La Source, Dept Infect Dis, Orleans, France; [Chaillon, Antoine; Barin, Francis] CHU Tours, Virol Lab, Tours, France; [Avettand-Fenoel, Veronique; Rouzioux, Christine] Univ Paris 05, EA 3620, Necker Hosp, Virol Lab, Paris, France; [Guigon, Aurelie] CHR Orleans La Source, Virol Lab, Orleans, France	Centre Hospitalier Regional d'Orleans; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Regional d'Orleans	Hocqueloux, L (corresponding author), CHR Orleans La Source, Dept Infect Dis, Orleans, France.	laurent.hocqueloux@chr-orleans.fr	chaillon, antoine/GNH-1623-2022; Chaillon, Antoine/GNH-6121-2022; Avettand-Fenoel, Véronique/O-6285-2017	Avettand-Fenoel, Véronique/0000-0002-7022-2990	Orleans' Regional Hospital	Orleans' Regional Hospital	This work was supported by an internal grant from Orleans' Regional Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Avettand-Fenoel V, 2008, AIDS, V22, P1880, DOI 10.1097/QAD.0b013e32830fbdbc; Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; BELEC L, 1995, CLIN DIAGN LAB IMMUN, V2, P57; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cu-Uvin S, 2010, AIDS, V24, P2486, DOI 10.1097/QAD.0b013e32833e5043; Debiaggi M, 2001, EUR J CLIN MICROBIOL, V20, P91, DOI 10.1007/s100960000442; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Delany S, 2008, JAIDS-J ACQ IMM DEF, V49, P406, DOI 10.1097/QAI.0b013e31818c7f75; Fiore JR, 2003, AIDS, V17, P2169, DOI 10.1097/00002030-200310170-00004; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Graham SM, 2010, J INFECT DIS, V202, P1538, DOI 10.1086/656790; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Henning TR, 2010, J INFECT DIS, V202, P1543, DOI 10.1086/656720; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kwara A, 2008, CLIN INFECT DIS, V46, P719, DOI 10.1086/527387; Launay O, 2011, ANTIVIR THER, V16, P843, DOI 10.3851/IMP1856; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Nagot N, 2005, JAIDS-J ACQ IMM DEF, V39, P632; Neely MN, 2007, JAIDS-J ACQ IMM DEF, V44, P38, DOI 10.1097/01.qai.0000248352.18007.1f; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Shaheen F, 1999, J HUMAN VIROL, V2, P154; Shekelle Paul, 2007, Evid Rep Technol Assess (Full Rep), P1; Spinillo A, 2001, BRIT J OBSTET GYNAEC, V108, P634, DOI 10.1111/j.1471-0528.2001.00141.x; Taylor S, 2010, CURR OPIN HIV AIDS, V5, P335, DOI 10.1097/COH.0b013e32833a0b69; Vernazza P, 2008, B MED SUISSES, V89, P165; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Yeni P, 2010, PRISE CHARGE MED PER	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e69686	10.1371/journal.pone.0069686	http://dx.doi.org/10.1371/journal.pone.0069686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990886	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470100011
J	McConville, A; Law, BS; Mahony, MJ				McConville, Anna; Law, Bradley S.; Mahony, Michael J.			Are Regional Habitat Models Useful at a Local-Scale? A Case Study of Threatened and Common Insectivorous Bats in South-Eastern Australia	PLOS ONE			English	Article							PIPISTRELLUS-PIPISTRELLUS; SPECIES DISTRIBUTIONS; LANDSCAPE STRUCTURE; CENTRAL COAST; CONSERVATION; PREDICTION; SELECTION; COEFFICIENT; PREFERENCES; PERFORMANCE	Habitat modelling and predictive mapping are important tools for conservation planning, particularly for lesser known species such as many insectivorous bats. However, the scale at which modelling is undertaken can affect the predictive accuracy and restrict the use of the model at different scales. We assessed the validity of existing regional-scale habitat models at a local-scale and contrasted the habitat use of two morphologically similar species with differing conservation status (Mormopterus norfolkensis and Mormopterus species 2). We used negative binomial generalised linear models created from indices of activity and environmental variables collected from systematic acoustic surveys. We found that habitat type (based on vegetation community) best explained activity of both species, which were more active in floodplain areas, with most foraging activity recorded in the freshwater wetland habitat type. The threatened M. norfolkensis avoided urban areas, which contrasts with M. species 2 which occurred frequently in urban bushland. We found that the broad habitat types predicted from local-scale models were generally consistent with those from regional-scale models. However, threshold-dependent accuracy measures indicated a poor fit and we advise caution be applied when using the regional models at a fine scale, particularly when the consequences of false negatives or positives are severe. Additionally, our study illustrates that habitat type classifications can be important predictors and we suggest they are more practical for conservation than complex combinations of raw variables, as they are easily communicated to land managers.	[McConville, Anna; Mahony, Michael J.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Law, Bradley S.] Forest Sci Ctr, Dept Primary Ind, Beecroft, NSW, Australia	University of Newcastle	McConville, A (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.	anna.mcconville@uon.edu.au		Law, Bradley/0000-0002-3991-3865	Tom Farrell Institute for the Environment; Donaldson Conservation Trust; Hunter-Central Rivers Catchment Management Authority; Royal Zoological Society of NSW (Ethel Mary Read Award); Wambo Coal Pty Ltd.; Australian Geographic Society	Tom Farrell Institute for the Environment; Donaldson Conservation Trust; Hunter-Central Rivers Catchment Management Authority; Royal Zoological Society of NSW (Ethel Mary Read Award); Wambo Coal Pty Ltd.; Australian Geographic Society	Funding for this PhD project (A. McConville) was sourced from the following: The Tom Farrell Institute for the Environment; Donaldson Conservation Trust; Hunter-Central Rivers Catchment Management Authority; Royal Zoological Society of NSW (Ethel Mary Read Award); Wambo Coal Pty Ltd.; and Australian Geographic Society. B. Law is employed by Department Primary Industries (a government department). Whilst these organisations have generously provided funding for this research as part of an overall PhD, they have had no input into research design, direction, methodology or writing of this manuscript.	ADAMS M, 1988, AUST J BIOL SCI, V41, P315, DOI 10.1071/BI9880315; Adams MD, 2009, FOREST ECOL MANAG, V258, P2090, DOI 10.1016/j.foreco.2009.08.002; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Arlettaz R, 1999, J ANIM ECOL, V68, P460, DOI 10.1046/j.1365-2656.1999.00293.x; Avila-Flores R, 2005, J MAMMAL, V86, P1193, DOI 10.1644/04-MAMM-A-085R1.1; Basham R, 2011, AUSTRAL ECOL, V36, P663, DOI 10.1111/j.1442-9993.2010.02202.x; Brambilla M, 2009, BIOL CONSERV, V142, P2033, DOI 10.1016/j.biocon.2009.03.033; Breheny P., 2012, VISUALIZING REGRESSI; Bureau of Meteorology, 2012, CLIM DAT ONL; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Corben C, 2008, ANALOOKW 3 5M; DEOLIVEIRA MC, 1998, ANABAT SYSTEM PRACTI; Elith J, 2002, ECOL MODEL, V157, P313, DOI 10.1016/S0304-3800(02)00202-8; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ferrier S, 2002, BIODIVERS CONSERV, V11, P2275, DOI 10.1023/A:1021302930424; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Flaquer C, 2009, ACTA CHIROPTEROL, V11, P149, DOI 10.3161/150811009X465767; Franklin J, 2009, MAPPING SPECIES DIST; Freeman EA, 2008, J STAT SOFTW, V23, P1; Geoscience Australia, 2012, OZCOASTS AUSTR ONL C; Gibson LA, 2004, J APPL ECOL, V41, P213, DOI 10.1111/j.0021-8901.2004.00896.x; Gonsalves Leroy, 2012, Pacific Conservation Biology, V18, P282; Greaves GJ, 2006, BIOL CONSERV, V132, P211, DOI 10.1016/j.biocon.2006.04.016; Grindal SD, 1999, CAN J ZOOL, V77, P972, DOI 10.1139/cjz-77-6-972; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hayes JP, 1997, J MAMMAL, V78, P514, DOI 10.2307/1382902; Hourigan C. L., 2006, Urban Ecosystems, V9, P67, DOI 10.1007/s11252-006-7902-4; House S., 2003, LOWER HUNTER CENTRAL; IUCN, 2014, IUCN RED LIST THREAT; Jaberg C, 2001, J APPL ECOL, V38, P1169, DOI 10.1046/j.0021-8901.2001.00668.x; Januchowski Stephanie R., 2008, Ecological Management & Restoration, V9, P134, DOI 10.1111/j.1442-8903.2008.00405.x; Keith DA, 2004, OECAN SHORES DESERT; Knott Tiffany, 1998, Pacific Conservation Biology, V4, P354; Laegdsgaard P., 2004, WETLANDS, V22, P29; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Law BS, 2011, WILDLIFE RES, V38, P173, DOI 10.1071/WR10204; Lloyd A, 2006, BIOL CONSERV, V129, P207, DOI 10.1016/j.biocon.2005.10.035; Lunney Daniel, 1998, Pacific Conservation Biology, V4, P186; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Manning AD, 2007, J BIOGEOGR, V34, P289, DOI 10.1111/j.1365-2699.2006.01603.x; McAlpine CA, 2008, J APPL ECOL, V45, P558, DOI 10.1111/j.1365-2664.2007.01431.x; Mcconville A, 2014, AUSTRAL ECOL, V39, P83, DOI 10.1111/aec.12047; McConville A, 2013, WILDLIFE RES, V40, P318, DOI 10.1071/WR12222; MCGARIGAL K, 1995, ECOL MONOGR, V65, P235, DOI 10.2307/2937059; MCKENZIE NL, 1986, J ANIM ECOL, V55, P401, DOI 10.2307/4727; Menzel JM, 2005, WETLANDS, V25, P542, DOI 10.1672/0277-5212(2005)025[0542:BRTCBA]2.0.CO;2; Mills DJ, 1996, FOREST ECOL MANAG, V85, P149, DOI 10.1016/S0378-1127(96)03756-5; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Mouton AM, 2010, ECOL MODEL, V221, P1995, DOI 10.1016/j.ecolmodel.2010.04.017; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; NCAR - Research Application Program, 2012, VERF FOR VER UT 1 32; Nicholls B, 2006, ECOGRAPHY, V29, P697, DOI 10.1111/j.2006.0906-7590.04575.x; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Oli MK, 2020, ECOLOGY, V101, DOI 10.1002/ecy.2969; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearce JL, 2001, J APPL ECOL, V38, P412, DOI 10.1046/j.1365-2664.2001.00608.x; Pennay M., 2004, BAT CALLS NSW REGION; R Development Core Team, 2012, R LANG ENV STAT COMP; RACEY PA, 1985, J ANIM ECOL, V54, P205, DOI 10.2307/4631; Razgour O, 2011, BIOL CONSERV, V144, P2922, DOI 10.1016/j.biocon.2011.08.010; Rempel RS, 2011, PATCH ANAL PATCH GRI; Reside AE, 2011, BIOLOGY AND CONSERVATION OF AUSTRALASIAN BATS, P155; Rhodes JR, 2006, CONSERV BIOL, V20, P449, DOI 10.1111/j.1523-1739.2006.00330.x; Rhodes MP, 2002, CAN J ZOOL, V80, P450, DOI 10.1139/Z02-029; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Threlfall C, 2011, CONSERVING BIODIVERS; Threlfall C, 2011, ECOGRAPHY, V34, P814, DOI 10.1111/j.1600-0587.2010.06939.x; Thuiller W, 2003, J VEG SCI, V14, P669, DOI 10.1111/j.1654-1103.2003.tb02199.x; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Walsh AL, 1996, J APPL ECOL, V33, P508, DOI 10.2307/2404980; Watrous KS, 2006, J WILDLIFE MANAGE, V70, P1228, DOI 10.2193/0022-541X(2006)70[1228:PMHCFT]2.0.CO;2; Wintle BA, 2005, AUSTRAL ECOL, V30, P719, DOI 10.1111/j.1442-9993.2005.01514.x	76	6	7	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72420	10.1371/journal.pone.0072420	http://dx.doi.org/10.1371/journal.pone.0072420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977296	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700168
J	Nakano, T; Afonso, LOB; Beckman, BR; Iwama, GK; Devlin, RH				Nakano, Toshiki; Afonso, Luis O. B.; Beckman, Brian R.; Iwama, George K.; Devlin, Robert H.			Acute Physiological Stress Down-Regulates mRNA Expressions of Growth-Related Genes in Coho Salmon	PLOS ONE			English	Article							YEAST PHAFFIA-RHODOZYMA; FACTOR-I; IGF-I; RAINBOW-TROUT; HORMONE RECEPTOR; GH RECEPTOR; FISH; CORTISOL; ENDOCRINE; TILAPIA	Growth and development in fish are regulated to a major extent by growth-related factors, such as liver-derived insulin-like growth factor (IGF) -1 in response to pituitary-secreted growth hormone (GH) binding to the GH receptor (GHR). Here, we report on the changes in the expressions of gh, ghr, and igf1 genes and the circulating levels of GH and IGF-1 proteins in juvenile coho salmon (Oncorhynchus kisutch) in response to handling as an acute physiological stressor. Plasma GH levels were not significantly different between stressed fish and prestressed control. Plasma IGF-1 concentrations in stressed fish 1.5 h post-stress were the same as in control fish, but levels in stressed fish decreased significantly 16 h post-stress. Real-time quantitative PCR (qPCR) analysis showed that ghr mRNA levels in pituitary, liver, and muscle decreased gradually in response to the stressor. After exposure to stress, hepatic igf1 expression transiently increased, whereas levels decreased 16 h post-stress. On the other hand, the pituitary gh mRNA level did not change in response to the stressor. These observations indicate that expression of gh, ghr, and igf1 responded differently to stress. Our results show that acute physiological stress can mainly down-regulate the expressions of growth-related genes in coho salmon in vivo. This study also suggests that a relationship between the neuroendocrine stress response and growth-related factors exists in fish.	[Nakano, Toshiki] Tohoku Univ, Marine Biochem Lab, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan; [Afonso, Luis O. B.] Natl Res Council Canada, Inst Marine Biosci IMB NRC, Halifax, NS, Canada; [Beckman, Brian R.] NOAA, NW Fisheries Sci Ctr, Seattle, WA USA; [Iwama, George K.] Univ No British Columbia, Prince George, BC V2L 5P2, Canada; [Devlin, Robert H.] Fisheries & Oceans Canada, W Vancouver Lab, Ctr Aquaculture & Environm Res CAER DFO UBC, W Vancouver, BC V7V 1N6, Canada	Tohoku University; International Business Machines (IBM); National Research Council Canada; National Oceanic Atmospheric Admin (NOAA) - USA; University of Northern British Columbia; Fisheries & Oceans Canada	Nakano, T (corresponding author), Tohoku Univ, Marine Biochem Lab, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan.	nakanot@bios.tohoku.ac.jp	Afonso, Luis/B-8171-2013	Afonso, Luis/0000-0002-5905-1131	Japan Society for the Promotion of Science (JSPS) [23580277]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research (KAKENHI, #23580277) from Japan Society for the Promotion of Science (JSPS) to TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Afonso LOB, 2003, FISH PHYSIOL BIOCHEM, V29, P173, DOI 10.1023/B:FISH.0000035939.81588.09; Aida K., 2002, BASICS FISH PHYSL, P204; Barton B.A., 1997, P1; Barton B.A., 1991, Annual Review of Fish Diseases, V1, P3, DOI 10.1016/0959-8030(91)90019-G; Basu N, 2001, GEN COMP ENDOCR, V124, P97, DOI 10.1006/gcen.2001.7688; Beauloye V, 1999, GROWTH HORM IGF RES, V9, P205, DOI 10.1054/ghir.1999.0110; Beckman BR, 2011, GEN COMP ENDOCR, V170, P233, DOI 10.1016/j.ygcen.2010.08.009; Bjornsson BT, 2002, FISH PHYSIOL BIOCHEM, V27, P227, DOI 10.1023/B:FISH.0000032728.91152.10; Breves JP, 2010, COMP BIOCHEM PHYS A, V155, P294, DOI 10.1016/j.cbpa.2009.10.033; Deane EE, 2009, REV FISH BIOL FISHER, V19, P97, DOI 10.1007/s11160-008-9091-0; DEVLIN RH, 1994, NATURE, V371, P209, DOI 10.1038/371209a0; Devlin RH, 2001, NATURE, V409, P781, DOI 10.1038/35057314; Devlin RH, 2009, P NATL ACAD SCI USA, V106, P3047, DOI 10.1073/pnas.0809798106; Donaldson E. M., 1979, FISH PHYSIOL, VVIII, P455; Duan CM, 1998, J NUTR, V128, p306S, DOI 10.1093/jn/128.2.306S; Duguay SJ, 1996, J MOL ENDOCRINOL, V16, P123, DOI 10.1677/jme.0.0160123; Dyer AR, 2004, AQUACULTURE, V236, P583, DOI 10.1016/j.aquaculture.2003.12.025; Ellis T, 2012, FISH PHYSIOL BIOCHEM, V38, P163, DOI 10.1007/s10695-011-9568-y; Fox BK, 2006, GEN COMP ENDOCR, V148, P340, DOI 10.1016/j.ygcen.2006.04.007; Fukada H, 2004, GEN COMP ENDOCR, V139, P61, DOI 10.1016/j.ygcen.2004.07.001; Hori TSF, 2008, COMP BIOCHEM PHYS C, V147, P416, DOI 10.1016/j.cbpc.2008.01.003; Ings JS, 2011, ENVIRON SCI TECHNOL, V45, P2368, DOI 10.1021/es103122g; Iwama George K., 2006, P319; Jentoft S, 2005, COMP BIOCHEM PHYS A, V141, P353, DOI 10.1016/j.cbpb.2005.06.006; Kajimura S, 2003, J ENDOCRINOL, V178, P91, DOI 10.1677/joe.0.1780091; Kameda M, 2008, P 5 WORLD FISH C YOK, p3f; Klein SE, 2008, MOL CELL ENDOCRINOL, V286, P148, DOI 10.1016/j.mce.2007.08.010; Kobayashi M, 2002, FUNDAMENTAL FISH PHY, P128; Kopchick JJ, 2000, MOL GENET METAB, V71, P293, DOI 10.1006/mgme.2000.3068; LeBlanc S, 2011, J EXP BIOL, V214, P1721, DOI 10.1242/jeb.056135; Leung LY, 2008, COMP BIOCHEM PHYS A, V151, P705, DOI 10.1016/j.cbpa.2008.08.023; Mommsen Thomas W., 2001, Fish Physiology, V18, P251; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Momoda TS, 2007, COMP BIOCHEM PHYS D, V2, P303, DOI 10.1016/j.cbd.2007.06.002; Moriyama S, 2000, BIOSCI BIOTECH BIOCH, V64, P1553, DOI 10.1271/bbb.64.1553; MORIYAMA S, 1994, GEN COMP ENDOCR, V96, P149, DOI 10.1006/gcen.1994.1167; Nakano T, 1999, BBA-GEN SUBJECTS, V1426, P119, DOI 10.1016/S0304-4165(98)00145-7; Nakano T, 1999, FISHERIES SCI, V65, P961, DOI 10.2331/fishsci.65.961; Nakano T, 2011, MER J FRE JAP SOC OC, V49, P111; Nakano T, 2011, YOSHOKU, V48, P64; Nakano T, 2004, MARINE BIOTECHNOL, V6, pS100; Nakano T., 1997, YOSHOKU, V34, P69; Nakano T, 2011, COMP PHYSL BIOCH, V28, P142; Nakano T, 2007, DIETARY SUPPLEMENTS FOR THE HEALTH AND QUALITY OF CULTURED FISH, P86, DOI 10.1079/9781845931995.0086; Pankhurst N.W., 1997, P73; PETER RE, 1979, FISH PHYSIOL, V8, P121; Peterson BC, 2005, DOMEST ANIM ENDOCRIN, V28, P391, DOI 10.1016/j.domaniend.2005.01.003; PICKERING AD, 1993, AQUACULTURE, V111, P51, DOI 10.1016/0044-8486(93)90024-S; Pierce AL, 2001, FISH PHYSIOL BIOCHEM, V25, P81, DOI 10.1023/A:1019717001668; Prunet P, 2012, FISH PHYSIOL BIOCHEM, V38, P43, DOI 10.1007/s10695-011-9522-z; Raven PA, 2008, GEN COMP ENDOCR, V159, P26, DOI 10.1016/j.ygcen.2008.07.011; Reinecke M, 2005, GEN COMP ENDOCR, V142, P20, DOI 10.1016/j.ygcen.2005.01.016; Reinecke M, 2010, J FISH BIOL, V76, P1233, DOI 10.1111/j.1095-8649.2010.02605.x; Saera-Vila A, 2009, COMP BIOCHEM PHYS A, V154, P197, DOI 10.1016/j.cbpa.2009.06.004; Small BC, 2006, DOMEST ANIM ENDOCRIN, V31, P340, DOI 10.1016/j.domaniend.2005.12.003; Swanson Penny, 1994, Biochemistry and Molecular Biology of Fishes, V3, P545; Takei Yoshio, 2006, P271; Tymchuk WE, 2009, ENDOCRINOLOGY, V150, P1809, DOI 10.1210/en.2008-0797; Wilkinson RJ, 2006, COMP BIOCHEM PHYS A, V145, P214, DOI 10.1016/j.cbpa.2006.06.010	59	29	31	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71421	10.1371/journal.pone.0071421	http://dx.doi.org/10.1371/journal.pone.0071421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990952	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700050
J	Wang, X; Wang, DF; Jing, P; Wu, YG; Xia, YZ; Chen, MR; Hong, L				Wang, Xian; Wang, Dangfeng; Jing, Pan; Wu, Yuangan; Xia, Yanzhi; Chen, Maorong; Hong, Ling			A Novel Golgi Retention Signal RPWS for Tumor Suppressor UBIAD1	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; CORNEAL-DYSTROPHY; TRANSPORT; PROTEIN; COPII; TERE1; GENE; MUTATIONS; APPARATUS; GLYCOSYLTRANSFERASES	UBIAD1 plays critical roles in physiology including vitamin K and CoQ10 biosynthesis as well as pathophysiology including dyslipimedia-induced SCD (Schnyder's corneal dystrophy), Parkinson's disease, cardiovascular disease and bladder carcinoma. Since the subcellular localization of UBIAD1 varies in different cell types, characterization of the exact subcellular localization of UBIAD1 in specific human disease is vital for understanding its molecular mechanism. As UBIAD1 suppresses bladder carcinoma, we studied its subcellular localization in human bladder carcinoma cell line T24. Since fluorescent images of UBIAD1-EGFP in T24, human prostate cancer cell line PC-3, human embryonic kidney cell line HEK293 and human hepatocyte cell line L02 are similar, these four cell lines were used for present study. Using a combination of fluorescent microscopy and immunohistochemistry, it was found that UBIAD1 localized on the Golgi and endoplasmic reticulum (ER), but not on the plasma membrane, of T24 and HEK293 cells. Using scanning electron microscopy and western blot analysis, we found that UBIAD1 is enriched in the Golgi fraction extracted from the L02 cells, verifying the Golgi localization of UBAID1. Site-directed mutagenesis showed that the RPWS motif, which forms an Arginine finger on the UBIAD1 N terminus, serves as the Golgi retention signal. With both cycloheximide and brefeldin A inhibition assays, it was shown that UBIAD1 may be transported from the endoplasmic reticulum (ER) to the Golgi by a COPII-mediated mechanism. Based upon flow cytometry analysis, it is shown that mutation of the RPWS motif reduced the UBIAD1-induced apoptosis of T24 cells, indicating that the proper Golgi localization of UBIAD1 influences its tumor suppressant activity. This study paves the way for further understanding the molecular mechanism of UBIAD1 in human diseases.	[Wang, Xian; Wang, Dangfeng; Jing, Pan; Wu, Yuangan; Xia, Yanzhi; Hong, Ling] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Genet & Dev Biol, Wuhan 430074, Hubei, Peoples R China; [Chen, Maorong] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biophys, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Hong, L (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Genet & Dev Biol, Wuhan 430074, Hubei, Peoples R China.	lhong@mail.hust.edu.cn	Chen, Maorong/AAF-4006-2019	Chen, Maorong/0000-0003-3744-8864	NSFC (P.R. China) [30971608, 81272210]; 863 Grant of Ministry of Science and Technology (P.R. China) [2007AA09Z449]; NSF of the Hubei Province (P.R. China) [2009CDB074]; Specific Key Project of Novel Medicine Discovery (P.R. China) [2009ZX09301-014]; International Collaboration Programs of Wuhan Science and Technology Bureau (P.R. China) [201070934334]	NSFC (P.R. China)(National Natural Science Foundation of China (NSFC)); 863 Grant of Ministry of Science and Technology (P.R. China); NSF of the Hubei Province (P.R. China); Specific Key Project of Novel Medicine Discovery (P.R. China); International Collaboration Programs of Wuhan Science and Technology Bureau (P.R. China)	This project was supported in part by the Grants from NSFC (P.R. China, No. 30971608, No. 81272210), 863 Grant of Ministry of Science and Technology (P.R. China, No. 2007AA09Z449), NSF of the Hubei Province (P.R. China, 2009CDB074), The Specific Key Project of Novel Medicine Discovery (P.R. China, 2009ZX09301-014) and International Collaboration Programs of Wuhan Science and Technology Bureau (P.R. China, No. 201070934334). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2004, J CELL SCI, V117, P5687, DOI 10.1242/jcs.01491; American Cancer Society (ACS), 2013, CANC FACTS FIG 2013; Banfield DK, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005264; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Fredericks WJ, 2011, DNA CELL BIOL, V30, P851, DOI 10.1089/dna.2011.1315; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Harris SL, 1996, J CELL BIOL, V132, P985, DOI 10.1083/jcb.132.6.985; Jackson CL, 2009, J CELL SCI, V122, P443, DOI 10.1242/jcs.032581; Kotting C, 2008, P NATL ACAD SCI USA, V105, P6260, DOI 10.1073/pnas.0712095105; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; LEELAVATHI DE, 1970, BIOCHIM BIOPHYS ACTA, V211, P124, DOI 10.1016/0005-2736(70)90087-8; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LIPSKY NG, 1985, SCIENCE, V228, P745, DOI 10.1126/science.2581316; Mayinger P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005314; McGarvey TW, 2005, J CELL BIOCHEM, V95, P419, DOI 10.1002/jcb.20432; McGarvey TW, 2003, PROSTATE, V54, P144, DOI 10.1002/pros.10174; McGarvey TW, 2001, ONCOGENE, V20, P1042, DOI 10.1038/sj.onc.1204143; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Mugoni V, 2013, CELL, V152, P504, DOI 10.1016/j.cell.2013.01.013; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; Nickerson ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010760; Okamoto M, 2008, EUKARYOT CELL, V7, P310, DOI 10.1128/EC.00333-07; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Sato K, 2004, J BIOCHEM, V136, P755, DOI 10.1093/jb/mvh184; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Shearer MJ, 2008, THROMB HAEMOSTASIS, V100, P530, DOI 10.1160/TH08-03-0147; Todorow Z, 2000, P NATL ACAD SCI USA, V97, P13643, DOI 10.1073/pnas.250472397; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Weiss JS, 2008, AM J MED GENET A, V146A, P271, DOI 10.1002/ajmg.a.32201; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; Weiss JS, 2010, CORNEA, V29, P777, DOI 10.1097/ICO.0b013e3181c84bcf; Wu CC, 2000, TRAFFIC, V1, P769, DOI 10.1034/j.1600-0854.2000.011004.x; Yellore VS, 2007, MOL VIS, V13, P1777	41	18	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72015	10.1371/journal.pone.0072015	http://dx.doi.org/10.1371/journal.pone.0072015			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977195	Green Submitted, gold, Green Published			2022-12-25	WOS:000323425700120
J	Wragg, D; Mwacharo, JM; Alcalde, JA; Wang, C; Han, JL; Gongora, J; Gourichon, D; Tixier-Boichard, M; Hanotte, O				Wragg, David; Mwacharo, Joram M.; Alcalde, Jose A.; Wang, Chen; Han, Jian-Lin; Gongora, Jaime; Gourichon, David; Tixier-Boichard, Michele; Hanotte, Olivier			Endogenous Retrovirus EAV-HP Linked to Blue Egg Phenotype in Mapuche Fowl	PLOS ONE			English	Article							ANION-TRANSPORTING POLYPEPTIDES; TISSUE-SPECIFIC EXPRESSION; VIRUS SUBGROUP-J; HOUSEKEEPING GENES; CHICKENS; CLASSIFICATION; ASSOCIATION; SEQUENCES; FRAMEWORK; PROMOTER	Oocyan or blue/green eggshell colour is an autosomal dominant trait found in native chickens (Mapuche fowl) of Chile and in some of their descendants in European and North American modern breeds. We report here the identification of an endogenous avian retroviral (EAV-HP) insertion in oocyan Mapuche fowl and European breeds. Sequencing data reveals 100% retroviral identity between the Mapuche and European insertions. Quantitative real-time PCR analysis of European oocyan chicken indicates over-expression of the SLCO1B3 gene (P<0.05) in the shell gland and oviduct. Predicted transcription factor binding sites in the long terminal repeats (LTR) indicate AhR/Ar, a modulator of oestrogen, as a possible promoter/enhancer leading to reproductive tissue-specific over-expression of the SLCO1B3 gene. Analysis of all jungle fowl species Gallus sp. supports the retroviral insertion to be a post-domestication event, while identical LTR sequences within domestic chickens are in agreement with a recent de novo mutation.	[Wragg, David; Mwacharo, Joram M.; Hanotte, Olivier] Univ Nottingham, Ctr Genet & Genom, Sch Biol, Nottingham NG7 2RD, England; [Alcalde, Jose A.] Pontificia Univ Catolica Chile, Fac Agron & Ingn Forestal, Santiago, Chile; [Wang, Chen; Han, Jian-Lin] Chinese Acad Agr Sci, CAAS ILRI Joint Lab Livestock & Forage Genet Reso, Inst Anim Sci, Beijing 100193, Peoples R China; [Han, Jian-Lin] Int Livestock Res Inst, Nairobi, Kenya; [Gongora, Jaime] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Gourichon, David] INRA, Poultry Expt Platform Tours UE1295, Nouzilly, France; [Tixier-Boichard, Michele] AgroParisTech, Inst Natl Rech Agron, Anim Genet & Integrat Biol UMR1313, Jouy En Josas, France	University of Nottingham; Pontificia Universidad Catolica de Chile; CGIAR; International Livestock Research Institute (ILRI); Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; CGIAR; International Livestock Research Institute (ILRI); University of Sydney; INRAE; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Hanotte, O (corresponding author), Univ Nottingham, Ctr Genet & Genom, Sch Biol, Univ Pk, Nottingham NG7 2RD, England.	olivier.hanotte@nottingham.ac.uk	Alcalde, Jose/AAA-5698-2020	Wragg, David/0000-0002-4007-953X; Gongora, Jaime/0000-0003-2215-656X; Hanotte, Olivier/0000-0002-2877-4767	BBSRC [BH/H009051/1]; Chinese Government	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Chinese Government	Funding for this study was made possible through a BBSRC PhD fellowship to the first author and a BBSRC research grant (BH/H009051/1) to the last author, as well as the Chinese Government contribution to the CAAS-ILRI Joint Laboratory on Livestock and Forage Genetic Resources. The Roslin Institute is supported by a core strategic grant from the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACON LD, 1988, POULTRY SCI, V67, P191, DOI 10.3382/ps.0670191; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Bolisetty M, 2012, MBIO, V3, DOI 10.1128/mBio.00344-12; Borisenko L, 2004, FOLIA BIOL-PRAGUE, V50, P136; Borisenko L, 2003, FOLIA BIOL-PRAGUE, V49, P177; Cassey P, 2012, BIOL J LINN SOC, V106, P657, DOI 10.1111/j.1095-8312.2012.01877.x; Cassey P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012054; Castello S., 1924, 2 C EXP MUND AV BARC, P109; Chang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-19; Cheng XG, 2005, DRUG METAB DISPOS, V33, P1276, DOI 10.1124/dmd.105.003988; Dalton TP, 2002, CHEM-BIOL INTERACT, V141, P77, DOI 10.1016/S0009-2797(02)00067-4; De Boever S, 2008, VET IMMUNOL IMMUNOP, V122, P312, DOI 10.1016/j.vetimm.2007.12.002; Delacour J., 1977, PHEASANTS WORLD; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desfarges S, 2010, VIRUSES-BASEL, V2, P111, DOI 10.3390/v2010111; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gao YS, 2008, S AFR J ANIM SCI, V38, P193; Gongora J, 2008, P NATL ACAD SCI USA, V105, P10308, DOI 10.1073/pnas.0801991105; Gorchein A, 2009, BIOMED CHROMATOGR, V23, P602, DOI 10.1002/bmc.1158; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; HANAFUSA H, 1963, P NATL ACAD SCI USA, V49, P572, DOI 10.1073/pnas.49.4.572; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Igic B, 2010, CHEMOECOLOGY, V20, P43, DOI 10.1007/s00049-009-0038-2; Jeong W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049204; KENNEDY GY, 1976, COMP BIOCHEM PHYS B, V55, P117, DOI 10.1016/0305-0491(76)90183-8; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; Lee JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034215; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim W, 2012, GEN COMP ENDOCR, V175, P65, DOI 10.1016/j.ygcen.2011.09.019; Lin JT, 2012, DEV GENES EVOL, V222, P369, DOI 10.1007/s00427-012-0420-x; MATSUMINE H, 1991, J BIOL CHEM, V266, P19900; Maurer G, 2011, J AVIAN BIOL, V42, P494, DOI 10.1111/j.1600-048X.2011.05368.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Moreno J, 2005, BEHAV ECOL, V16, P931, DOI 10.1093/beheco/ari072; Ohtake F, 2008, BIOCHEM BIOPH RES CO, V370, P541, DOI 10.1016/j.bbrc.2008.03.054; Punnett RC, 1933, J GENET, V27, P465, DOI 10.1007/BF02981757; RUDDELL A, 1995, VIROLOGY, V206, P1, DOI 10.1016/S0042-6822(95)80013-1; Sacco MA, 2004, J VIROL, V78, P10525, DOI 10.1128/JVI.78.19.10525-10535.2004; Sacco MA, 2000, J VIROL, V74, P1296, DOI 10.1128/JVI.74.3.1296-1306.2000; Sacco MA, 2001, J VIROL, V75, P11935, DOI 10.1128/JVI.75.23.11935-11938.2001; Sacco MA, 2001, J VIROL, V75, P2029, DOI 10.1128/JVI.75.4.2029-2032.2001; SAMUELSON LC, 1988, NUCLEIC ACIDS RES, V16, P8261, DOI 10.1093/nar/16.17.8261; Sindi S, 2009, BIOINFORMATICS, V25, pI222, DOI 10.1093/bioinformatics/btp208; TING CN, 1992, GENE DEV, V6, P1457, DOI 10.1101/gad.6.8.1457; Wang ZP, 2011, POULTRY SCI, V90, P836, DOI 10.3382/ps.2010-01143; Wang ZP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003183; Washburn K W., 1990, POULTRY BREEDING GEN, P781; Wragg D, 2012, HEREDITY, V109, P6, DOI 10.1038/hdy.2012.9; Zhao R, 2006, POULTRY SCI, V85, P546, DOI 10.1093/ps/85.3.546	51	37	42	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71393	10.1371/journal.pone.0071393	http://dx.doi.org/10.1371/journal.pone.0071393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990950	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000323425700046
J	Besnard, A; Caboche, J; Laroche, S				Besnard, Antoine; Caboche, Jocelyne; Laroche, Serge			Recall and Reconsolidation of Contextual Fear Memory: Differential Control by ERK and Zif268 Expression Dosage	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EARLY GENE ZIF268; AMPA RECEPTOR TRAFFICKING; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; MOLECULAR-MECHANISMS; RECOGNITION MEMORY; POTASSIUM CHANNEL; LATERAL AMYGDALA; COCAINE-SEEKING	Compelling evidence points to the existence of independent cellular processes involved in the consolidation and reconsolidation of memory. For instance, a double dissociation has been reported between hippocampal Extracellular-Regulated Kinase-1/2 (ERK1/2) activity being necessary for contextual fear conditioning (CFC) consolidation but not reconsolidation. Conversely, hippocampal expression of the immediate early gene Zif268 is necessary for CFC reconsolidation but not consolidation. Since we previously reported that ERK1/2 controls the transcription of Zif268 in the hippocampus, we examined the precise role of ERK1/2 activity and Zif268 gene expression dosage in CFC memory processing. For this, we first assessed performance of Zif268 homozygous and heterozygous mutant mice in a CFC paradigm. Whereas Zif268-/- mice displayed a deficit of both consolidation and reconsolidation, Zif268+/- mice displayed a selective deficit of reconsolidation only, therefore pointing to the relationship between Zif268 gene expression dosage and CFC memory processing. Zif268 gene expression dosage interfered with the reconsolidation process if and only if CFC memory was relatively recently encoded and directly reactivated. Furthermore, CFC memory strengthening previously reported to involve Zif268 expression in the hippocampus was spared in Zif268+/- mice. Finally, blocking ERK1/2 activity prior to CFC retrieval prevented the deficit of reconsolidation observed in Zif268+/- mice. Collectively, these results highlight a tight relationship between Zif268 gene expression dosage and CFC memory processing. They also suggest that ERK1/2 activity upon CFC memory recall is necessary for its retrieval, a prerequisite for its reactivation and subsequent reconsolidation.	[Besnard, Antoine; Caboche, Jocelyne] INSERM, UMRS Physiopathol Malad Syst Nerveux Cent 952, Paris, France; [Besnard, Antoine; Caboche, Jocelyne] CNRS, Physiopathol Malad Syst Nerveux Cent UMR7224, Paris, France; [Besnard, Antoine; Caboche, Jocelyne] Univ Paris 06, Paris, France; [Laroche, Serge] Univ Paris 11, Ctr Neurosci Paris Sud, Orsay, France; [Laroche, Serge] CNRS, UMR 8195, F-91405 Orsay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet	Besnard, A (corresponding author), Ctr Regenerat Med, Harvard Stem Cell Inst, Boston, MA USA.	besnard.antoine@mgh.harvard.edu	Besnard, Antoine/H-4270-2019	Besnard, Antoine/0000-0002-0929-8873	Centre National de la Recherche Scientifique; Agence Nationale pour la Recherche [ANR-08-BLAN]; Edmond Rothschild Chemical Dependency Institute Beth Israel Medical center; Fondation pour la Recherche Medicale; Fondation Jerome Lejeune	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Edmond Rothschild Chemical Dependency Institute Beth Israel Medical center; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Jerome Lejeune	This work has been supported by the "Centre National de la Recherche Scientifique", l' "Agence Nationale pour la Recherche" (ANR-08-BLAN). AB has been supported by the Edmond Rothschild Chemical Dependency Institute Beth Israel Medical center and Fondation pour la Recherche Medicale and the "Fondation Jerome Lejeune http://www.fondationlejeune.org." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anokhin KV, 2002, EUR J NEUROSCI, V15, P1759, DOI 10.1046/j.1460-9568.2002.02023.x; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Baumgartel K, 2008, NAT NEUROSCI, V11, P572, DOI 10.1038/nn.2113; Besnard A, 2012, PROG NEUROBIOL, V99, P61, DOI 10.1016/j.pneurobio.2012.07.002; Boccia MM, 2006, LEARN MEMORY, V13, P376, DOI 10.1101/lm.150306; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Bozon B, 2002, HIPPOCAMPUS, V12, P570, DOI 10.1002/hipo.10100; Bustos SG, 2006, NEUROSCIENCE, V139, P831, DOI 10.1016/j.neuroscience.2005.12.064; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; Cheval H, 2012, HIPPOCAMPUS, V22, P631, DOI 10.1002/hipo.20926; Davis S, 2003, BEHAV BRAIN RES, V142, P17, DOI 10.1016/S0166-4328(02)00421-7; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Davis S, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00177; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Debiec J, 2006, P NATL ACAD SCI USA, V103, P3428, DOI 10.1073/pnas.0507168103; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Doyere V, 2007, NAT NEUROSCI, V10, P414, DOI 10.1038/nn1871; Duvarci S, 2005, EUR J NEUROSCI, V21, P283, DOI 10.1111/j.1460-9568.2004.03824.x; Eisenberg M, 2004, EUR J NEUROSCI, V20, P3397, DOI 10.1111/j.1460-9568.2004.03818.x; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Fischer A, 2007, NEUROBIOL LEARN MEM, V87, P149, DOI 10.1016/j.nlm.2006.08.003; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; HAYCOCK JW, 1992, P NATL ACAD SCI USA, V89, P2365, DOI 10.1073/pnas.89.6.2365; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Kwon JT, 2012, LEARN MEMORY, V19, P487, DOI 10.1101/lm.025502.112; Lee JLC, 2006, J NEUROSCI, V26, P5881, DOI 10.1523/JNEUROSCI.0323-06.2006; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Lee JL, 2013, HIPPOCAMPUS, V23, P233, DOI 10.1002/hipo.22083; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Lonergan ME, 2010, NEURAL PLAST, V2010, P1, DOI 10.1155/2010/139891; MACTUTUS CF, 1979, SCIENCE, V204, P1319, DOI 10.1126/science.572083; Maddox SA, 2011, LEARN MEMORY, V18, P24, DOI 10.1101/lm.1980211; Malkani S, 2004, LEARN MEMORY, V11, P617, DOI 10.1101/lm.73104; Malkani S, 2000, NEUROSCIENCE, V97, P693, DOI 10.1016/S0306-4522(00)00058-0; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; McGahon B, 1999, NEUROSCIENCE, V90, P1167, DOI 10.1016/S0306-4522(98)00528-4; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Murav'eva E V, 2007, Neurosci Behav Physiol, V37, P411, DOI 10.1007/s11055-007-0028-1; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Thomas KL, 2002, EUR J NEUROSCI, V16, P1789, DOI 10.1046/j.1460-9568.2002.02247.x; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Valjent E, 2006, J NEUROSCI, V26, P4956, DOI 10.1523/JNEUROSCI.4601-05.2006; Wang SH, 2009, NAT NEUROSCI, V12, P905, DOI 10.1038/nn.2350; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	67	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72006	10.1371/journal.pone.0072006	http://dx.doi.org/10.1371/journal.pone.0072006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977192	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200051
J	Mo, ML; Okamoto, J; Chen, Z; Hirata, T; Mikami, I; Bosco-Clement, G; Li, H; Zhou, HM; Jablons, DM; He, BA				Mo, Min-Li; Okamoto, Junichi; Chen, Zhao; Hirata, Tomomi; Mikami, Iwao; Bosco-Clement, Genevieve; Li, Hui; Zhou, Hai-Meng; Jablons, David M.; He, Biao			Down-Regulation of SIX3 is Associated with Clinical Outcome in Lung Adenocarcinoma	PLOS ONE			English	Article							BRONCHIOLOALVEOLAR CARCINOMA; PROMOTER HYPERMETHYLATION; CANCER STATISTICS; PREDICT SURVIVAL; S100 PROTEINS; CELL; GENE; EXPRESSION; METHYLATION; FAMILY	Background: Lung cancer is a common cancer and the leading cause of cancer-related death worldwide. SIX3 is a human homologue of the highly conserved sine oculis gene family essential during embryonic development in vertebrates, and encodes a homeo-domain containing transcription factor. Little is known about the role of SIX3 in human tumorigenesis. This study is to assess the expression/function of SIX3 and the significance of SIX3 as a prognostic biomarker in lung adenocarcinoma. Methods: Quantitative real-time RT-PCR was used to analyze SIX3 mRNA expression and quantitative methylation specific PCR (MSP) was used to examine promoter methylation. MTS and colony formation assays were performed to examine cell proliferation. Wound healing assays were used to assess cell migration, and microarrays were utilized to examine genes regulated by SIX3 in lung cancer cells. Association of SIX3 expression levels with clinical outcomes of patients with lung adenocarcinoma was evaluated using the Kaplan-Meier method and a multivariate Cox proportional hazards regression model. Results: SIX3 was down-regulated in lung adenocarcinoma tissues compared to their matched adjacent normal tissues, and this down-regulation was associated with methylation of the SIX3 promoter. SIX3 was also methylation-silenced in lung cancer cell lines. Restoration of SIX3 in lung cancer cells lacking endogenous SIX3 suppressed cell proliferation and migration, and downregulated a number of genes involved in proliferation and metastasis such as S100P, TGFB3, GINS3 and BAG1. Moreover, SIX3 mRNA expression was associated with significantly improved overall survival (OS) and progression-free survival (PFS) in adenocarcinoma patients and patients with bronchioloalveolar carcinoma (BAC) features. Conclusions: SIX3 may play an important role as a novel suppressor in human lung cancer. SIX3 has potential as a novel prognostic biomarker for patients with lung adenocarcinomas.	[Mo, Min-Li; Chen, Zhao; Zhou, Hai-Meng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Okamoto, Junichi; Chen, Zhao; Hirata, Tomomi; Mikami, Iwao; Bosco-Clement, Genevieve; Li, Hui; Jablons, David M.; He, Biao] Univ Calif San Francisco, Dept Surg, Helen Diller Family Comprehens Canc Ctr, Thorac Oncol Program, San Francisco, CA USA; [Okamoto, Junichi; Hirata, Tomomi; Mikami, Iwao] Nippon Med Sch, Div Thorac Surg, Dept Surg, Tokyo 113, Japan; [Zhou, Hai-Meng] Tsinghua Univ, Yangtze Delta Reg Inst, Zhejiang Prov Key Lab Appl Enzymol, Jiaxing, Peoples R China	Tsinghua University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Nippon Medical School; Tsinghua University	Zhou, HM (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	zhm-dbs@mail.tsinghua.edu.cn; biao.he@ucsfmedctr.org			Joan's Legacy: Uniting Against Lung Cancer Research Grant; National Institutes of Health/NCI [R01CA125030]; Eileen D. Ludwig Endowed for Thoracic Oncology Research; Bonnie J. Addario Lung Cancer Foundation; Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Oberman, Satterley & Bosl Foundation; Barbara Isackson Lung Cancer Research Fund; National Key Basic Research and Development (973) Program of China [2011CB910800, 2012CB917304]; China Natural Science Foundation [31170732, 31270854]; Natural Science Foundation of Zhejiang Province [Y204499]	Joan's Legacy: Uniting Against Lung Cancer Research Grant; National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eileen D. Ludwig Endowed for Thoracic Oncology Research; Bonnie J. Addario Lung Cancer Foundation; Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Oberman, Satterley & Bosl Foundation; Barbara Isackson Lung Cancer Research Fund; National Key Basic Research and Development (973) Program of China(National Basic Research Program of China); China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by Joan's Legacy: Uniting Against Lung Cancer Research Grant; National Institutes of Health/NCI R01CA125030; the Eileen D. Ludwig Endowed for Thoracic Oncology Research; The Bonnie J. Addario Lung Cancer Foundation; the Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Oberman, Satterley & Bosl Foundation; the Barbara Isackson Lung Cancer Research Fund; the National Key Basic Research and Development (973) Program of China (No. 2011CB910800 and No. 2012CB917304); the China Natural Science Foundation (No. 31170732 and No. 31270854); and the Natural Science Foundation of Zhejiang Province (No. Y204499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bianchi F, 2007, J CLIN INVEST, V117, P3436, DOI 10.1172/JCI32007; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Coate LE, 2009, LANCET ONCOL, V10, P1001, DOI 10.1016/S1470-2045(09)70155-X; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Fackler MJ, 2004, CANCER RES, V64, P4442, DOI 10.1158/0008-5472.CAN-03-3341; Ganesan K, 2008, CANCER RES, V68, P4277, DOI 10.1158/0008-5472.CAN-07-6517; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gridelli C, 2007, J CLIN ONCOL, V25, P1898, DOI 10.1200/JCO.2006.10.3085; Grote HJ, 2006, CANCER CYTOPATHOL, V108, P129, DOI 10.1002/cncr.21717; Grote HJ, 2005, INT J CANCER, V116, P720, DOI 10.1002/ijc.21090; Harden SV, 2003, CLIN CANCER RES, V9, P1370; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; HOLM S, 1979, SCAND J STAT, V6, P65; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kempkensteffen C, 2006, J CANCER RES CLIN, V132, P765, DOI 10.1007/s00432-006-0124-6; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Lau SK, 2007, J CLIN ONCOL, V25, P5562, DOI 10.1200/JCO.2007.12.0352; Liu HY, 2010, CANCER BIOL THER, V9, P832, DOI 10.4161/cbt.9.10.11589; Lopez-Rios J, 2003, DEVELOPMENT, V130, P185, DOI 10.1242/dev.00185; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Nagahama Y, 2010, BIOCHEM BIOPH RES CO, V392, P150, DOI 10.1016/j.bbrc.2009.12.174; Okamoto J, 2011, CLIN LUNG CANCER, V12, P237, DOI 10.1016/j.cllc.2011.03.025; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Petrella BL, 2012, CANCER LETT, V325, P220, DOI 10.1016/j.canlet.2012.07.009; Ramirez de Molina A, 2007, LANCET ONCOL, V8, P889, DOI 10.1016/S1470-2045(07)70279-6; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Raz DJ, 2007, CURR OPIN PULM MED, V13, P290, DOI 10.1097/MCP.0b013e32816ebc62; Raz DJ, 2006, CLIN CANCER RES, V12, P3698, DOI 10.1158/1078-0432.CCR-06-0457; Raz DJ, 2006, CLIN LUNG CANCER, V7, P313, DOI 10.3816/CLC.2006.n.012; Reed CE, 2008, J THORAC CARDIOV SUR, V135, P627, DOI 10.1016/j.jtcvs.2007.10.058; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Therneau TM., 2015, INTRO RECURSIVE PART; Wang L, 2002, CLIN CANCER RES, V8, P2883; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	39	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71816	10.1371/journal.pone.0071816	http://dx.doi.org/10.1371/journal.pone.0071816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977152	Green Submitted, gold, Green Published			2022-12-25	WOS:000323570200048
J	Schulte-Herbruggen, B; Cowlishaw, G; Homewood, K; Rowcliffe, JM				Schulte-Herbrueggen, Bjoern; Cowlishaw, Guy; Homewood, Katherine; Rowcliffe, J. Marcus			The Importance of Bushmeat in the Livelihoods of West African Cash-Crop Farmers Living in a Faunally-Depleted Landscape	PLOS ONE			English	Article							RAIN-FOREST USE; TROPICAL FORESTS; WILD MEAT; STRATEGIES; INCOME; DIVERSIFICATION; CONSERVATION; DECLINES; INSIGHTS; VILLAGE	Bushmeat is an important resource in the livelihoods of many rural communities in sub-Saharan Africa and may be a crucial safety-net for the most vulnerable households, especially during times of economic hardship. However, little is known about the impacts of wildlife depletion on these functions. This study quantifies the role of bushmeat in diversified rural household economies in a wildlife depleted forest-farm landscape in Ghana, assessing its importance overall, as well as differentiated by the relative vulnerability of households. Using repeat socioeconomic questionnaires (N=787) among 63 households over a one-year period, the following hypotheses were tested: (a) vulnerable households harvest more bushmeat; (b) bushmeat contributes a greater proportion of household production in vulnerable households; (c) bushmeat is more important for cash income than consumption in vulnerable households; and (d) bushmeat sales are more important for vulnerable households. The bushmeat harvest value averaged less than US$1.0 per day for 89% of households and comprised less than 7% of household production value. Household wealth and gender of the household head had little effect on the importance of bushmeat. However, bushmeat harvest and sales were highest during the agricultural lean season. Overall, most harvested bushmeat (64%) was consumed, enabling households to spend 30% less on meat/fish purchases. These findings suggest that, despite heavily depleted wildlife and diversified livelihoods, bushmeat continues to have an important role in rural livelihoods by acting as a safety net for income smoothing and reducing household expenditure during times of economic hardship.	[Schulte-Herbrueggen, Bjoern; Cowlishaw, Guy; Rowcliffe, J. Marcus] Zool Soc London, Inst Zool, London NW1 4RY, England; [Schulte-Herbrueggen, Bjoern; Homewood, Katherine] UCL, Dept Anthropol, London, England	Zoological Society of London; University of London; University College London	Schulte-Herbruggen, B (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	bsh103@gmail.com	Rowcliffe, Marcus/G-3713-2018; Homewood, Katherine/K-6151-2019	Rowcliffe, Marcus/0000-0002-4286-6887; Homewood, Katherine/0000-0001-7391-985X	Economic and Social Research Council/NERC; Parkes Foundation	Economic and Social Research Council/NERC; Parkes Foundation	This work was supported by an Economic and Social Research Council/NERC research studentship (http://www.nerc.ac.uk/funding/available/postgrad/schemes/jointesrc.asp) with additional support from The Parkes Foundation (http://www.parkesfoundation.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AKAIKE H, 1973, 2 INT S INF THEOR, P268; Ambrose-Oji B, 2003, INT FOREST REV, V5, P106, DOI 10.1505/IFOR.5.2.106.17420; ANADU PA, 1988, HUM ECOL, V16, P199, DOI 10.1007/BF00888092; [Anonymous], 1992, LIT REV ANNOTATED BI; Arnold J. E. M., 1998, Incomes from the forest: methods for the development and conservation of forest products for local communities., P17; Bank World, 2004, SUST FOR DEV STRAT; Bassett TJ, 2005, GEOGR J, V171, P24, DOI 10.1111/j.1475-4959.2005.00147.x; Bates D., 2009, IME4 LINEAR MIXED EF; Bennett EL, 2002, CONSERV BIOL, V16, P590, DOI 10.1046/j.1523-1739.2002.01637.x; Bowen-Jones E., 2002, ASSESSMENT SOLUTION; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Brooks SE, 2008, THESIS U E ANGLIA; Brooks S, 2008, HUM ECOL, V36, P835, DOI 10.1007/s10745-008-9205-2; Brown D, 2003, INT FOREST REV, V5, P148, DOI 10.1505/IFOR.5.2.148.17414; Brown D, 2007, CONSERV SCI PRACT, V2, P111; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Campbell B.M., 2002, UNCOVERING HIDDEN HA, P1; Cavendish W, 1999, POVERTY INEQUALITY E; Chenevix Trench P, 1997, THESIS U COLL LONDON; Coad L, 2010, CONSERV BIOL, V24, P1510, DOI 10.1111/j.1523-1739.2010.01525.x; Coomes OT, 2004, ECOL ECON, V51, P47, DOI 10.1016/j.ecolecon.2004.04.004; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; Cowlishaw G, 2005, CONSERV BIOL, V19, P139; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Crookes D, 2007, S AFR J ECON MANAG S, V10, P457; Davies G, 2007, CONSERV SCI PRACT, V2, P15; de Merode E, 2004, BIOL CONSERV, V118, P573, DOI 10.1016/j.biocon.2003.10.005; DEI GJS, 1989, ECOL FOOD NUTR, V22, P225, DOI 10.1080/03670244.1989.9991071; Ellis F, 2000, J AGR ECON, V51, P289, DOI 10.1111/j.1477-9552.2000.tb01229.x; ESPA, 2010, COS SERV POV ALL PRO; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Falconer J, 1994, NONTIMBER FOREST PRO; Falconer J., 1990, MAJOR SIGNIFICANCE M; Gabre-Madhin EZ, 2004, WORLD DEV, V32, P745, DOI 10.1016/j.worlddev.2003.11.004; Gavin MC, 2010, CONSERV BIOL, V24, P89, DOI 10.1111/j.1523-1739.2009.01387.x; Godoy R, 2010, ANIM CONSERV, V13, P265, DOI 10.1111/j.1469-1795.2009.00330.x; Grandin BE, 1988, WEALTH RANKING SMALL, P49; Gyimah-Brempong K, 1993, J EC DEV, V18, P187; Hainmueller J., 2011, SUSTAINABLE DEV COCO; Hill Polly, 1956, GOLD COAST COCOA FAR; Hodasi JKM, 1995, SNAILS NATL EC; IFAD, 2001, ASS RUR POV W CENTR; Kumpel NF, 2009, ANIM CONSERV, V12, P531, DOI 10.1111/j.1469-1795.2009.00279.x; Kumpel NF, 2010, HUM ECOL, V38, P251, DOI 10.1007/s10745-010-9316-4; Leon P, 2008, HUM ECOL, V36, P249, DOI 10.1007/s10745-007-9139-0; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Nielsen MR, 2006, BIOL CONSERV, V128, P509, DOI 10.1016/j.biocon.2005.10.017; Noss AJ, 1997, HUM ECOL, V25, P71, DOI 10.1023/A:1021935903440; Noss AJ, 1998, ENVIRON CONSERV, V25, P228, DOI 10.1017/S0376892998000289; Ntiamoa-Baidu Y, 1998, SUST HARV PROD US; Okali C, 1975, DOMINASE MOBILE COCO, P35; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Perry RI, 2007, MAR POLICY, V31, P125, DOI 10.1016/j.marpol.2006.05.011; R Development Core Team, 2009, R FDN STAT COMP; Reardon T, 1997, WORLD DEV, V25, P735, DOI 10.1016/S0305-750X(96)00137-4; Roe D., 2010, LINKING BIODIVERSITY; Schulte-Herbruggen B., 2011, THESIS U COLL LONDON; Smith L. E. D., 2005, Water Policy, V7, P359; Starkey M., 2004, THESIS CAMBRIDGE U U; Sukhdev P, 2010, TEEB SYNTHESIS REPOR; Takasaki Y, 2004, ENVIRON DEV ECON, V9, P203, DOI 10.1017/S1355770X03001232; Takasaki Y, 2001, SOC NATUR RESOUR, V14, P291, DOI 10.1080/08941920151080237; Tieguhong J.C., 2009, J HORTIC FOR, V1, P65; Turnbull C.M., 1968, FOREST PEOPLE; Upton M., 1996, EC TROPICAL FARMING; Whitham C., 2009, THESIS IMPERIAL COLL; Wickramasinghe A, 1996, HUM ECOL, V24, P493, DOI 10.1007/BF02168864; Zuur Alain F., 2009, P1	69	53	54	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72807	10.1371/journal.pone.0072807	http://dx.doi.org/10.1371/journal.pone.0072807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	207BA	23977355	Green Submitted, Green Published, gold			2022-12-25	WOS:000323570200084
J	Perrachione, TK; Fedorenko, EG; Vinke, L; Gibson, E; Dilley, LC				Perrachione, Tyler K.; Fedorenko, Evelina G.; Vinke, Louis; Gibson, Edward; Dilley, Laura C.			Evidence for Shared Cognitive Processing of Pitch in Music and Language	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; CONGENITAL AMUSIA; HUMAN BRAIN; SYNTACTIC STRUCTURE; PATTERNS; SPEECH; DISCRIMINATION; DISAMBIGUATION; SENSITIVITY; EXPERIENCE	Language and music epitomize the complex representational and computational capacities of the human mind. Strikingly similar in their structural and expressive features, a longstanding question is whether the perceptual and cognitive mechanisms underlying these abilities are shared or distinct - either from each other or from other mental processes. One prominent feature shared between language and music is signal encoding using pitch, conveying pragmatics and semantics in language and melody in music. We investigated how pitch processing is shared between language and music by measuring consistency in individual differences in pitch perception across language, music, and three control conditions intended to assess basic sensory and domain-general cognitive processes. Individuals' pitch perception abilities in language and music were most strongly related, even after accounting for performance in all control conditions. These results provide behavioral evidence, based on patterns of individual differences, that is consistent with the hypothesis that cognitive mechanisms for pitch processing may be shared between language and music.	[Perrachione, Tyler K.; Fedorenko, Evelina G.; Gibson, Edward] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Vinke, Louis] Bowling Green State Univ, Dept Psychol, Bowling Green, OH 43403 USA; [Dilley, Laura C.] Michigan State Univ, Dept Communicat Sci & Disorders, E Lansing, MI 48824 USA	Massachusetts Institute of Technology (MIT); University System of Ohio; Bowling Green State University; Michigan State University	Perrachione, TK (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	tkp@bu.edu; evelina9@mit.edu	Fedorenko, Evelina/I-9868-2017	Fedorenko, Evelina/0000-0003-3823-514X	National Science Foundation; National Institute of Child Health and Human Development [5K99HD057522]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K99HD057522] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	TKP was supported by an National Science Foundation Graduate Research Fellowship; EGF is supported by grant 5K99HD057522 from National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ML, 2010, BEHAV BRAIN SCI, V33, P245, DOI 10.1017/S0140525X10000853; [Anonymous], 2014, TONE LINGUISTIC SURV; BEACH CM, 1991, J MEM LANG, V30, P644, DOI 10.1016/0749-596X(91)90030-N; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; Boersma P, 2001, GLOT INT, V5, P341; Breen M, 2010, LANG COGNITIVE PROC, V25, P1044, DOI 10.1080/01690965.2010.504378; Cross I, 2009, MUSIC SCI, P179; Darwin C., 1874, DESCENT MAN SELECTIO; Darwin CJ, 2003, J ACOUST SOC AM, V114, P2913, DOI 10.1121/1.1616924; Fedorenko E, 2012, J NEUROPHYSIOL, V108, P3289, DOI 10.1152/jn.00209.2012; Fedorenko E, 2011, P NATL ACAD SCI USA, V108, P16428, DOI 10.1073/pnas.1112937108; Fisher R, 1921, METRON, V1, P1, DOI DOI 10.1093/BIOMET/9.1-2.22; Fitch WT, 2006, COGNITION, V100, P173, DOI 10.1016/j.cognition.2005.11.009; GRIER JB, 1971, PSYCHOL BULL, V75, P424, DOI 10.1037/h0031246; Handel S., 1989, LISTENING INTRO PERC, DOI DOI 10.2307/898748; Hutchins S, 2010, J ACOUST SOC AM, V127, P504, DOI 10.1121/1.3270391; Jackendoff R, 2006, COGNITION, V100, P33, DOI 10.1016/j.cognition.2005.11.005; JOHNSON DM, 1987, J ACOUST SOC AM, V81, P427, DOI 10.1121/1.394907; Karlin JE, 1942, PSYCHOMETRIKA, V7, P251, DOI 10.1007/BF02288628; Kidd GR, 2007, J ACOUST SOC AM, V122, P418, DOI 10.1121/1.2743154; Koelsch S, 2011, PHYS LIFE REV, V8, P89, DOI 10.1016/j.plrev.2011.04.004; Kraljic T, 2005, COGNITIVE PSYCHOL, V50, P194, DOI 10.1016/j.cogpsych.2004.08.002; Krumbholz K, 2000, J ACOUST SOC AM, V108, P1170, DOI 10.1121/1.1287843; KRUMHANSL CL, 1982, MEM COGNITION, V10, P243, DOI 10.3758/BF03197636; Ladd DR, 2008, CAMB STUD LINGUIST, V79, P1; LERDAHL F, 1977, J MUSIC THEORY, V21, P111, DOI 10.2307/843480; Lerdahl F., 1983, GENERATIVE GRAMMAR T; Luo H, 2006, P NATL ACAD SCI USA, V103, P19558, DOI 10.1073/pnas.0607065104; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; MILLER GA, 1948, J ACOUST SOC AM, V20, P171, DOI 10.1121/1.1906360; MOULINES E, 1990, SPEECH COMMUN, V9, P453, DOI 10.1016/0167-6393(90)90021-Z; Nikjeh DA, 2009, J ACOUST SOC AM, V125, P328, DOI 10.1121/1.3021309; Parbery-Clark A, 2009, EAR HEARING, V30, P653, DOI 10.1097/AUD.0b013e3181b412e9; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Patel AD, 2008, MUSIC PERCEPT, V25, P357, DOI 10.1525/MP.2008.25.4.357; Peretz I, 1997, CAN J EXP PSYCHOL, V51, P354, DOI 10.1037/1196-1961.51.4.354; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; Pinker S., 1997, MIND WORKS; PRICE PJ, 1991, J ACOUST SOC AM, V90, P2956, DOI 10.1121/1.401770; Rogalsky C, 2011, J NEUROSCI, V31, P3843, DOI 10.1523/JNEUROSCI.4515-10.2011; Semal C, 2006, J ACOUST SOC AM, V120, P3907, DOI 10.1121/1.2357708; Slevc LR, 2006, PSYCHOL SCI, V17, P675, DOI 10.1111/j.1467-9280.2006.01765.x; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Spearman C., 1923, NATURE INTELLIGENCE; SPIEGEL MF, 1984, J ACOUST SOC AM, V76, P1690, DOI 10.1121/1.391605; Surprenant AM, 2001, J ACOUST SOC AM, V110, P2085, DOI 10.1121/1.1404973; Tillmann B, 2011, J ACOUST SOC AM, V130, P4089, DOI 10.1121/1.3658447; Tillmann B, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00120; Watson CS, 2002, SEMINARS HEARING, V23, P85; Wier CC, 1997, J ACOUST SOC AM, V61, P174; Wong PCM, 2007, APPL PSYCHOLINGUIST, V28, P565, DOI 10.1017/S0142716407070312; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Wong PCM, 2003, J SPEECH LANG HEAR R, V46, P413, DOI 10.1044/1092-4388(2003/034); Wong PCM, 2002, BRAIN RES BULL, V59, P83, DOI 10.1016/S0361-9230(02)00860-2; Xu YS, 2006, HUM BRAIN MAPP, V27, P173, DOI 10.1002/hbm.20176; Zarate JM, 2012, J ACOUST SOC AM, V132, P984, DOI 10.1121/1.4733535	57	23	23	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e73372	10.1371/journal.pone.0073372	http://dx.doi.org/10.1371/journal.pone.0073372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	204OU	23977386	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000120
J	Wiegmann, EM; Westendorf, E; Kalus, I; Pringle, TH; Lubke, T; Dierks, T				Wiegmann, Elena Marie; Westendorf, Eva; Kalus, Ina; Pringle, Thomas H.; Luebke, Torben; Dierks, Thomas			Arylsulfatase K, a Novel Lysosomal Sulfatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Enzyme Processing; Lysosomal Glycoproteins; Lysosomal Storage Disease; Lysosomes; Protein Sorting; ARSK; Arylsulfatase K; Sulfatase	FORMYLGLYCINE-GENERATING ENZYME; MOLECULAR CHARACTERIZATION; CRYSTAL-STRUCTURE; DEFICIENCY; PROTEINS; MICE; IDENTIFICATION; CONVERSION; MUTATIONS; MECHANISM	Background: Human sulfatases play key roles in physiology and cause numerous pathological conditions upon deficiency/misregulation. Results: ARSK is ubiquitously expressed, localizes to lysosomes, and shows arylsulfatase activity at acidic pH. Conclusion: ARSK is a novel lysosomal sulfatase acting on a ubiquitous substrate. Significance: ARSK functions in lysosomal degradation, possibly of glycosaminoglycans, and, in all probability, is associated with a non-classified lysosomal storage disorder. The human sulfatase family has 17 members, 13 of which have been characterized biochemically. These enzymes specifically hydrolyze sulfate esters in glycosaminoglycans, sulfolipids, or steroid sulfates, thereby playing key roles in cellular degradation, cell signaling, and hormone regulation. The loss of sulfatase activity has been linked to severe pathophysiological conditions such as lysosomal storage disorders, developmental abnormalities, or cancer. A novel member of this family, arylsulfatase K (ARSK), was identified bioinformatically through its conserved sulfatase signature sequence directing posttranslational generation of the catalytic formylglycine residue in sulfatases. However, overall sequence identity of ARSK with other human sulfatases is low (18-22%). Here we demonstrate that ARSK indeed shows desulfation activity toward arylsulfate pseudosubstrates. When expressed in human cells, ARSK was detected as a 68-kDa glycoprotein carrying at least four N-glycans of both the complex and high-mannose type. Purified ARSK turned over p-nitrocatechol and p-nitrophenyl sulfate. This activity was dependent on cysteine 80, which was verified to undergo conversion to formylglycine. Kinetic parameters were similar to those of several lysosomal sulfatases involved in degradation of sulfated glycosaminoglycans. An acidic pH optimum (approximate to 4.6) and colocalization with LAMP1 verified lysosomal functioning of ARSK. Further, it carries mannose 6-phosphate, indicating lysosomal sorting via mannose 6-phosphate receptors. ARSK mRNA expression was found in all tissues tested, suggesting a ubiquitous physiological substrate and a so far non-classified lysosomal storage disorder in the case of ARSK deficiency, as shown before for all other lysosomal sulfatases.	[Wiegmann, Elena Marie; Westendorf, Eva; Kalus, Ina; Luebke, Torben; Dierks, Thomas] Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany; [Pringle, Thomas H.] Sperling Fdn, Eugene, OR 97405 USA	University of Bielefeld	Dierks, T (corresponding author), Univ Bielefeld, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany.	thomas.dierks@uni-bielefeld.de	Dierks, Thomas/A-3596-2012; Lübke, Torben/B-6019-2012	Dierks, Thomas/0000-0001-6426-1339; Lubke, Torben/0000-0002-3342-0090	Deutsche Forschungsgemeinschaft; Shire Human Genetic Therapies Inc. (Lexington, MA)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Shire Human Genetic Therapies Inc. (Lexington, MA)	This work was supported by the Deutsche Forschungsgemeinschaft and Shire Human Genetic Therapies Inc. (Lexington, MA).	Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Chruszcz M, 2003, J INORG BIOCHEM, V96, P386, DOI 10.1016/S0162-0134(03)00176-4; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Dierks T, 1999, EMBO J, V18, P2084, DOI 10.1093/emboj/18.8.2084; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Dierks T, 2009, BBA-MOL CELL RES, V1793, P710, DOI 10.1016/j.bbamcr.2008.11.015; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; FRANCO B, 1995, CELL, V81, P15, DOI 10.1016/0092-8674(95)90367-4; Frese MA, 2008, J BIOL CHEM, V283, P11388, DOI 10.1074/jbc.M709917200; GIESELMANN V, 1983, J CELL BIOL, V97, P1, DOI 10.1083/jcb.97.1.1; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; HASILIK A, 1992, EXPERIENTIA, V48, P130, DOI 10.1007/BF01923507; Hopwood JJ, 2001, METABOLIC MOL BASES, P3725; KOBAYASHI T, 1992, BIOCHIM BIOPHYS ACTA, V1159, P243, DOI 10.1016/0167-4838(92)90051-E; Kollmann K, 2005, PROTEOMICS, V5, P3966, DOI 10.1002/pmic.200401247; Kollmann K, 2009, FEBS J, V276, P1356, DOI 10.1111/j.1742-4658.2009.06877.x; Koppe G., 1978, ARCH DIS CHILD, V53, P803; Kowalewski B, 2012, P NATL ACAD SCI USA, V109, P10310, DOI 10.1073/pnas.1202071109; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Mullerr-Loennies S, 2010, AM J PATHOL, V177, P240, DOI 10.2353/ajpath.2010.090954; Obaya AJ, 2006, GENE, V372, P110, DOI 10.1016/j.gene.2005.12.023; Preusser-Kunze A, 2005, J BIOL CHEM, V280, P14900, DOI 10.1074/jbc.M413383200; Qian MQ, 2008, MOL CELL PROTEOMICS, V7, P58, DOI 10.1074/mcp.M700217-MCP200; Sardiello M, 2005, HUM MOL GENET, V14, P3203, DOI 10.1093/hmg/ddi351; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Sleat DE, 2008, J PROTEOME RES, V7, P3010, DOI 10.1021/pr800135v; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P686, DOI 10.1074/mcp.M500343-MCP200; von Bulow R, 2001, J MOL BIOL, V305, P269, DOI 10.1006/jmbi.2000.4297; Waldow A, 1999, J BIOL CHEM, V274, P12284, DOI 10.1074/jbc.274.18.12284	37	13	15	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30019	30028		10.1074/jbc.M113.499541	http://dx.doi.org/10.1074/jbc.M113.499541			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986440	Green Published, hybrid			2022-12-25	WOS:000329868100003
J	Arapulisamy, O; Mannangatti, P; Jayanthi, LD				Arapulisamy, Obulakshmi; Mannangatti, Padmanabhan; Jayanthi, Lankupalle D.			Regulated Norepinephrine Transporter Interaction with the Neurokinin-1 Receptor Establishes Transporter Subcellular Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Catecholamines; G Protein-coupled Receptors (GPCR); Monoamine Transporters; Plasma Membrane; Protein-protein Interactions; Internalization; Lipid Rafts; Regulation	SUBSTANCE-P; NK1 RECEPTOR; LIPID RAFTS; PHARMACOLOGICAL BLOCKADE; MEMBRANE MICRODOMAINS; SEROTONIN TRANSPORTER; UP-REGULATION; PHOSPHORYLATION; ANTIDEPRESSANT; TRAFFICKING	Neurokinin-1 receptor (NK1R) mediates down-regulation of human norepinephrine (NE) transporter (hNET) via protein kinase C (PKC). However, native NET regulation by NK1R and the mechanism by which NK1R targets NET among other potential effectors are unknown. Effect of NK1R activation on native NET regulation and NET/NK1R interaction were studied using rat brain synaptosomes expressing native NET and NK1R as well as human placental trophoblast (HTR) cells coexpressing WT-hNET or NK1R/PKC-resistant hNET-T258A,S259A double mutant (NET-DM) and hNK1R. The selective NK1R agonist, GR73632, and Substance-P (SP) inhibited NE transport and reduced plasma membrane expression of NET and NK1R. Pretreatment with the NK1R antagonist, EMEND (aprepitant) prevented these NK1R-mediated effects. Immunoprecipitation experiments showed that NET forms stable complexes with NK1R. In HTR cells, combined biotinylation and immunoprecipitation studies revealed plasma membrane localization of NETNK1R complexes. Receptor activation resulted in the internalization of NETNK1R complexes. Lipid raft and immunoprecipitation analyses revealed the presence of NETNK1R complexes exclusively in non-raft membrane fractions under basal/unstimulated conditions. However, NK1R activation led to translocation of NETNK1R complexes to raft-rich membrane fractions. Importantly, PKC was found in association with raft-localized NET following SP treatment. Similar to WT-NET, PKC-resistant NET-DM was found in association with NK1R exclusively in non-raft fractions. However, SP treatment failed to translocate NET-DMNK1R complexes from non-raft fractions to raft fractions. Collectively, these results suggest that NK1R forms physical complexes with NET and that the receptor-mediated Thr(258) + Ser(259) motif-dependent translocation of NETNK1R complexes into raft-rich microdomains facilitates NET/NK1R interaction with PKC to coordinate spatially restricted NET regulation.	[Arapulisamy, Obulakshmi; Mannangatti, Padmanabhan; Jayanthi, Lankupalle D.] Med Univ S Carolina, Div Neurosci Res, Dept Neurosci, Charleston, SC 29425 USA; [Mannangatti, Padmanabhan; Jayanthi, Lankupalle D.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA	Medical University of South Carolina; Virginia Commonwealth University	Jayanthi, LD (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23219 USA.	ljayanthi@vcu.edu			National Institutes of Health from the NIGMS [R01-GM081054]; Virginia Commonwealth University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081054] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Virginia Commonwealth University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM081054 from the NIGMS and the start up fund from Virginia Commonwealth University (to L. D. J.).	Annamalai B, 2012, MOL PHARMACOL, V81, P73, DOI 10.1124/mol.111.073171; Annamalai B, 2010, J NEUROCHEM, V115, P23, DOI 10.1111/j.1471-4159.2010.06898.x; Apparsundaram S, 1998, J PHARMACOL EXP THER, V287, P733; Bauman AL, 2000, J NEUROSCI, V20, P7571; Becher A, 2001, J NEUROCHEM, V79, P787, DOI 10.1046/j.1471-4159.2001.00614.x; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Brocco M, 2008, EUR NEUROPSYCHOPHARM, V18, P729, DOI 10.1016/j.euroneuro.2008.06.002; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Chen R, 2010, FUTUR NEUROL, V5, P123, DOI 10.2217/FNL.09.76; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Fisher AS, 2007, EUR J NEUROSCI, V25, P1195, DOI 10.1111/j.1460-9568.2007.05369.x; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Garcia-Olivares J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059788; Ghisi V, 2009, CELL SIGNAL, V21, P87, DOI 10.1016/j.cellsig.2008.09.011; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; Jasmin L, 2002, P NATL ACAD SCI USA, V99, P1029, DOI 10.1073/pnas.012598599; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Jayanthi LD, 2002, BRIT J PHARMACOL, V135, P1927, DOI 10.1038/sj.bjp.0704658; Jeannotte AM, 2007, EUR J NEUROSCI, V26, P1509, DOI 10.1111/j.1460-9568.2007.05757.x; Johnson LA, 2005, J BIOL CHEM, V280, P10914, DOI 10.1074/jbc.M413887200; Kreibich AS, 2008, J NEUROSCI, V28, P6516, DOI 10.1523/JNEUROSCI.0390-08.2008; Lee FJS, 2007, EMBO J, V26, P2127, DOI 10.1038/sj.emboj.7601656; Lin Z, 2006, HANDB EXP PHARM, V175, P327; Mannangatti P, 2011, J BIOL CHEM, V286, P20239, DOI 10.1074/jbc.M111.226811; Matthies HJG, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-65; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Min MY, 2009, MOL CELL NEUROSCI, V42, P56, DOI 10.1016/j.mcn.2009.05.006; Miyano K, 2010, NEUROCHEM INT, V57, P923, DOI 10.1016/j.neuint.2010.09.012; Monastyrskaya K, 2005, J BIOL CHEM, V280, P7135, DOI 10.1074/jbc.M405806200; Mounir S, 2002, NEUROSCI RES, V44, P71, DOI 10.1016/S0168-0102(02)00087-1; Murphy JE, 2011, AM J PHYSIOL-CELL PH, V301, pC780, DOI 10.1152/ajpcell.00096.2011; Phenna S, 1996, BRIT J PHARMACOL, V119, P315, DOI 10.1111/j.1476-5381.1996.tb15988.x; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Ramnath RD, 2008, AM J PHYSIOL-CELL PH, V294, pC683, DOI 10.1152/ajpcell.00360.2007; Rupniak NMJ, 2001, BEHAV PHARMACOL, V12, P497, DOI 10.1097/00008877-200111000-00011; Rupniak NMJ, 2000, NEUROPHARMACOLOGY, V39, P1413, DOI 10.1016/S0028-3908(00)00052-6; Sager JJ, 2011, BIOCHEMISTRY-US, V50, P7295, DOI 10.1021/bi200405c; Samuvel DJ, 2008, J PHARMACOL EXP THER, V325, P293, DOI 10.1124/jpet.107.130534; Schmidlin F, 2001, J BIOL CHEM, V276, P25427, DOI 10.1074/jbc.M101688200; SCHOMIG E, 1989, N-S ARCH PHARMACOL, V340, P502; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Steiner JA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-26; Sung U, 2005, BIOCHEM BIOPH RES CO, V333, P671, DOI 10.1016/j.bbrc.2005.05.165; Sung U, 2003, J NEUROSCI, V23, P1697; Sung U, 2007, MOL CELL NEUROSCI, V34, P251, DOI 10.1016/j.mcn.2006.11.007; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; TRENDELENBURG U, 1991, TRENDS PHARMACOL SCI, V12, P334; Wang YM, 1999, BIOL PSYCHIAT, V46, P1124, DOI 10.1016/S0006-3223(99)00245-0; Yan TC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/0269881108100255; Yan TC, 2009, NEUROPHARMACOLOGY, V57, P627, DOI 10.1016/j.neuropharm.2009.08.021; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9; Zhu CB, 2011, MOL PHARMACOL, V80, P458, DOI 10.1124/mol.111.071399	54	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28599	28610		10.1074/jbc.M113.472878	http://dx.doi.org/10.1074/jbc.M113.472878			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23979140	Green Published, hybrid			2022-12-25	WOS:000330298800016
J	Boeva, V; Jouannet, S; Daveau, R; Combaret, V; Pierre-Eugene, C; Cazes, A; Louis-Brennetot, C; Schleiermacher, G; Ferrand, S; Pierron, G; Lermine, A; Frio, TR; Raynal, V; Vassal, G; Barillot, E; Delattre, O; Janoueix-Lerosey, I				Boeva, Valentina; Jouannet, Stephanie; Daveau, Romain; Combaret, Valerie; Pierre-Eugene, Cecile; Cazes, Alex; Louis-Brennetot, Caroline; Schleiermacher, Gudrun; Ferrand, Sandrine; Pierron, Gaelle; Lermine, Alban; Frio, Thomas Rio; Raynal, Virginie; Vassal, Gilles; Barillot, Emmanuel; Delattre, Olivier; Janoueix-Lerosey, Isabelle			Breakpoint Features of Genomic Rearrangements in Neuroblastoma with Unbalanced Translocations and Chromothripsis	PLOS ONE			English	Article							CHROMOSOME BREAKPOINTS; MOLECULAR ANALYSIS; PATIENT DISRUPTS; SEQUENCING DATA; ALIGNMENT TOOL; CELL-LINES; 17Q GAIN; GENES; CANCER; REPLICATION	Neuroblastoma is a pediatric cancer of the peripheral nervous system in which structural chromosome aberrations are emblematic of aggressive tumors. In this study, we performed an in-depth analysis of somatic rearrangements in two neuroblastoma cell lines and two primary tumors using paired-end sequencing of mate-pair libraries and RNA-seq. The cell lines presented with typical genetic alterations of neuroblastoma and the two tumors belong to the group of neuroblastoma exhibiting a profile of chromothripsis. Inter and intra-chromosomal rearrangements were identified in the four samples, allowing in particular characterization of unbalanced translocations at high resolution. Using complementary experiments, we further characterized 51 rearrangements at the base pair resolution that revealed 59 DNA junctions. In a subset of cases, complex rearrangements were observed with templated insertion of fragments of nearby sequences. Although we did not identify known particular motifs in the local environment of the breakpoints, we documented frequent microhomologies at the junctions in both chromothripsis and non-chromothripsis associated breakpoints. RNA-seq experiments confirmed expression of several predicted chimeric genes and genes with disrupted exon structure including ALK, NBAS, FHIT, PTPRD and ODZ4. Our study therefore indicates that both non-homologous end joining-mediated repair and replicative processes may account for genomic rearrangements in neuroblastoma. RNA-seq analysis allows the identification of the subset of abnormal transcripts expressed from genomic rearrangements that may be involved in neuroblastoma oncogenesis.	[Boeva, Valentina; Lermine, Alban; Barillot, Emmanuel] INSERM, U900, Paris, France; [Boeva, Valentina; Jouannet, Stephanie; Daveau, Romain; Pierre-Eugene, Cecile; Cazes, Alex; Louis-Brennetot, Caroline; Schleiermacher, Gudrun; Lermine, Alban; Raynal, Virginie; Barillot, Emmanuel; Delattre, Olivier; Janoueix-Lerosey, Isabelle] Inst Curie, Ctr Rech, Paris, France; [Boeva, Valentina; Lermine, Alban; Barillot, Emmanuel] Mines ParisTech, Fontainebleau, France; [Jouannet, Stephanie; Daveau, Romain; Pierre-Eugene, Cecile; Cazes, Alex; Louis-Brennetot, Caroline; Schleiermacher, Gudrun; Raynal, Virginie; Delattre, Olivier; Janoueix-Lerosey, Isabelle] Inst Curie, INSERM, U830, Paris, France; [Combaret, Valerie] Ctr Leon Berard, Lab Rech Translat, F-69373 Lyon, France; [Schleiermacher, Gudrun] Inst Curie, Dept Pediat, Paris, France; [Ferrand, Sandrine; Pierron, Gaelle; Delattre, Olivier] Inst Curie, Unite Genet Somat, Paris, France; [Frio, Thomas Rio] Inst Curie, NGS Platform, Paris, France; [Vassal, Gilles] Inst Gustave Roussy, Villejuif, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Gustave Roussy	Janoueix-Lerosey, I (corresponding author), Inst Curie, Ctr Rech, Paris, France.	janoueix@curie.fr	Cazes, Alex/K-9899-2019; Schleiermacher, Gudrun/AAN-4711-2021; Boeva, Valentina/C-2855-2017; Janoueix-Lerosey, Isabelle/G-1758-2018	Schleiermacher, Gudrun/0000-0002-0133-5879; Boeva, Valentina/0000-0002-4382-7185; Janoueix-Lerosey, Isabelle/0000-0003-0434-3003; LOUIS, Caroline/0000-0002-4952-3828; delattre, olivier/0000-0002-8730-2276; BARILLOT, Emmanuel/0000-0003-2724-2002	Institut National du Cancer; Ligue Nationale contre le Cancer (Equipe labellisee); ICGEX program; Association Hubert Gouin, Les Bagouz a Manon, les amis de Claire and Enfants et Sante; Annenberg Foundation	Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); ICGEX program; Association Hubert Gouin, Les Bagouz a Manon, les amis de Claire and Enfants et Sante; Annenberg Foundation	The U830 Inserm laboratory is supported by grants from the Institut National du Cancer, the Ligue Nationale contre le Cancer (Equipe labellisee), the Institut National du Cancer, the ICGEX program, the Association Hubert Gouin, Les Bagouz a Manon, les amis de Claire and Enfants et Sante. GS is supported by the Annenberg Foundation. The U900 Inserm laboratory is supported by the Ligue Nationale Contre le Cancer (Equipe labellisee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bednarek AK, 2000, CANCER RES, V60, P2140; Blumrich A, 2011, HUM MOL GENET, V20, P1488, DOI 10.1093/hmg/ddr027; Boeva V, 2011, BIOINFORMATICS, V27, P268, DOI 10.1093/bioinformatics/btq635; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Cazes A, 2013, CANCER RES, V73, P195, DOI 10.1158/0008-5472.CAN-12-1242; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Janoueix-Lerosey I, 2005, CELL CYCLE, V4, P1842, DOI 10.4161/cc.4.12.2257; Janoueix-Lerosey I, 2000, GENE CHROMOSOME CANC, V28, P276, DOI 10.1002/1098-2264(200007)28:3<276::AID-GCC5>3.0.CO;2-P; Janoueix-Lerosey I, 2010, ONCOGENE, V29, P1566, DOI 10.1038/onc.2009.518; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Kryh H, 2011, INT J ONCOL, V39, P1063, DOI 10.3892/ijo.2011.1120; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lastowska M, 1998, GENE CHROMOSOME CANC, V23, P116; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Magrangeas F, 2011, BLOOD, V118, P675, DOI 10.1182/blood-2011-03-344069; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schleiermacher G, 2005, ONCOGENE, V24, P3377, DOI 10.1038/sj.onc.1208486; Schleiermacher G, 2004, GENE CHROMOSOME CANC, V39, P143, DOI 10.1002/gcc.10313; Schleiermacher G, 2003, CANCER GENET CYTOGEN, V141, P32, DOI 10.1016/S0165-4608(02)00644-1; Schleiermacher G, 2010, J CLIN ONCOL, V28, P3122, DOI 10.1200/JCO.2009.26.7955; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Van Roy N, 2001, GENE CHROMOSOME CANC, V32, P126, DOI 10.1002/gcc.1174; Van Roy N, 2002, GENE CHROMOSOME CANC, V35, P113, DOI 10.1002/gcc.10034; Vandepoele K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002207; VANDERDRIFT P, 1995, GENE CHROMOSOME CANC, V14, P35, DOI 10.1002/gcc.2870140107; White PS, 1997, EUR J CANCER, V33, P1957, DOI 10.1016/S0959-8049(97)00311-0; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293; Zimonjic DB, 1997, CANCER RES, V57, P1166	41	31	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72182	10.1371/journal.pone.0072182	http://dx.doi.org/10.1371/journal.pone.0072182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991058	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800048
J	Gsell, AS; Domis, LND; van Donk, E; Ibelings, BW				Gsell, Alena S.; Domis, Lisette N. de Senerpont; van Donk, Ellen; Ibelings, Bas W.			Temperature Alters Host Genotype-Specific Susceptibility to Chytrid Infection	PLOS ONE			English	Article							ASTERIONELLA-FORMOSA BACILLARIOPHYCEAE; BY-ENVIRONMENT INTERACTIONS; PARASITE INTERACTIONS; PATHOGEN; FUNGI; ZYGORHIZIDIUM; REPRODUCTION; POLYMORPHISM; ASSOCIATION; SENSITIVITY	The cost of parasitism often depends on environmental conditions and host identity. Therefore, variation in the biotic and abiotic environment can have repercussions on both, species-level host-parasite interaction patterns but also on host genotype-specific susceptibility to disease. We exposed seven genetically different but concurrent strains of the diatom Asterionella formosa to one genotype of its naturally co-occurring chytrid parasite Zygorhizidium planktonicum across five environmentally relevant temperatures. We found that the thermal tolerance range of the tested parasite genotype was narrower than that of its host, providing the host with a "cold" and "hot" thermal refuge of very low or no infection. Susceptibility to disease was host genotype-specific and varied with temperature level so that no genotype was most or least resistant across all temperatures. This suggests a role of thermal variation in the maintenance of diversity in disease related traits in this phytoplankton host. The duration and intensity of chytrid parasite pressure on host populations is likely to be affected by the projected changes in temperature patterns due to climate warming both through altering temperature dependent disease susceptibility of the host and, potentially, through en-or disabling thermal host refugia. This, in turn may affect the selective strength of the parasite on the genetic architecture of the host population.	[Gsell, Alena S.; Domis, Lisette N. de Senerpont; van Donk, Ellen; Ibelings, Bas W.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [van Donk, Ellen] Univ Utrecht, Dept Biol, Utrecht, Netherlands; [Ibelings, Bas W.] Univ Geneva, Inst FA Forel, Versoix, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Utrecht University	Gsell, AS (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands.	gsell@igb-berlin.de	van Donk, Ellen/B-7272-2008; Gsell, Alena S/G-5157-2012; Domis, Lisette N. de Senerpont/C-2902-2008; KNAW, NIOO-KNAW/A-4320-2012	van Donk, Ellen/0000-0003-3279-4936; Gsell, Alena S/0000-0001-7795-1996; Domis, Lisette N. de Senerpont/0000-0001-7509-9541; KNAW, NIOO-KNAW/0000-0002-3835-159X	NWO-ALW [816.01.018, 817.01.007]	NWO-ALW(Netherlands Organization for Scientific Research (NWO))	The authors' work is supported by NWO-ALW grant 816.01.018 to EvD and BWI and 817.01.007 to LNdSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; BRAND L E, 1981, Journal of Plankton Research, V3, P193, DOI 10.1093/plankt/3.2.193; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; BRUNING K, 1991, J PLANKTON RES, V13, P103, DOI 10.1093/plankt/13.1.103; BRUNING K, 1991, J PLANKTON RES, V13, P707, DOI 10.1093/plankt/13.4.707; Cabanac AJ, 2004, J THERM BIOL, V29, P669, DOI 10.1016/j.jtherbio.2004.08.039; CANTER HM, 1948, NEW PHYTOL, V47, P238, DOI 10.1111/j.1469-8137.1948.tb05102.x; CANTER HM, 1950, ANN BOT-LONDON, V14, P263, DOI 10.1093/oxfordjournals.aob.a083246; CANTER HM, 1951, ANN BOT-LONDON, V15, P359; CANTER HM, 1951, ANN BOT-LONDON, V15, P129; Canter HM., 1969, BOT J LINN SOC, V62, P267; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; De Bruin A, 2004, J PHYCOL, V40, P823, DOI 10.1111/j.1529-8817.2004.04006.x; Doggett MS, 1996, MYCOLOGIA, V88, P720, DOI 10.2307/3760966; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Gsell AS, 2013, FRESHWATER BIOL, V58, P523, DOI 10.1111/j.1365-2427.2012.02786.x; Gsell AS, 2012, J PHYCOL, V48, P1197, DOI 10.1111/j.1529-8817.2012.01205.x; Gsell AS, 2013, ISME J; Hastie TJ., 1990, GEN ADDITIVE MODELS; HEDRICK PW, 1986, ANNU REV ECOL SYST, V17, P535; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; Ibelings BW, 2011, FRESHWATER BIOL, V56, P754, DOI 10.1111/j.1365-2427.2010.02565.x; Ibelings BW, 2004, J PHYCOL, V40, P437, DOI 10.1111/j.1529-8817.2004.03117.x; Kagami M, 2007, P R SOC B, V274, P1561, DOI 10.1098/rspb.2007.0425; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; Kingsolver JG, 2009, AM NAT, V174, P755, DOI 10.1086/648310; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Laine AL, 2007, J EVOLUTION BIOL, V20, P2371, DOI 10.1111/j.1420-9101.2007.01406.x; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Lefevre E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002324; MABERLY SC, 1994, FRESHWATER BIOL, V31, P19, DOI 10.1111/j.1365-2427.1994.tb00835.x; MANN DG, 1988, ALGAE AQUATIC ENV, P385; McNew G.L., 1960, PLANT PATHOLOGY ADV, P19; Mitchell SE, 2005, EVOLUTION, V59, P70, DOI 10.1111/j.0014-3820.2005.tb00895.x; POWELL MJ, 1993, MYCOLOGIA, V85, P1, DOI 10.2307/3760471; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Retallick RWR, 2007, DIS AQUAT ORGAN, V75, P201, DOI 10.3354/dao075201; Schoebel CN, 2011, BIOL LETTERS, V7, P108, DOI 10.1098/rsbl.2010.0616; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Sonstebo JH, 2011, APPL ENVIRON MICROB, V77, P1344, DOI 10.1128/AEM.02153-10; Sparrow F.K., 1960, AQUATIC PHYCOMYCETES; Stein J, 1980, HDB PHYCOLOGICAL MET; Thomas MB, 2003, TRENDS ECOL EVOL, V18, P344, DOI 10.1016/S0169-5347(03)00069-7; Utermohl H., 1931, Verhandlungen der Internationalen Vereinigung fuer Theoretische Limnologie Stuttgart, V5, P567; Vale PF, 2008, J EVOLUTION BIOL, V21, P1418, DOI 10.1111/j.1420-9101.2008.01555.x; VANDONK E, 1983, FRESHWATER BIOL, V13, P241; Wolinska J, 2009, TRENDS PARASITOL, V25, P236, DOI 10.1016/j.pt.2009.02.004; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; Wurzbacher CM, 2010, AQUAT MICROB ECOL, V59, P125, DOI 10.3354/ame01385	50	28	28	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71737	10.1371/journal.pone.0071737	http://dx.doi.org/10.1371/journal.pone.0071737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23990982	gold, Green Published			2022-12-25	WOS:000324228800017
J	Migita, K; Nakamura, M; Abiru, S; Jiuchi, Y; Nagaoka, S; Komori, A; Hashimoto, S; Bekki, S; Yamasaki, K; Komatsu, T; Shimada, M; Kouno, H; Hijioka, T; Kohjima, M; Nakamuta, M; Kato, M; Yoshizawa, K; Ohta, H; Nakamura, Y; Takezaki, E; Nishimura, H; Sato, T; Ario, K; Hirashima, N; Oohara, Y; Naganuma, A; Muro, T; Sakai, H; Mita, E; Sugi, K; Yamashita, H; Makita, F; Yatsuhashi, H; Ishibashi, H; Yasunami, M				Migita, Kiyoshi; Nakamura, Minoru; Abiru, Seigo; Jiuchi, Yuka; Nagaoka, Shinya; Komori, Atsumasa; Hashimoto, Satoru; Bekki, Shigemune; Yamasaki, Kazumi; Komatsu, Tatsuji; Shimada, Masaaki; Kouno, Hiroshi; Hijioka, Taizo; Kohjima, Motoyuki; Nakamuta, Makoto; Kato, Michio; Yoshizawa, Kaname; Ohta, Hajime; Nakamura, Yoko; Takezaki, Eiichi; Nishimura, Hideo; Sato, Takeaki; Ario, Keisuke; Hirashima, Noboru; Oohara, Yukio; Naganuma, Atsushi; Muro, Toyokichi; Sakai, Hironori; Mita, Eiji; Sugi, Kazuhiro; Yamashita, Haruhiro; Makita, Fujio; Yatsuhashi, Hiroshi; Ishibashi, Hiromi; Yasunami, Michio			Association of STAT4 Polymorphisms with Susceptibility to Type-1 Autoimmune Hepatitis in the Japanese Population	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; RISK-FACTOR; MECHANISMS; INFECTION; RESPONSES; DISEASES; REGION; IL-23; IL-12	Background/Aims: Recent studies demonstrated an association of STAT4 polymorphisms with autoimmune diseases including systemic lupus erythematosus and rheumatoid arthritis, indicating multiple autoimmune diseases share common susceptibility genes. We therefore investigated the influence of STAT4 polymorphisms on the susceptibility and phenotype of type-1 autoimmune hepatitis in a Japanese National Hospital Organization (NHO) AIH multicenter cohort study. Methodology/Principal Findings: Genomic DNA from 460 individuals of Japanese origin including 230 patients with type-1 autoimmune hepatitis and 230 healthy controls was analyzed for two single nucleotide polymorphisms in the STAT4 gene (rs7574865, rs7582694). The STAT4 rs7574865T allele conferred risk for type-1 autoimmune hepatitis (OR = 1.61, 95% CI = 1.23-2.11; P = 0.001), and patients without accompanying autoimmune diseases exhibited an association with the rs7574865T allele (OR = 1.50, 95% CI = 1.13-1.99; P = 0.005). Detailed genotype-phenotype analysis of type-1 autoimmune hepatitis patients with (n = 44) or without liver cirrhosis (n = 186) demonstrated that rs7574865 was not associated with the development of liver cirrhosis and phenotype (biochemical data and the presence of auto-antibodies). Conclusions/Significance: This is the first study to show a positive association between a STAT4 polymorphism and type-1 autoimmune hepatitis, suggesting that autoimmune hepatitis shares a gene commonly associated with risk for other autoimmune diseases.	[Migita, Kiyoshi; Abiru, Seigo; Jiuchi, Yuka; Nagaoka, Shinya; Komori, Atsumasa; Hashimoto, Satoru; Bekki, Shigemune; Yamasaki, Kazumi; Komatsu, Tatsuji; Shimada, Masaaki; Kouno, Hiroshi; Hijioka, Taizo; Kohjima, Motoyuki; Nakamuta, Makoto; Kato, Michio; Yoshizawa, Kaname; Ohta, Hajime; Nakamura, Yoko; Takezaki, Eiichi; Nishimura, Hideo; Sato, Takeaki; Ario, Keisuke; Hirashima, Noboru; Oohara, Yukio; Naganuma, Atsushi; Muro, Toyokichi; Sakai, Hironori; Mita, Eiji; Sugi, Kazuhiro; Yamashita, Haruhiro; Makita, Fujio; Yatsuhashi, Hiroshi; Ishibashi, Hiromi] Nagasaki Med Ctr, NHO AIH Study Grp, Omura, Nagasaki, Japan; [Nakamura, Minoru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hepatol, Nagasaki 852, Japan; [Yasunami, Michio] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan	Nagasaki University; Nagasaki University	Migita, K (corresponding author), Nagasaki Med Ctr, NHO AIH Study Grp, Omura, Nagasaki, Japan.	migita@nmc.hosp.go.jp		Naganuma, Atsushi/0000-0003-0663-0102	research grant for National Hospital Organization (NHO) network study	research grant for National Hospital Organization (NHO) network study	This study was supported by the research grant for National Hospital Organization (NHO) network study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson AK, 2009, ANN RHEUM DIS, V68, P1746, DOI 10.1136/ard.2008.097642; Agarwal K, 2000, HEPATOLOGY, V31, P49, DOI 10.1002/hep.510310110; Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Baranzini SE, 2009, CURR OPIN IMMUNOL, V21, P596, DOI 10.1016/j.coi.2009.09.014; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Czaja AJ, 1999, GASTROENTEROLOGY, V117, P645, DOI 10.1016/S0016-5085(99)70458-0; Czaja AJ, 2008, CLIN GASTROENTEROL H, V6, P379, DOI 10.1016/j.cgh.2007.12.048; Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Dieude P, 2009, ARTHRITIS RHEUM-US, V60, P2472, DOI 10.1002/art.24688; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; Hoey T, 2003, EMBO J, V22, P4237, DOI 10.1093/emboj/cdg393; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Kaplan MH, 2005, IMMUNOL RES, V31, P231, DOI 10.1385/IR:31:3:231; Kawasaki A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2516; Kim SW, 2012, DIGEST DIS SCI, V57, P2600, DOI 10.1007/s10620-012-2199-z; Kobayashi S, 2008, ARTHRITIS RHEUM, V58, P1940, DOI 10.1002/art.23494; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; Lee HS, 2008, ANN NY ACAD SCI, V1150, P93, DOI 10.1196/annals.1447.013; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Liang YL, 2012, MOL BIOL REP, V39, P8873, DOI 10.1007/s11033-012-1754-1; Longhi MS, 2010, J AUTOIMMUN, V34, P7, DOI 10.1016/j.jaut.2009.08.010; Manns MP, 2006, HEPATOLOGY, V43, pS132, DOI 10.1002/hep.21059; Migita K, 2012, LIVER INT, V32, P837, DOI 10.1111/j.1478-3231.2011.02734.x; Murphy KM, 1999, CURR TOP MICROBIOL, V238, P13; Nakamura K, 1998, J GASTROEN HEPATOL, V13, P490, DOI 10.1111/j.1440-1746.1998.tb00674.x; Namjou B, 2009, ARTHRITIS RHEUM-US, V60, P1085, DOI 10.1002/art.24387; Oldstone MBA, 2005, CURR TOP MICROBIOL, V296, P1; Piotrowski P, 2012, MOL BIOL REP, V39, P8861, DOI 10.1007/s11033-012-1752-3; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Sigurdsson S, 2008, HUM MOL GENET, V17, P2868, DOI 10.1093/hmg/ddn184; Strettell MDJ, 1997, GASTROENTEROLOGY, V112, P2028, DOI 10.1053/gast.1997.v112.pm9178696; Sugiura T, 2012, ANN RHEUM DIS, V71, P1646, DOI 10.1136/annrheumdis-2011-200839; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; Taylor KE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000084; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Xu ML, 2011, EUR J IMMUNOL, V41, P2828, DOI 10.1002/eji.201141291; Yamazaki A, 2011, HUM IMMUNOL, V72, P881, DOI 10.1016/j.humimm.2011.06.007; Yoshizawa K, 2005, J HEPATOL, V42, P578, DOI 10.1016/j.jhep.2004.12.019; Zervou MI, 2008, HUM IMMUNOL, V69, P647, DOI 10.1016/j.humimm.2008.07.004	41	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e71382	10.1371/journal.pone.0071382	http://dx.doi.org/10.1371/journal.pone.0071382			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23990947	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470700015
J	Liu, XY; Yang, G; Geng, XR; Cao, YJ; Li, N; Ma, L; Chen, S; Yang, PC; Liu, ZG				Liu, Xiaoyu; Yang, Gui; Geng, Xiao-Rui; Cao, Yanjuan; Li, Na; Ma, Li; Chen, Si; Yang, Ping-Chang; Liu, Zhigang			Microbial Products Induce Claudin-2 to Compromise Gut Epithelial Barrier Function	PLOS ONE			English	Article							TNF-ALPHA; PERMEABILITY; EXPRESSION; TRANSPORT; CELLS; SENSITIZATION; DISRUPTION; ALLERGY; MICE	The epithelial barrier dysfunction is an important pathogenic feature in a number of diseases. The underlying mechanism is to be further investigated. The present study aims to investigate the role of tight junction protein claudin-2 (Cldn2) in the compromising epithelial barrier function. In this study, the expression of Cldn2 in the epithelial layer of mice and patients with food allergy was observed by immunohistochemistry. The induction of Cldn2 was carried out with a cell culture model. The Cldn2-facilitated antigen internalization was observed by confocal microscopy. The epithelial barrier function in the gut epithelial monolayer was assessed by recording the transepithelial resistance and assessing the permeability to a macromolecular tracer. The results showed that the positive immune staining of Cldn2 was observed in the epithelial layer of the small intestine that was weakly stained in naive control mice, and strongly stained in sensitized mice as well as patients with food allergy. Exposure to cholera toxin or Staphylococcal enterotoxin B induced the expression of Cldn2 in HT-29 or T84 cells. Cldn2 could bind protein antigen to form complexes to facilitate the antigen transport across the epithelial barrier. Blocking Cldn2 prevented the allergen-related hypersensitivity the intestine. We conclude that the tight junction protein Cldn2 is involved in the epithelial barrier dysfunction.	[Liu, Xiaoyu; Cao, Yanjuan; Li, Na; Ma, Li; Chen, Si; Yang, Ping-Chang; Liu, Zhigang] Shenzhen Univ, Sch Med, State Key Lab Resp Dis Allergy, Shenzhen Key Lab Allergy & Immunol, Shenzhen, Peoples R China; [Yang, Gui; Geng, Xiao-Rui] Shenzhen ENT Inst, ENT Hosp, Longgang Cent Hosp, Shenzhen, Peoples R China	Shenzhen University; State Key Laboratory of Respiratory Disease	Liu, ZG (corresponding author), Shenzhen Univ, Sch Med, State Key Lab Resp Dis Allergy, Shenzhen Key Lab Allergy & Immunol, Shenzhen, Peoples R China.	zhigangliu195910@126.com	Yang, Ping-Chang/K-4669-2019; CHEN, SI/GZL-4800-2022		Natural Science Foundation of SZU [000004]; innovation of science and Technology Commission of Shenzhen Municipality [JCYJ20120613172559904]; Natural Science Foundation of China [30871752, 31101280]; Postdoctoral Scholarship of China [20060390196]; Shenzhen-Hong Kong Scientific Invention Foundation [CX Q2008026]; Key Laboratory Project of Shenzhen [SW201110010]; Guangdong Provincial Educational Ministry International Collaboration Research Initiative [2012gjhz0009]	Natural Science Foundation of SZU; innovation of science and Technology Commission of Shenzhen Municipality; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Scholarship of China; Shenzhen-Hong Kong Scientific Invention Foundation; Key Laboratory Project of Shenzhen; Guangdong Provincial Educational Ministry International Collaboration Research Initiative	This study was supported by grants from the Natural Science Foundation of SZU (No. 000004), the innovation of science and Technology Commission of Shenzhen Municipality (JCYJ20120613172559904), the Natural Science Foundation of China (No. 30871752, 31101280), Postdoctoral Scholarship of China (No. 20060390196), Shenzhen-Hong Kong Scientific Invention Foundation (CX Q2008026), the Key Laboratory Project of Shenzhen (No. SW201110010) and Guangdong Provincial Educational Ministry International Collaboration Research Initiative (No. 2012gjhz0009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailon E, 2012, J IMMUNOL METHODS, V381, P41, DOI 10.1016/j.jim.2012.04.007; Bu HF, 2010, J CELL PHYSIOL, V222, P658, DOI 10.1002/jcp.21985; Chen X, 2010, N AM J MED SCI, V2, P241, DOI 10.4297/najms.2010.2241; Denizot J, 2012, INFLAMM BOWEL DIS, V18, P294, DOI 10.1002/ibd.21787; Feng BS, 2008, J ALLERGY CLIN IMMUN, V122, P55, DOI 10.1016/j.jaci.2008.04.036; Furuse M., 2010, COLD SPRING HARB PER, V2; Goto Y, 2012, IMMUNOL REV, V245, P147, DOI 10.1111/j.1600-065X.2011.01078.x; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Kearney DE, 2011, J IMMUNOL, V187, P5363, DOI 10.4049/jimmunol.1003747; Knauf F, 2011, J AM SOC NEPHROL, V22, P2247, DOI 10.1681/ASN.2011040433; Larre I, 2011, P NATL ACAD SCI USA, V108, P20591, DOI 10.1073/pnas.1102617108; Lee AS, 2010, DIABETOLOGIA, V53, P741, DOI 10.1007/s00125-009-1626-y; Mallegol J, 2007, GASTROENTEROLOGY, V132, P1866, DOI 10.1053/j.gastro.2007.02.043; McKay DM, 1997, J IMMUNOL, V159, P2382; McKay DM, 2000, AM J PHYSIOL-GASTR L, V279, pG1094, DOI 10.1152/ajpgi.2000.279.5.G1094; Meertens L, 2008, J VIROL, V82, P3555, DOI 10.1128/JVI.01977-07; Perrier C, 2011, CLIN EXP ALLERGY, V41, P20, DOI 10.1111/j.1365-2222.2010.03639.x; Snoek SA, 2010, EXPERT REV GASTROENT, V4, P637, DOI [10.1586/egh.10.51, 10.1586/EGH.10.51]; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Tam Anthony, 2011, Ther Adv Respir Dis, V5, P255, DOI 10.1177/1753465810396539; Vetrano S, 2011, P NATL ACAD SCI USA, V108, P19830, DOI 10.1073/pnas.1107140108; Wang WC, 2011, J CELL BIOCHEM, V112, P1544, DOI 10.1002/jcb.23067; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Yang PC, 2006, AM J PATHOL, V168, P104, DOI 10.2353/ajpath.2006.050575; Yang PC, 2007, GASTROENTEROLOGY, V133, P1522, DOI 10.1053/j.gastro.2007.08.006; Yu LCH, 2001, GASTROENTEROLOGY, V121, P370, DOI 10.1053/gast.2001.26470	26	31	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e68547	10.1371/journal.pone.0068547	http://dx.doi.org/10.1371/journal.pone.0068547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990874	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100005
J	Sun, W; Park, YD; Sugui, JA; Fothergill, A; Southall, N; Shinn, P; McKew, JC; Kwon-Chung, KJ; Zheng, W; Williamson, PR				Sun, Wei; Park, Yoon-Dong; Sugui, Janyce A.; Fothergill, Annette; Southall, Noel; Shinn, Paul; McKew, John C.; Kwon-Chung, Kyung J.; Zheng, Wei; Williamson, Peter R.			Rapid Identification of Antifungal Compounds against Exserohilum rostratum Using High Throughput Drug Repurposing Screens	PLOS ONE			English	Article							CONTAMINATED METHYLPREDNISOLONE; PHENYLMERCURIC BORATE; ESCHERICHIA-COLI; MECHANISM; INHIBITION; LOCALIZATION; MENINGITIS; TARGET; ASSAY; MODE	A recent large outbreak of fungal infections by Exserohilum rostratum from contaminated compounding solutions has highlighted the need to rapidly screen available pharmaceuticals that could be useful in therapy. The present study utilized two newly-developed high throughput assays to screen approved drugs and pharmaceutically active compounds for identification of potential antifungal agents. Several known drugs were found that have potent effects against E. rostratum including the triazole antifungal posaconazole. Posaconazole is likely to be effective against infections involving septic joints and may provide an alternative for refractory central nervous system infections. The anti-E. rostratum activities of several other drugs including bithionol (an anti-parasitic drug), tacrolimus (an immunosuppressive agent) and floxuridine (an antimetabolite) were also identified from the drug repurposing screens. In addition, activities of other potential antifungal agents against E. rostratum were excluded, which may avoid unnecessary therapeutic trials and reveals the limited therapeutic alternatives for this outbreak. In summary, this study has demonstrated that drug repurposing screens can be quickly conducted within a useful time-frame. This would allow clinical implementation of identified alternative therapeutics and should be considered as part of the initial public health response to new outbreaks or rapidly-emerging microbial pathogens.	[Sun, Wei; Southall, Noel; Shinn, Paul; McKew, John C.; Zheng, Wei] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Park, Yoon-Dong; Sugui, Janyce A.; Kwon-Chung, Kyung J.; Williamson, Peter R.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Fothergill, Annette] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Williamson, Peter R.] Univ Illinois, Coll Med, Sect Infect Dis Immunol & Int Med, Chicago, IL USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Health San Antonio; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zheng, W (corresponding author), NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA.	wzheng@mail.nih.gov; williamsonpr@mail.nih.gov	Zheng, Wei/J-8889-2014; Zheng, Wei/GOE-5990-2022; Southall, Noel T/H-8991-2012	Zheng, Wei/0000-0003-1034-0757; Southall, Noel T/0000-0003-4500-880X; Sun, Wei/0000-0002-1306-3946	Intramural Research Program of the National Center for Advancing Translational Sciences; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001123] Funding Source: NIH RePORTER	Intramural Research Program of the National Center for Advancing Translational Sciences; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Programs of the National Center for Advancing Translational Sciences and National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT BJ, 1979, ANTIMICROB AGENTS CH, V16, P808, DOI 10.1128/AAC.16.6.808; Adler A, 2006, EUR J CLIN MICROBIOL, V25, P247, DOI 10.1007/s10096-006-0093-3; Berthet N, 2003, J ANTIMICROB CHEMOTH, V51, P1419, DOI 10.1093/jac/dkg245; Chen CZ, 2011, ANTIMICROB AGENTS CH, V55, P667, DOI 10.1128/AAC.00618-10; Cho SH, 2007, ANTIMICROB AGENTS CH, V51, P1380, DOI 10.1128/AAC.00055-06; CLINICAL AND LABORATORY STANDARDS INSTITUTE (CLSI), 2012, REFERENCE METHOD BRO, V4th; Coconnier-Polter MH, 2005, APPL ENVIRON MICROB, V71, P6115, DOI 10.1128/AEM.71.10.6115-6120.2005; CORTAT M, 1978, ZBL BAKT MIK HYG B, V166, P517; CORTAT M, 1978, ZBL BAKT MIK HYG B, V166, P528; Cree IA, 1997, TOXICOL IN VITRO, V11, P553, DOI 10.1016/S0887-2333(97)00060-X; Denys A, 2004, FEBS LETT, V564, P177, DOI 10.1016/S0014-5793(04)00361-8; DIAMOND RD, 1974, ANN INTERN MED, V80, P176, DOI 10.7326/0003-4819-80-2-176; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Finks J, 2013, MMWR-MORBID MORTAL W, V62, P377; FREDERICK JJ, 1974, ANTIMICROB AGENTS CH, V6, P712, DOI 10.1128/AAC.6.6.712; Ganne F, 2000, THROMB HAEMOSTASIS, V84, P680, DOI 10.1055/s-0037-1614087; Geier J, 2005, CONTACT DERMATITIS, V53, P117, DOI 10.1111/j.0105-1873.2005.0650d.x; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; Hu GW, 2008, J CLIN INVEST, V118, P1186, DOI 10.1172/JCI32053; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Juhas E, 2012, PEDIAT DERMATOLOGY; Kainer MA, 2012, NEW ENGL J MED, V367, P2194, DOI 10.1056/NEJMoa1212972; KANGAS L, 1984, MED BIOL, V62, P338; Kauffman CA, 2012, NEW ENGLAND J MED; Kerkering TM, 2013, ANN INTERN MED, V158, P154, DOI 10.7326/0003-4819-158-3-201302050-00568; Kusari S, 2009, J NAT PROD, V72, P1825, DOI 10.1021/np9002977; Lea WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007150; Lewis JS, 2008, EXPERT OPIN PHARMACO, V9, P927, DOI 10.1517/14656566.9.6.927; Lin SC, 2009, INT J DERMATOL, V48, P295, DOI 10.1111/j.1365-4632.2009.03803.x; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Melnick JG, 2008, INORG CHEM, V47, P6421, DOI 10.1021/ic8005426; Miller SC, 2010, BIOCHEM PHARMACOL, V79, P1272, DOI 10.1016/j.bcp.2009.12.021; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Murakami Y, 2000, INT J ONCOL, V17, P277; Nakagawa H, 1998, NEUROL SURG TOKYO, V26, P873; National Committee for Clinical Laboratory Standards, 2008, REF METH BROTH DIL S; OHMICHI M, 1993, BIOCHEMISTRY-US, V32, P4650, DOI 10.1021/bi00068a024; Rabjohns JLA, 2013, J BIOMOLECULAR UNPUB; RICHARD JL, 1971, MYCOPATH MYCOL APPL, V43, P165, DOI 10.1007/BF02051717; Shen M, 2013, IDENTIFICATION UNPUB; Smith RM, 2012, NEW ENGLAND J MED; TRIPATHI RK, 1969, J BACTERIOL, V100, P310, DOI 10.1128/JB.100.1.310-318.1969; Wang JX, 2002, EUR J PHARM BIOPHARM, V54, P285, DOI 10.1016/S0939-6411(02)00083-8; Wang Yuhong, 2010, Curr Chem Genomics, V4, P57, DOI 10.2174/1875397301004010057; Xia M, 2013, CANC BIOL T IN PRESS; Xu M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.357707; Yamaji-Hasegawa A, 2005, BIOCHEMISTRY-US, V44, P268, DOI 10.1021/bi048605l; Yuan H, 2012, NEW ENGL J MED, V367, P1220, DOI 10.1056/NEJMoa1203055	49	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e70506	10.1371/journal.pone.0070506	http://dx.doi.org/10.1371/journal.pone.0070506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990907	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100027
J	Zhang, Z; Li, M; He, JW; Fu, WZ; Zhang, CQ; Zhang, ZL				Zhang, Zeng; Li, Mei; He, Jin-Wei; Fu, Wen-Zhen; Zhang, Chang-Qing; Zhang, Zhen-Lin			Phenotype and Genotype Analysis of Chinese Patients with Osteogenesis Imperfecta Type V	PLOS ONE			English	Article							SKELETAL DYSPLASIAS; HYPERPLASTIC CALLUS; BONE FRAGILITY; MUTATIONS; 5'-UTR; GENE	Osteogenesis imperfecta (OI) type V is an autosomal-dominant disease characterized by calcification of the forearm interosseous membrane, radial head dislocation, a subphyseal metaphyseal radiodense line, and hyperplastic callus formation. The causative mutation, c.-14C>T in the 5'-untranslated region of IFITM5, was recently discovered to be involved in this disease. However, in spite of the little genotypic variability, considerable phenotypic variability has been recognized in two cohorts of patients, the majority of whom were Caucasians. Using exome sequencing, we identified the same heterozygous mutation in four Chinese families with OI type V. This study confirms the molecular cause of OI type V and describes the phenotype of Chinese patients with this disorder. In conclusion, the phenotype of Chinese patients was generally similar to that of Caucasian patients.	[Zhang, Zeng; Zhang, Chang-Qing] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Orthoped Surg, Shanghai 200030, Peoples R China; [Zhang, Zeng; He, Jin-Wei; Fu, Wen-Zhen; Zhang, Zhen-Lin] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Osteoporosis & Bone Dis, Metab Bone Dis & Genet Res Unit, Shanghai 200030, Peoples R China; [Li, Mei] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Endocrinol, Key Lab Endocrinol,Minist Hlth, Beijing 100730, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Zhang, ZL (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Osteoporosis & Bone Dis, Metab Bone Dis & Genet Res Unit, Shanghai 200030, Peoples R China.	zzl2002@medmail.com.cn		zhang, changqing/0000-0002-7408-4126	National Natural Science Foundation of China [81070692, 81000360, 81170803]; Science and Technology Commission of Shanghai Municipality [10DZ1950100]; Academic Leaders in Health Sciences in Shanghai [XBR2011014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Academic Leaders in Health Sciences in Shanghai	The study was supported by the National Natural Science Foundation of China (81070692, 81000360, 81170803), and Science and Technology Commission of Shanghai Municipality (10DZ1950100) and Academic Leaders in Health Sciences in Shanghai (XBR2011014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Almen MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031961; Asharani PV, 2012, AM J HUM GENET, V90, P661, DOI 10.1016/j.ajhg.2012.02.026; Barbosa-Buck CO, 2012, AM J MED GENET A, V158A, P1038, DOI 10.1002/ajmg.a.35246; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Cheung MS, 2007, J BONE MINER RES, V22, P1181, DOI 10.1359/jbmr.070418; Cho TJ, 2012, AM J HUM GENET, V91, P343, DOI 10.1016/j.ajhg.2012.06.005; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; COHN DH, 1986, P NATL ACAD SCI USA, V83, P6045, DOI 10.1073/pnas.83.16.6045; Cundy T, 2012, CALCIFIED TISSUE INT, V90, P439, DOI 10.1007/s00223-012-9588-3; DICKSON LA, 1984, P NATL ACAD SCI-BIOL, V81, P4524, DOI 10.1073/pnas.81.14.4524; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; Glorieux FH, 2008, BEST PRACT RES CL RH, V22, P85, DOI 10.1016/j.berh.2007.12.012; Hanagata N, 2011, J BONE MINER METAB, V29, P279, DOI 10.1007/s00774-010-0221-0; Hickford D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-155; Keupp K, 2013, AM J HUM GENET, V92, P565, DOI 10.1016/j.ajhg.2013.02.010; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Martinez-Glez V, 2012, HUM MUTAT, V33, P343, DOI 10.1002/humu.21647; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Pyott SM, 2013, AM J HUM GENET, V92, P590, DOI 10.1016/j.ajhg.2013.02.009; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Rauch F, 2013, J MED GENET, V50, P21, DOI 10.1136/jmedgenet-2012-101307; Semler O, 2012, AM J HUM GENET, V91, P349, DOI 10.1016/j.ajhg.2012.06.011; Shapiro JR, 2013, J BONE MINER RES, V28, P1523, DOI 10.1002/jbmr.1891; Shi Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002084; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Sillence DO, 2012, ANN NY ACAD SCI, V543, P1; Stevenson DA, 2012, AM J MED GENET A, V158A, P1046, DOI 10.1002/ajmg.a.35327; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang ZL, 2012, J BONE MINER METAB, V30, P69, DOI 10.1007/s00774-011-0284-6; Zhang ZL, 2012, AM J HUM GENET, V90, P125, DOI 10.1016/j.ajhg.2011.11.019	38	15	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72337	10.1371/journal.pone.0072337	http://dx.doi.org/10.1371/journal.pone.0072337			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977282	Green Submitted, gold, Green Published			2022-12-25	WOS:000324527300079
J	Fransen, K; Franzen, P; Magnuson, A; Elmabsout, AA; Nyhlin, N; Wickbom, A; Curman, B; Torkvist, L; D'Amato, M; Bohr, J; Tysk, C; Sirsjo, A; Halfvarson, J				Fransen, Karin; Franzen, Petra; Magnuson, Anders; Elmabsout, Ali Ateia; Nyhlin, Nils; Wickbom, Anna; Curman, Bengt; Torkvist, Leif; D'Amato, Mauro; Bohr, Johan; Tysk, Curt; Sirsjo, Allan; Halfvarson, Jonas			Polymorphism in the Retinoic Acid Metabolizing Enzyme CYP26B1 and the Development of Crohn's Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HUMAN CYTOCHROME-P450; VITAMIN-A; ISOTRETINOIN; IDENTIFICATION; CLASSIFICATION; RECEPTOR; FAMILY	Several studies suggest that Vitamin A may be involved in the pathogenesis of inflammatory bowel disease (IBD), but the mechanism is still unknown. Cytochrome P450 26 B1 (CYP26B1) is involved in the degradation of retinoic acid and the polymorphism rs2241057 has an elevated catabolic function of retinoic acid, why we hypothesized that the rs2241057 polymorphism may affect the risk of Crohn's disease (CD) and Ulcerative Colitis (UC). DNA from 1378 IBD patients, divided into 871 patients with CD and 507 with UC, and 1205 healthy controls collected at Orebro University Hospital and Karolinska University Hospital were analyzed for the CYP26B1 rs2241057 polymorphism with TaqMan (R) SNP Genotyping Assay followed by allelic discrimination analysis. A higher frequency of patients homozygous for the major (T) allele was associated with CD but not UC compared to the frequency found in healthy controls. A significant association between the major allele and non-stricturing, non-penetrating phenotype was evident for CD. However, the observed associations reached borderline significance only, after correcting for multiple testing. We suggest that homozygous carriers of the major (T) allele, relative to homozygous carriers of the minor (C) allele, of the CYP26B1 polymorphism rs2241057 may have an increased risk for the development of CD, which possibly may be due to elevated levels of retinoic acid. Our data may support the role of Vitamin A in the pathophysiology of CD, but the exact mechanisms remain to be elucidated.	[Fransen, Karin; Franzen, Petra; Elmabsout, Ali Ateia; Bohr, Johan; Tysk, Curt; Sirsjo, Allan; Halfvarson, Jonas] Univ Orebro, Sch Hlth & Med Sci, Dept Clin Med, Orebro, Sweden; [Magnuson, Anders] Orebro Univ Hosp, Clin Epidemiol & Biostat Unit, Orebro, Sweden; [Magnuson, Anders; Nyhlin, Nils; Wickbom, Anna; Curman, Bengt; Bohr, Johan; Tysk, Curt; Halfvarson, Jonas] Orebro Univ Hosp, Dept Internal Med, Div Gastroenterol, Orebro, Sweden; [Torkvist, Leif] Karolinska Univ Hosp, IBD Clin Res Grp, Stockholm, Sweden; [Torkvist, Leif] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [D'Amato, Mauro] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden	Orebro University; Orebro University; Orebro University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Fransen, K (corresponding author), Univ Orebro, Sch Hlth & Med Sci, Dept Clin Med, Orebro, Sweden.	karin.h.franzen@oru.se	Halfvarson, Jonas/AAU-4687-2020; D'Amato, Mauro/F-2450-2010; D'Amato, Mauro/B-5050-2019	D'Amato, Mauro/0000-0003-2743-5197; D'Amato, Mauro/0000-0003-2743-5197; Fransen, Karin/0000-0002-9826-0462; Halfvarson, Jonas/0000-0003-0122-7234	Orebro University; Bengt Ihre's foundation; Nanna Svartz' foundation; Orebro University Hospital Research Foundation; Orebro County Research Foundation; Swedish Foundation for Gastrointestinal research; Swedish Research Council	Orebro University; Bengt Ihre's foundation; Nanna Svartz' foundation; Orebro University Hospital Research Foundation; Orebro County Research Foundation; Swedish Foundation for Gastrointestinal research; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Orebro University and by grants from Bengt Ihre's foundation, Nanna Svartz' foundation, Orebro University Hospital Research Foundation, Orebro County Research Foundation, The Swedish Foundation for Gastrointestinal research and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai AP, 2009, J LEUKOCYTE BIOL, V86, P959, DOI 10.1189/jlb.0109006; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bernstein CN, 2009, AM J GASTROENTEROL, V104, P2774, DOI 10.1038/ajg.2009.417; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Cha HR, 2010, J IMMUNOL, V184, P6799, DOI 10.4049/jimmunol.0902944; Crockett SD, 2010, AM J GASTROENTEROL, V105, P1986, DOI 10.1038/ajg.2010.124; Danese S, 2012, GUT, V61, P918, DOI 10.1136/gutjnl-2011-300904; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Kang SG, 2009, GASTROENTEROLOGY, V137, P1391, DOI 10.1053/j.gastro.2009.06.063; Kastner P, 1997, DEVELOPMENT, V124, P313; Krivospitskaya O, 2012, MOL MED, V18, P712, DOI 10.2119/molmed.2012.00094; Lalevee S, 2011, J BIOL CHEM, V286, P33322, DOI 10.1074/jbc.M111.263681; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Reddy D, 2006, AM J GASTROENTEROL, V101, P1569, DOI 10.1111/j.1572-0241.2006.00632.x; Reifen R, 2002, J NUTR, V132, P2743, DOI 10.1093/jn/132.9.2743; Shale M, 2009, GUT, V58, P737, DOI 10.1136/gut.2008.170530; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Taimi M, 2004, J BIOL CHEM, V279, P77, DOI 10.1074/jbc.M308337200; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016089; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Wang CW, 2010, J IMMUNOL, V184, P5519, DOI 10.4049/jimmunol.0903942; Wermers JD, 2011, GASTROENTEROLOGY, V140, P1526, DOI 10.1053/j.gastro.2011.01.044; White JA, 1997, J BIOL CHEM, V272, P18538, DOI 10.1074/jbc.272.30.18538; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397	27	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72739	10.1371/journal.pone.0072739	http://dx.doi.org/10.1371/journal.pone.0072739			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977348	gold, Green Submitted, Green Published			2022-12-25	WOS:000323425700188
J	Liu, XJ; Lu, Y; Yuan, YH; Liu, SY; Guan, CY; Chen, SY; Liu, ZS				Liu, Xianjun; Lu, Ying; Yuan, Yuhui; Liu, Shuyan; Guan, Chunyun; Chen, Sheyuan; Liu, Zhongsong			De Novo Transcriptome of Brassica juncea Seed Coat and Identification of Genes for the Biosynthesis of Flavonoids	PLOS ONE			English	Article							RNA-SEQ; ARABIDOPSIS; GERMINATION; CARINATA; PATHWAY; PROTEIN; GENOME; TESTA; TOOL	Brassica juncea, a worldwide cultivated crop plant, produces seeds of different colors. Seed pigmentation is due to the deposition in endothelial cells of proanthocyanidins (PAs), end products from a branch of flavonoid biosynthetic pathway. To elucidate the gene regulatory network of seed pigmentation in B. juncea, transcriptomes in seed coat of a yellow-seeded inbred line and its brown-seeded near- isogenic line were sequenced using the next-generation sequencing platform Illumina/Solexa and de novo assembled. Over 116 million high-quality reads were assembled into 69,605 unigenes, of which about 71.5% (49,758 unigenes) were aligned to Nr protein database with a cut-off E-value of 10(-5). RPKM analysis showed that the brown-seeded testa up-regulated 802 unigenes and down-regulated 502 unigenes as compared to the yellow-seeded one. Biological pathway analysis revealed the involvement of forty six unigenes in flavonoid biosynthesis. The unigenes encoding dihydroflavonol reductase (DFR), leucoantho-cyanidin dioxygenase (LDOX) and anthocyanidin reductase (ANR) for late flavonoid biosynthesis were not expressed at all or at a very low level in the yellow-seeded testa, which implied that these genes for PAs biosynthesis be associated with seed color of B. juncea, as confirmed by qRT-PCR analysis of these genes. To our knowledge, it is the first time to sequence the transcriptome of seed coat in Brassica juncea. The unigene sequences obtained in this study will not only lay the foundations for insight into the molecular mechanisms underlying seed pigmentation in B. juncea, but also provide the basis for further genomics research on this species or its allies.	[Liu, Xianjun; Lu, Ying; Yuan, Yuhui; Liu, Shuyan; Guan, Chunyun; Chen, Sheyuan; Liu, Zhongsong] Hunan Agr Univ, Oilseed Crops Inst, Changsha, Hunan, Peoples R China	Hunan Agricultural University	Liu, ZS (corresponding author), Hunan Agr Univ, Oilseed Crops Inst, Changsha, Hunan, Peoples R China.	zsliu48@sohu.com			National Natural Science Foundation of China [31101176, 30971799, 31271762]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31101176, No. 30971799 and No. 31271762). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhov L, 2009, BOTANY, V87, P616, DOI 10.1139/B09-036; Auger B, 2010, J AGR FOOD CHEM, V58, P6246, DOI 10.1021/jf903619v; Bancroft I, 2011, NAT BIOTECHNOL, V29, P762, DOI 10.1038/nbt.1926; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burton W., 2003, Thirteenth Biennial Australian Research Assembly on Brassicas. Proceedings of a conference, Tamworth, New South Wales, Australia, 8-12 September 2003, P62; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chen GQ, 2013, PLANT J, V74, P663, DOI 10.1111/tpj.12151; Dean G, 2011, MOL PLANT, V4, P1074, DOI 10.1093/mp/ssr040; Debeaujon I, 2000, PLANT PHYSIOL, V122, P403, DOI 10.1104/pp.122.2.403; Fang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048006; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Jiang YQ, 2010, PLANT CELL REP, V29, P327, DOI 10.1007/s00299-010-0824-x; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044145; Li XA, 2010, J AGR FOOD CHEM, V58, P10918, DOI 10.1021/jf102208a; [刘淑艳 LIU Shuyan], 2007, [植物遗传资源学报, Journal of Plant Genetic Resources], V8, P351; Liu XianJun, 2009, Acta Agronomica Sinica, V35, P839, DOI 10.3724/SP.J.1006.2009.00839; Liu Zhong-song, 2012, Journal of Hunan Agricultural University, V38, P354, DOI 10.3724/SP.J.1238.2012.00354; Lu Y, 2012, PLANT BREEDING, V131, P176, DOI 10.1111/j.1439-0523.2011.01914.x; Marles MAS, 2003, PHYTOCHEMISTRY, V62, P663, DOI 10.1016/S0031-9422(02)00488-0; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nesi N, 2009, PLANT CELL REP, V28, P601, DOI 10.1007/s00299-008-0667-x; Oram RN, 2005, AUST J AGR RES, V56, P581, DOI 10.1071/AR04295; Ren CW, 1998, SEED SCI RES, V8, P385, DOI 10.1017/S0960258500004311; Saito K, 2013, PLANT PHYSL IN PRESS; Shirzadegan M, 2006, FETT SEIFEN ANSTR, V87, P235; SIMBAYA J, 1995, J AGR FOOD CHEM, V43, P2062, DOI 10.1021/jf00056a020; Van Verk MC, 2013, TRENDS PLANT SCI, V18, P175, DOI 10.1016/j.tplants.2013.02.001; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yan ML, 2011, MOL BREEDING, V28, P313, DOI 10.1007/s11032-010-9483-4; Yan MingLi, 2008, Acta Agronomica Sinica, V34, P1, DOI 10.3724/SP.J.1006.2008.00001; Yang K, 2010, J HERED, V101, P757, DOI 10.1093/jhered/esq078; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yilmaz A, 2011, NUCLEIC ACIDS RES, V39, pD1118, DOI 10.1093/nar/gkq1120; Zhang JF, 2009, PLANT MOL BIOL, V69, P553, DOI 10.1007/s11103-008-9437-y	40	34	37	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71110	10.1371/journal.pone.0071110	http://dx.doi.org/10.1371/journal.pone.0071110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990927	gold, Green Submitted, Green Published			2022-12-25	WOS:000323425700015
J	Pendall, E; Heisler-White, JL; Williams, DG; Dijkstra, FA; Carrillo, Y; Morgan, JA; LeCain, DR				Pendall, Elise; Heisler-White, Jana L.; Williams, David G.; Dijkstra, Feike A.; Carrillo, Yolima; Morgan, Jack A.; LeCain, Daniel R.			Warming Reduces Carbon Losses from Grassland Exposed to Elevated Atmospheric Carbon Dioxide	PLOS ONE			English	Article							SOIL RESPIRATION; PROCESS RESPONSES; LEAF RESPIRATION; ECOSYSTEM CARBON; ORGANIC-CARBON; CO2; DYNAMICS; PRECIPITATION; TEMPERATURE; ENHANCEMENT	The flux of carbon dioxide (CO2) between terrestrial ecosystems and the atmosphere may ameliorate or exacerbate climate change, depending on the relative responses of ecosystem photosynthesis and respiration to warming temperatures, rising atmospheric CO2, and altered precipitation. The combined effect of these global change factors is especially uncertain because of their potential for interactions and indirectly mediated conditions such as soil moisture. Here, we present observations of CO2 fluxes from a multi-factor experiment in semi-arid grassland that suggests a potentially strong climate carbon cycle feedback under combined elevated [CO2] and warming. Elevated [CO2] alone, and in combination with warming, enhanced ecosystem respiration to a greater extent than photosynthesis, resulting in net C loss over four years. The effect of warming was to reduce respiration especially during years of below-average precipitation, by partially offsetting the effect of elevated [CO2] on soil moisture and C cycling. Carbon losses were explained partly by stimulated decomposition of soil organic matter with elevated [CO2]. The climate - carbon cycle feedback observed in this semiarid grassland was mediated by soil water content, which was reduced by warming and increased by elevated [CO2]. Ecosystem models should incorporate direct and indirect effects of climate change on soil water content in order to accurately predict terrestrial feedbacks and long-term storage of C in soil.	[Pendall, Elise; Carrillo, Yolima] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Pendall, Elise; Carrillo, Yolima] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Heisler-White, Jana L.; Dijkstra, Feike A.; Morgan, Jack A.; LeCain, Daniel R.] ARS, USDA, Rangeland Resources Res Unit, Ft Collins, CO USA; [Heisler-White, Jana L.; Dijkstra, Feike A.; Morgan, Jack A.; LeCain, Daniel R.] ARS, USDA, Northern Plains Area, Ft Collins, CO USA; [Heisler-White, Jana L.; Williams, David G.] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Heisler-White, Jana L.; Williams, David G.] Univ Wyoming, Dept Ecosyst Sci, Laramie, WY 82071 USA; [Heisler-White, Jana L.; Williams, David G.] Univ Wyoming, Dept Management, Laramie, WY 82071 USA; [Heisler-White, Jana L.; Williams, David G.] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Dijkstra, Feike A.; Carrillo, Yolima] Univ Sydney, Fac Agr & Environm, Sydney, NSW 2006, Australia	University of Wyoming; University of Wyoming; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Wyoming; University of Wyoming; University of Wyoming; University of Wyoming; University of Sydney	Pendall, E (corresponding author), Univ Wyoming, Dept Bot, Laramie, WY 82071 USA.	Pendall@uwyo.edu	Williams, David G/A-6407-2014; Dijkstra, Feike A/H-2182-2012; Pendall, Elise/AAF-5667-2020	Williams, David G/0000-0003-3627-5260; Dijkstra, Feike A/0000-0002-6191-6018; Pendall, Elise/0000-0002-1651-8969	United States Department of Agriculture Agricultural Research Service Climate Change, Soils & Emissions Program, USDA-CSREES Soil Processes Program [2008-35107-18655]; United States Department of Energy's Office of Science (BER), through the Terrestrial Ecosystem Science program; Western Regional Center of the National Institute for Climatic Change Research at Northern Arizona University; NSF (DEB) [1021559]	United States Department of Agriculture Agricultural Research Service Climate Change, Soils & Emissions Program, USDA-CSREES Soil Processes Program; United States Department of Energy's Office of Science (BER), through the Terrestrial Ecosystem Science program(United States Department of Energy (DOE)); Western Regional Center of the National Institute for Climatic Change Research at Northern Arizona University; NSF (DEB)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by the United States Department of Agriculture Agricultural Research Service Climate Change, Soils & Emissions Program, USDA-CSREES Soil Processes Program (Grant no. 2008-35107-18655), United States Department of Energy's Office of Science (BER), through the Terrestrial Ecosystem Science program and the Western Regional Center of the National Institute for Climatic Change Research at Northern Arizona University, and by NSF (DEB# 1021559). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair EC, 2011, GLOBAL CHANGE BIOL, V17, P3546, DOI 10.1111/j.1365-2486.2011.02484.x; Angert A, 2005, P NATL ACAD SCI USA, V102, P10823, DOI 10.1073/pnas.0501647102; Atkin OK, 1998, AUST J PLANT PHYSIOL, V25, P437, DOI 10.1071/PP97159; Ayub G, 2011, NEW PHYTOL, V190, P1003, DOI 10.1111/j.1469-8137.2011.03673.x; Bachman S, 2010, OECOLOGIA, V162, P791, DOI 10.1007/s00442-009-1511-x; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Carrillo Y, 2012, ECOSYSTEMS, V15, P761, DOI 10.1007/s10021-012-9544-0; Carrillo Y, 2011, PLANT SOIL, V347, P339, DOI 10.1007/s11104-011-0853-4; Cox PM, 2000, NATURE, V408, P750, DOI 10.1038/35047138; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dieleman WIJ, 2012, GLOBAL CHANGE BIOL, V18, P2681, DOI 10.1111/j.1365-2486.2012.02745.x; Dijkstra FA, 2005, PLANT SOIL, V272, P41, DOI 10.1007/s11104-004-3848-6; Dijkstra FA, 2010, NEW PHYTOL, V187, P426, DOI 10.1111/j.1469-8137.2010.03293.x; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Jasoni RL, 2005, GLOBAL CHANGE BIOL, V11, P749, DOI 10.1111/j.1365-2486.2005.00948.x; Kimball BA, 2005, GLOBAL CHANGE BIOL, V11, P2041, DOI 10.1111/j.1365-2486.2005.01028.x; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Livingston GP, 2006, SOIL SCI SOC AM J, V70, P1459, DOI 10.2136/sssaj2005.0322; Luo YQ, 2008, GLOBAL CHANGE BIOL, V14, P1986, DOI 10.1111/j.1365-2486.2008.01629.x; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Luo YQ, 2011, GLOBAL CHANGE BIOL, V17, P843, DOI 10.1111/j.1365-2486.2010.02265.x; Miglietta F, 2001, ENVIRON MONIT ASSESS, V66, P107, DOI 10.1023/A:1026495830251; Morgan JA, 2004, OECOLOGIA, V140, P11, DOI 10.1007/s00442-004-1550-2; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Nie M, 2013, ECOL LETT, V16, P234, DOI 10.1111/ele.12034; Nowak RS, 2004, NEW PHYTOL, V162, P253, DOI 10.1111/j.1469-8137.2004.01033.x; Parton W, 2012, GLOBAL CHANGE BIOL, V18, P915, DOI 10.1111/j.1365-2486.2011.02611.x; Pataki DE, 2003, BIOSCIENCE, V53, P805, DOI 10.1641/0006-3568(2003)053[0805:TCIEFU]2.0.CO;2; Pendall E, 2004, NEW PHYTOL, V162, P311, DOI 10.1111/j.1469-8137.2004.01053.x; Pendall E, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001821; Pendall E, 2007, SOIL BIOL BIOCHEM, V39, P2628, DOI 10.1016/j.soilbio.2007.05.016; Piao SL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003339; Shen WJ, 2009, GLOBAL CHANGE BIOL, V15, P2274, DOI 10.1111/j.1365-2486.2009.01857.x; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x	40	47	50	15	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71921	10.1371/journal.pone.0071921	http://dx.doi.org/10.1371/journal.pone.0071921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977180	Green Published, gold			2022-12-25	WOS:000323425700113
J	Poligone, B; Hayden, MS; Chen, LJ; Pentland, AP; Jimi, E; Ghosh, S				Poligone, Brian; Hayden, Matthew S.; Chen, Luojing; Pentland, Alice P.; Jimi, Eijiro; Ghosh, Sankar			A Role for NF-kappa B Activity in Skin Hyperplasia and the Development of Keratoacanthomata in Mice	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; TRANSCRIPTIONAL ACTIVITY; ULTRAVIOLET-IRRADIATION; GENE-EXPRESSION; DISEASE; ALPHA; PHOSPHORYLATION; OVEREXPRESSION; TRANSFORMATION; INFLAMMATION	Background: Previous studies have implicated NF-kappa B signaling in both cutaneous development and oncogenesis. However, these studies have been limited in part by the lethality that results from extreme over-or under-expression of NF-kappa B in available mouse models. Even cre-driven tissue specific expression of transgenes, or targeted deletion of NF-kappa B can cause cell death. Therefore, the present study was undertaken to evaluate a novel mouse model of enhanced NF-kappa B activity in the skin. Methods: A knock-in homologous recombination technique was utilized to develop a mouse model (referred to as PD mice) with increased NF-kappa B activity. Results: The data show that increased NF-kappa B activity leads to hyperproliferation and dysplasia of the mouse epidermis. Chemical carcinogenesis in the context of enhanced NF-kappa B activity promotes the development of keratoacanthomata. Conclusion: Our findings support an important role for NF-kappa B in keratinocyte dysplasia. We have found that enhanced NF-kappa B activity renders keratinocytes susceptible to hyperproliferation and keratoacanthoma (KA) development but is not sufficient for transformation and SCC development. We therefore propose that NF-kappa B activation in the absence of additional oncogenic events can promote TNF-dependent, actinic keratosis-like dysplasia and TNF-independent, KAs upon chemical carcinogensis. These studies suggest that resolution of KA cannot occur when NF-kappa B activation is constitutively enforced.	[Poligone, Brian; Chen, Luojing; Pentland, Alice P.] Univ Rochester, Sch Med, Dept Dermatol, Rochester, NY USA; [Poligone, Brian; Chen, Luojing; Pentland, Alice P.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY USA; [Hayden, Matthew S.] Columbia Univ, Dept Dermatol, Coll Phys & Surg, New York, NY 10027 USA; [Hayden, Matthew S.; Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY USA; [Jimi, Eijiro] Kyushu Dent Coll, Div Mol Signaling & Biochem, Kitakyushu, Fukuoka 803, Japan	University of Rochester; University of Rochester; Columbia University; Columbia University; Kyushu Dental University	Poligone, B (corresponding author), Univ Rochester, Sch Med, Dept Dermatol, Rochester, NY USA.	brian_poligone@urmc.rochester.edu		Hayden, Matthew/0000-0003-1670-6430	National Institute of Arthritis and Musculoskeletal and Skin Diseases [5K08AR55986-3]; Wilmot Cancer Center Fellowship; National Institute of Allergy and Infectious Diseases [5R37AI033443]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR058886, K08AR055986] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wilmot Cancer Center Fellowship; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases: 5K08AR55986-3 and Wilmot Cancer Center Fellowship (BP) and National Institute of Allergy and Infectious Diseases: 5R37AI033443 (SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Brash DE, 2006, BRIT J DERMATOL, V154, P8, DOI 10.1111/j.1365-2133.2006.07230.x; Clausen OPF, 2006, J INVEST DERMATOL, V126, P2308, DOI 10.1038/sj.jid.5700375; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; DEGRUIJL FR, 1991, CANCER RES, V51, P979; Dong J, 2008, GENE DEV, V22, P1159, DOI 10.1101/gad.1657408; Dong J, 2010, GENE DEV, V24, P1709, DOI 10.1101/gad.1958410; Goel G, 2007, INT J TOXICOL, V26, P279, DOI 10.1080/10915810701464641; Iden S, 2012, CANCER CELL, V22, P389, DOI 10.1016/j.ccr.2012.08.004; Karin M, 2006, COMMUNICATION; Kim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039691; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Ko CJ, 2010, CLIN DERMATOL, V28, P254, DOI 10.1016/j.clindermatol.2009.06.010; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Li G, 1998, J INVEST DERMATOL, V110, P72, DOI 10.1046/j.1523-1747.1998.00090.x; Lind MH, 2004, P NATL ACAD SCI USA, V101, P4972, DOI 10.1073/pnas.0307106101; Loercher A, 2004, CANCER RES, V64, P6511, DOI 10.1158/0008-5472.CAN-04-0852; Page A, 2011, MOL CANCER RES, V5, P5; Page A, 2011, MOL CANCER RES, V9, P1329, DOI 10.1158/1541-7786.MCR-11-0168; Page A, 2010, J INVEST DERMATOL, V130, P1598, DOI 10.1038/jid.2010.28; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; PEREZ P, 1995, MOL CELL BIOL, V15, P3523; Ren Q, 2006, CANCER RES, V66, P5209, DOI 10.1158/0008-5472.CAN-05-4158; Roewert-Huber J, 2007, BRIT J DERMATOL, V157, P18, DOI 10.1111/j.1365-2133.2007.08267.x; Rogers LM, 2013, J INVEST DERMATOL, DOI DOI 10.1016/J.CELL.2008.01.020.PUBMED:18267068; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Suganuma M, 1999, CANCER RES, V59, P4516; Sur I, 2008, INT REV IMMUNOL, V27, P205, DOI 10.1080/08830180802130319; van Hogerlinden M, 2004, J INVEST DERMATOL, V123, P101, DOI 10.1111/j.0022-202X.2004.22706.x; van Hogerlinden M, 1999, CANCER RES, V59, P3299; van Hogerlinden M, 2002, ONCOGENE, V21, P4969, DOI 10.1038/sj.onc.1205620; VANDERSCHROEFF JG, 1990, J INVEST DERMATOL, V94, P423, DOI 10.1111/1523-1747.ep12874504; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Yao DG, 2006, CANCER RES, V66, P1302, DOI 10.1158/0008-5472.CAN-05-2341; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	38	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71887	10.1371/journal.pone.0071887	http://dx.doi.org/10.1371/journal.pone.0071887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977171	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700111
J	Virk, AP; Puri, M; Gupta, V; Capalash, N; Sharma, P				Virk, Antar Puneet; Puri, Minakshi; Gupta, Vijaya; Capalash, Neena; Sharma, Prince			Combined Enzymatic and Physical Deinking Methodology for Efficient Eco-Friendly Recycling of Old Newsprint	PLOS ONE			English	Article							GAMMA-PROTEOBACTERIUM JB; ALKALOPHILIC LACCASE; WHEAT-STRAW; PULP; XYLANASE; DEGRADATION; LIGNIN	Background: The development in the deinking process has made recycled fiber a major part of the raw material for pulp and paper industry. Enzymes have revolutionized the deinking process obtaining brightness levels surpassing conventional deinking processes. This study explores the deinking efficiencies of bacterial alkalophilic laccase (L) and xylanase (X) enzymes along with physical deinking methods of microwaving (MW) and sonication (S) for recycling of old newsprint (ONP). Methods and Results: The operational parameters viz. enzyme dose, pH and treatment time for X and L deinking were optimized statistically using Response Surface Methodology. Laccase did not require any mediator supplementation for deinking. Deinking of ONP pulp with a combination of xylanase and laccase enzymes was investigated, and fiber surface composition and morphological changes were studied using X-ray diffraction, fourier transform infrared spectroscopy and scanning electron microscopy. Compared to the pulp deinked with xylanase (47.9%) or laccase (62.2%) individually, the percentage reduction of effective residual ink concentration (ERIC) was higher for the combined xylanase/laccase-deinked pulp (65.8%). An increase in brightness (21.6%), breaking length (16.5%), burst factor (4.2%) tear factor (6.9%), viscosity (13%) and cellulose crystallinity (10.3%) along with decrease in kappa number (22%) and chemical consumption (50%) were also observed. Surface appeared more fibrillar along with changes in surface functional groups. A combination of physical and enzymatic processes (S-MW-XL) for deinking further improved brightness (28.8%) and decreased ERIC (73.9%) substantially. Conclusion: This is the first report on deinking of ONP with laccase without any mediator supplementation. XL pretreatment resulted in marked improvement in paper quality and a new sequence being reported for deinking (S-MW-XL) will contribute further in decreasing chemical consumption and making the process commercially feasible.	[Virk, Antar Puneet; Capalash, Neena] Panjab Univ, Dept Biotechnol, Chandigarh 160014, India; [Puri, Minakshi; Gupta, Vijaya; Sharma, Prince] Panjab Univ, Dept Microbiol, Chandigarh 160014, India	Panjab University; Panjab University	Sharma, P (corresponding author), Panjab Univ, Dept Microbiol, Chandigarh 160014, India.	princess@pu.ac.in		GUPTA, VIJAYA/0000-0002-0072-141X; Capalash, Neena/0000-0002-0197-8428				Arias ME, 2003, APPL ENVIRON MICROB, V69, P1953, DOI 10.1128/AEM.69.4.1953-1958.2003; BAILEY MJ, 1992, J BIOTECHNOL, V23, P257, DOI 10.1016/0168-1656(92)90074-J; Bains J, 2003, BIOTECHNOL LETT, V25, P1155, DOI 10.1023/A:1024569722413; Bajpai P, 2004, CRIT REV BIOTECHNOL, V24, P1, DOI 10.1080/07388550490465817; Bansal MC, 2011, IPPTA Q J INDIAN PUL, V23, P145; BUTA JG, 1989, J AGR FOOD CHEM, V37, P1382, DOI 10.1021/jf00089a038; CALL HP, 1992, PAPIER, V46, pV32; de la Hoz A, 2005, CHEM SOC REV, V34, P164, DOI 10.1039/b411438h; DEGRYSE E, 1978, ARCH MICROBIOL, V117, P189, DOI 10.1007/BF00402307; Eugenio ME, 2010, BIORESOURCE TECHNOL, V101, P1866, DOI 10.1016/j.biortech.2009.09.084; Geng X, 2002, APPL MICROBIOL BIOT, V60, P342, DOI 10.1007/s00253-002-1124-3; Gupta S, 2000, J APPL MICROBIOL, V88, P325, DOI 10.1046/j.1365-2672.2000.00974.x; Heinze T, 2001, PROG POLYM SCI, V26, P1689, DOI 10.1016/S0079-6700(01)00022-3; Ibarra D, 2012, J IND MICROBIOL BIOT, V39, P1, DOI 10.1007/s10295-011-0991-y; Leduc C, 2011, CELL CHEM TECHNOL, V45, P657; Maity C, 2012, APPL BIOCHEM BIOTECH, DOI 101007/s12010-012-9556-4; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mohandass C, 2005, J IND MICROBIOL BIOT, V32, P424, DOI 10.1007/s10295-005-0017-8; Oh SY, 2005, CARBOHYD RES, V340, P2376, DOI 10.1016/j.carres.2005.08.007; Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10; PATEL RN, 1993, APPL MICROBIOL BIOT, V39, P405, DOI 10.1007/BF00192102; Singh G, 2008, BIORESOURCE TECHNOL, V99, P7472, DOI 10.1016/j.biortech.2008.02.023; Tatsumi D, 2000, J WOOD SCI, V46, P405, DOI 10.1007/BF00776405; Vila C, 2011, BIORESOURCE TECHNOL, V102, P6554, DOI 10.1016/j.biortech.2011.03.068; Virk AP, 2012, BIOTECHNOL PROGR, V28, P1426, DOI 10.1002/btpr.1619; Virk AP, 2012, BIOTECHNOL PROGR, V28, P21, DOI 10.1002/btpr.727; Woldesenbet F, 2012, APPL BIOCHEM BIOTECH, V167, P100, DOI 10.1007/s12010-012-9663-2; Xu QH, 2011, BIORESOURCE TECHNOL, V102, P6536, DOI 10.1016/j.biortech.2011.03.051; Xu QH, 2007, APPITA J, V60, P372; Xu QH, 2009, WASTE MANAGE, V29, P1486, DOI 10.1016/j.wasman.2008.10.007	30	47	47	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72346	10.1371/journal.pone.0072346	http://dx.doi.org/10.1371/journal.pone.0072346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977287	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000093
J	Zhang, SQ; Sawmiller, D; Li, S; Rezai-Zadeh, K; Hou, HY; Zhou, SF; Shytle, D; Giunta, B; Fernandez, F; Mori, T; Tan, J				Zhang, She-Qing; Sawmiller, Darrell; Li, Song; Rezai-Zadeh, Kavon; Hou, Huayan; Zhou, Shufeng; Shytle, Douglas; Giunta, Brian; Fernandez, Frank; Mori, Takashi; Tan, Jun			Octyl Gallate Markedly Promotes Anti-Amyloidogenic Processing of APP through Estrogen Receptor-Mediated ADAM10 Activation	PLOS ONE			English	Article							PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; ALPHA-SECRETASE; EGCG; NEUROPROTECTION; MECHANISMS; CLEAVAGE; BIOLOGY	Our previous studies showed that the green tea-derived polyphenolic compound (-)-epigallocatechin-3 gallate (EGCG) reduces amyloid-beta (A beta) production in both neuronal and mouse Alzheimer's disease (AD) models in concert with activation of estrogen receptor-alpha/phosphatidylinositide 3-kinase/protein kinase B (ER alpha/PI3K/Akt) signaling and anti-amyloidogenic amyloid precursor protein (APP) alpha-secretase (a disintegrin and metallopeptidase domain-10, ADAM10) processing. Since the gallate moiety in EGCG may correspond to the 7 alpha position of estrogen, thereby facilitating ER binding, we extensively screened the effect of other gallate containing phenolic compounds on APP anti-amyloidogenic processing. Octyl gallate (OG; 10 mu M), drastically decreased A beta generation, in concert with increased APP alpha-proteolysis, in murine neuron-like cells transfected with human wild-type APP or "Swedish'' mutant APP. OG markedly increased production of the neuroprotective amino-terminal APP cleavage product, soluble APP-alpha (sAPP alpha). In accord with our previous study, these cleavage events were associated with increased ADAM10 maturation and reduced by blockade of ER alpha/PI3k/Akt signaling. To validate these findings in vivo, we treated A beta-overproducing Tg2576 mice with OG daily for one week by intracerebroventricular injection and found decreased A beta levels associated with increased sAPP alpha. These data indicate that OG increases anti-amyloidogenic APP alpha-secretase processing by activation of ER alpha/PI3k/Akt signaling and ADAM10, suggesting that this compound may be an effective treatment for AD.	[Zhang, She-Qing; Sawmiller, Darrell; Li, Song; Rezai-Zadeh, Kavon; Hou, Huayan; Fernandez, Frank; Tan, Jun] Univ S Florida, Morsani Coll Med, Silver Child Dev Ctr, Rashid Lab Dev Neurobiol, Tampa, FL 33620 USA; [Zhang, She-Qing] Shanghai Changhai Hosp, Dept Neurol, Shanghai, Peoples R China; [Sawmiller, Darrell; Giunta, Brian; Tan, Jun] James A Haley Vet Adm Hosp, Tampa, FL USA; [Li, Song] Dalian Univ Technol, Sch Phys & Optoelect Technol, Dept Biophys, Dalian, Peoples R China; [Zhou, Shufeng] Univ S Florida, Sch Pharm, Dept Therapeut Sci, Tampa, FL USA; [Shytle, Douglas] Univ S Florida, Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg, Tampa, FL USA; [Fernandez, Frank] Univ S Florida, Morsani Coll Med, Dept Psychiat & Behav Neurosci, Neuroimmunol Lab, Tampa, FL USA; [Mori, Takashi] Saitama Med Ctr & Univ, Dept Biomed Sci & Pathol, Kawagoe, Saitama, Japan	State University System of Florida; University of South Florida; Naval Medical University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; Dalian University of Technology; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Saitama Medical University	Zhang, SQ (corresponding author), Univ S Florida, Morsani Coll Med, Silver Child Dev Ctr, Rashid Lab Dev Neurobiol, Tampa, FL 33620 USA.	sheqingzhangi@126.com; jtan@health.usf.edu	Li, Song/C-6701-2014; Shytle, Roland D/J-4249-2012; Sawmiller, Darrell/AAQ-9722-2021	Li, Song/0000-0003-2713-9136; Sawmiller, Darrell/0000-0003-3599-6859	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Medical Research Service through a Veterans Affairs Merit grant; Japan Society for the Promotion of Science [22500320]; STCSM [12ZR1438200]; Veterans Affairs [I01BX001143] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Medical Research Service through a Veterans Affairs Merit grant(US Department of Veterans Affairs); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); STCSM(Science & Technology Commission of Shanghai Municipality (STCSM)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by funds from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Medical Research Service through a Veterans Affairs Merit grant to J.T., Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (22500320) to T. M., and STCSM Funds (12ZR1438200) to S.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum LW, 2005, J GERONTOL A-BIOL, V60, P736, DOI 10.1093/gerona/60.6.736; Chyu KY, 2004, CIRCULATION, V109, P2448, DOI 10.1161/01.CIR.0000128034.70732.C2; Fang H, 2001, CHEM RES TOXICOL, V14, P280, DOI 10.1021/tx000208y; Fernandez JW, 2010, FEBS LETT, V584, P4259, DOI 10.1016/j.febslet.2010.09.022; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Giunta B, 2010, NEUROSCI LETT, V471, P134, DOI 10.1016/j.neulet.2010.01.026; Golde TE, 2000, BBA-MOL BASIS DIS, V1502, P172, DOI 10.1016/S0925-4439(00)00043-0; Han Xianlin, 2005, Current Alzheimer Research, V2, P65, DOI 10.2174/1567205052772786; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hooper NM, 2002, CURR MED CHEM, V9, P1107, DOI 10.2174/0929867023370121; Huse JT, 2000, MOL NEUROBIOL, V22, P81; LANNFELT L, 1995, NAT MED, V1, P829, DOI 10.1038/nm0895-829; Levites Y, 2003, FASEB J, V17, P952, DOI 10.1096/fj.02-0881fje; Levites Y, 2002, J BIOL CHEM, V277, P30574, DOI 10.1074/jbc.M202832200; Lin Jen-Kun, 2000, Proceedings of the National Science Council Republic of China Part B Life Sciences, V24, P1; Mannella P, 2006, J NEUROSCI, V26, P9439, DOI 10.1523/JNEUROSCI.1443-06.2006; Miller D, 2001, ENVIRON HEALTH PERSP, V109, P133, DOI 10.2307/3434765; Moyers SB, 2004, NUTR REV, V62, P204, DOI [10.1301/nr.2004.may.204-211, 10.1111/j.1753-4887.2004.tb00041.x]; Musicco M, 2009, FUNCT NEUROL, V24, P89; Obregon DF, 2006, J BIOL CHEM, V281, P16419, DOI 10.1074/jbc.M600617200; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; Sambamurti K, 2002, NEUROMOL MED, V1, P1, DOI 10.1385/NMM:1:1:1; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Steiner H, 1999, BIOCHEM SOC T, V27, P234, DOI 10.1042/bst0270234; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092	30	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71913	10.1371/journal.pone.0071913	http://dx.doi.org/10.1371/journal.pone.0071913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977176	gold, Green Submitted, Green Published			2022-12-25	WOS:000323378000073
J	Shinya, S; Ohnuma, T; Yamashiro, R; Kimoto, H; Kusaoke, H; Anbazhagan, P; Juffer, AH; Fukamizo, T				Shinya, Shoko; Ohnuma, Takayuki; Yamashiro, Reina; Kimoto, Hisashi; Kusaoke, Hideo; Anbazhagan, Padmanabhan; Juffer, Andre H.; Fukamizo, Tamo			The First Identification of Carbohydrate Binding Modules Specific to Chitosan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate-binding Protein; Docking; Isothermal Titration Calorimetry; NMR; Oligosaccharide	DICTYOSTELIUM-DISCOIDEUM; FUNCTIONAL-ANALYSIS; AUTOMATED DOCKING; CHITIN-BINDING; PROTEIN; RECOGNITION; TITRATION; AFFINITY; DOMAIN; OLIGOSACCHARIDES	Background: Carbohydrate binding modules (CBMs) specific to chitosan have yet to be identified. Results: Two CBMs located at the C terminus of a chitosanase from Paenibacillus sp. IK-5 specifically bound chitosan oligosaccharides. Conclusion: Individual CBMs can accommodate at least two glucosamine units at loops extruded from the core -sandwich. Significance: The synergistic action of the two CBMs appears to facilitate chitosan hydrolysis. Two carbohydrate binding modules (DD1 and DD2) belonging to CBM32 are located at the C terminus of a chitosanase from Paenibacillus sp. IK-5. We produced three proteins, DD1, DD2, and tandem DD1/DD2 (DD1+DD2), and characterized their binding ability. Transition temperature of thermal unfolding (T-m) of each protein was elevated by the addition of cello-, laminari-, chitin-, or chitosan-hexamer (GlcN)(6). The T-m elevation (T-m) in DD1 was the highest (10.3 degrees C) upon the addition of (GlcN)(6) and was markedly higher than that in DD2 (1.0 degrees C). A synergistic effect was observed (T-m = 13.6 degrees C), when (GlcN)(6) was added to DD1+DD2. From isothermal titration calorimetry experiments, affinities to DD1 were not clearly dependent upon chain length of (GlcN)(n); G(r)degrees values were -7.8 (n = 6), -7.6 (n = 5), -7.6 (n = 4), -7.6 (n = 3), and -7.1 (n = 2) kcal/mol, and the value was not obtained for GlcN due to the lowest affinity. DD2 bound (GlcN)(n) with the lower affinities (G(r)degrees = -5.0 (n = 3) approximate to -5.2 (n = 6) kcal/mol). Isothermal titration calorimetry profiles obtained for DD1+DD2 exhibited a better fit when the two-site model was used for analysis and provided greater affinities to (GlcN)(6) for individual DD1 and DD2 sites (G(r)degrees = -8.6 and -6.4 kcal/mol, respectively). From NMR titration experiments, (GlcN)(n) (n = 2 approximate to 6) were found to bind to loops extruded from the core -sandwich of individual DD1 and DD2, and the interaction sites were similar to each other. Taken together, DD1+DD2 is specific to chitosan, and individual modules synergistically interact with at least two GlcN units, facilitating chitosan hydrolysis.	[Shinya, Shoko; Ohnuma, Takayuki; Yamashiro, Reina; Fukamizo, Tamo] Kinki Univ, Dept Adv Biosci, Nara 6318505, Japan; [Kimoto, Hisashi] Fukui Prefectural Univ, Dept Biosci, Fukui 9101195, Japan; [Kusaoke, Hideo] Fukui Univ Technol, Dept Environm & Biotechnol Frontier Engn, Fukui 9108505, Japan; [Anbazhagan, Padmanabhan; Juffer, Andre H.] Univ Oulu, Bioctr Oulu, FI-90074 Oulu, Finland; [Anbazhagan, Padmanabhan; Juffer, Andre H.] Univ Oulu, Dept Biochem, FI-90074 Oulu, Finland	Kindai University (Kinki University); Fukui Prefectural University; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu	Fukamizo, T (corresponding author), Kinki Univ, Dept Adv Biosci, 3327-204 Nakamachi, Nara 6318505, Japan.	fukamizo@nara.kindai.ac.jp	OHNUMA, Takayuki/T-8839-2019; Fukamizo, Tamo/AAY-7251-2020	Juffer, Andre/0000-0003-3533-0520	Strategic Project to Support the Formation of Research Bases at Private Universities; MEXT (Ministry of Education, Culture, Sports, Science, and Technology) [S1101035]; Japan Society for the Promotion of Science [25-3639]	Strategic Project to Support the Formation of Research Bases at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT (Ministry of Education, Culture, Sports, Science, and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Strategic Project to Support the Formation of Research Bases at Private Universities and a Matching Fund Subsidy from MEXT (Ministry of Education, Culture, Sports, Science, and Technology), 2011-2015 (S1101035).; Supported by a Research Fellowship for Young Scientists from Japan Society for the Promotion of Science (25-3639).	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Abbott DW, 2007, J MOL BIOL, V367, P1023, DOI 10.1016/j.jmb.2007.01.030; Akagi K, 2006, J BIOCHEM, V139, P483, DOI 10.1093/jb/mvj062; Aragao KS, 2008, PROTEINS, V73, P43, DOI 10.1002/prot.22038; Araki Y, 2010, BIOSCI BIOTECH BIOCH, V74, P802, DOI 10.1271/bbb.90845; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Boraston AB, 2006, J BIOL CHEM, V281, P587, DOI 10.1074/jbc.M509958200; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caspi J, 2009, APPL ENVIRON MICROB, V75, P7335, DOI 10.1128/AEM.01241-09; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dvortsov IA, 2012, MOL BIOL+, V46, P817, DOI 10.1134/S0026893312060039; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Garcia-Hernandez E, 2003, PROTEIN SCI, V12, P135, DOI 10.1110/ps.0222503; Goddard T.D., 2004, SPARKY 3; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Kezuka Y, 2006, J MOL BIOL, V358, P472, DOI 10.1016/j.jmb.2006.02.013; Kiedzierska A, 2007, BBA-PROTEINS PROTEOM, V1774, P1069, DOI 10.1016/j.bbapap.2007.07.007; Kimoto H, 2002, J BIOL CHEM, V277, P14695, DOI 10.1074/jbc.M108660200; Kimoto H, 2010, J MOL MICROB BIOTECH, V18, P14, DOI 10.1159/000274308; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Mathieu SV, 2010, J MOL BIOL, V400, P540, DOI 10.1016/j.jmb.2010.05.042; Mizutani K, 2012, APPL ENVIRON MICROB, V78, P4781, DOI 10.1128/AEM.07457-11; MONAGHAN RL, 1973, NATURE-NEW BIOL, V245, P78, DOI 10.1038/newbio245078a0; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Newstead SL, 2005, ACTA CRYSTALLOGR D, V61, P1483, DOI 10.1107/S0907444905026132; Ohnuma T, 2011, FEBS J, V278, P3991, DOI 10.1111/j.1742-4658.2011.08301.x; Onaga S, 2008, GLYCOBIOLOGY, V18, P414, DOI 10.1093/glycob/cwn018; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SIMPSON DL, 1974, BIOCHEMISTRY-US, V13, P3487, DOI 10.1021/bi00714a011; Simpson HD, 1999, J BACTERIOL, V181, P4611, DOI 10.1128/JB.181.15.4611-4616.1999; Synowiecki J, 2003, CRIT REV FOOD SCI, V43, P145, DOI 10.1080/10408690390826473; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSUKADA S, 1981, CARBOHYD RES, V88, P19, DOI 10.1016/S0008-6215(00)84598-X; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; van Bueren AL, 2009, J MOL BIOL, V385, P131, DOI 10.1016/j.jmb.2008.10.031; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VARUM KM, 1991, CARBOHYD RES, V217, P19, DOI 10.1016/0008-6215(91)84113-S; Vazana Y, 2010, APPL ENVIRON MICROB, V76, P3236, DOI 10.1128/AEM.00009-10; Vijayasarathy C, 2007, INVEST OPHTH VIS SCI, V48, P991, DOI 10.1167/iovs.06-0915; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471	50	16	17	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30042	30053		10.1074/jbc.M113.503243	http://dx.doi.org/10.1074/jbc.M113.503243			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986450	Green Published, hybrid			2022-12-25	WOS:000329868100005
J	Xu, GQ; Jiang, XG; Jaffrey, SR				Xu, Guoqiang; Jiang, Xiaogang; Jaffrey, Samie R.			A Mental Retardation-linked Nonsense Mutation in Cereblon Is Rescued by Proteasome Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MESSENGER-RNA; UBIQUITIN LIGASE; BINDING-PROTEIN; DEGRADATION; GENE; AUTOUBIQUITINATION; THALIDOMIDE; ABUNDANCE; MOUSE; IDENTIFICATION	A nonsense mutation in cereblon (CRBN) causes autosomal recessive nonsyndromic mental retardation. Cereblon is a substrate receptor for the Cullin-RING E3 ligase complex and couples the ubiquitin ligase to specific ubiquitination targets. The CRBN nonsense mutation (R419X) results in a protein lacking 24 amino acids at its C terminus. Although this mutation has been linked to mild mental retardation, the mechanism by which the mutation affects CRBN function is unknown. Here, we used biochemical and mass spectrometric approaches to explore the function of this mutant. We show that the protein retains its ability to assemble into a Cullin-RING E3 ligase complex and catalyzes the ubiquitination of CRBN-target proteins. However, we find that this mutant exhibits markedly increased levels of autoubiquitination and is more readily degraded by the proteasome than the wild type protein. We also show that the level of the mutant protein can be restored by a treatment of cells with a clinically utilized proteasome inhibitor, suggesting that this agent may be useful for the treatment of mental retardation associated with the CRBN R419X mutation. These data demonstrate that enhanced autoubiquitination and degradation account for the defect in CRBN activity that leads to mental retardation.	[Xu, Guoqiang; Jiang, Xiaogang] Soochow Univ, Dept Pharmacol, Coll Pharmaceut Sci, Jiangsu Key Lab Translat Res Neuropsychodis, Suzhou 215123, Jiangsu, Peoples R China; [Xu, Guoqiang; Jaffrey, Samie R.] Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10065 USA	Soochow University - China; Cornell University	Xu, GQ (corresponding author), Soochow Univ, Dept Pharmacol, Coll Pharmaceut Sci, Suzhou 215123, Jiangsu, Peoples R China.	gux2002@suda.edu.cn; srj2003@med.cornell.edu		Jaffrey, Samie/0000-0003-3615-6958; Xu, Guoqiang/0000-0002-4753-4769	National Institutes of Health [RR19355, RR22615]; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019355, S10RR022615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Columbia University). The full-length and dominant negative CUL4As and His6-ubiquitin plasmids were from Pengbo Zhou (Weill Medical College of Cornell University). Weare grateful to Michael S. Cohen and Alessia Deglincerti for assistance in molecular biology and plasmid transfection and Steven S. Gross (Weill Medical College) and Yuliang Ma (Weill Medical College) for helpful discussions in MS/ MS analysis. The mass spectrometry work was performed at the Weill Medical College of Cornell University mass spectrometry core facility using instrumentation supported by National Institutes of Health Grants RR19355 and RR22615.	Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BAUMANN B, 1985, EMBO J, V4, P351, DOI 10.1002/j.1460-2075.1985.tb03636.x; BELGRADER P, 1994, MOL CELL BIOL, V14, P6326, DOI 10.1128/MCB.14.9.6326; Bhat KP, 2010, J BIOL CHEM, V285, P25893, DOI 10.1074/jbc.M110.127746; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P61; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; CHENG J, 1994, MOL CELL BIOL, V14, P6317, DOI 10.1128/MCB.14.9.6317; Damaj G, 2003, LEUKEMIA, V17, P1914, DOI 10.1038/sj.leu.2403058; Ehninger D, 2005, NAT NEUROSCI, V8, P548, DOI 10.1038/nn0505-548; ENSSLE J, 1993, P NATL ACAD SCI USA, V90, P10091, DOI 10.1073/pnas.90.21.10091; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Haberland J, 1997, J BIOL CHEM, V272, P24717, DOI 10.1074/jbc.272.39.24717; Higgins JJ, 2000, NEUROLOGY, V55, P335, DOI 10.1212/WNL.55.3.335; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Hohberger B, 2009, FEBS LETT, V583, P633, DOI 10.1016/j.febslet.2009.01.018; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jo S, 2005, J NEUROCHEM, V94, P1212, DOI 10.1111/j.1471-4159.2005.03344.x; Lai ZH, 2002, P NATL ACAD SCI USA, V99, P14734, DOI 10.1073/pnas.212428599; Lee KM, 2012, BIOCHEM BIOPH RES CO, V427, P618, DOI 10.1016/j.bbrc.2012.09.108; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; Lin GY, 1998, VIROLOGY, V249, P189, DOI 10.1006/viro.1998.9317; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; MASHIMA Y, 1992, AM J HUM GENET, V51, P81; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Ren HG, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-40; Silva AJ, 2009, J NEURODEV DISORD, V1, P150, DOI 10.1007/s11689-009-9018-7; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wu FQ, 2011, MED MICROBIOL IMMUN, V200, P203, DOI 10.1007/s00430-011-0196-z; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zeier Z, 2009, GENE THER, V16, P1122, DOI 10.1038/gt.2009.83; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	47	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29573	29585		10.1074/jbc.M113.472092	http://dx.doi.org/10.1074/jbc.M113.472092			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23983124	Green Published, hybrid			2022-12-25	WOS:000330615300033
J	Luciani, P; Deledda, C; Benvenuti, S; Squecco, R; Cellai, I; Fibbi, B; Marone, IM; Giuliani, C; Modi, G; Francini, F; Vannelli, GB; Peri, A				Luciani, Paola; Deledda, Cristiana; Benvenuti, Susanna; Squecco, Roberta; Cellai, Ilaria; Fibbi, Benedetta; Marone, Ilaria Maddalena; Giuliani, Corinna; Modi, Giulia; Francini, Fabio; Vannelli, Gabriella Barbara; Peri, Alessandro			Exendin-4 Induces Cell Adhesion and Differentiation and Counteracts the Invasive Potential of Human Neuroblastoma Cells	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; RETINOIC-ACID; C-CELLS; EXPRESSION; RECEPTOR; METASTASIS; CANCER; GROWTH; INVOLVEMENT; GLP-1	Exendin-4 is a molecule currently used, in its synthetic form exenatide, for the treatment of type 2 diabetes mellitus. Exendin-4 binds and activates the Glucagon-Like Peptide-1 Receptor (GLP-1R), thus inducing insulin release. More recently, additional biological properties have been associated to molecules that belong to the GLP-1 family. For instance, Peptide YY and Vasoactive Intestinal Peptide have been found to affect cell adhesion and migration and our previous data have shown a considerable actin cytoskeleton rearrangement after exendin-4 treatment. However, no data are currently available on the effects of exendin-4 on tumor cell motility. The aim of this study was to investigate the effects of this molecule on cell adhesion, differentiation and migration in two neuroblastoma cell lines, SH-SY5Y and SK-N-AS. We first demonstrated, by Extra Cellular Matrix cell adhesion arrays, that exendin-4 increased cell adhesion, in particular on a vitronectin substrate. Subsequently, we found that this molecule induced a more differentiated phenotype, as assessed by i) the evaluation of neurite-like protrusions in 3D cell cultures, ii) the analysis of the expression of neuronal markers and iii) electrophysiological studies. Furthermore, we demonstrated that exendin-4 reduced cell migration and counteracted anchorage-independent growth in neuroblastoma cells. Overall, these data indicate for the first time that exendin-4 may have anti-tumoral properties.	[Luciani, Paola; Deledda, Cristiana; Benvenuti, Susanna; Cellai, Ilaria; Fibbi, Benedetta; Marone, Ilaria Maddalena; Giuliani, Corinna; Modi, Giulia; Peri, Alessandro] Univ Florence, Dept Expt & Clin Biomed Sci, Endocrine Unit, Ctr Res Transfer & High Educ Chron Inflammatory D, Florence, Italy; [Squecco, Roberta; Francini, Fabio] Univ Florence, Dept Physiol Sci, Florence, Italy; [Vannelli, Gabriella Barbara] Univ Florence, Dept Anat Histol & Forens Med, Florence, Italy	University of Florence; University of Florence; University of Florence	Peri, A (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci, Endocrine Unit, Ctr Res Transfer & High Educ Chron Inflammatory D, Florence, Italy.	a.peri@dfc.unifi.it	Peri, Alessandro/AAR-9664-2021; Squecco, Roberta/K-8961-2019; Deledda, Cristiana/AAB-8976-2019	francini, fabio/0000-0002-9255-1824	Ente Cassa di Risparmio di Firenze; Regione Toscana "Bando Salute"; Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN) [2009YJTBAZ]	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Regione Toscana "Bando Salute"(Regione Toscana); Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This study was supported by grants from Ente Cassa di Risparmio di Firenze, from the Regione Toscana "Bando Salute 2009'' and from Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2009 n. 2009YJTBAZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves C, 2012, DIABETES RES CLIN PR, V98, P271, DOI 10.1016/j.diabres.2012.09.008; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Benvenuti S, 2006, EXP CELL RES, V312, P2592, DOI 10.1016/j.yexcr.2006.04.016; Cellai I, 2006, BRIT J CANCER, V95, P879, DOI 10.1038/sj.bjc.6603344; Chambaut-Guerin AM, 2000, J NEUROCHEM, V74, P508, DOI 10.1046/j.1471-4159.2000.740508.x; Cheng HC, 1998, J BIOL CHEM, V273, P24207, DOI 10.1074/jbc.273.37.24207; Cheung BB, 2011, CURR CANCER DRUG TAR, V11, P826; Crespel A, 1996, ENDOCRINOLOGY, V137, P3674, DOI 10.1210/en.137.9.3674; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Formigli L, 2005, AM J PHYSIOL-CELL PH, V288, pC795, DOI 10.1152/ajpcell.00345.2004; Formigli L, 2009, J CELL SCI, V122, P1322, DOI 10.1242/jcs.035402; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; Giannini S, 2008, J ENDOCRINOL, V198, P523, DOI 10.1677/JOE-07-0613; Gladson CL, 1997, AM J PATHOL, V150, P1631; GOKE R, 1995, EUR J NEUROSCI, V7, P2294, DOI 10.1111/j.1460-9568.1995.tb00650.x; Havre PA, 2009, BRIT J CANCER, V101, P983, DOI 10.1038/sj.bjc.6605236; JOHNSTON JA, 1994, J IMMUNOL, V153, P1762; Joshi S, 2007, BBA-MOL BASIS DIS, V1772, P1093, DOI 10.1016/j.bbadis.2007.05.009; Knudsen LB, 2010, ENDOCRINOLOGY, V151, P1473, DOI 10.1210/en.2009-1272; Koehler JA, 2011, ENDOCRINOLOGY, V152, P3362, DOI 10.1210/en.2011-1201; Korner M, 2007, J NUCL MED, V48, P736, DOI 10.2967/jnumed.106.038679; Kolterman OG, 2005, AM J HEALTH-SYST PH, V62, P173, DOI 10.1093/ajhp/62.2.173; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Lam WA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-35; Lee M, 2005, J BIOL CHEM, V280, P125, DOI 10.1074/jbc.M408858200; Li P, 2004, J PEDIATR SURG, V39, P1512, DOI 10.1016/j.jpedsurg.2004.06.011; Ligumsky H, 2012, BREAST CANCER RES TR, V132, P449, DOI 10.1007/s10549-011-1585-0; Luciani P, 2010, CELL MOL LIFE SCI, V67, P3711, DOI 10.1007/s00018-010-0398-3; Ma M, 2001, CANC LETT, V31, P1; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Marx N, 2010, CELL MOL LIFE SCI, V67, P3549, DOI 10.1007/s00018-010-0396-5; Meyer A, 2004, NEOPLASIA, V6, P332, DOI 10.1593/neo.03445; NORDSTROM LA, 1995, MOL CELL NEUROSCI, V6, P56, DOI 10.1006/mcne.1995.1006; O'Neill GM, 2009, CELL ADHES MIGR, V3, P355, DOI 10.4161/cam.3.4.9468; Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Pola S, 2003, J BIOL CHEM, V278, P40601, DOI 10.1074/jbc.M306510200; Ross RA, 2003, CANCER LETT, V197, P35, DOI 10.1016/S0304-3835(03)00079-X; Sbrana F, 2008, AM J PHYSIOL-CELL PH, V295, pC160, DOI 10.1152/ajpcell.00014.2008; Shingu K, 2003, CANCER IMMUNOL IMMUN, V52, P546, DOI 10.1007/s00262-003-0392-9; Uchiyama A, 2007, BBA-MOL CELL BIOL L, V1771, P103, DOI 10.1016/j.bbalip.2006.10.001; VANNELLI GB, 1995, J NEUROSCI, V15, P4382; Wang LH, 2004, MT SINAI J MED, V71, P361	44	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e71716	10.1371/journal.pone.0071716	http://dx.doi.org/10.1371/journal.pone.0071716			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23990978	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470700020
J	Dalgard, C; Christiansen, L; Vogel, U; Dethlefsen, C; Tjonneland, A; Overvad, K				Dalgard, Christine; Christiansen, Lene; Vogel, Ulla; Dethlefsen, Claus; Tjonneland, Anne; Overvad, Kim			Variation in the Sodium-Dependent Vitamin C Transporter 2 Gene Is Associated with Risk of Acute Coronary Syndrome among Women	PLOS ONE			English	Article							GASTRIC-CANCER; DISEASE; SLC23A1; POLYMORPHISMS; CARDIOLOGY; PLASMA	Background: Vitamin C is associated with a lower risk of coronary heart disease possibly due to its anti-oxidative effects, beneficial effects on endothelial function and importance in collagen synthesis. The sodium-dependent vitamin C transporter 2 is responsible for the transport of vitamin C into various cells and malfunction of this protein leads to reduced vitamin C in tissue, including the arterial wall. We tested the hypothesis that candidate variations rs6139591 and rs1776964 in the gene coding for sodium-dependent vitamin C transporter 2 are associated with development of acute coronary syndrome. Design: In the Danish Diet, Cancer and Health cohort study, we performed a case-cohort study among 57,053 subjects aged 50-64 years. Results: During a mean follow-up period of 6.4 years, we identified 936 cases and randomly selected a sub-cohort (n = 1,580) with full information on genotypes and covariates. Using Cox proportional hazard models, we found that women with the rs6139591 TT genotype and a lower than median dietary vitamin C intake had a higher risk of acute coronary syndrome compared with those with the CC genotype (adjusted HR 5.39, 95% confidence interval, 2.01-14.50). We also observed a not as strong but positive although inconsistent association for women at a higher than median intake of vitamin C rich food. For the rs1776964 polymorphism, we found a higher risk (adjusted HR 3.45, 95% CI, 1.16-10.28) among TT-homozygous women with higher than median vitamin C intake compared with the CC genotype and low vitamin C intake. Among men, weaker and non-significant associations were observed for both polymorphisms. Conclusion: Genetic variation in the sodium-dependent vitamin C transporter 2 is associated with risk of incident acute coronary syndrome in women. The genotype effects may not be fully compensated by a higher intake of vitamin C rich food.	[Dalgard, Christine] Univ Southern Denmark, Inst Publ Hlth, Dept Environm Med, Odense, Denmark; [Christiansen, Lene] Univ Southern Denmark, Inst Publ Hlth, Dept Epidemiol, Odense, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Dethlefsen, Claus; Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Ctr Cardiovasc Res, Dept Cardiol, Aalborg, Denmark; [Tjonneland, Anne] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark	University of Southern Denmark; University of Southern Denmark; National Research Centre for the Working Environment; Aalborg University; Aalborg University Hospital; Aarhus University; Danish Cancer Society; Aarhus University	Dalgard, C (corresponding author), Univ Southern Denmark, Inst Publ Hlth, Dept Environm Med, Odense, Denmark.	cdalgaard@health.sdu.dk	Vogel, Ulla/ABC-2212-2020; Vogel, Ulla B/I-5048-2012	Vogel, Ulla/0000-0001-6807-1524; Vogel, Ulla B/0000-0001-6807-1524; Dalgard, Christine/0000-0001-8184-3429; Overvad, Kim/0000-0001-6429-7921; Dethlefsen, Claus/0000-0003-3994-6189; Tjonneland, Anne/0000-0003-4385-2097	Danish Heart Foundation [06-10-R44-A1306_06-S1-22338]; Danish Cancer Society	Danish Heart Foundation; Danish Cancer Society(Danish Cancer Society)	The present study was supported by the Danish Heart Foundation (06-10-R44-A1306_06-S1-22338). The Danish Diet, Cancer and Health cohort study was supported by Danish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard J, 1997, AM J CLIN NUTR, V66, P1165, DOI 10.1093/ajcn/66.5.1165; Cahill LE, 2009, J NUTRIGENET NUTRIGE, V2, P292, DOI 10.1159/000314597; Chen AA, 2009, CARCINOGENESIS, V30, P977, DOI 10.1093/carcin/bgp076; Eck P, 2004, HUM GENET, V115, P285, DOI 10.1007/s00439-004-1167-x; Erichsen HC, 2008, NUTR CANCER, V60, P652, DOI 10.1080/01635580802033110; Erichsen HC, 2006, AM J EPIDEMIOL, V163, P245, DOI 10.1093/aje/kwj035; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Franklin BA, 2011, CIRCULATION, V123, P2274, DOI 10.1161/CIRCULATIONAHA.110.981613; Harrison FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035623; Jenab M, 2006, CARCINOGENESIS, V27, P2250, DOI 10.1093/carcin/bgl096; Jensen MK, 2008, CIRCULATION, V117, P3062, DOI 10.1161/CIRCULATIONAHA.107.759951; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; KALBFLEISCH JD, 1988, STAT MED, V7, P149, DOI 10.1002/sim.4780070116; Kullo IJ, 2007, NAT CLIN PRACT CARD, V4, P558, DOI 10.1038/ncpcardio0982; Lauritzen J, 2007, FOODCALC; Liao YC, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-93; Lin HF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015124; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Nakata Y, 2002, CIRCULATION, V105, P1485, DOI 10.1161/01.CIR.0000012142.69612.25; Ogawa N, 2010, INT J HYPERTENS, V2010, DOI 10.4061/2010/790539; Pedersen CB, 2006, DAN MED BULL, V53, P441; Qiao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035746; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; Siega-Riz AM, 2003, AM J OBSTET GYNECOL, V189, P519, DOI 10.1067/S0002-9378(03)00363-6; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Varma S, 2008, BIOCHEMISTRY-US, V47, P2952, DOI 10.1021/bi701666q; Vogel U, 2010, ATHEROSCLEROSIS, V209, P155, DOI 10.1016/j.atherosclerosis.2009.08.036; Wilson JX, 2005, ANNU REV NUTR, V25, P105, DOI 10.1146/annurev.nutr.25.050304.092647; Wright ME, 2009, EUR J CANCER, V45, P1824, DOI 10.1016/j.ejca.2009.01.027; Yla-Herttuala S, 2011, THROMB HAEMOST, V106; Zanon-Moreno V, 2011, MOL VIS, V17, P2997	35	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e70421	10.1371/journal.pone.0070421	http://dx.doi.org/10.1371/journal.pone.0070421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990905	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100026
J	Guo, GC; Yao, WC; Zhang, QQ; Bo, YL				Guo, Guocai; Yao, Weicheng; Zhang, Quanqin; Bo, Yongli			Oleanolic Acid Suppresses Migration and Invasion of Malignant Glioma Cells by Inactivating MAPK/ERK Signaling Pathway	PLOS ONE			English	Article							HUMAN GLIOBLASTOMA; ASTROCYTOMA-CELLS; PROLIFERATION; APOPTOSIS; GROWTH; LINES; TRITERPENOIDS; ACTIVATION; EXPRESSION; PROMOTES	Mitogen-activated protein kinases/Extracellular signal-regulated kinase (MAPK/ERK) pathway is essential for migration and invasion of malignant glioma. It is efficient to inhibit migration and invasion of glioma cells by targeting this pathway. Oleanolic acid (OA) has been well demonstrated to suppress survival, growth and angiogenesis of glioma cells. However, it is still unknown if OA affects the migration and invasion of glioma cells. We utilized U-87 MG glioma cell lines and primary glioma cells from patients to study the effect of OA on migration and invasion of glioma cells with multidisciplinary approaches. In this study, we found that OA significantly decreased the ability of glioma cells to migrate and invade. Epithelial-mesenchymal transition (EMT) of glioma cells was also suppressed by OA treatment. Furthermore, MAPK/ERK pathway was greatly inhibited in glioma cells under OA treatment. MAPK/ERK reactivation induced by a recombinant lentiviral vector, Lv-MEK, was able to rescue the inhibitory effect of OA on migration and invasion of glioma cells. Taken together, we provided evidences that OA was a MAPK/ERK pathway-targeting anti-tumor agent. Although the concentrations we used exceeded its physiological level, OA may be used to prevent migration and invasion of glioma cells by developing its derivatives with enhanced bioactivity.	[Guo, Guocai; Yao, Weicheng; Bo, Yongli] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Neurosurg, Qingdao 266071, Peoples R China; [Zhang, Quanqin] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Internal Med, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University	Bo, YL (corresponding author), Qingdao Univ, Coll Med, Affiliated Hosp, Dept Neurosurg, Qingdao 266071, Peoples R China.	yonglibo@gmail.com			National Natural Sciences Foundation of China [81001104]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by funds from National Natural Sciences Foundation of China (No. 81001104). The website of the fund is http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dong L, 2010, NEUROSCI LETT, V484, P210, DOI 10.1016/j.neulet.2010.08.057; Fujiwara Y, 2011, ONCOL REP, V26, P1533, DOI 10.3892/or.2011.1454; Gao X, 2007, J NEURO-ONCOL, V84, P147, DOI 10.1007/s11060-007-9364-9; Gupta R, 2011, INT J ONCOL, V38, P733, DOI 10.3892/ijo.2010.883; Hua YQ, 2011, INVEST NEW DRUG, V29, P258, DOI 10.1007/s10637-009-9354-1; Kim EH, 2011, CANCER PREV RES, V4, P425, DOI 10.1158/1940-6207.CAPR-10-0153; Kim SY, 2007, BIOCHEM PHARMACOL, V74, P1642, DOI 10.1016/j.bcp.2007.08.015; Lucio KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028596; Martin R, 2007, CANCER RES, V67, P3741, DOI 10.1158/0008-5472.CAN-06-4759; Martin R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005975; Nickl-Jockschat T, 2007, INT J ONCOL, V30, P499; Omuro AMP, 2008, CURR OPIN INVEST DR, V9, P1287; Papadimitriou E, 2012, J NUTR BIOCH; Petri MK, 2011, HISTOL HISTOPATHOL, V26, P1531, DOI 10.14670/HH-26.1531; Petronelli A, 2009, ANTI-CANCER DRUG, V20, P880, DOI 10.1097/CAD.0b013e328330fd90; Ravanan P, 2011, MOL CANCER THER, V10, P1635, DOI 10.1158/1535-7163.MCT-10-0887; Reardon DA, 2011, NEURO-ONCOLOGY, V13, P353, DOI 10.1093/neuonc/noq203; Shen J, 2010, CANCER BIOL THER, V9, P33, DOI 10.4161/cbt.9.1.10279; Song H, 2006, NEUROSCI RES, V56, P29, DOI 10.1016/j.neures.2006.04.019; Thomas SL, 2010, NEURO-ONCOLOGY, V12, P941, DOI 10.1093/neuonc/noq048; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Uht RM, 2007, ONCOGENE, V26, P2885, DOI 10.1038/sj.onc.1210090; Wojciak-Kosior M, 2011, FOLIA HISTOCHEM CYTO, V49, P664, DOI 10.5603/FHC.2011.0050; Woods SA, 2002, NEURO-ONCOLOGY, V4, P242, DOI 10.1093/neuonc/4.4.242; Xie J, 2009, CANCER LETT, V282, P35, DOI 10.1016/j.canlet.2009.02.055; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	26	66	70	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72079	10.1371/journal.pone.0072079	http://dx.doi.org/10.1371/journal.pone.0072079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991044	gold, Green Submitted, Green Published			2022-12-25	WOS:000324470100075
J	Shipman, M; Lubick, K; Fouchard, D; Gurram, R; Grieco, P; Jutila, M; Dratz, EA				Shipman, Matt; Lubick, Kirk; Fouchard, David; Gurram, Rajani; Grieco, Paul; Jutila, Mark; Dratz, Edward A.			Proteomic and Systems Biology Analysis of the Monocyte Response to Coxiella burnetii Infection	PLOS ONE			English	Article							ENOYL-COA HYDRATASE; SMALL GTPASE RAB7; PROTEIN IDENTIFICATION; SUPEROXIDE-DISMUTASE; PHAGOSOME MATURATION; OXIDATIVE STRESS; Q-FEVER; HUMAN HEAT-SHOCK-PROTEIN-60; HOMOCYSTEINE TOXICITY; GENE-EXPRESSION	Coxiella burnetii is an obligate intracellular bacterial pathogen and the causative agent of Q fever. Chronic Q fever can produce debilitating fatigue and C. burnetii is considered a significant bioterror threat. C. burnetii occupies the monocyte phagolysosome and although prior work has explained features of the host-pathogen interaction, many aspects are still poorly understood. We have conducted a proteomic investigation of human Monomac I cells infected with the Nine Mile Phase II strain of C. burnetii and used the results as a framework for a systems biology model of the host response. Our principal methodology was multiplex differential 2D gel electrophoresis using ZDyes, a new generation of covalently linked fluorescent protein detection dyes under development at Montana State University. The 2D gel analysis facilitated the detection of changes in posttranslational modifications on intact proteins in response to infection. The systems model created from our data a framework for the design of experiments to seek a deeper understanding of the host-pathogen interactions.	[Shipman, Matt; Fouchard, David; Gurram, Rajani; Grieco, Paul; Dratz, Edward A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Lubick, Kirk; Jutila, Mark] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Shipman, M (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	mshipman59714@gmail.com			Department of Defense [W81XWH-07-2-0048]; National Institutes of Health (NIH) Cobre grant [1P20RR024237]; NIH [2R42RR021790A1]; Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024237] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health (NIH) Cobre grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Department of Defense grant #W81XWH-07-2-0048; National Institutes of Health (NIH) Cobre grant #1P20RR024237; NIH grant #2R42RR021790A1; and the Murdock Charitable Trust. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Kwaik Y, 1998, INFECT IMMUN, V66, P203; Adya R, 2009, ATHEROSCLEROSIS; Agnihotri G, 2003, BIOORGAN MED CHEM, V11, P9, DOI 10.1016/S0968-0896(02)00333-4; Alam S, 2006, MOL IMMUNOL, V43, P1432, DOI 10.1016/j.molimm.2005.07.025; Amer AO, 2002, CURR OPIN MICROBIOL, V5, P56, DOI 10.1016/S1369-5274(02)00286-2; Aragon AD, 2008, MOL BIOCHEM PARASIT, V162, P134, DOI 10.1016/j.molbiopara.2008.08.004; Ausiello CM, 2006, MICROBES INFECT, V8, P714, DOI 10.1016/j.micinf.2005.09.007; BACA OG, 1993, INFECT IMMUN, V61, P4232, DOI 10.1128/IAI.61.10.4232-4239.1993; Bangen JM, 2007, BIOCHEM BIOPH RES CO, V359, P709, DOI 10.1016/j.bbrc.2007.05.167; Banki K, 1998, J BIOL CHEM, V273, P11944, DOI 10.1074/jbc.273.19.11944; Banki K, 1996, J BIOL CHEM, V271, P32994, DOI 10.1074/jbc.271.51.32994; Banki K, 1999, J IMMUNOL, V162, P1466; Barry R, 2003, PROTEOMIC ANAL SULFO; Barry RC, 2006, ELECTROPHORESIS, V27, P2970, DOI 10.1002/elps.200500851; Benes P, 2006, DIFFERENTIATION, V74, P265, DOI 10.1111/j.1432-0436.2006.00077.x; BEUTLER JA, 1985, BRAIN RES, V330, P135, DOI 10.1016/0006-8993(85)90014-9; Bjurstrom H, 2008, J NEUROIMMUNOL, V205, P44, DOI 10.1016/j.jneuroim.2008.08.017; Breloer M, 2001, EUR J IMMUNOL, V31, P2051, DOI 10.1002/1521-4141(200107)31:7<2051::AID-IMMU2051>3.0.CO;2-H; Brett MT, 2004, OIKOS, V105, P647, DOI 10.1111/j.0030-1299.2004.12777.x; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Carroll IM, 2007, AM J PHYSIOL-GASTR L, V293, pG729, DOI 10.1152/ajpgi.00132.2007; Craig R, 2006, J PROTEOME RES, V5, P1843, DOI 10.1021/pr0602085; Craig R, 2005, RAPID COMMUN MASS SP, V19, P1844, DOI 10.1002/rcm.1992; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dratz EA, 2009, USA patent 9/1/2009, Patent No. [#7,582,260, 7582260]; Dratz EA, 2010, USA patent application, Montana State University, Patent No. [11/767,406, 11767406]; Dratz EA, 2010, USA patent 1/16/2010, Patent No. [7,833,799, 11620107833799]; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Feder ME, 2005, J EVOLUTION BIOL, V18, P901, DOI 10.1111/j.1420-9101.2005.00921.x; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fenyo D, 2007, J PROTEOME RES, V6, P1997, DOI 10.1021/pr070025y; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Flohe SB, 2003, J IMMUNOL, V170, P2340, DOI 10.4049/jimmunol.170.5.2340; Flohe SB, 2007, SHOCK, V27, P494, DOI 10.1097/SHK.0b013e31802dec51; Garg S, 2006, J BIOL CHEM, V281, P38712, DOI 10.1074/jbc.M606235200; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Garrett R. H., 2005, BIOCHEMISTRY, V3rd; Ghigo E, 2004, J INFECT DIS, V190, P1767, DOI 10.1086/425041; Ghigo E, 2002, J IMMUNOL, V169, P4488, DOI 10.4049/jimmunol.169.8.4488; GORG A, 1998, 2 DIMENSIONAL ELECTR; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Habich C, 2007, CELL MOL LIFE SCI, V64, P742, DOI 10.1007/s00018-007-6413-7; Habich C, 2003, FEBS LETT, V533, P105, DOI 10.1016/S0014-5793(02)03772-9; HACKSTADT T, 1985, INFECT IMMUN, V48, P359, DOI 10.1128/IAI.48.2.359-365.1985; Han J, 2004, J PROTEOME RES, V3, P807, DOI 10.1021/pr049945w; Han WX, 2008, HYPERTENSION, V51, P481, DOI 10.1161/HYPERTENSIONAHA.107.103275; Heinzen RA, 1996, INFECT IMMUN, V64, P796, DOI 10.1128/IAI.64.3.796-809.1996; Hinkle DJ, 2003, J NEUROSCI, V23, P11698; Howe D, 2000, INFECT IMMUN, V68, P3815, DOI 10.1128/IAI.68.7.3815-3821.2000; Howe D, 2006, CELL MICROBIOL, V8, P496, DOI 10.1111/j.1462-5822.2005.00641.x; Howe D, 2003, CELL MICROBIOL, V5, P469, DOI 10.1046/j.1462-5822.2003.00293.x; Howe D, 2010, INFECT IMMUN, V78, P3465, DOI 10.1128/IAI.00406-10; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Jung-Hui K, 2006, J MICROBIOL BIOTECHN, V16, P911; Kagawa Frank T, 2003, Semin Respir Infect, V18, P183; Kageyama T, 2009, BIOCHEM BIOPH RES CO, V378, P551, DOI 10.1016/j.bbrc.2008.11.084; Kang JH, 2006, PROTEOMICS, V6, P1261, DOI 10.1002/pmic.200500290; Karakousis PC, 2006, J CLIN MICROBIOL, V44, P2283, DOI 10.1128/JCM.02365-05; Karp NA, 2005, J PROTEOME RES, V4, P1867, DOI 10.1021/pr050084g; Karp NA, 2007, MOL CELL PROTEOMICS, V6, P1354, DOI 10.1074/mcp.M600274-MCP200; Kendal CE, 2007, PLACENTA, V28, P305, DOI 10.1016/j.placenta.2006.03.011; Kilmartin B, 2004, EUR J IMMUNOL, V34, P2041, DOI 10.1002/eji.200425108; Kitano M, 2008, NATURE, V453, P241, DOI 10.1038/nature06857; Koike E, 2006, BIOCHEM BIOPH RES CO, V341, P691, DOI 10.1016/J.BBRC.2006.01.016; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Leclere V, 2001, MICROBIOL-SGM, V147, P3105, DOI 10.1099/00221287-147-11-3105; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Li XJ, 2008, J AM SOC MASS SPECTR, V19, P855, DOI 10.1016/j.jasms.2008.02.011; Li XM, 2004, J PROTEOME RES, V3, P821, DOI 10.1021/pr049942j; Lubick K, 2007, J LEUKOCYTE BIOL, V82, P1062, DOI 10.1189/jlb.0407255; Lukashova V, 2001, J BIOL CHEM, V276, P24113, DOI 10.1074/jbc.M100720200; Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mollnau Hanke, 2006, BMC Cardiovasc Disord, V6, P44, DOI 10.1186/1471-2261-6-44; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Ohhira M, 2007, J GASTROENTEROL, V42, P969, DOI 10.1007/s00535-007-2119-8; Osterloh A, 2007, J BIOL CHEM, V282, P4669, DOI 10.1074/jbc.M608666200; Pedersen SK, 2003, J PROTEOME RES, V2, P303, DOI 10.1021/pr025588i; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perl A, 2007, IUBMB LIFE, V59, P365, DOI 10.1080/15216540701387188; Qian YM, 2008, BIOCHEM J, V415, P123, DOI 10.1042/BJ20080722; Raisner RM, 2008, GENETICS, V179, P1933, DOI 10.1534/genetics.108.088443; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Reyes-Garcia MG, 2007, J NEUROIMMUNOL, V188, P64, DOI 10.1016/j.jneuroim.2007.05.013; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Samoilis G, 2007, J PROTEOME RES, V6, P3032, DOI 10.1021/pr070077n; Schini-Kerth VB, 2009, CIRC RES, V93, P271; Schroecksnadel K, 2005, SCAND J IMMUNOL, V62, P155, DOI 10.1111/j.1365-3083.2005.01654.x; Schroecksnadel K, 2003, CLIN EXP IMMUNOL, V134, P53, DOI 10.1046/j.1365-2249.2003.02251.x; Scianimanico S, 1999, CELL MICROBIOL, V1, P19, DOI 10.1046/j.1462-5822.1999.00002.x; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Shipman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041278; Song M, 2005, CELL MOL LIFE SCI, V62, P119, DOI 10.1007/s00018-004-4339-x; Steinbrink K, 2000, IMMUNOBIOLOGY, V202, P442, DOI 10.1016/S0171-2985(00)80103-5; Takahashi M, 2007, ANTIVIR RES, V75, P152, DOI 10.1016/j.antiviral.2007.02.002; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Thorey IS, 2001, J BIOL CHEM, V276, P35818, DOI 10.1074/jbc.M104871200; Toohey JI, 2008, CONNECT TISSUE RES, V49, P57, DOI 10.1080/03008200801913742; Triccas JA, 2001, BMC MICROBIOLOGY, V1; Twine SM, 2005, J PROTEOME RES, V4, P1848, DOI 10.1021/pr050102u; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; Voth DE, 2007, CELL MICROBIOL, V9, P829, DOI 10.1111/j.1462-5822.2007.00901.x; Voth DE, 2009, INFECT IMMUN, V77, P205, DOI 10.1128/IAI.01124-08; Waag DM, 2005, BIOL WEAPONS DEFENSE, P185, DOI DOI 10.1385/1-59259-764-5:185; Watari E, 2001, INTERVIROLOGY, V44, P209, DOI 10.1159/000050048; Wenzel P, 2007, J BIOL CHEM, V282, P792, DOI 10.1074/jbc.M606477200; Wheeler MD, 2001, J BIOL CHEM, V276, P36664, DOI 10.1074/jbc.M105352200; XU HE, 1994, J BIOL CHEM, V269, P21177; Yu J, 2004, FEBS LETT, V562, P22, DOI 10.1016/S0014-5793(04)00170-X; Zamboni DS, 2003, MOL MICROBIOL, V49, P965, DOI 10.1046/j.1365-2958.2003.03626.x; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423; Zhao Y, 2007, J MED MICROBIOL, V56, P154, DOI 10.1099/jmm.0.46882-0; ZHENG Q, 2008, NUCL ACIDS RES; Zimny J, 2006, J BIOL CHEM, V281, P22485, DOI 10.1074/jbc.M603656200	125	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e69558	10.1371/journal.pone.0069558	http://dx.doi.org/10.1371/journal.pone.0069558			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990884	Green Published, gold			2022-12-25	WOS:000324470100010
J	Gineste, C; Duhamel, G; Le Fur, Y; Vilmen, C; Cozzone, PJ; Nowak, KJ; Bendahan, D; Gondin, J				Gineste, Charlotte; Duhamel, Guillaume; Le Fur, Yann; Vilmen, Christophe; Cozzone, Patrick J.; Nowak, Kristen J.; Bendahan, David; Gondin, Julien			Multimodal MRI and P-31-MRS Investigations of the ACTA1(Asp286Gly) Mouse Model of Nemaline Myopathy Provide Evidence of Impaired In Vivo Muscle Function, Altered Muscle Structure and Disturbed Energy Metabolism	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM ORIGIN; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; MAGNETIC-RESONANCE; CONGENITAL MYOPATHIES; CONTRACTILE FUNCTION; ALPHA-ACTIN; MICE; NEBULIN; DISEASE	Nemaline myopathy (NM), the most common non-dystrophic congenital disease of skeletal muscle, can be caused by mutations in the skeletal muscle alpha-actin gene (ACTA1) (similar to 25% of all NM cases and up to 50% of severe forms of NM). Muscle function of the recently generated transgenic mouse model carrying the human Asp286Gly mutation in the ACTA1 gene (Tg(ACTA1)(Asp286Gly)) has been mainly investigated in vitro. Therefore, we aimed at providing a comprehensive picture of the in vivo hindlimb muscle function of Tg(ACTA1)(Asp286Gly) mice by combining strictly noninvasive investigations. Skeletal muscle anatomy (hindlimb muscles, intramuscular fat volumes) and microstructure were studied using multimodal magnetic resonance imaging (Dixon, T-2, Diffusion Tensor Imaging [DTI]). Energy metabolism was studied using 31-phosphorus Magnetic Resonance Spectroscopy (P-31-MRS). Skeletal muscle contractile performance was investigated while applying a force-frequency protocol (1-150 Hz) and a fatigue protocol (6 min-1.7 Hz). Tg(ACTA1)(Asp286Gly) mice showed a mild muscle weakness as illustrated by the reduction of both absolute (30%) and specific (15%) maximal force production. Dixon MRI did not show discernable fatty infiltration in Tg(ACTA1) Asp286Gly mice indicating that this mouse model does not reproduce human MRI findings. Increased T-2 values were observed in Tg(ACTA1)(Asp286Gly) mice and might reflect the occurrence of muscle degeneration/regeneration process. Interestingly, T-2 values were linearly related to muscle weakness. DTI experiments indicated lower lambda(2) and lambda(3) values in Tg(ACTA1)(Asp286Gly) mice, which might be associated to muscle atrophy and/or the presence of histological anomalies. Finally 31P-MRS investigations illustrated an increased anaerobic energy cost of contraction in Tg(ACTA1)(Asp286Gly) mice, which might be ascribed to contractile and noncontractile processes. Overall, we provide a unique set of information about the anatomic, metabolic and functional consequences of the Asp286Gly mutation that might be considered as relevant biomarkers for monitoring the severity and/or the progression of NM and for assessing the efficacy of potential therapeutic interventions.	[Gineste, Charlotte; Duhamel, Guillaume; Le Fur, Yann; Vilmen, Christophe; Cozzone, Patrick J.; Bendahan, David; Gondin, Julien] Aix Marseille Univ, CNRS, CRMBM, Unite Mixte Rech UMR 7339, Marseille, France; [Nowak, Kristen J.] Univ Western Australia, Western Australian Inst Med Res, Med Res Ctr, Nedlands, WA 6009, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; University of Western Australia	Gondin, J (corresponding author), Aix Marseille Univ, CNRS, CRMBM, Unite Mixte Rech UMR 7339, Marseille, France.	julien.gondin@univ-amu.fr	Bendahan, David/AAU-1420-2020; Duhamel, Guillaume/AAP-2780-2020; GONDIN, Julien/D-6877-2019	Duhamel, Guillaume/0000-0001-5704-8513; 	ERA-NET E-Rare "European research projects on rare diseases" (grant NEMMYOP); French Ministry of Higher Education and Research; Association Francaise contre les Myopathies (AFM); Australian Research Council Future Fellowship [FT100100734]	ERA-NET E-Rare "European research projects on rare diseases" (grant NEMMYOP); French Ministry of Higher Education and Research; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Australian Research Council Future Fellowship(Australian Research Council)	This work was funded by the ERA-NET E-Rare "European research projects on rare diseases" (grant NEMMYOP). Charlotte GINESTE was supported by a fellowship from the French Ministry of Higher Education and Research and by the Association Francaise contre les Myopathies (AFM). Kristen NOWAK was supported by an Australian Research Council Future Fellowship FT100100734. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal PB, 2004, ANN NEUROL, V56, P86, DOI 10.1002/ana.20157; Bang ML, 2006, J CELL BIOL, V173, P905, DOI 10.1083/jcb.200603119; Bang ML, 2009, FASEB J, V23, P4117, DOI 10.1096/fj.09-137729; Bendahan D, 2004, CELL MOL LIFE SCI, V61, P1001, DOI 10.1007/s00018-004-3345-3; Bohm J, 2013, AM J HUM GENET, V92, P271, DOI 10.1016/j.ajhg.2012.12.007; Cea G, 2002, BRAIN, V125, P1635, DOI 10.1093/brain/awf163; Chevessier F, 2005, J PATHOL, V207, P313, DOI 10.1002/path.1832; Chevessier F, 2004, NEUROMUSCULAR DISORD, V14, P208, DOI 10.1016/j.nmd.2003.11.007; Cole MA, 2002, NEUROMUSCULAR DISORD, V12, P247, DOI 10.1016/S0960-8966(01)00278-4; Corbett MA, 2001, HUM MOL GENET, V10, P317, DOI 10.1093/hmg/10.4.317; Crawford K, 2002, MOL CELL BIOL, V22, P5887, DOI 10.1128/MCB.22.16.5887-5896.2002; Finanger EL, 2012, PHYS MED REH CLIN N, V23, P1, DOI 10.1016/j.pmr.2011.11.004; Fischmann A, 2011, J NEUROL, V258, P1333, DOI 10.1007/s00415-011-5937-9; Giannesini B, 2010, MAGN RESON MED, V64, P262, DOI 10.1002/mrm.22386; Gineste C, 2013, NEUROMUSCULAR DISORD, V23, P357, DOI 10.1016/j.nmd.2012.12.011; Gineste C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061517; Gloor M, 2011, J MAGN RESON IMAGING, V33, P203, DOI 10.1002/jmri.22431; Heemskerk AM, 2007, RADIOLOGY, V243, P413, DOI 10.1148/radiol.2432060491; HENRIKSEN O, 1994, ACTA RADIOL, V35, P96; Hogan MC, 1998, AM J PHYSIOL-ENDOC M, V274, pE397, DOI 10.1152/ajpendo.1998.274.3.E397; HOMSHER E, 1978, ANNU REV PHYSIOL, V40, P93, DOI 10.1146/annurev.ph.40.030178.000521; Jungbluth H, 2004, NEUROMUSCULAR DISORD, V14, P779, DOI 10.1016/j.nmd.2004.08.005; Kim HK, 2010, RADIOLOGY, V255, P899, DOI 10.1148/radiol.10091547; Kiphuth IC, 2010, J NEUROL, V257, P658, DOI 10.1007/s00415-009-5413-y; Le Fur Y, 2010, MAGN RESON MATER PHY, V23, P23, DOI 10.1007/s10334-009-0186-y; Lindqvist J, 2012, ACTA NEUROPATHOL, V123, P739, DOI 10.1007/s00401-012-0962-z; Marqueste T, 2008, J APPL PHYSIOL, V105, P299, DOI 10.1152/japplphysiol.00738.2007; Mathur S, 2011, MUSCLE NERVE, V43, P878, DOI 10.1002/mus.21986; Mattei JP, 2006, MAGN RESON MATER PHY, V19, P275, DOI 10.1007/s10334-006-0051-1; MOON RB, 1973, J BIOL CHEM, V248, P7276; Nguyen MAT, 2011, BRAIN, V134, P3513, DOI 10.1093/brain/awr274; Nguyen MAT, 2008, ADV EXP MED BIOL, V642, P66; North KN, 1997, J MED GENET, V34, P705, DOI 10.1136/jmg.34.9.705; Nowak KJ, 2012, EUR J HUM GENET, V20, DOI 10.1038/ejhg.2012.70; Ochala J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045923; Ochala J, 2010, NEUROMUSCULAR DISORD, V20, P98, DOI 10.1016/j.nmd.2009.11.010; Ottenheijm CAC, 2008, FASEB J, V22, P2912, DOI 10.1096/fj.07-104372; Ottenheijm CAC, 2011, HUM MOL GENET, V20, P2015, DOI 10.1093/hmg/ddr084; Quijano-Roy S, 2011, SEMIN PEDIATR NEUROL, V18, P221, DOI 10.1016/j.spen.2011.10.003; Ravenscroft G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028699; Ravenscroft G, 2011, BRAIN, V134, P1101, DOI 10.1093/brain/awr004; Ryan MM, 2003, NEUROLOGY, V60, P665, DOI 10.1212/01.WNL.0000046585.81304.BC; SALVIATI G, 1985, MUSCLE NERVE, V8, P299, DOI 10.1002/mus.880080406; Sanoudou D, 2003, P NATL ACAD SCI USA, V100, P4666, DOI 10.1073/pnas.0330960100; Schnell C, 2000, NEUROMUSCULAR DISORD, V10, P307, DOI 10.1016/S0960-8966(99)00123-6; Torriani M, 2012, SKELETAL RADIOL, V41, P437, DOI 10.1007/s00256-011-1240-1; Wallgren-Pettersson C, 2004, NEUROMUSCULAR DISORD, V14, P461, DOI 10.1016/j.nmd.2004.03.006; Walter G, 2005, MAGN RESON MED, V54, P1369, DOI 10.1002/mrm.20721; Wang CH, 2012, J CHILD NEUROL, V27, P363, DOI 10.1177/0883073812436605; Wren TAL, 2008, AM J ROENTGENOL, V190, pW8, DOI 10.2214/AJR.07.2732; Zhang J, 2011, EXP NEUROL, V212, P448; Zhang JY, 2008, EXP NEUROL, V212, P448, DOI 10.1016/j.expneurol.2008.04.033	52	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72294	10.1371/journal.pone.0072294	http://dx.doi.org/10.1371/journal.pone.0072294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977274	gold, Green Submitted, Green Published			2022-12-25	WOS:000324527300076
J	Stokowska, A; Olsson, S; Holmegaard, L; Jood, K; Blomstrand, C; Jern, C; Pekna, M				Stokowska, Anna; Olsson, Sandra; Holmegaard, Lukas; Jood, Katarina; Blomstrand, Christian; Jern, Christina; Pekna, Marcela			Cardioembolic and Small Vessel Disease Stroke Show Differences in Associations between Systemic C3 Levels and Outcome	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; COMPLEMENT COMPONENT C5A; CARDIOVASCULAR EVENTS; REACTIVE PROTEIN; BRAIN ISCHEMIA; ATHEROSCLEROSIS; ACTIVATION; MICE; INJURY; NEUROPROTECTION	Background: Activation of the complement system has been proposed to play a role in the pathophysiology of stroke. As the specific involvement of the complement proteins may be influenced by stroke etiology, we compared plasma C3 and C3a levels in patients with cardioembolic (CE) and small vessel disease (SVD) subtypes of ischemic stroke and control subjects and evaluated their association to outcome at three months and two years. Methodology/Principal Findings: Plasma C3 and C3a levels in 79 CE and 79 SVD stroke patients, sampled within 10 days and at three months after stroke, and age- and sex-matched control subjects from The Sahlgrenska Academy Study on Ischemic Stroke were measured by ELISA. Functional outcome was assesed with modified Rankin Scale. In the CE group, plasma C3 levels were elevated only in the acute phase, whereas C3a was elevated at both time points. The follow-up phase plasma C3 levels in the upper third were associated with an increased risk of unfavorable outcome at three months (OR 7.12, CI 1.72-29.46, P = 0.007) as well as after two years (OR 8.25, CI 1.61-42.28, P = 0.011) after stroke. These associations withstand adjustment for age and sex. Conversely, three-month follow-up plasma C3a/C3 level ratios in the middle third were associated with favorable outcome after two years both in the univariate analysis (OR 0.19, CI 0.05-0.82, P = 0.026) and after adjustment for age and sex (OR 0.19, CI 0.04-0.88, P = 0.033). In the SVD group, plasma C3 and C3a levels were elevated at both time points but showed no significant associations with outcome. Conclusions: Plasma C3 and C3a levels are elevated after CE and SVD stroke but show associations with outcome only in CE stroke.	[Stokowska, Anna; Olsson, Sandra; Holmegaard, Lukas; Jood, Katarina; Blomstrand, Christian; Jern, Christina; Pekna, Marcela] Univ Gothenburg, Sahlgrenska Acad, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden	University of Gothenburg	Stokowska, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden.	anna.stokowska@neuro.gu.se	Pekna, Marcela/AAM-3261-2021; Olsson, Sandra/L-5964-2013; Pekna, Marcela/AAM-3249-2021	Pekna, Marcela/0000-0003-2734-8237; Pekna, Marcela/0000-0003-2734-8237; Holmegaard, Lukas/0000-0003-3528-0316	Swedish Research Council [20116, 14605]; ALF Goteborg [142821, 148861]; Swedish Stroke Foundation; Swedish Heart and Lung Foundation [20100256]; Goteborg Foundation; Y. Land's Foundation; J. and B. Wennerstrom's Foundation; R. and T. Soderberg's Foundation; T. Nilsson's Foundation; Emelle's Foundation; E. Jacobson's Foundation; W. and M. Lundgren's Foundation; R. and U. Amlov's Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF Goteborg; Swedish Stroke Foundation; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Goteborg Foundation; Y. Land's Foundation; J. and B. Wennerstrom's Foundation; R. and T. Soderberg's Foundation; T. Nilsson's Foundation; Emelle's Foundation; E. Jacobson's Foundation; W. and M. Lundgren's Foundation; R. and U. Amlov's Foundation	This study was supported by grants from The Swedish Research Council (grant no 20116 to MP and 14605 to CJ, http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html); ALF Goteborg (grant 142821 to MP and 148861 to CJ, http://www.fou.nu/is/alfgbg); The Swedish Stroke Foundation (http://www.strokeforbundet.se/show.asp); The Swedish Heart and Lung Foundation (20100256, http://www.hjart-lungfonden.se/Om-Hjart-lungfonden/AboutHLF/); The Goteborg Foundation for Neurological Research (http://www.isnf.se/om.php); Y. Land's, J. and B. Wennerstrom's Foundations for Neurological Research; R. and T. Soderberg's Foundation (http://www.ratos.se/sv/Corporate-Responsibility/Samhallsengagemang/Torsten-Soderbergs-stiftelse-och-Ragnar-Soderbergs-stiftelse/); T. Nilsson's Foundation (http://www.torenilsonsstiftelse.nu/); Emelle's Foundation (http://www.nusjukvarden.se/sv/NU-sjukvarden/Omnusjukvarden/FoU-enheten/Innehall/Nyheter/Emelle-Fond/); E. Jacobson's Foundation; W. and M. Lundgren's Foundation (http://www.wmlundgren.se/); R. and U. Amlov's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Arumugam TV, 2006, CLIN CHIM ACTA, V374, P33, DOI 10.1016/j.cca.2006.06.010; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; Berg A, 2012, EXP NEUROL, V237, P8, DOI 10.1016/j.expneurol.2012.06.008; Buono C, 2002, CIRCULATION, V105, P3025, DOI 10.1161/01.CIR.0000019584.04929.83; Cervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008433; Costa C, 2006, BRAIN RES, V1100, P142, DOI 10.1016/j.brainres.2006.05.029; De Simoni MG, 2003, J CEREBR BLOOD F MET, V23, P232, DOI 10.1097/01.WCB.0000046146.31247.A1; Dressel A, 2011, CEREBROVASC DIS, V32, P123, DOI 10.1159/000329528; Haskard DO, 2008, CURR OPIN LIPIDOL, V19, P478, DOI 10.1097/MOL.0b013e32830f4a06; Hoffmeister HM, 2002, AM J CARDIOL, V89, P909; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Huang J, 1999, SCIENCE, V285, P595, DOI 10.1126/science.285.5427.595; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Jood K, 2005, STROKE, V36, P1383, DOI 10.1161/01.STR.0000169944.46025.09; Jung KW, 2012, J CLIN NEUROL, V8, P104, DOI 10.3988/jcn.2012.8.2.104; Kostner KM, 2006, CLIN CHIM ACTA, V365, P129, DOI 10.1016/j.cca.2005.08.028; Ladenvall C, 2006, STROKE, V37, P2018, DOI 10.1161/01.STR.0000231872.86071.68; Laine P, 2002, AM J CARDIOL, V90, P404, DOI 10.1016/S0002-9149(02)02498-0; Leung VWY, 2009, AM J PATHOL, V175, P1757, DOI 10.2353/ajpath.2009.090183; Lewis MJ, 2012, ARTHRITIS RHEUM-US, V64, P2707, DOI 10.1002/art.34451; Lewis RD, AM J PATHOL, V179, P1601; Lindsberg PJ, 1996, ANN NEUROL, V40, P587, DOI 10.1002/ana.410400408; Mocco J, 2006, CIRC RES, V99, P209, DOI 10.1161/01.RES.0000232544.90675.42; Mocco J, 2006, NEUROSURGERY, V59, P28, DOI [10.1227/01.NEU.0000219221.14280.65, 10.1227/01.neu.0000243280.75920.f4]; Mukherjee P, 2001, J NEUROCHEM, V77, P43, DOI 10.1046/j.1471-4159.2001.00167.x; Oksjoki R, 2007, FRONT BIOSCI-LANDMRK, V12, P4696, DOI 10.2741/2419; Olsson S, 2011, EUR J NEUROL, V18, P1272, DOI 10.1111/j.1468-1331.2011.03377.x; Osthoff M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021338; Palikhe A, 2007, AM J CARDIOL, V99, P890, DOI 10.1016/j.amjcard.2006.11.034; Pavlovski D, 2012, FASEB J, V26, P3680, DOI 10.1096/fj.11-202382; Pedersen ED, 2009, SCAND J IMMUNOL, V69, P555, DOI 10.1111/j.1365-3083.2009.02253.x; Pedersen ED, 2004, CLIN EXP IMMUNOL, V137, P117, DOI 10.1111/j.1365-2249.2004.02489.x; Persson L, 2005, CLIN EXP IMMUNOL, V142, P441, DOI 10.1111/j.1365-2249.2005.02954.x; Persson L, 2004, ARTERIOSCL THROM VAS, V24, P1062, DOI 10.1161/01.ATV.0000127302.24266.40; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Ramaglia V, 2012, P NATL ACAD SCI USA, V109, P965, DOI 10.1073/pnas.1111924109; Shinjyo N, 2009, STEM CELLS, V27, P2824, DOI 10.1002/stem.225; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; Speidl WS, 2010, ATHEROSCLEROSIS, V208, P285, DOI 10.1016/j.atherosclerosis.2009.07.030; Speidl WS, 2005, EUR HEART J, V26, P2294, DOI 10.1093/eurheartj/ehi339; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stokowska A, 2011, CEREBROVASC DIS, V32, P114, DOI 10.1159/000328238; Szeplaki G, 2009, ATHEROSCLEROSIS, V204, P315, DOI 10.1016/j.atherosclerosis.2008.07.044; Tamam Y, 2005, TOHOKU J EXP MED, V206, P91, DOI 10.1620/tjem.206.91; van Beek J, 2001, NEUROREPORT, V12, P289, DOI 10.1097/00001756-200102120-00022; Worthmann H, 2010, CEREBROVASC DIS, V30, P85, DOI 10.1159/000314624	47	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72133	10.1371/journal.pone.0072133	http://dx.doi.org/10.1371/journal.pone.0072133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977229	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300066
J	Alakhova, DY; Zhao, Y; Li, S; Kabanov, AV				Alakhova, Daria Y.; Zhao, Yi; Li, Shu; Kabanov, Alexander V.			Effect of Doxorubicin/Pluronic SP1049C on Tumorigenicity, Aggressiveness, DNA Methylation and Stem Cell Markers in Murine Leukemia	PLOS ONE			English	Article							PLURONIC BLOCK-COPOLYMERS; TUMOR-INITIATING CELLS; BREAST-CANCER CELLS; ACUTE MYELOID-LEUKEMIA; ALDEHYDE DEHYDROGENASE; EPIGENETIC CHANGES; CD133; MDR; PATHWAY; IDENTIFICATION	Purpose: Pluronic block copolymers are potent sensitizers of multidrug resistant cancers. SP1049C, a Pluronic-based micellar formulation of doxorubicin (Dox) has completed Phase II clinical trial and demonstrated safety and efficacy in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction. This study elucidates the ability of SP1049C to deplete cancer stem cells (CSC) and decrease tumorigenicity of cancer cells in vivo. Experimental Design: P388 murine leukemia ascitic tumor was grown in BDF1 mice. The animals were treated with: (a) saline, (b) Pluronics alone, (c) Dox or (d) SP1049C. The ascitic cancer cells were isolated at different passages and examined for 1) in vitro colony formation potential, 2) in vivo tumorigenicity and aggressiveness, 3) development of drug resistance and Wnt signaling activation 4) global DNA methylation profiles, and 5) expression of CSC markers. Results: SP1049C treatment reduced tumor aggressiveness, in vivo tumor formation frequency and in vitro clonogenic potential of the ascitic cells compared to drug, saline and polymer controls. SP1049C also prevented overexpression of BCRP and activation of Wnt-beta-catenin signaling observed with Dox alone. Moreover, SP1049C significantly altered the DNA methylation profiles of the cells. Finally, SP1049C decreased CD133(+) P388 cells populations, which displayed CSC-like properties and were more tumorigenic compared to CD133(-) cells. Conclusions: SP1049C therapy effectively suppresses the tumorigenicity and aggressiveness of P388 cells in a mouse model. This may be due to enhanced activity of SP1049C against CSC and/or altered epigenetic regulation restricting appearance of malignant cancer cell phenotype.	[Alakhova, Daria Y.; Zhao, Yi; Li, Shu; Kabanov, Alexander V.] Univ Nebraska Med Ctr, Coll Pharm, Ctr Drug Delivery & Nanomed, Omaha, NE USA; [Alakhova, Daria Y.; Zhao, Yi; Li, Shu; Kabanov, Alexander V.] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE USA; [Kabanov, Alexander V.] Moscow MV Lomonosov State Univ, Fac Chem, Lab Chem Design Bionanomat, Moscow 117234, Russia	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Lomonosov Moscow State University	Kabanov, AV (corresponding author), Univ N Carolina, Ctr Nanotechnol Drug Delivery, Chapel Hill, NC 27515 USA.	kabanov@email.unc.edu	Zhao, Yi/O-9117-2015; Kabanov, Alexander/AAY-5751-2020; Kabanov, Alexander V/N-3356-2013	Zhao, Yi/0000-0003-1975-7786; Kabanov, Alexander/0000-0002-3665-946X; Kabanov, Alexander V/0000-0002-3665-946X	National Institutes of Health [2RO1 CA89225, UO1 CA151806]; Center of Biomedical Research Excellence (COBRE) Nebraska Center for Nanomedicine [1P20RR021937]; China Scholarship Council PhD Scholarship; NATIONAL CANCER INSTITUTE [R01CA089225, U01CA151806] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Biomedical Research Excellence (COBRE) Nebraska Center for Nanomedicine; China Scholarship Council PhD Scholarship(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the National Institutes of Health 2RO1 CA89225, UO1 CA151806, Center of Biomedical Research Excellence (COBRE) Nebraska Center for Nanomedicine 1P20RR021937, and a China Scholarship Council PhD Scholarship (Yi Zhao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alakhov V, 1999, COLLOID SURFACE B, V16, P113, DOI 10.1016/S0927-7765(99)00064-8; Alakhov VY, 1996, BIOCONJUGATE CHEM, V7, P209, DOI 10.1021/bc950093n; Alakhova DY, 2010, J CONTROL RELEASE, V142, P89, DOI 10.1016/j.jconrel.2009.09.026; Baker EK, 2005, ONCOGENE, V24, P8061, DOI 10.1038/sj.onc.1208955; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Batrakova E, 1999, PHARM RES-DORDR, V16, P1373, DOI 10.1023/A:1018942823676; Batrakova EV, 2006, MOL PHARMACEUT, V3, P113, DOI 10.1021/mp050050g; Batrakova EV, 2004, PHARM RES-DORDR, V21, P2226, DOI 10.1007/s11095-004-7675-5; Batrakova EV, 2003, J PHARMACOL EXP THER, V304, P845, DOI 10.1124/jpet.102.043307; Batrakova EV, 2001, BRIT J CANCER, V85, P1987, DOI 10.1054/bjoc.2001.2165; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Burger PE, 2009, STEM CELLS, V27, P2220, DOI 10.1002/stem.135; Cairns BR, 2001, TRENDS CELL BIOL, V11, pS15, DOI 10.1016/S0962-8924(01)02125-0; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Cox CV, 2009, BLOOD, V113, P3287, DOI 10.1182/blood-2008-04-154187; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Danson S, 2004, BRIT J CANCER, V90, P2085, DOI 10.1038/sj.bjc.6601856; DAWE CJ, 1957, AM J PATHOL, V33, P603; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dore BT, 1998, CANCER CHEMOTH PHARM, V41, P275, DOI 10.1007/s002800050740; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Goldman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018269; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; Guzman ML, 2002, P NATL ACAD SCI USA, V99, P16220, DOI 10.1073/pnas.252462599; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049277; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Lujambio A, 2009, CELL CYCLE, V8, P377, DOI 10.4161/cc.8.3.7526; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Minko T, 2005, J CONTROL RELEASE, V105, P269, DOI 10.1016/j.jconrel.2005.03.019; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rappa G, 2008, STEM CELLS, V26, P3008, DOI 10.1634/stemcells.2008-0601; Rattis FM, 2004, CURR OPIN HEMATOL, V11, P88, DOI 10.1097/01.moh.0000133649.61121.ec; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rieger ME, 2010, MOL CELL BIOL, V30, P4267, DOI 10.1128/MCB.01418-09; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Rodenhiser DI, 2009, CLIN EXP METASTAS, V26, P5, DOI 10.1007/s10585-008-9166-2; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Sharma AK, 2008, J CONTROL RELEASE, V131, P220, DOI 10.1016/j.jconrel.2008.07.031; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Silva IA, 2011, CANCER RES, V71, P3991, DOI 10.1158/0008-5472.CAN-10-3175; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Todaro M, 2010, CANCER RES, V70, P8874, DOI 10.1158/0008-5472.CAN-10-1994; TODOROVA N, 2003, BIOTECHNOL BIOTECHNO, V17, P151; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Valle JW, 2011, INVEST NEW DRUG, V29, P1029, DOI 10.1007/s10637-010-9399-1; Venne A, 1996, CANCER RES, V56, P3626; Waud WR, 2011, CANCER DRUG DISCOV D, P23, DOI 10.1007/978-1-60761-968-0_2; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	65	62	63	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72238	10.1371/journal.pone.0072238	http://dx.doi.org/10.1371/journal.pone.0072238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977261	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700154
J	Santhakumar, V; Meera, P; Karakossian, MH; Otis, TS				Santhakumar, Vijayalakshmi; Meera, Pratap; Karakossian, Movses H.; Otis, Thomas S.			A Reinforcing Circuit Action of Extrasynaptic GABA(A) Receptor Modulators on Cerebellar Granule Cell Inhibition	PLOS ONE			English	Article							ALCOHOL ANTAGONIST RO15-4513; TONIC INHIBITION; DELTA-SUBUNIT; NEURONAL EXCITABILITY; ETHANOL SENSITIVITY; HIPPOCAMPAL-NEURONS; A RECEPTORS; RAT LINE; GABAERGIC TRANSMISSION; POSTSYNAPTIC CURRENTS	GABA(A) receptors (GABARs) are the targets of a wide variety of modulatory drugs which enhance chloride flux through GABAR ion channels. Certain GABAR modulators appear to acutely enhance the function of delta subunit-containing GABAR subtypes responsible for tonic forms of inhibition. Here we identify a reinforcing circuit mechanism by which these drugs, in addition to directly enhancing GABAR function, also increase GABA release. Electrophysiological recordings in cerebellar slices from rats homozygous for the ethanol-hypersensitive (alpha 6100Q) allele show that modulators and agonists selective for delta-containing GABARs such as THDOC, ethanol and THIP (gaboxadol) increased the frequency of spontaneous inhibitory postsynaptic currents (sIPSCs) in granule cells. Ethanol fails to augment granule cell sIPSC frequency in the presence of glutamate receptor antagonists, indicating that circuit mechanisms involving granule cell output contribute to ethanol-enhancement of synaptic inhibition. Additionally, GABAR antagonists decrease ethanol-induced enhancement of Golgi cell firing. Consistent with a role for glutamatergic inputs, THIP-induced increases in Golgi cell firing are abolished by glutamate receptor antagonists. Moreover, THIP enhances the frequency of spontaneous excitatory postsynaptic currents in Golgi cells. Analyses of knockout mice indicate that delta subunit-containing GABARs are required for enhancing GABA release in the presence of ethanol and THIP. The limited expression of the GABAR delta subunit protein within the cerebellar cortex suggests that an indirect, circuit mechanism is responsible for stimulating Golgi cell GABA release by drugs selective for extrasynaptic isoforms of GABARs. Such circuit effects reinforce direct actions of these positive modulators on tonic GABAergic inhibition and are likely to contribute to the potent effect of these compounds as nervous system depressants.	[Santhakumar, Vijayalakshmi; Meera, Pratap; Karakossian, Movses H.; Otis, Thomas S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Santhakumar, Vijayalakshmi] Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Rutgers State University New Brunswick; Rutgers State University Medical Center	Santhakumar, V (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	santhavi@njms.rutgers.edu	Santhakumar, Viji/K-4856-2019; Meera, Pratap B/C-6499-2009; Santhakumar, Vijayalakshmi/M-4192-2013	Santhakumar, Viji/0000-0001-6278-4187; 	National Institutes of Health [PO1 NS35985, R21 AA19737, R01 NS069861]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069861, P01NS035985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA019737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grant PO1 NS35985 and R21 AA19737 to T.S.O. and R01 NS069861 to V.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Bieda MC, 2004, J NEUROPHYSIOL, V92, P1658, DOI 10.1152/jn.00223.2004; Borghese CM, 2006, J PHARMACOL EXP THER, V316, P1360, DOI 10.1124/jpet.105.092452; Botta P, 2007, J PHARMACOL EXP THER, V323, P684, DOI 10.1124/jpet.107.127894; Botta P, 2007, ALCOHOL, V41, P187, DOI 10.1016/j.alcohol.2007.04.004; Botta P, 2012, ALCOHOL CLIN EXP RES, V36, P616, DOI 10.1111/j.1530-0277.2011.01658.x; Botta P, 2010, NEUROPSYCHOPHARMACOL, V35, P1984, DOI 10.1038/npp.2010.76; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Brickley SG, 2001, NEUROPHARMACOLOGY, V41, P730, DOI 10.1016/S0028-3908(01)00135-6; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Bright DP, 2011, J NEUROSCI, V31, P753, DOI 10.1523/JNEUROSCI.2996-10.2011; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Caraiscos VB, 2004, J NEUROSCI, V24, P8454, DOI 10.1523/JNEUROSCI.2063-04.2004; Carr LG, 2003, ALCOHOL, V31, P93, DOI 10.1016/j.alcohol.2003.07.003; Carta M, 2004, J NEUROSCI, V24, P3746, DOI 10.1523/JNEUROSCI.0067-04.2004; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chisari M, 2010, TRENDS NEUROSCI, V33, P299, DOI 10.1016/j.tins.2010.03.005; Dellal SS, 2012, J NEUROPHYSIOL, V107, P2958, DOI 10.1152/jn.01028.2011; Dieudonne S, 1998, J PHYSIOL-LONDON, V510, P845, DOI 10.1111/j.1469-7793.1998.845bj.x; Drasbek KR, 2007, J NEUROPHYSIOL, V97, P2293, DOI 10.1152/jn.00651.2006; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fleming RL, 2007, J NEUROPHYSIOL, V97, P3806, DOI 10.1152/jn.00101.2007; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hanchar HJ, 2006, P NATL ACAD SCI USA, V103, P8546, DOI 10.1073/pnas.0509903103; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Houston CM, 2012, J NEUROSCI, V32, P3887, DOI 10.1523/JNEUROSCI.5406-11.2012; Hull C, 2012, NEURON, V73, P149, DOI 10.1016/j.neuron.2011.10.030; Jia F, 2008, J PHARMACOL EXP THER, V324, P1127, DOI 10.1124/jpet.107.134569; Jia F, 2007, ALCOHOL, V41, P177, DOI 10.1016/j.alcohol.2007.03.010; Karakossian MH, 2004, J NEUROPHYSIOL; KORPI ER, 1993, NATURE, V361, P356, DOI 10.1038/361356a0; Korpi ER, 2001, EUR J PHARMACOL, V421, P31, DOI 10.1016/S0014-2999(01)01035-4; KORPI ER, 1992, EUR J PHARMACOL, V211, P427, DOI 10.1016/0014-2999(92)90402-P; KROGSGAARDLARSEN P, 1977, NATURE, V268, P53, DOI 10.1038/268053a0; Liang J, 2006, J NEUROSCI, V26, P1749, DOI 10.1523/JNEUROSCI.4702-05.2006; MCBAIN CJ, 1992, BRAIN RES, V592, P255, DOI 10.1016/0006-8993(92)91683-6; Meera P, 2011, J NEUROPHYSIOL, V106, P2057, DOI 10.1152/jn.00450.2011; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Moriguchi S, 2007, ALCOHOL CLIN EXP RES, V31, P89, DOI 10.1111/j.1530-0277.2006.00266.x; Nusser Z, 1998, J NEUROSCI, V18, P1693; Otis TS, 2008, J PHARMACOL EXP THER, V324, P399, DOI 10.1124/jpet.107.131557; Palay SL, 1982, CEREBELLUM NEW VISTA, Vxvii; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Pugh JR, 2011, J NEUROSCI, V31, P565, DOI 10.1523/JNEUROSCI.4506-10.2011; Saba L, 2001, MOL BRAIN RES, V87, P263, DOI 10.1016/S0169-328X(01)00003-1; Santhakumar V, 2006, J NEUROSCI, V26, P3357, DOI 10.1523/JNEUROSCI.4799-05.2006; Santhakumar V, 2010, NEUROSCIENCE, V167, P644, DOI 10.1016/j.neuroscience.2010.02.048; Santhakumar V, 2007, ALCOHOL, V41, P211, DOI 10.1016/j.alcohol.2007.04.011; Schmid G, 1999, NEUROPHARMACOLOGY, V38, P1273, DOI 10.1016/S0028-3908(99)00025-8; Smith SL, 2003, J NEUROSCI, V23, P367, DOI 10.1523/JNEUROSCI.23-02-00367.2003; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Stell BM, 2007, J NEUROSCI, V27, P9022, DOI 10.1523/JNEUROSCI.1954-07.2007; Stell BM, 2011, J NEUROPHYSIOL, V105, P2931, DOI 10.1152/jn.01125.2010; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Tretter V, 2001, J BIOL CHEM, V276, P10532, DOI 10.1074/jbc.M011054200; Valenzuela CF, 1998, J NEUROCHEM, V71, P1777; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Wallner M, 2006, P NATL ACAD SCI USA, V103, P8540, DOI 10.1073/pnas.0600194103; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Walsh JK, 2008, SLEEP MED, V9, P393, DOI 10.1016/j.sleep.2007.06.006; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Xiao C, 2007, J PHYSIOL-LONDON, V580, P731, DOI 10.1113/jphysiol.2006.124099; Yu J, 2013, J NEUROPHYSIOL; Zhang W, 2012, CEREBELLUM, V11, P121, DOI 10.1007/s12311-009-0151-3; Ziskind-Conhaim L, 2003, J NEUROPHYSIOL, V89, P806, DOI 10.1152/jn.00614.2002	70	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72976	10.1371/journal.pone.0072976	http://dx.doi.org/10.1371/journal.pone.0072976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977374	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700191
J	Khaja, ASS; Dizeyi, N; Kopparapu, PK; Anagnostaki, L; Harkonen, P; Persson, JL				Khaja, Azharuddin Sajid Syed; Dizeyi, Nishtman; Kopparapu, Pradeep Kumar; Anagnostaki, Lola; Harkonen, Pirkko; Persson, Jenny Liao			Cyclin A1 Modulates the Expression of Vascular Endothelial Growth Factor and Promotes Hormone-Dependent Growth and Angiogenesis of Breast Cancer	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; PROSTATE-CANCER; MONOCLONAL-ANTIBODIES; ESTROGEN-RECEPTOR; STEM-CELLS; THERAPY; ALPHA; VEGF; OVEREXPRESSION; PROLIFERATION	Alterations in cellular pathways related to both endocrine and vascular endothelial growth factors (VEGF) may contribute to breast cancer progression. Inhibition of the elevated levels of these pathways is associated with clinical benefits. However, molecular mechanisms by which endocrine-related pathways and VEGF signalling cooperatively promote breast cancer progression remain poorly understood. In the present study, we show that the A-type cyclin, cyclin A1, known for its important role in the initiation of leukemia and prostate cancer metastasis, is highly expressed in primary breast cancer specimens and metastatic lesions, in contrasting to its barely detectable expression in normal human breast tissues. There is a statistically significant correlation between cyclin A1 and VEGF expression in breast cancer specimens from two patient cohorts (p<0.01). Induction of cyclin A1 overexpression in breast cancer cell line MCF-7 results in an enhanced invasiveness and a concomitant increase in VEGF expression. In addition, there is a formation of protein-protein complexes between cyclin A1 and estrogen receptor ER-alpha cyclin A1 overexpression increases ER-alpha expression in MCF-7 and T47D cells. In mouse tumor xenograft models in which mice were implanted with MCF-7 cells that overexpressed cyclin A1 or control vector, cyclin A1 overexpression results in an increase in tumor growth and angiogenesis, which is coincident with an enhanced expression of VEGF, VEGFR1 and ER-alpha Our findings unravel a novel role for cyclin A1 in growth and progression of breast cancer, and suggest that multiple cellular pathways, including cell cycle regulators, angiogenesis and estrogen receptor signalling, may cooperatively contribute to breast cancer progression.	[Khaja, Azharuddin Sajid Syed; Dizeyi, Nishtman] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Kopparapu, Pradeep Kumar; Persson, Jenny Liao] Lund Univ, Dept Lab Med, Malmo, Sweden; [Anagnostaki, Lola] Skane Univ Hosp, Dept Clin Pathol, Malmo, Sweden; [Harkonen, Pirkko] Univ Turku, Inst Biomed, Turku, Finland	Lund University; Lund University; Lund University; Skane University Hospital; University of Turku	Persson, JL (corresponding author), Lund Univ, Dept Lab Med, Malmo, Sweden.	Jenny_L.Persson@med.lu.se	Syed Khaja, Azharuddin Sajid/AAF-2693-2021	Syed Khaja, Azharuddin Sajid/0000-0003-1594-1826; Persson, Jenny/0000-0001-7682-7678; Kopparapu, Pradeep Kumar/0000-0003-3941-748X	Swedish Cancer Foundation [CAN2009/92]; Swedish National Research Council [2009-2602]; Lund University Medical Faculty; Malmo Cancer Foundation	Swedish Cancer Foundation; Swedish National Research Council; Lund University Medical Faculty; Malmo Cancer Foundation	The Swedish Cancer Foundation, grant number: CAN2009/92. www.cf.se; the Swedish National Research Council, grant number: 2009-2602. www.vr.se; The Lund University Medical Faculty grant: www.med.lu; The Malmo Cancer Foundation, www.mascancer.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aesoy R, 2008, MOL CANCER RES, V6, P1630, DOI 10.1158/1541-7786.MCR-07-2172; Applanat MP, 2008, ADV EXP MED BIOL, V617, P437, DOI 10.1007/978-0-387-69080-3_42; ARTEAGA CL, 1994, CANCER RES, V54, P4703; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101; Coletta RD, 2008, CANCER RES, V68, P2204, DOI 10.1158/0008-5472.CAN-07-3141; DICKSON RB, 1986, CANCER RES, V46, P1707; Dienstmann R, 2012, CURR CLIN PHARMACOL, V7, P137, DOI 10.2174/157488412800228929; Ekberg J, 2005, EUR J HAEMATOL, V75, P106, DOI 10.1111/j.1600-0609.2005.00473.x; Ekberg J, 2004, ONCOGENE, V23, P9082, DOI 10.1038/sj.onc.1208090; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Foekens JA, 2001, CANCER RES, V61, P5407; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Giovannini M, 2010, CRIT REV ONCOL HEMAT, V76, P13, DOI 10.1016/j.critrevonc.2009.12.004; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; HORWITZ KB, 1978, CANCER RES, V38, P2434; Hu Z, 2010, BREAST CANCER RES TR, V120, P705, DOI 10.1007/s10549-009-0488-9; Jennbacken K, 2005, PROSTATE, V65, P110, DOI 10.1002/pros.20276; Landberg G, 2001, ONCOGENE, V20, P3497, DOI 10.1038/sj.onc.1204471; Lapointe J, 2001, ENDOCRINOLOGY, V142, P4331, DOI 10.1210/en.142.10.4331; Liao C, 2004, INT J CANCER, V108, P654, DOI 10.1002/ijc.11573; Liao C, 2001, P NATL ACAD SCI USA, V98, P6853, DOI 10.1073/pnas.121540098; LIBERATO MH, 1993, TUMOR BIOL, V14, P38, DOI 10.1159/000217823; Loden M, 2002, ONCOGENE, V21, P4680, DOI 10.1038/sj.onc.1205578; Modjtahedi H, 1998, INT J CANCER, V75, P310, DOI 10.1002/(SICI)1097-0215(19980119)75:2<310::AID-IJC22>3.0.CO;2-F; Muller-Tidow C, 2001, FEBS LETT, V490, P75, DOI 10.1016/S0014-5793(01)02128-7; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Ochsenreither S, 2012, BLOOD, V119, P5492, DOI 10.1182/blood-2011-07-365890; Qu ZC, 2008, CANCER RES, V68, P6232, DOI 10.1158/0008-5472.CAN-07-5654; Roy V, 2009, BREAST CANCER RES TR, V116, P31, DOI 10.1007/s10549-008-0268-y; Ruohola JK, 1999, MOL CELL ENDOCRINOL, V149, P29, DOI 10.1016/S0303-7207(99)00003-9; Ryden L, 2005, EUR J CANCER, V41, P256, DOI 10.1016/j.ejca.2004.06.030; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Shojaei F, 2012, CANCER LETT, V320, P130, DOI 10.1016/j.canlet.2012.03.008; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stein RA, 2009, J STEROID BIOCHEM, V114, P106, DOI 10.1016/j.jsbmb.2009.02.010; Strickler JH, 2012, CANCER CHEMOTH PHARM, V70, P251, DOI 10.1007/s00280-012-1911-1; Su JL, 2007, BRIT J CANCER, V96, P541, DOI 10.1038/sj.bjc.6603487; Sweeney C, 1996, DEVELOPMENT, V122, P53; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Wegiel B, 2005, ONCOGENE, V24, P6385, DOI 10.1038/sj.onc.1208795; Wegiel B, 2009, LEUKEMIA, V23, P251, DOI 10.1038/leu.2008.300; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; Wegiel B, 2008, JNCI-J NATL CANCER I, V100, P1022, DOI 10.1093/jnci/djn214; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yang R, 1997, CANCER RES, V57, P913; Yang R, 1999, BLOOD, V93, P2067; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497	50	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72210	10.1371/journal.pone.0072210	http://dx.doi.org/10.1371/journal.pone.0072210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23991063	Green Submitted, Green Published, gold			2022-12-25	WOS:000323124000082
J	Yang, J; Zheng, W; Wang, Q; Lara, C; Hussein, S; Chen, XZ				Yang, Jungwoo; Zheng, Wang; Wang, Qian; Lara, Carlos; Hussein, Shaimaa; Chen, Xing-Zhen			Translational up-regulation of polycystic kidney disease protein PKD2 by endoplasmic reticulum stress	FASEB JOURNAL			English	Article						ADPKD; P-eIF2 alpha; uORF	ACTIVATION; PERK; RNA; DEPHOSPHORYLATION; PHOSPHORYLATION; PROLIFERATION; DEGRADATION; EIF2-ALPHA; MECHANISMS; ISCHEMIA	Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in PKD1 or PKD2, and it affects over 10 million people worldwide. It is characterized by cyst formation in the kidney, liver and pancreas. Dosage changes in PKD1/PKD2 are important in ADPKD pathogenesis; therefore, their expression and function has to be strictly regulated. However, how they are regulated remain poorly understood. Recent studies have linked PKD2 regulation to endoplasmic reticulum (ER) stress that is implicated in neuronal, cardiac, and renal diseases. One major ER stress downstream is phosphorylation of eukaryotic initiation factor eIF2 alpha by kinase PERK, which attenuates global protein translation and enhances translation of selected proteins. Here, we showed in several mammalian cell lines that PKD2 protein expression is upregulated by different stresses that all increase phosphorylated eIF2 alpha (P-eIF2 alpha). Increasing P-eIF2 alpha by overexpression or inhibiting the phosphatase activity resulted in increased PKD2. PCR and polysome-binding assays showed that ER stress does not affect the PKD2 mRNA level but increase its binding with ribosomes, indicating that P-eIF2 alpha translationally up-regulates PKD2. By mutation analysis, we found that the upstream open reading frame (uORF) in the 5'-untrans-lated region of PKD2 mRNA represses PKD2 translation. Thus, ER stress and P-eIF2 alpha translationally upregulates PKD2 through bypassing the inhibitory uORF.	[Yang, Jungwoo; Zheng, Wang; Wang, Qian; Lara, Carlos; Hussein, Shaimaa; Chen, Xing-Zhen] Univ Alberta, Fac Med & Dent, Dept Physiol, Membrane Prot Dis Res Grp, Edmonton, AB T6G 2H7, Canada	University of Alberta	Chen, XZ (corresponding author), Univ Alberta, Fac Med & Dent, Dept Physiol, Membrane Prot Dis Res Grp, 7-29 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	xzchen@ualberta.ca	Hussein, Shaimaa/HHZ-5533-2022	Hussein, Shaimaa/0000-0003-0849-9670	Canadian Institutes of Health Research; Kidney Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada	The authors thank Dr. David Ron (New York University, New York, NY, USA) for providing Myc-tagged PERK, eIF2 alpha, eIF2 alpha-S51A, and Flag-tagged Gadd34 plasmids, and PERK<SUP>+/+</SUP> and PERK<SUP>-/-</SUP> MEF cells. PKD2<SUP>+/+</SUP> and PKD2<SUP>-/-</SUP> MCD cells were kindly provided by Dr. Guanqing Wu (Vanderbilt University, Nashville, TN, USA). This work was supported by grants from the Canadian Institutes of Health Research and Kidney Foundation of Canada (to X.Z.C.). X.Z.C. is a Senior Scholar of Alberta Innovates-Health Solutions.	Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; Cybulsky AV, 2010, KIDNEY INT, V77, P187, DOI 10.1038/ki.2009.389; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803; Dickhout JG, 2009, ANTIOXID REDOX SIGN, V11, P2341, DOI [10.1089/ars.2009.2705, 10.1089/ARS.2009.2705]; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Ghosh HS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00150; Grimm DH, 2006, J BIOL CHEM, V281, P137, DOI 10.1074/jbc.M507845200; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harris PC, 2010, J AM SOC NEPHROL, V21, P1073, DOI 10.1681/ASN.2010030328; Inagi R, 2009, NEPHRON EXP NEPHROL, V112, pE1, DOI 10.1159/000210573; Kim I, 2009, J AM SOC NEPHROL, V20, P2556, DOI 10.1681/ASN.2009030271; Kitamura M, 2008, AM J PHYSIOL-RENAL, V295, pF323, DOI 10.1152/ajprenal.00050.2008; Kurbegovic A, 2010, HUM MOL GENET, V19, P1174, DOI 10.1093/hmg/ddp588; Lass A, 2007, ARCH BIOCHEM BIOPHYS, V462, P62, DOI 10.1016/j.abb.2007.04.010; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Liang GQ, 2008, HUM MOL GENET, V17, P3254, DOI 10.1093/hmg/ddn221; Liang GQ, 2008, HUM MOL GENET, V17, P1109, DOI 10.1093/hmg/ddm383; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2006, J CELL BIOL, V172, P201, DOI 10.1083/jcb.200508099; Matsui Y, 2008, AUTOPHAGY, V4, P409, DOI 10.4161/auto.5638; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Montie HL, 2005, BBA-MOL BASIS DIS, V1741, P314, DOI 10.1016/j.bbadis.2005.04.007; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Obara T, 2006, J AM SOC NEPHROL, V17, P2706, DOI 10.1681/ASN.2006040412; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Park EY, 2009, J BIOL CHEM, V284, P7214, DOI 10.1074/jbc.M805890200; Prasad S, 2009, AM J PATHOL, V175, P1493, DOI 10.2353/ajpath.2009.090227; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Sammarco MC, 2005, ANAL BIOCHEM, V346, P210, DOI 10.1016/j.ab.2005.08.033; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Tran U, 2010, DEVELOPMENT, V137, P1107, DOI 10.1242/dev.046045; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wegierski T, 2009, EMBO J, V28, P490, DOI 10.1038/emboj.2008.307; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Wu YL, 2006, HUM MOL GENET, V15, P3280, DOI 10.1093/hmg/ddl404; Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200; Zhao Y, 2002, NEPHROL DIAL TRANSPL, V17, P2138, DOI 10.1093/ndt/17.12.2138	55	9	9	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4998	5009		10.1096/fj.13-236075	http://dx.doi.org/10.1096/fj.13-236075			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23985800				2022-12-25	WOS:000329999000033
J	Morada, M; Pendyala, L; Wu, G; Merali, S; Yarlett, N				Morada, Mary; Pendyala, Lakhsmi; Wu, Gang; Merali, Salim; Yarlett, Nigel			Cryptosporidium parvum Induces an Endoplasmic Stress Response in the Intestinal Adenocarcinoma HCT-8 Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Endoplasmic Reticulum Stress; Host-Pathogen Interactions; Parasitology; Polyamines; Unfolded Protein Response; C; parvum; SSAT	SPERMIDINE SPERMINE N1-ACETYLTRANSFERASE; ER STRESS; N-1-ACETYLTRANSFERASE; RETICULUM; CATABOLISM; APOPTOSIS; PROTEIN; UBIQUITINATION; TRANSCRIPTION; PURIFICATION	Invasion of human intestinal epithelial cells (HCT-8) by Cryptosporidium parvum resulted in a rapid induction of host cell spermidine/spermine N-1-acetyltransferase 1 (hSSAT-1) mRNA, causing a 4-fold increase in SSAT-1 enzyme activity after 24 h of infection. In contrast, host cell SSAT-2, spermine oxidase, and acetylpolyamine oxidase (hAPAO) remained unchanged during this period. Intracellular polyamine levels of C. parvum-infected human epithelial cells were determined, and it was found that spermidine remained unchanged and putrescine increased by 2.5-fold after 15 h and then decreased after 24 h, whereas spermine decreased by 3.9-fold after 15 h. Concomitant with these changes, N-1-acetylspermine and N-1-acetylspermidine both increased by 115- and 24-fold, respectively. Increased SSAT-1 has previously been shown to be involved in the endoplasmic reticulum (ER) stress response leading to apoptosis. Several stress response proteins were increased in HCT-8 cells infected with C. parvum, including calreticulin, a major calcium-binding chaperone in the ER; GRP78/BiP, a prosurvival ER chaperone; and Nrf2, a transcription factor that binds to antioxidant response elements, thus activating them. However, poly(ADP-ribose) polymerase, a protein involved in DNA repair and programmed cell death, was decreased. Cumulatively, these results suggest that the invasion of HCT-8 cells by C. parvum results in an ER stress response by the host cell that culminates in overexpression of host cell SSAT-1 and elevated N-1-acetylpolyamines, which can be used by a parasite that lacks ornithine decarboxylase.	[Morada, Mary; Wu, Gang; Yarlett, Nigel] Pace Univ, Haskins Labs, New York, NY 10038 USA; [Yarlett, Nigel] Pace Univ, Dept Chem & Phys Sci, New York, NY 10038 USA; [Pendyala, Lakhsmi] Roswell Pk Canc Res Inst, Buffalo, NY 14263 USA; [Merali, Salim] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; [Merali, Salim] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA	Pace University; Pace University; Roswell Park Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Yarlett, N (corresponding author), Pace Univ, Haskins Labs, 41 Pk Row, New York, NY 10038 USA.	nyarlett@pace.edu	Yarlett, Nigel/B-3523-2009		National Institutes of Health from the National Cooperative Drug Discovery/Development Groups (NCDDG) [AI40320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI040320] Funding Source: NIH RePORTER	National Institutes of Health from the National Cooperative Drug Discovery/Development Groups (NCDDG)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI40320 from the National Cooperative Drug Discovery/Development Groups (NCDDG; to N. Y.).	ARROWOOD MJ, 1987, J PARASITOL, V73, P314, DOI 10.2307/3282084; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bhardwaj N, 2005, INT J PARASITOL, V35, P75, DOI 10.1016/j.ijpara.2004.10.018; CAI J, 1992, BIOCHIM BIOPHYS ACTA, V1131, P317, DOI 10.1016/0167-4781(92)90032-U; Chen XM, 2005, J IMMUNOL, V175, P7447, DOI 10.4049/jimmunol.175.11.7447; Coleman CS, 1997, J BIOL CHEM, V272, P12164, DOI 10.1074/jbc.272.18.12164; Coleman CS, 1996, BIOCHEM J, V316, P697, DOI 10.1042/bj3160697; Coleman CS, 2001, BIOCHEM J, V358, P137, DOI 10.1042/0264-6021:3580137; Cook T, 2007, MICROBIOL-SGM, V153, P1123, DOI 10.1099/mic.0.2006/001768-0; Crowley-Weber CL, 2003, CHEM-BIOL INTERACT, V145, P53, DOI 10.1016/S0009-2797(02)00162-X; Fayer Ronald, 2007, P1, DOI 10.1201/9781420052275.ch1; GAJADHAR AA, 1991, MOL BIOCHEM PARASIT, V45, P147, DOI 10.1016/0166-6851(91)90036-6; Gass JN, 2008, MOL IMMUNOL, V45, P1035, DOI 10.1016/j.molimm.2007.07.029; GERNER EW, 1993, BIOCHEM J, V294, P491, DOI 10.1042/bj2940491; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Hector S, 2004, MOL CANCER THER, V3, P813; Ishii M, 2000, DIGEST DIS SCI, V45, P93, DOI 10.1023/A:1005413511320; Ishii M, 2002, INT J BIOCHEM CELL B, V34, P1134, DOI 10.1016/S1357-2725(02)00033-X; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; JANNE J, 1971, J BIOL CHEM, V246, P1725; JOHNSON AM, 1990, INT J PARASITOL, V20, P141, DOI 10.1016/0020-7519(90)90093-3; Keithly JS, 1997, MOL BIOCHEM PARASIT, V88, P35, DOI 10.1016/S0166-6851(97)00063-7; KILANI RT, 1987, AM J TROP MED HYG, V36, P505, DOI 10.4269/ajtmh.1987.36.505; Kincaid MM, 2007, MOL BIOL CELL, V18, P455, DOI 10.1091/mbc.E06-08-0696; Kohno K, 2007, ANTIOXID REDOX SIGN, V9, P2295, DOI 10.1089/ars.2007.1819; LIBBY PR, 1991, ARCH BIOCHEM BIOPHYS, V284, P238, DOI 10.1016/0003-9861(91)90291-P; LOUIE E, 1987, CLIN IMMUNOL IMMUNOP, V44, P329, DOI 10.1016/0090-1229(87)90077-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo R, 2008, J CELL BIOCHEM, V104, P1708, DOI 10.1002/jcb.21736; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Marverti G, 2001, EUR J CANCER, V37, P281, DOI 10.1016/S0959-8049(00)00389-0; OLEMOIYOI OK, 1995, SCIENCE, V267, P834, DOI 10.1126/science.7846527; Pallepati P, 2011, BBA-MOL CELL RES, V1813, P1987, DOI 10.1016/j.bbamcr.2011.07.021; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Perez-Leal O, 2012, MOL CELL BIOL, V32, P1453, DOI 10.1128/MCB.06444-11; Pichyangkul S, 1997, AM J TROP MED HYG, V57, P383, DOI 10.4269/ajtmh.1997.57.383; Seabra SH, 2004, J PARASITOL, V90, P455, DOI 10.1645/GE-179R; SEILER N, 1981, MED BIOL, V59, P334; Seiler N, 2004, AMINO ACIDS, V26, P217, DOI 10.1007/s00726-004-0070-z; SEILER N, 1987, CAN J PHYSIOL PHARM, V65, P2024, DOI 10.1139/y87-317; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang YL, 2001, BIOCHEM J, V355, P45, DOI 10.1042/0264-6021:3550045; Wang YL, 2001, CANCER RES, V61, P5370; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yarlett N, 2007, MOL BIOCHEM PARASIT, V152, P170, DOI 10.1016/j.molbiopara.2007.01.004; Zahedi K, 2007, AM J PHYSIOL-CELL PH, V292, pC1204, DOI 10.1152/ajpcell.00451.2006; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200	47	14	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30356	30364		10.1074/jbc.M113.459735	http://dx.doi.org/10.1074/jbc.M113.459735			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986438	hybrid, Green Published			2022-12-25	WOS:000329868100032
J	Chen, L; Bai, Y; Liao, GY; Peng, EJ; Wu, BL; Wang, YX; Zeng, XY; Xie, XL				Chen, Liang; Bai, Yi; Liao, Guiying; Peng, Ejun; Wu, Bolin; Wang, Yuxi; Zeng, Xiaoyong; Xie, Xiaolin			Electrospun Poly(L-lactide)/Poly(epsilon-caprolactone) Blend Nanofibrous Scaffold: Characterization and Biocompatibility with Human Adipose-Derived Stem Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; REGENERATIVE MEDICINE; MECHANICAL-PROPERTIES; CELLULAR-RESPONSE; TISSUE; BEHAVIOR; POLY(L-LACTIDE); POLY(EPSILON-CAPROLACTONE)	The essence of tissue engineering is the fabrication of autologous cells or induced stem cells in naturally derived or synthetic scaffolds to form specific tissues. Polymer is thought as an appealing source of cell-seeded scaffold owing to the diversity of its physicochemical property and can be electrospun into nano-size to mimic natural structure. Poly (L-lactic acid) (PLLA) and poly (epsilon-caprolactone) (PCL) are both excellent aliphatic polyester with almost "opposite" characteristics. The controlling combination of PLLA and PCL provides varying properties and makes diverse applications. Compared with the copolymers of the same components, PLLA/PCL blend demonstrates its potential in regenerative medicine as a simple, efficient and scalable alternative. In this study, we electrospun PLLA/PCL blends of different weight ratios into nanofibrous scaffolds (NFS) and their properties were detected including morphology, porosity, degradation, ATR-FTIR analysis, stress-stain assay, and inflammatory reaction. To explore the biocompatibility of the NFS we synthesized, human adipose-derived stem cells (hASCs) were used to evaluate proliferation, attachment, viability and multi-lineage differentiation. In conclusion, the electrospun PLLA/PCL blend nanofibrous scaffold with the indicated weight ratios all supported hASCs well. However, the NFS of 1/1 weight ratio showed better properties and cellular responses in all assessments, implying it a biocompatible scaffold for tissue engineering.	[Chen, Liang; Peng, Ejun; Wu, Bolin; Wang, Yuxi; Zeng, Xiaoyong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430074, Hubei, Peoples R China; [Bai, Yi] Wuhan Univ, Dept Oral Implantol, Sch & Hosp Stomatol, Wuhan 430072, Hubei, Peoples R China; [Liao, Guiying] China Univ Geosci, Sch Mat Sci & Chem Engn, Wuhan 430074, Hubei, Peoples R China; [Xie, Xiaolin] Huazhong Univ Sci & Technol, Hubei Key Lab Mat Chem & Serv Failure, Sch Chem & Chem Engn, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Wuhan University; China University of Geosciences; Huazhong University of Science & Technology	Zeng, XY (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430074, Hubei, Peoples R China.	xyzeng@tjh.tjmu.edu.cn	Xie, Xiaolin/H-4993-2014		National Scientific Foundation of China [30700171, 81270851]; Tongji Hospital; Wuhan University	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Tongji Hospital; Wuhan University	This work was financially supported by the National Scientific Foundation of China (Grant Nos. 30700171 and 81270851, http://www.nsfc.gov.cn), the Scientific Research Fund of Tongji Hospital (2012) and the Funding Project for the Young Teachers of Wuhan University (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami-Henriquez D, 2008, J BIOMED MATER RES A, V87A, P405, DOI 10.1002/jbm.a.31796; Atala A, 2004, REJUV RES, V7, P15, DOI 10.1089/154916804323105053; Baker SC, 2009, BIOMATERIALS, V30, P1321, DOI 10.1016/j.biomaterials.2008.11.033; Brayfield C, 2010, HANDCHIR MIKROCHIR P, V42, P124, DOI 10.1055/s-0030-1248269; Chen L, 2012, CELLS TISSUES ORGANS, V196, P13, DOI 10.1159/000330796; Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gunn J, 2010, TRENDS BIOTECHNOL, V28, P189, DOI 10.1016/j.tibtech.2009.12.006; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007; Lee JH, 2008, BIOCHEM BIOPH RES CO, V370, P456, DOI 10.1016/j.bbrc.2008.03.123; Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005; Liao GY, 2011, J APPL POLYM SCI, V120, P2154, DOI 10.1002/app.33398; Lopez-Rodriguez N, 2006, POLYM ENG SCI, V46, P1299, DOI 10.1002/pen.20609; McCullen SD, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/035002; McCullen SD, 2007, INT J NANOMED, V2, P253; Mehlhorn AT, 2009, TISSUE ENG PT A, V15, P1159, DOI 10.1089/ten.tea.2008.0069; Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042; Noh HK, 2006, BIOMATERIALS, V27, P3934, DOI 10.1016/j.biomaterials.2006.03.016; Roy X, 2006, ADV MATER, V18, P1015, DOI 10.1002/adma.200501210; Sarazin P, 2004, BIOMATERIALS, V25, P5965, DOI 10.1016/j.biomaterials.2004.01.065; Sarazin P, 2008, POLYMER, V49, P599, DOI 10.1016/j.polymer.2007.11.029; Schenke-Layland K, 2009, BIOMATERIALS, V30, P4665, DOI 10.1016/j.biomaterials.2009.05.033; Tsuji H, 2001, INT J BIOL MACROMOL, V29, P83, DOI 10.1016/S0141-8130(01)00158-1; Wang Y, 2008, BIOMATERIALS, V29, P2858, DOI 10.1016/j.biomaterials.2008.03.021; Wu DF, 2008, EUR POLYM J, V44, P2171, DOI 10.1016/j.eurpolymj.2008.04.023; Wu DF, 2009, BIOMACROMOLECULES, V10, P417, DOI 10.1021/bm801183f; Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3; Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	30	39	39	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71265	10.1371/journal.pone.0071265	http://dx.doi.org/10.1371/journal.pone.0071265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23990941	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800008
J	Lazarski, CA; Ford, J; Katzman, SD; Rosenberg, AF; Fowell, DJ				Lazarski, Christopher A.; Ford, Jill; Katzman, Shoshana D.; Rosenberg, Alexander F.; Fowell, Deborah J.			IL-4 Attenuates Th1-Associated Chemokine Expression and Th1 Trafficking to Inflamed Tissues and Limits Pathogen Clearance	PLOS ONE			English	Article							LEISHMANIA-MAJOR INFECTION; CD4(+) T-CELLS; MARROW-DERIVED CELLS; HELPER TYPE-1 CELLS; ALTERNATIVE ACTIVATION; IN-VIVO; IMMUNE-RESPONSES; INTERFERON-GAMMA; DOWN-REGULATION; ENDOTHELIAL-CELLS	Interleukin 4 (IL-4) plays a central role in the orchestration of Type 2 immunity. During T cell activation in the lymph node, IL-4 promotes Th2 differentiation and inhibits Th1 generation. In the inflamed tissue, IL-4 signals promote innate and adaptive Type-2 immune recruitment and effector function, positively amplifying the local Th2 response. In this study, we identify an additional negative regulatory role for IL-4 in limiting the recruitment of Th1 cells to inflamed tissues. To test IL-4 effects on inflammation subsequent to Th2 differentiation, we transiently blocked IL-4 during ongoing dermal inflammation (using anti-IL-4 mAb) and analyzed changes in gene expression. Neutralization of IL-4 led to the upregulation of a number of genes linked to Th1 trafficking, including CXCR3 chemokines, CCL5 and CCR5 and an associated increase in IFN gamma, Tbet and TNF alpha genes. These gene expression changes correlated with increased numbers of IFN gamma-producing CD4+ T cells in the inflamed dermis. Moreover, using an adoptive transfer approach to directly test the role of IL-4 in T cell trafficking to the inflamed tissues, we found IL-4 neutralization led to an early increase in Th1 cell recruitment to the inflamed dermis. These data support a model whereby IL-4 dampens Th1-chemokines at the site of inflammation limiting Th1 recruitment. To determine biological significance, we infected mice with Leishmania major, as pathogen clearance is highly dependent on IFN gamma-producing CD4+ T cells at the infection site. Short-term IL-4 blockade in established L. major infection led to a significant increase in the number of IFN gamma-producing CD4+ T cells in the infected ear dermis, with no change in the draining LN. Increased lymphocyte influx into the infected tissue correlated with a significant decrease in parasite number. Thus, independent of IL-4's role in the generation of immune effectors, IL-4 attenuates lymphocyte recruitment to the inflamed/infected dermis and limits pathogen clearance.	[Lazarski, Christopher A.; Ford, Jill; Katzman, Shoshana D.; Fowell, Deborah J.] Univ Rochester, Dept Microbiol & Immunol, Aab Inst Biomed Sci, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14627 USA; [Rosenberg, Alexander F.] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Fowell, DJ (corresponding author), Univ Rochester, Dept Microbiol & Immunol, Aab Inst Biomed Sci, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14627 USA.	Deborah_Fowell@urmc.rochester.edu			National Institutes of Health [AI072690, AI088427, F32-AI74272, T32-AI07285]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007285, F32AI074272, R21AI088427, R01AI072690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI072690 and AI088427 to DJF, F32-AI74272 to CAL and T32-AI07285 to SDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2009, PARASITOL RES, V105, P1445, DOI 10.1007/s00436-009-1577-8; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Carramolino L, 1999, J LEUKOCYTE BIOL, V66, P837, DOI 10.1002/jlb.66.5.837; Chang SJ, 2007, NAT IMMUNOL, V8, P723, DOI 10.1038/ni1473; Chen CC, 2005, INFECT IMMUN, V73, P5468, DOI 10.1128/IAI.73.9.5468-5481.2005; Cleary AM, 2003, J IMMUNOL, V170, P597, DOI 10.4049/jimmunol.170.1.597; Cuvelier SL, 2001, J EXP MED, V194, P1699, DOI 10.1084/jem.194.12.1699; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Feuerer M, 2006, J IMMUNOL, V176, P2857, DOI 10.4049/jimmunol.176.5.2857; Fine JS, 2003, INFLAMMATION, V27, P161, DOI 10.1023/A:1025076111950; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Hickey MJ, 1999, J IMMUNOL, V163, P3441; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; Katzman SD, 2008, J CLIN INVEST, V118, P801, DOI 10.1172/JCI33174; Khan IA, 2008, INFECT IMMUN, V76, P1305, DOI 10.1128/IAI.01236-07; King SBS, 2008, J IMMUNOL, V180, P754, DOI 10.4049/jimmunol.180.2.754; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kostka SL, 2009, J IMMUNOL, V182, P3039, DOI 10.4049/jimmunol.0713598; La Flamme AC, 2002, PARASITE IMMUNOL, V24, P339, DOI 10.1046/j.1365-3024.2002.00473.x; Lee YW, 2004, MOL MED, V10, P19, DOI 10.2119/2004-00024.Lee; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Locksley RM, 2009, J EXP MED, V206, P1643, DOI 10.1084/jem.20091442; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Luzina IG, 2012, J LEUKOCYTE BIOL, V92, P753, DOI 10.1189/jlb.0412214; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; Mikhak Z, 2006, J IMMUNOL, V176, P4959, DOI 10.4049/jimmunol.176.8.4959; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Negrao-Correa D, 2006, INT J PARASITOL, V36, P1185, DOI 10.1016/j.ijpara.2006.05.005; Norman MU, 2008, EUR J IMMUNOL, V38, P1368, DOI 10.1002/eji.200737847; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Park AY, 2000, J IMMUNOL, V165, P896, DOI 10.4049/jimmunol.165.2.896; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Potian JA, 2011, J EXP MED, V208, P1863, DOI 10.1084/jem.20091473; Rafi W, 2012, CURR OPIN HIV AIDS, V7, P239, DOI 10.1097/COH.0b013e3283524dc5; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Rook GAW, 2005, NAT REV IMMUNOL, V5, P661, DOI 10.1038/nri1666; Rook GAW, 2007, CURR MOL MED, V7, P327; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; Sasaki K, 2008, J IMMUNOL, V181, P104, DOI 10.4049/jimmunol.181.1.104; Sasaki K, 2009, J IMMUNOTHER, V32, P793, DOI 10.1097/CJI.0b013e3181acec1e; Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159; Singh TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051752; STANDIFORD TJ, 1990, J IMMUNOL, V145, P1435; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Sundrud MS, 2003, J IMMUNOL, V171, P3542, DOI 10.4049/jimmunol.171.7.3542; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; TAN JQ, 1995, J IMMUNOL, V154, P3742; Tozawa H, 2011, MOL CELL BIOL, V31, P2196, DOI 10.1128/MCB.01430-10; Urban JF, 2001, J IMMUNOL, V167, P6078, DOI 10.4049/jimmunol.167.11.6078; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhou Y, 2011, J IMMUNOL, V186, P4415, DOI 10.4049/jimmunol.1003307; Zhu JF, 2009, J EXP MED, V206, P329, DOI 10.1084/jem.20081666	71	45	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71949	10.1371/journal.pone.0071949	http://dx.doi.org/10.1371/journal.pone.0071949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991011	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800028
J	Liang, B; Yang, CJ; Zuo, XB; Li, Y; Ding, YT; Sheng, YJ; Zhou, FS; Cheng, H; Zheng, XD; Chen, G; Zhu, ZW; Zhu, J; Fu, XH; Wang, T; Dong, Y; Duan, DW; Tang, XF; Tang, HY; Gao, JP; Sun, LD; Yang, S; Zhang, XJ				Liang, Bo; Yang, Chunjun; Zuo, Xianbo; Li, Yang; Ding, Yantao; Sheng, Yujun; Zhou, Fusheng; Cheng, Hui; Zheng, Xiaodong; Chen, Gang; Zhu, Zhengwei; Zhu, Jun; Fu, Xuhui; Wang, Tao; Dong, Ying; Duan, Dawei; Tang, Xianfa; Tang, Huayang; Gao, Jinping; Sun, Liangdan; Yang, Sen; Zhang, Xuejun			Genetic Variants at 20p11 Confer Risk to Androgenetic Alopecia in the Chinese Han Population	PLOS ONE			English	Article							MALE-PATTERN BALDNESS; SUSCEPTIBILITY VARIANTS; RECEPTOR GENE; PREVALENCE; LOCUS	Background: Androgenetic alopecia (AGA) is a well-characterized type of progressive hair loss commonly seen in men, with different prevalences in different ethnic populations. It is generally considered to be a polygenic heritable trait. Several susceptibility genes/loci, such as AR/EDA2R, HDAC9 and 20p11, have been identified as being involved in its development in European populations. In this study, we aim to validate whether these loci are also associated with AGA in the Chinese Han population. Methods: We genotyped 16 previously reported single nucleotide polymorphisms (SNPs) with 445 AGA cases and 546 healthy controls using the Sequenom iPlex platform. The trend test was used to evaluate the association between these loci and AGA in the Chinese Han population. Conservatively accounting for multiple testing by the Bonferroni correction, the threshold for statistical significance was P <= 3.13 x 10(-3). Results: We identified that 5 SNPs at 20p11 were significantly associated with AGA in the Chinese Han population (1.84x10(-11)<= P <= 2.10x10(-6)). Conclusions: This study validated, for the first time, that 20p11 also confers risk for AGA in the Chinese Han population and implicated the potential common genetic factors for AGA shared by both Chinese and European populations.	[Liang, Bo; Yang, Chunjun; Zuo, Xianbo; Li, Yang; Ding, Yantao; Sheng, Yujun; Zhou, Fusheng; Cheng, Hui; Zheng, Xiaodong; Chen, Gang; Zhu, Zhengwei; Zhu, Jun; Fu, Xuhui; Wang, Tao; Dong, Ying; Duan, Dawei; Tang, Xianfa; Tang, Huayang; Gao, Jinping; Sun, Liangdan; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Liang, Bo; Yang, Chunjun; Zuo, Xianbo; Li, Yang; Ding, Yantao; Sheng, Yujun; Zhou, Fusheng; Cheng, Hui; Zheng, Xiaodong; Chen, Gang; Zhu, Zhengwei; Zhu, Jun; Fu, Xuhui; Wang, Tao; Dong, Ying; Duan, Dawei; Tang, Xianfa; Tang, Huayang; Gao, Jinping; Sun, Liangdan; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Liang, Bo; Yang, Chunjun; Zuo, Xianbo; Li, Yang; Ding, Yantao; Sheng, Yujun; Zhou, Fusheng; Cheng, Hui; Zheng, Xiaodong; Chen, Gang; Zhu, Zhengwei; Zhu, Jun; Fu, Xuhui; Wang, Tao; Dong, Ying; Duan, Dawei; Tang, Xianfa; Tang, Huayang; Gao, Jinping; Sun, Liangdan; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Anhui, Peoples R China; [Liang, Bo; Yang, Chunjun; Zuo, Xianbo; Li, Yang; Ding, Yantao; Sheng, Yujun; Zhou, Fusheng; Cheng, Hui; Zheng, Xiaodong; Chen, Gang; Zhu, Zhengwei; Zhu, Jun; Fu, Xuhui; Wang, Tao; Dong, Ying; Duan, Dawei; Tang, Xianfa; Tang, Huayang; Gao, Jinping; Sun, Liangdan; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, State Key Lab Incubat Base Dermatol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Zhang, XJ (corresponding author), Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China.	ayzxj@vip.sina.com	Chen, Gang/G-2722-2010; SHENG, Yu/GXZ-8269-2022	Liang, Bo/0000-0003-0267-8184	National Natural Science Foundation of China [30771941/H1106]; CMA-L'OREAL China Skin/Hair Grant	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CMA-L'OREAL China Skin/Hair Grant	This work was supported by the General Program of the National Natural Science Foundation of China (30771941/H1106) and CMA-L'OREAL China Skin/Hair Grant (2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockschmidt FF, 2011, BRIT J DERMATOL, V165, P1293, DOI 10.1111/j.1365-2133.2011.10708.x; Brockschmidt FF, 2010, BRIT J DERMATOL, V162, P899, DOI 10.1111/j.1365-2133.2010.09649.x; Chumlea WC, 2004, DERMATOLOGY, V209, P33, DOI 10.1159/000078584; Cobb JE, 2010, EXP DERMATOL, V19, P1026, DOI 10.1111/j.1600-0625.2010.01132.x; HAMILTON JB, 1951, ANN NY ACAD SCI, V53, P708, DOI 10.1111/j.1749-6632.1951.tb31971.x; Hillmer AM, 2005, AM J HUM GENET, V77, P140, DOI 10.1086/431425; Hillmer AM, 2008, NAT GENET, V40, P1279, DOI 10.1038/ng.228; NORWOOD OT, 1975, SOUTHERN MED J, V68, P1359, DOI 10.1097/00007611-197511000-00009; Prodi DA, 2008, J INVEST DERMATOL, V128, P2268, DOI 10.1038/jid.2008.60; Richards JB, 2008, NAT GENET, V40, P1282, DOI 10.1038/ng.255; Trueb RM, 2010, HAUTARZT, V61, P487, DOI 10.1007/s00105-009-1890-2; Wang TL, 2010, BRIT J DERMATOL, V162, P843, DOI 10.1111/j.1365-2133.2010.09640.x; Xu F, 2009, BRIT J DERMATOL, V160, P629, DOI 10.1111/j.1365-2133.2008.08909.x	13	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71771	10.1371/journal.pone.0071771	http://dx.doi.org/10.1371/journal.pone.0071771			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23990985	Green Published, gold, Green Submitted			2022-12-25	WOS:000324228800019
J	Yan, HB; Wang, XY; Lou, ZZ; Li, L; Blair, D; Yin, H; Cai, JZ; Dai, XL; Lei, MT; Zhu, XQ; Cai, XP; Jia, WZ				Yan, Hong-Bin; Wang, Xing-Ye; Lou, Zhong-Zi; Li, Li; Blair, David; Yin, Hong; Cai, Jin-Zhong; Dai, Xue-Ling; Lei, Meng-Tong; Zhu, Xing-Quan; Cai, Xue-Peng; Jia, Wan-Zhong			The Mitochondrial Genome of Paramphistomum cervi (Digenea), the First Representative for the Family Paramphistomidae	PLOS ONE			English	Article							TRANSFER-RNA GENES; ORIENTOBILHARZIA-TURKESTANICUM; PLATYHELMINTHES; DNA; PHYLOGENY; TAPEWORM; SEQUENCE; GENUS; ORGANIZATION; PARASITES	We determined the complete mitochondrial DNA (mtDNA) sequence of a fluke, Paramphistomum cervi (Digenea: Paramphistomidae). This genome (14,014 bp) is slightly larger than that of Clonorchis sinensis (13,875 bp), but smaller than those of other digenean species. The mt genome of P. cervi contains 12 protein-coding genes, 22 transfer RNA genes, 2 ribosomal RNA genes and 2 non-coding regions (NCRs), a complement consistent with those of other digeneans. The arrangement of protein-coding and ribosomal RNA genes in the P. cervi mitochondrial genome is identical to that of other digeneans except for a group of Schistosoma species that exhibit a derived arrangement. The positions of some transfer RNA genes differ. Bayesian phylogenetic analyses, based on concatenated nucleotide sequences and amino-acid sequences of the 12 protein-coding genes, placed P. cervi within the Order Plagiorchiida, but relationships depicted within that order were not quite as expected from previous studies. The complete mtDNA sequence of P. cervi provides important genetic markers for diagnostics, ecological and evolutionary studies of digeneans.	[Yan, Hong-Bin; Wang, Xing-Ye; Lou, Zhong-Zi; Li, Li; Yin, Hong; Dai, Xue-Ling; Zhu, Xing-Quan; Cai, Xue-Peng; Jia, Wan-Zhong] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov,Agr Minist, State Key Lab Vet Etiol Biol,Key Lab Vet Publ Hlt, Lanzhou, Gansu, Peoples R China; [Blair, David] James Cook Univ, Sch Marine & Trop Biol, Brisbane, Qld, Australia; [Cai, Jin-Zhong; Lei, Meng-Tong] Qinghai Acad Anim Sci & Vet Med, Vet Res Inst, Lab Plateau Vet Parasitol, Xining, Qinghai Provinc, Peoples R China; [Wang, Xing-Ye] Northwest A&F Univ, Coll Vet Med, Yangling, Shanxi Province, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; James Cook University; Qinghai University; Northwest A&F University - China	Cai, XP (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov,Agr Minist, State Key Lab Vet Etiol Biol,Key Lab Vet Publ Hlt, Lanzhou, Gansu, Peoples R China.	caixp@vip.163.com; jiawanzhong@caas.cn	Yin, Hong/AAC-5784-2020; Blair, David/O-2786-2019	Blair, David/0000-0002-4658-3251	"Special Fund for Agro-scientific Research in the Public Interest'' [201303037]; Science Fund for Creative Research Groups of Gansu Province [1210RJIA006]; NBCITS, MOA, the People's Republic of China [CARS-38]	"Special Fund for Agro-scientific Research in the Public Interest''; Science Fund for Creative Research Groups of Gansu Province(Science Fund for Creative Research Groups); NBCITS, MOA, the People's Republic of China	This study was supported by the "Special Fund for Agro-scientific Research in the Public Interest'' (Grant No. 201303037), the Science Fund for Creative Research Groups of Gansu Province (Grant No. 1210RJIA006), and NBCITS, MOA (CARS-38), the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adachi J, 2000, J MOL EVOL, V50, P348, DOI 10.1007/s002399910038; AGATSUMA T, 1994, J HELMINTHOL, V68, P7, DOI 10.1017/S0022149X00013407; ALTAIF KI, 1978, ANN TROP MED PARASIT, V72, P151, DOI 10.1080/00034983.1978.11719297; Anuracpreeda P, 2008, EXP PARASITOL, V118, P203, DOI 10.1016/j.exppara.2007.08.005; Arru E, 1970, Riv Parassitol, V31, P33; BIDA SA, 1977, TROP ANIM HEALTH PRO, V9, P21, DOI 10.1007/BF02297385; Blair D, 1999, PARASITOLOGY, V119, P303, DOI 10.1017/S0031182099004709; Burland T G, 2000, Methods Mol Biol, V132, P71; Cai XQ, 2012, PARASITOL RES, V110, P235, DOI 10.1007/s00436-011-2477-2; Deiana S., 1963, Ricerca Scientifica (2B) RC, V3, P449; DEIANA S., 1953, BOLL SOC ITAL BIOL SPERIM, V29, P1939; DESPRES L, 1991, MOL BIOCHEM PARASIT, V47, P139, DOI 10.1016/0166-6851(91)90156-Z; EDUARDO SL, 1982, SYST PARASITOL, V4, P189, DOI 10.1007/BF00009622; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HANNA REB, 1988, INT J PARASITOL, V18, P513, DOI 10.1016/0020-7519(88)90016-1; Jia WZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-447; Jia WZ, 2012, ACTA TROP, V123, P154, DOI 10.1016/j.actatropica.2012.04.006; Kang S, 2012, MITOCHONDR DNA, V23, P176, DOI 10.3109/19401736.2012.668900; Korchagina EV, 2009, MOL BIOL+, V43, P16, DOI 10.1134/S0026893309010038; KRANEBURG W, 1978, BERL MUNCH TIERARZTL, V91, P71; Kutz SJ, 2012, ADV PARASIT, V79, P99, DOI 10.1016/B978-0-12-398457-9.00002-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Le TH, 2000, MOL BIOL EVOL, V17, P1123, DOI 10.1093/oxfordjournals.molbev.a026393; Le TH, 2001, PARASITOLOGY, V123, P609, DOI 10.1017/S0031182001008733; Le TH, 2001, MOL BIOCHEM PARASIT, V117, P61, DOI 10.1016/S0166-6851(01)00330-9; Littlewood DTJ, 2006, MOL PHYLOGENET EVOL, V39, P452, DOI 10.1016/j.ympev.2005.12.012; Liu GH, 2011, MOL BIOL REP, V38, P2249, DOI 10.1007/s11033-010-0355-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McManus DP, 2006, PARASITOL INT, V55, pS31, DOI 10.1016/j.parint.2005.11.004; Morgan JAT, 2003, INT J PARASITOL, V33, P977, DOI 10.1016/S0020-7519(03)00132-2; OKIMOTO R, 1992, GENETICS, V130, P471; Olson PD, 2003, INT J PARASITOL, V33, P733, DOI 10.1016/S0020-7519(03)00049-3; Panyarachun B, 2010, EXP PARASITOL, V125, P95, DOI 10.1016/j.exppara.2009.12.020; de Leon GPP, 2007, SYST PARASITOL, V68, P49, DOI 10.1007/s11230-006-9081-3; Rangel-Ruiz LJ, 2003, VET PARASITOL, V116, P217, DOI 10.1016/j.vetpar.2003.07.002; ROLFE PF, 1988, AUST VET J, V65, P148, DOI 10.1111/j.1751-0813.1988.tb14443.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SHARMA PN, 1988, J HELMINTHOL, V62, P331, DOI 10.1017/S0022149X00011731; Shekhovtsov SV, 2010, PARASITOL INT, V59, P100, DOI 10.1016/j.parint.2009.10.012; Telford MJ, 2000, P NATL ACAD SCI USA, V97, P11359, DOI 10.1073/pnas.97.21.11359; von Nickisch-Rosenegk M, 2001, MOL BIOL EVOL, V18, P721, DOI 10.1093/oxfordjournals.molbev.a003854; Waeschenbach A, 2012, MOL PHYLOGENET EVOL, V63, P834, DOI 10.1016/j.ympev.2012.02.020; Wang CR, 2006, VET PARASITOL, V140, P378, DOI 10.1016/j.vetpar.2006.04.008; Wang CR, 2009, EXP PARASITOL, V121, P193, DOI 10.1016/j.exppara.2008.10.012; Wang Y, 2011, INFECT GENET EVOL, V11, P1964, DOI 10.1016/j.meegid.2011.08.030; Webster BL, 2007, J PARASITOL, V93, P553, DOI 10.1645/GE-1072R.1; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Zarowlecki MZ, 2007, INT J PARASITOL, V37, P1401, DOI 10.1016/j.ijpara.2007.04.014	49	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e71300	10.1371/journal.pone.0071300	http://dx.doi.org/10.1371/journal.pone.0071300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23990943	gold, Green Published, Green Accepted			2022-12-25	WOS:000324470700013
J	Chiou, SY; Wang, RY; Liao, KK; Yang, YR				Chiou, Shin-Yi; Wang, Ray-Yau; Liao, Kwong-Kum; Yang, Yea-Ru			Homologous Muscle Contraction during Unilateral Movement Does Not Show a Dominant Effect on Leg Representation of the Ipsilateral Primary Motor Cortex	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INTERHEMISPHERIC INHIBITION; EVOKED-POTENTIALS; HAND; FACILITATION; HUMANS; ACTIVATION; RESPONSES; REFLEX; OUTPUT	Co-activation of homo-and heterotopic representations in the primary motor cortex (M1) ipsilateral to a unilateral motor task has been observed in neuroimaging studies. Further analysis showed that the ipsilateral M1 is involved in motor execution along with the contralateral M1 in humans. Additionally, transcranial magnetic stimulation (TMS) studies have revealed that the size of the co-activation in the ipsilateral M1 has a muscle-dominant effect in the upper limbs, with a prominent decline of inhibition within the ipsilateral M1 occurring when a homologous muscle contracts. However, the homologous muscle-dominant effect in the ipsilateral M1 is less clear in the lower limbs. The present study investigates the response of corticospinal output and intracortical inhibition in the leg representation of the ipsilateral M1 during a unilateral motor task, with homo-or heterogeneous muscles. We assessed functional changes within the ipsilateral M1 and in corticospinal outputs associated with different contracting muscles in 15 right-handed healthy subjects. Motor tasks were performed with the right-side limb, including movements of the upper and lower limbs. TMS paradigms were measured, consisting of short-interval intracortical inhibition (SICI) and recruitment curves (RCs) of motor evoked potentials (MEPs) in the right M1, and responses were recorded from the left rectus femoris (RF) and left tibialis anterior (TA) muscles. TMS results showed that significant declines in SICI and prominent increases in MEPs of the left TA and left RF during unilateral movements. Cortical activations were associated with the muscles contracting during the movements. The present data demonstrate that activation of the ipsilateral M1 on leg representation could be increased during unilateral movement. However, no homologous muscle-dominant effect was evident in the leg muscles. The results may reflect that functional coupling of bilateral leg muscles is a reciprocal movement.	[Chiou, Shin-Yi; Wang, Ray-Yau; Yang, Yea-Ru] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan; [Liao, Kwong-Kum] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Liao, Kwong-Kum] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Yang, Yea-Ru] Taipei City Hosp, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei City Hospital	Yang, YR (corresponding author), Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan.	yryang@ym.edu.tw			Ministry of Education, Aim for the Top University Plan of National Yang-Ming University, Taiwan [98A-C-D160]; National Science Council [NSC96-2628-B-010-007-MY2]	Ministry of Education, Aim for the Top University Plan of National Yang-Ming University, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan)	This project was funded by the Ministry of Education, Aim for the Top University Plan (98A-C-D160) of National Yang-Ming University, Taiwan and the National Science Council (NSC96-2628-B-010-007-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkadhi H, 2002, AM J NEURORADIOL, V23, P1524; Boudrias MH, 2012, NEUROIMAGE, V59, P3398, DOI 10.1016/j.neuroimage.2011.11.025; Chen R, 1998, J NEUROPHYSIOL, V80, P2870, DOI 10.1152/jn.1998.80.6.2870; Chiou SY, 2013, CLIN NEUROPHYSIOL, V124, P1353, DOI 10.1016/j.clinph.2013.02.001; DAY BL, 1989, J PHYSIOL-LONDON, V412, P449, DOI 10.1113/jphysiol.1989.sp017626; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Doeltgen SH, 2009, J NEUROSCI METH, V178, P134, DOI 10.1016/j.jneumeth.2008.12.005; Duque J, 2005, CEREB CORTEX, V15, P588, DOI 10.1093/cercor/bhh160; Goodwill AM, 2012, MUSCLE NERVE, V46, P384, DOI 10.1002/mus.23316; Harris-Love ML, 2007, J NEUROPHYSIOL, V97, P2511, DOI 10.1152/jn.01331.2006; Hortobagyi T, 2003, J NEUROPHYSIOL, V90, P2451, DOI 10.1152/jn.01001.2002; Hortobagyi T, 2011, MED SCI SPORT EXER, V43, P1188, DOI 10.1249/MSS.0b013e31820a94b8; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; Kremenic IJ, 2009, MED SCI SPORT EXER, V41, P1461, DOI 10.1249/MSS.0b013e318199eb75; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; MacLellan MJ, 2012, J NEUROPHYSIOL, V107, P114, DOI 10.1152/jn.00693.2011; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P344, DOI 10.1016/S1388-2457(99)00243-6; Nagai N, 2012, BIOL PHARM BULL, V35, P239, DOI 10.1248/bpb.35.239; NASHNER LM, 1986, J NEUROPHYSIOL, V55, P1382, DOI 10.1152/jn.1986.55.6.1382; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; Post M, 2009, J NEUROSCI, V29, P6353, DOI 10.1523/JNEUROSCI.0631-09.2009; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Stedman A, 1998, MUSCLE NERVE, V21, P1033, DOI 10.1002/(SICI)1097-4598(199808)21:8<1033::AID-MUS7>3.0.CO;2-9; Stinear CM, 2001, EXP BRAIN RES, V139, P101, DOI 10.1007/s002210100758; Stippich C, 2007, NEUROIMAGE, V34, P1227, DOI 10.1016/j.neuroimage.2006.08.046; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Takada Y, 2000, J NEUROPHYSIOL, V83, P2063, DOI 10.1152/jn.2000.83.4.2063; Tazoe T, 2007, CLIN NEUROPHYSIOL, V118, P1204, DOI 10.1016/j.clinph.2007.03.005; Tomazin K, 2010, MUSCLE NERVE, V41, P406, DOI 10.1002/mus.21566; TOULOUSE P, 1980, ARCH PHYS MED REHAB, V61, P511; Uematsu A, 2010, EXP BRAIN RES, V206, P59, DOI 10.1007/s00221-010-2397-x; Verstynen T, 2011, J COGNITIVE NEUROSCI, V23, P2468, DOI 10.1162/jocn.2011.21612; Yiou E, 2007, HUM MOVEMENT SCI, V26, P357, DOI 10.1016/j.humov.2007.03.003; Zehr EP, 2009, EXERC SPORT SCI REV, V37, P102, DOI 10.1097/JES.0b013e31819c2ed6	34	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72231	10.1371/journal.pone.0072231	http://dx.doi.org/10.1371/journal.pone.0072231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991067	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100087
J	Manasa, J; Lessells, RJ; Skingsley, A; Naidu, KK; Newell, ML; McGrath, N; de Oliveira, T				Manasa, Justen; Lessells, Richard J.; Skingsley, Andrew; Naidu, Kevindra K.; Newell, Marie-Louise; McGrath, Nuala; de Oliveira, Tulio		Southern African Treatment	High-Levels of Acquired Drug Resistance in Adult Patients Failing First-Line Antiretroviral Therapy in a Rural HIV Treatment Programme in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; C-INFECTED PATIENTS; SUB-SAHARAN AFRICA; SCALE-UP; VIRAL LOAD; SUBTYPE; ACCUMULATION; OUTCOMES; PREVALENCE; COMMUNITY	Objective: To determine the frequency and patterns of acquired antiretroviral drug resistance in a rural primary health care programme in South Africa. Design: Cross-sectional study nested within HIV treatment programme. Methods: Adult (>= 18 years) HIV-infected individuals initially treated with a first-line stavudine- or zidovudine-based antiretroviral therapy (ART) regimen and with evidence of virological failure (one viral load >1000 copies/ml) were enrolled from 17 rural primary health care clinics. Genotypic resistance testing was performed using the in-house SATuRN/Life Technologies system. Sequences were analysed and genotypic susceptibility scores (GSS) for standard second-line regimens were calculated using the Stanford HIVDB 6.0.5 algorithms. Results: A total of 222 adults were successfully genotyped for HIV drug resistance between December 2010 and March 2012. The most common regimens at time of genotype were stavudine, lamivudine and efavirenz (51%); and stavudine, lamivudine and nevirapine (24%). Median duration of ART was 42 months (interquartile range (IQR) 32-53) and median duration of antiretroviral failure was 27 months (IQR 17-40). One hundred and ninety one (86%) had at least one drug resistance mutation. For 34 individuals (15%), the GSS for the standard second-line regimen was <2, suggesting a significantly compromised regimen. In univariate analysis, individuals with a prior nucleoside reverse-transcriptase inhibitor (NRTI) substitution were more likely to have a GSS <2 than those on the same NRTIs throughout (odds ratio (OR) 5.70, 95% confidence interval (CI) 2.60-12.49). Conclusions: There are high levels of drug resistance in adults with failure of first-line antiretroviral therapy in this rural primary health care programme. Standard second-line regimens could potentially have had reduced efficacy in about one in seven adults involved.	[Manasa, Justen; Lessells, Richard J.; Skingsley, Andrew; Naidu, Kevindra K.; Newell, Marie-Louise; McGrath, Nuala; de Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Lessells, Richard J.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Newell, Marie-Louise] UCL, MRC Ctr Epidemiol Child Hlth, Inst Child Hlth, London, England; [McGrath, Nuala] Univ Southampton, Acad Unit Primary Care & Populat Sci, Southampton, Hants, England; [McGrath, Nuala] Univ Southampton, Div Social Stat & Demog, Southampton, Hants, England; [de Oliveira, Tulio] UCL, Res Dept Infect, Div Infect & Immun, London, England	University of Kwazulu Natal; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Southampton; University of Southampton; University of London; University College London	Manasa, J (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa.	jmanasa@gmail.com	Newell, Marie-Louise/AAE-8222-2019; Manasa, Justen/T-6213-2018	Newell, Marie-Louise/0000-0002-1074-7699; Manasa, Justen/0000-0002-8874-907X; Lessells, Richard/0000-0003-0926-710X; McGrath, Nuala/0000-0002-1039-0159	Wellcome Trust [082384/Z/07/Z]; European Union [SANTE 2007 147-790]; US Centre for Diseases Control via CAPRISA; Swiss South African Joint Research Programme (SSJRP); United States Agency for International Development (USAID); President's Emergency Plan (PEPFAR) [674-A-00-08-00001-00]	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); US Centre for Diseases Control via CAPRISA; Swiss South African Joint Research Programme (SSJRP); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); President's Emergency Plan (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Wellcome Trust (082384/Z/07/Z), European Union (SANTE 2007 147-790), the US Centre for Diseases Control via CAPRISA (project title: Health Systems Strengthening and HIV Treatment Failure (HIV-TFC)) and the Swiss South African Joint Research Programme (SSJRP) research grant entitled "Swiss Prot/South Africa: Protein Bioinformatics Resource Development for Important Health-related Pathogens". The Hlabisa HIV Treatment and Care Programme has received support through the United States Agency for International Development (USAID) and the President's Emergency Plan (PEPFAR) under the terms of Award No. 674-A-00-08-00001-00. The opinions expressed herein are those of the authors and do not necessarily reflect the view of the USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, CENS 2011 MET; Atun R, 2011, JAIDS-J ACQ IMM DEF, V57, pS91, DOI 10.1097/QAI.0b013e3182218441; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Barnighausen T, 2009, AIDS RES HUM RETROV, V25, P405, DOI 10.1089/aid.2008.0211; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Barth RE, 2008, AIDS, V22, P2210, DOI 10.1097/QAD.0b013e328313bf87; Barth RE, 2012, ANTIVIR THER, V17, P377, DOI 10.3851/IMP2010; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Chaiyachati K, 2011, AIDS PATIENT CARE ST, V25, P163, DOI 10.1089/apc.2010.0257; Cooke GS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-585; Cozzi-Lepri A, 2009, J INFECT DIS, V200, P687, DOI 10.1086/604731; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; de Oliveira T, 2010, NATURE, V464, P673, DOI 10.1038/464673c; *DEP HLTH, 2004, NAT ANT TREATM GUID; Department of Health, 2010, CLIN GUID MAN HIV AI; Department of Health RoSA, 2011, NAT STRAT PLAN HIV S; Drummond AJ, 2010, GENEIOUS 5 1; El-Khatib Z., 2011, Journal of AIDS and Clinical Research, V2, P117; El-Khatib Z, 2010, AIDS, V24, P1679, DOI 10.1097/QAD.0b013e32833a097b; Fatti G, 2011, JAIDS-J ACQ IMM DEF, V58, pE17, DOI 10.1097/QAI.0b013e318229baab; Fox MP, 2012, J ACQUIR IMMUNE DEFI; Fried J, 2012, SEX TRANSM INFECT, V88, P147, DOI 10.1136/sextrans-2011-050140; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Hamers RL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4159; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Houlihan CF, 2010, INT J EPIDEMIOL; Johnston V, 2012, J ACQ IMMUN DEF SYND, DOI [10.1097/QAI.1090b1013e318266ee318263f, DOI 10.1097/QAI.1090B1013E318266EE318263F]; Johnston V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036997; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Keiser O, 2011, AIDS, V25, P1761, DOI 10.1097/QAD.0b013e328349822f; Larson HJ, 2011, B WORLD HEALTH ORGAN, V89, P846, DOI 10.2471/BLT.11.087114; Lessells RJ, 2012, CURR OPIN H IN PRESS; Levison JH, 2011, ANTIVIR THER, V16, P853, DOI 10.3851/IMP1819; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Manasa J, 2012, AIDS RES HUM RETROV, V28, P558, DOI [10.1089/aid.2011.0284, 10.1089/AID.2011.0284]; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; Mepham S, 2011, AIDS CARE, V23, P741, DOI 10.1080/09540121.2010.516341; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Miller MD, 2004, J INFECT DIS, V189, P837, DOI 10.1086/381784; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Navario P, 2009, LANCET, V374, P184, DOI 10.1016/S0140-6736(09)61312-X; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Orrell C, 2009, ANTIVIR THER, V14, P523; Pillay V, 2008, AIDS RES HUM RETROV, V24, P1449, DOI 10.1089/aid.2008.0180; Sigaloff KC, 2012, AIDS RES HUM RETROVI; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Singh A, 2011, JAIDS-J ACQ IMM DEF, V58, P233, DOI 10.1097/QAI.0b013e318228667f; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Theys K, 2013, ANTIMICROB AGENTS CH, V57, P1053, DOI 10.1128/AAC.01668-12; Tshabalala M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021241; UNAIDS, 2011, WORLD AIDS DAY REP 2; van Zyl GU, 2011, J MED VIROL, V83, P1764, DOI 10.1002/jmv.22189; Versteeg M, 2011, RUR HLTH KEY HLTH NA; Wallis CL, 2012, ANTIVIR THER, V17, P313, DOI 10.3851/IMP1985; Wallis CL, 2010, JAIDS-J ACQ IMM DEF, V53, P480, DOI 10.1097/QAI.0b013e3181bc478b; WHO, 2010, ANT THER HIV INF AD; Zaccarelli M, 2004, CLIN INFECT DIS, V38, P433, DOI 10.1086/381097	60	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72152	10.1371/journal.pone.0072152	http://dx.doi.org/10.1371/journal.pone.0072152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991055	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000324470100082
J	Shen, ZG; He, HY; Wu, YZ; Li, JT				Shen, Zigang; He, Haiyang; Wu, Yuzhang; Li, Jintao			Cyclosporin A Inhibits Rotavirus Replication and Restores Interferon-Beta Signaling Pathway In Vitro and In Vivo	PLOS ONE			English	Article							HEPATITIS-C; ALPHA EXPRESSION; INFECTION; VIRUS; CYCLOPHILIN; MICE; PROLIFERATION; HEPATOCYTES; DEGRADATION; EPITHELIUM	Rotavirus (RV) is the most common cause of severe diarrhea among infants and young children. Currently, there is no specific drug available against rotavirus, largely due to the lack of an ideal target molecule which has hampered drug development. Our previous studies have revealed that cyclosporin A (CsA) might be potentially useful as an anti-RV drug. We therefore used both cellular and mouse models to study the immunological safety and effectiveness of CsA as an anti-RV drug. We found that CsA treatment of HT-29 cells before, during, and after viral infection efficiently inhibited Wa strain RV replication and restored IFN-beta expression in a HT-29 cell line model. Exploring the underlying mechanisms showed that CsA promoted Interferon Regulatory Factor-5 (IRF-5) expression (a key positive regulator of the type I IFN signaling pathway), but not IRF-1, IRF-3, or IRF-7. Additionally, CsA inhibited SOCS-1 expression (the key negative regulator of IFN-alpha/beta), but not SOCS-2 or SOCS-3. The antiviral effect of CsA was confirmed in an RV-infected neonatal mouse model by evaluation of antigen clearance and assessment of changes in intestinal tissue pathology. Also, no differences in T cell frequency or proliferation between the CsA- and vehicle-treated groups were observed. Thus, both our in vitro and in vivo findings suggest that CsA, through modulating the expression of key regulators in IFN signaling pathway, promote type I IFN-based intracellular innate immunity in RV host cells. These findings suggest that CsA may be a useful candidate to develop a new anti-RV strategy, although further evaluation and characterization of CsA on RV-induced diarrhea are warranted.	[Shen, Zigang; He, Haiyang; Wu, Yuzhang; Li, Jintao] Third Mil Med Univ, PLA, Inst Immunol, Chongqing, Peoples R China	Army Medical University	Wu, YZ (corresponding author), Third Mil Med Univ, PLA, Inst Immunol, Chongqing, Peoples R China.	wuyuzhang20006@sohu.com; ljtqms@yahoo.com.cn		li, jintao/0000-0003-3637-2386; Wu, Yuzhang/0000-0002-4049-0214	Key Technology R&D Program of Chongqing Science and Technology Commission [CSTC, 2009AB5197]; National Natural Science Foundation of China [81271813, 81202326]	Key Technology R&D Program of Chongqing Science and Technology Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Key Technology R&D Program of Chongqing Science and Technology Commission [grant number CSTC, 2009AB5197] http://www.ctin.ac.cn/and the National Natural Science Foundation of China [grant number 81271813 and number 81202326), http://www.nsfc.gov.cn/nsfc/cen/00/download.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 1997, BONE MARROW TRANSPL, V20, P993, DOI 10.1038/sj.bmt.1700996; Allenspach K, 2006, J VET INTERN MED, V20, P239, DOI 10.1892/0891-6640(2006)20[239:PACEOC]2.0.CO;2; Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102; Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bosco DA, 2004, BIOCHEMISTRY-US, V43, P6110, DOI 10.1021/bi049841z; Boshuizen JA, 2003, J VIROL, V77, P13005, DOI 10.1128/JVI.77.24.13005-13016.2003; Chaplin PJ, 1996, J INTERF CYTOK RES, V16, P25, DOI 10.1089/jir.1996.16.25; DEBOISSIEU D, 1993, J PEDIATR GASTR NUTR, V16, P29; Feng N, 2008, J VIROL, V82, P7578, DOI 10.1128/JVI.00391-08; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; Graff JW, 2007, J GEN VIROL, V88, P613, DOI 10.1099/vir.0.82255-0; He H, PROTEOMICS, V13, P1121; He HY, 2012, BIOCHEM BIOPH RES CO, V422, P664, DOI 10.1016/j.bbrc.2012.05.050; Holloway G, 2009, J VIROL, V83, P4942, DOI 10.1128/JVI.01450-08; Inoue K, 2005, TRANSPLANT P, V37, P1233, DOI 10.1016/j.transproceed.2004.11.041; Inoue K, 2003, J GASTROENTEROL, V38, P567, DOI 10.1007/s00535-002-1104-5; KASAIAN MT, 1990, J IMMUNOL, V144, P299; Kawasaki H, 2007, J VIROL, V81, P9013, DOI 10.1128/JVI.00261-07; Liu D, 2010, J IMMUNOL, V184, P3098, DOI 10.4049/jimmunol.0903177; Liu JP, 2011, TRANSPL INFECT DIS, V13, P24, DOI 10.1111/j.1399-3062.2010.00556.x; Liu X, PLOS ONE, V7; Macartney KK, J PAEDIAT CHILD HLTH, V47, P266; MarkowskaDaniel I, 1996, COMP IMMUNOL MICROB, V19, P219, DOI 10.1016/0147-9571(96)00008-2; Melen K, 2004, J MED VIROL, V73, P536, DOI 10.1002/jmv.20123; Min BS, 2006, J VIROL METHODS, V137, P280, DOI 10.1016/j.jviromet.2006.06.028; Morales JM, 2005, KIDNEY INT, V68, P124; Renes IB, 2002, J PATHOL, V198, P60, DOI 10.1002/path.1183; SCHWERS A, 1985, ANN RECH VET, V16, P213; Sherry B, 2009, J INTERF CYTOK RES, V29, P559, DOI 10.1089/jir.2009.0072; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tate JE, LANCET INFECT DIS, V12, P136; Vlotides G, 2004, BIOCHEM BIOPH RES CO, V320, P1007, DOI 10.1016/j.bbrc.2004.06.051; Ward RL, 2009, CLIN INFECT DIS, V48, P222, DOI 10.1086/595702; Wolf A, 1997, J PHARMACOL EXP THER, V280, P1328; Zhang T, 2005, HEPATOLOGY, V42, P819, DOI 10.1002/hep.20854; Zhao C, 2007, J MED VIROL, V79, P1478, DOI 10.1002/jmv.20945	37	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71815	10.1371/journal.pone.0071815	http://dx.doi.org/10.1371/journal.pone.0071815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990993	Green Submitted, gold, Green Published			2022-12-25	WOS:000324470100056
J	Wise, PM; Wolf, M; Thom, SR; Bryant, B				Wise, Paul M.; Wolf, Madeline; Thom, Stephen R.; Bryant, Bruce			The Influence of Bubbles on the Perception Carbonation Bite	PLOS ONE			English	Article							ORAL SENSATION; TASTE; STIMULATION; INTENSITY; PUNGENCY; WATER; ITCH; PAIN; TEMPERATURE; POPULATION	Although many people naively assume that the bite of carbonation is due to tactile stimulation of the oral cavity by bubbles, it has become increasingly clear that carbonation bite comes mainly from formation of carbonic acid in the oral mucosa. In Experiment 1, we asked whether bubbles were in fact required to perceive carbonation bite. Subjects rated oral pungency from several concentrations of carbonated water both at normal atmospheric pressure (at which bubbles could form) and at 2.0 atmospheres pressure (at which bubbles did not form). Ratings of carbonation bite under the two pressure conditions were essentially identical, indicating that bubbles are not required for pungency. In Experiment 2, we created controlled streams of air bubbles around the tongue in mildly pungent CO2 solutions to determine how tactile stimulation from bubbles affects carbonation bite. Since innocuous sensations like light touch and cooling often suppress pain, we predicted that bubbles might reduce rated bite. Contrary to prediction, air bubbles flowing around the tongue significantly enhanced rated bite, without inducing perceived bite in blank (un-carbonated) solutions. Accordingly, though bubbles are clearly not required for carbonation bite, they may well modulate perceived bite. More generally, the results show that innocuous tactile stimulation can enhance chemogenic pain. Possible physiological mechanisms are discussed.	[Wise, Paul M.; Wolf, Madeline; Bryant, Bruce] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Thom, Stephen R.] Univ Penn, Inst Environm Med, Philadelphia, PA 19104 USA	Monell Chemical Senses Center; University of Pennsylvania	Wise, PM (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	pwise@monell.org			Anheuser-Busch InBev, Inc.	Anheuser-Busch InBev, Inc.	Anheuser-Busch InBev, Inc. (http://www.ab-inbev.com/). The funders had no substantive role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, with the following exceptions. Dr. Jerome Pellaud and Dr. Wilfried Lossignol of Anheuser-Busch InBev, Inc. served as pilot subjects for Experiment 1, and suggested simplification of the subject response alternatives. Specifically, they suggested collecting just ratings of "bite'' and "tickle-bubbles'' as opposed to asking subjects to rate additional sensations in order to make the task less demanding for subjects. Dr. Pellaud and Dr. Lossignol also offered helpful suggestions related to subject ergonomics. Dr. Pellaud read the manuscript with the option to delay publication to allow filing of patent applications, but the sponsor elected not to delay publication. The contents of the manuscript were determined by the authors.	Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Bhave G, 2004, J NEUROBIOL, V61, P88, DOI 10.1002/neu.20083; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; CLARK CC, 1994, CHEM SENSES, V19, P583, DOI 10.1093/chemse/19.6.583; COMETTOMUNIZ JE, 1985, PHYSIOL BEHAV, V34, P385, DOI 10.1016/0031-9384(85)90200-8; COMETTOMUNIZ JE, 1987, PERCEPTION, V16, P629, DOI 10.1068/p160629; Davidson S, 2009, NAT NEUROSCI, V12, P544, DOI 10.1038/nn.2292; Delwiche J, 2004, FOOD QUAL PREFER, V15, P137, DOI 10.1016/S0950-3293(03)00041-7; des Gachons CP, 2011, J NEUROSCI, V31, P999, DOI 10.1523/JNEUROSCI.1374-10.2011; Dessirier JM, 2001, CHEM SENSES, V26, P639, DOI 10.1093/chemse/26.6.639; Dessirier JM, 2000, CHEM SENSES, V25, P277, DOI 10.1093/chemse/25.3.277; Dunham JP, 2008, EUR J NEUROSCI, V27, P3151, DOI 10.1111/j.1460-9568.2008.06256.x; Field T, 2000, J BURN CARE REHABIL, V21, P189, DOI 10.1097/00004630-200021030-00002; FRUHSTORFER H, 1986, PAIN, V24, P259, DOI 10.1016/0304-3959(86)90048-5; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Green BG, 2005, BEHAV BRAIN RES, V162, P90, DOI 10.1016/j.bbr.2005.03.015; GREEN BG, 1992, CHEM SENSES, V17, P435, DOI 10.1093/chemse/17.4.435; Kammers MPM, 2010, CURR BIOL, V20, P1819, DOI 10.1016/j.cub.2010.08.038; Kappes SM, 2007, J FOOD SCI, V72, pS1, DOI 10.1111/j.1750-3841.2006.00205.x; KOMAI M, 1993, BRAIN RES, V612, P122, DOI 10.1016/0006-8993(93)91652-9; Liger-Belair G, 2005, J AGR FOOD CHEM, V53, P2788, DOI 10.1021/jf048259e; Morrot G, 2001, BRAIN LANG, V79, P309, DOI 10.1006/brln.2001.2493; OTTOSON D, 1981, PAIN, V10, P37, DOI 10.1016/0304-3959(81)90043-9; PERTOVAARA A, 1979, ACTA PHYSIOL SCAND, V107, P339, DOI 10.1111/j.1748-1716.1979.tb06485.x; Simons CT, 1999, J NEUROSCI, V19, P8134; Storey ML, 2006, J AM DIET ASSOC, V106, P1992, DOI 10.1016/j.jada.2006.09.009; Tomlinson C, 2008, CURR MED RES OPIN, V24, P1645, DOI 10.1185/03007990802120572; van Beilen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023857; Wang YYY, 2011, J GEN PHYSIOL, V137, P493, DOI 10.1085/jgp.201110615; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Wise PM, 2011, CHEM SENSES, V36, P581, DOI 10.1093/chemse/bjr024; Wise PM, 2003, CHEM SENSES, V28, P751, DOI 10.1093/chemse/bjg065; YAU NJN, 1991, CHEM SENSES, V16, P337, DOI 10.1093/chemse/16.4.337; Yau NJN., 1990, J SENS STUD, V5, P117, DOI [10.1111/j.1745-459X.1990.tb00484.x, DOI 10.1111/J.1745-459X.1990.TB00484.X]; Yosipovitch G, 2007, BRIT J DERMATOL, V156, P629, DOI 10.1111/j.1365-2133.2006.07711.x	35	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71488	10.1371/journal.pone.0071488	http://dx.doi.org/10.1371/journal.pone.0071488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990956	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100046
J	Fang, L; Xie, D; Wu, X; Cao, HD; Su, WF; Yang, JW				Fang, Li; Xie, Da; Wu, Xian; Cao, Hongdi; Su, Weifang; Yang, Junwei			Involvement of Endoplasmic Reticulum Stress in Albuminuria Induced Inflammasome Activation in Renal Proximal Tubular Cells	PLOS ONE			English	Article							TYPE-2 DIABETIC-NEPHROPATHY; MYOFIBROBLAST TRANSITION; NLRP3 INFLAMMASOME; ER STRESS; PROTEINURIA; PROGRESSION; MECHANISMS; TARGET	Albuminuria contributes to the progression of tubulointerstitial fibrosis. Although it has been demonstrated that ongoing albuminuria leads to tubular injury manifested by the overexpression of numerous proinflammatory cytokines, the mechanism remains largely unknown. In this study, we found that the inflammasome activation which has been recognized as one of the cornerstones of intracellular surveillance system was associated with the severity of albuminuria in the renal biopsies specimens. In vitro, bovine serum albumin (BSA) could also induce the activation of NLRP3 inflammasome in the cultured kidney epithelial cells (NRK-52E). Since there was a significant overlap of NLRP3 with the ER marker calreticulin, the ER stress provoked by BSA seemed to play a crucial role in the activation of inflammasome. Here, we demonstrated that the chemical chaperone taurine-conjugated ursodeoxycholic acid (TUDCA) which was proved to be an enhancer for the adaptive capacity of ER could attenuate the inflammasome activation induced by albuminuria not only in vitro but also in diabetic nephropathy. Taken together, these data suggested that ER stress seemed to play an important role in albuminuria-induced inflammasome activation, elimination of ER stress via TUDCA might hold promise as a novel avenue for preventing inflammasome activation ameliorating kidney epithelial cells injury induced by albuminuria.	[Fang, Li; Xie, Da; Wu, Xian; Cao, Hongdi; Su, Weifang; Yang, Junwei] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Yang, JW (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China.	jwyang@njmu.edu.cn			National Science Foundation of China [31171093]; "973" Science Program of the Ministry of Science and Technology, China [2011CB504000, 2012CB517600]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973" Science Program of the Ministry of Science and Technology, China	This work was supported by National Science Foundation of China Grants 31171093, "973" Science Program of the Ministry of Science and Technology, China (2011CB504000, 2012CB517600) to Junwei Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Bakris GL, 2008, CLIN J AM SOC NEPHRO, V3, pS3, DOI 10.2215/CJN.03250807; Bani-Hani AH, 2009, KIDNEY INT, V76, P500, DOI 10.1038/ki.2009.216; Burton C, 1996, AM J KIDNEY DIS, V27, P765, DOI 10.1016/S0272-6386(96)90512-0; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Dunne A, 2011, BIOCHEM SOC T, V39, P669, DOI 10.1042/BST0390669; Eddy AA, 2004, NEPHROL DIAL TRANSPL, V19, P277, DOI 10.1093/ndt/gfg533; Eijkelkamp WBA, 2007, J AM SOC NEPHROL, V18, P1540, DOI 10.1681/ASN.2006050445; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060546; Lee YJ, 2009, AM J PHYSIOL-RENAL, V296, pF1405, DOI 10.1152/ajprenal.90652.2008; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohse T, 2006, KIDNEY INT, V70, P1447, DOI 10.1038/sj.ki.5001704; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Tesch GH, 1997, NEPHROL DIAL TRANSPL, V12, P1109, DOI 10.1093/ndt/12.6.1109; Tojo A, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/481520; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wang XH, 2010, AM J PHYSIOL-RENAL, V299, pF973, DOI 10.1152/ajprenal.00216.2010; Wetmore JB, 2013, AM J HYPERTENS, V26, P234, DOI 10.1093/ajh/hps019; Yang JW, 2002, J AM SOC NEPHROL, V13, P96, DOI 10.1681/ASN.V13196; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zandi-Nejad K, 2004, KIDNEY INT, V66, pS76, DOI 10.1111/j.1523-1755.2004.09220.x; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou Y, 2010, AM J PHYSIOL-RENAL, V299, pF336, DOI 10.1152/ajprenal.00053.2010; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224; Zoja C, 2003, J AM SOC NEPHROL, V14, pS36, DOI 10.1097/01.ASN.0000068626.23485.E0	31	76	79	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72344	10.1371/journal.pone.0072344	http://dx.doi.org/10.1371/journal.pone.0072344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977286	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300082
J	Chertoff, M; Shrivastava, K; Gonzalez, B; Acarin, L; Gimenez-Llort, L				Chertoff, Mariela; Shrivastava, Kalpana; Gonzalez, Berta; Acarin, Laia; Gimenez-Llort, Lydia			Differential Modulation of TREM2 Protein during Postnatal Brain Development in Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DEVELOPING RAT-BRAIN; NASU-HAKOLA-DISEASE; MICROGLIAL CELLS; MYELOID CELLS; MOUSE-BRAIN; IN-VIVO; SUBVENTRICULAR ZONE; IMMUNE-SYSTEM; RETT-SYNDROME	During postnatal development, microglia, the resident innate immune cells of the central nervous system are constantly monitoring the brain parenchyma, cleaning the cell debris, the synaptic contacts overproduced and also maintaining the brain homeostasis. In this context, the postnatal microglia need some control over the innate immune response. One such molecule recently described to be involved in modulation of immune response is TREM2 (triggering receptor expressed on myeloid cells 2). Although some studies have observed TREM2 mRNA in postnatal brain, the regional pattern of the TREM2 protein has not been described. We therefore characterized the distribution of TREM2 protein in mice brain from Postnatal day (P) 1 to 14 by immunostaining. In our study, TREM2 protein was expressed only in microglia/macrophages and is developmentally downregulated in a region-dependent manner. Its expression persisted in white matter, mainly in caudal corpus callosum, and the neurogenic subventricular zone for a longer time than in grey matter. Additionally, the phenotypes of the TREM2+ microglia also differ; expressing CD16/32, MHCII and CD86 (antigen presentation markers) and CD68 (phagocytic marker) in different regions as well as with different intensity till P7. The mannose receptor (CD206) colocalized with TREM2 only at P1-P3 in the subventricular zone and cingulum, while others persisted at low intensities till P7. Furthermore, the spatiotemporal expression pattern and characterization of TREM2 indicate towards its other plausible roles in phagocytosis, progenitor's fate determination or microglia phenotype modulation during postnatal development. Hence, the increase of TREM2 observed in pathologies may recapitulate their function during postnatal development, as a better understanding of this period may open new pathway for future therapies.	[Chertoff, Mariela; Shrivastava, Kalpana; Gonzalez, Berta; Acarin, Laia] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, E-08193 Barcelona, Spain; [Gimenez-Llort, Lydia] Univ Autonoma Barcelona, Dept Psychiat & Forens Med, E-08193 Barcelona, Spain; [Chertoff, Mariela; Shrivastava, Kalpana; Gonzalez, Berta; Acarin, Laia; Gimenez-Llort, Lydia] Univ Autonoma Barcelona, Inst Neurosci, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona	Chertoff, M (corresponding author), Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, E-08193 Barcelona, Spain.	marielachertoff@gmail.com	Giménez-Llort, Lydia/I-3347-2015; Llort, Lydia Gimenez/AAS-7415-2020; Castellano, Bernardo/G-1428-2010; Giménez-Llort, Lydia/AAI-5182-2021; Gonzalez, Berta/G-1428-2010	Castellano, Bernardo/0000-0003-1976-971X; Giménez-Llort, Lydia/0000-0002-4091-489X; Chertoff, Mariela/0000-0001-5600-7445; Shrivastava, Kalpana/0000-0001-6532-2148; Gonzalez, Berta/0000-0002-1860-3980	Marie Curie International Incoming Fellowship [2009-IIF-253110]; Ministry of Science and Innovation, Government of Spain [BFU2009-08805]; Fundacion La Marato de TV3 [2011-110531]	Marie Curie International Incoming Fellowship(European Commission); Ministry of Science and Innovation, Government of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion La Marato de TV3	This study was supported by Marie Curie International Incoming Fellowship (2009-IIF-253110), BFU2009-08805 from the Ministry of Science and Innovation, Government of Spain and Fundacion La Marato de TV3 (2011-110531). MC holds a Marie Curie International Incoming fellowship from European Commision, and KS holds a postdoctoral fellowship from Fundacion La Marato de TV3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Barclay AN, 2002, TRENDS IMMUNOL, V23, P285, DOI 10.1016/S1471-4906(02)02223-8; Billiards SS, 2006, J COMP NEUROL, V497, P199, DOI 10.1002/cne.20991; BO L, 1994, J NEUROIMMUNOL, V51, P135, DOI 10.1016/0165-5728(94)90075-2; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Chew LJ, 2013, DEV NEUROSCI; CHHOR V, 2013, BRAIN BEHAV IMMUN; Chouery E, 2008, HUM MUTAT, V29, pE194, DOI 10.1002/humu.20836; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Colonna M, 2007, ADV EXP MED BIOL, V602, P97; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; CUADROS MA, 1993, J COMP NEUROL, V330, P113, DOI 10.1002/cne.903300110; Dalmau I, 1998, HIPPOCAMPUS, V8, P458, DOI 10.1002/(SICI)1098-1063(1998)8:5<458::AID-HIPO6>3.0.CO;2-N; Dalmau I, 2003, J COMP NEUROL, V458, P144, DOI 10.1002/cne.10572; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Derecki NC, 2013, TRENDS IMMUNOL, V34, P144, DOI 10.1016/j.it.2012.10.002; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Ekdahl CT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00041; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; Garay P. A., 2012, BRAIN BEHAV IMMUN; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Hristova M, 2010, GLIA, V58, P11, DOI 10.1002/glia.20896; Hu X, 2012, STROKE J CEREBRAL CI; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kato Takahiro A, 2013, Front Hum Neurosci, V7, P13, DOI 10.3389/fnhum.2013.00013; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kiialainen A, 2005, NEUROBIOL DIS, V18, P314, DOI 10.1016/j.nbd.2004.09.007; Kloss CUA, 1997, J NEUROSCI RES, V49, P248; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Lyons A, 2009, J NEUROCHEM, V110, P1547, DOI 10.1111/j.1471-4159.2009.06253.x; Menezes JRL, 2002, BRAZ J MED BIOL RES, V35, P1411, DOI 10.1590/S0100-879X2002001200002; MILLIGAN CE, 1991, J COMP NEUROL, V314, P125, DOI 10.1002/cne.903140112; Navascues J, 2000, AN ACAD BRAS CIENC, V72, P91, DOI 10.1590/S0001-37652000000100013; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Olah M, 2011, CNS NEUROL DISORD-DR, V10, P108, DOI 10.2174/187152711794488575; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2001, NEUROLOGY, V56, P1552, DOI 10.1212/WNL.56.11.1552; Paxinos G., 2007, ATLAS DEV MOUSE BRAI; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Piccio L, 2007, EUR J IMMUNOL, V37, P1290, DOI 10.1002/eji.200636837; Prada I, 2006, NEUROSCIENCE, V140, P1139, DOI 10.1016/j.neuroscience.2006.03.058; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Roumier A, 2004, J NEUROSCI, V24, P11421, DOI 10.1523/JNEUROSCI.2251-04.2004; Santambrogio L, 2001, P NATL ACAD SCI USA, V98, P6295, DOI 10.1073/pnas.111152498; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; Shrivastava K, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/781512; Shrivastava K, 2012, J COMP NEUROL, V520, P2657, DOI 10.1002/cne.23062; Sieber MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052982; Stefano L, 2009, J NEUROCHEM, V110, P284, DOI 10.1111/j.1471-4159.2009.06130.x; Suzuki K, 2013, JAMA PSYCHIAT, V70, P49, DOI 10.1001/jamapsychiatry.2013.272; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Tambuyzer BR, 2009, J LEUKOCYTE BIOL, V85, P352, DOI 10.1189/jlb.0608385; Tanaka J, 1999, NEUROSCI RES, V34, P207, DOI 10.1016/S0168-0102(99)00041-3; Tanaka J, 1996, EXP NEUROL, V137, P367, DOI 10.1006/exnr.1996.0038; Thrash JC, 2009, NEUROCHEM RES, V34, P38, DOI 10.1007/s11064-008-9657-1; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Xu Y, 2012, NEUROSCIENCE, V218, P35, DOI 10.1016/j.neuroscience.2012.05.036; Zhao YH, 2013, NEUROREPORT, V24, P318, DOI 10.1097/WNR.0b013e32835fb6b0	74	28	28	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72083	10.1371/journal.pone.0072083	http://dx.doi.org/10.1371/journal.pone.0072083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977213	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700131
J	Kumar, S; Shah, S; Tang, HM; Smith, M; Borras, T; Danias, J				Kumar, Sandeep; Shah, Shaily; Tang, Hai Michael; Smith, Matthew; Borras, Teresa; Danias, John			Tissue Plasminogen Activator in Trabecular Meshwork Attenuates Steroid Induced Outflow Resistance in Mice	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; MATRIX METALLOPROTEINASES; INTRAOCULAR-PRESSURE; AQUEOUS-HUMOR; ULTRASTRUCTURAL-CHANGES; FLUID-DYNAMICS; GENE-THERAPY; INHIBITORS; CORTICOSTEROIDS; DEXAMETHASONE	Tissue plasminogen activator, a serine protease encoded by the PLAT gene is present in the trabecular meshwork (TM) and other ocular tissues and has been reported to be downregulated by treatment with steroids in vitro. Steroids are known to cause changes in outflow facility of aqueous humor in many species. In the present study, we tested whether overexpression of PLAT can prevent and/or reverse the outflow facility of mouse eyes treated with steroids. Animals received bilateral injection with 20 mu l of triamcinolone acetonide (TA) (40mg/ml) suspension subconjunctivally to induce outflow facility changes. Some animals received unilateral intracameral injection with 2 mu l of adenoviral suspension [3-4x10(12) virus genomes per milliliter (vg/ml)] carrying sheep PLAT cDNA (AdPLAT) either concurrently with TA injection or one week after TA injection, whereas others received bilateral intracameral injection with 2 mu l of adenoviral suspension (9x10(12) vg/ml) carrying no transgene (AdNull) concurrently with TA injection. Animals were sacrificed one week after AdPLAT or AdNull treatment. Endogenous mRNA expression levels of mouse PAI-1 and MMP-2, -9 and -13 were also measured using qRT-PCR. Outflow facility one week after AdPLAT administration was increased by 60% and 63% respectively for animals that had not or had been pretreated with steroids. Overexpression of PLAT significantly upregulated expression of PAI-1, MMP-2, -9 and -13 compared to the levels found in TA only treated eyes. These findings suggest that overexpression of PLAT in TM of mouse eyes can both prevent and reverse the decrease in outflow facility caused by steroid treatment and is associated with upregulation of MMPs.	[Kumar, Sandeep; Tang, Hai Michael; Danias, John] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Kumar, Sandeep; Shah, Shaily; Danias, John] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Kumar, Sandeep; Shah, Shaily; Danias, John] SUNY Eye Inst, Brooklyn, NY USA; [Shah, Shaily] Mt Sinai Sch Med, New York, NY USA; [Smith, Matthew; Borras, Teresa] Univ N Carolina, Dept Ophthalmol, Chapel Hill, NC USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill	Kumar, S (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.	sandeep.sgpgi@gmail.com			National Eye Institute Grant [EY20670]; Research to Prevent Blindness, Inc., New York, NY; NATIONAL EYE INSTITUTE [R01EY011906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R15MH086928] Funding Source: NIH RePORTER	National Eye Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, Inc., New York, NY(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Eye Institute Grant EY20670 and a challenge grant from Research to Prevent Blindness, Inc., New York, NY to the Department of Ophthalmology, SUNY Downstate Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMALY MF, 1963, ARCH OPHTHALMOL-CHIC, V70, P492, DOI 10.1001/archopht.1963.00960050494011; ARMALY MF, 1963, ARCH OPHTHALMOL-CHIC, V70, P482, DOI 10.1001/archopht.1963.00960050484010; BECKER B, 1963, ARCH OPHTHALMOL-CHIC, V70, P500; Bonnefoy A, 2000, THROMB RES, V98, P323, DOI 10.1016/S0049-3848(99)00242-X; Borras T, 1999, GENE THER, V6, P515, DOI 10.1038/sj.gt.3300860; Borras T, 2001, J GENE MED, V3, P437, DOI 10.1002/jgm.210; Bradley JMB, 1998, INVEST OPHTH VIS SCI, V39, P2649; CLARK AF, 1994, INVEST OPHTH VIS SCI, V35, P281; Dan J, 2005, ARCH OPHTHALMOL-CHIC, V123, P220, DOI 10.1001/archopht.123.2.220; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P1138, DOI 10.1167/iovs.02-0553; El-Shabrawi Y, 2000, EYE, V14, P375, DOI 10.1038/eye.2000.92; Fuchshofer R, 2003, EXP EYE RES, V77, P757, DOI 10.1016/S0014-4835(03)00220-3; GEANON JD, 1987, EXP EYE RES, V44, P55, DOI 10.1016/S0014-4835(87)80025-8; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hsiao Y, 2008, J GASTROEN HEPATOL, V23, pE258, DOI 10.1111/j.1440-1746.2007.05100.x; Johnson D, 1997, ARCH OPHTHALMOL-CHIC, V115, P375, DOI 10.1001/archopht.1997.01100150377011; Jones R, 2006, CURR OPIN OPHTHALMOL, V17, P163; Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023; Kersey JP, 2006, EYE, V20, P407, DOI 10.1038/sj.eye.6701895; Kumar S, 2013, INVEST OPHTH VIS SCI, V54, P1280, DOI 10.1167/iovs.12-11223; Maatta M, 2005, J GLAUCOMA, V14, P64; MARSHALL GE, 1991, OPHTHALMOLOGY, V98, P692; Masos T, 2000, INVEST OPHTH VIS SCI, V41, P1006; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; Mayne R, 1993, CURR OPIN CELL BIOL, V5, P883, DOI 10.1016/0955-0674(93)90039-S; MURPHY G, 1992, ANN NY ACAD SCI, V667, P1, DOI 10.1111/j.1749-6632.1992.tb51590.x; Nakagami Y, 2000, J NEUROSCI, V20, P2003; Ning M, 2006, NEUROLOGY, V66, P1550, DOI 10.1212/01.wnl.0000216133.98416.b4; Nissirios N, 2007, J GLAUCOMA, V16, P57, DOI 10.1097/IJG.0b013e31802b3547; ROHEN JW, 1973, EXP EYE RES, V17, P19, DOI 10.1016/0014-4835(73)90164-4; ROLL P, 1979, KLIN MONATSBL AUGENH, V174, P421; Ronkko S, 2007, GRAEF ARCH CLIN EXP, V245, P697, DOI 10.1007/s00417-006-0440-1; Seftor R E, 1994, J Glaucoma, V3, P323; SMALLEY DM, 1994, INVEST OPHTH VIS SCI, V35, P48; SNYDER RW, 1993, EXP EYE RES, V57, P461, DOI 10.1006/exer.1993.1148; Spiga MG, 2010, INVEST OPHTH VIS SCI, V51, P3029, DOI 10.1167/iovs.09-4918; Stamer WD, 2013, INVEST OPHTH VIS SCI, V54, P2100, DOI 10.1167/iovs.12-11298; TRIPATHI BJ, 1987, OPHTHALMOLOGY, V94, P1434; Tsuji K, 2005, STROKE, V36, P1954, DOI 10.1161/01.STR.0000177517.01203.eb; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; WILSON K, 1993, CURR EYE RES, V12, P783, DOI 10.3109/02713689309020383; Zhou LL, 1998, INT J MOL MED, V1, P339	42	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72447	10.1371/journal.pone.0072447	http://dx.doi.org/10.1371/journal.pone.0072447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977299	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700169
J	Mao, JH; Wang, DY; Mataleena, P; He, B; Niu, DD; Katayama, K; Xu, XJ; Ojala, JRM; Wang, WJ; Shu, Q; Du, LZ; Liu, AM; Pikkarainen, T; Patrakka, J; Tryggvason, K				Mao, Jianhua; Wang, Dayan; Mataleena, Parikka; He, Bing; Niu, Dadi; Katayama, Kan; Xu, Xiangjun; Ojala, Juha R. M.; Wang, Wenjing; Shu, Qiang; Du, Lizhong; Liu, Aimin; Pikkarainen, Timo; Patrakka, Jaakko; Tryggvason, Karl			Myo1e Impairment Results in Actin Reorganization, Podocyte Dysfunction, and Proteinuria in Zebrafish and Cultured Podocytes	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; MATRIX INTERACTION; NEPHROTIC SYNDROME; DISEASE; GENES; DYSTROGLYCAN; ORGANIZATION; CYTOSKELETON; ENDOCYTOSIS; FILTRATION	Background: Podocytes serve as an important constituent of the glomerular filtration barrier. Recently, we and others identified Myo1e as a key molecular component of the podocyte cytoskeleton. Results: Myo1e mRNA and protein was expressed in human and mouse kidney sections as determined by Northern blot and reverse transcriptase PCR, and its expression was more evident in podocytes by immunofluorescence. By specific knock-down of MYO1E in zebrafish, the injected larvae exhibited pericardial edema and pronephric cysts, consistent with the appearance of protein in condensed incubation supernate. Furthermore, specific inhibition of Myo1e expression in a conditionally immortalized podocyte cell line induced morphological changes, actin cytoskeleton rearrangement, and dysfunction in cell proliferation, migration, endocytosis, and adhesion with the glomerular basement membrane. Conclusions: Our results revealed that Myo1e is a key component contributing to the functional integrity of podocytes. Its impairment may cause actin cytoskeleton re-organization, alteration of cell shape, and membrane transport, and podocyte drop-out from the glomerular basement membrane, which might eventually lead to an impaired glomerular filtration barrier and proteinuria.	[Mao, Jianhua; Wang, Dayan; Wang, Wenjing; Shu, Qiang; Du, Lizhong; Liu, Aimin] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Nephrol, Hangzhou 310003, Zhejiang, Peoples R China; [Mataleena, Parikka; He, Bing; Niu, Dadi; Katayama, Kan; Xu, Xiangjun; Ojala, Juha R. M.; Pikkarainen, Timo; Patrakka, Jaakko; Tryggvason, Karl] Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, Stockholm, Sweden	Zhejiang University; Karolinska Institutet	Mao, JH (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Dept Nephrol, Hangzhou 310003, Zhejiang, Peoples R China.	maojh88@gmail.com; Karl.tryggvason@ki.se	Patrakka, Jaakko/AAG-8796-2019; Mao, Jianhua/GOK-2713-2022; Parikka, Mataleena/D-4364-2014	Ojala, Juha/0000-0003-2018-6124; Parikka, Mataleena/0000-0001-5555-3815	National Natural Science Foundation of China [81270792, 81070561, 81170664]; Research Fund for the Doctoral Program of Higher Education of China [20120101110018]; Zhejiang Provincial Healthy Science Foundation of China [WKJ2010-2-014, 2012KYA119]; Provincial commonweal technology application research project of Zhejiang Province [2012C33048]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Zhejiang Provincial Natural Science Foundation of China [LY12H050037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Zhejiang Provincial Healthy Science Foundation of China; Provincial commonweal technology application research project of Zhejiang Province; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The project was supported by National Natural Science Foundation of China (Grant No. 81270792, 81070561 & 81170664), Research Fund for the Doctoral Program of Higher Education of China (20120101110018), Zhejiang Provincial Healthy Science Foundation of China (WKJ2010-2-014, 2012KYA119), Provincial commonweal technology application research project of Zhejiang Province (2012C33048), Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents and Zhejiang Provincial Natural Science Foundation of China (LY12H050037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Benesh AE, 2010, MOL BIOL CELL, V21, P970, DOI 10.1091/mbc.E09-07-0638; Blattner SM, 2005, CURR OPIN NEPHROL HY, V14, P404, DOI 10.1097/01.mnh.0000172730.67746.5b; Chase SE, 2012, AM J PHYSIOL-RENAL, V303, pF1099, DOI 10.1152/ajprenal.00251.2012; Cheng J, 2012, MOL BIOL CELL, V23, P2891, DOI 10.1091/mbc.E11-04-0383; Ebarasi L, 2009, DEV BIOL, V334, P1, DOI 10.1016/j.ydbio.2009.04.017; Eyre J, 2007, AM J PHYSIOL-RENAL, V292, pF674, DOI 10.1152/ajprenal.00272.2006; He B, 2011, J AM SOC NEPHROL, V22, P1019, DOI 10.1681/ASN.2010121291; He L, 2007, KIDNEY INT, V71, P889, DOI 10.1038/sj.ki.5002158; Ingelfinger JR, 2011, NEW ENGL J MED, V365, P368, DOI 10.1056/NEJMe1106093; Jarad G, 2011, AM J PHYSIOL-RENAL, V300, pF811, DOI 10.1152/ajprenal.00725.2010; Kim SV, 2006, SCIENCE, V314, P136, DOI 10.1126/science.1131920; Kojima K, 2004, J AM SOC NEPHROL, V15, P2079, DOI 10.1097/01.ASN.0000133531.43177.21; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Krendel M, 2009, J AM SOC NEPHROL, V20, P86, DOI 10.1681/ASN.2007111172; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Machuca E, 2009, HUM MOL GENET, V18, pR185, DOI 10.1093/hmg/ddp328; Majumdar A, 2000, DEV BIOL, V222, P147, DOI 10.1006/dbio.2000.9642; McConnell RE, 2010, TRENDS CELL BIOL, V20, P418, DOI 10.1016/j.tcb.2010.04.004; Mele C, 2011, NEW ENGL J MED, V365, P295, DOI 10.1056/NEJMoa1101273; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Nambiar R, 2010, CELL MOL LIFE SCI, V67, P1239, DOI 10.1007/s00018-009-0254-5; Nishibori Y, 2011, J AM SOC NEPHROL, V22, P2037, DOI 10.1681/ASN.2010111147; Patrakka J, 2007, J AM SOC NEPHROL, V18, P689, DOI 10.1681/ASN.2006060675; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; Reiser J, 2010, KIDNEY INT, V77, P662, DOI 10.1038/ki.2009.559; Ruotsalainen V, 2000, AM J PATHOL, V157, P1905, DOI 10.1016/S0002-9440(10)64829-8; Sanna-Cherchi S, 2011, KIDNEY INT, V80, P389, DOI 10.1038/ki.2011.148; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3	32	15	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72750	10.1371/journal.pone.0072750	http://dx.doi.org/10.1371/journal.pone.0072750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977349	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700189
J	Sluchanko, NN; Chebotareva, NA; Gusev, NB				Sluchanko, Nikolai N.; Chebotareva, Natalia A.; Gusev, Nikolai B.			Modulation of 14-3-3/Phosphotarget Interaction by Physiological Concentrations of Phosphate and Glycerophosphates	PLOS ONE			English	Article							NUCLEAR MAGNETIC-RESONANCE; 14-3-3 PROTEINS; BINDING; 14-3-3-PROTEINS; POTENTIALS; METABOLISM; MUSCLE; TISSUE; HSPB6	Molecular mechanisms governing selective binding of a huge number of various phosphorylated protein partners to 14-3-3 remain obscure. Phosphate can bind to 14-3-3 and therefore being present at high intracellular concentration, which undergoes significant changes under physiological conditions, phosphate can theoretically regulate interaction of 14-3-3 with phosphorylated targets. In order to check this hypothesis we analyzed effect of phosphate and other natural abundant anions on interaction of 14-3-3 with phosphorylated human small heat shock protein HspB6 (Hsp20) participating in regulation of different intracellular processes. Inorganic phosphate, glycerol-1-phosphate and glycerol-2-phosphate at physiologically relevant concentrations (5-15 mM) significantly destabilized complexes formed by 14-3-3 zeta and phosphorylated HspB6 (pHspB6), presumably, via direct interaction with the substrate-binding site of 14-3-3. Phosphate also destabilized complexes between pHspB6 and 14-3-3 gamma or the monomeric mutant form of 14-3-3 zeta. Inorganic sulfate and pyrophosphate were less effective in modulation of 14-3-3 interaction with its target protein. The inhibitory effect of all anions on pHspB6/14-3-3 interaction was concentration-dependent. It is hypothesized that physiological changes in phosphate anions concentration can modulate affinity and specificity of interaction of 14-3-3 with its multiple targets and therefore the actual phosphointeractome of 14-3-3.	[Sluchanko, Nikolai N.; Chebotareva, Natalia A.] Russian Acad Sci, Lab Mol Org Biol Struct, AN Bach Inst Biochem, Moscow, Russia; [Gusev, Nikolai B.] Moscow MV Lomonosov State Univ, Sch Biol, Dept Biochem, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Lomonosov Moscow State University	Sluchanko, NN (corresponding author), Russian Acad Sci, Lab Mol Org Biol Struct, AN Bach Inst Biochem, Moscow, Russia.	nikolai.sluchanko@mail.ru	Sluchanko, Nikolai/R-4110-2016; Chebotareva, Natalia/X-6019-2018	Sluchanko, Nikolai/0000-0002-8608-1416; Chebotareva, Natalia/0000-0002-3505-8777	Russian Foundation for Basic Research [12-04-31259, 13-04-00015]; program "Molecular and Cell Biology" of the Presidium of the Russian Academy of Sciences	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); program "Molecular and Cell Biology" of the Presidium of the Russian Academy of Sciences(Russian Academy of Sciences)	This investigation was supported by the Russian Foundation for Basic Research (12-04-31259 to NNS and 13-04-00015 to NBG) and the program "Molecular and Cell Biology" of the Presidium of the Russian Academy of Sciences (NNS and NAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Athwal GS, 1998, PLANT PHYSIOL, V118, P1041, DOI 10.1104/pp.118.3.1041; BOSTON PF, 1982, J NEUROCHEM, V38, P1475, DOI 10.1111/j.1471-4159.1982.tb07928.x; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Bugg NC, 1998, ANAESTHESIA, V53, P895, DOI 10.1046/j.1365-2044.1998.00463.x; BURT CT, 1977, SCIENCE, V195, P145, DOI 10.1126/science.188132; BURT CT, 1976, J BIOL CHEM, V251, P2584; Bustad HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049671; Bustos DM, 2005, J MOL GRAPH MODEL, V23, P490, DOI 10.1016/j.jmgm.2005.03.002; Camoni L, 2012, IUBMB LIFE, V64, P710, DOI 10.1002/iub.1058; Chernik IS, 2007, MOL CELL BIOCHEM, V295, P9, DOI 10.1007/s11010-006-9266-8; DAWSON MJ, 1980, J PHYSIOL-LONDON, V299, P465, DOI 10.1113/jphysiol.1980.sp013137; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Ge F, 2010, J PROTEOME RES, V9, P5848, DOI 10.1021/pr100616g; Ge Q, 2012, J BIOL CHEM, V287, P41914, DOI 10.1074/jbc.M112.418855; KORETSUNE Y, 1991, CIRC RES, V68, P255, DOI 10.1161/01.RES.68.1.255; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Pozdeyev N, 2006, J NEUROSCI, V26, P9153, DOI 10.1523/JNEUROSCI.1384-06.2006; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Sluchanko NN, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1528, DOI 10.1134/S0006297910130031; Sluchanko NN, 2012, BIOCHEMISTRY-US, V51, P6127, DOI 10.1021/bi300674e; Sluchanko NN, 2011, BIOCHEMISTRY-US, V50, P9797, DOI 10.1021/bi201374s; Sluchanko NN, 2011, ARCH BIOCHEM BIOPHYS, V506, P24, DOI 10.1016/j.abb.2010.11.003; Sluchanko NN, 2009, BIOCHEM BIOPH RES CO, V379, P990, DOI 10.1016/j.bbrc.2008.12.164; Uhart M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055703; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	30	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72597	10.1371/journal.pone.0072597	http://dx.doi.org/10.1371/journal.pone.0072597			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977325	Green Submitted, gold, Green Published			2022-12-25	WOS:000323425700179
J	Theunis, C; Crespo-Biel, N; Gafner, V; Pihlgren, M; Lopez-Deber, MP; Reis, P; Hickman, DT; Adolfsson, O; Chuard, N; Ndao, DM; Borghgraef, P; Devijver, H; Van Leuven, F; Pfeifer, A; Muhs, A				Theunis, Clara; Crespo-Biel, Natalia; Gafner, Valerie; Pihlgren, Maria; Lopez-Deber, Maria Pilar; Reis, Pedro; Hickman, David T.; Adolfsson, Oskar; Chuard, Nathalie; Ndao, Dorin Mlaki; Borghgraef, Peter; Devijver, Herman; Van Leuven, Fred; Pfeifer, Andrea; Muhs, Andreas			Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; ALZHEIMERS-DISEASE; MOUSE MODEL; NEUROFIBRILLARY TANGLES; PASSIVE-IMMUNIZATION; BRAIN; PATHOLOGY; IMMUNOTHERAPY; DEGENERATION; CONFORMATION	Progressive aggregation of protein Tau into oligomers and fibrils correlates with cognitive decline and synaptic dysfunction, leading to neurodegeneration in vulnerable brain regions in Alzheimer's disease. The unmet need of effective therapy for Alzheimer's disease, combined with problematic pharmacological approaches, led the field to explore immunotherapy, first against amyloid peptides and recently against protein Tau. Here we adapted the liposome-based amyloid vaccine that proved safe and efficacious, and incorporated a synthetic phosphorylated peptide to mimic the important phospho-epitope of protein Tau at residues pS396/pS404. We demonstrate that the liposome-based vaccine elicited, rapidly and robustly, specific antisera in wild-type mice and in Tau. P301L mice. Long-term vaccination proved to be safe, because it improved the clinical condition and reduced indices of tauopathy in the brain of the Tau. P301L mice, while no signs of neuroinflammation or other adverse neurological effects were observed. The data corroborate the hypothesis that liposomes carrying phosphorylated peptides of protein Tau have considerable potential as safe and effective treatment against tauopathies, including Alzheimer's disease.	[Theunis, Clara; Crespo-Biel, Natalia; Borghgraef, Peter; Devijver, Herman; Van Leuven, Fred] Katholieke Univ Leuven, Expt Genet Grp, Dept Human Genet, Louvain, Belgium; [Gafner, Valerie; Pihlgren, Maria; Lopez-Deber, Maria Pilar; Reis, Pedro; Hickman, David T.; Adolfsson, Oskar; Chuard, Nathalie; Ndao, Dorin Mlaki; Pfeifer, Andrea; Muhs, Andreas] ACImmune, Lausanne, Switzerland	KU Leuven	Van Leuven, F (corresponding author), Katholieke Univ Leuven, Expt Genet Grp, Dept Human Genet, Louvain, Belgium.	fred.vanleuven@med.kuleuven.be			KULeuven-Research Fund; KULeuven-Research Development; ACImmune sa, Lausanne, Switzerland	KULeuven-Research Fund(KU Leuven); KULeuven-Research Development; ACImmune sa, Lausanne, Switzerland	The investigations were supported by KULeuven-Research Fund and by KULeuven-Research & Development. The study was supported financially by ACImmune sa, Lausanne, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer A, 1995, Clin Anat, V8, P429; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Banks WA, 2010, IMMUNOTHERAPY-UK, V2, P1, DOI 10.2217/IMT.09.72; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Bi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026860; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; BueeScherrer V, 1996, MOL BRAIN RES, V39, P79, DOI 10.1016/0169-328X(96)00003-4; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Crespo-Biel N, 2012, INT J ALZHEIMERS DIS; Crowther RA, 2000, J STRUCT BIOL, V130, P271, DOI 10.1006/jsbi.2000.4270; d'Abramo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062402; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; Desai BS, 2007, CELL TRANSPLANT, V16, P285, DOI 10.3727/000000007783464731; Dutschmann M, 2010, J NEUROSCI, V30, P1810, DOI 10.1523/JNEUROSCI.5261-09.2010; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Fiala M, 2002, EUR J CLIN INVEST, V32, P360, DOI 10.1046/j.1365-2362.2002.00994.x; Fitzgerald KA, 2007, SCIENCE, V316, P1574, DOI 10.1126/science.1144483; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Furlan R, 2003, BRAIN, V126, P285, DOI 10.1093/brain/awg031; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Herrmann N, 2011, DRUGS, V71, P2031, DOI 10.2165/11595870-000000000-00000; Hickman DT, 2011, J BIOL CHEM, V286, P13966, DOI 10.1074/jbc.M110.186338; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jaworski T, 2010, BBA-MOL BASIS DIS, V1802, P808, DOI 10.1016/j.bbadis.2010.03.005; Klafki HW, 2006, BRAIN, V129, P2840, DOI 10.1093/brain/awl280; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Kremer A, 2011, J NEUROSCI, V31, P18036, DOI 10.1523/JNEUROSCI.4859-11.2011; Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Maurin H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063589; Menuet C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025770; Menuet C, 2011, RESP PHYSIOL NEUROBI, V178, P290, DOI 10.1016/j.resp.2011.06.030; Mitchell TW, 2000, J HISTOCHEM CYTOCHEM, V48, P1627, DOI 10.1177/002215540004801206; Muhs A, 2007, P NATL ACAD SCI USA, V104, P9810, DOI 10.1073/pnas.0703137104; NERENBERG ST, 1975, J LAB CLIN MED, V86, P887; Nicolau C, 2002, P NATL ACAD SCI USA, V99, P2332, DOI 10.1073/pnas.022627199; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Patterson KR, 2011, J BIOL CHEM; Pihlgren M, 2013, BLOOD, V121, P85, DOI 10.1182/blood-2012-02-413831; Pride M, 2008, NEURODEGENER DIS, V5, P194, DOI 10.1159/000113700; Rafii MS, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-7; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Rosenmann H, 2006, ARCH NEUROL-CHICAGO, V63, P1459, DOI 10.1001/archneur.63.10.1459; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; SUMI SM, 1992, NEUROLOGY, V42, P120, DOI 10.1212/WNL.42.1.120; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Torreilles F, 2000, MOL BRAIN RES, V78, P181, DOI 10.1016/S0169-328X(00)00073-5; Troquier L, 2012, CURR ALZHEIMER RES, V9, P397, DOI 10.2174/156720512800492503; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Vandebroek T, 2005, BIOCHEMISTRY-US, V44, P11466, DOI 10.1021/bi0506775; Vandebroek T, 2006, J BIOL CHEM, V281, P25388, DOI 10.1074/jbc.M602792200; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Zhang Y, 2011, NEUROSCIENTIST, V17, P163, DOI 10.1177/1073858410381532; ZLOKOVIC BV, 1990, EXP NEUROL, V107, P263, DOI 10.1016/0014-4886(90)90144-H	72	162	176	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72301	10.1371/journal.pone.0072301	http://dx.doi.org/10.1371/journal.pone.0072301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977276	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700162
J	Beers, E; Egberts, TCG; Leufkens, HGM; Jansen, PAF				Beers, Erna; Egberts, Toine C. G.; Leufkens, Hubert G. M.; Jansen, Paul A. F.			The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription	PLOS ONE			English	Article							CLINICAL-TRIALS; EXCLUSION; BENEFITS; CRITERIA; ADULTS; WOMEN; LIFE	Background: The ICH E7 guideline intends to improve the knowledge about medicines in geriatric patients. As a legislative document, it might not reflect the needs of healthcare professionals. This study investigated what information healthcare professionals, regulatory agencies and pharmaceutical industries consider necessary for rational drug prescribing to older individuals. Methods and Findings: A 29-item-questionnaire was composed, considering the representation in trials, pharmacokinetics, efficacy, safety, and convenience of use in older individuals, with space for additions. Forty-three European professionals with an interest in medication for older individuals were included. In order to investigate their relevance, five items were included in a second questionnaire, with 11 control items. Median scores, differences between clinical and non-clinical respondents and response consistency were analysed. Consistency was present in 10 control items. Therefore, all items of the first questionnaire and the five additional items were analysed. Thirty-seven (86%) respondents returned the first questionnaire; 31/37 (84%) the second. Information about age-related differences in adverse events, locomotor effects, drug-disease interactions, dosing instructions, and information about the proportion of included 65+ patients was considered necessary by most respondents. Clinicians considered information significantly more important than the non-clinical respondents about the inclusion of 75+, time-until-benefit in older people, anticholinergic effects, drug-disease interactions, and convenience of use. Main study limitations are the focus on information for daily practice, while the ICH E7 guideline is a legislative document focused on market approval of a new medicine. Also, a questionnaire with a Likert scale has its limitations; this was addressed by providing space for comments. Conclusions: This study reveals that items considered necessary are currently not included in the ICH E7 guideline. Also, clinicians' and non-clinicians' opinions differed significantly in 15% of the items. Therefore, all stakeholders should collaborate to improve the availability of information for the rational prescribing to older individuals.	[Beers, Erna; Jansen, Paul A. F.] Univ Med Ctr Utrecht, Dept Geriatr Med, Utrecht, Netherlands; [Beers, Erna; Jansen, Paul A. F.] Univ Med Ctr Utrecht, Expertise Ctr Pharmacotherapy Old Persons EPHOR, Utrecht, Netherlands; [Egberts, Toine C. G.; Leufkens, Hubert G. M.] Univ Utrecht, Dept Pharmacoepidemiol, UIPS, Utrecht, Netherlands; [Egberts, Toine C. G.; Leufkens, Hubert G. M.] Univ Utrecht, Dept Clin Pharmacol, UIPS, Utrecht, Netherlands; [Egberts, Toine C. G.] Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands; [Leufkens, Hubert G. M.; Jansen, Paul A. F.] Dutch Med Evaluat Board, The Hague, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center	Beers, E (corresponding author), Univ Med Ctr Utrecht, Dept Geriatr Med, Utrecht, Netherlands.	e.beers@umcutrecht.nl	Egberts, Toine/A-6625-2012; Egberts, Toine/K-4579-2019	Egberts, Toine/0000-0003-1758-7779; Egberts, Toine/0000-0003-1758-7779	Netherlands Organisation for Health Research and Development (ZonMW)	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	EB had support from the Dutch Society of Clinical Pharmacology & Biopharmacy (NVKF&B) for her training in clinical pharmacology and therapeutics; this manuscript was written in the context of her training. EB and PAFJ are working at the Expertise Centre Pharmacotherapy in Old Persons (EPHOR), which is financially supported by The Netherlands Organisation for Health Research and Development (ZonMW); no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.	Bartlett C, 2003, HEART, V89, P327, DOI 10.1136/heart.89.3.327; Beers E, 2013, DRUG AGING, V30, P255, DOI 10.1007/s40266-013-0059-y; Cherubini A, 2010, J AM GERIATR SOC, V58, P1791, DOI 10.1111/j.1532-5415.2010.03032.x; Committee for medicinal products for human use (CHMP), 2010, ICH TOP E7 STUD SUPP; Crome P, 2011, DRUG AGING, V28, P667, DOI 10.2165/11591990-000000000-00000; Dodd KS, 2011, J AM GERIATR SOC, V59, P506, DOI 10.1111/j.1532-5415.2010.03305.x; European Commission, 2012, GUID SUMM PROD CHAR; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Fitch K, 2001, ARCH INTERN MED; Fitzsimmons PR, 2012, PARKINSONISM RELAT D, V18, P585, DOI 10.1016/j.parkreldis.2012.03.003; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Holmes HM, 2006, ARCH INTERN MED, V166, P605, DOI 10.1001/archinte.166.6.605; Huisman-Baron M, 2011, DRUG AGING, V28, P391, DOI 10.2165/11587200-000000000-00000; ICH expert working group, 1993, GERIATRICS E; McMurdo MET, 2011, AGE AGEING, V40, P659, DOI 10.1093/ageing/afr115; McMurdo MET, 2005, BMJ-BRIT MED J, V331, P1036, DOI 10.1136/bmj.331.7524.1036; Molzon JA, 2011, CLIN PHARMACOL THER, V89, P503, DOI 10.1038/clpt.2011.10; PREDICT Consortium, 2010, PREDICT CHART RIGHTS; Rahmner PB, 2012, BRIT J CLIN PHARMACO, V73, P115, DOI 10.1111/j.1365-2125.2011.04058.x; Rockwood K, 2011, CAN MED ASSOC J, V183, pE487, DOI 10.1503/cmaj.101271; Rudolph JL, 2008, ARCH INTERN MED, V168, P508, DOI 10.1001/archinternmed.2007.106; Ward J, 2010, APPL ERGON, V41, P682, DOI 10.1016/j.apergo.2009.12.005; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Witham MD, 2007, DRUG AGING, V24, P187, DOI 10.2165/00002512-200724030-00002	24	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72060	10.1371/journal.pone.0072060	http://dx.doi.org/10.1371/journal.pone.0072060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	207BA	23977208	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200055
J	Iyer, EPR; Iyer, SC; Sullivan, L; Wang, D; Meduri, R; Graybeal, LL; Cox, DN				Iyer, Eswar Prasad R.; Iyer, Srividya Chandramouli; Sullivan, Luis; Wang, Dennis; Meduri, Ramakrishna; Graybeal, Lacey L.; Cox, Daniel N.			Functional Genomic Analyses of Two Morphologically Distinct Classes of Drosophila Sensory Neurons: Post-Mitotic Roles of Transcription Factors in Dendritic Patterning	PLOS ONE			English	Article							GENE LISTS; PROTEIN; MORPHOGENESIS; MECHANISMS; SYSTEM; ARBORS; RECONSTRUCTION; KNOT/COLLIER; PROTEOLYSIS; EXPRESSION	Background: Neurons are one of the most structurally and functionally diverse cell types found in nature, owing in large part to their unique class specific dendritic architectures. Dendrites, being highly specialized in receiving and processing neuronal signals, play a key role in the formation of functional neural circuits. Hence, in order to understand the emergence and assembly of a complex nervous system, it is critical to understand the molecular mechanisms that direct class specific dendritogenesis. Methodology/Principal Findings: We have used the Drosophila dendritic arborization (da) neurons to gain systems-level insight into dendritogenesis by a comparative study of the morphologically distinct Class-I (C-I) and Class-IV (C-IV) da neurons. We have used a combination of cell-type specific transcriptional expression profiling coupled to a targeted and systematic in vivo RNAi functional validation screen. Our comparative transcriptomic analyses have revealed a large number of differentially enriched/depleted gene-sets between C-I and C-IV neurons, including a broad range of molecular factors and biological processes such as proteolytic and metabolic pathways. Further, using this data, we have identified and validated the role of 37 transcription factors in regulating class specific dendrite development using in vivo class-specific RNAi knockdowns followed by rigorous and quantitative neurometric analysis. Conclusions/Significance: This study reports the first global gene-expression profiles from purified Drosophila C-I and C-IV da neurons. We also report the first large-scale semi-automated reconstruction of over 4,900 da neurons, which were used to quantitatively validate the RNAi screen phenotypes. Overall, these analyses shed global and unbiased novel insights into the molecular differences that underlie the morphological diversity of distinct neuronal cell-types. Furthermore, our class-specific gene expression datasets should prove a valuable community resource in guiding further investigations designed to explore the molecular mechanisms underlying class specific neuronal patterning.	[Iyer, Eswar Prasad R.; Iyer, Srividya Chandramouli; Sullivan, Luis; Wang, Dennis; Meduri, Ramakrishna; Graybeal, Lacey L.; Cox, Daniel N.] George Mason Univ, Sch Syst Biol, Krasnow Inst Adv Study, Fairfax, VA 22030 USA	George Mason University	Cox, DN (corresponding author), George Mason Univ, Sch Syst Biol, Krasnow Inst Adv Study, Fairfax, VA 22030 USA.	dcox5@gmu.edu	Iyer, Eswar/E-8443-2017	Cox, Daniel/0000-0001-9191-9212; Wang, Dennis/0000-0003-3955-8143; Wang, Dennis/0000-0003-0068-1005	National Institutes of Health [MH086928-02]; Thomas F. and Kate Miller Jeffress Memorial Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R15MH086928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas F. and Kate Miller Jeffress Memorial Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors acknowledge the National Institutes of Health (MH086928-02) (http://www.nimh.nih.gov) and the Thomas F. and Kate Miller Jeffress Memorial Trust for support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adryan B, 2006, BIOINFORMATICS, V22, P1532, DOI 10.1093/bioinformatics/btl143; Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Booker M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-50; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Corty MM, 2009, DEVELOPMENT, V136, P1049, DOI 10.1242/dev.014423; Crozatier M, 2008, DEV BIOL, V315, P232, DOI 10.1016/j.ydbio.2007.12.030; Cuntz H, 2012, P NATL ACAD SCI USA, V109, P11014, DOI 10.1073/pnas.1200430109; de la Torre-Ubieta L, 2011, NEURON, V72, P22, DOI 10.1016/j.neuron.2011.09.018; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Djagaeva I, 2009, PLOS ONE, V4; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Ghabrial AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002087; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Hattori Y, 2007, GENES CELLS, V12, P1011, DOI 10.1111/j.1365-2443.2007.01107.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang ML, 2000, NEURON, V25, P57, DOI 10.1016/S0896-6273(00)80871-5; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Im SH, 2012, DEV DYNAM, V241, P16, DOI 10.1002/dvdy.22737; Iyer Eswar Prasad R, 2009, J Vis Exp, DOI 10.3791/1599; Iyer Eswar Prasad R, 2013, Methods Mol Biol, V964, P215, DOI 10.1007/978-1-62703-251-3_13; Iyer SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033634; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jinushi-Nakao S, 2007, NEURON, V56, P963, DOI 10.1016/j.neuron.2007.10.031; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kim MD, 2006, GENE DEV, V20, P2806, DOI 10.1101/gad.1459706; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Leigh-Brown S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-215; Li WJ, 2004, NEURON, V43, P823, DOI 10.1016/j.neuron.2004.08.040; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; McDowall J, 2011, METHODS MOL BIOL, V694, P37, DOI 10.1007/978-1-60761-977-2_3; Medina PMB, 2006, GENETICS, V172, P2325, DOI 10.1534/genetics.105.051276; Mohr SE, 2012, WIRES RNA, V3, P145, DOI 10.1002/wrna.110; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Orgogozo V, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-4; Ou YM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-16; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Parrish JZ, 2009, NEURON, V63, P788, DOI 10.1016/j.neuron.2009.08.006; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Satoh D, 2008, NAT CELL BIOL, V10, P1164, DOI 10.1038/ncb1776; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Sugimura K, 2004, NEURON, V43, P809, DOI 10.1016/j.neuron.2004.08.016; Sulkowski MJ, 2011, BIOL BULL-US, V221, P300, DOI 10.1086/BBLv221n3p300; Sulkowski MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022611; Tsubouchi A, 2009, DEVELOPMENT, V136, P3757, DOI 10.1242/dev.042135; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Ye B, 2011, J NEUROSCI, V31, P3309, DOI 10.1523/JNEUROSCI.6307-10.2011; Zhang JZ, 2012, G3-GENES GENOM GENET, V2, P1563, DOI 10.1534/g3.112.003780; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	68	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72434	10.1371/journal.pone.0072434	http://dx.doi.org/10.1371/journal.pone.0072434			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977298	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000097
J	Fredenburgh, JC; Leslie, BA; Stafford, AR; Lim, T; Chan, HH; Weitz, JI				Fredenburgh, James C.; Leslie, Beverly A.; Stafford, Alan R.; Lim, Teresa; Chan, Howard H.; Weitz, Jeffrey I.			Zn2+ Mediates High Affinity Binding of Heparin to the alpha C Domain of Fibrinogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE-RICH GLYCOPROTEIN; SURFACE-PLASMON RESONANCE; PLATELET FACTOR-IV; ZINC IONS; PLASMINOGEN-ACTIVATOR; EQUILIBRIUM DIALYSIS; PROTECTS THROMBIN; BOUND THROMBIN; TISSUE FACTOR; COFACTOR-II	The nonspecific binding of heparin to plasma proteins compromises its anticoagulant activity by reducing the amount of heparin available to bind antithrombin. In addition, interaction of heparin with fibrin promotes formation of a ternary heparin-thrombin-fibrin complex that protects fibrin-bound thrombin from inhibition by the heparin-antithrombin complex. Previous studies have shown that heparin binds the E domain of fibrinogen. The current investigation examines the role of Zn2+ in this interaction because Zn2+ is released locally by platelets and both heparin and fibrinogen bind the cation, resulting in greater protection from inhibition by antithrombin. Zn2+ promotes heparin binding to fibrinogen, as determined by chromatography, fluorescence, and surface plasmon resonance. Compared with intact fibrinogen, there is reduced heparin binding to fragment X, a clottable plasmin degradation product of fibrinogen. A monoclonal antibody directed against a portion of the fibrinogen alpha C domain removed by plasmin attenuates binding of heparin to fibrinogen and a peptide analog of this region binds heparin in a Zn2+-dependent fashion. These results indicate that the alpha C domain of fibrinogen harbors a Zn2+-dependent heparin binding site. As a consequence, heparin-catalyzed inhibition of factor Xa by antithrombin is compromised by fibrinogen to a greater extent when Zn2+ is present. These results reveal the mechanism by which Zn2+ augments the capacity of fibrinogen to impair the anticoagulant activity of heparin.	[Fredenburgh, James C.; Leslie, Beverly A.; Stafford, Alan R.; Lim, Teresa; Chan, Howard H.; Weitz, Jeffrey I.] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada; [Fredenburgh, James C.; Leslie, Beverly A.; Stafford, Alan R.; Lim, Teresa; Chan, Howard H.; Weitz, Jeffrey I.] McMaster Univ, Dept Med, Hamilton, ON L8L 2X2, Canada; [Weitz, Jeffrey I.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8L 2X2, Canada	McMaster University; McMaster University; McMaster University	Weitz, JI (corresponding author), Thrombosis & Atherosclerosis Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	weitzj@taari.ca	Weitz, Jeffrey/AAD-1929-2019	Weitz, Jeffrey/0000-0002-1092-7550	Canadian Institutes of Health Research [FRN 3992, MOP 102735, CTP 79846]; Heart and Stroke Foundation of Ontario [T4729, T4730]; Ontario Research and Development Challenge Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Research and Development Challenge Fund(General Electric)	This work was supported in part by grants from the Canadian Institutes of Health Research (FRN 3992, MOP 102735, and CTP 79846), the Heart and Stroke Foundation of Ontario (T4729 and T4730), and the Ontario Research and Development Challenge Fund.	Bajaj SP, 2006, J BIOL CHEM, V281, P24873, DOI 10.1074/jbc.M509971200; Becker DL, 1999, J BIOL CHEM, V274, P6226, DOI 10.1074/jbc.274.10.6226; Becker DL, 1997, ADV EXP MED BIOL, V425, P55; BJORK I, 1989, BIOCHEMISTRY-US, V28, P1213; Boehm T, 1998, BIOCHEM BIOPH RES CO, V252, P190, DOI 10.1006/bbrc.1998.9617; Borza DB, 1998, J BIOL CHEM, V273, P5493, DOI 10.1074/jbc.273.10.5493; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chan HH, 2012, BIOCHEMISTRY-US, V51, P7964, DOI 10.1021/bi301046b; De Caterina R, 2007, EUR HEART J, V28, P880, DOI 10.1093/eurheartj/ehl492; Eckert R, 2003, FEBS LETT, V541, P121, DOI 10.1016/S0014-5793(03)00322-3; EHRLICH PH, 1983, BIOCHEMISTRY-US, V22, P4184, DOI 10.1021/bi00287a004; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Galanakis DK, 2010, BLOOD COAGUL FIBRIN, V21, P135, DOI 10.1097/MBC.0b013e3283358163; Gestwicki JE, 2001, ANAL CHEM, V73, P5732, DOI 10.1021/ac0105888; Gonzalez-Iglesias R, 2002, J MOL BIOL, V319, P527, DOI 10.1016/S0022-2836(02)00341-8; GUTHANS SL, 1982, ARCH BIOCHEM BIOPHYS, V218, P320, DOI 10.1016/0003-9861(82)90350-2; Heeb MJ, 2009, FASEB J, V23, P2244, DOI 10.1096/fj.08-123174; HOGG PJ, 1989, P NATL ACAD SCI USA, V86, P3619, DOI 10.1073/pnas.86.10.3619; HOGG PJ, 1990, J BIOL CHEM, V265, P241; KAZAMA Y, 1992, THROMB HAEMOSTASIS, V67, P50; Kluszynski BA, 1997, J BIOL CHEM, V272, P13541, DOI 10.1074/jbc.272.21.13541; Krezel A, 2011, INORG CHEM, V50, P72, DOI 10.1021/ic101212y; LANE DA, 1986, J BIOL CHEM, V261, P3980; LEUNG LLK, 1983, BLOOD, V62, P1016; LIJNEN HR, 1983, THROMB RES, V29, P443, DOI 10.1016/0049-3848(83)90248-7; MARX G, 1988, ARCH BIOCHEM BIOPHYS, V266, P285, DOI 10.1016/0003-9861(88)90260-3; Mcrae SJ, 2007, BIOCHEMISTRY-US, V46, P4195, DOI 10.1021/bi0617299; Mohri, 1994, J Thromb Thrombolysis, V1, P49, DOI 10.1007/BF01061996; NESHEIM M, 1990, J BIOL CHEM, V265, P21541; Odrljin TM, 1996, BLOOD, V88, P2050, DOI 10.1182/blood.V88.6.2050.bloodjournal8862050; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2; PARRISH RF, 1981, BIOCHEM J, V193, P407, DOI 10.1042/bj1930407; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; Rich JD, 2007, J THROMB THROMBOLYS, V23, P93, DOI 10.1007/s11239-006-9049-9; Rydengard V, 2006, FEBS J, V273, P2399, DOI 10.1111/j.1742-4658.2006.05246.x; Schaefer AVL, 2006, BIOCHEMISTRY-US, V45, P4257, DOI 10.1021/bi0525730; SCULLY MF, 1982, BIOCHIM BIOPHYS ACTA, V700, P130, DOI 10.1016/0167-4838(82)90301-6; SMITH JW, 1990, J BIOL CHEM, V265, P12267; Syme CD, 2006, BBA-PROTEINS PROTEOM, V1764, P246, DOI 10.1016/j.bbapap.2005.09.012; Thompson LC, 2011, PROTEIN SCI, V20, P366, DOI 10.1002/pro.567; Tubek S, 2008, BIOL TRACE ELEM RES, V121, P1, DOI 10.1007/s12011-007-8038-y; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Vu TT, 2013, THROMB HAEMOSTASIS, V109, P421, DOI 10.1160/TH12-07-0465; WOODHEAD NE, 1986, BIOCHEM J, V237, P281, DOI 10.1042/bj2370281; Yakovlev S, 2003, BIOCHEMISTRY-US, V42, P7709, DOI 10.1021/bi0344073; YOUNG E, 1993, THROMB HAEMOSTASIS, V70, P625	50	19	19	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29394	29402		10.1074/jbc.M113.469916	http://dx.doi.org/10.1074/jbc.M113.469916			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23990470	Green Published, hybrid			2022-12-25	WOS:000330615300018
J	Pham, P; Landolph, A; Mendez, C; Li, N; Goodman, MF				Phuong Pham; Landolph, Alice; Mendez, Carlos; Li, Nancy; Goodman, Myron F.			A Biochemical Analysis Linking APOBEC3A to Disparate HIV-1 Restriction and Skin Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSINE DEAMINASE; CYTIDINE DEAMINATION; FOREIGN DNA; NUCLEAR-DNA; HYPERMUTATION; PROTEINS; VIRUS; AID; EXPRESSION; MUTATIONS	Human deoxycytidine deaminase APOBEC3A (Apo3A) acts as an HIV-1 restriction factor in cells of myeloid lineage yet functions separately as a potent mutator for genomic DNA. Apo3A activity and C motif deamination specificity exhibit a striking dependence on pH that reflects these two distinct biological processes. Upon infection of macrophages, HIV-1 induces the formation of autophagosomes, and requires autophagosomes for replication, whereas inhibiting lysosomal fusion indicative of late stage autophagy. Here we show that Apo3A has optimal activity and a strict 5 '-YYCR motif specificity in the pH 5.8-6.1 range, characteristic of enclosed autophagosomal membrane compartments, and reflective of the mutation pattern of HIV-1. In contrast to the high activity and narrow specificity of Apo3A at acid pH, a 13-30-fold reduction in specific activity is accompanied by relaxed C deamination specificity at pH 7.4-8. Notably, Apo3A is also expressed in keratinocytes, and is up-regulated in skin lesions. AtpH7.9, we show that Apo3A generates transcription-dependent CC -> TT tandem mutations on the non-transcribed strand, a hallmark signature of skin cancer. The biochemical data taken in conjunction with the biological up-regulation of Apo3A in skin lesions suggests that enzyme-catalyzed deaminations at adjacent C sites followed by normal replication generating CC -> TT mutations provides an alternative molecular basis for the initiation events in skin cancer in contrast to well established pathways in which CC dimers formed in response to UV radiation either undergo nonenzymatic spontaneous deaminations or aberrant replication.	[Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA; Univ So Calif, Dept Chem, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA.	mgoodman@usc.edu		MENDEZ-DORANTES, CARLOS/0000-0002-8190-8568	National Institutes of Health [GM21422, ES013192]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013192, R56ES013192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021422, R01GM021422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM21422 and ES013192.	Aynaud MM, 2012, J BIOL CHEM, V287, P39182, DOI 10.1074/jbc.M112.372722; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bulliard Y, 2011, J VIROL, V85, P1765, DOI 10.1128/JVI.01651-10; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Cheney KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013521; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Doehle BP, 2005, J VIROL, V79, P8201, DOI 10.1128/JVI.79.13.8201-8207.2005; Espert L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005787; Giglia-Mari G, 2003, HUM MUTAT, V21, P217, DOI 10.1002/humu.10179; Goujon C, 2010, J VIROL, V84, P9254, DOI 10.1128/JVI.00854-10; Harjes S, 2013, J VIROL, V87, P7008, DOI 10.1128/JVI.03173-12; Jaszczur M, 2013, CELL MOL LIFE SCI, V70, P3089, DOI 10.1007/s00018-012-1212-1; Jiang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048672; Killian MS, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-16; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Koning FA, 2011, J VIROL, V85, P13448, DOI 10.1128/JVI.00775-11; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Lackey L, 2013, CELL CYCLE, V12, P762, DOI 10.4161/cc.23713; Lada AG, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-47; Land AM, 2013, J BIOL CHEM, V288, P17253, DOI 10.1074/jbc.M113.458661; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Love RP, 2012, J BIOL CHEM, V287, P30812, DOI 10.1074/jbc.M112.393181; LUKACS GL, 1990, J BIOL CHEM, V265, P21099; Madsen P, 1999, J INVEST DERMATOL, V113, P162, DOI 10.1046/j.1523-1747.1999.00682.x; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mu YX, 2012, J BIOL CHEM, V287, P28007, DOI 10.1074/jbc.M112.370189; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Ooms M, 2012, J VIROL, V86, P6097, DOI 10.1128/JVI.06570-11; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Peng W, 1996, BIOCHEMISTRY-US, V35, P10172, DOI 10.1021/bi960001x; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2007, DNA REPAIR, V6, P689, DOI 10.1016/j.dnarep.2007.01.001; Pham P, 2011, J BIOL CHEM, V286, P24931, DOI 10.1074/jbc.M111.241208; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Seksek O, 1996, J CELL SCI, V109, P257; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; Skinner AM, 2008, PHOTOCHEM PHOTOBIOL, V84, P222, DOI 10.1111/j.1751-1097.2007.00224.x; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; Trivedi NR, 2006, J INVEST DERMATOL, V126, P1071, DOI 10.1038/sj.jid.5700213; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Wiegand HL, 2007, J VIROL, V81, P13694, DOI 10.1128/JVI.01646-07; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836	62	36	38	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29294	29304		10.1074/jbc.M113.504175	http://dx.doi.org/10.1074/jbc.M113.504175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23979356	Green Published, hybrid			2022-12-25	WOS:000330615300009
J	Lim, C; Luhe, AL; JingYing, CT; Balagurunathan, B; Wu, JC; Zhao, H				Lim, Chanyuen; Luhe, Annette Lin; JingYing, Crystal Tear; Balagurunathan, Balaji; Wu, Jinchuan; Zhao, Hua			Size Of Gene Specific Inverted Repeat - Dependent Gene Deletion In Saccharomyces cerevisiae	PLOS ONE			English	Article							POINT MUTATIONS; 2-STEP METHOD; GENOME; YEAST; DISRUPTION; RECOMBINATION; CONSTRUCTION; REPLICATION; SELECTION; STRAINS	We describe here an approach for rapidly producing scar-free and precise gene deletions in S. cerevisiae with high efficiency. Preparation of the disruption gene cassette in this approach was simply performed by overlap extension-PCR of an invert repeat of a partial or complete sequence of the targeted gene with URA3. Integration of the prepared disruption gene cassette to the designated position of a target gene leads to the formation of a mutagenesis cassette within the yeast genome, which consists of a URA3 gene flanked by the targeted gene and its inverted repeat between two short identical direct repeats. The inherent instability of the inverted sequences in close proximity facilitates the self-excision of the entire mutagenesis cassette deposited in the genome and promotes homologous recombination resulting in a seamless deletion via a single transformation. This rapid assembly circumvents the difficulty during preparation of disruption gene cassettes composed of two inverted repeats of the URA3, which requires the engineering of unique restriction sites for subsequent digestion and T4 DNA ligation in vitro. We further identified that the excision of the entire mutagenesis cassette flanked by two DRs in the transformed S. cerevisiae is dependent on the length of the inverted repeat of which a minimum of 800 bp is required for effective gene deletion. The deletion efficiency improves with the increase of the inverted repeat till 1.2 kb. Finally, the use of gene-specific inverted repeats of target genes enables simultaneous gene deletions. The procedure has the potential for application on other yeast strains to achieve precise and efficient removal of gene sequences.	[Lim, Chanyuen; Luhe, Annette Lin; JingYing, Crystal Tear; Wu, Jinchuan; Zhao, Hua] ASTAR, Inst Chem & Engn Sci, Ind Biotechnol Div, Jurong Isl, Singapore; [Balagurunathan, Balaji] ASTAR, Inst Chem & Engn Sci, Proc Sci & Modeling Div, Jurong Isl, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Sustainability for Chemicals, Energy & Environment (ISCE2); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Sustainability for Chemicals, Energy & Environment (ISCE2)	Zhao, H (corresponding author), ASTAR, Inst Chem & Engn Sci, Ind Biotechnol Div, Jurong Isl, Singapore.	zhao_hua@ices.a-star.edu.sg	Balagurunathan, Balaji/Q-4282-2016; Balagurunathan, Balaji/GXZ-8736-2022	Balagurunathan, Balaji/0000-0003-0003-3040; Balagurunathan, Balaji/0000-0003-0003-3040	A*STAR, Singapore [ICES/12-174A01, ICES/12-574A01]	A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by a project grant from A*STAR, Singapore ICES/12-174A01 (HZ) and ICES/12-574A01 (HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Botstein D, 1997, SCIENCE, V277, P1259, DOI 10.1126/science.277.5330.1259; Botstein D, 2011, GENETICS, V189, P695, DOI 10.1534/genetics.111.130765; Brachmann CB, 1998, YEAST, V14, P115; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; GATIGNOL A, 1987, MOL GEN GENET, V207, P342, DOI 10.1007/BF00331599; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; Gray M, 2005, FEMS MICROBIOL LETT, V248, P31, DOI 10.1016/j.femsle.2005.05.018; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hirashima K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj011; Hong KK, 2012, CELL MOL LIFE SCI, V69, P2671, DOI 10.1007/s00018-012-0945-1; Inagaki H, 2009, GENOME RES, V19, P191, DOI 10.1101/gr.079244.108; Iraqui I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002976; Lambert S, 2010, MOL CELL, V39, P346, DOI 10.1016/j.molcel.2010.07.015; LANGLEROUAULT F, 1995, NUCLEIC ACIDS RES, V23, P3079, DOI 10.1093/nar/23.15.3079; Lartigue C, 2009, SCIENCE, V325, P1693, DOI 10.1126/science.1173759; Lobachev KS, 1998, GENETICS, V148, P1507; Nair NU, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn943; Noskov VN, 2010, NUCLEIC ACIDS RES, V38, P2570, DOI 10.1093/nar/gkq099; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Piccirillo S, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-120; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; STEARNS T, 1990, METHOD ENZYMOL, V185, P280; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846; Tang Weng Lin, 2009, Biotechnology Journal, V4, P1725, DOI 10.1002/biot.200900127; Toulmay A, 2006, YEAST, V23, P825, DOI 10.1002/yea.1397; TRAN HT, 1995, MOL CELL BIOL, V15, P5607; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhang ZW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf089	35	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72137	10.1371/journal.pone.0072137	http://dx.doi.org/10.1371/journal.pone.0072137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977230	Green Submitted, gold, Green Published			2022-12-25	WOS:000324527300067
J	Mignaqui, AC; Ruiz, V; Perret, S; St-Laurent, G; Chahal, PS; Transfiguracion, J; Sammarruco, A; Gnazzo, V; Durocher, Y; Wigdorovitz, A				Mignaqui, Ana Clara; Ruiz, Vanesa; Perret, Sylvie; St-Laurent, Gilles; Chahal, Parminder Singh; Transfiguracion, Julia; Sammarruco, Ayelen; Gnazzo, Victoria; Durocher, Yves; Wigdorovitz, Andres			Transient Gene Expression in Serum-Free Suspension-Growing Mammalian Cells for the Production of Foot-and-Mouth Disease Virus Empty Capsids	PLOS ONE			English	Article							LARGE-SCALE; RECOMBINANT PROTEIN; VACCINES; PARTICLES; TRANSFECTION; PROTECTION; SWINE; FMDV; 3C; IMMUNOGENICITY	Foot-and-mouth disease (FMD) is a highly contagious disease of cloven-hoofed animals. It produces severe economic losses in the livestock industry. Currently available vaccines are based on inactivated FMD virus (FMDV). The use of empty capsids as a subunit vaccine has been reported to be a promising candidate because it avoids the use of virus in the vaccine production and conserves the conformational epitopes of the virus. In this report, we explored transient gene expression (TGE) in serum-free suspension-growing mammalian cells for the production of FMDV recombinant empty capsids as a subunit vaccine. The recombinant proteins produced, assembled into empty capsids and induced protective immune response against viral challenge in mice. Furthermore, they were recognized by anti-FMDV bovine sera. By using this technology, we were able to achieve expression levels that are compatible with the development of a vaccine. Thus, TGE of mammalian cells is an easy to perform, scalable and cost-effective technology for the production of a recombinant subunit vaccine against FMDV.	[Mignaqui, Ana Clara; Ruiz, Vanesa; Sammarruco, Ayelen; Gnazzo, Victoria; Wigdorovitz, Andres] INTA, Ctr Invest Ciencias Vet & Agron, Inst Virol, Hurlingham, Buenos Aires, Argentina; [Mignaqui, Ana Clara; Ruiz, Vanesa; Gnazzo, Victoria; Wigdorovitz, Andres] Consejo Nacl Invest Cientificas & Tecnol, Buenos Aires, DF, Argentina; [Perret, Sylvie; St-Laurent, Gilles; Chahal, Parminder Singh; Transfiguracion, Julia; Durocher, Yves] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	Instituto Nacional de Tecnologia Agropecuaria (INTA); National Research Council Canada	Mignaqui, AC (corresponding author), INTA, Ctr Invest Ciencias Vet & Agron, Inst Virol, Hurlingham, Buenos Aires, Argentina.	amignaqui@cnia.inta.gov.ar	Durocher, Yves/K-8709-2019; Gnazzo, Victoria/AAY-8789-2021	Ruiz, Vanesa/0000-0002-5000-2819	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PAE-PICT-2001-00044]; Instituto Nacional de Tecnologia Agropecuaria, Argentina [PE AESA201721]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Instituto Nacional de Tecnologia Agropecuaria, Argentina	This work was supported by grants PAE-PICT-2001-00044 from Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina and PE AESA201721 from Instituto Nacional de Tecnologia Agropecuaria, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS CC, 1995, J GEN VIROL, V76, P3089, DOI 10.1099/0022-1317-76-12-3089; Baldi L, 2007, BIOTECHNOL LETT, V29, P677, DOI 10.1007/s10529-006-9297-y; BELSHAM GJ, 1991, J GEN VIROL, V72, P747, DOI 10.1099/0022-1317-72-3-747; BRAUTIGAM S, 1993, VIROLOGY, V192, P512, DOI 10.1006/viro.1993.1067; Capozzo AVE, 2002, VIRUS RES, V90, P91, DOI 10.1016/S0168-1702(02)00140-5; Cervera L, 2013, J BIOTECHNOL, V166, P152, DOI 10.1016/j.jbiotec.2013.05.001; D'Antuono A, 2010, VACCINE, V28, P7363, DOI 10.1016/j.vaccine.2010.09.011; De Jesus M, 2011, EUR J PHARM BIOPHARM, V78, P184, DOI 10.1016/j.ejpb.2011.01.005; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; Goodwin S, 2009, J VIROL, V83, P11275, DOI 10.1128/JVI.01263-09; Grubman MJ, 2005, BIOLOGICALS, V33, P227, DOI 10.1016/j.biologicals.2005.08.009; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Li W, 2001, FEBS LETT, V507, P3; Li ZY, 2011, VET MICROBIOL, V149, P99, DOI 10.1016/j.vetmic.2010.10.022; Li ZX, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-30; MARTINEZSALAS E, 1995, VIROLOGY, V212, P111, DOI 10.1006/viro.1995.1459; Mattion N, 2004, VACCINE, V22, P4149, DOI 10.1016/j.vaccine.2004.06.040; Mingxiao M, 2007, ANTIVIR RES, V76, P59, DOI 10.1016/j.antiviral.2007.05.003; Moraes MP, 2003, VACCINE, V22, P268, DOI 10.1016/S0264-410X(03)00560-7; Nallet S, 2009, VACCINE, V27, P6415, DOI 10.1016/j.vaccine.2009.06.019; Parida S, 2009, EXPERT REV VACCINES, V8, P347, DOI 10.1586/14760584.8.3.347; Pena L, 2008, VACCINE, V26, P5689, DOI 10.1016/j.vaccine.2008.08.022; Pham PL, 2006, MOL BIOTECHNOL, V34, P225, DOI 10.1385/MB:34:2:225; Polacek C, 2013, J GEN VIROL, V94, P1249, DOI 10.1099/vir.0.050492-0; Porta C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003255; Quattrocchi V, 2011, ANTIVIR RES, V92, P262, DOI 10.1016/j.antiviral.2011.08.007; Raymond C, 2011, METHODS, V55, P44, DOI 10.1016/j.ymeth.2011.04.002; Rodriguez LL, 2009, VACCINE, V27, pD90, DOI 10.1016/j.vaccine.2009.08.039; ROMBAUT B, 1991, VIROLOGY, V180, P781, DOI 10.1016/0042-6822(91)90091-O; ROWLANDS DJ, 1975, J GEN VIROL, V26, P227, DOI 10.1099/0022-1317-26-3-227; Ruiz V, 2011, REV ARGENT MICROBIOL, V42, P141; RWEYEMAMU MM, 1979, ARCH VIROL, V59, P69, DOI 10.1007/BF01317896; Sanz-Parra A, 1999, VIROLOGY, V259, P129, DOI 10.1006/viro.1999.9717; Seki C, 2009, VET MICROBIOL, V133, P239, DOI 10.1016/j.vetmic.2008.07.011; Shi CH, 2005, BIOCHEMISTRY-US, V44, P15705, DOI 10.1021/bi051292p; Strong R, 2004, J GEN VIROL, V85, P2953, DOI 10.1099/vir.0.80254-0; Subramanian BM, 2012, ANTIVIR RES, V96, P288, DOI 10.1016/j.antiviral.2012.09.019; Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353; Zhang L., 2011, APPL BIONICS BIOMECH, V8, P1	39	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72800	10.1371/journal.pone.0072800	http://dx.doi.org/10.1371/journal.pone.0072800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977353	gold, Green Published, Green Submitted			2022-12-25	WOS:000324527300097
J	Phuah, SY; Lee, SY; Kang, P; Kang, IN; Yoon, SY; Thong, MK; Hartman, M; Sng, JH; Yip, CH; Taib, NAM; Teo, SH				Phuah, Sze Yee; Lee, Sheau Yee; Kang, Peter; Kang, In Nee; Yoon, Sook-Yee; Thong, Meow Keong; Hartman, Mikael; Sng, Jen-Hwei; Yip, Cheng Har; Taib, Nur Aishah Mohd; Teo, Soo-Hwang			Prevalence of PALB2 Mutations in Breast Cancer Patients in Multi-Ethnic Asian Population in Malaysia and Singapore	PLOS ONE			English	Article							FANCONI-ANEMIA; GERMLINE MUTATIONS; MISSENSE MUTATIONS; PROTEIN FUNCTION; FAMILIES; BRCA1; WOMEN; RISK; PARTNER; GENES	Background: The partner and localizer of breast cancer 2 (PALB2) is responsible for facilitating BRCA2-mediated DNA repair by serving as a bridging molecule, acting as the physical and functional link between the breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) proteins. Truncating mutations in the PALB2 gene are rare but are thought to be associated with increased risks of developing breast cancer in various populations. Methods: We evaluated the contribution of PALB2 germline mutations in 122 Asian women with breast cancer, all of whom had significant family history of breast and other cancers. Further screening for nine PALB2 mutations was conducted in 874 Malaysian and 532 Singaporean breast cancer patients, and in 1342 unaffected Malaysian and 541 unaffected Singaporean women. Results: By analyzing the entire coding region of PALB2, we found two novel truncating mutations and ten missense mutations in families tested negative for BRCA1/2-mutations. One additional novel truncating PALB2 mutation was identified in one patient through genotyping analysis. Our results indicate a low prevalence of deleterious PALB2 mutations and a specific mutation profile within the Malaysian and Singaporean populations.	[Phuah, Sze Yee; Lee, Sheau Yee; Kang, Peter; Kang, In Nee; Yoon, Sook-Yee; Teo, Soo-Hwang] Sime Darby Med Ctr, Canc Res Initiat Fdn, Subang Jaya, Selangor, Malaysia; [Phuah, Sze Yee; Taib, Nur Aishah Mohd; Teo, Soo-Hwang] Univ Malaya, Med Ctr, Canc Res Inst, Breast Canc Res Unit,Fac Med, Kuala Lumpur, Malaysia; [Thong, Meow Keong] Univ Malaya, Med Ctr, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia; [Hartman, Mikael] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Hartman, Mikael] Natl Univ Hlth Syst, Singapore, Singapore; [Hartman, Mikael] Natl Univ Singapore, Dept Surg, Singapore 117548, Singapore; [Sng, Jen-Hwei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Yip, Cheng Har] Sime Darby Med Ctr, Subang Jaya, Selangor, Malaysia; [Taib, Nur Aishah Mohd; Teo, Soo-Hwang] Univ Malaya, Fac Med, Med Ctr, Dept Surg, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Universiti Malaya	Teo, SH (corresponding author), Sime Darby Med Ctr, Canc Res Initiat Fdn, Subang Jaya, Selangor, Malaysia.	soohwang.teo@carif.com.my	Taib, Nur Aishah Mohd/B-2370-2010; Thong, Meow-Keong/B-9960-2010; Kang, In Nee/AAK-7206-2020; Yip, Cheng-Har/B-1909-2010; Teo, Soo-hwang/H-2353-2014; Yoon, Sook Yee/AAH-1182-2021; Hartman, Mikael/B-4324-2011	Taib, Nur Aishah Mohd/0000-0001-8419-0478; Thong, Meow-Keong/0000-0002-7288-7910; Hartman, Mikael/0000-0001-5726-9965	Malaysian Ministry of Science, Technology and Innovation; Ministry of Higher Education University Malaya [UM.C/HlR/MOHE/06]; Cancer Research Initiatives Foundation; National Medical Research Council (NMRC/CG/NCIS)	Malaysian Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Ministry of Higher Education University Malaya; Cancer Research Initiatives Foundation; National Medical Research Council (NMRC/CG/NCIS)	This study was funded by research grants from the Malaysian Ministry of Science, Technology and Innovation, Ministry of Higher Education University Malaya (UM.C/HlR/MOHE/06), and Cancer Research Initiatives Foundation. The Singapore Breast Cancer Cohort Project is funded by the National Medical Research Council start-up Grant and Centre Grant (NMRC/CG/NCIS /2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Blanco A, 2012, BREAST CANCER RES TR, V132, P307, DOI 10.1007/s10549-011-1842-2; Cao AY, 2009, BREAST CANCER RES TR, V114, P457, DOI 10.1007/s10549-008-0036-z; Dansonka-Mieszkowska A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-20; Ding YC, 2011, BREAST CANCER RES TR, V126, P227, DOI 10.1007/s10549-010-1271-7; Erkko H, 2008, CLIN CANCER RES, V14, P4667, DOI 10.1158/1078-0432.CCR-08-0210; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Foulkes WD, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1828; Garcia MJ, 2009, BREAST CANCER RES TR, V113, P545, DOI 10.1007/s10549-008-9945-0; Haiman CA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003419; Hofstatter EW, 2011, FAM CANCER, V10, P225, DOI 10.1007/s10689-011-9426-1; Hollestelle A, 2010, CURR OPIN GENET DEV, V20, P268, DOI 10.1016/j.gde.2010.02.009; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Prokofyeva D, 2012, CLIN GENET, V82, P100, DOI 10.1111/j.1399-0004.2011.01824.x; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Slater EP, 2010, CLIN GENET, V78, P490, DOI 10.1111/j.1399-0004.2010.01425.x; Sluiter M, 2009, FAM CANCER, V8, P347, DOI 10.1007/s10689-009-9241-0; Southey MC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2796; Thirthagiri E, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2118; Tischkowitz M, 2007, P NATL ACAD SCI USA, V104, P6788, DOI 10.1073/pnas.0701724104; Toh GT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002024; Vallon-Christersson J, 2001, HUM MOL GENET, V10, P353, DOI 10.1093/hmg/10.4.353; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Zheng YL, 2012, CANCER-AM CANCER SOC, V118, P1362, DOI 10.1002/cncr.26388	27	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e73638	10.1371/journal.pone.0073638	http://dx.doi.org/10.1371/journal.pone.0073638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977390	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300109
J	Wang, YX; Wu, LJ; Yu, XW; Zhao, FF; Russell, A; Song, MS; Wang, W				Wang, YouXin; Wu, LiJuan; Yu, XinWei; Zhao, FeiFei; Russell, Alyce; Song, ManShu; Wang, Wei			The Expected Number of Background Disease Events during Mass Immunization in China	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; DEATHS; SAFETY; RATES	It is critical to distinguish events that are temporarily associated with, but not caused by, vaccination from those caused by vaccination during mass immunization. We performed a literature search in China National Knowledge Infrastructure and Pubmed databases. The number of coincident events was calculated based on its incidence rate and periods after receipt of a dose of hypothesized vaccine. We included background incidences of Guillain-Barre syndrome, anaphylaxis, seizure, sudden adult death syndrome, sudden cardiac death, spontaneous abortion, and preterm labour or delivery. In a cohort of 10 million individuals, 7.71 cases of Guillain-Barre syndrome would be expected to occur within six weeks of vaccination as coincident background cases. Even for rare events, a large number of events can be expected in a short period because of the large population targeted for immunization. These findings may encourage health authorities to screen the safety of vaccines against unpredictable pathogens.	[Wang, YouXin; Wu, LiJuan; Yu, XinWei; Zhao, FeiFei; Song, ManShu; Wang, Wei] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China; [Wang, YouXin; Wu, LiJuan; Yu, XinWei; Zhao, FeiFei; Song, ManShu; Wang, Wei] Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Wang, Wei] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Wang, YouXin; Russell, Alyce; Wang, Wei] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia	Capital Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Edith Cowan University	Song, MS (corresponding author), Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China.	songms@ccmu.edu.cn; wei.wang@ecu.edu.au	wang, YA XING/K-9671-2016; liu, li/HGC-0900-2022	wang, YA XING/0000-0003-2749-7793; Russell, Alyce/0000-0002-1667-7601; Song, Manshu/0000-0003-1433-7192; Wang, Youxin/0000-0002-6574-6706; wang, wei/0000-0002-1430-1360	Chinese Government Major Grants administrated under the 5-year Plan [2012BAI37B03, 2009ZX10004-903, 2008ZX100-01-003]; National Natural Science Foundation of China [81001281]; Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions; Grant of the Municipal Key Laboratory of Clinical Epidemiology, Beijing China [2012LCLB03]	Chinese Government Major Grants administrated under the 5-year Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions; Grant of the Municipal Key Laboratory of Clinical Epidemiology, Beijing China	The study was funded by the Chinese Government Major Grants administrated under the 5-year Plan (2012BAI37B03, 2009ZX10004-903, 2008ZX100-01-003), National Natural Science Foundation of China (81001281), Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions, and the Grant of the Municipal Key Laboratory of Clinical Epidemiology, Beijing China (2012LCLB03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black N, 1996, BRIT MED J, V312, P1215; Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Chen ML, 2001, ACAD J SUMS, V22, P68; Cheng JD, 2008, INT J INTERN MED, V125, P21; Cheng Q, 2002, J NEUROL, V249, P25, DOI 10.1007/PL00007844; Da G, 1997, TIBET J MED, V18, P23; Deeks SL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-329; Fung ICH, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-20; Guo Zhan-kun, 2010, Zhonghua Fu Chan Ke Za Zhi, V45, P99; Hong X, 2000, ACTA ACAD MED SINICA, V22, P115; Hua W, 2009, J AM COLL CARDIOL, V54, P1110, DOI 10.1016/j.jacc.2009.06.016; Kokia ES, 2007, VACCINE, V25, P8557, DOI 10.1016/j.vaccine.2007.10.021; Leung TN, 1998, AUST NZ J OBSTET GYN, V38, P138, DOI 10.1111/j.1479-828X.1998.tb02986.x; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Liu B, 2002, CHINA PUBLIC HLTH, V18, P890; Luo YL, 2007, J GANSU SCI CHIN, V19, P81; Ministry of Health People's Republic of China, 2010, 5 HLTH B 2010; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Ren H, 2007, J INT NEUROLOGY NEUR, V34, P10; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Shu M, 2011, VACCINE, V29, P3507, DOI 10.1016/j.vaccine.2009.10.106; Wang W, 2002, NATL MED J CHINA, V82, P49; Wang YX, 2010, PREV MED, V51, P445, DOI 10.1016/j.ypmed.2010.08.019; Wu ZD, 2005, J CHN PHYS CHIN, V7, P670; Xia J, 2008, HEALTH INFO LIBR J, V25, P55, DOI 10.1111/j.1471-1842.2007.00734.x; Yao RY, 2005, J BENGBU MED COLL CH, V30, P500	27	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71818	10.1371/journal.pone.0071818	http://dx.doi.org/10.1371/journal.pone.0071818			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977153	Green Published, gold			2022-12-25	WOS:000324527300042
J	Herrmann, IK; Castellon, M; Schwartz, DE; Hasler, M; Urner, M; Hu, GC; Minshall, RD; Beck-Schimmer, B				Herrmann, Inge K.; Castellon, Maricela; Schwartz, David E.; Hasler, Melanie; Urner, Martin; Hu, Guochang; Minshall, Richard D.; Beck-Schimmer, Beatrice			Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; VOLATILE ANESTHETICS; SEPSIS; INJURY	Volatile anesthetics are known to have immunomodulatory effects in conditions of organ injury. A recent study in an experimental sepsis model has shown remarkably improved survival when mice were exposed to volatile anesthetics. In the present study, we show that hexafluoroisopropanol - a water-soluble primary sevoflurane metabolite - has beneficial effects on the overall survival in a murine model of cecal ligation and puncture. Seven-day survival as well as tissue damage markers including transaminases and high mobility group box protein-1 were assessed as measures of end organ damage. In animals undergoing cecal ligation and puncture procedure hexafluoroisopropanol conditioning - but not late postconditioning 24 hours after sepsis induction - significantly increased survival rate (17% vs. 77%, p = 0.037) and attenuated secretion of organ damage markers. This study shows survival benefits by administration of the metabolite of a volatile anesthetic. If successfully translated, hexafluoroisopropanol might offer interesting therapeutic opportunities in the future treatment of abdominal sepsis.	[Herrmann, Inge K.; Hasler, Melanie; Urner, Martin; Beck-Schimmer, Beatrice] Univ Zurich Hosp, Inst Anesthesiol, CH-8091 Zurich, Switzerland; [Herrmann, Inge K.; Hasler, Melanie; Urner, Martin; Beck-Schimmer, Beatrice] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Herrmann, Inge K.; Hasler, Melanie; Urner, Martin; Beck-Schimmer, Beatrice] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Castellon, Maricela; Schwartz, David E.; Hu, Guochang; Minshall, Richard D.] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60680 USA; [Castellon, Maricela; Hu, Guochang; Minshall, Richard D.] Univ Illinois, Dept Pharmacol, Chicago, IL USA	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Beck-Schimmer, B (corresponding author), Univ Zurich Hosp, Inst Anesthesiol, CH-8091 Zurich, Switzerland.	beatrice.beckschimmer@uzh.ch	Urner, Martin/AAK-5701-2020; Herrmann, Inge/H-6318-2018	Urner, Martin/0000-0003-1133-4885; Herrmann, Inge/0000-0002-3018-6796	Swiss National Science Foundation, Berne, Switzerland [320030_141216]; National Institutes of Health, Bethesda, MD, USA [NIH P01 HL60678, R01 HL71626]; Emdo Foundation, Zurich, Switzerland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678, R01HL071626] Funding Source: NIH RePORTER	Swiss National Science Foundation, Berne, Switzerland(Swiss National Science Foundation (SNSF)); National Institutes of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emdo Foundation, Zurich, Switzerland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding came from the Swiss National Science Foundation, Berne, Switzerland, Grant No. 320030_141216; National Institutes of Health, Bethesda, MD, USA, NIH P01 HL60678 and R01 HL71626; Emdo Foundation, Zurich, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck-Schimmer B, 2008, ANN SURG, V248, P909, DOI 10.1097/SLA.0b013e31818f3dda; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; Fast JP, 2008, ANESTHESIOLOGY, V109, P651, DOI 10.1097/ALN.0b013e31818630ff; Guarracino F, 2006, J CARDIOTHOR VASC AN, V20, P477, DOI 10.1053/j.jvca.2006.05.012; Herrmann IK, 2013, ANESTHESIOL IN PRESS; Lee HT, 2007, AM J PHYSIOL-RENAL, V293, pF713, DOI 10.1152/ajprenal.00161.2007; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Urner M, 2011, AM J RESP CELL MOL, V45, P617, DOI 10.1165/rcmb.2010-0451OC; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100	10	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72057	10.1371/journal.pone.0072057	http://dx.doi.org/10.1371/journal.pone.0072057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977207	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000323425700129
J	Hung, SH; Tsai, MC; Liu, TC; Lin, HC; Chung, SD				Hung, Shih-Han; Tsai, Ming-Chieh; Liu, Tsai-Ching; Lin, Herng-Ching; Chung, Shiu-Dong			Routine Endoscopy for Esophageal Cancer Is Suggestive for Patients with Oral, Oropharyngeal and Hypopharyngeal Cancer	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; SQUAMOUS-CELL CARCINOMAS; NECK-CANCER; FIELD CANCERIZATION; TRIPLE ENDOSCOPY; RISK-FACTORS; 2ND CANCERS; BETEL-QUID; HEAD; ALCOHOL	Background: This study attempted to reveal the incidence and risk of synchronous and metachronous esophageal cancer in subjects with oral, oropharyngeal and hypopharyngeal cancer based on a population-wide database in Taiwan. Methods: We retrieved data for this cross-sectional study from the Taiwanese Longitudinal Health Insurance Database 2000. The study group included 2,965 subjects who had received their first-time diagnosis of oral/oropharyngeal/hypopharyngeal cancer in 2002 similar to 2009. We assigned the date of their first diagnosis of oral/oropharyngeal/hypopharyngeal cancer as the index date. We also randomly retrieved 29,650 comparison subjects matched with the study subjects in terms of gender and age group. We assigned their first medical utilization that occurred in the index year as the index date for the comparison group. We further performed a conditional logistic regression to investigate the association between esophageal cancer and oral cancer. Results: Results showed that prevalences of esophageal cancer within 3 months before and after the index date were respectively 2.19% and 0.04% for the study and comparison groups. A conditional logistic regression revealed that the odds ratio (OR) of esophageal cancer for subjects with oral/oropharyngeal/hypopharyngeal cancer was 55.33 (95% confidence interval (CI): 29.86 similar to 102.52) compared to comparison subjects. Furthermore, compared to comparison subjects, ORs for esophageal cancer were respectively 18.41 (95% CI: 8.50-39.85), 40.49 (95% CI: 15.11 similar to 108.64), and 240.96 (95% CI: 125.49 similar to 462.69) for study subjects with a malignancy of the oral cavity, oropharynx, and hypopharynx. Conclusion: We concluded that there were relatively high chances for synchronous and metachronous esophageal cancers being detected through panendoscopy in patients with oral, oropharyngeal, and hypopharyngeal cancers. The routine use of panendoscopy in such patients should be encouraged with a higher priority.	[Hung, Shih-Han] Taipei Med Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Tsai, Ming-Chieh] Gen Cathay Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan; [Liu, Tsai-Ching] Natl Taipei Univ, Dept Publ Finance, Taipei, Taiwan; [Lin, Herng-Ching; Chung, Shiu-Dong] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, New Taipei City, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Cathay General Hospital; National Taipei University; Taipei Medical University; Far Eastern Memorial Hospital	Chung, SD (corresponding author), Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan.	chungshiudong@gmail.com		Hung, Shih-Han/0000-0001-9591-5489				ABEMAYOR E, 1988, J SURG ONCOL, V38, P94, DOI 10.1002/jso.2930380207; Angadi PV, 2012, ORAL MAXILLOFAC SURG, V16, P171, DOI 10.1007/s10006-012-0317-x; ATKINSON D, 1982, AM J SURG, V144, P416, DOI 10.1016/0002-9610(82)90414-7; BENNINGER MS, 1993, HEAD NECK-J SCI SPEC, V15, P532, DOI 10.1002/hed.2880150610; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Chen YC, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d637; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cohn A M, 1980, Am J Otolaryngol, V1, P411, DOI 10.1016/S0196-0709(80)80022-6; DAY GL, 1994, J NATL CANCER I, V86, P131, DOI 10.1093/jnci/86.2.131; FRANCO EL, 1991, J CLIN EPIDEMIOL, V44, P615, DOI 10.1016/0895-4356(91)90021-Z; Guardiola E, 2004, CANCER, V101, P2028, DOI 10.1002/cncr.20623; Han WG, 1976, CANCER, V37, P85; HSAIRI M, 1989, HEAD NECK-J SCI SPEC, V11, P426, DOI 10.1002/hed.2880110508; Kagei K, 2002, JPN J CLIN ONCOL, V32, P120, DOI 10.1093/jjco/hyf028; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; KO YC, 1992, J ORAL PATHOL MED, V21, P261, DOI 10.1111/j.1600-0714.1992.tb01007.x; Lee CT, 2010, ENDOSCOPY, V42, P613, DOI 10.1055/s-0030-1255514; Lee CH, 2012, INT J CANCER, V131, pE733, DOI 10.1002/ijc.27401; MAISEL RH, 1981, ANN OTO RHINOL LARYN, V90, P460, DOI 10.1177/000348948109000509; Marichalar-Mendia X, 2010, ORAL ONCOL, V46, P9, DOI 10.1016/j.oraloncology.2009.09.005; Matsuda T, 2006, CHEM RES TOXICOL, V19, P1374, DOI 10.1021/tx060113h; Matsuo K, 2012, EUR J CANCER PREV, V21, P193, DOI 10.1097/CEJ.0b013e32834c9be5; MCGUIRT WF, 1982, LARYNGOSCOPE, V92, P569; MORITA M, 1994, INT J CANCER, V58, P207, DOI 10.1002/ijc.2910580211; Muto M, 2005, CARCINOGENESIS, V26, P1008, DOI 10.1093/carcin/bgi035; RITTER SB, 1976, JAMA-J AM MED ASSOC, V235, P1723, DOI 10.1001/jama.235.16.1723; Shen ML, 2009, J ORAL MAXIL SURG, V67, P718, DOI 10.1016/j.joms.2008.06.032; SHIBUYA H, 1995, CANCER, V76, P101, DOI 10.1002/1097-0142(19950701)76:1<101::AID-CNCR2820760115>3.0.CO;2-D; SHIOZAKI H, 1990, CANCER-AM CANCER SOC, V66, P2068, DOI 10.1002/1097-0142(19901115)66:10<2068::AID-CNCR2820661005>3.0.CO;2-W; Simchuk EJ, 2001, DIS ESOPHAGUS, V14, P247, DOI 10.1046/j.1442-2050.2001.00195.x; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; STRONG MS, 1984, J OTOLARYNGOL, V13, P1; Taiwan Cancer Registry Database, 2009, TAIW CANC REG DAT; THOMPSON WM, 1978, GASTROINTEST RADIOL, V3, P123, DOI 10.1007/BF01887051; Tincani AJ, 2000, HEAD NECK-J SCI SPEC, V22, P170, DOI 10.1002/(SICI)1097-0347(200003)22:2<170::AID-HED9>3.0.CO;2-7; van Oijen MGCT, 2000, CANCER EPIDEM BIOMAR, V9, P249; Wang CH, 2013, DIG ENDOSC; Wang W. Q., 2016, PLOS ONE, V11	39	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72097	10.1371/journal.pone.0072097	http://dx.doi.org/10.1371/journal.pone.0072097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977217	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000077
J	Li, ZH; Sun, H; Zhang, JB; Zhang, HJ; Meng, FY; Cui, ZF				Li, Zhaohui; Sun, He; Zhang, Jianbin; Zhang, Haijiao; Meng, Fanyu; Cui, Zhanfeng			Development of In Vitro 3D TissueFlex (R) Islet Model for Diabetic Drug Efficacy Testing	PLOS ONE			English	Article							MOUSE PANCREATIC-ISLETS; INSULIN-SECRETION; EXTRACELLULAR-MATRIX; MICROENCAPSULATED ISLETS; GLUCOSE-CONCENTRATION; CELL-SURVIVAL; GROWTH-FACTOR; BLOOD-FLOW; RAT ISLETS; CULTURE	Increasing individuals diagnosed with type II diabetes pose a strong demand for the development of more effective anti-diabetic drugs. However, expensive, ethically controversial animal-based screening for anti-diabetic compounds is not always predictive of the human response. The use of in vitro cell-based models in research presents obviously ethical and cost advantages over in vivo models. This study was to develop an in vitro three-dimensional (3D) perfused culture model of islets (Islet TF) for maintaining viability and functionality longer for diabetic drug efficacy tests. Briefly fresh isolated rat islets were encapsulated in ultrapure alginate and the encapsulated islets were cultured in TissueFlex (R), a multiple, parallel perfused microbioreactor system for 7 days. The encapsulated islets cultured statically in cell culture plates (3D static) and islets cultured in suspension (2D) were used as the comparisons. In this study we demonstrate for the first time that Islet TF model can maintain the in vitro islet viability, and more importantly, the elevated functionality in terms of insulin release and dynamic responses over a 7-day culture period. The Islet TF displays a high sensitivity in responding to drugs and drug dosages over conventional 2D and 3D static models. Actual drug administration in clinics could be simulated using the developed Islet TF model, and the patterns of insulin release response to the tested drugs were in agreement with the data obtained in vivo. Islet TF could be a more predictive in vitro model for routine short-and long-term anti-diabetic drug efficacy testing.	[Li, Zhaohui; Cui, Zhanfeng] Univ Oxford, Inst Biomed Engn, Oxford, England; [Sun, He; Zhang, Jianbin; Zhang, Haijiao; Meng, Fanyu] Tianjin Weikai Bioeng Ltd, Tianjin, Peoples R China	University of Oxford	Cui, ZF (corresponding author), Univ Oxford, Inst Biomed Engn, Oxford, England.	Zhanfeng.cui@eng.ox.ac.uk		Cui, Zhanfeng/0000-0002-9251-9752	Tianjin Municipal Science and Technology Commission; Administrative Commission of Tianjin Economic-Technological Development Area (TEDA), China; Biotechnology and Biological Science Research Council, UK; Biotechnology and Biological Sciences Research Council [BB/L003961/1] Funding Source: researchfish; BBSRC [BB/L003961/1] Funding Source: UKRI	Tianjin Municipal Science and Technology Commission; Administrative Commission of Tianjin Economic-Technological Development Area (TEDA), China; Biotechnology and Biological Science Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The experimental work was sponsored by the Tianjin Municipal Science and Technology Commission, and the Administrative Commission of Tianjin Economic-Technological Development Area (TEDA), China, and conducted in the Tianjin International Joint Academy of Biotechnology and Medicine. Dr Li's post is sponsored by the Biotechnology and Biological Science Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 1999, AM J PHYSIOL-ENDOC M, V277, pE996, DOI 10.1152/ajpendo.1999.277.6.E996; ANDERSSON A, 1978, DIABETOLOGIA, V14, P397, DOI 10.1007/BF01228134; ANDERSSON A, 1976, ACTA ENDOCRINOL-COP, V82, P318; Azzi J, 2010, EXPERT REV CLIN IMMU, V6, P111, DOI 10.1586/ECI.09.67; Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723; Beattie GM, 1996, DIABETES, V45, P1223, DOI 10.2337/diabetes.45.9.1223; Bentsi-Barnes K, 2011, ISLETS, V3, P284, DOI 10.4161/isl.3.5.15938; BOUMAN PR, 1961, METABOLISM, V10, P1095; BRENDEL MD, 1994, CELL TRANSPLANT, V3, P427, DOI 10.1177/096368979400300510; CHICHEPORTICHE D, 1988, DIABETOLOGIA, V31, P54; Clayton HA, 1996, CELL TRANSPLANT, V5, P1, DOI 10.1016/0963-6897(95)02005-5; Cui ZF, 2007, TOXICOL IN VITRO, V21, P1318, DOI 10.1016/j.tiv.2007.05.015; CUNNINGHAM JM, 1992, INT J ARTIF ORGANS, V15, P162; Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171; Dixit R, 2007, DRUG DISCOV TODAY, V12, P336, DOI 10.1016/j.drudis.2007.02.018; Domansky K, 2010, LAB CHIP, V10, P51, DOI 10.1039/b913221j; EIZIRIK DL, 1992, J CLIN INVEST, V90, P1263, DOI 10.1172/JCI115989; FRIDOLF T, 1991, DIABETES RES CLIN EX, V16, P185; HENQUIN JC, 1980, DIABETOLOGIA, V18, P151, DOI 10.1007/BF00290493; HENQUIN JC, 1975, AM J PHYSIOL, V228, P1669, DOI 10.1152/ajplegacy.1975.228.6.1669; Ilieva A, 1999, J ENDOCRINOL, V161, P357, DOI 10.1677/joe.0.1610357; JANSSON L, 1983, DIABETOLOGIA, V25, P45; Korbutt GS, 2004, DIABETOLOGIA, V47, P1810, DOI 10.1007/s00125-004-1531-3; Korin N, 2009, BIOMED MICRODEVICES, V11, P87, DOI 10.1007/s10544-008-9212-5; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Langlois G, 2009, ACTA BIOMATER, V5, P3433, DOI 10.1016/j.actbio.2009.05.029; Li AP, 2001, DRUG DISCOV TODAY, V6, P357, DOI 10.1016/S1359-6446(01)01712-3; Li ZH, 2011, J BIOMED MATER RES A, V99A, P211, DOI 10.1002/jbm.a.33177; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; LOUBATIERES A, 1957, ANN NY ACAD SCI, V71, P4, DOI 10.1111/j.1749-6632.1957.tb54569.x; Mallett AG, 2009, TISSUE ENG PT A, V15, P1301, DOI 10.1089/ten.tea.2008.0118; Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001; MENGER MD, 1994, J CLIN INVEST, V93, P2280, DOI 10.1172/JCI117228; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Nagata N, 2002, J BIOMAT SCI-POLYM E, V13, P579, DOI 10.1163/15685620260178418; Nauck MA, 1997, EXP CLIN ENDOCR DIAB, V105, P187, DOI 10.1055/s-0029-1211750; Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399; Pampaloni F, 2009, BIOTECHNOL GENET ENG, V26, P129; Qi M, 2008, ARTIF CELL BLOOD SUB, V36, P403, DOI 10.1080/10731190802369755; RAMIREZ CA, 1992, HORM METAB RES, V24, P197, DOI 10.1055/s-2007-1003293; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O; Vasir B, 1998, DIABETES, V47, P1894, DOI 10.2337/diabetes.47.12.1894; Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181; Weber LM, 2008, TISSUE ENG PT A, V14, P1959, DOI 10.1089/ten.tea.2007.0238; Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101	46	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72612	10.1371/journal.pone.0072612	http://dx.doi.org/10.1371/journal.pone.0072612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977329	gold, Green Submitted, Green Published			2022-12-25	WOS:000323378000105
J	Cheng, XW; Guo, S; Liu, Y; Chu, H; Hakimi, P; Berger, NA; Hanson, RW; Kao, HY				Cheng, Xiwen; Guo, Shuang; Liu, Yu; Chu, Hao; Hakimi, Parvin; Berger, Nathan A.; Hanson, Richard W.; Kao, Hung-Ying			Ablation of Promyelocytic Leukemia Protein (PML) Re-patterns Energy Balance and Protects Mice from Obesity Induced by a Western Diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; ALPHA TNF-ALPHA; INSULIN-RESISTANCE; SKELETAL-MUSCLE; NUCLEAR-BODIES; RAR-ALPHA; METABOLISM; TRANSLOCATION; TRANSCRIPTION; SUMOYLATION	The promyelocytic leukemia protein is a well known tumor suppressor, but its role in metabolism is largely unknown. Mice with a deletion in the gene for PML (KO mice) exhibit altered gene expression in liver, adipose tissue, and skeletal muscle, an accelerated rate of fatty acid metabolism, abnormal glucose metabolism, constitutive AMP-activating kinase (AMPK) activation, and insulin resistance in skeletal muscle. Last, an increased rate of energy expenditure protects PML KO mice from the effects of obesity induced by a Western diet. Collectively, our study uncovers a previously unappreciated role of PML in the regulation of metabolism and energy balance in mice.	[Cheng, Xiwen; Guo, Shuang; Liu, Yu; Hakimi, Parvin; Hanson, Richard W.; Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Berger, Nathan A.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Chu, Hao] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Kao, HY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	hxk43@cwru.edu	Hakimi, Parvin/AAB-1643-2021; Cheng, Xiwen/B-8385-2014	Cheng, Xiwen/0000-0001-7398-1522	National Institutes of Health [HL093269, DK078965, P20 CA103736, U54 CA116867]; Ellison Foundation [AG-SS-2420-10]; NATIONAL CANCER INSTITUTE [P20CA103736, U54CA116867] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL093269 and DK078965 (to H.-Y. K.) and P20 CA103736 and U54 CA116867 (Case Comprehensive Cancer Center Program in Aging and Energy Balance, NCI; to N. A. B.). This work was also supported by The Ellison Foundation Senior Scholars Award AG-SS-2420-10 (to R. W. H.).	Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; BALLARD FJ, 1969, BIOCHEM J, V112, P195, DOI 10.1042/bj1120195; Blagih J, 2012, IMMUNOL REV, V249, P59, DOI 10.1111/j.1600-065X.2012.01157.x; Buchner DA, 2008, PHYSIOL GENOMICS, V35, P116, DOI 10.1152/physiolgenomics.00033.2008; Carracedo A, 2012, J CLIN INVEST, V122, P3088, DOI 10.1172/JCI62129; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cheng Xiwen, 2012, Front Oncol, V2, P210, DOI 10.3389/fonc.2012.00210; Cheng XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-453; Cheng XW, 2012, J BIOL CHEM, V287, P23356, DOI 10.1074/jbc.M112.340505; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Eskiw CH, 2003, J CELL SCI, V116, P4455, DOI 10.1242/jcs.00758; Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Gao CZ, 2008, MOL BIOL CELL, V19, P3020, DOI 10.1091/mbc.E07-11-1203; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; HimmsHagen J, 1997, SCIENCE, V276, P1132, DOI 10.1126/science.276.5315.1132; Hoover-Plow Jane, 2006, BMC Blood Disord, V6, P6, DOI 10.1186/1471-2326-6-6; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kim MK, 2011, AM J PHYSIOL-ENDOC M, V301, pE1130, DOI 10.1152/ajpendo.00092.2011; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kokkotou E, 2005, AM J PHYSIOL-REG I, V289, pR117, DOI 10.1152/ajpregu.00861.2004; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lim JH, 2011, J BIOL CHEM, V286, P44403, DOI 10.1074/jbc.M111.289512; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; McCabe BJ, 2006, ANAL BIOCHEM, V350, P171, DOI 10.1016/j.ab.2006.01.020; McCabe BJ, 2004, METAB ENG, V6, P25, DOI 10.1016/j.ymben.2003.09.003; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Muratani M, 2002, NAT CELL BIOL, V4, P106, DOI 10.1038/ncb740; Nadeau JH, 2005, NEW ENGL J MED, V352, P1598, DOI 10.1056/NEJMe058054; RANDLE PJ, 1963, LANCET, V1, P785; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Reineke EL, 2009, INT J BIOL SCI, V5, P366; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Westerterp Klaas R., 1993, American Journal of Clinical Nutrition, V57, p759S, DOI 10.1093/ajcn/57.5.759S; Wu WS, 2003, J BIOL CHEM, V278, P12294, DOI 10.1074/jbc.M211849200; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	50	21	21	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29746	29759		10.1074/jbc.M113.487595	http://dx.doi.org/10.1074/jbc.M113.487595			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23986437	Green Published, hybrid			2022-12-25	WOS:000330615300050
J	Soysa, R; Wilson, ZN; Elferich, J; Forquer, I; Shinde, U; Riscoe, MK; Yates, PA; Ullman, B				Soysa, Radika; Wilson, Zachary N.; Elferich, Johannes; Forquer, Isaac; Shinde, Ujwal; Riscoe, Michael K.; Yates, Phillip A.; Ullman, Buddy			Substrate Inhibition of Uracil Phosphoribosyltransferase by Uracil Can Account for the Uracil Growth Sensitivity of Leishmania donovani Pyrimidine Auxotrophs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII; GENE AMPLIFICATION; TRYPANOSOMA-BRUCEI; HAMSTER-CELLS; UMP SYNTHESIS; BIOSYNTHESIS; GENOME; OLIGOMERIZATION; OVERPRODUCTION; PURIFICATION	The pathogenic protozoan parasite Leishmania donovani is capable of both de novo pyrimidine biosynthesis and salvage of pyrimidines from the host milieu. Genetic analysis has authenticated L. donovani uracil phosphoribosyltransferase (LdUPRT), an enzyme not found in mammalian cells, as the focal enzyme of pyrimidine salvage because all exogenous pyrimidines that can satisfy the requirement of the parasite for pyrimidine nucleotides are funneled to uracil and then phosphoribosylated to UMP in the parasite by LdUPRT. To characterize this unique parasite enzyme, LdUPRT was expressed in Escherichia coli, and the recombinant enzyme was purified to homogeneity. Kinetic analysis revealed apparent K-m values of 20 and 99 mu M for the natural substrates uracil and phosphoribosylpyrophosphate, respectively, as well as apparent K-m values 6 and 7 mu M for the pyrimidine analogs 5-fluorouracil and 4-thiouracil, respectively. Size exclusion chromatography revealed the native LdUPRT to be tetrameric and retained partial structure and activity in high concentrations of urea. L. donovani mutants deficient in de novo pyrimidine biosynthesis, which require functional LdUPRT for growth, are hypersensitive to high concentrations of uracil, 5-fluorouracil, and 4-thiouracil in the growth medium. This hypersensitivity can be explained by the observation that LdUPRT is substrate-inhibited by uracil and 4-thiouracil, but 5-fluorouracil toxicity transpires via an alternative mechanism. This substrate inhibition of LdUPRT provides a protective mechanism for the parasite by facilitating purine and pyrimidine nucleotide pool balance and by sparing phosphoribosylpyrophosphate for consumption by the nutritionally indispensable purine salvage process.	[Soysa, Radika; Wilson, Zachary N.; Elferich, Johannes; Shinde, Ujwal; Yates, Phillip A.; Ullman, Buddy] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Forquer, Isaac; Riscoe, Michael K.] Vet Affairs Med Ctr, Expt Chemotherapy Lab, Portland, OR 97239 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ullman, B (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol L224, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	ullmanb@ohsu.edu		Wilson, Zachary/0000-0003-4269-4058; Elferich, Johannes/0000-0002-9911-706X	National Institutes of Health [AI023682]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023682, R01AI023682] Funding Source: NIH RePORTER; Direct For Biological Sciences [0746589] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grant AI023682 (to B.U.).	Ali JAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058034; Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Boitz JM, 2006, J BIOL CHEM, V281, P16084, DOI 10.1074/jbc.M600188200; Carter D, 1997, MOL BIOCHEM PARASIT, V87, P137, DOI 10.1016/S0166-6851(97)00058-3; CARTER NS, 2003, MOL MED PARASITOLOGY, P197; Cleary MD, 2005, NAT BIOTECHNOL, V23, P232, DOI 10.1038/nbt1061; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; French JB, 2011, J BIOL CHEM, V286, P20930, DOI 10.1074/jbc.M111.228213; HAMMOND DJ, 1982, BIOCHIM BIOPHYS ACTA, V718, P1, DOI 10.1016/0304-4165(82)90002-2; Hashimoto M, 2012, BIOCHEM BIOPH RES CO, V417, P1002, DOI 10.1016/j.bbrc.2011.12.073; HASSAN HF, 1986, COMP BIOCHEM PHYS B, V84, P217, DOI 10.1016/0305-0491(86)90209-9; ILTZSCH MH, 1994, BIOCHEM PHARMACOL, V48, P781, DOI 10.1016/0006-2952(94)90057-4; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Mikus Judith, 2000, Parasitology International, V48, P265, DOI 10.1016/S1383-5769(99)00020-3; NATALINI P, 1979, J BIOL CHEM, V254, P1558; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; OPPERDOES FR, 1988, TRENDS BIOCHEM SCI, V13, P255, DOI 10.1016/0968-0004(88)90158-2; PETERS GJ, 1986, CANCER RES, V46, P20; PFEFFERKORN ER, 1977, J PROTOZOOL, V24, P449, DOI 10.1111/j.1550-7408.1977.tb04774.x; Schumacher MA, 2002, P NATL ACAD SCI USA, V99, P78, DOI 10.1073/pnas.012399599; Schumacher MA, 1998, EMBO J, V17, P3219, DOI 10.1093/emboj/17.12.3219; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; Shoemaker Laura K, 2004, Cancer Control, V11, P46; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; SUTTLE DP, 1979, J BIOL CHEM, V254, P4602; WAHL GM, 1979, J BIOL CHEM, V254, P8679; Wilson ZN, 2012, J BIOL CHEM, V287, P12759, DOI 10.1074/jbc.M112.346502; Zeiner Gusti M., 2008, V419, P135, DOI 10.1007/978-1-59745-033-1_9	31	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29954	29964		10.1074/jbc.M113.478826	http://dx.doi.org/10.1074/jbc.M113.478826			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23986453	Green Published, hybrid			2022-12-25	WOS:000330615300068
J	Benito-Gutierrez, E; Weber, H; Bryant, DV; Arendt, D				Benito-Gutierrez, Elia; Weber, Hermann; Bryant, Diana Virginia; Arendt, Detlev			Methods for Generating Year-Round Access to Amphioxus in the Laboratory	PLOS ONE			English	Article							LANCELET BRANCHIOSTOMA-BELCHERI; CEPHALOCHORDATE AMPHIOXUS; CHORDATE AMPHIOXUS; SPAWNING BEHAVIOR; EMBRYOS; LANCEOLATUM; CULTURE; REPRODUCTION; BIOLOGY; SYSTEM	Cephalochordates, commonly known as amphioxus, are key to understanding vertebrate origins. However, laboratory work suffers from limited access to adults and embryonic material. Here we report the design and experimental validation of an inland marine facility that allows establishing stable amphioxus colonies in the laboratory and obtaining embryos at any time of day and over almost the entire year, far exceeding natural conditions. This is achieved by mimicking the natural benthic environment, natural day-and moon-light, natural substrate and by providing a strictly controlled and seasonally fluctuating temperature regimen. Moreover, supplemented algae diets allow animals to refill their gonads in consecutive years. Spontaneous spawning, a major problem in previous setups, no longer occurs in our facility; instead, all breeding is induced and fertilization occurs fully in vitro. Our system makes amphioxus a standard laboratory animal model.	[Benito-Gutierrez, Elia; Weber, Hermann; Bryant, Diana Virginia; Arendt, Detlev] European Mol Biol Lab, Dev Biol Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Benito-Gutierrez, E (corresponding author), European Mol Biol Lab, Dev Biol Unit, Heidelberg, Germany.	elia.begu@embl.de; arendt@embl.de	Gutierrez, Elia Benito/ABG-6788-2021	Gutierrez, Elia Benito/0000-0003-2435-0948	La Generalitat de Catalunya, Beatriu de Pinos Program [2006BP-A10108]; EMBL, Interdisciplinary Postdocs Program (EIPOD); European Community [227799]	La Generalitat de Catalunya, Beatriu de Pinos Program(Generalitat de Catalunya); EMBL, Interdisciplinary Postdocs Program (EIPOD); European Community(European Commission)	The authors are grateful for financial support to E.B.G. in the course of this investigation from La Generalitat de Catalunya, Beatriu de Pinos Program (2006BP-A10108), from EMBL, Interdisciplinary Postdocs Program (EIPOD) and from the European Community, ASSEMBLE grant agreement number 227799. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Fuentes M, 2004, J EXP ZOOL PART B, V302B, P384, DOI 10.1002/jez.b.20025; Fuentes M, 2007, J EXP ZOOL PART B, V308B, P484, DOI 10.1002/jez.b.21179; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Holland LZ, 2011, METHODS MOL BIOL, V770, P423, DOI 10.1007/978-1-61779-210-6_16; Holland LZ, 2004, METHOD CELL BIOL, V74, P195; Kubokawa K, 2003, ZOOL SCI, V20, P889, DOI 10.2108/zsj.20.889; Li G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050838; Mizuta T, 2004, J EXP MAR BIOL ECOL, V309, P239, DOI 10.1016/j.jembe.2004.03.017; Onai T, 2010, DEV BIOL, V344, P377, DOI 10.1016/j.ydbio.2010.05.016; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Schubert M, 2005, DEVELOPMENT, V132, P61, DOI 10.1242/dev.01554; Schubert M, 2006, DEV BIOL, V296, P190, DOI 10.1016/j.ydbio.2006.04.457; Somorjai IML, 2008, AQUACULTURE, V281, P145, DOI 10.1016/j.aquaculture.2008.05.023; Theodosiou M, 2011, J EXP ZOOL PART B, V316B, P263, DOI 10.1002/jez.b.21397; Yamaguchi T, 2003, ZOOL SCI, V20, P907, DOI 10.2108/zsj.20.907; Yasui K, 2007, ZOOL SCI, V24, P514, DOI 10.2108/zsj.24.514; Yu JK, 2004, DEV BIOL, V274, P452, DOI 10.1016/j.ydbio.2004.07.010; Zhang QJ, 2007, J EXP ZOOL PART B, V308B, P464, DOI 10.1002/jez.b.21172; Zhang SC, 2001, OPHELIA, V54, P115, DOI 10.1080/00785236.2001.10409459	20	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71599	10.1371/journal.pone.0071599	http://dx.doi.org/10.1371/journal.pone.0071599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23990962	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800010
J	Iram, A; Alam, T; Khan, JM; Khan, TA; Khan, RH; Naeem, A				Iram, Afshin; Alam, Tauqeer; Khan, Javed M.; Khan, Taqi A.; Khan, Rizwan H.; Naeem, Aabgeena			Molten Globule of Hemoglobin Proceeds into Aggregates and Advanced Glycated End Products	PLOS ONE			English	Article							WHEAT-GERM; LOW PH; PROTEINS; FLUORESCENCE; STATE; ACID; METHYLGLYOXAL; CONFORMATION; SPECTROSCOPY; CELLULASE	Conformational alterations of bovine hemoglobin (Hb) upon sequential addition of glyoxal over a range of 0-90% v/v were investigated. At 20% v/v glyoxal, molten globule (MG) state of Hb was observed by altered tryptophan fluorescence, high ANS binding, existence of intact heme, native-like secondary structure as depicted by far-UV circular dichroism (CD) and ATR-FTIR spectra as well as loss in tertiary structure as confirmed by near-UV CD spectra. In addition, size exclusion chromatography analysis depicted that MG state at 20% v/v glyoxal corresponded to expanded pre-dissociated dimers. Aggregates of Hb were detected at 70% v/v glyoxal. These aggregates of Hb had altered tryptophan environment, low ANS binding, exposed heme, increased beta-sheet secondary structure, loss in tertiary structure, enhanced thioflavin T (ThT) fluorescence and red shifted Congo Red (CR) absorbance. On incubating Hb with 30% v/v glyoxal for 0-20 days, advanced glycation end products (AGEs) were detected on day 20. These AGEs were characterised by enhanced tryptophan fluorescence at 450 nm, exposure of heme, increase in intermolecular beta-sheets, enhanced ThT fluorescence and red shift in CR absorbance. Comet assay revealed aggregates and AGEs to be genotoxic in nature. Scanning electron microscopy confirmed the amorphous structure of aggregates and branched fibrils of AGEs. The transformation of alpha-helix to beta-sheet usually alters the normal protein to amyloidogenic resulting in a variety of protein conformational disorders such as diabetes, prion and Huntington's.	[Iram, Afshin; Alam, Tauqeer; Khan, Taqi A.; Naeem, Aabgeena] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh, Uttar Pradesh, India; [Khan, Javed M.; Khan, Rizwan H.] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Naeem, A (corresponding author), Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh, Uttar Pradesh, India.	aabgeenanaim@gmail.com	khan, Javed Masood/AAZ-8079-2021; Khan, Rizwan/GXZ-5789-2022; Khan, Rizwan Hasan/F-8276-2014; Khan, Taqi Ahmed/I-3300-2019	khan, Javed Masood/0000-0003-0567-5712; Khan, Rizwan Hasan/0000-0002-9965-8982; Khan, Taqi Ahmed/0000-0002-1367-2311	CSIR (Council of Scientific and Industrial Research) [37(1365)/09/EMR-II]; UGC-SRF	CSIR (Council of Scientific and Industrial Research)(Council of Scientific & Industrial Research (CSIR) - India); UGC-SRF(University Grants Commission, India)	Financial support received from the CSIR (Council of Scientific and Industrial Research) (37(1365)/09/EMR-II) in the form of project is gratefully acknowledged. AI is a recipient of UGC-SRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Ahmad E, 2010, BIOCHIMIE, V92, P885, DOI 10.1016/j.biochi.2010.03.023; Bom APDA, 2010, J BIOL CHEM, V285, P2857, DOI 10.1074/jbc.M109.075861; Bakhti M, 2007, J BIOCHEM, V141, P827, DOI 10.1093/jb/mvm096; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Booth AA, 1997, J BIOL CHEM, V272, P5430, DOI 10.1074/jbc.272.9.5430; BOYIRI T, 1995, BIOCHEMISTRY-US, V34, P15021, DOI 10.1021/bi00046a008; BYCHKOVA VE, 1988, FEBS LETT, V238, P231, DOI 10.1016/0014-5793(88)80485-X; Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752; Chung HS, 2004, J PHYS CHEM B, V108, P15332, DOI 10.1021/jp0479926; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Gomes R, 2005, BIOCHEM J, V385, P339, DOI 10.1042/BJ20040833; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; GRYCZYNSKI Z, 1995, J BIOL CHEM, V270, P19232, DOI 10.1074/jbc.270.33.19232; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; HAYNES R, 1967, BIOCHEMISTRY-US, V6, P541, DOI 10.1021/bi00854a023; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Iram A, 2013, ARCH BIOCHEM BIOPHYS, V533, P69, DOI 10.1016/j.abb.2013.02.019; Iram A, 2013, INT J BIOL MACROMOL, V52, P286, DOI 10.1016/j.ijbiomac.2012.10.023; Iram A, 2012, INT J BIOL MACROMOL, V50, P932, DOI 10.1016/j.ijbiomac.2012.02.012; Iram A, 2012, J FLUORESC, V22, P47, DOI 10.1007/s10895-011-0929-9; KELLETT GL, 1971, J MOL BIOL, V59, P387, DOI 10.1016/0022-2836(71)90306-8; Khan TA, 2012, AMINO ACIDS, V43, P1311, DOI 10.1007/s00726-011-1204-8; Khodarahmi R, 2009, PROTEIN J, V28, P349, DOI 10.1007/s10930-009-9200-5; Khurana R, 2001, J BIOL CHEM, V276, P22715, DOI 10.1074/jbc.M011499200; Kumar MS, 2004, BIOCHEM J, V379, P273, DOI 10.1042/BJ20031633; LINTNER K, 1979, BIOCHEM BIOPH RES CO, V91, P803, DOI 10.1016/0006-291X(79)91951-X; Naeem A, 2011, CELL BIOCHEM BIOPHYS, V61, P237, DOI 10.1007/s12013-011-9200-x; Nagy A, 2009, CZECH J FOOD SCI, V27, P320, DOI 10.17221/48/2008-CJFS; Nath D, 2001, BIOCHEM BIOPH RES CO, V288, P1218, DOI 10.1006/bbrc.2001.5918; PAN WP, 1991, J BIOMED ENG, V13, P415, DOI 10.1016/0141-5425(91)90023-Z; Pawar SA, 2002, EUR J BIOCHEM, V26, P76331; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; RAJENDRAN S, 1990, INDIAN J BIOCHEM BIO, V27, P300; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; SEGNITZ B, 1995, P NATL ACAD SCI USA, V92, P2179, DOI 10.1073/pnas.92.6.2179; Sen S, 2005, BIOPHYS CHEM, V113, P289, DOI 10.1016/j.bpc.2004.05.005; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; STRYER L, 1968, SCIENCE, V162, P526, DOI 10.1126/science.162.3853.526; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Wang YQ, 2007, INT J BIOL MACROMOL, V41, P243, DOI 10.1016/j.ijbiomac.2007.02.011	44	71	72	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72075	10.1371/journal.pone.0072075	http://dx.doi.org/10.1371/journal.pone.0072075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991043	Green Published, gold, Green Submitted			2022-12-25	WOS:000324228800043
J	Kruschitz, R; Wallner-Liebmann, SJ; Hamlin, MJ; Moser, M; Ludvik, B; Schnedl, WJ; Tafeit, E				Kruschitz, Renate; Wallner-Liebmann, Sandra J.; Hamlin, Michael J.; Moser, Maximilian; Ludvik, Bernhard; Schnedl, Wolfgang J.; Tafeit, Erwin			Detecting Body Fat-A Weighty Problem BMI versus Subcutaneous Fat Patterns in Athletes and Non-Athletes	PLOS ONE			English	Article							ADIPOSE-TISSUE TOPOGRAPHY; TYPE-2 DIABETIC MEN; MASS INDEX; SAT-TOP; QUETELET INDEX; OPTICAL-DEVICE; OVERWEIGHT; PERCENTAGE; OBESITY; WOMEN	We aimed to describe the relationship between BMI and the subcutaneous adipose tissue topography within young athletes and non-athletic controls, to comparatively evaluate the diagnostic powers of subcutaneous adipose tissue thicknesses at different body sites, furthermore to explore appropriate cut-offs to discriminate between athletes and controls. Measurements were determined in 64 males and 42 females, who were subsequently separated into two even groups (athletes and non-athletes). The optical device LIPOMETER was applied at standardised body sites to measure the thickness of subcutaneous adipose tissue layers. To calculate the power of the different body sites and the BMI to discriminate between athletes and non-athletes, receiver operating characteristic curve analysis was performed. In men, the neck (optimal cut-off value 2.3 mm) and trunk (optimal cut-off value 15.5 mm) provided the strongest discrimination power: with 90.6% (58 of 64) of the subjects being correctly classified into athletes or non-athletes. Discrimination power of the BMI values was 64.1% (41 of 64 were correctly classified). In women, the upper back (optimal cut-off value 3.3 mm) and arms (optimal cut-off value 15.9 mm) provided the strongest discrimination power with 88.1% (37 of 42 being correctly classified). When using BMI to discriminate between athletes and non-athletes only 52.4% (22 of 42) were correctly classified. These results suggest that compared to BMI levels, subcutaneous fat patterns are a more accurate way of discriminating between athletes and non-athletes. In particular the neck and the trunk compartment in men and the upper back and arms compartment in women, were the best sites to discriminate between young athletes and non-athletes on the basis of their fat patterns.	[Kruschitz, Renate; Ludvik, Bernhard] Med Univ Vienna, Clin Internal Med 3, Dept Endocrinol & Metab, Vienna, Austria; [Kruschitz, Renate; Wallner-Liebmann, Sandra J.] Med Univ Graz, Inst Pathophysiol & Immunol, Graz, Austria; [Kruschitz, Renate] SIPCAN Special Inst Prevent Cardiol & Nutr, Salzburg, Austria; [Hamlin, Michael J.] Lincoln Univ, Environm Soc & Design Fac, Christchurch, New Zealand; [Moser, Maximilian] Med Univ Graz, Inst Physiol, Graz, Austria; [Kruschitz, Renate; Tafeit, Erwin] Med Univ Graz, Inst Physiol Chem, Graz, Austria	Medical University of Vienna; Medical University of Graz; Lincoln University - New Zealand; Medical University of Graz; Medical University of Graz	Wallner-Liebmann, SJ (corresponding author), Med Univ Graz, Inst Pathophysiol & Immunol, Graz, Austria.	Sandra.wallner@medunigraz.at	Hamlin, Michael/D-7513-2018; Moser, Maximilian/J-6105-2014	Hamlin, Michael/0000-0001-7941-8554; Schnedl, Wolfgang/0000-0002-5212-5230; Holasek, Sandra/0000-0002-2958-3516; Moser, Maximilian/0000-0001-9292-5091				ACSM, 2006, ACSMS GUID EX TEST P, P57; Blew RM, 2002, OBES RES, V10, P799, DOI 10.1038/oby.2002.108; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Curtin F, 1997, J CLIN EPIDEMIOL, V50, P837, DOI 10.1016/S0895-4356(97)00063-2; Dudeja V, 2001, BRIT J NUTR, V86, P105, DOI 10.1079/BJN2001382; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; GARROW JS, 1985, INT J OBESITY, V9, P147; Goh VHH, 2004, J LIPID RES, V45, P1892, DOI 10.1194/jlr.M400159-JLR200; Heo M, 2012, AM J CLIN NUTR, V95, P594, DOI 10.3945/ajcn.111.025171; Heymsfield SB, 2009, INT J OBESITY, V33, P1363, DOI 10.1038/ijo.2009.184; Heymsfield SB, 2005, HDB OBESITY ETIOLOGY, P33; Ho-Pham Lan T, 2011, Mayo Clin Proc, V86, P584, DOI 10.4065/mcp.2011.0097; Horejsi R, 2002, EXP BIOL MED, V227, P794, DOI 10.1177/153537020222700911; HORTOBAGYI T, 1994, EUR J CLIN NUTR, V48, P369; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; Jurimae T, 2005, COLLEGIUM ANTROPOL, V29, P499; MALINA RM, 1982, MED SCI SPORT EXER, V14, P445, DOI 10.1249/00005768-198206000-00007; Moller R, 2000, AM J HUM BIOL, V12, P231, DOI 10.1002/(SICI)1520-6300(200003/04)12:2<231::AID-AJHB9>3.0.CO;2-X; Moon JR, 2009, EUR J APPL PHYSIOL, V105, P119, DOI 10.1007/s00421-008-0881-9; MUELLER WH, 1986, HUM BIOL, V58, P955; Nevill AM, 2006, AM J PHYS ANTHROPOL, V129, P151, DOI 10.1002/ajpa.20262; Ode JJ, 2007, MED SCI SPORT EXER, V39, P403, DOI 10.1249/01.mss.0000247008.19127.3e; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Prentice A M, 2001, Obes Rev, V2, P141, DOI 10.1046/j.1467-789x.2001.00031.x; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; SEIDELL JC, 1989, INFUSIONSTHERAPIE, V16, P276; SMALLEY KJ, 1990, AM J CLIN NUTR, V52, P405, DOI 10.1093/ajcn/52.3.405; Sudi KM, 2000, AM J HUM BIOL, V12, P803, DOI 10.1002/1520-6300(200011/12)12:6<803::AID-AJHB8>3.0.CO;2-0; Tafeit E, 2000, AM J PHYS ANTHROPOL, V113, P381, DOI 10.1002/1096-8644(200011)113:3<381::AID-AJPA8>3.0.CO;2-T; Tafeit E, 1999, ARTIF INTELL MED, V17, P181, DOI 10.1016/S0933-3657(99)00017-2; Tafeit E, 2003, EXP BIOL MED, V228, P710, DOI 10.1177/153537020322800610; Tafeit E, 2001, AM J PHYS ANTHROPOL, V115, P57, DOI 10.1002/ajpa.1056; Tafeit E, 2000, AM J HUM BIOL, V12, P388, DOI 10.1002/(SICI)1520-6300(200005/06)12:3<388::AID-AJHB9>3.3.CO;2-T; Tafeit E, 2008, COLLEGIUM ANTROPOL, V32, P607; Tafeit E, 2009, COLLEGIUM ANTROPOL, V33, P391; Torstveit MK, 2012, MED SCI SPORT EXER, V44, P949, DOI 10.1249/MSS.0b013e31823fe4ef; Vikram NK, 2003, DIABETES NUTR METAB, V16, P32; Wallner SJ, 2004, INT J OBESITY, V28, P1143, DOI 10.1038/sj.ijo.0802736; Wellens RI, 1996, OBES RES, V4, P35, DOI 10.1002/j.1550-8528.1996.tb00510.x; Witt KA, 2005, J AM DIET ASSOC, V105, P599, DOI 10.1016/j.jada.2005.01.008; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	41	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72002	10.1371/journal.pone.0072002	http://dx.doi.org/10.1371/journal.pone.0072002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991025	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800035
J	Hirata, RP; Jorgensen, TS; Rosager, S; Arendt-Nielsen, L; Bliddal, H; Henriksen, M; Graven-Nielsen, T				Hirata, Rogerio Pessoto; Jorgensen, Tanja Schjodt; Rosager, Sara; Arendt-Nielsen, Lars; Bliddal, Henning; Henriksen, Marius; Graven-Nielsen, Thomas			Altered Visual and Feet Proprioceptive Feedbacks during Quiet Standing Increase Postural Sway in Patients with Severe Knee Osteoarthritis	PLOS ONE			English	Article							EXPERIMENTAL MUSCLE PAIN; OLDER-ADULTS; BALANCE; STRENGTH; RISK; STABILITY; OBESITY; STANCE; STIMULATION; ORIENTATION	Objective: The objective was to investigate how postural control in knee osteoarthritis (KOA) patients, with different structural severities and pain levels, is reorganized under different sensory conditions. Methods: Forty-two obese patients (BMI range from 30.1 to 48.7 kg*m(-2), age range from 50 to 74 years) with KOA were evaluated. One minute of quiet standing was assessed on a force platform during 4 different sensory conditions, applied 3 times at random: Eyes open (EO) and eyes closed (EC) standing on firm and soft (foam) surfaces (EO-soft and EC-soft). Centre of pressure (Cop) standard deviation, speed, range and Cop mean position in both directions (anterior-posterior and medial-lateral) were extracted from the force platform data. Structural disease severity was assessed from semiflexed standing radiographs and graded by the Kellgren and Lawrence (KL) score. Pain intensity immediately before the measurements was assessed by numeric rating scale (range: 0-10). Results: The patients were divided into "less severe'' (KL 1 and 2, n = 24) and "severe'' (KL>2, n = 18) group. The CoP range in the medial-lateral direction was larger in the severe group when compared with the less severe group during EC-soft condition (P<0.01). Positive correlation between pain intensity and postural sway (range in medial-lateral direction) was found during EC condition, indicating that the higher the pain intensity, the less effective is the postural control applied to restore an equilibrium position while standing without visual information. Conclusion: The results support that: (i) the postural reorganization under manipulation of the different sensory information is worse in obese KOA patients with severe degeneration and/or high pain intensity when compared with less impaired patients, and (ii) higher pain intensity is related to worse body balance in obese KOA patients.	[Hirata, Rogerio Pessoto; Jorgensen, Tanja Schjodt; Arendt-Nielsen, Lars; Graven-Nielsen, Thomas] Aalborg Univ, Fac Med, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, Aalborg, Denmark; [Jorgensen, Tanja Schjodt; Rosager, Sara; Bliddal, Henning; Henriksen, Marius] Copenhagen Univ Hosp, Clin Motor Funct Lab, Parker Inst, Frederiksberg, Denmark	Aalborg University; University of Copenhagen	Graven-Nielsen, T (corresponding author), Aalborg Univ, Fac Med, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, Aalborg, Denmark.	tgn@hst.aau.dk	Arendt-Nielsen, Lars/T-4885-2018; Hirata, Rogerio Pessoto/G-8371-2011; Henriksen, Marius/ABD-7887-2020; Bliddal, Henning/AAB-3168-2019	Hirata, Rogerio Pessoto/0000-0002-9943-2713; Henriksen, Marius/0000-0003-1091-2962; Bliddal, Henning/0000-0002-7951-1668; Arendt-Nielsen, Lars/0000-0003-0892-1579; Graven-Nielsen, Thomas/0000-0002-7787-4860	Danish Ministry of Health and Prevention; Oak Foundation	Danish Ministry of Health and Prevention; Oak Foundation	Funded by The Danish Ministry of Health and Prevention and The Oak Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Baloh RW, 1998, ARCH NEUROL-CHICAGO, V55, P649, DOI 10.1001/archneur.55.5.649; Blouin JS, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-23; Cicuttini FM, 1997, J RHEUMATOL, V24, P1164; Ciubotariu A, 2007, EXP BRAIN RES, V181, P147, DOI 10.1007/s00221-007-0913-4; Corbeil P, 2004, PAIN, V108, P43, DOI 10.1016/j.pain.2003.12.001; Corbeil P, 2001, IEEE T NEUR SYS REH, V9, P126, DOI 10.1109/7333.928572; Davis M A, 1988, Clin Geriatr Med, V4, P241; DAVIS MA, 1989, AM J EPIDEMIOL, V130, P278, DOI 10.1093/oxfordjournals.aje.a115334; de Freitas PB, 2009, HUM MOVEMENT SCI, V28, P515, DOI 10.1016/j.humov.2009.02.001; Dutil M, 2012, AGE DORDR; Felson DT, 2009, ARTHRIT RHEUM-ARTHR, V61, P1070, DOI 10.1002/art.24606; FELSON DT, 1988, EPIDEMIOL REV, V10, P1; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; Foley SJ, 2006, OSTEOARTHR CARTILAGE, V14, P533, DOI 10.1016/j.joca.2005.12.007; Graven-Nielsen T, 2002, MUSCLE NERVE, V26, P708, DOI 10.1002/mus.10225; Gudbergsen H, 2013, OSTEOARTHRI IN PRESS; Handrigan GA, 2010, J BIOMECH, V43, P383, DOI 10.1016/j.jbiomech.2009.08.041; Hassan BS, 2002, ANN RHEUM DIS, V61, P422, DOI 10.1136/ard.61.5.422; Hassan BS, 2001, ANN RHEUM DIS, V60, P612, DOI 10.1136/ard.60.6.612; Hay L, 1996, EXP BRAIN RES, V108, P129; Henriksen M, 2012, KNEE, V19, P392, DOI 10.1016/j.knee.2011.07.003; Henriksen M, 2011, J PAIN, V12, P460, DOI 10.1016/j.jpain.2010.10.004; Hinman RS, 2002, RHEUMATOLOGY, V41, P1388, DOI 10.1093/rheumatology/41.12.1388; Hirata RP, 2012, EUR J APPL PHYSIOL, V112, P2511, DOI 10.1007/s00421-011-2226-3; Hirata RP, 2011, J PAIN, V12, P911, DOI 10.1016/j.jpain.2011.02.356; Hirata RP, 2010, CLIN BIOMECH, V25, P931, DOI 10.1016/j.clinbiomech.2010.06.001; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Horak FB, 2010, RESTOR NEUROL NEUROS, V28, P57, DOI 10.3233/RNN-2010-0515; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; Hurley MV, 1997, ANN RHEUM DIS, V56, P641, DOI 10.1136/ard.56.11.641; Isbagio Harry, 2004, Acta Med Indones, V36, P87; Jadelis K, 2001, J AM GERIATR SOC, V49, P884, DOI 10.1046/j.1532-5415.2001.49178.x; Jeka JJ, 1996, PERCEPT PSYCHOPHYS, V58, P409, DOI 10.3758/BF03206817; Jeka JJ, 2008, EXP BRAIN RES, V191, P453, DOI 10.1007/s00221-008-1539-x; LICHTENSTEIN MJ, 1988, J AM GERIATR SOC, V36, P996, DOI 10.1111/j.1532-5415.1988.tb04365.x; Lin SI, 2002, J MOTOR BEHAV, V34, P37, DOI 10.1080/00222890209601929; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Masui T, 2006, J ORTHOP SCI, V11, P353, DOI 10.1007/s00776-006-1034-9; Messier SP, 2002, ARTHRIT RHEUM-ARTHR, V47, P141, DOI 10.1002/art.10339; Mignardot JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014387; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Pai YC, 2000, J BIOMECH, V33, P387, DOI 10.1016/S0021-9290(99)00199-2; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Riecke BF, 2012, OSTEOARTHR CARTILAGE, V18, P746; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Shakoor N., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P35; Stelmach G E, 1985, Clin Geriatr Med, V1, P679; STELMACH GE, 1989, INT J AGING HUM DEV, V29, P205, DOI 10.2190/KKP0-W3Q5-6RDN-RXYT; Strang AJ, 2011, EUR J APPL PHYSIOL, V111, P1485, DOI 10.1007/s00421-010-1770-6; TEASDALE N, 1991, J GERONTOL, V46, pB238, DOI 10.1093/geronj/46.6.B238; Teasdale N, 2001, GAIT POSTURE, V14, P203, DOI 10.1016/S0966-6362(01)00134-5; Van der Kooij H, 2001, BIOL CYBERN, V84, P103, DOI 10.1007/s004220000196; Wegener L, 1997, J ORTHOP SPORT PHYS, V25, P13, DOI 10.2519/jospt.1997.25.1.13; Weiler HT, 2000, RHEUMATOLOGY, V39, P850, DOI 10.1093/rheumatology/39.8.850; WHIPPLE R, 1993, J GERONTOL, V48, P71, DOI 10.1093/geronj/48.Special_Issue.71; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X	58	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e71253	10.1371/journal.pone.0071253	http://dx.doi.org/10.1371/journal.pone.0071253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23990940	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470700012
J	Li, J; Sun, H; Jin, L; Cao, W; Zhang, J; Guo, CY; Ding, K; Luo, C; Ye, WC; Jiang, RW				Li, Juan; Sun, Hua; Jin, Lu; Cao, Wei; Zhang, Jin; Guo, Chong-Yi; Ding, Ke; Luo, Cheng; Ye, Wen-Cai; Jiang, Ren-Wang			Alleviation of Podophyllotoxin Toxicity Using Coexisting Flavonoids from Dysosma versipellis	PLOS ONE			English	Article							MICROTUBULE POLYMERIZATION; CARDIOVASCULAR-DISEASE; ARYLTETRALIN LIGNANS; OXIDATIVE STRESS; NATURAL-PRODUCTS; GENE-EXPRESSION; IN-VITRO; QUERCETIN; CANCER; MECHANISMS	Podophyllotoxin (POD) is a lignan-type toxin existing in many herbs used in folk medicine. Until now, no effective strategy is available for the management of POD intoxication. This study aims to determine the protective effects of avonoids (quercetin and kaempferol) on POD-induced toxicity. In Vero cells, both avonoids protected POD-induced cytotoxicity by recovering alleviating G2/M arrest, decreasing ROS generation and changes of membrane potential, and recovering microtubule structure. In Swiss mice, the group given both POD and avonoids group had significantly lower mortality rate and showed less damages in the liver and kidney than the group given POD alone. As compared to the POD group, the POD plus avonoids group exhibited decreases in plasma transaminases, alkaline phosphatase, lactate dehydrogenase, plasma urea, creatinine and malondialdehyde levels, and increases in superoxide dismutase and glutathione levels. Histological examination of the liver and kidney showed less pathological changes in the treatment of POD plus avonoids group. The protective mechanisms were due to the antioxidant activity of avonoids against the oxidative stress induced by POD and the competitive binding of avonoids against POD for the same colchicines-binding sites. The latter binding was confirmed by the tubulin assembly assay in combination with molecular docking analyses. In conclusion, this study for the first time demonstrated that the coexisting flavonoids have great protective effects against the POD toxicity, and results of this study highlighted the great potential of searching for effective antidotes against toxins based on the pharmacological clues.	[Li, Juan; Sun, Hua; Jin, Lu; Cao, Wei; Guo, Chong-Yi; Ye, Wen-Cai; Jiang, Ren-Wang] Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Guangzhou, Guangdong, Peoples R China; [Li, Juan] Hubei Univ Tradit Chinese Med, Key Lab Tradit Chinese Med Resource & Compound Pr, Wuhan, Peoples R China; [Jin, Lu; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab New Drug Res, Shanghai 200031, Peoples R China; [Zhang, Jin; Ding, Ke] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China	Jinan University; Hubei University of Chinese Medicine; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Jiang, RW (corresponding author), Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Guangzhou, Guangdong, Peoples R China.	trwjiang@jnu.edu.cn		Li, Juan/0000-0002-9838-0990; ding, ke/0000-0001-8167-0476; Ding, Ke/0000-0001-9016-812X	National Natural Science Foundation of China [21072078]; Doctoral Fund of Ministry of Education of China [20114401110005]; Guangdong High Level Talent Scheme; Fundamental Research Funds for the Central Universities [21612603, 21611398]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Guangdong High Level Talent Scheme; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This project was supported by National Natural Science Foundation of China (21072078), Doctoral Fund of Ministry of Education of China (20114401110005), Guangdong High Level Talent Scheme to RWJ and the Fundamental Research Funds for the Central Universities (21612603 and 21611398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Bestwick CS, 2005, BBA-MOL BASIS DIS, V1740, P340, DOI 10.1016/j.bbadis.2004.10.005; Botta B, 2001, CURR MED CHEM, V8, P1363, DOI 10.2174/0929867013372292; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Canel C, 2000, PHYTOCHEMISTRY, V54, P115, DOI 10.1016/S0031-9422(00)00094-7; Charlton JL, 1998, J NAT PROD, V61, P1447, DOI 10.1021/np980136z; Chatelut E, 2003, INVEST NEW DRUG, V21, P141, DOI 10.1023/A:1023565227808; Chen JC, 2005, EUR J PHARMACOL, V521, P9, DOI 10.1016/j.ejphar.2005.08.005; Chen Y, 2004, CHIN J PRIM MED PHAR, V11, P1330; Chou SL, 2008, CLIN TOXICOL, V46, P159, DOI 10.1080/15563650701397159; Coseri S, 2009, MINI-REV MED CHEM, V9, P560, DOI 10.2174/138955709788167592; Couchoud C, 1999, KIDNEY INT, V55, P1878, DOI 10.1046/j.1523-1755.1999.00411.x; de Boer VCJ, 2005, J NUTR, V135, P1718, DOI 10.1093/jn/135.7.1718; DOBB GJ, 1984, MED J AUSTRALIA, V140, P495, DOI 10.5694/j.1326-5377.1984.tb108174.x; Fang J, 2003, CHIN COMMUNITY DOCTO, V19, P46; FELICIANO AS, 1993, PLANTA MED, V59, P246, DOI 10.1055/s-2006-959660; FILLEY CM, 1982, NEUROLOGY, V32, P308, DOI 10.1212/WNL.32.3.308; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gamblin TC, 1996, BIOCHEMISTRY-US, V35, P12576, DOI 10.1021/bi961135d; Gao R, 2004, PEST MANAG SCI, V60, P1131, DOI 10.1002/ps.922; Gong X., 2006, J APOPLEXY NERV DIS, V27, P14; Graf BA, 2005, J MED FOOD, V8, P281, DOI 10.1089/jmf.2005.8.281; Gupta K, 2004, BIOCHEMISTRY-US, V43, P6645, DOI 10.1021/bi036112v; Gupta K, 2002, BIOCHEMISTRY-US, V41, P13029, DOI 10.1021/bi025952r; HANEMAAIJER R, 1991, J NEUROSCI RES, V30, P163, DOI 10.1002/jnr.490300117; Huang WW, 2013, INT J ONCOL, V42, P2069, DOI 10.3892/ijo.2013.1909; JACKSON DE, 1985, PHYTOCHEMISTRY, V24, P2407, DOI 10.1016/S0031-9422(00)83052-6; Jiang RW, 2007, J NAT PROD, V70, P283, DOI 10.1021/np060430o; Jiang RW, 2005, PHYTOCHEMISTRY, V66, P2674, DOI 10.1016/j.phytochem.2005.09.028; JORDAN MA, 1992, J CELL SCI, V102, P401; Kalender Y, 2012, ENVIRON TOXICOL PHAR, V33, P141, DOI 10.1016/j.etap.2011.12.008; KANDASWAMI C, 1994, ADV EXP MED BIOL, V366, P351; KAO WF, 1992, HUM EXP TOXICOL, V11, P480, DOI 10.1177/096032719201100607; Knowles LM, 2000, NUTR CANCER, V38, P116, DOI 10.1207/S15327914NC381_16; Kumar A, 2008, PHYTOTHER RES, V22, P1563, DOI 10.1002/ptr.2454; Kumar R, 2011, J NUTR BIOCHEM, V22, P723, DOI 10.1016/j.jnutbio.2010.06.003; Li J, 2012, TOXICOL APPL PHARM, V265, P190, DOI 10.1016/j.taap.2012.10.010; Liang M, 2010, J MED PLANTS RES, V4, P717; Lobert S, 1996, BIOCHEMISTRY-US, V35, P6806, DOI 10.1021/bi953037i; Ma C, 1993, Yao Xue Xue Bao, V28, P690; Mack TGA, 2000, MOL CELL NEUROSCI, V15, P51, DOI 10.1006/mcne.1999.0802; Magedov IV, 2007, BIOORG MED CHEM LETT, V17, P1381, DOI 10.1016/j.bmcl.2006.11.095; McCullough ML, 2011, CANCER EPIDEM BIOMAR, V20, P1089, DOI 10.1158/1055-9965.EPI-10-1173; Mink PJ, 2007, AM J CLIN NUTR, V85, P895, DOI 10.1093/ajcn/85.3.895; Morales AI, 2006, FOOD CHEM TOXICOL, V44, P2092, DOI 10.1016/j.fct.2006.07.012; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murota K, 2000, ARCH BIOCHEM BIOPHYS, V384, P391, DOI 10.1006/abbi.2000.2123; Naik SR, 2011, EXP TOXICOL PATHOL, V63, P419, DOI 10.1016/j.etp.2010.03.001; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Panemangalore M, 2009, J ENVIRON SCI HEAL B, V44, P357, DOI 10.1080/03601230902801034; Raucy JL, 2003, DRUG METAB DISPOS, V31, P533, DOI 10.1124/dmd.31.5.533; Remesh A., 2012, INT J BASIC CLIN PHA, V1, P2, DOI [10.5455/2319-2003.ijbcp000812, DOI 10.5455/2319-2003.IJBCP000812]; ROSSER BG, 1995, GASTROENTEROLOGY, V108, P252, DOI 10.1016/0016-5085(95)90032-2; Sadowska-Woda I, 2010, TOXICOL IN VITRO, V24, P460, DOI 10.1016/j.tiv.2009.09.024; Samanta A., 2011, CARBON, V100, P12; Samuel T, 2010, NUTR CANCER, V62, P1025, DOI 10.1080/01635581.2010.492087; Shin SY, 2010, CANCER LETT, V287, P231, DOI 10.1016/j.canlet.2009.06.019; Silva B, 2008, NEUROTOX RES, V13, P265, DOI 10.1007/BF03033510; Singh D, 2004, ARCH MED RES, V35, P484, DOI 10.1016/j.arcmed.2004.10.004; Smith A, 1998, DANCE MAG, V72, P101; Tomlinson TR, 1998, MED PLANTS THEIR ROL; Touil YS, 2009, NUTR CANCER, V61, P310, DOI 10.1080/01635580802521346; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; UENO I, 1983, JPN J EXP MED, V53, P41; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walle T, 2007, EXPERT OPIN DRUG MET, V3, P379, DOI 10.1517/17425255.3.3.379; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Yamasaki H, 1997, PLANT PHYSIOL, V115, P1405, DOI 10.1104/pp.115.4.1405; Yang C. M., 1994, Biomedical and Environmental Sciences, V7, P259; You YJ, 2005, CURR PHARM DESIGN, V11, P1695, DOI 10.2174/1381612053764724; Yousef MI, 2010, FOOD CHEM TOXICOL, V48, P3246, DOI 10.1016/j.fct.2010.08.034; Zhang QY, 2005, TOXICOLOGY, V212, P46, DOI 10.1016/j.tox.2005.04.006; Zhang ZJ, 2011, INT J MOL MED, V27, P195, DOI 10.3892/ijmm.2010.571; Zhou Y, 2008, CHROMATOGRAPHIA, V68, P781, DOI 10.1365/s10337-008-0786-0; 金钟大, 2003, [中国中药杂志, China Journal of Chinese Materia Medica], V28, P477; 李湘力, 2007, [中国针灸, Chinese Acupuncture and Moxibustion], V27, P114	77	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72099	10.1371/journal.pone.0072099	http://dx.doi.org/10.1371/journal.pone.0072099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991049	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100079
J	Saul, H; Madella, M; Fischer, A; Glykou, A; Hartz, S; Craig, OE				Saul, Hayley; Madella, Marco; Fischer, Anders; Glykou, Aikaterini; Hartz, Soenke; Craig, Oliver E.			Phytoliths in Pottery Reveal the Use of Spice in European Prehistoric Cuisine	PLOS ONE			English	Article							RICE DOMESTICATION; AGRICULTURE; CUCURBITA; PRODUCTS; MAIZE; CHINA	Here we present evidence of phytoliths preserved in carbonised food deposits on prehistoric pottery from the western Baltic dating from 6,100 cal BP to 5750 cal BP. Based on comparisons to over 120 European and Asian species, our observations are consistent with phytolith morphologies observed in modern garlic mustard seed (Alliaria petiolata (M. Bieb) Cavara & Grande). As this seed has a strong flavour, little nutritional value, and the phytoliths are found in pots along with terrestrial and marine animal residues, these findings are the first direct evidence for the spicing of food in European prehistoric cuisine. Our evidence suggests a much greater antiquity to the spicing of foods than is evident from the macrofossil record, and challenges the view that plants were exploited by hunter-gatherers and early agriculturalists solely for energy requirements, rather than taste.	[Saul, Hayley; Craig, Oliver E.] Univ York, BioArCh, York, N Yorkshire, England; [Madella, Marco] Spanish Natl Res Council, Inst Catalana Recerca & Estudis Avancats, Inst Mila & Fontanals, Barcelona, Spain; [Fischer, Anders] Danish Agcy Culture, Copenhagen, Denmark; [Glykou, Aikaterini] Univ Kiel, Inst Prehist & Protohist Archaeol, Kiel, Germany; [Hartz, Soenke] Stiftung Schleswig Holstein Landesmuseen, Schloss Gottorf, Schleswig, Germany	University of York - UK; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institucion Mila y Fontanals (IMF); ICREA; University of Kiel	Saul, H (corresponding author), Univ York, BioArCh, York, N Yorkshire, England.		Madella, Marco/M-3320-2014; Fischer, Anders/AAC-7579-2020	Madella, Marco/0000-0002-9324-1545; Fischer, Anders/0000-0003-0852-5904; Saul, Hayley/0000-0001-9764-7115; Glykou, Aikaterini/0000-0002-3382-1177	Arts and Humanities Research Council (AHRC) [AH/E008232/1]; Arts and Humanities Research Council [AH/E008232/1] Funding Source: researchfish; AHRC [AH/E008232/1] Funding Source: UKRI; ICREA Funding Source: Custom	Arts and Humanities Research Council (AHRC); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); ICREA(ICREA)	The Baltic Forgaers and Early Farmers Ceramic Research Project is an Arts and Humanities Research Council (AHRC) funded project (AH/E008232/1). The AHRC website can be found at http://www.ahrc.ac.uk/Pages/Home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MS, 2013, J ARCHAEOL SCI, V40, P2799, DOI 10.1016/j.jas.2013.02.011; Andrews A. C., 1949, CP, V44, P91; [Anonymous], 1999, WEALTH NATIONS BOOKS; Chandler-Ezell K, 2006, ECON BOT, V60, P103, DOI 10.1663/0013-0001(2006)60[103:RATPAS]2.0.CO;2; Craig OE, 2007, ARCHAEOMETRY, V49, P135, DOI 10.1111/j.1475-4754.2007.00292.x; Craig OE, 2011, P NATL ACAD SCI USA, V108, P17910, DOI 10.1073/pnas.1107202108; Dick M., 1991, NEW LIGHT EARLY FARM, P257; Dudd SN, 1998, SCIENCE, V282, P1478, DOI 10.1126/science.282.5393.1478; Fischer A, 2003, RADIOCARBON, V45, P449, DOI 10.1017/S003382220003280X; Fischer A., 2002, NEOLITHISATION DENMA, P343; Fischer A, 2007, J ARCHAEOL SCI, V34, P2125, DOI 10.1016/j.jas.2007.02.028; Freedman P.H., 2008, OUT E SPICES MEDIEVA; Hansel FA, 2004, TETRAHEDRON LETT, V45, P2999, DOI 10.1016/j.tetlet.2004.01.111; Hart JP, 2003, AM ANTIQUITY, V68, P619, DOI 10.2307/3557065; Hartz S., 2011, BERICHTE ROMISCH GER, V89, P241; Hillman G., 1975, P PREHIST SOC, V41, P70; Hopf, 2004, DOMESTICATION PLANTS; Kashyap A., 2010, ANTIQUITY, V84; Kislev M.E, 1988, ATIQOT, V18, P76; Koch E, 1998, KONGLIGE NORDISKE B; Liu L, 2007, HOLOCENE, V17, P1059, DOI 10.1177/0959683607085121; Liu L, 2011, J ARCHAEOL SCI, V38, P3524, DOI 10.1016/j.jas.2011.08.015; Livarda A, 2011, VEG HIST ARCHAEOBOT, V20, P143, DOI 10.1007/s00334-010-0273-z; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Lu HY, 2002, BOREAS, V31, P378, DOI 10.1080/030094802320942581; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Madella M, 2009, QUATERN INT, V193, P32, DOI 10.1016/j.quaint.2007.06.012; Mason L., 2004, FOOD CULTURE GREAT B; Mellart J, 1970, EXCAVATIONS HACILAR, V1; Mickleburgh HL, 2012, J ARCHAEOL SCI, V39, P2468, DOI 10.1016/j.jas.2012.02.020; Olsen J, 2009, BOREAS, V38, P458, DOI 10.1111/j.1502-3885.2009.00088.x; Piperno D. R., 2006, PHYTOLITH COMPREHENS; Piperno DR, 2000, J ARCHAEOL SCI, V27, P193, DOI 10.1006/jasc.1999.0443; Piperno DR, 2003, SCIENCE, V299, P1054, DOI 10.1126/science.1080365; Rosen A.M., 1992, PHYTOLITH SYSTEMATIC, P129; ROWLEYCONWY P, 1984, J ANTHROPOL ARCHAEOL, V3, P300, DOI 10.1016/0278-4165(84)90005-9; Saul H, 2012, J ARCHAEOL SCI, V39, P3483, DOI 10.1016/j.jas.2012.05.033; SCHULTZE-MOTEL J, 1979, Kulturpflanze, V27, P207; Simonetti G., 1990, SIMON SCHUSTERS GUID; Strabo, 1917, GEOGRAPHY STRABO; Turner J., 2004, SPICE HIST TEMPTATIO; Van Zeist W, 1984, PALAEOHISTORIA, V24, P165; Wasylikowa K., 1991, PROGR OLD WORLD PALA, P207; Whittle, 2007, EARLY NEOLITHIC GREA, P447; Zarrillo S, 2008, P NATL ACAD SCI USA, V105, P5006, DOI 10.1073/pnas.0800894105; Zhao Z.J., 2000, GEOARCHAEOLOGY, V15, P203, DOI [10.1002/(SICI)1520-6548(200002)15:23.0.CO;2-J, DOI 10.1002/(SICI)1520-6548(200002)15:2]; [No title captured]	48	24	24	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e70583	10.1371/journal.pone.0070583	http://dx.doi.org/10.1371/journal.pone.0070583			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	218YW	23990910	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100030
J	Chen, Y; Chatterjee, SS; Porcella, SF; Yu, YS; Otto, M				Chen, Yan; Chatterjee, Som S.; Porcella, Stephen F.; Yu, Yun-Song; Otto, Michael			Complete Genome Sequence of a Panton-Valentine Leukocidin-Negative Community-Associated Methicillin-Resistant Staphylococcus aureus Strain of Sequence type 72 from Korea	PLOS ONE			English	Article							VIRULENCE DETERMINANTS; SOUTH-KOREA; MRSA; INFECTION; USA300; GENES	In the past decade, community-associated (CA-) infections with methicillin-resistant Staphylococcus aureus (MRSA) have emerged throughout the world. Different CA-MRSA strains dominate in different geographical locations. Many CA-MRSA lineages contain genes coding for the Panton-Valentine leukocidin. However, the role of this leukotoxin in CA-MRSA pathogenesis is still controversial. The genome sequences of two key PVL-positive CA-MRSA strains (USA300, USA400) have been reported, but we lack information on the more recently found PVL-negative CA-MRSA strains. One such strain is the PVL-negative ST72, the main cause of CA-MRSA infections in Korea. Here, we report the entire genome sequence of CA-MRSA ST72 and analyze its gene content with a focus on virulence factors. Our results show that this strain does not have considerable differences in virulence factor content compared to other CA-MRSA strains (USA300, USA400), indicating that other toxins do not substitute for the lack of PVL in ST72. This finding is in accordance with the notion that differential expression of widespread virulence determinants, rather than the acquisition of additional virulence factors on mobile genetic elements, such as PVL, is responsible for the increased virulence of CA-compared to hospital-associated MRSA.	[Chen, Yan; Chatterjee, Som S.; Otto, Michael] Natl Inst Allergy & Infect Dis, US Natl Inst Hlth, Lab Human Bacterial Pathogenesis, Pathogen Mol Genet Sect, Bethesda, MD USA; [Chen, Yan; Yu, Yun-Song] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Infect Dis, Hangzhou 310027, Peoples R China; [Porcella, Stephen F.] Natl Inst Allergy & Infect Dis, US Natl Inst Hlth, Res Technol Branch, Genom Unit, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Zhejiang University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Otto, M (corresponding author), Natl Inst Allergy & Infect Dis, US Natl Inst Hlth, Lab Human Bacterial Pathogenesis, Pathogen Mol Genet Sect, Bethesda, MD USA.	motto@niaid.nih.gov	; Chen, Yan/U-1480-2018	Otto, Michael/0000-0002-2222-4115; Chen, Yan/0000-0002-7679-1713	Intramural Program of the NIAID [ZIA AI000904-12]; Ministry of Health of the People's Republic of China [201002021]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904, ZICAI001052] Funding Source: NIH RePORTER	Intramural Program of the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Health of the People's Republic of China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Intramural Program of the NIAID (ZIA AI000904-12); Ministry of Health of the People's Republic of China (no. 201002021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Bae IG, 2009, J CLIN MICROBIOL, V47, P3952, DOI 10.1128/JCM.01643-09; Daly KM, 2010, J BACTERIOL, V192, P1131, DOI 10.1128/JB.01375-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Lee SS, 2010, J CLIN MICROBIOL, V48, P311, DOI 10.1128/JCM.00297-09; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Otto M, 2013, BIOESSAYS, V35, P4, DOI 10.1002/bies.201200112; Otto M, 2012, CELL MICROBIOL, V14, P1513, DOI 10.1111/j.1462-5822.2012.01832.x; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Park C, 2009, J MED MICROBIOL, V58, P1314, DOI 10.1099/jmm.0.009688-0; Thurlow LR, 2013, CELL HOST MICROBE, V13, P100, DOI 10.1016/j.chom.2012.11.012; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; WIELAND B, 1994, J BACTERIOL, V176, P7719, DOI 10.1128/JB.176.24.7719-7726.1994	27	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72803	10.1371/journal.pone.0072803	http://dx.doi.org/10.1371/journal.pone.0072803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977354	Green Submitted, gold, Green Published			2022-12-25	WOS:000324527300098
J	Buchsbaum, BR; Erickson, DT; Kayser, AS				Buchsbaum, Bradley R.; Erickson, Drew T.; Kayser, Andrew S.			Decomposing Effects of Time on Task Reveals an Anteroposterior Gradient of Perceptual Decision Regions	PLOS ONE			English	Article							CORTEX; REPRESENTATIONS; MECHANISMS; SPEED; AREA	In perceptual decision making, the selection of an appropriate action depends critically on an organism's ability to use sensory inputs to accumulate evidence for a decision. However, differentiating decision-related processes from effects of "time on task'' can be difficult. Here we combine the response signal paradigm, in which the experimenter rather than the subject dictates the time of the response, and independent components analysis (ICA) to search for signatures consistent with time on task and decision making, respectively, throughout the brain. Using this novel approach, we identify two such independent components from BOLD activity related to a random dot motion task: one sensitive to the main effect of stimulus duration, and one to both the main effect of motion coherence and its interaction with duration. Furthermore, we demonstrate that these two components are expressed differently throughout the brain, with activity in occipital regions most reflective of the former, activity within intraparietal sulcus modulated by both factors, and more anterior regions including the anterior insula, pre-SMA, and inferior frontal sulcus driven almost exclusively by the latter. Consistent with these ICA findings, cluster analysis identifies a posterior-to-anterior gradient that differentiates regions sensitive to time on task from regions whose activity is strongly tied to motion coherence. Together, these findings demonstrate that progressively more anterior regions are likely to participate in progressively more proximate decision-related processes.	[Buchsbaum, Bradley R.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Erickson, Drew T.; Kayser, Andrew S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Kayser, Andrew S.] Vet Affairs Northern Calif Hlth Care Syst, Dept Neurol, Martinez, CA USA	University of Toronto; University of California System; University of California San Francisco	Kayser, AS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	akayser@gallo.ucsf.edu			state of California through the Ernest Gallo Clinic and Research Center	state of California through the Ernest Gallo Clinic and Research Center	This research was supported by funds provided by the state of California to Doctor Kayser through the Ernest Gallo Clinic and Research Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Ding L, 2010, J NEUROSCI, V30, P15747, DOI 10.1523/JNEUROSCI.2894-10.2010; Erickson DT, 2013, NEUROIMAGE; Fellows Lesley K, 2004, Behav Cogn Neurosci Rev, V3, P159; Genovesio A, 2009, NEURON, V63, P254, DOI 10.1016/j.neuron.2009.06.018; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Grinband J, 2011, NEUROIMAGE, V57, P303, DOI 10.1016/j.neuroimage.2010.12.027; Heekeren HR, 2006, P NATL ACAD SCI USA, V103, P10023, DOI 10.1073/pnas.0603949103; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; Ho TC, 2009, J NEUROSCI, V29, P8675, DOI 10.1523/JNEUROSCI.5984-08.2009; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kayser AS, 2010, J NEUROSCI, V30, P15778, DOI 10.1523/JNEUROSCI.3163-10.2010; Kayser AS, 2010, J NEUROPHYSIOL, V103, P1179, DOI 10.1152/jn.00364.2009; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Pelleg D., 2000, P 17 INT C MACH LEAR, P727, DOI DOI 10.1007/3-540-44491-2_3; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Ploran EJ, 2011, CEREB CORTEX; Ploran EJ, 2011, CEREB CORTEX, V21, P2650, DOI 10.1093/cercor/bhr055; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ratcliff R, 2006, COGNITIVE PSYCHOL, V53, P195, DOI 10.1016/j.cogpsych.2005.10.002; REED AV, 1973, SCIENCE, V181, P574, DOI 10.1126/science.181.4099.574; Roitman JD, 2002, J NEUROSCI, V22, P9475; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; Stark A, 2008, CEREB CORTEX, V18, P2358, DOI 10.1093/cercor/bhm260; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tosoni A, 2008, NAT NEUROSCI, V11, P1446, DOI 10.1038/nn.2221; Unterrainer JM, 2006, J PHYSIOL-PARIS, V99, P308, DOI 10.1016/j.jphysparis.2006.03.014; Weissman DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062405; Yang J, 2009, J NEUROPHYSIOL, V101, P2693, DOI 10.1152/jn.00061.2009; Yang JN, 2008, CEREB CORTEX, V18, P38, DOI 10.1093/cercor/bhm029; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257	35	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72074	10.1371/journal.pone.0072074	http://dx.doi.org/10.1371/journal.pone.0072074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977212	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700130
J	Mishra, NN; Yang, SJ; Chen, L; Muller, C; Saleh-Mghir, A; Kuhn, S; Peschel, A; Yeaman, MR; Nast, CC; Kreiswirth, BN; Cremieux, AC; Bayer, AS				Mishra, Nagendra N.; Yang, Soo-Jin; Chen, Liang; Muller, Claudette; Saleh-Mghir, Azzam; Kuhn, Sebastian; Peschel, Andreas; Yeaman, Michael R.; Nast, Cynthia C.; Kreiswirth, Barry N.; Cremieux, Anne-Claude; Bayer, Arnold S.			Emergence of Daptomycin Resistance in Daptomycin-Naive Rabbits with Methicillin-Resistant Staphylococcus aureus Prosthetic Joint Infection Is Associated with Resistance to Host Defense Cationic Peptides and mprF Polymorphisms	PLOS ONE			English	Article							VANCOMYCIN-INTERMEDIATE STRAINS; PLATELET MICROBICIDAL PROTEIN; FLOW-CYTOMETRIC DETECTION; IN-VITRO ACTIVITIES; CELL-MEMBRANE; PHOSPHATIDYLSERINE EXPRESSION; REDUCED SUSCEPTIBILITY; MECHANISMS; NONSUSCEPTIBILITY; IDENTIFICATION	Background: Previous studies of both clinically-derived and in vitro passage-derived daptomycin-resistant (DAP-R) Staphylococcus aureus strains demonstrated the coincident emergence of increased DAP MICs and resistance to host defense cationic peptides (HDP-R). Methods: In the present investigation, we studied a parental DAP-susceptible (DAP-S) methicillin-resistant Staphylococcus aureus (MRSA) strain and three isogenic variants with increased DAP MICs which were isolated from both DAP-treated and DAP-untreated rabbits with prosthetic joint infections. These strains were compared for: in vitro susceptibility to distinct HDPs differing in size, structure, and origin; i.e.; thrombin-induced platelet microbicidal proteins [tPMPs] and human neutrophil peptide-1 [hNP-1]; cell membrane (CM) phospholipid and fatty acid content; CM order; envelope surface charge; cell wall thickness; and mprF single nucleotide polymorphisms (SNPs) and expression profiles. Results: In comparison with the parental strain, both DAP-exposed and DAP-naive strains exhibited: (i) significantly reduced susceptibility to each HDP (P<0.05); (ii) thicker cell walls (P<0.05); (iii) increased synthesis of CM lysyl-phosphatidylglycerol (L-PG); (iv) reduced content of CM phosphatidylglycerol (PG); and (v) SNPs within the mprF locus No significant differences were observed between parental or variant strains in outer CM content of L-PG, CM fluidity, CM fatty acid contents, surface charge, mprF expression profiles or MprF protein content. An isolate which underwent identical in vivo passage, but without evolving increased DAP MICs, retained parental phenotypes and genotype. Conclusions: These results suggest: i) DAP MIC increases may occur in the absence of DAP exposures in vivo and may be triggered by organism exposure to endogenous HDPs: and ii) gain-in-function SNPs in mprF may contribute to such HDP-DAP cross-resistance phenotypes, although the mechanism of this relationship remains to be defined.	[Mishra, Nagendra N.; Yang, Soo-Jin; Yeaman, Michael R.; Bayer, Arnold S.] Harbor Univ Calif, Los Angeles Med Ctr, Los Angeles Biomed Res Inst, Div Infect Dis, Torrance, CA USA; [Mishra, Nagendra N.; Yang, Soo-Jin; Yeaman, Michael R.; Nast, Cynthia C.; Bayer, Arnold S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Chen, Liang; Kreiswirth, Barry N.] Publ Hlth Res Inst, TB Ctr, Newark, NJ USA; [Muller, Claudette; Cremieux, Anne-Claude] Bichat Claude Bernard Hosp, Paris, France; [Saleh-Mghir, Azzam] EA 3647 Versailles St Quentin Univ, R Poincare Hosp, Garches, France; [Kuhn, Sebastian; Peschel, Andreas] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Yeaman, Michael R.] Harbor Univ Calif, Los Angeles Med Ctr, Div Mol Med, Torrance, CA USA; [Nast, Cynthia C.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Eberhard Karls University of Tubingen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Cedars Sinai Medical Center	Yang, SJ (corresponding author), Harbor Univ Calif, Los Angeles Med Ctr, Los Angeles Biomed Res Inst, Div Infect Dis, Torrance, CA USA.	sjyang@ucla.edu	Crémieux, A/AAP-9147-2020	Chen, Liang/0000-0001-5845-2235	National Institutes of Health [AI-39108, AI-39001]; German Research Council [SFB766]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039108, R29AI039001, R01AI039001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Council(German Research Foundation (DFG)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the National Institutes of Health: AI-39108 (to ASB) and AI-39001 (to MRY); and from the German Research Council: SFB766 (to AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; Anderson KL, 2010, FEMS IMMUNOL MED MIC, V60, P208, DOI 10.1111/j.1574-695X.2010.00736.x; Bayer AS, 2013, ANN NY ACAD SCI, V1277, P139, DOI 10.1111/j.1749-6632.2012.06819.x; Belmatoug N, 1996, J INFECT DIS, V174, P414, DOI 10.1093/infdis/174.2.414; Bertsche U, 2011, ANTIMICROB AGENTS CH, V55, P3922, DOI 10.1128/AAC.01226-10; Boucher H, 2010, CLIN INFECT DIS, V51, pS183, DOI 10.1086/653519; Boucher HW, 2007, CLIN INFECT DIS, V45, P601, DOI 10.1086/520655; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Chang YH, 2011, ANTIMICROB AGENTS CH, V55, P5480, DOI 10.1128/AAC.05312-11; Chen L, 2009, J CLIN MICROBIOL, V47, P3692, DOI 10.1128/JCM.00766-09; Coulter SN, 1998, MOL MICROBIOL, V30, P393, DOI 10.1046/j.1365-2958.1998.01075.x; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; DYER DW, 1983, APPL ENVIRON MICROB, V46, P283, DOI 10.1128/AEM.46.1.283-285.1983; Edwards AM, 2011, TRENDS MICROBIOL, V19, P184, DOI 10.1016/j.tim.2010.12.005; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Hussain M, 2001, J BACTERIOL, V183, P6778, DOI 10.1128/JB.183.23.6778-6786.2001; Jeong DW, 2011, J BACTERIOL, V193, P4672, DOI 10.1128/JB.00353-11; Jones T, 2008, ANTIMICROB AGENTS CH, V52, P269, DOI 10.1128/AAC.00719-07; Kilelee E, 2010, ANTIMICROB AGENTS CH, V54, P4476, DOI 10.1128/AAC.00191-10; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Krishna S, 2012, SEMIN IMMUNOPATHOL, V34, P261, DOI 10.1007/s00281-011-0292-6; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Mishra NN, 2012, J INFECT DIS, V206, P1160, DOI 10.1093/infdis/jis482; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P4012, DOI 10.1128/AAC.00223-11; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P526, DOI 10.1128/AAC.00680-10; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; MISHRA NN, 51 ICAAC CHIC IL SEP, P52235; Mukhopadhyay K, 2007, MICROBIOL-SGM, V153, P1187, DOI 10.1099/mic.0.2006/003111-0; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Sakoulas G, 2005, ANTIMICROB AGENTS CH, V49, P2687, DOI 10.1128/AAC.49.7.2687-2692.2005; Saleh-Mghir A, 2011, ANTIMICROB AGENTS CH, V55, P4589, DOI 10.1128/AAC.00675-11; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Sieradzki K, 2003, J CLIN MICROBIOL, V41, P1687, DOI 10.1128/JCM.41.4.1687-1693.2003; Sieradzki K, 1997, J BACTERIOL, V179, P2557, DOI 10.1128/jb.179.8.2557-2566.1997; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Yang SJ, 2012, INFECT IMMUN, V80, P74, DOI 10.1128/IAI.05669-11; Yang SJ, 2010, ANTIMICROB AGENTS CH, V54, P3161, DOI 10.1128/AAC.00487-10; Yang SJ, 2010, ANTIMICROB AGENTS CH, V54, P3079, DOI 10.1128/AAC.00122-10; Yang SJ, 2009, J INFECT DIS, V200, P1916, DOI 10.1086/648473; Yeaman MR, 1997, INFECT IMMUN, V65, P1023, DOI 10.1128/IAI.65.3.1023-1031.1997; Yeaman MR, 1998, J CLIN INVEST, V101, P178, DOI 10.1172/JCI562; YEAMAN MR, 1992, INFECT IMMUN, V60, P2368, DOI 10.1128/IAI.60.6.2368-2374.1992; Yount NY, 2009, P NATL ACAD SCI USA, V106, P14972, DOI 10.1073/pnas.0904465106; Yu WQ, 2012, PLOS ONE, V7, P384, DOI 10.1371/journal.pone.0030076; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	51	67	68	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71151	10.1371/journal.pone.0071151	http://dx.doi.org/10.1371/journal.pone.0071151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23990934	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700024
J	Albouhair, S; Morgado, E; Lavau, C				Albouhair, Stephanie; Morgado, Ester; Lavau, Catherine			Flt3 Does Not Play a Critical Role in Murine Myeloid Leukemias Induced by MLL Fusion Genes	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; THERAPEUTIC TARGET; EXPRESSION; CLASSIFICATION; REARRANGEMENTS; COOPERATION; PROGENITORS; INHIBITION; SIGNATURES	Leukemias harboring MLL translocations are frequent in children and adults, and respond poorly to therapies. The receptor tyrosine kinase FLT3 is highly expressed in these leukemias. In vitro studies have shown that pediatric MLL-rearranged ALL cells are sensitive to FLT3 inhibitors and clinical trials are ongoing to measure their therapeutic efficacy. We sought to determine the contribution of Flt3 in the pathogenesis of MLL-rearranged leukemias using a myeloid leukemia mouse model. Bone marrow from Flt3 null mice transduced with MLL-ENL or MLL-CBP was transplanted into host mice and Flt3(-/-) leukemias were compared to their Flt3 wild type counterparts. Flt3 deficiency did not delay disease onset and had minimal impact on leukemia characteristics. To determine the anti-leukemic effect of FLT3 inhibition we studied the sensitivity of MLL-ENL leukemia cells to the FLT3 inhibitor PKC412 ex vivo. As previously reported for human MLL-rearranged leukemias, murine MLL-ENL leukemia cells with higher Flt3 levels were more sensitive to the cytotoxicity of PKC412. Interestingly, Flt3 deficient leukemia samples also displayed some sensitivity to PKC412. Our findings demonstrate that myeloid leukemias induced by MLL-rearranged genes are not dependent upon Flt3 signaling. They also highlight the discrepancy between the sensitivity of cells to Flt3 inhibition in vitro and the lack of contribution of Flt3 to the pathogenesis of MLL-rearranged leukemias in vivo.	[Albouhair, Stephanie; Morgado, Ester; Lavau, Catherine] Ctr Natl Rech Sci, UMR7151, Paris, France	Centre National de la Recherche Scientifique (CNRS)	Lavau, C (corresponding author), Duke Univ, Med Ctr, Durham, NC 27706 USA.	catherine.lavau@duke.edu	Lavau, Catherine/Q-2928-2019	Lavau, Catherine/0000-0003-4800-1320	GIS maladies rares; Fondation de France; Sang pour Cent La Vie; Ligue Comite de Paris; Ministere de la Recherche fellowship	GIS maladies rares; Fondation de France(Fondation de France); Sang pour Cent La Vie; Ligue Comite de Paris; Ministere de la Recherche fellowship	GIS maladies rares, Fondation de France, Sang pour Cent La Vie and the Ligue Comite de Paris. SA is a recipient of a Ministere de la Recherche fellowship; CL is an INSERM scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2005, P NATL ACAD SCI USA, V102, P19069, DOI 10.1073/pnas.0506637102; Armstrong SA, 2003, CANCER CELL, V3, P173, DOI 10.1016/S1535-6108(03)00003-5; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Brasel K, 1996, BLOOD, V88, P2004, DOI 10.1182/blood.V88.6.2004.bloodjournal8862004; Brown P, 2005, BLOOD, V105, P812, DOI 10.1182/blood-2004-06-2498; Eguchi M, 2003, INT J HEMATOL, V78, P390, DOI 10.1007/BF02983811; Forster A, 2003, CANCER CELL, V3, P449, DOI 10.1016/S1535-6108(03)00106-5; Jiang X, 2012, CANCER CELL, V22, P524, DOI 10.1016/j.ccr.2012.08.028; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Kohlmann A, 2005, LEUKEMIA, V19, P953, DOI 10.1038/sj.leu.2403746; Lavau C, 2000, P NATL ACAD SCI USA, V97, P10984, DOI 10.1073/pnas.190167297; Lavau C, 2000, EMBO J, V19, P4655, DOI 10.1093/emboj/19.17.4655; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Lee-Sherick AB, 2010, BRIT J HAEMATOL, V151, P295, DOI 10.1111/j.1365-2141.2010.08282.x; Levis M, 2006, BLOOD, V108, P3477, DOI 10.1182/blood-2006-04-015743; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Morgado E, 2007, BLOOD, V109, P4020, DOI 10.1182/blood-2006-01-039586; Ross ME, 2004, BLOOD, V104, P3679, DOI 10.1182/blood-2004-03-1154; Rozovskaia T, 2003, P NATL ACAD SCI USA, V100, P7853, DOI 10.1073/pnas.1132115100; Stam RW, 2005, BLOOD, V106, P2484, DOI 10.1182/blood-2004-09-3667; Stubbs MC, 2008, LEUKEMIA, V22, P66, DOI 10.1038/sj.leu.2404951; Su X, 2006, GENE CHROMOSOME CANC, V45, P846, DOI 10.1002/gcc.20348; Tsutsumi S, 2003, CANCER RES, V63, P4882; Wang GG, 2006, MOL CELL BIOL, V26, P3902, DOI 10.1128/MCB.26.10.3902-3916.2006; Wang J, 2005, EMBO J, V24, P368, DOI 10.1038/sj.emboj.7600521; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zheng R, 2004, BLOOD, V103, P267, DOI 10.1182/blood-2003-06-1969	28	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72261	10.1371/journal.pone.0072261	http://dx.doi.org/10.1371/journal.pone.0072261			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977266	Green Submitted, Green Published, gold			2022-12-25	WOS:000323570200066
J	Rubin, J; Khosravi, H; Bruce, KL; Lydon, ME; Behrens, SH; Chernoff, YO; Bommarius, AS				Rubin, Jonathan; Khosravi, Hasan; Bruce, Kathryn L.; Lydon, Megan E.; Behrens, Sven H.; Chernoff, Yury O.; Bommarius, Andreas S.			Ion-specific Effects on Prion Nucleation and Strain Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Protein Aggregation; Protein Conformation; Translation Release Factors; Yeast; Chaotrope; Hofmeister Series; Kosmotrope	YEAST PRION; FIBRIL FORMATION; PROTEIN AGGREGATION; SACCHAROMYCES-CEREVISIAE; AMYLOID FORMATION; PSI+; DISEASES; TRANSMISSION; INHERITANCE; VARIANTS	Ordered, fibrous, self-seeding aggregates of misfolded proteins known as amyloids are associated with important diseases in mammals and control phenotypic traits in fungi. A given protein may adopt multiple amyloid conformations, known as variants or strains, each of which leads to a distinct disease pattern or phenotype. Here, we study the effect of Hofmeister ions on amyloid nucleation and strain generation by the prion domain-containing fragment (Sup35NM) of a yeast protein Sup35p. Strongly hydrated anions (kosmotropes) initiate nucleation quickly and cause rapid fiber elongation, whereas poorly hydrated anions (chaotropes) delay nucleation and mildly affect the elongation rate. For the first time, we demonstrate that kosmotropes favor formation of amyloid strains that are characterized by lower thermostability and higher frangibility in vitro and stronger phenotypic and proliferation patterns effectively in vivo as compared with amyloids formed in chaotropes. These phenomena point to inherent differences in the biochemistry of Hofmeister ions. Our work shows that the ionic composition of a solution not only influences the kinetics of amyloid nucleation but also determines the amyloid strain that is preferentially formed.	[Rubin, Jonathan; Behrens, Sven H.; Bommarius, Andreas S.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Rubin, Jonathan; Khosravi, Hasan; Bruce, Kathryn L.; Behrens, Sven H.; Chernoff, Yury O.; Bommarius, Andreas S.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Khosravi, Hasan; Lydon, Megan E.; Bommarius, Andreas S.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Bruce, Kathryn L.; Chernoff, Yury O.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Chernoff, YO (corresponding author), Georgia Inst Technol, Sch Biol, 310 Ferst Dr, Atlanta, GA 30332 USA.	yury.chernoff@biology.gatech.edu; andreas.bommarius@chbe.gatech.edu	Chernoff, Yury O/J-2833-2014	Behrens, Sven/0000-0002-3528-4053; Chernoff, Yury/0000-0002-8934-9051	National Institutes of Health [R01GM093294]; National Science Foundation (NSF) [MCB-1024854]; NSF Industry/University Cooperative Research Centers (I/UCRC) Program Center for Pharmaceutical Development (CPD) [0969003]; United States Department of Education; Medtronics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Industry/University Cooperative Research Centers (I/UCRC) Program Center for Pharmaceutical Development (CPD)(National Science Foundation (NSF)); United States Department of Education(US Department of Education); Medtronics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the subaward (to Y. O. C.) on National Institutes of Health Grant R01GM093294. This work was also supported by National Science Foundation (NSF) Grant MCB-1024854 (to Y. O. C.), NSF Industry/University Cooperative Research Centers (I/UCRC) Program Center for Pharmaceutical Development (CPD) Grant 0969003 (to A. S. B. and S. H. B.), the Graduate Assistance in Areas of National Need (GAANN) fellowship through the United States Department of Education (to J. R. and K. L B.), and the Petite Undergraduate Scholar program through Medtronics (to H. K.).	Allen KD, 2005, GENETICS, V169, P1227, DOI 10.1534/genetics.104.037168; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Bailleul PA, 1999, GENETICS, V153, P81; Baynes BM, 2004, BIOPHYS J, V87, P1631, DOI 10.1529/biophysj.104.042473; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; Bruce KL, 2011, SEMIN CELL DEV BIOL, V22, P444, DOI 10.1016/j.semcdb.2011.03.005; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen BX, 2007, P NATL ACAD SCI USA, V104, P2791, DOI 10.1073/pnas.0611158104; Chen BX, 2010, MOL MICROBIOL, V76, P1483, DOI 10.1111/j.1365-2958.2010.07177.x; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2000, EMBO J, V19, P1441, DOI 10.1093/emboj/19.7.1441; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; Derkatch IL, 1996, GENETICS, V144, P1375; Diaz-Espinoza R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031678; Dobson CM, 2002, NATURE, V418, P729, DOI 10.1038/418729a; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Halfmann R., 2008, J VIS EXP, P838; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; Kim AY, 2000, LANGMUIR, V16, P2101, DOI 10.1021/la990841n; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Lodderstedt G, 2008, BIOCHEMISTRY-US, V47, P2181, DOI 10.1021/bi701322g; Peula-Garcia JM, 2010, J PHYS CHEM C, V114, P11133, DOI 10.1021/jp912035v; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Munishkina LA, 2004, BIOCHEMISTRY-US, V43, P3289, DOI 10.1021/bi034938r; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; Pegram LM, 2008, J PHYS CHEM B, V112, P9428, DOI 10.1021/jp800816a; Pegram LM, 2010, P NATL ACAD SCI USA, V107, P7716, DOI 10.1073/pnas.0913376107; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ross ED, 2010, PRION, V4, DOI 10.4161/pri.4.2.12190; Rubin J, 2010, J PHYS CHEM B, V114, P4383, DOI 10.1021/jp912126w; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Sorci M, 2009, PROTEINS, V77, P62, DOI 10.1002/prot.22417; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Tessier PM, 2009, NAT STRUCT MOL BIOL, V16, P598, DOI 10.1038/nsmb.1617; Toombs JA, 2012, P NATL ACAD SCI USA, V109, P6519, DOI 10.1073/pnas.1119366109; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Tuite MF, 2006, METHODS, V39, P9, DOI 10.1016/j.ymeth.2006.04.001; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Verges KJ, 2011, NAT STRUCT MOL BIOL, V18, P493, DOI 10.1038/nsmb.2030; Walters RH, 2012, J MOL BIOL, V421, P329, DOI 10.1016/j.jmb.2012.03.017; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Wickner RB, 2011, PRION, V5, P258, DOI [10.4161/pri.5.4.17748, 10.4161/pri.17748]; Wickner RB, 2007, PRION, V1, P94, DOI 10.4161/pri.1.2.4664; Wolfe LS, 2010, P NATL ACAD SCI USA, V107, P16863, DOI 10.1073/pnas.1002867107; Yeh V, 2010, PROTEIN SCI, V19, P47, DOI 10.1002/pro.281	61	20	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30300	30308		10.1074/jbc.M113.467829	http://dx.doi.org/10.1074/jbc.M113.467829			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23990463	Green Published, hybrid			2022-12-25	WOS:000329868100027
J	Murphy, CM; Michael, WM				Murphy, Christopher M.; Michael, W. Matthew			Control of DNA Replication by the Nucleus/Cytoplasm Ratio in Xenopus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; DROSOPHILA MIDBLASTULA TRANSITION; CELL-CYCLE; EGG EXTRACTS; CHECKPOINT; ATR; INITIATION; EMBRYOS; CHK1; DAMAGE	The nucleus/cytoplasm (N/C) ratio controls S phase dynamics in many biological systems, most notably the abrupt remodeling of the cell cycle that occurs at the midblastula transition in early Xenopus laevis embryos. After an initial series of rapid cleavage cycles consisting only of S and M phases, a critical N/C ratio is reached, which causes a sharp increase in the length of S phase as the cell cycle is reconfigured to resemble somatic cell cycles. How the N/C ratio determines the length of S phase has been a longstanding problem in developmental biology. Using Xenopus egg extracts, we show that DNA replication at high N/C ratio is restricted by one or more limiting substances. We report here that the protein phosphatase PP2A, in conjunction with its B55 alpha regulatory subunit, becomes limiting for replication origin firing at high N/C ratio, and this in turn leads to reduced origin activation and an increase in the time required to complete S phase. Increasing the levels of PP2A catalytic subunit or B55 alpha experimentally restores rapid DNA synthesis at high N/C ratio. Inversely, reduction of PP2A or B55 alpha levels sharply extends S phase even in low N/C extracts. These results identify PP2A-B55 alpha as a link between DNA replication and N/C ratio in egg extracts and suggest a mechanism that may influence the onset of the midblastula transition in vivo.	[Murphy, Christopher M.; Michael, W. Matthew] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA; [Murphy, Christopher M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of Southern California; Harvard University	Michael, WM (corresponding author), Univ So Calif, Dept Biol Sci, RRI 104B,1050 Childs Way, Los Angeles, CA 90089 USA.	mattm@usc.edu	McDermott, Michael Francis/GZM-5330-2022		National Institutes of Health [GM067735]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067735 (to W.M.M.).	Anderson JA, 1997, MOL BIOL CELL, V8, P1195, DOI 10.1091/mbc.8.7.1195; BRANDT H, 1975, J BIOL CHEM, V250, P8038; Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Clute P, 1997, DEV BIOL, V185, P1, DOI 10.1006/dbio.1997.8540; Di Talia S, 2013, CURR BIOL, V23, P127, DOI 10.1016/j.cub.2012.11.029; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; Farrell JA, 2013, CURR BIOL, V23, P118, DOI 10.1016/j.cub.2012.11.036; Finkielstein CV, 2001, P NATL ACAD SCI USA, V98, P1006, DOI 10.1073/pnas.98.3.1006; Gotoh T, 2011, DEV BIOL, V353, P302, DOI 10.1016/j.ydbio.2011.03.002; GRAHAM CF, 1966, DEV BIOL, V14, P439, DOI 10.1016/0012-1606(66)90024-8; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; Ikehara T, 2006, PROTEIN EXPRES PURIF, V45, P150, DOI 10.1016/j.pep.2005.06.002; Iwao Y, 2005, DEV GROWTH DIFFER, V47, P283; KANE DA, 1993, DEVELOPMENT, V119, P447; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; Krasinska L, 2011, MOL CELL, V44, P437, DOI 10.1016/j.molcel.2011.10.007; Lin XH, 1998, P NATL ACAD SCI USA, V95, P14693, DOI 10.1073/pnas.95.25.14693; Luciani MG, 2004, J CELL SCI, V117, P6019, DOI 10.1242/jcs.01400; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Marheineke Kathrin, 2009, V521, P575, DOI [10.1007/978-1-60327-817-5_33, 10.1007/978-1-60327-815-7_33]; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; NEWPORT J, 1989, J CELL SCI, P149; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Petersen P, 2006, MOL CELL BIOL, V26, P1997, DOI 10.1128/MCB.26.5.1997-2011.2006; R Development Core Team, 2009, R FDN STAT COMP; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Stokes MP, 2002, J CELL BIOL, V158, P863, DOI 10.1083/jcb.200204127; Sung HW, 2013, CURR BIOL, V23, P133, DOI 10.1016/j.cub.2012.12.013; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takada S, 2007, DEVELOPMENT, V134, P1737, DOI 10.1242/dev.02831; Vastag Livia, 2011, PLoS One, V6, pe16881, DOI 10.1371/journal.pone.0016881; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Walter J, 1999, PRACT APPROACH SER, V199, P201	41	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29382	29393		10.1074/jbc.M113.499012	http://dx.doi.org/10.1074/jbc.M113.499012			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23986447	Green Published, hybrid			2022-12-25	WOS:000330615300017
J	Wan, W; Bian, W; McDonald, M; Kijac, A; Wemmer, DE; Stubbs, G				Wan, William; Bian, Wen; McDonald, Michele; Kijac, Aleksandra; Wemmer, David E.; Stubbs, Gerald			Heterogeneous Seeding of a Prion Structure by a Generic Amyloid Form of the Fungal Prion-forming Domain HET-s(218-289)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HET-S PRION; RAY FIBER DIFFRACTION; PODOSPORA-ANSERINA; PROTEIN; FIBRILS; MODEL; CORE; MICROSCOPY; AGGREGATE; MECHANISM	The fungal prion-forming domain HET-s(218-289) forms infectious amyloid fibrils at physiological pH that were shown by solid-state NMR to be assemblies of a two-rung beta-solenoid structure. Under acidic conditions, HET-s(218-289) has been shown to form amyloid fibrils that have very low infectivity in vivo, but structural information about these fibrils has been very limited. Weshow by x-ray fiber diffraction that the HET-s(218289) fibrils formed under acidic conditions have a stacked beta-sheet architecture commonly found in short amyloidogenic peptides and denatured protein aggregates. At physiological pH, stacked beta-sheet fibrils nucleate the formation of the infectious beta-solenoid prions in a process of heterogeneous seeding, but do so with kinetic profiles distinct from those of spontaneous or homogeneous (seeded with infectious beta-solenoid fibrils) fibrillization. Several serial passages of stacked beta-sheet-seeded solutions lead to fibrillization kinetics similar to homogeneously seeded solutions. Our results directly show that structural mutation can occur between substantially different amyloid architectures, lending credence to the suggestion that the processes of strain adaptation and crossing species barriers are facilitated by structural mutation.	[Wan, William; Bian, Wen; McDonald, Michele; Stubbs, Gerald] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Wan, William; Bian, Wen; McDonald, Michele; Stubbs, Gerald] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Kijac, Aleksandra; Wemmer, David E.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kijac, Aleksandra; Wemmer, David E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Kijac, Aleksandra] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA	Vanderbilt University; Vanderbilt University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Stubbs, G (corresponding author), Vanderbilt Univ, Dept Biol Sci, 1210 MRB 3,465 21st Ave South, Nashville, TN 37232 USA.	gerald.stubbs@vanderbilt.edu		Wan, William/0000-0003-2497-3010	Department of Energy; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM111072, P41GM103543, T32GM008320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002132, F31AG040947] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the staff of beamline 4-2 at the Stanford Synchrotron Radiation Lightsource (SSRL) and BioCAT at the Advanced Photon Source (APS), Amy Kendall for discussions and assistance with data collection, Xi Meng for purification of the labeled HET-s protein, and Jochem Struppe of Bruker Biospin for help with pulse sequence implementation. The SSRL is a national user facility operated by Stanford University on behalf of the Department of Energy. The SSRL Structural Molecular Biology Program is supported by the Department of Energy and National Institutes of Health. The APS is supported by the Department of Energy. BioCAT and BioCARS are supported by the National Institutes of Health.	ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2004, J BIOL CHEM, V279, P7671, DOI 10.1074/jbc.M310594200; Benkemoun L, 2011, MOL MICROBIOL, V82, P1392, DOI 10.1111/j.1365-2958.2011.07893.x; Bian W, 2006, J APPL CRYSTALLOGR, V39, P752, DOI 10.1107/S0021889806025386; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Debets AJM, 2012, P NATL ACAD SCI USA, V109, P10432, DOI 10.1073/pnas.1205333109; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; FRASER RDB, 1976, J APPL CRYSTALLOGR, V9, P81, DOI 10.1107/S0021889876010674; Geddes A. J., 1968, J MOL BIOL, V32, P343; GONZALEZ A, 1995, ACTA CRYSTALLOGR D, V51, P792, DOI 10.1107/S0907444995003027; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hetz C, 2003, TRENDS MOL MED, V9, P237, DOI 10.1016/S1471-4914(03)00069-8; Holmes BB, 2012, CURR OPIN NEUROL, V25, P721, DOI 10.1097/WCO.0b013e32835a3ee0; HOLMES KC, 1974, ACTA CRYSTALLOGR A, VA 30, P635, DOI 10.1107/S0567739474001537; HOLMES KC, 1958, VIROLOGY, V6, P328, DOI 10.1016/0042-6822(58)90086-2; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117; KLUG A, 1958, ACTA CRYSTALLOGR, V11, P199, DOI 10.1107/S0365110X58000517; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Makarava N, 2012, J BIOL CHEM, V287, P30205, DOI 10.1074/jbc.M112.392985; Makarava N, 2012, J NEUROSCI, V32, P7345, DOI 10.1523/JNEUROSCI.6351-11.2012; Makarava N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002419; McDonald M, 2008, J APPL CRYSTALLOGR, V41, P206, DOI 10.1107/S0021889807060803; McGlinchey RP, 2009, P NATL ACAD SCI USA, V106, P13731, DOI 10.1073/pnas.0906509106; Mizuno N, 2011, P NATL ACAD SCI USA, V108, P3252, DOI 10.1073/pnas.1011342108; Ostapchenko VG, 2010, J MOL BIOL, V400, P908, DOI 10.1016/j.jmb.2010.05.051; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; PRUSINER SB, 2007, FIELDS VIROLOGY, P3059; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Rhodes G., 2006, CRYSTALLOGRAPHY MADE, P211; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Rudall K. M., 1946, S FIBROUS PROTEINS, P15; Sabate R, 2007, J MOL BIOL, V370, P768, DOI 10.1016/j.jmb.2007.05.014; Saupe SJ, 2011, SEMIN CELL DEV BIOL, V22, P460, DOI 10.1016/j.semcdb.2011.02.019; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sen A, 2007, J BIOL CHEM, V282, P5545, DOI 10.1074/jbc.M611464200; Shewmaker F, 2008, BIOCHEMISTRY-US, V47, P4000, DOI 10.1021/bi7024589; Siemer AB, 2006, J BIOMOL NMR, V34, P75, DOI 10.1007/s10858-005-5582-7; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Wan W, 2012, BIOPHYS J, V102, P2339, DOI [10.1016/j.bpj.2012.04.011, 10.1016/j.bpj.2012.04.01]; Wasmer C, 2008, ANGEW CHEM INT EDIT, V47, P5839, DOI 10.1002/anie.200704896; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wasmer C, 2010, J MOL BIOL, V402, P311, DOI 10.1016/j.jmb.2010.06.053; Wickner RB, 1999, MICROBIOL MOL BIOL R, V63, P844, DOI 10.1128/MMBR.63.4.844-861.1999; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106	53	13	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29604	29612		10.1074/jbc.M113.505511	http://dx.doi.org/10.1074/jbc.M113.505511			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23986444	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000330615300036
J	Carlson, AL; Fujisaki, J; Wu, J; Runnels, JM; Turcotte, R; Lo Celso, C; Scadden, DT; Strom, TB; Lin, CP				Carlson, Alicia L.; Fujisaki, Joji; Wu, Juwell; Runnels, Judith M.; Turcotte, Raphael; Lo Celso, Cristina; Scadden, David T.; Strom, Terry B.; Lin, Charles P.			Tracking Single Cells in Live Animals Using a Photoconvertible Near-Infrared Cell Membrane Label	PLOS ONE			English	Article							REGULATORY T-CELLS; RED FLUORESCENT PROTEINS; IN-VIVO; HEMATOPOIETIC STEM; OPTICAL HIGHLIGHTER; IMMUNE-SYSTEM; GENERATION; CONVERSION; EFFECTOR; LINEAGE	We describe a novel photoconversion technique to track individual cells in vivo using a commercial lipophilic membrane dye, DiR. We show that DiR exhibits a permanent fluorescence emission shift ( photoconversion) after light exposure and does not reacquire the original color over time. Ratiometric imaging can be used to distinguish photoconverted from non-converted cells with high sensitivity. Combining the use of this photoconvertible dye with intravital microscopy, we tracked the division of individual hematopoietic stem/progenitor cells within the calvarium bone marrow of live mice. We also studied the peripheral differentiation of individual T cells by tracking the gain or loss of FoxP3-GFP expression, a marker of the immune suppressive function of CD4(+) T cells. With the near-infrared photoconvertible membrane dye, the entire visible spectral range is available for simultaneous use with other fluorescent proteins to monitor gene expression or to trace cell lineage commitment in vivo with high spatial and temporal resolution.	[Carlson, Alicia L.; Fujisaki, Joji; Wu, Juwell; Runnels, Judith M.; Turcotte, Raphael; Lin, Charles P.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Carlson, Alicia L.; Fujisaki, Joji; Wu, Juwell; Runnels, Judith M.; Turcotte, Raphael; Lin, Charles P.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Carlson, Alicia L.; Fujisaki, Joji; Wu, Juwell; Runnels, Judith M.; Turcotte, Raphael; Strom, Terry B.; Lin, Charles P.] Harvard Univ, Sch Med, Boston, MA USA; [Turcotte, Raphael] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Lo Celso, Cristina; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Scadden, David T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Scadden, David T.; Lin, Charles P.] Harvard Stem Cell Inst, Cambridge, MA USA; [Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Strom, Terry B.] Beth Israel Deaconess Med Ctr, Transplant Inst, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Beth Israel Deaconess Medical Center	Lin, CP (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	charles_lin@hms.harvard.edu		Turcotte, Raphael/0000-0002-2257-4190; Lo Celso, Cristina/0000-0002-1163-4207	National Institutes of Health (NIH) [HL097748, HL97794, CA086355, HL100402]; NIH [5 PO1 AI041521-12]; Juvenile Diabetes Research Foundation [7-2005-1329, 4-2007-1057]; JDRF Center in Immunologic Tolerance; NATIONAL CANCER INSTITUTE [P50CA086355] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402, R01HL097794, R01HL097748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073748, P01AI041521] Funding Source: NIH RePORTER; BBSRC [BB/I004033/1, BB/K021168/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I004033/1, BB/K021168/1] Funding Source: researchfish; Medical Research Council [MR/J006742/1] Funding Source: researchfish	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); JDRF Center in Immunologic Tolerance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by National Institutes of Health (NIH) grants HL097748, HL97794, CA086355, and HL100402. TBS was supported by NIH grant 5 PO1 AI041521-12, Juvenile Diabetes Research Foundation grants 7-2005-1329 and 4-2007-1057, and the JDRF Center in Immunologic Tolerance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Ando R, 2007, BIOPHYS J, V92, pL97, DOI 10.1529/biophysj.107.105882; Andresen M, 2005, P NATL ACAD SCI USA, V102, P13070, DOI 10.1073/pnas.0502772102; Andresen M, 2008, NAT BIOTECHNOL, V26, P1035, DOI 10.1038/nbt.1493; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chirico G, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.030901; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; DELMONTE F, 1995, CHEM MATER, V7, P292, DOI 10.1021/cm00050a010; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Fan ZG, 2010, NAT MED, V16, P718, DOI 10.1038/nm.2155; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Griswold SL, 2011, GENESI IN PRESS 0111; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Habuchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003944; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Kremers GJ, 2009, NAT METHODS, V6, P355, DOI [10.1038/NMETH.1319, 10.1038/nmeth.1319]; Lassailly F, 2010, BLOOD, V115, P5347, DOI 10.1182/blood-2009-05-224030; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Marchant JS, 2001, NAT BIOTECHNOL, V19, P645, DOI 10.1038/90249; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mishra A, 2000, CHEM REV, V100, P1973, DOI 10.1021/cr990402t; Nowotschin S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-49; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pittet MJ, 2008, IMMUNOL REV, V221, P107, DOI 10.1111/j.1600-065X.2008.00584.x; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Stiel AC, 2008, BIOPHYS J, V95, P2989, DOI 10.1529/biophysj.108.130146; Stiel AC, 2007, BIOCHEM J, V402, P35, DOI 10.1042/BJ20061401; Strom TB, 2009, J AM SOC NEPHROL, V20, P1677, DOI 10.1681/ASN.2008101027; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; Verkhusha VV, 2005, CHEM BIOL, V12, P279, DOI 10.1016/j.chembiol.2005.01.005; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	51	40	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e69257	10.1371/journal.pone.0069257	http://dx.doi.org/10.1371/journal.pone.0069257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23990881	gold, Green Published			2022-12-25	WOS:000324228800005
J	Mazzaccara, C; Conti, V; Liguori, R; Simeon, V; Toriello, M; Severini, A; Perricone, C; Meccariello, A; Meccariello, P; Vitale, DF; Filippelli, A; Sacchetti, L				Mazzaccara, Cristina; Conti, Valeria; Liguori, Rosario; Simeon, Vittorio; Toriello, Mario; Severini, Angelo; Perricone, Corrado; Meccariello, Alfonso; Meccariello, Pasquale; Vitale, Dino Franco; Filippelli, Amelia; Sacchetti, Lucia			Warfarin Anticoagulant Therapy: A Southern Italy Pharmacogenetics-Based Dosing Model	PLOS ONE			English	Article							INTERINDIVIDUAL VARIABILITY; VKORC1; CYP4F2; CYP2C9; METAANALYSIS; POLYMORPHISM; MAINTENANCE; POPULATION; VARIANTS; GENE	Background and Aim: Warfarin is the most frequently prescribed anticoagulant worldwide. However, warfarin therapy is associated with a high risk of bleeding and thromboembolic events because of a large interindividual dose-response variability. We investigated the effect of genetic and non genetic factors on warfarin dosage in a South Italian population in the attempt to setup an algorithm easily applicable in the clinical practice. Materials and Methods: A total of 266 patients from Southern Italy affected by cardiovascular diseases were enrolled and their clinical and anamnestic data recorded. All patients were genotyped for CYP2C9*2,*3, CYP4F2*3, VKORC1-1639 G>A by the TaqMan assay and for variants VKORC1 1173 C>T and VKORC1 3730 G>A by denaturing high performance liquid chromatography and direct sequencing. The effect of genetic and not genetic factors on warfarin dose variability was tested by multiple linear regression analysis, and an algorithm based on our data was established and then validated by the Jackknife procedure. Results: Warfarin dose variability was influenced, in decreasing order, by VKORC1-1639 G>A (29.7%), CYP2C9*3 (11.8%), age (8.5%), CYP2C9*2 (3.5%), gender (2.0%) and lastly CYP4F2*3 (1.7%); VKORC1 1173 C>T and VKORC1 3730 G>A exerted a slight effect (<1% each). Taken together, these factors accounted for 58.4% of the warfarin dose variability in our population. Data obtained with our algorithm significantly correlated with those predicted by the two online algorithms: Warfarin dosing and Pharmgkb (p<0.001; R-2 = 0.805 and p<0.001; R-2 = 0.773, respectively). Conclusions: Our algorithm, which is based on six polymorphisms, age and gender, is user-friendly and its application in clinical practice could improve the personalized management of patients undergoing warfarin therapy.	[Mazzaccara, Cristina; Liguori, Rosario; Sacchetti, Lucia] CEINGE Biotecnol Avanzate Sc Ar L, Naples, Italy; [Mazzaccara, Cristina; Liguori, Rosario; Toriello, Mario; Severini, Angelo; Sacchetti, Lucia] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Conti, Valeria; Filippelli, Amelia] Univ Salerno, Dipartimento Med & Chirurg, I-84100 Salerno, Italy; [Simeon, Vittorio] Ist Ricovero & Cura Carattere Sci, Ctr Riferimento Oncol Basilicata, Lab Ric Preclin & Traslaz Oncol, Rionero In Vulture, Pz, Italy; [Perricone, Corrado] AORN Santobono Pausillipon, Naples, Italy; [Meccariello, Alfonso; Meccariello, Pasquale] Univ Naples Federico II, Dipartimento Med Interna, Naples, Italy; [Vitale, Dino Franco] IRCCS Ist Campoli Telese, Fdn Salvatore Maugeri, Benevento, Italy	CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Salerno; IRCCS CROB; University of Naples Federico II; Istituti Clinici Scientifici Maugeri IRCCS	Sacchetti, L (corresponding author), CEINGE Biotecnol Avanzate Sc Ar L, Naples, Italy.	sacchett@unina.it	Simeon, Vittorio/K-6373-2016; Mazzaccara, Cristina/AAC-5361-2022; toriello, mario/AAA-4255-2022; Filippelli, Amelia/AAC-5321-2022	Simeon, Vittorio/0000-0003-2387-4125; Mazzaccara, Cristina/0000-0001-7774-2799; Filippelli, Amelia/0000-0002-8235-9118; conti, valeria/0000-0001-6964-2739	CEINGE Regione Campania [DGRC 1901/2009]; POR Campania FSE	CEINGE Regione Campania; POR Campania FSE(Regione Campania)	The present work was supported by grants from CEINGE Regione Campania (DGRC 1901/2009); POR Campania FSE 2007-2013, project CREME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell J, 2012, HEMATOL-AM SOC HEMAT, P221; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Borgiani P, 2009, PHARMACOGENOMICS, V10, P261, DOI 10.2217/14622416.10.2.261; Borgiani P, 2007, PHARMACOGENOMICS, V8, P1545, DOI 10.2217/14622416.8.11.1545; Burmester JK, 2011, CLIN MED RES, V9, P119, DOI 10.3121/cmr.2011.951; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Cini M, 2012, EUR J CLIN PHARMACOL, V68, P1167, DOI 10.1007/s00228-012-1226-5; Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Danese E, 2012, CLIN PHARMACOL THER, V92, P746, DOI 10.1038/clpt.2012.184; Fareed J, 2012, ANNU REV PHARMACOL, V52, P79, DOI 10.1146/annurev-pharmtox-010611-134633; Finkelman BS, 2011, J AM COLL CARDIOL, V57, P612, DOI 10.1016/j.jacc.2010.08.643; Gage BF, 2008, J THROMB THROMBOLYS, V25, P45, DOI 10.1007/s11239-007-0104-y; Gong IY, 2011, BLOOD, V118, P3163, DOI 10.1182/blood-2011-03-345173; Gould WW, 1995, STATA TECHNICAL B, V24, p[sg34, 25]; Gulseth MP, 2009, AM J HEALTH-SYST PH, V66, P123, DOI 10.2146/ajhp080127; Hill CE, 2008, CLIN LAB MED, V28, P513, DOI 10.1016/j.cll.2008.09.002; Homme MB, 2008, CLIN LAB MED, V28, P539, DOI 10.1016/j.cll.2008.10.002; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; Kamali F, 2010, ANNU REV MED, V61, P63, DOI 10.1146/annurev.med.070808.170037; Kim MJ, 2009, J CLIN PHARMACOL, V49, P138, DOI 10.1177/0091270008328098; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Kringen MK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/739751; Kurnik D, 2009, PHARMACOGENOMICS, V10, P1955, DOI 10.2217/PGS.09.149; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Lane S, 2012, BRIT J CLIN PHARMACO, V73, P66, DOI 10.1111/j.1365-2125.2011.04051.x; Leitner JM, 2008, PHARMACOGENOMICS, V9, P423, DOI 10.2217/14622416.9.4.423; Lenzini P, 2010, CLIN PHARMACOL THER, V87, P572, DOI 10.1038/clpt.2010.13; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Liang RJ, 2012, THROMB RES, V130, P38, DOI 10.1016/j.thromres.2011.11.043; Limdi NA, 2008, PHARMACOGENOMICS, V9, P511, DOI 10.2217/14622416.9.5.511; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Mahajan P, 2011, INT J CLIN PHARM-NET, V33, P10, DOI 10.1007/s11096-011-9486-1; McDonald MG, 2009, MOL PHARMACOL, V75, P1337, DOI 10.1124/mol.109.054833; Miller CS, 2012, AM J CARDIOL, V110, P453, DOI 10.1016/j.amjcard.2012.03.049; Pavani A, 2012, PHARMACOGENOMICS J, V12, P306, DOI 10.1038/tpj.2011.4; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Ross KA, 2010, J HUM GENET, V55, P582, DOI 10.1038/jhg.2010.73; Sanderson S, 2005, GENET MED, V7, P97, DOI 10.1097/01.GIM.0000153664.65759.CF; Scott SA, 2010, PHARMACOGENOMICS, V11, P781, DOI [10.2217/pgs.10.49, 10.2217/PGS.10.49]; Suarez-Kurtz G, 2011, BRIT J CLIN PHARMACO, V72, P451, DOI 10.1111/j.1365-2125.2011.04018.x; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Teh LK, 2012, J CLIN PHARM THER, V37, P232, DOI 10.1111/j.1365-2710.2011.01262.x; Wu Alan Hb, 2011, Clin Proteomics, V8, P12, DOI 10.1186/1559-0275-8-12; Yang LM, 2010, THROMB RES, V125, pE159, DOI 10.1016/j.thromres.2009.10.017; You JHS, 2011, EXPERT OPIN PHARMACO, V12, P435, DOI 10.1517/14656566.2011.521153; Zambon CF, 2011, PHARMACOGENOMICS, V12, P15, DOI [10.2217/pgs.10.162, 10.2217/PGS.10.162]	48	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e71505	10.1371/journal.pone.0071505	http://dx.doi.org/10.1371/journal.pone.0071505			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23990957	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800009
J	Coura-Vital, W; Reis, AB; Fausto, MA; Leal, GGD; Marques, MJ; Veloso, VM; Carneiro, M				Coura-Vital, Wendel; Reis, Alexandre Barbosa; Fausto, Maria Arlene; de Almeida Leal, Gleisiane Gomes; Marques, Marcos Jose; Veloso, Vanja Maria; Carneiro, Mariangela			Risk Factors for Seroconversion by Leishmania infantum in a Cohort of Dogs from an Endemic Area of Brazil	PLOS ONE			English	Article							CANINE VISCERAL LEISHMANIASIS; PHLEBOTOMINE SAND FLIES; HIGH TRANSMISSION; PARASITE DENSITY; IMMUNE-RESPONSE; MINAS-GERAIS; VACCINE; INFECTION; STATE; PCR	Visceral leishmaniasis (VL) has recently emerged in various urban and peri-urban areas of Brazil and other countries. Understanding the urbanization of VL requires identification of risk factors associated with human and canine infection. To determine the predictors of risk for canine VL, a survey was conducted of 1,443 dogs, from which a cohort was selected (n = 455) and evaluated for approximately 26 months. Serology was conducted with two enzyme-linked immunosorbent assays (ELISA): one conducted in the Laboratory of Zoonosis of the Belo Horizonte Health Department (LZOON) and the other in the Laboratory of Immunopathology of the Federal University of Ouro Preto (LIMP). A molecular diagnostic method (PCR-restriction fragment length polymorphism) and a structured questionnaire were also used. To identify the factors associated with seroconversion, two time-dependent Cox regression models were performed with different sensitivities (model 1, seroconversion by ELISA/LZOON; model 2, seroconversion by ELISA/LIMP). The overall incidences of seroconversion were 6.5/1000 dogs-months and 11.2/1000 dogs-months for ELISA/LZOON and ELISA/LIMP, respectively. Increased risk of seroconversion was associated with short fur (model 1: hazard ratio [HR] 1.9), the presence of dry leaves (model 1: HR 2.8) or manure (model 1: HR 3.5) in the backyard, dogs sleeping predominantly in the backyard (model 2: HR 2.1), the presence of symptoms (model 2: HR 2.0), and positive molecular results during follow-up (model 2: HR 1.5). Decreased risk was associated with insecticide spraying in the house (model 2: HR 0.5). These results indicate that more-vulnerable domiciles, certain dog behaviors, lack of vector control measures, and positive molecular results were associated with the occurrence of canine VL. Furthermore, it is important to emphasize that PCR-positive dogs should be monitored, owing to the possibility of seroconversion. Identifying risk factors for seroconversion in dogs is crucial for developing adequate strategies for VL prevention and control.	[Coura-Vital, Wendel; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Posgrad Infectol & Med Trop, Belo Horizonte, MG, Brazil; [Coura-Vital, Wendel; Reis, Alexandre Barbosa; de Almeida Leal, Gleisiane Gomes] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil; [Coura-Vital, Wendel; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Fausto, Maria Arlene] Univ Fed Ouro Preto, Escola Nutr, Dept Alimentos, Ouro Preto, MG, Brazil; [Marques, Marcos Jose] Univ Fed Alfenas, Dept Ciencias Biol, Alfenas, MG, Brazil; [Veloso, Vanja Maria] Univ Fed Ouro Preto, Escola Farm, Dept Farm, Ouro Preto, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Universidade Federal de Alfenas; Universidade Federal de Ouro Preto	Coura-Vital, W (corresponding author), Univ Fed Minas Gerais, Fac Med, Posgrad Infectol & Med Trop, Belo Horizonte, MG, Brazil.	wendelcoura@gmail.com	Marques, Marcos/AAR-3672-2021; Coura-Vital, Wendel/AAP-9624-2021; Reis, Alexandre Barbosa/I-9945-2014; Marques, Marcos José/G-8384-2012	Marques, Marcos/0000-0003-3459-3169; Reis, Alexandre Barbosa/0000-0001-8123-4164; /0000-0002-1434-7676	CAPES/PNPD grant [23038.007183/2011-23]; DECIT/MS/CNPq/BR/grant [576062/2008-1]; FAPEMIG/BR/grant [CBB - APQ-3073-4.01/07]; CNPq/BR/grant [472554/2007-7]; PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant [CBB-APQ-00356-10]; CNPq; CAPES/PNPD	CAPES/PNPD grant; DECIT/MS/CNPq/BR/grant; FAPEMIG/BR/grant; CNPq/BR/grant; PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the CAPES/PNPD grant 23038.007183/2011-23, DECIT/MS/CNPq/BR/grant 576062/2008-1, FAPEMIG/BR/grant CBB - APQ-3073-4.01/07, CNPq/BR/grant 472554/2007-7 and PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant CBB-APQ-00356-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ABR and MC are grateful by the CNPq fellowships and WCV by CNPq and CAPES/PNPD fellowships.	Barbosa-de-Deus R, 2002, CLIN DIAGN LAB IMMUN, V9, P1361, DOI 10.1128/CDLI.9.6.1361-1366.2002; Borja-Cabrera GP, 2008, VACCINE, V26, P4991, DOI 10.1016/j.vaccine.2008.07.029; Brasil 2011. Ministerio da Sadde, 2011, 012011CGDTCGLABDEVIT; Cardoso L, 2007, VET IMMUNOL IMMUNOP, V117, P35, DOI 10.1016/j.vetimm.2007.01.014; Coura-Vital W, 2011, Vet J, V190, pe43, DOI 10.1016/j.tvjl.2011.04.005; Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; Courtenay O, 2009, MED VET ENTOMOL, V23, P245, DOI 10.1111/j.1365-2915.2009.00815.x; da Silva JP, 2012, REV SOC BRAS MED TRO, V45, P480, DOI 10.1590/S0037-86822012005000009; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P531, DOI 10.1016/j.pt.2012.08.007; de Andrade HM, 2006, VET PARASITOL, V140, P231, DOI 10.1016/j.vetpar.2006.03.031; DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; do Rosario EY, 2005, MEM I OSWALDO CRUZ, V100, P197, DOI 10.1590/S0074-02762005000200015; DYE C, 1993, EPIDEMIOL INFECT, V110, P647, DOI 10.1017/S0950268800051074; Feliciangeli MD, 2004, MED VET ENTOMOL, V18, P71, DOI 10.1111/j.0269-283X.2004.0487.x; Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095; Franca-Silva JC, 2003, VET PARASITOL, V111, P161, DOI 10.1016/S0304-4017(02)00351-5; Fujiwara RT, 2005, VET RES, V36, P827, DOI 10.1051/vetres:2005033; Galvez R, 2010, VET PARASITOL, V169, P327, DOI 10.1016/j.vetpar.2009.11.025; Giunchetti RC, 2008, VACCINE, V26, P623, DOI 10.1016/j.vaccine.2007.11.057; Gradoni L, 2001, VET PARASITOL, V100, P87, DOI 10.1016/S0304-4017(01)00486-1; Grimaldi G, 2012, AM J TROP MED HYG, V86, P966, DOI 10.4269/ajtmh.2012.12-0040; Harhay MO, 2011, TRENDS PARASITOL, V27, P403, DOI 10.1016/j.pt.2011.04.001; Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2; Killick-Kendrick R., 1999, Canine leishmaniasis: an update. Proceedings of the International Canine Leishmaniasis Forum, Barcelona, Spain, 1999., P26; KillickKendrick R, 1997, MED VET ENTOMOL, V11, P105, DOI 10.1111/j.1365-2915.1997.tb00298.x; Lemesre JL, 2007, VACCINE, V25, P4223, DOI 10.1016/j.vaccine.2007.02.083; Manzillo VF, 2006, VET PARASITOL, V142, P142, DOI 10.1016/j.vetpar.2006.06.029; Ministerio da Saude, 2006, MAN VIG CONTR LEISHM; Ministry of Health of Brazil, 2012, CAS CONF LEISHM VISC; de Araujo VEM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001511; MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4; Michalsky EM, 2007, VET PARASITOL, V147, P67, DOI 10.1016/j.vetpar.2007.03.004; Moreira ED, 2003, AM J TROP MED HYG, V69, P393, DOI 10.4269/ajtmh.2003.69.393; Moreno J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001683; Costa CHN, 2011, REV SOC BRAS MED TRO, V44, P232, DOI 10.1590/S0037-86822011005000014; Costa CHN, 2008, CAD SAUDE PUBLICA, V24, P2959, DOI 10.1590/S0102-311X2008001200027; Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006; Otranto D, 2009, CLIN VACCINE IMMUNOL, V16, P337, DOI 10.1128/CVI.00268-08; de Almeida ADPF, 2009, REV SOC BRAS MED TRO, V42, P156, DOI 10.1590/S0037-86822009000200012; Passantino A, 2010, REV SCI TECH OIE, V29, P537; Passos VMA, 1999, ACTA TROP, V72, P251, DOI 10.1016/S0001-706X(98)00100-4; PBH, 2010, PERC POS LEISHM VISC; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; Quinnell RJ, 2001, PARASITOLOGY, V122, P253, DOI 10.1017/S0031182001007363; Quinnell RJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001992; Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001; Roatt BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049780; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Rondon FCM, 2008, VET PARASITOL, V155, P24, DOI 10.1016/j.vetpar.2008.04.014; Silva DA, 2011, VET PARASITOL, V179, P257, DOI 10.1016/j.vetpar.2011.01.048; Solano-Gallego L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-86; Neto RGT, 2010, VET PARASITOL, V169, P248, DOI 10.1016/j.vetpar.2010.01.023; Vittinghoff E, 2012, REGRESSION METHODS B; Werneck GL, 2008, EPIDEMIOL SERV SAUDE, V17, P87; [No title captured]	57	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e71833	10.1371/journal.pone.0071833	http://dx.doi.org/10.1371/journal.pone.0071833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23990996	gold, Green Published			2022-12-25	WOS:000324470700021
J	Duval, BD; Anderson-Teixeira, KJ; Davis, SC; Keogh, C; Long, SP; Parton, WJ; DeLucia, EH				Duval, Benjamin D.; Anderson-Teixeira, Kristina J.; Davis, Sarah C.; Keogh, Cindy; Long, Stephen P.; Parton, William J.; DeLucia, Evan H.			Predicting Greenhouse Gas Emissions and Soil Carbon from Changing Pasture to an Energy Crop	PLOS ONE			English	Article							NITROUS-OXIDE EMISSIONS; ORGANIC-MATTER LEVELS; MANAGEMENT OPTIONS; CLIMATE-CHANGE; GREAT-PLAINS; SUGARCANE; BIOFUELS; LAND; DAYCENT; CORN	Bioenergy related land use change would likely alter biogeochemical cycles and global greenhouse gas budgets. Energy cane (Saccharum officinarum L.) is a sugarcane variety and an emerging biofuel feedstock for cellulosic bio-ethanol production. It has potential for high yields and can be grown on marginal land, which minimizes competition with grain and vegetable production. The DayCent biogeochemical model was parameterized to infer potential yields of energy cane and how changing land from grazed pasture to energy cane would affect greenhouse gas (CO2, CH4 and N2O) fluxes and soil C pools. The model was used to simulate energy cane production on two soil types in central Florida, nutrient poor Spodosols and organic Histosols. Energy cane was productive on both soil types (yielding 46-76 Mg dry mass.ha(-1)). Yields were maintained through three annual cropping cycles on Histosols but declined with each harvest on Spodosols. Overall, converting pasture to energy cane created a sink for GHGs on Spodosols and reduced the size of the GHG source on Histosols. This change was driven on both soil types by eliminating CH4 emissions from cattle and by the large increase in C uptake by greater biomass production in energy cane relative to pasture. However, the change from pasture to energy cane caused Histosols to lose 4493 g CO2 eq.m(-2) over 15 years of energy cane production. Cultivation of energy cane on former pasture on Spodosol soils in the southeast US has the potential for high biomass yield and the mitigation of GHG emissions.	[Duval, Benjamin D.; Anderson-Teixeira, Kristina J.; Davis, Sarah C.; Long, Stephen P.; DeLucia, Evan H.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA; [Duval, Benjamin D.; Long, Stephen P.; DeLucia, Evan H.] Global Change Solut, Urbana, IL USA; [Keogh, Cindy; Parton, William J.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Long, Stephen P.; DeLucia, Evan H.] Univ Illinois, Dept Plant Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; Colorado State University; University of Illinois System; University of Illinois Urbana-Champaign	DeLucia, EH (corresponding author), Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA.	delucia@illinois.edu	Long, Stephen/AAA-1741-2019; Anderson-Teixeira, Kristina J./U-6075-2019; Long, Stephen P/A-2488-2008	Long, Stephen/0000-0002-8501-7164; Long, Stephen P/0000-0002-8501-7164	Energy Bioscience Institute	Energy Bioscience Institute	This research was funded by the Energy Bioscience Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PR, 2007, ECOL APPL, V17, P675, DOI 10.1890/05-2018; Anderson-Teixeira KJ, 2009, GCB BIOENERGY, V1, P75, DOI 10.1111/j.1757-1707.2008.01001.x; [Anonymous], SOURC DAIL SURF WEAT; BALLCOELHO B, 1992, PLANT SOIL, V142, P297, DOI 10.1007/BF00010975; Barbour M.G., 1988, N AM TERRESTRIAL VEG; Baucum L. E., 2009, SSAGR232 U FLOR IFAS; Beale CV, 1997, BIOMASS BIOENERG, V12, P419, DOI 10.1016/S0961-9534(97)00016-0; Borjesson P, 2009, APPL ENERG, V86, P589, DOI 10.1016/j.apenergy.2008.11.025; BOWDEN RD, 1993, CAN J FOREST RES, V23, P1402, DOI 10.1139/x93-177; Brady NC, 2002, NATURE PROPERTY SOIL, V13; Chapin FS, 2006, ECOSYSTEMS, V9, P1041, DOI 10.1007/s10021-005-0105-7; Chapin FS, 2002, PRINCIPALS TERRESTRI; Crawley MJ., 2007, R BOOK; David MB, 2009, BIOGEOCHEMISTRY, V93, P7, DOI 10.1007/s10533-008-9273-9; Davis SC, 2012, FRONT ECOL ENVIRON, V10, P69, DOI 10.1890/110003; Davis SC, 2010, ECOSYSTEMS, V13, P144, DOI 10.1007/s10021-009-9306-9; Davis SC, 2009, TRENDS PLANT SCI, V14, P140, DOI 10.1016/j.tplants.2008.12.006; Del Grosso S, 2002, ENVIRON POLLUT, V116, pS75, DOI 10.1016/S0269-7491(01)00260-3; Del Grosso SJ, 2008, J ENVIRON QUAL, V37, P1383, DOI 10.2134/jeq2007.0292; Del Grosso SJ, 2006, J ENVIRON QUAL, V35, P1451, DOI 10.2134/jeq2005.0160; Del Grosso SJ, 2008, NITROGEN IN THE ENVIRONMENT: SOURCES, PROBLEMS, AND MANAGEMENT, 2ND EDITION, P571, DOI 10.1016/B978-0-12-374347-3.00018-4; Del Grosso SJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P1045, DOI 10.1029/1999GB001225; Del Grosso SJ, 2005, SOIL TILL RES, V83, P9, DOI 10.1016/j.still.2005.02.007; Del Grosso SJ, 2000, NON-CO2 GREENHOUSE GASES: SCIENTIFIC UNDERSTANDING, CONTROL AND IMPLEMENTATION, P303; DeRamus HA, 2003, J ENVIRON QUAL, V32, P269, DOI 10.2134/jeq2003.0269; Dien BS, 2002, INT SUGAR J, V104, P204; Donner SD, 2008, P NATL ACAD SCI USA, V105, P4513, DOI 10.1073/pnas.0708300105; Eitzinger J, 2000, SOIL SCI, V165, P525, DOI 10.1097/00010694-200007000-00001; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Fargione JE, 2010, ANNU REV ECOL EVOL S, V41, P351, DOI 10.1146/annurev-ecolsys-102209-144720; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Galdos MV, 2010, PLANT SOIL, V326, P243, DOI 10.1007/s11104-009-0004-3; Gilbert RA, 2006, FIELD CROP RES, V95, P156, DOI 10.1016/j.fcr.2005.02.006; Glaz B., 1993, Journal - American Society of Sugar Cane Technologists, V13, P7; Glaz B, 2012, COMMUNICATION; Glaz B, 2010, AGRON J, V102, P372, DOI 10.2134/agronj2009.0262; Graham-Rowe D, 2011, NATURE, V474, pS6, DOI 10.1038/474S06a; Hansen EM, 2004, BIOMASS BIOENERG, V26, P97, DOI 10.1016/S0961-9534(03)00102-8; Hartman MD, 2011, ECOL APPL, V21, P1105, DOI 10.1890/10-0036.1; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Hersom M, 2005, AN155 U FLOR I FOOD; Hill J, 2009, P NATL ACAD SCI USA, V106, P2077, DOI 10.1073/pnas.0812835106; HOWDEN SM, 1994, CLIMATIC CHANGE, V27, P49, DOI 10.1007/BF01098473; Hoy JW, 1999, PLANT DIS, V83, P1170, DOI 10.1094/PDIS.1999.83.12.1170; Kelly RH, 2000, J GEOPHYS RES-ATMOS, V105, P20093, DOI 10.1029/2000JD900259; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Liebig MA, 2010, J ENVIRON QUAL, V39, P799, DOI 10.2134/jeq2009.0272; Mark T., 2009, SO AGR EC ASS ANN M; Melillo JM, 2009, SCIENCE, V326, P1397, DOI 10.1126/science.1180251; Morgan K. T., 2009, SL295; Morris Dolen R., 2005, Journal of Food Agriculture & Environment, V3, P190; Morris DR, 2004, SOIL SCI SOC AM J, V68, P817, DOI 10.2136/sssaj2004.0817; Mosier A, 1998, NUTR CYCL AGROECOSYS, V52, P225, DOI 10.1023/A:1009740530221; Muchovej R. M., 2004, Journal - American Society of Sugar Cane Technologists, V24, P225; Newman Y, 2010, U FLORIDA PUBLICATIO; O'Hare M, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024001; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Parton WJ, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001193; Parton WJ, 1998, GLOBAL PLANET CHANGE, V19, P35, DOI 10.1016/S0921-8181(98)00040-X; PARTON WJ, 1987, SOIL SCI SOC AM J, V51, P1173, DOI 10.2136/sssaj1987.03615995005100050015x; PARTON WJ, 1994, SSSA SPEC PUBL, P147; Paustian K, 2000, BIOGEOCHEMISTRY, V48, P147, DOI 10.1023/A:1006271331703; Pepper DA, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002226; PITMAN WD, 1992, TROP GRASSLANDS, V26, P206; Plevin RJ, 2010, ENVIRON SCI TECHNOL, V44, P8015, DOI 10.1021/es101946t; R Development Core Team, 2007, R LANG ENV STAT COMP; Rice RW, 2002, SSARG228 UFIFAS FLOR; Robertson GP, 2011, ECOL APPL, V21, P1055, DOI 10.1890/09-0456.1; Rowlings D., 2010, Proceedings of the 19th World Congress of Soil Science: Soil solutions for a changing world, Brisbane, Australia, 1-6 August 2010. Congress Symposium 4: Greenhouse gases from soils, P199; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; SLADDEN SE, 1991, BIOMASS BIOENERG, V1, P123, DOI 10.1016/0961-9534(91)90035-B; Smeets EMW, 2009, GLOBAL CHANGE BIOL, V15, P1, DOI 10.1111/j.1365-2486.2008.01704.x; Smith CM, 2013, J ENVIRON QUAL, V42, P219, DOI 10.2134/jeq2012.0210; Solomon BD, 2007, BIOMASS BIOENERG, V31, P416, DOI 10.1016/j.biombioe.2007.01.023; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Stehfest E, 2006, NUTR CYCL AGROECOSYS, V74, P207, DOI 10.1007/s10705-006-9000-7; Steiner J, 2012, COMMUNICATION; Stirling GR, 2001, AUSTRALAS PLANT PATH, V30, P323, DOI 10.1071/AP01044; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Thorburn PJ, 2010, AGR ECOSYST ENVIRON, V136, P343, DOI 10.1016/j.agee.2009.12.014; Tilman D, 1998, NATURE, V396, P211, DOI 10.1038/24254; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; US Environmental Protection Agency, 2011, FLOR SUG MET; VALENTINE DW, 1994, J GEOPHYS RES-ATMOS, V99, P1563, DOI 10.1029/93JD00391; Vallis I, 1996, SOIL TILL RES, V38, P115, DOI 10.1016/0167-1987(96)01014-8; Wiedenfeld B, 2008, AGRON J, V100, P665, DOI 10.2134/agronj2007.0286; YADAV RL, 1992, EXP AGR, V28, P57, DOI 10.1017/S0014479700023012; Zeri M, 2011, AGR ECOSYST ENVIRON, V144, P319, DOI 10.1016/j.agee.2011.09.006	91	19	19	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72019	10.1371/journal.pone.0072019	http://dx.doi.org/10.1371/journal.pone.0072019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991028	gold, Green Submitted, Green Published			2022-12-25	WOS:000324470100071
J	Gari, S; Malungo, JRS; Martin-Hilber, A; Musheke, M; Schindler, C; Merten, S				Gari, Sara; Malungo, Jacob R. S.; Martin-Hilber, Adriane; Musheke, Maurice; Schindler, Christian; Merten, Sonja			HIV Testing and Tolerance to Gender Based Violence: A Cross-Sectional Study in Zambia	PLOS ONE			English	Article							ANTENATAL CLINICS; HIV/AIDS STIGMA; WOMEN; GOSSIP; AIDS; INFECTION; ATTITUDES; FAMILY; RISK; CAPE	This paper explores the effect of social relations and gender-based conflicts on the uptake of HIV testing in the South and Central provinces of Zambia. We conducted a community-based cross-sectional study of 1716 randomly selected individuals. Associations were examined using mixed-effect multivariable logistic regression. A total of 264 men (64%) and 268 women (56%) had never tested for HIV. The strongest determinants for not being tested were disruptive couple relationships (OR = 2.48 95% CI = 1.00-6.19); tolerance to gender-based violence (OR = 2.10 95% CI = 1.05-4.32) and fear of social rejection (OR = 1.48 95% CI = 1.23-1.80). In the Zambian context, unequal power relationships within the couple and the community seem to play a pivotal role in the decision to test which until now have been largely underestimated. Policies, programs and interventions to rapidly increase HIV testing need to urgently address gender-power inequity in relationships and prevent gender-based violence to reduce the negative impact on the lives of couples and families.	[Gari, Sara; Musheke, Maurice; Schindler, Christian; Merten, Sonja] Univ Basel, Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Malungo, Jacob R. S.] Univ Zambia, Dept Populat Studies, Lusaka, Zambia; [Martin-Hilber, Adriane] Univ Basel, Swiss Trop & Publ Hlth Inst, Swiss Ctr Int Hlth, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Zambia; University of Basel; Swiss Tropical & Public Health Institute	Gari, S (corresponding author), Univ Basel, Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	sara.gari@unibas.ch	Schindler, Christian/D-3472-2015	Merten, Sonja/0000-0003-4115-106X	Spanish agency for International Development Cooperation (AECID); ART access study Swiss National Science Foundation (SNSF) [PDFMP3-123185]	Spanish agency for International Development Cooperation (AECID); ART access study Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	Sara Gari received financial support through a ProDoc Research grant from the Spanish agency for International Development Cooperation (AECID). Funding for the project was received from the ART access study Swiss National Science Foundation (SNSF; project number PDFMP3-123185). The sponsors of this study had no role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Adams JL, 2011, VIOLENCE AGAINST WOM, V17, P1014, DOI 10.1177/1077801211414166; Allen S., 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; Andreassen R, 1998, ETNOFOOR, V11, P41; ANKRAH EM, 1993, AIDS CARE, V5, P5, DOI 10.1080/09540129308258580; Ayles HM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-63; Bennet, 2000, AIDS BEHAV, V4, P261, DOI [https://doi.org/10.1023/A:1009568718804, DOI 10.1023/A:1009568718804, 10.1023/A:1009568718804.]; Besnier N, 1994, PACIFIC STUDIES, V17, P1; Campbell C, 2002, AIDS CARE, V14, P41, DOI 10.1080/09540120220097928; Conkling M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-10; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; CSO, 2010, ZAMB SEX BEH SURV; Deacon H, 2006, J COMMUNITY APPL SOC, V16, P418, DOI 10.1002/casp.900; Decker MR, 2009, JAIDS-J ACQ IMM DEF, V51, P593, DOI 10.1097/QAI.0b013e3181a255d6; Desgrees-du-Lou A, 2008, REPROD HEALTH MATTER, V16, P151, DOI 10.1016/S0968-8080(08)32407-0; DUNBAR R, 1992, NEW SCI, V136, P28; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Ekanem E E, 2004, Afr J Reprod Health, V8, P91, DOI 10.2307/3583183; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Fox MP, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-8; Fylkesnes K, 2004, TROP MED INT HEALTH, V9, P566, DOI 10.1111/j.1365-3156.2004.01231.x; Genberg BL, 2008, AIDS BEHAV, V12, P772, DOI 10.1007/s10461-007-9340-6; Glick P, 2007, J POPUL ECON, V20, P383, DOI 10.1007/s00148-006-0085-8; Global HIV/AIDS response, 2011, EP UPD HLTH SECT PRO; GLUCKMAN M, 1963, CURR ANTHROPOL, V4, P307, DOI 10.1086/200378; HANNERZ U, 1967, ETHNOS, V32, P35, DOI 10.1080/00141844.1967.9980988; Hardouin JB, 2004, MSP STATA MODULE PER; Herek GM, 1998, AIDS PUBLIC POLICY J, V13, P36; Holzemer WL, 2007, AIDS CARE, V19, P1002, DOI 10.1080/09540120701245999; Hutchinson PL, 2006, AIDS CARE, V18, P446, DOI 10.1080/09540120500213511; Irungu TK, 2008, HIV MED, V9, P111, DOI 10.1111/j.1468-1293.2007.00538.x; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024256; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Jurgensen M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-2; Kakoko DC, 2006, AIDS CARE, V18, P554, DOI 10.1080/09540120500259779; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Koku EF, 2011, J COMMUN HEALTH, V36, P289, DOI 10.1007/s10900-010-9310-1; Li L, 2006, AIDS BEHAV, V10, P509, DOI 10.1007/s10461-006-9071-0; LOEVINGER J, 1948, PSYCHOL BULL, V45, P507, DOI 10.1037/h0055827; Malungo JRS, 2001, SOC SCI MED, V53, P371, DOI 10.1016/S0277-9536(00)00342-7; Molenaar I. W, 1984, TIJDSCHRIFT ONDERWIJ, V9, P257; Molenaar I. W., 2000, MSP5 WINDOWS PROGRAM; OMCT, 2007, HUM RIGHTS VIOL ZA 2, P9; Pequegnat W, 2000, WORKING WITH FAMILIES IN THE ERA OF HIV/AIDS, P3; Pettifor A, 2010, AIDS BEHAV, V14, P913, DOI 10.1007/s10461-008-9462-5; Pitpitan EV, 2012, SOC SCI MED, V75, P1417, DOI 10.1016/j.socscimed.2012.06.020; Pool R, 2001, AIDS CARE, V13, P605, DOI 10.1080/09540120120063232; Poundstone KE, 2004, EPIDEMIOL REV, V26, P22, DOI 10.1093/epirev/mxh005; RADIMER KL, 1990, J NUTR, V120, P1544, DOI 10.1093/jn/120.suppl_11.1544; Sabini J., 1982, MORALITIES EVERYDAY; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Singh K, 2013, GENDER EQUALITY ED I; Stadler J, 2003, AIDS EDUC PREV, V15, P357, DOI 10.1521/aeap.15.5.357.23823; UNAIDS, 2009, JOINT ACT RES, P2009; UNAIDS, 2011, AIDS EP UPD 2009 POP; UNAIDS/WHO, 2004, WOM AIDS EXTR AIDS E; UNGASS, 2012, ZAMB COUNTR PROGR RE; UNIFEM, 2011, VIOL WOM FACTS FIG; Vamos S, 2013, QUALITY RELATIONSHIP; Watkins SC, 2009, POETICS, V37, P162, DOI 10.1016/j.poetic.2009.03.002; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; Were W, 2003, LANCET, V361, P1569, DOI 10.1016/S0140-6736(03)13212-6; Wolff B, 2005, HEALTH POLICY PLANN, V20, P109, DOI 10.1093/heapol/czi013; Wringe A, 2008, TROP MED INT HEALTH, V13, P319, DOI 10.1111/j.1365-3156.2008.02005.x; Zou J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-75	66	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71922	10.1371/journal.pone.0071922	http://dx.doi.org/10.1371/journal.pone.0071922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218YW	23991005	gold, Green Published, Green Accepted			2022-12-25	WOS:000324470100064
J	Pozzi, V; Sartini, D; Morganti, S; Giuliante, R; Di Ruscio, G; Santarelli, A; Rocchetti, R; Rubini, C; Tomasetti, M; Giannatempo, G; Orlando, F; Provinciali, M; Lo Muzio, L; Emanuelli, M				Pozzi, Valentina; Sartini, Davide; Morganti, Stefano; Giuliante, Rachela; Di Ruscio, Giulia; Santarelli, Andrea; Rocchetti, Romina; Rubini, Corrado; Tomasetti, Marco; Giannatempo, Giovanni; Orlando, Fiorenza; Provinciali, Mauro; Lo Muzio, Lorenzo; Emanuelli, Monica			RNA-Mediated Gene Silencing of Nicotinamide N-Methyltransferase Is Associated with Decreased Tumorigenicity in Human Oral Carcinoma Cells	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-1-BETA; 1-METHYLNICOTINAMIDE MNA; TUMOR-MARKER; EXPRESSION; CANCER; IDENTIFICATION; ACTIVATION; DIFFERENTIATION; PROLIFERATION; RADIATION	Oral squamous cell carcinoma (OSCC) is the most common type of oral cancer. Despite progress in the treatment of OSCC, overall survival has not improved substantially in the last three decades. Therefore, identification of reliable biomarkers becomes essential to develop effective anti-cancer therapy. In this study, we focused on the enzyme Nicotinamide N-methyltransferase (NNMT), which plays a fundamental role in the biotransformation of many xenobiotics. Although several tumors have been associated with abnormal NNMT expression, its role in cancer cell metabolism remains largely unknown. In this report, 7 human oral cancer cell lines were examined for NNMT expression by Real-Time PCR, Western blot and HPLC-based catalytic assay. Subsequently, we evaluated the in vitro effect of shRNA-mediated silencing of NNMT on cell proliferation. In vivo tumorigenicity of oral cancer cells with stable knockdown of NNMT was assayed by using xenograft models. High expression levels of NNMT were found in PE/CA PJ-15 cells, in keeping with the results of Western blot and catalytic activity assay. PE/CA PJ-15 cell line was stably transfected with shRNA plasmids against NNMT and analyzed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and soft agar Assays. Transfected and control cells were injected into athymic mice in order to evaluate the effect of NNMT silencing on tumor growth. NNMT downregulation resulted in decreased cell proliferation and colony formation ability on soft agar. In athymic mice, NNMT silencing induced a marked reduction in tumour volume. Our results show that the downregulation of NNMT expression in human oral carcinoma cells significantly inhibits cell growth in vitro and tumorigenicity in vivo. All these experimental data seem to suggest that NNMT plays a critical role in the proliferation and tumorigenic capacity of oral cancer cells, and its inhibition could represent a potential molecular approach to the treatment of oral carcinoma.	[Pozzi, Valentina; Sartini, Davide; Morganti, Stefano; Giuliante, Rachela; Di Ruscio, Giulia; Santarelli, Andrea; Emanuelli, Monica] Polytech Univ Marche, Dept Clin Sci, Ancona, Italy; [Santarelli, Andrea] IRCCS INRCA, Ancona, Italy; [Rocchetti, Romina; Rubini, Corrado] Polytech Univ Marche, Dept Biomed Sci & Publ Hlth, Ancona, Italy; [Tomasetti, Marco] Polytech Univ Marche, Dept Mol & Clin Sci, Ancona, Italy; [Giannatempo, Giovanni; Lo Muzio, Lorenzo] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Orlando, Fiorenza] IRCCS INRCA, Expt Anim Models Aging Units, Ancona, Italy; [Provinciali, Mauro] IRCCS INRCA, Adv Technol Ctr Aging Res, Sci Technol Area, Ancona, Italy	Marche Polytechnic University; IRCCS INRCA; Marche Polytechnic University; Marche Polytechnic University; University of Foggia; IRCCS INRCA; IRCCS INRCA	Emanuelli, M (corresponding author), Polytech Univ Marche, Dept Clin Sci, Ancona, Italy.	m.emanuelli@univpm.it	Santarelli, Andrea/P-6310-2014; Orlando, Fiorenza/AAB-3441-2021; Muzio, Lorenzo Lo/C-8533-2011; Santarelli, Andrea/O-1580-2019; Provinciali, Mauro/K-5683-2016	Santarelli, Andrea/0000-0003-4218-3354; Orlando, Fiorenza/0000-0001-7351-4430; Muzio, Lorenzo Lo/0000-0003-4633-4893; Santarelli, Andrea/0000-0003-4218-3354; Provinciali, Mauro/0000-0002-0568-3002	Italian Ministry for University and Research [20089E83YR_004]	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Ministry for University and Research through PRIN 20089E83YR_004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSOY S, 1994, J BIOL CHEM, V269, P14835; Audrito V, 2011, CANCER RES, V71, P4473, DOI 10.1158/0008-5472.CAN-10-4452; BALDUCCI E, 1995, BIOCHEM J, V310, P395, DOI 10.1042/bj3100395; Bartus M, 2008, PHARMACOL REP, V60, P127; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bryniarski K, 2008, EUR J PHARMACOL, V578, P332, DOI 10.1016/j.ejphar.2007.09.011; Brzozowski T, 2008, J PHARMACOL EXP THER, V326, P105, DOI 10.1124/jpet.108.136457; Chlopicki S, 2007, BRIT J PHARMACOL, V152, P230, DOI 10.1038/sj.bjp.0707383; D'Andrea FP, 2011, RADIOTHER ONCOL, V99, P373, DOI 10.1016/j.radonc.2011.05.086; Debigare R, 2008, COPD, V5, P75, DOI 10.1080/15412550801940457; Emanuelli M, 2010, HISTOL HISTOPATHOL, V25, P15, DOI 10.14670/HH-25.15; Francis SMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017442; Jang JS, 2004, ONCOL RES, V14, P491, DOI 10.3727/0965040042380441; Kassem HS, 2002, INT J CANCER, V101, P454, DOI 10.1002/ijc.10631; Kim J, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-20; Lim BH, 2006, EXP MOL MED, V38, P455, DOI 10.1038/emm.2006.54; Lo Muzio L, 2014, MOL CARCINOGEN, V53, P264, DOI 10.1002/mc.21960; Markert JM, 2001, PHYSIOL GENOMICS, V5, P21, DOI 10.1152/physiolgenomics.2001.5.1.21; Mateuszuk L, 2009, PHARMACOL REP, V61, P76; Okamoto H, 2003, AM J CLIN NUTR, V77, P406, DOI 10.1093/ajcn/77.2.406; Parsons RB, 2011, BIOCHEM J, V436, P145, DOI 10.1042/BJ20101685; Peng Y, 2011, BIOCHEMISTRY-US, V50, P7800, DOI 10.1021/bi2007614; Pozzi V, 2011, INT J IMMUNOPATH PH, V24, P69, DOI 10.1177/039463201102400109; Roessler M, 2005, CLIN CANCER RES, V11, P6550, DOI 10.1158/1078-0432.CCR-05-0983; Rogers CD, 2006, CANCER BIOL THER, V5, P1383, DOI 10.4161/cbt.5.10.3323; Sartini D, 2013, CELL BIOCH BIOPHYS; Sartini D, 2007, MOL MED, V13, P415, DOI 10.2119/2007-00035.Sartini; Sartini D, 2006, J UROLOGY, V176, P2248, DOI 10.1016/j.juro.2006.07.046; Sartini D, 2013, CELL BIOCHEM BIOPHYS, V65, P473, DOI 10.1007/s12013-012-9451-1; Sartini D, 2012, BIOL CHEM, V393, P505, DOI 10.1515/hsz-2012-0112; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Tang SW, 2011, CARCINOGENESIS, V32, P138, DOI 10.1093/carcin/bgq225; Tomida M, 2008, J CANCER RES CLIN, V134, P551, DOI 10.1007/s00432-007-0318-6; Tomida M, 2009, J CANCER RES CLIN, V135, P1223, DOI 10.1007/s00432-009-0563-y; Williams AC, 2005, J CLIN NEUROSCI, V12, P6, DOI 10.1016/j.jocn.2004.10.002; Wu JY, 2010, ORAL ONCOL, V46, P226, DOI 10.1016/j.oraloncology.2010.01.007; Wu Y, 2008, ONCOGENE, V27, P6679, DOI 10.1038/onc.2008.264; Xiong P, 2011, PROTEIN J, V30, P499, DOI 10.1007/s10930-011-9354-9; Xu JM, 2006, THYROID, V16, P151, DOI 10.1089/thy.2006.16.151; Xu JM, 2005, MOL ENDOCRINOL, V19, P527, DOI 10.1210/me.2004-0215; Xu JM, 2003, J CLIN ENDOCR METAB, V88, P4990, DOI 10.1210/jc.2002-021843; Yao M, 2005, J PATHOL, V205, P377, DOI 10.1002/path.1693; Zhang J, 2003, BIOESSAYS, V25, P808, DOI 10.1002/bies.10317	43	41	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e71272	10.1371/journal.pone.0071272	http://dx.doi.org/10.1371/journal.pone.0071272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23990942	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100041
J	Hu, J; Wang, N; Wang, YJ				Hu, Jia; Wang, Ning; Wang, Ya-Jie			XRCC3 and RAD51 Expression Are Associated with Clinical Factors in Breast Cancer	PLOS ONE			English	Article							IONIZING-RADIATION; REPAIR; RECEPTOR; CELLS; CARCINOMA; SURVIVAL; GENE; EGFR; PROGESTERONE; METAANALYSIS	Aims: XRCC3 and RAD51 are two important members in homologous recombination repair pathway. This study was performed to detect the expressions of these two molecules in breast cancer and explore their correlations with clinicopathological factors. Methods and Results: Immunohistochemistry was used to detect protein expressions of XRCC3 and RAD51 in 248 cases of breast cancer tissue and 78 cases of adjacent non-cancerous tissue. Data showed that expressions for both XRCC3 and RAD51 were significantly increased in breast cancer. High XRCC3 expression was associated with large tumor size and positive PR and HER2 status, while high RAD51 expression was associated with axillary lymph node metastasis and positive PR and HER2 status. The result of multivariate analysis demonstrated that HER2, PR and RAD51 were significantly association with XRCC3. And besides XRCC3, axillary lymph node metastasis and PR were significantly correlated with RAD51. Conclusions: XRCC3 and RAD51 were significantly associated with clinicopathological factors and they might play important roles in the development and progress of breast cancer.	[Hu, Jia] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Oncol 2, Beijing, Peoples R China; [Hu, Jia; Wang, Ning; Wang, Ya-Jie] Second Mil Med Univ, Changhai Hosp, Dept Oncol, Shanghai, Peoples R China	Chinese People's Liberation Army General Hospital; Naval Medical University	Wang, YJ (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Oncol, Shanghai, Peoples R China.	yajiewa0820@163.com			Natural Science Foundation of The People's Republic of China [81072175]; Shanghai Science and Technology Committee [114119a7500, 06DZ19505]; Research Programme of Shanghai Health Bureau [2009113, 2011198]	Natural Science Foundation of The People's Republic of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Research Programme of Shanghai Health Bureau	This study was supported by Natural Science Foundation of The People's Republic of China (No. 81072175), Shanghai Science and Technology Committee (No. 114119a7500 and No. 06DZ19505) and the Research Programme of Shanghai Health Bureau (No. 2009113 and No. 2011198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 2000, AM J CLIN PATHOL, V113, P171, DOI 10.1309/9X6X-1EL6-5QB1-YLD2; Ang KK, 2002, CANCER RES, V62, P7350; Angele S, 2003, HISTOPATHOLOGY, V43, P347, DOI 10.1046/j.1365-2559.2003.01713.x; Barbano R, 2011, INT J CANCER, V129, P536, DOI 10.1002/ijc.25736; Bartkova J, 2008, MOL ONCOL, V2, P296, DOI 10.1016/j.molonc.2008.09.007; Bergkvist GT, 2011, CANCER BIOL THER, V11, P927, DOI 10.4161/cbt.11.11.15525; Bishop DK, 1998, J BIOL CHEM, V273, P21482, DOI 10.1074/jbc.273.34.21482; Cuatrecasas M, 2006, HISTOL HISTOPATHOL, V21, P149, DOI 10.14670/HH-21.149; Golding SE, 2009, CANCER BIOL THER, V8, P730, DOI 10.4161/cbt.8.8.7927; He XF, 2012, MOL BIOL REP, V39, P5125, DOI 10.1007/s11033-011-1308-y; Krause M, 2006, RADIOTHER ONCOL, V80, P112, DOI 10.1016/j.radonc.2006.07.017; Kriegs M, 2010, DNA REPAIR, V9, P889, DOI 10.1016/j.dnarep.2010.05.005; Leake R, 2000, J CLIN PATHOL, V53, P634, DOI 10.1136/jcp.53.8.634; Leo JCL, 2005, INT J CANCER, V117, P561, DOI 10.1002/ijc.21186; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Loignon M, 2007, CELL CYCLE, V6, P606, DOI 10.4161/cc.6.5.3923; Maacke H, 2000, INT J CANCER, V88, P907, DOI 10.1002/1097-0215(20001215)88:6<907::AID-IJC11>3.0.CO;2-4; Martelli A, 2003, MUTAT RES-GEN TOX EN, V536, P69, DOI 10.1016/S1383-5718(03)00036-6; Martinez-Marignac VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016394; Mohammed ZMA, 2012, HISTOPATHOLOGY, V61, P283, DOI 10.1111/j.1365-2559.2012.04244.x; Murdoch WJ, 1998, J ENDOCRINOL, V156, P503, DOI 10.1677/joe.0.1560503; Myllynen L, 2011, RADIOTHER ONCOL, V101, P147, DOI 10.1016/j.radonc.2011.05.046; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Qiu LX, 2010, BREAST CANCER RES TR, V122, P489, DOI 10.1007/s10549-009-0726-1; Ralhan R, 2007, CANCER LETT, V248, P1, DOI 10.1016/j.canlet.2006.06.004; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Toulany M, 2010, RADIOTHER ONCOL, V97, P338, DOI 10.1016/j.radonc.2010.03.008; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Wang ZM, 2001, J NATL CANCER I, V93, P1473, DOI 10.1093/jnci/93.19.1473; Yanagisawa T, 1998, ORAL ONCOL, V34, P524, DOI 10.1016/S1368-8375(98)00045-1; Zhang B, 2011, LANCET ONCOL, V12, P477, DOI 10.1016/S1470-2045(11)70076-6	31	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72104	10.1371/journal.pone.0072104	http://dx.doi.org/10.1371/journal.pone.0072104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977219	gold, Green Published, Green Submitted			2022-12-25	WOS:000324527300063
J	Lee, JH; Choi, CW; Lee, T; Kim, SI; Lee, JC; Shin, JH				Lee, Jung Hwa; Choi, Chi-Won; Lee, Taewon; Kim, Seung Il; Lee, Je-Chul; Shin, Ji-Hyun			Transcription Factor sigma(B) Plays an Important Role in the Production of Extracellular Membrane-Derived Vesicles in Listeria monocytogenes	PLOS ONE			English	Article							OSMOLYTE TRANSPORTERS BETL; PSEUDOMONAS-AERUGINOSA; STRESS-RESPONSE; GROWTH; VIRULENCE; RELEASE; ACID; OPUC; INDUCTION; SECRETION	Gram-negative bacteria produce extracellular outer membrane vesicles (OMVs) that interact with host cells. Unlike Gram-negative bacteria, less is known about the production and role of extracellular membrane vesicles (MVs) in Gram-positive bacteria. The food-borne pathogen Listeria monocytogenes can survive under extreme environmental and energy stress conditions and the transcription factor sigma(B) is involved in this survival ability. Here, we first determined the production of MVs from L. monocytogenes and evaluated whether general stress transcription factor sigma(B) affected production of MVs in L. monocytogenes. L. monocytogenes secreted MVs during in vitro broth culture. The wild-type strain actively produced MVs approximately nine times more and also produced more intact shapes of MVs than those of the isogenic Delta sigB mutant. A proteomic analysis showed that 130 and 89 MV proteins were identified in the wild-type and Delta sigB mutant strains, respectively. Wild-type strain-derived MVs contained proteins regulated by sigma(B) such as transporters (OpuCA and OpuCC), stress response (Kat), metabolism (LacD), translation (InfC), and cell division protein (FtsZ). Gene Ontology (GO) enrichment analysis showed that wild-type-derived MV proteins corresponded to several GO terms, including response to stress (heat, acid, and bile resistance) and extracellular polysaccharide biosynthetic process, but not the Delta sigB mutant. Internalin B (InlB) was almost three times more contained in MVs derived from the wild-type strain than in MVs derived from the Delta sigB mutant. Taken together, these results suggest that sigma(B) plays a pivotal role in the production of MVs and protein profiles contained in MVs. L. monocytogenes MVs may contribute to host infection and survival ability under various stressful conditions.	[Lee, Jung Hwa; Lee, Je-Chul] Kyungpook Natl Univ, Sch Med, Dept Microbiol, Taegu, South Korea; [Choi, Chi-Won; Kim, Seung Il] Korea Basic Sci Inst, Div Life Sci, Taejon, South Korea; [Lee, Taewon] Korea Univ, Dept Math & Informat, Sejong, South Korea; [Shin, Ji-Hyun] Dankook Univ, Coll Med, Dept Pharmacol, Cheonan, South Korea	Kyungpook National University; Korea Basic Science Institute (KBSI); Korea University; Dankook University	Lee, JC (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Microbiol, Taegu, South Korea.	leejc@knu.ac.kr; sjih@hotmail.com		Lee, Taewon/0000-0003-4741-5054	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science, ICT and Future Planning [2012R1A1A3008038]; Korea Basic Science Institute [T33414]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea Basic Science Institute	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (grant no. 2012R1A1A3008038 to J.H.S) and the Korea Basic Science Institute (T33414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azizoglu RO, 2010, APPL ENVIRON MICROB, V76, P6998, DOI 10.1128/AEM.01223-10; Bauman SJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-26; Becker LA, 1998, J BACTERIOL, V180, P4547, DOI 10.1128/JB.180.17.4547-4554.1998; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DORWARD DW, 1990, APPL ENVIRON MICROB, V56, P1960, DOI 10.1128/AEM.56.6.1960-1962.1990; Dutta S, 2004, MICROBIOL IMMUNOL, V48, P965, DOI 10.1111/j.1348-0421.2004.tb03626.x; Ferreira A, 2001, APPL ENVIRON MICROB, V67, P4454, DOI 10.1128/AEM.67.10.4454-4457.2001; Fiocca R, 1999, J PATHOL, V188, P220, DOI 10.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C; Fraser KR, 2003, APPL ENVIRON MICROB, V69, P2015, DOI 10.1128/AEM.69.4.2015-2022.2003; Garner MR, 2006, INFECT IMMUN, V74, P876, DOI 10.1128/IAI.74.2.876-886.2006; Gedde MM, 2000, INFECT IMMUN, V68, P999, DOI 10.1128/IAI.68.2.999-1003.2000; Gurung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027958; Hain T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-20; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Kazmierczak MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003; Kim SH, 2006, J FOOD PROTECT, V69, P3031, DOI 10.4315/0362-028X-69.12.3031; Kim YH, 2006, PROTEOMICS, V6, P1301, DOI 10.1002/pmic.200500329; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Li ZS, 1996, J BACTERIOL, V178, P2479, DOI 10.1128/jb.178.9.2479-2488.1996; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; Nieuwland R, 2010, THROMB RES, V125, pS49, DOI 10.1016/j.thromres.2010.01.037; Parida SK, 1998, MOL MICROBIOL, V28, P81, DOI 10.1046/j.1365-2958.1998.00776.x; Pentecost M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000900; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Raengpradub S, 2008, APPL ENVIRON MICROB, V74, P158, DOI 10.1128/AEM.00951-07; Rivera J, 2010, P NATL ACAD SCI USA, V107, P19002, DOI 10.1073/pnas.1008843107; Rolhion N, 2005, J BACTERIOL, V187, P2286, DOI 10.1128/JB.187.7.2286-2296.2005; Schooling SR, 2006, J BACTERIOL, V188, P5945, DOI 10.1128/JB.00257-06; Schwab U, 2005, FEMS MICROBIOL LETT, V245, P329, DOI 10.1016/j.femsle.2005.03.025; Shin JH, 2010, MICROBIOL-SGM, V156, P2660, DOI 10.1099/mic.0.041202-0; Shin JH, 2010, FEMS MICROBIOL LETT, V308, P94, DOI 10.1111/j.1574-6968.2010.01998.x; Sleator RD, 2001, APPL ENVIRON MICROB, V67, P2692, DOI 10.1128/AEM.67.6.2692-2698.2001; Sue D, 2004, MICROBIOL-SGM, V150, P3843, DOI 10.1099/mic.0.27257-0; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; van der Veen S, 2007, MICROBIOL-SGM, V153, P3593, DOI 10.1099/mic.0.2007/006361-0; van der Veen S, 2011, INT J MED MICROBIOL, V301, P334, DOI 10.1016/j.ijmm.2010.11.006; WAI SN, 1995, MICROBIOL IMMUNOL, V39, P451, DOI 10.1111/j.1348-0421.1995.tb02228.x; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Wemekamp-Kamphuis HH, 2004, APPL ENVIRON MICROB, V70, P2912, DOI 10.1128/AEM.70.5.2912-2918.2004; Wemekamp-Kamphuis HH, 2002, APPL ENVIRON MICROB, V68, P4710, DOI 10.1128/AEM.68.10.4710-4716.2002; Wiedmann M, 1998, J BACTERIOL, V180, P3650, DOI 10.1128/JB.180.14.3650-3656.1998	47	52	54	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e73196	10.1371/journal.pone.0073196	http://dx.doi.org/10.1371/journal.pone.0073196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977379	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300105
J	Li, QJ; Zheng, JM; Tan, HW; Li, XC; Chen, GJ; Jia, ZC				Li, Quanjie; Zheng, Jimin; Tan, Hongwei; Li, Xichen; Chen, Guangju; Jia, Zongchao			Unique Kinase Catalytic Mechanism of AceK with a Single Magnesium Ion	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; PHOSPHORYL-TRANSFER; ISOCITRATE DEHYDROGENASE; CRYSTAL-STRUCTURE; SUBUNIT; INSIGHTS	Isocitrate dehydrogenase kinase/phosphatase (AceK) is the founding member of the protein phosphorylation system in prokaryotes. Based on the novel and unique structural characteristics of AceK recently uncovered, we sought to understand its kinase reaction mechanism, along with other features involved in the phosphotransfer process. Herein we report density functional theory QM calculations of the mechanism of the phosphotransfer reaction catalysed by AceK. The transition states located by the QM calculations indicate that the phosphorylation reaction, catalysed by AceK, follows a dissociative mechanism with Asp457 serving as the catalytic base to accept the proton delivered by the substrate. Our results also revealed that AceK prefers a single Mg2+-containing active site in the phosphotransfer reaction. The catalytic roles of conserved residues in the active site are discussed.	[Li, Quanjie; Zheng, Jimin; Tan, Hongwei; Li, Xichen; Chen, Guangju; Jia, Zongchao] Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China; [Jia, Zongchao] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Beijing Normal University; Queens University - Canada	Tan, HW (corresponding author), Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China.	hongwei.tan@bnu.edu.cn; gjchen@bnu.edu.cn	li, xichen/C-7324-2017	li, xichen/0000-0002-1643-4327	National Natural Science Foundation of China [21133003, 21073015, 21131003]; Specialized Research Fund for the Doctoral Program of Higher Education [20110003120013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (No. 21133003, No. 21073015, No. 21131003). In addition, this work was also supported by Specialized Research Fund for the Doctoral Program of Higher Education, No 20110003120013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JA, 1992, BIOCHEMISTRY-US, V31, P8516, DOI 10.1021/bi00151a019; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Case D.A., 2006, AMBER, V9; Cheng YH, 2005, J AM CHEM SOC, V127, P1553, DOI 10.1021/ja0464084; De Proft F, 2001, CHEM REV, V101, P1451, DOI 10.1021/cr9903205; Diaz N, 2004, J AM CHEM SOC, V126, P529, DOI 10.1021/ja037277u; Frisch MJ, 2009, GAUSSIAN 09 RECISION; GARNAK M, 1979, J BIOL CHEM, V254, P7915; Geerlings P, 2003, CHEM REV, V103, P1793, DOI 10.1021/cr990029p; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hart JC, 1999, CHEM COMMUN, P79, DOI 10.1039/a808955h; Hart JC, 1998, J AM CHEM SOC, V120, P13535, DOI 10.1021/ja982632f; Herberg FW, 1999, BIOCHEMISTRY-US, V38, P6352, DOI 10.1021/bi982672w; Hirano Y, 2002, J PHYS CHEM B, V106, P5788, DOI 10.1021/jp014538i; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Hutter MC, 1999, PROTEIN SCI, V8, P2728; Khavrutskii IV, 2009, BIOCHEMISTRY-US, V48, P11532, DOI 10.1021/bi901475g; LAPORTE DC, 1982, NATURE, V300, P458, DOI 10.1038/300458a0; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Montenegro M, 2011, PHYS CHEM CHEM PHYS, V13, P530, DOI 10.1039/c0cp01062f; Reiher M, 2001, THEOR CHEM ACC, V107, P48, DOI 10.1007/s00214-001-0300-3; Schlichting I, 1997, BIOCHEMISTRY-US, V36, P9290, DOI 10.1021/bi970974c; Szarek P, 2008, J PHYS CHEM B, V112, P11819, DOI 10.1021/jp8040633; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; Valiev M, 2003, J AM CHEM SOC, V125, P9926, DOI 10.1021/ja029618u; Valiev M, 2007, J PHYS CHEM B, V111, P13455, DOI 10.1021/jp074853q; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; Zheng JM, 2012, PHILOS T R SOC B, V367, P2656, DOI 10.1098/rstb.2011.0426; Zheng JM, 2010, NATURE, V465, P961, DOI 10.1038/nature09088; Zhou BJ, 2009, J PHYS CHEM A, V113, P5144, DOI 10.1021/jp810827w	31	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72048	10.1371/journal.pone.0072048	http://dx.doi.org/10.1371/journal.pone.0072048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977203	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700126
J	Schreiber, O; Petersson, J; Walden, T; Ahl, D; Sandler, S; Phillipson, M; Holm, L				Schreiber, Olof; Petersson, Joel; Walden, Tomas; Ahl, David; Sandler, Stellan; Phillipson, Mia; Holm, Lena			iNOS-Dependent Increase in Colonic Mucus Thickness in DSS-Colitic Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MUCIN; EXPRESSION; BARRIER; SECRETION; MUCOSA; LAYERS; GEL	Aim: To investigate colonic mucus thickness in vivo in health and during experimental inflammatory bowel disease. Methods: Colitis was induced with 5% DSS in drinking water for 8 days prior to experiment, when the descending colonic mucosa of anesthetized rats was studied using intravital microscopy. Mucus thickness was measured with micropipettes attached to a micromanipulator. To assess the contributions of NOS and prostaglandins in the regulation of colonic mucus thickness, the non-selective NOS-inhibitor L-NNA (10 mg/kg bolus followed by 3 mg/kg/h), the selective iNOS-inhibitor L-NIL (10 mg/kg bolus followed by 3 mg/kg/h) and the non-selective COX-inhibitor diclofenac (5 mg/kg) were administered intravenously prior to experiment. To further investigate the role of iNOS in the regulation of colonic mucus thickness, iNOS -/- mice were used. Results: Colitic rats had a thicker firmly adherent mucus layer following 8 days of DSS treatment than untreated rats (88 +/- 2 mu m vs 76 +/- 1 mu m). During induction of colitis, the thickness of the colonic mucus layer initially decreased but was from day 3 significantly thicker than in untreated rats. Diclofenac reduced the mucus thickness similarly in colitic and untreated rats (-16 +/- 5 mu m vs -14 +/- 2 mu m). While L-NNA had no effect on colonic mucus thickness in DSS or untreated controls (+3 +/- 2 mm vs +3 +/- 1 mu m), L-NIL reduced the mucus thickness significantly more in colitic rats than in controls (-33 +/- 4 mu m vs -10 +/- 3 mu m). The importance of iNOS in regulating the colonic mucus thickness was confirmed in iNOS-/- mice, which had thinner colonic mucus than wild-type mice (35 +/- 3 mu m vs 50 +/- 2 mu m, respectively). Furthermore, immunohistochemistry revealed increased levels of iNOS in the colonic surface epithelium following DSS treatment. Conclusion: Both prostaglandins and nitric oxide regulate basal colonic mucus thickness. During onset of colitis, the thickness of the mucus layer is initially reduced followed by an iNOS mediated increase.	[Schreiber, Olof; Petersson, Joel; Walden, Tomas; Ahl, David; Sandler, Stellan; Phillipson, Mia; Holm, Lena] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Uppsala University	Holm, L (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	Lena.holm@mcb.uu.se		Phillipson, Mia/0000-0002-2387-0266	Swedish Research Council [04X-08646, 57P-20680-01-4]; Ruth and Rikard Juhlin's Foundation; Nanna Svartz Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ruth and Rikard Juhlin's Foundation; Nanna Svartz Foundation	These studies were supported by grants from the Swedish Research Council (04X-08646, 57P-20680-01-4), Ruth and Rikard Juhlin's Foundation, and Nanna Svartz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 1998, INT J BIOCHEM CELL B, V30, P797, DOI 10.1016/S1357-2725(98)00028-4; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; COOPER HS, 1993, LAB INVEST, V69, P238; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; Dicksved J, 2012, PLOS ONE, P7, DOI [10.1371/journal.-pone.0046399, DOI 10.1371/J0URNAL.-P0NE.0046399]; Faure M, 2003, DIGEST DIS SCI, V48, P1366, DOI 10.1023/A:1024175629909; Fyderek K, 2009, WORLD J GASTROENTERO, V15, P5287, DOI 10.3748/wjg.15.5287; Holm L, 2012, METHODS MOL BIOL, V842, P217, DOI 10.1007/978-1-61779-513-8_12; Holm M, 2001, DIGEST DIS SCI, V46, P1765, DOI 10.1023/A:1010674109111; JACOBS LR, 1985, J CLIN INVEST, V75, P112, DOI 10.1172/JCI111662; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; KAFTAN SM, 1989, J PATHOL, V159, P75, DOI 10.1002/path.1711590115; Kubes P, 2000, AM J MED, V109, P150, DOI 10.1016/S0002-9343(00)00480-0; Larsson JMH, 2011, INFLAMM BOWEL DIS, V17, P2299, DOI 10.1002/ibd.21625; Lee HW, 2002, J BIOL CHEM, V277, P32624, DOI 10.1074/jbc.M200353200; MILLER MJS, 1995, GASTROENTEROLOGY, V109, P1475, DOI 10.1016/0016-5085(95)90633-9; Moncada S, 1997, PHARMACOL REV, V49, P137; Murano M, 2000, CLIN EXP IMMUNOL, V120, P51, DOI 10.1046/j.1365-2249.2000.01183.x; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Nakano S, 1999, J GASTROENTEROL, V34, P207, DOI 10.1007/s005350050245; Okayama M, 2007, DIGEST DIS SCI, V52, P2095, DOI 10.1007/s10620-006-9597-z; Palatka K, 2005, SCAND J GASTROENTERO, V40, P670, DOI 10.1080/00365520510015539; Perner A, 2002, SCAND J GASTROENTERO, V37, P944, DOI 10.1080/003655202760230919; Petersson J, 2011, AM J PHYSIOL-GASTR L, V300, pG327, DOI 10.1152/ajpgi.00422.2010; Petersson J, 2007, AM J PHYSIOL-GASTR L, V293, pG1281, DOI 10.1152/ajpgi.00357.2007; Phillipson M, 2003, AM J PHYSIOL-GASTR L, V285, pG154, DOI 10.1152/ajpgi.00432.2002; Phillipson M, 2008, AM J PHYSIOL-GASTR L, V295, pG806, DOI 10.1152/ajpgi.90252.2008; Plaisancie P, 1998, AM J PHYSIOL-GASTR L, V275, pG1073, DOI 10.1152/ajpgi.1998.275.5.G1073; PULLAN RD, 1994, GUT, V35, P353, DOI 10.1136/gut.35.3.353; Renes IB, 2002, AM J PHYSIOL-GASTR L, V282, pG382, DOI 10.1152/ajpgi.00229.2001; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Strugala V, 2008, INT J CLIN PRACT, V62, P762, DOI 10.1111/j.1742-1241.2007.01665.x; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; Vallance BA, 2004, AM J PHYSIOL-GASTR L, V287, pG865, DOI 10.1152/ajpgi.00187.2004; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wallace JL, 2001, GASTROENTEROL CLIN N, V30, P971, DOI 10.1016/S0889-8553(05)70223-5; Zhang XJ, 1998, NITRIC OXIDE-BIOL CH, V2, P187, DOI 10.1006/niox.1998.0177	40	36	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71843	10.1371/journal.pone.0071843	http://dx.doi.org/10.1371/journal.pone.0071843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977158	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700106
J	Chen, ZG; Schiffman, M; Herrero, R; DeSalle, R; Anastos, K; Segondy, M; Sahasrabuddhe, VV; Gravitt, PE; Hsing, AW; Burk, RD				Chen, Zigui; Schiffman, Mark; Herrero, Rolando; DeSalle, Rob; Anastos, Kathryn; Segondy, Michel; Sahasrabuddhe, Vikrant V.; Gravitt, Patti E.; Hsing, Ann W.; Burk, Robert D.			Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; SQUAMOUS INTRAEPITHELIAL LESIONS; GENITAL HUMAN-PAPILLOMAVIRUS; GRADE CERVICAL LESIONS; NEUTRALIZING ANTIBODIES; SEQUENCE-ANALYSIS; VARIANT LINEAGES; RISK; ASSOCIATION; INFECTION	Background: The species Alphapapillomavirus 7 (alpha-7) contains human papillomavirus genotypes that account for 15% of invasive cervical cancers and are disproportionately associated with adenocarcinoma of the cervix. Complete genome analyses enable identification and nomenclature of variant lineages and sublineages. Methods: The URR/E6 region was sequenced to screen for novel variants of HPV18, 39, 45, 59, 68, 70, 85 and 97 from 1147 cervical samples obtained from multiple geographic regions that had previously been shown to contain an alpha-7 HPV isolate. To study viral heterogeneity, the complete 8 kb genome of 128 isolates, including 109 sequenced for this analysis, were annotated and analyzed. Viral evolution was characterized by constructing phylogenic trees using maximum-likelihood and Bayesian algorithms. Global and pairwise alignments were used to calculate total and ORF/region nucleotide differences; lineages and sublineages were assigned using an alphanumeric system. The prototype genome was assigned to the A lineage or A1 sublineage. Results: The genomic diversity of alpha-7 HPV types ranged from 1.1% to 6.7% nucleotide sequence differences; the extent of genome-genome pairwise intratype heterogeneity was 1.1% for HPV39, 1.3% for HPV59, 1.5% for HPV45, 1.6% for HPV70, 2.1% for HPV18, and 6.7% for HPV68. ME180 (previously a subtype of HPV68) was designated as the representative genome for HPV68 sublineage C1. Each ORF/region differed in sequence diversity, from most variable to least variable: noncoding region 1 (NCR1) / noncoding region 2 (NCR2) > upstream regulatory region (URR) > E6 / E7 > E2 / L2 > E1 / L1. Conclusions: These data provide estimates of the maximum viral genomic heterogeneity of alpha-7 HPV type variants. The proposed taxonomic system facilitates the comparison of variants across epidemiological and molecular studies. Sequence diversity, geographic distribution and phylogenetic topology of this clinically important group of HPVs suggest an independent evolutionary history for each type.	[Chen, Zigui; Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Schiffman, Mark; Sahasrabuddhe, Vikrant V.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Herrero, Rolando] Fdn INCIENSA, San Jose, Costa Rica; [DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Anastos, Kathryn] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Anastos, Kathryn] Montefiore Med Ctr, Bronx, NY 10467 USA; [Anastos, Kathryn; Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol & Publ Hlth, Bronx, NY 10467 USA; [Anastos, Kathryn; Burk, Robert D.] Albert Einstein Coll Med, Dept Obstet, Bronx, NY 10467 USA; [Segondy, Michel] Montpellier Univ Hosp, Dept Biol & Pathol, Montpellier, France; [Sahasrabuddhe, Vikrant V.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37235 USA; [Gravitt, Patti E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Hsing, Ann W.] Canc Prevent Inst Calif, Fremont, CA USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Museum of Natural History (AMNH); Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Universite de Montpellier; CHU de Montpellier; Vanderbilt University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cancer Prevention Institute of California; Yeshiva University; Albert Einstein College of Medicine	Burk, RD (corresponding author), Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA.	robert.burk@einstein.yu.edu	Chen, Zigui/E-8490-2017; Schiffman, Mark/B-9766-2015	Chen, Zigui/0000-0002-8577-1298; 	National Cancer Institute [CA78527]; Einstein-Montefiore Center for AIDS; National Institutes of Health [AI-51519]; Einstein Cancer Research Center from the National Cancer Institute [P30CA013330]; FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA078527, P30CA013330, U01CA078527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035004, P30AI051519] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Einstein-Montefiore Center for AIDS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein Cancer Research Center from the National Cancer Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Cancer Institute (CA78527), the Einstein-Montefiore Center for AIDS funded by the National Institutes of Health (AI-51519) and the Einstein Cancer Research Center (P30CA013330) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2011, TRENDS MICROBIOL, V19, P24, DOI 10.1016/j.tim.2010.09.005; Arias-Pulido H, 2005, VIROLOGY, V338, P22, DOI 10.1016/j.virol.2005.04.022; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bernard HU, 2011, VIRUS TAXONOMY, P235; Burk Robert D, 2011, Acta Dermatovenerol Alp Pannonica Adriat, V20, P113; Burk RD, 2009, PUBLIC HEALTH GENOM, V12, P281, DOI 10.1159/000214919; Chan PKS, 2013, INT J CANCER, V132, P2528, DOI 10.1002/ijc.27932; Chan PKS, 2002, J NATL CANCER I, V94, P1249, DOI 10.1093/jnci/94.16.1249; Chen Z, 2007, INT J CANCER, V121, P2947; Chen ZG, 2005, J VIROL, V79, P7014, DOI 10.1128/JVI.79.11.7014-7023.2005; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Chen ZG, 2009, VIROLOGY, V393, P304, DOI 10.1016/j.virol.2009.07.012; Chen Z, 2009, J VIROL, V83, P1443, DOI 10.1128/JVI.02068-08; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Cornet I, 2013, BRIT J CANCER, V108, P240, DOI 10.1038/bjc.2012.508; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Delius H, 1994, Curr Top Microbiol Immunol, V186, P13; Didelot-Rousseau MN, 2006, BRIT J CANCER, V95, P355, DOI 10.1038/sj.bjc.6603252; Forman D, 2012, VACCINE S5, V30, pF12, DOI [10.1016/j.vaccine.2012.07.055, DOI 10.1016/J.VACCINE.2012.07.055.PUBMED:23199955]; Godinez JM, 2013, INFECT GENET EVOL, V13, P96, DOI 10.1016/j.meegid.2012.09.011; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Hildesheim A, 2001, JNCI-J NATL CANCER I, V93, P315, DOI 10.1093/jnci/93.4.315; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Katoh Kazutaka, 2010, Bioinformatics, V26, P1899, DOI 10.1093/bioinformatics/btq224; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Khouadri S, 2006, J INFECT DIS, V194, P886, DOI 10.1086/507431; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; LIAW KL, 1995, INT J CANCER, V62, P565, DOI 10.1002/ijc.2910620513; Longuet M, 1996, J CLIN MICROBIOL, V34, P738, DOI 10.1128/JCM.34.3.738-744.1996; Lurchachaiwong W, 2010, INTERVIROLOGY, V53, P161, DOI 10.1159/000274977; MADDISON D. R., 2005, MACCLADE 4 ANAL PHYL; Marks M, 2011, INT J CANCER, V128, P2962, DOI 10.1002/ijc.25628; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; ONG CK, 1993, J VIROL, V67, P6424, DOI 10.1128/JVI.67.11.6424-6431.1993; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rector A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r57; REUTER S, 1991, J VIROL, V65, P5564, DOI 10.1128/JVI.65.10.5564-5568.1991; RHO J, 1994, VIROLOGY, V203, P158, DOI 10.1006/viro.1994.1467; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sahasrabuddhe VV, 2007, BRIT J CANCER, V96, P1480, DOI 10.1038/sj.bjc.6603737; Schiffman M, 2013, CANCER EPIDEM BIOMAR, V22, P553, DOI 10.1158/1055-9965.EPI-12-1406; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Singh DK, 2009, J INFECT DIS, V199, P1851, DOI 10.1086/599123; Smith B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021375; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL UNPUB; Terai M, 2001, J GEN VIROL, V82, P2035, DOI 10.1099/0022-1317-82-9-2035; Wheeler CM, 1997, J CLIN MICROBIOL, V35, P11, DOI 10.1128/JCM.35.1.11-19.1997; Wongworapat K, 2008, SEX TRANSM DIS, V35, P172, DOI 10.1097/OLQ.0b013e318158af65; Wu Xue-ling, 2010, Virologica Sinica, V25, P8, DOI 10.1007/s12250-010-3078-4; Wu XL, 2009, J MED VIROL, V81, P693, DOI 10.1002/jmv.21435; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297; Xi LF, 2012, INT J CANCER, V131, P2300, DOI 10.1002/ijc.27520	57	41	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72565	10.1371/journal.pone.0072565	http://dx.doi.org/10.1371/journal.pone.0072565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977318	gold, Green Published, Green Submitted			2022-12-25	WOS:000323570200075
J	Solomon, GM; Frederick, C; Zhang, SY; Gaggar, A; Harris, T; Woodworth, BA; Steele, C; Rowe, SM				Solomon, George M.; Frederick, Carla; Zhang, Shaoyan; Gaggar, Amit; Harris, Tom; Woodworth, Bradford A.; Steele, Chad; Rowe, Steven M.			IP-10 Is a Potential Biomarker of Cystic Fibrosis Acute Pulmonary Exacerbations	PLOS ONE			English	Article							LIQUID INTERFACE CULTURES; AIRWAY EPITHELIAL-CELLS; SPUTUM BIOMARKERS; LUNG-FUNCTION; NASAL LAVAGE; CF PATIENTS; INFLAMMATION; EXPRESSION; CHILDREN; DISEASE	Background: Cystic fibrosis (CF) is characterized by acute pulmonary exacerbations (APE). The CF nasal airway exhibits a similar ion transport defect as the lung, and colonization, infection, and inflammation within the nasal passages are common among CF patients. Nasal lavage fluid (NLF) is a minimally invasive means to collect upper airway samples. Methods: We collected NLF at the onset and resolution of CF APE and compared a 27-plex cytokine profile to stable CF outpatients and normal controls. We also tested IP-10 levels in the bronchoalveolar lavage fluid (BALF) of CF patients. Well-differentiated murine sinonasal monolayers were exposed to bacterial stimulus, and IP-10 levels were measured to test epithelial secretion. Results: Subjects hospitalized for APE had elevated IP-10 (2582 pg/mL [95% CL of mean: 818,8165], N= 13) which significantly decreased (647 pg/mL [357,1174], P< 0.05, N = 13) following antimicrobial therapy. Stable CF outpatients exhibited intermediately elevated levels (680 pg/mL [281,1644], N= 13) that were less than CF inpatients upon admission (P= 0.056) but not significantly different than normal controls (342 pg/mL [110,1061]; P= 0.3, N= 10). IP-10 was significantly increased in CF BALF (2673 pg/mL [1306,5458], N= 10) compared to healthy post-lung transplant patients (8.4 pg/mL [0.03,2172], N= 5, P< 0.001). IP-10 levels from well-differentiated CF murine nasal epithelial monolayers exposed to Pseudomonas PAO-1 bacteria-free prep or LPS (100 nM) apically for 24 hours were significantly elevated (1159 +/- 147, P< 0.001 for PAO-1; 1373 +/- 191, P< 0.001 for LPS vs. 305 +/- 68 for vehicle controls). Human sino-nasal epithelial cells derived from CF patients had a similar response to LPS (34% increase, P< 0.05, N= 6). Conclusions: IP-10 is elevated in the nasal lavage of CF patients with APE and responds to antimicrobial therapy. IP-10 is induced by airway epithelia following stimulation with bacterial pathogens in a murine model. Additional research regarding IP-10 as a potential biomarker is warranted.	[Solomon, George M.] Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Denver, CO USA; [Frederick, Carla] Women & Childrens Hosp Buffalo, Lung & Cyst Fibrosis Ctr, Buffalo, NY USA; [Gaggar, Amit; Steele, Chad; Rowe, Steven M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Harris, Tom; Rowe, Steven M.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Gaggar, Amit; Rowe, Steven M.] Univ Alabama Birmingham, Dept Cell Integrat & Dev Biol, Birmingham, AL USA; [Gaggar, Amit; Rowe, Steven M.] Univ Alabama Birmingham, Lung Hlth Ctr, Birmingham, AL USA; [Woodworth, Bradford A.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Gaggar, Amit; Woodworth, Bradford A.; Rowe, Steven M.] Univ Alabama Birmingham, Cyst Fibrosis Res Ctr, Birmingham, AL USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Women & Children's Hospital of Buffalo; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Rowe, SM (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	smrowe@uab.edu			National Institutes of Health [P30 DK072482, 1K08HL107142-02, RO1 HL-102371]; Cystic Fibrosis Foundation [CLANCY09Y2, CLANCY05Y2]; Flight Attendant's Medical Research Institute Young Clinical Scientist Award [072218]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102371, T32HL105346, K08HL107142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Flight Attendant's Medical Research Institute Young Clinical Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was sponsored by the National Institutes of Health (P30 DK072482 to the University of Alabama at Birmingham Cystic Fibrosis Research Center; 1K08HL107142-02 to BAW; RO1 HL-102371 to AG), the Cystic Fibrosis Foundation (CLANCY09Y2 AND CLANCY05Y2), and Flight Attendant's Medical Research Institute Young Clinical Scientist Award (072218 to BAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy MO, 2006, AM J PHYSIOL-LUNG C, V290, pL909, DOI 10.1152/ajplung.00430.2005; Antunes MB, 2007, BIOTECHNIQUES, V43, P195, DOI 10.2144/000112531; Beiersdorf N, 2013, J CYST FIBROS, V12, P249, DOI 10.1016/j.jcf.2012.08.015; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Campbell J. Darren, 2004, FASEB Journal, V18, P329; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; DAVIDSON TM, 1995, LARYNGOSCOPE, V105, P354, DOI 10.1288/00005537-199504000-00002; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Jensen PO, 2006, J CYST FIBROS, V5, P145, DOI 10.1016/j.jcf.2005.12.004; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kingdom TT, 1996, ARCH OTOLARYNGOL, V122, P1209; Lettinga KD, 2003, THORAX, V58, P63, DOI 10.1136/thorax.58.1.63; Lighter J, 2009, INT J TUBERC LUNG D, V13, P731; Liou TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042748; Mayer-Hamblett N, 2007, AM J RESP CRIT CARE, V175, P822, DOI 10.1164/rccm.200609-1354OC; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nikasinovic-Fournier L, 2002, J LAB CLIN MED, V139, P173, DOI 10.1067/mlc.2002.121661; Pitrez PMC, 2005, RESPIROLOGY, V10, P177, DOI 10.1111/j.1440-1843.2005.00649.x; RAMSEY B, 1992, J ALLERGY CLIN IMMUN, V90, P547, DOI 10.1016/0091-6749(92)90183-3; Reeves EP, 2012, J CYST FIBROS, V11, P100, DOI 10.1016/j.jcf.2011.09.010; Riechelmann H, 2003, EUR RESPIR J, V21, P600, DOI 10.1183/09031936.03.00072003; Roderfeld M, 2009, J CYST FIBROS, V8, P338, DOI 10.1016/j.jcf.2009.06.001; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rowe SM, 2013, CHEST; Sagel Scott D, 2007, Proc Am Thorac Soc, V4, P406, DOI 10.1513/pats.200703-044BR; Sagel SD, 2012, AM J RESP CRIT CARE, V186, P857, DOI 10.1164/rccm.201203-0507OC; Sagel SD, 2002, J PEDIATR-US, V141, P811, DOI 10.1067/mpd.2002.129847; Salvatore CM, 2009, ANTIMICROB AGENTS CH, V53, P1546, DOI 10.1128/AAC.00979-08; Shahabuddin S, 2006, AM J PHYSIOL-CELL PH, V291, pC34, DOI 10.1152/ajpcell.00441.2005; Sui YJ, 2004, AM J PATHOL, V164, P1557, DOI 10.1016/S0002-9440(10)63714-5; Togias A, 2003, J ALLERGY CLIN IMMUN, V111, P1171, DOI 10.1067/mai.2003.1592; UMETSU DT, 1990, LANCET, V335, P1077, DOI 10.1016/0140-6736(90)92642-U; Virgin FW, 2012, AM J RHINOL ALLERGY, V26, P70, DOI 10.2500/ajra.2012.26.3705; Woodworth BA, 2007, AM J RHINOL, V21, P533, DOI 10.2500/ajr.2007.21.3068; Zhang SY, 2009, AM J RHINOL ALLERGY, V23, P149, DOI 10.2500/ajra.2009.23.3285	37	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72398	10.1371/journal.pone.0072398	http://dx.doi.org/10.1371/journal.pone.0072398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977293	Green Submitted, Green Published, gold			2022-12-25	WOS:000323570200068
J	You, ZP; Liao, MJ; Zhang, H; Yang, HC; Pan, XJ; Houghton, JE; Sui, SF; Tai, PC				You, Zhipeng; Liao, Meijiang; Zhang, Hao; Yang, Hsiuchin; Pan, Xijian; Houghton, John E.; Sui, Sen-fang; Tai, Phang C.			Phospholipids Induce Conformational Changes of SecA to Form Membrane-Specific Domains: AFM Structures and Implication on Protein-Conducting Channels	PLOS ONE			English	Article							ESCHERICHIA-COLI SECA; DISTINCT ATP-BINDING; PREPROTEIN TRANSLOCASE; DIMERIC SECA; PRESECRETORY PROTEINS; ESSENTIAL COMPONENT; INVERTED VESICLES; PRECURSOR PROTEIN; C-DOMAIN; IN-VITRO	SecA, an essential component of the Sec machinery, exists in a soluble and a membrane form in Escherichia coli. Previous studies have shown that the soluble SecA transforms into pore structures when it interacts with liposomes, and integrates into membranes containing SecYEG in two forms: SecA(S) and SecA(M); the latter exemplified by two tryptic membrane-specific domains, an N-terminal domain (N39) and a middle M48 domain (M48). The formation of these lipid-specific domains was further investigated. The N39 and M48 domains are induced only when SecA interacts with anionic liposomes. Additionally, the N-terminus, not the C-terminus of SecA is required for inducing such conformational changes. Proteolytic treatment and sequence analyses showed that liposome-embedded SecA yields the same M48 and N39 domains as does the membrane-embedded SecA. Studies with chemical extraction and resistance to trypsin have also shown that these proteoliposome-embedded SecA fragments exhibit the same stability and characteristics as their membrane-embedded SecA equivalents. Furthermore, the cloned lipid-specific domains N39 and M48, but not N68 or C34, are able to form partial, but imperfect ring-like structures when they interact with phospholipids. These ring-like structures are characteristic of a SecA pore-structure, suggesting that these domains contribute part of the SecA-dependent protein-conducting channel. We, therefore, propose a model in which SecA alone is capable of forming a lipid-specific, asymmetric dimer that is able to function as a viable protein-conducting channel in the membrane, without any requirement for SecYEG.	[You, Zhipeng; Liao, Meijiang; Zhang, Hao; Yang, Hsiuchin; Houghton, John E.; Tai, Phang C.] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [You, Zhipeng; Liao, Meijiang; Zhang, Hao; Yang, Hsiuchin; Houghton, John E.; Tai, Phang C.] Georgia State Univ, Ctr Biotechnol & Drug Design, Atlanta, GA 30303 USA; [Pan, Xijian; Sui, Sen-fang] Tsinghua Univ, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Tsinghua University	Tai, PC (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA.	biopct@gsu.edu	Zhang, Hao/H-4026-2014		NIH [GM34766]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034766] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a NIH grant GM34766 which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKITA M, 1991, BIOCHEM BIOPH RES CO, V174, P211, DOI 10.1016/0006-291X(91)90507-4; Baars L, 2008, J BACTERIOL, V190, P3505, DOI 10.1128/JB.01631-07; BREUKINK E, 1995, J BIOL CHEM, V270, P7902, DOI 10.1074/jbc.270.14.7902; BREUKINK E, 1992, BIOCHEMISTRY-US, V31, P1119, DOI 10.1021/bi00119a021; CABELLI RJ, 1991, J BIOL CHEM, V266, P24420; CABELLI RJ, 1988, CELL, V55, P683, DOI 10.1016/0092-8674(88)90227-9; CHEN LL, 1987, NATURE, V328, P164, DOI 10.1038/328164a0; CHEN LL, 1985, P NATL ACAD SCI USA, V82, P4384, DOI 10.1073/pnas.82.13.4384; Chen XC, 1996, J BIOL CHEM, V271, P29698, DOI 10.1074/jbc.271.47.29698; Chen XC, 1998, J BACTERIOL, V180, P527, DOI 10.1128/JB.180.3.527-537.1998; Chen Y, 2007, J STRUCT BIOL, V159, P149, DOI 10.1016/j.jsb.2007.01.015; Dapic V, 2000, J BIOL CHEM, V275, P25000, DOI 10.1074/jbc.M001100200; Ding HY, 2003, BIOCHEMISTRY-US, V42, P13468, DOI 10.1021/bi035099b; Ding HY, 2001, BIOCHEMISTRY-US, V40, P1835, DOI 10.1021/bi002058w; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; DRIESSEN AJM, 1993, BIOCHEMISTRY-US, V32, P13190, DOI 10.1021/bi00211a030; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Eichler J, 1998, J BACTERIOL, V180, P5776, DOI 10.1128/JB.180.21.5776-5779.1998; Eichler J, 1998, J BIOL CHEM, V273, P21675, DOI 10.1074/jbc.273.34.21675; Eichler J, 1997, P NATL ACAD SCI USA, V94, P5574, DOI 10.1073/pnas.94.11.5574; Eichler J, 1997, EMBO J, V16, P2188, DOI 10.1093/emboj/16.9.2188; Fekkes P, 1998, MOL MICROBIOL, V29, P1179, DOI 10.1046/j.1365-2958.1998.00997.x; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; Hsieh YH, 2013, BIOCHEM BIOPH RES CO, V431, P388, DOI 10.1016/j.bbrc.2013.01.042; Hsieh YH, 2011, J BIOL CHEM, V286, P44702, DOI 10.1074/jbc.M111.300111; Hwang J, 1997, J BACTERIOL, V179, P689, DOI 10.1128/jb.179.3.689-696.1997; Jilaveanu LB, 2006, J BACTERIOL, V188, P335, DOI 10.1128/JB.188.1.335-338.2006; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; KIMURA E, 1991, J BIOL CHEM, V266, P6600; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Lin BR, 2006, J MEMBRANE BIOL, V214, P103, DOI 10.1007/s00232-006-0079-1; Lin BR, 2012, J MEMBRANE BIOL, V245, P747, DOI 10.1007/s00232-012-9477-8; Manting EH, 1997, J BACTERIOL, V179, P5699, DOI 10.1128/jb.179.18.5699-5704.1997; Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x; MATSUYAMA S, 1990, J BIOL CHEM, V265, P8760; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; Mori H, 1998, J BIOCHEM, V124, P122, DOI 10.1093/oxfordjournals.jbchem.a022070; Nakatogawa H, 2000, J BIOL CHEM, V275, P33209, DOI 10.1074/jbc.C000550200; Natale P, 2004, J BIOL CHEM, V279, P13769, DOI 10.1074/jbc.M312892200; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; OLIVER DB, 1982, CELL, V30, P311, DOI 10.1016/0092-8674(82)90037-X; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Price A, 1996, J BIOL CHEM, V271, P31580, DOI 10.1074/jbc.271.49.31580; Ramamurthy V, 1997, J BIOL CHEM, V272, P23239, DOI 10.1074/jbc.272.37.23239; SCHMIDT MG, 1988, J BACTERIOL, V170, P3404, DOI 10.1128/jb.170.8.3404-3414.1988; SHINKAI A, 1991, J BIOL CHEM, V266, P5827; SKVIRSKY RC, 1995, J BACTERIOL, V177, P6153, DOI 10.1128/jb.177.21.6153-6159.1995; Snyders S, 1997, J BIOL CHEM, V272, P11302; Tai PC., 1991, METHOD CELL BIOL, V34, P167, DOI 10.1016/S0091-679X(08)61680-5; Tang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016498; Tang Y, 2010, SCI CHINA LIFE SCI, V53, P1049, DOI 10.1007/s11427-010-4061-x; Traxler B, 1996, J BIOL CHEM, V271, P12394, DOI 10.1074/jbc.271.21.12394; ULBRANDT ND, 1992, J BIOL CHEM, V267, P15184; van der Does C, 1998, BIOCHEMISTRY-US, V37, P201, DOI 10.1021/bi972105t; van der Does C, 2000, J BIOL CHEM, V275, P2472, DOI 10.1074/jbc.275.4.2472; van Klompenburg W, 1998, J MEMBRANE BIOL, V162, P1, DOI 10.1007/s002329900336; van Voorst F, 1998, BIOCHEMISTRY-US, V37, P12261, DOI 10.1021/bi9809021; vanderDoes C, 1996, MOL MICROBIOL, V22, P619, DOI 10.1046/j.1365-2958.1996.d01-1712.x; Vrontou E, 2004, BBA-MOL CELL RES, V1694, P67, DOI 10.1016/j.bbamcr.2004.06.003; Wang HY, 2008, J BACTERIOL, V190, P1413, DOI 10.1128/JB.01633-07; Wang HW, 2003, P NATL ACAD SCI USA, V100, P4221, DOI 10.1073/pnas.0737415100; Wang LG, 2000, J BIOL CHEM, V275, P10154, DOI 10.1074/jbc.275.14.10154; WATANABE M, 1990, P NATL ACAD SCI USA, V87, P1960, DOI 10.1073/pnas.87.5.1960; WATANABE M, 1993, P NATL ACAD SCI USA, V90, P9011, DOI 10.1073/pnas.90.19.9011; Yang YB, 1997, J BIOL CHEM, V272, P13660, DOI 10.1074/jbc.272.21.13660; Yang YB, 1997, J BACTERIOL, V179, P7386, DOI 10.1128/jb.179.23.7386-7393.1997; YU CA, 1975, J BIOL CHEM, V250, P1383; ZIMMERMAN DL, 1990, J BIOL CHEM, V265, P4048	72	9	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e72560	10.1371/journal.pone.0072560	http://dx.doi.org/10.1371/journal.pone.0072560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977317	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200074
J	Bonsante, F; Iacobelli, S; Latorre, G; Rigo, J; De Felice, C; Robillard, PY; Gouyon, JB				Bonsante, Francesco; Iacobelli, Silvia; Latorre, Giuseppe; Rigo, Jacques; De Felice, Claudio; Robillard, Pierre Yves; Gouyon, Jean Bernard			Initial Amino Acid Intake Influences Phosphorus and Calcium Homeostasis in Preterm Infants - It Is Time to Change the Composition of the Early Parenteral Nutrition	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; REFEEDING SYNDROME; ELECTROLYTE; PROTEIN; HYPOPHOSPHATEMIA; NITROGEN; BALANCE; FLUID	Background: Early aggressive parenteral nutrition (PN), consisting of caloric and nitrogen intake soon after birth, is currently proposed for the premature baby. Some electrolyte disturbances, such as hypophosphatemia and hypercalcemia, considered unusual in early life, were recently described while using this PN approach. We hypothesize that, due to its impact on cell metabolism, the initial amino acid (AA) amount may specifically influence the metabolism of phosphorus, and consequently of calcium. We aim to evaluate the influence of AA intake on calcium-phosphorus metabolism, and to create a calculation tool to estimate phosphorus needs. Methods: Prospective observational study. Phosphate and calcium plasma concentrations and calcium balance were evaluated daily during the first week of life in very preterm infants, and their relationship with nutrition was studied. For this purpose, infants were divided into three groups: high, medium and low AA intake (HAA, MAA, LAA). A calculation formula to assess phosphorus needs was elaborated, with a theoretical model based on AA and calcium intake, and the cumulative deficit of phosphate intake was estimated. Results: 154 infants were included. Hypophosphatemia (12.5%) and hypercalcemia (9.8%) were more frequent in the HAA than in the MAA (4.6% and 4.8%) and in the LAA group (0% and 1.9%); both p<0.001. Discussion: Calcium-phosphorus homeostasis was influenced by the early AA intake. We propose to consider phosphorus and calcium imbalances as being part of a syndrome, related to incomplete provision of nutrients after the abrupt discontinuation of the placental nutrition at birth (PI-ReFeeding syndrome). We provide a simple tool to calculate the optimal phosphate intake. The early introduction of AA in the PN soon after birth might be completed by an early intake of phosphorus, since AA and phosphorus are (along with potassium) the main determinants of cellular growth.	[Latorre, Giuseppe] Miulli Hosp, NICU, Acquaviva Delle Fonti, Italy; [Latorre, Giuseppe] Miulli Hosp, Acquaviva Delle Fonti, Italy; [Rigo, Jacques] Univ Liege, Neonatal Unit, Dept Paediat, Liege, Belgium; [De Felice, Claudio] Univ Hosp, Policlin Scotte, NICU, Siena, Italy; [De Felice, Claudio] Univ Hosp, Policlin Scotte, Siena, Italy	University of Liege; University of Siena; University Hospital of Siena; University of Siena; University Hospital of Siena		fbonsante@yahoo.com	Robillard, Pierre-Yves/AAD-9774-2021; La Torre, Giuseppe/AAI-6866-2020; De Felice, Claudio/AAB-6859-2022	La Torre, Giuseppe/0000-0002-1233-2040; De Felice, Claudio/0000-0002-9881-3119	University Hospital of Dijon	University Hospital of Dijon	The study was entirely supported by the institution, University Hospital of Dijon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonsante F, 2011, EUR J CLIN NUTR, V65, P1088, DOI 10.1038/ejcn.2011.79; BRITSCHGI F, 1991, SCHWEIZ MED WSCHR, V121, P1163; Elser JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001028; Elser JJ, 2007, PLOS BIOL, V5, P1403, DOI 10.1371/journal.pbio.0050181; Elstgeest LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009033; Ghaddar S, 2012, J RENAL NUTR, V22, P67, DOI 10.1053/j.jrn.2011.05.001; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P11923, DOI 10.1073/pnas.0504756102; Iacobelli S, 2010, Minerva Pediatr, V62, P203; Iacobelli S, 2010, NEONATOLOGY, V98, P84, DOI 10.1159/000276979; Ichikawa G, 2012, J PEDIATR ENDOCR MET, V25, P317, DOI 10.1515/jpem-2011-0485; Jamin A, 2010, NEONATOLOGY, V97, P321, DOI 10.1159/000260135; Koletzko Berthold, 2005, J Pediatr Gastroenterol Nutr, V41 Suppl 2, pS1, DOI 10.1097/01.mpg.0000181841.07090.f4; Mariotti F, 2008, CRIT REV FOOD SCI, V48, P177, DOI 10.1080/10408390701279749; Mizumoto H, 2012, PEDIATR INT, V54, P715, DOI 10.1111/j.1442-200X.2012.03590.x; Moltu SJ, 2013, CLIN NUTR, V32, P207, DOI 10.1016/j.clnu.2012.09.004; Pieltain C, 2013, WORLD REV NUTR DIET, V106, P181, DOI 10.1159/000342680; Ponomareva NI, 2009, RUSS J GEN CHEM+, V79, P186, DOI 10.1134/S1070363209020030; Rigo J, 2011, NEONATAL PERINATAL M, P1523; Rigo J, 2012, NEONATOLOGY PRACTICA, V47, P311; Rigo J., 2012, CALCIUM PHOSPHORUS H, P333; Skipper A, 2012, NUTR CLIN PRACT, V27, P34, DOI 10.1177/0884533611427916; Thureen PJ, 2003, PEDIATR RES, V53, P24, DOI 10.1203/00006450-200301000-00008; VANGOUDOEVER JB, 1995, J PEDIATR-US, V127, P458, DOI 10.1016/S0022-3476(95)70083-8	23	72	72	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72880	10.1371/journal.pone.0072880	http://dx.doi.org/10.1371/journal.pone.0072880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977367	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000115
J	Wang, HB; Zou, ZR; Wang, SS; Gong, M				Wang, Haibo; Zou, Zhurong; Wang, Shasha; Gong, Ming			Global Analysis of Transcriptome Responses and Gene Expression Profiles to Cold Stress of Jatropha curcas L.	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; LOW-TEMPERATURE; FREEZING TOLERANCE; LIPID-COMPOSITION; PLASMA-MEMBRANE; PHOSPHOLIPASE-D; CBF GENES; ACCLIMATION; MULTIPLE; DEHYDRIN	Background: Jatropha curcas L., also called the Physic nut, is an oil-rich shrub with multiple uses, including biodiesel production, and is currently exploited as a renewable energy resource in many countries. Nevertheless, because of its origin from the tropical MidAmerican zone, J. curcas confers an inherent but undesirable characteristic (low cold resistance) that may seriously restrict its large-scale popularization. This adaptive flaw can be genetically improved by elucidating the mechanisms underlying plant tolerance to cold temperatures. The newly developed Illumina Hiseq(TM) 2000 RNA-seq and Digital Gene Expression (DGE) are deep high-throughput approaches for gene expression analysis at the transcriptome level, using which we carefully investigated the gene expression profiles in response to cold stress to gain insight into the molecular mechanisms of cold response in J. curcas. Results: In total, 45,251 unigenes were obtained by assembly of clean data generated by RNA-seq analysis of the J. curcas transcriptome. A total of 33,363 and 912 complete or partial coding sequences (CDSs) were determined by protein database alignments and ESTScan prediction, respectively. Among these unigenes, more than 41.52% were involved in approximately 128 known metabolic or signaling pathways, and 4,185 were possibly associated with cold resistance. DGE analysis was used to assess the changes in gene expression when exposed to cold condition (12 degrees C) for 12, 24, and 48 h. The results showed that 3,178 genes were significantly upregulated and 1,244 were downregulated under cold stress. These genes were then functionally annotated based on the transcriptome data from RNA-seq analysis. Conclusions: This study provides a global view of transcriptome response and gene expression profiling of J. curcas in response to cold stress. The results can help improve our current understanding of the mechanisms underlying plant cold resistance and favor the screening of crucial genes for genetically enhancing cold resistance in J. curcas.	[Wang, Haibo; Zou, Zhurong; Wang, Shasha; Gong, Ming] Yunnan Normal Univ, Key Lab Biomass Energy & Environm Biotechnol Yunn, Engn Res Ctr Sustainable Dev & Utilizat Biomass E, Sch Life Sci,Minist Educ, Kunming, Yunnan, Peoples R China; [Wang, Haibo] Qujing Normal Univ, Coll Biol Resources & Environm Sci, Qujing, Yunnan, Peoples R China	Yunnan Normal University	Gong, M (corresponding author), Yunnan Normal Univ, Key Lab Biomass Energy & Environm Biotechnol Yunn, Engn Res Ctr Sustainable Dev & Utilizat Biomass E, Sch Life Sci,Minist Educ, Kunming, Yunnan, Peoples R China.	gongming6307@163.com	Wang, Huanan/N-1971-2013; Leeuwenburgh, S.C.G./L-4483-2015; Oner, FC/L-7769-2013	Leeuwenburgh, S.C.G./0000-0003-1471-6133; Oner, FC/0000-0003-0858-8243; Alblas, Jacqueline/0000-0002-2996-9697; Dhert, Wouter/0000-0001-9150-6143; Weinans, Harrie/0000-0002-2275-6170	National Foundations of Natural Sciences, China [31260064, 31060160, 31160169]; Education Bureau of Yunnan Province [ZD2010004, 2010Z087]	National Foundations of Natural Sciences, China; Education Bureau of Yunnan Province	This work was supported by several grants from the National Foundations of Natural Sciences, China (No. 31260064 to MG, No. 31060160, 31160169 to ZZ) and the Education Bureau of Yunnan Province (No. ZD2010004 to MG, No. 2010Z087 to ZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148; Ao PX, 2013, ACTA PHYSIOL PLANT, V35, P153, DOI 10.1007/s11738-012-1058-z; Asif MH, 2010, TREE GENET GENOMES, V6, P941, DOI 10.1007/s11295-010-0303-0; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Biello D, 2009, SCI AM, V19, P68; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Bogdanovic J, 2008, EUR BIOPHYS J BIOPHY, V37, P1241, DOI 10.1007/s00249-008-0260-9; Bravo LA, 2003, PHYSIOL PLANTARUM, V118, P262, DOI 10.1034/j.1399-3054.2003.00060.x; Carels N, 2009, ADV BOT RES, V50, P39, DOI 10.1016/S0065-2296(08)00802-1; Carvalho CR, 2008, PLANT SCI, V174, P613, DOI 10.1016/j.plantsci.2008.03.010; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Costa GGL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-462; Dahmer N, 2009, CROP BREED APPL BIOT, V9, P386, DOI 10.12702/1984-7033.v09n04a14; Danyluk J, 1998, PLANT CELL, V10, P623, DOI 10.1105/tpc.10.4.623; Deore AC, 2008, PLANT BIOTECHNOL REP, V2, P7, DOI 10.1007/s11816-008-0042-y; Dhonukshe P, 2003, PLANT CELL, V15, P2666, DOI 10.1105/tpc.014977; Dong CH, 2006, P NATL ACAD SCI USA, V103, P8281, DOI 10.1073/pnas.0602874103; Fairless D, 2007, NATURE, V449, P652, DOI 10.1038/449652a; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fursova OV, 2009, GENE, V429, P98, DOI 10.1016/j.gene.2008.10.016; Gardiner JC, 2001, PLANT CELL, V13, P2143, DOI 10.1105/tpc.13.9.2143; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Gong ZZ, 2002, P NATL ACAD SCI USA, V99, P11507, DOI 10.1073/pnas.172399299; Goulas E, 2006, PLANT J, V47, P720, DOI 10.1111/j.1365-313X.2006.02821.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo Z, 2006, PLANT PHYSIOL BIOCH, V44, P828, DOI 10.1016/j.plaphy.2006.10.024; Hendrickson L, 2006, FEBS LETT, V580, P4959, DOI 10.1016/j.febslet.2006.07.081; Hurry V, 2000, PLANT J, V24, P383, DOI 10.1046/j.1365-313x.2000.00888.x; Ivanov AG, 2006, PLANT CELL PHYSIOL, V47, P1146, DOI 10.1093/pcp/pcj089; Jha TB, 2007, PLANT BIOTECHNOL REP, V1, P135, DOI 10.1007/s11816-007-0027-2; Johnson TS, 2011, PLANT CELL REP, V30, P1573, DOI 10.1007/s00299-011-1083-1; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Kiegle E, 2000, PLANT J, V23, P267, DOI 10.1046/j.1365-313x.2000.00786.x; Korn M, 2008, PLANT CELL ENVIRON, V31, P813, DOI 10.1111/j.1365-3040.2008.01800.x; KOSTER KL, 1992, PLANT PHYSIOL, V98, P108, DOI 10.1104/pp.98.1.108; Krinke O, 2007, J EXP BOT, V58, P361, DOI 10.1093/jxb/erl220; Kumar GRK, 2011, ANAL BIOCHEM, V413, P63, DOI 10.1016/j.ab.2011.01.046; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Lee HJ, 2001, GENE DEV, V15, P912, DOI 10.1101/gad.866801; Li ZhongGuang, 2011, Seed, V30, P4; Mangelsen E, 2011, MOL PLANT, V4, P97, DOI 10.1093/mp/ssq058; Miranda JA, 2007, PLANTA, V226, P1411, DOI 10.1007/s00425-007-0579-y; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nakaminami K, 2006, P NATL ACAD SCI USA, V103, P10122, DOI 10.1073/pnas.0603168103; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; Natarajan P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-606; Openshaw K, 2000, BIOMASS BIOENERG, V19, P1, DOI 10.1016/S0961-9534(00)00019-2; PAPAGEORGIOU GC, 1995, PHOTOSYNTH RES, V44, P243, DOI 10.1007/BF00048597; Pramanik MHR, 2005, PLANT MOL BIOL, V58, P751, DOI 10.1007/s11103-005-7404-4; Puhakainen T, 2004, PLANT MOL BIOL, V54, P743, DOI 10.1023/B:PLAN.0000040903.66496.a4; Ruelland E, 2009, ADV BOT RES, V49, P35, DOI 10.1016/S0065-2296(08)00602-2; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Sasaki K, 2007, BIOCHEM BIOPH RES CO, V364, P633, DOI 10.1016/j.bbrc.2007.10.059; Sato S, 2011, DNA RES, V18, P65, DOI 10.1093/dnares/dsq030; SIMINOVITCH D, 1981, CRYOBIOLOGY, V18, P166, DOI 10.1016/0011-2240(81)90088-2; Soontornchainaksaeng P., 2003, Thai Forest Bulletin (Botany), P105; Strand A, 2003, PLANT CELL ENVIRON, V26, P523, DOI 10.1046/j.1365-3040.2003.00983.x; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; Uemura M, 1997, PLANT PHYSIOL, V114, P1493, DOI 10.1104/pp.114.4.1493; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wang CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023632; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Yang CY, 2012, RENEW SUST ENERG REV, V16, P2178, DOI 10.1016/j.rser.2012.01.043; Ye J, 2009, PLANT BIOTECHNOL J, V7, P964, DOI 10.1111/j.1467-7652.2009.00457.x; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Zarka DG, 2003, PLANT PHYSIOL, V133, P910, DOI 10.1104/pp.103.027169; Zhu J, 2008, P NATL ACAD SCI USA, V105, P4945, DOI 10.1073/pnas.0801029105; Zuther E, 2004, FEBS LETT, V576, P169, DOI 10.1016/j.febslet.2004.09.006	72	175	202	9	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82817	10.1371/journal.pone.0082817	http://dx.doi.org/10.1371/journal.pone.0082817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349370	gold, Green Published, Green Submitted			2022-12-25	WOS:000328705200103
J	Zhu, Y; Pires, KMP; Whitehead, KJ; Olsen, CD; Wayment, B; Zhang, YC; Bugger, H; Ilkun, O; Litwin, SE; Thomas, G; Kozma, SC; Abel, ED				Zhu, Yi; Pires, Karla M. P.; Whitehead, Kevin J.; Olsen, Curtis D.; Wayment, Benjamin; Zhang, Yi Cheng; Bugger, Heiko; Ilkun, Olesya; Litwin, Sheldon E.; Thomas, George; Kozma, Sara C.; Abel, E. Dale			Mechanistic Target of Rapamycin (Mtor) Is Essential for Murine Embryonic Heart Development and Growth	PLOS ONE			English	Article							GENE-EXPRESSION; MAMMALIAN TARGET; CARDIAC-FUNCTION; IN-VIVO; COMPLEX; MOUSE; MUSCLE; RICTOR; PHOSPHORYLATION; PROLIFERATION	Mechanistic target of rapamycin (Mtor) is required for embryonic inner cell mass proliferation during early development. However, Mtor expression levels are very low in the mouse heart during embryogenesis. To determine if Mtor plays a role during mouse cardiac development, cardiomyocyte specific Mtor deletion was achieved using alpha myosin heavy chain (alpha-MHC) driven Cre recombinase. Initial mosaic expression of Cre between embryonic day (E) 10.5 and E11.5 eliminated a subset of cardiomyocytes with high Cre activity by apoptosis and reduced overall cardiac proliferative capacity. The remaining cardiomyocytes proliferated and expanded normally. However loss of 50% of cardiomyocytes defined a threshold that impairs the ability of the embryonic heart to sustain the embryo's circulatory requirements. As a result 92% of embryos with cardiomyocyte Mtor deficiency died by the end of gestation. Thus Mtor is required for survival and proliferation of cardiomyocytes in the developing heart.	[Zhu, Yi; Pires, Karla M. P.; Zhang, Yi Cheng; Bugger, Heiko; Ilkun, Olesya; Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT 84112 USA; [Zhu, Yi; Pires, Karla M. P.; Zhang, Yi Cheng; Bugger, Heiko; Ilkun, Olesya; Abel, E. Dale] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA; [Zhu, Yi; Abel, E. Dale] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT USA; [Whitehead, Kevin J.; Olsen, Curtis D.; Wayment, Benjamin; Litwin, Sheldon E.] Univ Utah, Sch Med, Div Cardiol, Salt Lake City, UT USA; [Pires, Karla M. P.] Univ Estado Rio De Janeiro, Lab Morphometry & Cardiovasc Morphol, Inst Biol, Biomed Ctr, Rio De Janeiro, Brazil; [Thomas, George; Kozma, Sara C.] Univ Cincinnati, Coll Med, Dept Internal Med, Metab Dis Inst,Div Hematol Oncol, Cincinnati, OH USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Universidade do Estado do Rio de Janeiro; University System of Ohio; University of Cincinnati	Abel, ED (corresponding author), Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT 84112 USA.	dale.abel@hmbg.utah.edu	Thomas, George/K-9235-2014; Bugger, Heiko/ABA-4180-2021	Thomas, George/0000-0003-3518-8149; Zhang, Yi/0000-0003-2228-0341; Slakeski, Nada/0000-0001-9776-6018; Abel, E. Dale/0000-0001-5290-0738; Reynolds, Eric/0000-0002-6618-4856; Dashper, Stuart/0000-0003-0106-8691; Bugger, Heiko/0000-0002-3524-0405	 [U01HL087947];  [R01DK092065]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027506] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087947, U54HL112311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK091317, R01DK092065] Funding Source: NIH RePORTER	; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	EDA was funded by U01HL087947, R01DK092065. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altunkaynak ME, 2011, ANAT HISTOL EMBRYOL, V40, P402, DOI 10.1111/j.1439-0264.2011.01085.x; Belke DD, 2002, J CLIN INVEST, V109, P629, DOI 10.1172/JCI200213946; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Gaussin V, 2002, P NATL ACAD SCI USA, V99, P2878, DOI 10.1073/pnas.042390499; Hentges KE, 2001, P NATL ACAD SCI USA, V98, P13796, DOI 10.1073/pnas.241184198; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lazorchak AS, 2010, MOL CELL, V39, P433, DOI 10.1016/j.molcel.2010.07.031; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shen WH, 2008, J BIOL CHEM, V283, P13842, DOI 10.1074/jbc.M801510200; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Valencik ML, 2001, TRANSGENIC RES, V10, P269, DOI 10.1023/A:1016601928465; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Yin ZR, 2008, CIRCULATION, V117, P1414, DOI 10.1161/CIRCULATIONAHA.107.759233; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008	28	88	90	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54221	10.1371/journal.pone.0054221	http://dx.doi.org/10.1371/journal.pone.0054221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342106	Green Published, Green Submitted, gold			2022-12-25	WOS:000314759400135
J	Wei, YW; Li, MH; Chen, H; Lewis, BJ; Yu, DP; Zhou, L; Zhou, WM; Fang, XM; Zhao, W; Dai, LM				Wei, Yawei; Li, Maihe; Chen, Hua; Lewis, Bernard J.; Yu, Dapao; Zhou, Li; Zhou, Wangming; Fang, Xiangmin; Zhao, Wei; Dai, Limin			Variation in Carbon Storage and Its Distribution by Stand Age and Forest Type in Boreal and Temperate Forests in Northeastern China	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; GLOBAL CLIMATE-CHANGE; OLD-GROWTH FORESTS; BIOMASS; PLANT; CHRONOSEQUENCE; DECOMPOSITION; LITTERFALL; PATTERNS; WORLDS	The northeastern forest region of China is an important component of total temperate and boreal forests in the northern hemisphere. But how carbon (C) pool size and distribution varies among tree, understory, forest floor and soil components, and across stand ages remains unclear. To address this knowledge gap, we selected three major temperate and two major boreal forest types in northeastern (NE) China. Within both forest zones, we focused on four stand age classes (young, mid-aged, mature and over-mature). Results showed that total C storage was greater in temperate than in boreal forests, and greater in older than in younger stands. Tree biomass C was the main C component, and its contribution to the total forest C storage increased with increasing stand age. It ranged from 27.7% in young to 62.8% in over-mature stands in boreal forests and from 26.5% in young to 72.8% in over-mature stands in temperate forests. Results from both forest zones thus confirm the large biomass C storage capacity of old-growth forests. Tree biomass C was influenced by forest zone, stand age, and forest type. Soil C contribution to total forest C storage ranged from 62.5% in young to 30.1% in over-mature stands in boreal and from 70.1% in young to 26.0% in over-mature in temperate forests. Thus soil C storage is a major C pool in forests of NE China. On the other hand, understory and forest floor C jointly contained less than 13% and <5%, in boreal and temperate forests respectively, and thus play a minor role in total forest C storage in NE China.	[Wei, Yawei; Li, Maihe; Chen, Hua; Lewis, Bernard J.; Yu, Dapao; Zhou, Li; Zhou, Wangming; Fang, Xiangmin; Zhao, Wei; Dai, Limin] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Li, Maihe] Swiss Fed Res Inst WSL, Tree Physiol Grp, Birmensdorf, Switzerland; [Chen, Hua] Univ Illinois, Springfield, IL USA; [Wei, Yawei; Fang, Xiangmin; Zhao, Wei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Illinois System; University of Illinois Springfield; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Dai, LM (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	lmdai@iae.ac.cn	Li, Mai-He/L-6390-2013	Li, Mai-He/0000-0002-7029-2841; Fang, Yi-ping/0000-0003-2966-9528; Yu, Dapao/0000-0001-6991-2807; Wei, Yanqiang/0000-0003-1301-528X	"Strategic Priority Research Program'' of the Chinese Academy of Sciences [XDA05060200]; National Key Technologies R&D Program of China [2012BAD22B04]; Chinese Academy of Sciences visiting professorship for senior international scientists [2012T1Z0006]	"Strategic Priority Research Program'' of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Technologies R&D Program of China(National Key Technology R&D Program); Chinese Academy of Sciences visiting professorship for senior international scientists	This work was supported by the "Strategic Priority Research Program'' of the Chinese Academy of Sciences, Grant No. XDA05060200, National Key Technologies R&D Program of China (2012BAD22B04) and the Chinese Academy of Sciences visiting professorship for senior international scientists (2012T1Z0006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bousquet P, 1999, J GEOPHYS RES-ATMOS, V104, P26161, DOI 10.1029/1999JD900342; BROWN S, 1984, SCIENCE, V223, P1290, DOI 10.1126/science.223.4642.1290; Bu R, 2008, FOREST ECOL MANAG, V254, P407, DOI 10.1016/j.foreco.2007.09.080; Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Chen C., 1989, HDB MAIN TREE SPECIE; Fonseca W, 2011, FOREST ECOL MANAG, V262, P1400, DOI 10.1016/j.foreco.2011.06.036; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Han M., 1994, LONG TERM RES CHINAS, P451; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jonsson M, 2010, BIOL LETTERS, V6, P116, DOI 10.1098/rsbl.2009.0613; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Khatiwala S, 2009, NATURE, V462, P346, DOI 10.1038/nature08526; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Law BE, 2003, GLOBAL CHANGE BIOL, V9, P510, DOI 10.1046/j.1365-2486.2003.00624.x; Liu CJ, 2004, GLOBAL ECOL BIOGEOGR, V13, P105, DOI 10.1111/j.1466-882X.2004.00072.x; Lu R, 1999, METHODS SOIL AGR CHE; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Martin JL, 2005, GLOBAL CHANGE BIOL, V11, P1883, DOI 10.1111/j.1365-2486.2005.01019.x; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Ostertag R, 2008, ECOSYSTEMS, V11, P701, DOI 10.1007/s10021-008-9152-1; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Piao SL, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000014; Piao SL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037381; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Saha SK, 2009, AGROFOREST SYST, V76, P53, DOI 10.1007/s10457-009-9228-8; Smith P, 2010, NATURE, V464, P499, DOI 10.1038/464499a; Smithwick EAH, 2002, ECOL APPL, V12, P1303, DOI 10.1890/1051-0761(2002)012[1303:PUBOCS]2.0.CO;2; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tan K, 2007, FOREST ECOL MANAG, V240, P114, DOI 10.1016/j.foreco.2006.12.018; Vivanco L, 2008, J ECOL, V96, P727, DOI 10.1111/j.1365-2745.2008.01393.x; Wang CK, 2003, GLOBAL CHANGE BIOL, V9, P1066, DOI 10.1046/j.1365-2486.2003.00645.x; Wang CK, 2006, FOREST ECOL MANAG, V222, P9, DOI 10.1016/j.foreco.2005.10.074; Wang CK, 2001, GLOBAL CHANGE BIOL, V7, P719, DOI 10.1046/j.1354-1013.2001.00441.x; Wang Hui, 2005, Journal of Forestry Research (Harbin), V16, P27, DOI 10.1007/BF02856849; Wang XP, 2008, FOREST ECOL MANAG, V255, P4007, DOI 10.1016/j.foreco.2008.03.055; Wang XP, 2006, FOREST ECOL MANAG, V234, P264, DOI 10.1016/j.foreco.2006.07.007; [王雪军 WANG XueJun], 2008, [生态学报, Acta Ecologica Sinica], V28, P4757; Wiesmeier M, 2012, GLOBAL CHANGE BIOL, V18, P2233, DOI 10.1111/j.1365-2486.2012.02699.x; Wynn JG, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002576; Xing Y, 2005, THESIS NE FORESTRY U; Yanai RD, 2003, ECOSYSTEMS, V6, P197, DOI 10.1007/s10021-002-0206-5; Yang YH, 2007, BIOGEOCHEMISTRY, V84, P131, DOI 10.1007/s10533-007-9109-z; Zhang Na, 2003, Yingyong Shengtai Xuebao, V14, P659; Zhang Xin-Ping, 2008, Zhiwu Shengtai Xuebao, V32, P1031, DOI 10.3773/j.issn.1005-264x.2008.05.008; Zhou GY, 2006, SCIENCE, V314, P1417, DOI 10.1126/science.1130168; Zhou L, 2011, ANN FOREST SCI, V68, P953, DOI 10.1007/s13595-011-0101-3; Zhu BA, 2010, J PLANT RES, V123, P439, DOI 10.1007/s10265-009-0301-1	49	81	91	11	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e72201	10.1371/journal.pone.0072201	http://dx.doi.org/10.1371/journal.pone.0072201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977252	gold, Green Published			2022-12-25	WOS:000324527300071
J	Wei, YQ; Fang, YP				Wei, Yanqiang; Fang, Yiping			Spatio-Temporal Characteristics of Global Warming in the Tibetan Plateau during the Last 50 Years Based on a Generalised Temperature Zone - Elevation Model	PLOS ONE			English	Article							CLIMATE-CHANGE; SPATIAL INTERPOLATION; MASS-BALANCE; IMPACTS; PERMAFROST; GLACIERS; RETREAT; MIGRATION; GREENLAND; PATTERNS	Temperature is one of the primary factors influencing the climate and ecosystem, and examining its change and fluctuation could elucidate the formation of novel climate patterns and trends. In this study, we constructed a generalised temperature zone elevation model (GTEM) to assess the trends of climate change and temporal-spatial differences in the Tibetan Plateau (TP) using the annual and monthly mean temperatures from 1961-2010 at 144 meteorological stations in and near the TP. The results showed the following: (1) The TP has undergone robust warming over the study period, and the warming rate was 0.318 degrees C/decade. The warming has accelerated during recent decades, especially in the last 20 years, and the warming has been most significant in the winter months, followed by the spring, autumn and summer seasons. (2) Spatially, the zones that became significantly smaller were the temperature zones of -6 degrees C and -4 degrees C, and these have decreased 499.44 and 454.26 thousand sq km from 1961 to 2010 at average rates of 25.1% and 11.7%, respectively, over every 5-year interval. These quickly shrinking zones were located in the northwestern and central TP. (3) The elevation dependency of climate warming existed in the TP during 1961-2010, but this tendency has gradually been weakening due to more rapid warming at lower elevations than in the middle and upper elevations of the TP during 1991-2010. The higher regions and some low altitude valleys of the TP were the most significantly warming regions under the same categorizing criteria. Experimental evidence shows that the GTEM is an effective method to analyse climate changes in high altitude mountainous regions.	[Wei, Yanqiang; Fang, Yiping] Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Sichuan, Peoples R China; [Wei, Yanqiang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wei, YQ (corresponding author), Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Sichuan, Peoples R China.	weiyq@imde.ac.cn	Li, Mai-He/L-6390-2013	Li, Mai-He/0000-0002-7029-2841; Fang, Yi-ping/0000-0003-2966-9528; Yu, Dapao/0000-0001-6991-2807; Wei, Yanqiang/0000-0003-1301-528X	National Basic Research Program of China (973 Program) [2010CB951704]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was financially supported by the research grant from the National Basic Research Program of China (973 Program, No. 2010CB951704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Aizen VB, 2002, QUATERN INT, V97-8, P27, DOI 10.1016/S1040-6182(02)00049-6; Diaz-Varela RA, 2010, ECOL MODEL, V221, P621, DOI 10.1016/j.ecolmodel.2009.11.010; AZZALINI A, 1985, SCAND J STAT, V12, P171; Baker BB, 2007, ARCT ANTARCT ALP RES, V39, P200, DOI 10.1657/1523-0430(2007)39[200:ATARGI]2.0.CO;2; Beardall J, 2009, PLANT ECOL DIVERS, V2, P191, DOI 10.1080/17550870903271363; Beniston M, 1996, THEOR APPL CLIMATOL, V53, P231, DOI 10.1007/BF00871739; Beniston M, 1997, CLIMATIC CHANGE, V36, P233, DOI 10.1023/A:1005380714349; Benn DI, 2000, QUATERN INT, V65-6, P15, DOI 10.1016/S1040-6182(99)00034-8; Berthier E, 2008, REMOTE SENS ENVIRON, V112, P2443, DOI 10.1016/j.rse.2007.11.004; Bolch T, 2007, GLOBAL PLANET CHANGE, V56, P1, DOI 10.1016/j.gloplacha.2006.07.009; Bonnaventure PP, 2011, CLIMATIC CHANGE, V105, P293, DOI 10.1007/s10584-010-9818-5; Bradley RS, 2006, SCIENCE, V312, P1755, DOI 10.1126/science.1128087; Byg A, 2009, GLOBAL ENVIRON CHANG, V19, P156, DOI 10.1016/j.gloenvcha.2009.01.010; Casal TGD, 2004, CLIM DYNAM, V23, P407, DOI 10.1007/s00382-004-0441-x; Chen B, 2003, CLIM DYNAM, V20, P401, DOI 10.1007/s00382-002-0282-4; Chen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025008; China Meteorological Administration, 2006, CLIM ENV CHIN; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cui XF, 2006, GLOBAL PLANET CHANGE, V54, P33, DOI 10.1016/j.gloplacha.2005.07.006; DeGaetano AT, 2007, J APPL METEOROL CLIM, V46, P1981, DOI 10.1175/2007JAMC1536.1; Ding YJ, 2006, ANN GLACIOL-SER, V43, P97, DOI 10.3189/172756406781812005; Du MY, 2004, GLOBAL PLANET CHANGE, V41, P241, DOI 10.1016/j.gloplacha.2004.01.010; Duan AM, 2005, CLIM DYNAM, V24, P793, DOI 10.1007/s00382-004-0488-8; Fang YP, 2011, J MT SCI-ENGL, V8, P437, DOI 10.1007/s11629-011-1004-3; Francou B, 2004, CR GEOSCI, V337, P97; Harley CDG, 2009, P NATL ACAD SCI USA, V106, P11172, DOI 10.1073/pnas.0904946106; Hughes L, 2011, REG ENVIRON CHANGE, V11, pS189, DOI 10.1007/s10113-010-0158-9; IPCC, 2007, SUMM POL CLIM CHANG, DOI [10.1260/095830507781076194, DOI 10.1260/095830507781076194]; Jacobson M. Z, 2005, FUNDAMENTALS ATMOSPH; Jin HJ, 2008, COLD REG SCI TECHNOL, V53, P317, DOI 10.1016/j.coldregions.2007.07.005; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kang SC, 2010, ENV RES LETT; Kerr RA, 2007, SCIENCE, V316, P188, DOI 10.1126/science.316.5822.188; Kintisch E, 2007, SCIENCE, V318, P1846, DOI 10.1126/science.318.5858.1846; Kurtzman D, 1999, CLIMATE RES, V13, P33, DOI 10.3354/cr013033; Kutuzov S, 2009, GLOBAL PLANET CHANGE, V69, P59, DOI 10.1016/j.gloplacha.2009.07.001; Lahsen M, 2010, CURR OPIN ENV SUST, V2, P364, DOI 10.1016/j.cosust.2010.10.009; Lee TD, 2005, FOREST ECOL MANAG, V212, P75, DOI 10.1016/j.foreco.2005.03.007; Leemans R, 2004, GLOBAL ENVIRON CHANG, V14, P219, DOI 10.1016/j.gloenvcha.2004.04.009; Li ZX, 2010, QUATERN INT, V218, P166, DOI 10.1016/j.quaint.2008.09.005; Li ZX, 2010, QUATERN INT, V218, P13, DOI 10.1016/j.quaint.2009.05.010; Liao SB, 2010, COMPUTAT GEOSCI, V14, P539, DOI 10.1007/s10596-009-9169-3; [廖顺宝 Liao Shunbao], 2004, [地理研究, Geographical Research], V23, P633; Lin XW, 2011, AGR FOREST METEOROL, V151, P792, DOI 10.1016/j.agrformet.2011.01.009; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Liu XD, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006915; Liu XD, 2009, GLOBAL PLANET CHANGE, V68, P164, DOI 10.1016/j.gloplacha.2009.03.017; Loczy, 1899, ENCY BRITANNICA NEW; Lowell TV, 2000, P NATL ACAD SCI USA, V97, P1351, DOI 10.1073/pnas.97.4.1351; Meintanis SG, 2007, J STAT PLAN INFER, V137, P2681, DOI 10.1016/j.jspi.2006.04.012; Mudholkar GS, 2000, J STAT PLAN INFER, V83, P291, DOI 10.1016/S0378-3758(99)00096-8; Ninyerola M, 2007, INT J CLIMATOL, V27, P1231, DOI 10.1002/joc.1462; Oerlemans J, 2006, GLOBAL PLANET CHANGE, V50, P148, DOI 10.1016/j.gloplacha.2005.12.002; OERLEMANS J, 1994, SCIENCE, V264, P243, DOI 10.1126/science.264.5156.243; Oerlemans J, 2009, NATURE, V462, P572, DOI 10.1038/462572a; Parolo G, 2008, BASIC APPL ECOL, V9, P100, DOI 10.1016/j.baae.2007.01.005; Penuelas J, 2007, ECOGRAPHY, V30, P829, DOI 10.1111/j.2007.0906-7590.05247.x; Pepin NC, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005047; Schwalb A, 2010, QUATERN INT, V218, P1, DOI 10.1016/j.quaint.2010.02.017; Shortridge AM, 2004, INT J GEOGR INF SCI, V18, P539, DOI 10.1080/13658810410001702012; Sivakumar MVK, 2011, CLIMATE CHANGE AND FOOD SECURITY IN SOUTH ASIA, P13, DOI 10.1007/978-90-481-9516-9_2; Soini E, 2005, AGR SYST, V85, P306, DOI 10.1016/j.agsy.2005.06.013; Sundal AV, 2011, NATURE, V469, P522, DOI 10.1038/nature09740; Thornton PK, 2009, AGR SYST, V101, P113, DOI 10.1016/j.agsy.2009.05.002; Vuille M, 2000, GEOPHYS RES LETT, V27, P3885, DOI 10.1029/2000GL011871; Vuille M, 2003, CLIMATIC CHANGE, V59, P75, DOI 10.1023/A:1024406427519; Wang B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034330; Xue X, 2009, GEOMORPHOLOGY, V108, P182, DOI 10.1016/j.geomorph.2009.01.004; Yang B, 2008, GLOBAL PLANET CHANGE, V60, P126, DOI 10.1016/j.gloplacha.2006.07.035; Yang B, 2009, GLOBAL PLANET CHANGE, V69, P71, DOI 10.1016/j.gloplacha.2009.07.008; Yang MX, 2010, EARTH-SCI REV, V103, P31, DOI 10.1016/j.earscirev.2010.07.002; Yang T, 2012, GLOBAL PLANET CHANGE, V80-81, P1, DOI 10.1016/j.gloplacha.2011.08.006; Yao T, 2007, ARCT ANTARCT ALP RES, V39, P642, DOI 10.1657/1523-0430(07-510)[YAO]2.0.CO;2; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/NCLIMATE1580, 10.1038/nclimate1580]; You QL, 2010, GLOBAL PLANET CHANGE, V72, P11, DOI 10.1016/j.gloplacha.2010.04.003; You QL, 2010, GLOBAL PLANET CHANGE, V71, P124, DOI 10.1016/j.gloplacha.2010.01.020; You QL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032669; Zemp M, 2007, GLOBAL PLANET CHANGE, V56, P83, DOI 10.1016/j.gloplacha.2006.07.002; [张镱锂 Zhang Yili], 2002, [地理研究, Geographical Research], V21, P1; Zhao L, 2004, GLOBAL PLANET CHANGE, V43, P19, DOI 10.1016/j.gloplacha.2004.02.003	81	81	91	11	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e60044	10.1371/journal.pone.0060044	http://dx.doi.org/10.1371/journal.pone.0060044			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23977252	Green Published, Green Submitted, gold			2022-12-25	WOS:000317717300051
J	Archer, W; Braun, DR				Archer, Will; Braun, David R.			Investigating the Signature of Aquatic Resource Use within Pleistocene Hominin Dietary Adaptations	PLOS ONE			English	Article							CARNIVORE TOOTH-MARKS; OLDUVAI GORGE; CUT MARKS; PERCUSSION MARKS; MECHANICAL-PROPERTIES; STABLE-ISOTOPES; KOOBI FORA; LONG BONES; PLIOPLEISTOCENE; SEASONALITY	There is general agreement that the diet of early hominins underwent dramatic changes shortly after the appearance of stone tools in the archaeological record. It is often assumed that this change is associated with dietary expansion to incorporate large mammal resources. Although other aspects of the hominin diet, such as aquatic or vegetal resources, are assumed to be a part of hominin subsistence, identifying evidence of these adaptations has proved difficult. Here we present a series of analyses that provide methodological support for the inclusion of aquatic resources in hominin dietary reconstructions. We suggest that bone surface modifications in aquatic species are morphologically distinguishable from bone surface modifications on terrestrial taxa. We relate these findings to differences that we document in the surface mechanical properties of the two types of bone, as reflected by significant differences in bone surface microhardness values between aquatic and terrestrial species. We hypothesize that the characteristics of bone surface modifications on aquatic taxa inhibit the ability of zooarchaeologists to consistently diagnose them correctly. Contingently, this difficulty influences correspondence levels between zooarchaeologists, and may therefore result in misinterpretation of the taphonomic history of early Pleistocene aquatic faunal assemblages. A blind test using aquatic specimens and a select group of 9 experienced zooarchaeologists as participants was designed to test this hypothesis. Investigation of 4 different possible explanations for blind test results suggest the dominant factors explaining patterning relate to (1) the specific methodologies employed to diagnose modifications on aquatic specimens and (2) the relative experience of participants with modifications on aquatic bone surfaces. Consequently we argue that an important component of early hominin diets may have hitherto been overlooked as a result of (a) the paucity of referential frameworks within which to identify such a component and (b) the inability of applied identification methodologies to consistently do so.	[Archer, Will; Braun, David R.] Max Planck Inst Evolutionary Anthropol, Human Evolut Dept, Leipzig, Germany; [Braun, David R.] Univ Cape Town, Dept Archaeol, ZA-7925 Cape Town, South Africa; [Braun, David R.] George Washington Univ, Ctr Adv Study Hominin Paleobiol, Washington, DC USA	Max Planck Society; University of Cape Town; George Washington University	Archer, W (corresponding author), Max Planck Inst Evolutionary Anthropol, Human Evolut Dept, Leipzig, Germany.	will.archer@eva.mpg.de		Archer, Will/0000-0003-1174-0605	Centre for African Origins at the Archaeology Department of the University of Cape Town, South Africa	Centre for African Origins at the Archaeology Department of the University of Cape Town, South Africa	Funding for this research was provided by the Centre for African Origins at the Archaeology Department of the University of Cape Town, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperson-Afil N, 2009, SCIENCE, V326, P1677, DOI 10.1126/science.1180695; Archer W, 2013, J HUM EVOL IN PRESS; ASHBY MF, 1995, P R SOC-MATH PHYS SC, V450, P123, DOI 10.1098/rspa.1995.0075; Bartram L. E., 1991, INTERPRETATION ARCHA, P77, DOI [DOI 10.1007/978-1-4899-2602-9_5, 10.1007/978-1-4899-2602-9_5]; BEHRENSMEYER AK, 1986, NATURE, V319, P768, DOI 10.1038/319768a0; Bello SM, 2008, J ARCHAEOL SCI, V35, P1542, DOI 10.1016/j.jas.2007.10.018; Binford L.R., 1981, BONES ANCIENT MEN MO; Blasco R, 2011, J HUM EVOL, V11, P265; Blasco R, 2008, J ARCHAEOL SCI, V35, P2839, DOI 10.1016/j.jas.2008.05.013; BLUMENSCHINE R J, 1991, Philosophical Transactions of the Royal Society of London B Biological Sciences, V334, P211, DOI 10.1098/rstb.1991.0110; Blumenschine R.j., 1991, CULTURAL BEGINNINGS, P17; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; BLUMENSCHINE RJ, 1986, J HUM EVOL, V15, P639, DOI 10.1016/S0047-2484(86)80002-1; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; BLUMENSCHINE RJ, 1987, CURR ANTHROPOL, V28, P383, DOI 10.1086/203544; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; BLUMENSCHINE RJ, 1994, J HUM EVOL, V27, P197, DOI 10.1006/jhev.1994.1042; Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; BLUMENSCHINE RJ, 1991, J HUM EVOL, V21, P451, DOI 10.1016/0047-2484(91)90095-D; BLUMENSCHINE RJ, 1988, J ARCHAEOL SCI, V15, P483, DOI 10.1016/0305-4403(88)90078-7; Blumenschine RJ, 2007, J HUM EVOL, V53, P420, DOI 10.1016/j.jhevol.2007.01.011; Braun DR, 2009, ARCHAEOMETRY, V51, P26, DOI 10.1111/j.1475-4754.2008.00393.x; Braun DR, 2010, P NATL ACAD SCI USA, V107, P10002, DOI 10.1073/pnas.1002181107; Bunn H.T., 1983, BAR International Series, V163, P143; BUNN HT, 1981, NATURE, V291, P574, DOI 10.1038/291574a0; BUNN HT, 1988, J ANTHROPOL ARCHAEOL, V7, P412, DOI 10.1016/0278-4165(88)90004-9; CAPALDO SD, 1994, AM ANTIQUITY, V59, P724, DOI 10.2307/282345; Colley S.M., 1990, Archaeological Method and Theory, V2, P207; Cunnane S., 2010, HUMAN BRAIN EVOLUTIO; CURREY J, 1984, AM ZOOL, V24, P5; Currey J.D., 2002, BONES; CURREY JD, 1990, J MATER SCI-MATER M, V1, P14, DOI 10.1007/BF00705348; de Heinzelin J, 1999, SCIENCE, V284, P625; Dean MN, 2009, INTEGR COMP BIOL, V49, P15, DOI 10.1093/icb/icp012; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2005, J HUM EVOL, V48, P109, DOI 10.1016/j.jhevol.2004.09.004; Dominguez-Rodrigo M, 2003, EVOL ANTHROPOL, V12, P275, DOI 10.1002/evan.10119; Dominguez-Rodrigo M, 2003, J ARCHAEOL SCI, V30, P381, DOI 10.1006/jasc.2002.0842; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P2643, DOI 10.1016/j.jas.2009.07.017; Dominguez-Rodrigo M, 1999, J HUM EVOL, V37, P793, DOI 10.1006/jhev.1999.0358; Dominguez-Rodrigo M, 1998, J ARCHAEOL SCI; Dominguez-Rodrigo M, 2011, P NATL ACAD SCI USA, V108, pE117, DOI 10.1073/pnas.1104647108; Dominguez-Rodrigo M, 2010, P NATL ACAD SCI USA, V107, P20929, DOI 10.1073/pnas.1013711107; Dominguez-Rodrigo M, 2009, VERTEBR PALEOBIOL PA, P129, DOI 10.1007/978-1-4020-9060-8_11; DominguezRodrigo M, 2007, VERTEBR PALEOBIOL PA, P1; Faith JT, 2009, J HUM EVOL, V56, P247, DOI 10.1016/j.jhevol.2008.12.008; Ferraro J, 2007, INTERPRETATION ARCHA; FIORILLO A.R., 1989, BONE MODIFICATION U, P61; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; GIFFORDGONZALEZ D, 1991, J ANTHROPOL ARCHAEOL, V10, P215, DOI 10.1016/0278-4165(91)90014-O; Grine FE, 2012, AM J PHYS ANTHROPOL, V148, P285, DOI 10.1002/ajpa.22086; Henry AG, 2012, NATURE, V487, P90, DOI 10.1038/nature11185; Jones K.T., 1983, CARNIVORES HUMAN SCA, P171; Joordens JCA, 2009, J HUM EVOL, V57, P656, DOI 10.1016/j.jhevol.2009.06.003; Lee-Thorp JA, 2010, PHILOS T R SOC B, V365, P3389, DOI 10.1098/rstb.2010.0059; Lyman RL, 2005, J ARCHAEOL SCI, V32, P1722, DOI 10.1016/j.jas.2005.06.003; McPherron SP, 2011, P NATL ACAD SCI USA, V108, pE116, DOI 10.1073/pnas.1101298108; O'Connell JF, 2002, J HUM EVOL, V43, P831, DOI 10.1006/jhev.2002.0604; ONTANON M, 1992, ADV BIOMAT, V10, P171; Pante MC, 2010, J ARCHAEOL SCI, V37, P846, DOI 10.1016/j.jas.2009.11.014; Paxton H, 2006, J FISH BIOL, V68, P481, DOI 10.1111/j.0022-1112.2006.00926.x; Pickering TR, 2004, J HUM EVOL, V46, P595, DOI 10.1016/j.jhevol.2004.03.002; Pickering TR, 2003, J ARCHAEOL SCI, V30, P1469, DOI 10.1016/S0305-4403(03)00042-6; Pickering TR, 2013, J ARCHAEOL SCI, V40, P1295, DOI 10.1016/j.jas.2012.09.025; Plavcan JM, 2005, CAM S BIO EVOL ANTHR, V44, P401, DOI 10.1017/CBO9780511542343.015; Pobiner BL, 2007, HOMINID PALEOECOLOGY; Rybczynski N, 1996, J ARCHAEOL SCI, V23, P863, DOI 10.1006/jasc.1996.0080; SHIPMAN P, 1983, J ANTHROPOL ARCHAEOL, V2, P57, DOI 10.1016/0278-4165(83)90008-9; SPETH JD, 1989, J HUM EVOL, V18, P329, DOI 10.1016/0047-2484(89)90035-3; STEWART KM, 1994, J ARCHAEOL SCI, V21, P237, DOI 10.1006/jasc.1994.1024; STEWART KM, 1994, J HUM EVOL, V27, P229, DOI 10.1006/jhev.1994.1044; Stiner MC, 1999, SCIENCE, V283, P190, DOI 10.1126/science.283.5399.190; TAPPEN M, 1995, J HUM EVOL, V29, P483, DOI 10.1006/jhev.1995.1070; Ungar PS, 2006, ANNU REV ANTHROPOL, V35, P209, DOI 10.1146/annurev.anthro.35.081705.123153; van Woerden JT, 2012, EVOLUTION, V66, P191, DOI 10.1111/j.1558-5646.2011.01434.x; van Woerden JT, 2010, AM NAT, V176, P758, DOI 10.1086/657045; Willis LA, 2008, J ARCHAEOL SCI, V35, P1438, DOI 10.1016/j.jas.2007.10.010; YELLEN JE, 1995, SCIENCE, V268, P553, DOI 10.1126/science.7725100; Zohar I, 2008, PALAEOGEOGR PALAEOCL, V258, P292, DOI 10.1016/j.palaeo.2007.11.004; Zohar I, 2011, J HUM EVOL, V60, P343, DOI 10.1016/j.jhevol.2010.10.007	80	85	86	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e69899	10.1371/journal.pone.0069899	http://dx.doi.org/10.1371/journal.pone.0069899			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218YW	23990891	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100016
J	Conte, M; Vasuri, F; Trisolino, G; Bellavista, E; Santoro, A; Degiovanni, A; Martucci, E; D'Errico-Grigioni, A; Caporossi, D; Capri, M; Maier, AB; Seynnes, O; Barberi, L; Musaro, A; Narici, MV; Franceschi, C; Salvioli, S				Conte, Maria; Vasuri, Francesco; Trisolino, Giovanni; Bellavista, Elena; Santoro, Aurelia; Degiovanni, Alessio; Martucci, Ermanno; D'Errico-Grigioni, Antonia; Caporossi, Daniela; Capri, Miriam; Maier, Andrea B.; Seynnes, Olivier; Barberi, Laura; Musaro, Antonio; Narici, Marco V.; Franceschi, Claudio; Salvioli, Stefano			Increased Plin2 Expression in Human Skeletal Muscle Is Associated with Sarcopenia and Muscle Weakness	PLOS ONE			English	Article							INSULIN SENSITIVITY; FAT INFILTRATION; PERILIPIN 2; APOPTOSIS; STORAGE; P53; OXIDATION; STRENGTH; EXERCISE; PROTEIN	Human aging is associated with a progressive loss of muscle mass and strength and a concomitant fat accumulation in form of inter-muscular adipose tissue, causing skeletal muscle function decline and immobilization. Fat accumulation can also occur as intra-muscular triglycerides (IMTG) deposition in lipid droplets, which are associated with perilipin proteins, such as Perilipin2 (Plin2). It is not known whether Plin2 expression changes with age and if this has consequences on muscle mass and strength. We studied the expression of Plin2 in the vastus lateralis (VL) muscle of both healthy subjects and patients affected by lower limb mobility limitation of different age. We found that Plin2 expression increases with age, this phenomenon being particularly evident in patients. Moreover, Plin2 expression is inversely correlated with quadriceps strength and VL thickness. To investigate the molecular mechanisms underpinning this phenomenon, we focused on IGF-1/p53 network/signalling pathway, involved in muscle physiology. We found that Plin2 expression strongly correlates with increased p53 activation and reduced IGF-1 expression. To confirm these observations made on humans, we studied mice overexpressing muscle-specific IGF-1, which are protected from sarcopenia. These mice resulted almost negative for the expression of Plin2 and p53 at two years of age. We conclude that fat deposition within skeletal muscle in form of Plin2-coated lipid droplets increases with age and is associated with decreased muscle strength and thickness, likely through an IGF-1- and p53-dependent mechanism. The data also suggest that excessive intramuscular fat accumulation could be the initial trigger for p53 activation and consequent loss of muscle mass and strength.	[Conte, Maria; Bellavista, Elena; Santoro, Aurelia; Capri, Miriam; Franceschi, Claudio; Salvioli, Stefano] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Conte, Maria; Bellavista, Elena; Santoro, Aurelia; Capri, Miriam; Franceschi, Claudio; Salvioli, Stefano] Univ Bologna, Interdept Ctr L Galvani CIG, Bologna, Italy; [Vasuri, Francesco; Degiovanni, Alessio; D'Errico-Grigioni, Antonia] Univ Bologna, S Orsola Malpighi Hosp, F Addarii Inst Oncol & Transplant Pathol, Bologna, Italy; [Trisolino, Giovanni; Martucci, Ermanno] Ist Ortoped Rizzoli, Bologna, Italy; [Caporossi, Daniela] Univ Rome Foro Italico, Dept Hlth Sci, Rome, Italy; [Maier, Andrea B.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Seynnes, Olivier] Norwegian Sch Sport Sci, Oslo, Norway; [Barberi, Laura; Musaro, Antonio] Univ Roma La Sapienza, IIM, DAHFMO Unit Histol & Med Embryol, Inst Pasteur Cenci Bolognetti, I-00185 Rome, Italy; [Narici, Marco V.] Univ Nottingham, Sch Grad Entry Med & Hlth, Div Clin Physiol, Derby Royal Hosp, Derby, England	University of Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Istituto Ortopedico Rizzoli; Foro Italico University of Rome; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Norwegian School of Sport Sciences; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Nottingham	Conte, M (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.	m.conte@unibo.it	Salvioli, Stefano/K-6663-2016; Musaro, Antonio/P-2953-2019; Franceschi, Claudio/L-4484-2017; Capri, Miriam/K-4700-2016; Maier, Andrea B./Q-5548-2019; Musarò, Antonio/K-9598-2016; Trisolino, Giovanni/I-3717-2019; Vasuri, Francesco/K-5418-2016; Maier, Andrea/W-7060-2019; Caporossi, Daniela/D-7434-2011; Bakker, Matthew/B-8610-2013	Salvioli, Stefano/0000-0002-6191-1225; Musaro, Antonio/0000-0002-2944-9739; Franceschi, Claudio/0000-0001-9841-6386; Capri, Miriam/0000-0001-9077-0401; Musarò, Antonio/0000-0002-2944-9739; Trisolino, Giovanni/0000-0002-0361-9920; Vasuri, Francesco/0000-0002-1145-6025; Maier, Andrea/0000-0001-7206-1724; Caporossi, Daniela/0000-0001-9628-0665; Salomon, Christine/0000-0003-4976-598X; Bakker, Matthew/0000-0003-0345-0587; D'ERRICO, ANTONIETTA/0000-0003-2747-3732; Santoro, Aurelia/0000-0002-7187-1116; Seynnes, Olivier/0000-0002-1289-246X; Conte, Maria/0000-0002-4621-9898	European Union [223576]; MRC [MR/K00414X/1] Funding Source: UKRI; Medical Research Council [MR/K00414X/1] Funding Source: researchfish	European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2011) under grant agreement no 223576 (MYOAGE) to CF, MN and AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2004, J BIOL CHEM, V279, P10070, DOI 10.1074/jbc.M308522200; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bosma M, 2012, DIABETES, V61, P2679, DOI 10.2337/db11-1402; Boylston WH, 2004, AGING CELL, V3, P283, DOI 10.1111/j.1474-9728.2004.00115.x; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Dirks-Naylor Amie J, 2011, Curr Aging Sci, V4, P269; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Gandolfi G, 2011, MEAT SCI, V88, P631, DOI 10.1016/j.meatsci.2011.02.020; Gjelstad IMF, 2012, ARCH PHYSIOL BIOCHEM, V118, P22, DOI 10.3109/13813455.2011.630009; Goodpaster BH, 2008, J APPL PHYSIOL, V105, P1498, DOI 10.1152/japplphysiol.90425.2008; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; HUSSAIN MA, 1993, J CLIN INVEST, V92, P2249, DOI 10.1172/JCI116828; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Koster A, 2011, J GERONTOL A-BIOL, V66, P888, DOI 10.1093/gerona/glr070; Marcus RL, 2010, J NUTR HEALTH AGING, V14, P362, DOI 10.1007/s12603-010-0081-2; Marcus Robin L, 2012, J Aging Res, V2012, P629637, DOI 10.1155/2012/629637; Minnaard R, 2009, J CLIN ENDOCR METAB, V94, P4077, DOI 10.1210/jc.2009-0352; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Okura T, 2000, EUR J PHARMACOL, V407, P227, DOI 10.1016/S0014-2999(00)00758-5; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Schwarzkopf M., 2008, BASIC APPL MYOL, V18, P131; Scrable H, 2009, EXP GERONTOL, V44, P93, DOI 10.1016/j.exger.2008.05.017; Shaw CS, 2010, ANNU REV NUTR, V30, P13, DOI 10.1146/annurev.nutr.012809.104817; Shaw C, 2009, HISTOCHEM CELL BIOL, V131, P575, DOI 10.1007/s00418-009-0558-4; Shepherd SO, 2013, J PHYSIOL-LONDON, V591, P657, DOI 10.1113/jphysiol.2012.240952; Shepherd SO, 2012, EXP PHYSIOL, V97, P970, DOI 10.1113/expphysiol.2012.064592; Timmers S, 2012, P NATL ACAD SCI USA, V109, P11711, DOI 10.1073/pnas.1206868109; Vasuri F, 2010, BIOCHEM BIOPH RES CO, V397, P301, DOI 10.1016/j.bbrc.2010.05.104; Wang H, 2011, TRENDS ENDOCRIN MET, V22, P197, DOI 10.1016/j.tem.2011.03.008; Wang XQ, 2009, BIOCHEM BIOPH RES CO, V380, P286, DOI 10.1016/j.bbrc.2009.01.060; Wilkes EA, 2009, AM J CLIN NUTR, V90, P1343, DOI 10.3945/ajcn.2009.27543; Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002	32	59	61	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e73709	10.1371/journal.pone.0073709	http://dx.doi.org/10.1371/journal.pone.0073709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	24339897	Green Published, gold			2022-12-25	WOS:000323378000121
J	Hwang, YS; Suk, S; Lin, S; Tierney, M; Du, B; Seo, T; Mitchell, A; Sacco, A; Varghese, S				Hwang, Yongsung; Suk, Samuel; Lin, Susan; Tierney, Matthew; Du, Bin; Seo, Timothy; Mitchell, Aaron; Sacco, Alessandra; Varghese, Shyni			Directed In Vitro Myogenesis of Human Embryonic Stem Cells and Their In Vivo Engraftment	PLOS ONE			English	Article							SKELETAL-MUSCLE REGENERATION; MUSCULAR-DYSTROPHY; SATELLITE CELLS; SELF-RENEWAL; DIFFERENTIATION; TRANSPLANTATION; GENERATION; DERIVATION; MODEL; PROGENITORS	Development of human embryonic stem cell (hESC)-based therapy requires derivation of in vitro expandable cell populations that can readily differentiate to specified cell types and engraft upon transplantation. Here, we report that hESCs can differentiate into skeletal muscle cells without genetic manipulation. This is achieved through the isolation of cells expressing a mesodermal marker, platelet-derived growth factor receptor-alpha (PDGFRA), following embryoid body (EB) formation. The ESC-derived cells differentiated into myoblasts in vitro as evident by upregulation of various myogenic genes, irrespective of the presence of serum in the medium. This result is further corroborated by the presence of sarcomeric myosin and desmin, markers for terminally differentiated cells. When transplanted in vivo, these pre-myogenically committed cells were viable in tibialis anterior muscles 14 days post-implantation. These hESC-derived cells, which readily undergo myogenic differentiation in culture medium containing serum, could be a viable cell source for skeletal muscle repair and tissue engineering to ameliorate various muscle wasting diseases.	[Hwang, Yongsung; Suk, Samuel; Lin, Susan; Du, Bin; Mitchell, Aaron; Sacco, Alessandra; Varghese, Shyni] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA; [Tierney, Matthew] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA USA; [Seo, Timothy; Varghese, Shyni] Univ Calif San Diego, Dept Nanoengn, San Diego, CA 92103 USA	University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Varghese, S (corresponding author), Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA.	svarghese@ucsd.edu			California Institute of Regenerative Medicine [RN2-00945, RT2-01889]	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine)	The authors thank the California Institute of Regenerative Medicine for their financial support (RN2-00945 and RT2-01889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro LAS, 2011, STEM CELLS, V29, P2030, DOI 10.1002/stem.759; Asakura A, 2007, P NATL ACAD SCI USA, V104, P16552, DOI 10.1073/pnas.0708145104; Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056; Awaya T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051638; Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Bhagavati S, 2005, BIOCHEM BIOPH RES CO, V333, P644, DOI 10.1016/j.bbrc.2005.05.135; Brafman DA, 2010, BIOMATERIALS, V31, P9135, DOI 10.1016/j.biomaterials.2010.08.007; Chang CW, 2013, BIOMATERIALS, V34, P912, DOI 10.1016/j.biomaterials.2012.10.020; Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020; Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Darabi R, 2009, EXP NEUROL, V220, P212, DOI 10.1016/j.expneurol.2009.08.002; Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Filareto A., 2012, J STEM CELL RES THER, V10, pS10, DOI 10.4172/2157-7633.S10-001; Gallego MJ, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt28; Goudenege S, 2012, MOL THER, V20, P2153, DOI 10.1038/mt.2012.188; Gunaseeli I, 2010, CURR MED CHEM, V17, P759, DOI 10.2174/092986710790514480; Heins N, 2004, STEM CELLS, V22, P367, DOI 10.1634/stemcells.22-3-367; Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106; Hwang YS, 2011, REGEN MED, V6, P505, DOI [10.2217/RME.11.38, 10.2217/rme.11.38]; Jang J, 2012, EXP MOL MED, V44, P202, DOI DOI 10.3858/EMM.2012.44.3.015; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Le Grand F, 2004, EXP CELL RES, V301, P232, DOI 10.1016/j.yexcr.2004.07.028; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Liu YN, 2007, STEM CELLS DEV, V16, P695, DOI 10.1089/scd.2006.0118; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303; Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Rao LJ, 2012, STEM CELL REV REP, V8, P1109, DOI 10.1007/s12015-012-9413-4; Ren KF, 2008, ADV FUNCT MATER, V18, P1378, DOI 10.1002/adfm.200701297; Rossi CA, 2010, ORGANOGENESIS, V6, P167, DOI 10.4161/org.6.3.12419; Sakurai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047078; Salani S, 2012, J CELL MOL MED, V16, P1353, DOI 10.1111/j.1582-4934.2011.01498.x; Sangaj N, 2010, BIOMACROMOLECULES, V11, P3294, DOI 10.1021/bm101041f; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Suzuki H, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-72; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Varghese S, 2010, STEM CELLS, V28, P765, DOI 10.1002/stem.325; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wilschut KJ, 2012, STEM CELL TRANSL MED, V1, P833, DOI 10.5966/sctm.2012-0071; Yin H, 2013, CELL METAB, V17, P210, DOI 10.1016/j.cmet.2013.01.004; Zheng JK, 2006, CELL RES, V16, P713, DOI 10.1038/sj.cr.7310080	49	31	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72023	10.1371/journal.pone.0072023	http://dx.doi.org/10.1371/journal.pone.0072023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977197	gold, Green Published			2022-12-25	WOS:000323425700121
J	Poldervaart, MT; Wang, H; van der Stok, J; Weinans, H; Leeuwenburgh, SCG; Oner, FC; Dhert, WJA; Alblas, J				Poldervaart, Michelle T.; Wang, Huanan; van der Stok, Johan; Weinans, Harrie; Leeuwenburgh, Sander C. G.; Oner, F. Cumhur; Dhert, Wouter J. A.; Alblas, Jacqueline			Sustained Release of BMP-2 in Bioprinted Alginate for Osteogenicity in Mice and Rats	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; GROWTH-FACTOR RELEASE; IN-VITRO; GELATIN; HYDROGELS; DIFFERENTIATION; MICROSPHERES; SCAFFOLDS; REGENERATION; BIOMATERIAL	The design of bioactive three-dimensional (3D) scaffolds is a major focus in bone tissue engineering. Incorporation of growth factors into bioprinted scaffolds offers many new possibilities regarding both biological and architectural properties of the scaffolds. This study investigates whether the sustained release of bone morphogenetic protein 2 (BMP-2) influences osteogenicity of tissue engineered bioprinted constructs. BMP-2 loaded on gelatin microparticles (GMPs) was used as a sustained release system, which was dispersed in hydrogel-based constructs and compared to direct inclusion of BMP-2 in alginate or control GMPs. The constructs were supplemented with goat multipotent stromal cells (gMSCs) and biphasic calcium phosphate to study osteogenic differentiation and bone formation respectively. BMP-2 release kinetics and bioactivity showed continuous release for three weeks coinciding with osteogenicity. Osteogenic differentiation and bone formation of bioprinted GMP containing constructs were investigated after subcutaneous implantation in mice or rats. BMP-2 significantly increased bone formation, which was not influenced by the release timing. We showed that 3D printing of controlled release particles is feasible and that the released BMP-2 directs osteogenic differentiation in vitro and in vivo.	[Poldervaart, Michelle T.; Weinans, Harrie; Oner, F. Cumhur; Dhert, Wouter J. A.; Alblas, Jacqueline] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands; [Wang, Huanan; Leeuwenburgh, Sander C. G.] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6525 ED Nijmegen, Netherlands; [van der Stok, Johan; Weinans, Harrie] Erasmus Univ, Med Ctr Rotterdam, Dept Orthopaed, Rotterdam, Netherlands; [Weinans, Harrie] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands; [Weinans, Harrie] Univ Med Ctr Utrecht, Dept Rheumatol, Utrecht, Netherlands; [Dhert, Wouter J. A.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology; Utrecht University; Utrecht University Medical Center; Utrecht University	Alblas, J (corresponding author), Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands.	j.alblas@umcutrecht.nl	Wang, Huanan/N-1971-2013; Leeuwenburgh, S.C.G./L-4483-2015; Oner, FC/L-7769-2013	Leeuwenburgh, S.C.G./0000-0003-1471-6133; Oner, FC/0000-0003-0858-8243; Alblas, Jacqueline/0000-0002-2996-9697; Dhert, Wouter/0000-0001-9150-6143; Weinans, Harrie/0000-0002-2275-6170	BioMedical Materials institute [P2.04]; Dutch Ministry of Economic Affairs; KNAW; China-Netherlands Programme Strategic Alliances (PSA) [2008DFB50120]; Smart Mix Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	BioMedical Materials institute; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); KNAW; China-Netherlands Programme Strategic Alliances (PSA); Smart Mix Program of the Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science	This research forms part of the Project P2.04 BONE-IP of the research program of the BioMedical Materials institute, co-funded by the Dutch Ministry of Economic Affairs. HW was funded by KNAW, China-Netherlands Programme Strategic Alliances (PSA) (No. 2008DFB50120) (http://www.knaw.nl/Pages/DEF/27/261.bGFuZz1FTkc.html). JA gratefully acknowledges the support of the Smart Mix Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angle SR, 2012, J MUSCULOSKEL NEURON, V12, P28; Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069; Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2; Boerckel JD, 2011, BIOMATERIALS; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; CROSS M, 1991, CELL, V64, P271, DOI 10.1016/0092-8674(91)90638-F; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Fedorovich NE, 2011, TISSUE ENG PT A, V17, P2113, DOI [10.1089/ten.TEA.2011.0019, 10.1089/ten.tea.2011.0019]; Fedorovich NE, 2011, TISSUE ENG A; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Garrison KR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006950.pub2; Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072; Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010; Geuze RE, 2012, TISSUE ENG PT A, V18, P2052, DOI [10.1089/ten.tea.2011.0560, 10.1089/ten.TEA.2011.0560]; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009; Habraken WJEM, 2009, J BIOMED MATER RES A, V91A, P614, DOI 10.1002/jbm.a.32263; Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031; Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223; Leeuwenburgh SCG, 2010, BIOMACROMOLECULES, V11, P2653, DOI 10.1021/bm1006344; Ogawa T, 2010, J BIOMAT SCI-POLYM E, V21, P609, DOI 10.1163/156856209X434638; Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002; Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/00007632-200208151-00010; RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I; Silber JS, 2003, SPINE, V28, P134, DOI 10.1097/00007632-200301150-00008; Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102; Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7; THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805; Varde NK, 2004, EXPERT OPIN BIOL TH, V4, P35, DOI 10.1517/eobt.4.1.35.25256; Wang L, 2003, BIOMATERIALS, V24, P3475, DOI 10.1016/S0142-9612(03)00167-4; Wegman F, 2011, EUR CELLS MATER, V21, P230, DOI 10.22203/eCM.v021a18; Wegman F, 2012, J TISSUE ENG REGEN M; Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5; Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023	39	175	202	9	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72610	10.1371/journal.pone.0072610	http://dx.doi.org/10.1371/journal.pone.0072610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	24349370	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700181
J	Chen, YH; Li, M; Li, B; Wang, WF; Lin, AJ; Sheng, MJ				Chen, Yihui; Li, Min; Li, Bing; Wang, Weifang; Lin, Anjuan; Sheng, Minjie			Effect of Reactive Oxygen Species Generation in Rabbit Corneal Epithelial Cells on Inflammatory and Apoptotic Signaling Pathways in the Presence of High Osmotic Pressure	PLOS ONE			English	Article							NF-KAPPA-B; FAS-LIGAND; DRY EYE; HYPEROSMOTIC ACTIVATION; CD95 LIGAND; EXPRESSION; STRESS; SYSTEM; JNK; REJECTION	It is generally accepted that high osmotic pressure (HOP) of lacrimal fluid is the core mechanism causing ocular inflammation and injury. However, the association between HOP and the regulation of cell inflammatory response and apoptotic pathways remains unclear. In the present study, we used HOP to interfere with in vitro cultured rabbit corneal epithelial cells, and found that HOP increased the generation of reactive oxygen species (ROS) in rabbit corneal epithelial cells, and increased ROS in turn induced the activation of JNK inflammatory signaling pathway, which further promoted the expression of pro-inflammatory factor NF-kappa beta and induced the generation of inflammatory factor IL-1 beta and TNF-alpha. In addition, HOP-induced ROS in rabbit corneal epithelial cells regulated the CD95/CD95L-mediated cell apoptotic signaling pathway by activating JNK inflammatory signaling pathway. These findings may serve as new theoretical basis and a new way of thinking about the treatment of ocular diseases, especially dry eye.	[Chen, Yihui; Li, Min; Li, Bing; Wang, Weifang; Lin, Anjuan; Sheng, Minjie] Tongji Univ, Dept Ophthalmol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China	Tongji University	Sheng, MJ (corresponding author), Tongji Univ, Dept Ophthalmol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.	cyh80h@163.com	Woo, Patrick Chiu Yat/C-4449-2009	Woo, Patrick Chiu Yat/0000-0001-9401-1832; hu, yong fei/0000-0002-2158-6018	Natural Science Foundation of Shanghai [11ZR1427900]; Youth Research Project of Shanghai Municipal Health Bureau [2010Y164]; Young Talent Training Plan of Tongji University [2010KJ018]; Young Talent Training Plan of Shanghai Tenth PeopleShanghai Tenth People?? Hospital [11RQ108]; Shanghai Health Hospital Development Center Foundation Project [SHDC12007104]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Youth Research Project of Shanghai Municipal Health Bureau; Young Talent Training Plan of Tongji University; Young Talent Training Plan of Shanghai Tenth PeopleShanghai Tenth People?? Hospital; Shanghai Health Hospital Development Center Foundation Project	This work was supported by grants from the Natural Science Foundation of Shanghai (No. 11ZR1427900); the Youth Research Project of Shanghai Municipal Health Bureau(No. 2010Y164); the Young Talent Training Plan of Tongji University(No. 2010KJ018); the Young Talent Training Plan of Shanghai Tenth PeopleShanghai Tenth People?? Hospital (No. 11RQ108); Shanghai Health Hospital Development Center Foundation Project (SHDC12007104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; Brignole F, 1998, EXP EYE RES, V67, P687, DOI 10.1006/exer.1998.0566; Bron AJ, 2009, OCUL SURF, V7, P78, DOI 10.1016/S1542-0124(12)70299-9; Chwa M, 2006, INVEST OPHTH VIS SCI, V47, P1902, DOI 10.1167/iovs.05-0828; Eisner V, 2006, FEBS LETT, V580, P4495, DOI 10.1016/j.febslet.2006.07.029; Green DR, 2001, NAT REV MOL CELL BIO, V2, P917, DOI 10.1038/35103104; Guo J, 2005, ACTA PHARMACOL SIN, V26, P780, DOI 10.1111/j.1745-7254.2005.00140.x; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Li HL, 2005, INT J MOL MED, V16, P41; Liu HX, 2009, INVEST OPHTH VIS SCI, V50, P3671, DOI 10.1167/iovs.08-2689; Luo Lihui, 2005, Eye Contact Lens, V31, P186, DOI 10.1097/01.ICL.0000162759.79740.46; Mohan RR, 1997, EXP EYE RES, V65, P575, DOI 10.1006/exer.1997.0371; Nakamura S, 2007, INVEST OPHTH VIS SCI, V48, P1552, DOI 10.1167/iovs.06-1027; Perry Henry D, 2008, Am J Manag Care, V14, pS79; Pinkenburg O, 2004, J VIROL METHODS, V120, P119, DOI 10.1016/j.jviromet.2004.04.007; Png E, 2011, J CELL PHYSIOL, V226, P693, DOI 10.1002/jcp.22389; Rakhorst HA, 2006, INT J ORAL MAX SURG, V35, P935, DOI 10.1016/j.ijom.2006.06.011; Reinehr R, 2006, ACTA PHYSIOL, V187, P199, DOI 10.1111/j.1748-1716.2006.01541.x; Reinehr R, 2007, METHOD ENZYMOL, V428, P145, DOI 10.1016/S0076-6879(07)28008-5; Sagrista ML, 2002, FREE RADICAL RES, V36, P329, DOI 10.1080/10715760290019354; Shimizu H, 2012, LIFE SCI, V90, P525, DOI 10.1016/j.lfs.2012.01.013; Stuart PM, 1997, J CLIN INVEST, V99, P396, DOI 10.1172/JCI119173; Tong JK, 2010, AM J RESP CELL MOL, V43, P342, DOI 10.1165/rcmb.2008-0454OC; Uchino Yuichi, 2012, Cornea, V31 Suppl 1, pS63, DOI 10.1097/ICO.0b013e31826a5de1; VAUX DL, 1995, NATURE, V377, P576, DOI 10.1038/377576a0; Wilson SE, 1996, INVEST OPHTH VIS SCI, V37, P1582; Xie CM, 2011, FREE RADICAL BIO MED, V51, P1365, DOI 10.1016/j.freeradbiomed.2011.06.016; Yamagami S, 1997, TRANSPLANTATION, V64, P1107, DOI 10.1097/00007890-199710270-00004; Zietz C, 2001, AM J PATHOL, V159, P963, DOI 10.1016/S0002-9440(10)61772-5	31	34	36	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72900	10.1371/journal.pone.0072900	http://dx.doi.org/10.1371/journal.pone.0072900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	24098729	Green Submitted, Green Published, gold			2022-12-25	WOS:000323378000116
J	Fan, JB; Park, H; Tan, S; Lee, M				Fan, Jiabing; Park, Hyejin; Tan, Steven; Lee, Min			Enhanced Osteogenesis of Adipose Derived Stem Cells with Noggin Suppression and Delivery of BMP-2	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; COMBINATORIAL GENE-THERAPY; IN-VITRO; STROMAL CELLS; DIFFERENTIATION; EXPRESSION; COMPLICATIONS; OSTEOBLAST; INDUCE; MATRIX	Bone morphogenetic proteins (BMPs) are believed to be the most potent osteoinductive factors. However, BMPs are highly pleiotropic molecules and their supra-physiological high dose requirement leads to adverse side effects and inefficient bone formation. Thus, there is a need to develop alternative osteoinductive growth factor strategies that can effectively complement BMP activity. In this study, we intrinsically stimulated BMP signaling in adipose derived stem cells (ASCs) by downregulating noggin, a potent BMP antagonist, using an RNAi strategy. ASCs transduced with noggin shRNA significantly enhanced osteogenic differentiation of cells. The potency of endogenous BMPs was subsequently enhanced by stimulating ASCs with exogenous BMPs at a significantly reduced dose. The level of mineralization in noggin shRNA treated ASCs when treated with BMP-2 was comparable to that of control shRNA treated cell treated with 10-fold more BMP-2. The complementary strategy of noggin suppression + BMP-2 to enhance osteogenesis was further confirmed in 3D in vitro environments using scaffolds consisting of chitosan (CH), chondroitin sulfate (CS), and apatite layer on their surfaces designed to slowly release BMP-2. This finding supports the novel therapeutic potential of this complementary strategy in bone regeneration.	[Fan, Jiabing; Park, Hyejin; Tan, Steven; Lee, Min] Univ Calif Los Angeles, Div Adv Prosthodont, Los Angeles, CA 90024 USA; [Lee, Min] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lee, M (corresponding author), Univ Calif Los Angeles, Div Adv Prosthodont, Los Angeles, CA 90024 USA.	leemin@ucla.edu	Fan, Jiabing/J-6581-2015; Fan, Jinjiang/C-2010-2009	Fan, Jinjiang/0000-0003-3102-4833; Papadopoulos, Vassilios/0000-0002-1183-8568	National Institutes of Health [R01 AR060213, R21 DE021819]; International Association for Dental Research; Academy of Osseointegration; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE021819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Association for Dental Research; Academy of Osseointegration; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health grants R01 AR060213 and R21 DE021819, the International Association for Dental Research, and the Academy of Osseointegration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Aghaloo T, 2007, MOL THER, V15, P1872, DOI 10.1038/sj.mt.6300270; Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956; Carlisle Elliot, 2005, Spine J, V5, p240S, DOI 10.1016/j.spinee.2005.02.014; Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261; Devlin RD, 2003, ENDOCRINOLOGY, V144, P1972, DOI 10.1210/en.2002-220918; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Fan JB, 2010, ACTA BIOMATER, V6, P1178, DOI 10.1016/j.actbio.2009.08.042; Gazzerro E, 2003, BONE, V32, P111, DOI 10.1016/S8756-3282(02)00948-1; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hannallah D, 2004, J BONE JOINT SURG AM, V86A, P80, DOI 10.2106/00004623-200401000-00013; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hu JL, 2012, J BIOMED MATER RES A, V100A, P1680, DOI 10.1002/jbm.a.34115; James AW, 2011, STEM CELLS DEV, V20, P427, DOI 10.1089/scd.2010.0082; James AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007120; Kilgore ML, 2009, J BONE MINER RES, V24, P2050, DOI [10.1359/jbmr.090523, 10.1359/JBMR.090523]; Koh JT, 2008, J DENT RES, V87, P845, DOI 10.1177/154405910808700906; Kuwahara K, 2011, TISSUE ENG PT A, V17, P2955, DOI 10.1089/ten.tea.2011.0290; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lee M, 2009, BIOMATERIALS, V30, P6094, DOI 10.1016/j.biomaterials.2009.07.046; Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177; Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062; Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004; McKay B, 2002, SPINE, V27, pS66, DOI 10.1097/00007632-200208151-00014; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Park H, 2013, CARBOHYD POLYM, DOI DOI 10.1016/J.CARBP0L.2013.05.023; Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Smucker JD, 2006, SPINE, V31, P2813, DOI 10.1097/01.brs.0000245863.52371.c2; Stafford DA, 2011, DEVELOPMENT, V138, P1005, DOI 10.1242/dev.051938; Sun Yubo, 2012, Open Rheumatol J, V6, P24, DOI 10.2174/1874312901206010024; Takayama K, 2009, J BONE MINER METAB, V27, P402, DOI 10.1007/s00774-009-0054-x; Wan DC, 2007, J BIOL CHEM, V282, P26450, DOI 10.1074/jbc.M703282200; Warren SM, 2003, NATURE, V422, P625, DOI 10.1038/nature01545; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.tea.2010.0555, 10.1089/ten.TEA.2010.0555]; Zhang D, 2013, BIOMATERIALS, V34, P3962, DOI 10.1016/j.biomaterials.2013.02.029; Zhao M, 2005, J CELL BIOCHEM, V95, P1, DOI 10.1002/jcb.20411; Zhu W, 2006, BONE, V39, P61, DOI 10.1016/j.bone.2005.12.018	41	60	62	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72474	10.1371/journal.pone.0072474	http://dx.doi.org/10.1371/journal.pone.0072474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	24124589	gold, Green Submitted, Green Published			2022-12-25	WOS:000323378000098
J	Morgan, MAJ; Muller, PSS; Mould, A; Newland, SA; Nichols, J; Robertson, EJ; Cooke, A; Bikoff, EK				Morgan, Marc A. J.; Muller, Pari S. S.; Mould, Arne; Newland, Stephen A.; Nichols, Jennifer; Robertson, Elizabeth J.; Cooke, Anne; Bikoff, Elizabeth K.			The Nonconventional MHC Class II Molecule DM Governs Diabetes Susceptibility in NOD Mice	PLOS ONE			English	Article							INVARIANT CHAIN; ANTIGEN PRESENTATION; PEPTIDE BINDING; CELL MATURATION; MUTANT MICE; H2-M; COMPLEXES; MOUSE; REQUIREMENTS; REPERTOIRE	The spontaneous destruction of insulin producing pancreatic beta cells in non-obese diabetic (NOD) mice provides a valuable model of type 1 diabetes. As in humans, disease susceptibility is controlled by the classical MHC class II genes that guide CD4(+) T cell responses to self and foreign antigens. It has long been suspected that the dedicated class II chaperone designated HLA-DM in humans or H-2M in mice also makes an important contribution, but due to tight linkage within the MHC, a possible role played by DM peptide editing has not been previously tested by conventional genetic approaches. Here we exploited newly established germ-line competent NOD ES cells to engineer a loss of function allele. DM deficient NOD mice display defective class II peptide occupancy and surface expression, and are completely protected against type 1 diabetes. Interestingly the mutation results in increased proportional representation of CD4(+)Foxp3(+) regulatory T cells and the absence of pathogenic CD4(+) T effectors. Overall, this striking phenotype establishes that DM-mediated peptide selection plays an essential role in the development of autoimmune diabetes in NOD mice.	[Morgan, Marc A. J.; Muller, Pari S. S.; Mould, Arne; Robertson, Elizabeth J.; Bikoff, Elizabeth K.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Newland, Stephen A.; Cooke, Anne] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Nichols, Jennifer] Univ Cambridge, MRC, Cambridge Stem Cell Inst, Wellcome Trust, Cambridge, England	University of Oxford; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute	Bikoff, EK (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	elizabeth.bikoff@path.ox.ac.uk	Cooke, Anne/S-4763-2019; Mallat, Ziad/D-4041-2012; Hardy, Christopher/A-8794-2008; Chariton, Anthony/F-2373-2011; Court, Leon/J-7138-2013	Cooke, Anne/0000-0003-3327-6081; Mallat, Ziad/0000-0003-0443-7878; Hardy, Christopher/0000-0002-7419-566X; Chariton, Anthony/0000-0002-5809-3372; , Bin/0000-0001-9190-968X; Nichols, Jennifer/0000-0002-8650-1388; Court, Leon/0000-0003-3673-9504; Mould, Arne/0000-0002-2004-4348	Wellcome Trust; MRC [G0801841] Funding Source: UKRI; Medical Research Council [G0801841] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Wellcome Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; Bikoff EK, 2001, J IMMUNOL, V166, P5087, DOI 10.4049/jimmunol.166.8.5087; Brode S, 2006, J IMMUNOL, V177, P6603, DOI 10.4049/jimmunol.177.10.6603; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; Denzin LK, 2005, IMMUNOL REV, V207, P279, DOI 10.1111/j.0105-2896.2005.00302.x; Derbinski J, 2010, CURR OPIN IMMUNOL, V22, P592, DOI 10.1016/j.coi.2010.08.003; Fallang LE, 2008, J IMMUNOL, V181, P5451, DOI 10.4049/jimmunol.181.8.5451; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Gunther S, 2010, P NATL ACAD SCI USA, V107, P22219, DOI 10.1073/pnas.1014708107; Guerder S, 2012, CURR OPIN IMMUNOL, V24, P99, DOI 10.1016/j.coi.2012.01.008; Hanna J, 2009, CELL STEM CELL, V5, P124, DOI 10.1016/j.stem.2009.06.007; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; Hausmann DHF, 1999, J EXP MED, V189, P1723, DOI 10.1084/jem.189.11.1723; HERMEL E, 1995, IMMUNOGENETICS, V42, P136, DOI 10.1007/BF00178588; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Hou TY, 2011, J IMMUNOL, V187, P2442, DOI 10.4049/jimmunol.1100255; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; Karlsson L, 2005, CURR OPIN IMMUNOL, V17, P65, DOI 10.1016/j.coi.2004.11.003; Kenty G, 1998, J IMMUNOL, V160, P606; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Koonce CH, 2004, J IMMUNOL, V173, P3271, DOI 10.4049/jimmunol.173.5.3271; Koonce CH, 2003, J IMMUNOL, V170, P3751, DOI 10.4049/jimmunol.170.7.3751; Kovats S, 1998, J EXP MED, V187, P245, DOI 10.1084/jem.187.2.245; Latek RR, 2000, IMMUNITY, V12, P699, DOI 10.1016/S1074-7613(00)80220-4; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Lieberman SM, 2003, TISSUE ANTIGENS, V62, P359, DOI 10.1034/j.1399-0039.2003.00152.x; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Mellanby RJ, 2008, AUTOIMMUNITY, V41, P383, DOI 10.1080/08916930801991021; Mellanby RJ, 2006, J IMMUNOL, V177, P7588, DOI 10.4049/jimmunol.177.11.7588; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Mohan JF, 2011, J EXP MED, V208, P2375, DOI 10.1084/jem.20111502; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Peleraux A, 1996, IMMUNOGENETICS, V43, P204, DOI 10.1007/BF00587301; Rich JD, 2003, J IMMUNOL, V171, P853, DOI 10.4049/jimmunol.171.2.853; Schulze MSED, 2012, CURR OPIN IMMUNOL, V24, P105, DOI 10.1016/j.coi.2011.11.004; Serreze DV, 2001, CURR DIRECT AUTOIMMU, V4, P31; Stadinski B, 2010, IMMUNITY, V32, P446, DOI 10.1016/j.immuni.2010.04.008; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Suri A, 2005, J CLIN INVEST, V115, P2268, DOI 10.1172/JCI25350; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; Tourne S, 1997, P NATL ACAD SCI USA, V94, P9255, DOI 10.1073/pnas.94.17.9255; Yi W, 2010, J CLIN INVEST, V120, P1324, DOI 10.1172/JCI40220	45	84	89	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56738	10.1371/journal.pone.0056738	http://dx.doi.org/10.1371/journal.pone.0056738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23991013	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300189
J	Huang, HZ; Ding, Y; Sun, XZS; Nguyen, TA				Huang, Hongzhou; Ding, Ying; Sun, Xiuzhi S.; Nguyen, Thu A.			Peptide Hydrogelation and Cell Encapsulation for 3D Culture of MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							IN-VITRO; SCAFFOLDS; DESIGN; BETA; DIFFERENTIATION; NANOFIBERS; MEDICINE; BIOLOGY; TISSUES; GROWTH	Three-dimensional (3D) cell culture plays an invaluable role in tumor biology by providing in vivo like microenviroment and responses to therapeutic agents. Among many established 3D scaffolds, hydrogels demonstrate a distinct property as matrics for 3D cell culture. Most of the existing pre-gel solutions are limited under physiological conditions such as undesirable pH or temperature. Here, we report a peptide hydrogel that shows superior physiological properties as an in vitro matrix for 3D cell culture. The 3D matrix can be accomplished by mixing a self-assembling peptide directly with a cell culture medium without any pH or temperature adjustment. Results of dynamic rheological studies showed that this hydrogel can be delivered multiple times via pipetting without permanently destroying the hydrogel architecture, indicating the deformability and remodeling ability of the hydrogel. Human epithelial cancer cells, MCF-7, are encapsulated homogeneously in the hydrogel matrix during hydrogelation. Compared with two-dimensional (2D) monolayer culture, cells residing in the hydrogel matrix grow as tumor-like clusters in 3D formation. Relevant parameters related to cell morphology, survival, proliferation, and apoptosis were analyzed using MCF-7 cells in 3D hydrogels. Interestingly, treatment of cisplatin, an anti-cancer drug, can cause a significant decrease of cell viability of MCF-7 clusters in hydrogels. The responses to cisplatin were dose- and time-dependent, indicating the potential usage of hydrogels for drug testing. Results of confocal microscopy and Western blotting showed that cells isolated from hydrogels are suitable for downstream proteomic analysis. The results provided evidence that this peptide hydrogel is a promising 3D cell culture material for drug testing.	[Huang, Hongzhou; Sun, Xiuzhi S.] Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA; [Ding, Ying] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Nguyen, Thu A.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Kansas State University	Sun, XZS (corresponding author), Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA.	xss@k-state.edu; tnguyen@vet.k-state.edu	Ding, Ying/M-8060-2017	Ding, Ying/0000-0001-8600-9740	KSU Targeted Excellence Program; KSU Research Foundation Scholarship Program; Kansas Agricultural Experiment Station [12-181-J]; NATIONAL CANCER INSTITUTE [R15CA152922] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; Directorate For Engineering [1321261] Funding Source: National Science Foundation	KSU Targeted Excellence Program; KSU Research Foundation Scholarship Program; Kansas Agricultural Experiment Station; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This project was partially funded by KSU Targeted Excellence Program and KSU Research Foundation Scholarship Program as well as the contribution (no. 12-181-J) from the Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azab AK, 2006, J CONTROL RELEASE, V111, P281, DOI 10.1016/j.jconrel.2005.12.014; Barralet JE, 2005, J MATER SCI-MATER M, V16, P515, DOI 10.1007/s10856-005-0526-z; Branco MC, 2010, BIOMATERIALS, V31, P9527, DOI 10.1016/j.biomaterials.2010.08.047; Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217; Cavalli S, 2010, CHEM SOC REV, V39, P241, DOI 10.1039/b906701a; Chawla K, 2011, BIOMACROMOLECULES, V12, P560, DOI 10.1021/bm100980w; Chignola R, 2000, CELL PROLIFERAT, V33, P219, DOI 10.1046/j.1365-2184.2000.00174.x; CHIRILA TV, 1993, BIOMATERIALS, V14, P26, DOI 10.1016/0142-9612(93)90072-A; Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171; Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI 10.1038/NNANO.2010.246; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027; Feder-Mengus C, 2008, TRENDS MOL MED, V14, P333, DOI 10.1016/j.molmed.2008.06.001; GORLACH A, 1994, INT J CANCER, V56, P249, DOI 10.1002/ijc.2910560218; Gurski LA, 2010, BIOMATERIALS, V31, P4248, DOI 10.1016/j.biomaterials.2010.01.141; Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h; Huang HZ, 2011, SOFT MATTER, V7, P8905, DOI 10.1039/c1sm05157a; Kelter G, 2005, ANTI-CANCER DRUG, V16, P1091, DOI 10.1097/00001813-200511000-00008; Kyle S, 2009, TRENDS BIOTECHNOL, V27, P423, DOI 10.1016/j.tibtech.2009.04.002; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100; Liu SQ, 2010, SOFT MATTER, V6, P67, DOI 10.1039/b916705f; Mather ML, 2010, REGEN MED, V5, P809, DOI 10.2217/RME.10.32; Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Perez-Castillejos R, 2010, MATER TODAY, V13, P32, DOI 10.1016/S1369-7021(10)70015-8; Rapaport H, 2008, ADV FUNCT MATER, V18, P2889, DOI 10.1002/adfm.200800117; Salick DA, 2009, ADV MATER, V21, P4120, DOI 10.1002/adma.200900189; SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005; Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g; Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107; Shea LD, 1999, NAT BIOTECHNOL, V17, P551, DOI 10.1038/9853; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k; ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508; Zhang S, 2008, ADV CANCER RES, V99, P335, DOI 10.1016/S0065-230X(07)99005-3	40	158	163	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59482	10.1371/journal.pone.0059482	http://dx.doi.org/10.1371/journal.pone.0059482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527204	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562600075
